PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Amtul, Z; Uhrig, M; Rozmahel, RF; Beyreuther, K				Amtul, Zareen; Uhrig, Markus; Rozmahel, Richard F.; Beyreuther, Konrad			Structural Insight into the Differential Effects of Omega-3 and Omega-6 Fatty Acids on the Production of A beta Peptides and Amyloid Plaques	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EICOSAPENTAENOIC ACID; ALZHEIMERS-DISEASE; ARACHIDONIC-ACID; CORTICAL-NEURONS; GENE-EXPRESSION; TRANSGENIC MICE; INFUSED RATS; CHOLESTEROL; METABOLISM; PROTEIN	Several studies have shown the protective effects of dietary enrichment of various lipids in several late-onset animal models of Alzheimer Disease (AD); however, none of the studies has determined which structure within a lipid determines its detrimental or beneficial effects on AD. High-sensitivity enzyme-linked immunosorbent assay (ELISA) shows that saturated fatty acids (SFAs), upstream omega-3 FAs, and arachidonic acid (AA) resulted in significantly higher secretion of both A beta 40 and 42 peptides compared with long chain downstream omega-3 and monounsaturated FAs (MUFA). Their distinct detrimental action is believed to be due to a structural template found in their fatty acyl chains that lack SFAs, upstream omega-3 FAs, and AA. Immunoblotting experiments and use of APP-C99-transfected COS-7 cells suggest that FA-driven altered production of A beta is mediated through gamma-secretase cleavage of APP. An early-onset AD transgenic mouse model expressing the double-mutant form of human amyloid precursor protein (APP); Swedish (K670N/M671L) and Indiana (V717F), corroborated in vitro findings by showing lower levels of A beta and amyloid plaques in the brain, when they were fed a low fat diet enriched in DHA. Our work contributes to the clarification of aspects of structure-activity relationships.	[Amtul, Zareen; Uhrig, Markus] Heidelberg Univ, ZMBH, Heidelberg, Germany; [Beyreuther, Konrad] Heidelberg Univ, NAR, Heidelberg, Germany; [Rozmahel, Richard F.] Univ Western Ontario, Dept Biochem, London, ON N6A 4L6, Canada	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Western University (University of Western Ontario)	Amtul, Z (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.	zamtul@uwo.ca	AMTUL, ZAREEN/Y-6364-2019		FP5 framework LipiDiet project [QLK-2002-172]; FP7 project LipiDiDiet [211696]; London and Middlesex Alzheimer Association; Canadian Institutes of Health Research [MOP49546]; Alexander von Humboldt; Ontario Mental Health Foundation	FP5 framework LipiDiet project; FP7 project LipiDiDiet; London and Middlesex Alzheimer Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alexander von Humboldt(Alexander von Humboldt Foundation); Ontario Mental Health Foundation	Grants from the FP5 framework LipiDiet project QLK-2002-172, the FP7 project LipiDiDiet 211696, London and Middlesex Alzheimer Association (Marion and Chester Fish Alzheimer Disease Research Grant), the Canadian Institutes of Health Research (MOP49546) (to R. F. R.), and the Alexander von Humboldt and Ontario Mental Health Foundation Awards (to Z. A.) funded this research.	AGREN JJ, 1995, LIPIDS, V30, P365, DOI 10.1007/BF02536047; Amtul Z., 2010, OLEIC IN PRESS  1005, DOI [10.1111/j.1750-3639.2010.00449, DOI 10.1111/J.1750-3639.2010.00449]; Amtul Z, 2010, NEUROSCI LETT, V481, P73, DOI 10.1016/j.neulet.2010.06.046; BIRCH EE, 1992, INVEST OPHTH VIS SCI, V33, P3242; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Carta G, 2002, PROSTAG LEUKOTR ESS, V67, P187, DOI 10.1054/plef.2002.0417; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chiu LCM, 2000, INT J ONCOL, V17, P789; Colin A, 2003, ENCEPHALE, V29, P49; DAVIS PJ, 1992, BIOCHEM CELL BIOL, V70, P1313, DOI 10.1139/o92-178; Eldho NV, 2003, J AM CHEM SOC, V125, P6409, DOI 10.1021/ja029029o; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Hartmann T, 1996, J BIOL CHEM, V271, P13208, DOI 10.1074/jbc.271.22.13208; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; Hashimoto M, 2005, J NUTR, V135, P549, DOI 10.1093/jn/135.3.549; HOMAN R, 1991, J LIPID RES, V32, P231; Horrobin DF, 2002, PROSTAG LEUKOTR ESS, V66, P83, DOI 10.1054/plef.2001.0338; Huber T, 2002, J AM CHEM SOC, V124, P298, DOI 10.1021/ja011383j; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Iizuka T, 1996, BIOCHEM BIOPH RES CO, V218, P238, DOI 10.1006/bbrc.1996.0042; Jensen M, 2000, MOL MED, V6, P291, DOI 10.1007/BF03401938; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; KULKARNI PS, 1987, J OCUL PHARMACOL, V3, P349, DOI 10.1089/jop.1987.3.349; KULKARNI PS, 1986, PROSTAGLANDINS, V31, P1159, DOI 10.1016/0090-6980(86)90217-0; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lichtenthaler SF, 2002, P NATL ACAD SCI USA, V99, P1365, DOI 10.1073/pnas.032395699; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Oda M, 2002, BIOCHEM J, V367, P329, DOI 10.1042/BJ20021089; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Patil S, 2005, NEUROSCI LETT, V384, P288, DOI 10.1016/j.neulet.2005.05.003; Patil S, 2006, NEUROSCI LETT, V406, P55, DOI 10.1016/j.neulet.2006.07.015; Pitman MC, 2004, BIOCHEMISTRY-US, V43, P15318, DOI 10.1021/bi048231w; Price PT, 2000, CURR OPIN LIPIDOL, V11, P3, DOI 10.1097/00041433-200002000-00002; SANDERS TAB, 1981, BRIT J NUTR, V45, P613, DOI 10.1079/BJN19810139; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; St George-Hyslop PH, 2000, SCI AM, V283, P76, DOI 10.1038/scientificamerican1200-76; STUBBS CD, 1990, BIOCHEM SOC T, V18, P779, DOI 10.1042/bst0180779; TAGAWA K, 1992, ANN NY ACAD SCI, V674, P129, DOI 10.1111/j.1749-6632.1992.tb27482.x; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; YAGALOFF KA, 1995, PROSTAG LEUKOTR ESS, V52, P293, DOI 10.1016/0952-3278(95)90029-2	49	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6100	6107		10.1074/jbc.M110.183608	http://dx.doi.org/10.1074/jbc.M110.183608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	20971855	hybrid, Green Published			2022-12-27	WOS:000287476400019
J	Bayburt, TH; Vishnivetskiy, SA; McLean, MA; Morizumi, T; Huang, CC; Tesmer, JJG; Ernst, OP; Sligar, SG; Gurevich, VV				Bayburt, Timothy H.; Vishnivetskiy, Sergey A.; McLean, Mark A.; Morizumi, Takefumi; Huang, Chih-chin; Tesmer, John J. G.; Ernst, Oliver P.; Sligar, Stephen G.; Gurevich, Vsevolod V.			Monomeric Rhodopsin Is Sufficient for Normal Rhodopsin Kinase (GRK1) Phosphorylation and Arrestin-1 Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PHOSPHOLIPID-BILAYER NANODISCS; VISUAL ARRESTIN; CRYSTAL-STRUCTURE; METARHODOPSIN-II; 48-KDA PROTEIN; MEMBRANE-PROTEINS; FUNCTIONAL UNIT; ACTIVATION; TRANSDUCIN	G-protein-coupled receptor (GPCR) oligomerization has been observed in a wide variety of experimental contexts, but the functional significance of this phenomenon at different stages of the life cycle of class A GPCRs remains to be elucidated. Rhodopsin (Rh), a prototypical class A GPCR of visual transduction, is also capable of forming dimers and higher order oligomers. The recent demonstration that Rh monomer is sufficient to activate its cognate G protein, transducin, prompted us to test whether the same monomeric state is sufficient for rhodopsin phosphorylation and arrestin-1 binding. Here we show that monomeric active rhodopsin is phosphorylated by rhodopsin kinase (GRK1) as efficiently as rhodopsin in the native disc membrane. Monomeric phosphorylated light-activated Rh (P-Rh*) in nanodiscs binds arrestin-1 essentially as well as P-Rh* in native disc membranes. We also measured the affinity of arrestin-1 for P-Rh* in nanodiscs using a fluorescence-based assay and found that arrestin-1 interacts with monomeric P-Rh* with low nanomolar affinity and 1:1 stoichiometry, as previously determined in native disc membranes. Thus, similar to transducin activation, rhodopsin phosphorylation by GRK1 and high affinity arrestin-1 binding only requires a rhodopsin monomer.	[Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Vishnivetskiy, Sergey A.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Morizumi, Takefumi; Ernst, Oliver P.] Charite, D-10117 Berlin, Germany; [Huang, Chih-chin; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, 116 Morrill Hall,505 S Goodwin, Urbana, IL 61801 USA.	s-sligar@uiuc.edu; vsevolod.gurevich@vanderbilt.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008; Morizumi, Takefumi/AAA-2063-2021	Gurevich, Vsevolod/0000-0002-3950-5351; Morizumi, Takefumi/0000-0002-2785-209X; McLean, Mark/0000-0001-9125-293X; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [EY011500, GM081756, GM077561, GM033775, HL071818]; Deutsche Forschungsgemeinschaft [Sfb740, ER 294/1-1]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM033775, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY011500, GM081756, and GM077561 (to V.V.G.), GM033775 (to S.G.S.), and HL071818 (to J.J.T.). This work was also supported by Deutsche Forschungsgemeinschaft Grants Sfb740 and ER 294/1-1 (to O.P.E.).	Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BUCZYLKO J, 1993, METH NEUROSCI, V15, P226; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Gross OP, 2010, J NEUROSCI, V30, P3450, DOI 10.1523/JNEUROSCI.5391-09.2010; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1992, J BIOL CHEM, V267, P21919; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; GUREVICH VV, 1995, J BIOL CHEM, V270, P6010, DOI 10.1074/jbc.270.11.6010; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2008, STRUCTURE, V16, P924, DOI 10.1016/j.str.2008.03.006; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Jastrzebska B, 2009, FASEB J, V23, P371, DOI 10.1096/fj.07-114835; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; KOTAKE S, 1991, ARCH BIOCHEM BIOPHYS, V285, P126, DOI 10.1016/0003-9861(91)90338-J; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; LODOLA A, 1978, BIOCHEM J, V169, P577, DOI 10.1042/bj1690577; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Pascal G, 2005, MOL PHARMACOL, V68, P905, DOI 10.1124/mol.105.013847; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762	80	149	150	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1420	1428		10.1074/jbc.M110.151043	http://dx.doi.org/10.1074/jbc.M110.151043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966068	hybrid, Green Published			2022-12-27	WOS:000286005000054
J	Novak, I; Wang, J; Henriksen, KL; Haanes, KA; Krabbe, S; Nitschke, R; Hede, SE				Novak, Ivana; Wang, Jing; Henriksen, Katrine L.; Haanes, Kristian A.; Krabbe, Simon; Nitschke, Roland; Hede, Susanne E.			Pancreatic Bicarbonate Secretion Involves Two Proton Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-K+-ATPASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; APICAL PLASMA-MEMBRANE; NON-GASTRIC H,K-ATPASE; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL EXPRESSION; FLUID SECRETION; ALPHA-SUBUNIT; CHOLECYSTOKININ-OCTAPEPTIDE; DIFFERENTIAL LOCALIZATION	Pancreas secretes fluid rich in digestive enzymes and bicarbonate. The alkaline secretion is important in buffering of acid chyme entering duodenum and for activation of enzymes. This secretion is formed in pancreatic ducts, and studies to date show that plasma membranes of duct epithelium express H+/HCO3- transporters, which depend on gradients created by the Na+/K+ -ATPase. However, the model cannot fully account for high-bicarbonate concentrations, and other active transporters, i.e. pumps, have not been explored. Here we show that pancreatic ducts express functional gastric and non-gastric H+ -K+ -ATPases. We measured intracellular pH and secretion in small ducts isolated from rat pancreas and showed their sensitivity to H+ -K+ pump inhibitors and ion substitutions. Gastric and non-gastric H+ -K+ pumps were demonstrated on RNA and protein levels, and pumps were localized to the plasma membranes of pancreatic ducts. Quantitative analysis of H+/HCO3- and fluid transport shows that the H+ -K+ pumps can contribute to pancreatic secretion in several species. Our results call for revision of the bicarbonate transport physiology in pancreas, and most likely other epithelia. Furthermore, because pancreatic ducts play a central role in several pancreatic diseases, it is of high relevance to understand the role of H+ -K+ pumps in pathophysiology.	[Novak, Ivana; Wang, Jing; Henriksen, Katrine L.; Haanes, Kristian A.; Krabbe, Simon; Hede, Susanne E.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen O, Denmark; [Nitschke, Roland] Univ Freiburg, Life Imaging Ctr Biol Anal, D-79104 Freiburg, Germany; [Nitschke, Roland] Univ Freiburg, Ctr Biol Signaling Studies, D-79104 Freiburg, Germany	University of Copenhagen; University of Freiburg; University of Freiburg	Novak, I (corresponding author), Univ Copenhagen, Dept Biol, August Krogh Bldg,Univ Parken 13, DK-2100 Copenhagen O, Denmark.	inovak@bio.ku.dk	Haanes, Kristian Agmund/I-5881-2013; Nitschke, Roland/F-9525-2010; Novak, Ivana/M-2791-2014	Haanes, Kristian Agmund/0000-0001-5182-8957; Nitschke, Roland/0000-0002-9397-8475; Novak, Ivana/0000-0002-8917-8010	Danish Natural Science Research Council [09-059772, 272-05-0420, 21-03-0558]; Lundbeck Foundation [R17-A1366, 68/04]; Lundbeck Foundation [R17-2007-1366] Funding Source: researchfish	Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was funded by grants from the Danish Natural Science Research Council (09-059772, 272-05-0420, 21-03-0558). The Lundbeck Foundation has granted Ph.D. stipends (to J. W. and K. A. H.) (R17-A1366) and postdoctoral fellowship (to S. E. H.) (68/04).	ALI AE, 1990, PANCREAS, V5, P314, DOI 10.1097/00006676-199005000-00011; BASTANI B, 1995, J AM SOC NEPHROL, V5, P1476; Bouwens L, 1998, DIABETOLOGIA, V41, P629, DOI 10.1007/s001250050960; BRORASMUSSEN F, 1956, ACTA PHYSIOL SCAND, V37, P97, DOI 10.1111/j.1748-1716.1956.tb01346.x; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; Caplan MJ, 2007, J CLIN GASTROENTEROL, V41, pS217, DOI 10.1097/MCG.0b013e31803233da; CASE RM, 1969, J PHYSIOL-LONDON, V201, P335, DOI 10.1113/jphysiol.1969.sp008759; CASE RM, 1968, J PHYSIOL-LONDON, V196, P133, DOI 10.1113/jphysiol.1968.sp008499; CHEY WY, 1979, J PHYSIOL-LONDON, V293, P435, DOI 10.1113/jphysiol.1979.sp012898; Codina J, 1998, J BIOL CHEM, V273, P7894, DOI 10.1074/jbc.273.14.7894; Crambert G, 2002, AM J PHYSIOL-CELL PH, V283, pC305, DOI 10.1152/ajpcell.00590.2001; DeOndarza J, 1997, AM J PHYSIOL-GASTR L, V272, pG124, DOI 10.1152/ajpgi.1997.272.1.G124; DOMSCHKE S, 1976, GASTROENTEROLOGY, V70, P533; Dunbar LA, 2000, J CELL BIOL, V148, P769, DOI 10.1083/jcb.148.4.769; Dunbar LA, 2001, J BIOL CHEM, V276, P29617, DOI 10.1074/jbc.R100023200; Fernandez-Salazar MP, 2004, J PHYSIOL-LONDON, V556, P415, DOI 10.1113/jphysiol.2004.061762; GITHENS S, 1980, J CELL BIOL, V85, P122, DOI 10.1083/jcb.85.1.122; GITHENS S, 1988, J PEDIATR GASTR NUTR, V7, P486, DOI 10.1097/00005176-198807000-00004; GRAY MA, 1988, J MEMBRANE BIOL, V105, P131, DOI 10.1007/BF02009166; Grishin AV, 1996, AM J PHYSIOL-RENAL, V271, pF539, DOI 10.1152/ajprenal.1996.271.3.F539; GROTMOL T, 1985, ACTA PHYSIOL SCAND, V124, P71, DOI 10.1111/j.1748-1716.1985.tb07633.x; Haanes KA, 2010, BIOCHEM J, V429, P303, DOI 10.1042/BJ20091337; Hede SE, 1999, J BIOL CHEM, V274, P31784, DOI 10.1074/jbc.274.45.31784; Herrmann M, 2007, SCAND J GASTROENTERO, V42, P1275, DOI 10.1080/00365520701405579; Hyde K, 1997, GASTROENTEROLOGY, V113, P914, DOI 10.1016/S0016-5085(97)70187-2; Ishiguro H, 1998, J PHYSIOL-LONDON, V511, P407, DOI 10.1111/j.1469-7793.1998.407bh.x; Jaisser F, 1999, AM J PHYSIOL-RENAL, V276, pF812, DOI 10.1152/ajprenal.1999.276.6.F812; KODAMA T, 1983, ACTA PATHOL JAPON, V33, P297; Kone BC, 1998, J BIOL CHEM, V273, P2543, DOI 10.1074/jbc.273.5.2543; Kraut JA, 2001, AM J PHYSIOL-RENAL, V281, pF763, DOI 10.1152/ajprenal.2001.281.4.F763; KUMPULAINEN T, 1981, GASTROENTEROLOGY, V80, P796; Lee JK, 2007, WORLD J GASTROENTERO, V13, P6296, DOI 10.3748/wjg.13.6296; LEE JS, 1995, J CLIN INVEST, V96, P2002, DOI 10.1172/JCI118247; Lee MG, 2000, J CLIN INVEST, V105, P1651, DOI 10.1172/JCI9207; Lerner M, 2006, CELL PHYSIOL BIOCHEM, V18, P75, DOI 10.1159/000095169; Li DM, 2009, APPL BIOCHEM BIOTECH, V158, P253, DOI 10.1007/s12010-008-8391-0; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; Novak I, 2008, PURINERG SIGNAL, V4, P237, DOI 10.1007/s11302-007-9087-6; NOVAK I, 1988, PFLUG ARCH EUR J PHY, V411, P58, DOI 10.1007/BF00581647; NOVAK I, 1991, PFLUG ARCH EUR J PHY, V419, P76, DOI 10.1007/BF00373750; NOVAK I, 1988, PFLUG ARCH EUR J PHY, V411, P546, DOI 10.1007/BF00582376; Novak I, 2001, PFLUG ARCH EUR J PHY, V441, P761, DOI 10.1007/s004240000472; PADFIELD PJ, 1989, PANCREAS, V4, P204, DOI 10.1097/00006676-198904000-00009; Pestov NB, 1998, FEBS LETT, V440, P320, DOI 10.1016/S0014-5793(98)01483-5; Pestov NB, 2002, AM J PHYSIOL-CELL PH, V282, pC907, DOI 10.1152/ajpcell.00258.2001; Pestov NB, 2006, AM J PHYSIOL-CELL PH, V291, pC366, DOI 10.1152/ajpcell.00042.2006; Rajendran VM, 1998, AM J PHYSIOL-GASTR L, V274, pG424, DOI 10.1152/ajpgi.1998.274.2.G424; Reinhardt J, 2000, AM J PHYSIOL-RENAL, V279, pF417, DOI 10.1152/ajprenal.2000.279.3.F417; Sachs G, 2007, J CLIN GASTROENTEROL, V41, pS226, DOI 10.1097/MCG.0b013e31803233b7; SEOW KTFP, 1991, PANCREAS, V6, P385, DOI 10.1097/00006676-199107000-00002; SEWELL WA, 1975, J PHYSIOL-LONDON, V252, P379, DOI 10.1113/jphysiol.1975.sp011149; Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x; Shibata T, 2006, AM J PHYSIOL-CELL PH, V291, pC1038, DOI 10.1152/ajpcell.00266.2006; Shumaker H, 1999, AM J PHYSIOL-CELL PH, V276, pC16, DOI 10.1152/ajpcell.1999.276.1.C16; Silver RB, 1999, AM J PHYSIOL-RENAL, V276, pF799, DOI 10.1152/ajprenal.1999.276.6.F799; Sorensen CE, 2003, J PHYSIOL-LONDON, V551, P881, DOI 10.1113/jphysiol.2003.049411; Steward MC, 2005, ANNU REV PHYSIOL, V67, P377, DOI 10.1146/annurev.physiol.67.031103.153247; Swarts HGP, 2005, J BIOL CHEM, V280, P33115, DOI 10.1074/jbc.M504535200; Szalmay G, 2001, J PHYSIOL-LONDON, V535, P795, DOI 10.1111/j.1469-7793.2001.00795.x; VILLANGER O, 1995, GASTROENTEROLOGY, V108, P850, DOI 10.1016/0016-5085(95)90460-3; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; Wood CM, 2010, J EXP BIOL, V213, P2681, DOI 10.1242/jeb.039164; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57	63	40	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					280	289		10.1074/jbc.M110.136382	http://dx.doi.org/10.1074/jbc.M110.136382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978133	Green Published, hybrid			2022-12-27	WOS:000285782800031
J	Porter, MY; Xie, KQ; Pozharski, E; Koelle, MR; Martemyanov, KA				Porter, Morwenna Y.; Xie, Keqiang; Pozharski, Edwin; Koelle, Michael R.; Martemyanov, Kirill A.			A Conserved Protein Interaction Interface on the Type 5 G Protein beta Subunit Controls Proteolytic Stability and Activity of R7 Family Regulator of G Protein Signaling Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RGS PROTEINS; CRYSTAL-STRUCTURE; GAMMA DIMER; MEMBRANE ANCHOR; DEP DOMAIN; EXPRESSION; COMPLEXES; PHOTORECEPTORS; LOCALIZATION; SELECTIVITY	Regulators of G protein signaling (RGS) proteins of the R7 subfamily limit signaling by neurotransmitters in the brain and by light in the retina. They form obligate complexes with the G beta 5 protein that are subject to proteolysis to control their abundance and alter signaling. The mechanisms that regulate this proteolysis, however, remain unclear. We used genetic screens to find mutations in G beta 5 that selectively destabilize one of the R7 RGS proteins in Caenorhabditis elegans. These mutations cluster at the binding interface between G beta 5 and the N terminus of R7 RGS proteins. Equivalent mutations within mammalian G beta 5 allowed the interface to still bind the N-terminal DEP domain of R7 RGS proteins, and mutant G beta 5-R7 RGS complexes initially formed in cells but were then rapidly degraded by proteolysis. Molecular dynamics simulations suggest the mutations weaken the G beta 5-DEP interface, thus promoting dynamic opening of the complex to expose determinants of proteolysis known to exist on the DEP domain. We propose that conformational rearrangements at the G beta 5-DEP interface are key to controlling the stability of R7 RGS protein complexes.	[Porter, Morwenna Y.; Koelle, Michael R.] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Xie, Keqiang; Martemyanov, Kirill A.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Pozharski, Edwin] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Yale University; University of Minnesota System; University of Minnesota Twin Cities; University System of Maryland; University of Maryland Baltimore	Koelle, MR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.	michael.koelle@yale.edu; martemyanov@umn.edu	Xie, Keqiang/D-4437-2015; Pozharski, Edwin/AAM-7692-2020; Xie, Keqiang/J-9668-2012	Pozharski, Edwin/0000-0001-7012-5376; 	National Institutes of Health [EY018139, DA021743, DA026405, NS036918, MH082201]; McKnight Land Grant Professorship; NATIONAL EYE INSTITUTE [R01EY018139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH082201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021743, K02DA026405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Land Grant Professorship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants EY018139 (to K. A. M.), DA021743 (to K. A. M.), DA026405 (to K. A. M.), NS036918 (to M. R. K.), and MH082201 (to M. R. K.). This work was also supported by the McKnight Land Grant Professorship (to K. A. M.).	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Anderson GR, 2009, MOL CELL BIOL, V29, P3033, DOI 10.1128/MCB.01449-08; Bany I. A., 2004, GENETIC CELLULAR ANA; Bastiani Carol, 2006, WormBook, P1; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Benzing T, 2002, J BIOL CHEM, V277, P32954, DOI 10.1074/jbc.M200859200; BRENNER S, 1974, GENETICS, V77, P71; Burchett SA, 1998, J NEUROCHEM, V70, P2216; Cao Y, 2009, J NEUROSCI, V29, P9301, DOI 10.1523/JNEUROSCI.1367-09.2009; Chase DL, 2004, METHOD ENZYMOL, V389, P305; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; Chou KC, 2000, ANAL BIOCHEM, V286, P1, DOI 10.1006/abio.2000.4757; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Howlett AC, 2009, J BIOL CHEM, V284, P16386, DOI 10.1074/jbc.M900800200; Hu G, 2003, J BIOL CHEM, V278, P14550, DOI 10.1074/jbc.M212046200; Jedema HP, 2008, EUR J NEUROSCI, V27, P2433, DOI 10.1111/j.1460-9568.2008.06208.x; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Jose AM, 2007, GENETICS, V175, P93, DOI 10.1534/genetics.106.065516; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Porter MY, 2009, PROG MOL BIOL TRANSL, V86, P15, DOI 10.1016/S1877-1173(09)86002-X; Porter MY, 2010, MOL BIOL CELL, V21, P232, DOI 10.1091/mbc.E09-07-0642; Posokhova E, 2010, J PROTEOME RES, V9, P1510, DOI 10.1021/pr901022m; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Robatzek M, 2000, GENETICS, V156, P1069; Robatzek M, 2001, CURR BIOL, V11, P288, DOI 10.1016/S0960-9822(01)00074-4; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Singh RK, 2007, J PHARMACOL EXP THER, V322, P133, DOI 10.1124/jpet.107.120386; Skiba NP, 2001, J BIOL CHEM, V276, P37365, DOI 10.1074/jbc.M106431200; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Tekumalla PK, 2001, BIOL PSYCHIAT, V50, P813, DOI 10.1016/S0006-3223(01)01234-3; Traynor JR, 2009, TRENDS PHARMACOL SCI, V30, P105, DOI 10.1016/j.tips.2008.11.006; van der Linden AM, 2001, GENETICS, V158, P221; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilkie TM, 2000, CURR BIOL, V10, pR853, DOI 10.1016/S0960-9822(00)00823-X; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100	57	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41100	41112		10.1074/jbc.M110.163600	http://dx.doi.org/10.1074/jbc.M110.163600			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959458	hybrid, Green Published			2022-12-27	WOS:000285414400072
J	Titushin, MS; Feng, YG; Stepanyuk, GA; Li, Y; Markova, SV; Golz, S; Wang, BC; Lee, J; Wang, JF; Vysotski, ES; Liu, ZJ				Titushin, Maxim S.; Feng, Yingang; Stepanyuk, Galina A.; Li, Yang; Markova, Svetlana V.; Golz, Stefan; Wang, Bi-Cheng; Lee, John; Wang, Jinfeng; Vysotski, Eugene S.; Liu, Zhi-Jie			NMR-derived Topology of a GFP-photoprotein Energy Transfer Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN-FLUORESCENT PROTEIN; STRUCTURAL DETERMINANTS; CRYSTAL-STRUCTURE; IN-VITRO; BIOLUMINESCENCE; PROGRAM; ELECTROSTATICS; SOFTWARE; DOCKING; HADDOCK	Forster resonance energy transfer within a protein-protein complex has previously been invoked to explain emission spectral modulation observed in several bioluminescence systems. Here we present a spatial structure of a complex of the Ca2+ regulated photoprotein clytin with its green-fluorescent protein (cgGFP) from the jellyfish Clytia gregaria, and show that it accounts for the bioluminescence properties of this system in vitro. We adopted an indirect approach of combining x-ray crystallography determined structures of the separate proteins, NMR spectroscopy, computational docking, and mutagenesis. Heteronuclear NMR spectroscopy using variously N-15, C-13, H-2-enriched proteins enabled assignment of backbone resonances of more than 94% of the residues of both proteins. In a mixture of the two proteins at millimolar concentrations, complexation was inferred from perturbations of certain H-1-N-15 HSQC-resonances, which could be mapped to those residues involved at the interaction site. A docking computation using HADDOCK was employed constrained by the sites of interaction, to deduce an overall spatial structure of the complex. Contacts within the clytin-cgGFP complex and electrostatic complementarity of interaction surfaces argued for a weak protein-protein complex. A weak affinity was also observed by isothermal titration calorimetry (K-D = 0.9 mM). Mutation of clytin residues located at the interaction site reduced the degree of protein-protein association concomitant with a loss of effectiveness of cgGFP in color-shifting the bioluminescence. It is suggested that this clytin-cgGFP structure corresponds to the transient complex previously postulated to account for the energy transfer effect of GFP in the bioluminescence of aequorin or Renilla luciferase.	[Wang, Jinfeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Titushin, Maxim S.; Stepanyuk, Galina A.; Markova, Svetlana V.; Vysotski, Eugene S.] Russian Acad Sci, Inst Biophys, Siberian Branch, Lab Photobiol, Krasnoyarsk 660036, Russia; [Golz, Stefan] Bayer Schering Pharma AG, BSP GDD GTR TD GT, D-42096 Wuppertal, Germany; [Stepanyuk, Galina A.; Wang, Bi-Cheng; Lee, John] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Bayer AG; Bayer Healthcare Pharmaceuticals; University System of Georgia; University of Georgia	Liu, ZJ (corresponding author), Datun Rd 15, Beijing 100101, Peoples R China.	zjliu@ibp.ac.cn	Markova, Svetlana V./AAT-7574-2020; Vysotski, Eugene/I-1761-2013; Liu, Zhi-Jie/A-3946-2012; Li, Yang/G-3685-2011; Li, Yang/M-1246-2013; Feng, Yingang/B-6304-2008	Markova, Svetlana V./0000-0001-5702-1193; Vysotski, Eugene/0000-0002-5884-3081; Liu, Zhi-Jie/0000-0001-7279-2893; Feng, Yingang/0000-0002-0879-1316	National Natural Science Foundation of China; Ministry of Science and Technology of China; Russian Foundation for Basic Research [08-09-92209]; University of Georgia Research Foundation; Georgia Research Alliance; RAS; Bayer AG (Germany); CAS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); University of Georgia Research Foundation; Georgia Research Alliance; RAS(Russian Academy of SciencesRegione Sardegna); Bayer AG (Germany)(Bayer AG); CAS(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China, Ministry of Science and Technology of China, CAS Research Grant, CAS Fellowship for Young International Scientists Grant, Russian Foundation for Basic Research (08-09-92209 RFBR-China joint grant), SB RAS Grant 2, "Molecular and Cell Biology" program of RAS, Bayer AG (Germany), and by the University of Georgia Research Foundation and the Georgia Research Alliance.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON JM, 1973, J BIOL CHEM, V248, P2937; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Banci L, 2006, P NATL ACAD SCI USA, V103, P8320, DOI 10.1073/pnas.0600142103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cutler M. W., 1995, THESIS RUTGERS U NEW; Cutler MW, 1997, BIOLUMINESCENCE AND CHEMILUMINESCENCE, P403; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Koglin A, 2006, SCIENCE, V312, P273, DOI 10.1126/science.1122928; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; Liu ZJ, 2003, BIOCHEM BIOPH RES CO, V311, P433, DOI 10.1016/j.bbrc.2003.09.231; Liu ZJ, 2000, PROTEIN SCI, V9, P2085, DOI 10.1110/ps.9.11.2085; LO CL, 1999, J MOL BIOL, V285, P2177; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Markova SV, 2010, PHOTOCH PHOTOBIO SCI, V9, P757, DOI 10.1039/c0pp00023j; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORIN JG, 1971, J CELL PHYSIOL, V77, P313, DOI 10.1002/jcp.1040770305; MORISE H, 1974, BIOCHEMISTRY-US, V13, P2656, DOI 10.1021/bi00709a028; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; NICOLAS MT, 1987, J CELL BIOL, V105, P723, DOI 10.1083/jcb.105.2.723; Ohashi W, 2005, J BIOMOL NMR, V31, P375, DOI 10.1007/s10858-005-1609-3; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vysotski ES, 2004, ACCOUNTS CHEM RES, V37, P405, DOI 10.1021/ar0400037; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; WAMPLER JE, 1973, BIOCHIM BIOPHYS ACTA, V314, P104, DOI 10.1016/0005-2728(73)90068-6; WAMPLER JE, 1971, BIOCHEMISTRY-US, V10, P2903; Ward W.W., 1978, Methods in Enzymology, V57, P257; WARD WW, 1978, PHOTOCHEM PHOTOBIOL, V27, P389, DOI 10.1111/j.1751-1097.1978.tb07621.x; WARD WW, 1979, J BIOL CHEM, V254, P781; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; WARD WW, 1976, J PHYS CHEM-US, V80, P2289, DOI 10.1021/j100561a030; Xu YQ, 2006, NAT METHODS, V3, P931, DOI 10.1038/NMETH938; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152; Zhang NX, 2006, J MOL BIOL, V363, P188, DOI 10.1016/j.jmb.2006.08.026	54	43	43	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40891	40900		10.1074/jbc.M110.133843	http://dx.doi.org/10.1074/jbc.M110.133843			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20926380	hybrid, Green Published			2022-12-27	WOS:000285414400053
J	Ishikawa, S; Taira, T; Takahashi-Niki, K; Niki, T; Ariga, H; Iguchi-Ariga, SMM				Ishikawa, Shizuma; Taira, Takahiro; Takahashi-Niki, Kazuko; Niki, Takeshi; Ariga, Hiroyoshi; Iguchi-Ariga, Sanae M. M.			Human DJ-1-specific Transcriptional Activation of Tyrosine Hydroxylase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1 MUTANTS; PARKIN-DEFICIENT MICE; OXIDATIVE STRESS; ANDROGEN RECEPTOR; PROTEIN; MUTATIONS; INACTIVATION; DEGENERATION; INHIBITION; EXPRESSION	Loss-of-function mutation in the DJ-1 gene causes a subset of familial Parkinson disease. The mechanism underlying DJ-1-related selective vulnerability in the dopaminergic pathway is, however, not known. DJ-1 has multiple functions, including transcriptional regulation, and one of transcriptional target genes for DJ-1 is the tyrosine hydroxylase (TH) gene, the product of which is a key enzyme for dopamine biosynthesis. It has been reported that DJ-1 is a neuroprotective transcriptional co-activator that sequesters a transcriptional co-repressor polypyrimidine tract-binding protein-associated splicing factor (PSF) from the TH gene promoter. In this study, we found that knockdown of human DJ-1 by small interference RNA in human dopaminergic cell lines attenuated TH gene expression and 4-dihydroxy-L-phenylalanine production but that knockdown or knock-out of mouse DJ-1 in mouse cell lines or in mice did not affect such expression and TH activity. In reporter assays using the human TH gene promoter linked to the luciferase gene, stimulation of TH promoter activity was observed in human cells, but not mouse cells, that had been transfected with DJ-1. Although human DJ-1 and mouse DJ-1 were associated either with human or with mouse PSF, TH promoter activity inhibited by PSF was restored by human DJ-1 but not by mouse DJ-1. Chromatin immunoprecipitation assays revealed that the complex of PSF with DJ-1 bound to the human but not the mouse TH gene promoter. These results suggest a novel species-specific transcriptional regulation of the TH promoter by DJ-1 and one of the mechanisms for no reduction of TH in DJ-1-knock-out mice.	[Takahashi-Niki, Kazuko; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Ishikawa, Shizuma; Niki, Takeshi; Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Ishikawa, Shizuma] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Taira, Takahiro] Yamanashi Univ, Interdisciplinary Grad Sch Med & Engn, Chuoh 4093898, Japan	Hokkaido University; Hokkaido University; Hokkaido University; University of Yamanashi	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp; myan@res.agr.hokudai.ac.jp	Ariga, Hiroyoshi/B-5895-2013; Ariga, Sanae/H-9647-2013	Ariga, Hiroyoshi/0000-0001-7384-2143; 	Ministry of Education, Science, Culture, and Sports; National Institute of Biomedical Innovation in Japan; Grants-in-Aid for Scientific Research [22790809, 21390014] Funding Source: KAKEN	Ministry of Education, Science, Culture, and Sports(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation in Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Science, Culture, and Sports and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation in Japan.	Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Aron L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000349; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; Inden M, 2006, NEUROBIOL DIS, V24, P144, DOI 10.1016/j.nbd.2006.06.004; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Perez FA, 2005, P NATL ACAD SCI USA, V102, P2174, DOI 10.1073/pnas.0409598102; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Sawada H, 2004, J BIOL CHEM, V279, P10710, DOI 10.1074/jbc.M308434200; Shinbo YM, 2005, INT J ONCOL, V26, P641; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	42	63	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39718	39731		10.1074/jbc.M110.137034	http://dx.doi.org/10.1074/jbc.M110.137034			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20938049	Green Published, hybrid			2022-12-27	WOS:000285185500016
J	Ma, L; Xu, MX; Oberhauser, AF				Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.			Naturally Occurring Osmolytes Modulate the Nanomechanical Properties of Polycystic Kidney Disease Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; RAT RENAL INNER; ORGANIC OSMOLYTES; ALPHA-CHYMOTRYPSIN; MOLECULAR-MECHANISM; PROTEIN-STRUCTURE; WATER-STRESS; UREA; DENATURATION; DYNAMICS	Polycystin-1 (PC1) is a large membrane protein that is expressed along the renal tubule and exposed to a wide range of concentrations of urea. Urea is known as a common denaturing osmolyte that affects protein function by destabilizing their structure. However, it is known that the native conformation of proteins can be stabilized by protecting osmolytes that are found in the mammalian kidney. PC1 has an unusually long ectodomain with a multimodular structure including 16 Ig-like polycystic kidney disease (PKD) domains. Here, we used single-molecule force spectroscopy to study directly the effects of several naturally occurring osmolytes on the mechanical properties of PKD domains. This experimental approach more closely mimics the conditions found in vivo. We show that upon increasing the concentration of urea there is a remarkable decrease in the mechanical stability of human PKD domains. We found that protecting osmolytes such as sorbitol and trimethylamine N-oxide can counteract the denaturing effect of urea. Moreover, we found that the refolding rate of a structurally homologous archaeal PKD domain is significantly slowed down in urea, and this effect was counteracted by sorbitol. Our results demonstrate that naturally occurring osmolytes can have profound effects on the mechanical unfolding and refolding pathways of PKD domains. Based on these findings, we hypothesize that osmolytes such as urea or sorbitol may modulate PC1 mechanical properties and may lead to changes in the activation of the associated polycystin-2 channel or other intracellular events mediated by PC1.	[Ma, Liang; Xu, Meixiang; Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Oberhauser, Andres F.] Univ Texas Galveston, Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Oberhauser, AF (corresponding author), Univ Texas Galveston, Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	afoberha@utmb.edu			National Institutes of Health [R01DK073394]; John Sealy Memorial Endowment Fund for Biomedical Research; Polycystic Kidney Foundation [116a2r]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Sealy Memorial Endowment Fund for Biomedical Research; Polycystic Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK073394. This work was also supported by the John Sealy Memorial Endowment Fund for Biomedical Research and by the Polycystic Kidney Foundation Grant 116a2r.	Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; BAGNASCO S, 1986, J BIOL CHEM, V261, P5872; Baskakov I, 1998, J BIOL CHEM, V273, P4831, DOI 10.1074/jbc.273.9.4831; Baskakov I, 1998, BIOPHYS J, V74, P2666, DOI 10.1016/S0006-3495(98)77972-X; Beck DAC, 2007, METHOD ENZYMOL, V428, P373, DOI 10.1016/S0076-6879(07)28022-X; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Bolen D W, 2001, Methods Mol Biol, V168, P17; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burns JN, 2010, ACS CHEM BIOL, V5, P477, DOI 10.1021/cb900282e; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Cao Y, 2008, J MOL BIOL, V375, P316, DOI 10.1016/j.jmb.2007.10.024; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; Fischer H, 2001, AM J PHYSIOL-LUNG C, V281, pL52, DOI 10.1152/ajplung.2001.281.1.L52; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2005, J MOL BIOL, V349, P861, DOI 10.1016/j.jmb.2005.04.008; Forman JR, 2009, STRUCTURE, V17, P1582, DOI 10.1016/j.str.2009.09.013; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10540, DOI 10.1073/pnas.0902090106; GARCIAPEREZ A, 1991, PHYSIOL REV, V71, P1081, DOI 10.1152/physrev.1991.71.4.1081; Goyton A. C., 1997, HUMAN PHYSL MECH DIS; GREENE RF, 1974, J BIOL CHEM, V249, P5388; GUDER WG, 1990, KLIN WOCHENSCHR, V68, P1091, DOI 10.1007/BF01798058; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Holthauzen LMF, 2010, BIOCHEMISTRY-US, V49, P1310, DOI 10.1021/bi9015499; Howard Marybeth, 2002, Methods Mol Med, V70, P267; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2008, CELL MOL LIFE SCI, V65, P605, DOI 10.1007/s00018-007-7362-x; Idrissi A, 2005, SPECTROCHIM ACTA A, V61, P1, DOI 10.1016/j.saa.2004.02.039; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Kumar R, 1999, J BIOL CHEM, V274, P24737, DOI 10.1074/jbc.274.35.24737; LIN TY, 1994, BIOCHEMISTRY-US, V33, P12695, DOI 10.1021/bi00208a021; Loo Tip W., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000361; Ma L, 2009, J BIOL CHEM, V284, P32942, DOI 10.1074/jbc.M109.021832; MACMILLEN RE, 1967, SCIENCE, V158, P383, DOI 10.1126/science.158.3799.383; MARKO JF, 1995, PHYS REV E, V52, P2912, DOI 10.1103/PhysRevE.52.2912; Mountain RD, 2003, J AM CHEM SOC, V125, P1950, DOI 10.1021/ja020496f; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Qian F, 2005, J BIOL CHEM, V280, P40723, DOI 10.1074/jbc.M509650200; Ratnaparkhi GS, 2001, J BIOL CHEM, V276, P28789, DOI 10.1074/jbc.M101906200; Sakaki N, 2005, BIOPHYS J, V88, P2047, DOI 10.1529/biophysj.104.054668; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1; SCHMIDTNIELSEN B, 1979, YALE J BIOL MED, V52, P545; SCHMOLKE M, 1989, RENAL PHYSIOL BIOCH, V12, P347; Schmolke M, 1996, EUR J CLIN CHEM CLIN, V34, P499; Schmolke M, 1996, AM J PHYSIOL-RENAL, V271, pF645, DOI 10.1152/ajprenal.1996.271.3.F645; SIZELAND PCB, 1993, KIDNEY INT, V43, P448, DOI 10.1038/ki.1993.66; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Street TO, 2010, PROTEIN SCI, V19, P57, DOI 10.1002/pro.282; Streets AJ, 2003, J AM SOC NEPHROL, V14, P1804, DOI 10.1097/01.ASN.0000076075.49819.9B; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Venkatesu P, 2009, J PHYS CHEM B, V113, P5327, DOI 10.1021/jp8113013; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; WIRTHENSOHN G, 1989, AM J PHYSIOL, V256, pF128, DOI 10.1152/ajprenal.1989.256.1.F128; Wu JW, 1999, PROTEIN SCI, V8, P2090, DOI 10.1110/ps.8.10.2090; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yancey PH, 2001, AM ZOOL, V41, P699, DOI 10.1668/0003-1569(2001)041[0699:WSOAP]2.0.CO;2; YANCEY PH, 1979, BIOCHEM J, V183, P317, DOI 10.1042/bj1830317; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	72	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38438	38443		10.1074/jbc.M110.183913	http://dx.doi.org/10.1074/jbc.M110.183913			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937836	hybrid, Green Published			2022-12-27	WOS:000284625600049
J	Sich, NM; O'Donnell, TJ; Coulter, SA; John, OA; Carter, MS; Cremo, CR; Baker, JE				Sich, Nicholas M.; O'Donnell, Timothy J.; Coulter, Sarah A.; John, Olivia A.; Carter, Michael S.; Cremo, Christine R.; Baker, Josh E.			Effects of Actin-Myosin Kinetics on the Calcium Sensitivity of Regulated Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN; SKELETAL-MUSCLE; COOPERATIVE BINDING; ACTIVATION; SUBFRAGMENT-1; FORCE; HEART; BLEBBISTATIN; CROSSBRIDGE; LENGTH	Activation of thin filaments in striated muscle occurs when tropomyosin exposes myosin binding sites on actin either through calcium-troponin (Ca-Tn) binding or by actin-myosin (A-M) strong binding. However, the extent to which these binding events contributes to thin filament activation remains unclear. Here we propose a simple analytical model in which strong A-M binding and Ca-Tn binding independently activates the rate of A-M weak-to-strong binding. The model predicts how the level of activation varies with pCa as well as A-M attachment, N center dot k(att), and detachment, k(det), kinetics. To test the model, we use an in vitro motility assay to measure the myosin-based sliding velocities of thin filaments at different pCa, N center dot k(att), and kdet values. We observe that the combined effects of varying pCa, N center dot k(att), and kdet are accurately fit by the analytical model. The model and supporting data imply that changes in attachment and detachment kinetics predictably affect the calcium sensitivity of striated muscle mechanics, providing a novel A-M kinetic-based interpretation for perturbations (e.g. disease-related mutations) that alter calcium sensitivity.	[Sich, Nicholas M.; O'Donnell, Timothy J.; Coulter, Sarah A.; John, Olivia A.; Carter, Michael S.; Cremo, Christine R.; Baker, Josh E.] Univ Nevada, Sch Med, Dept Biochem, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Baker, JE (corresponding author), Univ Nevada, Sch Med, Dept Biochem, Rm 163,Mail Stop 330,1664 N Virginia St, Reno, NV 89557 USA.	jebaker@unr.edu			National Institutes of Health [5P20RR018751-06, 1R21AR055749-01, 1R01HL090938-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants 5P20RR018751-06, 1R21AR055749-01, 1R01HL090938-01 from the National Institutes of Health.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Baker JE, 2002, BIOPHYS J, V82, p374A; Baker JE, 1999, BIOPHYS J, V77, P2657, DOI 10.1016/S0006-3495(99)77100-6; BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; BREMEL RD, 1972, NATURE-NEW BIOL, V238, P97, DOI 10.1038/newbio238097a0; Butters CA, 1997, J BIOL CHEM, V272, P13196, DOI 10.1074/jbc.272.20.13196; Campbell KB, 2004, AM J PHYSIOL-HEART C, V286, pH1535, DOI 10.1152/ajpheart.01029.2003; Craig R, 2001, J MOL BIOL, V311, P1027, DOI 10.1006/jmbi.2001.4897; Debold EP, 2010, J MOL CELL CARDIOL, V48, P286, DOI 10.1016/j.yjmcc.2009.09.014; EBASHI S, 1984, J MOL CELL CARDIOL, V16, P129, DOI 10.1016/S0022-2828(84)80701-4; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Farmna G. P., 2007, PFLUG ARCH EUR J PHY, V455, P995; Fitzsimons DP, 2007, ADV EXP MED BIOL, V592, P177; Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Gordon AM, 2001, NEWS PHYSIOL SCI, V16, P49; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; Greenberg MJ, 2010, AM J PHYSIOL-REG I, V298, pR989, DOI 10.1152/ajpregu.00566.2009; Greenberg MJ, 2010, J MOL CELL CARDIOL, V48, P277, DOI 10.1016/j.yjmcc.2009.10.015; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 1997, BIOPHYS J, V72, pTU250; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; HASELGROVE JC, 1973, COLD SPRING HARB SYM, V37, P341, DOI 10.1101/SQB.1973.037.01.044; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; HUXLEY HE, 1973, COLD SPRING HARB SYM, V37, P361, DOI 10.1101/SQB.1973.037.01.046; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lehman W, 2001, J MOL BIOL, V307, P739, DOI 10.1006/jmbi.2001.4514; Lehman W., 2008, TROPOMYOSIN; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; Li XC, 2010, J MOL BIOL, V395, P327, DOI 10.1016/j.jmb.2009.10.060; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Margossian S. S., 1982, METHODS ENZYMOLOGY; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Pardee J. D., 1982, METHODS ENZYMOLOGY; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; Potters J. D., 1982, METHODS ENZYMOLOGY; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Razumova MV, 2000, BIOPHYS J, V78, P3120, DOI 10.1016/S0006-3495(00)76849-4; REID RE, 1980, J THEOR BIOL, V84, P401, DOI 10.1016/S0022-5193(80)80013-0; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; Shimamoto Y, 2007, BIOPHYS J, V93, P4330, DOI 10.1529/biophysj.107.110650; Smillie L. B., 1982, METHODS ENZYMOLOGY; Sun YB, 2010, J MOL CELL CARDIOL, V48, P859, DOI 10.1016/j.yjmcc.2009.11.019; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; SWEITZER NK, 1990, J GEN PHYSIOL, V96, P1221, DOI 10.1085/jgp.96.6.1221; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800	58	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39150	39159		10.1074/jbc.M110.142232	http://dx.doi.org/10.1074/jbc.M110.142232			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889979	Green Published, hybrid			2022-12-27	WOS:000284941300045
J	Ainle, FN; O'Donnell, JS; Johnson, JA; Brown, L; Gleeson, EM; Smith, OP; Preston, RJS				Ainle, Fionnuala Ni; O'Donnell, James S.; Johnson, Jennifer A.; Brown, Laura; Gleeson, Eimear M.; Smith, Owen P.; Preston, Roger J. S.			Activated Protein C N-Linked Glycans Modulate Cytoprotective Signaling Function on Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FACTOR-VIII; ANTICOAGULANT ACTIVITY; GLA DOMAIN; RECEPTOR-1; GLYCOSYLATION; THROMBIN; COFACTOR; CLEAVAGE; SEPSIS; IDENTIFICATION	Activated protein C (APC) has potent anticoagulant and anti-inflammatory properties that limit clot formation, inhibit apoptosis, and protect vascular endothelial cell barrier integrity. In this study, the role of N-linked glycans in modulating APC endothelial cytoprotective signaling via endothelial cell protein C receptor/protease-activated receptor 1 (PAR1) was investigated. Enzymatic digestion of APC N-linked glycans (PNG-APC) decreased the APC concentration required to achieve half-maximal inhibition of thrombin-induced endothelial cell barrier permeability by 6-fold. Furthermore, PNG-APC exhibited increased protection against staurosporine-induced endothelial cell apoptosis when compared with untreated APC. To investigate the specific N-linked glycans responsible, recombinant APC variants were generated in which each N-linked glycan attachment site was eliminated. Of these, APC-N329Q was up to 5-fold more efficient in protecting endothelial barrier function when compared with wild type APC. Based on these findings, an APC variant (APC-L38D/N329Q) was generated with minimal anticoagulant activity, but 5-fold enhanced endothelial barrier protective function and 30-fold improved anti-apoptotic function when compared with wild type APC. These data highlight the previously unidentified role of APC N-linked glycosylation in modulating endothelial cell protein C receptor-dependent cytoprotective signaling via PAR1. Furthermore, our data suggest that plasma beta-protein C, characterized by aberrant N-linked glycosylation at Asn-329, may be particularly important for maintenance of APC cytoprotective functions in vivo.	[Preston, Roger J. S.] Trinity Coll Dublin, Inst Mol Med, Haemostasis Res Grp, Dublin 2, Ireland; [O'Donnell, James S.] St James Hosp, Natl Ctr Hereditary Coagulat Disorders, Dublin 8, Ireland; [Smith, Owen P.] Our Ladys Hosp Sick Children, Dept Haematol, Dublin 12, Ireland	Trinity College Dublin; Trinity College Dublin; Our Ladys Children Hospital Crumlin	O'Donnell, JS (corresponding author), Trinity Coll Dublin, St Jamess Hosp, Inst Mol Med, Haemostasis Res Grp, Dublin 8, Ireland.	jodonne@tcd.ie	O'Donnell, James/A-6171-2009; Smith, Owen/AAU-8929-2020	O'Donnell, James/0000-0003-0309-3313; Ni Ainle, Fionnuala/0000-0003-0163-792X; Preston, Roger/0000-0003-0108-4077	Molecular Medicine Ireland; Science Foundation Ireland (SFI)	Molecular Medicine Ireland; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was supported by a Molecular Medicine Ireland Clinician Scientist Fellowship (to F. N. A.), a Science Foundation Ireland (SFI) Starting Investigator Research Grant (to R. J. S. P. and E. M. G.), and SFI PIYRA (J. S. O'D.).	Bae JS, 2007, BLOOD, V110, p520A; Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Cheng T, 2003, NAT MED, V9, P338, DOI 10.1038/nm826; Cohen J, 2001, CRIT CARE MED, V29, P880, DOI 10.1097/00003246-200104000-00039; Compton SJ, 2002, BIOCHEM J, V368, P495, DOI 10.1042/BJ20020706; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; FAY PJ, 1991, J BIOL CHEM, V266, P20139; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FOSTER D, 1984, P NATL ACAD SCI-BIOL, V81, P4766, DOI 10.1073/pnas.81.15.4766; Gil GC, 2009, PROTEOMICS, V9, P2555, DOI 10.1002/pmic.200800775; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Harmon S, 2008, J BIOL CHEM, V283, P30531, DOI 10.1074/jbc.M802338200; Iba T, 2005, CRIT CARE MED, V33, P368, DOI 10.1097/01.CCM.0000153415.04995.88; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MILETICH JP, 1990, J BIOL CHEM, V265, P11397; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 2003, BIOCHEM J, V373, P65, DOI 10.1042/BJ20030341; Niessen F, 2009, BLOOD, V113, P2859, DOI 10.1182/blood-2008-12-192385; OWEN WG, 1981, J BIOL CHEM, V256, P5532; Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Preston RJS, 2009, J BIOL CHEM, V284, P5869, DOI 10.1074/jbc.M804703200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Simioni P, 1996, BLOOD, V88, P2101, DOI 10.1182/blood.V88.6.2101.bloodjournal8862101; Soto AG, 2010, J BIOL CHEM, V285, P18781, DOI 10.1074/jbc.M110.111088; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; YAN SCB, 1990, BIO-TECHNOL, V8, P655, DOI 10.1038/nbt0790-655; Yang LK, 2007, J BIOL CHEM, V282, P25493, DOI 10.1074/jbc.M702131200; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106	36	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1323	1330		10.1074/jbc.M110.159475	http://dx.doi.org/10.1074/jbc.M110.159475			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21044954	Green Published, hybrid			2022-12-27	WOS:000286005000044
J	Koshiba, T; Holman, HA; Kubara, K; Yasukawa, K; Kawabata, S; Okamoto, K; Macfarlane, J; Shaw, JM				Koshiba, Takumi; Holman, Holly A.; Kubara, Kenji; Yasukawa, Kai; Kawabata, Shun-ichiro; Okamoto, Koji; Macfarlane, Jane; Shaw, Janet M.			Structure-Function Analysis of the Yeast Mitochondrial Rho GTPase, Gem1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINESIN HEAVY-CHAIN; AXONAL-TRANSPORT; MIRO GTPASE; ACTIVATING PROTEINS; ESCHERICHIA-COLI; BUDDING YEAST; BINDING; MORPHOLOGY; SYNAPSES; IDENTIFICATION	Mitochondria undergo continuous cycles of homotypic fusion and fission, which play an important role in controlling organelle morphology, copy number, and mitochondrial DNA maintenance. Because mitochondria cannot be generated de novo, the motility and distribution of these organelles are essential for their inheritance by daughter cells during division. Mitochondrial Rho (Miro) GTPases are outer mitochondrial membrane proteins with two GTPase domains and two EF-hand motifs, which act as receptors to regulate mitochondrial motility and inheritance. Here we report that although all of these domains are biochemically active, only the GTPase domains are required for the mitochondrial inheritance function of Gem1p (the yeast Miro ortholog). Mutations in either of the Gem1p GTPase domains completely abrogated mitochondrial inheritance, although the mutant proteins retained half the GTPase activity of the wild-type protein. Although mitochondrial inheritance was not dependent upon Ca2+ binding by the two EF-hands of Gem1p, a functional N-terminal EF-hand I motif was critical for stable expression of Gem1p in vivo. Our results suggest that basic features of Miro protein function are conserved from yeast to humans, despite differences in the cellular machinery mediating mitochondrial distribution in these organisms.	[Koshiba, Takumi; Kubara, Kenji; Yasukawa, Kai; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, Fukuoka 8128581, Japan; [Holman, Holly A.; Macfarlane, Jane; Shaw, Janet M.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyushu University; Utah System of Higher Education; University of Utah; Osaka University	Koshiba, T (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	koshiba@kyudai.jp	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043	National Institutes of Health [5T32HL007576, R01GM84970]; Kyushu University; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Takeda Science Foundation; NCRR, National Institutes of Health [Grant M01-RR00064]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kyushu University; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5T32HL007576 (to H. A. H.) and R01GM84970 (to J. M. S.). This work was also supported by the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (P & P type D; 20301), Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders, Uehara Memorial Foundation, and Takeda Science Foundation (to T. K.). Support for sequencing and oligonucleotide services at the University of Utah was provided by NCRR, National Institutes of Health, Grant M01-RR00064 (to L. Betz).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; [Anonymous], 1991, Methods Enzymol, V194, P1; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fransson A, 2006, BIOCHEM BIOPH RES CO, V344, P500, DOI 10.1016/j.bbrc.2006.03.163; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Itoh T, 2002, MOL CELL BIOL, V22, P7744, DOI 10.1128/MCB.22.22.7744-7757.2002; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; Jeyaraju DV, 2009, BBA-BIOENERGETICS, V1787, P1363, DOI 10.1016/j.bbabio.2008.12.005; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lehoux IE, 2003, PROTEIN EXPRES PURIF, V30, P203, DOI 10.1016/S1046-5928(03)00107-4; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; Maniatis T., 1982, MOL CLONING; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reis K, 2009, FEBS LETT, V583, P1391, DOI 10.1016/j.febslet.2009.04.015; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sherman F., 1986, METHODS YEAST GENETI; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wang XD, 2001, GENE DEV, V15, P2922; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	44	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					354	362		10.1074/jbc.M110.180034	http://dx.doi.org/10.1074/jbc.M110.180034			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036903	Green Published, hybrid			2022-12-27	WOS:000285782800038
J	Zadjali, F; Pike, ACW; Vesterlund, M; Sun, JM; Wu, CG; Li, SSC; Ronnstrand, L; Knapp, S; Bullock, AN; Flores-Morales, A				Zadjali, Fahad; Pike, Ashley C. W.; Vesterlund, Mattias; Sun, Jianmin; Wu, Chenggang; Li, Shawn S. C.; Ronnstrand, Lars; Knapp, Stefan; Bullock, Alex N.; Flores-Morales, Amilcar			Structural Basis for c-KIT Inhibition by the Suppressor of Cytokine Signaling 6 (SOCS6) Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; COMPLEX REVEALS; KINASE-ACTIVITY; ACTIVATION; BOX; PROTEIN; PHOSPHORYLATION; AUTOINHIBITION; TRANSFORMATION; SPECIFICITY	The c-KIT receptor tyrosine kinase mediates the cellular response to stem cell factor (SCF). Whereas c-KIT activity is important for the proliferation of hematopoietic cells, melanocytes and germ cells, uncontrolled c-KIT activity contributes to the growth of diverse human tumors. Suppressor of cytokine signaling 6 (SOCS6) is a member of the SOCS family of E3 ubiquitin ligases that can interact with c-KIT and suppress c-KIT-dependent pathways. Here, we analyzed the molecular mechanisms that determine SOCS6 substrate recognition. Our results show that the SH2 domain of SOCS6 is essential for its interaction with c-KIT pY568. The 1.45-angstrom crystal structure of SOCS6 SH2 domain bound to the c-KIT substrate peptide (c-KIT residues 564-574) revealed a highly complementary and specific interface giving rise to a high affinity interaction (K-d = 0.3 mu M). Interestingly, the SH2 binding pocket extends to substrate residue position pY + 6 and envelopes the c-KIT phosphopeptide with a large BG loop insertion that contributes significantly to substrate interaction. We demonstrate that SOCS6 has ubiquitin ligase activity toward c-KIT and regulates c-KIT protein turnover in cells. Our data support a role of SOCS6 as a feedback inhibitor of SCF-dependent signaling and provides molecular data to account for target specificity within the SOCS family of ubiquitin ligases.	[Pike, Ashley C. W.; Knapp, Stefan; Bullock, Alex N.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Zadjali, Fahad; Vesterlund, Mattias] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Zadjali, Fahad] Sultan Qaboos Univ, Coll Med & Hlth Sci, Alkoudh 123, Oman; [Sun, Jianmin; Ronnstrand, Lars] Lund Univ, Skane Univ Hosp, Dept Lab Med, Wallenberg Lab, S-20502 Malmo, Sweden; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Wu, Chenggang; Li, Shawn S. C.] Univ Western Ontario, Siebens Drake Med Res Inst, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [Flores-Morales, Amilcar] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark	University of Oxford; Karolinska Institutet; Lund University; Skane University Hospital; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Oxford; Novo Nordisk Foundation; University of Copenhagen	Bullock, AN (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk; amilcar.flores@cpr.ku.dk	Knapp, Stefan/AAG-2347-2019; ZADJALI, FAHAD/B-5091-2019; Vesterlund, Mattias/AAX-8014-2021; Sun, Jianmin/AAX-5094-2021	Knapp, Stefan/0000-0001-5995-6494; ZADJALI, FAHAD/0000-0001-5891-4700; Sun, Jianmin/0000-0003-2327-4285; Ronnstrand, Lars/0000-0003-1275-5809; Vesterlund, Mattias/0000-0001-9471-6592	Novo Nordisk Foundation Center for Protein Research; Swedish Research Council; Cancer-fonden; Sultan Qaboos University; Swedish Cancer Society; Swedish Childrens Cancer Society; Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Canadian Cancer Society; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Novo Nordisk Foundation Center for Protein Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer-fonden(Swedish Cancer Society); Sultan Qaboos University; Swedish Cancer Society(Swedish Cancer Society); Swedish Childrens Cancer Society; Gunnar Nilsson Cancer Society; Alfred Osterlund Foundation; Skane University Hospital; Skane University Hospital Cancer Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was funded by a grant from the Novo Nordisk Foundation Center for Protein Research, the Swedish Research Council, and Cancer-fonden (to A. F. M.).; Supported by a fellowship from Sultan Qaboos University.; Supported through grants from the Swedish Cancer Society, the Swedish Research Council and the Swedish Childrens Cancer Society, Gunnar Nilsson Cancer Society, Alfred Osterlund Foundation, Skane University Hospital Funds, and Skane University Hospital Cancer Foundation.; Supported through grants from the Canadian Cancer Society.; We thank Pavel Savitsky for cloning, Chitra Bhatia for initial peptide screening, and Frank von Delft, Ewa Pilka, and the staff at the Swiss Light Source for help with diffraction data collection. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; Bergamin E, 2006, STRUCTURE, V14, P1285, DOI 10.1016/j.str.2006.06.011; Bullock AN, 2007, STRUCTURE, V15, P1493, DOI 10.1016/j.str.2007.09.016; Bullock AN, 2006, P NATL ACAD SCI USA, V103, P7637, DOI 10.1073/pnas.0601638103; Choi YB, 2010, J BIOL CHEM, V285, P7271, DOI 10.1074/jbc.M109.073726; Dibb NJ, 2004, NAT REV CANCER, V4, P718, DOI 10.1038/nrc1434; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frantsve J, 2001, MOL CELL BIOL, V21, P3547, DOI 10.1128/MCB.21.10.3547-3557.2001; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Hwang MN, 2007, BIOCHEM BIOPH RES CO, V360, P333, DOI 10.1016/j.bbrc.2007.06.062; Isozaki K, 2006, CURR GENOMICS, V7, P469, DOI 10.2174/138920206779315755; Kamizono S, 2001, J BIOL CHEM, V276, P12530, DOI 10.1074/jbc.M010074200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lai R. H., CANC LETT, V288, P75; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Munugalavadla V, 2007, BLOOD, V110, P1612, DOI 10.1182/blood-2006-10-053058; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholson SE, 1999, EMBO J, V18, P375, DOI 10.1093/emboj/18.2.375; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Rottapel R, 2002, ONCOGENE, V21, P4351, DOI 10.1038/sj.onc.1205537; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang JG, 2001, P NATL ACAD SCI USA, V98, P13261, DOI 10.1073/pnas.231486498	41	46	49	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					480	490		10.1074/jbc.M110.173526	http://dx.doi.org/10.1074/jbc.M110.173526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030588	hybrid, Green Published			2022-12-27	WOS:000285782800051
J	Moreno-Cermeno, A; Obis, E; Belli, G; Cabiscol, E; Ros, J; Tamarit, J				Moreno-Cermeno, Armando; Obis, Elia; Belli, Gemma; Cabiscol, Elisa; Ros, Joaquim; Tamarit, Jordi			Frataxin Depletion in Yeast Triggers Up-regulation of Iron Transport Systems before Affecting Iron-Sulfur Enzyme Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; FRIEDREICH ATAXIA; GENE-EXPRESSION; CLUSTER FORMATION; OXIDATIVE STRESS; DEFICIENT STRAIN; SUPEROXIDE-DISMUTASE; DROSOPHILA MODEL; PROMOTER SYSTEM; HOMOLOG	The primary function of frataxin, a mitochondrial protein involved in iron homeostasis, remains controversial. Using a yeast model of conditional expression of the frataxin homologue YFH1, we analyzed the primary effects of YFH1 depletion. The main conclusion unambiguously points to the up-regulation of iron transport systems as a primary effect of YFH1 down-regulation. We observed that inactivation of aconitase, an iron-sulfur enzyme, occurs long after the iron uptake system has been activated. Decreased aconitase activity should be considered part of a group of secondary events promoted by iron overloading, which includes decreased superoxide dismutase activity and increased protein carbonyl formation. Impaired manganese uptake, which contributes to superoxide dismutase deficiency, has also been observed in YFH1-deficient cells. This low manganese content can be attributed to the down-regulation of the metal ion transporter Smf2. Low Smf2 levels were not observed in AFT1/YFH1 double mutants, indicating that high iron levels could be responsible for the Smf2 decline. In summary, the results presented here indicate that decreased iron-sulfur enzyme activities in YFH1-deficient cells are the consequence of the oxidative stress conditions suffered by these cells.	[Moreno-Cermeno, Armando; Obis, Elia; Belli, Gemma; Cabiscol, Elisa; Ros, Joaquim; Tamarit, Jordi] Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Inst Recerca Biomed Lleida, Lleida 25008, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida	Ros, J (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Fac Med, Inst Recerca Biomed Lleida, Montserrat Roig 2, Lleida 25008, Spain.	joaquim.ros@cmb.udl.es	ROS, Joaquim/ABG-7487-2020; Cabiscol, Elisa/A-4584-2009; Obis, Elia/J-4705-2016; belli, gemma/A-7424-2011; Ros, Joaquim/A-7507-2010; Tamarit, Jordi/C-6316-2008; Bellí, Gemma/AAD-5325-2019; Obis, Elia/ACM-1208-2022	ROS, Joaquim/0000-0003-0901-8648; Cabiscol, Elisa/0000-0003-2795-7999; Obis, Elia/0000-0002-6838-1634; belli, gemma/0000-0002-4161-3204; Tamarit, Jordi/0000-0003-3227-6928; Bellí, Gemma/0000-0002-4161-3204; Obis, Elia/0000-0002-6838-1634	Ministerio de Ciencia e Innovacion [BFU2007-66249/BMC, CSD2007-00020]; Generalitat de Catalunya (Spain) [SGR0677]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya (Spain)(Generalitat de Catalunya)	This study was supported by Grants BFU2007-66249/BMC and CSD2007-00020 from the Ministerio de Ciencia e Innovacion and SGR0677 from the Generalitat de Catalunya (Spain).	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Diaz-Ruiz R, 2008, J BIOL CHEM, V283, P26948, DOI 10.1074/jbc.M800408200; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Irazusta V., 2009, FREE RADIC BIOL MED; Irazusta V, 2008, FREE RADICAL BIO MED, V44, P1712, DOI 10.1016/j.freeradbiomed.2008.01.014; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kaplan J, 1999, P NATL ACAD SCI USA, V96, P10948, DOI 10.1073/pnas.96.20.10948; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Li LT, 2001, J BIOL CHEM, V276, P5036, DOI 10.1074/jbc.M008969200; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lu CY, 2007, ARCH BIOCHEM BIOPHYS, V457, P111, DOI 10.1016/j.abb.2006.09.010; Luk EEC, 2001, J BIOL CHEM, V276, P47556, DOI 10.1074/jbc.M108923200; Manchenko G. P., 1994, HDB DETECTION ENZYME, P98; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Pfaffl MW., 2006, REAL TIME PCR, P63; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Reverter-Branchat G, 2007, MICROBIOL-SGM, V153, P3667, DOI 10.1099/mic.0.2007/009340-0; Robinson JB., 1987, MITOCHONDRIA PRACTIC, P153, DOI DOI 10.1016/J.BBRC.2005.02.135; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schagerlof U., 2008, S BIOCH DOWNLOADED, V47, P4948; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; SWANSON WH, 1948, J BACTERIOL, V56, P115, DOI 10.1128/JB.56.1.115-124.1948; Tamarit J, 2006, ANAL BIOCHEM, V351, P149, DOI 10.1016/j.ab.2005.12.001; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Wishart JA, 2005, YEAST, V22, P565, DOI 10.1002/yea.1225	56	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41653	41664		10.1074/jbc.M110.149443	http://dx.doi.org/10.1074/jbc.M110.149443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956517	Green Published, hybrid			2022-12-27	WOS:000285622600053
J	Meitzler, JL; Brandman, R; de Montellano, PRO				Meitzler, Jennifer L.; Brandman, Relly; de Montellano, Paul R. Ortiz			Perturbed Heme Binding Is Responsible for the Blistering Phenotype Associated with Mutations in the Caenorhabditis elegans Dual Oxidase 1 (DUOX1) Peroxidase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY NADPH OXIDASES; HORSERADISH-PEROXIDASE; MAMMALIAN PEROXIDASES; HUMAN MYELOPEROXIDASE; CATALYZED OXIDATION; POTENTIAL FUNCTIONS; HYDROGEN-PEROXIDE; DROSOPHILA GUT; LACTOPEROXIDASE; MODEL	Dual oxidase (DUOX) enzymes support a wide variety of essential reactions, from cellular signaling to thyroid hormone biosynthesis. In Caenorhabditis elegans, the DUOX system (CeDUOX1/2) plays a crucial role in innate immunity and in stabilizing the cuticle by forming tyrosine cross-links. The current model suggests that superoxide generated by CeDUOX1 at the C-terminal NADPH oxidase domain is rapidly converted to H2O2. The H2O2 is then utilized by the N-terminal peroxidase- like domain to cross-link tyrosines. We have now created a series of mutations in the isolated peroxidase domain, CeDUOX1(1-589). One set of mutations investigate the roles of a putative distal tyrosine (Tyr(105)) and Glu(238), a proposed covalent heme-binding residue. The results confirm that Glu(238) covalently binds to the heme group. A second set of mutations (G246D and D392N) responsible for a C. elegans blistering cuticle phenotype was also investigated. Surprisingly, although not among the catalytic residues, both mutations affected heme co-factor binding. The G246D mutant bound less total heme than the wild type, but a higher fraction of it was covalently bound. In contrast, the D392N mutant appears to fold normally but does not bind heme. Molecular dynamics simulations of a CeDUOX1(1-589) homology model implicate displacements of the proximal histidine residue as the likely cause. Both enzymes are structurally stable and through altered heme interactions exhibit partial or complete loss of tyrosine crosslinking activity, explaining the blistering phenotype. This result argues that the CeDUOX peroxidase domain is primarily responsible for tyrosine cross-linking.	[Meitzler, Jennifer L.; Brandman, Relly; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94518 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu		Meitzler, Jennifer/0000-0001-9798-2124				Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P10747, DOI 10.1021/bi010478v; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAYSE GS, 1972, BIOCHIM BIOPHYS ACTA, V284, P34; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boscolo B, 2007, BBA-PROTEINS PROTEOM, V1774, P1164, DOI 10.1016/j.bbapap.2007.07.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Colas C, 2002, J BIOL CHEM, V277, P7191, DOI 10.1074/jbc.M109523200; Cover TM, 1991, ELEMENTS INFORM THEO, P12, DOI [10.1002/0471200611.ch2, DOI 10.1002/0471200611.CH2]; DARDEN T, 1993, J CHEM PHYS, V98, P10092; DE D, 2000, F J Biol Chem, V275, P23227; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Eswar N., 2006, COMP PROTEIN STRUCTU; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Gogonea V, 2006, J PHYS CHEM B, V110, P22861, DOI 10.1021/jp061653q; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hildebrandt A G, 1978, Methods Enzymol, V52, P342; Huang LS, 2006, J BIOL CHEM, V281, P18983, DOI 10.1074/jbc.M602307200; JACQUET A, 1994, BIOCHEM BIOPH RES CO, V202, P73, DOI 10.1006/bbrc.1994.1895; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; MODI S, 1991, BIOCHIM BIOPHYS ACTA, V1080, P45, DOI 10.1016/0167-4838(91)90110-L; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Pacquelet S, 2008, J BIOL CHEM, V283, P24649, DOI 10.1074/jbc.M709108200; SALMASO BLN, 1994, BIOPHYS J, V67, P436, DOI 10.1016/S0006-3495(94)80499-0; Shin K, 2000, BIOCHEM BIOPH RES CO, V271, P831, DOI 10.1006/bbrc.2000.2713; STUGARD CE, 1989, INFECT IMMUN, V57, P3534, DOI 10.1128/IAI.57.11.3534-3539.1989; Suriano G, 2001, BIOORG MED CHEM LETT, V11, P2827, DOI 10.1016/S0960-894X(01)00533-9; Tanaka T, 2003, BIOSCI BIOTECH BIOCH, V67, P2254, DOI 10.1271/bbb.67.2254; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014	50	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40991	41000		10.1074/jbc.M110.170902	http://dx.doi.org/10.1074/jbc.M110.170902			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947510	hybrid, Green Published			2022-12-27	WOS:000285414400062
J	Wang, GY				Wang, Guangyu			State-dependent Regulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gating by a High Affinity Fe3+ Bridge between the Regulatory Domain and Cytoplasmic Loop 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							R-DOMAIN; NUCLEOTIDE-BINDING; ABC TRANSPORTER; ATP BINDING; PHOSPHORYLATION SITES; CHLORIDE CHANNEL; PROTEIN; ACTIVATION; MUTATIONS; MECHANISM	The unique regulatory (R) domain differentiates the human CFTR channel from other ATP-binding cassette transporters and exerts multiple effects on channel function. However, the underlying mechanisms are unclear. Here, an intracellular high affinity (2.3 x 10(-19) M) Fe3+ bridge is reported as a novel approach to regulating channel gating. It inhibited CFTR activity by primarily reducing an open probability and an opening rate, and inhibition was reversed by EDTA and phenanthroline. His-950, His-954, Cys-832, His-775, and Asp-836 were found essential for inhibition and phosphorylated Ser-768 may enhance Fe3+ binding. More importantly, inhibition by Fe3+ was state-dependent. Sensitivity to Fe3+ was reduced when the channel was locked in an open state by AMP-PNP. Similarly, a K978C mutation from cytoplasmic loop 3 (CL3), which promotes ATP-independent channel opening, greatly weakened inhibition by Fe3+ no matter whether NBD2 was present or not. Therefore, although ATP binding-induced dimerization of NBD1-NBD2 is required for channel gating, regulation of CFTR activity by Fe3+ may involve an interaction between the R domain and CL3. These findings may support proximity of the R domain to the cytoplasmic loops. They also suggest that Fe3+ homeostasis may play a critical role in regulating pathophysiological CFTR activity because dysregulation of this protein causes cystic fibrosis, secretary diarrhea, and infertility.	[Wang, Guangyu] Univ Nevada, Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Wang, Guangyu] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Wang, Guangyu] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Wang, GY (corresponding author), Univ Nevada, Sch Med, Dept Pharmacol, 1664 N Virginia St MS 318,Manville Med Bldg,Rm 9, Reno, NV 89557 USA.	wangg@medicine.nevada.edu		Wang, Guangyu/0000-0002-5581-6926	National Institutes of Health [2R56DK056796-10]; American Heart Association [10SDG4120011]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK056796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R56DK056796-10. This work was also supported by American Heart Association Grant 10SDG4120011 (to G. W.).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bruns CM, 2001, BIOCHEMISTRY-US, V40, P15631, DOI 10.1021/bi0156759; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dhungana S, 2003, P NATL ACAD SCI USA, V100, P3659, DOI 10.1073/pnas.0536897100; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; RIORDAN JR, 1989, SCIENCE, V245, P1066; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Smith JJ, 2005, PROTEIN SCI, V14, P64, DOI 10.1110/ps.04965405; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; SPRINGMAN EB, 1990, P NATL ACAD SCI USA, V87, P364, DOI 10.1073/pnas.87.1.364; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; Vankeerberghen A, 1999, BIOCHEMISTRY-US, V38, P14988, DOI 10.1021/bi991520d; Wang GY, 2007, J BIOL CHEM, V282, P13637, DOI 10.1074/jbc.M609182200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004	37	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40438	40447		10.1074/jbc.M110.161497	http://dx.doi.org/10.1074/jbc.M110.161497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952391	hybrid, Green Published			2022-12-27	WOS:000285414400006
J	Kumano, T; Tomita, T; Nishiyama, M; Kuzuyama, T				Kumano, Takuto; Tomita, Takeo; Nishiyama, Makoto; Kuzuyama, Tomohisa			Functional Characterization of the Promiscuous Prenyltransferase Responsible for Furaquinocin Biosynthesis IDENTIFICATION OF A PHYSIOLOGICAL POLYKETIDE SUBSTRATE AND ITS PRENYLATED REACTION PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-CLUSTER; STREPTOMYCES-CINNAMONENSIS; HETEROLOGOUS EXPRESSION; ANTIBIOTICS; SYNTHASE; FAMILY	Furaquinocin is a natural polyketide-isoprenoid hybrid (meroterpenoid) that exhibits antitumor activity and is produced by the Streptomyces sp. strain KO-3988. Bioinformatic analysis of furaquinocin biosynthesis has identified Fur7 as a possible prenyltransferase that attaches a geranyl group to an unidentified polyketide scaffold. Here, we report the identification of a physiological polyketide substrate for Fur7, as well as its reaction product and the biochemical characterization of Fur7. A Streptomyces albus transformant (S. albus/pWHM-Fur2_del7) harboring the furaquinocin biosynthetic gene cluster lacking the fur7 gene did not produce furaquinocin but synthesized the novel intermediate 2-methoxy-3-methyl-flaviolin. After expression and purification from Escherichia coli, the recombinant Fur7 enzyme catalyzed the transfer of a geranyl group to 2-methoxy-3-methyl-flaviolin to yield 6-prenyl-2-methoxy-3-methyl-flaviolin and 7-O-geranyl-2-methoxy-3-methyl- flaviolin in a 10: 1 ratio. The reaction proceeded independently of divalent cations. When 6-prenyl-2-methoxy3- methyl-flaviolin was added to the culture medium of S. albus/pWHM-Fur2_del7, furaquinocin production was restored. The promiscuous substrate specificity of Fur7 was demonstrated with respect to prenyl acceptor substrates and prenyl donor substrates. The steady-state kinetic constants of Fur7 with each prenyl acceptor substrate were also calculated.	[Kumano, Takuto; Tomita, Takeo; Nishiyama, Makoto; Kuzuyama, Tomohisa] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Kuzuyama, T (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	utkuz@mail.ecc.u-tokyo.ac.jp	Kumano, Takuto/ABC-3242-2020	Kumano, Takuto/0000-0002-9240-4074; Kuzuyama, Tomohisa/0000-0002-7221-5858; Nishiyama, Makoto/0000-0001-8143-8052	Ministry of Economy, Trade, and Industry; Naito Foundation	Ministry of Economy, Trade, and Industry; Naito Foundation(Naito Memorial Foundation)	This work was supported in part by the "Development of Fundamental Technologies for Production of High Value Materials using Transgenic Plants" R&D project funded by the Ministry of Economy, Trade, and Industry and by a grant from the Naito Foundation.	Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; Funa N, 2005, J BIOL CHEM, V280, P14514, DOI 10.1074/jbc.M500190200; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haagen Y, 2006, CHEMBIOCHEM, V7, P2016, DOI 10.1002/cbic.200600338; ISHIBASHI M, 1991, J ANTIBIOT, V44, P390, DOI 10.7164/antibiotics.44.390; Izumikawa M, 2003, J IND MICROBIOL BIOT, V30, P510, DOI 10.1007/s10295-003-0075-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; KOMIYAMA K, 1990, J ANTIBIOT, V43, P247, DOI 10.7164/antibiotics.43.247; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; SHIN-YA K, 1990, Tetrahedron Letters, V31, P6025, DOI 10.1016/S0040-4039(00)98019-5; SHINYA K, 1990, J ANTIBIOT, V43, P444, DOI 10.7164/antibiotics.43.444; SHIOMI K, 1986, J ANTIBIOT, V39, P494, DOI 10.7164/antibiotics.39.494; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200	22	30	31	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39663	39671		10.1074/jbc.M110.153957	http://dx.doi.org/10.1074/jbc.M110.153957			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937800	Green Published, hybrid			2022-12-27	WOS:000285185500010
J	Song, XM; Wang, XF; Zhuo, W; Shi, HB; Feng, D; Sun, Y; Liang, Y; Fu, Y; Zhou, DF; Luo, YZ				Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Zhou, Daifu; Luo, Yongzhang			The Regulatory Mechanism of Extracellular Hsp90 alpha on Matrix Metalloproteinase-2 Processing and Tumor Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HSP90 MOLECULAR CHAPERONE; ENDOTHELIAL-CELLS; CANCER PROGRESSION; INHIBITOR; PROTEIN; HEAT-SHOCK-PROTEIN-90; INVASION; BINDING; METASTASIS; GROWTH	Heat shock protein 90 alpha (Hsp90 alpha) is a ubiquitously expressed molecular chaperone that is essential for eukaryotic homeostasis. Hsp90 alpha can also be secreted extracellularly, where it has been shown to be involved in tumor metastasis. Extracellular Hsp90 alpha interacts with and promotes the proteolytic activity of matrix metalloproteinase-2 (MMP-2). However, the regulatory mechanism of Hsp90 alpha on MMP-2 activity is still unknown. Here we show that Hsp90 alpha stabilizes MMP-2 and protects it from degradation in tumor cells. Further investigation reveals that this stabilization effect is isoform-specific, ATP-independent, and mediated by the interaction between the Hsp90 alpha middle domain and the MMP-2 C-terminal hemopexin domain. Moreover, this mechanism also applies to endothelial cells that secrete more Hsp90 alpha in their proliferating status. Furthermore, endothelial cell transmigration, Matrigel plug, and tumor angiogenesis assays demonstrate that extracellular Hsp90 alpha promotes angiogenesis in an MMP-2-dependent manner. In sum, this study provides new insights into the molecular mechanism of how Hsp90 alpha regulates its extracellular client proteins and also reveals for the first time the function of extracellular Hsp90 alpha in promoting tumor angiogenesis.	[Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing 100084, Peoples R China; [Song, Xiaomin; Wang, Xiaofeng; Zhuo, Wei; Shi, Hubing; Feng, Dan; Sun, Yi; Liang, Yun; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China; [Zhou, Daifu; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Natl Engn Lab Antitumor Prot Therapeut, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Luo, YZ (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing Key Lab Prot Therapeut, Beijing 100084, Peoples R China.	yluo@tsinghua.edu.cn	Feng, Dan/F-7205-2013; Shi, Hubing/B-8445-2014; Liang, Yun/K-5639-2013	Feng, Dan/0000-0001-5926-8894; Song, Xiaomin/0000-0002-2586-9285	National Natural Science Foundation of China [30670419, 30771083, 30490171]; National High Technology Research and Development Program of China [2007AA02Z155]; State Key Development Program for Basic Research of China [2006CB91030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China)	This work was supported in part by General Programs of the National Natural Science Foundation of China Grants 30670419 and 30771083, Major Program of National Natural Science Foundation of China Grant 30490171, the National High Technology Research and Development Program of China Grant 2007AA02Z155, and the State Key Development Program for Basic Research of China Grant 2006CB91030.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; BERGMANN U, 1995, BIOCHEMISTRY-US, V34, P2819, DOI 10.1021/bi00009a011; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2009, J BIOL CHEM, V284, P12821, DOI 10.1074/jbc.M809627200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Diaz N, 2008, J AM CHEM SOC, V130, P14070, DOI 10.1021/ja806090v; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Futagami S, 2008, J GASTROEN HEPATOL, V23, pS222, DOI 10.1111/j.1440-1746.2008.05442.x; Grenert JP, 1999, J BIOL CHEM, V274, P17525, DOI 10.1074/jbc.274.25.17525; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; Kern J, 2009, BLOOD, V114, P3960, DOI 10.1182/blood-2009-03-209668; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Minami Y, 2000, J BIOL CHEM, V275, P9055, DOI 10.1074/jbc.275.12.9055; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; Osenkowski P, 2005, J BIOL CHEM, V280, P26160, DOI 10.1074/jbc.M414379200; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Stetler-Stevenson WG, 2005, TRENDS MOL MED, V11, P97, DOI 10.1016/j.molmed.2005.01.007; Tramentozzi E, 2008, MOL IMMUNOL, V45, P3639, DOI 10.1016/j.molimm.2008.04.020; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yonehara M, 1996, J BIOL CHEM, V271, P2641, DOI 10.1074/jbc.271.5.2641	48	87	90	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40039	40049		10.1074/jbc.M110.181941	http://dx.doi.org/10.1074/jbc.M110.181941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937816	Green Published, hybrid			2022-12-27	WOS:000285185500049
J	Yang, JY; Cai, J; Zhang, Y; Wang, XM; Li, W; Xu, JY; Li, F; Guo, XP; Deng, K; Zhong, M; Chen, YL; Lai, LX; Pei, DQ; Esteban, MA				Yang, Jiayin; Cai, Jie; Zhang, Ya; Wang, Xianming; Li, Wen; Xu, Jianyong; Li, Feng; Guo, Xiangpeng; Deng, Kang; Zhong, Mei; Chen, Yonglong; Lai, Liangxue; Pei, Duanqing; Esteban, Miguel A.			Induced Pluripotent Stem Cells Can Be Used to Model the Genomic Imprinting Disorder Prader-Willi Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLASTS; METHYLATION; GENES; EXPRESSION; INDUCTION; CULTURE; OCT4	The recent discovery of induced pluripotent stem cell (iPSC) technology provides an invaluable tool for creating in vitro representations of human genetic conditions. This is particularly relevant for those diseases that lack adequate animal models or where the species comparison is difficult, e.g. imprinting diseases such as the neurogenetic disorder Prader-Willi syndrome (PWS). However, recent reports have unveiled transcriptional and functional differences between iPSCs and embryonic stem cells that in cases are attributable to imprinting errors. This has suggested that human iPSCs may not be useful to model genetic imprinting diseases. Here, we describe the generation of iPSCs from a patient with PWS bearing a partial translocation of the paternally expressed chromosome 15q11-q13 region to chromosome 4. The resulting iPSCs match all standard criteria of bona fide reprogramming and could be readily differentiated into tissues derived from the three germ layers, including neurons. Moreover, these iPSCs retain a high level of DNA methylation in the imprinting center of the maternal allele and show concomitant reduced expression of the disease-associated small nucleolar RNA HBII85/SNORD116. These results indicate that iPSCs may be a useful tool to study PWS and perhaps other genetic imprinting diseases as well.	[Yang, Jiayin; Cai, Jie; Zhang, Ya; Wang, Xianming; Li, Wen; Xu, Jianyong; Li, Feng; Guo, Xiangpeng; Chen, Yonglong; Lai, Liangxue; Pei, Duanqing; Esteban, Miguel A.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Wang, Xianming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; [Deng, Kang; Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn; maestebanb@gmail.com	Lai, Liangxue/H-4545-2011	Yang, Jiayin/0000-0001-9134-1959	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences [KSCX2-YW-R244]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]; National Natural Science Foundation of China [90813033]; Ministry of Science and Technology of China [2007CB948002, 2009CB941102, 2006AA02A103]; Ministry of Science and Technology [2010DFB30430]	Guangzhou Institutes of Biomedicine and Health; Chinese Academy of Sciences(Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by startup funding from the Guangzhou Institutes of Biomedicine and Health and Grant KSCX2-YW-R244 from the Chinese Academy of Sciences (to M.A.E.); Grant 2008A1-E4011 from the Bureau of Science and Technology of Guangzhou Municipality, Grant 90813033 from the National Natural Science Foundation of China, Grants 2007CB948002 and 2009CB941102 from the 973 Program of the Ministry of Science and Technology of China, and Grant 2010DFB30430 from the Ministry of Science and Technology International Technology Cooperation Program (to D.P.); and Grant 2006AA02A103 from the 863 Program of the Ministry of Science and Technology of China (to L.L.).	Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Constancia M, 1998, GENOME RES, V8, P881, DOI 10.1101/gr.8.9.881; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Koerner MV, 2010, CURR OPIN GENET DEV, V20, P164, DOI 10.1016/j.gde.2010.01.009; Lako M, 2010, STEM CELLS, V28, P845, DOI 10.1002/stem.411; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Leung KN, 2009, HUM MOL GENET, V18, P4227, DOI 10.1093/hmg/ddp373; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Saitoh S, 1996, P NATL ACAD SCI USA, V93, P7811, DOI 10.1073/pnas.93.15.7811; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; SZABO P, 1994, DEVELOPMENT, V120, P1651; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Weksberg R, 2003, HUM MOL GENET, V12, pR61, DOI 10.1093/hmg/ddg067; Wilmut I, 2007, CELL STEM CELL, V1, P593, DOI 10.1016/j.stem.2007.11.013; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	84	86	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40303	40311		10.1074/jbc.M110.183392	http://dx.doi.org/10.1074/jbc.M110.183392			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956530	Green Published, hybrid			2022-12-27	WOS:000285185500073
J	Li, W; Johnson, DJD; Adams, TE; Pozzi, N; De Filippis, V; Huntington, JA				Li, Wei; Johnson, Daniel J. D.; Adams, Ty E.; Pozzi, Nicola; De Filippis, Vincenzo; Huntington, James A.			Thrombin Inhibition by Serpins Disrupts Exosite II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ALPHA(1)-PROTEINASE INHIBITOR; PROTEINASE INHIBITION; COVALENT COMPLEX; BINDING EXOSITE; ALPHA-THROMBIN; MECHANISM; PROTHROMBIN; TRYPSIN; ACTIVATION	Thrombin uses three principal sites, the active site, exosite I, and exosite II, for recognition of its many cofactors and substrates. It is synthesized in the zymogen form, prothrombin, and its activation at the end of the blood coagulation cascade results in the formation of the active site and exosite I and the exposure of exosite II. The physiological inhibitors of thrombin are all serpins, whose mechanism involves significant conformational change in both serpin and protease. It has been shown that the formation of the thrombin-serpin final complex disorders the active site and exosite I of thrombin, but exosite II is thought to remain functional. It has also been hypothesized that thrombin contains a receptor-binding site that is exposed upon final complex formation. The position of this cryptic site may depend on the regions of thrombin unfolded by serpin complexation. Here we investigate the conformation of thrombin in its final complex with serpins and find that in addition to exosite I, exosite II is also disordered, as reflected by a loss of affinity for the gamma`-peptide of fibrinogen and for heparin and by susceptibility to limited proteolysis. This disordering of exosite II occurs for all tested natural thrombin-inhibiting serpins. Our data suggest a novel framework for understanding serpin function, especially with respect to thrombin inhibition, where serpins functionally "rezymogenize" proteases to ensure complete loss of activity and cofactor binding.	[Li, Wei; Johnson, Daniel J. D.; Adams, Ty E.; Huntington, James A.] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Pozzi, Nicola; De Filippis, Vincenzo] Univ Padua, Dept Pharmaceut Sci, I-35131 Padua, Italy	University of Cambridge; University of Padua	Huntington, JA (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Wellcome Trust MRC Bldg, Cambridge CB2 0XY, England.	jah52@cam.ac.uk	Pozzi, Nicola/AAE-4910-2020; Pozzi, Nicola/AAV-4876-2021	Pozzi, Nicola/0000-0003-2309-7100	National Institutes of Health [HL68629]; British Heart Foundation; Medical Research Council; MRC [G117/444, G0601596] Funding Source: UKRI; Medical Research Council [G117/444, G0601596] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL68629 (J. A. H.) and by grants from the British Heart Foundation (to J. A. H.) and the Medical Research Council (J. A. H.).	ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; Calugaru SV, 2001, J BIOL CHEM, V276, P32446, DOI 10.1074/jbc.M104731200; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Dementiev A, 2006, J BIOL CHEM, V281, P3452, DOI 10.1074/jbc.M510564200; Egelund R, 2001, EUR J BIOCHEM, V268, P673, DOI 10.1046/j.1432-1327.2001.01921.x; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fredenburgh JC, 2001, J BIOL CHEM, V276, P44828, DOI 10.1074/jbc.M108710200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; He XH, 1997, BIOCHEMISTRY-US, V36, P8969, DOI 10.1021/bi9704717; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; KASLIK G, 1995, FEBS LETT, V370, P179, DOI 10.1016/0014-5793(95)00816-R; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LIU LW, 1991, J BIOL CHEM, V266, P23632; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; PADMANABHAN K, 1993, J BIOL CHEM, V268, P17651; Peterson FC, 2001, BIOCHEMISTRY-US, V40, P6284, DOI 10.1021/bi010100x; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; WU QY, 1994, J BIOL CHEM, V269, P3725; Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200	32	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38621	38629		10.1074/jbc.M110.144964	http://dx.doi.org/10.1074/jbc.M110.144964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889971	Green Published, hybrid			2022-12-27	WOS:000284625600066
J	Yang, F; Xia, XA; Lei, HY; Wang, ED				Yang, Fang; Xia, Xian; Lei, Hui-Yan; Wang, En-Duo			Hemin Binds to Human Cytoplasmic Arginyl-tRNA Synthetase and Inhibits Its Catalytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOACYL-TRANSFER-RNA; END RULE PATHWAY; RIBONUCLEIC-ACID SYNTHETASE; REV-ERB-ALPHA; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; REGULATORY MOTIF; 2 FORMS; DEGRADATION; ACTIVATION	The free form of human cytoplasmic arginyl-tRNA synthetase (hcArgRS) is hypothesized to participate in ubiquitin-dependent protein degradation by offering arginyl-tRNA(Arg) to arginyl-tRNA transferase (ATE1). We investigated the effect of hemin on hcArgRS based on the fact that hemin regulates several critical proteins in the "N-end rule" protein degradation pathway. Extensive biochemical evidence has established that hemin could bind to both forms of hcArgRS in vitro. Based on the spectral changes of the Soret band on site-directed protein mutants, we identified Cys-115 as a specific axial ligand of hemin binding that is located in the Add1 domain. Hemin inhibited the catalytic activity of full-length and N-terminal 72-amino acid-truncated hcArgRSs by blocking amino acid activation. Kinetic analysis demonstrated that the K-m values for tRNA(Arg), arginine, and ATP in the presence of hemin were not altered, but k(cat) values dramatically decreased compared with those in the absence of hemin. By comparison, the activity of prokaryotic ArgRS was not affected obviously by hemin. Gel filtration chromatography suggested that hemin induced oligomerization of both the isolated Add1 domain and the wild type enzyme, which could account for the inhibition of catalytic activity. However, the catalytic activity of an hcArgRS mutant with Cys-115 replaced by alanine (hcArgRS-C115A) was also inhibited by hemin, suggesting that hemin binding to Cys-115 is not responsible for the inhibition of enzymatic activity and that the specific binding may participate in other biological functions.	[Yang, Fang; Xia, Xian; Lei, Hui-Yan; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	edwang@sibs.ac.cn	Milton, Ross D/J-7164-2012		National Key Basic Research Foundation of China [2006CB910301]; Natural Science Foundation of China [30930022]; Postdoctoral Science Foundation of China; Postdoctoral Foundation of Shanghai; Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS); Chinese Academy of Science; Sanofi-Aventis-SIBS	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Postdoctoral Foundation of Shanghai; Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS); Chinese Academy of Science(Chinese Academy of Sciences); Sanofi-Aventis-SIBS	This work was supported by National Key Basic Research Foundation of China Grant 2006CB910301, Natural Science Foundation of China Grant 30930022, the Postdoctoral Science Foundation of China, the Postdoctoral Foundation of Shanghai, the Postdoctoral Foundation of Shanghai Institutes for Biological Sciences (SIBS), a K. C. Wong postdoctoral fellowship of the Chinese Academy of Science, and a Sanofi-Aventis-SIBS postdoctoral fellowship.	BIRDSALL WJ, 1989, BIOCHIM BIOPHYS ACTA, V1007, P176, DOI 10.1016/0167-4781(89)90036-5; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JF, 1999, PROTEIN EXPRES PURIF, V15, P115, DOI 10.1006/prep.1998.0999; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Delagoutte B, 2000, EMBO J, V19, P5599, DOI 10.1093/emboj/19.21.5599; DEUTSCHER MP, 1982, J BIOL CHEM, V257, P6003; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; ETLINGER JD, 1980, J BIOL CHEM, V255, P4563; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; FERBER S, 1987, NATURE, V326, P808, DOI 10.1038/326808a0; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Guigou L, 2005, BIOCHEMISTRY-US, V44, P16540, DOI 10.1021/bi051575h; Guigou L, 2004, BIOCHEMISTRY-US, V43, P4592, DOI 10.1021/bi036150e; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; Hori Y, 2005, BBA-GENE STRUCT EXPR, V1730, P47, DOI 10.1016/j.bbaexp.2005.06.003; Hou SW, 2006, ACCOUNTS CHEM RES, V39, P918, DOI 10.1021/ar040020w; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Konno M, 2009, FEBS J, V276, P4763, DOI 10.1111/j.1742-4658.2009.07178.x; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; Lazard M, 2000, J MOL BIOL, V302, P991, DOI 10.1006/jmbi.2000.4102; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Li J, 2003, BIOCHEM J, V376, P773, DOI 10.1042/BJ20030957; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Liu MF, 1999, BIOCHEMISTRY-US, V38, P11006, DOI 10.1021/bi990392q; Liu X, 2009, ELECTROPHORESIS, V30, P3034, DOI 10.1002/elps.200900151; MEHLER AH, 1967, J BIOL CHEM, V242, P5495; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; PAPAS TS, 1972, BIOCHEMISTRY-US, V11, P4602, DOI 10.1021/bi00774a029; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Scolaro LM, 2004, J AM CHEM SOC, V126, P7178, DOI 10.1021/ja049669m; Shimada A, 2001, P NATL ACAD SCI USA, V98, P13537, DOI 10.1073/pnas.231267998; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; Wakasugi K, 2007, BIOCHEMISTRY-US, V46, P11291, DOI 10.1021/bi7012068; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	49	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39437	39446		10.1074/jbc.M110.159913	http://dx.doi.org/10.1074/jbc.M110.159913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923763	hybrid, Green Published			2022-12-27	WOS:000284941300070
J	Gaspar, ML; Hofbauer, HF; Kohlwein, SD; Henry, SA				Gaspar, Maria L.; Hofbauer, Harald F.; Kohlwein, Sepp D.; Henry, Susan A.			Coordination of Storage Lipid Synthesis and Membrane Biogenesis EVIDENCE FOR CROSS-TALK BETWEEN TRIACYLGLYCEROL METABOLISM AND PHOSPHATIDYLINOSITOL SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; PLASMA-MEMBRANE; GENE-EXPRESSION; INOSITOL; SPHINGOLIPIDS; PARTICLES; CHOLESTEROL; LIPOLYSIS; TURNOVER	Despite the importance of triacylglycerols (TAG) and steryl esters (SE) in phospholipid synthesis in cells transitioning from stationary-phase into active growth, there is no direct evidence for their requirement in synthesis of phosphatidylinositol (PI) or other membrane phospholipids in logarithmically growing yeast cells. We report that the dga1 Delta lro1 Delta are1 Delta are2 Delta strain, which lacks the ability to synthesize both TAG and SE, is not able to sustain normal growth in the absence of inositol (Ino(-) phenotype) at 37 degrees C especially when choline is present. Un-like many other strains exhibiting an Ino(-) phenotype, the dga1 Delta lro1 Delta are1 Delta are2 Delta strain does not display a defect in INO1 expression. However, the mutant exhibits slow recovery of PI content compared with wild type cells upon reintroduction of inositol into logarithmically growing cultures. The tgl3 Delta tgl4 Delta tgl5 Delta strain, which is able to synthesize TAG but unable to mobilize it, also exhibits attenuated PI formation under these conditions. However, unlike dga1 Delta lro1 Delta are1 Delta are2 Delta, the tgl3 Delta tgl4 Delta tgl5 Delta strain does not display an Ino(-) phenotype, indicating that failure to mobilize TAG is not fully responsible for the growth defect of the dga1 Delta lro1 Delta are1 Delta are2 Delta strain in the absence of inositol. Moreover, synthesis of phospholipids, especially PI, is dramatically reduced in the dga1 Delta lro1 Delta are1 Delta are2 Delta strain even when it is grown continuously in the presence of inositol. The mutant also utilizes a greater proportion of newly synthesized PI than wild type for the synthesis of inositol-containing sphingolipids, especially in the absence of inositol. Thus, we conclude that storage lipid synthesis actively influences membrane phospholipid metabolism in logarithmically growing cells.	[Gaspar, Maria L.; Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Hofbauer, Harald F.; Kohlwein, Sepp D.] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Cornell University; University of Graz	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 249 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014	Kohlwein, Sepp Dieter/0000-0002-1030-0598; Hofbauer, Harald F./0000-0003-2617-5901	National Institutes of Health [GM-19629]; Austrian Science Fund FWF [Lipotox F3005]; Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF) [F 3005, W 901] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, R01GM019629, F32GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S.A.H.). This work was also supported by grants from the Austrian Science Fund FWF (Project Lipotox F3005) and the Austrian Federal Ministry for Science and Research (Project GOLD (Genomics of Lipid-associated Disorders)) in the framework of the Austrian Genomics Program (GEN-AU) (to S.D.K.).	Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; Brachmann CB, 1998, YEAST, V14, P115; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Christie W.W., 2003, LIPID ANAL ISOLATION, P105; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Jensen-Pergakes K, 2001, J BACTERIOL, V183, P4950, DOI 10.1128/JB.183.17.4950-4957.2001; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LANGE Y, 1989, J BIOL CHEM, V264, P3786; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Mullner H, 2004, ACTA BIOCHIM POL, V51, P323; Murphy S, 2009, BBA-MOL CELL BIOL L, V1791, P441, DOI 10.1016/j.bbalip.2008.07.004; NOMURA S, 1972, J BIOCHEM-TOKYO, V71, P783, DOI 10.1093/oxfordjournals.jbchem.a129827; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sandager L, 2000, BIOCHEM SOC T, V28, P700; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Weerheim AM, 2002, ANAL BIOCHEM, V302, P191, DOI 10.1006/abio.2001.5552; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	53	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1696	1708		10.1074/jbc.M110.172296	http://dx.doi.org/10.1074/jbc.M110.172296			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20972264	Green Published, hybrid			2022-12-27	WOS:000286191500009
J	Piguet, J; Schreiter, C; Segura, JM; Vogel, H; Hovius, R				Piguet, Joachim; Schreiter, Christoph; Segura, Jean-Manuel; Vogel, Horst; Hovius, Ruud			Acetylcholine Receptor Organization in Membrane Domains in Muscle Cells EVIDENCE FOR RAPSYN-INDEPENDENT AND RAPSYN-DEPENDENT MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PARTICLE TRACKING; TETRATRICOPEPTIDE REPEAT DOMAINS; NEUROMUSCULAR-JUNCTION; LIVE CELLS; MOLECULE TRACKING; PLASMA-MEMBRANE; MYASTHENIC SYNDROME; MOUSE MUSCLE; PROTEIN; AGRIN	Nicotinic acetylcholine receptors (nAChR) in muscle fibers are densely packed in the postsynaptic region at the neuromuscular junction. Rapsyn plays a central role in directing and clustering nAChR during cellular differentiation and neuromuscular junction formation; however, it has not been demonstrated whether rapsyn is the only cause of receptor immobilization. Here, we used single-molecule tracking methods to investigate nAChR mobility in plasma membranes of myoblast cells during their differentiation to myotubes in the presence and absence of rapsyn. We found that in myoblasts the majority of nAChR were immobile and that similar to 20% of the receptors showed restricted diffusion in small domains of similar to 50 nm. In myoblasts devoid of rapsyn, the fraction of mobile nAChR was considerably increased, accompanied by a 3-fold decrease in the immobile population of nAChR with respect to rapsyn-expressing cells. Half of the mobile receptors were confined to domains of similar to 120 nm. Measurements performed in heterologously transfected HEK cells confirmed the direct immobilization of nAChR by rapsyn. However, irrespective of the presence of rapsyn, about one-third of nAChR were confined in 300-nm domains. Our results show (i) that rapsyn efficiently immobilizes nAChR independently of other postsynaptic scaffold components; (ii) nAChR is constrained in confined membrane domains independently of rapsyn; and (iii) in the presence of rapsyn, the size of these domains is strongly reduced.	[Piguet, Joachim; Schreiter, Christoph; Segura, Jean-Manuel; Vogel, Horst; Hovius, Ruud] Ecole Polytech Fed Lausanne, Lab Chim Phys Polymeres & Membranes, CH-1015 Lausanne, Switzerland	Ecole Polytechnique Federale de Lausanne	Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Chim Phys Polymeres & Membranes, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch; ruud.hovius@epfl.ch	Piguet, Joachim/E-2329-2011; Vogel, Horst/AAJ-5490-2021; Hovius, Ruud/B-5647-2009	Piguet, Joachim/0000-0002-4762-4887; Hovius, Ruud/0000-0001-9258-6587	CTI Innovation Promotion Agency [580903]; Swiss National Science Foundation [31003A-118148]; Ecole Polytechnique Federale de Lausanne	CTI Innovation Promotion Agency; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne	This work was supported by CTI Innovation Promotion Agency Grant 580903, Swiss National Science Foundation Grant 31003A-118148, and internal funds from the Ecole Polytechnique Federale de Lausanne.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Antolik C, 2007, NEUROSCIENCE, V145, P56, DOI 10.1016/j.neuroscience.2006.11.047; Antolik C, 2006, NEUROSCIENCE, V141, P87, DOI 10.1016/j.neuroscience.2006.03.035; Barrantes FJ, 2010, J MOL NEUROSCI, V40, P87, DOI 10.1007/s12031-009-9262-z; Bromann PA, 2004, NEUROSCIENCE, V125, P417, DOI 10.1016/j.neuroscience.2003.12.031; Bruneau E, 2007, J BIOL CHEM, V282, P9932, DOI 10.1074/jbc.M608714200; BURDEN SJ, 1985, P NATL ACAD SCI USA, V82, P8270, DOI 10.1073/pnas.82.23.8270; Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031; Dobbins GC, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-18; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; FRAIL DE, 1988, J BIOL CHEM, V263, P15602; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Fuhrer C, 1999, J NEUROSCI, V19, P6405; Gajsek N, 2008, CHEM-BIOL INTERACT, V175, P50, DOI 10.1016/j.cbi.2008.05.027; Gervasio OL, 2005, J PHYSIOL-LONDON, V562, P673, DOI 10.1113/jphysiol.2004.077685; Guignet EG, 2007, CHEMPHYSCHEM, V8, P1221, DOI 10.1002/cphc.200700065; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Hezel M, 2010, MOL BIOL CELL, V21, P302, DOI 10.1091/mbc.E09-05-0381; Kasai Y, 2005, NUCLEIC ACIDS RES, V33, pD550; Kellner RR, 2007, NEUROSCIENCE, V144, P135, DOI 10.1016/j.neuroscience.2006.08.071; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lee Y, 2008, NEUROSCIENCE, V153, P997, DOI 10.1016/j.neuroscience.2008.03.009; Lee Y, 2009, NEUROSCIENCE, V163, P222, DOI 10.1016/j.neuroscience.2009.05.057; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; Pato C, 2008, CHEM-BIOL INTERACT, V175, P64, DOI 10.1016/j.cbi.2008.03.020; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schreiter C, 2005, CHEMBIOCHEM, V6, P2187, DOI 10.1002/cbic.200500216; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; SOBEL A, 1977, EUR J BIOCHEM, V80, P215, DOI 10.1111/j.1432-1033.1977.tb11874.x; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang B, 2007, J NEUROSCI, V27, P3968, DOI 10.1523/JNEUROSCI.4691-06.2007	50	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					363	369		10.1074/jbc.M110.139782	http://dx.doi.org/10.1074/jbc.M110.139782			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978122	Green Published, hybrid			2022-12-27	WOS:000285782800039
J	Chen, ZH; Schilde, C; Schaap, P				Chen, Zhi-hui; Schilde, Christina; Schaap, Pauline			Functional Dissection of Adenylate Cyclase R, an Inducer of Spore Encapsulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RESPONSE REGULATORS; HISTIDINE-KINASE; ESCHERICHIA-COLI; DICTYOSTELIUM-DISCOIDEUM; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; NUCLEOTIDE-BINDING; CRYSTAL-STRUCTURE; OSMOSENSOR ENVZ; RECEIVER DOMAIN	Cyclic AMP acting on protein kinase A controls sporulation and encystation in social and solitary amoebas. In Dictyostelium discoideum, adenylate cyclase R (ACR), is essential for spore encapsulation. In addition to its cyclase (AC) domain, ACR harbors seven transmembrane helices, a histidine kinase domain, and two receiver domains. We investigated the role of these domains in the regulation of AC activity. Expression of an ACR-YFP fusion protein in acr(-) cells rescued their sporulation defective phenotype and revealed that ACR is associated with the nuclear envelope and endoplasmic reticulum. Loss of the transmembrane helices (Delta TM) caused a 60% reduction of AC activity, but Delta TM-ACR still rescued the acr(-) phenotype. The isolated AC domain was properly expressed but inactive. Mutation of three essential ATP-binding residues in the histidine kinase domain did not affect the AC activity or phenotypic rescue. Mutation of the essential phosphoryl-accepting aspartate in receivers 1, 2, or both had only modest effects on AC activity and did not affect phenotypic rescue, indicating that AC activity is not critically regulated by phosphorelay. Remarkably, the dimerizing histidine phosphoacceptor subdomain, which in ACR lacks the canonical histidine for autophosphorylation, was essential for AC activity. Transformation of wild-type cells with an ACR allele (Delta CRA) that is truncated after this domain inhibited AC activity of endogenous ACR and replicated the acr(-) phenotype. Combined with the observation that the isolated AC domain was inactive, the dominant- negative effect of Delta CRA strongly suggests that the defunct phosphoacceptor domain acquired a novel role in enforcing dimerization of the AC domain.	[Chen, Zhi-hui; Schilde, Christina; Schaap, Pauline] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Schaap, P (corresponding author), MSI WTB JBC Complex,Dow St, Dundee DD1 5EH, Scotland.	p.schaap@dundee.ac.uk	Schaap, Pauline/A-3682-2009; Schaap, Pauline/M-5355-2019	Schaap, Pauline/0000-0003-4500-2555; Schaap, Pauline/0000-0003-4500-2555	Wellcome Trust [076618]; Biotechnology and Biological Sciences Research Council [BB/G020426/1, BB/D013453/1] Funding Source: researchfish; BBSRC [BB/G020426/1, BB/D013453/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 076618 (to P. S.).	Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Anjard C., 2005, DICTYOSKLIUM GENOMIC, P59; Aubry L, 1999, ANNU REV CELL DEV BI, V15, P469, DOI 10.1146/annurev.cellbio.15.1.469; Baker DA, 2004, TRENDS PARASITOL, V20, P227, DOI 10.1016/j.pt.2004.02.007; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0; BUTLER JR, 1992, BIOCHEM CELL BIOL, V70, P169, DOI 10.1139/o92-025; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Dutta R, 2000, J BIOL CHEM, V275, P38645, DOI 10.1074/jbc.M005872200; Dutta R, 1996, J BIOL CHEM, V271, P1424, DOI 10.1074/jbc.271.3.1424; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gooi P, 2008, CORNEA, V27, P246, DOI 10.1097/ICO.0b013e31815b82a2; Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866; Hirschman A, 2001, BIOCHEMISTRY-US, V40, P13876, DOI 10.1021/bi0113622; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Kasahara M, 1999, J BIOL CHEM, V274, P15167, DOI 10.1074/jbc.274.21.15167; Kawabe Y, 2009, P NATL ACAD SCI USA, V106, P7089, DOI 10.1073/pnas.0901617106; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Linder JU, 2008, CURR OPIN STRUC BIOL, V18, P667, DOI 10.1016/j.sbi.2008.11.008; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meima ME, 2002, MOL BIOL CELL, V13, P3870, DOI 10.1091/mbc.E02-05-0285; Meima ME, 1999, DEV BIOL, V212, P182, DOI 10.1006/dbio.1999.9352; Misono KS, 2005, PEPTIDES, V26, P957, DOI 10.1016/j.peptides.2004.12.021; Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772; Okamoto S, 2004, PHOTOCHEM PHOTOBIOL, V80, P429, DOI 10.1562/0031-8655(2004)080&lt;0429:APPATT&gt;2.0.CO;2; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Saran S, 2004, MOL BIOL CELL, V15, P1479, DOI 10.1091/mbc.E03-08-0622; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; SHELDEN E, 1995, J CELL SCI, V108, P1105; Soderbom F, 1999, DEVELOPMENT, V126, P5463; Stewart RC, 1998, BIOCHEMISTRY-US, V37, P12269, DOI 10.1021/bi980970n; Tanaka T, 1998, NATURE, V396, P88, DOI 10.1038/23968; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Turner NA, 2000, J ANTIMICROB CHEMOTH, V46, P27, DOI 10.1093/jac/46.1.27; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045; Zhu Y, 2002, MOL MICROBIOL, V45, P653, DOI 10.1046/j.1365-2958.2002.03061.x	51	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41724	41731		10.1074/jbc.M110.156380	http://dx.doi.org/10.1074/jbc.M110.156380			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966074	Green Published, hybrid			2022-12-27	WOS:000285622600059
J	Huang, QQ; Szebenyi, DME				Huang, Qingqiu; Szebenyi, Doletha M. E.			Structural Basis for the Interaction between the Growth Factor-binding Protein GRB 10 and the E3 Ubiquitin Ligase NEDD4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; INSULIN-RECEPTOR; SH2 DOMAIN; GLUCOSE-HOMEOSTASIS; C2 DOMAINS; GENE; DISRUPTION; REGULATOR	In addition to inhibiting insulin receptor and IGF1R kinase activity by directly binding to the receptors, GRB10 can also negatively regulate insulin and IGF1 signaling by mediating insulin receptor and IGF1R degradation through ubiquitination. It has been shown that GRB10 can interact with the C2 domain of the E3 ubiquitin ligase NEDD4 through its Src homology 2 (SH2) domain. Therefore, GRB10 might act as a connector, bringing NEDD4 close to IGF1R to facilitate the ubiquitination of IGF1R by NEDD4. This is the first case in which it has been found that an SH2 domain could colocalize a ubiquitin ligase and its substrate. Here we report the crystal structure of the NEDD4 C2-GRB10 SH2 complex at 2.0A. The structure shows that there are three interaction interfaces between NEDD4 C2 and GRB10 SH2. The main interface centers on an antiparallel beta-sheet composed of the F beta-strand of GRB10 SH2 and the C beta-strand of NEDD4 C2. NEDD4 C2 binds at nonclassical sites on the SH2 domain surface, far from the classical phosphotyrosine-binding pocket. Hence, this interaction is phosphotyrosine-independent, and GRB10 SH2 can bind the C2 domain of NEDD4 and the kinase domain of IGF1R simultaneously. Based on these results, a model of how NEDD4 interacts with IGF1R through GRB10 has been proposed. This report provides further evidence that SH2 domains can participate in important signaling interactions beyond the classical recognition of phosphotyrosine.	[Huang, Qingqiu; Szebenyi, Doletha M. E.] Cornell Univ, MacCHESS, Ithaca, NY 14853 USA	Cornell University	Huang, QQ (corresponding author), Cornell Univ, MacCHESS, Ithaca, NY 14853 USA.	qh24@cornell.edu	Szebenyi, Marian/GMX-2709-2022		National Institutes of Health, NCRR [RR-01646]; National Science Foundation [DMR 0225180]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health, NCRR, Grant RR-01646. This work is based upon research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation under Award DMR 0225180.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Cariou B, 2004, FASEB J, V18, P965, DOI 10.1096/fj.03-0824fje; Ceccarelli DFJ, 2009, NAT STRUCT MOL BIOL, V16, P803, DOI 10.1038/nsmb0809-803; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Corbalan-Garcia S, 2010, BIOFACTORS, V36, P1, DOI 10.1002/biof.68; Depetris RS, 2005, MOL CELL, V20, P325, DOI 10.1016/j.molcel.2005.09.001; Paola R, 2010, J INTERN MED, V267, P132, DOI 10.1111/j.1365-2796.2009.02089.x; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Giorgetti-Peraldi S, 2001, ONCOGENE, V20, P3959, DOI 10.1038/sj.onc.1204520; Han DC, 2002, J BIOL CHEM, V277, P45655, DOI 10.1074/jbc.M203165200; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; He WM, 1998, J BIOL CHEM, V273, P6860, DOI 10.1074/jbc.273.12.6860; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Holt LJ, 2009, MOL ENDOCRINOL, V23, P1406, DOI 10.1210/me.2008-0386; Hu JJ, 2003, MOL CELL, V12, P1379, DOI 10.1016/S1097-2765(03)00487-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min L, 2009, P NATL ACAD SCI USA, V106, P21143, DOI 10.1073/pnas.0911309106; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Morrione A, 2003, J CELL PHYSIOL, V197, P307, DOI 10.1002/jcp.10363; Murdaca J, 2004, J BIOL CHEM, V279, P26754, DOI 10.1074/jbc.M311802200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newton AC, 1998, BBA-REV BIOMEMBRANES, V1376, P155, DOI 10.1016/S0304-4157(98)00003-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Sawyer TK, 1998, BIOPOLYMERS, V47, P243, DOI 10.1002/(SICI)1097-0282(1998)47:3<243::AID-BIP4>3.0.CO;2-P; Shen TL, 2004, FRONT BIOSCI-LANDMRK, V9, P192, DOI 10.2741/1229; Shiura H, 2005, BIOCHEM BIOPH RES CO, V329, P909, DOI 10.1016/j.bbrc.2005.02.047; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Sondermann H, 2005, CELL, V121, P158, DOI 10.1016/j.cell.2005.04.001; Stein EG, 2003, J BIOL CHEM, V278, P13257, DOI 10.1074/jbc.M212026200; Stein EG, 2001, FEBS LETT, V493, P106, DOI 10.1016/S0014-5793(01)02282-7; Tezuka N, 2007, BIOCHEM BIOPH RES CO, V356, P648, DOI 10.1016/j.bbrc.2007.03.019; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Waksman Gabriel, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007331; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07	48	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42130	42139		10.1074/jbc.M110.143412	http://dx.doi.org/10.1074/jbc.M110.143412			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980250	Green Published, hybrid			2022-12-27	WOS:000285622600097
J	Cheung, HH; Beug, ST; Jean, MS; Brewster, A; Kelly, NL; Wang, SM; Korneluk, RG				Cheung, Herman H.; Beug, Shawn T.; Jean, Martine St.; Brewster, Audrey; Kelly, N. Lynn; Wang, Shaomeng; Korneluk, Robert G.			Smac Mimetic Compounds Potentiate Interleukin-1 beta-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; TNF-ALPHA; IAP ANTAGONISTS; C-FLIP; CANCER; TUMOR; ACTIVATION; INHIBITOR; CIAP1	Smac mimetic compounds (SMCs) potentiate TNF beta-mediated cancer cell death by targeting the inhibitor of apoptosis (IAP) proteins. In addition to TNF alpha, the tumor microenvironment is exposed to a number of pro-inflammatory cytokines, including IL-1 beta. Here, we investigated the potential impact of IL-1 beta on SMC-mediated death of cancer cells. Synergy was seen in a subset of a diverse panel of 21 cancer cell lines to the combination of SMC and IL-1 beta treatment, which required IL1 beta-induced activation of the NF-kappa B pathway. Elevated NF-kappa B activity resulted in the production of TNF alpha, which led to apoptosis dependent on caspase-8 and RIP1. In addition, concurrent silencing of cIAP1, cIAP2, and X-linked IAP by siRNA was most effective for triggering IL-1 beta-mediated cell death. Importantly, SMC-resistant cells that produced TNF in response to IL-1 beta treatment were converted to an SMC-sensitive phenotype by c-FLIP knockdown. Reciprocally, ectopic expression of c-FLIP blocked cell death caused by combined SMC and IL-1 beta treatment in sensitive cancer cells. Together, our study indicates that a positive feed-forward loop by pro-inflammatory cytokines can be exploited by SMCs to induce apoptosis in cancer cells.	[Cheung, Herman H.; Beug, Shawn T.; Jean, Martine St.; Brewster, Audrey; Kelly, N. Lynn; Korneluk, Robert G.] Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, Ottawa, ON K1H 8L1, Canada; [Korneluk, Robert G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Korneluk, Robert G.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Wang, Shaomeng] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Wang, Shaomeng] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Korneluk, RG (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Apoptosis Res Ctr, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	bob@arc.cheo.ca		Wang, Shaomeng/0000-0002-8782-6950	Canadian Institutes of Health Research; Ottawa Neuroblastoma Fund; Ottawa Regional Cancer Foundation; James Birrell Neuroblastoma Research Fund; Ontario Institute for Cancer Research (OICR); Terry Fox Research Institute; Ministry of Research and Innovation from the province of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ottawa Neuroblastoma Fund; Ottawa Regional Cancer Foundation; James Birrell Neuroblastoma Research Fund; Ontario Institute for Cancer Research (OICR); Terry Fox Research Institute; Ministry of Research and Innovation from the province of Ontario	This work was supported by Canadian Institutes of Health Research, Ottawa Neuroblastoma Fund, Ottawa Regional Cancer Foundation, James Birrell Neuroblastoma Research Fund, and joint funding from Ontario Institute for Cancer Research (OICR) and Terry Fox Research Institute. Funding for OICR is provided by the Ministry of Research and Innovation from the province of Ontario. R. G. K. is a founder and shareholder of Aegera Therapeutics Inc., which designed SMC-AEG40730. S. W. is a shareholder and consultant for Ascenta Therapeutics Inc., which has licensed technologies related to Smac mimetic compounds.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Casciano I, 2004, CELL DEATH DIFFER, V11, P131, DOI 10.1038/sj.cdd.4401327; Cheung HH, 2008, MOL BIOL CELL, V19, P2729, DOI 10.1091/mbc.E08-01-0107; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; Cheung HH, 2009, CANCER RES, V69, P7729, DOI 10.1158/0008-5472.CAN-09-1794; Cheung HH, 2001, J NEUROCHEM, V78, P524, DOI 10.1046/j.1471-4159.2001.00433.x; Dai Y, 2009, AM J TRANSL RES, V1, P1; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Dineen SP, 2010, CANCER RES, V70, P2852, DOI 10.1158/0008-5472.CAN-09-3892; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Foster FM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2328; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Herrmann O, 2005, NAT MED, V11, P1322, DOI 10.1038/nm1323; Huerta S, 2010, SURGERY, V148, P346, DOI 10.1016/j.surg.2010.05.006; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kim S, 2004, J PEDIATR SURG, V39, P509, DOI 10.1016/j.jpedsurg.2003.12.009; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Probst BL, 2010, CELL DEATH DIFFER, V17, P1645, DOI 10.1038/cdd.2010.44; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Sayers TJ, 2003, BLOOD, V102, P303, DOI 10.1182/blood-2002-09-2975; Servida F., 2010, INVEST NEW IN PRESS; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; SIZIOPIKOU KP, 1991, CANCER, V68, P1035, DOI 10.1002/1097-0142(19910901)68:5<1035::AID-CNCR2820680522>3.0.CO;2-D; Sun HY, 2007, J AM CHEM SOC, V129, P15279, DOI 10.1021/ja074725f; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2009, J BIOL CHEM, V284, P34553, DOI 10.1074/jbc.M109.040139; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	51	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40612	40623		10.1074/jbc.M110.183616	http://dx.doi.org/10.1074/jbc.M110.183616			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956527	Green Published, hybrid			2022-12-27	WOS:000285414400024
J	Hanschmann, EM; Lonn, ME; Schutte, LD; Funke, M; Godoy, JR; Eitner, S; Hudemann, C; Lillig, CH				Hanschmann, Eva-Maria; Loenn, Maria Elisabet; Schuette, Lena Dorothee; Funke, Maria; Godoy, Jose R.; Eitner, Susanne; Hudemann, Christoph; Lillig, Christopher Horst			Both Thioredoxin 2 and Glutaredoxin 2 Contribute to the Reduction of the Mitochondrial 2-Cys Peroxiredoxin Prx3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN PEROXIREDOXIN; ANTIOXIDANT DEFENSE; EXPRESSION PATTERN; IDENTIFICATION; GLUTATHIONE; THIOLTRANSFERASE; ACCUMULATION; DISULFIDE; PROTEINS; PROTECTS	The proteins from the thioredoxin family are crucial actors in redox signaling and the cellular response to oxidative stress. The major intracellular source for oxygen radicals are the components of the respiratory chain in mitochondria. Here, we show that the mitochondrial 2-Cys peroxiredoxin (Prx3) is not only substrate for thioredoxin 2 (Trx2), but can also be reduced by glutaredoxin 2 (Grx2) via the dithiol reaction mechanism. Grx2 reduces Prx3 exhibiting catalytic constants (K-m, 23.8 mu mol.liter(-1); V-max, 1.2 mu mol.(mg.min)(-1)) similar to Trx2 (K-m, 11.2 mu mol.liter(-1); V-max, 1.1 mu mol.(mg.min)(-1)). The reduction of the catalytic disulfide of the atypical 2-Cys Prx5 is limited to the Trx system. Silencing the expression of either Trx2 or Grx2 in HeLa cells using specific siRNAs did not change the monomer: dimer ratio of Prx3 detected by a specific 2-Cys Prx redox blot. Only combined silencing of the expression of both proteins led to an accumulation of oxidized protein. We further demonstrate that the distribution of Prx3 in different mouse tissues is either linked to the distribution of Trx2 or Grx2. These results introduce Grx2 as a novel electron donor for Prx3, providing further insights into pivotal cellular redox signaling mechanisms.	[Lillig, Christopher Horst] Univ Marburg, Dept Clin Cytobiol & Cytopathol, Inst Klin Zytobiol & Zytopathol, Fachbereich Med, DE-35037 Marburg, Germany	Philipps University Marburg	Lillig, CH (corresponding author), Univ Marburg, Dept Clin Cytobiol & Cytopathol, Inst Klin Zytobiol & Zytopathol, Fachbereich Med, Robert Koch Str 6, DE-35037 Marburg, Germany.	horst@lillig.de	Hanschmann, Eva-Maria/AAS-9261-2021; Godoy, Jose/ABF-3804-2020; Hudemann, Christoph/ABF-4275-2020; Lillig, Christopher Horst/AAD-7098-2019	Hudemann, Christoph/0000-0001-5807-6882; Lillig, Christopher Horst/0000-0003-2509-5117	Deutsche Forschungsgemeinschaft [SFB593-N01]; von Behring-Rontgen Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Foundation	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB593-N01 and by a grant from the von Behring-Rontgen Foundation.	AONBERTOLINO ML, 2010, BIOCH BIOPH IN PRESS; Araki M, 1999, J BIOL CHEM, V274, P2271, DOI 10.1074/jbc.274.4.2271; Banmeyer I, 2005, FEBS LETT, V579, P2327, DOI 10.1016/j.febslet.2005.03.027; Brehelin C, 2003, PLANT PHYSIOL, V132, P2045, DOI 10.1104/pp.103.022533; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Cox AG, 2008, FREE RADICAL BIO MED, V44, P1001, DOI 10.1016/j.freeradbiomed.2007.11.017; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; DAMMEYER P, 2010, BIOCH BIOPH IN PRESS; Essler S, 2009, FEBS LETT, V583, P3531, DOI 10.1016/j.febslet.2009.10.017; Finkemeier I, 2005, J BIOL CHEM, V280, P12168, DOI 10.1074/jbc.M413189200; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Gama F, 2008, PHYSIOL PLANTARUM, V133, P599, DOI 10.1111/j.1399-3054.2008.01097.x; Gladyshev VN, 2001, J BIOL CHEM, V276, P30374, DOI 10.1074/jbc.M100020200; GODOY JR, 2010, BIOCH BIOPH IN PRESS; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P3672; HOLMGREN A, 1978, J BIOL CHEM, V253, P7424; Hudemann C, 2009, ANTIOXID REDOX SIGN, V11, P1, DOI 10.1089/ars.2008.2068; Joensson Thomas J., 2007, V44, P115; Johansson C, 2004, J BIOL CHEM, V279, P7537, DOI 10.1074/jbc.M312719200; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Li LQ, 2007, BIOCHEM BIOPH RES CO, V355, P715, DOI 10.1016/j.bbrc.2007.02.022; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lonn ME, 2008, ANTIOXID REDOX SIGN, V10, P547, DOI 10.1089/ars.2007.1821; Lundberg M, 2004, BIOCHEM BIOPH RES CO, V319, P801, DOI 10.1016/j.bbrc.2004.04.199; Lundberg M, 2001, J BIOL CHEM, V276, P26269, DOI 10.1074/jbc.M011605200; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002; Neumann CA, 2009, CELL CYCLE, V8, P4072, DOI 10.4161/cc.8.24.10242; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rouhier N, 2002, J BIOL CHEM, V277, P13609, DOI 10.1074/jbc.M111489200; Seo MS, 2000, J BIOL CHEM, V275, P20346, DOI 10.1074/jbc.M001943200; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	42	81	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40699	40705		10.1074/jbc.M110.185827	http://dx.doi.org/10.1074/jbc.M110.185827			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929858	hybrid, Green Published			2022-12-27	WOS:000285414400033
J	Saha, PK; Reddy, VT; Konopleva, M; Andreeff, M; Chan, L				Saha, Pradip K.; Reddy, Vasumathi T.; Konopleva, Marina; Andreeff, Michael; Chan, Lawrence			The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid Methyl Ester Has Potent Anti-diabetic Effects in Diet-induced Diabetic Mice and Lepr(db/db) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; JEGHERS CANCER SYNDROME; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; INSULIN-RESISTANCE; RECEPTOR-GAMMA; 2-CYANO-3,12-DIOXOOLEAN-1,9-DIEN-28-OIC ACID; SYNTHETIC TRITERPENOIDS; GLUCOSE-TRANSPORT; ENDOTHELIAL-CELLS	The triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic-acid (CDDO) and its methyl ester (CDDO-Me) are undergoing clinical trials in cancer and leukemia therapy. Here we report that CDDO-Me ameliorates diabetes in high fat diet-fed type 2 diabetic mice and in Leprdb/db mice. CDDO-Me reduces proinflammatory cytokine expression in these animals. Oral CDDO-Me administration reduces total body fat, plasma triglyceride, and free fatty acid levels. It also improves glucose tolerance and insulin tolerance tests. Its potent glucose-lowering activity results from enhanced insulin action. Hyperinsulinemic-euglycemic clamp reveals an increased glucose infusion rate required to maintain euglycemia and showed a significant increase in muscle-specific insulin-stimulated glucose uptake (71% soleus, 58% gastrocnemius) and peripheral glucose clearance as documented by a 48% increase in glucose disposal rate. CDDO-Me activates AMP-activated protein kinase (AMPK) and via LKB1 activation in muscle and liver in vivo. Treatment of isolated hepatocytes with CDDO-Me directly stimulates AMPK activity and LKB1 phosphorylation and decreases acetyl-coA carboxylase activity; it also down-regulates lipogenic gene expression, suppresses gluconeogenesis, and increases glucose uptake. Inhibition of AMPK phosphorylation using compound C and lentiviral-mediated knockdown of AMPK completely blocks the CDDO-Me-induced effect on hepatocytes as well as C2C12 cells. We conclude that the triterpenoid CDDO-Me has potent anti-diabetic action in diabetic mouse models that is mediated at least in part through AMPK activation. The in vivo anti-diabetogenic effects occur at a dose substantially lower than that used for anti-leukemia therapy. We suggest that CDDO-Me holds promise as a potential anti-diabetic agent.	[Saha, Pradip K.; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Reddy, Vasumathi T.; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chan, Lawrence] Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Blood & Marrow Transplantat, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Bioimmunotherapy, Houston, TX 77030 USA; [Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chan, L (corresponding author), Baylor Coll Med, Dept Med & Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.edu	Li-Mei, Cheng/L-2214-2013		National Institutes of Health [HL51586, P30-DK079638]; Betty Rutherford Chair in Diabetes Research; St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Betty Rutherford Chair in Diabetes Research; St. Luke's Episcopal Hospital; T. T. & W. F. Chao Global Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL51586 (to L. C.) and P30-DK079638. This work was also supported by the Betty Rutherford Chair in Diabetes Research, St. Luke's Episcopal Hospital, and the T. T. & W. F. Chao Global Foundation. M. A. and M. K. have stocks and consulting agreements with Reata Pharmaceuticals, Inc.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Cidad P, 2004, BIOCHEM J, V384, P629, DOI 10.1042/BJ20040886; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; DEZUBE BJ, 2007, ANN M AACR NCI EORTC; Fujii N, 2004, P NUTR SOC, V63, P205, DOI 10.1079/PNS2004340; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hayashi T, 1998, DIABETES, V47, pA3; HONG DS, 2008, AM SOC CLIN ONC ASCO; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HUANG MT, 1994, CANCER RES, V54, P701; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Ikeda T, 2004, MOL CANCER THER, V3, P39, DOI 10.2463/mrms.3.39; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; Koschmieder S, 2007, BLOOD, V110, P3695, DOI 10.1182/blood-2006-11-058941; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Liby K, 2008, CANCER RES, V68, P6727, DOI 10.1158/0008-5472.CAN-08-1123; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Melichar B, 2004, GYNECOL ONCOL, V93, P149, DOI 10.1016/j.ygyno.2004.01.008; NISHINO H, 1988, CANCER RES, V48, P5210; Saha PK, 2004, J BIOL CHEM, V279, P35150, DOI 10.1074/jbc.M405499200; Sakamoto K, 2005, ARTERIOSCL THROM VAS, V25, P327, DOI 10.1161/01.ATV.0000152611.50953.e2; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sapkota GP, 2001, J BIOL CHEM, V276, P19469, DOI 10.1074/jbc.M009953200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Shishodia S, 2006, CLIN CANCER RES, V12, P1828, DOI 10.1158/1078-0432.CCR-05-2044; SORIANO HE, 1992, TRANSPLANTATION, V54, P717, DOI 10.1097/00007890-199210000-00029; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Stadheim TA, 2001, CANCER RES, V61, P1533; Suh N, 1998, CANCER RES, V58, P717; Suh NJ, 1999, CANCER RES, V59, P336; Tabe Y, 2007, CANCER BIOL THER, V6, P1967, DOI 10.4161/cbt.6.12.4982; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; YASWEN P, 1984, CANCER RES, V44, P324; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou H, 2005, BIOCHEM BIOPH RES CO, V338, P793, DOI 10.1016/j.bbrc.2005.10.007; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200	62	86	103	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40581	40592		10.1074/jbc.M110.176545	http://dx.doi.org/10.1074/jbc.M110.176545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956520	Green Published, hybrid			2022-12-27	WOS:000285414400021
J	Zheng, YX; Brash, AR				Zheng, Yuxiang; Brash, Alan R.			On the Role of Molecular Oxygen in Lipoxygenase Activation COMPARISON AND CONTRAST OF EPIDERMAL LIPOXYGENASE-3 WITH SOYBEAN LIPOXYGENASE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIMILAR BIOCHEMICAL REACTIONS; LINOLEIC-ACID HYDROPEROXIDES; ALLENE OXIDE SYNTHASE; SOYBEAN LIPOXYGENASE-1; ANAEROBIC REACTION; FATTY-ACIDS; RETICULOCYTE LIPOXYGENASE; CYSTEINE.FECL3 CATALYST; PRODUCT STEREOCHEMISTRY; LIPID HYDROPEROXIDE	The oxygenation of polyunsaturated fatty acids by lipoxygenases (LOX) is associated with a lag phase during which the resting ferrous enzyme is converted to the active ferric form by reaction with fatty acid hydroperoxide. Epidermal lipoxygenase-3 (eLOX3) is atypical in displaying hydroperoxide isomerase activity with fatty acid hydroperoxides through cycling of the ferrous enzyme. Yet eLOX3 is capable of dioxygenase activity, albeit with a long lag phase and need for high concentrations of hydroperoxide activator. Here, we show that higher O-2 concentration shortens the lag phase in eLOX3, although it reduces the rate of hydroperoxide consumption, effects also associated with an A451G mutation known to affect the disposition of molecular oxygen in the LOX active site. These observations are consistent with a role of O-2 in interrupting hydroperoxide isomerase cycling. Activation of eLOX3, A451G eLOX3, and soybean LOX-1 with 13-hydroperoxy-linoleic acid forms oxygenated end products, which we identified as 9R- and 9S-hydroperoxy-12S,13S-trans-epoxyoctadec-10E-enoic acids. We deduce that activation partly depends on reaction of O-2 with the intermediate of hydroperoxide cleavage, the epoxyallylic radical, giving an epoxyallylic peroxyl radical that does not further react with Fe(III)-OH; instead, it dissociates and leaves the enzyme in the activated free ferric state. eLOX3 differs from soybean LOX-1 in more tightly binding the epoxyallylic radical and having limited access to O-2 within the active site, leading to a deficiency in activation and a dominant hydroperoxide isomerase activity.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	brash@vanderbilt.edu			National Institutes of Health [AR-051968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR-051968 (to A. R. B.).	Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; Coffa G, 2005, J BIOL CHEM, V280, P38756, DOI 10.1074/jbc.M504870200; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; DEGROOT JJM, 1973, BIOCHIM BIOPHYS ACTA, V326, P279, DOI 10.1016/0005-2760(73)90254-3; DEGROOT JJM, 1975, FEBS LETT, V56, P50, DOI 10.1016/0014-5793(75)80109-8; DIX TA, 1985, J BIOL CHEM, V260, P5358; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; GARDNER HW, 1981, BIOCHIM BIOPHYS ACTA, V665, P113, DOI 10.1016/0005-2760(81)90239-3; GARDNER HW, 1978, LIPIDS, V13, P246, DOI 10.1007/BF02533664; GARDNER HW, 1981, BIOCHIM BIOPHYS ACTA, V665, P100, DOI 10.1016/0005-2760(81)90238-1; GARDNER HW, 1981, BIOCHIM BIOPHYS ACTA, V665, P126, DOI 10.1016/0005-2760(81)90240-X; GARDNER HW, 1989, FREE RADICAL BIO MED, V7, P65, DOI 10.1016/0891-5849(89)90102-0; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; GARSSEN GJ, 1972, BIOCHEM J, V130, P435, DOI 10.1042/bj1300435; HAINING JL, 1958, J BIOL CHEM, V232, P193; Ivanov I, 2005, FEBS J, V272, P2523, DOI 10.1111/j.1742-4658.2005.04673.x; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; KUHN H, 1986, FEBS LETT, V203, P247, DOI 10.1016/0014-5793(86)80752-9; Marnett LJ, 1995, BIOCHEM SOC SYMP, P65, DOI 10.1042/bss0610065; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; NELSON MJ, 1988, J AM CHEM SOC, V110, P2985, DOI 10.1021/ja00217a056; OBRIEN PJ, 1969, CAN J BIOCHEM CELL B, V47, P485, DOI 10.1139/o69-076; Qian SY, 2003, FREE RADICAL BIO MED, V34, P1017, DOI 10.1016/S0891-5849(03)00031-5; Reeder BJ, 1998, BIOCHEM J, V330, P1317; SALZMANN U, 1984, BIOCHIM BIOPHYS ACTA, V795, P535, DOI 10.1016/0005-2760(84)90183-8; SCHEWE T, 1986, ADV ENZYMOL RAMB, V58, P191; SCHILSTRA MJ, 1994, BIOCHEMISTRY-US, V33, P3974, DOI 10.1021/bi00179a025; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; SCHILSTRA MJ, 1992, BIOCHEMISTRY-US, V31, P7692, DOI 10.1021/bi00148a033; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; VANDERHEIJDT LM, 1993, LIPIDS, V28, P779, DOI 10.1007/BF02536230; VANOS CPA, 1982, BIOCHIM BIOPHYS ACTA, V713, P173; VERHAGEN J, 1977, BIOCHIM BIOPHYS ACTA, V486, P114, DOI 10.1016/0005-2760(77)90075-3; VERHAGEN J, 1979, ADV BIOCH PHYSL PLAN, P231; VLIEGENTHART JFG, 1982, BIOL, V5, P29; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39866, DOI 10.1074/jbc.M110.155374; Zheng YX, 2010, J BIOL CHEM, V285, P13427, DOI 10.1074/jbc.M109.084632	50	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39876	39887		10.1074/jbc.M110.180794	http://dx.doi.org/10.1074/jbc.M110.180794			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20923767	Green Published, hybrid			2022-12-27	WOS:000285185500032
J	Bai, YJ; Dergham, P; Nedev, H; Xu, J; Galan, A; Rivera, JC; Shi, ZH; Mehta, HM; Woo, SB; Sarunic, MV; Neet, KE; Saragovi, HU				Bai, Yujing; Dergham, Pauline; Nedev, Hinyu; Xu, Jing; Galan, Alba; Rivera, Jose Carlos; Shi ZhiHua; Mehta, Hrishikesh M.; Woo, Sang B.; Sarunic, Marinko V.; Neet, Kenneth E.; Saragovi, H. Uri			Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75(NTR) Activity Is Neurotoxic through a Paracrine Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P75 NEUROTROPHIN RECEPTOR; GANGLION-CELL DEATH; EXPERIMENTAL GLAUCOMA; INTRAOCULAR-PRESSURE; MOUSE MODEL; IN-VIVO; DEGENERATION; EXPRESSION; SURVIVAL; LIGANDS	In normal adult retinas, NGF receptor TrkA is expressed in retinal ganglion cells (RGC), whereas glia express p75(NTR). During retinal injury, endogenous NGF, TrkA, and p75(NTR) are up-regulated. Paradoxically, neither endogenous NGF nor exogenous administration of wild type NGF can protect degenerating RGCs, even when administered at high frequency. Here we elucidate the relative contribution of NGF and each of its receptors to RGC degeneration in vivo. During retinal degeneration due to glaucoma or optic nerve transection, treatment with a mutant NGF that only activates TrkA, or with a biological response modifier that prevents endogenous NGF and proNGF from binding to p75(NTR) affords significant neuroprotection. Treatment of normal eyes with an NGF mutant-selective p75(NTR) agonist causes progressive RGC death, and in injured eyes it accelerates RGC death. The mechanism of p75(NTR) action during retinal degeneration due to glaucoma is paracrine, by increasing production of neurotoxic proteins TNF-alpha and alpha(2)-macroglobulin. Antagonists of p75(NTR) inhibit TNF-alpha and alpha(2)-macroglobulin up-regulation during disease, and afford neuroprotection. These data reveal a balance of neuroprotective and neurotoxic mechanisms in normal and diseased retinas, and validate each neurotrophin receptor as a pharmacological target for neuroprotection.	[Bai, Yujing; Dergham, Pauline; Nedev, Hinyu; Galan, Alba; Shi ZhiHua; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Xu, Jing; Sarunic, Marinko V.] Simon Fraser Univ, Dept Engn Sci, Burnaby, BC V5A 1S6, Canada; [Rivera, Jose Carlos] Hosp St Justine, Dept Pediat & Pharmacol, Montreal, PQ H3T 1C5, Canada; [Mehta, Hrishikesh M.; Woo, Sang B.; Neet, Kenneth E.] Rosalind Franklin Univ Med & Sci, Dept Biochem & Mol Biol, Chicago, IL 60064 USA; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Ctr Canc, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Bloomfield Ctr Res Ageing, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; Simon Fraser University; Universite de Montreal; Chicago Medical School; Rosalind Franklin University Medical & Science; McGill University; McGill University; McGill University; McGill University	Saragovi, HU (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca	Mehta, Hrishikesh/K-1108-2016	Mehta, Hrishikesh/0000-0001-9140-9765; Sarunic, Marinko/0000-0002-5636-9056	United States Public Health Service, National Institutes of Health [NS24380]; Canadian Institutes of Health Research [MOP 192060]; Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024380] Funding Source: NIH RePORTER	United States Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS24380 from the United States Public Health Service (to K. E. N.), Canadian Institutes of Health Research Grant MOP 192060 (to H. U. S.), and a grant from the Canadian Institutes of Health Research/Natural Sciences and Engineering Research of Canada Collaborative Health Research Projects (to M. V. S.).	BAI Y, 2010, INVEST OPHT IN PRESS; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Cui Q, 2002, INVEST OPHTH VIS SCI, V43, P1954; Danias J, 2003, INVEST OPHTH VIS SCI, V44, P1138, DOI 10.1167/iovs.02-0553; GARCIAVALENZUELA E, 1995, EXP EYE RES, V61, P33, DOI 10.1016/S0014-4835(95)80056-5; Hu B, 1998, GLIA, V24, P187, DOI 10.1002/(SICI)1098-1136(199810)24:2<187::AID-GLIA4>3.3.CO;2-Z; Hughes AL, 2001, J NEUROSCI RES, V63, P10, DOI 10.1002/1097-4547(20010101)63:1<10::AID-JNR2>3.0.CO;2-R; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Laquis S, 1998, BRAIN RES, V784, P100, DOI 10.1016/S0006-8993(97)01189-X; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2005, EYE, V19, P1241, DOI 10.1038/sj.eye.6701746; Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293; Ryden M., 1997, J BIOL CHEM, V272, P16322; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Scotter EL, 2008, J NEUROSCI METH, V171, P174, DOI 10.1016/j.jneumeth.2008.02.007; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Tezel Gulgun, 2004, Curr Opin Ophthalmol, V15, P80, DOI 10.1097/00055735-200404000-00003; THANOS S, 1991, NEUROSCI LETT, V127, P108, DOI 10.1016/0304-3940(91)90906-A; Urcola JH, 2006, EXP EYE RES, V83, P429, DOI 10.1016/j.exer.2006.01.025; Wax MB, 2002, MOL NEUROBIOL, V26, P45, DOI 10.1385/MN:26:1:045	36	79	85	5	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39392	39400		10.1074/jbc.M110.147801	http://dx.doi.org/10.1074/jbc.M110.147801			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20943663	Green Published, hybrid			2022-12-27	WOS:000284941300066
J	Chang, SH; Chung, Y; Dong, C				Chang, Seon Hee; Chung, Yeonseok; Dong, Chen			Vitamin D Suppresses Th17 Cytokine Production by Inducing C/EBP Homologous Protein (CHOP) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; T-CELLS; 25-HYDROXYVITAMIN D; ROR-GAMMA; DIFFERENTIATION; PROGRAM	Vitamin D has been shown to have immunomodulatory function, but the molecular basis for it has not been well understood. In this study, we found that vitamin D receptor expression was induced in a CD4+ effector T cell lineage, Th17 cells, which required the transcription factors, ROR alpha, ROR gamma t, and STAT3. Treatment of mice with an active ligand of vitamin D receptor (VDR), 1,25-dihydroxyvitamin D-3 (1,25D3), ameliorated experimental autoimmune encephalomyelitis, accompanied with reduced IL-17 and IL-17F expression. In vitro, treatment of CD4+ T cells with the physiological doses of 1,25D3 preferentially inhibited cytokine production by Th17 cells, in a VDR-dependent manner, without affecting the expression of transcription factors or surface molecules. Moreover, at these concentrations, cytokine expression was suppressed only at protein but not at mRNA levels. Stimulation of Th17 cells with 1,25D3, in a concentration-dependent manner, induced the expression of C/EBP homologous protein (CHOP), a molecule involved in endoplasmic reticulum stress and translational inhibition. In addition, overexpression of CHOP in developing Th17 cells suppressed their cytokine production. Our results suggest a novel, post-transcriptional mechanism whereby Th17 cytokines are inhibited by VDR, which may underscore future therapeutic usage of vitamin D in treatment of autoimmune diseases.	[Dong, Chen] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA; Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dong, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77054 USA.	cdong@mdanderson.org	Chang, Seon Hee/AAQ-9521-2020; dong, chen/B-3181-2009	Chang, Seon Hee/0000-0002-9389-508X; dong, chen/0000-0002-0084-9130; Chung, Yeonseok/0000-0001-5780-4841	National Institutes of Health [5R01AR050772-09]; Research Trust Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Trust Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AR050772-09 (to C.D.) and a Research Trust Fellowship (to C.D.).	Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Holick MF, 1996, J NUTR, V126, pS1159, DOI 10.1093/jn/126.suppl_4.1159S; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Mahon BD, 2003, J CELL BIOCHEM, V89, P922, DOI 10.1002/jcb.10580; MORA JR, 2008, NAT REV IMMUNOL; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pedersen LB, 2007, J NEUROSCI RES, V85, P2480, DOI 10.1002/jnr.21382; Penna G, 2006, J IMMUNOL, V177, P8504, DOI 10.4049/jimmunol.177.12.8504; Platz EA, 2000, CANCER EPIDEM BIOMAR, V9, P1059; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	23	140	147	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38751	38755		10.1074/jbc.C110.185777	http://dx.doi.org/10.1074/jbc.C110.185777			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20974859	Green Published, hybrid			2022-12-27	WOS:000284941300003
J	Serpa, J; Caiado, F; Carvalho, T; Torre, C; Goncalves, LG; Casalou, C; Lamosa, P; Rodrigues, M; Zhu, ZP; Lam, EWF; Dias, S				Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Goncalves, Luis G.; Casalou, Cristina; Lamosa, Pedro; Rodrigues, Margarida; Zhu, Zhenping; Lam, Eric W. F.; Dias, Sergio			Butyrate-rich Colonic Microenvironment Is a Relevant Selection Factor for Metabolically Adapted Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; ENDOTHELIAL GROWTH-FACTOR; CANCER CELLS; SIGNALING PATHWAYS; COLORECTAL-CANCER; SODIUM-BUTYRATE; GENE-EXPRESSION; CARCINOMA CELLS; RAT COLON; IN-VIVO	The short chain fatty acid (SCFA) buyrate is a product of colonic fermentation of dietary fibers. It is the main source of energy for normal colonocytes, but cannot be metabolized by most tumor cells. Butyrate also functions as a histone deacetylase (HDAC) inhibitor to control cell proliferation and apoptosis. In consequence, butyrate and its derived drugs are used in cancer therapy. Here we show that aggressive tumor cells that retain the capacity of metabolizing butyrate are positively selected in their microenvironment. In the mouse xenograft model, butyrate-preselected human colon cancer cells gave rise to subcutaneous tumors that grew faster and were more angiogenic than those derived from untreated cells. Similarly, butyrate-preselected cells demonstrated a significant increase in rates of homing to the lung after intravenous injection. Our data showed that butyrate regulates the expression of VEGF and its receptor KDR at the transcriptional level potentially through FoxM1, resulting in the generation of a functional VEGF: KDR autocrine growth loop. Cells selected by chronic exposure to butyrate express higher levels of MMP2, MMP9, alpha 2 and alpha 3 integrins, and lower levels of E-cadherin, a marker for epithelial to mesenchymal transition. The orthotopic model of colon cancer showed that cells preselected by butyrate are able to colonize the animals locally and at distant organs, whereas control cells can only generate a local tumor in the cecum. Together our data shows that a butyrate-rich microenvironment may select for tumor cells that are able to metabolize butyrate, which are also phenotypically more aggressive.	[Dias, Sergio] CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Angiogenesis Grp,Ctr Lisboa, P-1099023 Lisbon, Portugal; [Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Casalou, Cristina; Dias, Sergio] Inst Gulbenkian Ciencias, P-2780157 Oeiras, Portugal; [Serpa, Jacinta; Caiado, Francisco; Carvalho, Tania; Torre, Cheila; Casalou, Cristina; Dias, Sergio] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, P-1169056 Lisbon, Portugal; [Goncalves, Luis G.; Lamosa, Pedro] Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Rodrigues, Margarida] CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Serv Anat Patol,Ctr Lisboa, P-1099023 Lisbon, Portugal; [Zhu, Zhenping] ImClone Syst, New York, NY 10014 USA; [Lam, Eric W. F.] Canc Res UK Labs, London W12 ONN, England; [Lam, Eric W. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Surg & Canc, London W12 ONN, England	Portuguese Institute of Oncology; Instituto Gulbenkian de Ciencia; Universidade Nova de Lisboa; Portuguese Institute of Oncology; Eli Lilly; Cancer Research UK; Imperial College London	Dias, S (corresponding author), CIPM IPOLFG, EPE, Inst Portugues Oncol Francisco Gentil, Angiogenesis Grp,Ctr Lisboa, Rua Prof Lima Basto, P-1099023 Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Dias, Sergio/L-1250-2014; /AAD-5368-2019; Serpa, Jacinta/A-4772-2013; Lam, Eric W-F/AAW-8566-2020; Casalou, Cristina/AAU-6804-2021; Carvalho, Tânia/GNM-6203-2022; Carvalho, Tânia/X-2873-2019; Serpa, Jacinta/GLV-1532-2022; Serpa, Jacinta/AAD-1861-2020; Gonçalves, Luís Gafeira/D-3683-2011	Dias, Sergio/0000-0002-7603-4616; Lam, Eric W-F/0000-0003-1274-3576; Casalou, Cristina/0000-0003-3198-2783; Carvalho, Tânia/0000-0002-5283-5013; Serpa, Jacinta/0000-0002-1548-5907; Gonçalves, Luís Gafeira/0000-0001-5683-3552; Cheila, Torre/0000-0001-5518-6082; Lamosa, Pedro/0000-0002-3003-1516; Caiado, Francisco/0000-0003-4096-4448	Fundacao Luso Americana para o Desenvolvimento (FLAD); Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul; Fundacao Para a Ciencia e a Tecnologia (Portuguese Government); FCT; FEDER	Fundacao Luso Americana para o Desenvolvimento (FLAD); Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul; Fundacao Para a Ciencia e a Tecnologia (Portuguese Government)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission)	This work was supported in part by grants from the Fundacao Luso Americana para o Desenvolvimento (FLAD) and Liga Portuguesa Contra o Cancro (LPCC), Nucleo Regional Sul.; Supported by Fundacao Para a Ciencia e a Tecnologia (Portuguese Government) Fellowships.; We acknowledge the Servico de Anatomia Patologica, Instituto Portugues de Oncologia de Francisco Gentil, Centro de Lisboa, EPE (CIPM/IPOLFG) for the support in histological analysis. We thank Prof. Helena Santos (ITQB) for the scientific support in NMR experiments. We acknowledge the use of the NMR spectrometers at CERMAX, which are part of the National NMR Network and were acquired with funds from FCT and FEDER.	Barnett DK, 1996, DEV DYNAM, V205, P64, DOI 10.1002/(SICI)1097-0177(199601)205:1<64::AID-AJA6>3.0.CO;2-3; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Calvani M, 2008, CANCER RES, V68, P285, DOI 10.1158/0008-5472.CAN-07-5564; Chai F, 2000, CARCINOGENESIS, V21, P7, DOI 10.1093/carcin/21.1.7; Contreras HR, 2010, UROL ONCOL-SEMIN ORI, V28, P534, DOI 10.1016/j.urolonc.2009.03.018; de Silanes IL, 2004, CANCER RES, V64, P4593, DOI 10.1158/0008-5472.CAN-04-0711; Di Simone N, 2009, J CELL MOL MED, V13, P388, DOI 10.1111/j.1582-4934.2008.00337.x; Dias S, 2001, P NATL ACAD SCI USA, V98, P10857, DOI 10.1073/pnas.191117498; Dormond O, 2007, J BIOL CHEM, V282, P23679, DOI 10.1074/jbc.M700563200; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gentner B, 2009, ANTICANCER RES, V29, P67; HEERDT BG, 1994, CANCER RES, V54, P3288; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Izumi T, 2007, AM J SURG PATHOL, V31, P85, DOI 10.1097/01.pas.0000213413.33558.85; Krimi RB, 2009, DIABETES, V58, P2032, DOI 10.2337/db08-1786; Lee TK, 2007, CANCER LETT, V254, P308, DOI 10.1016/j.canlet.2007.03.017; Leng SL, 2001, CARCINOGENESIS, V22, P1625, DOI 10.1093/carcin/22.10.1625; Mariadason JM, 2001, GASTROENTEROLOGY, V120, P889, DOI 10.1053/gast.2001.22472; Medina V, 1998, JPEN-PARENTER ENTER, V22, P14, DOI 10.1177/014860719802200114; Miranda E, 2006, BRIT J CANCER, V95, P1101, DOI 10.1038/sj.bjc.6603337; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Park S, 2008, ENDOCRINOLOGY, V149, P445, DOI 10.1210/en.2007-0754; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Santos SCR, 2004, BLOOD, V103, P3883, DOI 10.1182/BLOOD-2003-05-1634; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Shi SL, 2006, WORLD J GASTROENTERO, V12, P1694, DOI 10.3748/wjg.v12.i11.1694; Struckmann K, 2008, J PATHOL, V214, P464, DOI 10.1002/path.2310; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	33	51	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39211	39223		10.1074/jbc.M110.156026	http://dx.doi.org/10.1074/jbc.M110.156026			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926374	hybrid, Green Published			2022-12-27	WOS:000284941300051
J	Zucconi, BE; Ballin, JD; Brewer, BY; Ross, CR; Huang, J; Toth, EA; Wilson, GM				Zucconi, Beth E.; Ballin, Jeff D.; Brewer, Brandy Y.; Ross, Christina R.; Huang, Jun; Toth, Eric A.; Wilson, Gerald M.			Alternatively Expressed Domains of AU-rich Element RNA-binding Protein 1 (AUF1) Regulate RNA-binding Affinity, RNA-induced Protein Oligomerization, and the Local Conformation of Bound RNA Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; 3'-UNTRANSLATED REGION; FLUORESCENCE ANISOTROPY; STRANDED-DNA; STEM-LOOP; HUR; STABILITY; ISOFORMS; DESTABILIZATION; PHOSPHORYLATION	AU-rich element RNA-binding protein 1 (AUF1) binding to AU-rich elements (AREs) in the 3'-untranslated regions of mRNAs encoding many cytokines and other regulatory proteins modulates mRNA stability, thereby influencing protein expression. AUF1-mRNA association is a dynamic paradigm directed by various cellular signals, but many features of its function remain poorly described. There are four isoforms of AUF1 that result from alternative splicing of exons 2 and 7 from a common pre-mRNA. Preliminary evidence suggests that the different isoforms have varied functional characteristics, but no detailed quantitative analysis of the properties of each isoform has been reported despite their differential expression and regulation. Using purified recombinant forms of each AUF1 protein variant, we used chemical cross-linking and gel filtration chromatography to show that each exists as a dimer in solution. We then defined the association mechanisms of each AUF1 isoform for ARE-containing RNA substrates and quantified relevant binding affinities using electrophoretic mobility shift and fluorescence anisotropy assays. Although all AUF1 isoforms generated oligomeric complexes on ARE substrates by sequential dimer association, sequences encoded by exon 2 inhibited RNA-binding affinity. By contrast, the exon 7-encoded domain enhanced RNA-dependent protein oligomerization, even permitting cooperative RNA-binding activity in some contexts. Finally, fluorescence resonance energy transfer-based assays showed that the different AUF1 isoforms remodel bound RNA substrates into divergent structures as a function of protein: RNA stoichiometry. Together, these data describe isoform-specific characteristics among AUF1 ribonucleoprotein complexes, which likely constitute a mechanistic basis for differential functions and regulation among members of this protein family.	[Wilson, Gerald M.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, GM (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	gwils001@umaryland.edu	Wilson, Gerald/AAF-3874-2019; Ballin, Jeff D/AAC-3869-2022; Ballin, Jeff/D-3752-2011	Ballin, Jeff D/0000-0002-2712-130X; Ballin, Jeff/0000-0002-2712-130X; Wilson, Gerald/0000-0002-1273-7507	National Institutes of Health, NCI [R01 CA102428]; National Institutes of Health, NIGMS [T32 GM066706]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA102428 from NCI (to G. M. W.).; Supported in part by National Institutes of Health Grant T32 GM066706 from NIGMS.	Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; Arao Y, 2000, ARCH BIOCHEM BIOPHYS, V380, P228, DOI 10.1006/abbi.2000.1938; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bhattacharyya SN, 2006, COLD SPRING HARB SYM, V71, P513, DOI 10.1101/sqb.2006.71.038; Blum JL, 2005, AM J PHYSIOL-HEART C, V289, pH2543, DOI 10.1152/ajpheart.00545.2005; Bouvet P, 2001, J MOL BIOL, V309, P763, DOI 10.1006/jmbi.2001.4691; BREWER G, 1991, MOL CELL BIOL, V11, P2460, DOI 10.1128/MCB.11.5.2460; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Chang N, 2010, MOL CELL BIOL, V30, P3875, DOI 10.1128/MCB.00169-10; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1994, MOL CELL BIOL, V14, P416, DOI 10.1128/MCB.14.1.416; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; DeMaria CT, 1997, J BIOL CHEM, V272, P27635, DOI 10.1074/jbc.272.44.27635; Eversole A, 2000, MOL CELL BIOL, V20, P5425, DOI 10.1128/MCB.20.15.5425-5432.2000; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Fawal M, 2006, BLOOD, V108, P2780, DOI 10.1182/blood-2006-04-014902; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Glaser ND, 2006, AM J PHYSIOL-HEART C, V291, pH1183, DOI 10.1152/ajpheart.01162.2005; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Heyduk T, 1996, METHOD ENZYMOL, V274, P492; Ing NH, 2008, J BIOL CHEM, V283, P1764, DOI 10.1074/jbc.M704745200; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Jezewska MJ, 1998, J MOL BIOL, V284, P1113, DOI 10.1006/jmbi.1998.2252; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Levi R, 2006, J AM SOC NEPHROL, V17, P107, DOI 10.1681/ASN.2005070679; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Mawji IA, 2004, J BIOL CHEM, V279, P8655, DOI 10.1074/jbc.M312190200; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mili S, 2001, MOL CELL BIOL, V21, P7307, DOI 10.1128/MCB.21.21.7307-7319.2001; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Okunola HL, 2009, MOL CELL BIOL, V29, P5620, DOI 10.1128/MCB.01678-08; Paschoud S, 2006, MOL CELL BIOL, V26, P8228, DOI 10.1128/MCB.01155-06; Pautz A, 2009, J BIOL CHEM, V284, P2755, DOI 10.1074/jbc.M809314200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Raineri I, 2004, NUCLEIC ACIDS RES, V32, P1279, DOI 10.1093/nar/gkh282; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, METHODS, V17, P74, DOI 10.1006/meth.1998.0709; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	66	51	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39127	39139		10.1074/jbc.M110.180182	http://dx.doi.org/10.1074/jbc.M110.180182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926381	hybrid, Green Published			2022-12-27	WOS:000284941300043
J	Loyer, P; Busson, A; Trembley, JH; Hyle, J; Grenet, J; Zhao, W; Ribault, C; Montier, T; Kidd, VJ; Lahti, JM				Loyer, Pascal; Busson, Adeline; Trembley, Janeen H.; Hyle, Judith; Grenet, Jose; Zhao, Wei; Ribault, Catherine; Montier, Tristan; Kidd, Vincent J.; Lahti, Jill M.			The RNA Binding Motif Protein 15B (RBM15B/OTT3) Is a Functional Competitor of Serine-Arginine (SR) Proteins and Antagonizes the Positive Effect of the CDK11(p110)-Cyclin L2 alpha Complex on Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SIGNALING PATHWAY; SPLIT-ENDS; SPEN PROTEINS; CYCLIN L1; RS DOMAIN; IN-VIVO; KINASE; CELLS; NUCLEAR	Here, we report the identification of the RNA binding motif protein RBM15B/OTT3 as a new CDK11(p110) binding partner that alters the effects of CDK11 on splicing. RBM15B was initially identified as a binding partner of the Epstein-Barr virus mRNA export factor and, more recently, as a cofactor of the nuclear export receptor NXF1. In this study, we found that RBM15B co-elutes with CDK11(p110), cyclin L2 alpha, and serine-arginine (SR) proteins, including SF2/ASF, in a large nuclear complex of similar to 1-MDa molecular mass following size exclusion chromatography. Using co-immunoprecipitation experiments and in vitro pulldown assays, we mapped two distinct domains of RBM15B that are essential for its direct interaction with the N-terminal extension of CDK11(p110), cyclin L2 alpha, and SR proteins such as 9G8 and SF2/ASF. Finally, we established that RBM15B is a functional competitor of the SR proteins SF2/ASF and 9G8, inhibits formation of the functional spliceosomal E complex, and antagonizes the positive effect of the CDK11(p110)-cyclin L2 alpha complex on splicing both in vitro and in vivo.	[Loyer, Pascal; Trembley, Janeen H.; Hyle, Judith; Grenet, Jose; Kidd, Vincent J.; Lahti, Jill M.] St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Zhao, Wei] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Montier, Tristan] Univ Bretagne Occidentale, INSERM, Sci & Ingn Biol Sante IFR148, U613, F-29218 Brest 2, France; [Loyer, Pascal; Busson, Adeline; Ribault, Catherine] Univ Rennes 1, Hop Pontchaillou, INSERM, UMR Foie 991, F-35033 Rennes, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Lahti, JM (corresponding author), St Jude Childrens Hosp, Dept Genet & Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Jill.Lahti@stjude.org	LOYER, Pascal/K-1838-2019	LOYER, PASCAL/0000-0002-5656-2673; Trembley, Janeen/0000-0003-3597-2611	National Institutes of Health [R01GM044088]; Cancer Center [P30CA021765]; American Lebanese Syrian Associated Charities; INSERM; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM044088 and Cancer Center Support Grant P30CA021765. This work was also supported by the American Lebanese Syrian Associated Charities and INSERM.	Ariyoshi M, 2003, GENE DEV, V17, P1909, DOI 10.1101/gad.266203; Berke JD, 2001, NEURON, V32, P277, DOI 10.1016/S0896-6273(01)00465-2; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; Chen HH, 2006, MOL CELL BIOL, V26, P2736, DOI 10.1128/MCB.26.7.2736-2745.2006; Chen HH, 2007, BIOCHEM BIOPH RES CO, V354, P735, DOI 10.1016/j.bbrc.2007.01.049; Colley SM, 2008, IUBMB LIFE, V60, P159, DOI 10.1002/iub.22; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; Dickinson LA, 2002, J BIOL CHEM, V277, P25465, DOI 10.1074/jbc.M202266200; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Even Y, 2006, J CELL BIOCHEM, V99, P890, DOI 10.1002/jcb.20986; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Herrmann A, 2007, FASEB J, V21, P3142, DOI 10.1096/fj.07-8377com; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Hu DL, 2007, J CELL SCI, V120, P2424, DOI 10.1242/jcs.007963; Juillard F, 2009, J VIROL, V83, P12759, DOI 10.1128/JVI.01276-09; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Laurent V, 2010, BIOTECHNOL J, V5, P314, DOI 10.1002/biot.200900255; Lee C. S., 2003, CURRENT PROTOCOL MOL, V63, P2711; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; Loyer P, 1998, J CELL SCI, V111, P1495; Loyer P, 2008, J BIOL CHEM, V283, P7721, DOI 10.1074/jbc.M708188200; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Mayeda A, 1999, MOL CELL BIOL, V19, P1853; Mayeda A, 1999, METH MOL B, V118, P309; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Nasim MT, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf108; Niu C, 2009, BLOOD, V114, P2087, DOI 10.1182/blood-2009-01-197921; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Petretti C, 2006, EMBO REP, V7, P418, DOI 10.1038/sj.embor.7400639; Rebay I, 2000, GENETICS, V154, P695; Sawada T, 2008, J BIOL CHEM, V283, P26820, DOI 10.1074/jbc.M802315200; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Trembley JH, 2005, MOL CELL BIOL, V25, P1446, DOI 10.1128/MCB.25.4.1446-1457.2005; Trembley JH, 2004, PROG NUCLEIC ACID RE, V77, P263, DOI 10.1016/S0079-6603(04)77007-5; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Valente ST, 2009, MOL CELL, V36, P279, DOI 10.1016/j.molcel.2009.10.004; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782	49	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					147	159		10.1074/jbc.M110.192518	http://dx.doi.org/10.1074/jbc.M110.192518			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044963	Green Published, hybrid			2022-12-27	WOS:000285782800016
J	Lee, HJ; Finkelstein, D; Li, XF; Wu, DQ; Shi, DL; Zheng, JJ				Lee, Ho-Jin; Finkelstein, David; Li, Xiaofeng; Wu, Dianqing; Shi, De-Li; Zheng, Jie J.			Identification of Transmembrane Protein 88 (TMEM88) as a Dishevelled-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; PDZ DOMAIN; SUBCELLULAR-LOCALIZATION; CONVERGENT EXTENSION; CHROMOSOME 17P13.1; DEP DOMAIN; SYSTEM; INHIBITION; MEMBRANE; ADJACENT	Wnt signaling pathways are involved in embryonic development and adult tissue maintenance and have been implicated in tumorigenesis. Dishevelled (Dvl/Dsh) protein is one of key components in Wnt signaling and plays essential roles in regulating these pathways through protein-protein interactions. Identifying and characterizing Dvl-binding proteins are key steps toward understanding biological functions. Given that the tripeptide VWV (Val-Trp-Val) binds to the PDZ domain of Dvl, we searched publically available databases to identify proteins containing the VWV motif at the C terminus that could be novel Dvl-binding partners. On the basis of the cellular localization and expression patterns of the candidates, we selected for further study the TMEM88 (target protein transmembrane 88), a two-transmembrane-type protein. The interaction between the PDZ domain of Dvl and the C-terminal tail of TMEM88 was confirmed by using NMR and fluorescence spectroscopy. Furthermore, in HEK293 cells, TMEM88 attenuated the Wnt/beta-catenin signaling induced by Wnt-1 ligand in a dose-dependent manner, and TMEM88 knockdown by RNAi increased Wnt activity. In Xenopus, TMEM88 protein is sublocalized at the cell membrane and inhibits Wnt signaling induced by Xdsh but not beta-catenin. In addition, TMEM88 protein inhibits the formation of a secondary axis normally induced by Xdsh. The findings suggest that TMEM88 plays a role in regulating Wnt signaling. Indeed, analysis of microarray data revealed that the expression of the Tmem88 gene was strongly correlated with that of Wnt signaling-related genes in embryonic mouse intestines. Together, we propose that TMEM88 associates with Dvl proteins and regulates Wnt signaling in a context-dependent manner.	[Lee, Ho-Jin; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Li, Xiaofeng; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Li, Xiaofeng] ENZO Biochem Inc, Farmingdale, NY 11735 USA; [Shi, De-Li] CNRS, Dev Biol Lab, UMR7622, F-75005 Paris, France	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Zheng, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, Mail Stop 311,262 Danny Thomas Blvd, Memphis, TN 38105 USA.	jie.zheng@stjude.org	Shi, De-Li/AAG-1807-2021; Lee, Ho-Jin/N-1973-2015; Lee, Ho-Jin/O-9944-2014	Lee, Ho-Jin/0000-0002-3251-4984; Zheng, Jie/0000-0001-6524-6800	National Institutes of Health [GM081492]; National Institutes of Health, NCI Cancer Center [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081492 and by National Institutes of Health, NCI Cancer Center Support Grant CA21765. This work was also supported by the American Lebanese Syrian Associated Charities.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Chang H, 2004, BRIT J HAEMATOL, V127, P280, DOI 10.1111/j.1365-2141.2004.05199.x; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cousin P, 2000, GENOMICS, V63, P60, DOI 10.1006/geno.1999.6062; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dolan K, 1999, HUM PATHOL, V30, P1508, DOI 10.1016/S0046-8177(99)90175-2; Flavin RJ, 2009, MODERN PATHOL, V22, P197, DOI 10.1038/modpathol.2008.135; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Han K, 2004, BIOINFORMATICS, V20, P2466, DOI 10.1093/bioinformatics/bth253; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jung HL, 2004, J NEURO-ONCOL, V67, P41, DOI 10.1023/B:NEON.0000021773.71127.fb; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lee HB, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.04C032; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee HJ, 2009, BIOORGAN MED CHEM, V17, P1701, DOI 10.1016/j.bmc.2008.12.060; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Malbon CC, 2006, CURR TOP DEV BIOL, V72, P153, DOI 10.1016/S0070-2153(05)72002-0; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Pellecchia M, 2002, NAT REV DRUG DISCOV, V1, P211, DOI 10.1038/nrd748; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Suzuki H, 2003, GENOME RES, V13, P1534, DOI 10.1101/gr.956303; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang NX, 2008, DRUG NEWS PERSPECT, V21, P137, DOI 10.1358/dnp.2008.21.3.1203409; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	48	35	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41549	41556		10.1074/jbc.M110.193383	http://dx.doi.org/10.1074/jbc.M110.193383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044957	Green Published, hybrid			2022-12-27	WOS:000285622600042
J	Martinez-Barriocanal, A; Comas-Casellas, E; Schwartz, S; Martin, M; Sayos, J				Martinez-Barriocanal, Agueda; Comas-Casellas, Emma; Schwartz, Simo, Jr.; Martin, Margarita; Sayos, Joan			CD300 Heterocomplexes, a New and Family-restricted Mechanism for Myeloid Cell Signaling Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR IRP60 CD300A; INHIBITORY RECEPTOR; FUNCTIONAL-CHARACTERIZATION; IMMUNOGLOBULIN SUPERFAMILY; 3-DIMENSIONAL STRUCTURE; EXTRACELLULAR DOMAIN; ACTIVATING RECEPTORS; ADAPTER PROTEINS; IMMUNE-RESPONSES; CUTTING EDGE	The CD300 family of myeloid immunoglobulin receptors includes activating (CD300b, CD300e) and inhibitory members (CD300a, CD300f), as well as molecules of uncertain function presenting a negative charge within their transmembrane domain (CD300c, CD300d). In this paper, we establish that CD300c is a functional immune receptor able to deliver activating signals upon ligation in RBL-2H3 mast cells. CD300c signaling is partially mediated by a direct association with the immune receptor tyrosine-based activation motif-bearing adaptor Fc epsilon R gamma. The existence of complementary transmembrane- charged residues in certain CD300 receptors suggested the formation of heterodimers within this family. Indeed, we proved the interaction between CD300b and CD300c in transfected COS-7 cells and demonstrated that it has important functional consequences. Unexpectedly, dimmer formation was dependent on the immunoglobulin domains rather than the charged transmembrane residues. Concordantly, all CD300 members were found to interact with each other, even with themselves, forming both homo-and heterodimers. We found that the combination of CD300 receptors in a complex differentially modulates the signaling outcome, strongly suggesting a new mechanism by which CD300 complexes could regulate the activation of myeloid cells upon interaction with their natural ligands.	[Sayos, Joan] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, CIBBIM Nanomed Program,Immunobiol Grp, Barcelona 08035, Spain; [Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Inst Recerca VHIR, Hosp Univ Vall dHebron, CIBBIM Nanomed Program,Drug Delivery & Targeting, Barcelona 08035, Spain; [Martinez-Barriocanal, Agueda; Comas-Casellas, Emma; Schwartz, Simo, Jr.; Sayos, Joan] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBBE, Barcelona 08035, Spain; [Martin, Margarita] Univ Barcelona, Fac Med, Inst Invest Biomed August Pi i Sunyer, Biochem Unit, Barcelona 08036, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Instituto de Salud Carlos III; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS		agmartinez@ir.vhebron.net; jsayos@ir.vhebron.net	Schwartz, Simo/H-7776-2012; Martinez, Agueda/AAB-7186-2019; Andorra, Margarita Martin/H-2025-2015; Sayos, Joan/B-6119-2009	Martinez, Agueda/0000-0002-8809-160X; Andorra, Margarita Martin/0000-0002-9245-4899; Sayos, Joan/0000-0002-4664-3461; Comas-Casellas, Emma/0000-0002-8567-6848; Schwartz, Simo/0000-0001-8297-7971	Plan Nacional I + D [SAF2004-00972, SAF2009-07548]; Fondo de Investigaciones Sanitarias [PI080366]; Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) [2009 SGR 493]; Ministerio de Ciencia e Inovacion; Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III [CP06/00058]	Plan Nacional I + D; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Ciencia e Inovacion(Spanish Government); Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III	This work was supported in part by Plan Nacional I + D Grants SAF2004-00972 and SAF2009-07548, Fondo de Investigaciones Sanitarias Grant PI080366, and Agencia de Gestio d'Ajuts Universitaris i de Recerca de Catalunya (AGAUR) (2009 SGR 493).; Supported by a fellowship from the Ministerio de Ciencia e Inovacion. To whom correspondence may be addressed. E-mail: agmartinez@ir.vhebron.net.; Supported by a contract from the Fondo de Investigaciones Sanitarias from Instituto de Salud Carlos III (CP06/00058).	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Alvarez-Errico D, 2004, EUR J IMMUNOL, V34, P3690, DOI 10.1002/eji.200425433; Alvarez-Errico D, 2007, J IMMUNOL, V178, P808, DOI 10.4049/jimmunol.178.2.808; Bachelet I, 2005, J IMMUNOL, V175, P7989, DOI 10.4049/jimmunol.175.12.7989; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brckalo T, 2010, EUR J IMMUNOL, V40, P722, DOI 10.1002/eji.200939468; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Chang CW, 1999, J IMMUNOL, V163, P4651; Chiesa S, 2005, MOL IMMUNOL, V42, P477, DOI 10.1016/j.molimm.2004.07.030; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Clark GJ, 2001, TISSUE ANTIGENS, V57, P415, DOI 10.1034/j.1399-0039.2001.057005415.x; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Dietrich J, 2000, MICROBES INFECT, V2, P323, DOI 10.1016/S1286-4579(00)00294-X; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fujimoto M, 2006, INT IMMUNOL, V18, P1499, DOI 10.1093/intimm/dxl083; Geng LP, 2001, P NATL ACAD SCI USA, V98, P11527, DOI 10.1073/pnas.191378198; Hedin KE, 1997, J IMMUNOL, V159, P5431; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Izawa K, 2007, J BIOL CHEM, V282, P17997, DOI 10.1074/jbc.M701100200; Izawa K, 2009, J IMMUNOL, V183, P925, DOI 10.4049/jimmunol.0900552; JACKSON DG, 1992, EUR J IMMUNOL, V22, P1157, DOI 10.1002/eji.1830220508; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Marquez JA, 2007, J MOL BIOL, V367, P310, DOI 10.1016/j.jmb.2007.01.011; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Munitz A, 2006, BLOOD, V107, P1996, DOI 10.1182/blood-2005-07-2926; Nakajima T, 2002, BLOOD, V100, P3861, DOI 10.1182/blood-2002-02-0602; Nakano T, 2008, MOL IMMUNOL, V45, P289, DOI 10.1016/j.molimm.2007.04.011; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Sayos J, 2001, BLOOD, V97, P3867, DOI 10.1182/blood.V97.12.3867; Shields MJ, 1998, J IMMUNOL, V160, P2297; Smith KM, 1998, J IMMUNOL, V161, P7; Speckman RA, 2003, HUM GENET, V112, P34, DOI 10.1007/s00439-002-0851-y; Springer TA, 2004, ADV PROTEIN CHEM, V68, P29; Tomasello E, 2000, SEMIN IMMUNOL, V12, P139, DOI 10.1006/smim.2000.0216; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Wienands J, 2000, CURR TOP MICROBIOL, V245, P53; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Yamanishi Y, 2008, BLOOD, V111, P688, DOI 10.1182/blood-2007-04-085787; Zamoyska R, 1998, CURR OPIN IMMUNOL, V10, P82, DOI 10.1016/S0952-7915(98)80036-8	54	31	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41781	41794		10.1074/jbc.M110.140889	http://dx.doi.org/10.1074/jbc.M110.140889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959446	Green Published, hybrid			2022-12-27	WOS:000285622600066
J	Yoshioka, M; Nakayama, Y; Yoshida, M; Ohashi, K; Morita, N; Kobayashi, H; Yamamoto, Y				Yoshioka, Miho; Nakayama, Yosuke; Yoshida, Mari; Ohashi, Kensuke; Morita, Noriko; Kobayashi, Hideki; Yamamoto, Yasusi			Quality Control of Photosystem II FtsH HEXAMERS ARE LOCALIZED NEAR PHOTOSYSTEM II AT GRANA FOR THE SWIFT REPAIR OF DAMAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; DEPENDENT PROTEASE FTSH; THYLAKOID MEMBRANES; METALLOPROTEASE FTSH; CHLOROPLASTIC FTSH; CRYSTAL-STRUCTURE; LEAF VARIEGATION; OXYGEN EVOLUTION; HIGHER-PLANTS; SPINACH	The reaction center-binding D1 protein of Photosystem II is oxidatively damaged by excessive visible light or moderate heat stress. The metalloprotease FtsH has been suggested as responsible for the degradation of the D1 protein. We have analyzed the distribution and subunit structures of FtsH in spinach thylakoids and various membrane fractions derived from the thylakoids using clear native polyacrylamide gel electrophoresis and Western blot analysis. FtsH was found not only in the stroma thylakoids but also in the Photosystem II-enriched grana membranes. Monomeric, dimeric, and hexameric FtsH proteases were present as major subunit structures in thylakoids, whereas only hexameric FtsH proteases were detected in Triton X-100-solubilized Photosystem II membranes. Importantly, among the membrane fractions examined, hexameric FtsH proteases were most abundant in the Photosystem II membranes. In accordance with this finding, D1 degradation took place in the Photosystem II membranes under light stress. Sucrose density gradient centrifugation analysis of thylakoids and the Photosystem II membranes solubilized with n-dodecyl-beta-D-maltoside and a chemical cross-linking study of thylakoids showed localization of FtsH near the Photosystem II light-harvesting chlorophyll-protein super-complexes in the grana. These results suggest that part of the FtsH hexamers are juxtapositioned to PSII complexes in the grana in darkness, carrying out immediate degradation of the photodamaged D1 protein under light stress.	[Yamamoto, Yasusi] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Kobayashi, Hideki] Okayama Univ, Ctr Fac Dev, Okayama 7008530, Japan	Okayama University; Okayama University	Yamamoto, Y (corresponding author), 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	yasusiya@cc.okayama-u.ac.jp	Yamamoto, Yasusi/B-2637-2011; Yoshioka-Nishimura, Miho/C-2745-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan [20570039]; Wesco Science Promotion Foundation; Ryobi Foundation; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wesco Science Promotion Foundation; Ryobi Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research Number 20570039 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Wesco Science Promotion Foundation, and the Ryobi Foundation (to Y.Y.). Support also comes from Japan Society for the Promotion of Science Research Fellowships for Young Scientists (to Miho Yoshioka).	Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Albertsson PA, 2001, TRENDS PLANT SCI, V6, P349, DOI 10.1016/S1360-1385(01)02021-0; Andersson B, 1997, PHYSIOL PLANTARUM, V100, P780, DOI 10.1034/j.1399-3054.1997.1000405.x; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Arvidsson PO, 1999, AUST J PLANT PHYSIOL, V26, P687, DOI 10.1071/PP99072; Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; DUNAHAY TG, 1984, BIOCHIM BIOPHYS ACTA, V764, P179, DOI 10.1016/0005-2728(84)90027-6; ENAMI I, 1989, BIOCHIM BIOPHYS ACTA, V977, P33, DOI 10.1016/S0005-2728(89)80006-4; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; KUWABARA T, 1982, PLANT CELL PHYSIOL, V23, P533, DOI 10.1093/oxfordjournals.pcp.a076378; LETO KJ, 1985, EMBO J, V4, P1645, DOI 10.1002/j.1460-2075.1985.tb03832.x; Lindahl M, 1996, J BIOL CHEM, V271, P29329, DOI 10.1074/jbc.271.46.29329; Mullineaux CW, 2008, PHOTOCHEM PHOTOBIOL, V84, P1310, DOI 10.1111/j.1751-1097.2008.00420.x; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Packer L, 1972, Methods Enzymol, V24, P181; Sakamoto W, 2003, PLANT CELL, V15, P2843, DOI 10.1105/tpc.017319; Sakamoto W, 2002, GENES CELLS, V7, P769, DOI 10.1046/j.1365-2443.2002.00558.x; SALTER AH, 1992, BIOCHEMISTRY-US, V31, P3990, DOI 10.1021/bi00131a014; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; SHIPTON CA, 1991, P NATL ACAD SCI USA, V88, P6691, DOI 10.1073/pnas.88.15.6691; Silva P, 2003, PLANT CELL, V15, P2152, DOI 10.1105/tpc.012609; Sinvany-Villalobo G, 2004, PLANT PHYSIOL, V135, P1336, DOI 10.1104/pp.104.043299; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Yamamoto Y, 2004, METH MOL B, V274, P29; Yamamoto Y, 2004, METH MOL B, V274, P217; YAMAMOTO Y, 1982, BIOCHIM BIOPHYS ACTA, V679, P347, DOI 10.1016/0005-2728(82)90306-1; YAMAMOTO Y, 1981, FEBS LETT, V133, P265, DOI 10.1016/0014-5793(81)80520-0; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zaltsman A, 2005, PLANT CELL, V17, P2782, DOI 10.1105/tpc.105.035071	45	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41972	41981		10.1074/jbc.M110.117432	http://dx.doi.org/10.1074/jbc.M110.117432			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20921219	Green Published, hybrid			2022-12-27	WOS:000285622600083
J	Li, YH; Chen, MHC; Gong, HY; Hu, SY; Li, YW; Lin, GH; Lin, CC; Liu, W; Wu, JL				Li, Yen-Hsing; Chen, Mark Hung-Chih; Gong, Hong-Yi; Hu, Shao-Yang; Li, Ya-Wen; Lin, Gen-Hwa; Lin, Ching-Chun; Liu, Wangta; Wu, Jen-Leih			Progranulin A-mediated MET Signaling Is Essential for Liver Morphogenesis in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRANULIN-EPITHELIN PRECURSOR; HEPATOCYTE GROWTH-FACTOR; HUMAN HEPATOCELLULAR-CARCINOMA; PROMOTES TUMOR-GROWTH; BREAST-CANCER CELLS; C-MET; GENE-EXPRESSION; DEFICIENT MICE; MESSENGER-RNA; BETA-CATENIN	The mechanism that regulates embryonic liver morphogenesis remains elusive. Progranulin (PGRN) is postulated to play a critical role in regulating pathological liver growth. Nevertheless, the exact regulatory mechanism of PGRN in relation to its functional role in embryonic liver development remains to be elucidated. In our study, the knockdown of progranulin A (GrnA), an orthologue of mammalian PGRN, using antisense morpholinos resulted in impaired liver morphogenesis in zebrafish (Danio rerio). The vital role of GrnA in hepatic outgrowth and not in liver bud formation was further confirmed using whole-mount in situ hybridization markers. In addition, a GrnA deficiency was also found to be associated with the deregulation of MET-related genes in the neonatal liver using a microarray analysis. In contrast, the decrease in liver size that was observed in grnA morphants was avoided when ectopic MET expression was produced by co-injecting met mRNA and grnA morpholinos. This phenomenon suggests that GrnA might play a role in liver growth regulation via MET signaling. Furthermore, our study has shown that GrnA positively modulates hepatic MET expression both in vivo and in vitro. Therefore, our data have indicated that GrnA plays a vital role in embryonic liver morphogenesis in zebrafish. As a result, a novel link between PGRN and MET signaling is proposed.	[Wu, Jen-Leih] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 115, Taiwan; [Li, Yen-Hsing; Li, Ya-Wen; Lin, Gen-Hwa; Lin, Ching-Chun; Liu, Wangta; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Li, Yen-Hsing; Wu, Jen-Leih] Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 402, Taiwan; [Li, Yen-Hsing; Wu, Jen-Leih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Chen, Mark Hung-Chih] Hungkuang Univ, Biotechnol Res Inst, Dept Biotechnol, Bioluminescence Life Image Lab, Taichung 433, Taiwan; [Gong, Hong-Yi] Natl Taiwan Ocean Univ, Coll Life Sci, Dept Aquaculture, Chilung 202, Taiwan; Natl Pingtung Univ Sci & Technol, Dept Life Sci, Pingtung 912, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan; National Chung Hsing University; National Chung Hsing University; Hungkuang University; National Taiwan Ocean University; National Pingtung University Science & Technology	Wu, JL (corresponding author), Acad Sinica, ICOB, 128,Sec 2, Taipei 11529, Taiwan.	jlwu@gate.sinica.edu.tw	Chen, Mark/B-2750-2011; Gong, Hong-Yi/ABE-2571-2020	Gong, Hong-Yi/0000-0002-6240-0582	National Science Council of Taiwan; National Science Council [97-2317-B-001-002, 97-2313-B-241-001-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council 97-2317-B-001-002 Grant (to J.-L. W.) and National Science Council 97-2313-B-241-001-MY3 Grant (to M. H.-C. C. and J.-L. W.) from the National Science Council of Taiwan.	Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Boon EMJ, 2002, CANCER RES, V62, P5126; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chen MHC, 2007, GEN COMP ENDOCR, V150, P212, DOI 10.1016/j.ygcen.2006.08.005; Cheung ST, 2004, CLIN CANCER RES, V10, P7629, DOI 10.1158/1078-0432.CCR-04-0960; Chou MY, 2008, J EXP BIOL, V211, P3077, DOI 10.1242/jeb.019950; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Finkbeiner MR, 2009, ONCOGENE, V28, P1421, DOI 10.1038/onc.2008.485; Gambarotta G, 1996, ONCOGENE, V13, P1911; Grisendi S, 2001, J BIOL CHEM, V276, P46632, DOI 10.1074/jbc.M104323200; Haines L, 2004, DEVELOPMENT, V131, P4857, DOI 10.1242/dev.01374; He ZH, 1999, CANCER RES, V59, P3222; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Hu MC, 2007, BIOCHEM BIOPH RES CO, V359, P778, DOI 10.1016/j.bbrc.2007.05.183; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kim WE, 2006, CLIN CANCER RES, V12, P4192, DOI 10.1158/1078-0432.CCR-05-2663; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Latimer AJ, 2008, DEV DYNAM, V237, P3904, DOI 10.1002/dvdy.21794; Liu YH, 1998, EXP CELL RES, V242, P174, DOI 10.1006/excr.1998.4107; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Miyata Y, 2009, HUM PATHOL, V40, P496, DOI 10.1016/j.humpath.2008.09.011; Nakaigawa N, 2006, CANCER RES, V66, P3699, DOI 10.1158/0008-5472.CAN-05-0617; Nikopoulos GN, 2008, BIOTECHNIQUES, V44, P547, DOI 10.2144/000112725; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; PALMITER RD, 1983, SCIENCE, V222, P809, DOI 10.1126/science.6356363; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pizarro GO, 2007, INT J CANCER, V120, P2339, DOI 10.1002/ijc.22559; Ren Y, 2006, ONCOGENE, V25, P3501, DOI 10.1038/sj.onc.1209395; Rudolph D, 2000, GENE DEV, V14, P854; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Shepard JL, 2004, METHOD CELL BIOL, V76, P109; SUZUKI K, 1994, HEPATOLOGY, V20, P1231; Tangkeangsirisin W, 2004, CANCER RES, V64, P1737, DOI 10.1158/0008-5472.CAN-03-2364; Tavian D, 2000, INT J CANCER, V87, P644, DOI 10.1002/1097-0215(20000901)87:5<644::AID-IJC4>3.3.CO;2-N; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Ueki T, 1997, HEPATOLOGY, V25, P619, DOI 10.1002/hep.510250321; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang R, 2001, J CELL BIOL, V153, P1023, DOI 10.1083/jcb.153.5.1023; Watanabe T, 2006, MOL CANCER RES, V4, P499, DOI 10.1158/1541-7786.MCR-05-0141; Xia XM, 1998, BIOCHEM BIOPH RES CO, V245, P539, DOI 10.1006/bbrc.1998.8498; YIN F, 2010, FASEB J IN PRESS; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	60	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41001	41009		10.1074/jbc.M110.138743	http://dx.doi.org/10.1074/jbc.M110.138743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961855	Green Published, hybrid			2022-12-27	WOS:000285414400063
J	Altun, M; Besche, HC; Overkleeft, HS; Piccirillo, R; Edelmann, MJ; Kessler, BM; Goldberg, AL; Ulfhake, B				Altun, Mikael; Besche, Henrike C.; Overkleeft, Herman S.; Piccirillo, Rosanna; Edelmann, Mariola J.; Kessler, Benedikt M.; Goldberg, Alfred L.; Ulfhake, Brun			Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							26 S-PROTEASOME; SKELETAL-MUSCLE; PROTEIN-DEGRADATION; HEAT-SHOCK; ATROPHY INVOLVE; GENE-EXPRESSION; DISEASE; LIGASE; PROTEOLYSIS; RESTRICTION	Among the hallmarks of aged organisms are an accumulation of misfolded proteins and a reduction in skeletal muscle mass ("sarcopenia"). We have examined the effects of aging and dietary restriction (which retards many age-related changes) on components of the ubiquitin proteasome system (UPS) in muscle. The hindlimb muscles of aged (30 months old) rats showed a marked loss of muscle mass and contained 2-3-fold higher levels of 26S proteasomes than those of adult (4 months old) controls. 26S proteasomes purified from muscles of aged and adult rats showed a similar capacity to degrade peptides, proteins, and an ubiquitylated substrate, but differed in levels of proteasome-associated proteins (e. g. the ubiquitin ligase E6AP and deubiquitylating enzyme USP14). Also, the activities of many other deubiquitylating enzymes were greatly enhanced in the aged muscles. Nevertheless, their content of polyubiquitylated proteins was higher than in adult animals. The aged muscles contained higher levels of the ubiquitin ligase CHIP, involved in eliminating misfolded proteins, and MuRF1, which ubiquitylates myofibrillar proteins. These muscles differed from ones rapidly atrophying due to disease, fasting, or disuse in that Atrogin-1/MAFbx expression was low and not inducible by glucocorticoids. Thus, the muscles of aged rats showed many adaptations indicating enhanced proteolysis by the UPS, which may enhance their capacity to eliminate misfolded proteins and seems to contribute to the sarcopenia. Accordingly, dietary restriction decreased or prevented the aging-associated increases in proteasomes and other UPS components and reduced muscle wasting.	[Altun, Mikael; Ulfhake, Brun] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Altun, Mikael; Edelmann, Mariola J.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Oxford OX3 7BN, England; [Besche, Henrike C.; Piccirillo, Rosanna; Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Gorlaeaus Labs, NL-2333 CC Leiden, Netherlands	Karolinska Institutet; University of Oxford; Harvard University; Harvard Medical School; Leiden University; Leiden University - Excl LUMC	Altun, M (corresponding author), Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.	mikael.altun@ki.se	Ulfhake, Brun/AAG-8969-2020; Piccirillo, Rosanna/K-6619-2016; Altun, Mikael/AAF-5496-2020; Piccirillo, Rosanna/AAQ-3653-2020; Altun, Mikael/AAI-9527-2020; Kessler, Benedikt/AAY-8614-2021	Piccirillo, Rosanna/0000-0002-1613-9352; Piccirillo, Rosanna/0000-0002-1613-9352; Altun, Mikael/0000-0002-6937-6124; Kessler, Benedikt/0000-0002-8160-2446; Ulfhake, Brun/0000-0001-5037-7461; Besche, Henrike/0000-0002-9841-9218; Edelmann, Mariola/0000-0003-0459-7716; Overkleeft, Herman/0000-0001-6976-7005	NIGMS [GM51923]; NIA [AR055255]; Ellison Foundation; Swedish MRC [10800]; M & M Wallenbergs Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; Medical Research Council [G0501068] Funding Source: researchfish; MRC [G0501068] Funding Source: UKRI	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Foundation(Lawrence Ellison Foundation); Swedish MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); M & M Wallenbergs Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51923 from the NIGMS and AR055255 from the NIA (to H. C. B. and A. L. G.), grants from the Ellison Foundation (to H. C. B. and A. L. G.), the Swedish MRC Project 10800 and the M & M Wallenbergs Foundation (to B. U.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Altun M, 2007, PHYSIOL BEHAV, V92, P911, DOI 10.1016/j.physbeh.2007.06.017; Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; Attaix D, 2005, INT J BIOCHEM CELL B, V37, P1962, DOI 10.1016/j.biocel.2005.04.009; Balagopal P, 1997, AM J PHYSIOL-ENDOC M, V273, pE790, DOI 10.1152/ajpendo.1997.273.4.E790; Bardag-Gorce F, 1999, MOL BIOL REP, V26, P89, DOI 10.1023/A:1006968208077; Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Bulteau AL, 2000, EXP GERONTOL, V35, P767, DOI 10.1016/S0531-5565(00)00136-4; Cai DQ, 2004, ARCH BIOCHEM BIOPHYS, V425, P42, DOI 10.1016/j.abb.2004.02.027; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clavel S, 2006, MECH AGEING DEV, V127, P794, DOI 10.1016/j.mad.2006.07.005; Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Edstrom E, 2005, AGING CELL, V4, P65, DOI 10.1111/j.1474-9728.2005.00145.x; Edstrom E, 2006, J GERONTOL A-BIOL, V61, P663, DOI 10.1093/gerona/61.7.663; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Gorbea C, 2004, J BIOL CHEM, V279, P54849, DOI 10.1074/jbc.M410444200; Gorbea C, 2010, J BIOL CHEM, V285, P31616, DOI 10.1074/jbc.M110.154120; Goto S, 2001, ANN NY ACAD SCI, V928, P54; Grune T, 2001, J GERONTOL A-BIOL, V56, pB459, DOI 10.1093/gerona/56.11.B459; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6; Hepple RT, 2008, AM J PHYSIOL-REG I, V295, pR1231, DOI 10.1152/ajpregu.90478.2008; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kim JY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055027; Kimura Y, 2009, CELL, V137, P549, DOI 10.1016/j.cell.2009.02.028; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Pattison JS, 2003, PHYSIOL GENOMICS, V15, P34, DOI 10.1152/physiolgenomics.00040.2003; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petropoulos I, 2000, J GERONTOL A-BIOL, V55, pB220, DOI 10.1093/gerona/55.5.B220; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Selsby JT, 2005, EXP GERONTOL, V40, P37, DOI 10.1016/j.exger.2004.08.012; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Stone M, 2004, J MOL BIOL, V344, P697, DOI 10.1016/j.jmb.2004.09.057; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; WELLE S, 1993, AM J PHYSIOL, V264, pE693, DOI 10.1152/ajpendo.1993.264.5.E693; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Whitman SA, 2005, PFLUG ARCH EUR J PHY, V450, P437, DOI 10.1007/s00424-005-1473-8; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008; Zhang L, 2007, FEBS LETT, V581, P5543, DOI 10.1016/j.febslet.2007.10.054; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	85	153	161	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39597	39608		10.1074/jbc.M110.129718	http://dx.doi.org/10.1074/jbc.M110.129718			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940294	Green Published, hybrid			2022-12-27	WOS:000285185500004
J	Azimi, I; Matthias, LJ; Center, RJ; Wong, JWH; Hogg, PJ				Azimi, Iman; Matthias, Lisa J.; Center, Rob J.; Wong, Jason W. H.; Hogg, Philip J.			Disulfide Bond That Constrains the HIV-1 gp120 V3 Domain Is Cleaved by Thioredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN; CD4 RECEPTOR; REDUCTION; ISOMERASE; CORECEPTOR; BINDING; REDOX; ASSOCIATION; INHIBITION; PROTEINS	A functional disulfide bond in both the HIV envelope glycoprotein, gp120, and its immune cell receptor, CD4, is involved in viral entry, and compounds that block cleavage of the disulfide bond in these proteins inhibit HIV entry and infection. The disulfide bonds in both proteins are cleaved at the cell surface by the small redox protein, thioredoxin. The target gp120 disulfide and its mechanism of cleavage were determined using a thioredoxin kinetic trapping mutant and mass spectrometry. A single disulfide bond was cleaved in isolated and cell surface gp120, but not the gp160 precursor, and the extent of the reaction was enhanced when gp120 was bound to CD4. The Cys(32) sulfur ion of thioredoxin attacks the Cys(296) sulfur ion of the gp120 V3 domain Cys(296)-Cys(331) disulfide bond, cleaving the bond. Considering that V3 sequences largely determine the chemokine receptor preference of HIV, we propose that cleavage of the V3 domain disulfide, which is facilitated by CD4 binding, regulates chemokine receptor binding. There are 20 possible disulfide bond configurations, and, notably, the V3 domain disulfide has the same unusual -RHStaple configuration as the functional disulfide bond cleaved in CD4.	[Azimi, Iman; Matthias, Lisa J.; Wong, Jason W. H.; Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Azimi, Iman; Matthias, Lisa J.; Wong, Jason W. H.; Hogg, Philip J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Center, Rob J.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Melbourne	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Azimi, Iman/E-2043-2011; Wong, Jason/A-9466-2008	Azimi, Iman/0000-0001-9477-9999; Wong, Jason/0000-0003-2953-7728; Hogg, Philip/0000-0001-6486-2863	National Health and Medical Research Council of Australia; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council of Australia and the Australian Research Council.	Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; AZIMI I, 2010, ANTIOX REDO IN PRESS; Barbouche R, 2003, J BIOL CHEM, V278, P3131, DOI 10.1074/jbc.M205467200; Billington J, 2007, J VIROL, V81, P4604, DOI 10.1128/JVI.02138-06; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Einfeld D, 1996, CURR TOP MICROBIOL, V214, P133; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gopalan G, 2004, P NATL ACAD SCI USA, V101, P13945, DOI 10.1073/pnas.0405240101; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Stathakis P, 1999, J BIOL CHEM, V274, P8910, DOI 10.1074/jbc.274.13.8910; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Wiita AP, 2007, NATURE, V450, P124, DOI 10.1038/nature06231; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413	37	29	30	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40072	40080		10.1074/jbc.M110.185371	http://dx.doi.org/10.1074/jbc.M110.185371			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943653	hybrid, Green Published			2022-12-27	WOS:000285185500052
J	Finkelstein, M; Etkovitz, N; Breitbart, H				Finkelstein, Maya; Etkovitz, Nir; Breitbart, Haim			Role and Regulation of Sperm Gelsolin Prior to Fertilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TYROSINE PHOSPHORYLATION; CYTOSKELETAL CALYX; MOUSE SPERM; CAPACITATION; SRC; FILAMENTS; IDENTIFICATION	To acquire fertilization competence, spermatozoa should undergo several biochemical changes in the female reproductive tract, known as capacitation. The capacitated spermatozoon can interact with the egg zona pellucida resulting in the occurrence of the acrosome reaction, a process that allowed its penetration into the egg and fertilization. Sperm capacitation requires actin polymerization, whereas F-actin must disperse prior to the acrosome reaction. Here, we suggest that the actin-severing protein, gelsolin, is inactive during capacitation and is activated prior to the acrosome reaction. The release of bound gelsolin from phosphatidylinositol 4,5-bisphosphate (PIP2) by PBP10, a peptide containing the PIP2-binding domain of gelsolin, or by activation of phospholipase C, which hydrolyzes PIP2, caused rapid Ca2+-dependent F-actin depolymerization as well as enhanced acrosome reaction. Using immunoprecipitation assays, we showed that the tyrosine kinase SRC and gelsolin coimmunoprecipitate, and activating SRC by adding 8-bromo-cAMP (8-Br-cAMP) enhanced the amount of gelsolin in this precipitate. Moreover, 8-Br-cAMP enhanced tyrosine phosphorylation of gelsolin and its binding to PIP2(4,5), both of which inactivated gelsolin, allowing actin polymerization during capacitation. This actin polymerization was blocked by inhibiting the Src family kinases, suggesting that gelsolin is activated under these conditions. These results are further supported by our finding that PBP10 was unable to cause complete F-actin breakdown in the presence of 8-Br-cAMP or vanadate. In conclusion, inactivation of gelsolin during capacitation occurs by its binding to PIP2 and tyrosine phosphorylation by SRC. The release of gelsolin from PIP2 together with its dephosphorylation enables gelsolin activation, resulting in the acrosome reaction.	[Finkelstein, Maya; Etkovitz, Nir; Breitbart, Haim] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel	Bar Ilan University	Breitbart, H (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	breith@mail.biu.ac.il						Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Ashish, 2007, J BIOL CHEM, V282, P25884, DOI 10.1074/jbc.M702446200; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baldi E, 2002, J REPROD IMMUNOL, V53, P121, DOI 10.1016/S0165-0378(01)00089-4; BANNO Y, 1992, J BIOL CHEM, V267, P6488; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitbart H, 2005, REPRODUCTION, V129, P263, DOI 10.1530/rep.1.00269; Breitbart H, 2003, CELL MOL BIOL, V49, P321; Brener E, 2003, BIOL REPROD, V68, P837, DOI 10.1095/biolreprod.102.009233; Cabello-Agueros JF, 2003, CELL MOTIL CYTOSKEL, V56, P94, DOI 10.1002/cm.10135; Cheng J, 1997, J BIOL CHEM, V272, P17312, DOI 10.1074/jbc.272.28.17312; Cohen G, 2004, DEV BIOL, V267, P230, DOI 10.1016/j.ydbio.2003.10.034; Cunningham CC, 2001, J BIOL CHEM, V276, P43390, DOI 10.1074/jbc.M105289200; De Corte V, 1999, PROTEIN SCI, V8, P234; DeCorte V, 1997, FEBS LETT, V401, P191, DOI 10.1016/S0014-5793(96)01471-8; delasHeras MA, 1997, TISSUE CELL, V29, P47, DOI 10.1016/S0040-8166(97)80071-7; Etkovitz N, 2007, BIOL REPROD, V77, P263, DOI 10.1095/biolreprod.106.056705; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Gremm D, 2000, EUR J BIOCHEM, V267, P4339, DOI 10.1046/j.1432-1327.2000.01463.x; Guttman JA, 2002, J CELL SCI, V115, P499; Heid HW, 2002, EXP CELL RES, V279, P177, DOI 10.1006/excr.2002.5603; Howes EA, 2001, J ANDROL, V22, P62; JANMEY PA, 1987, J BIOL CHEM, V262, P12228; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; LAX Y, 1994, FEBS LETT, V339, P234, DOI 10.1016/0014-5793(94)80422-2; LISCOVITCH M, 1994, J BIOL CHEM, V269, P21403; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Pelletier RM, 1999, BIOL REPROD, V60, P1128, DOI 10.1095/biolreprod60.5.1128; SPUNGIN B, 1995, J CELL SCI, V108, P2525; Steed PM, 1996, BIOCHEMISTRY-US, V35, P5229, DOI 10.1021/bi952370j; Sun HQ, 1997, J CELL BIOL, V138, P811, DOI 10.1083/jcb.138.4.811; TANAKA H, 1994, FEBS LETT, V355, P4, DOI 10.1016/0014-5793(94)01155-9; Varano G, 2008, HUM REPROD, V23, P2652, DOI 10.1093/humrep/den314; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VONBULOW M, 1995, EXP CELL RES, V219, P407, DOI 10.1006/excr.1995.1246; vonBulow M, 1997, EXP CELL RES, V233, P216, DOI 10.1006/excr.1997.3564; YIN HL, 1980, J BIOL CHEM, V255, P9494; YIN HL, 1987, BIOESSAYS, V7, P176, DOI 10.1002/bies.950070409	42	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39702	39709		10.1074/jbc.M110.170951	http://dx.doi.org/10.1074/jbc.M110.170951			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937821	Green Published, hybrid			2022-12-27	WOS:000285185500014
J	Katsoulidis, E; Mavrommatis, E; Woodard, J; Shields, MA; Sassano, A; Carayol, N; Sawicki, KT; Munshi, HG; Platanias, LC				Katsoulidis, Efstratios; Mavrommatis, Evangelos; Woodard, Jennifer; Shields, Mario A.; Sassano, Antonella; Carayol, Nathalie; Sawicki, Konrad T.; Munshi, Hidayatullah G.; Platanias, Leonidas C.			Role of Interferon alpha (IFN alpha)-inducible Schlafen-5 in Regulation of Anchorage-independent Growth and Invasion of Malignant Melanoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HISTONE DEACETYLASE ACTIVITY; STIMULATED GENE-EXPRESSION; MESSENGER-RNA TRANSLATION; HIGH-RISK MELANOMA; DELTA PKC-DELTA; P70 S6 KINASE; I INTERFERONS; IFN-ALPHA; T-CELLS	IFN alpha exerts potent inhibitory activities against malignant melanoma cells in vitro and in vivo, but the mechanisms by which it generates its antitumor effects remain unknown. We examined the effects of interferon alpha(IFN alpha) on the expression of human members of the Schlafen (SLFN) family of genes, a group of cell cycle regulators that mediate growth-inhibitory responses. Using quantitative RT-real time PCR, we found detectable basal expression of all the different human SLFN genes examined (SLFN5, SLFN11, SLFN12, SLFN13, and SLFN14), in malignant melanoma cells and primary normal human melanocytes, but SLFN5 basal expression was suppressed in all analyzed melanoma cell lines. Treatment of melanoma cells with IFN alpha resulted in induction of expression of SLFN5 in malignant cells, suggesting a potential involvement of this gene in the antitumor effects of IFN alpha. Importantly, stable knockdown of SLFN5 in malignant melanoma cells resulted in increased anchorage-independent growth, as evidenced by enhanced colony formation in soft agar assays. Moreover, SLFN5 knockdown also resulted in increased invasion in three-dimensional collagen, suggesting a dual role for SLFN5 in the regulation of invasion and anchorage-independent growth of melanoma cells. Altogether, our findings suggest an important role for the SLFN family of proteins in the generation of the anti-melanoma effects of IFN alpha and for the first time directly implicate a member of the human SLFN family in the regulation of cell invasion.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; Jesse Brown Veteran Affairs Med Ctr, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super,Lurie 3-125, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Sawicki, Konrad T/AAY-4083-2021	Sawicki, Konrad T/0000-0003-2124-0081	National Institutes of Health [CA77816, CA121192, C100579, CA126888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA121192, R01CA126888, P30CA060553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, C100579, and CA126888. This work was also supported by a merit review grant from the Department of Veterans Affairs.	Bell TA, 2006, GENETICS, V172, P411, DOI 10.1534/genetics.105.047118; Berger M, 2010, NAT IMMUNOL, V11, P335, DOI 10.1038/ni.1847; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Certa U, 2001, BRIT J CANCER, V85, P107, DOI 10.1054/bjoc.2001.1865; Chang HM, 2004, P NATL ACAD SCI USA, V101, P9578, DOI 10.1073/pnas.0400567101; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVID M, 1995, SCIENCE, V269, P1721, DOI 10.1126/science.7569900; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Geserick P, 2004, INT IMMUNOL, V16, P1535, DOI 10.1093/intimm/dxh155; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hancock BW, 2004, J CLIN ONCOL, V22, P53, DOI 10.1200/JCO.2004.03.185; Horton MR, 2010, NAT IMMUNOL, V11, P281, DOI 10.1038/ni0410-281; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Katsoulidis E, 2005, J INTERF CYTOK RES, V25, P749, DOI 10.1089/jir.2005.25.749; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2001, J CLIN ONCOL, V19, P2370, DOI 10.1200/JCO.2001.19.9.2370; Klampfer L, 2004, J BIOL CHEM, V279, P30358, DOI 10.1074/jbc.M401359200; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Lesinski GB, 2007, CLIN CANCER RES, V13, P5010, DOI 10.1158/1078-0432.CCR-06-3092; Malakhov MP, 2003, J BIOL CHEM, V278, P16608, DOI 10.1074/jbc.M208435200; Malakhova OA, 2003, GENE DEV, V17, P455, DOI 10.1101/gad.1056303; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Neumann B, 2008, BIOCHEM BIOPH RES CO, V370, P62, DOI 10.1016/j.bbrc.2008.03.032; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Parmar Simrit, 2003, Current Opinion in Oncology, V15, P431, DOI 10.1097/00001622-200311000-00005; Patel VB, 2009, BIOCHEM BIOPH RES CO, V388, P752, DOI 10.1016/j.bbrc.2009.08.094; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; RALPH SJ, 1995, J IMMUNOL, V154, P2248; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Sakamoto S, 2004, J BIOL CHEM, V279, P40362, DOI 10.1074/jbc.M406400200; Schwarz DA, 1998, IMMUNITY, V9, P657, DOI 10.1016/S1074-7613(00)80663-9; Smith SC, 2009, NAT REV CANCER, V9, P253, DOI 10.1038/nrc2594; Sohn WJ, 2007, MOL IMMUNOL, V44, P3273, DOI 10.1016/j.molimm.2007.03.001; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Uddin S, 2000, J BIOL CHEM, V275, P27634; Uddin S, 1997, J IMMUNOL, V158, P2390; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Vlasakova J, 2007, BLOOD, V109, P1373, DOI 10.1182/blood-2006-02-003418; Wong LH, 1997, J BIOL CHEM, V272, P28779, DOI 10.1074/jbc.272.45.28779; Zhang YF, 2008, BIOCHEM J, V413, P239, DOI 10.1042/BJ20071510	60	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40333	40341		10.1074/jbc.M110.151076	http://dx.doi.org/10.1074/jbc.M110.151076			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956525	Green Published, hybrid			2022-12-27	WOS:000285185500076
J	Touchberry, CD; Bales, IK; Stone, JK; Rohrberg, TJ; Parelkar, NK; Nguyen, T; Fuentes, O; Liu, X; Qu, CK; Andresen, JJ; Valdivia, HH; Brotto, M; Wacker, MJ				Touchberry, Chad D.; Bales, Ian K.; Stone, Jessica K.; Rohrberg, Travis J.; Parelkar, Nikhil K.; Nguyen, Tien; Fuentes, Oscar; Liu, Xia; Qu, Cheng-Kui; Andresen, Jon J.; Valdivia, Hector H.; Brotto, Marco; Wacker, Michael J.			Phosphatidylinositol 3,5-Bisphosphate (PI(3,5)P2) Potentiates Cardiac Contractility via Activation of the Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PIP2	Phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2) is the most recently identified phosphoinositide, and its functions have yet to be fully elucidated. Recently, members of our muscle group have shown that PI(3,5)P2 plays an important role in skeletal muscle function by altering Ca2+ homeostasis. Therefore, we hypothesized that PI(3,5)P2 may also modulate cardiac muscle contractility by altering intracellular Ca2+ ([Ca2+](i)) in cardiac myocytes. We first confirmed that PI(3,5)P2 was present and increased by insulin treatment of cardiomyocytes via immunohistochemistry. To examine the acute effects of PI(3,5)P2 treatment, electrically paced left ventricular muscle strips were incubated with PI(3,5)P2. Treatment with PI(3,5)P2 increased the magnitude of isometric force, the rate of force development, and the area associated with the contractile waveforms. These enhanced contractile responses were also observed in MIP/Mtmr14(-/-) mouse hearts, which we found to have elevated levels of PI(3,5)P2. In cardiac myocytes loaded with fura-2, PI(3,5)P2 produced a robust elevation in [Ca2+](i). The PI(3,5)P2-induced elevation of [Ca2+](i) was not present in conditions free of extracellular Ca2+ and was completely blocked by ryanodine. We investigated whether the phosphoinositide acted directly with the Ca2+ release channels of the sarcoplasmic reticulum (ryanodine receptors; RyR2). PI(3,5)P2 increased [H-3] ryanodine binding and increased the open probability (P-o) of single RyR2 channels reconstituted in lipid bilayers. This strongly suggests that the phosphoinositide binds directly to the RyR2 channel. Thus, we provide inaugural evidence that PI(3,5)P2 is a powerful activator of sarcoplasmic reticulum Ca2+ release and thereby modulates cardiac contractility.	[Touchberry, Chad D.; Bales, Ian K.; Stone, Jessica K.; Rohrberg, Travis J.; Parelkar, Nikhil K.; Nguyen, Tien; Andresen, Jon J.; Brotto, Marco; Wacker, Michael J.] Univ Missouri, Muscle Biol Res Grp, Sch Med, Kansas City, MO 64108 USA; [Andresen, Jon J.; Brotto, Marco; Wacker, Michael J.] Univ Missouri, Muscle Biol Res Grp, Sch Nursing, Kansas City, MO 64108 USA; [Fuentes, Oscar] Univ Bio Bio, Dept Ciencias Basicas, Chillan 3780000, Chile; [Liu, Xia; Qu, Cheng-Kui] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Valdivia, Hector H.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53711 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Universidad del Bio-Bio; Case Western Reserve University; University of Wisconsin System; University of Wisconsin Madison	Wacker, MJ (corresponding author), 2464 Charlotte St, Kansas City, MO 64108 USA.	wackerm@umkc.edu	Touchberry, Chad D/L-8469-2013; Touchberry, Chad/GPX-8299-2022	Touchberry, Chad/0000-0002-6569-6921; Wacker, Michael/0000-0002-1768-562X	National Institutes of Health, NIAMS [1RC2AR058962-0110]; Missouri Life Sciences Research Board [09-1101]; American Heart Association; DIPRODE-UBB; National Institutes of Health, H. L. B. I. [ROI-HL055438]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058962] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Missouri Life Sciences Research Board; American Heart Association(American Heart Association); DIPRODE-UBB; National Institutes of Health, H. L. B. I.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RC2AR058962-0110 from the NIAMS (to M. B., J. J. A., and M. J. W.) and ROI-HL055438 (to H. H. V.) from the H. L. B. I. This work was also supported by Missouri Life Sciences Research Board Grant 09-1101 (to M. B., J. J. A., and M. J. W.), an American Heart Association grant (to M. B. and J. J. A.), and a DIPRODE-UBB grant (to O. F.).	BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bidlingmaier S, 2007, MOL CELL PROTEOMICS, V6, P2012, DOI 10.1074/mcp.M700223-MCP200; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Hama Hiroko, 2004, Methods Mol Biol, V284, P243; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; McCrea HJ, 2009, PHYSIOLOGY, V24, P8, DOI 10.1152/physiol.00035.2008; MULIERI LA, 1989, CIRC RES, V65, P1441, DOI 10.1161/01.RES.65.5.1441; Shen CC, 2007, J PHYSIOL-LONDON, V582, P1011, DOI 10.1113/jphysiol.2007.132720; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tanaka H, 1998, COMP BIOCHEM PHYS A, V120, P431, DOI 10.1016/S1095-6433(98)10043-0; Wacker MJ, 2009, J PHARMACOL EXP THER, V331, P917, DOI 10.1124/jpet.109.157677; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237; Zhu XS, 2004, J BIOL CHEM, V279, P26588, DOI 10.1074/jbc.M403284200; Zhu XS, 2004, CELL CALCIUM, V35, P165, DOI 10.1016/j.ceca.2003.09.002	19	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40312	40321		10.1074/jbc.M110.179689	http://dx.doi.org/10.1074/jbc.M110.179689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947503	hybrid, Green Published			2022-12-27	WOS:000285185500074
J	Loveridge, C; Tonelli, F; Leclercq, T; Lim, KG; Long, JS; Berdyshev, E; Tate, RJ; Natarajan, V; Pitson, SM; Pyne, NJ; Pyne, S				Loveridge, Carolyn; Tonelli, Francesca; Leclercq, Tamara; Lim, Keng Gat; Long, Jaclyn S.; Berdyshev, Evgeny; Tate, Rothwelle J.; Natarajan, Viswanathan; Pitson, Stuart M.; Pyne, Nigel J.; Pyne, Susan			The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; PLASMA-MEMBRANE; 1-PHOSPHATE; EXPRESSION; RECEPTOR; PHOSPHORYLATION; CERAMIDE; PROLIFERATION	Sphingosine kinase 1 (SK1) is an enzyme that catalyzes the phosphorylation of sphingosine to produce the bioactive lipid sphingosine 1-phosphate (S1P). We demonstrate here that the SK1 inhibitor, SKi (2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole) induces the proteasomal degradation of SK1 in human pulmonary artery smooth muscle cells, androgen-sensitive LNCaP prostate cancer cells, MCF-7 and MCF-7 HER2 breast cancer cells and that this is likely mediated by ceramide as a consequence of catalytic inhibition of SK1 by SKi. Moreover, SK1 is polyubiquitinated under basal conditions, and SKi appears to increase the degradation of SK1 by activating the proteasome. In addition, the proteasomal degradation of SK1a and SK1b in androgen-sensitive LNCaP cells is associated with the induction of apoptosis. However, SK1b in LNCaP-AI cells (androgen-independent) is less sensitive to SKi-induced proteasomal degradation and these cells are resistant to SKi-induced apoptosis, thereby implicating the ubiquitin-proteasomal degradation of SK1 as an important mechanism controlling cell survival.	[Loveridge, Carolyn; Tonelli, Francesca; Lim, Keng Gat; Long, Jaclyn S.; Tate, Rothwelle J.; Pyne, Nigel J.; Pyne, Susan] Univ Strathclyde, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland; [Berdyshev, Evgeny; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; [Leclercq, Tamara; Pitson, Stuart M.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Leclercq, Tamara; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	University of Strathclyde; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centre for Cancer Biology; SA Pathology; University of Adelaide	Pyne, S (corresponding author), Univ Strathclyde, Cell Biol Grp, Glasgow G4 0RE, Lanark, Scotland.	susan.pyne@strath.ac.uk	Pitson, Stuart/B-9342-2009; Pyne, Susan/AAF-5001-2019	Pitson, Stuart/0000-0002-9527-2740; Pyne, Susan/0000-0002-6608-9584; Tonelli, Francesca/0000-0002-4600-6630; Pyne, Nigel/0000-0002-5657-4578; Tate, Rothwelle/0000-0001-5857-4267; Loveridge, Carolyn/0000-0002-6237-8661	National Institutes of Health [R01 HL079396]; CRUK [23158/A7536]; British Heart Foundation [PG/06/137/21825]; Fay Fuller Foundation; Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago; National Health and Medical Research Council of Australia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRUK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Fay Fuller Foundation; Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL079396 (to V. N.). This work was also supported by Grants 23158/A7536 from CRUK, PG/06/137/21825 from the British Heart Foundation (to S. P. and N. J. P.), and by the Fay Fuller Foundation (to S. M. P. and T. L.).; Supported by The Institute for Personalized Respiratory Medicine, The University of Illinois, Chicago.; Recipient of a Senior Research Fellowship from National Health and Medical Research Council of Australia.	Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Akao Y, 2006, BIOCHEM BIOPH RES CO, V342, P1284, DOI 10.1016/j.bbrc.2006.02.070; Alderton F, 2001, J BIOL CHEM, V276, P28578, DOI 10.1074/jbc.M102771200; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Calatayud CA, 2005, DEV NEUROSCI-BASEL, V27, P397, DOI 10.1159/000088454; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Dayon A., 2008, PLOS ONE, V4, pe8408; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; Garzotto M, 1999, CANCER RES, V59, P5194; Goetzl EJ, 1999, CANCER RES, V59, P4732; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kono K, 2000, J ANTIBIOT, V53, P459, DOI 10.7164/antibiotics.53.459; Kono K, 2000, J ANTIBIOT, V53, P759, DOI 10.7164/antibiotics.53.759; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Merrill AH, 2000, METHOD ENZYMOL, V312, P3; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Nava VE, 2000, CANCER RES, V60, P4468; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pchejetski D, 2008, MOL CANCER THER, V7, P1836, DOI 10.1158/1535-7163.MCT-07-2322; Pham DH, 2008, BIOTECHNIQUES, V45, P155, DOI 10.2144/000112896; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Pyne S, 2009, CELL SIGNAL, V21, P14, DOI 10.1016/j.cellsig.2008.08.008; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4	38	94	99	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38841	38852		10.1074/jbc.M110.127993	http://dx.doi.org/10.1074/jbc.M110.127993			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926375	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000284941300013
J	Maxson, JE; Chen, JX; Enns, CA; Zhang, AS				Maxson, Julia E.; Chen, Juxing; Enns, Caroline A.; Zhang, An-Sheng			Matriptase-2-and Proprotein Convertase-cleaved Forms of Hemojuvelin Have Different Roles in the Down-regulation of Hepcidin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE HEMOCHROMATOSIS; IRON-METABOLISM; SOLUBLE HEMOJUVELIN; PROTEIN; MEMBRANE; NEOGENIN; OVERLOAD; LIVER; BMP6; ACTIVATION	Hemojuvelin (HJV) is an important regulator of iron metabolism. Membrane-anchored HJV up-regulates expression of the iron regulatory hormone, hepcidin, through the bone morphogenic protein (BMP) signaling pathway by acting as a BMP co-receptor. HJV can be cleaved by the furin family of proprotein convertases, which releases a soluble form of HJV that suppresses BMP signaling and hepcidin expression by acting as a decoy that competes with membrane HJV for BMP ligands. Recent studies indicate that matriptase-2 binds and degrades HJV, leading to a decrease in cell surface HJV. In the present work, we show that matriptase-2 cleaves HJV at Arg(288), which produces one major soluble form of HJV. This shed form of HJV has decreased ability to bind BMP6 and does not suppress BMP6-induced hepcidin expression. These results suggest that the matriptase-2 and proprotein convertase-cleavage products have different roles in the regulation of hepcidin expression.	[Maxson, Julia E.; Chen, Juxing; Enns, Caroline A.; Zhang, An-Sheng] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University	Enns, CA (corresponding author), Dept Cell & Dev Biol L215, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	ennsca@ohsu.edu; zhanga@ohsu.edu			National Institutes of Health [DK080765, DK72166, T32 HD049309]; Vertex Pharmaceuticals; American Heart Association [10PRE3530017]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080765, R01DK072166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vertex Pharmaceuticals(Vertex Pharmaceuticals); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080765 (to A.-S. Z.) and DK72166 (to C. A. E.).; Supported in part by National Institutes of Health Grant T32 HD049309, by a scholarship from Vertex Pharmaceuticals, and by American Heart Association predoctoral fellowship 10PRE3530017.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Camaschella C, 1998, BAILLIERE CLIN GASTR, V12, P227, DOI 10.1016/S0950-3528(98)90132-4; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuninger D, 2006, J CELL SCI, V119, P3273, DOI 10.1242/jcs.03074; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2008, BLOOD CELL MOL DIS, V40, P122, DOI 10.1016/j.bcmd.2007.06.023; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Maxson JE, 2009, BLOOD, V113, P1786, DOI 10.1182/blood-2008-08-174565; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Zhang AS, 2008, J BIOL CHEM, V283, P17494, DOI 10.1074/jbc.M710527200; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200; Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200	30	55	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39021	39028		10.1074/jbc.M110.183160	http://dx.doi.org/10.1074/jbc.M110.183160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937842	hybrid, Green Published			2022-12-27	WOS:000284941300032
J	Sinclair, J; Hamza, I				Sinclair, Jason; Hamza, Iqbal			A Novel Heme-responsive Element Mediates Transcriptional Regulation in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GATA-FACTOR; ERYTHROID-CELLS; FACTOR BACH1; BETA-GLOBIN; C-ELEGANS; GENE; EXPRESSION; INTESTINE; PROTEINS	Hemes are prosthetic groups that participate in diverse biochemical pathways across phylogeny. Although heme can also regulate broad physiological processes by directly modulating gene expression in Metazoa, the regulatory pathways for sensing and responding to heme are not well defined. Caenorhabditis elegans is a heme auxotroph and relies solely on environmental heme for sustenance. Worms respond to heme availability by regulating heme-responsive genes such as hrg-1, an intestinal heme transporter that is up-regulated by >60-fold during heme depletion. To identify the mechanism for the heme-dependent regulation of hrg-1, we interrogated the hrg-1 promoter. Deletion and mutagenesis studies of the hrg-1 promoter revealed a 23-bp heme-responsive element that is both necessary and sufficient for heme-dependent regulation of hrg-1. Furthermore, our studies show that the heme regulation of hrg-1 is mediated by both activation and repression in conjunction with ELT-2 and ELT-4, transcription factors that specify intestinal expression.	Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Hamza, I (corresponding author), Univ Maryland, Anim Sci Ctr 2413, Dept Avian & Anim Sci, College Pk, MD 20742 USA.	hamza@umd.edu		Hamza, Iqbal/0000-0003-0045-0610	National Institutes of Health [R01 DK74797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK74797 (to I. H.).	Aiyar A, 1996, Methods Mol Biol, V57, P177; Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Blumenthal Thomas, 2005, WormBook, P1, DOI 10.1895/wormbook.1.5.1; BRENNER S, 1974, GENETICS, V77, P71; Fukushige T, 2003, GENETICS, V165, P575; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Ishii TM, 1998, METHOD ENZYMOL, V293, P53; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Koh K, 2001, DEVELOPMENT, V128, P2867; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee James D, 2007, WormBook, P1; METZ R, 1991, ONCOGENE, V6, P2165; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; Nass R., 2007, CURR PROTOC TOXICOL; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Rees EM, 2004, CURR OPIN MICROBIOL, V7, P175, DOI 10.1016/j.mib.2004.02.004; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Romney SJ, 2008, J BIOL CHEM, V283, P716, DOI 10.1074/jbc.M707043200; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SPIETH J, 1991, MOL CELL BIOL, V11, P4651, DOI 10.1128/MCB.11.9.4651; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Tahara T, 2004, BIOCHEM BIOPH RES CO, V324, P77, DOI 10.1016/j.bbrc.2004.09.022; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; Wenger RH, 2000, J EXP BIOL, V203, P1253; Williams C, 1999, MOL CELL BIOL, V19, P376; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	37	18	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39536	39543		10.1074/jbc.M110.167619	http://dx.doi.org/10.1074/jbc.M110.167619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20938051	hybrid, Green Published			2022-12-27	WOS:000284941300079
J	Sorci, L; Blaby, I; De Ingeniis, J; Gerdes, S; Raffaelli, N; Lagard, VD; Osterman, A				Sorci, Leonardo; Blaby, Ian; De Ingeniis, Jessica; Gerdes, Svetlana; Raffaelli, Nadia; Lagard, Valerie de Crecy; Osterman, Andrei			Genomics-driven Reconstruction of Acinetobacter NAD Metabolism INSIGHTS FOR ANTIBACTERIAL TARGET SELECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; TRANSCRIPTIONAL REGULATION; SP ADP1; BIOSYNTHESIS; SYNTHETASE; INHIBITORS; ENZYME; PHOSPHORIBOSYLTRANSFERASE; FERMENTATION; REGENERATION	Enzymes involved in the last steps of NAD biogenesis, nicotinate mononucleotide adenylyltransferase (NadD) and NAD synthetase (NadE), are conserved and essential in most bacterial species and are established targets for antibacterial drug development. Our genomics-based reconstruction of NAD metabolism in the emerging pathogen Acinetobacter baumannii revealed unique features suggesting an alternative targeting strategy. Indeed, genomes of all analyzed Acinetobacter species do not encode NadD, which is functionally replaced by its distant homolog NadM. We combined bioinformatics with genetic and biochemical techniques to elucidate this and other important features of Acinetobacter NAD metabolism using a model (nonpathogenic) strain Acinetobacter baylyi sp. ADP1. Thus, a comparative kinetic characterization of PncA, PncB, and NadV enzymes allowed us to suggest distinct physiological roles for the two alternative, deamidating and nondeamidating, routes of nicotinamide salvage/recycling. The role of the NiaP transporter in both nicotinate and nicotinamide salvage was confirmed. The nondeamidating route was shown to be transcriptionally regulated by an ADP-ribose-responsive repressor NrtR. The NadM enzyme was shown to possess dual substrate specificity toward both nicotinate and nicotinamide mononucleotide substrates, which is consistent with its essential role in all three routes of NAD biogenesis, de novo synthesis as well as the two salvage pathways. The experimentally confirmed unconditional essentiality of nadM provided support for the choice of the respective enzyme as a drug target. In contrast, nadE, encoding a glutamine-dependent NAD synthetase, proved to be dispensable when the nondeamidating salvage pathway functioned as the only route of NAD biogenesis.	[Blaby, Ian; Lagard, Valerie de Crecy] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Sorci, Leonardo; De Ingeniis, Jessica; Osterman, Andrei] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Gerdes, Svetlana] Fellowship Interpretat Genomes, Burr Ridge, IL 60527 USA; [Raffaelli, Nadia] Univ Politecn Marche, Biochem Sect, Dept Mol Pathol & Innovat Therapies, I-60131 Ancona, Italy	State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute; Marche Polytechnic University	Lagard, VD (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	vcrecy@ufl.edu; osterman@sanfordburnham.org	SORCI, LEONARDO/AAD-7395-2019; Blaby, Ian/C-3292-2014; de Crecy-Lagard, Valerie/AAN-8995-2020	SORCI, LEONARDO/0000-0002-4356-8873; 	National Institutes of Health (NIAID) [R01 AI066244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066244] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI066244 (NIAID; to A. O. and V. d. C. L.).	Aravind L, 2002, PROTEINS, V48, P1, DOI 10.1002/prot.10064; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bieganowski P, 2003, J BIOL CHEM, V278, P33049, DOI 10.1074/jbc.M302257200; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; Boshoff HIM, 1998, J BACTERIOL, V180, P5809, DOI 10.1128/JB.180.22.5809-5814.1998; Burgos ES, 2008, BIOCHEMISTRY-US, V47, P11086, DOI 10.1021/bi801198m; Copeland RA., 2000, ENZYMES PRACTICAL IN, P137; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; de Berardinis V, 2009, CURR OPIN MICROBIOL, V12, P568, DOI 10.1016/j.mib.2009.07.005; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Fyfe PK, 2009, ANGEW CHEM INT EDIT, V48, P9176, DOI 10.1002/anie.200903407; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Gross JW, 1998, BIOCHEMISTRY-US, V37, P4189, DOI 10.1021/bi972014w; Gutnick David L., 2008, P231; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang NA, 2010, J MED CHEM, V53, P5229, DOI 10.1021/jm100377f; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Maicas S, 2002, MICROBIOL-SGM, V148, P325, DOI 10.1099/00221287-148-1-325; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Moro WB, 2009, J COMB CHEM, V11, P617, DOI 10.1021/cc9000357; Moro WB, 2009, BIOORG MED CHEM LETT, V19, P2001, DOI 10.1016/j.bmcl.2009.02.034; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pD111, DOI 10.1093/nar/gkp894; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Osterman AL, 2007, PROG DRUG RES, V64, p[131, 133], DOI DOI 10.1007/978-3-7643-7567-6_; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Raffaelli N, 1997, J BACTERIOL, V179, P7718, DOI 10.1128/jb.179.24.7718-7723.1997; RAFFAELLI N, 1994, FEBS LETT, V355, P233, DOI 10.1016/0014-5793(94)01195-8; Raffaelli N, 1999, FEBS LETT, V444, P222, DOI 10.1016/S0014-5793(99)00068-X; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2032, DOI 10.1093/nar/gkn046; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; Sambrook J., 2001, MOL CLONING LAB MANU; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Sorci L, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P213; Sorci L, 2009, CHEM BIOL, V16, P849, DOI 10.1016/j.chembiol.2009.07.006; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Teramoto H, 2010, APPL ENVIRON MICROB, V76, P5488, DOI 10.1128/AEM.00906-10; Velu SE, 2007, J MED CHEM, V50, P2612, DOI 10.1021/jm061349l; Verho R, 2003, APPL ENVIRON MICROB, V69, P5892, DOI 10.1128/AEM.69.10.5892-5897.2003; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Vilcheze C, 2010, MOL MICROBIOL, V76, P365, DOI 10.1111/j.1365-2958.2010.07099.x	51	32	32	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39490	39499		10.1074/jbc.M110.185629	http://dx.doi.org/10.1074/jbc.M110.185629			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926389	Green Published, hybrid			2022-12-27	WOS:000284941300075
J	Chae, H; Han, K; Kim, KS; Park, H; Lee, J; Lee, Y				Chae, Huiseok; Han, Kook; Kim, Kwang-sun; Park, Hongmarn; Lee, Jungmin; Lee, Younghoon			Rho-dependent Termination of ssrS (6S RNA) Transcription in Escherichia coli IMPLICATION FOR 3 ' PROCESSING OF 6S RNA AND EXPRESSION OF DOWNSTREAM ygfA (PUTATIVE 5-FORMYL-TETRAHYDROFOLATE CYCLO-LIGASE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI BIOFILMS; GENE-EXPRESSION; ARGININE TRNA(CCG); NONCODING RNAS; GROWTH DEFECT; STABLE RNAS; REGULATORS; PROTEIN; POLYMERASE; MUTATIONS	It is well known that 6S RNA, a global regulatory noncoding RNA that modulates gene expression in response to the cellular stresses in Escherichia coli, is generated by processing from primary ssrS (6S RNA) transcripts derived from two different promoters. The 5' processing of 6S RNA from primary transcripts has been well studied; however, it remains unclear how the 3'-end of this RNA is generated although previous studies have suggested that exoribonucleolytic trimming is necessary for 3' processing. Here, we describe several Rho-dependent termination sites located similar to 90 bases downstream of the mature 3'-end of 6S RNA. Our data suggest that the 3'-end of 6S RNA is generated via exoribonucleolytic trimming, rather than endoribonucleolytic cleavage, following the transcription termination events. The termination sites identified in this study are within the open reading frame of the downstream ygfA (putative 5-formyl-tetrahydrofolate cyclo-ligase) gene, a part of the highly conserved bacterial operon ssrS-ygfA, which is up-regulated during the biofilm formation. Our findings reveal that ygfA expression, which also aids the formation of multidrug-tolerant persister cells, could be regulated by Rho-dependent termination activity in the cell.	[Chae, Huiseok; Han, Kook; Park, Hongmarn; Lee, Jungmin; Lee, Younghoon] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Kim, Kwang-sun] Korea Res Inst Biosci & Biotechnol KRIBB, Taejon 305806, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Lee, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	Younghoon.Lee@kaist.ac.kr	Kim, Kwang-sun/AAB-6478-2020; Lee, Younghoon/C-1991-2011	Lee, Younghoon/0000-0002-3841-719X; Kim, Kwang-sun/0000-0003-3703-5461	21C Frontier Microbial Genomics and Application Center Program [MG08-0201-2-0]; Korea government (MEST) [2010-0000241, 2010-0029167]	21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program (MG08-0201-2-0) and the National Research Foundation of Korea (NRF) Grant by the Korea government (MEST) (2010-0000241; 2010-0029167).	ALIFANO P, 1991, CELL, V64, P553; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; BROWNLEE GG, 1971, NATURE-NEW BIOL, V229, P147, DOI 10.1038/newbio229147a0; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Ciampi MS, 2006, MICROBIOL-SGM, V152, P2515, DOI 10.1099/mic.0.28982-0; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Deutscher M. P., 1993, NUCLEASES; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Gottesman S, 2004, ANNU REV MICROBIOL, V58, P303, DOI 10.1146/annurev.micro.58.030603.123841; Graham JE, 2004, NUCLEIC ACIDS RES, V32, P3093, DOI 10.1093/nar/gkh630; Graham JE, 1998, J BIOL CHEM, V273, P20764, DOI 10.1074/jbc.273.33.20764; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Hansen S, 2008, ANTIMICROB AGENTS CH, V52, P2718, DOI 10.1128/AAC.00144-08; HSU LM, 1985, J BACTERIOL, V161, P1162, DOI 10.1128/JB.161.3.1162-1170.1985; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kim KS, 2004, NUCLEIC ACIDS RES, V32, P6057, DOI 10.1093/nar/gkh939; Kim MS, 1998, BIOCHEM MOL BIOL INT, V46, P1153; Kim MS, 1997, MOL GEN GENET, V254, P464, DOI 10.1007/s004380050440; Kim S, 1996, J BIOL CHEM, V271, P19330, DOI 10.1074/jbc.271.32.19330; Kim Y., 2009, THESIS KAIST; KIRSEBOM LA, 1988, J MOL BIOL, V204, P879, DOI 10.1016/0022-2836(88)90048-4; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LEE SY, 1978, J BACTERIOL, V133, P1015, DOI 10.1128/JB.133.2.1015-1023.1978; Li ZW, 1998, P NATL ACAD SCI USA, V95, P2856, DOI 10.1073/pnas.95.6.2856; Park JW, 2002, BIOCHEM BIOPH RES CO, V290, P1183, DOI 10.1006/bbrc.2001.6331; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Trotochaud AE, 2005, NAT STRUCT MOL BIOL, V12, P313, DOI 10.1038/nsmb917; Trotochaud AE, 2004, J BACTERIOL, V186, P4978, DOI 10.1128/JB.186.15.4978-4985.2004; Wachi M, 1997, MOL GEN GENET, V253, P515, DOI 10.1007/s004380050352; Wassarman KM, 2007, MOL MICROBIOL, V65, P1425, DOI 10.1111/j.1365-2958.2007.05894.x; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Willkomm DK, 2005, NUCLEIC ACIDS RES, V33, P1949, DOI 10.1093/nar/gki334; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	40	22	24	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					114	122		10.1074/jbc.M110.150201	http://dx.doi.org/10.1074/jbc.M110.150201			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036909	Green Published, hybrid			2022-12-27	WOS:000285782800012
J	Dedieu, A; Gaillard, JC; Pourcher, T; Darrouzet, E; Armengaud, J				Dedieu, Alain; Gaillard, Jean-Charles; Pourcher, Thierry; Darrouzet, Elisabeth; Armengaud, Jean			Revisiting Iodination Sites in Thyroglobulin with an Organ-oriented Shotgun Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE FORMATION; TANDEM MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; BOVINE THYROGLOBULIN; DEHYDROALANINE RESIDUES; COMPLEMENTARY-DNA; RICH PEPTIDES; CATHEPSIN-B; SEQUENCE; PROTEOMICS	Thyroglobulin (Tg) is secreted by thyroid epithelial cells. It is essential for thyroid hormonogenesis and iodine storage. Although studied for many years, only indirect and partial surveys of its post-translational modifications were reported. Here, we present a direct proteomic approach, used to study the degree of iodination of mouse Tg without any preliminary purification. A comprehensive coverage of Tg was obtained using a combination of different proteases, MS/MS fragmentation procedures with inclusion lists and a hybrid mass high-resolution LTQ-Orbitrap XL mass spectrometer. Although only 16 iodinated sites are currently known for human Tg, we uncovered 37 iodinated tyrosine residues, most of them being mono-or diiodinated. We report the specific isotopic pattern of thyroxine modification, not recognized as a normal peptide pattern. Four hormonogenic sites were detected. Two donor sites were identified through the detection of a pyruvic acid residue in place of the initial tyrosine. Evidence for polypeptide cleavages sites due to the action of cathepsins and dipeptidyl proteases in the thyroid were also detected. This work shows that semi-quantitation of Tg iodination states is feasible for human biopsies and should be of significant medical interest for further characterization of human thyroid pathologies.	[Dedieu, Alain; Gaillard, Jean-Charles; Armengaud, Jean] Commissariat Energie Atom, DSV, iBEB, Lab Biochim Syst Pertubes, F-30207 Bagnols Sur Ceze, France; [Pourcher, Thierry; Darrouzet, Elisabeth] Commissariat Energie Atom, DSV, iBEB, Lab Transporters Imagerie & Radiotherapie Oncol, F-30207 Bagnols Sur Ceze, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Dedieu, A (corresponding author), CEA Marcoule, DSV, iBEB, SBTN,LBSP, F-30207 Bagnols Sur Ceze, France.	alain.dedieu@cea.fr		Pourcher, Thierry/0000-0003-2839-4622; ARMENGAUD, Jean/0000-0003-1589-445X				Armengaud J, 2010, EXPERT REV PROTEOMIC, V7, P65, DOI 10.1586/EPR.09.104; Barker WC, 1999, NUCLEIC ACIDS RES, V27, P39, DOI 10.1093/nar/27.1.39; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Brix K, 2001, BIOL CHEM, V382, P717, DOI 10.1515/BC.2001.087; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Deshpande V, 1999, BBA-PROTEIN STRUCT M, V1430, P157, DOI 10.1016/S0167-4838(99)00015-1; DUNN AD, 1991, J BIOL CHEM, V266, P20198; DUNN AD, 1991, ENDOCRINOLOGY, V128, P3073, DOI 10.1210/endo-128-6-3073; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; Dunn J. T., 1995, EUR J ENDOCRINOL, V132, P603; DUNN JT, 1983, J BIOL CHEM, V258, P9093; Dunn JT, 1999, BIOCHIMIE, V81, P505, DOI 10.1016/S0300-9084(99)80102-3; DUNN JT, 1987, J BIOL CHEM, V262, P16948; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Friedrichs B, 2003, J CLIN INVEST, V111, P1733, DOI 10.1172/JCI200315990; GAVARET JM, 1981, J BIOL CHEM, V256, P9167; GAVARET JM, 1977, J BIOL CHEM, V252, P3281; GAVARET JM, 1980, J BIOL CHEM, V255, P5281; Gentile F, 1997, J BIOL CHEM, V272, P639; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Jordans S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-23; Kersey P, 2000, BIOINFORMATICS, V16, P1048, DOI 10.1093/bioinformatics/16.11.1048; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; KIM PS, 1984, ENDOCRINOLOGY, V114, P369, DOI 10.1210/endo-114-2-369; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kuster B, 1998, CURR OPIN STRUC BIOL, V8, P393, DOI 10.1016/S0959-440X(98)80075-4; LAMAS L, 1989, J BIOL CHEM, V264, P13541; LEJEUNE PJ, 1983, FEBS LETT, V156, P77, DOI 10.1016/0014-5793(83)80252-X; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; MALTHIERY Y, 1989, BIOCHIMIE, V71, P195, DOI 10.1016/0300-9084(89)90057-6; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; MARRIQ C, 1989, FEBS LETT, V242, P414, DOI 10.1016/0014-5793(89)80513-7; MERCKEN L, 1985, NATURE, V316, P647, DOI 10.1038/316647a0; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; MUSTI AM, 1986, P NATL ACAD SCI USA, V83, P323, DOI 10.1073/pnas.83.2.323; OHMIYA Y, 1990, J BIOL CHEM, V265, P9066; PALUMBO G, 1990, J BIOL CHEM, V265, P8887; Salek M, 2005, PROTEOMICS, V5, P351, DOI 10.1002/pmic.200400949; SENKO MW, 1994, ANAL CHEM, V66, P415, DOI 10.1021/ac00075a016; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taurog A, 1996, ARCH BIOCHEM BIOPHYS, V330, P24, DOI 10.1006/abbi.1996.0222; Tepel C, 2000, J CELL SCI, V113, P4487; Tharakan R, 2010, PROTEOMICS, V10, P1160, DOI 10.1002/pmic.200900433; TURNER CD, 1983, ARCH BIOCHEM BIOPHYS, V222, P245, DOI 10.1016/0003-9861(83)90522-2; Valkenborg D, 2008, J AM SOC MASS SPECTR, V19, P703, DOI 10.1016/j.jasms.2008.01.009; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	49	36	36	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					259	269		10.1074/jbc.M110.159483	http://dx.doi.org/10.1074/jbc.M110.159483			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978121	hybrid, Green Published			2022-12-27	WOS:000285782800029
J	Ionel, A; Velazquez-Muriel, JA; Luque, D; Cuervo, A; Caston, JR; Valpuesta, JM; Martin-Benito, J; Carrascosa, JL				Ionel, Alina; Velazquez-Muriel, Javier A.; Luque, Daniel; Cuervo, Ana; Caston, Jose R.; Valpuesta, Jose M.; Martin-Benito, Jaime; Carrascosa, Jose L.			Molecular Rearrangements Involved in the Capsid Shell Maturation of Bacteriophage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-MICROSCOPY; VIRUS MATURATION; COMMON ANCESTRY; NEW-GENERATION; PROTEIN GPD; CRYO-EM; VISUALIZATION; RESOLUTION; MECHANISM; EVOLUTION	Maturation of dsDNA bacteriophages involves assembling the virus prohead from a limited set of structural components followed by rearrangements required for the stability that is necessary for infecting a host under challenging environmental conditions. Here, we determine the mature capsid structure of T7 at 1 nm resolution by cryo-electron microscopy and compare it with the prohead to reveal the molecular basis of T7 shell maturation. The mature capsid presents an expanded and thinner shell, with a drastic rearrangement of the major protein monomers that increases in their interacting surfaces, in turn resulting in a new bonding lattice. The rearrangements include tilting, in-plane rotation, and radial expansion of the subunits, as well as a relative bending of the A-and P-domains of each subunit. The unique features of this shell transformation, which does not employ the accessory proteins, inserted domains, or molecular interactions observed in other phages, suggest a simple capsid assembling strategy that may have appeared early in the evolution of these viruses.	[Martin-Benito, Jaime; Carrascosa, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, Madrid 28049, Spain; [Velazquez-Muriel, Javier A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Velazquez-Muriel, Javier A.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carrascosa, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Macromol Struct, Darwin 3, Madrid 28049, Spain.	jlcarras@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Caston, Jose R/L-5896-2014; Valpuesta, José M/T-1977-2017; Luque, Daniel/I-6467-2015; Caston, Jose/AAB-8825-2021	Caston, Jose R/0000-0003-2350-9048; Valpuesta, José M/0000-0001-7468-8053; Luque, Daniel/0000-0002-0151-6020; Caston, Jose/0000-0003-2350-9048; Cuervo, Ana/0000-0001-9414-503X; Martin-Benito Romero, Jaime/0000-0002-8541-4709	National Institutes of Health [R01 GM083960, R01GM54762, PN2 EY016525]; Direccion General de Investigacion of the Ministry of Science and Innovation [BFU2008-02328/BM, CSD2007-00010]; Madrid Government [S-2009/MAT-1507]; Ministry of Science and Innovation [BIO2008-02361]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960, R01GM054762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direccion General de Investigacion of the Ministry of Science and Innovation; Madrid Government; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM083960, R01GM54762, and PN2 EY016525 (to A. Sali). This work was also supported by Grants BFU2008-02328/BMC and Consolider CSD2007-00010 from the Direccion General de Investigacion of the Ministry of Science and Innovation (to J. L. C.), S-2009/MAT-1507 from the Direccion General de Univertsidades e Investigacion from the Madrid Government (to J. L. C.), BIO2008-02361 from the Direccion General de Investigacion of the Ministry of Science and Innovation (to J. R. C.).	Ackermann HW, 1999, ADV VIRUS RES, V51, P135; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Belnap DM, 2000, J VIROL, V74, P1342, DOI 10.1128/JVI.74.3.1342-1354.2000; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Casjens S, 1997, STRUCTURAL BIOL VIRU, P38; Cerritelli ME, 2003, ADV PROTEIN CHEM, V64, P301; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujisawa H, 1997, GENES CELLS, V2, P537, DOI 10.1046/j.1365-2443.1997.1450343.x; Gertsman I, 2009, NATURE, V458, P646, DOI 10.1038/nature07686; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Hendrix RW, 2005, ADV VIRUS RES, V64, P1, DOI 10.1016/S0065-3527(05)64001-8; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; KING J, 1997, STRUCTURAL BIOL VIRU, P288; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008; STEVEN AC, 1991, J STRUCT BIOL, V106, P221, DOI 10.1016/1047-8477(91)90072-5; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yang F, 2000, NAT STRUCT BIOL, V7, P230	49	46	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					234	242		10.1074/jbc.M110.187211	http://dx.doi.org/10.1074/jbc.M110.187211			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20962334	Green Published, hybrid			2022-12-27	WOS:000285782800026
J	Xu, D; Fuster, MM; Lawrence, R; Esko, JD				Xu, Ding; Fuster, Mark M.; Lawrence, Roger; Esko, Jeffrey D.			Heparan Sulfate Regulates VEGF(165)- and VEGF(121)-mediated Vascular Hyperpermeability*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VEGF RECEPTOR; EXTRACELLULAR DOMAIN; NEUROPILIN-1 BINDS; CRYSTAL-STRUCTURE; SOLUBLE RECEPTOR; COMPLEX REVEALS; TERNARY COMPLEX; SRC ACTIVITY; PERMEABILITY	VEGF was first described as vascular permeability factor, a potent inducer of vascular leakage. Genetic evidence indicates that VEGF-stimulated endothelial proliferation in vitro and angiogenesis in vivo depend on heparan sulfate, but a requirement for heparan sulfate in vascular hyperpermeability has not been explored. Here we show that altering endothelial cell heparan sulfate biosynthesis in vivo decreases hyperpermeability induced by both VEGF(165) and VEGF(121). Because VEGF(121) does not bind heparan sulfate, the requirement for heparan sulfate suggested that it interacted with VEGF receptors rather than the ligand. By applying proximity ligation assays to primary brain endothelial cells, we show a direct interaction in situ between heparan sulfate and the VEGF receptor, VEGFR2. Furthermore, the number of heparan sulfate-VEGFR2 complexes increased in response to both VEGF(165) and VEGF(121). Genetic or heparin lyase-mediated alteration of endothelial heparan sulfate attenuated phosphorylation of VEGFR2 in response to VEGF(165) and VEGF(121), suggesting that the functional VEGF receptor complex contains heparan sulfate. Pharmacological blockade of heparan sulfate-protein interactions inhibited hyperpermeability in vivo, suggesting heparan sulfate as a potential target for treating hyperpermeability associated with ischemic disease.	[Xu, Ding; Lawrence, Roger; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Fuster, Mark M.] Univ Calif San Diego, Div Pulm & Crit Care, Dept Med, San Diego, CA 92103 USA; [Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Esko, JD (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA.	jesko@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712	National Institutes of Health [HL57345]; American Heart Association [0825274F]; Veterans Affairs Career Development program; American Cancer Society [RSG-08-153-01-CS]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345, P01HL107150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Veterans Affairs Career Development program; American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL57345 ( to J. D. E.). This work was also supported by Post-doctoral Fellowship 0825274F from the American Heart Association ( to D. X.) as well as support from the Veterans Affairs Career Development program and the American Cancer Society (Grant RSG-08-153-01-CS) ( to M. M. F.).	Ashikari- Hada S, 2005, J BIOL CHEM, V280, P31508, DOI 10.1074/jbc.M414581200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; CHIANG MK, 1995, GROWTH FACTORS, V12, P1, DOI 10.3109/08977199509003208; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Constien R, 2001, GENESIS, V30, P36, DOI 10.1002/gene.1030; Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gengrinovitch S, 1999, J BIOL CHEM, V274, P10816, DOI 10.1074/jbc.274.16.10816; Gille H, 2001, J BIOL CHEM, V276, P3222, DOI 10.1074/jbc.M002016200; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; GitayGoren H, 1996, J BIOL CHEM, V271, P5519, DOI 10.1074/jbc.271.10.5519; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Izvolsky KI, 2008, GENESIS, V46, P8, DOI 10.1002/dvg.20355; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kleinig TJ, 2009, CURR OPIN NEUROL, V22, P294, DOI 10.1097/WCO.0b013e32832b4db3; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matyal R, 2005, INT ANESTHESIOL CLIN, V43, P135, DOI 10.1097/01.aia.0000157499.41843.a3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robinson CJ, 2001, J CELL SCI, V114, P853; Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Willett CG, 2004, NAT MED, V10, P145, DOI 10.1038/nm988	60	72	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					737	745		10.1074/jbc.M110.177006	http://dx.doi.org/10.1074/jbc.M110.177006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974861	Green Published, hybrid			2022-12-27	WOS:000285782800073
J	Komatsu, H; Feingold-Link, E; Sharp, KA; Rastogi, T; Axelsen, PH				Komatsu, Hiroaki; Feingold-Link, Elana; Sharp, Kim A.; Rastogi, Tanvi; Axelsen, Paul H.			Intrinsic Linear Heterogeneity of Amyloid beta Protein Fibrils Revealed by Higher Resolution Mass-per-length Determinations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; TRANSMISSION ELECTRON-MICROSCOPE; ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; QUATERNARY STRUCTURE; CONGO RED; A-BETA(1-40); PEPTIDE; OXIDATION; FIBRILLOGENESIS	Amyloid beta proteins spontaneously form fibrils in vitro that vary in their thermodynamic stability and in morphological characteristics such as length, width, shape, longitudinal twist, and the number of component filaments. It is vitally important to determine which variant best represents the type of fibril that accumulates in Alzheimer disease. In the present study, the nature of morphological variation was examined by dark-field and transmission electron microscopy in a preparation of seeded amyloid beta protein fibrils that formed at relatively low protein concentrations and exhibited remarkably high thermodynamic stability. The number of filaments comprising these fibrils changed frequently from two to six along their length, and these changes only became apparent when mass-per-length (MPL) determinations are made with sufficient resolution. The MPL results could be reproduced by a simple stochastic model with a single adjustable parameter. The presence of more than two primary filaments could not be discerned by transmission electron microscopy, and they had no apparent relationship to the longitudinal twist of the fibrils. However, the pitch of the twist was strongly affected by the pH of the negative stain. We conclude that highly stable amyloid fibrils may form in which a surprising amount of intrinsic linear heterogeneity may be obscured by MPL measurements of insufficient resolution, and by the negative stains used for imaging fibrils by electron microscopy.	[Komatsu, Hiroaki; Feingold-Link, Elana; Axelsen, Paul H.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Sharp, Kim A.; Rastogi, Tanvi; Axelsen, Paul H.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Axelsen, Paul H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Axelsen, PH (corresponding author), Univ Penn, Dept Pharmacol, 105 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	axe@upenn.edu		Tal, Elana/0000-0001-7065-8121	National Institute on Aging; American Health Assistance Foundation; Alzheimer Association	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Health Assistance Foundation; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation)	This work was supported in part by grants from the National Institute on Aging, the American Health Assistance Foundation, and the Alzheimer Association.	Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; Arimon M, 2005, FASEB J, V19, P1344, DOI 10.1096/fj.04-3137fje; Benzinger TLS, 2000, BIOCHEMISTRY-US, V39, P3491, DOI 10.1021/bi991527v; Bose PP, 2010, ACS CHEM NEUROSCI, V1, P315, DOI 10.1021/cn900041x; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Carter DB, 1998, NEUROBIOL AGING, V19, P37, DOI 10.1016/S0197-4580(97)00164-4; Chaney MO, 1998, PROTEIN ENG, V11, P761, DOI 10.1093/protein/11.9.761; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Feja B, 1997, J STRUCT BIOL, V119, P72, DOI 10.1006/jsbi.1997.3861; Feja B, 1999, MICRON, V30, P299, DOI 10.1016/S0968-4328(99)00032-3; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; JACKSON M, 1991, BIOCHIM BIOPHYS ACTA, V1078, P231, DOI 10.1016/0167-4838(91)90563-F; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Karsai A, 2006, J STRUCT BIOL, V155, P316, DOI 10.1016/j.jsb.2005.12.015; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Liu L, 2008, J MOL BIOL, V377, P1236, DOI 10.1016/j.jmb.2008.01.057; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MORI H, 1992, J BIOL CHEM, V267, P17082; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Paravastu AK, 2006, BIOPHYS J, V90, P4618, DOI 10.1529/biophysj.105.076927; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Rubin N, 2008, J AM CHEM SOC, V130, P4602, DOI 10.1021/ja800328y; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sachse C, 2006, J MOL BIOL, V362, P347, DOI 10.1016/j.jmb.2006.07.011; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; SELKOE DJ, 1986, METHOD ENZYMOL, V134, P388; Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SHECHTER Y, 1986, J BIOL CHEM, V261, P66; Shivaprasad S, 2004, BIOCHEMISTRY-US, V43, P15310, DOI 10.1021/bi048019s; Sousa AA, 2007, J MICROSC-OXFORD, V228, P25, DOI 10.1111/j.1365-2818.2007.01819.x; Usui K, 2009, P NATL ACAD SCI USA, V106, P18563, DOI 10.1073/pnas.0804758106; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Wang ZG, 2003, ULTRAMICROSCOPY, V97, P73, DOI 10.1016/S0304-3991(03)00031-7; Wetzel R, 2007, BIOCHEMISTRY-US, V46, P1, DOI 10.1021/bi0620959; ZEITLER E, 1962, J APPL PHYS, V33, P847, DOI 10.1063/1.1777179; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106	56	25	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41843	41851		10.1074/jbc.M110.165068	http://dx.doi.org/10.1074/jbc.M110.165068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940298	Green Published, hybrid			2022-12-27	WOS:000285622600072
J	Lee, JH; Khadka, P; Baek, SH; Chung, IK				Lee, Ji Hoon; Khadka, Prabhat; Baek, Seung Han; Chung, In Kwon			CHIP Promotes Human Telomerase Reverse Transcriptase Degradation and Negatively Regulates Telomerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; E3 UBIQUITIN LIGASE; NUCLEAR-LOCALIZATION; MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; CELL-LINES; COMPLEX; HSP90; HTERT; P23	The maintenance of eukaryotic telomeres requires telomerase, which is minimally composed of a telomerase reverse transcriptase (TERT) and an associated RNA component. Telomerase activity is tightly regulated by expression of human (h) TERT at both the transcriptional and post-translational levels. The Hsp90 and p23 molecular chaperones have been shown to associate with hTERT for the assembly of active telomerase. Here, we show that CHIP (C terminus of Hsc70-interacting protein) physically associates with hTERT in the cytoplasm and regulates the cellular abundance of hTERT through a ubiquitin-mediated degradation. Overexpression of CHIP prevents nuclear translocation of hTERT and promotes hTERT degradation in the cytoplasm, thereby inhibiting telomerase activity. In contrast, knockdown of endogenous CHIP results in the stabilization of cytoplasmic hTERT. However, it does not affect the level of nuclear hTERT and has no effect on telomerase activity and telomere length. We further show that the binding of CHIP and Hsp70 to hTERT inhibits nuclear translocation of hTERT by dissociating p23. However, Hsp90 binding to hTERT was not affected by CHIP overexpression. These results suggest that CHIP can remodel the hTERT-chaperone complexes. Finally, the amount of hTERT associated with CHIP peaks in G(2)/M phases but decreases during S phase, suggesting a cell cycle-dependent regulation of hTERT. Our data suggest that CHIP represents a new pathway for modulating telomerase activity in cancer.	[Chung, In Kwon] Yonsei Univ, Dept Biol, Seoul 20749, South Korea; Yonsei Univ, Dept Biomed Sci, World Class Univ Program, Grad Sch, Seoul 20749, South Korea	Yonsei University; Yonsei University	Chung, IK (corresponding author), Yonsei Univ, Dept Biol, Seoul 20749, South Korea.	topoviro@yonsei.ac.kr	Lee, Ji Hoon/AAV-5473-2021	Lee, Ji Hoon/0000-0002-7488-3999; Baek, Seung Han/0000-0002-8722-0027	Korean Ministry of Education, Science, and Technology [R31-2009-000-10086-0]; Korea Research Foundation [KRF-M1075604000107N560400110, KRF-20090084897]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported in part by World Class University Fund R31-2009-000-10086-0 from the Korean Ministry of Education, Science, and Technology and by Korea Research Foundation Grants KRF-M1075604000107N560400110 and KRF-20090084897.	Akiyama M, 2003, CANCER RES, V63, P18; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cerone MA, 2005, ONCOGENE, V24, P7893, DOI 10.1038/sj.onc.1208934; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Deng Z, 2007, CURR BIOL, V17, P1989, DOI 10.1016/j.cub.2007.10.054; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Huang Z, 2004, MOL CELL BIOL, V24, P8951, DOI 10.1128/MCB.24.20.8951-8962.2004; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Keppler BR, 2006, J BIOL CHEM, V281, P19840, DOI 10.1074/jbc.M511067200; Kharbanda S, 2000, CURR BIOL, V10, P568, DOI 10.1016/S0960-9822(00)00483-8; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; Kimura A, 2004, ONCOGENE, V23, P4505, DOI 10.1038/sj.onc.1207582; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lee JH, 2010, CANCER LETT, V290, P76, DOI 10.1016/j.canlet.2009.08.026; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Marcand S, 2000, CURR BIOL, V10, P487, DOI 10.1016/S0960-9822(00)00450-4; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sampathi S, 2009, J BIOL CHEM, V284, P3682, DOI 10.1074/jbc.M805362200; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	52	58	62	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42033	42045		10.1074/jbc.M110.149831	http://dx.doi.org/10.1074/jbc.M110.149831			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959453	Green Published, hybrid			2022-12-27	WOS:000285622600089
J	Louafi, F; Martinez-Nunez, RT; Sanchez-Elsner, T				Louafi, Fethi; Martinez-Nunez, Rocio T.; Sanchez-Elsner, Tilman			MicroRNA-155 Targets SMAD2 and Modulates the Response of Macrophages to Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; PULMONARY-FIBROSIS; SIGNAL-TRANSDUCTION; DENDRITIC CELLS; EXPRESSION; TGF-BETA-1; PATHWAY; GENE; FIBROBLASTS; ACTIVATION	Transforming growth factor-beta (TGF-beta) is a pleiotropic cytokine with important effects on processes such as fibrosis, angiogenesis, and immunosupression. Using bioinformatics, we identified SMAD2, one of the mediators of TGF-beta signaling, as a predicted target for a microRNA, microRNA-155 (miR-155). MicroRNAs are a class of small non-coding RNAs that have emerged as an important class of gene expression regulators. miR-155 has been found to be involved in the regulation of the immune response in myeloid cells. Here, we provide direct evidence of binding of miR-155 to a predicted binding site and the ability of miR-155 to repress SMAD2 protein expression. We employed a lentivirally transduced monocyte cell line (THP1-155) containing an inducible miR-155 transgene to show that endogenous levels of SMAD2 protein were decreased after sustained overexpression of miR-155. This decrease in SMAD2 led to a reduction in both TGF-beta-induced SMAD-2 phosphorylation and SMAD-2-dependent activation of the expression of the CAGA(12)LUC reporter plasmid. Overexpression of miR-155 altered the cellular responses to TGF-beta by changing the expression of a set of genes that is involved in inflammation, fibrosis, and angiogenesis. Our study provides firm evidence of a role for miR-155 in directly repressing SMAD2 expression, and our results demonstrate the relevance of one of the two predicted target sites in SMAD2 3'-UTR. Altogether, our data uncover an important role for miR-155 in modulating the cellular response to TGF-beta with possible implications in several human diseases where homeostasis of TGF-beta might be altered.	[Louafi, Fethi; Martinez-Nunez, Rocio T.; Sanchez-Elsner, Tilman] Univ Southampton, Sch Med, Southampton Gen Hosp, JunkRNA Lab,Div Infect Inflammat & Immun, Southampton SO16 6YD, Hants, England	University of Southampton	Sanchez-Elsner, T (corresponding author), Gen Hosp MP 813, Tremona Rd, Southampton SO16 6YD, Hants, England.	Sanchez-Elsner@soton.ac.uk		Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Sanchez-Elsner, Tilman/0000-0003-1915-2410	Medical Research Council [G0801984]; MRC [G0801984] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0801984 (to T. S.-E.).	Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Bosse Y, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-66; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Geissmann F, 1999, J IMMUNOL, V162, P4567; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang SA, 2010, CANCER RES, V70, P3119, DOI 10.1158/0008-5472.CAN-09-4250; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Martin MM, 2006, J BIOL CHEM, V281, P18277, DOI 10.1074/jbc.M601496200; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Min AK, 2010, BIOCHEM BIOPH RES CO, V393, P536, DOI 10.1016/j.bbrc.2010.02.050; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ralser M, 2006, BIOCHEM BIOPH RES CO, V347, P747, DOI 10.1016/j.bbrc.2006.06.151; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Senoo T, 2010, THORAX, V65, P334, DOI 10.1136/thx.2009.119974; Shih SC, 2001, GROWTH FACTORS, V19, P19, DOI 10.3109/08977190109001073; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Tili E, 2009, INT REV IMMUNOL, V28, P264, DOI 10.1080/08830180903093796	35	154	168	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41328	41336		10.1074/jbc.M110.146852	http://dx.doi.org/10.1074/jbc.M110.146852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036908	Green Published, hybrid			2022-12-27	WOS:000285622600018
J	Fukuda, T; Sugita, S; Inatome, R; Yanagi, S				Fukuda, Toshifumi; Sugita, Satoko; Inatome, Ryoko; Yanagi, Shigeru			CAMDI, a Novel Disrupted in Schizophrenia 1 (DISC1)-binding Protein, Is Required for Radial Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY LIGHT-CHAIN; NEURONAL MIGRATION; BEHAVIORAL PHENOTYPES; DISC1; CENTROSOME; DYNEIN; BRAIN; MICE; LIS1; DISRUPTED-IN-SCHIZOPHRENIA-1	Centrosomes play a crucial role in the directed migration of developing neurons. However, the underlying mechanism is poorly understood. This study has identified a novel disrupted in schizophrenia 1 (DISC1)-interacting protein, named CAMDI after coiled-coil protein associated with myosin II and DISC1, which translocates to the centrosome in a DISC1-dependent manner. Knockdown of CAMDI by shRNA revealed severely impaired radial migration with disoriented centrosomes. A yeast two-hybrid screen identified myosin II as a binding protein of CAMDI. CAMDI interacts preferentially with phosphomyosin II and induces an accumulation of phosphomyosin II at the centrosome in a DISC1-dependent manner. Interestingly, one single nucleotide polymorphism of the CAMDI gene (R828W) is identified, and its gene product was found to reduce the binding ability to phosphomyosin II. Furthermore, mice with overexpression of R828W in neurons exhibit an impaired radial migration. Our findings indicate that CAMDI is required for radial migration probably through DISC1 and myosin II-mediated centrosome positioning during neuronal development.	[Fukuda, Toshifumi; Sugita, Satoko; Inatome, Ryoko; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Sch Life Sci, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Fukuda, T (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Sch Life Sci, Tokyo 1920392, Japan.	tfukuda@ls.toyaku.ac.jp; syanagi@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020	Yanagi, Shigeru/0000-0002-1392-8663	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T. F., R. I., and S. Y.).	Asada N, 2007, J NEUROSCI, V27, P11769, DOI 10.1523/JNEUROSCI.1938-07.2007; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Brandon NJ, 2009, J NEUROSCI, V29, P12768, DOI 10.1523/JNEUROSCI.3355-09.2009; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Conroy J, 2009, AM J MED GENET B, V150B, P535, DOI 10.1002/ajmg.b.30854; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; Gressens P, 2006, CURR OPIN NEUROL, V19, P135, DOI 10.1097/01.wco.0000218228.73678.e1; Hatten ME, 2005, J CELL BIOL, V170, P867, DOI 10.1083/jcb.200506140; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; KAMISOYAMA H, 1994, BIOCHEMISTRY-US, V33, P840, DOI 10.1021/bi00169a027; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kilpinen H, 2008, MOL PSYCHIATR, V13, P187, DOI 10.1038/sj.mp.4002031; Korth C, 2009, REV NEUROSCIENCE, V20, P321; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Li W, 2007, P NATL ACAD SCI USA, V104, P18280, DOI 10.1073/pnas.0706900104; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2006, TRENDS NEUROSCI, V29, P655, DOI 10.1016/j.tins.2006.10.001; Mencarelli MA, 2007, AM J MED GENET A, V143A, P858, DOI 10.1002/ajmg.a.31602; Metin C, 2008, J NEUROSCI, V28, P11746, DOI 10.1523/JNEUROSCI.3860-08.2008; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Pletnikov MV, 2008, MOL PSYCHIATR, V13, P173, DOI [10.1038/sj.mp.4002079, 10.1038/sj.mp.4002144]; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; SWEENEY HL, 1994, P NATL ACAD SCI USA, V91, P1490, DOI 10.1073/pnas.91.4.1490; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005	45	40	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40554	40561		10.1074/jbc.M110.179481	http://dx.doi.org/10.1074/jbc.M110.179481			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956536	hybrid, Green Published			2022-12-27	WOS:000285414400018
J	Hammes, UZ; Meier, S; Dietrich, D; Ward, JM; Rentsch, D				Hammes, Ulrich Z.; Meier, Stefan; Dietrich, Daniela; Ward, John M.; Rentsch, Doris			Functional Properties of the Arabidopsis Peptide Transporters AtPTR1 and AtPTR5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; OLIGOPEPTIDE TRANSPORTER; SEED DEVELOPMENT; AFFINITY; GERMINATION; EXPRESSION; NITRATE; PLANTS; IDENTIFICATION; MECHANISMS	The Arabidopsis di- and tripeptide transporters AtPTR1 and AtPTR5 were expressed in Xenopus laevis oocytes, and their selectivity and kinetic properties were determined by voltage clamping and by radioactive uptake. Dipeptide transport by AtPTR1 and AtPTR5 was found to be electrogenic and dependent on protons but not sodium. In the absence of dipeptides, both transporters showed proton-dependent leak currents that were inhibited by Phe-Ala (AtPTR5) and Phe-Ala, Trp-Ala, and Phe-Phe (AtPTR1). Phe-Ala was shown to reduce leak currents by binding to the substrate-binding site with a high apparent affinity. Inhibition of leak currents was only observed when the aromatic amino acids were present at the N-terminal position. AtPTR1 and AtPTR5 transport activity was voltage-dependent, and currents increased supralinearly with more negative membrane potentials and did not saturate. The voltage dependence of the apparent affinities differed between Ala-Ala, Ala-Lys, and Ala-Asp and was not conserved between the two transporters. The apparent affinity of AtPTR1 for these dipeptides was pH-dependent and decreased with decreasing proton concentration. In contrast to most proton-coupled transporters characterized so far, -I-max increased at high pH, indicating that regulation of the transporter by pH overrides the importance of protons as co-substrate.	[Hammes, Ulrich Z.; Meier, Stefan; Dietrich, Daniela; Rentsch, Doris] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland; [Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Bern; University of Minnesota System; University of Minnesota Twin Cities	Rentsch, D (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	doris.rentsch@ips.unibe.ch	Dietrich, Daniela/AAC-2755-2020	Dietrich, Daniela/0000-0001-7241-4585; Ward, John/0000-0001-8185-0434; Rentsch, Doris/0000-0003-4313-7683	Swiss National Science Foundation [31003A_127340, 3100A0-107507]; United States Department of Energy [DE-FG02-07ER15886]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Swiss National Science Foundation Grants 31003A_127340 and 3100A0-107507 (to D. R.) and United States Department of Energy Grant DE-FG02-07ER15886 (to J. M. W.).	Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0; Chen XZ, 2000, BIOCHEM BIOPH RES CO, V272, P726, DOI 10.1006/bbrc.2000.2851; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Chiang CS, 2004, J BIOL CHEM, V279, P30150, DOI 10.1074/jbc.M405192200; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DANIEL H, 1992, J BIOL CHEM, V267, P9565; Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2; Dietrich D, 2004, PLANT J, V40, P488, DOI 10.1111/j.1365-313X.2004.02224.x; Fang G, 2000, J BACTERIOL, V182, P2530, DOI 10.1128/JB.182.9.2530-2535.2000; Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p; Jeong JY, 2004, PLANT PHYSIOL, V134, P969, DOI 10.1104/pp.103.032102; Komarova NY, 2008, PLANT PHYSIOL, V148, P856, DOI 10.1104/pp.108.123844; Kottra G, 2002, J BIOL CHEM, V277, P32683, DOI 10.1074/jbc.M204192200; Mackenzie B, 1996, J BIOL CHEM, V271, P5430, DOI 10.1074/jbc.271.10.5430; MEHARG AA, 1995, J MEMBRANE BIOL, V145, P49; Miranda M, 2003, PLANT PHYSIOL, V132, P1950, DOI 10.1104/pp.103.024422; Paungfoo-Lonhienne C, 2009, J EXP BOT, V60, P2665, DOI 10.1093/jxb/erp111; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Segonzac C, 2007, PLANT CELL, V19, P3760, DOI 10.1105/tpc.106.048173; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Song W, 1997, PLANT PHYSIOL, V114, P927, DOI 10.1104/pp.114.3.927; Sugiura M, 2007, PLANT CELL PHYSIOL, V48, P1022, DOI 10.1093/pcp/pcm073; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Ward JM, 1997, PLANT PHYSIOL, V114, P1151, DOI 10.1104/pp.114.4.1151; Waterworth WM, 2006, ANN BOT-LONDON, V98, P1, DOI 10.1093/aob/mcl099; West CE, 1998, PLANT J, V15, P221, DOI 10.1046/j.1365-313X.1998.00199.x; Zhou JJ, 1998, J BIOL CHEM, V273, P12017, DOI 10.1074/jbc.273.20.12017	32	23	25	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39710	39717		10.1074/jbc.M110.141457	http://dx.doi.org/10.1074/jbc.M110.141457			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937801	Green Published, hybrid			2022-12-27	WOS:000285185500015
J	Screen, M; Britton, M; Downey, SL; Verdoes, M; Voges, MJ; Blom, AEM; Geurink, PP; Risseeuw, MDP; Florea, BI; van der Linden, WA; Pletnev, AA; Overkleeft, HS; Kisselev, AF				Screen, Michael; Britton, Matthew; Downey, Sondra L.; Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Pletnev, Alexandre A.; Overkleeft, Herman S.; Kisselev, Alexei F.			Nature of Pharmacophore Influences Active Site Specificity of Proteasome Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; SELECTIVE INHIBITOR; PEPTIDE; YEAST; BORTEZOMIB; MECHANISM; SUBSTRATE; PROTEIN; CELLS	Proteasomes degrade most proteins in mammalian cells and are established targets of anti-cancer drugs. The majority of proteasome inhibitors are composed of short peptides with an electrophilic functionality (pharmacophore) at the C terminus. All eukaryotic proteasomes have three types of active sites as follows: chymotrypsin-like, trypsin-like, and caspase-like. It is widely believed that active site specificity of inhibitors is determined primarily by the peptide sequence and not the pharmacophore. Here, we report that active site specificity of inhibitors can also be tuned by the chemical nature of the pharmacophore. Specifically, replacement of the epoxyketone by vinyl sulfone moieties further improves the selectivity of beta 5-specific inhibitors NC-005, YU-101, and PR-171 (carfilzomib). This increase in specificity is likely the basis of the decreased cytotoxicity of vinyl sulfone-based inhibitors to HeLa cells as compared with that of epoxyketone-based inhibitors.	[Screen, Michael; Britton, Matthew; Downey, Sondra L.; Kisselev, Alexei F.] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Screen, Michael; Britton, Matthew; Downey, Sondra L.; Pletnev, Alexandre A.; Kisselev, Alexei F.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Pletnev, Alexandre A.] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA; [Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Overkleeft, Herman S.] Leiden Inst Chem, NL-2333 CC Leiden, Netherlands; [Verdoes, Martijn; Voges, Mathias J.; Blom, Annet E. M.; Geurink, Paul P.; Risseeuw, Martijn D. P.; Florea, Bogdan I.; van der Linden, Wouter A.; Overkleeft, Herman S.] Netherlands Prote Ctr, NL-2333 CC Leiden, Netherlands; [Screen, Michael; Britton, Matthew] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Leiden University; University of Bath	Kisselev, AF (corresponding author), 1 Med Ctr Dr,HB7936, Lebanon, NH 03756 USA.	Alexei.F.Kisselev@Dartmouth.edu	Blom, Annet/S-8615-2019; Florea, Bogdan I./AAM-9975-2020; Verdoes, Martijn/A-4911-2015; Verdoes, Martijn/AAD-5239-2022	Verdoes, Martijn/0000-0001-8753-3528; Verdoes, Martijn/0000-0001-8753-3528; Overkleeft, Herman/0000-0001-6976-7005; Geurink, Paul/0000-0003-1849-1111	National Institutes of Health, NCI [RO1]; Netherlands Organization for Scientific Research; Netherlands Genomics Initiative; NATIONAL CANCER INSTITUTE [R01CA124634] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 Grant from NCI (to A.F.K.).; Supported by The Netherlands Organization for Scientific Research and The Netherlands Genomics Initiative. To whom correspondence may be addressed: Gorlaeus Laboratories, Einsteinweg 55, 2300 CC Leiden, The Netherlands. Tel.: 31715274342; Fax: 317-527-4307; h.s.overkleeft@chem.leidenuniv.nl.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Britton M, 2009, CHEM BIOL, V16, P1278, DOI 10.1016/j.chembiol.2009.11.015; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013; Chen P, 1996, CELL, V86, P961, DOI 10.1016/S0092-8674(00)80171-3; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Groll M, 2002, CHEM BIOL, V9, P655, DOI 10.1016/S1074-5521(02)00144-8; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; KIRSCHKE H, 1994, METHOD ENZYMOL, V244, P500; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Marastoni M, 2005, J MED CHEM, V48, P5038, DOI 10.1021/JM040905D; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Piva R, 2008, BLOOD, V111, P2765, DOI 10.1182/blood-2007-07-100651; van Swieten PF, 2007, BIOORG MED CHEM LETT, V17, P3402, DOI 10.1016/j.bmcl.2007.03.092; Verdoes M, 2007, ORG BIOMOL CHEM, V5, P1416, DOI 10.1039/b702268a; Verdoes M, 2006, CHEM BIOL, V13, P1217, DOI 10.1016/j.chembiol.2006.09.013; Verdoes M, 2010, ORG BIOMOL CHEM, V8, P2719, DOI 10.1039/c001036g	29	50	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40125	40134		10.1074/jbc.M110.160606	http://dx.doi.org/10.1074/jbc.M110.160606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937826	Green Published, hybrid			2022-12-27	WOS:000285185500058
J	Thakur, S; Du, JJ; Hourani, S; Ledent, C; Li, JM				Thakur, Sapna; Du, Junjie; Hourani, Susanna; Ledent, Catherine; Li, Jian-Mei			Inactivation of Adenosine A(2A) Receptor Attenuates Basal and Angiotensin II-induced ROS Production by Nox2 in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; MICE; RELAXATION; PATHOPHYSIOLOGY; PHARMACOLOGY; ACTIVATION; P47(PHOX); PATHWAY; MEDIATE	Endothelial cells (ECs) express a Nox2 enzyme, which, by generating reactive oxygen species (ROS), contributes to EC redox signaling and angiotensin II (AngII)-induced endothelial dysfunction. ECs also express abundantly an adenosine A(2A) receptor (A(2A)R), but its role in EC ROS production remains unknown. In this study, we investigated the role of A(2A)R in the regulation of Nox2 activity and signaling in ECs with or without acute AngII stimulation. In cultured ECs (SVEC4-10), AngII (100 nM, 30 min) significantly increased Nox2 membrane translocation and association with A(2A)R. These were accompanied by p47(phox), ERK1/2, p38 MAPK, and Akt phosphorylation and an increased ROS production (169 +/- 0.04%). These AngII effects were inhibited back to the control levels by a specific A(2A)R antagonist (SCH58261), or adenosine deaminase, or by knockdown of A(2A)R or Nox2 using specific siRNAs. Knockdown of A(2A)R, as determined by Western blotting, decreased Nox2 and p47(phox) expression. In wild-type mouse aorta, SCH58261 significantly reduced acute AngII-induced ROS production and preserved endothelium-dependent vessel relaxation to acetylcholine. These results were further confirmed by using aortas from A(2A)R knock-out mice. In conclusion, A(2A)R is involved in the regulation of EC ROS production by Nox2. Inhibition or blockade of A(2A)R protects ECs from acute AngII-induced oxidative stress, MAPK activation, and endothelium dysfunction.	[Thakur, Sapna; Du, Junjie; Hourani, Susanna; Li, Jian-Mei] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Ledent, Catherine] Univ Libre Bruxelles, Inst Rech Interdisplinaire Biol Humane & Mol, B-1070 Brussels, Belgium	University of Surrey; Universite Libre de Bruxelles	Li, JM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, AY Bldg, Guildford GU2 7XH, Surrey, England.	j.li@surrey.ac.uk			British Heart Foundation [PG/06/073/21118]; Wellcome Trust [078637/Z/05/Z]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the British Heart Foundation Grant PG/06/073/21118 and the Wellcome Trust Grant 078637/Z/05/Z.	Barry-Lane PA, 2001, J CLIN INVEST, V108, P1513, DOI 10.1172/JCI11927; Bengtsson SH, 2003, CLIN EXP PHARMACOL P, V30, P849, DOI 10.1046/j.1440-1681.2003.03929.x; Cheng KT, 2008, ARTERIOSCL THROM VAS, V28, P913, DOI 10.1161/ATVBAHA.107.148338; Ernens I, 2006, CIRC RES, V99, P590, DOI 10.1161/01.RES.0000241428.82502.d4; Fan LM, 2009, ARTERIOSCL THROM VAS, V29, P1651, DOI 10.1161/ATVBAHA.109.191502; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Li JM, 2007, FREE RADICAL BIO MED, V43, P976, DOI 10.1016/j.freeradbiomed.2007.06.001; Li JM, 2004, CIRCULATION, V109, P1307, DOI 10.1161/01.CIR.0000118463.23388.B9; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Nadeem A, 2009, J PHARMACOL EXP THER, V330, P99, DOI 10.1124/jpet.109.151613; Park L, 2005, J NEUROSCI, V25, P1769, DOI 10.1523/JNEUROSCI.5207-04.2005; Ponnoth DS, 2009, AM J PHYSIOL-HEART C, V297, pH1655, DOI 10.1152/ajpheart.00192.2009; Prentice D, 2001, EUR J PHARMACOL, V415, P251, DOI 10.1016/S0014-2999(01)00841-X; Ribe D, 2008, FREE RADICAL BIO MED, V44, P1433, DOI 10.1016/j.freeradbiomed.2007.12.035; Sands WA, 2005, IMMUNOL LETT, V101, P1, DOI 10.1016/j.imlet.2005.04.005; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	23	57	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40104	40113		10.1074/jbc.M110.184606	http://dx.doi.org/10.1074/jbc.M110.184606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940302	hybrid, Green Published			2022-12-27	WOS:000285185500056
J	Wang, Z; Collighan, RJ; Gross, SR; Danen, EHJ; Orend, G; Telci, D; Griffin, M				Wang, Zhuo; Collighan, Russell J.; Gross, Stephane R.; Danen, Erik H. J.; Orend, Gertraud; Telci, Dilek; Griffin, Martin			RGD-independent Cell Adhesion via a Tissue Transglutaminase-Fibronectin Matrix Promotes Fibronectin Fibril Deposition and Requires Syndecan-4/2 and alpha 5 beta 1 Integrin Co-signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; SWISS 3T3 FIBROBLASTS; EXTRACELLULAR-MATRIX; BINDING SITE; TUMOR PROGRESSION; GROWTH; IDENTIFICATION; EXPRESSION; APOPTOSIS; PROTEIN	Fibronectin (FN) deposition mediated by fibroblasts is an important process in matrix remodeling and wound healing. By monitoring the deposition of soluble biotinylated FN, we show that the stress-induced TG-FN matrix, a matrix complex of tissue transglutaminase (TG2) with its high affinity binding partner FN, can increase both exogenous and cellular FN deposition and also restore it when cell adhesion is interrupted via the presence of RGD-containing peptides. This mechanism does not require the transamidase activity of TG2 but is activated through an RGD-independent adhesion process requiring a heterocomplex of TG2 and FN and is mediated by a syndecan-4 and beta 1 integrin co-signaling pathway. By using alpha 5 null cells, beta 1 integrin functional blocking antibody, and a alpha 5 beta 1 integrin targeting peptide A5-1, we demonstrate that the alpha 5 and beta 1 integrins are essential for TG-FN to compensate RGD-induced loss of cell adhesion and FN deposition. The importance of syndecan-2 in this process was shown using targeting siRNAs, which abolished the compensation effect of TG-FN on the RGD-induced loss of cell adhesion, resulting in disruption of actin skeleton formation and FN deposition. Unlike syndecan-4, syndecan-2 does not interact directly with TG2 but acts as a downstream effector in regulating actin cytoskeleton organization through the ROCK pathway. We demonstrate that PKC alpha is likely to be the important link between syndecan-4 and syndecan-2 signaling and that TG2 is the functional component of the TG-FN heterocomplex in mediating cell adhesion via its direct interaction with heparan sulfate chains.	[Wang, Zhuo; Collighan, Russell J.; Gross, Stephane R.; Telci, Dilek; Griffin, Martin] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Danen, Erik H. J.] Leiden Univ, Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Toxicol, NL-2300 RA Leiden, Netherlands; [Orend, Gertraud] INSERM, Strasbourg, France	Aston University; Leiden University; Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Griffin, M (corresponding author), Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	M.Griffin@aston.ac.uk	Telci, Dilek/N-5053-2019; Telci, Dilek/B-5880-2017; Orend, Gertraud/E-8446-2015	Telci, Dilek/0000-0002-2793-6533; Telci, Dilek/0000-0002-2793-6533; Orend, Gertraud/0000-0003-2522-1195; danen, erik/0000-0002-0491-6345; Griffin, Martin/0000-0003-3824-306X; gross, stephane/0000-0002-0867-8866; WANG, ZHUO/0000-0002-2212-8318	Marie Curie TRACKS RTN [MRTN-CT-2006-036032]; INSERM; Agence National de la Recherche; Association pour la Recherche sur le Cancer; Institut National du Cancer; University Hospital Hautepierre; University Strasbourg	Marie Curie TRACKS RTN; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Institut National du Cancer(Institut National du Cancer (INCA) France); University Hospital Hautepierre; University Strasbourg	This work was supported in part by Marie Curie TRACKS RTN Grant MRTN-CT-2006-036032. The laboratory of G.O. is supported by INSERM, the Agence National de la Recherche, the Association pour la Recherche sur le Cancer, the Institut National du Cancer, the University Hospital Hautepierre, and the University Strasbourg.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; Buckley CD, 1999, NATURE, V397, P534, DOI 10.1038/17409; Collighan RJ, 2009, AMINO ACIDS, V36, P659, DOI 10.1007/s00726-008-0190-y; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; FREUND KF, 1994, BIOCHEMISTRY-US, V33, P10109, DOI 10.1021/bi00199a039; Gambetti S, 2005, BIOCHIMIE, V87, P551, DOI 10.1016/j.biochi.2005.01.012; Gaudry CA, 1999, J BIOL CHEM, V274, P30707, DOI 10.1074/jbc.274.43.30707; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Hsiao HL, 2005, MOL CELL BIOCHEM, V272, P75, DOI 10.1007/s11010-005-7638-0; Huang WT, 2001, CANCER RES, V61, P8586; Huveneers S, 2008, J CELL SCI, V121, P2452, DOI 10.1242/jcs.033001; Isobe T, 1999, EUR J CELL BIOL, V78, P876, DOI 10.1016/S0171-9335(99)80089-2; Kim EY, 2008, BIOCHEM BIOPH RES CO, V377, P1288, DOI 10.1016/j.bbrc.2008.10.166; Klass CM, 2000, J CELL SCI, V113, P493; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Kramer KL, 2002, CELL, V111, P981, DOI 10.1016/S0092-8674(02)01200-X; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Leblanc A, 1999, PROTEIN EXPRES PURIF, V17, P89, DOI 10.1006/prep.1999.1107; Liaw L, 1999, BRAZ J MED BIOL RES, V32, P805, DOI 10.1590/S0100-879X1999000700002; Madden HL, 2000, AM J RESP CRIT CARE, V162, P1553, DOI 10.1164/ajrccm.162.4.2001015; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; Mostafavi-Pour Z, 2001, MATRIX BIOL, V20, P63, DOI 10.1016/S0945-053X(00)00131-1; NOTO K, 1995, INT IMMUNOL, V7, P835, DOI 10.1093/intimm/7.5.835; Orosco A, 2006, J CELL BIOCHEM, V98, P838, DOI 10.1002/jcb.20826; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Rudolph P, 1999, AM J DERMATOPATH, V21, P414, DOI 10.1097/00000372-199910000-00002; Scardigli R, 1996, EXP CELL RES, V227, P223, DOI 10.1006/excr.1996.0271; Scarpellini A, 2009, J BIOL CHEM, V284, P18411, DOI 10.1074/jbc.M109.012948; Shi Q, 2003, MOL BIOL CELL, V14, P4306, DOI 10.1091/mbc.E03-01-0046; Small K, 1999, J BIOL CHEM, V274, P21291, DOI 10.1074/jbc.274.30.21291; Sottile J, 2000, J CELL SCI, V113, P4287; Switala-Jelen K, 2004, FOLIA BIOL-PRAGUE, V50, P143; Tchilian EZ, 1997, IMMUNOLOGY, V92, P321, DOI 10.1046/j.1365-2567.1997.00351.x; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Telci D, 2008, J BIOL CHEM, V283, P20937, DOI 10.1074/jbc.M801763200; Verderio E, 1999, J HISTOCHEM CYTOCHEM, V47, P1417, DOI 10.1177/002215549904701108; Verderio E, 1998, EXP CELL RES, V239, P119, DOI 10.1006/excr.1997.3874; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; WOODS A, 1984, J CELL BIOL, V99, P1743, DOI 10.1083/jcb.99.5.1743; Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	53	66	67	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40212	40229		10.1074/jbc.M110.123703	http://dx.doi.org/10.1074/jbc.M110.123703			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929862	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000285185500066
J	Esposito, AM; Kinzy, TG				Esposito, Anthony M.; Kinzy, Terri Goss			The Eukaryotic Translation Elongation Factor 1B gamma Has a Non-guanine Nucleotide Exchange Factor Role in Protein Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; DEGRADATION; REQUIREMENT; MUTATIONS; NETWORK	The turnover of damaged proteins is critical to cell survival during stressful conditions such as heat shock or oxidative stress. The accumulation of misfolded proteins in the endoplasmic reticulum (ER) is toxic to cells. Therefore these proteins must be efficiently exported from the ER and degraded by the proteasome or the vacuole. Previously it was shown that the loss of eukaryotic elongation factor 1B gamma (eEF1B gamma) from the yeast Saccharomyces cerevisiae results in resistance to oxidative stress. Strains lacking eEF1B gamma show severe defects in protein turnover during conditions of oxidative stress. Furthermore, these strains accumulate a greater amount of oxidized proteins, which correlates with changes in heat shock chaperones. These strains show severe defects in vacuole morphology and defects related to the maturation of carboxypeptidase Y that is not dependent on the catalytic subunit of the eEF1B complex as a guanine nucleotide exchange factor. Finally, eEF1B gamma co-immunoprecipitates with an essential component of ER-Golgi transport vesicles. Taken together, these results support a broader protein metabolism role for eEF1B gamma.	[Esposito, Anthony M.; Kinzy, Terri Goss] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kinzy, TG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes La, Piscataway, NJ 08854 USA.	kinzytg@umdnj.edu		Kinzy, Terri/0000-0003-1394-9226	National Institutes of Health [GM57483]; National Science Foundation [MCB0516688]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057483] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57483 ( to T.G.K.). This work was also supported by National Science Foundation Grant MCB0516688 ( to T.G.K.).	Amshoff C, 1999, BIOL CHEM, V380, P669, DOI 10.1515/BC.1999.083; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CARVALHO MDD, 1984, ARCH BIOCHEM BIOPHYS, V234, P603, DOI 10.1016/0003-9861(84)90310-2; CREUTZ CE, 1991, YEAST, V7, P229, DOI 10.1002/yea.320070305; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Esposito A. M., 2010, JOVE            0615, DOI [10. 3791/ 1948, DOI 10.3791/1948]; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldberg A. L., 2003, V Microbiology, V426, P895; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kim SS, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2722291; KINZY TG, 1994, NUCLEIC ACIDS RES, V22, P2703, DOI 10.1093/nar/22.13.2703; LAWRENCE BP, 1993, J CELL SCI, V105, P473; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; Olarewaju Olubunmi, 2004, RNA Biol, V1, P89, DOI 10.4161/rna.1.2.1033; Ozturk SB, 2006, GENETICS, V174, P651, DOI 10.1534/genetics.106.059899; Pimpl P, 2006, PLANT CELL, V18, P198, DOI 10.1105/tpc.105.036665; RIPMASTER TL, 1993, MOL CELL BIOL, V13, P7901, DOI 10.1128/MCB.13.12.7901; Shenton D, 2006, J BIOL CHEM, V281, P29011, DOI 10.1074/jbc.M601545200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tran PT, 2004, METHODS, V33, P220, DOI 10.1016/j.ymeth.2003.11.017; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WIEMKEN A, 1970, Archiv fuer Mikrobiologie, V70, P89, DOI 10.1007/BF00412200	29	13	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37995	38004		10.1074/jbc.M110.160887	http://dx.doi.org/10.1074/jbc.M110.160887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926387	Green Published, hybrid			2022-12-27	WOS:000284625600007
J	Zhang, L; Jin, M; Margariti, A; Wang, G; Luo, ZL; Zampetaki, A; Zeng, LF; Ye, S; Zhu, JH; Xiao, QH				Zhang, Li; Jin, Min; Margariti, Andriana; Wang, Gang; Luo, Zhenling; Zampetaki, Anna; Zeng, Lingfang; Ye, Shu; Zhu, Jianhua; Xiao, Qingzhong			Sp1-dependent Activation of HDAC7 Is Required for Platelet-derived Growth Factor-BB-induced Smooth Muscle Cell Differentiation from Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTONE DEACETYLASES; TRANSCRIPTION FACTOR; ENDOTHELIAL-CELLS; INTIMAL HYPERPLASIA; FAMILY; SP1; EXPRESSION; COMPLEX; COREPRESSORS; HYPERTROPHY	We have previously demonstrated that histone deacetylase 7 (HDAC7) expression and splicing play an important role in smooth muscle cell (SMC) differentiation from embryonic stem (ES) cells, but the molecular mechanisms of increased HDAC7 expression during SMC differentiation are currently unknown. In this study, we found that platelet-derived growth factor-BB (PDGF-BB) induced a 3-fold increase in the transcripts of HDAC7 in differentiating ES cells. Importantly, our data also revealed that PDGF-BB regulated HDAC7 expression not through phosphorylation of HDAC7 but through transcriptional activation. By dissecting its promoters with progressive deletion analysis, we identified the sequence between -343 and -292 bp in the 5`-flanking region of the Hdac7 gene promoter as the minimal PDGF-BB-responsive element, which contains one binding site for the transcription factor, specificity protein 1 (Sp1). Mutation of the Sp1 site within this PDGF-BB-responsive element abolished PDGF-BB-induced HDAC7 activity. PDGF-BB treatment enhanced Sp1 binding to the Hdac7 promoter in differentiated SMCs in vivo as demonstrated by the chromatin immunoprecipitation assay. Moreover, we also demonstrated that knockdown of Sp1 abrogated PDGF-BB-induced HDAC7 up-regulation and SMC differentiation gene expression in differentiating ES cells, although enforced expression of Sp1 alone was sufficient to increase the activity of the Hdac7 promoter and expression levels of SMC differentiation genes. Importantly, we further demonstrated that HDAC7 was required for Sp1-induced SMC differentiation of gene expression. Our data suggest that Sp1 plays an important role in the regulation of Hdac7 gene expression in SMC differentiation from ES cells. These findings provide novel molecular insights into the regulation of HDAC7 and enhance our knowledge in SMC differentiation and vessel formation during embryonic development.	[Zhang, Li; Zhu, Jianhua] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Min] Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou 310000, Zhejiang, Peoples R China; [Margariti, Andriana; Wang, Gang; Luo, Zhenling; Zampetaki, Anna; Zeng, Lingfang] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London SE5 9NU, England; [Ye, Shu; Xiao, Qingzhong] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Clin Pharmacol, London EC1M 6BQ, England	Zhejiang University; Zhejiang University; University of London; King's College London; University of London; Queen Mary University London	Zhu, JH (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China.	zjh_john@medmail.com; q.xiao@qmul.ac.uk	Ye, Shu/R-6384-2017; Ye, Shu/C-4067-2009; Margariti, Andriana/AAH-5318-2019	Ye, Shu/0000-0002-4126-4278; Zampetaki, Anna/0000-0002-7257-8624; Zeng, Lingfang/0000-0002-0390-4561	British Heart Foundation; National Natural Science Foundation of China [30900571]; Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province [2010R1066]; Natural Science Foundation of Zhejiang Province [Y2090411]; National Institute of Health Research; British Heart Foundation [FS/09/044/28007] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Institute of Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work was supported in part by the British Heart Foundation, National Natural Science Foundation of China Grant 30900571, Qiangjiang Talent Project of Science and Technology Department of Zhejiang Province (2010R1066), and Natural Science Foundation of Zhejiang Province Grant Y2090411. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institute of Health Research.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; BLANK RS, 1990, J CELL PHYSIOL, V142, P635, DOI 10.1002/jcp.1041420325; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deng XB, 2005, J BIOL CHEM, V280, P4894, DOI 10.1074/jbc.M411894200; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; FISCHER KD, 1993, J BIOL CHEM, V268, P23915; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, BIOCHEM CELL BIOL, V79, P337, DOI 10.1139/bcb-79-3-337; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628; Karamboulas C, 2006, J CELL SCI, V119, P4305, DOI 10.1242/jcs.03185; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Margariti A, 2009, J CELL SCI, V122, P460, DOI 10.1242/jcs.034850; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Miyata T, 2005, J CELL PHYSIOL, V204, P948, DOI 10.1002/jcp.20362; Nishishita T, 2004, J CELL BIOCHEM, V91, P584, DOI 10.1002/jcb.10718; Pepe AE, 2010, CIRC RES, V106, P870, DOI 10.1161/CIRCRESAHA.109.211417; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yin XK, 2006, PROTEOMICS, V6, P6437, DOI 10.1002/pmic.200600351; Zampetaki A, 2005, AM J PHYSIOL-HEART C, V288, pH2946, DOI 10.1152/ajpheart.00919.2004; Zampetaki A, 2007, AM J PHYSIOL-CELL PH, V293, pC1226, DOI 10.1152/ajpcell.00152.2007; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	49	33	34	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38463	38472		10.1074/jbc.M110.153999	http://dx.doi.org/10.1074/jbc.M110.153999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889501	Green Published, hybrid			2022-12-27	WOS:000284625600052
J	Assumpcao, TCF; Alvarenga, PH; Ribeiro, JMC; Andersen, JF; Francischetti, IMB				Assumpcao, Teresa C. F.; Alvarenga, Patricia H.; Ribeiro, Jose M. C.; Andersen, John F.; Francischetti, Ivo M. B.			Inhibits Platelet Aggregation, Vasoconstriction, and Angiogenesis through Unique Binding Specificity for TXA(2), PGF(2 alpha), and 15(S)-HETE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; BLOODSUCKING BUG; TRIATOMA-INFESTANS; RHODNIUS-PROLIXUS; GLYCOPROTEIN-VI; GENE DISRUPTION; SALIVARY-GLANDS; PROTEIN FAMILY; TICK SALIVA; COLLAGEN	Dipetalodipin (DPTL) is an 18 kDa protein cloned from salivary glands of the triatomine Dipetalogaster maxima. DPTL belongs to the lipocalin superfamily and has strong sequence similarity to pallidipin, a salivary inhibitor of collagen-induced platelet aggregation. DPTL expressed in Escherichia coli was found to inhibit platelet aggregation by collagen, U-46619, or arachidonic acid without affecting aggregation induced by ADP, convulxin, PMA, and ristocetin. An assay based on incubation of DPTL with small molecules (e. g. prostanoids, leukotrienes, lipids, biogenic amines) followed by chromatography, mass spectrometry, and isothermal titration calorimetry showed that DPTL binds with high affinity to carbocyclic TXA(2), TXA(2) mimetic (U-46619), TXB2, PGH(2) mimetic (U-51605), PGD(2), PGJ(2), and PGF(2 alpha). It also interacts with 15(S)-HETE, being the first lipocalin described to date to bind to a derivative of 15-lipoxygenase. Binding was not observed to other prostaglandins (e.g. PGE(1), PGE(2), 8-iso-PGF(2 alpha), prostacyclin), leukotrienes (e.g,. LTB4, LTC4, LTD4, LTE4), HETEs (e.g. 5(S)-HETE, 12(S)-HETE, 20-HETE), lipids (e.g. arachidonic acid, PAF), and biogenic amines (e.g. ADP, serotonin, epinephrine, norepinephrine, histamine). Consistent with its binding specificity, DPTL prevents contraction of rat uterus stimulated by PGF(2 alpha) and induces relaxation of aorta previously contracted with U-46619. Moreover, it inhibits angiogenesis mediated by 15(S)-HETE and did not enhance inhibition of collagen-induced platelet aggregation by SQ29548 (TXA(2) antagonist) and indomethacin. A3-D model for DPTL and pallidipin is presented that indicates the presence of a conserved Arg(39) and Gln(135) in the binding pocket of both lipocalins. Results suggest that DPTL blocks platelet aggregation, vasoconstriction, and angiogenesis through binding to distinct eicosanoids involved in inflammation.	[Assumpcao, Teresa C. F.; Alvarenga, Patricia H.; Ribeiro, Jose M. C.; Andersen, John F.; Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, LMVR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Francischetti, IMB (corresponding author), NIAID, Vector Biol Sect, LMVR, NIH, 12735 Twinbrook Pkwy,Rm 2E-28, Bethesda, MD 20892 USA.	ifrancischetti@niaid.nih.gov	Alvarenga, Patricia Hessab/I-2272-2012	Hessab Alvarenga, Patricia/0000-0002-2236-6308; Ribeiro, Jose/0000-0002-9107-0818	Division of Intramural Research, NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001012, ZIAAI000810] Funding Source: NIH RePORTER	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health.	Andersen JF, 1997, BIOCHEMISTRY-US, V36, P4423, DOI 10.1021/bi9628883; Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Boyce JA, 2005, CHEM IMMUNOL ALLERGY, V87, P59, DOI 10.1159/000087571; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Cosemans JMEM, 2005, ATHEROSCLEROSIS, V181, P19, DOI 10.1016/j.atherosclerosis.2004.12.037; Feletou M, 2010, J CARDIOVASC PHARM, V55, P317, DOI 10.1097/FJC.0b013e3181d8bc8a; Firuzi O, 2008, FASEB J, V22, P1169, DOI 10.1096/fj.07-9131.com; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Francischetti IMB, 2000, J BIOL CHEM, V275, P12639, DOI 10.1074/jbc.275.17.12639; Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4; Francischetti IMB, 2005, THROMB HAEMOSTASIS, V94, P167, DOI 10.1160/TH04-09-0566; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325; Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198; Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Jung SM, 2000, TRENDS CARDIOVAS MED, V10, P285, DOI 10.1016/S1050-1738(01)00064-0; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; KELLER PM, 1992, J BIOL CHEM, V267, P6899; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P862, DOI 10.1016/j.ibmb.2008.06.002; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P22, DOI 10.1016/j.ibmb.2007.09.002; Moers A, 2004, J BIOL CHEM, V279, P45354, DOI 10.1074/jbc.M408962200; Morita A, 2006, FEBS J, V273, P2955, DOI 10.1111/j.1742-4658.2006.05306.x; Mumford AD, 2010, BLOOD, V115, P363, DOI 10.1182/blood-2009-08-236976; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NOESKEJUNGBLUT C, 1994, J BIOL CHEM, V269, P5050; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Patricia MK, 1999, ARTERIOSCL THROM VAS, V19, P2615, DOI 10.1161/01.ATV.19.11.2615; Pratico D, 2008, ATHEROSCLEROSIS, V201, P8, DOI 10.1016/j.atherosclerosis.2008.04.037; Reddy VB, 2006, J BIOL CHEM, V281, P16197, DOI 10.1074/jbc.M509429200; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sangamnatdej S, 2002, INSECT MOL BIOL, V11, P79, DOI 10.1046/j.0962-1075.2001.00311.x; Shimura C, 2010, AM J PATHOL, V176, P227, DOI 10.2353/ajpath.2010.090111; Sordillo LM, 2008, FREE RADICAL BIO MED, V44, P34, DOI 10.1016/j.freeradbiomed.2007.09.002; Tang EHC, 2009, PHARMACOL THERAPEUT, V122, P140, DOI 10.1016/j.pharmthera.2009.02.006; Tang L, 2008, ATHEROSCLEROSIS, V199, P265, DOI 10.1016/j.atherosclerosis.2007.11.038; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633	50	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39001	39012		10.1074/jbc.M110.152835	http://dx.doi.org/10.1074/jbc.M110.152835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889972	Green Published, hybrid			2022-12-27	WOS:000284941300030
J	Xu, DZ; Yao, YX; Lu, L; Costa, M; Dai, W				Xu, Dazhong; Yao, Yixin; Lu, Luo; Costa, Max; Dai, Wei			Plk3 Functions as an Essential Component of the Hypoxia Regulatory Pathway by Direct Phosphorylation of HIF-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE-3; CELL-CYCLE ARREST; INDUCIBLE FACTOR; GROWTH-FACTOR; CANCER CELLS; LUNG-CANCER; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; EXPRESSION; POLO-LIKE-KINASE-3; FACTOR-1-ALPHA	Polo-like kinase 3 (Plk3) plays an important role in the regulation of cell cycle progression and stress responses. Plk3 also has a tumor-suppressing activity as aging PLK3-null mice develop tumors in multiple organs. The growth of highly vascularized tumors in PLK3-null mice suggests a role for Plk3 in angiogenesis and cellular responses to hypoxia. By studying primary isogenic murine embryonic fibroblasts, we tested the hypothesis that Plk3 functions as a component in the hypoxia signaling pathway. PLK3(-/-) murine embryonic fibroblasts contained an enhanced level of HIF-1 alpha under hypoxic conditions. Immunoprecipitation and pulldown analyses revealed that Plk3 physically interacted with HIF-1 alpha under hypoxia. Purified recombinant Plk3, but not a kinase-defective mutant, phosphorylated HIF-1 alpha in vitro, resulting in a major mobility shift. Mass spectrometry identified two unique serine residues that were phosphorylated by Plk3. Moreover, ectopic expression followed by cycloheximide or pulse-chase treatment demonstrated that phospho-mutants exhibited a much longer half-life than the wild-type counterpart, strongly suggesting that Plk3 directly regulates HIF-1 alpha stability in vivo. Combined, our study identifies Plk3 as a new and essential player in the regulation of the hypoxia signaling pathway.	[Dai, Wei] NYU, Dept Environm Med & Pharmacol, Langone Med Ctr, Sch Med, Tuxedo Pk, NY 10987 USA; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	New York University; NYU Langone Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dai, W (corresponding author), NYU, Dept Environm Med & Pharmacol, Langone Med Ctr, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org	costa, max/H-1754-2012	Dai, Wei/0000-0003-0169-8327; Xu, Dazhong/0000-0001-9264-3342; Yao, Yixin/0000-0003-1891-7186	United States Public Service Awards [CA090658, CA113349, AG029953]; NATIONAL CANCER INSTITUTE [R01CA090658, R01CA113349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015281, R01EY018343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG029953] Funding Source: NIH RePORTER	United States Public Service Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Service Awards CA090658 and CA113349 (to W. D.) and AG029953 (to D. X.).	Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Chizhikov V, 2001, MOL CARCINOGEN, V30, P151, DOI 10.1002/mc.1023; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Gong RJ, 2005, BIOCHEM BIOPH RES CO, V330, P27, DOI 10.1016/j.bbrc.2005.02.122; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Mylonis I, 2008, J BIOL CHEM, V283, P27620, DOI 10.1074/jbc.M803081200; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Perotti D, 1999, HAEMATOLOGICA, V84, P110; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Zhong H, 2000, CANCER RES, V60, P1541; Zimmerman WC, 2007, CELL CYCLE, V6, P1314, DOI 10.4161/cc.6.11.4275; Zimmerman WC, 2007, P NATL ACAD SCI USA, V104, P1847, DOI 10.1073/pnas.0610856104	27	61	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38944	38950		10.1074/jbc.M110.160325	http://dx.doi.org/10.1074/jbc.M110.160325			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889502	Green Published, hybrid			2022-12-27	WOS:000284941300024
J	Jin, ZN; Johnson, KA				Jin, Zhinan; Johnson, Kenneth A.			Role of a GAG Hinge in the Nucleotide-induced Conformational Change Governing Nucleotide Specificity by T7 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETIC MECHANISM; INDUCED-FIT; FINGERS SUBDOMAIN; I KLENOW; REPLICATION; FIDELITY; SIMULATION; FRAGMENT; EXPLORER; PROGRAM	A nucleotide-induced change in DNA polymerase structure governs the kinetics of polymerization by high fidelity DNA polymerases. Mutation of a GAG hinge (G542A/G544A) in T7 DNA polymerase resulted in a 1000-fold slower rate of conformational change, which then limited the rate of correct nucleotide incorporation. Rates of misincorporation were comparable to that seen for wild-type enzyme so that the net effect of the mutation was a large decrease in fidelity. We demonstrate that a presumably modest change from glycine to alanine 20A from the active site can severely restrict the flexibility of the enzyme structure needed to recognize and incorporate correct substrates with high specificity. These results emphasize the importance of the substrate-induced conformational change in governing nucleotide selectivity by accelerating the incorporation of correct base pairs but not mismatches.	[Jin, Zhinan; Johnson, Kenneth A.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Chem & Biochem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Dept Chem & Biochem, 2500 Speedway, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu	jin, zhinan/D-4217-2013		National Institutes of Health [R01 GM 071404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM 071404 (to K. A. J.). K. A. J. is President of KinTek Corp., which provided the rapid quench-flow instruments and the global data fitting software used in this study.	Bakhtina M, 2007, BIOCHEMISTRY-US, V46, P5463, DOI 10.1021/bi700084w; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Brieba LG, 2005, STRUCTURE, V13, P1653, DOI 10.1016/j.str.2005.07.020; Dolghih E, 2009, J PHYS CHEM A, V113, P4639, DOI 10.1021/jp811395r; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fersht A. R., 1999, ENZYME STRUCTURE MEC, P370; Hanes JW, 2007, NUCLEIC ACIDS RES, V35, P6973, DOI 10.1093/nar/gkm695; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; JOHNSON KA, 1978, BIOCHEMISTRY-US, V17, P3432, DOI 10.1021/bi00610a002; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2003, BIOCHEMISTRY-US, V42, P10200, DOI 10.1021/bi0341206; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Showalter AK, 2002, BIOCHEMISTRY-US, V41, P10571, DOI 10.1021/bi026021i; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Tsai YC, 2009, ANAL BIOCHEM, V384, P136, DOI 10.1016/j.ab.2008.09.006; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030	27	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1312	1322		10.1074/jbc.M110.156737	http://dx.doi.org/10.1074/jbc.M110.156737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20978284	Green Published, hybrid			2022-12-27	WOS:000286005000043
J	Koharudin, LMI; Furey, W; Gronenborn, AM				Koharudin, Leonardus M. I.; Furey, William; Gronenborn, Angela M.			Novel Fold and Carbohydrate Specificity of the Potent Anti-HIV Cyanobacterial Lectin from Oscillatoria agardhii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HYDROGEN-BOND ACCEPTORS; CYANOVIRIN-N; INACTIVATING PROTEIN; STRUCTURAL BASIS; CULTURED CYANOBACTERIUM; ENVELOPE GLYCOPROTEIN; AROMATIC RINGS; DC-SIGN; BINDING	Oscillatoria agardhii agglutinin (OAA) is a recently discovered cyanobacterial lectin that exhibits potent anti-HIV activity. Up to now, only its primary structure and carbohydrate binding data have been available. To elucidate the structural basis for the antiviral mechanism of OAA, we determined the structure of this lectin by x-ray crystallography at 1.2 angstrom resolution and mapped the specific carbohydrate recognition sites of OAA by NMR spectroscopy. The overall architecture of OAA comprises 10 beta-strands that fold into a single, compact, beta-barrel-like domain, creating a unique topology compared with all known protein structures in the Protein Data Bank. OAA sugar binding was tested against Man-9 and various disaccharide components of Man-9. Two symmetric carbohydrate-binding sites were located on the protein, and a preference for Man alpha(1-6) Man-linked sugars was found. Altogether, our structural results explain the antiviral activity OAA and add to the growing body of knowledge about antiviral lectins.	[Koharudin, Leonardus M. I.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Adm Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3,Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu		Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080642 (to A.M.G.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bewley CA, 2001, STRUCTURE, V9, P931, DOI 10.1016/S0969-2126(01)00653-0; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bokesch HR, 2003, BIOCHEMISTRY-US, V42, P2578, DOI 10.1021/bi0205698; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Chiba H, 2004, BIOCHEM BIOPH RES CO, V316, P203, DOI 10.1016/j.bbrc.2004.02.036; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Koharudin LMI, 2009, PROTEINS, V77, P904, DOI 10.1002/prot.22514; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McFeeters RL, 2007, J MOL BIOL, V369, P451, DOI 10.1016/j.jmb.2007.03.030; Moore JP, 1997, CURR OPIN IMMUNOL, V9, P551, DOI 10.1016/S0952-7915(97)80110-0; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PERUTZ MF, 1993, PHILOS T R SOC A, V345, P105, DOI 10.1098/rsta.1993.0122; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Sato T, 2009, FISHERIES SCI, V75, P743, DOI 10.1007/s12562-009-0074-4; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; SATTLER M, 1995, J BIOMOL NMR, V5, P97, DOI 10.1007/BF00227475; Tanaka H, 2009, P NATL ACAD SCI USA, V106, P15633, DOI 10.1073/pnas.0907572106; Wilkinson D, 1996, CURR BIOL, V6, P1051, DOI 10.1016/S0960-9822(02)70661-1; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Yamaguchi M, 1999, BIOCHEM BIOPH RES CO, V265, P703, DOI 10.1006/bbrc.1999.1749; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	39	49	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1588	1597		10.1074/jbc.M110.173278	http://dx.doi.org/10.1074/jbc.M110.173278			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20961847	Green Published, hybrid			2022-12-27	WOS:000286005000071
J	Duan, L; Raja, SM; Chen, GS; Virmani, S; Williams, SH; Clubb, RJ; Mukhopadhyay, C; Rainey, MA; Ying, GG; Dimri, M; Chen, J; Reddi, AL; Naramura, M; Band, V; Band, H				Duan, Lei; Raja, Srikumar M.; Chen, Gengsheng; Virmani, Sumeet; Williams, Stetson H.; Clubb, Robert J.; Mukhopadhyay, Chandrani; Rainey, Mark A.; Ying, Guoguang; Dimri, Manjari; Chen, Jing; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid			Negative Regulation of EGFR-Vav2 Signaling Axis by Cbl Ubiquitin Ligase Controls EGF Receptor-mediated Epithelial Cell Adherens Junction Dynamics and Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; NUCLEOTIDE-EXCHANGE FACTORS; RHO-FAMILY GTPASES; C-CBL; TUMOR PROGRESSION; TYROSINE KINASES; DOWN-REGULATION; E-CADHERIN; BREAST-CANCER; VAV PROTEINS	The E3 ubiquitin ligase Casitas B lymphoma protein (Cbl) controls the ubiquitin-dependent degradation of EGF receptor (EGFR), but its role in regulating downstream signaling elements with which it associates and its impact on biological outcomes of EGFR signaling are less clear. Here, we demonstrate that stimulation of EGFR on human mammary epithelial cells disrupts adherens junctions (AJs) through Vav2 and Rac1/Cdc42 activation. In EGF-stimulated cells, Cbl regulates the levels of phosphorylated Vav2 thereby attenuating Rac1/Cdc42 activity. Knockdown of Cbl and Cbl-b enhanced the EGF-induced disruption of AJs and cell motility. Overexpression of constitutively active Vav2 activated Rac1/Cdc42 and reorganized junctional actin cytoskeleton; these effects were suppressed by WT Cbl and enhanced by a ubiquitin ligase-deficient Cbl mutant. Cbl forms a complex with phospho-EGFR and phospho-Vav2 and facilitates phospho-Vav2 ubiquitinylation. Cbl can also interact with Vav2 directly in a Cbl Tyr-700-dependent manner. A ubiquitin ligase-deficient Cbl mutant enhanced the morphological transformation of mammary epithelial cells induced by constitutively active Vav2; this effect requires an intact Cbl Tyr-700. These results indicate that Cbl ubiquitin ligase plays a critical role in the maintenance of AJs and suppression of cell migration through down-regulation of EGFR-Vav2 signaling.	[Band, Hamid] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Duan, Lei; Raja, Srikumar M.; Williams, Stetson H.; Clubb, Robert J.; Mukhopadhyay, Chandrani; Rainey, Mark A.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska, Med Ctr, Dept Pharmacol & Neurosci, Omaha, NE 68198 USA; [Band, Vimla] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA; [Duan, Lei; Raja, Srikumar M.; Chen, Gengsheng; Virmani, Sumeet; Rainey, Mark A.; Ying, Guoguang; Dimri, Manjari; Chen, Jing; Reddi, Alagarsamy L.; Naramura, Mayumi; Band, Vimla; Band, Hamid] Northwestern Univ, Dept Med, N Shore Univ Hlth Syst, Evanston, IL 60201 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Northwestern University	Duan, L (corresponding author), Rush Univ, Dept Radiat Oncol, Med Ctr, 1750 W Harrison St, Chicago, IL 60612 USA.	lei_duan@rush.edu; sraja@unmc.edu; hband@unmc.edu	Band, Hamid/AAF-4701-2020	Naramura, Mayumi/0000-0003-3658-0767	National Institutes of Health [CA87986, CA99163, CA105489, CA116552, CA94143, CA96844]; Department of Defense Breast Cancer [W81XWH-05-1-0231, DAMD17-02-1-0508, W81XWH-07-1-0351]; Nebraska Department of Health and Human Services [LB-506]; Nebraska Center for Nanomedicine [NCN-COBRE]; NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA105489, R01CA087986, R01CA096844, R01CA116552, R01CA099163, R01CA094143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer(United States Department of Defense); Nebraska Department of Health and Human Services; Nebraska Center for Nanomedicine; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87986, CA99163, CA105489, and CA116552 (to H. B.) and CA94143 and CA96844 (to V. B.). This work was also supported by Department of Defense Breast Cancer Research Grants W81XWH-05-1-0231, DAMD17-02-1-0508, and W81XWH-07-1-0351 (to V. B.), Nebraska Department of Health and Human Services Grant LB-506 (to S. M. R.), and Nebraska Center for Nanomedicine-Center for Biomedical Research Excellence Grant NCN-COBRE (seed grant to S. M. R.).; We thank Drs. Senthil Muthuswamy (MCF10A cells), Jonathan Higgins and Michael Brenner (anti-E-cadherin hybridoma), Martin Schwartz (GST-RBD), John G. Collard (GST-PBD), and Brian Druker (4G10 antibody) for gifts of critical reagents. We thank Dr. Aharon Solomon for help with statistical analyses and other members of the Band laboratories for helpful suggestions and discussion. We thank Janice Taylor and James Talaska for providing assistance with confocal microscopy. The confocal laser scanning microscope and other core facilities used in this study were supported by Nebraska Research Initiative and University of Nebraska Medical Center-Eppley Cancer Center Core Support Grant from the NCI, National Institutes of Health.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016/S0093-7754(03)00185-4; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bacher U, 2010, ANN HEMATOL, V89, P643, DOI 10.1007/s00277-010-0920-6; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; BEHRENS J, 1993, BREAST CANCER RES TR, V24, P175, DOI 10.1007/BF01833258; BIRCHMEIER W, 1995, CIBA F SYMP, V189, P124; Birchmeier W, 1995, CIBA FOUND S, V189, P174; Birchmeier W, 1995, CIBA FOUND S, V189, P136; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Bustelo XR, 1996, CRIT REV ONCOGENESIS, V7, P65, DOI 10.1615/CritRevOncog.v7.i1-2.50; CHRYSOGELOS SA, 1994, BREAST CANCER RES TR, V29, P29, DOI 10.1007/BF00666179; Crowley MR, 2005, DEV BIOL, V279, P58, DOI 10.1016/j.ydbio.2004.11.034; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Duan L, 2010, J BIOL CHEM, V285, P1555, DOI 10.1074/jbc.M109.057976; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Ettenberg SA, 2001, J BIOL CHEM, V276, P27677, DOI 10.1074/jbc.M102641200; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fang DY, 2001, NAT IMMUNOL, V2, P870, DOI 10.1038/ni0901-870; Fernandez-Zapico ME, 2005, CANCER CELL, V7, P39, DOI 10.1016/j.ccr.2004.11.024; Fournier TM, 2000, MOL BIOL CELL, V11, P3397, DOI 10.1091/mbc.11.10.3397; Fujita Y., 2005, NOVART FDN SYMP, V269; Fujita Y., 2005, NOVART FDN SYMP, V269, P223; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hornstein I, 2004, CELL SIGNAL, V16, P1, DOI 10.1016/S0898-6568(03)00110-4; Huang F, 2008, IMMUNOL REV, V224, P229, DOI 10.1111/j.1600-065X.2008.00655.x; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Jost M, 2000, EUR J DERMATOL, V10, P505; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kamei T, 1999, ONCOGENE, V18, P6776, DOI 10.1038/sj.onc.1203114; KHAZAIE K, 1993, CANCER METAST REV, V12, P255, DOI 10.1007/BF00665957; Lee H, 2008, INT J BIOCHEM CELL B, V40, P1930, DOI 10.1016/j.biocel.2008.02.013; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; Marengere LEM, 1997, J IMMUNOL, V159, P70; MCNEILL H, 1990, CELL, V62, P309, DOI 10.1016/0092-8674(90)90368-O; Miura-Shimura Y, 2003, J BIOL CHEM, V278, P38495, DOI 10.1074/jbc.M305656200; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; RAJKUMAR T, 1994, BREAST CANCER RES TR, V29, P3, DOI 10.1007/BF00666177; Reddi AL, 2007, J BIOL CHEM, V282, P29336, DOI 10.1074/jbc.M701797200; Rodahl LM, 2009, BIOCHEM SOC T, V37, P137, DOI 10.1042/BST0370137; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shao Y, 2003, EMBO REP, V4, P425, DOI 10.1038/sj.embor.embor813; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; SOULE HD, 1990, CANCER RES, V50, P6075; STAMPFER MR, 1993, EXP CELL RES, V208, P175, DOI 10.1006/excr.1993.1236; TAKAISHI K, 1994, ONCOGENE, V9, P273; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Teckchandani AM, 2001, ONCOGENE, V20, P1739, DOI 10.1038/sj.onc.1204246; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Turner M, 2002, ADV EXP MED BIOL, V512, P29; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang J, 2002, J IMMUNOL, V169, P2236, DOI 10.4049/jimmunol.169.5.2236; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	85	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					620	633		10.1074/jbc.M110.188086	http://dx.doi.org/10.1074/jbc.M110.188086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940296	Green Published, hybrid			2022-12-27	WOS:000285782800064
J	Dutta, AK; Khimji, AK; Kresge, C; Bugde, A; Dougherty, M; Esser, V; Ueno, Y; Glaser, SS; Alpini, G; Rockey, DC; Feranchak, AP				Dutta, Amal K.; Khimji, Al-karim; Kresge, Charles; Bugde, Abhijit; Dougherty, Michael; Esser, Victoria; Ueno, Yoshiyuki; Glaser, Shannon S.; Alpini, Gianfranco; Rockey, Don C.; Feranchak, Andrew P.			Identification and Functional Characterization of TMEM16A, a Ca2+-activated Cl- Channel Activated by Extracellular Nucleotides, in Biliary Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL RAT-LIVER; CELL-LINE; CHLORIDE CHANNEL; CYSTIC-FIBROSIS; BICARBONATE SECRETION; UNANESTHETIZED DOG; PROTEIN-KINASE; CALCIUM; BILE; CHOLANGIOCYTES	Cl- channels in the apical membrane of biliary epithelial cells (BECs) provide the driving force for ductular bile formation. Although a cystic fibrosis transmembrane conductance regulator has been identified in BECs and contributes to secretion via secretin binding basolateral receptors and increasing [cAMP](i), an alternate Cl- secretory pathway has been identified that is activated via nucleotides (ATP, UTP) binding apical P2 receptors and increasing [Ca2+](i). The molecular identity of this Ca2+-activated Cl- channel is unknown. The present studies in human, mouse, and rat BECs provide evidence that TMEM16A is the operative channel and contributes to Ca2+-activated Cl- secretion in response to extracellular nucleotides. Furthermore, Cl- currents measured from BECs isolated from distinct areas of intrahepatic bile ducts revealed important functional differences. Large BECs, but not small BECs, exhibit cAMP-stimulated Cl- currents. However, both large and small BECs express TMEM16A and exhibit Ca2+-activated Cl- efflux in response to extracellular nucleotides. Incubation of polarized BEC monolayers with IL-4 increased TMEM16A protein expression, membrane localization, and transepithelial secretion (I-sc). These studies represent the first molecular identification of an alternate, noncystic fibrosis transmembrane conductance regulator, Cl- channel in BECs and suggest that TMEM16A may be a potential target to modulate bile formation in the treatment of cholestatic liver disorders.	[Dutta, Amal K.; Kresge, Charles; Feranchak, Andrew P.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Khimji, Al-karim; Esser, Victoria; Rockey, Don C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Ueno, Yoshiyuki] Tohoku Univ, Sch Med, Sendai, Miyagi 980085, Japan; [Glaser, Shannon S.; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Dept Med, Div Res, Temple, TX 76504 USA; [Glaser, Shannon S.; Alpini, Gianfranco] Texas A&M Hlth Sci Ctr, Coll Med, Scott & White Digest Dis Res Ctr, Temple, TX 76504 USA; [Bugde, Abhijit] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tohoku University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), UT SW Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@UTSouthwestern.edu	Ueno, Yoshiyuki/R-9242-2019	Ueno, Yoshiyuki/0000-0001-5623-4250	NIDDK, National Institutes of Health [DK054811, DK 50574, DK078587]; American Association for the Study of Liver Diseases American Liver Foundation; Children's Medical Center Foundation; Cystic Fibrosis Foundation [FERANC08G0]; Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078587, R01DK050574, R01DK054811] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Association for the Study of Liver Diseases American Liver Foundation; Children's Medical Center Foundation; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK054811 (to G. A.), DK 50574 (to D. C. R.), and DK078587 (to A. P. F.). This work was also supported by the American Association for the Study of Liver Diseases American Liver Foundation Liver Scholar award (to A. K. D.), the Children's Medical Center Foundation (to A. K. D.), Cystic Fibrosis Foundation Grant FERANC08G0 (to A. P. F.), and the Veterans Affairs Merit award (to G. A.).	Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG289, DOI 10.1152/ajpgi.1997.272.2.G289; Alpini G, 1997, AM J PHYSIOL-GASTR L, V272, pG1064, DOI 10.1152/ajpgi.1997.272.5.G1064; Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073; BASAVAPPA S, 1993, GASTROENTEROLOGY, V104, pA874; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHANG D, 1988, COMPUT BIOL MED, V18, P351, DOI 10.1016/0010-4825(88)90022-4; Clarke LL, 2000, AM J PHYSIOL-GASTR L, V279, pG132, DOI 10.1152/ajpgi.2000.279.1.G132; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Dutta AK, 2009, AM J PHYSIOL-GASTR L, V297, pG1009, DOI 10.1152/ajpgi.00223.2009; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Feranchak AP, 2001, J CLIN INVEST, V108, P1495, DOI 10.1172/JCI200112190; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Fiorotto R, 2007, GASTROENTEROLOGY, V133, P1603, DOI 10.1053/j.gastro.2007.08.071; FITZ JG, 1994, AM J PHYSIOL, V266, pG544, DOI 10.1152/ajpgi.1994.266.4.G544; Fitz JG, 2002, SEMIN LIVER DIS, V22, P241, DOI 10.1055/s-2002-34502; FITZ JG, 1993, J CLIN INVEST, V91, P319, DOI 10.1172/JCI116188; Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007; Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; KUMAR U, 1986, LIVER, V6, P369; LIDOFSKY SD, 1993, J BIOL CHEM, V268, P14632; MCGILL JM, 1994, AM J PHYSIOL, V266, pG731, DOI 10.1152/ajpgi.1994.266.4.G731; McGill JM, 2001, AM J PHYSIOL-GASTR L, V280, pG738, DOI 10.1152/ajpgi.2001.280.4.G738; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; PREISIG R, 1962, J CLIN INVEST, V41, P1152, DOI 10.1172/JCI104568; Roman RM, 1996, AM J PHYSIOL-GASTR L, V271, pG239, DOI 10.1152/ajpgi.1996.271.2.G239; Salter KD, 2000, LAB INVEST, V80, P1775, DOI 10.1038/labinvest.3780187; Schlenker T, 1997, AM J PHYSIOL-GASTR L, V273, pG1108, DOI 10.1152/ajpgi.1997.273.5.G1108; Schlenker T, 1996, AM J PHYSIOL-GASTR L, V271, pG304, DOI 10.1152/ajpgi.1996.271.2.G304; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x; Vroman B, 1996, LAB INVEST, V74, P303; Wang Y, 1997, J CLIN INVEST, V99, P2890, DOI 10.1172/JCI119483; WHEELER HO, 1960, J CLIN INVEST, V39, P161, DOI 10.1172/JCI104015; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	46	72	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					766	776		10.1074/jbc.M110.164970	http://dx.doi.org/10.1074/jbc.M110.164970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041307	hybrid, Green Published			2022-12-27	WOS:000285782800076
J	Nygaard, EB; Lagerstedt, JO; Bjerre, G; Shi, BA; Budamagunta, M; Poulsen, KA; Meinild, S; Rigor, RR; Voss, JC; Cala, PM; Pedersen, SF				Nygaard, Eva B.; Lagerstedt, Jens O.; Bjerre, Gabriel; Shi, Biao; Budamagunta, Madhu; Poulsen, Kristian A.; Meinild, Stine; Rigor, Robert R.; Voss, John C.; Cala, Peter M.; Pedersen, Stine F.			Structural Modeling and Electron Paramagnetic Resonance Spectroscopy of the Human Na+/H+ Exchanger Isoform 1, NHE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN-LABELED PROTEINS; LOOP-GAP RESONATOR; ESCHERICHIA-COLI; T4 LYSOZYME; CONFORMATIONAL-CHANGES; TRANSMEMBRANE DOMAINS; LACTOSE PERMEASE; XENOPUS-OOCYTES; SITE; ANTIPORTER	We previously presented evidence that transmembrane domain (TM) IV and TM X-XI are important for inhibitor binding and ion transport by the human Na+/H+ exchanger, hNHE1 (Pedersen, S. F., King, S. A., Nygaard, E. B., Rigor, R. R., and Cala, P. M. (2007) J. Biol. Chem. 282, 19716-19727). Here, we present a structural model of the transmembrane part of hNHE1 that further supports this conclusion. The hNHE1 model was based on the crystal structure of the Escherichia coli Na+/H+ antiporter, NhaA, and previous cysteine scanning accessibility studies of hNHE1 and was validated by EPR spectroscopy of spin labels in TM IV and TM XI, as well as by functional analysis of hNHE1 mutants. Removal of all endogenous cysteines in hNHE1, introduction of the mutations A173C (TM IV) and/or I461C (TM XI), and expression of the constructs in mammalian cells resulted in functional hNHE1 proteins. The distance between these spin labels was similar to 15 A, confirming that TM IV and TM XI are in close proximity. This distance was decreased both at pH 5.1 and in the presence of the NHE1 inhibitor cariporide. A similar TM IV.TM XI distance and a similar change upon a pH shift were found for the cariporide-insensitive Pleuronectes americanus (pa) NHE1; however, in paNHE1, cariporide had no effect on TM IV.TM XI distance. The central role of the TM IV.TM XI arrangement was confirmed by the partial loss of function upon mutation of Arg(425), which the model predicts stabilizes this arrangement. The data are consistent with a role for TM IV and TM XI rearrangements coincident with ion translocation and inhibitor binding by hNHE1.	[Nygaard, Eva B.; Bjerre, Gabriel; Poulsen, Kristian A.; Meinild, Stine; Cala, Peter M.; Pedersen, Stine F.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Lagerstedt, Jens O.] Lund Univ, Biomed Ctr, Dept Expt Med Sci, Lund, Sweden; [Lagerstedt, Jens O.; Budamagunta, Madhu; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Shi, Biao; Rigor, Robert R.; Cala, Peter M.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of Copenhagen; Lund University; University of California System; University of California Davis; University of California System; University of California Davis	Cala, PM (corresponding author), Univ Copenhagen, Dept Biol, Univ Parken 13, DK-2100 Copenhagen, Denmark.	sfpedersen@bio.ku.dk; pmcala@ucdavis.edu	Budamagunta, Madhu S/C-4628-2011; Lagerstedt, Jens/AAF-9567-2021; Pedersen, Stine Falsig/O-1133-2019; Pedersen, Stine Falsig/M-8347-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Pedersen, Stine Falsig/0000-0002-3044-7714; Voss, John/0000-0001-9279-209X; Lagerstedt, Jens/0000-0002-4313-2666; Rigor, Robert/0000-0001-6234-1992	National Institutes of Health [HL-21179]; Danish National Research Council; Swedish Research Council; University of Copenhagen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021179, R37HL021179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Council(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Copenhagen; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-21179 (to P. M. C.). This work was also supported by funds from the Danish National Research Council (to S. F. P.) and the Swedish Research Council (to J. O. L.) and a Biocampus Scholarship from University of Copenhagen (to E. B. N.).	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Bolin KA, 1998, J MAGN RESON, V131, P248, DOI 10.1006/jmre.1998.1365; Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; COUNILLON L, 1993, P NATL ACAD SCI USA, V90, P4508, DOI 10.1073/pnas.90.10.4508; CoupayeGerard B, 1996, AM J PHYSIOL-CELL PH, V271, pC1639, DOI 10.1152/ajpcell.1996.271.5.C1639; Deweerd K, 2001, BIOCHEMISTRY-US, V40, P15846, DOI 10.1021/bi011414n; Fajer MI, 2007, J AM CHEM SOC, V129, P13840, DOI 10.1021/ja071404v; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; Galili L, 2004, J BIOL CHEM, V279, P23104, DOI 10.1074/jbc.M400288200; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; HUBBELL WL, 1987, REV SCI INSTRUM, V58, P1879, DOI 10.1063/1.1139536; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Lagerstedt JO, 2004, FEBS LETT, V578, P262, DOI 10.1016/j.febslet.2004.11.012; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; LU L, 1990, BIOPHYS J, V57, P1117, DOI 10.1016/S0006-3495(90)82632-1; Mchaourab HS, 1997, BIOCHEMISTRY-US, V36, P307, DOI 10.1021/bi962114m; McLean LA, 1999, AM J PHYSIOL-CELL PH, V276, pC1025, DOI 10.1152/ajpcell.1999.276.5.C1025; Meinild AK, 2009, J BIOL CHEM, V284, P16226, DOI 10.1074/jbc.M109.003137; Moncoq K, 2008, J BIOL CHEM, V283, P4145, DOI 10.1074/jbc.M704844200; Nimigean CM, 2006, NAT PROTOC, V1, P1207, DOI 10.1038/nprot.2006.166; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 1996, J BIOL CHEM, V271, P19922, DOI 10.1074/jbc.271.33.19922; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pedersen SF, 2006, AM J PHYSIOL-REG I, V291, pR1, DOI 10.1152/ajpregu.00782.2005; Pedersen SF, 2003, BIOPHYS J, V84, p151A; Pedersen SF, 2007, J BIOL CHEM, V282, P19716, DOI 10.1074/jbc.M701637200; Pedersen Stine F., 2003, Bulletin of the Mount Desert Island Biological Laboratory, V42, P38; Rasmussen M, 2008, AM J PHYSIOL-CELL PH, V294, pC197, DOI 10.1152/ajpcell.00268.2007; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shrode LD, 1998, AM J PHYSIOL-CELL PH, V275, pC431, DOI 10.1152/ajpcell.1998.275.2.C431; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Touret N, 2001, BIOCHEMISTRY-US, V40, P5095, DOI 10.1021/bi0025464; Voss J, 1996, BIOCHEMISTRY-US, V35, P12915, DOI 10.1021/bi9608774; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WANG DH, 1995, AM J PHYSIOL-CELL PH, V269, pC392, DOI 10.1152/ajpcell.1995.269.2.C392; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	48	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					634	648		10.1074/jbc.M110.159202	http://dx.doi.org/10.1074/jbc.M110.159202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974853	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000285782800065
J	Avila, RL; D'Antonio, M; Bachi, A; Inouye, H; Feltri, ML; Wrabetz, L; Kirschner, DA				Avila, Robin L.; D'Antonio, Maurizio; Bachi, Angela; Inouye, Hideyo; Feltri, M. Laura; Wrabetz, Lawrence; Kirschner, Daniel A.			P0 (Protein Zero) Mutation S34C Underlies Instability of Internodal Myelin in S63C Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW AXONAL-TRANSPORT; DEMYELINATING PERIPHERAL NEUROPATHIES; EXPERIMENTAL DIABETIC-NEUROPATHY; EXTRACELLULAR DOMAIN; MEMBRANE-STRUCTURE; HEREDITARY MOTOR; DEJERINE-SOTTAS; SCHWANN-CELLS; NERVE MYELIN; NEUROFILAMENT PHOSPHORYLATION	P0 constitutes 50-60% of protein in peripheral nerve myelin and is essential for its structure and stability. Mutations within the P0 gene (MPZ) underlie a variety of hereditary neuropathies. MpzS63C transgenic mice encode a P0 with a serine to cysteine substitution at position 34 in the extracellular domain of mature P0 (P0S34C), associated with the hypomyelinating Dejerine-Sottas syndrome in human. S63C mice develop a dysmyelinating neuropathy, with packing defects in peripheral myelin. Here, we used x-ray diffraction to examine time-dependent packing defects in unfixed myelin. At similar to 7 h post-dissection, WT and S63C(+/+) myelin showed native periods (175 angstrom) with the latter developing at most a few percent swollen myelin, whereas up to similar to 50% of S63C(+/-) (mutant P0 on heterozygous P0 null background) or P0(+/+) myelin swelled to periods of similar to 205 angstrom. In the same time frame, S63C(-/-) myelin was stable, remaining swollen at similar to 210 angstrom. Surprisingly, treatment of whole S63C(-/-) nerves with a reducing agent completely reverted swollen arrays to native spacing and also normalized the swollen arrays that had formed in S63C(+/-) myelin, the genotype most closely related to the human disorder. Western blot revealed P0-positive bands at similar to 27 and similar to 50 kDa, and MALDI-TOF mass spectrometry showed these bands consisted of Ser(34)-containing peptides or P0 dimers having oxidized Cys(34) residues. We propose that P0S34C forms ectopic disulfide bonds in trans between apposed Cys(34) side chains that retard wrapping during myelin formation causing hypomyelination. Moreover, the new bonds create a packing defect by stabilizing swollen membrane arrays that leads to demyelination.	[Kirschner, Daniel A.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [D'Antonio, Maurizio; Bachi, Angela; Feltri, M. Laura; Wrabetz, Lawrence] DIBIT, Div Genet & Cell Biol, San Raffaele Sci Inst, I-20132 Milan, Italy	Boston College; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kirschner, DA (corresponding author), Boston Coll, Dept Biol, 140 Commonwealth Ave, Chestnut Hill, MA 02467 USA.	kirschnd@bc.edu	bachi, angela/B-3527-2015; D'Antonio, Maurizio/AHI-1781-2022; Feltri, Maria Laura/J-5286-2018	bachi, angela/0000-0003-4842-6556; D'Antonio, Maurizio/0000-0003-0637-8971; Kirschner, Daniel/0000-0003-3498-1452	NINDS [NS55256, NS45630]; Boston College, Telethon, Italy [GGP07100, GGP08021]; European Community [NGIDD-HEALTH-F2-2008-201535]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045630, R01NS055256] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Boston College, Telethon, Italy; European Community(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS55256 and NS45630 from NINDS. This work was also supported by institutional funds from Boston College (to D. A. K.), Telethon, Italy, Grants GGP07100 and GGP08021, and European Community Grants NGIDD-HEALTH-F2-2008-201535 (to L.W. and M. L. F.).	Agrawal D, 2009, J STRUCT BIOL, V168, P521, DOI 10.1016/j.jsb.2009.06.019; AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; Alexander L.E., 1979, XRAY DIFFRACTION MET; Avila RL, 2005, J NEUROPATH EXP NEUR, V64, P976, DOI 10.1097/01.jnen.0000186925.95957.dc; Bjartmar C, 1999, J NEUROCYTOL, V28, P383, DOI 10.1023/A:1007010205037; BLAUROCK AE, 1991, NEUROPATH APPL NEURO, V17, P309, DOI 10.1111/j.1365-2990.1991.tb00728.x; DEWAEGH S, 1990, J NEUROSCI, V10, P1855; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HAN JC, 1994, ANAL BIOCHEM, V220, P5, DOI 10.1006/abio.1994.1290; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; INOUYE H, 1989, BIOPHYS J, V56, P129, DOI 10.1016/S0006-3495(89)82658-X; INOUYE H, 1988, BIOPHYS J, V53, P235, DOI 10.1016/S0006-3495(88)83085-6; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Kirschner D. A., 2004, MYELIN BIOL DISORDER, V1, P523; Kirschner DA, 1996, J NEUROSCI RES, V46, P502, DOI 10.1002/(SICI)1097-4547(19961115)46:4<502::AID-JNR12>3.0.CO;2-#; KIRSCHNER DA, 1980, NATURE, V283, P207, DOI 10.1038/283207a0; KIRSCHNER DA, 1975, P NATL ACAD SCI USA, V72, P3513, DOI 10.1073/pnas.72.9.3513; KIRSCHNER DA, 1989, J NEUROCHEM, V53, P1599, DOI 10.1111/j.1471-4159.1989.tb08558.x; KIRSCHNER DA, 1980, J ULTRA MOL STRUCT R, V73, P211, DOI 10.1016/S0022-5320(80)90125-2; KIRSCHNER DA, 1994, J NEUROSCI RES, V39, P63, DOI 10.1002/jnr.490390109; Kirschner Daniel A., 1992, P3; LEVISON ME, 1969, EXPERIENTIA, V25, P126, DOI 10.1007/BF01899076; LEWIS SD, 1976, BIOCHEMISTRY-US, V15, P5009, DOI 10.1021/bi00668a010; LEWIS SD, 1981, BIOCHEMISTRY-US, V20, P48, DOI 10.1021/bi00504a009; Li H, 2005, ACTA CRYSTALLOGR E, V61, pM761, DOI 10.1107/S1600536805009098; Martini R, 2001, MUSCLE NERVE, V24, P456, DOI 10.1002/mus.1027; MARTINI R, 1995, J NEUROSCI, V15, P4488; MEDORI R, 1988, J NEUROSCI, V8, P1814; MEDORI R, 1988, NEUROLOGY, V38, P597, DOI 10.1212/WNL.38.4.597; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Peters A., 1991, FINE STRUCTURE NERVO; Pinitglang S, 1997, BIOCHEMISTRY-US, V36, P9968, DOI 10.1021/bi9705974; Shapiro L, 1996, NEURON, V17, P435, DOI 10.1016/S0896-6273(00)80176-2; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shy ME, 2002, LANCET NEUROL, V1, P110, DOI 10.1016/S1474-4422(02)00042-X; Shy ME, 2004, BRAIN, V127, P371, DOI 10.1093/brain/awh048; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WATSON DF, 1994, NEUROLOGY, V44, P2383, DOI 10.1212/WNL.44.12.2383; WELLS CA, 1993, J NEUROCHEM, V61, P1987, DOI 10.1111/j.1471-4159.1993.tb07434.x; WHITAKER JR, 1965, J AM CHEM SOC, V87, P2728, DOI 10.1021/ja01090a034; Wrabetz L, 2006, J NEUROSCI, V26, P2358, DOI 10.1523/JNEUROSCI.3819-05.2006; Wrabetz L, 2000, J CELL BIOL, V148, P1021, DOI 10.1083/jcb.148.5.1021; Yin X, 2000, J CELL BIOL, V148, P1009, DOI 10.1083/jcb.148.5.1009; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174	50	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42001	42012		10.1074/jbc.M110.166967	http://dx.doi.org/10.1074/jbc.M110.166967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20937820	Green Published, hybrid			2022-12-27	WOS:000285622600086
J	Wirths, O; Erck, C; Martens, H; Harmeier, A; Geumann, C; Jawhar, S; Kumar, S; Multhaup, G; Walter, J; Ingelsson, M; Degerman-Gunnarsson, M; Kalimo, H; Huitinga, I; Lannfelt, L; Bayer, TA				Wirths, Oliver; Erck, Christian; Martens, Henrik; Harmeier, Anja; Geumann, Constanze; Jawhar, Sadim; Kumar, Sathish; Multhaup, Gerd; Walter, Jochen; Ingelsson, Martin; Degerman-Gunnarsson, Malin; Kalimo, Hannu; Huitinga, Inge; Lannfelt, Lars; Bayer, Thomas A.			Identification of Low Molecular Weight Pyroglutamate A beta Oligomers in Alzheimer Disease A NOVEL TOOL FOR THERAPY AND DIAGNOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; AMYLOID PRECURSOR PROTEIN; MOUSE MODEL; SYNAPTIC PLASTICITY; TRANSGENIC MICE; IN-VIVO; PASSIVE-IMMUNIZATION; GLUTAMINYL CYCLASE; NATURAL OLIGOMERS; PLAQUE-FORMATION	N-terminally truncated A beta peptides starting with pyroglutamate (A beta pE3) represent a major fraction of all A beta peptides in the brain of Alzheimer disease (AD) patients. A beta pE3 has a higher aggregation propensity and stability and shows increased toxicity compared with full-length A beta. In the present work, we generated a novel monoclonal antibody (9D5) that selectively recognizes oligomeric assemblies of A beta pE3 and studied the potential involvement of oligomeric A beta pE3 in vivo using transgenic mouse models as well as human brains from sporadic and familial AD cases. 9D5 showed an unusual staining pattern with almost nondetectable plaques in sporadic AD patients and non-demented controls. Interestingly, in sporadic and familial AD cases prominent intraneuronal and blood vessel staining was observed. Using a novel sandwich ELISA significantly decreased levels of oligomers in plasma samples from patients with AD compared with healthy controls were identified. Moreover, passive immunization of 5XFAD mice with 9D5 significantly reduced overall A beta plaque load and A beta pE3 levels, and normalized behavioral deficits. These data indicate that 9D5 is a therapeutically and diagnostically effective monoclonal antibody targeting low molecular weight A beta pE3 oligomers.	[Bayer, Thomas A.] Univ Med Gottingen, Div Mol Psychiat, Grad Sch, Dept Mol Psychiat & Alzheimer, D-37075 Gottingen, Germany; [Erck, Christian; Martens, Henrik; Geumann, Constanze] Synapt Syst, D-37079 Gottingen, Germany; [Harmeier, Anja; Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol Mol Cell Biol, D-53127 Bonn, Germany; [Ingelsson, Martin; Degerman-Gunnarsson, Malin; Lannfelt, Lars] Uppsala Univ, Dept Publ Hlth, SE-75185 Uppsala, Sweden; [Ingelsson, Martin; Degerman-Gunnarsson, Malin; Lannfelt, Lars] Uppsala Univ, Caring Sci Rudbeck Lab, SE-75185 Uppsala, Sweden; [Kalimo, Hannu] Univ Helsinki, Dept Pathol, FI-00014 Helsinki, Finland; [Huitinga, Inge] Netherlands Inst Neurosci, Netherlands Brain Bank, NL-1105 BA Amsterdam, Netherlands	University of Gottingen; Free University of Berlin; University of Bonn; Uppsala University; Uppsala University; University of Helsinki; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Bayer, TA (corresponding author), Univ Med Gottingen, Div Mol Psychiat, Grad Sch, Dept Mol Psychiat & Alzheimer, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019; Wirths, Oliver/C-7342-2019; Wang, Caihong/T-5837-2019	Wirths, Oliver/0000-0002-4115-0334; Wang, Caihong/0000-0002-6808-3709; Kumar, Sathish/0000-0002-2792-7047; Walter, Jochen/0000-0002-4678-2912	German Federal Ministry for Economy; Fritz Thyssen Stiftung	German Federal Ministry for Economy; Fritz Thyssen Stiftung	This work was supported by the German Federal Ministry for Economy (to T. A. B., C. E., and H. M.) and the Fritz Thyssen Stiftung (to O. W.).	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Buttini M, 2005, J NEUROSCI, V25, P9096, DOI 10.1523/JNEUROSCI.1697-05.2005; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Klyubin I, 2008, J NEUROSCI, V28, P4231, DOI 10.1523/JNEUROSCI.5161-07.2008; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2009, FEBS J, V276, P995, DOI 10.1111/j.1742-4658.2008.06836.x; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mohajeri MH, 2002, J BIOL CHEM, V277, P33012, DOI 10.1074/jbc.M203193200; MORI H, 1992, J BIOL CHEM, V267, P17082; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Rohrer DC, 1996, CELL TRANSPLANT, V5, P57, DOI 10.1016/0963-6897(95)02023-3; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tseng Bertrand P., 2004, Current Alzheimer Research, V1, P231, DOI 10.2174/1567205043332045; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	50	85	94	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41517	41524		10.1074/jbc.M110.178707	http://dx.doi.org/10.1074/jbc.M110.178707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971852	hybrid, Green Published			2022-12-27	WOS:000285622600038
J	Grembecka, J; Belcher, AM; Hartley, T; Cierpicki, T				Grembecka, Jolanta; Belcher, Amalia M.; Hartley, Thomas; Cierpicki, Tomasz			Molecular Basis of the Mixed Lineage Leukemia-Menin Interaction IMPLICATIONS FOR TARGETING MIXED LINEAGE LEUKEMIAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; HOX GENE-EXPRESSION; MLL GENE; NMR-SPECTROSCOPY; INFANT LEUKEMIA; TRANSFORMATION; TRITHORAX; PROTEINS; LEUKEMOGENESIS; ASSIGNMENT	Chromosomal translocations targeting the mixed lineage leukemia (MLL) gene result in MLL fusion proteins that are found in aggressive human acute leukemias. Disruption of MLL by such translocations leads to overexpression of Hox genes, resulting in a blockage of hematopoietic differentiation that ultimately leads to leukemia. Menin, which directly binds MLL, has been identified as an essential oncogenic co-factor required for the leukemogenic activity of MLL fusion proteins. Here, we characterize the molecular basis of the MLL-menin interaction. Using C-13-detected NMR experiments, we have mapped the residues within the intrinsically unstructured fragment of MLL that are required for binding to menin. Interestingly, we found that MLL interacts with menin with a nanomolar affinity (K-d similar to 10 nM) through two motifs, MBM1 and MBM2 (menin binding motifs 1 and 2). These motifs are located within the N-terminal 43-amino acid fragment of MLL, and the MBM1 represents a high affinity binding motif. Using alanine scanning mutagenesis of MBM1, we found that the hydrophobic residues Phe(9), Pro(10), and Pro(13) are most critical for binding. Furthermore, based on exchange-transferred nuclear Overhauser effect measurements, we established that MBM1 binds to menin in an extended conformation. In a series of competition experiments we showed that a peptide corresponding to MBM1 efficiently dissociates the menin-MLL complex. Altogether, our work establishes the molecular basis of the menin interaction with MLL and MLL fusion proteins and provides the necessary foundation for development of small molecule inhibitors targeting this interaction in leukemias with MLL translocations.	[Grembecka, Jolanta; Hartley, Thomas; Cierpicki, Tomasz] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Belcher, Amalia M.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Michigan System; University of Michigan; University of Virginia	Grembecka, J (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr,MSRB1,Rm 4510, Ann Arbor, MI 48109 USA.	jolantag@umich.edu; tomaszc@umich.edu			Leukemia and Lymphoma Society [6070-09]; University of Virginia Cancer Center; Children's Leukemia Research Foundation; Department of Pathology, University of Michigan	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); University of Virginia Cancer Center; Children's Leukemia Research Foundation; Department of Pathology, University of Michigan(University of Michigan System)	This work was supported by Leukemia and Lymphoma Society TRP Grant 6070-09 (to J.G.), a University of Virginia Cancer Center grant (to J.G. and T.C.), a Children's Leukemia Research Foundation grant (to J.G.), and startup funds provided by the Department of Pathology, University of Michigan (to J.G. and T.C.).	Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bermel W, 2005, ANGEW CHEM INT EDIT, V44, P3089, DOI 10.1002/anie.200461794; Bermel W, 2009, J MAGN RESON, V198, P275, DOI 10.1016/j.jmr.2009.02.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caslini C, 2007, CANCER RES, V67, P7275, DOI 10.1158/0008-5472.CAN-06-2369; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen YX, 2006, P NATL ACAD SCI USA, V103, P1018, DOI 10.1073/pnas.0510347103; Cox MC, 2004, AM J CLIN PATHOL, V122, P298, DOI 10.1309/RX27R8GJQM330C22; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Greaves MF, 1996, LEUKEMIA, V10, P372; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hess JL, 2004, CRIT REV EUKAR GENE, V14, P235, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.10; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Post CB, 2003, CURR OPIN STRUC BIOL, V13, P581, DOI 10.1016/j.sbi.2003.09.012; SEDKOV Y, 1994, DEVELOPMENT, V120, P1907; Slany RK, 2005, HEMATOL ONCOL, V23, P1, DOI 10.1002/hon.739; SORENSEN PHB, 1994, J CLIN INVEST, V93, P429, DOI 10.1172/JCI116978; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeisig BB, 2004, MOL CELL BIOL, V24, P617, DOI 10.1128/MCB.24.2.617-628.2004	27	63	65	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40690	40698		10.1074/jbc.M110.172783	http://dx.doi.org/10.1074/jbc.M110.172783			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961854	hybrid, Green Published			2022-12-27	WOS:000285414400032
J	Ju, JH; Naura, AS; Errami, Y; Zerfaoui, M; Kim, H; Kim, JG; Abd Elmageed, ZY; Abdel-Mageed, AB; Giardina, C; Beg, AA; Smulson, ME; Boulares, AH				Ju, Jihang; Naura, Amarjit S.; Errami, Youssef; Zerfaoui, Mourad; Kim, Hogyoung; Kim, Jong G.; Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.; Giardina, Charles; Beg, Amer A.; Smulson, Mark E.; Boulares, A. Hamid			Phosphorylation of p50 NF-kappa B at a Single Serine Residue by DNA-dependent Protein Kinase Is Critical for VCAM-1 Expression upon TNF Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; ADHESION MOLECULES; IMMUNE-SYSTEM; DAMAGE; ACTIVATION; ATHEROSCLEROSIS; INVOLVEMENT; MODULATION; APOPTOSIS	The DNA binding activity of NF-kappa B is critical for VCAM-1 expression during inflammation. DNA-dependent protein kinase (DNA-PK) is thought to be involved in NF-kappa B activation. Here we show that DNA-PK is required for VCAM-1 expression in response to TNF. The phosphorylation and subsequent degradation of I-kappa B alpha as well as the serine 536 phosphorylation and nuclear translocation of p65 NF-kappa B were insufficient for VCAM-1 expression in response to TNF. The requirement for p50 NF-kappa B in TNF-induced VCAM-1 expression may be associated with its interaction with and phosphorylation by DNA-PK, which appears to be dominant over the requirement for p65 NF-kappa B activation. p50 NF-kappa B binding to its consensus sequence increased its susceptibility to phosphorylation by DNA-PK. Additionally, DNA-PK activity appeared to increase the association between p50/p50 and p50/p65 NF-kappa B dimers upon binding to DNA and after binding of p50 NF-kappa B to the VCAM-1 promoter. Analyses of the p50 NF-kappa B protein sequence revealed that both serine 20 and serine 227 at the amino terminus of the protein are putative sites for phosphorylation by DNA-PK. Mutation of serine 20 completely eliminated phosphorylation of p50 NF-kappa B by DNA-PK, suggesting that serine 20 is the only site in p50 NF-kappa B for phosphorylation by DNA-PK. Re-establishing wildtype p50 NF-kappa B, but not its serine 20/alanine mutant, in p50 NF-kappa B-/- fibroblasts reversed VCAM-1 expression after TNF treatment, demonstrating the importance of the serine 20 phosphorylation site in the induction of VCAM-1 expression. Together, these results elucidate a novel mechanism for the involvement of DNA-PK in the positive regulation of p50 NF-kappa B to drive VCAM-1 expression.	[Ju, Jihang; Naura, Amarjit S.; Errami, Youssef; Zerfaoui, Mourad; Kim, Hogyoung; Kim, Jong G.; Boulares, A. Hamid] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; [Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.] Tulane Univ Med Ctr Hosp & Clin, Dept Urol, New Orleans, LA 70112 USA; [Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Beg, Amer A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Smulson, Mark E.] Georgetown Univ, Sch Med, Dept Biochem, Washington, DC 20057 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; University of Connecticut; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Georgetown University	Boulares, AH (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	hboulr@lsuhsc.edu	Elmageed, Zakaria Y Abd/O-3456-2018	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Abdel-Mageed, Asim/0000-0001-8590-783X; Errami, Youssef/0000-0002-0432-4331	National Institutes of Health [HL072889]; American Cancer Society [RSG-116608]; Louisiana Cancer Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Louisiana Cancer Research Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL072889 (to A.H.B.). This work was also supported by Grant RSG-116608 from the American Cancer Society and funds from the Louisiana Cancer Research Consortium (to A.H.B.).	Andreassi MG, 2008, J MOL MED, V86, P1033, DOI 10.1007/s00109-008-0358-7; Basu S, 1998, BIOCHEM BIOPH RES CO, V247, P79, DOI 10.1006/bbrc.1998.8741; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Boulares HA, 1999, TOXICOL SCI, V48, P264, DOI 10.1093/toxsci/48.2.264; Braun M, 1999, CARDIOVASC RES, V41, P395, DOI 10.1016/S0008-6363(98)00302-2; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; DAS KC, 1995, MOL CELL BIOCHEM, V148, P45, DOI 10.1007/BF00929502; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Hughes JM, 2000, MEDIAT INFLAMM, V9, P93, DOI 10.1080/096293500411550; Huo Y, 2001, ACTA PHYSIOL SCAND, V173, P35, DOI 10.1046/j.1365-201X.2001.00882.x; Kasper H.-U., 1996, General and Diagnostic Pathology, V141, P289; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lee CW, 2006, J CELL PHYSIOL, V207, P174, DOI 10.1002/jcp.20549; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu L, 1998, MOL CELL BIOL, V18, P4221, DOI 10.1128/MCB.18.7.4221; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; Panta GR, 2004, MOL CELL BIOL, V24, P1823, DOI 10.1128/MCB.24.5.1823-1835.2004; Rojas AI, 1999, CRIT REV ORAL BIOL M, V10, P337, DOI 10.1177/10454411990100030601; SATRIANO J, 1994, J CLIN INVEST, V94, P1629, DOI 10.1172/JCI117505; Shin WS, 2002, ATHEROSCLEROSIS, V160, P91, DOI 10.1016/S0021-9150(01)00571-8; Simbulan-Rosenthal CM, 1999, ONCOGENE, V18, P5015, DOI 10.1038/sj.onc.1202900; Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; ten Hacken NHT, 1998, CLIN EXP ALLERGY, V28, P1518; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wheelhouse NM, 2003, INT J MOL MED, V12, P889; Zerfaoui M, 2008, CELL SIGNAL, V20, P186, DOI 10.1016/j.cellsig.2007.10.007; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646	36	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41152	41160		10.1074/jbc.M110.158352	http://dx.doi.org/10.1074/jbc.M110.158352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20966071	Green Published, hybrid			2022-12-27	WOS:000285414400077
J	Park, H; Boyington, JC				Park, HaJeung; Boyington, Jeffrey C.			The 1.5 angstrom Crystal Structure of Human Receptor for Advanced Glycation Endproducts (RAGE) Ectodomains Reveals Unique Features Determining Ligand Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							END-PRODUCTS RAGE; CELL-SURFACE RECEPTOR; PATTERN-RECOGNITION; SCAVENGER RECEPTORS; ALZHEIMERS-DISEASE; NMR SYSTEM; PROTEINS; ACTIVATION; S100B; CRYSTALLOGRAPHY	Interaction of the pattern recognition receptor, RAGE with key ligands such as advanced glycation end products (AGE), S100 proteins, amyloid beta, and HMGB1 has been linked to diabetic complications, inflammatory and neurodegenerative disorders, and cancer. To help answer the question of how a single receptor can recognize and respond to a diverse set of ligands we have investigated the structure and binding properties of the first two extracellular domains of human RAGE, which are implicated in various ligand binding and subsequent signaling events. The 1.5-angstrom crystal structure reveals an elongated molecule with a large basic patch and a large hydrophobic patch, both highly conserved. Isothermal titration calorimetry (ITC) and deletion experiments indicate S100B recognition by RAGE is an entropically driven process involving hydrophobic interaction that is dependent on Ca2+ and on residues in the C'D loop (residues 54-67) of domain 1. In contrast, competition experiments using gel shift assays suggest that RAGE interaction with AGE is driven by the recognition of negative charges on AGE-proteins. We also demonstrate that RAGE can bind to dsDNA and dsRNA. These findings reveal versatile structural features of RAGE that help explain its ability to recognize of multiple ligands.	[Park, HaJeung; Boyington, Jeffrey C.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Park, H (corresponding author), Scripps Res Inst, Jupiter, FL 33458 USA.	hajpark@scripps.edu; boyingtonj@niaid.nih.gov		ADSIT, FLOYD/0000-0002-1971-3604; Park, HaJeung/0000-0003-4898-7919	National Institutes of Health, NIEHS	National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIEHS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BAUDIER J, 1982, FEBS LETT, V148, P231, DOI 10.1016/0014-5793(82)80813-2; Bhattacharya S, 2003, BIOCHEMISTRY-US, V42, P14416, DOI 10.1021/bi035089a; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BRETT J, 1993, AM J PATHOL, V143, P1699; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Drohat AC, 1999, PROTEIN SCI, V8, P800; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N., 2006, CURR PROT BIOINF, V15, P1, DOI [10.1002/0471250953.bi0506s15, DOI 10.1002/0471250953.BI0506S15]; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horner AA, 2004, CURR OPIN ALLERGY CL, V4, P555, DOI 10.1097/00130832-200412000-00014; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LO TWC, 1994, J BIOL CHEM, V269, P32299; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palaniyar N, 2004, J BIOL CHEM, V279, P32728, DOI 10.1074/jbc.M403763200; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Ramasamy R, 2005, TRENDS CARDIOVAS MED, V15, P237, DOI 10.1016/j.tcm.2005.08.003; Rustandi RR, 2000, NAT STRUCT BIOL, V7, P570; Sasahira T, 2007, HISTOPATHOLOGY, V51, P166, DOI 10.1111/j.1365-2559.2007.02739.x; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Smith SP, 1998, STRUCTURE, V6, P211, DOI 10.1016/S0969-2126(98)00022-7; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vorup-Jensen T, 2005, P NATL ACAD SCI USA, V102, P1614, DOI 10.1073/pnas.0409057102; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	49	102	107	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40762	40770		10.1074/jbc.M110.169276	http://dx.doi.org/10.1074/jbc.M110.169276			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943659	Green Published, hybrid			2022-12-27	WOS:000285414400040
J	Wu, SH; Arevalo, JC; Neubrand, VE; Zhang, H; Arancio, O; Chao, MV				Wu, Synphen H.; Arevalo, Juan Carlos; Neubrand, Veronika E.; Zhang, Hong; Arancio, Ottavio; Chao, Moses V.			The Ankyrin Repeat-rich Membrane Spanning (ARMS)/Kidins220 Scaffold Protein Is Regulated by Activity-dependent Calpain Proteolysis and Modulates Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-BRAIN; MEDIATED TRUNCATION; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; GENE-EXPRESSION; AMPA RECEPTORS; MAP KINASE; PHOSPHORYLATION; ACTIVATION; DEPOLARIZATION	The expression of forms of synaptic plasticity, such as the phenomenon of long-term potentiation, requires the activity-dependent regulation of synaptic proteins and synapse composition. Here we show that ARMS (ankyrin repeat-rich membrane spanning protein)/Kidins220, a transmembrane scaffold molecule and BDNF TrkB substrate, is significantly reduced in hippocampal neurons after potassium chloride depolarization. The activity-dependent proteolysis of ARMS/Kidins220 was found to occur through calpain, a calcium-activated protease. Moreover, hippocampal long-term potentiation in ARMS/ Kidins220(+/-) mice was enhanced, and inhibition of calpain in these mice reversed these effects. These results provide an explanation for a role for the ARMS/Kidins220 protein in synaptic plasticity events and suggest that the levels of ARMS/ Kidins220 can be regulated by neuronal activity and calpain action to influence synaptic function.	[Wu, Synphen H.; Arevalo, Juan Carlos; Chao, Moses V.] NYU, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; [Wu, Synphen H.; Arevalo, Juan Carlos; Chao, Moses V.] NYU, Dept Physiol & Neurosci, New York, NY 10016 USA; [Chao, Moses V.] NYU, Dept Cell Biol, New York, NY 10016 USA; [Neubrand, Veronika E.] London Res Inst, Mol Neuropathobiol Lab, Canc Res UK, London WC2A 3PX, England; [Zhang, Hong; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst, New York, NY 10032 USA	New York University; New York University; New York University; Cancer Research UK; Columbia University	Wu, SH (corresponding author), 540 1st Ave,SK 5-15, New York, NY 10016 USA.	synphen.wu@nyumc.org	IBSAL, Secretaría/H-3719-2011; Neubrand, Veronika Elisabeth/AAA-3195-2019; Arévalo, Juan Carlos/J-8154-2014; arancio, ottavio/AAB-7959-2019	Neubrand, Veronika Elisabeth/0000-0002-3793-8487; Arévalo, Juan Carlos/0000-0003-1994-3095; Chao, Moses/0000-0002-6969-3744; arancio, ottavio/0000-0001-6335-164X	National Institutes of Health [NS21072, HD23315, NS049442]; Medical Scientist Training Program; Marie Curie International Reintegration Grant within the 7th European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072, R01NS049442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Reintegration Grant within the 7th European Community; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS21072 and HD23315 (to M. V. C.) and NS049442 (to O. A.). This work was also supported by the Medical Scientist Training Program (to S. H. W.), and a Marie Curie International Reintegration Grant within the 7th European Community Framework Programme (to J. C. A.).	Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; Bi RF, 1998, BRAIN RES, V797, P154, DOI 10.1016/S0006-8993(98)00433-8; Bi XN, 1997, J NEUROCHEM, V68, P1484; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; CHAO MV, 1992, CELL, V68, P995, DOI 10.1016/0092-8674(92)90068-N; Cortes RY, 2007, DEV NEUROBIOL, V67, P1687, DOI 10.1002/dneu.20542; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guttmann RP, 2002, J PHARMACOL EXP THER, V302, P1023, DOI 10.1124/jpet.102.036962; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jia JM, 2008, J BIOL CHEM, V283, P21242, DOI 10.1074/jbc.M800282200; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Li XR, 2007, MOL BIOCHEM PARASIT, V155, P26, DOI 10.1016/j.molbiopara.2007.05.004; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Lu XY, 2000, BRAIN RES, V863, P143, DOI 10.1016/S0006-8993(00)02112-0; Lu XY, 2001, J NEUROCHEM, V77, P1553, DOI 10.1046/j.1471-4159.2001.00359.x; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Park HJ, 2010, MOL CELLS, V30, P143, DOI 10.1007/s10059-010-0099-7; ROSEN LB, 1994, NEURON, V12, P1207, DOI 10.1016/0896-6273(94)90438-3; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sutachan JJ, 2010, J NEUROSCI RES, V88, P3447, DOI 10.1002/jnr.22513; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Yuen EY, 2007, J PHYSIOL-LONDON, V580, P241, DOI 10.1113/jphysiol.2006.122754; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010	42	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40472	40478		10.1074/jbc.M110.171371	http://dx.doi.org/10.1074/jbc.M110.171371			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943655	Green Published, hybrid			2022-12-27	WOS:000285414400009
J	Sengupta, D; Linstedt, AD				Sengupta, Debrup; Linstedt, Adam D.			Mitotic Inhibition of GRASP65 Organelle Tethering Involves Polo-like Kinase 1 (PLK1) Phosphorylation Proximate to an Internal PDZ Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GOLGI CISTERNAL STACKING; REGULATES GOLGI; HELA-CELLS; PROTEIN; MITOSIS; COMPLEX; FRAGMENTATION; DOMAIN; CHECKPOINT; SECRETION	GRASP65 links cis-Golgi cisternae via a homotypic, N-terminal PDZ interaction, and its mitotic phosphorylation disrupts this activity. Neither the identity of the PDZ ligand involved in the GRASP65 self-interaction nor the mechanism by which phosphorylation inhibits its interaction is known. Phospho-mimetic mutation of known cyclin-dependent kinase 1/cyclin B sites, all of which are in the C-terminal "regulatory domain" of the molecule, failed to block organelle tethering. However, we identified a site phosphorylated by Polo-like kinase 1 (PLK1) in the GRASP65 N-terminal domain for which mutation to aspartic acid blocked tethering and alanine substitution prevented mitotic Golgi unlinking. Further, using interaction assays, we discovered an internal PDZ ligand adjacent to the PLK phosphorylation site that was required for tethering. These results reveal the mechanism of phosphoinhibition as direct inhibition by PLK1 of the PDZ ligand underlying the GRASP65 self-interaction.	[Sengupta, Debrup; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), 4400 5th Ave, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [GM-56779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-56779 (to A. D. L.).	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Birrane G, 2003, J BIOL CHEM, V278, P1399, DOI 10.1074/jbc.C200571200; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Carcedo CH, 2004, SCIENCE, V305, P93, DOI 10.1126/science.1097775; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Colanzi A, 2007, EMBO J, V26, P2465, DOI 10.1038/sj.emboj.7601686; D'Angelo G, 2009, J BIOL CHEM, V284, P34849, DOI 10.1074/jbc.M109.068403; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feinstein TN, 2007, MOL BIOL CELL, V18, P594, DOI 10.1091/mbc.E06-06-0530; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Jesch SA, 1998, MOL BIOL CELL, V9, P623, DOI 10.1091/mbc.9.3.623; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Jesch SA, 2001, TRAFFIC, V2, P873, DOI 10.1034/j.1600-0854.2001.21203.x; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; LUCOCQ JM, 1987, J CELL BIOL, V104, P865, DOI 10.1083/jcb.104.4.865; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MISTELI T, 1995, J CELL SCI, V108, P2715; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rabouille C, 2007, CELL CYCLE, V6, P2723, DOI 10.4161/cc.6.22.4896; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; Tang DM, 2010, TRAFFIC, V11, P827, DOI 10.1111/j.1600-0854.2010.01055.x; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Yoshimura S, 2005, J BIOL CHEM, V280, P23048, DOI 10.1074/jbc.M502442200; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152	53	37	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39994	40003		10.1074/jbc.M110.189449	http://dx.doi.org/10.1074/jbc.M110.189449			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937827	hybrid, Green Published			2022-12-27	WOS:000285185500044
J	Cheng, GM; Takahashi, M; Shunmugavel, A; Wallenborn, JG; DePaoli-Roach, AA; Gergs, U; Neumann, J; Kuppuswamy, D; Menick, DR; Cooper, G				Cheng, Guangmao; Takahashi, Masaru; Shunmugavel, Anandakumar; Wallenborn, J. Grace; DePaoli-Roach, Anna A.; Gergs, Ulrich; Neumann, Joachim; Kuppuswamy, Dhandapani; Menick, Donald R.; Cooper, George			Basis for MAP4 Dephosphorylation-related Microtubule Network Densification in Pressure Overload Cardiac Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; CONTRACTILE DYSFUNCTION; NEUROFIBRILLARY DEGENERATION; P21-ACTIVATED KINASE; NEGATIVE REGULATOR; CATALYTIC SUBUNIT; CYTOSKELETAL ROLE; MESSENGER-RNA; PHOSPHORYLATION; TAU	Increased activity of Ser/Thr protein phosphatases types 1 (PP1) and 2A (PP2A) during maladaptive cardiac hypertrophy contributes to cardiac dysfunction and eventual failure, partly through effects on calcium metabolism. A second maladaptive feature of pressure overload cardiac hypertrophy that instead leads to heart failure by interfering with cardiac contraction and intracellular transport is a dense microtubule network stabilized by decoration with microtubule-associated protein 4 (MAP4). In an earlier study we showed that the major determinant of MAP4-microtubule affinity, and thus microtubule network density and stability, is site-specific MAP4 dephosphorylation at Ser-924 and to a lesser extent at Ser-1056; this was found to be prominent in hypertrophied myocardium. Therefore, in seeking the etiology of this MAP4 dephosphorylation, we looked here at PP2A and PP1, as well as the upstream p21-activated kinase 1, in maladaptive pressure overload cardiac hypertrophy. The activity of each was increased persistently during maladaptive hypertrophy, and overexpression of PP2A or PP1 in normal hearts reproduced both the microtubule network phenotype and the dephosphorylation of MAP4 Ser-924 and Ser-1056 seen in hypertrophy. Given the major microtubule-based abnormalities of contractile and transport function in maladaptive hypertrophy, these findings constitute a second important mechanism for phosphatase-dependent pathology in the hypertrophied and failing heart.	[Cheng, Guangmao; Takahashi, Masaru; Shunmugavel, Anandakumar; Wallenborn, J. Grace; Kuppuswamy, Dhandapani; Menick, Donald R.; Cooper, George] Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, Charleston, SC 29403 USA; [DePaoli-Roach, Anna A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Gergs, Ulrich; Neumann, Joachim] Univ Halle Wittenberg, Fak Med, Inst Pharmakol & Toxikol, D-06112 Halle, Germany; [Cooper, George] Dept Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Indiana University System; Indiana University-Purdue University Indianapolis; Martin Luther University Halle Wittenberg	Cooper, G (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Div Cardiol, Dept Med, POB 250773,114 Doughty St, Charleston, SC 29403 USA.	cooperge@musc.edu		Gergs, Ulrich/0000-0001-6986-485X	National Institutes of Health [HL48788, HL094545, HL104287]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048788, R01HL094545, R21HL104287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL48788 (to G.C., D.K., and D.R.M.) and HL094545 and HL104287 (to G.C.). This work was also supported by a Department of Veterans Affairs Merit Review Grant (to G.C.).	Boknik P, 2000, N-S ARCH PHARMACOL, V362, P222, DOI 10.1007/s002100000283; BURNS RG, 1992, FEBS LETT, V297, P205, DOI 10.1016/0014-5793(92)80538-R; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cheng G, 2008, AM J PHYSIOL-HEART C, V294, pH2231, DOI 10.1152/ajpheart.91515.2007; CHIDSEY CA, 1966, PHARMACOL REV, V18, P685; Chinnakkannu P, 2010, J BIOL CHEM, V285, P21837, DOI 10.1074/jbc.M110.120709; COOPER G, 1973, CIRC RES, V33, P213, DOI 10.1161/01.RES.33.2.213; Cooper G, 2006, AM J PHYSIOL-HEART C, V291, pH1003, DOI 10.1152/ajpheart.00132.2006; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; DREWES G, 1993, FEBS LETT, V336, P425, DOI 10.1016/0014-5793(93)80850-T; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Echeverria V, 2008, NEUROSCI LETT, V444, P92, DOI 10.1016/j.neulet.2008.07.092; El-Armouche A, 2006, BIOCHEM BIOPH RES CO, V346, P700, DOI 10.1016/j.bbrc.2006.05.182; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Hein S, 2008, AM J PHYSIOL-HEART C, V294, pH1130, DOI 10.1152/ajpheart.91528.2007; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Ke YB, 2004, CIRC RES, V94, P194, DOI 10.1161/01.RES.0000111522.02730.56; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kostin S, 2000, Heart Fail Rev, V5, P271; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Liu CWY, 1999, J BIOL CHEM, V274, P29470, DOI 10.1074/jbc.274.41.29470; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; Rodriguez P, 2006, J BIOL CHEM, V281, P38599, DOI 10.1074/jbc.M604139200; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Scholz D, 2008, AM J PHYSIOL-HEART C, V294, pH1135, DOI 10.1152/ajpheart.01275.2007; SCHULZE E, 1986, J CELL BIOL, V102, P1020, DOI 10.1083/jcb.102.3.1020; Sheehan KA, 2007, AM J PHYSIOL-REG I, V293, pR963, DOI 10.1152/ajpregu.00253.2007; Sheehan KA, 2009, AM J PHYSIOL-CELL PH, V296, pC47, DOI 10.1152/ajpcell.00012.2008; Tagawa H, 1996, P ASSOC AM PHYSICIAN, V108, P218; Tagawa H, 1996, CIRCULATION, V93, P1230, DOI 10.1161/01.CIR.93.6.1230; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; TSUTSUI H, 1993, SCIENCE, V260, P682, DOI 10.1126/science.8097594; Yoon SY, 2008, NEUROSCI LETT, V437, P111, DOI 10.1016/j.neulet.2008.03.083; Zile MR, 2001, J AM COLL CARDIOL, V37, P1080, DOI 10.1016/S0735-1097(00)01207-9	48	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38125	38140		10.1074/jbc.M110.148650	http://dx.doi.org/10.1074/jbc.M110.148650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889984	Green Published, hybrid			2022-12-27	WOS:000284625600020
J	Fei, EK; Ma, XC; Zhu, CQ; Xue, T; Yan, J; Xu, YX; Zhou, JN; Wang, GH				Fei, Erkang; Ma, Xiaochuan; Zhu, Cuiqing; Xue, Ting; Yan, Jie; Xu, Yuxia; Zhou, Jiangning; Wang, Guanghui			Nucleocytoplasmic Shuttling of Dysbindin-1, a Schizophrenia-related Protein, Regulates Synapsin I Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYSTROBREVIN-BINDING-PROTEIN; HIGH-RISK HAPLOTYPE; SUSCEPTIBILITY GENE; PREFRONTAL CORTEX; DTNBP1 GENE; NEUROTRANSMITTER RELEASE; HIPPOCAMPAL-FORMATION; ORGANELLES COMPLEX-1; NEURITE OUTGROWTH; NUCLEAR EXPORT	Dysbindin-1 is a 50-kDa coiled-coil-containing protein encoded by the gene DTNBP1 (dystrobrevin-binding protein 1), a candidate genetic factor for schizophrenia. Genetic variations in this gene confer a susceptibility to schizophrenia through a decreased expression of dysbindin-1. It was reported that dysbindin-1 regulates the expression of presynaptic proteins and the release of neurotransmitters. However, the precise functions of dysbindin-1 are largely unknown. Here, we show that dysbindin-1 is a novel nucleocytoplasmic shuttling protein and translocated to the nucleus upon treatment with leptomycin B, an inhibitor of exportin-1/CRM1-mediated nuclear export. Dysbindin-1 harbors a functional nuclear export signal necessary for its nuclear export, and the nucleocytoplasmic shuttling of dysbindin-1 affects its regulation of synapsin I expression. In brains of sandy mice, a dysbindin-1-null strain that displays abnormal behaviors related to schizophrenia, the protein and mRNA levels of synapsin I are decreased. These findings demonstrate that the nucleocytoplasmic shuttling of dysbindin-1 regulates synapsin I expression and thus may be involved in the pathogenesis of schizophrenia.	[Fei, Erkang; Ma, Xiaochuan; Xue, Ting; Zhou, Jiangning; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Zhu, Cuiqing; Yan, Jie; Xu, Yuxia] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	FEI, Erkang/AAI-9825-2021; Wang, Guanghui/U-3979-2017; Zhou, JiangNing/N-3374-2013; 薛, 挺/D-4799-2011	Wang, Guanghui/0000-0001-8551-6468; 薛, 挺/0000-0002-5644-6613; FEI, Erkang/0000-0002-3581-9521	National Natural Sciences Foundation of China [30770664, 30970921, 30900412]; Chinese Academy of Sciences [KSCX2-YW-R-138]; Anhui Educational Committee [ZD2008008-2]; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation [20090450808]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Anhui Educational Committee; K.C. Wong Education Foundation (Hong Kong); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by National Natural Sciences Foundation of China Grants 30770664 and 30970921, Chinese Academy of Sciences Knowledge Innovation Project Grant KSCX2-YW-R-138, and Anhui Educational Committee Grant ZD2008008-2.; Supported by the K.C. Wong Education Foundation (Hong Kong), China Postdoctoral Science Foundation-funded Project 20090450808, and National Natural Sciences Foundation of China Grant 30900412.	BAHLER M, 1990, BIOESSAYS, V12, P259, DOI 10.1002/bies.950120603; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Bray NJ, 2008, HUM MOL GENET, V17, P1169, DOI 10.1093/hmg/ddn006; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; BROWNING MD, 1993, BIOL PSYCHIAT, V34, P529, DOI 10.1016/0006-3223(93)90195-J; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Corradi A, 2008, J CELL SCI, V121, P3042, DOI 10.1242/jcs.035063; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Duan JB, 2007, HUM HERED, V64, P97, DOI 10.1159/000101961; EASTWOOD SL, 1995, NEUROSCIENCE, V66, P309, DOI 10.1016/0306-4522(94)00586-T; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harrison PJ, 2003, LANCET, V361, P417, DOI 10.1016/S0140-6736(03)12379-3; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Ji YY, 2009, P NATL ACAD SCI USA, V106, P19593, DOI 10.1073/pnas.0904289106; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; Li T, 1996, PSYCHIAT GENET, V6, P131, DOI 10.1097/00041444-199623000-00005; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Owen MJ, 2004, J CLIN INVEST, V113, P1255, DOI 10.1172/JCI200421470; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pae CU, 2009, EUR ARCH PSY CLIN N, V259, P137, DOI 10.1007/s00406-008-0830-y; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Porton B, 2007, SCHIZOPHR RES, V94, P366, DOI 10.1016/j.schres.2007.04.016; Rethelyi JM, 2010, AM J MED GENET B, V153B, P792, DOI 10.1002/ajmg.b.31049; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tosato S, 2007, AM J MED GENET B, V144B, P647, DOI 10.1002/ajmg.b.30484; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; Vawter MP, 2002, MOL PSYCHIATR, V7, P571, DOI 10.1038/sj.mp.4001158; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Wessman J, 2009, BIOL PSYCHIAT, V66, P990, DOI 10.1016/j.biopsych.2009.05.034; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Yang JZ, 2003, MOL PSYCHIATR, V8, P706, DOI 10.1038/sj.mp.4001377; Yang YH, 2004, J BIOL CHEM, V279, P38820, DOI 10.1074/jbc.M401663200; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Zuo LJ, 2009, PSYCHIAT GENET, V19, P292, DOI 10.1097/YPG.0b013e32832a50bc	73	20	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38630	38640		10.1074/jbc.M110.107912	http://dx.doi.org/10.1074/jbc.M110.107912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921223	Green Published, hybrid			2022-12-27	WOS:000284625600067
J	Horvath, P; Hunziker, A; Erdossy, J; Krishna, S; Semsey, S				Horvath, Peter; Hunziker, Alexander; Erdossy, Janos; Krishna, Sandeep; Semsey, Szabolcs			Timing of Gene Transcription in the Galactose Utilization System of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE REPRESSION; STATIONARY-PHASE; EXPRESSION; GROWTH; POLARITY; PROTEIN; PROMOTERS	In the natural environment, bacterial cells have to adjust their metabolism to alterations in the availability of food sources. The order and timing of gene expression are crucial in these situations to produce an appropriate response. We used the galactose regulation in Escherichia coli as a model system for understanding how cells integrate information about food availability and cAMP levels to adjust the timing and intensity of gene expression. We simulated the feast-famine cycle of bacterial growth by diluting stationary phase cells in fresh medium containing galactose as the sole carbon source. We followed the activities of six promoters of the galactose system as cells grew on and ran out of galactose. We found that the cell responds to a decreasing external galactose level by increasing the internal galactose level, which is achieved by limiting galactose metabolism and increasing the expression of transporters. We show that the cell alters gene expression based primarily on the current state of the cell and not on monitoring the level of extracellular galactose in real time. Some decisions have longer term effects; therefore, the current state does subtly encode the history of food availability. In summary, our measurements of timing of gene expression in the galactose system suggest that the system has evolved to respond to environments where future galactose levels are unpredictable rather than regular feast and famine cycles.	[Hunziker, Alexander; Krishna, Sandeep; Semsey, Szabolcs] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen O, Denmark; Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary	University of Copenhagen; Niels Bohr Institute; Eotvos Lorand University	Semsey, S (corresponding author), Niels Bohr Inst, Ctr Models Life, Blegdamsvej 17, DK-2100 Copenhagen O, Denmark.	semsey@nbi.dk	Semsey, Szabolcs/L-6329-2013; Erdőssy, János/ABB-2741-2021	Semsey, Szabolcs/0000-0002-4522-5495; krishna, sandeep/0000-0002-0581-173X	Hungarian Scientific Research Fund (OTKA) [PD75496]; Danish National Research Foundation	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Hungarian Scientific Research Fund (OTKA) Grant PD75496 (to S.S.) and by the Danish National Research Foundation.	ADHYA S, 2003, SCI STKE, pPE22; Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; EPSTEIN W, 1975, P NATL ACAD SCI USA, V72, P2300, DOI 10.1073/pnas.72.6.2300; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Geanacopoulos M, 1997, J BACTERIOL, V179, P228, DOI 10.1128/jb.179.1.228-234.1997; GUIDIRONTANI C, 1984, MOL GEN GENET, V195, P96, DOI 10.1007/BF00332730; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; Hunziker A, 2010, P NATL ACAD SCI USA, V107, P12998, DOI 10.1073/pnas.0915003107; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Johnson CH, 2004, CURR ISSUES MOL BIOL, V6, P103; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Krishna S, 2009, J MOL BIOL, V391, P671, DOI 10.1016/j.jmb.2009.06.043; Lee HJ, 2008, J MOL BIOL, V378, P318, DOI 10.1016/j.jmb.2008.02.067; Lee SJ, 2009, P NATL ACAD SCI USA, V106, P19515, DOI 10.1073/pnas.0910586106; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Moller T, 2002, GENE DEV, V16, P1696, DOI 10.1101/gad.231702; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Otten R.H.J.M., 1989, ANNEALING ALGORITHM; Park YH, 2006, J BIOL CHEM, V281, P6448, DOI 10.1074/jbc.M512672200; Reddy P, 1998, J BACTERIOL, V180, P732, DOI 10.1128/JB.180.3.732-736.1998; RYU S, 1993, P NATL ACAD SCI USA, V90, P75, DOI 10.1073/pnas.90.1.75; SCHUPP JM, 1995, BIOTECHNIQUES, V19, P18; Semsey S, 2006, J MOL BIOL, V358, P355, DOI 10.1016/j.jmb.2006.02.022; Semsey S, 2007, MOL MICROBIOL, V65, P465, DOI 10.1111/j.1365-2958.2007.05798.x; Semsey S, 2009, J BACTERIOL, V191, P4487, DOI 10.1128/JB.00056-09; Shin M, 2005, GENE DEV, V19, P2388, DOI 10.1101/gad.1316305; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; ULLMANN A, 1979, P NATL ACAD SCI USA, V76, P3194, DOI 10.1073/pnas.76.7.3194; WEICKERT MJ, 1993, J BACTERIOL, V175, P251, DOI 10.1128/JB.175.1.251-258.1993; WEICKERT MJ, 1993, MOL MICROBIOL, V10, P245, DOI 10.1111/j.1365-2958.1993.tb01950.x	38	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38062	38068		10.1074/jbc.M110.152264	http://dx.doi.org/10.1074/jbc.M110.152264			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923764	Green Published, hybrid			2022-12-27	WOS:000284625600014
J	Alzhanov, DT; McInerney, SF; Rotwein, P				Alzhanov, Damir T.; McInerney, Stephanie F.; Rotwein, Peter			Long Range Interactions Regulate Igf2 Gene Transcription during Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; SIGNALING PATHWAYS; MYOD BINDING; LIFE-SPAN; H19 GENE; INSULIN; EXPRESSION; METHYLATION; HYPERTROPHY; ACTIVATION	The differentiation, maintenance, and repair of skeletal muscle is controlled by interactions between genetically determined transcriptional programs regulated by myogenic transcription factors and environmental cues activated by growth factors and hormones. Signaling through the insulin-like growth factor 1 (IGF1) receptor by locally produced IGF2 defines one such pathway that is critical for normal muscle growth and for regeneration after injury. IGF2 gene and protein expression are induced as early events in muscle differentiation, but the responsible molecular mechanisms are unknown. Here we characterize a distal DNA element within the imprinted mouse Igf2-H19 locus with properties of a muscle transcriptional enhancer. We find that this region undergoes a transition to open chromatin during differentiation, whereas adjacent chromatin remains closed, and that it interacts in differentiating muscle nuclei but not in mesenchymal precursor cells with the Igf2 gene found more than 100 kb away, suggesting that chromatin looping or sliding to bring the enhancer in proximity to Igf2 promoters is also an early event in muscle differentiation. Because this element directly stimulates the transcriptional activity of an Igf2 promoter-reporter gene in differentiating myoblasts, our results indicate that we have identified a bona fide distal transcriptional enhancer that supports Igf2 gene activation in skeletal muscle cells. Because this DNA element is conserved in the human IGF2-H19 locus, our results further suggest that its muscle enhancer function also is conserved among different mammalian species.	[Alzhanov, Damir T.; McInerney, Stephanie F.; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Hudon, Stephanie/0000-0001-5255-9381; Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [R01 DK42748-21, T32 DK007680, T32 DK007674]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007674, R01DK042748, T32DK007680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK42748-21 (to P. R.) and Training Grants T32 DK007680 and T32 DK007674 (to D. T. A.). This work was also supported by a predoctoral fellowship from the American Heart Association (to S. F. M.).	Ainscough JFX, 2000, DEVELOPMENT, V127, P3923; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Barton ER, 2002, J CELL BIOL, V157, P137, DOI 10.1083/jcb.200108071; Barton-Davis ER, 1998, P NATL ACAD SCI USA, V95, P15603, DOI 10.1073/pnas.95.26.15603; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DEVOL DL, 1990, AM J PHYSIOL, V259, pE89, DOI 10.1152/ajpendo.1990.259.1.E89; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Ishihara K, 2000, GENOME RES, V10, P664, DOI 10.1101/gr.10.5.664; Kaffer CR, 2000, GENE DEV, V14, P1908; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; KOU K, 1993, MOL ENDOCRINOL, V7, P291, DOI 10.1210/me.7.2.291; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Palacios D, 2006, J CELL PHYSIOL, V207, P1, DOI 10.1002/jcp.20489; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Pfeifer K, 1996, P NATL ACAD SCI USA, V93, P13876, DOI 10.1073/pnas.93.24.13876; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rotwein P, 1999, CONT ENDOCRINOL, V17, P19; Rotwein P, 2003, GROWTH HORM IGF RES, V13, P303, DOI 10.1016/j.ghir.2003.09.001; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Stewart CEH, 1996, J CELL PHYSIOL, V169, P23, DOI 10.1002/(SICI)1097-4652(199610)169:1<23::AID-JCP3>3.0.CO;2-G; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Wilson EM, 2004, MOL BIOL CELL, V15, P497, DOI 10.1091/mbc.E03-05-0351; Wilson EM, 2003, J BIOL CHEM, V278, P41109, DOI 10.1074/jbc.C300299200; Yoon YS, 2007, MOL CELL BIOL, V27, P3499, DOI 10.1128/MCB.02170-06	53	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38969	38977		10.1074/jbc.M110.160986	http://dx.doi.org/10.1074/jbc.M110.160986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937833	Green Published, hybrid			2022-12-27	WOS:000284941300027
J	Husain, A; Sato, D; Jeelani, G; Mi-ichi, F; Ali, V; Suematsu, M; Soga, T; Nozaki, T				Husain, Afzal; Sato, Dan; Jeelani, Ghulam; Mi-ichi, Fumika; Ali, Vahab; Suematsu, Makoto; Soga, Tomoyoshi; Nozaki, Tomoyoshi			Metabolome Analysis Revealed Increase in S-Methylcysteine and Phosphatidylisopropanolamine Synthesis upon L-Cysteine Deprivation in the Anaerobic Protozoan Parasite Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-METABOLISM; MASS-SPECTROMETRY; GIARDIA-LAMBLIA; CHINESE CABBAGE; BIOSYNTHESIS; SYNTHASE; PROTIST; ENZYME; PHOSPHATIDYLCHOLINE; ACETYLTRANSFERASE	L-Cysteine is ubiquitous in all living organisms and is involved in a variety of functions, including the synthesis of iron-sulfur clusters and glutathione and the regulation of the structure, stability, and catalysis of proteins. In the protozoan parasite Entamoeba histolytica, the causative agent of amebiasis, L-cysteine plays an essential role in proliferation, adherence, and defense against oxidative stress; however, the essentiality of this amino acid in the pathways it regulates is not well understood. In the present study, we applied capillary electrophoresis time-of-flight mass spectrometry to quantitate charged metabolites modulated in response to L-cysteine deprivation in E. histolytica, which was selected as a model for examining the biological roles of L-cysteine. L-Cysteine deprivation had profound effects on glycolysis, amino acid, and phospholipid metabolism, with sharp decreases in the levels of L-cysteine, L-cystine, and S-adenosylmethionine and a dramatic accumulation of O-acetylserine and S-methylcysteine. We further demonstrated that S-methylcysteine is synthesized from methanethiol and O-acetylserine by cysteine synthase, which was previously considered to be involved in sulfur-assimilatory L-cysteine biosynthesis. In addition, L-cysteine depletion repressed glycolysis and energy generation, as it reduced acetylCoA, ethanol, and the major nucleotide di- and triphosphates, and led to the accumulation of glycolytic intermediates. Interestingly, L-cysteine depletion increased the synthesis of isopropanolamine and phosphatidylisopropanolamine, and it was confirmed that their increment was not a result of oxidative stress but was a specific response to L-cysteine depletion. We also identified a pathway in which isopropanolamine is synthesized from methylglyoxal via aminoacetone. To date, this study represents the first case where L-cysteine deprivation leads to drastic changes in core metabolic pathways, including energy, amino acid, and phospholipid metabolism.	[Husain, Afzal; Jeelani, Ghulam; Mi-ichi, Fumika; Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Husain, Afzal; Ali, Vahab] Gunma Univ, Grad Sch Med, Dept Parasitol, Maebashi, Gunma 3718511, Japan; [Sato, Dan; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Jeelani, Ghulam; Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem & Integrat Med Biol, Shinjuku Ku, Tokyo 1608582, Japan	National Institute of Infectious Diseases (NIID); Gunma University; Keio University; Keio University	Nozaki, T (corresponding author), Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	nozaki@nih.go.jp	Suematsu, Makoto/I-8135-2013; Soga, Tomoyoshi/B-8105-2014; Mi-ichi, Fumika/O-9668-2015; Suematsu, Makoto/O-5762-2018; HUSAIN, AFZAL/GRO-1733-2022	Suematsu, Makoto/0000-0002-7165-6336; Soga, Tomoyoshi/0000-0001-9502-2509; Suematsu, Makoto/0000-0002-7165-6336; HUSAIN, AFZAL/0000-0002-6627-5520; Mi-ichi, Fumika/0000-0001-7042-2266	Ministry of Education, Culture, Sports, Science and Technology of Japan [18GS0314, 18050006, 18073001, 20590429]; Ministry of Health, Labour and Welfare of Japan [H20-Shinkosaiko-016]; Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research 18GS0314, 18050006, and 18073001 (to T. N.) and 20590429 (to D. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant H20-Shinkosaiko-016 for research on emerging and re-emerging infectious diseases from the Ministry of Health, Labour and Welfare of Japan, and a grant for research to promote the development of anti-AIDS pharmaceuticals from the Japan Health Sciences Foundation (to T. N.).; Supported by the Monbukagakusho Scholarship from the Ministry of Education, Culture, Sports, Science and Technology.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; Ali V, 2007, CLIN MICROBIOL REV, V20, P164, DOI 10.1128/CMR.00019-06; Anderson IJ, 2005, EXP PARASITOL, V110, P173, DOI 10.1016/j.exppara.2005.03.010; Ariyanayagam MR, 1999, MOL BIOCHEM PARASIT, V103, P61, DOI 10.1016/S0166-6851(99)00118-8; Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; Clark CG, 2007, ADV PARASIT, V65, P51, DOI 10.1016/S0065-308X(07)65002-7; Clark CG, 2002, CLIN MICROBIOL REV, V15, P329, DOI 10.1128/CMR.15.3.329-341.2002; Cullis P.R., 1996, NEW COMPREHENSIVE BI, V31, P1; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; FAHEY RC, 1984, SCIENCE, V224, P70, DOI 10.1126/science.6322306; GILLIN FD, 1981, EXP PARASITOL, V51, P382, DOI 10.1016/0014-4894(81)90125-9; GILLIN FD, 1981, EXP PARASITOL, V52, P9, DOI 10.1016/0014-4894(81)90055-2; GILLIN FD, 1980, J PROTOZOOL, V27, P474, DOI 10.1111/j.1550-7408.1980.tb05402.x; Giovanelli J., 1980, BIOCH PLANTS, VVolume 5, P453, DOI [DOI 10.1016/B978-0-12-675405-6.50018-8, 10.1016/b978-0-12-675405-6.50018-8]; GORDON LI, 1991, FREE RADICAL RES COM, V15, P65, DOI 10.3109/10715769109049126; GREEN ML, 1964, BIOCHEM J, V92, P537, DOI 10.1042/bj0920537; Heikinheimo L, 2002, TRAFFIC, V3, P367, DOI 10.1034/j.1600-0854.2002.30506.x; HORNER WH, 1959, J BIOL CHEM, V234, P2935; Husain A, 2010, MOL BIOCHEM PARASIT, V170, P100, DOI 10.1016/j.molbiopara.2009.11.004; Hussain S, 2009, MOL BIOCHEM PARASIT, V163, P39, DOI 10.1016/j.molbiopara.2008.09.006; Inoue Y, 1995, Adv Microb Physiol, V37, P177, DOI 10.1016/S0065-2911(08)60146-0; Jeelani G, 2010, J BIOL CHEM, V285, P26889, DOI 10.1074/jbc.M110.106310; KELLEY JJ, 1984, J BIOL CHEM, V259, P2124; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; KUHLMANN MK, 1991, J BIOL CHEM, V266, P15042; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MAE T, 1976, PLANT CELL PHYSIOL, V17, P459; MAE T, 1971, PLANT CELL PHYSIOL, V12, P881, DOI 10.1093/oxfordjournals.pcp.a074692; Mehlotra RK, 1996, CRIT REV MICROBIOL, V22, P295, DOI 10.3109/10408419609105484; MEYER W, 1979, BIOCHIM BIOPHYS ACTA, V575, P463, DOI 10.1016/0005-2760(79)90116-4; Nozaki T, 1999, J BIOL CHEM, V274, P32445, DOI 10.1074/jbc.274.45.32445; Nozaki T, 2005, ADV PARASIT, V60, P1, DOI 10.1016/S0065-308X(05)60001-2; Nozaki T, 1998, MOL BIOCHEM PARASIT, V97, P33, DOI 10.1016/S0166-6851(98)00129-7; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Ramos E, 2007, EXP PARASITOL, V116, P257, DOI 10.1016/j.exppara.2007.01.011; Ramos-Martinez E, 2009, INT J PARASITOL, V39, P693, DOI 10.1016/j.ijpara.2008.11.004; RAY M, 1987, J BIOL CHEM, V262, P5974; Rebeille F, 2006, P NATL ACAD SCI USA, V103, P15687, DOI 10.1073/pnas.0606195103; Ronald C. D., 1971, PHYTOCHEMISTRY, V10, P1745; Sato D, 2008, FEBS J, V275, P548, DOI 10.1111/j.1742-4658.2007.06221.x; Sato D, 2010, INT J ANTIMICROB AG, V35, P56, DOI 10.1016/j.ijantimicag.2009.08.016; Sato S, 2004, PLANT J, V40, P151, DOI 10.1111/j.1365-313X.2004.02187.x; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SMITH JD, 1988, BIOCHEM J, V254, P301, DOI 10.1042/bj2540301; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Tokoro M, 2003, J BIOL CHEM, V278, P42717, DOI 10.1074/jbc.M212414200; WEINBACH EC, 1974, EXP PARASITOL, V35, P232, DOI 10.1016/0014-4894(74)90027-7; Westrop GD, 2006, J BIOL CHEM, V281, P25062, DOI 10.1074/jbc.M600688200; WIEBERS JL, 1964, J BACTERIOL, V88, P1798, DOI 10.1128/JB.88.6.1798-1804.1964; Wirtz M, 2010, J BIOL CHEM, V285, P32810, DOI 10.1074/jbc.M110.157446; YEAGLE PL, 1989, FASEB J, V3, P1833, DOI 10.1096/fasebj.3.7.2469614; ZHOU X, 1992, J LIPID RES, V33, P1233; ZUO X, 1995, FEMS MICROBIOL LETT, V130, P253	65	37	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39160	39170		10.1074/jbc.M110.167304	http://dx.doi.org/10.1074/jbc.M110.167304			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923776	Green Published, hybrid			2022-12-27	WOS:000284941300046
J	Yuan, ZG; Peng, LR; Radhakrishnan, R; Seto, E				Yuan, Zhigang; Peng, Lirong; Radhakrishnan, Rangasudhagar; Seto, Edward			Histone Deacetylase 9 (HDAC9) Regulates the Functions of the ATDC (TRIM29) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEF2 TRANSCRIPTION FACTOR; MYOCYTE ENHANCER FACTOR-2; GENE-EXPRESSION; MUSCLE DIFFERENTIATION; ACTIVATION; BINDING; FAMILY; ASSOCIATION; REPRESSION; COMPLEX	Histone deacetylase 9 (HDAC9), like most Class II HDACs, catalyzes the removal of acetyl moieties from the epsilon-amino groups of conserved lysine residues in the N-terminal tail of histones. Biologically, HDAC9 regulates a wide variety of normal and abnormal physiological functions, including cardiac growth, T-regulatory cell function, neuronal disorders, muscle differentiation, development, and cancer. In a biochemical approach to identify non-histone substrates of HDAC9, we found that HDAC9 co-purifies specifically with the ataxia telangiectasia group D-complementing (ATDC; also called TRIM29) protein. HDAC9 deacetylates ATDC, alters the ability of ATDC to associate with p53, and consequently inhibits the cell proliferation-promoting activity of ATDC. These results implicate the importance of non-histone deacetylation by HDAC9 and confirm and further extend the multifunctions of this Class II deacetylase.	[Yuan, Zhigang; Peng, Lirong; Radhakrishnan, Rangasudhagar; Seto, Edward] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org	radhakrishnan, rangasudhagar/B-8557-2016	radhakrishnan, rangasudhagar/0000-0001-6616-8525	National Institutes of Health [GM081650]; American Heart Association [0755298]; Kaul Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Kaul Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081650 (to E. S.). This work was also supported by American Heart Association Grant 0755298 and a grant from the Kaul Foundation (to E. S.).	Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Glozak MA, 2009, J BIOL CHEM, V284, P11446, DOI 10.1074/jbc.M809394200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kao HY, 2001, J BIOL CHEM, V276, P47496, DOI 10.1074/jbc.M107631200; LEONHARDT EA, 1994, GENOMICS, V19, P130, DOI 10.1006/geno.1994.1022; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; Mahlknecht U, 2002, BIOCHEM BIOPH RES CO, V293, P182, DOI 10.1016/S0006-291X(02)00193-6; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Morrison BE, 2008, EXP BIOL MED, V233, P980, DOI 10.3181/0802-RM-48; Peng YH, 2003, ONCOGENE, V22, P4478, DOI 10.1038/sj.onc.1206777; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; REDDY BA, 1992, TRENDS BIOCHEM SCI, V17, P344, DOI 10.1016/0968-0004(92)90308-V; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rezai-Zadeh N, 2004, METHOD ENZYMOL, V377, P167; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Sparrow DB, 1999, EMBO J, V18, P5085, DOI 10.1093/emboj/18.18.5085; Sugo N, 2010, EUR J NEUROSCI, V31, P1521, DOI 10.1111/j.1460-9568.2010.07218.x; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang AH, 2005, J BIOL CHEM, V280, P29117, DOI 10.1074/jbc.M500295200; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang CL, 2001, P NATL ACAD SCI USA, V98, P7354, DOI 10.1073/pnas.131198498; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056; Zhou XB, 2001, P NATL ACAD SCI USA, V98, P10572, DOI 10.1073/pnas.191375098	50	57	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39329	39338		10.1074/jbc.M110.179333	http://dx.doi.org/10.1074/jbc.M110.179333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20947501	Green Published, hybrid			2022-12-27	WOS:000284941300060
J	Jones, AK; Rayes, D; Al-Diwani, A; Maynard, TPR; Jones, R; Hernando, G; Buckingham, SD; Bouzat, C; Sattelle, DB				Jones, Andrew K.; Rayes, Diego; Al-Diwani, Adam; Maynard, Thomas P. R.; Jones, Rachel; Hernando, Guillermina; Buckingham, Steven D.; Bouzat, Cecilia; Sattelle, David B.			A Cys-loop Mutation in the Caenorhabditis elegans Nicotinic Receptor Subunit UNC-63 Impairs but Does Not Abolish Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MYASTHENIC SYNDROMES; ACETYLCHOLINE-RECEPTORS; AGONIST BINDING; GENE ENCODES; NEMATODE; INVERTEBRATE; FAMILY; MUSCLE	The nematode Caenorhabditis elegans is an established model organism for studying neurobiology. UNC-63 is a C. elegans nicotinic acetylcholine receptor (nAChR) alpha-subunit. It is an essential component of the levamisole-sensitive muscle nAChR (L-nAChR) and therefore plays an important role in cholinergic transmission at the nematode neuromuscular junction. Here, we show that worms with the unc-63(x26) allele, with its alpha C151Y mutation disrupting the Cys-loop, have deficient muscle function reflected by impaired swimming (thrashing). Single-channel recordings from cultured muscle cells from the mutant strain showed a 100-fold reduced frequency of opening events and shorter channel openings of L-nAChRs compared with those of wild-type worms. Anti-UNC-63 antibody staining in both cultured adult muscle and embryonic cells showed that L-nAChRs were expressed at similar levels in the mutant and wild-type cells, suggesting that the functional changes in the receptor, rather than changes in expression, are the predominant effect of the mutation. The kinetic changes mimic those reported in patients with fast-channel congenital myasthenic syndromes. We show that pyridostigmine bromide and 3,4-diaminopyridine, which are drugs used to treat fast-channel congenital myasthenic syndromes, partially rescued the motility defect seen in unc-63(x26). The C. elegans unc-63(x26) mutant may therefore offer a useful model to assist in the development of therapies for syndromes produced by altered function of human nAChRs.	[Rayes, Diego; Hernando, Guillermina; Bouzat, Cecilia] Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Jones, Andrew K.; Al-Diwani, Adam; Maynard, Thomas P. R.; Jones, Rachel; Buckingham, Steven D.] Univ Oxford, Dept Physiol Anat & Genet, Funct Genom Unit, MRC, Oxford OX1 3QX, England; [Sattelle, David B.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; University of Oxford; University of Manchester	Bouzat, C (corresponding author), Univ Nacl Sur, Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Bahia Blanca, B-8000FWB, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar; david.sattelle@dpag.ox.ac.uk	, Diego/AAH-4523-2020	Jones, Andrew/0000-0002-7835-0890; Hernando, Guillermina/0000-0002-8411-5467; Al-Diwani, Adam/0000-0001-6596-7579	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional del Sur; Fundacion F. Fiorini; Fondo para la Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica; Medical Research Council; Royal Society; Medical Research Council [MC_U137761447] Funding Source: researchfish; MRC [MC_U137761447] Funding Source: UKRI	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional del Sur; Fundacion F. Fiorini; Fondo para la Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Universidad Nacional del Sur, the Fundacion F. Fiorini, and Fondo para la Investigacion Cientifica y Tecnologica, Agencia Nacional de Promocion Cientifica y Tecnologica (to C.B.); the Medical Research Council (to S.D.B., A.A.-D., A.K.J., T.P.R.M., and R.J.); and a Royal Society International Joint Project Award (to C.B. and D.B.S.).	Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Culetto E, 2004, J BIOL CHEM, V279, P42476, DOI 10.1074/jbc.M404370200; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Duerr Janet S, 2006, WormBook, P1; Eimer S, 2007, EMBO J, V26, P4313, DOI 10.1038/sj.emboj.7601858; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Francis MM, 2003, TRENDS NEUROSCI, V26, P90, DOI 10.1016/S0166-2236(02)00041-3; Green WN, 1997, J BIOL CHEM, V272, P20945, DOI 10.1074/jbc.272.33.20945; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066; Jones AK, 2004, BIOESSAYS, V26, P39, DOI 10.1002/bies.10377; Jones Andrew K., 2007, Invertebrate Neuroscience, V7, P129, DOI 10.1007/s10158-007-0049-z; Kaas B, 2010, INVERTEBR NEUROSCI, V10, P17, DOI 10.1007/s10158-010-0101-2; Kalamida D, 2007, FEBS J, V274, P3799, DOI 10.1111/j.1742-4658.2007.05935.x; KAO PN, 1986, J BIOL CHEM, V261, P8085; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Milone M, 1998, ANN NY ACAD SCI, V841, P184, DOI 10.1111/j.1749-6632.1998.tb10925.x; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Rand James B, 2007, WormBook, P1; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Salkoff L, 2005, WormBook, P1; Sattelle David B., 2006, Invertebrate Neuroscience, V6, P1, DOI 10.1007/s10158-005-0014-7; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Towers PR, 2005, J NEUROCHEM, V93, P1, DOI 10.1111/j.1471-4159.2004.02951.x; Vincent A, 2000, EUR J BIOCHEM, V267, P6717, DOI 10.1046/j.1432-1327.2000.01785.x; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	43	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2550	2558		10.1074/jbc.M110.177238	http://dx.doi.org/10.1074/jbc.M110.177238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20966081	Green Published, hybrid			2022-12-27	WOS:000286464300020
J	Thompson, RC; Herscovitch, M; Zhao, I; Ford, TJ; Gilmore, TD				Thompson, Ryan C.; Herscovitch, Melanie; Zhao, Ian; Ford, Tyler J.; Gilmore, Thomas D.			NF-kappa B Down-regulates Expression of the B-lymphoma Marker CD10 through a miR-155/PU.1 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CELL LYMPHOMA; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; CD10/NEUTRAL ENDOPEPTIDASE-24.11; NEUTRAL ENDOPEPTIDASE; BURKITTS-LYMPHOMA; BINDING-SITES; MICRORNA-155; PU.1	Cell-surface protein CD10 is a prognostic marker for diffuse large B-cell lymphoma (DLBCL), where high expression of CD10 is found in the germinal center B-cell (GCB) subtype and CD10 expression is low or absent in the activated B-cell (ABC) subtype. As compared with the GCB subtype, patients with ABC DLBCL have a poorer prognosis after standard treatment, and ABC tumor cells have higher NF-kappa B activity. Herein, we show that increased expression of the NF-kappa B target micro-RNA miR-155 is correlated with reduced expression of transcription factor PU.1 and CD10 in several B-lymphoma cell lines. Moreover, electromobility shift assays and luciferase reporter assays indicate that PU.1 can directly activate expression from the CD10 promoter. Expression of a DLBCL-derived mutant of the adaptor CARD11 (a constitutive activator of NF-kappa B) in the GCB-like human BJAB cell line or v-Rel in the chicken DT40 B-lymphoma cell line causes reduced expression of PU.1. The CARD11 mutant also causes a decrease in CD10 levels in BJAB cells. Similarly, overexpression of miR-155, which is known to down-regulate PU.1, leads to reduced expression of CD10 in BJAB cells. Finally, we show that CD10 expression is reduced in BJAB cells after treatment with the NF-kappa B inducer lipopolysaccharide (LPS). Additionally, miR-155 is induced by LPS treatment or expression of the CARD11 mutant in BJAB cells. These results point to an NF-kappa B-dependent mechanism for down-regulation of CD10 in B-cell lymphoma: namely, that increased NF-kappa B activity leads to increased miR-155, which results in decreased PU.1, and consequently reduced CD10 mRNA and protein.	[Thompson, Ryan C.; Herscovitch, Melanie; Zhao, Ian; Ford, Tyler J.; Gilmore, Thomas D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Gilmore, TD (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu			National Institutes of Health [CA047763]; American Recovery and Reinvestment Act of 2009 [CA047763021S3]; National Institutes of Health NHLBI Hematology [T32 HL007501]; National Science and Engineering Research Council of Canada; Beckman Foundation; NATIONAL CANCER INSTITUTE [R01CA047763, R29CA047763] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act of 2009; National Institutes of Health NHLBI Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Beckman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA047763 and American Recovery and Reinvestment Act of 2009 supplement Grant CA047763021S3 (to T.D.G.).; Supported by National Institutes of Health NHLBI Hematology Training Grant T32 HL007501.; Supported by a pre-doctoral fellowship from the National Science and Engineering Research Council of Canada.; Supported by an undergraduate award from the Beckman Foundation Scholars Program.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Bolisetty MT, 2009, J VIROL, V83, P12009, DOI 10.1128/JVI.01182-09; Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; Carter KL, 2002, J VIROL, V76, P10427, DOI 10.1128/JVI.76.20.10427-10436.2002; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; CONTRERASSALAZAR B, 1990, J VIROL, V64, P5441, DOI 10.1128/JVI.64.11.5441-5447.1990; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Derudder E, 2003, BIOCHEM BIOPH RES CO, V308, P744, DOI 10.1016/S0006-291X(03)01474-8; Deschamps L, 2006, HUM PATHOL, V37, P802, DOI 10.1016/j.humpath.2006.02.024; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gupta N, 2008, CANCER RES, V68, P808, DOI 10.1158/0008-5472.CAN-07-3169; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; ISHIMARU F, 1995, BLOOD, V85, P3199, DOI 10.1182/blood.V85.11.3199.bloodjournal85113199; Ishimaru F, 1996, EXP HEMATOL, V24, P43; Javeed Iqbal, 2007, Indian Journal of Cancer, V44, P72; Kalaitzidis D, 2002, ONCOGENE, V21, P8759, DOI 10.1038/sj.onc.1206033; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kwon UK, 2006, BIOCHEM BIOPH RES CO, V344, P146, DOI 10.1016/j.bbrc.2006.03.119; Langner C, 2004, HISTOPATHOLOGY, V45, P460, DOI 10.1111/j.1365-2559.2004.01982.x; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li SL, 1999, J BIOL CHEM, V274, P32453, DOI 10.1074/jbc.274.45.32453; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; MENEZES J, 1975, BIOMEDICINE, V22, P276; Nagel S, 2007, CANCER RES, V67, P1461, DOI 10.1158/0008-5472.CAN-06-2615; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Phillips AJ, 1998, VIROLOGY, V250, P350, DOI 10.1006/viro.1998.9385; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; Rahadiani N, 2008, BIOCHEM BIOPH RES CO, V377, P579, DOI 10.1016/j.bbrc.2008.10.007; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; SALLES G, 1992, BLOOD, V80, P2021; Scherr M, 2003, CELL CYCLE, V2, P251, DOI 10.4161/cc.2.3.376; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Sumitomo M, 2005, BBA-PROTEINS PROTEOM, V1751, P52, DOI 10.1016/j.bbapap.2004.11.001; SUNDAY ME, 1992, J CLIN INVEST, V90, P2517, DOI 10.1172/JCI116145; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Torlakovic E, 2005, J PATHOL, V206, P312, DOI 10.1002/path.1777; Vaughn CP, 2006, PROTEOMICS, V6, P3223, DOI 10.1002/pmic.200500539; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Zhu N, 2007, MOL CELL BIOL, V27, P8859, DOI 10.1128/MCB.01724-07	60	73	82	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1675	1682		10.1074/jbc.M110.177063	http://dx.doi.org/10.1074/jbc.M110.177063			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20947507	hybrid, Green Published			2022-12-27	WOS:000286191500007
J	Kuehn, HS; Jung, MY; Beaven, MA; Metcalfe, DD; Gilfillan, AM				Kuehn, Hye Sun; Jung, Mi-Yeon; Beaven, Michael A.; Metcalfe, Dean D.; Gilfillan, Alasdair M.			Prostaglandin E-2 Activates and Utilizes mTORC2 as a Central Signaling Locus for the Regulation of Mast Cell Chemotaxis and Mediator Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; NF-KAPPA-B; REACTIVE OXYGEN; RAC ACTIVATION; PROTEIN-KINASE; RESPONSES; RECEPTORS; DEGRANULATION; PATHWAYS; PHOSPHORYLATION	Prostaglandin (PG) E-2, a potent mediator produced in inflamed tissues, can substantially influence mast cell responses including adhesion to basement membrane proteins, chemotaxis, and chemokine production. However, the signaling pathways by which PGE(2) induces mast cell chemotaxis and chemokine production remains undefined. In this study, we identified the downstream target of phosphatidylinositol 3-kinase, mammalian target of rapamycin (mTOR), as a key regulator of these responses. In mouse bone marrow-derived mast cells, PGE(2) was found to induce activation of mTORC1 (mTOR complexed to raptor) as indicated by increased p70S6K and 4E-BP1 phosphorylation, and activation of mTORC2 (mTOR complexed to rictor), as indicated by increased phosphorylation of AKT at position Ser(473). Selective inhibition of the mTORC1 cascade by rapamycin or by the use of raptor-targeted shRNA failed to decrease PGE(2)-mediated chemotaxis or chemokine generation. However, inhibition of the mTORC2 cascade through the dual mTORC1/mTORC2 inhibitor Torin, or through rictor-targeted shRNA, resulted in a significant attenuation in PGE2-mediated chemotaxis, which was associated with a comparable decrease in actin polymerization. Furthermore, mTORC2 down-regulation decreased PGE(2)-induced production of the chemokine monocyte chemoattractant protein-1 (CCL2), which was linked to a significant reduction in ROS production. These findings are consistent with the conclusion that activation of mTORC2, downstream of PI3K, represents a critical signaling locus for chemotaxis and chemokine release from PGE(2)-activated mast cells.	[Gilfillan, Alasdair M.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Gilfillan, AM (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C206,10 Ctr Dr,MSC 1881, Bethesda, MD 20892 USA.	agilfillan@niaid.nih.gov			NIAID; NHLBI within the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000965] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI within the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Division of Intramural Research of NIAID and NHLBI within the National Institutes of Health.	Ali K, 2008, J IMMUNOL, V180, P2538, DOI 10.4049/jimmunol.180.4.2538; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; Bonazzi A, 2000, AM J RESP CRIT CARE, V162, P2272, DOI 10.1164/ajrccm.162.6.2003127; CHUNG KF, 2005, SCI STKE, pPE47; Cloutier A, 2007, J LEUKOCYTE BIOL, V81, P567, DOI 10.1189/jlb.0806536; DELPRETE G, 1992, ALLERGY, V47, P450; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Faour WH, 2001, J BIOL CHEM, V276, P31720, DOI 10.1074/jbc.M104036200; Feng CL, 2006, BLOOD, V107, P3243, DOI 10.1182/blood-2005-07-2772; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gomi K, 2000, J IMMUNOL, V165, P6545, DOI 10.4049/jimmunol.165.11.6545; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; HIRASAWA N, 1995, J IMMUNOL, V154, P5391; Hogaboam G, 1998, J IMMUNOL, V160, P6166; HUMES JL, 1977, NATURE, V269, P149, DOI 10.1038/269149a0; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kay LJ, 2006, BRIT J PHARMACOL, V147, P707, DOI 10.1038/sj.bjp.0706664; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Kirshenbaum Arnold S, 2006, Methods Mol Biol, V315, P105; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; Kuehn HS, 2008, CELL SIGNAL, V20, P625, DOI 10.1016/j.cellsig.2007.11.016; Kuehn HS, 2007, IMMUNOL LETT, V113, P59, DOI 10.1016/j.imlet.2007.08.007; Kuehn HS, 2010, J CELL SCI, V123, P2576, DOI 10.1242/jcs.071043; Kuehn HS, 2008, J IMMUNOL, V181, P7706, DOI 10.4049/jimmunol.181.11.7706; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MADDEN KB, 1991, J IMMUNOL, V147, P1387; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MEININGER CJ, 1992, BLOOD, V79, P958; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Nakayama T, 2006, J LEUKOCYTE BIOL, V79, P95, DOI 10.1189/jlb.0405226; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sakanaka M, 2008, AM J PHYSIOL-CELL PH, V295, pC1427, DOI 10.1152/ajpcell.00218.2008; Samayawardhena LA, 2007, BLOOD, V109, P3679, DOI 10.1182/blood-2006-11-057315; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tkaczyk C, 2003, J BIOL CHEM, V278, P48474, DOI 10.1074/jbc.M301350200; Tkaczyk C, 2002, J IMMUNOL METHODS, V268, P239, DOI 10.1016/S0022-1759(02)00210-7; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Weller CL, 2007, P NATL ACAD SCI USA, V104, P11712, DOI 10.1073/pnas.0701700104; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					391	402		10.1074/jbc.M110.164772	http://dx.doi.org/10.1074/jbc.M110.164772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980255	Green Published, hybrid			2022-12-27	WOS:000285782800042
J	Voss, I; Goss, T; Murozuka, E; Altmann, B; McLean, KJ; Rigby, SEJ; Munro, AW; Scheibe, R; Hase, T; Hanke, GT				Voss, Ingo; Goss, Tatjana; Murozuka, Emiko; Altmann, Bianca; McLean, Kirsty J.; Rigby, Stephen E. J.; Munro, Andrew W.; Scheibe, Renate; Hase, Toshiharu; Hanke, Guy T.			FdC1, a Novel Ferredoxin Protein Capable of Alternative Electron Partitioning, Increases in Conditions of Acceptor Limitation at Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLE-SHEATH-CELLS; ARABIDOPSIS-THALIANA; FUNCTIONAL INTERACTION; NITRITE REDUCTASE; QUANTUM YIELD; REDOX SIGNALS; NUCLEAR GENES; EXPRESSION; SPINACH; CHLOROPLAST	In higher plants, [2Fe-2S] ferredoxin (Fd) proteins are the unique electron acceptors from photosystem I (PSI). Fds are soluble, and distribute electrons to many enzymes, including Fd: NADP(H) reductase (FNR), for the photoreduction of NADP(+). In addition to well studied [2Fe-2S] Fd proteins, higher plants also possess genes for significantly different, as yet uncharacterized Fd proteins, with extended C termini (FdCs). Whether these FdC proteins function as photosynthetic electron transfer proteins is not known. We examined whether these proteins play a role as alternative electron acceptors at PSI, using quantitative RT-PCR to follow how their expression changes in response to acceptor limitation at PSI, in mutant Arabidopsis plants lacking 90-95% of photosynthetic [2Fe-2S] Fd. Expression of the gene encoding one FdC protein, FdC1, was identified as being strongly up-regulated. We confirmed that this protein was chloroplast localized and increased in abundance on PSI acceptor limitation. We purified the recombinant FdC1 protein, which exhibited a UV-visible spectrum consistent with a [2Fe-2S] cluster, confirmed by EPR analysis. Measurements of electron transfer show that FdC1 is capable of accepting electrons from PSI, but cannot support photoreduction of NADP(+). Whereas FdC1 was capable of electron transfer with FNR, redox potentiometry showed that it had a more positive redox potential than photosynthetic Fds by around 220 mV. These results indicate that FdC1 electron donation to FNR is prevented because it is thermodynamically unfavorable. Based on our data, we speculate that FdC1 has a specific function in conditions of acceptor limitation at PSI, and channels electrons away from NADP(+) photoreduction.	[Voss, Ingo; Goss, Tatjana; Altmann, Bianca; Scheibe, Renate; Hanke, Guy T.] Univ Osnabruck, Dept Plant Physiol, D-49076 Osnabruck, Germany; [Murozuka, Emiko; Hase, Toshiharu] Osaka Univ, Lab Regulat Biol React, Inst Prot Res, Suita, Osaka 5650871, Japan; [McLean, Kirsty J.; Rigby, Stephen E. J.; Munro, Andrew W.] Univ Manchester, Manchester Interdisciplinary Bioctr, Fac Life Sci, Manchester M1 7DN, Lancs, England	University Osnabruck; Osaka University; University of Manchester	Hanke, GT (corresponding author), Univ Osnabruck, Dept Plant Physiol, Barbara Str 11, D-49076 Osnabruck, Germany.	Guy.Hanke@biologie.uni-osnabrueck.DE	Hase, Toshiharu/H-9271-2013; McLean, Kirsty J/GXI-2853-2022; Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X; Hanke, Guy/0000-0002-6167-926X; McLean, Kirsty/0000-0002-7193-5044	Deutsche Forschungsgemeinschaft [HA5921/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant HA5921/1-1.	ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; ARNON DI, 1963, SCIENCE, V140, P378, DOI 10.1126/science.140.3565.378; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; Backhausen JE, 2000, PHOTOSYNTH RES, V64, P1, DOI 10.1023/A:1026523809147; Backhausen JE, 1998, PLANTA, V207, P105, DOI 10.1007/s004250050461; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; Dunford AJ, 2007, BIOCHEMISTRY-US, V46, P5018, DOI 10.1021/bi7001339; Dutton P L, 1978, Methods Enzymol, V54, P411; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ESCOUBAS JM, 1995, P NATL ACAD SCI USA, V92, P10237, DOI 10.1073/pnas.92.22.10237; Fey V, 2005, J BIOL CHEM, V280, P5318, DOI 10.1074/jbc.M406358200; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gou P, 2006, BIOCHEMISTRY-US, V45, P14389, DOI 10.1021/bi061779d; Hanke GT, 2004, PLANT PHYSIOL, V134, P255, DOI 10.1104/pp.103.032755; Hanke GT, 2008, PLANT CELL ENVIRON, V31, P1017, DOI 10.1111/j.1365-3040.2008.01814.x; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; HASE T, 1991, PLANT PHYSIOL, V96, P77, DOI 10.1104/pp.96.1.77; HEDERSTEDT L, 1985, J BIOL CHEM, V260, P5554; Hihara Y, 2003, J BACTERIOL, V185, P1719, DOI 10.1128/JB.185.5.1719-1725.2003; Holtgrefe S, 2003, PLANT PHYSIOL, V133, P1768, DOI 10.1104/pp.103.026013; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HOSLER JP, 1985, BIOCHIM BIOPHYS ACTA, V808, P21, DOI 10.1016/0005-2728(85)90023-4; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Joliot P, 2006, BBA-BIOENERGETICS, V1757, P362, DOI 10.1016/j.bbabio.2006.02.018; Kanervo E, 2005, PHOTOCH PHOTOBIO SCI, V4, P1072, DOI 10.1039/b507866k; KIMATA Y, 1989, PLANT PHYSIOL, V89, P1193, DOI 10.1104/pp.89.4.1193; Kimata-Ariga Y, 2000, EMBO J, V19, P5041, DOI 10.1038/sj.emboj.7593319; KLUGHAMMER C, 1994, PLANTA, V192, P261, DOI 10.1007/BF01089043; Knaff D. B., 1996, ADV PHOTOSYNTHESIS O, P333; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; LELONG C, 1994, J BIOL CHEM, V269, P10034; Matsumura T, 1999, PLANT PHYSIOL, V119, P481, DOI 10.1104/pp.119.2.481; MCSWAIN BD, 1968, P NATL ACAD SCI USA, V61, P989, DOI 10.1073/pnas.61.3.989; MIYAKE C, 1994, PLANT CELL PHYSIOL, V35, P539, DOI 10.1093/oxfordjournals.pcp.a078628; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Nakamura K, 2006, J BIOL CHEM, V281, P36758, DOI 10.1074/jbc.M606797200; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; PARDO MB, 1990, ARCH MICROBIOL, V153, P528, DOI 10.1007/BF00245260; Pfannschmidt T, 2001, J BIOL CHEM, V276, P36125, DOI 10.1074/jbc.M105701200; Piippo M, 2006, PHYSIOL GENOMICS, V25, P142, DOI 10.1152/physiolgenomics.00256.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHMITZ S, 1995, BBA-BIOENERGETICS, V1231, P335, DOI 10.1016/0005-2728(95)00097-3; Seidel T, 2004, J BIOTECHNOL, V112, P165, DOI 10.1016/j.jbiotec.2004.04.027; SHIN M, 1965, J BIOL CHEM, V240, P1405; Snyrychova I, 2006, PHOTOCH PHOTOBIO SCI, V5, P472, DOI 10.1039/b514394b; SUZUKI A, 1985, PLANT PHYSIOL, V78, P374, DOI 10.1104/pp.78.2.374; TERASHIMA I, 1985, PLANT CELL PHYSIOL, V26, P63; VANCAMP W, 1994, BIO-TECHNOL, V12, P165, DOI 10.1038/nbt0294-165; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; VIDAKOVIC M, 1995, BIOCHEMISTRY-US, V34, P13906, DOI 10.1021/bi00042a023; VORST O, 1993, PLANT J, V3, P793, DOI 10.1111/j.1365-313X.1993.00793.x; Voss I, 2008, PHYSIOL PLANTARUM, V133, P584, DOI 10.1111/j.1399-3054.2008.01112.x; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	59	39	45	1	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					50	59		10.1074/jbc.M110.161562	http://dx.doi.org/10.1074/jbc.M110.161562			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20966083	hybrid, Green Published			2022-12-27	WOS:000285782800006
J	Wang, AP; Liu, ML; Liu, XL; Dong, LQ; Glickman, RD; Slaga, TJ; Zhou, ZG; Liu, F				Wang, Anping; Liu, Meilian; Liu, Xianling; Dong, Lily Q.; Glickman, Randolph D.; Slaga, Thomas J.; Zhou, Zhiguang; Liu, Feng			Up-regulation of Adiponectin by Resveratrol THE ESSENTIAL ROLES OF THE Akt/FOXO1 AND AMP-ACTIVATED PROTEIN KINASE SIGNALING PATHWAYS AND DsbA-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR FOXO1; DSBA-L; GENE-EXPRESSION; ADIPOSE-TISSUE; SIRT1; MICE; MECHANISM; CELLS; PHOSPHORYLATION	The natural polyphenol resveratrol (RSV) displays a wide spectrum of health beneficial activities, yet the precise mechanisms remain to be fully elucidated. Here we show that RSV promotes the multimerization and cellular levels of adiponectin in 3T3-L1 adipocytes. The stimulatory effect of RSV was not affected by knocking out Sirt1, but was diminished by suppressing the expression levels of DsbA-L, a recently identified adiponectin-interactive protein that promotes adiponectin multimerization. Suppression of the Akt signaling pathway resulted in an increase in the expression levels of DsbA-L and adiponectin. On the other hand, knocking out FOXO1 or suppressing the activity or expression levels of the AMP-activated protein kinase (AMPK) down-regulated DsbA-L and adiponectin. The stimulatory effect of RSV on adiponectin and DsbA-L expression was completely diminished in FOXO1-suppressed and AMPK-inactivated 3T3-L1 adipocytes. Taken together, our results demonstrate that RSV promotes adiponectin multimerization in 3T3-L1 adipocytes via a Sirt1-independent mechanism. In addition, we show that the stimulatory effect of RSV is regulated by both the Akt/FOXO1 and the AMPK signaling pathways. Last, we show that DsbA-L plays a critical role in the promoting effect of RSV on adiponectin multimerization and cellular levels.	[Wang, Anping; Liu, Meilian; Slaga, Thomas J.; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Glickman, Randolph D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Zhou, Zhiguang; Liu, Feng] Cent S Univ, Metab Syndrome Res Ctr, Xiangya Hosp 2, Xiangya 410011, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Central South University	Liu, ML (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	lium2@uthscsa.edu; liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022	Zhou, Zhiguang/0000-0002-0374-1838	National Institutes of Health [RO1 DK76902, DK69930]; San Antonio Life Sciences Institute (SALSI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076902, R56DK069930, R01DK069930] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Antonio Life Sciences Institute (SALSI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76902 (to F.L.) and DK69930 (to L.Q.D.) and a Research Award from the San Antonio Life Sciences Institute (SALSI) (to T.J.S., R.D.G., and F.L.).	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chen HY, 2008, VISION RES, V48, P690, DOI 10.1016/j.visres.2007.10.014; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Fisher FM, 2005, DIABETOLOGIA, V48, P1084, DOI 10.1007/s00125-005-1758-7; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Mader I, 2010, FASEB J, V24, P1997, DOI 10.1096/fj.09-142943; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Riojas RA, 2006, J BIOL CHEM, V281, P21588, DOI 10.1074/jbc.M600393200; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Zang MW, 2006, DIABETES, V55, pA13; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	40	69	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					60	66		10.1074/jbc.M110.188144	http://dx.doi.org/10.1074/jbc.M110.188144			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980258	Green Published, hybrid			2022-12-27	WOS:000285782800007
J	Koo, BH; Han, JH; Il Yeom, Y; Kim, DS				Koo, Bon-Hun; Han, Jung Ho; Il Yeom, Young; Kim, Doo-Sik			Thrombin-dependent MMP-2 Activity Is Regulated by Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-MATRIX METALLOPROTEINASE-2; SMOOTH-MUSCLE-CELLS; HUMAN PROGELATINASE-A; GELATINASE-A; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; IV COLLAGENASE; EXOSITE-II; ALLOSTERIC LINKAGE; BINDING-PROPERTIES	Like most metalloproteases, matrix metalloprotease 2 (MMP-2) is synthesized as a zymogen. MMP-2 propeptide plays a role in inhibition of catalytic activity through a cysteine-zinc ion pairing, disruption of which results in full enzyme activation. A variety of proteases have been shown to be involved in the activation of pro-MMP-2, including metalloproteases and serine proteases. In the previous study we showed that MMP-2 activation occurred via specific cleavages of the propeptide by thrombin followed by intermolecular autoproteolytic processing for full enzymatic activity. Thrombin also degraded MMP-2, but this degradation was reduced greatly under cell-associated conditions with a concomitant increase in activation, prompting us to elucidate the molecular mechanisms underlying thrombin-mediated MMP-2 activation. In the present study we demonstrate that heparan sulfate is essential for thrombin-mediated activation of pro-MMP-2. Binding of heparan sulfate to thrombin is primarily responsible for this activation process, presumably through conformational changes at the active site. Furthermore, interaction of MMP-2 with exosites 1 and 2 of thrombin is crucial for thrombin-mediated MMP-2 degradation, and inhibition of this interaction by heparan sulfate or hirudin fragment results in a decrease in MMP-2 degradation. Finally, we demonstrated interaction between exosite 1 and hemopexin-like domain of MMP-2, suggesting a regulatory role of hemopexin-like domain in MMP-2 degradation. Taken together, our experimental data suggest a novel regulatory mechanism of thrombin-dependent MMP-2 enzymatic activity by heparan sulfate proteoglycans.	[Koo, Bon-Hun] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Han, Jung Ho] Seoul Natl Univ, Coll Med, Med Res Ctr, Seoul 110799, South Korea; [Il Yeom, Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon 305806, South Korea	Yonsei University; Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, DS (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 134 Sinchon Dong, Seoul 120749, South Korea.	dskim@yonsei.ac.kr			Ministry of Education, Science, and Technology [2009-0081760]	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Future-based Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (no. 2009-0081760).	Baramova EN, 1997, FEBS LETT, V405, P157, DOI 10.1016/S0014-5793(97)00175-0; Bescond A, 1999, BIOCHEM BIOPH RES CO, V263, P498, DOI 10.1006/bbrc.1999.1391; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Callahan MK, 2004, J NEUROIMMUNOL, V153, P150, DOI 10.1016/j.jneuroim.2004.05.004; Chen DX, 2008, J EXP MED, V205, P1739, DOI 10.1084/jem.20071427; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; CRABBE T, 1994, FEBS LETT, V345, P14, DOI 10.1016/0014-5793(94)00412-9; CRABBE T, 1993, EUR J BIOCHEM, V218, P431, DOI 10.1111/j.1432-1033.1993.tb18393.x; Crawley JTB, 2005, BLOOD, V105, P1085, DOI 10.1182/blood-2004-03-1101; Esmon CT, 1996, J BIOL CHEM, V271, P13882, DOI 10.1074/jbc.271.23.13882; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Galis ZS, 1997, ARTERIOSCL THROM VAS, V17, P483, DOI 10.1161/01.ATV.17.3.483; Gioia M, 2009, J MOL BIOL, V386, P419, DOI 10.1016/j.jmb.2008.12.021; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Jackson MT, 2009, ARTHRITIS RHEUM-US, V60, P780, DOI 10.1002/art.24303; Jain A, 2008, BIOCHEMISTRY-US, V47, P10162, DOI 10.1021/bi801068p; KAHAN C, 1992, J BIOL CHEM, V267, P13369; Koo BH, 2009, J BIOL CHEM, V284, P23375, DOI 10.1074/jbc.M109.036848; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Lazure C, 2002, CURR PHARM DESIGN, V8, P511, DOI 10.2174/1381612023395691; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Monea S, 2002, J CELL PHYSIOL, V192, P160, DOI 10.1002/jcp.10126; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Morrison CJ, 2001, J BIOL CHEM, V276, P47402, DOI 10.1074/jbc.M108643200; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; MURPHY G, 1994, J BIOL CHEM, V269, P6632; Nakada M, 2001, CANCER RES, V61, P8896; Nguyen M, 1999, LAB INVEST, V79, P467; Nie J, 2003, CANCER RES, V63, P6758; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rahgozar S, 2007, ARTHRITIS RHEUM-US, V56, P605, DOI 10.1002/art.22367; Rauch BH, 2002, CIRC RES, V90, P1122, DOI 10.1161/01.RES.0000019240.72809.76; Segers K, 2007, J BIOL CHEM, V282, P33915, DOI 10.1074/jbc.M701123200; SHIMADA K, 1985, J CLIN INVEST, V75, P1308, DOI 10.1172/JCI111831; Somerville RPT, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-216; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; Wallon UM, 1997, J BIOL CHEM, V272, P7473, DOI 10.1074/jbc.272.11.7473; Wang ZB, 2009, NEUROSCI LETT, V451, P199, DOI 10.1016/j.neulet.2009.01.003; WOESSNER JF, 1994, ANN NY ACAD SCI, V732, P11; Yu WH, 2000, J BIOL CHEM, V275, P4183, DOI 10.1074/jbc.275.6.4183	54	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41270	41279		10.1074/jbc.M110.171595	http://dx.doi.org/10.1074/jbc.M110.171595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041295	Green Published, hybrid			2022-12-27	WOS:000285622600012
J	Styer, AM; Mirshahi, UL; Wang, CA; Girard, L; Jin, TH; Logothetis, DE; Mirshahi, T				Styer, Amanda M.; Mirshahi, Uyenlinh L.; Wang, Chuan; Girard, Laura; Jin, Taihao; Logothetis, Diomedes E.; Mirshahi, Tooraj			G Protein beta gamma Gating Confers Volatile Anesthetic Inhibition to Kir3 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECTIFYING K+ CHANNELS; GATED POTASSIUM CHANNELS; HIPPOCAMPAL CA3 NEURONS; GENERAL-ANESTHESIA; INHALED ANESTHETICS; ANGSTROM RESOLUTION; MOLECULAR TARGETS; CRYSTAL-STRUCTURE; BINDING-SITES; GIRK CHANNELS	G protein-activated inwardly rectifying potassium (GIRK or Kir3) channels are directly gated by the beta gamma subunits of G proteins and contribute to inhibitory neurotransmitter signaling pathways. Paradoxically, volatile anesthetics such as halothane inhibit these channels. We find that neuronal Kir3 currents are highly sensitive to inhibition by halothane. Given that Kir3 currents result from increased G beta gamma available to the channels, we asked whether reducing available G beta gamma to the channel would adversely affect halothane inhibition. Remarkably, scavenging G beta gamma using the C-terminal domain of beta-adrenergic receptor kinase (c beta ARK) resulted in channel activation by halothane. Consistent with this effect, channel mutants that impair G beta gamma activation were also activated by halothane. A single residue, phenylalanine 192, occupies the putative G beta gamma gate of neuronal Kir3.2 channels. Mutation of Phe-192 at the gate to other residues rendered the channel non-responsive, either activated or inhibited by halothane. These data indicated that halothane predominantly interferes with G beta gamma-mediated Kir3 currents, such as those functioning during inhibitory synaptic activity. Our report identifies the molecular correlate for anesthetic inhibition of Kir3 channels and highlights the significance of these effects in modulating neurotransmitter-mediated inhibitory signaling.	[Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Jin, Taihao; Logothetis, Diomedes E.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Logothetis, Diomedes E.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, 100 N Acad Ave, Danville, PA 17822 USA.	tmirshahi@geisinger.edu			American Heart Association [0765275U]; Geisinger Clinic	American Heart Association(American Heart Association); Geisinger Clinic	This work was supported, in whole or in part, by American Heart Association-Great Rivers Affiliate Beginning Grant-in-Aid 0765275U and by funds from the Geisinger Clinic (to T. M.).	Andres-Enguix I, 2007, J BIOL CHEM, V282, P20977, DOI 10.1074/jbc.M610692200; Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Blednow YA, 2003, P NATL ACAD SCI USA, V100, P277, DOI 10.1073/pnas.012682399; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chen XD, 2006, P NATL ACAD SCI USA, V103, P3422, DOI 10.1073/pnas.0507710103; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Chiara DC, 2003, BIOCHEMISTRY-US, V42, P13457, DOI 10.1021/bi0351561; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; Eger EI, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_4.S3; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Franks NP, 2006, BRIT J PHARMACOL, V147, pS72, DOI 10.1038/sj.bjp.0706441; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Franks NP, 1998, TOXICOL LETT, V101, P1, DOI 10.1016/S0378-4274(98)00158-1; Goslin K., 1998, CULTURING NERVE CELL, P339; Guy-David L, 2007, NEURON, V55, P537, DOI 10.1016/j.neuron.2007.08.001; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Jelacic TM, 2000, J BIOL CHEM, V275, P36211, DOI 10.1074/jbc.M007087200; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Koyrakh L, 2005, J NEUROSCI, V25, P11468, DOI 10.1523/JNEUROSCI.3484-05.2005; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Lazarenko RM, 2010, J NEUROSCI, V30, P9324, DOI 10.1523/JNEUROSCI.1956-10.2010; Leaney JL, 2003, EUR J NEUROSCI, V18, P2110, DOI 10.1046/j.1460-9568.2003.02933.x; LERMA J, 1986, BRAIN RES, V384, P145, DOI 10.1016/0006-8993(86)91230-8; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lopes CMB, 1998, BRIT J PHARMACOL, V125, P309, DOI 10.1038/sj.bjp.0702069; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, pU7; Marker CL, 2006, J NEUROSCI, V26, P12251, DOI 10.1523/JNEUROSCI.3693-06.2006; Marker CL, 2002, NEUROREPORT, V13, P2509, DOI 10.1097/00001756-200212200-00026; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Milovic S, 2004, J BIOL CHEM, V279, P34240, DOI 10.1074/jbc.M403448200; Minami K, 1998, J BIOL CHEM, V273, P8248, DOI 10.1074/jbc.273.14.8248; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; MIRSHAHI T, 2003, SCI STKE, pPE32; Mitrovic I, 2003, P NATL ACAD SCI USA, V100, P271, DOI 10.1073/pnas.0136822100; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Patel AJ, 1999, NAT NEUROSCI, V2, P422, DOI 10.1038/8084; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Sadja R, 2002, P NATL ACAD SCI USA, V99, P10783, DOI 10.1073/pnas.162346199; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sodickson DL, 1998, J NEUROSCI, V18, P8153; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Torrecilla M, 2002, J NEUROSCI, V22, P4328, DOI 10.1523/JNEUROSCI.22-11-04328.2002; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Weigl LG, 2001, MOL PHARMACOL, V60, P282, DOI 10.1124/mol.60.2.282; Yamakura T, 2001, ANESTHESIOLOGY, V95, P144, DOI 10.1097/00000542-200107000-00025; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	63	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41290	41299		10.1074/jbc.M110.178541	http://dx.doi.org/10.1074/jbc.M110.178541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044958	hybrid, Green Published			2022-12-27	WOS:000285622600014
J	Walther, C; Nagel, S; Gimenez, LE; Morl, K; Gurevich, VV; Beck-Sickinger, AG				Walther, Cornelia; Nagel, Stefanie; Gimenez, Luis E.; Moerl, Karin; Gurevich, Vsevolod V.; Beck-Sickinger, Annette G.			Ligand-induced Internalization and Recycling of the Human Neuropeptide Y-2 Receptor Is Regulated by Its Carboxyl-terminal Tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; RESONANCE ENERGY-TRANSFER; MUSCARINIC ACETYLCHOLINE-RECEPTOR; ACIDIC AMINO-ACIDS; BETA-ARRESTIN; Y-RECEPTORS; C-TERMINUS; PHOSPHORYLATION SITES; DIFFERENTIAL DISTRIBUTION; THREONINE RESIDUES	Agonist-induced internalization of G protein-coupled receptors plays an important role in signal regulation. The underlying mechanisms of the internalization of the human neuropeptide Y-2 receptor (hY(2)R), as well as its desensitization, endocytosis, and resensitization are mainly unknown. In the present study we have investigated the role of carboxyl-terminal (C-terminal) Ser/Thr residues and acidic amino acids in regulating receptor internalization, arrestin interaction, and recycling by fluorescence microscopy, cell surface enzyme-linked immunosorbent assay, and bioluminescence resonance energy transfer in several cell lines. Strikingly, C-terminal truncation mutants revealed two different internalization motifs. Whereas a distal motif (DSXTEXT379)-D-373 was found to be the primary regulatory internalization sequence acting in concert with arrestin-3, the proximal motif (DXXXSEX)-D-347-SXT356 promoted ligand-induced internalization in an arrestin-3-independent manner. Moreover, we identified a regulatory sequence located between these internalization motifs ((357)FKAKKNLEVRKN(368)), which serves as an inhibitory element. We found that hY(2)R recycling is also governed by structural determinants within the proximal internalization motif. In conclusion, these results indicate that the hY(2)R C terminus is involved in multiple molecular events that regulate internalization, interaction with arrestin-3, and receptor resensitization. Our findings provide novel insights into complex mechanisms of controlled internalization of hY(2)R, which is likely applicable to other GPCRs.	[Walther, Cornelia; Nagel, Stefanie; Moerl, Karin; Beck-Sickinger, Annette G.] Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, D-04103 Leipzig, Germany; [Gimenez, Luis E.; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Leipzig University; Vanderbilt University	Beck-Sickinger, AG (corresponding author), Univ Leipzig, Inst Biochem, Fac Biosci Pharm & Psychol, Bruderstr 34, D-04103 Leipzig, Germany.	beck-sickinger@uni-leipzig.de	Gurevich, Vsevolod/A-3236-2008; Gimenez, Luis E Diaz/D-9291-2011	Gurevich, Vsevolod/0000-0002-3950-5351; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [GM081756]; Deutsche Forschungsgemeinschaft [SFB-610/TP-A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM081756 (to V.V.G.) and Deutsche Forschungsgemeinschaft (AGB-S) Grant SFB-610/TP-A1.	BECKSICKINGER AG, 1994, EUR J BIOCHEM, V225, P947, DOI 10.1111/j.1432-1033.1994.0947b.x; Berglund MM, 2003, J PHARMACOL EXP THER, V306, P147, DOI 10.1124/jpet.103.051227; Bohme I, 2008, CELL SIGNAL, V20, P1740, DOI 10.1016/j.cellsig.2008.05.017; Bohme I, 2007, PEPTIDES, V28, P226, DOI 10.1016/j.peptides.2006.08.042; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Brinkmann V, 2009, BRIT J PHARMACOL, V158, P1173, DOI 10.1111/j.1476-5381.2009.00451.x; Cabrele C, 2000, J PEPT SCI, V6, P97, DOI 10.1002/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; DUMONT Y, 1990, EUR J PHARMACOL, V191, P501, DOI 10.1016/0014-2999(90)94189-5; El Bahh B, 2005, EUR J NEUROSCI, V22, P1417, DOI 10.1111/j.1460-9568.2005.04338.x; FLOOD JF, 1989, PEPTIDES, V10, P963, DOI 10.1016/0196-9781(89)90176-9; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Haack M, 2009, CHEM BIOL DRUG DES, V73, P573, DOI 10.1111/j.1747-0285.2009.00823.x; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Hofliger MM, 2003, J RECEPT SIG TRANSD, V23, P351, DOI 10.1081/RRS-120026974; Holliday ND, 2005, MOL PHARMACOL, V67, P655, DOI 10.1124/mol.104.006114; Jala VR, 2005, J BIOL CHEM, V280, P4880, DOI 10.1074/jbc.M409821200; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Karoor V, 1998, J BIOL CHEM, V273, P33035, DOI 10.1074/jbc.273.49.33035; Karra E, 2009, J PHYSIOL-LONDON, V587, P19, DOI 10.1113/jphysiol.2008.164269; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kocan M, 2009, METHODS MOL BIOL, V552, P305, DOI 10.1007/978-1-60327-317-6_22; Korner M, 2007, PEPTIDES, V28, P419, DOI 10.1016/j.peptides.2006.08.037; Krueger KM, 1997, J BIOL CHEM, V272, P5; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Kuravi S, 2010, BIOPHYS J, V98, P2391, DOI 10.1016/j.bpj.2010.02.004; Lee KB, 2000, J BIOL CHEM, V275, P35767, DOI 10.1074/jbc.M002225200; Lee KB, 2000, J BIOL CHEM, V275, P9284, DOI 10.1074/jbc.275.13.9284; Lindner D, 2008, NUTRITION, V24, P907, DOI 10.1016/j.nut.2008.06.025; Lindner D, 2008, BIOCHEMISTRY-US, V47, P5905, DOI 10.1021/bi800181k; Lindner D, 2009, CELL SIGNAL, V21, P61, DOI 10.1016/j.cellsig.2008.09.007; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Merten N, 2007, J BIOL CHEM, V282, P7543, DOI 10.1074/jbc.M608902200; Millar RP, 2010, MOL ENDOCRINOL, V24, P261, DOI 10.1210/me.2009-0473; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Parker E, 2002, EUR J PHARMACOL, V440, P173, DOI 10.1016/S0014-2999(02)01427-9; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Potter RM, 2006, J IMMUNOL, V176, P5418, DOI 10.4049/jimmunol.176.9.5418; PROSSNITZ ER, 1995, J BIOL CHEM, V270, P1130, DOI 10.1074/jbc.270.3.1130; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; Reiner S, 2009, MOL PHARMACOL, V76, P1162, DOI 10.1124/mol.109.060467; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2001, CANCER RES, V61, P4636; Richardson MD, 2003, J NEUROCHEM, V84, P854, DOI 10.1046/j.1471-4159.2003.01577.x; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; SHEIKH SP, 1989, J BIOL CHEM, V264, P6648; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Smith-White MA, 2001, BRIT J PHARMACOL, V132, P861, DOI 10.1038/sj.bjp.0703879; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; Thomas WG, 1998, MOL ENDOCRINOL, V12, P1513, DOI 10.1210/me.12.10.1513; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Whistler JL, 2001, J BIOL CHEM, V276, P34331, DOI 10.1074/jbc.M104627200; WIDDOWSON PS, 1993, BRAIN RES, V631, P27, DOI 10.1016/0006-8993(93)91182-R; Zhang X, 2005, J NEUROCHEM, V95, P169, DOI 10.1111/j.1471-4159.2005.03352.x	76	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41578	41590		10.1074/jbc.M110.162156	http://dx.doi.org/10.1074/jbc.M110.162156			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959467	Green Published, hybrid			2022-12-27	WOS:000285622600045
J	Yan, ZH; Garg, SK; Banerjee, R				Yan, Zhonghua; Garg, Sanjay K.; Banerjee, Ruma			Regulatory T Cells Interfere with Glutathione Metabolism in Dendritic Cells and T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIGEN-PRESENTING CELLS; IMMUNE-RESPONSES; TRYPTOPHAN CATABOLISM; SELF-TOLERANCE; CUTTING EDGE; REDOX; ACTIVATION; LYMPHOCYTES; SUPPRESSION; CYSTEINE	Naturally occurring CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) suppress proliferation of CD4(+)CD25(-) effector T cells (Teffs) by mechanisms that are not well understood. We have previously demonstrated a novel mechanism of Treg suppression, i.e. interference with extracellular redox remodeling that occurs during activation of T cells by dendritic cells. In this study, we demonstrate that Treg-mediated redox perturbation is antigen-dependent but not antigen-specific, is CTLA-4-dependent, and requires cell-cell contact. Furthermore, we show that Tregs use multiple strategies for extracellular redox remodeling, including diminished GSH synthesis in dendritic cells via decreased expression of gamma-glutamylcysteine synthetase, the limiting enzyme for GSH synthesis. Tregs also consume extracellular cysteine and partition it more proficiently to the oxidation product (sulfate), whereas Teffs divert more of the cysteine pool toward protein and GSH synthesis. Tregs appear to block GSH redistribution from the nucleus to the cytoplasm in Teffs, which is abrogated by the addition of exogenous cysteine. Together, these data provide novel insights into modulation of sulfur-based redox metabolism by Tregs, leading to suppression of T cell activation and proliferation.	[Yan, Zhonghua; Garg, Sanjay K.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu			National Institutes of Health [HL58984, DK64959]; NIDDK [5P60 DK20572]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064959, P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL58984 and DK64959. The work performed in the Morphology and Image Analysis Cores of the Michigan Diabetes Research and Training Center was supported by National Institutes of Health Grant 5P60 DK20572 from NIDDK.	Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Castellani P, 2008, EUR J IMMUNOL, V38, P2419, DOI 10.1002/eji.200838439; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Foster DJ, 2009, J NEUROCHEM, V108, P437, DOI 10.1111/j.1471-4159.2008.05773.x; GAJEWSKI TF, 1989, IMMUNOL REV, V111, P79, DOI 10.1111/j.1600-065X.1989.tb00543.x; Garg S. K., 2010, ANTIOXID RE IN PRESS; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Grimble RF, 2006, J NUTR, V136, p1660S, DOI 10.1093/jn/136.6.1660S; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Homann D, 1999, IMMUNITY, V11, P463, DOI 10.1016/S1074-7613(00)80121-1; ISHII T, 1981, J CELL PHYSIOL, V107, P283, DOI 10.1002/jcp.1041070215; ISHII T, 1987, J CELL PHYSIOL, V133, P330, DOI 10.1002/jcp.1041330217; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mahnke K, 2007, CELL IMMUNOL, V250, P1, DOI 10.1016/j.cellimm.2008.01.004; Markovic J, 2007, J BIOL CHEM, V282, P20416, DOI 10.1074/jbc.M609582200; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; MESSINA JP, 1989, J IMMUNOL, V143, P1974; Misra N, 2004, J IMMUNOL, V172, P4676, DOI 10.4049/jimmunol.172.8.4676; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moriarty-Craige SE, 2004, ANNU REV NUTR, V24, P481, DOI 10.1146/annurev.nutr.24.012003.132208; Pallardo FV, 2009, MOL ASPECTS MED, V30, P77, DOI 10.1016/j.mam.2009.01.001; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Sido B, 2000, J EXP MED, V192, P907, DOI 10.1084/jem.192.6.907; Sido B, 2008, GASTROENTEROLOGY, V134, P179, DOI 10.1053/j.gastro.2007.11.001; Staal FJT, 1998, EUR J CLIN INVEST, V28, P194; STIPANUK MH, 1992, J NUTR, V122, P420, DOI 10.1093/jn/122.3.420; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; Szymczak-Workman AL, 2009, J IMMUNOL, V182, P5188, DOI 10.4049/jimmunol.0803123; Tanchot C, 2004, J IMMUNOL, V172, P4285, DOI 10.4049/jimmunol.172.7.4285; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yan ZH, 2010, BIOCHEMISTRY-US, V49, P1059, DOI 10.1021/bi902022n; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Yu P, 2005, J IMMUNOL, V174, P6772, DOI 10.4049/jimmunol.174.11.6772	47	73	73	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41525	41532		10.1074/jbc.M110.189944	http://dx.doi.org/10.1074/jbc.M110.189944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21037289	hybrid, Green Published			2022-12-27	WOS:000285622600039
J	Zhong, XM; Li, N; Liang, S; Huang, QH; Coukos, G; Zhang, L				Zhong, Xiaomin; Li, Ning; Liang, Shun; Huang, Qihong; Coukos, George; Zhang, Lin			Identification of MicroRNAs Regulating Reprogramming Factor LIN28 in Embryonic Stem Cells and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; LET-7 MICRORNA; NUCLEAR EXPORT; PROMOTES TRANSFORMATION; RNA-INTERFERENCE; BINDING PROTEIN; GENE-EXPRESSION; MESSENGER-RNA; SELF-RENEWAL; C-ELEGANS	LIN28 (a homologue of the Caenorhabditis elegans lin-28 gene) is an evolutionarily conserved RNA-binding protein and a master regulator controlling the pluripotency of embryonic stem cells. Together with OCT4, SOX2, and NANOG, LIN28 can reprogram somatic cells, producing induced pluripotent stem cells. Expression of LIN28 is highly restricted to embryonic stem cells and developing tissues. In human tumors, LIN28 is up-regulated and functions as an oncogene promoting malignant transformation and tumor progression. However, the mechanisms of transcriptional and post-transcriptional regulation of LIN28 are still largely unknown. To examine microRNAs (miRNAs) that repress LIN28 expression, a combined in silico prediction and miRNA library screening approach was used in the present study. Four miRNAs directly regulating LIN28 (let-7, mir-125, mir-9, and mir-30) were initially identified by this approach and further validated by quantitative RT-PCR, Western blot analysis, and a LIN28 3 ' UTR reporter assay. We found that expression levels of these four miRNAs were clustered together and inversely correlated with LIN28 expression during embryonic stem cell differentiation. In addition, the expression of these miRNAs was remarkably lower in LIN28-positive tumor cells compared with LIN28-negative tumor cells. Importantly, we demonstrated that these miRNAs were able to regulate the expression and activity of let-7, mediated by LIN28. Taken together, our studies demonstrate that miRNAs let-7, mir-125, mir-9, and mir-30 directly repress LIN28 expression in embryonic stem and cancer cells. Global down-regulation of these miRNAs may be one of the mechanisms of LIN28 reactivation in human cancers.	[Zhang, Lin] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Res Early Detect & Cure Ovarian Canc, Philadelphia, PA 19104 USA; [Coukos, George] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Huang, Qihong] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Zhang, L (corresponding author), Univ Penn, Sch Med, Dept Obstet & Gynecol, Rm 1209 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Coukos, George/ABG-7389-2020; Zhang, Lin/K-8478-2012	Coukos, George/0000-0001-8813-7367	National Institutes of Health, NCI [R01CA142776]; Ovarian Cancer SPORE [P50-CA83638-7951]; Breast Cancer Alliance; Mary Kay Ash Charitable Foundation; United States Department of Defense [W81XWH-10-1-0082]; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA142776, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer SPORE; Breast Cancer Alliance; Mary Kay Ash Charitable Foundation; United States Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant R01CA142776 and Ovarian Cancer SPORE P50-CA83638-7951 Project 3. This work was also supported in part by grants from the Breast Cancer Alliance, the Ovarian Cancer Research Fund (Liz Tilberis Scholar), and the Mary Kay Ash Charitable Foundation and by United States Department of Defense Grant W81XWH-10-1-0082.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darr H, 2009, STEM CELLS, V27, P352, DOI 10.1634/stemcells.2008-0720; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	84	131	147	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41961	41971		10.1074/jbc.M110.169607	http://dx.doi.org/10.1074/jbc.M110.169607			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20947512	Green Published, hybrid			2022-12-27	WOS:000285622600082
J	Eto, K; Noda, Y; Horikawa, S; Uchida, S; Sasaki, S				Eto, Kayoko; Noda, Yumi; Horikawa, Saburo; Uchida, Shinichi; Sasaki, Sei			Phosphorylation of Aquaporin-2 Regulates Its Water Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL AQUAPORIN-2; COLLECTING DUCT; TRAFFICKING; KIDNEY; VESICLES; ACTIN; AQP2; PATHOPHYSIOLOGY; IDENTIFICATION; SERINE-261	Vasopressin-regulated water reabsorption through the water channel aquaporin-2 (AQP2) in renal collecting ducts maintains body water homeostasis. Vasopressin activates PKA, which phosphorylates AQP2, and this phosphorylation event is required to increase the water permeability and water reabsorption of the collecting duct cells. It has been established that the phosphorylation of AQP2 induces its apical membrane insertion, rendering the cell water-permeable. However, whether this phosphorylation regulates the water permeability of this channel still remains unclear. To clarify the role of AQP2 phosphorylation in water permeability, we expressed recombinant human AQP2 in Escherichia coli, purified it, and reconstituted it into proteoliposomes. AQP2 proteins not reconstituted into liposomes were removed by fractionating on density step gradients. AQP2-reconstituted liposomes were then extruded through polycarbonate filters to obtain unilamellar vesicles. PKA phosphorylation significantly increased the osmotic water permeability of AQP2-reconstituted liposomes. We then examined the roles of AQP2 phosphorylation at Ser-256 and Ser-261 in the regulation of water permeability using phosphorylation mutants reconstituted into proteoliposomes. The water permeability of the non-phosphorylation-mimicking mutant S256A-AQP2 and non-phosphorylated WT-AQP2 was similar, and that of the phosphorylation-mimicking mutant S256D-AQP2 and phosphorylated WT-AQP2 was similar. The water permeability of S261A-AQP2 and S261D-AQP2 was similar to that of non-phosphorylated WT-AQP2. This study shows that PKA phosphorylation of AQP2 at Ser-256 enhances its water permeability.	[Noda, Yumi] Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo 1138519, Japan; [Horikawa, Saburo] Tokyo Med & Dent Univ, Div Pathophysiol, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Noda, Y (corresponding author), Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ynodmed2@tmd.ac.jp	Uchida, Shinichi/D-1111-2013		Japan Society for the Promotion of Science [17GS0312, 21591053]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid 17GS0312 and 21591053 from the Japan Society for the Promotion of Science.	Boone M, 2008, PFLUG ARCH EUR J PHY, V456, P1005, DOI 10.1007/s00424-008-0498-1; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Christensen BM, 2000, AM J PHYSIOL-RENAL, V278, pF29, DOI 10.1152/ajprenal.2000.278.1.F29; Fischer G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000130; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; Hedfalk K, 2006, CURR OPIN STRUC BIOL, V16, P447, DOI 10.1016/j.sbi.2006.06.009; Higashimoto Y, 2000, J BIOL CHEM, V275, P23199, DOI 10.1074/jbc.M002674200; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Hoffert JD, 2007, AM J PHYSIOL-RENAL, V292, pF691, DOI 10.1152/ajprenal.00284.2006; Hoffert JD, 2009, J BIOL CHEM, V284, P14683, DOI 10.1074/jbc.R900006200; Hoffert JD, 2006, P NATL ACAD SCI USA, V103, P7159, DOI 10.1073/pnas.0600895103; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lande MB, 1996, J BIOL CHEM, V271, P5552, DOI 10.1074/jbc.271.10.5552; Li YH, 2009, INT J BIOCHEM CELL B, V41, P2466, DOI 10.1016/j.biocel.2009.07.017; Loonen AJM, 2008, SEMIN NEPHROL, V28, P252, DOI 10.1016/j.semnephrol.2008.03.006; Lu HJ, 2008, AM J PHYSIOL-RENAL, V295, pF290, DOI 10.1152/ajprenal.00072.2008; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nishimoto G, 1999, AM J PHYSIOL-RENAL, V276, pF254, DOI 10.1152/ajprenal.1999.276.2.F254; Noda Y, 2005, BIOCHEM BIOPH RES CO, V330, P1041, DOI 10.1016/j.bbrc.2005.03.079; Noda Y, 2004, BIOCHEM BIOPH RES CO, V322, P740, DOI 10.1016/j.bbrc.2004.07.195; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Noda Y, 2008, J CELL BIOL, V182, P587, DOI 10.1083/jcb.200709177; Noda Y, 2008, PFLUG ARCH EUR J PHY, V456, P737, DOI 10.1007/s00424-007-0404-2; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Noda Y, 2010, NAT REV NEPHROL, V6, P168, DOI 10.1038/nrneph.2009.231; Nyblom M, 2009, J MOL BIOL, V387, P653, DOI 10.1016/j.jmb.2009.01.065; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Xie LK, 2010, AM J PHYSIOL-RENAL, V298, pF1018, DOI 10.1152/ajprenal.00580.2009; Yamashita Y, 2000, AM J PHYSIOL-RENAL, V278, pF395, DOI 10.1152/ajprenal.2000.278.3.F395; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001	36	56	57	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40777	40784		10.1074/jbc.M110.151928	http://dx.doi.org/10.1074/jbc.M110.151928			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971851	Green Published, hybrid			2022-12-27	WOS:000285414400042
J	Su, V; Nakagawa, R; Koval, M; Lau, AF				Su, Vivian; Nakagawa, Reid; Koval, Michael; Lau, Alan F.			Ubiquitin-independent Proteasomal Degradation of Endoplasmic Reticulum-localized Connexin43 Mediated by CIP75	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; DAMAGE-INDUCIBLE PROTEINS; CARDIAC MYOCYTES; ORNITHINE DECARBOXYLASE; POLYUBIQUITIN CHAINS; UBA DOMAINS; INTERCELLULAR COMMUNICATION; DEPENDENT DEGRADATION; P53 DEGRADATION; 26S PROTEASOME	Connexin43 (Cx43) is a transmembrane protein that forms gap junction channels. Regulation of Cx43 turnover is one mechanism to control the level of intercellular communication that occurs through gap junction channels. Proteasomal degradation of Cx43 is regulated in part through CIP75, a ubiquitin-like and ubiquitin-associated domain containing protein. CIP75 interacts with endoplasmic reticulum-localized Cx43, as demonstrated through co-immunoprecipitation and immunofluorescence microscopy experiments. CIP75 also binds to free monoubiquitin and lysine 48-linked tetraubiquitin chains in vitro and binds to ubiquitinated proteins in cellular lysates. However, analysis of Cx43 that immunoprecipitated with CIP75 demonstrated that the Cx43 associated with CIP75 was not ubiquitinated, and a mutant form of Cx43 that lacked lysines capable of ubiquitination retained the capacity to interact with CIP75. These results suggest that although CIP75 can interact with ubiquitinated cellular proteins, its interaction with Cx43 and stimulation of Cx43 proteasomal degradation does not require the ubiquitination of Cx43.	[Su, Vivian; Nakagawa, Reid; Lau, Alan F.] Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, Honolulu, HI 96813 USA; [Koval, Michael] Emory Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Lau, Alan F.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; Emory University; Emory University; University of Hawaii System; University of Hawaii Manoa	Lau, AF (corresponding author), Canc Res Ctr Hawaii, Nat Prod & Canc Biol Program, 651 Ilalo St,BSB 222L, Honolulu, HI 96813 USA.	aflau@crch.hawaii.edu	Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614	National Institutes of shuttle, NCI [CA052098]; NATIONAL CANCER INSTITUTE [R01CA052098] Funding Source: NIH RePORTER	National Institutes of shuttle, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of shuttle or an adaptor protein to bring target substrates to the Health, NCI, Grant CA052098 (to A. F. L.).	Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Brignone C, 2004, ONCOGENE, V23, P4121, DOI 10.1038/sj.onc.1207540; Bruce AF, 2008, CARDIOVASC RES, V77, P757, DOI 10.1093/cvr/cvm083; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Das Sarma J, 2002, J BIOL CHEM, V277, P20911, DOI 10.1074/jbc.M111498200; Das S, 2009, MOL BIOL CELL, V20, P2593, DOI 10.1091/mbc.E08-07-0790; Duffy HS, 2004, CIRC RES, V94, P215, DOI 10.1161/01.RES.0000113924.06926.11; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Girao H, 2003, MOL VIS, V9, P24; GLASS JR, 1987, J CELL PHYSIOL, V130, P133, DOI 10.1002/jcp.1041300119; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Goh Amanda M., 2008, BMC Biochemistry, V9, P4, DOI 10.1186/1471-2091-9-4; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kieken F, 2010, J BIOMOL NMR, V46, P245, DOI 10.1007/s10858-010-9397-9; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; Laird DW, 2008, J BIOL CHEM, V283, P2997, DOI 10.1074/jbc.R700041200; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Li XL, 2008, J BIOL CHEM, V283, P5748, DOI 10.1074/jbc.M709288200; Martin PEM, 2004, CARDIOVASC RES, V62, P378, DOI 10.1016/j.cardiores.2004.01.016; Maza J, 2005, J BIOL CHEM, V280, P21115, DOI 10.1074/jbc.M412612200; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Rutz ML, 2001, EUR J CELL BIOL, V80, P20, DOI 10.1078/0171-9335-00140; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Su V, 2009, HYBRIDOMA, V28, P79, DOI 10.1089/hyb.2008.0082; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Verma R, 2000, CELL, V101, P341, DOI 10.1016/S0092-8674(00)80843-0; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang D, 2008, J MOL BIOL, V377, P162, DOI 10.1016/j.jmb.2007.12.029	76	42	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40979	40990		10.1074/jbc.M110.170753	http://dx.doi.org/10.1074/jbc.M110.170753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940304	Green Published, hybrid			2022-12-27	WOS:000285414400061
J	Aquilini, E; Azevedo, J; Merino, S; Jimenez, N; Tomas, JM; Regue, M				Aquilini, Eleonora; Azevedo, Joana; Merino, Susana; Jimenez, Natalia; Tomas, Juan M.; Regue, Miguel			Three Enzymatic Steps Required for the Galactosamine Incorporation into Core Lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; PROTEUS-MIRABILIS; POLYACRYLAMIDE GELS; REGION; OLIGOSACCHARIDE; BIOSYNTHESIS; GENE; IDENTIFICATION; INFECTION	The core lipopolysaccharides (LPS) of Proteus mirabilis as well as those of Klebsiella pneumoniae and Serratia marcescens are characterized by the presence of a hexosamine-galacturonic acid disaccharide (alpha HexN-(1,4)-alpha GalA) attached by an alpha 1,3 linkage to L-glycero-D-manno-heptopyranose II (L-glycero-alpha-D-manno-heptosepyranose II). In K. pneumoniae, S. marcescens, and some P. mirabilis strains, HexN is D-glucosamine, whereas in other P. mirabilis strains, it corresponds to D-galactosamine. Previously, we have shown that two enzymes are required for the incorporation of D-glucosamine into the core LPS of K. pneumoniae; the WabH enzyme catalyzes the incorporation of GlcNAc from UDP-GlcNAc to outer core LPS, and WabN catalyzes the deacetylation of the incorporated GlcNAc. Here we report the presence of two different HexNAc transferases depending on the nature of the HexN in P. mirabilis core LPS. In vivo and in vitro assays using LPS truncated at the level of galacturonic acid as acceptor show that these two enzymes differ in their specificity for the transfer of GlcNAc or GalNAc. By contrast, only one WabN homologue was found in the studied P. mirabilis strains. Similar assays suggest that the P. mirabilis WabN homologue is able to deacetylate both GlcNAc and GalNAc. We conclude that incorporation of D-galactosamine requires three enzymes: Gne epimerase for the generation of UDP-GalNAc from UDP-GlcNAc, N-acetylgalactosaminyltransferase (WabP), and LPS: HexNAc deacetylase.	[Merino, Susana; Jimenez, Natalia; Tomas, Juan M.] Univ Barcelona, Dept Microbiol, Fac Biol, E-08071 Barcelona, Spain; [Aquilini, Eleonora; Azevedo, Joana; Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Dept Microbiol, Fac Biol, E-08071 Barcelona, Spain.	jtomas@ub.edu	Aquilini, Eleonora/AAD-4741-2019; Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Aquilini, Eleonora/0000-0001-7545-7863; Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259; Jimenez, Natalia/0000-0002-7057-0426; Marques, Joana/0000-0003-1827-2912	Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain; Generalitat de Catalunya (Centre de Referencia en Biotecnologia); Generalitat de Catalunya	Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain(Spanish Government); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D + i and Fondo de Investigaciones Sanitarias grants (Ministerio de Educacion, Ciencia y Deporte, and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia).; Recipient of a predoctoral fellowship from Generalitat de Catalunya.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amor K, 2000, INFECT IMMUN, V68, P1116, DOI 10.1128/IAI.68.3.1116-1124.2000; Aquilini E, 2010, J BACTERIOL, V192, P4413, DOI 10.1128/JB.00494-10; Belas Robert, 1996, P271; BOITEUX S, 1987, EMBO J, V6, P3177, DOI 10.1002/j.1460-2075.1987.tb02629.x; Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06; Coderch N, 2004, J BACTERIOL, V186, P978, DOI 10.1128/JB.186.4.978-988.2004; FAIRLEY KF, 1971, LANCET, V2, P615; Frirdich E, 2004, J BIOL CHEM, V279, P27928, DOI 10.1074/jbc.M402549200; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Geerlof A, 1999, J BIOL CHEM, V274, P27105, DOI 10.1074/jbc.274.38.27105; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Knirel YA, 1999, POL J CHEM, V73, P895; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LARSSON P, 1984, METHOD MICROBIOL, V14, P187, DOI 10.1016/S0580-9517(08)70451-3; Miller J. H., 1972, EXPT MOL GENETICS, P433; NASSIF X, 1989, INFECT IMMUN, V57, P546, DOI 10.1128/IAI.57.2.546-552.1989; Olsthoorn MMA, 1999, J MASS SPECTROM, V34, P622, DOI 10.1002/(SICI)1096-9888(199906)34:6<622::AID-JMS814>3.3.CO;2-M; Pearson MM, 2008, J BACTERIOL, V190, P4027, DOI 10.1128/JB.01981-07; PENNER JL, 1980, J CLIN MICROBIOL, V12, P304, DOI 10.1128/JCM.12.3.304-309.1980; PRADEL E, 1991, J BACTERIOL, V173, P6428, DOI 10.1128/jb.173.20.6428-6431.1991; Rashid T, 2007, CLIN RHEUMATOL, V26, P1036, DOI 10.1007/s10067-006-0491-z; Regue M, 2005, J BIOL CHEM, V280, P36648, DOI 10.1074/jbc.M506278200; Regue M, 2005, J BACTERIOL, V187, P4198, DOI 10.1128/JB.187.12.4198-4206.2005; Regue M, 2001, J BACTERIOL, V183, P3564, DOI 10.1128/JB.183.12.3564-3573.2001; RUBIN RH, 1986, KIDNEY, P1085; Sambrook J., 2002, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, AUST J CHEM, V55, P61, DOI 10.1071/CH01184; Vinogradov E, 2001, CARBOHYD RES, V335, P291, DOI 10.1016/S0008-6215(01)00216-6; Wang QA, 2010, APPL ENVIRON MICROB, V76, P5471, DOI 10.1128/AEM.02946-09; WARREN JW, 1991, MED CLIN N AM, V75, P481, DOI 10.1016/S0025-7125(16)30465-5; WARREN JW, 1988, J INFECT DIS, V158, P1341, DOI 10.1093/infdis/158.6.1341; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zych K, 2000, ADV EXP MED BIOL, V485, P339	38	5	5	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39739	39749		10.1074/jbc.M110.168385	http://dx.doi.org/10.1074/jbc.M110.168385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959463	hybrid, Green Published			2022-12-27	WOS:000285185500018
J	Evankovich, J; Cho, SW; Zhang, RL; Cardinal, J; Dhupar, R; Zhang, LM; Klune, JR; Zlotnicki, J; Billiar, T; Tsung, A				Evankovich, John; Cho, Sung W.; Zhang, Ruilin; Cardinal, Jon; Dhupar, Rajeev; Zhang, Lemeng; Klune, John R.; Zlotnicki, Jason; Billiar, Timothy; Tsung, Allan			High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN PROTEIN HMGB1; INHIBITOR TRICHOSTATIN-A; GLYCATION END-PRODUCTS; LIVER ISCHEMIA; RAT HEPATOCYTES; CELL-ACTIVATION; HEPATOMA-CELLS; NUCLEAR IMPORT; ACIDIC TAIL; IN-VITRO	The mobilization and extracellular release of nuclear high mobility group box-1 (HMGB1) by ischemic cells activates inflammatory pathways following liver ischemia/reperfusion (I/R) injury. In immune cells such as macrophages, post-translational modification by acetylation appears to be critical for active HMGB1 release. Hyperacetylation shifts its equilibrium from a predominant nuclear location toward cytosolic accumulation and subsequent release. However, mechanisms governing its release by parenchymal cells such as hepatocytes are unknown. In this study, we found that serum HMGB1 released following liver I/R in vivo is acetylated, and that hepatocytes exposed to oxidative stress in vitro also released acetylated HMGB1. Histone deacetylases (HDACs) are a family of enzymes that remove acetyl groups and control the acetylation status of histones and various intracellular proteins. Levels of acetylated HMGB1 increased with a concomitant decrease in total nuclear HDAC activity, suggesting that suppression in HDAC activity contributes to the increase in acetylated HMGB1 release after oxidative stress in hepatocytes. We identified the isoforms HDAC1 and HDAC4 as critical in regulating acetylated HMGB1 release. Activation of HDAC1 was decreased in the nucleus of hepatocytes undergoing oxidative stress. In addition, HDAC1 knockdown with siRNA promoted HMGB1 translocation and release. Furthermore, we demonstrate that HDAC4 is shuttled from the nucleus to cytoplasm in response to oxidative stress, resulting in decreased HDAC activity in the nucleus. Together, these findings suggest that decreased nuclear HDAC1 and HDAC4 activities in hepatocytes following liver I/R is a mechanism that promotes the hyperacetylation and subsequent release of HMGB1.	[Evankovich, John; Cho, Sung W.; Zhang, Ruilin; Cardinal, Jon; Dhupar, Rajeev; Zhang, Lemeng; Klune, John R.; Zlotnicki, Jason; Billiar, Timothy; Tsung, Allan] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tsung, A (corresponding author), Univ Pittsburgh, Dept Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	tsunga@upmc.edu			National Institutes of Health [R01-GM50441]; Howard Hughes Medical Institute; American College of Surgeons; Association for Academic Surgery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American College of Surgeons; Association for Academic Surgery Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50441 (to T. B.), Howard Hughes Medical Institute Physician-Scientist Award (to A. T.), American College of Surgeons Research Fellowship (to A. T.), Association for Academic Surgery Foundation Research Fellowship (to S. W. C.), and Howard Hughes Medical Institute Research Training for Medical Student Fellowship (to J. E.).	Armeanu S, 2005, J HEPATOL, V42, P210, DOI 10.1016/j.jhep.2004.10.020; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; BUSTIN M, 1978, J BIOL CHEM, V253, P1694; Carlisi D, 2008, INT J ONCOL, V32, P177; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; FUJII K, 2009, CELL PROLIF; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Henkens T, 2007, TOXICOL APPL PHARM, V218, P64, DOI 10.1016/j.taap.2006.10.012; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Oh YJ, 2009, J IMMUNOL, V182, P5800, DOI 10.4049/jimmunol.0801873; Papeleu P, 2003, J HEPATOL, V39, P374, DOI 10.1016/S0168-8278(03)00288-5; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Semino C, 2005, BLOOD, V106, P609, DOI 10.1182/blood-2004-10-3906; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; STERNER R, 1979, J BIOL CHEM, V254, P1577; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Topalova D, 2008, INT J BIOCHEM CELL B, V40, P1536, DOI 10.1016/j.biocel.2007.11.014; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Tsung A, 2006, AM J PHYSIOL-GASTR L, V290, pG1261, DOI 10.1152/ajpgi.00460.2005; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vanhaecke T, 2004, BIOCHEM PHARMACOL, V68, P753, DOI 10.1016/j.bcp.2004.05.022; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WEST MA, 1989, GASTROENTEROLOGY, V96, P1572, DOI 10.1016/0016-5085(89)90529-5; Xu H, 2010, J IMMUNOL, V184, P1492, DOI 10.4049/jimmunol.0902660; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang XH, 2008, J IMMUNOL, V181, P5015, DOI 10.4049/jimmunol.181.7.5015	45	189	197	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39888	39897		10.1074/jbc.M110.128348	http://dx.doi.org/10.1074/jbc.M110.128348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937823	hybrid, Green Published			2022-12-27	WOS:000285185500033
J	van der Velden, LM; Wichers, CGK; van Breevoort, AED; Coleman, JA; Molday, RS; Berger, R; Klomp, LWJ; van de Graaf, SFJ				van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Coleman, Jonathan A.; Molday, Robert S.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.			Heteromeric Interactions Required for Abundance and Subcellular Localization of Human CDC50 Proteins and Class 1 P-4-ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; INTRAHEPATIC CHOLESTASIS TYPE-1; YEAST PLASMA-MEMBRANE; PHOSPHOLIPID TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSPORT; HEREDITARY CHOLESTASIS; BETA-SUBUNITS; EXPRESSION; DRS2P	Members of the P-4 family of P-type ATPases (P-4-ATPases) are believed to function as phospholipid flippases in complex with CDC50 proteins. Mutations in the human class 1 P-4-ATPase gene ATP8B1 cause a severe syndrome characterized by impaired bile flow (intrahepatic cholestasis), often leading to end-stage liver failure in childhood. In this study, we determined the specificity of human class 1 P-4-ATPase interactions with CDC50 proteins and the functional consequences of these interactions on protein abundance and localization of both protein classes. ATP8B1 and ATP8B2 co-immunoprecipitated with CDC50A and CDC50B, whereas ATP8B4, ATP8A1, and ATP8A2 associated only with CDC50A. ATP8B1 shifted from the endoplasmic reticulum (ER) to the plasma membrane upon coexpression of CDC50A or CDC50B. ATP8A1 and ATP8A2 translocated from the ER to the Golgi complex and plasma membrane upon coexpression of CDC50A, but not CDC50B. ATP8B2 and ATP8B4 already displayed partial plasma membrane localization in the absence of CDC50 coexpression but displayed a large increase in plasma membrane abundance upon coexpression of CDC50A. ATP8B3 did not bind CDC50A and CDC50B and was invariably present in the ER. Our data show that interactions between CDC50 proteins and class 1 P-4-ATPases are essential for ER exit and stability of both subunits. Furthermore, the subcellular localization of the complex is determined by the P-4-ATPase, not the CDC50 protein. The interactions of CDC50A and CDC50B with multiple members of the human P-4-ATPase family suggest that these proteins perform broader functions in human physiology than thus far assumed.	[van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.] UMC Utrecht, Dept Metab & Endocrine Dis, NL-3508 AB Utrecht, Netherlands; [van der Velden, Lieke M.; Wichers, Catharina G. K.; van Breevoort, Adriana E. D.; Berger, Ruud; Klomp, Leo W. J.; van de Graaf, Stan F. J.] Netherlands Metabol Ctr, NL-3508 AB Utrecht, Netherlands; [Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Ophthalmol & Visual Sci, Vancouver, BC V6T IZ3, Canada; [Coleman, Jonathan A.; Molday, Robert S.] Univ British Columbia, Ctr Macular Res, Dept Biochem & Mol Biol, Vancouver, BC V6T IZ3, Canada	Utrecht University; Utrecht University Medical Center; University of British Columbia; University of British Columbia	van de Graaf, SFJ (corresponding author), UMC Utrecht, Dept Metab & Endocrine Dis, KC 02-069-1,POB 85090, NL-3508 AB Utrecht, Netherlands.	s.vandegraaf-4@umcutrecht.nl		Coleman, Jonathan/0000-0003-0001-6195; van de Graaf, Stan/0000-0003-4238-4359	Netherlands Organization for Scientific Research (NWO) [016.096.108]; Wilhelmina Children's Foundation; Utrecht University; Dutch Digestive Disease Foundation	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Wilhelmina Children's Foundation; Utrecht University; Dutch Digestive Disease Foundation	This work was supported by Netherlands Organization for Scientific Research (NWO) SFJvdG Project 016.096.108 and by the Wilhelmina Children's Foundation, the Utrecht University High Potential Program, and the Dutch Digestive Disease Foundation (to L.W.J.K.).	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Farge E, 1999, AM J PHYSIOL-CELL PH, V276, pC725, DOI 10.1152/ajpcell.1999.276.3.C725; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Gong EY, 2009, REPRODUCTION, V137, P345, DOI 10.1530/REP-08-0048; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Halleck MS, 1998, GENOME RES, V8, P354, DOI 10.1101/gr.8.4.354; Halleck MS, 1999, PHYSIOL GENOMICS, V1, P139, DOI 10.1152/physiolgenomics.1999.1.3.139; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Knisely AS, 1997, ARCH DIS CHILD, V77, P276, DOI 10.1136/adc.77.3.276; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Lykavieris P, 2003, J HEPATOL, V39, P447, DOI 10.1016/S0168-8278(03)00286-1; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Noji T, 2006, BIOCHEM BIOPH RES CO, V344, P323, DOI 10.1016/j.bbrc.2006.03.095; Osada N, 2007, GENE, V392, P151, DOI 10.1016/j.gene.2006.11.021; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Radji M, 2001, YEAST, V18, P195, DOI 10.1002/1097-0061(200102)18:3<195::AID-YEA660>3.0.CO;2-L; Ruaud AF, 2009, TRAFFIC, V10, P88, DOI 10.1111/j.1600-0854.2008.00844.x; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	37	83	91	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40088	40096		10.1074/jbc.M110.139006	http://dx.doi.org/10.1074/jbc.M110.139006			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947505	Green Published, hybrid			2022-12-27	WOS:000285185500054
J	Diebold, ML; Loeliger, E; Koch, M; Winston, F; Cavarelli, J; Romier, C				Diebold, Marie-Laure; Loeliger, Erin; Koch, Michael; Winston, Fred; Cavarelli, Jean; Romier, Christophe			Noncanonical Tandem SH2 Enables Interaction of Elongation Factor Spt6 with RNA Polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; IN-VIVO; CHROMATIN-STRUCTURE; PROTEIN COMPLEXES; CRYSTAL-STRUCTURE; DOMAIN; YEAST; GENE; BINDING	Src homology 2 (SH2) domains are mostly found in multicellular organisms where they recognize phosphotyrosine-containing signaling proteins. Spt6, a conserved transcription factor and putative histone chaperone, contains a C-terminal SH2 domain conserved from yeast to human. In mammals, this SH2 domain recognizes phosphoserines rather than phosphotyrosines and is essential for the recruitment of Spt6 by elongating RNA polymerase II (RNAPII), enabling Spt6 to participate in the coupling of transcription elongation, chromatin modulation, and mRNA export. We have determined the structure of the entire Spt6 C-terminal region from Antonospora locustae, revealing the presence of two highly conserved tandem SH2 domains rather than a single SH2 domain. Although the first SH2 domain has a canonical organization, the second SH2 domain is highly noncanonical and appears to be unique in the SH2 family. However, both SH2 domains have phosphate-binding determinants. Our biochemical and genetic data demonstrate that the complete tandem, but not the individual SH2 domains, are necessary and sufficient for the interaction of Spt6 with RNAPII and are important for Spt6 function in vivo. Furthermore, our data suggest that binding of RNAPII to the Spt6 tandem SH2 is more extensive than the mere recognition of a doubly phosphorylated C-terminal domain peptide by the tandem SH2. Taken together, our results show that Spt6 interaction with RNAPII via a novel arrangement of canonical and noncanonical SH2 domains is crucial for Spt6 function in vivo.	Univ Strasbourg, CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire,Dept Biol & Ge, F-67404 Illkirch Graffenstaden, France; [Loeliger, Erin; Winston, Fred] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School		romier@igbmc.fr	Cavarelli, Jean/P-3566-2016	Cavarelli, Jean/0000-0001-8620-8723; Romier, Christophe/0000-0002-3680-935X; Diebold-Durand, Marie-Laure/0000-0002-2061-9260	National Institutes of Health [GM32967]; CNRS; INSERM; Universite de Strasbourg; European Commission [LSHG-CT-2006-031220]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032967, T32GM007753, R01GM032967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32967. This work was also supported by the CNRS, INSERM, the Universite de Strasbourg, and the European Commission SPINE2-Complexes Contract LSHG-CT-2006-031220.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bae JH, 2009, CELL, V138, P514, DOI 10.1016/j.cell.2009.05.028; Besse Sylvie, 1995, Gene Expression, V4, P143; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; CCP4, 1994, ACTA CRYSTALLOGR D, V50, P760; Chapman RD, 2008, TRENDS GENET, V24, P289, DOI 10.1016/j.tig.2008.03.010; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Fischbeck JA, 2002, GENETICS, V162, P1605; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu ZG, 2007, BIOCHEM BIOPH RES CO, V353, P47, DOI 10.1016/j.bbrc.2006.11.133; MACLENNAN AJ, 1993, TRENDS BIOCHEM SCI, V18, P464; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; NEIGEBORN L, 1987, MOL CELL BIOL, V7, P672, DOI 10.1128/MCB.7.2.672; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Rose M, 1990, LAB COURSE MANUAL ME; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SERAPHIN B, 1989, CELL, V59, P349, DOI 10.1016/0092-8674(89)90296-1; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WINSTON F, 1984, GENETICS, V107, P179; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	55	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38389	38398		10.1074/jbc.M110.146696	http://dx.doi.org/10.1074/jbc.M110.146696			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926373	hybrid, Green Published			2022-12-27	WOS:000284625600045
J	Ikeda, H; Miyatake, M; Koshikawa, N; Ochiai, K; Yamada, K; Kiss, A; Donlin, MJ; Panneton, WM; Churchill, JD; Green, M; Siddiqui, AM; Leinweber, AL; Crews, NR; Ezerskiy, LA; Rendell, VR; Belcheva, MM; Coscia, CJ				Ikeda, Hiroko; Miyatake, Mayumi; Koshikawa, Noriaki; Ochiai, Kuniyasu; Yamada, Kiyoshi; Kiss, Alexi; Donlin, Maureen J.; Panneton, W. Michael; Churchill, James D.; Green, Michael; Siddiqui, Akbar M.; Leinweber, Andrew L.; Crews, Nicholas R.; Ezerskiy, Lubov A.; Rendell, Victoria R.; Belcheva, Mariana M.; Coscia, Carmine J.			Morphine Modulation of Thrombospondin Levels in Astrocytes and Its Implications for Neurite Outgrowth and Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; MU-OPIOID-RECEPTORS; C6 GLIOMA-CELLS; PRIMARY ASTROGLIAL CULTURES; NUCLEUS-ACCUMBENS SHELL; DENDRITIC SPINES; GENE-EXPRESSION; GLIAL-CELLS	Opioid receptor signaling via EGF receptor (EGFR) transactivation and ERK/MAPK phosphorylation initiates diverse cellular responses that are cell type-dependent. In astrocytes, multiple mu opioid receptor-mediated mechanisms of ERK activation exist that are temporally distinctive and feature different outcomes. Upon discovering that chronic opiate treatment of rats down-regulates thrombospondin 1 (TSP1) expression in the nucleus accumbens and cortex, we investigated the mechanism of action of this modulation in astrocytes. TSP1 is synthesized in astrocytes and is released into the extracellular matrix where it is known to play a role in synapse formation and neurite outgrowth. Acute morphine (hours) reduced TSP1 levels in astrocytes. Chronic (days) opioids repressed TSP1 gene expression and reduced its protein levels by mu opioid receptor and ERK-dependent mechanisms in astrocytes. Morphine also depleted TSP1 levels stimulated by TGF beta 1 and abolished ERK activation induced by this factor. Chronic morphine treatment of astrocyte-neuron co-cultures reduced neurite outgrowth and synapse formation. Therefore, inhibitory actions of morphine were detected after both acute and chronic treatments. An acute mechanism of morphine signaling to ERK that entails depletion of TSP1 levels was suggested by inhibition of morphine activation of ERK by a function-blocking TSP1 antibody. This raises the novel possibility that acute morphine uses TSP1 as a source of EGF-like ligands to activate EGFR. Chronic morphine inhibition of TSP1 is reminiscent of the negative effect of mu opioids on EGFR-induced astrocyte proliferation via a phospho-ERK feedback inhibition mechanism. Both of these variations of classical EGFR transactivation may enable opiates to diminish neurite outgrowth and synapse formation.	[Ikeda, Hiroko; Miyatake, Mayumi; Kiss, Alexi; Donlin, Maureen J.; Leinweber, Andrew L.; Crews, Nicholas R.; Ezerskiy, Lubov A.; Rendell, Victoria R.; Belcheva, Mariana M.; Coscia, Carmine J.] St Louis Univ, EA Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Ikeda, Hiroko; Koshikawa, Noriaki] Nihon Univ, Sch Dent, Dept Pharmacol, Tokyo 1018310, Japan; [Ochiai, Kuniyasu; Yamada, Kiyoshi] Nihon Univ, Sch Dent, Dept Microbiol, Tokyo 1018310, Japan	Saint Louis University; Nihon University; Nihon University	Coscia, CJ (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	cosciacc@slu.edu	Kiss, Alexi/AAH-6830-2021; Donlin, Maureen J./M-4709-2019	Ezerskiy, Lubov/0000-0002-1869-0658; Kiss, Alexi/0000-0003-2330-6929; Donlin, Maureen/0000-0001-7312-079X	National Institutes of Health [DA-005412]; Nihon University; Ministry of Education, Culture, Sports, Science and Technology; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005412, F32DA005412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nihon University; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-005412 (to C. J. C.). This work was also supported by individual research grant from Nihon University and a grant for promotion of multidisciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology (to H. I.).	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Ammon-Treiber S, 2005, ADDICT BIOL, V10, P81, DOI 10.1080/13556210412331308994; BARG J, 1991, PEPTIDES, V12, P845, DOI 10.1016/0196-9781(91)90144-E; BARG J, 1994, J NEUROSCI, V14, P5858; Barker AJ, 2008, J NEUROSCI, V28, P8150, DOI 10.1523/JNEUROSCI.1744-08.2008; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Belcheva MM, 2005, J BIOL CHEM, V280, P27662, DOI 10.1074/jbc.M502593200; Blondel O, 2000, J NEUROSCI, V20, P8012; Bohn LM, 2000, J NEUROCHEM, V74, P564, DOI 10.1046/j.1471-4159.2000.740564.x; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Dibrov A, 2006, GROWTH FACTORS, V24, P1, DOI 10.1080/08977190500365995; ERIKSSON PS, 1991, NEUROPHARMACOLOGY, V30, P1233, DOI 10.1016/0028-3908(91)90170-G; ERIKSSON PS, 1990, NEUROCHEM RES, V15, P1123, DOI 10.1007/BF01101714; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Gurwell JA, 1996, BRAIN RES, V737, P175, DOI 10.1016/0006-8993(96)00728-7; Hansson E, 2003, FASEB J, V17, P341, DOI 10.1096/fj.02-0429rev; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hauser KF, 1998, PERSPECT DEV NEUROBI, V5, P437; HAUSER KF, 1987, BRAIN RES, V416, P157, DOI 10.1016/0006-8993(87)91509-5; Hauser KF, 2000, EUR J NEUROSCI, V12, P1281, DOI 10.1046/j.1460-9568.2000.01015.x; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hemby SE, 2004, NEUROSCIENCE, V126, P689, DOI 10.1016/j.neuroscience.2004.01.056; Hou YN, 2006, NEUROSCI LETT, V395, P244, DOI 10.1016/j.neulet.2005.10.086; Hou YN, 2004, DEV BRAIN RES, V151, P149, DOI 10.1016/j.devbrainres.2004.05.002; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Joo CK, 2008, ONCOGENE, V27, P614, DOI 10.1038/sj.onc.1210649; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim E, 2006, J BIOL CHEM, V281, P33749, DOI 10.1074/jbc.M603862200; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; Liao DZ, 2007, J NEUROPHYSIOL, V97, P1485, DOI 10.1152/jn.00790.2006; Lin H, 2009, NEUROPSYCHOPHARMACOL, V34, P2097, DOI 10.1038/npp.2009.34; LISKA DJ, 1994, J CELL PHYSIOL, V158, P495, DOI 10.1002/jcp.1041580314; Liu A, 2009, MICROVASC RES, V77, P13, DOI 10.1016/j.mvr.2008.08.008; Liu AG, 2009, J BIOL CHEM, V284, P6389, DOI 10.1074/jbc.M809198200; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Miljkovic-Licina M, 2004, BIOSYSTEMS, V76, P75, DOI 10.1016/j.biosystems.2004.05.030; Miyatake M, 2009, J NEUROCHEM, V110, P662, DOI 10.1111/j.1471-4159.2009.06156.x; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Nakagawa T, 2005, J AM SOC NEPHROL, V16, P899, DOI 10.1681/ASN.2004080689; Narita M, 2006, J NEUROCHEM, V97, P1494, DOI 10.1111/j.1471-4159.2006.03849.x; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSHEA KS, 1991, NEURON, V7, P231, DOI 10.1016/0896-6273(91)90261-W; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467; Rios C, 2006, BRIT J PHARMACOL, V148, P387, DOI 10.1038/sj.bjp.0706757; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; ScottDrew S, 1997, J NEUROSCI RES, V50, P202, DOI 10.1002/(SICI)1097-4547(19971015)50:2<202::AID-JNR9>3.0.CO;2-J; Semiali A, 2008, AM J RESP CELL MOL, V38, P202, DOI 10.1165/rcmb.2007-0031OC; Spijker S, 2004, FASEB J, V18, P848, DOI 10.1096/fj.03-0612fje; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stiene-Martin A, 2001, GLIA, V36, P78, DOI 10.1002/glia.1097; STIENEMARTIN A, 1991, DEV BRAIN RES, V60, P1, DOI 10.1016/0165-3806(91)90149-D; Suzuki M, 2006, EUR J PHARMACOL, V535, P166, DOI 10.1016/j.ejphar.2006.01.033; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Ueda H, 2009, FRONT BIOSCI, V14, P5260, DOI 10.2741/3596; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ullian EM, 2004, MOL CELL NEUROSCI, V25, P241, DOI 10.1016/j.mcn.2003.10.011; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Van den Oever MC, 2008, NAT NEUROSCI, V11, P1053, DOI 10.1038/nn.2165; Van den Pol AN, 2000, NEUROSCIENCE, V95, P603; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Xu M, 2007, J NEUROSCI, V27, P2570, DOI 10.1523/JNEUROSCI.3728-06.2007; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470; Ziolkowska B, 2005, J NEUROSCI, V25, P4996, DOI 10.1523/JNEUROSCI.4376-04.2005	87	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38415	38427		10.1074/jbc.M110.109827	http://dx.doi.org/10.1074/jbc.M110.109827			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889977	Green Published, hybrid			2022-12-27	WOS:000284625600047
J	Madge, LA; May, MJ				Madge, Lisa A.; May, Michael J.			Classical NF-kappa B Activation Negatively Regulates Noncanonical NF-kappa B-dependent CXCL12 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; SIGNALING SYSTEM; GENE-EXPRESSION; PATHWAYS; TRANSCRIPTION; NF-KAPPA-B2; CHEMOKINES; INFLAMMATION; RECEPTORS	Ligation of the lymphotoxin-beta receptor (LT beta R) by LIGHT (lymphotoxin-related inducible ligand that competes for glycoprotein D binding to herpes virus entry mediator on T cells (TNFSF14)) activates the noncanonical (NC) NF-kappa B (nuclear factor-kappa B) pathway and up-regulates CXCL12 gene expression by human umbilical vein endothelial cells (HUVEC). In contrast, TNF only activates classical NF-kappa B signaling and does not up-regulate CXCL12. To determine whether cross-talk between the classical and NC pathways affects CXCL12 expression, we investigated the effects of TNF on LIGHT signaling in HUVEC. We show here that TNF inhibits both basal and LIGHT-induced CXCL12 expression. Negative regulation by TNF requires the classical NF-kappa B pathway as inhibition of basal and induced CXCL12 was reversed in HUVEC-expressing dominant negative I kappa B (inhibitor of NF-kappa B) kinase (IKK)beta (IKK beta(K44M)). TNF did not inhibit the NC NF-kappa B pathway activation as LIGHT-induced p100 processing to p52 was intact; however, TNF either alone or together with LIGHT up-regulated p100 and RelB expression and induced the nuclear localization of p100-RelB complexes. Enhanced p100 and RelB expression was inhibited by IKK beta(K44M), which led us to question whether the I kappa B function of elevated p100 mediates the inhibition of CXCL12 expression by TNF. We retrovirally transduced HUVEC to express p100 at a level similar to that up-regulated by TNF; however, basal and LIGHT-induced CXCL12 expression was normal in the transduced cells. In contrast, ectopic RelB expression recapitulated the effects of TNF on NC signaling and inhibited basal and LIGHT-induced CXCL12 expression by HUVEC. Our findings therefore demonstrate that TNF-induced classical NF-kappa B signaling up-regulates RelB expression that inhibits both basal and NC NF-kappa B-dependent CXCL12 expression.	[May, Michael J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	May, MJ (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, 3800 Spruce St,OVH 200E, Philadelphia, PA 19104 USA.	maym@vet.upenn.edu		May, Michael/0000-0002-2485-3716	National Institutes of Health [RO1HL080612, RO1HL080612-04S1]; W.W. Smith Charitable Trust [H0703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.W. Smith Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL080612 and RO1HL080612-04S1. This work was also supported by W.W. Smith Charitable Trust Grant H0703.	Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Croxton R, 2006, CANCER RES, V66, P9026, DOI 10.1158/0008-5472.CAN-06-1047; Dejardin E, 1999, ONCOGENE, V18, P2567, DOI 10.1038/sj.onc.1202599; DEJARDIN E, 1995, ONCOGENE, V11, P1835; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Derudder E, 2003, J BIOL CHEM, V278, P23278, DOI 10.1074/jbc.M300106200; Fedyk ER, 2001, J IMMUNOL, V166, P5749, DOI 10.4049/jimmunol.166.9.5749; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Legarda-Addison D, 2007, J IMMUNOL, V178, P7767, DOI 10.4049/jimmunol.178.12.7767; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Lotzer K, 2010, ARTERIOSCL THROM VAS, V30, P395, DOI 10.1161/ATVBAHA.109.191395; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Madge LA, 2008, J IMMUNOL, V180, P3467, DOI 10.4049/jimmunol.180.5.3467; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Puto LA, 2008, GENE DEV, V22, P998, DOI 10.1101/gad.1632208; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Speirs K, 2004, J IMMUNOL, V172, P752, DOI 10.4049/jimmunol.172.2.752; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Sung ML, 2009, CIRC RES, V105, P755, DOI 10.1161/CIRCRESAHA.109.206524; Suto H, 2009, INT IMMUNOL, V21, P467, DOI 10.1093/intimm/dxp014; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao GT, 2006, CYTOKINE GROWTH F R, V17, P281, DOI 10.1016/j.cytogfr.2006.04.005; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Zarnegar B, 2008, P NATL ACAD SCI USA, V105, P3503, DOI 10.1073/pnas.0707959105; Zhang Q, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2391	45	34	35	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38069	38077		10.1074/jbc.M110.147207	http://dx.doi.org/10.1074/jbc.M110.147207			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923761	Green Published, hybrid			2022-12-27	WOS:000284625600015
J	Ito, S; Osaka, M; Higuchi, Y; Nishijima, F; Ishii, H; Yoshida, M				Ito, Shunsuke; Osaka, Mizuko; Higuchi, Yusuke; Nishijima, Fuyuhiko; Ishii, Hideto; Yoshida, Masayuki			Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC-RENAL-FAILURE; CHRONIC KIDNEY-DISEASE; E-DEFICIENT MICE; ADHESION MOLECULES; OXIDATIVE STRESS; ORAL ADSORBENT; KAPPA-B; GLOMERULAR SCLEROSIS; FEMORAL-ARTERY; IN-VITRO	Despite a positive correlation between chronic kidney disease and atherosclerosis, the causative role of uremic toxins in leukocyte-endothelial interactions has not been reported. We thus examined the effects of indoxyl sulfate, a uremic toxin, on leukocyte adhesion to activated endothelial cells and the underlying mechanisms. Pretreatment of human umbilical vein endothelial cells (HUVEC) with indoxyl sulfate significantly enhanced the adhesion of human monocytic cells (THP-1 cell line) to TNF-alpha-activated HUVEC under physiological flow conditions. Treatment with indoxyl sulfate enhanced the expression level of E-selectin, but not that of ICAM-1 or VCAM-1, in HUVEC. Indoxyl sulfate treatment enhanced the activation of JNK, p38 MAPK, and NF-kappa B in TNF-alpha-activated HUVEC. Inhibitors of JNK and NF-kappa B attenuated indoxyl sulfate-induced E-selectin expression in HUVEC and subsequent THP-1 adhesion. Furthermore, treatment with the NAD(P)H oxidase inhibitor apocynin and the glutathione donor N-acetylcysteine inhibited indoxyl sulfate-induced enhancement of THP-1 adhesion to HUVEC. Next, we examined the in vivo effect of indoxyl sulfate in nephrectomized chronic kidney disease model mice. Indoxyl sulfate-induced leukocyte adhesion to the femoral artery was significantly reduced by anti-E-selectin antibody treatment. These findings suggest that indoxyl sulfate enhances leukocyte-endothelial interactions through up-regulation of E-selectin, presumably via the JNK- and NF-kappa B-dependent pathway.	Tokyo Med & Dent Univ, Dept Life Sci & Med Eth, Grad Sch Med, Bunkyo Ku, Tokyo 1138510, Japan; [Ito, Shunsuke; Higuchi, Yusuke; Nishijima, Fuyuhiko] Kureha Corp, Biomed Res Labs, Tokyo 1698503, Japan	Tokyo Medical & Dental University (TMDU)		masa.vasc@tmd.ac.jp			Ministry of Education, Science, and Technology [10178102]; Ministry of Culture of Japan; Ministry of Health, Labor, and Welfare of Japan; Ono Medical Research Foundation	Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Culture of Japan; Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ono Medical Research Foundation	This work was supported in part by Ministry of Education, Science, and Technology Grant-in-aid for Scientific Research 10178102 and special coordination funds, a grant-in-aid from the Ministry of Culture of Japan, a grant from the Ministry of Health, Labor, and Welfare of Japan, and a grant-in-aid from the Ono Medical Research Foundation.	Amann K, 2004, J AM SOC NEPHROL, V15, P1664, DOI 10.1097/01.ASN.0000128365.76153.5B; Asgeirsdottir S. A., 2007, MOL PHARM, V72, P121; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; BOLTON WK, 1987, KIDNEY INT, V32, P869, DOI 10.1038/ki.1987.288; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Dou L, 2007, J THROMB HAEMOST, V5, P1302, DOI 10.1111/j.1538-7836.2007.02540.x; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Fujii H, 2009, NEPHROL DIAL TRANSPL, V24, P2089, DOI 10.1093/ndt/gfp007; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gotoh R, 2004, ARTERIOSCL THROM VAS, V24, P2063, DOI 10.1161/01.ATV.0000145942.31404.20; Hagita S, 2008, HYPERTENSION, V51, P797, DOI 10.1161/HYPERTENSIONAHA.107.098855; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Kren S, 1999, KIDNEY INT, V56, P333, DOI 10.1046/j.1523-1755.1999.00527.x; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Lin CW, 2007, BIOMATERIALS, V28, P1355, DOI 10.1016/j.biomaterials.2006.11.006; Malaponte G, 2007, INT J MOL MED, V20, P471; Malatino LS, 2007, J INTERN MED, V262, P479, DOI 10.1111/j.1365-2796.2007.01841.x; Murakami S, 2001, MICROVASC RES, V62, P383, DOI 10.1006/mvre.2001.2356; Nakamura T., 2011, METABOLISM IN PRESS; Nakatani K, 2004, KIDNEY INT, V65, P1290, DOI 10.1111/j.1523-1755.2004.00537.x; Namikoshi T, 2009, HYPERTENS RES, V32, P194, DOI 10.1038/hr.2008.29; Nishiwaki Y, 2003, BIOCHEM BIOPH RES CO, V310, P1062, DOI 10.1016/j.bbrc.2003.09.125; NIWA T, 1994, J LAB CLIN MED, V124, P96; NIWA T, 1994, AM J NEPHROL, V14, P207, DOI 10.1159/000168716; Osaka M, 2007, AM J PHYSIOL-HEART C, V292, pH1876, DOI 10.1152/ajpheart.00708.2006; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Shimoishi K, 2007, PHARM RES-DORDR, V24, P1283, DOI 10.1007/s11095-007-9248-x; Testa A, 2006, NEPHROL DIAL TRANSPL, V21, P1921, DOI 10.1093/ndt/gfl115; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 1999, J AM SOC NEPHROL, V10, P1815; Wheeler DC, 1996, LANCET, V348, P1673, DOI 10.1016/S0140-6736(05)65816-3; Wolf D, 2001, J IMMUNOL, V166, P1300, DOI 10.4049/jimmunol.166.2.1300; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; Yoshida M, 1998, J IMMUNOL, V161, P933; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143	39	125	128	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38869	38875		10.1074/jbc.M110.166686	http://dx.doi.org/10.1074/jbc.M110.166686			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937831	Green Published, hybrid			2022-12-27	WOS:000284941300016
J	You, R; Zheng, MZ; McKeown-Longo, PJ				You, Ran; Zheng, Mingzhe; McKeown-Longo, Paula J.			The First Type III Repeat in Fibronectin Activates an Inflammatory Pathway in Dermal Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOGNITION; ANASTELLIN; PEPTIDE; INJURY; SITES; FORM	Remodeling of the fibronectin matrix occurs during a variety of pathological and regenerative processes. Cellular generated tensional forces can alter the secondary and tertiary structure of the fibronectin matrix and regulate the exposure of cryptic activities that directly impact cell behavior. In the present study, we evaluated the effect of the partially unfolded Type III fibronectin module, FnIII-1c, on gene expression in dermal fibroblasts. Microarray and PCR analysis indicated that the addition of FnIII-1c to human dermal fibroblasts induced the expression of several inflammatory genes including the cytokines, IL-8 and TNF-alpha. ELISA analysis indicated that the increased gene expression was accompanied by the secretion of IL-8 and TNF-alpha protein. FnIII-1c-induced gene expression was preceded by increased phosphorylation of I kappa B kinase (IKK) and I kappa B alpha as well as the nuclear translocation of NF kappa B. PCR and ELISA analysis showed that inhibition of the NF kappa B signaling pathway completely blocked the induction of IL-8 and TNF-alpha. Blocking antibodies to Toll-like receptor 4 inhibited both the activation of the NF kappa B signaling pathway as well as cytokine expression in response to FnIII-1c. These data suggest that fibronectin matrix remodeling can induce the expression of cytokines by stromal cells present in the tissue microenvironment.	[You, Ran; Zheng, Mingzhe; McKeown-Longo, Paula J.] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA	Albany Medical College	McKeown-Longo, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, MC-165,47 New Scotland Ave, Albany, NY 12208 USA.	mckeowp@mail.amc.edu			National Institutes of Health [CA-69612]; NATIONAL CANCER INSTITUTE [R01CA069612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by, in whole or in part, by National Institutes of Health Grant CA-69612 (to P.J.M.-L.).	Ambesi A, 2005, CANCER RES, V65, P148; Ambesi A, 2009, MOL CANCER RES, V7, P255, DOI 10.1158/1541-7786.MCR-08-0195; Antia M, 2008, FARADAY DISCUSS, V139, P229, DOI 10.1039/b718714a; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Hocking DC, 2008, CIRC RES, V102, P372, DOI 10.1161/CIRCRESAHA.107.158501; Klein RM, 2003, J CELL SCI, V116, P4663, DOI 10.1242/jcs.00778; Kubow KE, 2009, INTEGR BIOL-UK, V1, P635, DOI 10.1039/b914996a; Mao Y, 2005, J CELL SCI, V118, P4427, DOI 10.1242/jcs.02566; Meighan CM, 2008, CURR OPIN CELL BIOL, V20, P520, DOI 10.1016/j.ceb.2008.05.010; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Mitsi M, 2008, J BIOL CHEM, V283, P34796, DOI 10.1074/jbc.M806692200; Miura S, 2007, BIOL PHARM BULL, V30, P891, DOI 10.1248/bpb.30.891; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pasqualini R, 1996, NAT MED, V2, P1197, DOI 10.1038/nm1196-1197; Shinde AV, 2008, J BIOL CHEM, V283, P2858, DOI 10.1074/jbc.M708306200; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Suki Bela, 2007, Drug Discov Today Dis Models, V4, P139, DOI 10.1016/j.ddmod.2007.10.002; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Taylor KR, 2007, J BIOL CHEM, V282, P18265, DOI 10.1074/jbc.M606352200; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Yi M, 2003, P NATL ACAD SCI USA, V100, P11435, DOI 10.1073/pnas.1635112100; You R, 2009, MATRIX BIOL, V28, P101, DOI 10.1016/j.matbio.2009.01.003; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	31	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 19	2010	285	47					36255	36259		10.1074/jbc.C110.176990	http://dx.doi.org/10.1074/jbc.C110.176990			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	679FE	20923762	Green Published, hybrid			2022-12-27	WOS:000284146100001
J	Praper, T; Sonnen, A; Viero, G; Kladnik, A; Froelich, CJ; Anderluh, G; Dalla Serra, M; Gilbert, RJC				Praper, Tilen; Sonnen, Andreas; Viero, Gabriella; Kladnik, Ales; Froelich, Christopher J.; Anderluh, Gregor; Dalla Serra, Mauro; Gilbert, Robert J. C.			Human Perforin Employs Different Avenues to Damage Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING PROTEIN; CHOLESTEROL-DEPENDENT CYTOLYSINS; T-CELL GRANULES; BACTERIAL TOXINS; DIVALENT-CATIONS; PREPORE COMPLEX; GRANZYME-B; C2 DOMAIN; MECHANISM; PNEUMOLYSIN	Perforin (PFN) is a pore-forming protein produced by cytotoxic lymphocytes that aids in the clearance of tumor or virus-infected cells by a mechanism that involves the formation of transmembrane pores. The properties of PFN pores and the mechanism of their assembly remain unclear. Here, we studied pore characteristics by functional and structural methods to show that perforin forms pores more heterogeneous than anticipated. Planar lipid bilayer experiments indicate that perforin pores exhibit a broad range of conductances, from 0.15 to 21 nanosiemens. In comparison with large pores that possessed low noise and remained stably open, small pores exhibited high noise and were very unstable. Furthermore, the opening step and the pore size were dependent on the lipid composition of the membrane. The heterogeneity in pore sizes was confirmed with cryo-electron microscopy and showed a range of sizes matching that observed in the conductance measurements. Furthermore, two different membrane-bound PFN conformations were observed, interpreted as pre-pore and pore states of the protein. The results collectively indicate that PFN forms heterogeneous pores through a multistep mechanism and provide a new paradigm for understanding the range of different effects of PFN and related membrane attack complex/perforin domain proteins observed in vivo and in vitro.	[Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana 1000, Slovenia; [Sonnen, Andreas; Gilbert, Robert J. C.] Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Viero, Gabriella; Dalla Serra, Mauro] Bruno Kessler Fdn, I-38123 Trento, Povo, Italy; [Viero, Gabriella; Dalla Serra, Mauro] Inst Biophys, Natl Res Council, I-38123 Trento, Povo, Italy; [Froelich, Christopher J.] NorthShore Univ HealthSyt Res Inst, Dept Med, Evanston, IL 60201 USA	University of Ljubljana; University of Oxford; Wellcome Centre for Human Genetics; Fondazione Bruno Kessler; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); NorthShore University Health System	Anderluh, G (corresponding author), Univ Ljubljana, Biotech Fac, Dept Biol, Vecna Pot 111, Ljubljana 1000, Slovenia.	gregor.anderluh@bf.uni-lj.si; mauro.dallaserra@cnr.it; gilbert@strubi.ox.ac.uk	Serra, Mauro Dalla/AAK-9299-2021; Viero, Gabriella/G-2096-2012; Anderluh, Gregor/C-6905-2014; Kladnik, Aleš/B-6045-2008; Serra, Mauro Dalla/A-6218-2010	Serra, Mauro Dalla/0000-0003-1048-2739; Viero, Gabriella/0000-0002-6755-285X; Anderluh, Gregor/0000-0002-9916-8465; Kladnik, Aleš/0000-0002-3466-0088; Serra, Mauro Dalla/0000-0003-1048-2739; Gilbert, Robert/0000-0001-9336-5604	National Institutes of Health [5RO1AI04494-03]; Slovenian-Italian collaborative grant; FEBS; Slovene Human Resources Development and Scholarship fund; Slovenian Research Agency; Wellcome Trust; Royal Society International Joint Project; EMBO	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian-Italian collaborative grant; FEBS; Slovene Human Resources Development and Scholarship fund; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society International Joint Project(Royal Society of London); EMBO(European Molecular Biology Organization (EMBO))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1AI04494-03. This work was also supported in part by a Slovenian-Italian collaborative grant.; Supported by the FEBS Collaborative Experimental Scholarship for Central and Eastern Europe and by the Slovene Human Resources Development and Scholarship fund.; Supported by Slovenian Research Agency.; Recipient of a Wellcome Trust 4-year Ph.D. Studentship in Structural Biology.; Supported in part by the award of a Royal Society International Joint Project grant and EMBO short term fellowship.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Baran K, 2009, IMMUNITY, V30, P684, DOI 10.1016/j.immuni.2009.03.016; BASHFORD CL, 1988, J IMMUNOL, V141, P3965; BASHFORD CL, 1988, J MEMBRANE BIOL, V103, P79, DOI 10.1007/BF01871934; Bayley H, 1997, CURR BIOL, V7, pR763, DOI 10.1016/S0960-9822(06)00399-X; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BHAKDI S, 1985, INFECT IMMUN, V47, P47; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; Dalla Serra M, 2000, METH MOL B, V145, P171; Ecker A, 2008, MOL MICROBIOL, V70, P209, DOI 10.1111/j.1365-2958.2008.06407.x; Ecker A, 2007, EXP PARASITOL, V116, P504, DOI 10.1016/j.exppara.2007.01.015; El-Rachkidy RG, 2008, BIOCHEM BIOPH RES CO, V368, P786, DOI 10.1016/j.bbrc.2008.01.151; Findlay HE, 2006, J PHYS-CONDENS MAT, V18, pS1281, DOI 10.1088/0953-8984/18/28/S11; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; From C, 2008, FEMS MICROBIOL LETT, V286, P85, DOI 10.1111/j.1574-6968.2008.01256.x; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; Heller WT, 1997, BIOPHYS J, V73, P239, DOI 10.1016/S0006-3495(97)78064-0; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KORCHEV YE, 1992, J MEMBRANE BIOL, V127, P195; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Palmer M, 2004, FEMS MICROBIOL LETT, V238, P281, DOI 10.1016/j.femsle.2004.07.059; Peterlin P, 2008, COLLOID SURFACE B, V64, P77, DOI 10.1016/j.colsurfb.2008.01.004; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Poklar N, 1999, BIOCHEMISTRY-US, V38, P14999, DOI 10.1021/bi9916022; Praper T, 2010, MOL IMMUNOL, V47, P2492, DOI 10.1016/j.molimm.2010.06.001; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P5668, DOI 10.1073/pnas.83.15.5668; YOUNG JDE, 1986, J EXP MED, V164, P144, DOI 10.1084/jem.164.1.144; YOUNG JDE, 1986, SCIENCE, V233, P184, DOI 10.1126/science.2425429; YOUNG LHY, 1990, LANCET, V336, P1019, DOI 10.1016/0140-6736(90)92486-2	59	68	69	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2946	2955		10.1074/jbc.M110.169417	http://dx.doi.org/10.1074/jbc.M110.169417			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20889983	hybrid, Green Published			2022-12-27	WOS:000286464300058
J	Maier, E; Hebenstreit, D; Posselt, G; Hammerl, P; Duschl, A; Horejs-Hoeck, J				Maier, Elisabeth; Hebenstreit, Daniel; Posselt, Gernot; Hammerl, Peter; Duschl, Albert; Horejs-Hoeck, Jutta			Inhibition of Suppressive T Cell Factor 1 (TCF-1) Isoforms in Naive CD4(+) T Cells Is Mediated by IL-4/STAT6 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DENDRITIC CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; BETA-CATENIN; IN-VIVO; THYMOCYTE DEVELOPMENT; STAT5 ACTIVATION; STEM-CELLS; TH2 CELLS; IL-4	The Wnt pathway transcription factor T cell factor 1 (TCF-1) plays essential roles in the control of several developmental processes, including T cell development in the thymus. Although previously regarded as being required only during early T cell development, recent studies demonstrate an important role for TCF-1 in T helper 2 (Th2) cell polarization. TCF-1 was shown to activate expression of the Th2 transcription factor GATA-binding protein 3 (GATA3) and thus to promote the development of IL-4-producing Th2 cells independent of STAT6 signaling. In this study, we show that TCF-1 is down-regulated in human naive CD4(+) T cells cultured under Th2-polarizing conditions. The down-regulation is largely due to the polarizing cytokine IL-4 because IL-4 alone is sufficient to substantially inhibit TCF-1 expression. The IL-4-induced suppression of TCF-1 is mediated by STAT6, as shown by electrophoretic mobility shift assays, chromatin immunoprecipitation, and STAT6 knockdown experiments. Moreover, we found that IL-4/STAT6 predominantly inhibits the shorter, dominant-negative TCF-1 isoforms, which were reported to inhibit IL-4 transcription. Thus, this study provides a model for an IL-4/STAT6-dependent fine tuning mechanism of TCF-1-driven T helper cell polarization.	[Maier, Elisabeth; Posselt, Gernot; Hammerl, Peter; Duschl, Albert; Horejs-Hoeck, Jutta] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Horejs-Hoeck, J (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.	jutta.horejs_hoeck@sbg.ac.at	Posselt, Gernot/K-1747-2015; Horejs-Hoeck, Jutta/AAF-1735-2019; hebenstreit, daniel/GWZ-2082-2022; Duschl, Albert/E-5872-2011; Horejs-Hoeck, Jutta/E-5010-2011	Posselt, Gernot/0000-0002-0593-6620; Horejs-Hoeck, Jutta/0000-0002-0984-204X; hebenstreit, daniel/0000-0003-0144-6728; Duschl, Albert/0000-0002-7034-9860; Horejs-Hoeck, Jutta/0000-0002-0984-204X	University of Salzburg; Austrian "Fond zur Forderung der Wissenschaftlichen Forschung" [P18409]; Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg; MRC [MC_U105161047] Funding Source: UKRI; Medical Research Council [MC_U105161047] Funding Source: researchfish	University of Salzburg; Austrian "Fond zur Forderung der Wissenschaftlichen Forschung"(Austrian Science Fund (FWF)); Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the University of Salzburg priority program "BioScience and Health" and by Austrian "Fond zur Forderung der Wissenschaftlichen Forschung" Grant P18409.; Recipient of a DOC-fFORTE fellowship of the Austrian Academy of Sciences at the Department of Molecular Biology, University of Salzburg.	Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bennett BL, 1997, J BIOL CHEM, V272, P10212; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Saint-Vis B, 1998, J IMMUNOL, V160, P1666; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Friedrich K, 1999, INT IMMUNOL, V11, P1283, DOI 10.1093/intimm/11.8.1283; Harnaha J, 2006, DIABETES, V55, P158, DOI 10.2337/diabetes.55.01.06.db05-0340; Hebenstreit D, 2003, J IMMUNOL, V171, P5901, DOI 10.4049/jimmunol.171.11.5901; Hebenstreit D, 2008, J BIOL CHEM, V283, P22490, DOI 10.1074/jbc.M804096200; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; KOHLER I, 1993, EUR J IMMUNOL, V23, P3066, DOI 10.1002/eji.1830231204; Maier E, 2007, HUM IMMUNOL, V68, P986, DOI 10.1016/j.humimm.2007.10.012; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Nguyen VT, 2000, J IMMUNOL, V165, P6235, DOI 10.4049/jimmunol.165.11.6235; Okamoto M, 2009, J IMMUNOL, V183, P2995, DOI 10.4049/jimmunol.0900692; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Rogge L, 1999, J IMMUNOL, V162, P3926; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Scheinman EJ, 2009, J BIOL CHEM, V284, P3037, DOI 10.1074/jbc.M807302200; Schilham MW, 1998, J IMMUNOL, V161, P3984; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2001, EUR J IMMUNOL, V31, P285, DOI 10.1002/1521-4141(200101)31:1<285::AID-IMMU285>3.3.CO;2-4; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; van Panhuys N, 2008, P NATL ACAD SCI USA, V105, P12423, DOI 10.1073/pnas.0806372105; VANDEWETERING M, 1992, J BIOL CHEM, V267, P8530; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wirnsberger G, 2006, EUR J IMMUNOL, V36, P1882, DOI 10.1002/eji.200635972; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	53	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					919	928		10.1074/jbc.M110.144949	http://dx.doi.org/10.1074/jbc.M110.144949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20980261	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000286005000003
J	Hwang, YM; Stathopulos, PB; Dimmick, K; Yang, H; Badiei, HR; Tong, MS; Rumfeldt, JAO; Chen, P; Karanassios, V; Meiering, EM				Hwang, Young-Mi; Stathopulos, Peter B.; Dimmick, Kristin; Yang, Hong; Badiei, Hamid R.; Tong, Ming Sze; Rumfeldt, Jessica A. O.; Chen, Pu; Karanassios, Vassili; Meiering, Elizabeth M.			Nonamyloid Aggregates Arising from Mature Copper/Zinc Superoxide Dismutases Resemble Those Observed in Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-LIKE INCLUSIONS; CU,ZN-SUPEROXIDE DISMUTASE; PROTEIN AGGREGATION; FAMILIAL ALS; FIBRIL FORMATION; WILD-TYPE; IN-VITRO; MOLECULAR MECHANISM; SOLUBLE OLIGOMERS; AMYLOID FORMATION	Protein aggregation is a hallmark of many diseases, including amyotrophic lateral sclerosis (ALS) where aggregation of copper/zinc superoxide dismutase (SOD1) is implicated in pathogenesis. We report here that fully metallated (holo) SOD1 under physiologically relevant solution conditions can undergo changes in metallation and/or dimerization over time and form aggregates that do not exhibit classical characteristics of amyloid. The relevance of the observed aggregation to disease is demonstrated by structural and tinctorial analyses, including the novel observation of binding of an anti-SOD1 antibody that specifically recognizes aggregates in ALS patients and mice models. ALS-associated SOD1 mutations can promote aggregation but are not essential. The SOD1 aggregation is characterized by a lag phase, which is diminished by self-or cross-seeding and by heterogeneous nucleation. We interpret these findings in terms of an expanded aggregation mechanism consistent with other in vitro and in vivo findings that point to multiple pathways for the formation of toxic aggregates by different forms of SOD1.	[Meiering, Elizabeth M.] Univ Waterloo, Guelph Waterloo Ctr Grad Studies Chem & Biochem, Dept Biol & Chem, Waterloo, ON N2L 3G1, Canada; [Yang, Hong; Chen, Pu] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada; [Stathopulos, Peter B.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; [Stathopulos, Peter B.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 3H2, Canada; [Yang, Hong] Univ Hlth Network, Latner Thorac Surg Res Labs, Toronto, ON M5G 1L7, Canada; [Badiei, Hamid R.] MDS Analyt Technol, ICP MS Technol, Concord, ON L4K 4V8, Canada; [Rumfeldt, Jessica A. O.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of Waterloo; University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of California System; University of California San Diego	Meiering, EM (corresponding author), Univ Waterloo, Guelph Waterloo Ctr Grad Studies Chem & Biochem, Dept Biol & Chem, 200 Univ Ave, Waterloo, ON N2L 3G1, Canada.	meiering@uwaterloo.ca	Yang, Hong/E-3478-2014; Yang, Hong/AAZ-1061-2020	Yang, Hong/0000-0002-6707-8481; Stathopulos, Peter B./0000-0002-0536-6656	ALS Society of Canada; Muscular Dystrophy Canada; Canadian Institutes of Health Research	ALS Society of Canada; Muscular Dystrophy Canada(Muscular Dystrophy Association); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the ALS Society of Canada, Muscular Dystrophy Canada, and the Canadian Institutes of Health Research.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Banci L, 2005, J BIOL CHEM, V280, P35815, DOI 10.1074/jbc.M506637200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2007, BIOCHEMISTRY-US, V46, P9953, DOI 10.1021/bi700620r; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Cao XH, 2008, J BIOL CHEM, V283, P16169, DOI 10.1074/jbc.M801522200; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Crow JP, 1997, J NEUROCHEM, V69, P1936; D'Arrigo A, 2010, J MOL NEUROSCI, V41, P404, DOI 10.1007/s12031-010-9332-2; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hornberg A, 2007, J MOL BIOL, V365, P333, DOI 10.1016/j.jmb.2006.09.048; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Jaarsma D, 2006, MITOCHONDRION, V6, P48, DOI 10.1016/j.mito.2005.10.005; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kato S, 2001, NEUROPATHOLOGY, V21, P67, DOI 10.1046/j.1440-1789.2001.00359.x; Kato S, 2008, ACTA NEUROPATHOL, V115, P97, DOI 10.1007/s00401-007-0308-4; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Lomakin A, 1999, METHOD ENZYMOL, V309, P429; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAILER K, 1989, J INORG BIOCHEM, V37, P151, DOI 10.1016/0162-0134(89)80038-8; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto S, 1996, CLIN NEUROPATHOL, V15, P41; Molnar KS, 2009, J BIOL CHEM, V284, P30965, DOI 10.1074/jbc.M109.023945; Morel B, 2006, J MOL BIOL, V356, P453, DOI 10.1016/j.jmb.2005.11.062; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nordlund A, 2009, P NATL ACAD SCI USA, V106, P9667, DOI 10.1073/pnas.0812046106; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; Rumfeldt JAO, 2006, J MOL BIOL, V355, P106, DOI 10.1016/j.jmb.2005.10.042; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Sandelin E, 2007, J BIOL CHEM, V282, P21230, DOI 10.1074/jbc.M700765200; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Seetharaman SV, 2009, EXP BIOL MED, V234, P1140, DOI 10.3181/0903-MR-104; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shipp EL, 2003, BIOCHEMISTRY-US, V42, P1890, DOI 10.1021/bi026704y; Souillac PO, 2003, BIOCHEMISTRY-US, V42, P8094, DOI 10.1021/bi034652m; Souillac PO, 2002, J BIOL CHEM, V277, P12666, DOI 10.1074/jbc.M109229200; Stathopulos P., 2005, CHEMISTRY, P133; Stathopulos PB, 2006, J BIOL CHEM, V281, P6184, DOI 10.1074/jbc.M509496200; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Stathopulos PB, 2004, PROTEIN SCI, V13, P3017, DOI 10.1110/ps.04831804; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Valentine JS, 2002, FREE RADICAL BIO MED, V33, P1314, DOI 10.1016/S0891-5849(02)01080-8; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Vassall KA, 2006, BIOCHEMISTRY-US, V45, P7366, DOI 10.1021/bi0600953; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	97	43	43	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41701	41711		10.1074/jbc.M110.113696	http://dx.doi.org/10.1074/jbc.M110.113696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974846	Green Published, hybrid			2022-12-27	WOS:000285622600057
J	Caolo, V; van den Akker, NMS; Verbruggen, S; Donners, MMPC; Swennen, G; Schulten, H; Waltenberger, J; Post, MJ; Molin, DGM				Caolo, Vincenza; van den Akker, Nynke M. S.; Verbruggen, Sanne; Donners, Marjo M. P. C.; Swennen, Geertje; Schulten, Henny; Waltenberger, Johannes; Post, Mark J.; Molin, Daniel G. M.			Feed-forward Signaling by Membrane-bound Ligand Receptor Circuit THE CASE OF NOTCH DELTA-LIKE 4 LIGAND IN ENDOTHELIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; STEM-CELL DIFFERENTIATION; VASCULAR DEVELOPMENT; TRANSCRIPTION FACTORS; PROGENITOR CELLS; NOTCH LIGAND; VEGF; ARTERIAL; ANGIOGENESIS; ACTIVATION	The DELTA like-4 ligand (DLL4) belongs to the highly conserved NOTCH family and is specifically expressed in the endothelium. DLL4 regulates crucial processes in vascular growth, including endothelial cell (EC) sprouting and arterial specification. Its expression is increased by VEGF-A. In the present study, we show that VEGF-induced DLL4 expression depends on NOTCH activation. VEGF-induced DLL4 expression was prevented by the blockage of NOTCH signaling with gamma-secretase or ADAM inhibitors in human cardiac microvascular ECs. Similar to VEGF-A, recombinant DLL4 itself stimulated NOTCH signaling and resulted in up-regulation of DLL4, suggesting a positive feed-forward mechanism. These effects were abrogated by NOTCH inhibitors but not by inhibition of VEGF signaling. NOTCH activation alone suffices to induce DLL4 expression as illustrated by the positive effect of NOTCH intracellular domain (NICD)-1 or -4 overexpression. To discriminate between NICD/RBP-J kappa and FOXC2-regulated DLL4 expression, DLL4 promoter activity was assessed in promoter deletion experiments. NICD induced promoter activity was dependent on RBP-J kappa site but independent of the FOXC2 binding site. Accordingly, constitutively active FOXC2 did not affect DLL4 expression. The notion that the positive feed-forward mechanism might propagate NOTCH activation to neighboring ECs was supported by our observation that DLL4-eGFP-transfected ECs induced DLL4 expression in nontransfected cells in their vicinity. In summary, our data provide evidence for a mechanism by which VEGF or ligand-induced NOTCH signaling up-regulates DLL4 through a positive feed-forward mechanism. By this mechanism, DLL4 could propagate its own expression and enable synchronization of NOTCH expression and signaling between ECs.	[Caolo, Vincenza; Verbruggen, Sanne; Swennen, Geertje; Schulten, Henny; Post, Mark J.; Molin, Daniel G. M.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6229 ER Maastricht, Netherlands; [van den Akker, Nynke M. S.; Waltenberger, Johannes] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Cardiol, NL-6229 ER Maastricht, Netherlands; [Donners, Marjo M. P. C.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Mol Genet, NL-6229 ER Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Molin, DGM (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Physiol, Univ Singel 50, NL-6229 ER Maastricht, Netherlands.	d.molin@fys.unimaas.nl	Waltenberger, Johannes/I-1813-2013	Waltenberger, Johannes/0000-0002-2417-9880	Netherlands Heart Foundation [2005B254]; Marie Curie FP6 Early Stage Researcher Training Grant [MEST-CT-2005-020706];  [200T034]	Netherlands Heart Foundation(Netherlands Heart Foundation); Marie Curie FP6 Early Stage Researcher Training Grant; 	This work was supported by The Netherlands Heart Foundation Grant 2005B254 (to M.P.), the Dr. E. Dekker Grant 200T034 (to M.D.), and the Marie Curie FP6 Early Stage Researcher Training Grant MEST-CT-2005-020706 (to Cardiovascular Research Institute Maastricht).	Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Delwig A, 2008, CELL MOL LIFE SCI, V65, P2232, DOI 10.1007/s00018-008-8127-x; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; Gerin I, 2009, J BIOL CHEM, V284, P10755, DOI 10.1074/jbc.M809115200; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Harrington LS, 2008, MICROVASC RES, V75, P144, DOI 10.1016/j.mvr.2007.06.006; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jen WC, 1997, DEVELOPMENT, V124, P1169; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lanner F, 2007, ARTERIOSCL THROM VAS, V27, P487, DOI 10.1161/01.ATV.0000255990.91805.6d; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363; Miao HQ, 2006, BIOCHEM BIOPH RES CO, V345, P438, DOI 10.1016/j.bbrc.2006.04.119; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Segarra M, 2008, BLOOD, V112, P1904, DOI 10.1182/blood-2007-11-126045; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shawber CJ, 2003, ANN NY ACAD SCI, V995, P162, DOI 10.1111/j.1749-6632.2003.tb03219.x; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Tian L, 2008, INT IMMUNOL, V20, P1181, DOI 10.1093/intimm/dxn076; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; van den Akker NMS, 2008, CARDIOVASC RES, V78, P366, DOI 10.1093/cvr/cvm108; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831; Zhang G, 2008, FEBS LETT, V582, P2957, DOI 10.1016/j.febslet.2008.07.031	49	43	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40681	40689		10.1074/jbc.M110.176065	http://dx.doi.org/10.1074/jbc.M110.176065			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959466	Green Published, hybrid			2022-12-27	WOS:000285414400031
J	Kohli, RM; Maul, RW; Guminski, AF; McClure, RL; Gajula, KS; Saribasak, H; McMahon, MA; Siliciano, RF; Gearhart, PJ; Stivers, JT				Kohli, Rahul M.; Maul, Robert W.; Guminski, Amy F.; McClure, Rhonda L.; Gajula, Kiran S.; Saribasak, Huseyin; McMahon, Moira A.; Siliciano, Robert F.; Gearhart, Patricia J.; Stivers, James T.			Local Sequence Targeting in the AID/APOBEC Family Differentially Impacts Retroviral Restriction and Antibody Diversification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; HUMAN APOBEC3G; HIV-1 INFECTION; DNA INTEGRATION; IN-VIVO; AID; CELLS	Nucleic acid cytidine deaminases of the activation-induced deaminase (AID)/APOBEC family are critical players in active and innate immune responses, playing roles as target-directed, purposeful mutators. AID specifically deaminates the host immunoglobulin (Ig) locus to evolve antibody specificity, whereas its close relative, APOBEC3G (A3G), lethally mutates the genomes of retroviral pathogens such as HIV. Understanding the basis for the target-specific action of these enzymes is essential, as mistargeting poses significant risks, potentially promoting oncogenesis (AID) or fostering drug resistance (A3G). AID prefers to deaminate cytosine in WRC (W = A/T, R = A/G) motifs, whereas A3G favors deamination of CCC motifs. This specificity is largely dictated by a single, divergent protein loop in the enzyme family that recognizes the DNA sequence. Through grafting of this substrate-recognition loop, we have created enzyme variants of A3G and AID with altered local targeting to directly evaluate the role of sequence specificity on immune function. We find that grafted loops placed in the A3G scaffold all produced efficient restriction of HIV but that foreign loops in the AID scaffold compromised hypermutation and class switch recombination. Local targeting, therefore, appears alterable for innate defense against retroviruses by A3G but important for adaptive antibody maturation catalyzed by AID. Notably, AID targeting within the Ig locus is proportionally correlated to its in vitro ability to target WRC sequences rather than non-WRC sequences. Although other mechanisms may also contribute, our results suggest that local sequence targeting by AID/APOBEC3 enzymes represents an elegant example of co-evolution of enzyme specificity with its target DNA sequence.	[Maul, Robert W.; McClure, Rhonda L.; Saribasak, Huseyin; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Kohli, Rahul M.; Gajula, Kiran S.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Guminski, Amy F.; McMahon, Moira A.; Stivers, James T.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins University	Gearhart, PJ (corresponding author), NIA, Lab Mol Gerontol, NIH, 251 Bayview Blvd, Baltimore, MD 21224 USA.	gearhartp@mail.nih.gov; jstivers@jhmi.edu	Gajula, Kiran/I-1115-2019; Maul, Robert W./Y-6818-2019; Gearhart, Patricia/Y-7227-2019; Saribasak, Huseyin/C-9331-2012	Gajula, Kiran/0000-0002-2047-2457; McMahon, Moira/0000-0001-9810-8623; Saribasak, Huseyin/0000-0003-0055-062X; Maul, Robert/0000-0002-6958-8514; Kohli, Rahul/0000-0002-7689-5678	NIA; National Institutes of Health;  [GM06669];  [GM056834];  [KAI089242A]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI089242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000715] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health (Intramural Research Program), T32 Grant GM06669, and Grants GM056834 (to J. T. S.) and KAI089242A (to R. M. K.).	Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Berkhout B, 2002, AIDS RES HUM RETROV, V18, P133, DOI 10.1089/08892220252779674; Bogerd HP, 2008, RNA, V14, P1228, DOI 10.1261/rna.964708; Bransteitter R, 2004, J BIOL CHEM, V279, P51612, DOI 10.1074/jbc.M408135200; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2007, NAT STRUCT MOL BIOL, V14, P7, DOI 10.1038/nsmb0107-7; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fugmann SD, 2004, EUR J IMMUNOL, V34, P844, DOI 10.1002/eji.200324418; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Hackney JA, 2009, ADV IMMUNOL, V101, P163, DOI 10.1016/S0065-2776(08)01005-5; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Langlois MA, 2008, J VIROL, V82, P4660, DOI 10.1128/JVI.02469-07; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mbisa JL, 2010, J VIROL, V84, P5250, DOI 10.1128/JVI.02358-09; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Okazaki Il-mi, 2007, Adv Immunol, V94, P245, DOI 10.1016/S0065-2776(06)94008-5; Opi S, 2007, J VIROL, V81, P8236, DOI 10.1128/JVI.02694-06; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Rausch JW, 2009, J BIOL CHEM, V284, P7047, DOI 10.1074/jbc.M807258200; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Russell RA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-16; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1997, J VIROL, V71, P5259, DOI 10.1128/JVI.71.7.5259-5267.1997; Smith RA, 2005, VIRUS RES, V107, P215, DOI 10.1016/j.virusres.2004.11.011; WAGNER SD, 1995, NATURE, V376, P732, DOI 10.1038/376732a0; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wang M, 2009, NAT STRUCT MOL BIOL, V16, P769, DOI 10.1038/nsmb.1623; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	53	59	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40956	40964		10.1074/jbc.M110.177402	http://dx.doi.org/10.1074/jbc.M110.177402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929867	Green Published, hybrid			2022-12-27	WOS:000285414400059
J	Lakshminarayanan, R; Bromley, KM; Lei, YP; Snead, ML; Moradian-Oldak, J				Lakshminarayanan, Rajamani; Bromley, Keith M.; Lei, Ya-Ping; Snead, Malcolm L.; Moradian-Oldak, Janet			Perturbed Amelogenin Secondary Structure Leads to Uncontrolled Aggregation in Amelogenesis Imperfecta Mutant Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; IN-VITRO; CONFORMATIONAL STABILITY; DISORDERED PROTEINS; PORCINE AMELOGENIN; CALCIUM-BINDING; DENTAL ENAMEL; TOOTH ENAMEL; IDENTIFICATION; PHENOTYPE	Mutations in amelogenin sequence result in defective enamel, and the diverse group of genetically altered conditions is collectively known as amelogenesis imperfecta (AI). Despite numerous studies, the detailed molecular mechanism of defective enamel formation is still unknown. In this study, we have examined the biophysical properties of a recombinant murine amelogenin (rM180) and two point mutations identified from human DNA sequences in two cases of AI (T21I and P41T). At pH 5.8 and 25 degrees C, wild type (WT) rM180 and mutant P41T existed as monomers, and mutant T21I formed lower order oligomers. CD, dynamic light scattering, and fluorescence studies indicated that rM180 and P41T can be classified as a premolten globule-like subclass protein at 25 degrees C. Thermal denaturation and refolding monitored by CD ellipticity at 224 nm indicated the presence of a strong hysteresis in mutants compared with WT. Variable temperature tryptophan fluorescence and dynamic light scattering studies showed that WT transformed to a partially folded conformation upon heating and remained stable. The partially folded conformation formed by P41T, however, readily converted into a heterogeneous population of aggregates. T21I existed in an oligomeric state at room temperature and, upon heating, rapidly formed large aggregates over a very narrow temperature range. Thermal denaturation and refolding studies indicated that the mutants are less stable and exhibit poor refolding ability compared with WT rM180. Our results suggest that alterations in self-assembly of amelogenin are a consequence of destabilization of the intrinsic disorder. Therefore, we propose that, like a number of other human diseases, AI appears to be due to the destabilization of the secondary structure as a result of amelogenin mutations.	[Lakshminarayanan, Rajamani; Bromley, Keith M.; Lei, Ya-Ping; Snead, Malcolm L.; Moradian-Oldak, Janet] Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, Los Angeles, CA 90033 USA	University of Southern California	Moradian-Oldak, J (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Sch Dent, 2250 Alcazar St,CSA 103, Los Angeles, CA 90033 USA.	joldak@usc.edu	Rajamani, Lakshminarayanan/AAG-5541-2019	Rajamani, Lakshminarayanan/0000-0001-8214-5315; Bromley, Keith/0000-0002-8001-3818	National Institutes of Health [DE-013414, DE-02009, DE-15644]; NIDCR [DE-13045, DE-06988]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013045, R01DE006988, R01DE013414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015644, R37DE013045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE-013414, DE-02009, and DE-15644 (to J. M. O.) and DE-13045 and DE-06988 (to M. L. S.) from NIDCR.	Almstedt K, 2008, BIOCHEMISTRY-US, V47, P1288, DOI 10.1021/bi701720p; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bulaj G, 2001, J MOL BIOL, V313, P639, DOI 10.1006/jmbi.2001.5046; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Chai H, 2009, P NATL ACAD SCI USA, V106, P7289, DOI 10.1073/pnas.0902466106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Danielsson J, 2005, FEBS J, V272, P3938, DOI 10.1111/j.1742-4658.2005.04812.x; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Fan DM, 2009, J STRUCT BIOL, V166, P88, DOI 10.1016/j.jsb.2009.01.003; Fasshauer D, 2002, NAT STRUCT BIOL, V9, P144, DOI 10.1038/nsb750; FINCHAM AG, 1994, CALCIFIED TISSUE INT, V55, P398, DOI 10.1007/BF00299322; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Harada A, 2007, BIOSCI BIOTECH BIOCH, V71, P2952, DOI 10.1271/bbb.70354; Hart PS, 2002, ARCH ORAL BIOL, V47, P261, DOI 10.1016/S0003-9969(02)00003-1; Hill RB, 2000, STRUCT FOLD DES, V8, P471, DOI 10.1016/S0969-2126(00)00130-1; Huq NL, 2005, ARCH ORAL BIOL, V50, P599, DOI 10.1016/j.archoralbio.2004.12.009; Ishijima J, 2007, J BIOCHEM, V142, P201, DOI 10.1093/jb/mvm130; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lakshminarayanan R, 2009, PROTEINS, V76, P560, DOI 10.1002/prot.22369; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Le TQ, 2006, EUR J ORAL SCI, V114, P320, DOI 10.1111/j.1600-0722.2006.00313.x; LENCH NJ, 1995, HUM MUTAT, V5, P251, DOI 10.1002/humu.1380050310; Lim KH, 2007, BIOCHEM BIOPH RES CO, V353, P443, DOI 10.1016/j.bbrc.2006.12.043; Mahoney EK, 2004, BIOMATERIALS, V25, P5091, DOI 10.1016/j.biomaterials.2004.02.044; MATTHEWS BW, 1995, ADV PROTEIN CHEM, V46, P249, DOI 10.1016/S0065-3233(08)60337-X; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Moradian-Oldak J., 2010, AMELOGENINS MULTIFAC, P106; Myers JK, 1996, BIOPHYS J, V71, P2033, DOI 10.1016/S0006-3495(96)79401-8; Nicolini C, 2004, BIOPHYS J, V86, P1385, DOI 10.1016/S0006-3495(04)74209-5; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; PAIN RH, 2004, CURRENT PROTOCOLS PR; Paine ML, 2002, J BIOL CHEM, V277, P17112, DOI 10.1074/jbc.M110473200; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Ramirez-Alvarado M, 2002, J MOL BIOL, V323, P17, DOI 10.1016/S0022-2836(02)00840-9; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Robinson C, 2004, J MATER CHEM, V14, P2242, DOI 10.1039/b401154f; Schartl W, 2007, SPRINGER LAB MAN POL, P1; Shen C, 2008, PROTEINS, V71, P1744, DOI 10.1002/prot.21857; SHORTLE D, 1992, Q REV BIOPHYS, V25, P205, DOI 10.1017/S0033583500004674; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; SINCLAIR JF, 1994, NAT STRUCT BIOL, V1, P320, DOI 10.1038/nsb0594-320; SNEAD ML, 1983, P NATL ACAD SCI-BIOL, V80, P7254, DOI 10.1073/pnas.80.23.7254; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Tanimoto K, 2008, J DENT RES, V87, P451, DOI 10.1177/154405910808700516; Toyosawa S, 1998, P NATL ACAD SCI USA, V95, P13056, DOI 10.1073/pnas.95.22.13056; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Wright JT, 2003, CONNECT TISSUE RES, V44, P72, DOI 10.1080/03008200390152124; Xie ZH, 2007, ACTA BIOMATER, V3, P865, DOI 10.1016/j.actbio.2007.05.007; Xie ZH, 2008, BIOMATERIALS, V29, P2697, DOI 10.1016/j.biomaterials.2008.02.022	66	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40593	40603		10.1074/jbc.M110.131136	http://dx.doi.org/10.1074/jbc.M110.131136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929860	Green Published, hybrid			2022-12-27	WOS:000285414400022
J	Liu, H; Tian, N; Arany, I; Bigler, SA; Waxman, DJ; Shah, SV; Baliga, R				Liu, Hua; Tian, Niu; Arany, Istvan; Bigler, Steven A.; Waxman, David J.; Shah, Sudhir V.; Baliga, Radhakrishna			Cytochrome P450 2B1 Mediates Complement-dependent Sublytic Injury in a Model of Membranous Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVE HEYMANN NEPHRITIS; AMINONUCLEOSIDE-INDUCED CYTOTOXICITY; CATALYTIC IRON; HYDROGEN-PEROXIDE; LIPID-PEROXIDATION; HYDROXYL RADICALS; ATTACK COMPLEX; EXPRESSION; GENERATION; PROTEINS	Membranous nephropathy is a disease that affects the filtering units of the kidney, the glomeruli, and results in proteinuria accompanied by loss of kidney function. Passive Heymann nephritis is an experimental model that mimics membranous nephropathy in humans, wherein the glomerular epithelial cell (GEC) injury induced by complement C5b-9 leads to proteinuria. We examined the role of cytochrome P450 2B1 (CYP2B1) in this complement-mediated sublytic injury. Overexpression of CYP2B1 in GECs significantly increased the formation of reactive oxygen species, cytotoxicity, and collapse of the actin cytoskeleton following treatment with anti-tubular brush-border antiserum (anti-Fx1A). In contrast, silencing of CYP2B1 markedly attenuated anti-Fx1A-induced reactive oxygen species generation and cytotoxicity with preservation of the actin cytoskeleton. Gelsolin, which maintains an organized actin cytoskeleton, was significantly decreased by complement C5b-9-mediated injury but was preserved in CYP2B1-silenced cells. In rats injected with anti-Fx1A, the cytochrome P450 inhibitor cimetidine blocked an increase in catalytic iron and ROS generation, reduced the formation of malondialdehyde adducts, maintained a normal distribution of nephrin in the glomeruli, and provided significant protection at the onset of proteinuria. Thus, GEC CYP2B1 contributes to complement C5b-9-mediated injury and plays an important role in the pathogenesis of passive Heymann nephritis.	[Baliga, Radhakrishna] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS 39216 USA; [Bigler, Steven A.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Waxman, David J.] Boston Univ, Dept Biol, Div Cell & Mol Biol, Boston, MA 02215 USA; [Shah, Sudhir V.] Univ Arkansas Med Sci, Dept Internal Med, Div Nephrol, Little Rock, AR 72205 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Boston University; University of Arkansas System; University of Arkansas Medical Sciences	Baliga, R (corresponding author), Univ Mississippi, Med Ctr, Dept Pediat, Res Wing R116A,2500 N State St, Jackson, MS 39216 USA.	rbaliga@umc.edu	Baliga, Radhakrishna/G-2871-2015	Waxman, David/0000-0001-7982-9206	National Institutes of Health [5 P42 ES07381]; University of Mississippi Medical Center; American Heart Association [0655716Z]; Boston University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi Medical Center; American Heart Association(American Heart Association); Boston University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by National Institutes of Health Grant 5 P42 ES07381 (to D. J. W.). This work was also supported by the Intramural Research Support Program through the University of Mississippi Medical Center (to R. B.), by American Heart Association Grant-in-aid 0655716Z (to I. A.) and by the Superfund Research Program at Boston University (to D. J. W.).	Baliga R, 1996, KIDNEY INT, V49, P362, DOI 10.1038/ki.1996.53; Baliga R, 1998, KIDNEY INT, V54, P1562, DOI 10.1046/j.1523-1755.1998.00161.x; Baliga R, 1998, KIDNEY INT, V53, P394, DOI 10.1046/j.1523-1755.1998.00767.x; Baliga R, 1996, KIDNEY INT, V50, P1118, DOI 10.1038/ki.1996.418; Baliga R, 1996, J AM SOC NEPHROL, V7, P1183; BALIGA R, 1992, AM J PHYSIOL, V263, pF56, DOI 10.1152/ajprenal.1992.263.1.F56; BALIGA R, 1997, CURRENT NEPHROLOGY, P135; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Benigni A, 2001, J AM SOC NEPHROL, V12, P941, DOI 10.1681/ASN.V125941; BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6; Bradd S J, 1993, Methods Mol Biol, V19, P211; BRIGGS RT, 1975, J CELL BIOL, V67, P566, DOI 10.1083/jcb.67.3.566; BYSANI GK, 1990, J CLIN INVEST, V86, P1434, DOI 10.1172/JCI114859; COUSER WG, 1993, KIDNEY INT, V44, pS19; COUSER WG, 1988, ANNU REV MED, V39, P517; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; CYBULSKY AV, 1986, J CLIN INVEST, V77, P1096, DOI 10.1172/JCI112408; Cybulsky AV, 2002, J BIOL CHEM, V277, P41342, DOI 10.1074/jbc.M204694200; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; GUTTERIDGE JMC, 1982, BIOCHEM J, V206, P605, DOI 10.1042/bj2060605; GUTTERIDGE JMC, 1986, FEBS LETT, V201, P291, DOI 10.1016/0014-5793(86)80626-3; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JOHNSON RJ, 1987, J CLIN INVEST, V79, P1379, DOI 10.1172/JCI112965; Kappus H., 1993, HDB EXP PHARM, V105, P145; KARUZINA II, 1994, FREE RADICAL BIO MED, V16, P73, DOI 10.1016/0891-5849(94)90245-3; KUTHAN H, 1978, FEBS LETT, V91, P343, DOI 10.1016/0014-5793(78)81206-X; Liu H, 2003, NEPHRON EXP NEPHROL, V94, pE17, DOI 10.1159/000070815; Liu H, 2002, KIDNEY INT, V62, P868, DOI 10.1046/j.1523-1755.2002.00515.x; Liu H, 2001, AM J PHYSIOL-RENAL, V280, pF88, DOI 10.1152/ajprenal.2001.280.1.F88; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lueck A, 1998, J CELL SCI, V111, P3633; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; NEALE TJ, 1993, P NATL ACAD SCI USA, V90, P3645, DOI 10.1073/pnas.90.8.3645; NEALE TJ, 1994, J CLIN INVEST, V94, P1577, DOI 10.1172/JCI117499; Ni XG, 2008, MOL MED, V14, P582, DOI 10.2119/2008-00020.Ni; NORDBLOM GD, 1977, ARCH BIOCHEM BIOPHYS, V180, P343, DOI 10.1016/0003-9861(77)90047-9; PALLER MS, 1994, P NATL ACAD SCI USA, V91, P7002, DOI 10.1073/pnas.91.15.7002; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; QUIGG RJ, 1988, KIDNEY INT, V34, P43, DOI 10.1038/ki.1988.143; RASHBASTEP J, 1994, MOL PHARMACOL, V45, P150; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; ROSREMEDIOS CG, 2003, PHYSIOL REV, V83, P433; SALANT DJ, 1989, KIDNEY INT, V35, P976, DOI 10.1038/ki.1989.81; SHAH SV, 1988, AM J PHYSIOL, V254, pF337, DOI 10.1152/ajprenal.1988.254.3.F337; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Tian N, 2010, KIDNEY INT, V78, P182, DOI 10.1038/ki.2010.100; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Tzanakakis ES, 2002, CELL BIOL TOXICOL, V18, P13, DOI 10.1023/A:1014415128392; Ueda N, 1996, KIDNEY INT, V49, P370, DOI 10.1038/ki.1996.54; United States Renal Data System, 2009, ATL END STAG REN DIS; Yuan HP, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134946	53	6	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40901	40910		10.1074/jbc.M110.165498	http://dx.doi.org/10.1074/jbc.M110.165498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947506	hybrid, Green Published			2022-12-27	WOS:000285414400054
J	Soleimanpour, SA; Crutchlow, MF; Ferrari, AM; Raum, JC; Groff, DN; Rankin, MM; Liu, CY; De Leon, DD; Naji, A; Kushner, JA; Stoffers, DA				Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Rankin, Matthew M.; Liu, Chengyang; De Leon, Diva D.; Naji, Ali; Kushner, Jake A.; Stoffers, Doris A.			Calcineurin Signaling Regulates Human Islet beta-Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; PROTEIN-KINASE-B; DIABETES-MELLITUS; CYCLIN D1; GLUCOSE-HOMEOSTASIS; KIDNEY-TRANSPLANTATION; COACTIVATOR TORC2; PRIMARY MECHANISM; IRS-2 EXPRESSION; GENE-EXPRESSION	The calcium-regulated phosphatase calcineurin intersects with both calcium and cAMP-mediated signaling pathways in the pancreatic beta-cell. Pharmacologic calcineurin inhibition, necessary to prevent rejection in the setting of organ transplantation, is associated with post-transplant beta-cell failure. We sought to determine the effect of calcineurin inhibition on beta-cell replication and survival in rodents and in isolated human islets. Further, we assessed whether the GLP-1 receptor agonist and cAMP stimulus, exendin-4 (Ex-4), could rescue beta-cell replication and survival following calcineurin inhibition. Following treatment with the calcineurin inhibitor tacrolimus, human beta-cell apoptosis was significantly increased. Although we detected no human beta-cell replication, tacrolimus significantly decreased rodent beta-cell replication. Ex-4 nearly normalized both human beta-cell survival and rodent beta-cell replication when co-administered with tacrolimus. We found that tacrolimus decreased Akt phosphorylation, suggesting that calcineurin could regulate replication and survival via the PI3K/Akt pathway. We identify insulin receptor substrate-2 (Irs2), a known cAMP-responsive element-binding protein target and upstream regulator of the PI3K/Akt pathway, as a novel calcineurin target in beta-cells. Irs2 mRNA and protein are decreased by calcineurin inhibition in both rodent and human islets. The effect of calcineurin on Irs2 expression is mediated at least in part through the nuclear factor of activated T-cells (NFAT), as NFAT occupied the Irs2 promoter in a calcineurin-sensitive manner. Ex-4 restored Irs2 expression in tacrolimustreated rodent and human islets nearly to baseline. These findings reveal calcineurin as a regulator of human beta-cell survival in part through regulation of Irs2, with implications for the pathogenesis and treatment of diabetes following organ transplantation.	[Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Stoffers, Doris A.] Univ Penn, Div Endocrinol Diabet & Metab, Dept Med, Philadelphia, PA 19104 USA; [Soleimanpour, Scott A.; Crutchlow, Michael F.; Ferrari, Alana M.; Raum, Jeffrey C.; Groff, David N.; Stoffers, Doris A.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Rankin, Matthew M.; De Leon, Diva D.; Kushner, Jake A.] Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Rankin, Matthew M.; De Leon, Diva D.; Kushner, Jake A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Liu, Chengyang; Naji, Ali] Univ Penn, Dept Surg, Div Transplant Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Stoffers, DA (corresponding author), 415 Curie Blvd,726 CRB, Philadelphia, PA 19104 USA.	stoffers@mail.med.upenn.edu	De Leon, Diva D./V-8626-2019; Ferrari, Alana/S-4566-2019; Kushner, Jake A/AFJ-8198-2022; Kushner, Jake A/AAF-5049-2022; Stoffers, Doris/H-6157-2012	De Leon, Diva D./0000-0003-1225-8087; Ferrari, Alana/0000-0002-9058-8041; Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Soleimanpour, Scott/0000-0001-6777-4498	National Institutes of Health [DK49210, DK062965, U42 (RR016600), K12 (RR017625)]; American Diabetes Association [7-01-CD-15]; Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine [4100043362]; Iacocca Foundation; Benjamin and Mary Siddons Measey Foundation; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center [P30 DK50306]; Kirschstein NRSA [DK007314-27]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR016600, K12RR017625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, R01DK062965, P30DK050306, T32DK007314] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine; Iacocca Foundation; Benjamin and Mary Siddons Measey Foundation; University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center; Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK49210 and DK062965 (to D. A. S.), U42 (RR016600) (to A. N.), and National Institutes of Health Career Development Award K12 (RR017625) (to M. F. C.). This work was also supported by American Diabetes Association Career Development Award 7-01-CD-15 (to D. A. S.), Commonwealth of Pennsylvania Center for Excellence in Regenerative Medicine Grant 4100043362 (to D. A. S., A. N., and J. A. K.), a research grant from The Iacocca Foundation (to D. A. S. and A. N.), Kirschstein NRSA-T32 Award DK007314-27 (to S. A. S.), a grant from the Benjamin and Mary Siddons Measey Foundation (to S. A. S.), and Morphology Core of the University of Pennsylvania Center for Molecular Studies in Digestive and Liver Disease Center Grant P30 DK50306.	Baid S, 2001, TRANSPLANTATION, V72, P1066, DOI 10.1097/00007890-200109270-00015; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Buzzi F, 2010, MOL CELL BIOL, V30, P601, DOI 10.1128/MCB.00719-09; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cosio FG, 2005, KIDNEY INT, V67, P2415, DOI 10.1111/j.1523-1755.2005.00349.x; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Crutchlow MF, 2007, CURR OPIN ORGAN TRAN, V12, P55, DOI 10.1097/MOT.0b013e328012b281; Davidson J, 2003, TRANSPLANTATION, V75, pSS3, DOI 10.1097/01.TP.0000069952.49242.3E; De Leon DD, 2006, PHYSIOL GENOMICS, V24, P133, DOI 10.1152/physiolgenomics.00156.2005; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; Deramaudt TB, 2006, J BIOL CHEM, V281, P38385, DOI 10.1074/jbc.M605891200; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Dickson LM, 2001, J BIOL CHEM, V276, P21110, DOI 10.1074/jbc.M101257200; Drachenberg CB, 1999, TRANSPLANTATION, V68, P396, DOI 10.1097/00007890-199908150-00012; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fatrai S, 2006, DIABETES, V55, P318, DOI 10.2337/diabetes.55.02.06.db05-0757; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Holst LS, 1998, BIOCHEM BIOPH RES CO, V250, P181, DOI 10.1006/bbrc.1998.9166; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kahl CR, 2004, MOL BIOL CELL, V15, P1833, DOI 10.1091/mbc.e03-10-0730; Kang JH, 2006, DIABETOLOGIA, V49, P969, DOI 10.1007/s00125-006-0179-6; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kim MJ, 2006, J ENDOCRINOL, V188, P623, DOI 10.1677/joe.1.06480; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lawrence MC, 2002, DIABETES, V51, P691, DOI 10.2337/diabetes.51.3.691; Lawrence MC, 2001, MOL ENDOCRINOL, V15, P1758, DOI 10.1210/me.15.10.1758; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Muller D, 2006, DIABETES, V55, P2835, DOI 10.2337/db06-0532; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Rao P, 2005, DIABETES, V54, P1664, DOI 10.2337/diabetes.54.6.1664; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stoffers DA, 1998, J CLIN INVEST, V102, P232, DOI 10.1172/JCI2242; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	67	101	107	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40050	40059		10.1074/jbc.M110.154955	http://dx.doi.org/10.1074/jbc.M110.154955			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943662	hybrid, Green Published			2022-12-27	WOS:000285185500050
J	Yamasaki, K; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Ca2+ Release to Lumen from ADP-sensitive Phosphoenzyme E1PCa(2) without Bound K+ of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLED ATP HYDROLYSIS; STABLE STRUCTURAL ANALOG; CALCIUM-PUMP; INSENSITIVE PHOSPHOENZYME; ADENOSINE-TRIPHOSPHATASE; PHOSPHORYLATED INTERMEDIATE; CA-2+-TRANSPORT ATPASE; CRYSTAL-STRUCTURE; TRANSPORT SITES; HEAT-PRODUCTION	During Ca2+ transport by sarcoplasmic reticulum Ca2+-ATPase, the conformation change of ADP-sensitive phosphoenzyme (E1PCa(2)) to ADP-insensitive phosphoenzyme (E2PCa(2)) is followed by rapid Ca2+ release into the lumen. Here, we find that in the absence of K+, Ca2+ release occurs considerably faster than E1PCa(2) to E2PCa(2) conformation change. Therefore, the lumenal Ca2+ release pathway is open to some extent in the K+-free E1PCa(2) structure. The Ca2+ affinity of this E1P is as high as that of the unphosphorylated ATPase (E1), indicating the Ca2+ binding sites are not disrupted. Thus, bound K+ stabilizes the E1PCa(2) structure with occluded Ca2+, keeping the Ca2+ pathway to the lumen closed. We found previously (Yamasaki, K., Wang, G., Daiho, T., Danko, S., and Suzuki, H. (2008) J. Biol. Chem. 283, 29144-29155) that the K+ bound in E2P reduces the Ca2+ affinity essential for achieving the high physiological Ca2+ gradient and to fully open the lumenal Ca2+ gate for rapid Ca2+ release (E2PCa(2)-> E2P + 2Ca(2+)). These findings show that bound K+ is critical for stabilizing both E1PCa(2) and E2P structures, thereby contributing to the structural changes that efficiently couple phosphoenzyme processing and Ca2+ handling.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21570127] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research C (to K. Y.) and B (to H. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Barata H, 2002, J BIOL CHEM, V277, P16868, DOI 10.1074/jbc.M200648200; BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Champeil P, 1997, BIOCHEMISTRY-US, V36, P12383, DOI 10.1021/bi9709699; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; de Meis L, 2001, J BIOL CHEM, V276, P25078, DOI 10.1074/jbc.M103318200; DUGGAN PF, 1970, J GEN PHYSIOL, V56, P147, DOI 10.1085/jgp.56.2.147; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.bb.18.060189.002001; HANEL AM, 1991, BIOCHEMISTRY-US, V30, P11320, DOI 10.1021/bi00111a019; HASSELBACH W, 1961, BIOCHEM Z, V333, P518; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; INESI G, 1987, J BIOL CHEM, V262, P16338; KANAZAWA T, 1970, J BIOCHEM-TOKYO, V67, P693, DOI 10.1093/oxfordjournals.jbchem.a129297; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; Lee AG, 2002, BBA-BIOMEMBRANES, V1565, P246, DOI 10.1016/S0005-2736(02)00573-4; LEE AG, 1995, BIOCHEM J, V305, P225, DOI 10.1042/bj3050225; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; MALAN NT, 1975, FEBS LETT, V60, P122, DOI 10.1016/0014-5793(75)80432-7; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; MEDDA P, 1987, EUR J BIOCHEM, V165, P251, DOI 10.1111/j.1432-1033.1987.tb11435.x; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAKAMURA J, 1989, J BIOL CHEM, V264, P17029; NAKAMURA S, 1994, J BIOL CHEM, V269, P16015; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P11331, DOI 10.1021/bi00111a020; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P8626, DOI 10.1021/bi00423a018; Reis M, 2001, J BIOL CHEM, V276, P42793, DOI 10.1074/jbc.M107625200; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; YU X, 1995, J BIOL CHEM, V270, P4361, DOI 10.1074/jbc.270.9.4361; Zhang ZS, 2001, J BIOL CHEM, V276, P15232, DOI 10.1074/jbc.M010813200	58	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38674	38683		10.1074/jbc.M110.183343	http://dx.doi.org/10.1074/jbc.M110.183343			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937807	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000284625600072
J	Guo, Y; Au, WC; Shakoury-Elizeh, M; Protchenko, O; Basrai, M; Prinz, WA; Philpott, CC				Guo, Yan; Au, Wei-Chun; Shakoury-Elizeh, Minoo; Protchenko, Olga; Basrai, Munira; Prinz, William A.; Philpott, Caroline C.			Phosphatidylserine Is Involved in the Ferrichrome-induced Plasma Membrane Trafficking of Arn1 in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN-DEPENDENT TRAFFICKING; CROSS-PATHWAY REGULATION; PHOSPHOLIPID METHYLATION; PROTEIN LOCALIZATION; INOSITOL SYNTHESIS; GENETIC-ANALYSIS; BUDDING YEAST; PKH-KINASES; IRON UPTAKE	Arn1 is an integral membrane protein that mediates the uptake of ferrichrome, an important nutritional source of iron, in Saccharomyces cerevisiae. In the absence of ferrichrome, Arn1p is sorted directly from the trans-Golgi network to the vacuolar lumen for degradation. In the presence of low levels of ferrichrome, the siderophore binds to a receptor domain on Arn1, triggering the redistribution of Arn1 to the plasma membrane. When extracellular ferrichrome levels are high, Arn1 cycles between the plasma membrane and intracellular vesicles. To further understand the mechanisms of trafficking of Arn1p, we screened 4580 viable yeast deletion mutants for mislocalization of Arn1-GFP using synthetic genetic array technology. We identified over 100 genes required for trans-Golgi network-to-vacuole trafficking of Arn1-GFP and only two genes, SER1 and SER2, required for the ferrichrome-induced plasma membrane trafficking of Arn1-GFP. SER1 and SER2 encode two enzymes of the major serine biosynthetic pathway, and the Arn1 trafficking defect in the ser1 Delta strain was corrected with supplemental serine or glycine. Plasma membrane trafficking of Hxt3, a structurally related glucose transporter, was unaffected by SER1 deletion. Serine is required for the synthesis of multiple cellular components, including purines, sphingolipids, and phospholipids, but of these only phosphatidylserine corrected the Arn1 trafficking defects of the ser1 Delta strain. Strains with defects in phospholipid synthesis also exhibited alterations in Arn1p trafficking, indicating that the intracellular trafficking of some transporters is dependent on the phospholipid composition of the cellular membranes.	[Guo, Yan; Shakoury-Elizeh, Minoo; Protchenko, Olga; Philpott, Caroline C.] NIDDK, Liver Dis Branch, Bethesda, MD 20892 USA; [Prinz, William A.] NIDDK, Lab Cell Biol & Biochem, Bethesda, MD 20892 USA; [Au, Wei-Chun; Basrai, Munira] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Philpott, CC (corresponding author), Bldg 10 Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Protchenko, Olga/AAU-9237-2021; Basrai, Munira/AAV-4422-2020	Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health (NIH), NIDDK, Intramural Research Program; NCI, NIH; NATIONAL CANCER INSTITUTE [ZIABC010822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054512] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NIDDK, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health (NIH), NIDDK, Intramural Research Program (to Y. G., M. S.-E., O. P., W. A. P., and C. C. P.) and by NCI, NIH (to W.-C. A. and M. B.).	Barfield RM, 2009, MOL BIOL CELL, V20, P4985, DOI 10.1091/mbc.E09-04-0324; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579; Kim Y, 2002, EMBO J, V21, P3632, DOI 10.1093/emboj/cdf382; Kim Y, 2007, MOL BIOL CELL, V18, P1790, DOI 10.1091/mbc.E06-09-0861; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Manna D, 2008, J BIOL CHEM, V283, P26047, DOI 10.1074/jbc.M802617200; MCGRAW P, 1989, GENETICS, V122, P317; MELCHER K, 1992, CURR GENET, V21, P295, DOI 10.1007/BF00351686; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nakamura H, 2000, BIOSCI BIOTECH BIOCH, V64, P167, DOI 10.1271/bbb.64.167; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Philpott CC, 2006, BBA-MOL CELL RES, V1763, P636, DOI 10.1016/j.bbamcr.2006.05.008; Philpott CC, 1998, EMBO J, V17, P5026, DOI 10.1093/emboj/17.17.5026; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; SHERMAN F, 1991, P3; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; SUMMERS EF, 1988, GENETICS, V120, P909; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yun CW, 2000, J BIOL CHEM, V275, P16354, DOI 10.1074/jbc.M001456200	42	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39564	39573		10.1074/jbc.M110.177055	http://dx.doi.org/10.1074/jbc.M110.177055			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923770	hybrid, Green Published			2022-12-27	WOS:000284941300082
J	Kowlessur, D; Tobacman, LS				Kowlessur, Devanand; Tobacman, Larry S.			Low Temperature Dynamic Mapping Reveals Unexpected Order and Disorder in Troponin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIN FILAMENT PROTEINS; HUMAN CARDIAC TROPONIN; PHOTO-CROSS-LINKING; C-TERMINAL REGION; HYDROGEN-EXCHANGE; MUSCLE-CONTRACTION; SKELETAL-MUSCLE; INHIBITORY REGION; MASS-SPECTROMETRY; STRIATED-MUSCLE	Troponin is a pivotal regulatory protein that binds Ca2+ reversibly to act as the muscle contraction on-off switch. To understand troponin function, the dynamic behavior of the Ca2+-saturated cardiac troponin core domain was mapped in detail at 10 degrees C, using H/D exchange-mass spectrometry. The low temperature conditions of the present study greatly enhanced the dynamic map compared with previous work. Approximately 70% of assessable peptide bond hydrogens were protected from exchange sufficiently for dynamic measurement. This allowed the first characterization by this method of many regions of regulatory importance. Most of the TnI COOH terminus was protected from H/D exchange, implying an intrinsically folded structure. This region is critical to the troponin inhibitory function and has been implicated in thin filament activation. Other new findings include unprotected behavior, suggesting high mobility, for the residues linking the two domains of TnC, as well as for the inhibitory peptide residues preceding the TnI switch helix. These data indicate that, in solution, the regulatory subdomain of cardiac troponin is mobile relative to the remainder of troponin. Relatively dynamic properties were observed for the interacting TnI switch helix and TnC NH2-domain, contrasting with stable, highly protected properties for the interacting TnI helix 1 and TnC COOH-domain. Overall, exchange protection via protein folding was relatively weak or for a majority of peptide bond hydrogens. Several regions of TnT and TnI were unfolded even at low temperature, suggesting intrinsic disorder. Finally, change in temperature prominently altered local folding stability, suggesting that troponin is an unusually mobile protein under physiological conditions.	Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	LST@uic.edu			National Institutes of Health [HL063774, HL038834]; Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063774, R29HL038834, R01HL038834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Community Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834, and also by the CBC/UIC Proteomics and Informatics Facility, established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium.	Arrington CB, 2000, METHOD ENZYMOL, V323, P104; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Burkart EM, 2003, J BIOL CHEM, V278, P11265, DOI 10.1074/jbc.M210712200; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Foster DB, 2003, CIRC RES, V93, P917, DOI 10.1161/01.RES.0000099889.35340.6F; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Mathur MC, 2008, BIOPHYS J, V94, P542, DOI 10.1529/biophysj.107.113944; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Milne JS, 1999, J MOL BIOL, V290, P811, DOI 10.1006/jmbi.1999.2924; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Smith DL, 1997, J MASS SPECTROM, V32, P135, DOI 10.1002/(SICI)1096-9888(199702)32:2<135::AID-JMS486>3.0.CO;2-M; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	47	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38978	38986		10.1074/jbc.M110.181305	http://dx.doi.org/10.1074/jbc.M110.181305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889975	Green Published, hybrid			2022-12-27	WOS:000284941300028
J	Koprowski, P; Grajkowski, W; Isacoff, EY; Kubalski, A				Koprowski, Piotr; Grajkowski, Wojciech; Isacoff, Ehud Y.; Kubalski, Andrzej			Genetic Screen for Potassium Leaky Small Mechanosensitive Channels (MscS) in Escherichia coli RECOGNITION OF CYTOPLASMIC beta DOMAIN AS A NEW GATING ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-CONDUCTANCE MSCS; MUTATIONS; PROTEIN; PORE; IDENTIFICATION; MUTAGENESIS; TRANSITION; MECHANISM; TRANSPORT; DYNAMICS	Mechanosensitive membrane channels in bacteria respond to the mechanical stretching of the membrane. They will open when bacteria are subjected to rapid osmotic down shock. MscS is a bacterial mechanosensitive channel of small conductance. It is a heptameric membrane protein whose transmembrane part, including the gate and its kinetics, has been well characterized. MscS has a large cytoplasmic domain of a cage-like shape that changes its conformation upon gating, but its involvement in gating is not understood. We screened MscS for mutations that cause potassium leak in Escherichia coli strains deficient in potassium transport systems. We did a phenotypic analysis of single and multiple mutants and recorded the single channel activities of some of them. After these analyses, we attributed the effects of a number of mutations to particular functional states of the channel. Our screen revealed that MscS leaks potassium in a desensitized and in an inactivated state. It also appeared that the lower part of TM3 (transmembrane, pore-forming helix) and the cytoplasmic beta domain are tightly packed in the inactivated state but are dissociated in the open state. We attribute the TM3-beta interaction to stabilization of the inactivated state in MscS and to the control of tight closure of its membrane pore.	[Koprowski, Piotr; Grajkowski, Wojciech; Kubalski, Andrzej] M Nencki Inst Expt Biol, Dept Cell Biol, PL-02093 Warsaw, Poland; [Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of California System; University of California Berkeley	Kubalski, A (corresponding author), M Nencki Inst Expt Biol, Dept Cell Biol, Pasteur 3, PL-02093 Warsaw, Poland.	a.kubalski@nencki.gov.pl	isacoff, ehud/AAP-1459-2020; Koprowski, Piotr R/R-4088-2016	Koprowski, Piotr R/0000-0002-7571-2446; Isacoff, Ehud Y./0000-0003-4775-9359	National Institutes of Health [R01 NS35549]; Polish Ministry of Education [2P04C0167, NN301338033]; Human Frontier Science Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Education; Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS35549 (to E. Y. I.). This work was also supported by Grants 2P04C0167 and NN301338033 from the Polish Ministry of Education (to A. K., P. K., and W. G.) and by a Human Frontier Science Program Long Term Fellowship (to P. K.).	Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Akitake B, 2007, BIOPHYS J, V92, P2771, DOI 10.1529/biophysj.106.098715; Anishkin A, 2004, BIOPHYS J, V86, p6A; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Anishkin A, 2008, BIOPHYS J, V94, P1252, DOI 10.1529/biophysj.107.110171; Anishkin A, 2009, J BIOL CHEM, V284, P19153, DOI 10.1074/jbc.R109.009357; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Belyy V, 2010, NAT STRUCT MOL BIOL, V17, P451, DOI 10.1038/nsmb.1775; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; DOSCH DC, 1991, J BACTERIOL, V173, P687, DOI 10.1128/jb.173.2.687-696.1991; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006; Grajkowski W, 2005, BIOPHYS J, V88, p289A; Humphrey W., 1996, J MOL GRAPHICS, V14, P37; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Koprowski P, 2003, J BIOL CHEM, V278, P11237, DOI 10.1074/jbc.M212073200; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li C, 2007, MOL MICROBIOL, V64, P560, DOI 10.1111/j.1365-2958.2007.05672.x; Machiyama H, 2009, BIOPHYS J, V97, P1048, DOI 10.1016/j.bpj.2009.05.021; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Nomura T, 2006, BIOPHYS J, V91, P2874, DOI 10.1529/biophysj.106.084541; Okada K, 2002, J BIOL CHEM, V277, P27682, DOI 10.1074/jbc.M202497200; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Parfenova LV, 2006, J BIOL CHEM, V281, P21131, DOI 10.1074/jbc.M603109200; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; Sotomayor M, 2006, BIOPHYS J, V90, P3496, DOI 10.1529/biophysj.105.080069; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Sotomayor M, 2007, BIOPHYS J, V92, P886, DOI 10.1529/biophysj.106.095232; Spronk SA, 2006, BIOPHYS J, V90, P3555, DOI 10.1529/biophysj.105.080432; Sun S, 2006, PHYSIOL GENOMICS, V26, P1, DOI 10.1152/physiolgenomics.00026.2006; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2004, BIOPHYS J, V86, p545A	40	31	33	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					877	888		10.1074/jbc.M110.176131	http://dx.doi.org/10.1074/jbc.M110.176131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978126	Green Published, hybrid			2022-12-27	WOS:000285782800087
J	Moren, A; Raja, E; Heldin, CH; Moustakas, A				Moren, Anita; Raja, Erna; Heldin, Carl-Henrik; Moustakas, Aristidis			Negative Regulation of TGF beta Signaling by the Kinase LKB1 and the Scaffolding Protein LIP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITIONS; BONE MORPHOGENETIC PROTEIN; TUMOR-SUPPRESSOR SMAD4; CELLS; CANCER; DIFFERENTIATION; ACTIVATION; RECEPTORS; POLYPOSIS	Signal transduction by the Smad pathway elicits critical biological responses to many extracellular polypeptide factors, including TGF beta and bone morphogenetic protein. Regulation of Smad signaling imparts several cytoplasmic and nuclear mechanisms, some of which entail protein phosphorylation. Previous work established a protein complex between Smad4 and the scaffolding protein LKB1-interacting protein 1 (LIP1). LKB1 is a well studied tumor suppressor kinase that regulates cell growth and polarity. Here, we analyzed the LKB1-LIP1 and the Smad4-LIP1 protein complexes and found that LIP1 can self-oligomerize. We further demonstrate that LKB1 is capable of phosphorylating Smad4 on Thr(77) of its DNA-binding domain. LKB1 inhibits Smad4 from binding to either TGF beta- or bone morphogenetic protein-specific promoter sequences, which correlates with the negative regulatory effect LKB1 exerts on Smad4-dependent transcription. Accordingly, LKB1 negatively regulates TGF beta gene responses and epithelial- mesenchymal transition. Thus, LKB1 and LIP1 provide negative control of TGF beta signaling.	[Moren, Anita; Raja, Erna; Heldin, Carl-Henrik; Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Moustakas, Aristidis] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University; Uppsala University	Moustakas, A (corresponding author), Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	aris.moustakas@licr.uu.se			Ludwig Institute for Cancer Research, Swedish Research Council [K2007-66X-14936-04-3]; European Commission [LSHG-CT-2005-518254]	Ludwig Institute for Cancer Research, Swedish Research Council(Swedish Research Council); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Ludwig Institute for Cancer Research, Swedish Research Council Grant K2007-66X-14936-04-3, and the European Commission FP6 Program network of excellence ENFIN with Contract LSHG-CT-2005-518254.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Katoh Y, 2004, MOL CELL ENDOCRINOL, V217, P109, DOI 10.1016/j.mce.2003.10.016; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Londesborough A, 2008, DEVELOPMENT, V135, P2331, DOI 10.1242/dev.017038; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moren A, 2003, J BIOL CHEM, V278, P33571, DOI 10.1074/jbc.M300159200; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Shen Zan, 2005, Zhonghua Yi Xue Za Zhi, V85, P15; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Vaahtomeri K, 2008, J CELL SCI, V121, P3531, DOI 10.1242/jcs.032706; Wicks SJ, 2000, MOL CELL BIOL, V20, P8103, DOI 10.1128/MCB.20.21.8103-8111.2000; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yakmovych I, 2001, FASEB J, V15, P553; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	35	39	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					341	353		10.1074/jbc.M110.190660	http://dx.doi.org/10.1074/jbc.M110.190660			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974850	Green Published, hybrid			2022-12-27	WOS:000285782800037
J	Abramian, AM; Comenencia-Ortiz, E; Vithlani, M; Tretter, EV; Sieghart, W; Davies, PA; Moss, SJ				Abramian, Armen M.; Comenencia-Ortiz, Eydith; Vithlani, Mansi; Tretter, Eva Verena; Sieghart, Werner; Davies, Paul A.; Moss, Stephen J.			Protein Kinase C Phosphorylation Regulates Membrane Insertion of GABA(A) Receptor Subtypes That Mediate Tonic Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE STABILITY; HIPPOCAMPAL PYRAMIDAL NEURONS; GRANULE CELLS; ALPHA-BUNGAROTOXIN; A RECEPTORS; SYNAPTIC INHIBITION; DELTA-SUBUNITS; DENTATE GYRUS; HIGH-AFFINITY; BINDING-SITE	Tonic inhibition in the brain is mediated largely by specialized populations of extrasynaptic receptors, gamma-aminobutyric acid receptors (GABA(A)Rs). In the dentate gyrus region of the hippocampus, tonic inhibition is mediated primarily by GABA(A)R subtypes assembled from alpha 4 beta 2/3 with or without the delta subunit. Although the gating of these receptors is subject to dynamic modulation by agents such as anesthetics, barbiturates, and neurosteroids, the cellular mechanisms neurons use to regulate their accumulation on the neuronal plasma membrane remain to be determined. Using immunoprecipitation coupled with metabolic labeling, we demonstrate that the alpha 4 subunit is phosphorylated at Ser(443) by protein kinase C (PKC) in expression systems and hippocampal slices. In addition, the beta 3 subunit is phosphorylated on serine residues 408/409 by PKC activity, whereas the delta subunit did not appear to be a PKC substrate. We further demonstrate that the PKC-dependent increase of the cell surface expression of alpha 4 subunit-containing GABA(A)Rs is dependent on Ser(443). Mechanistically, phosphorylation of Ser(443) acts to increase the stability of the alpha 4 subunit within the endoplasmic reticulum, thereby increasing the rate of receptor insertion into the plasma membrane. Finally, we show that phosphorylation of Ser(443) increases the activity of alpha 4 subunit-containing GABA(A)Rs by preventing current run-down. These results suggest that PKC-dependent phosphorylation of the alpha 4 subunit plays a significant role in enhancing the cell surface stability and activity of GABA(A)R subtypes that mediate tonic inhibition.	[Abramian, Armen M.; Comenencia-Ortiz, Eydith; Vithlani, Mansi; Davies, Paul A.; Moss, Stephen J.] Tufts Univ, Dept Neurosci, Boston, MA 02111 USA; [Abramian, Armen M.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Sieghart, Werner] Med Univ Vienna, Brain Res Ctr, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	Tufts University; University of Pennsylvania; Medical University of Vienna; University of London; University College London	Moss, SJ (corresponding author), Tufts Univ, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	stephen.moss@tufts.edu	Sieghart, Werner/A-4877-2013; Davies, Paul A/P-4595-2017	Sieghart, Werner/0000-0002-0443-0302; Davies, Paul A/0000-0002-3973-3143	National Institutes of Health/NINDS [NS048045, NS051195, NS056359, NS054900]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081986, T32NS061764, R01NS056359, R01NS051195, R21NS080064, P01NS054900, R01NS048045] Funding Source: NIH RePORTER	National Institutes of Health/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health/NINDS Grants NS048045, NS051195, NS056359, and NS054900 (to S. J. M.). S. J. M. serves as a consultant for Pfizer Pharmaceuticals, a relationship that is regulated by Tufts University and does not impact on this work.	Behr J, 1998, J NEUROPHYSIOL, V79, P1726, DOI 10.1152/jn.1998.79.4.1726; Bencsits E, 1999, J BIOL CHEM, V274, P19613, DOI 10.1074/jbc.274.28.19613; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200; Bright DP, 2007, J NEUROSCI, V27, P2560, DOI 10.1523/JNEUROSCI.5100-06.2007; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Carlson GC, 2008, NAT PROTOC, V3, P249, DOI 10.1038/nprot.2007.539; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chandra D, 2006, P NATL ACAD SCI USA, V103, P15230, DOI 10.1073/pnas.0604304103; Cheng VY, 2006, ANESTHESIOLOGY, V105, P325, DOI 10.1097/00000542-200608000-00015; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng HJ, 2006, J NEUROSCI, V26, P1499, DOI 10.1523/JNEUROSCI.2913-05.2006; Hamann M, 2002, NEURON, V33, P625, DOI 10.1016/S0896-6273(02)00593-7; HEINEMANN U, 1992, EPILEPSY RES, P273; Jacob TC, 2009, P NATL ACAD SCI USA, V106, P12500, DOI 10.1073/pnas.0903943106; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004; Katchalski-Katzir E, 2003, BIOPHYS CHEM, V100, P293, DOI 10.1016/S0301-4622(02)00287-9; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Liang J, 2008, ALCOHOL CLIN EXP RES, V32, P19, DOI 10.1111/j.1530-0277.2007.00564.x; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Maguire J, 2007, J NEUROSCI, V27, P2155, DOI 10.1523/JNEUROSCI.4945-06.2007; Maldonado-Aviles JG, 2009, AM J PSYCHIAT, V166, P450, DOI 10.1176/appi.ajp.2008.08101484; MCDONALD BJ, 1994, J BIOL CHEM, V269, P18111; McDonald BJ, 1998, NAT NEUROSCI, V1, P23, DOI 10.1038/223; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; Mortensen M, 2006, J PHYSIOL-LONDON, V577, P841, DOI 10.1113/jphysiol.2006.117952; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Park JB, 2006, ENDOCRINOLOGY, V147, P3746, DOI 10.1210/en.2006-0218; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Semyanov A, 2003, NAT NEUROSCI, V6, P484, DOI 10.1038/nn1043; Senawongse P, 2005, J CHEM INF MODEL, V45, P1147, DOI 10.1021/ci050047+; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sun CS, 2004, BRAIN RES, V1029, P207, DOI 10.1016/j.brainres.2004.09.056; Tang X, 2010, J NEUROPHYSIOL, V103, P1007, DOI 10.1152/jn.00801.2009; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Tretter V, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.007.2008; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Zhang NH, 2007, J NEUROSCI, V27, P7520, DOI 10.1523/JNEUROSCI.1555-07.2007	55	74	77	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41795	41805		10.1074/jbc.M110.149229	http://dx.doi.org/10.1074/jbc.M110.149229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940303	Green Published, hybrid			2022-12-27	WOS:000285622600067
J	Anderson, DR; Duryee, MJ; Anchan, RK; Garvin, RP; Johnston, MD; Porter, TR; Thiele, GM; Klassen, LW				Anderson, Daniel R.; Duryee, Michael J.; Anchan, Rajeev K.; Garvin, Robert P.; Johnston, Michael D.; Porter, Thomas R.; Thiele, Geoffrey M.; Klassen, Lynell W.			Albumin-based Microbubbles Bind Up-regulated Scavenger Receptors following Vascular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCLINICAL ATHEROSCLEROSIS; RISK; TOLL-LIKE-RECEPTOR-4; COMPLEMENT; EXPRESSION; INFLAMMATION; PERSISTENCE; ADHERENCE; VARIANTS; PLAQUE	We have shown previously that perfluorocarbon-exposed sonicated dextrose albumin (PESDA) microbubbles bind to injured vascular tissue and can be detected with ultrasound imaging techniques. Prior studies have shown that scavenger receptors (SRs) are regulators of innate and adaptive immune responses and are involved in the progression of vascular disease such as atherosclerosis. In this study, we sought to determine the molecular mechanism of PESDA binding to ballooninjured vasculature. RT-PCR analysis of angioplastied aortas demonstrated a significantly (p <= 0.01) increased expression of SRs. Binding to SRs was confirmed using SR-expressing CHO cells, and this binding was blocked by competitive inhibition with the SR-binding ligands oxidized LDL and malondialdehyde-acetaldehyde-modified LDL. Confocal imaging confirmed the co-localization of PESDA microbubbles to CD36, SRB-1, and Toll-like receptor 4, but not to monocytes/macrophages. This study demonstrates that PESDA binds to SRs and that this binding is in major part dependent upon the oxidized nature of PESDA microbubble shell proteins. The extent of SR mRNA expression was increased with injury and associated with microbubble retention as defined by scanning electron microscopy and immunohistochemistry. These findings clarify the mechanisms of how albumin-based microbubbles bind to injured and inflamed vasculature and further support the potential of this imaging technique to detect early vascular innate inflammatory pathophysiologic processes.	[Anderson, Daniel R.; Porter, Thomas R.] Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, Omaha, NE 68198 USA; [Duryee, Michael J.; Thiele, Geoffrey M.; Klassen, Lynell W.] Univ Nebraska Med Ctr, Div Rheumatol, Dept Internal Med, Omaha, NE 68198 USA; [Thiele, Geoffrey M.; Klassen, Lynell W.] Univ Nebraska Med Ctr, Dept Pathol Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Anderson, DR (corresponding author), Univ Nebraska Med Ctr, Div Cardiol, Dept Internal Med, 982265 Nebraska Med Ctr, Omaha, NE 68198 USA.	danderso@unmc.edu		Duryee, Michael/0000-0001-9104-2238; Thiele, Geoffrey/0000-0001-5688-8596	National Scientist Development Grant-American Heart Association [07030210N]; National Institutes of Health; Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center	National Scientist Development Grant-American Heart Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center	This work was supported by National Scientist Development Grant-American Heart Association Grant 07030210N and the National Institutes of Health Student Loan Repayment Program (to D.R.A.) and by the Division of Cardiology, Department of Internal Medicine, at the University of Nebraska Medical Center.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Anderson DR, 2007, CARDIOVASC RES, V73, P597, DOI 10.1016/j.cardiores.2006.11.029; Boekholdt SM, 2003, CIRCULATION, V107, P2416, DOI 10.1161/01.CIR.0000068311.40161.28; Buono C, 2002, CIRCULATION, V105, P3025, DOI 10.1161/01.CIR.0000019584.04929.83; Edfeldt K, 2004, EUR HEART J, V25, P1447, DOI 10.1016/j.ehj.2004.05.004; Erickson B, 2008, CARDIOL REV, V16, P273, DOI 10.1097/CRD.0b013e3181709fd8; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Hart ML, 2004, MOL IMMUNOL, V41, P165, DOI 10.1016/j.molimm.2004.03.013; Karim R, 2008, AM J CARDIOL, V102, P825, DOI 10.1016/j.amjcard.2008.05.039; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kathiresan S, 2007, AM J CARDIOL, V99, P310, DOI 10.1016/j.amjcard.2006.08.028; LEE KD, 1992, BIOCHIM BIOPHYS ACTA, V1111, P1, DOI 10.1016/0005-2736(92)90267-P; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Libby Peter, 2004, Am J Med, V116 Suppl 6A, p9S; Lindner JR, 1998, CIRCULATION, V98, P2187, DOI 10.1161/01.CIR.98.20.2187; Lindner JR, 2000, CIRCULATION, V101, P668, DOI 10.1161/01.CIR.101.6.668; Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; RASBAND WS, 2001, BIOPHOTONICS INT, V11, P36; Tsutsui JM, 2004, J AM COLL CARDIOL, V44, P1036, DOI 10.1016/j.jacc.2004.05.056; Wickelgren I, 2006, SCIENCE, V312, P184, DOI 10.1126/science.312.5771.184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	28	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40645	40653		10.1074/jbc.M110.134809	http://dx.doi.org/10.1074/jbc.M110.134809			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20966069	Green Published, hybrid			2022-12-27	WOS:000285414400027
J	Chen, SR; Chen, H; Yuan, WX; Wess, J; Pan, HL				Chen, Shao-Rui; Chen, Hong; Yuan, Wei-Xiu; Wess, Juergen; Pan, Hui-Lin			Dynamic Control of Glutamatergic Synaptic Input in the Spinal Cord by Muscarinic Receptor Subtypes Defined Using Knockout Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSAL-HORN NEURONS; ACETYLCHOLINE-RECEPTOR; CHOLINERGIC RECEPTORS; AUTORADIOGRAPHIC LOCALIZATION; PROJECTION NEURONS; GABA(B) RECEPTORS; GLYCINERGIC INPUT; NEUROPATHIC PAIN; GABAERGIC INPUTS; TRANSMISSION	Activation of muscarinic acetylcholine receptors (mAChRs) in the spinal cord inhibits pain transmission. At least three mAChR subtypes (M-2, M-3, andM(4)) are present in the spinal dorsal horn. However, it is not clear how each mAChR subtype contributes to the regulation of glutamatergic input to dorsal horn neurons. We recorded spontaneous excitatory postsynaptic currents (sEPSCs) from lamina II neurons in spinal cord slices from wild-type (WT) and mAChR subtype knock-out (KO) mice. The mAChR agonist oxotremorine-M increased the frequency of glutamatergic sEPSCs in 68.2% neurons from WT mice and decreased the sEPSC frequency in 21.2% neurons. Oxotremorine-M also increased the sEPSC frequency in similar to 50% neurons fromM(3)-single KO andM(1)/M-3 double-KO mice. In addition, the M-3 antagonist J104129 did not block the stimulatory effect of oxotremorine-M in the majority of neurons from WT mice. Strikingly, in M-5-single KO mice, oxotremorine-M increased sEPSCs in only 26.3% neurons, and J104129 abolished this effect. InM2/M-4 double-KO mice, but not M-2-or M-4-single KO mice, oxotremorine-M inhibited sEPSCs in significantly fewer neurons compared with WT mice, and blocking group II/III metabotropic glutamate receptors abolished this effect. The M-2/M-4 antagonist himbacine either attenuated the inhibitory effect of oxotremorine-M or potentiated the stimulatory effect of oxotremorine-M in WT mice. Our study demonstrates that activation of the M-2 and M-4 receptor subtypes inhibits synaptic glutamate release to dorsal horn neurons. M-5 is the predominant receptor subtype that potentiates glutamatergic synaptic transmission in the spinal cord.	[Chen, Shao-Rui] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, Houston, TX 77030 USA; [Wess, Juergen] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Chen, SR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	schen@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM64830, NS45602]; N.G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N.G. and Helen T. Hawkins endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Grants GM64830 and NS45602 from the National Institutes of Health and by the N.G. and Helen T. Hawkins endowment (to H.-L. P.).	ALLEN TGJ, 1993, J PHYSIOL-LONDON, V466, P173; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Cai YQ, 2009, J NEUROCHEM, V111, P1000, DOI 10.1111/j.1471-4159.2009.06396.x; Chen SR, 2005, J PHARMACOL EXP THER, V313, P765, DOI 10.1124/jpet.104.082537; Chen SR, 2004, NEUROSCIENCE, V125, P141, DOI 10.1016/j.neuroscience.2004.01.015; Chen SR, 2003, J PHARMACOL EXP THER, V307, P676, DOI 10.1124/jpet.103.055905; Chen YP, 2005, J PHARMACOL EXP THER, V315, P696, DOI 10.1124/jpet.105.091314; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Doller D, 1999, BIOORG MED CHEM LETT, V9, P901, DOI 10.1016/S0960-894X(99)00101-8; Duttaroy A, 2002, MOL PHARMACOL, V62, P1084, DOI 10.1124/mol.62.5.1084; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Hoglund AU, 1997, J PHARMACOL EXP THER, V281, P470; Hood DD, 1997, J PHARMACOL EXP THER, V282, P86; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; MCKINNEY M, 1993, PROG BRAIN RES, V98, P333; MILLER JH, 1992, J PHARMACOL EXP THER, V263, P663; Mitsuya M, 1999, BIOORGAN MED CHEM, V7, P2555, DOI 10.1016/S0968-0896(99)00177-7; Nakayama M, 2001, J CLIN ANESTH, V13, P86, DOI 10.1016/S0952-8180(01)00218-5; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Pan HL, 2008, PHARMACOL THERAPEUT, V117, P141, DOI 10.1016/j.pharmthera.2007.09.003; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; RIBEIRODASILVA A, 1990, J COMP NEUROL, V295, P370, DOI 10.1002/cne.902950303; SCATTON B, 1984, NEUROSCI LETT, V49, P239, DOI 10.1016/0304-3940(84)90296-9; Schoppa NE, 1997, J NEUROPHYSIOL, V78, P1468, DOI 10.1152/jn.1997.78.3.1468; VILLIGER JW, 1985, BRAIN RES, V345, P196, DOI 10.1016/0006-8993(85)90854-6; Wang XL, 2006, J PHYSIOL-LONDON, V571, P403, DOI 10.1113/jphysiol.2005.102905; WANKE E, 1994, EUR J NEUROSCI, V6, P381, DOI 10.1111/j.1460-9568.1994.tb00281.x; WEI J, 1994, J NEUROCHEM, V63, P815; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; YAMAMURA HI, 1983, EUR J PHARMACOL, V91, P147, DOI 10.1016/0014-2999(83)90379-5; Yung KKL, 1997, NEUROSCI LETT, V229, P81, DOI 10.1016/S0304-3940(97)00426-6; Zhang HM, 2009, NEUROSCIENCE, V158, P875, DOI 10.1016/j.neuroscience.2008.10.042; Zhang HM, 2006, MOL PHARMACOL, V69, P1048, DOI 10.1124/mol.105.018069; Zhang HM, 2005, J PHARMACOL EXP THER, V313, P697, DOI 10.1124/jpet.104.079939; Zhang HM, 2007, J PHARMACOL EXP THER, V323, P963, DOI 10.1124/jpet.107.127795; Zhang HM, 2007, J NEUROPHYSIOL, V97, P102, DOI 10.1152/jn.00586.2006; Zhou HY, 2008, J PHARMACOL EXP THER, V324, P1000, DOI 10.1124/jpet.107.133470; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; ZHUO M, 1991, PAIN, V46, P211, DOI 10.1016/0304-3959(91)90078-C	44	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40427	40437		10.1074/jbc.M110.176966	http://dx.doi.org/10.1074/jbc.M110.176966			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940295	Green Published, hybrid			2022-12-27	WOS:000285414400005
J	Jain, S; Tillinger, A; Mopidevi, B; Pandey, VG; Chauhan, CK; Fiering, SN; Warming, S; Kumar, A				Jain, Sudhir; Tillinger, Andrej; Mopidevi, Brahmaraju; Pandey, Varunkumar G.; Chauhan, Chetankumar K.; Fiering, Steven N.; Warming, Soren; Kumar, Ashok			Transgenic Mice with -6A Haplotype of the Human Angiotensinogen Gene Have Increased Blood Pressure Compared with -6G Haplotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ESSENTIAL-HYPERTENSION; MOLECULAR-GENETICS; PROMOTER ACTIVITY; HUMAN RENIN; C/EBP BETA; EXPRESSION; TRANSCRIPTION; RAT	Hypertension is a serious risk factor for cardiovascular disease, and the angiotensinogen (AGT) gene locus is associated with human essential hypertension. The human AGT (hAGT) gene has an A/G polymorphism at -6, and the -6A allele is associated with increased blood pressure. However, transgenic mice containing 1.2 kb of the promoter with -6A of the hAGT gene show neither increased plasma AGT level nor increased blood pressure compared with -6G. We have found that the hAGT gene has three additional SNPs (A/G at -1670, C/G at -1562, and T/G at -1561). Variants -1670A, -1562C, and -1561T almost always occur with -6A, and variants -1670G, -1562G, and -1561G almost always occur with -6G. Therefore, the hAGT gene may be subdivided into either -6A or -6G haplotypes. We show that these polymorphisms affect the binding of HNF-1 alpha and glucocorticoid receptor to the promoter, and a reporter construct containing a 1.8-kb hAGT gene promoter with -6A haplotype has 4-fold increased glucocorticoid-induced promoter activity as compared with -6G haplotype. In order to understand the physiological significance of these haplotypes in an in vivo situation, we have generated double transgenic mice containing either the -6A or -6G haplotype of the hAGT gene and the human renin gene. Our ChIP assay shows that HNF-1 alpha and glucocorticoid receptor have stronger affinity for the chromatin obtained from the liver of transgenic mice containing -6A haplotype. Our studies also show that transgenic mice containing -6A haplotype have increased plasma AGT level and increased blood pressure as compared with -6G haplotype. Our studies explain the molecular mechanism involved in association of the -6A allele of the hAGT gene with hypertension.	[Jain, Sudhir; Tillinger, Andrej; Mopidevi, Brahmaraju; Pandey, Varunkumar G.; Chauhan, Chetankumar K.; Kumar, Ashok] New York Med Coll, Dept Pathol, Valhalla, NY 10595 USA; [Fiering, Steven N.] Dartmouth Med Sch, Dept Microbiol Immunol & Genet, Hanover, NH 03755 USA; [Warming, Soren] NCI Frederick, Mouse Canc Genet Program, NIH, Frederick, MD 21702 USA	New York Medical College; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Kumar, A (corresponding author), New York Med Coll, Dept Pathol, Rm 455,Basic Sci Bldg, Valhalla, NY 10595 USA.	ashok_kumar@nymc.edu	Warming, Soren/ABD-5729-2021; Tillinger, Andrej/E-7964-2018; Mopidevi, Brahmaraju/D-6003-2015	Tillinger, Andrej/0000-0003-4643-7040; Mopidevi, Brahmaraju/0000-0003-1231-7796; Warming, Soren/0000-0002-5721-0741	National Institutes of Health [HL081752, HL66296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105113, R01HL081752, R01HL066296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL081752 and HL66296 (to A. K.).	Atzmon G, 2002, HORM METAB RES, V34, P622, DOI 10.1055/s-2002-38250; Aubert J, 1997, BIOCHEM J, V328, P701, DOI 10.1042/bj3280701; Bailly A, 2001, NUCLEIC ACIDS RES, V29, P3495, DOI 10.1093/nar/29.17.3495; BAUMANN H, 1992, J BIOL CHEM, V267, P19744; BEALE EG, 1992, FASEB J, V6, P3330, DOI 10.1096/fasebj.6.15.1281456; BRASIER AR, 1989, MOL ENDOCRINOL, V3, P1022, DOI 10.1210/mend-3-6-1022; BRASIER AR, 1990, MOL ENDOCRINOL, V4, P1921, DOI 10.1210/mend-4-12-1921; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Butz GM, 2001, PHYSIOL GENOMICS, V5, P89, DOI 10.1152/physiolgenomics.2001.5.2.89; CAMPBELL DJ, 1986, J CLIN INVEST, V78, P31, DOI 10.1172/JCI112566; Cassuto H, 1997, FEBS LETT, V412, P597, DOI 10.1016/S0014-5793(97)00867-3; Cassuto H, 2005, J BIOL CHEM, V280, P33873, DOI 10.1074/jbc.M504119200; Castellano M, 2003, J HYPERTENS, V21, pS219; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Corvol P, 1997, ENDOCR REV, V18, P662, DOI 10.1210/er.18.5.662; Corvol P, 1997, PATHOL BIOL, V45, P229; Cvetkovic B, 2002, PHYSIOL GENOMICS, V11, P253, DOI 10.1152/physiolgenomics.00076.2002; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ESPINAS ML, 1995, MOL CELL BIOL, V15, P5346; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; IWAI N, 1995, HYPERTENSION, V25, P688, DOI 10.1161/01.HYP.25.4.688; Jain S, 2005, J MOL MED, V83, P121, DOI 10.1007/s00109-004-0621-5; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; KLETT C, 1992, ENDOCRINOLOGY, V130, P3660, DOI 10.1210/en.130.6.3660; Klett CPR, 2001, AM J PHYSIOL-REG I, V281, pR1437, DOI 10.1152/ajpregu.2001.281.5.R1437; Kretowski A, 2007, DIABETES, V56, P863, DOI 10.2337/db06-1321; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Litchfield WR, 1998, HYPERTENSION, V31, P569, DOI 10.1161/01.HYP.31.2.569; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matsuno F, 1996, J BIOCHEM-TOKYO, V119, P524; Narayanan CS, 1998, BIOCHEM BIOPH RES CO, V251, P388, DOI 10.1006/bbrc.1998.9430; Nejatizadeh A, 2008, J HYPERTENS, V26, P1094, DOI 10.1097/HJH.0b013e3282fad951; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rasmussen-Torvik LJ, 2005, HYPERTENSION, V46, P1294, DOI 10.1161/01.HYP.0000192653.17209.84; Schmidt H, 2004, STROKE, V35, P2592, DOI 10.1161/01.STR.0000144646.96121.d2; Schmidt H, 2001, STROKE, V32, P405, DOI 10.1161/01.STR.32.2.405; Sethi AS, 2003, ARTERIOSCL THROM VAS, V23, pA17; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Sinn PL, 1999, J BIOL CHEM, V274, P35785, DOI 10.1074/jbc.274.50.35785; Suh DS, 1997, MOL ENDOCRINOL, V11, P1822, DOI 10.1210/me.11.12.1822; Suh DS, 1996, MOL ENDOCRINOL, V10, P1227, DOI 10.1210/me.10.10.1227; TANIMOTO K, 1994, J BIOL CHEM, V269, P31334; Walker BR, 1998, HYPERTENSION, V31, P891, DOI 10.1161/01.HYP.31.4.891; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	52	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41172	41186		10.1074/jbc.M110.167585	http://dx.doi.org/10.1074/jbc.M110.167585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978123	Green Published, hybrid			2022-12-27	WOS:000285414400079
J	Yang, Y; Koo, S; Lin, CS; Neu, B				Yang, Yang; Koo, Stephanie; Lin, Cheryl Shuyi; Neu, Bjoern			Specific Binding of Red Blood Cells to Endothelial Cells Is Regulated by Nonadsorbing Macromolecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLSERINE-POSITIVE ERYTHROCYTES; MEMBRANE PHOSPHOLIPID ASYMMETRY; VASCULAR ENDOTHELIUM; DEPLETION FLOCCULATION; ADHESION; ADHERENCE; DEXTRAN; DISEASE; ELECTROPHORESIS; AGGREGATION	Abnormal adhesion of red blood cells to the endothelium has been linked to the pathophysiology of several diseases associated with vascular disorders. Various biochemical changes, including phosphatidylserine exposure on the outer membrane of red blood cells as well as plasma protein levels, have been identified as being likely to play a key role, but the detailed interplay between plasma factors and cellular factors remains unknown. It has been proposed that the adhesion-promoting effect of plasma proteins originates from ligand interaction, but evidence substantiating this assumption is often missing. In this work, we identified an alternative pathway by demonstrating that nonadsorbing macromolecules can also have a marked impact on the adhesion efficiency of red blood cells with enhanced phosphatidylserine exposure to endothelial cells. It is concluded that this adhesion-promoting effect originates from macromolecular depletion interaction and thereby presents an alternative mechanism by which plasma proteins could regulate cell-cell interactions. These findings should thus be of potential value for a detailed understanding of the pathophysiology of diseases associated with vascular complications and might be applicable to a wide range of cell-cell interactions in plasma or plasma-like media.	[Yang, Yang; Koo, Stephanie; Lin, Cheryl Shuyi; Neu, Bjoern] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Neu, B (corresponding author), Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 639798, Singapore.	neu@ntu.edu.sg	Neu, Bjoern/G-6213-2010		Ministry of Education (Singapore); Biomedical Research Council A*Star (Singapore)	Ministry of Education (Singapore)(Ministry of Education, Singapore); Biomedical Research Council A*Star (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was supported by grants from the Ministry of Education (Singapore) and from the Biomedical Research Council A*Star (Singapore).	Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baumler H, 1996, BIORHEOLOGY, V33, P333, DOI 10.1016/0006-355X(96)00026-1; BAUMLER H, 1987, STUD BIOPHYS, V120, P113; BELL GI, 1984, BIOPHYS J, V45, pA24; Betal SG, 2008, TRANSL RES, V152, P165, DOI 10.1016/j.trsl.2008.07.007; Bonomini M, 2002, KIDNEY INT, V62, P1358, DOI 10.1046/j.1523-1755.2002.00560.x; Bratosin D, 1998, BIOCHIMIE, V80, P173, DOI 10.1016/S0300-9084(98)80024-2; BUXBAUM K, 1982, BIOCHEMISTRY-US, V21, P3235, DOI 10.1021/bi00256a032; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; FEIGIN RI, 1980, J COLLOID INTERF SCI, V75, P525, DOI 10.1016/0021-9797(80)90475-0; Frenette PS, 2007, J CLIN INVEST, V117, P850, DOI 10.1172/JCI30920; Gallagher PG, 2003, BLOOD, V101, P4625, DOI 10.1182/blood-2001-12-0329; Guchhait P, 2007, HAEMATOLOGICA, V92, P1266, DOI 10.3324/haematol.11379; Hebbel RP, 2008, TRANSFUS CLIN BIOL, V15, P14, DOI 10.1016/j.tracli.2008.03.011; Hebbel RP, 2004, MICROCIRCULATION, V11, P129, DOI 10.1080/10739680490278402; HEBBEL RP, 1981, BLOOD, V58, P947; HEBBEL RP, 1980, J CLIN INVEST, V65, P154, DOI 10.1172/JCI109646; HEBBEL RP, 1980, NEW ENGL J MED, V302, P992, DOI 10.1056/NEJM198005013021803; Jenkins P, 1996, LANGMUIR, V12, P3107, DOI 10.1021/la940901j; Kuypers FA, 1996, BLOOD, V87, P1179, DOI 10.1182/blood.V87.3.1179.bloodjournal8731179; Kuypers FA, 1996, AM J HEMATOL, V51, P45, DOI 10.1002/(SICI)1096-8652(199601)51:1<45::AID-AJH8>3.0.CO;2-7; Neu B, 2003, BIOPHYS J, V85, P75, DOI 10.1016/S0006-3495(03)74456-7; Neu B, 2002, BIOPHYS J, V83, P2482, DOI 10.1016/S0006-3495(02)75259-4; Neu B, 2001, BIORHEOLOGY, V38, P53; Rad S, 2009, ELECTROPHORESIS, V30, P450, DOI 10.1002/elps.200800318; RICHARDSON SGN, 1979, BRIT J HAEMATOL, V41, P95, DOI 10.1111/j.1365-2141.1979.tb03685.x; Setty BNY, 2008, BLOOD, V111, P905, DOI 10.1182/blood-2007-07-099465; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; Shiu YT, 2003, ANN BIOMED ENG, V31, P1299, DOI 10.1114/1.1630320; VINCENT B, 1990, COLLOID SURFACE, V50, P241, DOI 10.1016/0166-6622(90)80267-8; VINCENT B, 1986, COLLOID SURFACE, V18, P261, DOI 10.1016/0166-6622(86)80317-1; Wandersee NJ, 2005, BRIT J HAEMATOL, V131, P366, DOI 10.1111/j.1365-2141.2005.05767.x; Wautier JL, 2004, CIRC RES, V95, P233, DOI 10.1161/01.RES.0000137876.28454.64; WAUTIER JL, 1983, J LAB CLIN MED, V101, P911; WAUTIER JL, 1981, NEW ENGL J MED, V305, P237, DOI 10.1056/NEJM198107303050501; Wood BL, 1996, BLOOD, V88, P1873; Yang Y, 2010, LANGMUIR, V26, P2680, DOI 10.1021/la902977y; Zhang ZWW, 2009, BIOPHYS J, V97, P1031, DOI 10.1016/j.bpj.2009.06.006	39	23	24	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40489	40495		10.1074/jbc.M110.116608	http://dx.doi.org/10.1074/jbc.M110.116608			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952392	Green Published, hybrid			2022-12-27	WOS:000285414400011
J	Cui, JM; Qasim, S; Davidson, AL				Cui, Jinming; Qasim, Sabiha; Davidson, Amy L.			Uncoupling Substrate Transport from ATP Hydrolysis in the Escherichia coli Maltose Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; CATALYTIC TRANSITION-STATE; ABC TRANSPORTER; ACTIVE-TRANSPORT; PROTEIN; MECHANISM; STREPTOCOCCUS; RECEPTOR; SYSTEM; MOTION	Members of the ATP-binding cassette superfamily couple the energy from ATP hydrolysis to the active transport of substrates across the membrane. The maltose transporter, a well characterized model system, consists of a periplasmic maltose-binding protein (MBP) and a multisubunit membrane transporter, MalFGK(2). On the basis of the structure of the MBP-MalFGK(2) complex in an outward-facing conformation (Oldham, M. L., Khare, D., Quiocho, F. A., Davidson, A. L., and Chen, J. (2007) Nature 450, 515-521), we identified two mutants in transmembrane domains MalF and MalG that generated futile cycling; although interaction with MBP stimulated the ATPase activity of the transporter, maltose was not transported. Both mutants appeared to disrupt the normal transfer of maltose from MBP to MalFGK(2). In the first case, substitution of aspartate for glycine in the maltose-binding site of MalF likely generated a futile cycle by preventing maltose from binding to MalFGK(2) during the catalytic cycle. In the second case, a four-residue deletion of a periplasmic loop of MalG limited its reach into the maltose-binding pocket of MBP, allowing maltose to remain associated with MBP during the catalytic cycle. Retention of maltose in the MBP binding site in the deletion mutant, as well as insertion of this loop into the binding site in the wild type, was detected by EPR as a change in mobility of a nitroxide spin label positioned near the maltose-binding pocket of MBP.	[Cui, Jinming; Qasim, Sabiha; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Davidson, AL (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	adavidso@purdue.edu	Cui, Jinming/G-2214-2012		National Institutes of Health [GM49261, GM070515]; Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049261, R56GM070515, R29GM049261, R01GM070515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM49261 and GM070515. This work was also supported by a Purdue Research Foundation research grant.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; DEAN DA, 1989, P NATL ACAD SCI USA, V86, P9134, DOI 10.1073/pnas.86.23.9134; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; Ehrle R, 1996, J BACTERIOL, V178, P2255, DOI 10.1128/jb.178.8.2255-2262.1996; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; FIKES JD, 1987, J BACTERIOL, V169, P2352, DOI 10.1128/jb.169.6.2352-2359.1987; Gould AD, 2010, J BIOL CHEM, V285, P11290, DOI 10.1074/jbc.M109.089078; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Hall JA, 1997, J BIOL CHEM, V272, P17615, DOI 10.1074/jbc.272.28.17615; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jacso T, 2009, BIOCHEMISTRY-US, V48, P2216, DOI 10.1021/bi801376m; Jones AL, 2000, MOL MICROBIOL, V37, P1444, DOI 10.1046/j.1365-2958.2000.02099.x; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; KNOWLES PF, 1972, MAGNETIC RESONANCE B; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; Sauna ZE, 2008, J BIOL CHEM, V283, P35010, DOI 10.1074/jbc.M806446200; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2006, INFECT IMMUN, V74, P4605, DOI 10.1128/IAI.00477-06; SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503	41	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39986	39993		10.1074/jbc.M110.147819	http://dx.doi.org/10.1074/jbc.M110.147819			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959448	Green Published, hybrid			2022-12-27	WOS:000285185500043
J	Murphy, BA; Bunda, S; Mitts, T; Hinek, A				Murphy, Brooke A.; Bunda, Severa; Mitts, Thomas; Hinek, Aleksander			The Hyperthermia-enhanced Association between Tropoelastin and Its 67-kDa Chaperone Results in Better Deposition of Elastic Fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETROVIRALLY MEDIATED OVEREXPRESSION; FORMATION IN-VITRO; BINDING-PROTEIN; EXTRACELLULAR-MATRIX; COSTELLO-SYNDROME; BETA-GALACTOSIDASE; SPLICED VARIANT; IMPAIRED ELASTOGENESIS; INFRARED RADIATION; HURLER-DISEASE	The results of our in vitro experiments indicate that exposing cultured human aortic smooth muscle cells and dermal fibroblasts to 39 to 41 degrees C induces a significant up-regulation in the net deposition of elastic fibers, but not of collagen I or fibronectin, and also decreases the deposition of chondroitin sulfate-containing moieties. We further demonstrate that mild hyperthermia also rectifies the insufficient elastogenesis notable in cultures of fibroblasts derived from the stretch-marked skin of adult patients and in cultures of dermal fibroblasts from children with Costello syndrome, which is characterized by the accumulation of chondroitin 6-sulfate glycosaminoglycans that induce shedding and inactivation of the 67-kDa elastin-binding protein. We have previously established that this protein serves as a reusable chaperone for tropoelastin and that its recycling is essential for the normal deposition of elastic fibers. We now report that hyperthermia not only inhibits deposition of chondroitin 6-sulfate moieties and the consequent preservation of elastin-binding protein molecules but also induces their faster recycling. This, in turn, triggers a more efficient preservation of tropoelastin, enhancement of its secretion and extracellular assembly into elastic fibers. The presented results encourage using mild hyperthermia to restore elastic fiber production in damaged adult skin and to enhance elastogenesis in children with genetic elastinopathies.	[Murphy, Brooke A.; Bunda, Severa; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Cardiovasc Res Program, Toronto, ON M5G 1X8, Canada; [Hinek, Aleksander] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Mitts, Thomas] Human Matrix Sci LLC, Visalia, CA 93291 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Hinek, A (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.on.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation of Ontario [NA 4381]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Canadian Institute of Health Research Grant PG 13920 and Heart and Stroke Foundation of Ontario Grant NA 4381 (to A.H.).	Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003; Bunda S, 2009, J BIOL CHEM, V284, P16633, DOI 10.1074/jbc.M109.008748; Chen Z, 2005, J INVEST DERMATOL, V124, P70, DOI 10.1111/j.0022-202X.2004.23550.x; Chen Z, 2009, PHOTODERMATOL PHOTO, V25, P310, DOI 10.1111/j.1600-0781.2009.00465.x; Cho S, 2009, J INVEST DERM SYMP P, V14, P15, DOI 10.1038/jidsymp.2009.7; Costello JM, 1996, AM J MED GENET, V62, P199, DOI 10.1002/ajmg.1320620203; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hinek A, 2000, AM J HUM GENET, V66, P859, DOI 10.1086/302829; Hinek A, 2000, AM J PATHOL, V156, P925, DOI 10.1016/S0002-9440(10)64961-9; HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hinek A, 2000, AM J HUM GENET, V67, P23, DOI 10.1086/302968; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Hinek A, 2005, AM J MED GENET A, V133A, P1, DOI 10.1002/ajmg.a.30495; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hinek A, 1995, CIBA F SYMP, V192, P185; Huang R, 2006, CIRC RES, V98, P370, DOI 10.1161/01.RES.0000202051.28319.c8; Hwang JY, 2008, AM J PATHOL, V173, P1919, DOI 10.2353/ajpath.2008.070875; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kielty CM, 2002, J CELL SCI, V115, P2817; LEE KS, 1994, CLIN EXP DERMATOL, V19, P285, DOI 10.1111/j.1365-2230.1994.tb01196.x; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Merrilees MJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-41; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mitts TF, 2010, J INVEST DERMATOL, V130, P2396, DOI 10.1038/jid.2010.155; Mitts Thomas F, 2005, Aesthet Surg J, V25, P593, DOI 10.1016/j.asj.2005.09.004; Morrone A, 2000, HUM MUTAT, V15, P354, DOI 10.1002/(SICI)1098-1004(200004)15:4<354::AID-HUMU8>3.3.CO;2-C; MUSTO L, 1996, J HISTOTECHNOL, V9, P173; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nollen EAA, 2002, J CELL SCI, V115, P2809; O'Brien KD, 2004, ATHEROSCLEROSIS, V177, P29, DOI 10.1016/j.atherosclerosis.2004.07.007; Park HG, 2005, CELL MOL LIFE SCI, V62, P10, DOI 10.1007/s00018-004-4208-7; Patterson CE, 2000, MOL BIOL CELL, V11, P3925, DOI 10.1091/mbc.11.11.3925; PIERAGGI MT, 1982, VIRCHOWS ARCH A, V396, P279, DOI 10.1007/BF00431387; Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319; Rissmann A, 2002, KLIN PADIATR, V214, P132, DOI 10.1055/s-2002-30149; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Starcher B, 1999, CONNECT TISSUE RES, V40, P273, DOI 10.3109/03008209909000705; Trautinger F, 2001, J PHOTOCH PHOTOBIO B, V63, P70, DOI 10.1016/S1011-1344(01)00203-2; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; WEGROWSKI Y, 1993, FEBS LETT, V334, P121, DOI 10.1016/0014-5793(93)81695-V; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 1997, AM J PATHOL, V151, P963; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wust P, 2007, HEALTH PHYS, V92, P565, DOI 10.1097/01.HP.0000258918.36430.a3; Zouboulis CC, 2003, HAUTARZT, V54, P825, DOI 10.1007/s00105-003-0581-7	52	2	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40282	40293		10.1074/jbc.M110.169656	http://dx.doi.org/10.1074/jbc.M110.169656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947500	hybrid, Green Published			2022-12-27	WOS:000285185500071
J	Petrusca, DN; Gu, YA; Adamowicz, JJ; Rush, NI; Hubbard, WC; Smith, PA; Berdyshev, EV; Birukov, KG; Lee, CH; Tuder, RM; Twigg, HL; Vandivier, RW; Petrache, I				Petrusca, Daniela N.; Gu, Yuan; Adamowicz, Jeremy J.; Rush, Natalia I.; Hubbard, Walter C.; Smith, Patricia A.; Berdyshev, Evgeni V.; Birukov, Konstantin G.; Lee, Chao-Hung; Tuder, Rubin M.; Twigg, Homer L., III; Vandivier, R. William; Petrache, Irina			Sphingolipid-mediated Inhibition of Apoptotic Cell Clearance by Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; RHO FAMILY PROTEINS; CIGARETTE-SMOKE; PHOSPHATIDYLSERINE RECEPTOR; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; CERAMIDE; PHAGOCYTOSIS; ENGULFMENT	A decreased clearance of apoptotic cells (efferocytosis) by alveolar macrophages (AM) may contribute to inflammation in emphysema. The up-regulation of ceramides in response to cigarette smoking (CS) has been linked to AM accumulation and increased detection of apoptotic alveolar epithelial and endothelial cells in lung parenchyma. We hypothesized that ceramides inhibit the AM phagocytosis of apoptotic cells. Release of endogenous ceramides via sphingomyelinase or exogenous ceramide treatments dose-dependently impaired apoptotic Jurkat cell phagocytosis by primary rat or human AM, irrespective of the molecular species of ceramide. Similarly, in vivo augmentation of lung ceramides via intratracheal instillation in rats significantly decreased the engulfment of instilled target apoptotic thymocytes by resident AM. The mechanism of ceramide-induced efferocytosis impairment was dependent on generation of sphingosine via ceramidase. Sphingosine treatment recapitulated the effects of ceramide, dose-dependently inhibiting apoptotic cell clearance. The effect of ceramide on efferocytosis was associated with decreased membrane ruffle formation and attenuated Rac1 plasma membrane recruitment. Constitutively active Rac1 overexpression rescued AM efferocytosis against the effects of ceramide. CS exposure significantly increased AM ceramides and recapitulated the effect of ceramides on Rac1 membrane recruitment in a sphingosine-dependent manner. Importantly, CS profoundly inhibited AM efferocytosis via ceramide-dependent sphingosine production. These results suggest that excessive lung ceramides may amplify lung injury in emphysema by causing both apoptosis of structural cells and inhibition of their clearance by AM.	[Petrusca, Daniela N.] Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Indianapolis, IN 46202 USA; [Hubbard, Walter C.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; [Berdyshev, Evgeni V.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lee, Chao-Hung] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Petrache, Irina] RL Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Tuder, Rubin M.; Vandivier, R. William] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Johns Hopkins University; University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Petrusca, DN (corresponding author), Indiana Univ, Div Pulm Allergy Crit Care & Occupat Med, Dept Med, Walther Hall R3 C400,980 W Walnut St, Indianapolis, IN 46202 USA.	ipetrach@iupui.edu	Birukov, Konstantin/FJB-5755-2022; Petrache, Irina/AAZ-9648-2020		National Institutes of Health [1 S10 RR16798]; American Heart Association [0826103G, RO1HL077328]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 S10 RR16798 ( to W. C. H. for funding the API4000 LCMS/MS system). This work was also supported by American Heart Association Grants 0826103G ( to D. N. P.) and RO1HL077328 ( to I. P.).	Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Deigner HP, 2001, FASEB J, V15, P807, DOI 10.1096/fj.15.3.807; Demedts IK, 2005, CURR OPIN PHARMACOL, V5, P257, DOI 10.1016/j.coph.2004.12.005; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; ELLIS RE, 1991, GENETICS, V129, P79; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Gomez-Munoz A, 2004, FEBS LETT, V562, P5, DOI 10.1016/S0014-5793(04)00211-X; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HED J, 1987, J IMMUNOL METHODS, V101, P119, DOI 10.1016/0022-1759(87)90224-9; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Hinkovska-Galcheva V, 2005, J BIOL CHEM, V280, P26612, DOI 10.1074/jbc.M501359200; Hodge S, 2003, IMMUNOL CELL BIOL, V81, P289, DOI 10.1046/j.1440-1711.2003.t01-1-01170.x; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Lee CK, 2006, PROTEOMICS, V6, P6455, DOI 10.1002/pmic.200600124; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Medler TR, 2008, AM J RESP CELL MOL, V38, P639, DOI 10.1165/rcmb.2007-0274OC; Merrill AH, 1997, TOXICOL APPL PHARM, V142, P208, DOI 10.1006/taap.1996.8029; Monick MM, 1998, AM J PHYSIOL-LUNG C, V275, pL389, DOI 10.1152/ajplung.1998.275.2.L389; Monick MM, 2001, J IMMUNOL, V167, P5977, DOI 10.4049/jimmunol.167.10.5977; Nakaya M, 2006, J BIOL CHEM, V281, P8836, DOI 10.1074/jbc.M510972200; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; Perez R, 2006, J IMMUNOL, V176, P2555, DOI 10.4049/jimmunol.176.4.2555; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2003, FASEB J, V17, P407, DOI 10.1096/fj.02-0672com; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; Sakai M, 2000, BIOCHEM BIOPH RES CO, V278, P79, DOI 10.1006/bbrc.2000.3767; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Spiegel S, 1996, CURR OPIN CELL BIOL, V8, P159, DOI 10.1016/S0955-0674(96)80061-5; Szulc ZM, 2006, BIOORGAN MED CHEM, V14, P7083, DOI 10.1016/j.bmc.2006.07.016; Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Tuder RM, 2003, AM J RESP CELL MOL, V28, P551, DOI 10.1165/rcmb.F269; Twigg HL, 1999, AM J RESP CRIT CARE, V159, P1439, DOI 10.1164/ajrccm.159.5.9808031; Uller L, 2006, TRENDS PHARMACOL SCI, V27, P461, DOI 10.1016/j.tips.2006.07.006; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006	56	59	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40322	40332		10.1074/jbc.M110.137604	http://dx.doi.org/10.1074/jbc.M110.137604			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956540	hybrid, Green Published			2022-12-27	WOS:000285185500075
J	Tanaka, T; Yokoyama, M; Matsumoto, S; Fukatsu, R; You, ZY; Masai, H				Tanaka, Taku; Yokoyama, Mika; Matsumoto, Seiji; Fukatsu, Rino; You, Zhiying; Masai, Hisao			Fission Yeast Swi1-Swi3 Complex Facilitates DNA Binding of Mrc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; S-PHASE; CHECKPOINT RESPONSE; PRIA PROTEIN; DAMAGE; PROGRESSION; TIPIN; ACTIVATION; HELICASE; CLASPIN	Replication fork protection complex Swi1-Swi3 and replication checkpoint mediator Mrc1 are required for maintenance of replication fork integrity during the course of DNA replication in the fission yeast Schizosaccharomyces pombe. These proteins play crucial roles in stabilizing stalled forks and activating replication checkpoint signaling pathways. Although they are conserved replication fork components, precise biochemical roles of these proteins are not known. Here we purified Mrc1 and Swi1-Swi3 proteins and show that these proteins bind to DNA independently but synergistically in vitro. Mrc1 binds preferentially to arrested fork or D-loop-like structures, although the affinity is relatively low, whereas the Swi1-Swi3 complex binds to double-stranded DNA with higher affinity. In the presence of a low concentration of Swi1-Swi3, Mrc1 generates a novel ternary complex and binds to various types of DNA with higher affinity. Moreover, purified Mrc1 and Swi1-Swi3 physically interact with each other, and this interaction is lost by mutations in the known DNA binding domain of Mrc1 (K235E, K236E). The interaction is also lost in a mutant form of Swi1 (E662K) that is specifically defective in polar fork arrest at a site called RTS1 and causes sensitivity to genotoxic agents, although the DNA binding affinity of Swi1-Swi3 is not affected by this mutation. As expected, the synergistic effect of the Swi1-Swi3 on DNA binding of Mrc1 is also lost by these mutations affecting the interaction between Mrc1 and Swi1-Swi3. Our results reveal an aspect of molecular interactions that may play an important role in replication pausing and fork stabilization.	[Tanaka, Taku; Yokoyama, Mika; Matsumoto, Seiji; Fukatsu, Rino; You, Zhiying; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	masai-hs@igakuken.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a grant-in-aid for scientific research on priority area "Chromosome Cycle" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Takeda Science Foundation; and the Astellas Foundation for Research on Metabolic Disorders (to H. M.).	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Cobb JA, 2004, CURR OPIN GENET DEV, V14, P292, DOI 10.1016/j.gde.2004.04.001; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Foss EJ, 2001, GENETICS, V157, P567; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Hodgson B, 2007, MOL BIOL CELL, V18, P3894, DOI 10.1091/mbc.E07-05-0500; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumar S, 2009, MOL CELL BIOL, V29, P602, DOI 10.1128/MCB.01319-08; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Mizukoshi T, 2003, J BIOL CHEM, V278, P42234, DOI 10.1074/jbc.C300285200; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; Yin L, 2008, MOL BIOL CELL, V19, P4374, DOI 10.1091/mbc.E08-01-0020; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhao H, 2004, J BIOL CHEM, V279, P53023, DOI 10.1074/jbc.M410449200	41	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39609	39622		10.1074/jbc.M110.173344	http://dx.doi.org/10.1074/jbc.M110.173344			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20924116	hybrid, Green Published			2022-12-27	WOS:000285185500005
J	Velayos-Baeza, A; Levecque, C; Kobayashi, K; Holloway, ZG; Monaco, AP				Velayos-Baeza, Antonio; Levecque, Clotilde; Kobayashi, Kazuhiro; Holloway, Zoe G.; Monaco, Anthony P.			The Dyslexia-associated KIAA0319 Protein Undergoes Proteolytic Processing with gamma-Secretase-independent Intramembrane Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR INHIBITOR TYPE-1; END RULE PATHWAY; ALZHEIMERS-DISEASE; NEURONAL MIGRATION; RECEPTOR LIGANDS; GENE KIAA0319; MEMBRANE; METALLOPROTEINASES; PRESENILIN; ADAMS	The KIAA0319 gene has been associated with reading disability in several studies. It encodes a plasma membrane protein with a large, highly glycosylated, extracellular domain. This protein is proposed to function in adhesion and attachment and thought to play an important role during neuronal migration in the developing brain. We have previously proposed that endocytosis of this protein could constitute an important mechanism to regulate its function. Here we show that KIAA0319 undergoes ectodomain shedding and intramembrane cleavage. At least five different cleavage events occur, four in the extracellular domain and one within the transmembrane domain. The ectodomain shedding processing cleaves the extracellular domain, generating several small fragments, including the N-terminal region with the Cys-rich MANEC domain. It is possible that these fragments are released to the extracellular medium and trigger cellular responses. The intramembrane cleavage releases the intracellular domain from its membrane attachment. Our results suggest that this cleavage event is not carried out by gamma-secretase, the enzyme complex involved in similar processing in many other type I proteins. The soluble cytoplasmic domain of KIAA0319 is able to translocate to the nucleus, accumulating in nucleoli after overexpression. This fragment has an unknown role, although it could be involved in regulation of gene expression. The absence of DNA-interacting motifs indicates that such a function would most probably be mediated through interaction with other proteins, not by direct DNA binding. These results suggest that KIAA0319 not only has a direct role in neuronal migration but may also have additional signaling functions.	[Velayos-Baeza, Antonio; Levecque, Clotilde; Kobayashi, Kazuhiro; Holloway, Zoe G.; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Monaco, AP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	anthony.monaco@well.ox.ac.uk	Monaco, Anthony P/A-4495-2010; Kobayashi, Kazuhiro/AAH-8638-2021; Velayos-Baeza, Antonio/K-6310-2019	Monaco, Anthony P/0000-0001-7480-3197; Kobayashi, Kazuhiro/0000-0001-7801-147X; Velayos-Baeza, Antonio/0000-0002-7717-4477; Levecque, Clotilde/0000-0002-0519-337X	Wellcome Trust [076566/Z/05/Z, 075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (076566/Z/05/Z; 075491/Z/04).	Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Annaert W, 2002, ANNU REV CELL DEV BI, V18, P25, DOI 10.1146/annurev.cellbio.18.020402.142302; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cole SL, 2008, CURR ALZHEIMER RES, V5, P100, DOI 10.2174/156720508783954758; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Fisher SE, 2006, TRENDS COGN SCI, V10, P250, DOI 10.1016/j.tics.2006.04.003; Gabel LA, 2010, NEUROBIOL DIS, V38, P173, DOI 10.1016/j.nbd.2009.06.019; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Guo JH, 2004, TRENDS BIOCHEM SCI, V29, P172, DOI 10.1016/j.tibs.2004.02.007; Hass MR, 2009, SEMIN CELL DEV BIOL, V20, P201, DOI 10.1016/j.semcdb.2008.11.014; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levecque C, 2009, AM J PHYSIOL-CELL PH, V297, pC160, DOI 10.1152/ajpcell.00630.2008; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; McGrath LM, 2006, TRENDS MOL MED, V12, P333, DOI 10.1016/j.molmed.2006.05.007; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2007, ANNU REV GENOM HUM G, V8, P57, DOI 10.1146/annurev.genom.8.080706.092312; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Sanderson MP, 2006, GROWTH FACTORS, V24, P121, DOI 10.1080/08977190600634373; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Stemmler MP, 2008, MOL BIOSYST, V4, P835, DOI 10.1039/b719215k; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tolia A, 2009, SEMIN CELL DEV BIOL, V20, P211, DOI 10.1016/j.semcdb.2008.10.007; Tousseyn T, 2009, J BIOL CHEM, V284, P11738, DOI 10.1074/jbc.M805894200; Urban S, 2002, CURR OPIN GENET DEV, V12, P512, DOI 10.1016/S0959-437X(02)00334-9; Velayos-Baeza A, 2008, HUM MOL GENET, V17, P859, DOI 10.1093/hmg/ddm358; Velayos-Baeza A, 2007, MAMM GENOME, V18, P627, DOI 10.1007/s00335-007-9051-3; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005	51	30	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40148	40162		10.1074/jbc.M110.145961	http://dx.doi.org/10.1074/jbc.M110.145961			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943657	Green Published, hybrid			2022-12-27	WOS:000285185500060
J	Kramara, J; Willcox, S; Gunisova, S; Kinsky, S; Nosek, J; Griffith, JD; Tomaska, L				Kramara, Juraj; Willcox, Smaranda; Gunisova, Stanislava; Kinsky, Slavomir; Nosek, Jozef; Griffith, Jack D.; Tomaska, Lubomir			Tay1 Protein, a Novel Telomere Binding Factor from Yarrowia lipolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; MAMMALIAN TELOMERES; SEQUENCE; TRANSCRIPTION; CONSERVATION; COMPLEX; DOMAIN; TRF1; END; IDENTIFICATION	Inspection of the complete genome of the yeast Yarrowia lipolytica for the presence of genes encoding homologues of known telomere-binding proteins surprisingly revealed no counterparts of typical yeast Myb domain-containing telomeric factors including Rap1 or Taz1. Instead, we identified a gene, YALIOD10923g, encoding a protein containing two Myb domains, exhibiting a high degree of similarity to the Myb domain of human telomeric proteins TRF1 and TRF2 and homologous to an essential fission yeast protein Mug152 whose expression is elevated during meiosis. The protein, which we named Tay1p (telomere-associated in Yarrowia lipolytica 1), was purified for biochemical studies. Using a model Y. lipolytica telomere, we demonstrate that the protein preferentially binds to Y. lipolytica telomeric tracts. Tay1p binds along the telomeric tract as dimers and larger oligomers, and it is able to remodel the telomeric DNA into both looped structures and synaptic complexes of two model telomere DNAs. The ability of Tay1p to induce dimerization of telomeres in vitro goes in line with its oligomeric nature, where each oligomer can employ several Myb domains to form intermolecular telomere clusters. We also provide experimental evidence that Tay1p may be associated with Y. lipolytica telomeres in vivo. Together with its homologues from Schizosaccharomyces pombe and several basidiomycetous fungi (Sanchez-Alonso, P., and Guzman, P. (2008) Fungal Genet. Biol. 45, S54-S62), Tay1p constitutes a novel family of putative telomeric factors whose analysis may be instrumental in understanding the function and evolution of double-stranded DNA telomeric proteins.	[Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; Comenius Univ, Fac Nat Sci, Dept Genet, Bratislava 84215, Slovakia; Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava 84215, Slovakia	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Comenius University Bratislava; Comenius University Bratislava	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Mason Farm Rd,CB7095, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu; tomaska@fns.uniba.sk	Nosek, Jozef/A-7581-2008; Gunišová, Stanislava/I-1765-2014; Kinsky, Slavomir/G-6312-2014; Tomaska, Lubomir/I-3071-2014	Nosek, Jozef/0000-0002-1020-5451; Tomaska, Lubomir/0000-0003-4886-1910	National Institutes of Health [GM31819, ES013773, TW005654]; Howard Hughes Medical Institute [55005622]; Agentura na podporu vyskumu a vyvoja [20-001604, 0024-07]; Vedecta grantova agentura [1/0132/09, 1/0219/08]; SAIA (Slovak Academy Information Agency); Europsky fond regionalneho rozvoja; Slovak Academy Information Agency; FOGARTY INTERNATIONAL CENTER [R03TW005654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Agentura na podporu vyskumu a vyvoja; Vedecta grantova agentura; SAIA (Slovak Academy Information Agency); Europsky fond regionalneho rozvoja; Slovak Academy Information Agency; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819, ES013773, and TW005654 (to J.D.G.). This work was also supported by Howard Hughes Medical Institute Grant 55005622 (to J.N.) and Slovak grant agencies Agentura na podporu vyskumu a vyvoja (20-001604 (to L. T.) and 0024-07 (J.N.)) and Vedecta grantova agentura 1/0132/09 (to L. T.) and 1/0219/08 (to J.N.). J. K. was supported by a travel fellowship from SAIA (Slovak Academy Information Agency). This contribution/publication is the result of the project implementation: "Centre of excellence for exploitation of informational biomacromolecules in the disease prevention and improvement of quality of life" supported by the Research and Development Operational Programme funded by the Europsky fond regionalneho rozvoja.; Supported by a travel fellowship from the Slovak Academy Information Agency.	ARNDT KT, 1987, SCIENCE, V237, P874, DOI 10.1126/science.3303332; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brandt U, 2005, BIOCHEM SOC T, V33, P840, DOI 10.1042/BST0330840; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Chen DC, 1997, APPL MICROBIOL BIOT, V48, P232, DOI 10.1007/s002530051043; Cockell MM, 2009, EUKARYOT CELL, V8, P207, DOI 10.1128/EC.00174-08; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Cohn M, 2006, TOP CURR GENET, V15, P101, DOI 10.1007/4735_106; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAIGNANFORNIER B, 1992, P NATL ACAD SCI USA, V89, P6746, DOI 10.1073/pnas.89.15.6746; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denis V, 1998, MOL GEN GENET, V259, P246, DOI 10.1007/s004380050810; Denis V, 1998, MOL MICROBIOL, V30, P557, DOI 10.1046/j.1365-2958.1998.01087.x; Drummond AJ, 2009, GENEIOUS VERSION 4 8; Edso JR, 2008, FEMS YEAST RES, V8, P1289, DOI 10.1111/j.1567-1364.2008.00431.x; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Gunisova S, 2009, RNA, V15, P546, DOI 10.1261/rna.1194009; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Kanoh J, 2003, CELL MOL LIFE SCI, V60, P2295, DOI 10.1007/s00018-003-3245-y; Kinsky S, 2010, CURR GENET, V56, P413, DOI 10.1007/s00294-010-0310-6; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KOVAC L, 1968, BIOCHIM BIOPHYS ACTA, V153, P32, DOI 10.1016/0005-2728(68)90143-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Lue NF, 2010, TRENDS BIOCHEM SCI, V35, P8, DOI 10.1016/j.tibs.2009.08.006; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; Nicholas K. B., 1997, EMBNET NEWS, V4, P14; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; PERTUISET B, 1995, CURR GENET, V27, P123, DOI 10.1007/BF00313425; Pitt CW, 2008, J BIOL CHEM, V283, P2693, DOI 10.1074/jbc.M708784200; Rhodin J, 2006, J MOL BIOL, V355, P335, DOI 10.1016/j.jmb.2005.10.078; RHODINEDSO J, 2009, THESIS LUND U; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Springer C, 1996, J BIOL CHEM, V271, P29637, DOI 10.1074/jbc.271.47.29637; Stansel RM, 2001, EMBO J, V20, P5532; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Szabo R, 1999, FOLIA MICROBIOL, V44, P19, DOI 10.1007/BF02816215; SZABO R, 2001, THESIS COMENIUS U BR; Teixeira MT, 2005, CHROMOSOME RES, V13, P535, DOI 10.1007/s10577-005-0999-0; Tomaska L, 2004, J BIOL CHEM, V279, P50764, DOI 10.1074/jbc.M409790200; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; VANATTIKUM H, 2010, EPIGENOMICS; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	63	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38078	38092		10.1074/jbc.M110.127605	http://dx.doi.org/10.1074/jbc.M110.127605			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923774	Green Published, hybrid			2022-12-27	WOS:000284625600016
J	Nakano, N; Itoh, S; Watanabe, Y; Maeyama, K; Itoh, F; Kato, M				Nakano, Naoko; Itoh, Susumu; Watanabe, Yukihide; Maeyama, Kota; Itoh, Fumiko; Kato, Mitsuyasu			Requirement of TCF7L2 for TGF-beta-dependent Transcriptional Activation of the TMEPAI Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; NEDD4-BINDING PROTEIN; SIGNALING PATHWAYS; WNT; PROMOTER; CANCER; EXPRESSION; SMAD4; BINDING; PMEPA1	The TGF-beta and Wnt pathways are involved in cell fate and tumorigenicity. A recent report indicated that a TGF-beta target gene, TMEPAI (transmembrane prostate androgen-induced RNA), is possibly also a downstream target of Wnt signaling. Although TMEPAI was believed to be involved in tumorigenicity because of its blockage of TGF-beta signaling, how TGF-beta and Wnt signals affect the activation of the TMEPAI gene is not well understood. Herein, we show that the TMEPAI promoter is regulated synergistically by TGF-beta/Smad and Wnt/beta-catenin/T cell factor (TCF) 7L2. The critical cis-element for dual signals, termed TGF-beta-responsive TCF7L2-binding element (TTE), is located in intron 1 of the TMEPAI gene. TCF7L2, but not Smad proteins, bound to TTE, whereas the disruption of TTE by mutagenesis remarkably counteracted both TGF-beta and TCF7L2 responses. The introduction of mutations in critical Smad-binding elements blocked the activation of the TMEPAI promoter by TCF7L2. Furthermore, our DNA-protein interaction experiments revealed the indirect binding of TCF7L2 to Smad-binding elements via Smad3 upon TGF-beta stimulation as well as its TGF-beta-dependent association with TTE. We demonstrate that the Wnt/beta-catenin/TCF7L2 pathway is preferentially able to alter the transcriptional regulation of the TGF-beta-target gene, TMEPAI.	[Nakano, Naoko; Itoh, Susumu] Showa Pharmaceut Univ, Biochem Lab, Tokyo 1948543, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan; [Nakano, Naoko; Itoh, Susumu] Showa Pharmaceut Univ, High Technol Res Ctr, Tokyo 1948543, Japan	Showa Pharmaceutical University; University of Tsukuba; Showa Pharmaceutical University	Itoh, S (corresponding author), Showa Pharmaceut Univ, Biochem Lab, 3-3165 Higashi Tamagawa Gakuen, Tokyo 1948543, Japan.	sitoh@ac.shoyaku.ac.jp		Itoh, Fumiko/0000-0002-6134-5331; Itoh, Susumu/0000-0002-7967-0730	Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Japan Chemical Industry Association;  [17390073];  [20012007];  [21590328]	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Chemical Industry Association; ; ; 	This work was supported by Grants-in-aid for Scientific Research 17390073, 20012007, and 21590328 (to M.K. and S.I.), the Takeda Science Foundation (to S.I.), a Genome Network Project grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M.K.), a grant-in-aid for Japan Society for the Promotion of Science Fellows (to Y.W. and F.I.), and a long range research initiative grant from the Japan Chemical Industry Association (to M.K.).	Anazawa Y, 2004, ONCOGENE, V23, P7621, DOI 10.1038/sj.onc.1207270; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Brunschwig EB, 2003, CANCER RES, V63, P1568; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Giannini G, 2003, MOL CARCINOGEN, V38, P188, DOI 10.1002/mc.10162; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Hussein SM, 2003, J BIOL CHEM, V278, P48805, DOI 10.1074/jbc.M305472200; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Lei S, 2004, J BIOL CHEM, V279, P42492, DOI 10.1074/jbc.M404025200; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li HY, 2008, J BIOL CHEM, V283, P28988, DOI 10.1074/jbc.M710528200; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Noda D, 2006, ONCOGENE, V25, P5591, DOI 10.1038/sj.onc.1209571; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Rae FK, 2001, MOL CARCINOGEN, V32, P44, DOI 10.1002/mc.1063; Reichling T, 2005, CANCER RES, V65, P166; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sasaki T, 2003, CANCER RES, V63, P801; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Watanabe Y, 2010, MOL CELL, V37, P123, DOI 10.1016/j.molcel.2009.10.028; Weerkamp F, 2006, TRENDS IMMUNOL, V27, P125, DOI 10.1016/j.it.2006.01.006; Weise A, 2010, NUCLEIC ACIDS RES, V38, P1964, DOI 10.1093/nar/gkp1197; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu LL, 2003, CANCER RES, V63, P4299; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	44	38	38	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38023	38033		10.1074/jbc.M110.132209	http://dx.doi.org/10.1074/jbc.M110.132209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889500	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000284625600010
J	Yang, Y; Shi, WW; Cui, NR; Wu, ZY; Jiang, C				Yang, Yang; Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Jiang, Chun			Oxidative Stress Inhibits Vascular K-ATP Channels by S-Glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNEL; PROTEIN-KINASE-C; SMOOTH-MUSCLE; KIR6.1/SUR2B CHANNEL; REDOX REGULATION; NITRIC-OXIDE; KAPPA-B; ACTIVATION; NITROSYLATION; EXPRESSION	The K-ATP channel is an important player in vascular tone regulation. Its opening and closure lead to vasodilation and vasoconstriction, respectively. Such functions may be disrupted in oxidative stress seen in a variety of cardiovascular diseases, while the underlying mechanism remains unclear. Here, we demonstrated that S-glutathionylation was a modulation mechanism underlying oxidant-mediated vascular K-ATP channel regulation. An exposure of isolated mesenteric rings to hydrogen peroxide (H2O2) impaired the K-ATP channel-mediated vascular dilation. In whole-cell recordings and inside-out patches, H2O2 or diamide caused a strong inhibition of the vascular K-ATP channel (Kir6.1/SUR2B) in the presence, but not in the absence, of glutathione (GSH). Similar channel inhibition was seen with oxidized glutathione (GSSG) and thiol-modulating reagents. The oxidant-mediated channel inhibition was reversed by the reducing agent dithiothreitol (DTT) and the specific deglutathionylation reagent glutaredoxin-1 (Grx1). Consistent with S-glutathionylation, streptavidin pull-down assays with biotinylated glutathione ethyl ester (BioGEE) showed incorporation of GSH to the Kir6.1 subunit in the presence of H2O2. These results suggest that S-glutathionylation is an important mechanism for the vascular K-ATP channel modulation in oxidative stress.	[Yang, Yang; Shi, Weiwei; Cui, Ningren; Wu, Zhongying; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, POB 4010, Atlanta, GA 30302 USA.	cjiang@gsu.edu	Yang, Yang/B-3440-2008; SHI, WEIWEI/B-3477-2008	Yang, Yang/0000-0003-4275-0515; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD060959 and the American Heart Association (09GRNT2010037).	Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Ardanaz N, 2006, EXP BIOL MED, V231, P237; Armstead WM, 1999, STROKE, V30, P153, DOI 10.1161/01.STR.30.1.153; Brown LAS, 2007, AM J PHYSIOL-LUNG C, V292, pL824, DOI 10.1152/ajplung.00346.2006; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cao K, 2002, BIOCHEM BIOPH RES CO, V296, P463, DOI 10.1016/S0006-291X(02)00892-6; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Erdos B, 2004, STROKE, V35, P964, DOI 10.1161/01.STR.0000119753.05670.F1; Figtree GA, 2009, CIRC RES, V105, P185, DOI 10.1161/CIRCRESAHA.109.199547; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Kris-Etherton PM, 2004, CIRCULATION, V110, P637, DOI 10.1161/01.CIR.0000137822.39831.F1; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; Miura H, 2003, CIRC RES, V92, P151, DOI 10.1161/01.RES.0000052671.53256.49; Moran LK, 2001, CURR MED CHEM, V8, P763, DOI 10.2174/0929867013372904; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pryor WA, 2006, AM J PHYSIOL-REG I, V291, pR491, DOI 10.1152/ajpregu.00614.2005; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi WW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.058313; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Waypa GB, 2006, CIRC RES, V99, P970, DOI 10.1161/01.RES.0000247068.75808.3f; Weintraub NL, 2003, CIRC RES, V92, P127, DOI 10.1161/01.RES.0000056965.71699.02; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zha XM, 2009, P NATL ACAD SCI USA, V106, P3573, DOI 10.1073/pnas.0813402106; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	42	53	58	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38641	38648		10.1074/jbc.M110.162578	http://dx.doi.org/10.1074/jbc.M110.162578			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926382	Green Published, hybrid			2022-12-27	WOS:000284625600068
J	Kawano, T; Shimoda, M; Matsumoto, H; Ryuda, M; Tsuzuki, S; Hayakawa, Y				Kawano, Takeshi; Shimoda, Masami; Matsumoto, Hitoshi; Ryuda, Masasuke; Tsuzuki, Seiji; Hayakawa, Yoichi			Identification of a Gene, Desiccate, Contributing to Desiccation Resistance in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; GROWTH-BLOCKING PEPTIDE; STRESS; MECHANISMS; TRANSCRIPTION; RECEPTORS; TOLERANCE; EVOLUTION; RECOVERY; BINDING	Suitable alterations in gene expression are believed to allow animals to survive drastic changes in environmental conditions. Drosophila melanogaster larvae cease eating and exit moist food to search for dry pupation sites after the foraging stage in what is known as the wandering stage. Although the behavioral change from foraging to wandering causes desiccation stress, the mechanism by which Drosophila larvae protect themselves from desiccation remains obscure. Here, we identified a gene, CG14686 (designated as Desiccate (Desi)), whose expression was elevated during the wandering stage. The Desi expression level was reversibly decreased by transferring wandering larvae to wet conditions and increased again by transferring them to dry conditions. Elevation of Desi expression was also observed in foraging larvae when they were placed in dry conditions. Desi encoded a 261-amino acid single-pass transmembrane protein with notable motifs, such as SH2 and PDZ domain-binding motifs and a cAMP-dependent protein kinase phosphorylation motif, in the cytoplasmic region, and its expression was observed mainly in the epidermal cells of the larval integuments. Overexpression of Desi slightly increased the larval resistance to desiccation stress during the second instar. Furthermore, Desi RNAi larvae lost more weight under dry conditions, and subsequently, their mortalities significantly increased compared with control larvae. Under dry conditions, consumption of carbohydrate was much higher in Desi RNAi larvae than control larvae. Based on these results, it is reasonable to conclude that Desi contributes to the resistance of Drosophila larvae to desiccation stress.	[Hayakawa, Yoichi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8900065, Japan; [Shimoda, Masami] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Matsumoto, Hitoshi; Ryuda, Masasuke; Tsuzuki, Seiji; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan	Kagoshima University; National Institute of Agrobiological Sciences - Japan; Saga University	Hayakawa, Y (corresponding author), Honjo 1, Saga 8408502, Japan.	hayakayo@cc.saga-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to Y. H.).	Ainsley JA, 2008, DEV BIOL, V322, P46, DOI 10.1016/j.ydbio.2008.07.003; Beisenherz-Huss C, 2001, MOL CELL ENDOCRINOL, V183, P101, DOI 10.1016/S0303-7207(01)00588-3; Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012; CHARDIN P, 1995, FEBS LETT, V369, P47, DOI 10.1016/0014-5793(95)00578-W; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Fanning AS, 1996, CURR BIOL, V6, P1385, DOI 10.1016/S0960-9822(96)00737-3; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Folk DG, 2004, J EXP BIOL, V207, P2671, DOI 10.1242/jeb.01048; Folk DG, 2001, J EXP BIOL, V204, P3323; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; HAYAKAWA Y, 1982, INSECT BIOCHEM, V12, P361, DOI 10.1016/0020-1790(82)90032-4; Hayakawa Y, 2000, CELL TISSUE RES, V300, P459, DOI 10.1007/s004419900152; Marican C, 2004, INSECT BIOCHEM MOLEC, V34, P823, DOI 10.1016/j.ibmb.2004.05.002; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Nishizaki T, 1998, BRAIN RES, V812, P242, DOI 10.1016/S0006-8993(98)00836-1; Oda Y, 2010, P NATL ACAD SCI USA, V107, P15862, DOI 10.1073/pnas.1003785107; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riddiford Lynn M., 1993, P899; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryuda M, 2008, APPL ENTOMOL ZOOL, V43, P563, DOI 10.1303/aez.2008.563; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Sorensen JG, 2007, J EVOLUTION BIOL, V20, P1624, DOI 10.1111/j.1420-9101.2007.01326.x; STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Telonis-Scott M, 2003, J INSECT PHYSIOL, V49, P1013, DOI 10.1016/S0022-1910(03)00184-7; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0	29	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38889	38897		10.1074/jbc.M110.168864	http://dx.doi.org/10.1074/jbc.M110.168864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937803	hybrid, Green Published			2022-12-27	WOS:000284941300018
J	Pain, J; Balamurali, MM; Dancis, A; Pain, D				Pain, Jayashree; Balamurali, M. M.; Dancis, Andrew; Pain, Debkumar			Mitochondrial NADH Kinase, Pos5p, Is Required for Efficient Iron-Sulfur Cluster Biogenesis in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCTASE HOMOLOG ARH1P; YEAST FRATAXIN; PROTEIN TRANSLOCATION; GENE; IDENTIFICATION; GTP; MATURATION; SCAFFOLD; HOMEOSTASIS; COMPONENT	In Saccharomyces cerevisiae, the mitochondrial inner membrane readily allows transport of cytosolic NAD(+), but not NADPH, to the matrix. Pos5p is the only known NADH kinase in the mitochondrial matrix. The enzyme phosphorylates NADH to NADPH and is the major source of NADPH in the matrix. The importance of mitochondrial NADPH for cellular physiology is underscored by the phenotypes of the Delta pos5 mutant, characterized by oxidative stress sensitivity and iron-sulfur (Fe-S) cluster deficiency. Fe-S clusters are essential cofactors of proteins such as aconitase [4Fe-4S] and ferredoxin [2Fe-2S] in mitochondria. Intact mitochondria isolated from wild-type yeast can synthesize these clusters and insert them into the corresponding apoproteins. Here, we show that this process of Fe-S cluster biogenesis in wild-type mitochondria is greatly stimulated and kinetically favored by the addition of NAD(+) or NADH in a dose-dependent manner, probably via transport into mitochondria and subsequent conversion into NADPH. Unlike wild-type mitochondria, Delta pos5 mitochondria cannot efficiently synthesize Fe-S clusters on endogenous aconitase or imported ferredoxin, although cluster biogenesis in isolated Delta pos5 mitochondria is restored to a significant extent by a small amount of imported Pos5p. Interestingly, Fe-S cluster biogenesis in wild-type mitochondria is further enhanced by overexpression of Pos5p. The effects of Pos5p on Fe-S cluster generation in mitochondria indicate that one or more steps in the biosynthetic process require NADPH. The role of mitochondrial NADPH in Fe-S cluster biogenesis appears to be distinct from its function in anti-oxidant defense.	[Pain, Debkumar] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07101 USA; [Dancis, Andrew] Univ Penn, Div Hematol Oncol, Dept Med, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave,MSB I-669, Newark, NJ 07101 USA.	painde@umdnj.edu	MM, Balamurali/ABG-9767-2020	MM, Balamurali/0000-0001-7948-9950	National Institutes of Health, NIA [AG030504]; American Heart Association [09GRNT2260364];  [R37DK053953]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG030504 from NIA (to D. P.) and Grant R37DK053953 (to A. D.). This work was also supported by American Heart Association Grant 09GRNT2260364 (to D. P.).	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Amutha B, 2009, METHOD ENZYMOL, V456, P247, DOI 10.1016/S0076-6879(08)04414-5; Atkinson A, 2009, CHEM REV, V109, P4708, DOI 10.1021/cr900006y; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Gu YJ, 2005, J BIOL CHEM, V280, P18604, DOI 10.1074/jbc.M500847200; HINKLE PC, 1991, BIOCHEMISTRY-US, V30, P3576, DOI 10.1021/bi00228a031; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Karthikeyan G, 2002, HUM MOL GENET, V11, P1351, DOI 10.1093/hmg/11.11.1351; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kawai S, 2001, FEMS MICROBIOL LETT, V200, P181, DOI 10.1111/j.1574-6968.2001.tb10712.x; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; KREMS B, 1995, CURR GENET, V27, P427, DOI 10.1007/BF00311211; Labbe-Bois Rosine, 1994, V11, P413; Lacour T, 1998, J BIOL CHEM, V273, P23984, DOI 10.1074/jbc.273.37.23984; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Luttik MAH, 1998, J BIOL CHEM, V273, P24529, DOI 10.1074/jbc.273.38.24529; MCGUINNESS ET, 1985, INT J BIOCHEM, V17, P1, DOI 10.1016/0020-711X(85)90079-5; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Pedrajas JR, 2002, BIOCHEM J, V364, P617, DOI 10.1042/BJ20020570; Pedrajas JR, 1999, J BIOL CHEM, V274, P6366, DOI 10.1074/jbc.274.10.6366; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Shi F, 2005, FEBS J, V272, P3337, DOI 10.1111/j.1742-4658.2005.04749.x; Shianna KV, 2006, MITOCHONDRION, V6, P94, DOI 10.1016/j.mito.2006.02.003; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Strand MK, 2003, EUKARYOT CELL, V2, P809, DOI 10.1128/EC.2.4.809-820.2003; Stuart GR, 2009, MITOCHONDRION, V9, P211, DOI 10.1016/j.mito.2009.02.004; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; TZAGOLOFF A, 1982, MITOCHONDRIA, P199; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; YING W, 2008, YEAST, V10, P1511; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	53	26	27	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39409	39424		10.1074/jbc.M110.178947	http://dx.doi.org/10.1074/jbc.M110.178947			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889970	Green Published, hybrid			2022-12-27	WOS:000284941300068
J	Tokhtaeva, E; Sachs, G; Vagin, O				Tokhtaeva, Elmira; Sachs, George; Vagin, Olga			Diverse Pathways for Maturation of the Na,K-ATPase beta(1) and beta(2) Subunits in the Endoplasmic Reticulum of Madin-Darby Canine Kidney Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; ACTIVATED ADENOSINE-TRIPHOSPHATASE; UNFOLDED PROTEIN RESPONSE; N-GLYCOSYLATION SITES; XENOPUS-OOCYTES; QUALITY-CONTROL; INTRACELLULAR-TRANSPORT; FUNCTIONAL EXPRESSION; MOLECULAR-WEIGHT; ALPHA-SUBUNITS	Proper folding of the Na,K-ATPase beta subunits followed by assembly with the alpha subunits is necessary for their export from the endoplasmic reticulum (ER). Here we examine roles of the ER lectin chaperone, calnexin, and non-lectin chaperone, BiP, in folding and quality control of the beta(1) and beta(2) subunits in Madin-Darby canine kidney cells. Short term prevention of glycan-calnexin interactions by castanospermine slightly increases ER retention of beta(1), suggesting minor involvement of calnexin in subunit folding. However, both prolonged incubation with castanospermine and removal of N-glycosylation sites do not affect the alpha(1)-assembly or trafficking of beta(1) but increase the amount of the beta(1)-bound BiP, showing that BiP can compensate for calnexin in assisting beta(1) folding. In contrast to beta(1), prevention of either N-glycosylation or glycan-calnexin interactions abolishes the alpha(1)-assembly and export of beta(2) from the ER despite increased beta(2)-BiP binding. Mutations in the alpha(1)-interacting regions of beta(1) and beta(2) subunits impair alpha(1) assembly but do not affect folding of the beta subunits tested by their sensitivity to trypsin. At the same time, these mutations increase the amount of beta-bound BiP but not of beta-bound calnexin and increase ER retention of both beta-isoforms. BiP, therefore, prevents the ER export of folded but alpha(1)-unassembled beta subunits. These alpha(1)-unassembled beta subunits are degraded faster than alpha(1)-bound beta subunits, preventing ER overload. In conclusion, folding of the beta(1) and beta(2) subunits is assisted predominantly by BiP and calnexin, respectively. Folded beta(1) and beta(2) either assemble with alpha(1) or bind BiP. The alpha(1)-bound beta subunits traffic to the Golgi, whereas BiP-bound beta subunits are retained and degraded in the ER.	Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA; Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Vagin, O (corresponding author), 11301 Wilshire Blvd,VAGLAHS W LA,Bldg 113,Rm 324, Los Angeles, CA 90073 USA.	olgav@ucla.edu			National Institutes of Health [DK077149, DK058333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058333, R01DK058333, R01DK077149] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK077149 and DK058333.	ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; Bae EH, 2008, AM J PHYSIOL-RENAL, V294, pF272, DOI 10.1152/ajprenal.00352.2007; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beggah AT, 1997, ANN NY ACAD SCI, V834, P537, DOI 10.1111/j.1749-6632.1997.tb52311.x; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; BROTHERUS JR, 1983, BIOCHIM BIOPHYS ACTA, V731, P290, DOI 10.1016/0005-2736(83)90021-4; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Caramelo JJ, 2007, SEMIN CELL DEV BIOL, V18, P732, DOI 10.1016/j.semcdb.2007.09.006; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; CRAIG WS, 1980, J BIOL CHEM, V255, P6262; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Eriyamremu GE, 2005, BIOMETALS, V18, P1, DOI 10.1007/s10534-004-1202-3; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; HAMADA T, 1991, TOXICOL PATHOL, V19, P138, DOI 10.1177/019262339101900208; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; JAUNIN P, 1992, J BIOL CHEM, V267, P577; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; Karthikeyan J, 2009, J ENVIRON BIOL, V30, P895; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kitamura M, 2010, BIOMETALS, V23, P941, DOI 10.1007/s10534-010-9296-2; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; KYTE J, 1971, J BIOL CHEM, V246, P4157; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Liu LJ, 2006, AM J PHYSIOL-CELL PH, V291, pC569, DOI 10.1152/ajpcell.00002.2006; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MILLER RP, 1988, BIOCHIM BIOPHYS ACTA, V954, P50, DOI 10.1016/0167-4838(88)90054-4; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Peng L, 1997, J NEUROSCI, V17, P3488; PETERSON GL, 1981, J BIOL CHEM, V256, P3751; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; SHANBAKY NM, 1995, BIOCHEM CELL BIOL, V73, P261, DOI 10.1139/o95-032; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; TAKEDA K, 1988, FEBS LETT, V238, P201, DOI 10.1016/0014-5793(88)80256-4; Tamura T., 2010, MOL MEMBR B IN PRESS; Therien AG, 1996, J BIOL CHEM, V271, P7104, DOI 10.1074/jbc.271.12.7104; Tian J, 2008, PHYSIOLOGY, V23, P205, DOI 10.1152/physiol.00008.2008; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	64	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39289	39302		10.1074/jbc.M110.172858	http://dx.doi.org/10.1074/jbc.M110.172858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937802	hybrid, Green Published			2022-12-27	WOS:000284941300057
J	Xu, H; Wickner, W				Xu, Hao; Wickner, William			Phosphoinositides Function Asymmetrically for Membrane Fusion, Promoting Tethering and 3Q-SNARE Subcomplex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOTYPIC VACUOLE FUSION; TRANS-SNARE COMPLEXES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; YEAST VACUOLE; REGULATORY LIPIDS; PLASMA-MEMBRANE; T-SNARE; VAM7P; DOCKING; PHOSPHOLIPIDS	Phosphatidylinositol 3-phosphate (PI(3)P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) are essential for rapid SNARE-dependent fusion of yeast vacuoles and other organelles. These phosphoinositides also regulate the fusion of reconstituted proteoliposomes. The reconstituted reaction allows separate analysis of phosphoinositide-responsive subreactions: fusion with SNAREs alone, with the addition of the HOPS tethering factor, and with the further addition of the SNARE complex disassembly chaperones Sec17p and Sec18p. Using assays of membrane tethering, trans-SNARE pairing, and lipid mixing, we found that PI(3)P and PI(4,5)P-2 have distinct functions that are asymmetric with respect to R-SNARE (Nyv1p) and the 3Q-SNAREs (Vam3p, Vti1p, and Vam7p). Fusion reactions with the Q-SNAREs and R-SNARE on separate membranes showed that PI(3)P has two distinct functions. PI(3)P on Q-SNARE proteoliposomes promoted Vam7p binding and association with the other two Q-SNAREs. PI(3)P on R-SNARE proteoliposomes was recognized by the PX domain of Vam7p on Q-SNARE proteoliposomes to promote tethering, although this function could be supplanted by the tethering activity of HOPS. PI(4,5)P-2 stimulated fusion when it was on R-SNARE proteoliposomes, apposed to Q-SNARE proteoliposomes bearing PI(3)P. These functions are essential for the phosphoinositide-dependent synergy between HOPS and Sec17p/Sec18p in promoting rapid fusion.	[Xu, Hao; Wickner, William] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Wickner, W (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail Bldg,Remsen 425, Hanover, NH 03755 USA.	bill.wickner@dartmouth.edu	Xu, Hao/B-3194-2011	Xu, Hao/0000-0002-5776-0276	National Institutes of Health [GM23377-35]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023377, R37GM023377] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM23377-35.	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fukuda R, 2000, NATURE, V407, P198, DOI 10.1038/35025084; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hickey CM, 2009, J BIOL CHEM, V284, P16118, DOI 10.1074/jbc.M109.000737; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Lorente-Rodriguez A., 2010, THESIS DARTMOUTH COL; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Vieira OV, 2003, MOL CELL BIOL, V23, P2501, DOI 10.1128/MCB.23.7.2501-2514.2003; Weninger K, 2003, P NATL ACAD SCI USA, V100, P14800, DOI 10.1073/pnas.2036428100; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128	35	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39359	39365		10.1074/jbc.M110.183111	http://dx.doi.org/10.1074/jbc.M110.183111			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937838	Green Published, hybrid			2022-12-27	WOS:000284941300063
J	Huang, ZY; Hunter, S; Chien, P; Kim, MK; Han-Kim, TH; Indik, ZK; Schreiber, AD				Huang, Zhen-Yu; Hunter, Sharon; Chien, Paul; Kim, Moo-Kyung; Han-Kim, Tae-Hee; Indik, Zena K.; Schreiber, Alan D.			Interaction of Two Phagocytic Host Defense Systems Fc gamma RECEPTORS AND COMPLEMENT RECEPTOR 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SYK; CYTOPLASMIC DOMAIN; MEDIATED PHAGOCYTOSIS; NEUTROPHIL ADHESION; ESCHERICHIA-COLI; MAC-1 CD11B/CD18; COMPLEMENT; RECEPTORS; MACROPHAGES; CHAIN	Phagocytosis of foreign pathogens by cells of the immune system is a vitally important function of innate immunity. The phagocytic response is initiated when ligands on the surface of invading microorganisms come in contact with receptors on the surface of phagocytic cells such as neutrophils, monocytes/macrophages, and dendritic cells. The complement receptor CR3 (CD11b/CD18, Mac-1) mediates the phagocytosis of complement protein (C3bi)-coated particles. Fc gamma receptors (Fc gamma Rs) bind IgG-opsonized particles and provide a mechanism for immune clearance and phagocytosis of IgG-coated particles. We have observed that stimulation of Fc gamma Rs modulates CR3-mediated phagocytosis and that Fc gamma RIIA and Fc gamma RI exert opposite (stimulatory and inhibitory) effects. We have also determined that an intact Fc gamma R immunoreceptor tyrosine-based activation motif is required for these effects, and we have investigated the involvement of downstream effectors. The ability to up-regulate or down-regulate CR3 signaling has important implications for therapeutics in disorders involving the host defense system.	[Huang, Zhen-Yu; Hunter, Sharon; Chien, Paul; Kim, Moo-Kyung; Han-Kim, Tae-Hee; Indik, Zena K.; Schreiber, Alan D.] Univ Penn, Sch Med, Dept Hematol Oncol, Philadelphia, PA 19104 USA	University of Pennsylvania	Huang, ZY (corresponding author), 421 Curie Blvd,BRB2-3,Rm 736, Philadelphia, PA 19104 USA.	zyh@mail.med.upenn.edu; schreibr@mail.med.upenn.edu						ARAUJOJORGE T, 1993, INFECT IMMUN, V61, P4925, DOI 10.1128/IAI.61.11.4925-4928.1993; Boekhoudt GH, 2007, J LEUKOCYTE BIOL, V81, P1086, DOI 10.1189/jlb.0906543; BROWN EJ, 1988, J CLIN INVEST, V81, P365, DOI 10.1172/JCI113328; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Caron E, 2000, CURR BIOL, V10, pR489, DOI 10.1016/S0960-9822(00)00555-8; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; Edberg JC, 2002, J BIOL CHEM, V277, P41287, DOI 10.1074/jbc.M207835200; Edberg JC, 1999, J BIOL CHEM, V274, P30328, DOI 10.1074/jbc.274.42.30328; EHLENBERGER AG, 1977, J EXP MED, V145, P357, DOI 10.1084/jem.145.2.357; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GHAZIZADEH S, 1995, BIOCHEM J, V305, P669, DOI 10.1042/bj3050669; Greenberg S, 2002, CURR OPIN IMMUNOL, V14, P136, DOI 10.1016/S0952-7915(01)00309-0; Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Huang ZY, 2006, J LEUKOCYTE BIOL, V80, P1553, DOI 10.1189/jlb.0106019; Huang ZY, 2004, J LEUKOCYTE BIOL, V76, P491, DOI 10.1189/jlb.1103562; Indik Z K, 1995, Semin Immunol, V7, P45, DOI 10.1016/1044-5323(95)90007-1; INDIK ZK, 1994, EXP HEMATOL, V22, P599; INDIK ZK, 1995, BLOOD, V85, P1175, DOI 10.1182/blood.V85.5.1175.bloodjournal8551175; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Isakov N, 1997, J LEUKOCYTE BIOL, V61, P6, DOI 10.1002/jlb.61.1.6; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Kiefer F, 1998, MOL CELL BIOL, V18, P4209, DOI 10.1128/MCB.18.7.4209; Kim MK, 2001, CLIN IMMUNOL, V98, P125, DOI 10.1006/clim.2000.4955; Kohl J, 2006, ADV EXP MED BIOL, V586, P71; Kruse K, 2010, APOPTOSIS, V15, P1098, DOI 10.1007/s10495-010-0478-8; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; Li Y, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2590; Lourenco EV, 2009, CURR MOL MED, V9, P242, DOI 10.2174/156652409787847263; McKenzie S E, 1998, Curr Opin Hematol, V5, P16, DOI 10.1097/00062752-199801000-00003; MITCHELL MA, 1994, BLOOD, V84, P1753; Morgan BP, 2003, MOL IMMUNOL, V40, P159, DOI 10.1016/S0161-5890(03)00111-1; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; PARK JG, 1993, J CLIN INVEST, V92, P2073, DOI 10.1172/JCI116804; Quigg RJ, 2004, CURR DIRECT AUTOIMMU, V7, P165; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2; SCHREIBER AD, 1975, J CLIN INVEST, V56, P1189, DOI 10.1172/JCI108196; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Strzelecka A, 1997, FEBS LETT, V400, P11, DOI 10.1016/S0014-5793(96)01359-2; SZUCS G, 1994, SCAND J IMMUNOL, V40, P481, DOI 10.1111/j.1365-3083.1994.tb03493.x; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tohyama Y, 2006, IUBMB LIFE, V58, P304, DOI 10.1080/15216540600746377; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; vanVugt MJ, 1996, BLOOD, V87, P3593, DOI 10.1182/blood.V87.9.3593.bloodjournal8793593; Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876	57	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					160	168		10.1074/jbc.M110.163030	http://dx.doi.org/10.1074/jbc.M110.163030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044955	hybrid, Green Published			2022-12-27	WOS:000285782800017
J	Ruangchan, N; Tongsook, C; Sucharitakul, J; Chaiyen, P				Ruangchan, Nantidaporn; Tongsook, Chanakan; Sucharitakul, Jeerus; Chaiyen, Pimchai			pH-dependent Studies Reveal an Efficient Hydroxylation Mechanism of the Oxygenase Component of p-Hydroxyphenylacetate 3-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHENOL 4-MONOOXYGENASE TFTD; HYDROXYBENZOATE HYDROXYLASE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; ALKANESULFONATE MONOOXYGENASE; ACINETOBACTER-BAUMANNII; STYRENE MONOOXYGENASE; OXIDOREDUCTASE TFTC; PHENOL HYDROXYLASE; CRYSTAL-STRUCTURES; FLAVIN REDUCTASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase (HPAH) catalyzes the hydroxylation of HPA at the ortho-position to yield 3,4-dihydroxyphenylacetate. The enzyme is a flavin-dependent two-component monooxygenase that consists of a reductase component and an oxygenase component (C-2). C-2 catalyzes the hydroxylation of HPA using oxygen and reduced FMN as co-substrates. To date, the effects of pH on the oxygenation of the two-component monooxygenases have never been reported. Here, we report the reaction kinetics of C-2 center dot FMNH- with oxygen at various pH values investigated by stopped-flow and rapid quenched-flow techniques. In the absence of HPA, the rate constant for the formation of C4a-hydroperoxy-FMN (similar to 1.1 x 10(6) M(-1)s(-1)) was unaffected at pH 6.2-9.9, which indicated that the pK(a) of the enzyme-bound reduced FMN was less than 6.2. The rate constant for the following H2O2 elimination step increased with higher pH, which is consistent with a pK(a) of >9.4. In the presence of HPA, the rate constants for the formation of C4a-hydroperoxy-FMN (similar to 4.8 x 10(4) M(-1)s(-1)) and the ensuing hydroxylation step (15-17 s(-1)) were not significantly affected by the pH. In contrast, the following steps of C4a-hydroxy-FMN dehydration to form oxidized FMN occurred through two pathways that were dependent on the pH of the reaction. One pathway, dominant at low pH, allowed the detection of a C4a-hydroxy-FMN intermediate, whereas the pathway dominant at high pH produced oxidized FMN without an apparent accumulation of the intermediate. However, both pathways efficiently catalyzed hydroxylation without generating significant amounts of wasteful H2O2 at pH 6.2-9.9. The decreased accumulation of the intermediate at higher pH was due to the greater rates of C4a-hydroxy-FMN decay caused by the abolishment of substrate inhibition in the dehydration step at high pH.	[Ruangchan, Nantidaporn; Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Dept Biochem, Bangkok 10400, Thailand; [Ruangchan, Nantidaporn; Tongsook, Chanakan; Chaiyen, Pimchai] Mahidol Univ, Ctr Excellence Prot Struct & Funct, Fac Sci, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok 10330, Thailand	Mahidol University; Mahidol University; Chulalongkorn University	Chaiyen, P (corresponding author), Mahidol Univ, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Chaiyen, Pimchai/R-5052-2019	Chaiyen, Pimchai/0000-0002-8533-1604	Thailand Research Fund [BRG5180002, MRG5380240]; Faculty of Science, Mahidol University; Development and Promotion of Science and Technology Talents Project (Thailand)	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Development and Promotion of Science and Technology Talents Project (Thailand)	This work was supported by Grants BRG5180002 (to P. C.) and MRG5380240 (to J. S.) from the Thailand Research Fund and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Development and Promotion of Science and Technology Talents Project (Thailand).	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; ARUNACHALAM U, 1992, J BIOL CHEM, V267, P25848; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 2004, BIOCHEMISTRY-US, V43, P3933, DOI 10.1021/bi035734d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Crozier-Reabe KR, 2008, BIOCHEMISTRY-US, V47, P12420, DOI 10.1021/bi8010434; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; ENTSCH B, 1991, J BIOL CHEM, V266, P17341; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; EVANS MG, 1949, T FARADAY SOC, V45, P224, DOI 10.1039/tf9494500224; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; GUNSALUSMIGUEL A, 1972, J BIOL CHEM, V247, P398; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; ISHIMITSU T, 1979, TALANTA, V26, P67, DOI 10.1016/0039-9140(79)80160-5; Kantz A, 2005, ARCH BIOCHEM BIOPHYS, V442, P102, DOI 10.1016/j.abb.2005.07.020; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; Macheroux Peter, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091/6/26; MAEDAYORITA K, 1993, J BIOL CHEM, V268, P4134; MERENYI G, 1991, J AM CHEM SOC, V113, P3146, DOI 10.1021/ja00008a051; Neumann CS, 2010, P NATL ACAD SCI USA, V107, P5798, DOI 10.1073/pnas.1001681107; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Ortiz-Maldonado M, 2004, BIOCHEMISTRY-US, V43, P15246, DOI 10.1021/bi048115t; Ortiz-Maldonado M, 1999, BIOCHEMISTRY-US, V38, P8124, DOI 10.1021/bi990560e; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; POWLOWSKI J, 1989, J BIOL CHEM, V264, P16008; SCHOPFER LM, 1980, J BIOL CHEM, V255, P5355; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Suske WA, 1999, J BIOL CHEM, V274, P33355, DOI 10.1074/jbc.274.47.33355; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Tischler D, 2009, J BACTERIOL, V191, P4996, DOI 10.1128/JB.00307-09; Valton J, 2006, J BIOL CHEM, V281, P27, DOI 10.1074/jbc.M506146200; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Hellemond EW, 2007, APPL ENVIRON MICROB, V73, P5832, DOI 10.1128/AEM.02708-06; VENKATARAM UV, 1984, J CHEM SOC CHEM COMM, P899, DOI 10.1039/c39840000899; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Witschel M, 1997, J BACTERIOL, V179, P6937, DOI 10.1128/jb.179.22.6937-6943.1997; Xun LY, 2004, J BIOL CHEM, V279, P6696, DOI 10.1074/jbc.M312072200; Yeh E, 2005, P NATL ACAD SCI USA, V102, P3960, DOI 10.1073/pnas.0500755102; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhan X, 2008, BIOCHEMISTRY-US, V47, P2221, DOI 10.1021/bi701853w	65	40	41	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					223	233		10.1074/jbc.M110.163881	http://dx.doi.org/10.1074/jbc.M110.163881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030590	hybrid, Green Published			2022-12-27	WOS:000285782800025
J	Dutta, D; Ray, S; Home, P; Saha, B; Wang, SJ; Sheibani, N; Tawfik, O; Cheng, NK; Paul, S				Dutta, Debasree; Ray, Soma; Home, Pratik; Saha, Biswarup; Wang, Shoujian; Sheibani, Nader; Tawfik, Osama; Cheng, Niki; Paul, Soumen			Regulation of Angiogenesis by Histone Chaperone HIRA-mediated Incorporation of Lysine 56-acetylated Histone H3.3 at Chromatin Domains of Endothelial Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEGF RECEPTOR FLT-1; CHOROIDAL NEOVASCULARIZATION; TRANSCRIPTIONAL ACTIVATION; H3K56 ACETYLATION; GENOMIC REGIONS; DNA-REPLICATION; TYROSINE KINASE; GROWTH-FACTOR; BONE-MARROW; IN-VIVO	Angiogenesis is critically dependent on endothelial cell-specific transcriptional mechanisms. However, the molecular processes that regulate chromatin domains and thereby dictate transcription of key endothelial genes are poorly understood. Here, we report that, in endothelial cells, angiogenic signal-mediated transcriptional induction of Vegfr1 (vascular endothelial growth factor receptor 1) is dependent on the histone chaperone, HIRA (histone cell cycle regulation-defective homolog A). Our molecular analyses revealed that, in response to angiogenic signals, HIRA is induced in endothelial cells and mediates incorporation of lysine 56 acetylated histone H3.3 (H3acK56) at the chromatin domain of Vegfr1. HIRA-mediated incorporation of H3acK56 is a general mechanism associated with transcriptional induction of several angiogenic genes in endothelial cells. Depletion of HIRA inhibits H3acK56 incorporation and transcriptional induction of Vegfr1 and other angiogenic genes. Our functional analyses revealed that depletion of HIRA abrogates endothelial network formation on Matrigel and inhibits angiogenesis in an in vivo Matrigel plug assay. Furthermore, analysis in a laser-induced choroidal neovascularization model showed that depletion of HIRA significantly inhibits neovascularization. Our results for the first time decipher a histone chaperone (HIRA)-dependent molecular mechanism in endothelial gene regulation and indicate that histone chaperones could be new targets for angiogenesis therapy.	[Dutta, Debasree; Ray, Soma; Home, Pratik; Saha, Biswarup; Tawfik, Osama; Cheng, Niki; Paul, Soumen] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, Kansas City, KS 66160 USA; [Wang, Shoujian; Paul, Soumen] Univ Kansas, Med Ctr, Inst Reprod Hlth & Regenerat Med, Kansas City, KS 66160 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Wisconsin System; University of Wisconsin Madison	Paul, S (corresponding author), Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Div Canc & Dev Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	spaul2@kumc.edu	Home, Pratik/D-5061-2014; Sheibani, Nader/AAG-2379-2020; Saha, Biswarup/T-7341-2019	Sheibani, Nader/0000-0003-2723-9217; Saha, Biswarup/0000-0003-2797-7308	National Institutes of Health [HL094892, HD062546, P20 RRO24214, EY16995, EY18179, P30 EY16665]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062546] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY016665, R01EY018179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094892, R21HL106311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094892, HD062546, P20 RRO24214, EY16995, EY18179, and P30 EY16665.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dutta D, 2008, J BIOL CHEM, V283, P25404, DOI 10.1074/jbc.M804349200; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Home P, 2009, J BIOL CHEM, V284, P28729, DOI 10.1074/jbc.M109.016840; Kappas NC, 2008, J CELL BIOL, V181, P847, DOI 10.1083/jcb.200709114; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kim HJ, 2007, EMBO J, V26, P4467, DOI 10.1038/sj.emboj.7601870; Lee HK, 2006, FEBS LETT, V580, P2253, DOI 10.1016/j.febslet.2006.03.033; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sengupta T, 2008, MOL CELL BIOL, V28, P6160, DOI 10.1128/MCB.00919-08; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Su XJ, 2003, MOL VIS, V9, P171; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taylor DS, 1999, P NATL ACAD SCI USA, V96, P1633, DOI 10.1073/pnas.96.4.1633; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011	54	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41567	41577		10.1074/jbc.M110.190025	http://dx.doi.org/10.1074/jbc.M110.190025			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041298	Green Published			2022-12-27	WOS:000285622600044
J	Gaudy, AM; Clementi, AH; Campbell, JS; Smrcka, AV; Mooney, RA				Gaudy, Allison M.; Clementi, Alicia H.; Campbell, Jean S.; Smrcka, Alan V.; Mooney, Robert A.			Suppressor of Cytokine Signaling-3 Is a Glucagon-inducible Inhibitor of PKA Activity and Gluconeogenic Gene Expression in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-A; SOCS-BOX MOTIF; INSULIN-RESISTANCE; CYCLIC-AMP; HEPATIC GLUCONEOGENESIS; PHOSPHOLIPASE-C; ADIPOSE-TISSUE; FACTOR-ALPHA; TYROSINE PHOSPHORYLATION	SOCS3 is a cytokine-inducible negative regulator of cytokine receptor signaling. Recently, SOCS3 was shown to be induced by a cAMP-dependent pathway involving exchange protein directly activated by cAMP (Epac). We observed in livers of fasted mice that Socs3 mRNA was increased 4-fold compared with refed mice, suggesting a physiologic role for SOCS3 in the fasted state that may involve glucagon and Epac. Treating primary hepatocytes with glucagon resulted in a 4-fold increase in Socs3 mRNA levels. The Epac-selective cAMP analog 8-4-(chlorophenylthio)-2'-O-methyladenosine-3',5'-monophosphate, acetoxymethyl ester (cpTOME) increased Socs3 expression comparably. In gain-of-function studies, adenoviral expression of SOCS3 in primary hepatocytes caused a 50% decrease in 8-br-cAMP-dependent PKA phosphorylation of the transcription factor CREB. Induction of the gluconeogenic genes Ppargc1a, Pck1, and G6pc by glucagon or 8-br-cAMP was suppressed nearly 50%. In loss-of-function studies, hepatocytes from liver-specific SOCS3 knock-out mice responded to 8-br-cAMP with a 200% greater increase in Ppargc1a and Pck1 expression, and a 30% increase in G6pc expression, relative to wild-type cells. Suppression of SOCS3 by shRNA in hepatocytes resulted in a 60% increase in cAMP-dependent G6pc and Pck1 expression relative to control cells. SOCS3 expression also inhibited cAMP-dependent phosphorylation of the IP3 receptor but did not inhibit nuclear localization of the catalytic subunit of PKA. Using an in vitro kinase assay, cAMP-dependent PKA activity was reduced by 80% in hepatocytes expressing ectopic SOCS3. These data indicate that cAMP activates both the PKA and Epac pathways with induction of SOCS3 by the Epac pathway negatively regulating the PKA pathway.	[Clementi, Alicia H.; Mooney, Robert A.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Gaudy, Allison M.; Smrcka, Alan V.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Campbell, Jean S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Rochester; University of Rochester; University of Washington; University of Washington Seattle	Mooney, RA (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, 601 Elmwood Ave, Rochester, NY 14642 USA.	Robert_Mooney@urmc.rochester.edu		Campbell, Jean/0000-0002-9187-2204	American Diabetes Association [7-04-RA-78]; United States Public Health Service [R01-DK060732, R01-GM053536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Research Grant from the American Diabetes Association (7-04-RA-78) (to R. A. M.). Additional support was provided by United States Public Health Service Grants R01-DK060732 (to R. A. M.) and R01-GM053536 (to A. V. S.).	Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; ARIAS J, 1994, NATURE, V370, P226, DOI 10.1038/370226a0; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Barradeau S, 2002, TRENDS CARDIOVAS MED, V12, P235, DOI 10.1016/S1050-1738(02)00167-6; Borland G, 2009, J BIOL CHEM, V284, P17391, DOI 10.1074/jbc.M109.015370; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Cheng XD, 1998, P NATL ACAD SCI USA, V95, P9849, DOI 10.1073/pnas.95.17.9849; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dunphy JL, 1998, MOL CELL ENDOCRINOL, V141, P179, DOI 10.1016/S0303-7207(98)00096-3; Edwards AS, 2000, CURR OPIN CELL BIOL, V12, P217, DOI 10.1016/S0955-0674(99)00085-X; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Giacca A, 1997, ENDOCRINOLOGY, V138, P999, DOI 10.1210/en.138.3.999; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GOODMAN MN, 1980, AM J PHYSIOL, V239, pE269; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Ishizuka K, 2007, ENDOCRINOLOGY, V148, P2994, DOI 10.1210/en.2006-1702; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Lewis GF, 1997, AM J PHYSIOL-ENDOC M, V272, pE371, DOI 10.1152/ajpendo.1997.272.3.E371; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lubis Adisaputra Ramadhinara, 2008, Acta Med Indones, V40, P89; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moore MJ, 2002, J BIOL CHEM, V277, P47878, DOI 10.1074/jbc.M204970200; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Rui LY, 2001, J BIOL CHEM, V276, P40362, DOI 10.1074/jbc.M105332200; Sands WA, 2006, MOL CELL BIOL, V26, P6333, DOI 10.1128/MCB.00207-06; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Senn JJ, 2002, DIABETES, V51, pA303; Starr R, 1998, INT J BIOCHEM CELL B, V30, P1081, DOI 10.1016/S1357-2725(98)00067-3; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Thoresen GH, 1999, CELL BIOL INT, V23, P13, DOI 10.1006/cbir.1998.0314; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Ueno H, 2001, GENOMICS, V78, P91, DOI 10.1006/geno.2001.6641; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wang ZW, 2001, FASEB J, V15, P108, DOI 10.1096/fj.00-0310com; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Woolson HD, 2009, CELL SIGNAL, V21, P1706, DOI 10.1016/j.cellsig.2009.07.009; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071	64	13	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41356	41365		10.1074/jbc.M110.159111	http://dx.doi.org/10.1074/jbc.M110.159111			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978125	hybrid, Green Published			2022-12-27	WOS:000285622600021
J	Kajimoto, T; Sawamura, S; Tohyama, Y; Mori, Y; Newton, AC				Kajimoto, Taketoshi; Sawamura, Seishiro; Tohyama, Yumi; Mori, Yasuo; Newton, Alexandra C.			Protein Kinase C delta-specific Activity Reporter Reveals Agonist-evoked Nuclear Activity Controlled by Src Family of Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; ENCODED FLUORESCENT REPORTER; ESTER-INDUCED APOPTOSIS; PKC-DELTA; TYROSINE PHOSPHORYLATION; SPATIOTEMPORAL DYNAMICS; GROWTH-FACTOR; ACTIVATION; TRANSLOCATION; DIACYLGLYCEROL	Conventional and novel protein kinase C (PKC) isozymes transduce the abundance of signals mediated by phospholipid hydrolysis; however redundancy in regulatory mechanisms confounds dissecting the unique signaling properties of each of the eight isozymes constituting these two subgroups. Previously, we created a genetically encoded reporter (C kinase activity reporter (CKAR)) to visualize the rate, amplitude, and duration of agonist-evoked PKC signaling at specific locations within the cell. Here we designed a reporter, delta CKAR, that specifically measures the activation signature of one PKC isozyme, PKC delta, in cells, revealing unique spatial and regulatory properties of this isozyme. Specifically, we show two mechanisms of activation: 1) agonist-stimulated activation at the plasma membrane (the site of most robust PKC delta signaling), Golgi, and mitochondria that is independent of Src and can be triggered by phorbol esters and 2) agonist-stimulated activation in the nucleus that requires Src kinase activation and cannot be triggered by phorbol esters. Translocation studies reveal that the G-protein-coupled receptor agonist UTP induces the translocation of PKC delta into the nucleus by a mechanism that depends on the C2 domain and requires Src kinase activity. However, translocation from the cytosol into the nucleus is not required for the Src-dependent regulation of nuclear activity; a construct of PKC delta prelocalized to the nucleus continues to be activated by UTP by a mechanism dependent on Src kinase activity. These data identify the nucleus as a signaling hub for PKC delta that is driven by receptor-mediated signaling pathways (but not phorbol esters) and differs from signaling at plasma membrane and Golgi in that it is controlled by Src family kinases.	[Kajimoto, Taketoshi; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kajimoto, Taketoshi; Sawamura, Seishiro; Mori, Yasuo] Kyoto Univ, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Tohyama, Yumi] Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan	University of California System; University of California San Diego; Kyoto University; Himeji Dokkyo University	Newton, AC (corresponding author), 9500 Gilman Dr 0721, La Jolla, CA 92093 USA.	anewton@ucsd.edu			National Institutes of Health [P01 DK54441, GM 43154]; JSPS, Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS, Uehara Memorial Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceUehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK54441 and GM 43154 (to A.C.N.). This work was also supported by a grant-in-aid for Japan Society for the Promotion of Science (JSPS) Fellows from the JSPS, Uehara Memorial Foundation (to T.K.).	Bailey K, 2005, BBA-MOL CELL BIOL L, V1733, P199, DOI 10.1016/j.bbalip.2004.12.013; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hamaguchi A, 2003, J BIOL CHEM, V278, P41557, DOI 10.1074/jbc.M305294200; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kajimoto T, 2001, MOL CELL BIOL, V21, P1769, DOI 10.1128/MCB.21.5.1769-1783.2001; KIELBASSA K, 1995, J BIOL CHEM, V270, P6156, DOI 10.1074/jbc.270.11.6156; Kunkel M. T., 2010, CURR PROT CHEM BIOL, V1, P17; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Kunkel MT, 2009, J BIOL CHEM, V284, P24653, DOI 10.1074/jbc.M109.024547; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Lakshmi S, 2006, NEUROSCIENCE, V141, P179, DOI 10.1016/j.neuroscience.2006.03.074; Li LW, 1999, MOL CELL BIOL, V19, P8547; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; MURRAY NR, 1994, J BIOL CHEM, V269, P21385; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Peterson TS, 2010, MOL NEUROBIOL, V41, P356, DOI 10.1007/s12035-010-8115-7; Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Ryu J, 2002, ARCH BIOCHEM BIOPHYS, V403, P71, DOI 10.1016/S0003-9861(02)00261-8; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Bilbao PS, 2010, ARCH BIOCHEM BIOPHYS, V499, P40, DOI 10.1016/j.abb.2010.05.001; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798	50	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41896	41910		10.1074/jbc.M110.184028	http://dx.doi.org/10.1074/jbc.M110.184028			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959447	Green Published, hybrid			2022-12-27	WOS:000285622600077
J	Skovierova, H; Larrouy-Maumus, G; Pham, H; Belanova, M; Barilone, N; DasGupta, A; Mikusova, K; Gicquel, B; Gilleron, M; Brennan, PJ; Puzo, G; Nigou, J; Jackson, M				Skovierova, Henrieta; Larrouy-Maumus, Gerald; Pham, Ha; Belanova, Martina; Barilone, Nathalie; DasGupta, Arunava; Mikusova, Katarina; Gicquel, Brigitte; Gilleron, Martine; Brennan, Patrick. J.; Puzo, Germain; Nigou, Jerome; Jackson, Mary			Biosynthetic Origin of the Galactosamine Substituent of Arabinogalactan in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY-ELECTROPHORESIS; CELL-WALL; MYCOTHIOL; SMEGMATIS; GLYCOSYLTRANSFERASES; LIPOPOLYSACCHARIDES; LIPOARABINOMANNANS; IDENTIFICATION; DEACETYLASE; SYNTHASE	The arabinogalactan (AG) of slow growing pathogenic Mycobacterium spp. is characterized by the presence of galactosamine (GalN) modifying some of the interior branched arabinosyl residues. The biosynthetic origin of this substituent and its role(s) in the physiology and/or pathogenicity of mycobacteria are not known. We report on the discovery of a polyprenyl-phospho-N-acetylgalactosaminyl synthase (PpgS) and the glycosyltransferase Rv3779 from Mycobacterium tuberculosis required, respectively, for providing and transferring the GalN substrate for the modification of AG. Disruption of either ppgS (Rv3631) or Rv3779 totally abolished the synthesis of the GalN substituent of AG in M. tuberculosis H37Rv. Conversely, expression of ppgS in Mycobacterium smegmatis conferred upon this species otherwise devoid of ppgS ortholog and any detectable polyprenyl-phospho-N-acetylgalactosaminyl synthase activity the ability to synthesize polyprenyl-phospho-N-acetylgalactosamine (polyprenyl-P-GalNAc) from polyprenyl-P and UDP-GalNAc. Interestingly, this catalytic activity was increased 40-50-fold by co-expressing Rv3632, the encoding gene of a small membrane protein apparently co-transcribed with ppgS in M. tuberculosis H37Rv. The discovery of this novel lipid-linked sugar donor and the involvement of a the glycosyltransferase C-type glycosyltransferase in its transfer onto its final acceptor suggest that pathogenic mycobacteria modify AG on the periplasmic side of the plasma membrane. The availability of a ppgS knock-out mutant of M. tuberculosis provides unique opportunities to investigate the physiological function of the GalN substituent and the potential impact it may have on host-pathogen interactions.	[Larrouy-Maumus, Gerald; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] CNRS, IPBS, Dept Mecanisms Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Brennan, Patrick. J.] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Larrouy-Maumus, Gerald; Gilleron, Martine; Puzo, Germain; Nigou, Jerome] Univ Toulouse 3, Univ Toulouse, IPBS, F-31077 Toulouse, France; [Belanova, Martina; Mikusova, Katarina] Comenius Univ, Dept Biochem, Fac Nat Sci, Bratislava 84215, Slovakia; [Barilone, Nathalie; DasGupta, Arunava; Gicquel, Brigitte] Inst Pasteur, Unite Genet Mycobacterienne, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Colorado State University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Comenius University Bratislava; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nigou, J (corresponding author), CNRS, IPBS, Dept Mecanisms Mol Infect Mycobacteriennes, 205 Route Narbonne, F-31077 Toulouse, France.	Jerome.Nigou@ipbs.fr; Mary.Jackson@colostate.edu	Brennan, Patrick J/G-6896-2017; Mikusova, Katarina/I-3622-2014; Jackson, Mary/D-5345-2017; Nigou, Jérôme/D-6802-2019	Jackson, Mary/0000-0002-9212-0258; Nigou, Jérôme/0000-0002-6233-2487; Mikusova, Katarina/0000-0002-0100-4877; GILLERON, Martine/0000-0002-2581-3302; Larrouy-Maumus, Gerald/0000-0001-6614-8698	National Institutes of Health through the NIAID [AI064798, AI018357, R37 AI18357]; AIDS-Fogarty International Research Collaboration Award [TW 006487]; FOGARTY INTERNATIONAL CENTER [R03TW006487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018357, R01AI064798, R37AI018357, R22AI018357] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS-Fogarty International Research Collaboration Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI064798 and AI018357 through the NIAID. This work was also supported by AIDS-Fogarty International Research Collaboration Award Grant TW 006487 and its parent National Institutes of Health Grant R37 AI18357 through the NIAID.	ACHARYA PVN, 1970, J BACTERIOL, V102, P733, DOI 10.1128/JB.102.3.733-739.1970; Baulard AR, 2003, J BIOL CHEM, V278, P2242, DOI 10.1074/jbc.M207922200; BEER W, 1986, J BASIC MICROB, V26, P201, DOI 10.1002/jobm.3620260405; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bhamidi S, 2008, J BIOL CHEM, V283, P12992, DOI 10.1074/jbc.M800222200; Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHIU TH, 1988, BIOCHIM BIOPHYS ACTA, V963, P359, DOI 10.1016/0005-2760(88)90302-5; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Dinadayala P, 2006, J BIOL CHEM, V281, P20027, DOI 10.1074/jbc.M603395200; DRAPER P, 1971, J GEN MICROBIOL, V69, P313, DOI 10.1099/00221287-69-3-313; Draper P, 1997, BIOCHEM J, V327, P519, DOI 10.1042/bj3270519; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee A, 2006, BIOCHEMISTRY-US, V45, P15817, DOI 10.1021/bi060688d; Ludwiczak P, 2001, ANAL CHEM, V73, P2323, DOI 10.1021/ac001368h; Mikusova K, 2000, J BIOL CHEM, V275, P33890, DOI 10.1074/jbc.M006875200; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Newton GL, 2000, J BACTERIOL, V182, P6958, DOI 10.1128/JB.182.24.6958-6963.2000; Nigou J, 2000, J MOL BIOL, V299, P1353, DOI 10.1006/jmbi.2000.3821; Nigou J, 1997, J BIOL CHEM, V272, P23094, DOI 10.1074/jbc.272.37.23094; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; PFANNENSTIEL MA, 1987, J BACTERIOL, V169, P796, DOI 10.1128/jb.169.2.796-801.1987; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Scherman H, 2009, J BACTERIOL, V191, P6769, DOI 10.1128/JB.00431-09; SCHULTZ J, 1974, ARCH BIOCHEM BIOPHYS, V160, P311, DOI 10.1016/S0003-9861(74)80039-1; SONESSON A, 1994, MICROBIOL-SGM, V140, P2663, DOI 10.1099/00221287-140-10-2663; Song F, 2009, BIOCHEMISTRY-US, V48, P1173, DOI 10.1021/bi802212t; Wang XY, 2009, BIOCHEMISTRY-US, V48, P1162, DOI 10.1021/bi802211k; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; YOKOYAMA K, 1989, J BIOL CHEM, V264, P21621	34	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41348	41355		10.1074/jbc.M110.188110	http://dx.doi.org/10.1074/jbc.M110.188110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21030587	Green Published, hybrid			2022-12-27	WOS:000285622600020
J	Dong, CH; Jang, M; Scharein, B; Malach, A; Rivarola, M; Liesch, J; Groth, G; Hwang, I; Chang, C				Dong, Chun-Hai; Jang, Mihue; Scharein, Benjamin; Malach, Anuschka; Rivarola, Maximo; Liesch, Jeff; Groth, Georg; Hwang, Inhwan; Chang, Caren			Molecular Association of the Arabidopsis ETR1 Ethylene Receptor and a Regulator of Ethylene Signaling, RTE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; HISTIDINE KINASE-ACTIVITY; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FAMILY-MEMBERS; GENE FAMILY; THALIANA; BINDING	The plant hormone ethylene plays important roles in growth and development. Ethylene is perceived by a family of membrane-bound receptors that actively repress ethylene responses. When the receptors bind ethylene, their signaling is shut off, activating responses. REVERSION-TO-ETHYLENE SENSITIVITY (RTE1) encodes a novel membrane protein conserved in plants and metazoans. Genetic analyses in Arabidopsis thaliana suggest that RTE1 promotes the signaling state of the ethylene receptor ETR1 through the ETR1 N-terminal domain. RTE1 and ETR1 have been shown to co-localize to the endoplasmic reticulum (ER) and Golgi apparatus in Arabidopsis. Here, we demonstrate a physical association of RTE1 and ETR1 using in vivo and in vitro methods. Interaction of RTE1 and ETR1 was revealed in vivo by bimolecular fluorescence complementation (BiFC) in a tobacco cell transient assay and in stably transformed Arabidopsis. The association was also observed using a truncated version of ETR1 comprising the N terminus (amino acids 1-349). Interaction of RTE1 and ETR1 was confirmed by co-immunoprecipitation from Arabidopsis. The interaction occurs with high affinity (K-d, 117 nM) based on tryptophan fluorescence spectroscopy using purified recombinant RTE1 and a tryptophan-less version of purified recombinant ETR1. An amino acid substitution (C161Y) in RTE1 that is known to confer an ETR1 loss-of-function phenotype correspondingly gives a nearly 12-fold increase in the dissociation constant (K-d, 1.38 mu M). These findings indicate that a high affinity association of RTE1 and ETR1 is important in the regulation of ETR1.	[Chang, Caren] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Jang, Mihue; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea; [Jang, Mihue; Hwang, Inhwan] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; [Scharein, Benjamin; Malach, Anuschka; Groth, Georg] Univ Dusseldorf, Dept Plant Biochem, D-40225 Dusseldorf, Germany	University System of Maryland; University of Maryland College Park; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Heinrich Heine University Dusseldorf	Chang, C (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, Biosci Res Bldg, College Pk, MD 20742 USA.	carenc@umd.edu	Rivarola, Maximo L/C-1261-2014	Rivarola, Maximo/0000-0003-2818-1037; Jang, Mihue/0000-0002-2135-2983	National Institutes of Health [1R01GM071855]; Ministry of Education, Science and Technology, Korea; Deutsche Forschungsgemeinschaft, Heinrich-Heine-Universitat Dusseldorf [SFB 590]; University of Maryland Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Deutsche Forschungsgemeinschaft, Heinrich-Heine-Universitat Dusseldorf(German Research Foundation (DFG)); University of Maryland Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant 1R01GM071855 from the National Institutes of Health (to C.C.), a grant from the World Class University project of the Ministry of Education, Science and Technology, Korea (to I.H.), and a grant of the Deutsche Forschungsgemeinschaft (to G.G.) within the SFB 590 "Inharente und adaptive Differenzierungsprozesse" at the Heinrich-Heine-Universitat Dusseldorf. .; Supported in part by the University of Maryland Agricultural Experiment Station.	Abeles F, 1992, ETHYLENE PLANT BIOL; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Citovsky V, 2008, METHODS, V45, P196, DOI 10.1016/j.ymeth.2008.06.007; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Conceicao ADS, 1997, PLANT CELL, V9, P571, DOI 10.2307/3870508; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; GREENBLATT J, 1981, CELL, V24, P421, DOI 10.1016/0092-8674(81)90332-9; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kendrick MD, 2008, CURR OPIN PLANT BIOL, V11, P479, DOI 10.1016/j.pbi.2008.06.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIN B, 2007, CELLS, P73; Liang F, 1997, P NATL ACAD SCI USA, V94, P8579, DOI 10.1073/pnas.94.16.8579; Ma B, 2006, PLANT PHYSIOL, V141, P587, DOI 10.1104/pp.106.080523; MASON SW, 1992, J MOL BIOL, V223, P55, DOI 10.1016/0022-2836(92)90715-V; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Resnick JS, 2008, PLANT J, V56, P423, DOI 10.1111/j.1365-313X.2008.03615.x; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Rivarola M, 2009, PLANT PHYSIOL, V150, P547, DOI 10.1104/pp.109.138461; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Sanderfoot AA, 2001, MOL BIOL CELL, V12, P3733, DOI 10.1091/mbc.12.12.3733; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Scharein B, 2008, ANAL BIOCHEM, V377, P72, DOI 10.1016/j.ab.2008.03.015; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; ZHOU M, 1993, BIOCHEMISTRY-US, V32, P8193, DOI 10.1021/bi00083a020; Zhou X, 2007, PLANT PHYSIOL, V145, P75, DOI 10.1104/pp.107.104299	49	70	78	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40706	40713		10.1074/jbc.M110.146605	http://dx.doi.org/10.1074/jbc.M110.146605			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952388	hybrid, Green Published			2022-12-27	WOS:000285414400034
J	Sirinupong, N; Brunzelle, J; Ye, J; Pirzada, A; Nico, L; Yang, Z				Sirinupong, Nualpun; Brunzelle, Joseph; Ye, Jun; Pirzada, Ali; Nico, Lindsey; Yang, Zhe			Crystal Structure of Cardiac-specific Histone Methyltransferase SmyD1 Reveals Unusual Active Site Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-ANALYSIS; MYND DOMAIN; PROTEIN; METHYLATION; MECHANISM; SOFTWARE; ENCODES; TARGET; MODEL; BOP	SmyD1 is a cardiac-and muscle-specific histone methyltransferase that methylates histone H3 at lysine 4 and regulates gene transcription in early heart development. The unique domain structure characterized by a "split" SET domain, a conserved MYND zinc finger, and a novel C-terminal domain (CTD) distinguishes SmyD1 from other SET domain containing methyltransferases. Here we report the crystal structure of full-length SmyD1 in complex with the cofactor analog sinefungin at 2.3 angstrom. The structure reveals that SmyD1 folds into a wrench-shaped structure with two thick "grips" separated by a large, deep concave opening. Importantly, our structural and functional analysis suggests that SmyD1 appears to be regulated by an autoinhibition mechanism, and that unusually spacious target lysine-access channel and the presence of the CTD domain both negatively contribute to the regulation of this cardiovascularly relevant methyltransferase. Furthermore, our structure also provides a structural basis for the interaction between SmyD1 and cardiac transcription factor skNAC, and suggests that the MYND domain may primarily serve as a protein interaction module and cooperate SmyD1 with skNAC to regulate cardiomyocyte growth and maturation. Overall, our data provide novel insights into the mechanism of SmyD1 regulation, which would be helpful in further understanding the role of this protein in heart development and cardiovascular diseases.	[Sirinupong, Nualpun; Ye, Jun; Pirzada, Ali; Nico, Lindsey; Yang, Zhe] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory	Yang, Z (corresponding author), 540 E Canfield St, Detroit, MI 48201 USA.	zyang@med.wayne.edu	Ye, Jun/J-8823-2012; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	American Heart Association	American Heart Association(American Heart Association)	This work was supported by the American Heart Association.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Kunizaki M, 2007, CANCER RES, V67, P10759, DOI 10.1158/0008-5472.CAN-07-1132; Kwon C, 2009, NAT CELL BIOL, V11, P951, DOI 10.1038/ncb1906; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruden DM, 2005, HUM MOL GENET, V14, pR149, DOI 10.1093/hmg/ddi103; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Silva FP, 2008, ONCOGENE, V27, P2686, DOI 10.1038/sj.onc.1210929; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Yotov WV, 1996, GENE DEV, V10, P1763, DOI 10.1101/gad.10.14.1763; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	31	59	61	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40635	40644		10.1074/jbc.M110.168187	http://dx.doi.org/10.1074/jbc.M110.168187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943667	Green Published, hybrid			2022-12-27	WOS:000285414400026
J	Yuan, J; Sterckx, Y; Mitchenall, LA; Maxwell, A; Loris, R; Waldor, MK				Yuan, Jie; Sterckx, Yann; Mitchenall, Lesley A.; Maxwell, Anthony; Loris, Remy; Waldor, Matthew K.			Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RANGE PLASMID RK2; TOXIN-ANTITOXIN SYSTEMS; P-BAD PROMOTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BACTERIAL TOXIN; F-PLASMID; STRUCTURAL BASIS; STRAND-PASSAGE; NALIDIXIC-ACID	DNA gyrase is an essential bacterial enzyme required for the maintenance of chromosomal DNA topology. This enzyme is the target of several protein toxins encoded in toxin-antitoxin ( TA) loci as well as of man-made antibiotics such as quinolones. The genome of Vibrio cholerae, the cause of cholera, contains three putative TA loci that exhibit modest similarity to the RK2 plasmid-borne parDE TA locus, which is thought to target gyrase although its mechanism of action is uncharacterized. Here we investigated the V. cholerae parDE2 locus. We found that this locus encodes a functional proteic TA pair that is active in Escherichia coli as well as V. cholerae. ParD2 co-purified with ParE2 and interacted with it directly. Unlike many other antitoxins, ParD2 could prevent but not reverse ParE2 toxicity. ParE2, like the unrelated F-encoded toxin CcdB and quinolones, targeted the GyrA subunit and stalled the DNA-gyrase cleavage complex. However, in contrast to other gyrase poisons, ParE2 toxicity required ATP, and it interfered with gyrase-dependent DNA supercoiling but not DNA relaxation. ParE2 did not bind GyrA fragments bound by CcdB and quinolones, and a set of strains resistant to a variety of known gyrase inhibitors all exhibited sensitivity to ParE2. Together, our findings suggest that ParE2 and presumably its many plasmid-and chromosome-encoded homologues inhibit gyrase in a different manner than previously described agents.	[Waldor, Matthew K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Yuan, Jie; Waldor, Matthew K.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Yuan, Jie; Waldor, Matthew K.] Tufts Univ, Sch Med, Program Immunol, Boston, MA 02115 USA; [Sterckx, Yann; Loris, Remy] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Sterckx, Yann; Loris, Remy] Vlaams Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Tufts University; Tufts University; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Waldor, MK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu	Loris, Remy/GPG-0894-2022; Sterckx, Yann G.-J./F-2269-2017	Sterckx, Yann G.-J./0000-0002-7420-0983; Waldor, Matthew/0000-0003-1843-7000; Loris, Remy/0000-0002-8862-3338; Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430	National Institutes of Health [R37 AI-42347]; Howard Hughes Medical Institute; Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R37 AI-42347. This work was also supported by the Howard Hughes Medical Institute (to M. K. W.). Part of this work was supported by grants from Vlaams Instituut voor Biotechnologie, Vrije Universiteit Brussel and FWO-Vlaanderen. This work was also supported by the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (to A.M.).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bocs S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-5; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Dalton KM, 2010, BIOCHEMISTRY-US, V49, P2205, DOI 10.1021/bi902133s; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2004, ACTA CRYSTALLOGR D, V60, P1132, DOI 10.1107/S0907444904007814; De Jonge N, 2007, ACTA CRYSTALLOGR F, V63, P356, DOI 10.1107/S1744309107012092; De Jonge N, 2010, J BIOL CHEM, V285, P5606, DOI 10.1074/jbc.M109.068429; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Easter CL, 1997, J BACTERIOL, V179, P6472, DOI 10.1128/jb.179.20.6472-6479.1997; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hallez R, 2010, MOL MICROBIOL, V76, P719, DOI 10.1111/j.1365-2958.2010.07129.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jiang Y, 2002, MOL MICROBIOL, V44, P971, DOI 10.1046/j.1365-2958.2002.02921.x; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Nieba L, 1997, ANAL BIOCHEM, V252, P217, DOI 10.1006/abio.1997.2326; Nollmann M, 2007, BIOCHIMIE, V89, P490, DOI 10.1016/j.biochi.2007.02.012; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Simic M, 2009, J BIOL CHEM, V284, P20002, DOI 10.1074/jbc.M109.014035; Smith AB, 2006, NUCLEIC ACIDS RES, V34, P4667, DOI 10.1093/nar/gkl636; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Thoden JB, 2005, J BIOL CHEM, V280, P36905, DOI 10.1074/jbc.M508446200; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Yamaichi Y, 2007, P NATL ACAD SCI USA, V104, P630, DOI 10.1073/pnas.0608341104	55	51	54	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40397	40408		10.1074/jbc.M110.138776	http://dx.doi.org/10.1074/jbc.M110.138776			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952390	hybrid, Green Published			2022-12-27	WOS:000285185500082
J	Gravel, S; Malouf, C; Boulais, PE; Berchiche, YA; Oishi, S; Fujii, N; Leduc, R; Sinnett, D; Heveker, N				Gravel, Stephanie; Malouf, Camille; Boulais, Philip E.; Berchiche, Yamina A.; Oishi, Shinya; Fujii, Nobutaka; Leduc, Richard; Sinnett, Daniel; Heveker, Nikolaus			The Peptidomimetic CXCR4 Antagonist TC14012 Recruits beta-Arrestin to CXCR7 ROLES OF RECEPTOR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; WEAK PARTIAL AGONISTS; HIV PEPTIDE T140; CHEMOKINE RECEPTOR; T-LYMPHOCYTES; AMD3100; PHOSPHORYLATION; INHIBITION; ACTIVATION; MIGRATION	CXCR7 is an atypical chemokine receptor that signals through beta-arrestin in response to agonists without detectable activation of heterotrimeric G-proteins. Its cognate chemokine ligand CXCL12 also binds CXCR4, a chemokine receptor of considerable clinical interest. Here we report that TC14012, a peptidomimetic inverse agonist of CXCR4, is an agonist on CXCR7. The potency of beta-arrestin recruitment to CXCR7 by TC14012 is much higher than that of the previously reported CXCR4 antagonist AMD3100 and differs only by one log from that of the natural ligand CXCL12 (EC50 350 nM for TC14012, as compared with 30 nM for CXCL12 and 140 mu M for AMD3100). Moreover, like CXCL12, TC14012 leads to Erk 1/2 activation in U373 glioma cells that express only CXCR7, but not CXCR4. Given that with TC14012 and AMD3100 two structurally unrelated CXCR4 antagonists turn out to be agonists on CXCR7, this likely reflects differences in the activation mechanism of the arrestin pathway by both receptors. To identify the receptor domain responsible for these opposed effects, we investigated CXCR4 and CXCR7 C terminus-swapping chimeras. Using quantitative bioluminescence resonance energy transfer, we find that the CXCR7 receptor core formed by the seven-transmembrane domains and the connecting loops determines the agonistic activity of both TC14012 and AMD3100. Moreover, we find that the CXCR7 chimera bearing the CXCR4 C-terminal constitutively associates with arrestin in the absence of ligands. Our data suggest that the CXCR4 and CXCR7 cores share ligand-binding surfaces for the binding of the synthetic ligands, indicating that CXCR4 inhibitors should be tested also on CXCR7.	[Gravel, Stephanie; Malouf, Camille; Berchiche, Yamina A.; Heveker, Nikolaus] Univ Montreal, Dept Biochem, Montreal, PQ H3T 1J4, Canada; [Gravel, Stephanie; Malouf, Camille; Berchiche, Yamina A.; Sinnett, Daniel; Heveker, Nikolaus] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Boulais, Philip E.; Leduc, Richard] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan; [Sinnett, Daniel] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1C5, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Kyoto University; Universite de Montreal	Heveker, N (corresponding author), 6737 Hop St Justine, Ctr Rech, 3175 Chemin Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	nikolaus.heveker@recherche-ste-justine.qc.ca	Oishi, Shinya/C-1350-2011; sinnett, daniel/S-4589-2017; Heveker, Nikolaus/G-5306-2012	Oishi, Shinya/0000-0002-2833-2539; sinnett, daniel/0000-0003-3625-6676; Malouf, Camille/0000-0002-1066-8376; Berchiche, Yamina/0000-0002-9559-9209	Canadian Institutes of Health Research (CIHR); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Fondation de l'Hopital Sainte-Justine; Groupe de Recherche Universitaire sur le Medicament; "Fonds de la recherche en sante du Quebec" (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Fondation de l'Hopital Sainte-Justine; Groupe de Recherche Universitaire sur le Medicament; "Fonds de la recherche en sante du Quebec" (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, scholarships from the "Fondation de l'Hopital Sainte-Justine" and the "Groupe de Recherche Universitaire sur le Medicament" (to S.G.), a grant from the "Fonds de la recherche en sante du Quebec" (FRSQ) (to C.M.), and CIHR fellowships (to P.E.B. and Y.A.B.).	Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Boulais PE, 2009, BIOCHEM PHARMACOL, V78, P1382, DOI 10.1016/j.bcp.2009.07.007; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Charest PG, 2005, EMBO REP, V6, P334, DOI 10.1038/sj.embor.7400373; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Labrosse B, 1998, J VIROL, V72, P6381, DOI 10.1128/JVI.72.8.6381-6388.1998; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Narumi T, 2010, ORG BIOMOL CHEM, V8, P616, DOI 10.1039/b917236j; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Oishi S, 2008, CHEMBIOCHEM, V9, P1154, DOI 10.1002/cbic.200700761; Perroy J, 2003, EMBO J, V22, P3816, DOI 10.1093/emboj/cdg383; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Schiller PW, 2010, LIFE SCI, V86, P598, DOI 10.1016/j.lfs.2009.02.025; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tamamura H, 2001, BIOORG MED CHEM LETT, V11, P1897, DOI 10.1016/S0960-894X(01)00323-7; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Trent JO, 2003, J BIOL CHEM, V278, P47136, DOI 10.1074/jbc.M307850200; Wu B., 2010, SCIENCE IN PRESS; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200	30	72	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					37939	37943		10.1074/jbc.C110.147470	http://dx.doi.org/10.1074/jbc.C110.147470			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20956518	Green Published, hybrid			2022-12-27	WOS:000284625600001
J	Ikeda, O; Sekine, Y; Mizushima, A; Nakasuji, M; Miyasaka, Y; Yamamoto, C; Muromoto, R; Nanbo, A; Oritani, K; Yoshimura, A; Matsuda, T				Ikeda, Osamu; Sekine, Yuichi; Mizushima, Akihiro; Nakasuji, Misa; Miyasaka, Yuto; Yamamoto, Chikako; Muromoto, Ryuta; Nanbo, Asuka; Oritani, Kenji; Yoshimura, Akihiko; Matsuda, Tadashi			Interactions of STAP-2 with Brk and STAT3 Participate in Cell Growth of Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRECEPTOR TYROSINE KINASE; MAMMARY EPITHELIAL-CELLS; TUMOR KINASE; EXPRESSION; ACTIVATION; PROTEIN; SUBSTRATE; MIGRATION; INVASION; BRK/SIK	STAP-2 (signal transducing adaptor protein-2) is a recently identified adaptor protein that contains pleckstrin homology (PH) and Src homology 2-like domains, as well as a STAT3-binding motif in its C-terminal region. STAP-2 is also a substrate of breast tumor kinase (Brk). In breast cancers, Brk expression is deregulated and promotes STAT3-dependent cell proliferation. In the present study, manipulated STAP-2 expression demonstrated essential roles of STAP-2 in Brk-mediated STAT3 activation. STAP-2 interacts with both Brk and STAT3. In addition, small interfering RNA-mediated reduction of endogenous STAP-2 expression strongly decreased Brk-mediated STAT3 activation in T47D breast cancer cells. The PH domain of STAP-2 is involved in multiple steps: the binding between Brk and STAP-2, the activation and tyrosine phosphorylation of STAT3, and the activation of Brk. Notably, a STAP-2 PH-Brk fusion protein exhibited robust kinase activity and increased activation and tyrosine phosphorylation of STAT3. Finally, STAP-2 knockdown in T47D cells induced a significant decrease of proliferation, as strong as that of Brk or STAT3 knockdown. Taken together, our findings are likely to inform the development of a novel therapeutic strategy, as well as the determination of novel prognostic values, in breast carcinomas.	[Matsuda, Tadashi] Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Oritani, Kenji] Osaka Univ, Grad Sch Med, Dept Hematol & Oncol, Osaka 5650871, Japan; [Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan	Hokkaido University; Osaka University; Keio University	Matsuda, T (corresponding author), Hokkaido Univ, Dept Immunol, Grad Sch Pharmaceut Sci, Kita Ku, Kita 12 Nishi 6, Sapporo, Hokkaido 0600812, Japan.	tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012; Nanbo, Asuka/C-6630-2012; Yoshimura, Akihiko/K-5515-2013; Nanbo, Asuka/P-2478-2019; Sekine, Yuichi/S-8813-2019	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; Nanbo, Asuka/0000-0001-8764-1350; Nanbo, Asuka/0000-0001-8764-1350; Sekine, Yuichi/0000-0002-2861-603X; Misa, Togi/0000-0002-7424-4548	Suhara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Suhara Memorial Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Suhara Memorial Foundation and Grant-in-Aid for scientific research from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg J, 2000, BREAST CANCER RES, V2, P86, DOI 10.1186/bcr38; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Harvey AJ, 2003, ONCOGENE, V22, P5006, DOI 10.1038/sj.onc.1206577; Ikeda O, 2008, MOL CELL BIOL, V28, P5027, DOI 10.1128/MCB.00194-08; Ikeda O, 2009, BIOCHEM BIOPH RES CO, V384, P71, DOI 10.1016/j.bbrc.2009.04.076; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; LEE ST, 1993, ONCOGENE, V8, P3403; Liu L, 2006, ONCOGENE, V25, P4904, DOI 10.1038/sj.onc.1209501; Llor X, 1999, CLIN CANCER RES, V5, P1767; Lukong KE, 2009, CELL SIGNAL, V21, P1415, DOI 10.1016/j.cellsig.2009.04.008; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Minoguchi M, 2003, J BIOL CHEM, V278, P11182, DOI 10.1074/jbc.M211230200; Mitchell PJ, 2000, ONCOGENE, V19, P4273, DOI 10.1038/sj.onc.1203775; Mitchell PJ, 1997, ONCOGENE, V15, P1497, DOI 10.1038/sj.onc.1201292; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2005, J BIOL CHEM, V280, P8188, DOI 10.1074/jbc.M411692200; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Shen CH, 2008, CANCER RES, V68, P7779, DOI 10.1158/0008-5472.CAN-08-0997; SIYANOVA EY, 1994, ONCOGENE, V9, P2053; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794	30	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38093	38103		10.1074/jbc.M110.162388	http://dx.doi.org/10.1074/jbc.M110.162388			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20929863	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000284625600017
J	El-Kasaby, A; Just, H; Malle, E; Stolt-Bergner, PC; Sitte, HH; Freissmuth, M; Kudlacek, O				El-Kasaby, Ali; Just, Herwig; Malle, Elisabeth; Stolt-Bergner, Peggy C.; Sitte, Harald H.; Freissmuth, Michael; Kudlacek, Oliver			Mutations in the Carboxyl-terminal SEC24 Binding Motif of the Serotonin Transporter Impair Folding of the Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DOPAMINE TRANSPORTER; NEUROTRANSMITTER TRANSPORTERS; GABA TRANSPORTER-1; C-TERMINUS; OLIGOMER FORMATION; IN-VIVO; PROTEIN; EXPORT; TRAFFICKING	The serotonin transporter (SERT) is a member of the SLC6 family of solute carriers. SERT plays a crucial role in synaptic neurotransmission by retrieving released serotonin. The intracellular carboxyl terminus of various neurotransmitter transporters has been shown to be important for the correct delivery of SLC6 family members to the cell surface. Here we studied the importance of the C terminus in trafficking and folding of human SERT. Serial truncations followed by mutagenesis identified sequence spots (PG(601,602), RII607-609) within the C terminus relevant for export of SERT from the endoplasmic reticulum (ER). RI607,608 is homologous to the RL-motif that in other SLC6 family members provides a docking site for the COPII component Sec24D. The primary defect resulting from mutation at PG(601,602) and RI607,608 was impaired folding, because mutated transporters failed to bind the inhibitor [H-3] imipramine. In contrast, when retained in the ER (e. g. by dominant negative Sar1) the wild type transporter bound [3H] imipramine with an affinity comparable to that of the surface-expressed transporter. SERT-RI(607,608)AA and SERT-RII(607-609)AAA were partially rescued by treatment of cells with the nonspecific chemical chaperone DMSO or the specific pharmacochaperone ibogaine (which binds to the inward facing conformation of SERT) but not by other classes of ligands (inhibitors, substrates, amphetamines). These observations (i) demonstrate an hitherto unappreciated role of the C terminus in the folding of SERT, (ii) indicates that the folding trajectory proceeds via an inward facing intermediate, and (iii) suggest a model where the RI-motif plays a crucial role in preventing premature Sec24-recruitment and export of incorrectly folded transporters.	[El-Kasaby, Ali; Just, Herwig; Sitte, Harald H.; Freissmuth, Michael; Kudlacek, Oliver] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Malle, Elisabeth; Stolt-Bergner, Peggy C.] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Medical University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Kudlacek, O (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Wahringer Str 13A, A-1090 Vienna, Austria.	oliver.kudlacek@meduniwien.ac.at	Sitte, Harald/N-2681-2013; Sitte, Harald/O-7025-2019	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Stolt-Bergner, Peggy/0000-0002-5887-2915; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551	Austrian Science Fund/FWF [SFB3506, SFB3507, SFB3510]; Egyptian Ministry of Higher Education and State for Scientific Research; Austrian Science Fund (FWF) [F 3507, F 3506] Funding Source: researchfish	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); Egyptian Ministry of Higher Education and State for Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund/FWF (SFB3506, to H. H. S.; SFB3507, to P. C. S.-B., and SFB3510, to M. F.) and a stipend from the Egyptian Ministry of Higher Education and State for Scientific Research (to A. E.).	Albert AD, 2005, PROG LIPID RES, V44, P99, DOI 10.1016/j.plipres.2005.02.001; Bauman PA, 2002, ARCH BIOCHEM BIOPHYS, V404, P80, DOI 10.1016/S0003-9861(02)00232-1; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Korkhov VM, 2008, J MOL BIOL, V378, P337, DOI 10.1016/j.jmb.2008.02.056; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Larsen MB, 2006, BIOCHEMISTRY-US, V45, P1331, DOI 10.1021/bi0508688; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; Masson J, 1999, PHARMACOL REV, V51, P439; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Moss FJ, 2009, J GEN PHYSIOL, V134, P489, DOI 10.1085/jgp.200910314; Nelson N, 1998, J NEUROCHEM, V71, P1785; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Rudnick G, 2006, J MEMBRANE BIOL, V213, P101, DOI 10.1007/s00232-006-0878-4; Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2	39	47	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39201	39210		10.1074/jbc.M110.118000	http://dx.doi.org/10.1074/jbc.M110.118000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889976	hybrid, Green Published			2022-12-27	WOS:000284941300050
J	Kennedy, EM; Gavegnano, C; Nguyen, L; Slater, R; Lucas, A; Fromentin, E; Schinazi, RF; Kim, B				Kennedy, Edward M.; Gavegnano, Christina; Nguyen, Laura; Slater, Rebecca; Lucas, Amanda; Fromentin, Emilie; Schinazi, Raymond F.; Kim, Baek			Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEADY-STATE KINETICS; DNA-POLYMERASE-BETA; NUCLEOSIDE ANALOGS; HIV-1 INFECTION; DNTP BINDING; IN-VIVO; FIDELITY; CELLS; INHIBITION; SEQUENCE	We biochemically simulated HIV-1 DNA polymerization in physiological nucleotide pools found in two HIV-1 target cell types: terminally differentiated/non-dividing macrophages and activated/dividing CD4(+) T cells. Quantitative tandem mass spectrometry shows that macrophages harbor 22-320-fold lower dNTP concentrations and a greater disparity between ribonucleoside triphosphate (rNTP) and dNTP concentrations than dividing target cells. A biochemical simulation of HIV-1 reverse transcription revealed that rNTPs are efficiently incorporated into DNA in the macrophage but not in the T cell environment. This implies that HIV-1 incorporates rNTPs during viral replication in macrophages and also predicts that rNTP chain terminators lacking a 3'-OH should inhibit HIV-1 reverse transcription in macrophages. Indeed, 3'-deoxyadenosine inhibits HIV-1 proviral DNA synthesis in human macrophages more efficiently than in CD4(+) T cells. This study reveals that the biochemical landscape of HIV-1 replication in macrophages is unique and that ribonucleoside chain terminators may be a new class of anti-HIV-1 agents specifically targeting viral macrophage infection.	[Kennedy, Edward M.; Nguyen, Laura; Slater, Rebecca; Lucas, Amanda; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Decatur, GA 30033 USA; [Gavegnano, Christina; Fromentin, Emilie; Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu	Schinazi, Raymond F/B-6777-2017	Kennedy, Edward/0000-0002-2817-4809	National Institutes of Health [AI049781, T32 AI007362, TL1 RR024135, 2P30-AI-050409, R01-AI-076535, 5R37-AI-041980, 5R37-AI-025899]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049781, R37AI025899, R01AI076535, R37AI041980, T32AI007362, P30AI050409, R56AI049781] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI049781 (to B. K.), T32 AI007362 (to E. M. K.), TL1 RR024135 (to A. L.), 2P30-AI-050409, R01-AI-076535, 5R37-AI-041980, and 5R37-AI-025899. This work was also supported by the Department of Veterans Affairs (to R. F. S.).	Aggarwal S., PLOS ONE, V5, pe10372; Arts EJ, 1996, J VIROL, V70, P712, DOI 10.1128/JVI.70.2.712-720.1996; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; BJORKLUND S, 1990, BIOCHEMISTRY-US, V29, P5452; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Boule JB, 2001, J BIOL CHEM, V276, P31388, DOI 10.1074/jbc.M105272200; Boyer JC, 1996, METHOD ENZYMOL, V275, P523; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Fernandes PA, 2003, CHEM-EUR J, V9, P5916, DOI 10.1002/chem.200304948; Fromentin E, 2010, ANAL CHEM, V82, P1982, DOI 10.1021/ac902737j; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Jamburuthugoda VK, 2006, J BIOL CHEM, V281, P13388, DOI 10.1074/jbc.M600291200; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kennedy EM, 2009, BIOCHEMISTRY-US, V48, P11161, DOI 10.1021/bi9010122; KOPP EB, 1991, NUCLEIC ACIDS RES, V19, P3035, DOI 10.1093/nar/19.11.3035; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; LETVIN NL, 1983, P NATL ACAD SCI-BIOL, V80, P2718, DOI 10.1073/pnas.80.9.2718; McElhinny SAN, 2003, MOL CELL BIOL, V23, P2309, DOI 10.1128/MCB.23.7.2309-2315.2003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; OBRIEN WA, 1994, J VIROL, V68, P1258, DOI 10.1128/JVI.68.2.1258-1263.1994; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SCHUITEMAKER H, 1994, EMBO J, V13, P5929, DOI 10.1002/j.1460-2075.1994.tb06938.x; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Skasko M, 2008, J VIROL, V82, P7716, DOI 10.1128/JVI.00120-08; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; STRIDH S, 1983, ARCH VIROL, V77, P223, DOI 10.1007/BF01309269; Sun GL, 2001, J VIROL, V75, P11902, DOI 10.1128/JVI.75.23.11902-11906.2001; Traut T., 1994, MOL CELL BIOCHEM, V140, P1573; VANTWOUT AB, 1994, J CLIN INVEST, V94, P2060, DOI 10.1172/JCI117560; Wainberg MA, 1996, SCIENCE, V271, P1282, DOI 10.1126/science.271.5253.1282; Weiss KK, 2000, BIOCHEMISTRY-US, V39, P10684, DOI 10.1021/bi000788y; Weiss KK, 2004, BIOCHEMISTRY-US, V43, P4490, DOI 10.1021/bi035258r; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; WESTERVELT P, 1992, J VIROL, V66, P2577, DOI 10.1128/JVI.66.4.2577-2582.1992; Wilkinson DA, 1998, J INFECT DIS, V178, P1163, DOI 10.1086/515675; Willey S, 2005, ANTIVIR RES, V68, P96, DOI 10.1016/j.antiviral.2005.07.006; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	55	77	77	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39380	39391		10.1074/jbc.M110.178582	http://dx.doi.org/10.1074/jbc.M110.178582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20924117	Green Published, hybrid			2022-12-27	WOS:000284941300065
J	Hellman, M; Arumae, U; Yu, LY; Lindholm, P; Peranen, J; Saarma, M; Permi, P				Hellman, Maarit; Arumae, Urmas; Yu, Li-ying; Lindholm, Paivi; Peranen, Johan; Saarma, Mart; Permi, Perttu			Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF) Has a Unique Mechanism to Rescue Apoptotic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; RETRACTED ARTICLE. SEE; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; PG 480; BINDING; BAX; DNA; DOMAIN; DYANA	Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects neurons and repairs the Parkinson disease-like symptoms in a rat 6-hydroxydopamine model. We show a three-dimensional solution structure of human MANF that differs drastically from other neurotrophic factors. Remarkably, the C-terminal domain of MANF (C-MANF) is homologous to the SAP domain of Ku70, a well known inhibitor of proapoptotic Bax (Bcl-2-associated X protein). Cellular studies confirm that MANF and C-MANF protect neurons intracellularly as efficiently as Ku70.	[Hellman, Maarit; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Arumae, Urmas; Yu, Li-ying; Lindholm, Paivi; Peranen, Johan; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Lab Mol Neurosci, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki	Permi, P (corresponding author), Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, POB 65, FI-00014 Helsinki, Finland.	perttu.permi@helsinki.fi	Arumäe, Urmas/E-8290-2016	Arumäe, Urmas/0000-0003-3658-6464; Pulkkila, Paivi/0000-0003-3022-5035	Academy of Finland [122170, 131144]; Sigrid Juselius Foundation;  [11186236];  [1126735]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); ; 	This work was supported by the Academy of Finland Grants 122170 and 131144 (to P. P.) and Grants 11186236 and 1126735 (to M. S.), and a Sigrid Juselius Foundation grant (to M. S.).	Airavaara M, 2009, J COMP NEUROL, V515, P116, DOI 10.1002/cne.22039; Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Butte MJ, 2001, CELL MOL LIFE SCI, V58, P1003, DOI 10.1007/PL00000915; CASE DA, 2004, AMBER 8; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Gama V, 2009, CELL DEATH DIFFER, V16, P758, DOI 10.1038/cdd.2009.6; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hellman M, 2010, BIOMOL NMR ASSIGN, V4, P215, DOI 10.1007/s12104-010-9251-8; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; Lindholm P, 2008, MOL CELL NEUROSCI, V39, P356, DOI 10.1016/j.mcn.2008.07.016; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Parkash V, 2008, J BIOL CHEM, V283, P35164, DOI 10.1074/jbc.M802543200; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Raaijmakers H, 2001, J MOL BIOL, V308, P311, DOI 10.1006/jmbi.2001.4592; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Tibbetts MD, 2004, STRUCTURE, V12, P2257, DOI 10.1016/j.str.2004.10.007; Vaughn AE, 2007, CELL DEATH DIFFER, V14, P973, DOI 10.1038/sj.cdd.4402084; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Yu LY, 2003, J CELL BIOL, V163, P987, DOI 10.1083/jcb.200305083	33	105	114	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2675	2680		10.1074/jbc.M110.146738	http://dx.doi.org/10.1074/jbc.M110.146738			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	21047780	hybrid, Green Published			2022-12-27	WOS:000286464300033
J	Kamada, R; Nomura, T; Anderson, CW; Sakaguchi, K				Kamada, Rui; Nomura, Takao; Anderson, Carl W.; Sakaguchi, Kazuyasu			Cancer-associated p53 Tetramerization Domain Mutants QUANTITATIVE ANALYSIS REVEALS A LOW THRESHOLD FOR TUMOR SUPPRESSOR INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; OLIGOMERIZATION DOMAIN; MISSENSE MUTATION; CRYSTAL-STRUCTURE; NUCLEAR EXPORT; LI-FRAUMENI; C-TERMINUS; PROTEIN; PHOSPHORYLATION; STABILITY	The tumor suppressor p53, a 393-amino acid transcription factor, induces cell cycle arrest and apoptosis in response to genotoxic stress. Its inactivation via the mutation of its gene is a key step in tumor progression, and tetramer formation is critical for p53 post-translational modification and its ability to activate or repress the transcription of target genes vital in inhibiting tumor growth. About 50% of human tumors have TP53 gene mutations; most are missense ones that presumably lower the tumor suppressor activity of p53. In this study, we explored the effects of known tumor-derived missense mutations on the stability and oligomeric structure of p53; our comprehensive, quantitative analyses encompassed the tetramerization domain peptides representing 49 such substitutions in humans. Their effects on tetrameric structure were broad, and the stability of the mutant peptides varied widely (Delta T-m = 4.8 similar to -46.8 degrees C). Because formation of a tetrameric structure is critical for protein-protein interactions, DNA binding, and the post-translational modification of p53, a small destabilization of the tetrameric structure could result in dysfunction of tumor suppressor activity. We suggest that the threshold for loss of tumor suppressor activity in terms of the disruption of the tetrameric structure of p53 could be extremely low. However, other properties of the tetramerization domain, such as electrostatic surface potential and its ability to bind partner proteins, also may be important.	[Kamada, Rui; Nomura, Takao; Sakaguchi, Kazuyasu] Hokkaido Univ, Fac Sci, Dept Chem, Biol Chem Lab, Sapporo, Hokkaido 0600810, Japan; [Anderson, Carl W.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Hokkaido University; United States Department of Energy (DOE); Brookhaven National Laboratory	Sakaguchi, K (corresponding author), North 10,West 8,Kita Ku, Sapporo, Hokkaido 0600810, Japan.	kazuyasu@sci.hokudai.ac.jp	Kamada, Rui/P-9714-2019	Kamada, Rui/0000-0002-6118-5091	Ministry of Education, Culture, Sports, Science and Technology and Scientific Research [16041202]; Japan Society for the Promotion of Science [21310133, 18310140, 20004981, 19001703]; Brookhaven National Laboratory; U.S. Department of Energy	Ministry of Education, Culture, Sports, Science and Technology and Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Brookhaven National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by Grants-in-aid for Scientific Research on Priority Areas 16041202 from The Ministry of Education, Culture, Sports, Science and Technology and Scientific Research (B) 21310133 and 18310140 from Japan Society for the Promotion of Science (to K. S.), "Molecular and System Life Science" Promotion of Novel Interdisciplinary Fields Based on Nanotechnology and Materials from The Ministry of Education, Culture, Sports, Science and Technology (to K. S.), Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists 20004981 (to R. K.) and 19001703 (to T. N.) from Japan Society for the Promotion of Science, and Program Development funds from the Brookhaven National Laboratory under contract with the U.S. Department of Energy (to C. W. A.).	Atz J, 2000, J CELL BIOCHEM, V76, P572, DOI 10.1002/(SICI)1097-4644(20000315)76:4<572::AID-JCB6>3.0.CO;2-6; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chene P, 2000, BIOTECHNIQUES, V28, P240; Chene P, 2001, ONCOGENE, V20, P2611, DOI 10.1038/sj.onc.1204373; CLORE GM, 1995, NAT STRUCT BIOL, V2, P321, DOI 10.1038/nsb0495-321; Davison TS, 1998, ONCOGENE, V17, P651, DOI 10.1038/sj.onc.1202062; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Hainaut P, 2000, ADV CANCER RES, V77, P81; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Higashimoto Y, 2006, BIOCHEMISTRY-US, V45, P1608, DOI 10.1021/bi051192j; Imagawa T, 2009, ANAL BIOCHEM, V387, P249, DOI 10.1016/j.ab.2009.01.030; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Itahana Y, 2009, J BIOL CHEM, V284, P5158, DOI 10.1074/jbc.M805696200; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000919; JOHNSON CR, 1995, BIOCHEMISTRY-US, V34, P5309, DOI 10.1021/bi00016a002; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawaguchi T, 2005, ONCOGENE, V24, P6976, DOI 10.1038/sj.onc.1208839; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; Maki CG, 1996, CANCER RES, V56, P2649; Maki CG, 1999, J BIOL CHEM, V274, P16531, DOI 10.1074/jbc.274.23.16531; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Merritt Joshua, 2007, Genomic Med, V1, P113, DOI 10.1007/s11568-007-9011-8; Miller M, 1996, FEBS LETT, V399, P166, DOI 10.1016/S0014-5793(96)01231-8; Nie Y, 2000, MOL CELL BIOL, V20, P741, DOI 10.1128/MCB.20.3.741-748.2000; Nomura T, 2009, BIOPOLYMERS, V91, P78, DOI 10.1002/bip.21084; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Poon GMK, 2007, J MOL BIOL, V365, P1217, DOI 10.1016/j.jmb.2006.10.051; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Rigacci S, 2008, BIOPHYS J, V94, P3635, DOI 10.1529/biophysj.107.122283; Rollenhagen C, 1998, INT J CANCER, V78, P372, DOI 10.1002/(SICI)1097-0215(19981029)78:3<372::AID-IJC19>3.0.CO;2-8; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Shieh SY, 2000, GENE DEV, V14, P289; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SWANSON JA, 1991, J CELL BIOL, V115, P941, DOI 10.1083/jcb.115.4.941; van Dieck J, 2009, J BIOL CHEM, V284, P13804, DOI 10.1074/jbc.M901351200; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Warnock LJ, 2008, CANCER BIOL THER, V7, P1483, DOI 10.4161/cbt.7.9.6473; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Zambetti GP, 2007, J CELL PHYSIOL, V213, P370, DOI 10.1002/jcp.21217; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	55	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					252	258		10.1074/jbc.M110.174698	http://dx.doi.org/10.1074/jbc.M110.174698			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978130	Green Published, hybrid			2022-12-27	WOS:000285782800028
J	Qi, QA; Xia, MC; Bai, YT; Yu, SH; Cantorna, M; August, A				Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery			Interleukin-2-inducible T Cell Kinase (Itk) Network Edge Dependence for the Maturation of iNKT Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; CUTTING EDGE; NKT CELLS; RECEPTOR; BET; HOMEOSTASIS; EFFECTOR; REQUIREMENTS; EXPRESSION; DEFICIENT	Invariant natural killer T (iNKT) cells are a unique subset of innate T lymphocytes that are selected by CD1d. They have diverse immune regulatory functions via the rapid production of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4). In the absence of signaling nodes Itk and Txk, Tec family non-receptor tyrosine kinases, mice exhibit a significant block in iNKT cell development. We now show here that although the Itk node is required for iNKT cell maturation, the kinase domain edge of Itk is not required for continued maturation iNKT cells in the thymus compared with Itk-null mice. This rescue is dependent on the expression of the Txk node. Furthermore, this kinase domain independent edge rescue correlates with the increased expression of the transcription factors T-bet, the IL-2/IL-15 receptor beta chain CD122, and suppression of eomesodermin expression. By contrast, alpha-galactosyl ceramide induced cytokine secretion is dependent on the kinase domain edge of Itk. These findings indicate that the Itk node uses a kinase domain independent edge, a scaffolding function, in the signaling pathway leading to the maturation of iNKT cells. Furthermore, the findings indicate that phosphorylation of substrates by the Itk node is only partially required for maturation of iNKT cells, while functional activation of iNKT cells is dependent on the kinase domain/activity edge of Itk.	[August, Avery] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Qi, Qian; Xia, Mingcan; Bai, Yuting; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Qi, Qian; Xia, Mingcan; Yu, Sanhong; Cantorna, Margherita; August, Avery] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, C5 181 VMC, Ithaca, NY 14853 USA.	averyaugust@cornell.edu	Qi, Qian/E-7454-2012		National Institutes of Health [AI051626, AI065566]; Huck Institutes for the Life Sciences; Pennsylvania Department of Health; National Center for Complementary & Integrative Health [R01AT005378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R56AI065566, R01AI065566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes for the Life Sciences; Pennsylvania Department of Health; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051626 and AI065566 (to A. A.).; Graduate Fellows of the Huck Institutes for the Life Sciences.; We thank members of the August Laboratory and the CMIID for feedback and discussion. We also thank E. Kunze, N. Bem, and S. Magargee in the Center for Quantitative Cell Analysis at Penn State. Work in the Center for Molecular Immunology & Infectious Disease is supported in part under a grant from the Pennsylvania Department of Health. There are no conflicts of interests to report.	Andreotti AH, 1997, NATURE, V385, P93, DOI 10.1038/385093a0; Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Eberl G, 1999, J IMMUNOL, V163, P4091; Felices M, 2008, J IMMUNOL, V180, P3007, DOI 10.4049/jimmunol.180.5.3007; Gadue P, 1999, J EXP MED, V190, P1189, DOI 10.1084/jem.190.8.1189; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Godfrey DI, 2010, NAT IMMUNOL, V11, P197, DOI 10.1038/ni.1841; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hao SL, 2006, FEBS LETT, V580, P2691, DOI 10.1016/j.febslet.2006.04.023; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jordan MS, 2006, J IMMUNOL, V176, P2430, DOI 10.4049/jimmunol.176.4.2430; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kishimoto H, 2007, BLOOD, V109, P3316, DOI 10.1182/blood-2006-07-038059; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Matsuda JL, 2006, BLOOD, V107, P2797, DOI 10.1182/blood-2005-08-3103; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Nichols KE, 2005, NAT MED, V11, P340, DOI 10.1038/nm1189; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Ohteki T, 1997, J IMMUNOL, V159, P5931; Pasquier B, 2005, J EXP MED, V201, P695, DOI 10.1084/jem.20042432; Qi Q, 2006, J BIOL CHEM, V281, P38529, DOI 10.1074/jbc.M609180200; Qi Q, 2009, J BIOL CHEM, V284, P29882, DOI 10.1074/jbc.M109.003129; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Stanic AK, 2004, J IMMUNOL, V172, P4667, DOI 10.4049/jimmunol.172.8.4667; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Yu SH, 2008, P NATL ACAD SCI USA, V105, P5207, DOI 10.1073/pnas.0711558105; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S; Zullo AJ, 2007, J IMMUNOL, V178, P58, DOI 10.4049/jimmunol.178.1.58	47	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					138	146		10.1074/jbc.M110.148205	http://dx.doi.org/10.1074/jbc.M110.148205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036902	Green Published, hybrid			2022-12-27	WOS:000285782800015
J	Tsuchiya, S; Fujiwara, T; Sato, F; Shimada, Y; Tanaka, E; Sakai, Y; Shimizu, K; Tsujimoto, G				Tsuchiya, Soken; Fujiwara, Takeshi; Sato, Fumiaki; Shimada, Yutaka; Tanaka, Eiji; Sakai, Yoshiharu; Shimizu, Kazuharu; Tsujimoto, Gozoh			MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGNOSTIC-FACTOR; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; HYPOXIA; CARCINOMA; SURVIVAL; DIFFERENTIATION; HSA-MIR-210; ESOPHAGUS	The importance of microRNAs (miRNAs) in human malignancies has been well recognized. Here, we report that the expression of microRNA-210 (miR-210) is down-regulated in human esophageal squamous cell carcinoma and derived cell lines. Marked decreases in the level of miR-210 were observed especially in poorly differentiated carcinomas. We found that miR-210 inhibits cancer cell survival and proliferation by inducing cell death and cell cycle arrest in G(1)/G(0) and G(2)/M. Finally, we identified fibroblast growth factor receptor-like 1 (FGFRL1) as a target of miR-210 in esophageal squamous cell carcinoma and demonstrated that FGFRL1 accelerates cancer cell proliferation by preventing cell cycle arrest in G1/G0. Taken together, our findings show an important role for miR-210 as a tumor-suppressive microRNA with effects on cancer cell proliferation.	[Tsujimoto, Gozoh] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto 6068501, Japan; [Tsuchiya, Soken; Fujiwara, Takeshi; Sato, Fumiaki; Shimizu, Kazuharu] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Sakyo Ku, Kyoto 6068501, Japan; [Shimada, Yutaka] Toyama Univ, Grad Sch Med & Pharmaceut Sci Res, Dept Surg & Sci, Toyama 9300194, Japan; [Tanaka, Eiji; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University; University of Toyama; Kyoto University	Tsujimoto, G (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Sakyo Ku, 46-29 Yoshida Shimoadachi, Kyoto 6068501, Japan.	gtsuji@pharm.kyoto-u.ac.jp			Kyoto University; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization	Kyoto University; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by grants from Kyoto University (to S. T.), the Takeda Science Foundation (to S. T.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. T. and G. T.), and the New Energy and Industrial Technology Development Organization (to G. T.).	Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Gee HE, 2010, CANCER-AM CANCER SOC, V116, P2148, DOI 10.1002/cncr.25009; Giannakakis A, 2008, CANCER BIOL THER, V7, P255, DOI 10.4161/cbt.7.2.5297; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hino K, 2008, RNA, V14, P1433, DOI 10.1261/rna.810208; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Isohata N, 2009, INT J CANCER, V125, P1212, DOI 10.1002/ijc.24400; Ito T, 2008, CANCER RES, V68, P3214, DOI 10.1158/0008-5472.CAN-07-3043; Joshi J, 2008, EMBO J, V27, P2181, DOI 10.1038/emboj.2008.149; Karp CM, 2008, CANCER RES, V68, P4105, DOI 10.1158/0008-5472.CAN-07-6814; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Mathe EA, 2009, CLIN CANCER RES, V15, P6192, DOI 10.1158/1078-0432.CCR-09-1467; Ogawa R, 2009, MED MOL MORPHOL, V42, P102, DOI 10.1007/s00795-009-0443-1; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Sobin L H, 2002, TNM CLASSIFICATION M, P60; Tanaka E, 2007, CLIN CANCER RES, V13, P1331, DOI 10.1158/1078-0432.CCR-06-1192; Thepot A, 2010, INT J CANCER, V127, P2051, DOI 10.1002/ijc.25221; Tsuchiya S, 2006, J PHARMACOL SCI, V101, P267, DOI 10.1254/jphs.CPJ06013X; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	29	161	173	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					420	428		10.1074/jbc.M110.170852	http://dx.doi.org/10.1074/jbc.M110.170852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044961	hybrid, Green Published			2022-12-27	WOS:000285782800045
J	Wang, QY; Wu, HL; Wang, AM; Du, PF; Pei, XL; Li, HF; Yin, XP; Huang, LF; Xiong, XL				Wang, Qiuyan; Wu, Huili; Wang, Anming; Du, Pengfei; Pei, Xiaolin; Li, Haifeng; Yin, Xiaopu; Huang, Lifeng; Xiong, Xiaolong			Prospecting Metagenomic Enzyme Subfamily Genes for DNA Family Shuffling by a Novel PCR-based Approach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED EVOLUTION; LIPASE; SEQUENCE; PURIFICATION; DISCOVERY; LIBRARIES	DNA family shuffling is a powerful method for enzyme engineering, which utilizes recombination of naturally occurring functional diversity to accelerate laboratory-directed evolution. However, the use of this technique has been hindered by the scarcity of family genes with the required level of sequence identity in the genome database. We describe here a strategy for collecting metagenomic homologous genes for DNA shuffling from environmental samples by truncated metagenomic gene-specific PCR (TMGS-PCR). Using identified metagenomic gene-specific primers, twenty-three 921-bp truncated lipase gene fragments, which shared 64-99% identity with each other and formed a distinct subfamily of lipases, were retrieved from 60 metagenomic samples. These lipase genes were shuffled, and selected active clones were characterized. The chimeric clones show extensive functional and genetic diversity, as demonstrated by functional characterization and sequence analysis. Our results indicate that homologous sequences of genes captured by TMGS-PCR can be used as suitable genetic material for DNA family shuffling with broad applications in enzyme engineering.	[Wang, Qiuyan; Wu, Huili; Wang, Anming; Du, Pengfei; Pei, Xiaolin; Li, Haifeng; Yin, Xiaopu; Huang, Lifeng] Hangzhou Normal Univ, Ctr Biomed & Hlth, Hangzhou 310012, Zhejiang, Peoples R China; [Xiong, Xiaolong] Hangzhou Normal Univ, Sch Life Sci, Hangzhou 310012, Zhejiang, Peoples R China	Hangzhou Normal University; Hangzhou Normal University	Wang, QY (corresponding author), Hangzhou Normal Univ, Ctr Biomed & Hlth, 222 Wenyi Rd, Hangzhou 310012, Zhejiang, Peoples R China.	qywanghznu@gmail.com	Pei, Xiaolin/ACY-6781-2022		National Natural Science Foundation of China [30900253, 20906016]; Natural Science Foundation of Zhejiang Province [Y4080317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (30900253, 20906016), and the Natural Science Foundation of Zhejiang Province (Y4080317).	Arnold FH, 1999, CURR OPIN CHEM BIOL, V3, P54, DOI 10.1016/S1367-5931(99)80010-6; Bell PJL, 2002, MICROBIOL-SGM, V148, P2283, DOI 10.1099/00221287-148-8-2283; Bittker JA, 2004, P NATL ACAD SCI USA, V101, P7011, DOI 10.1073/pnas.0402202101; Blow N, 2008, NATURE, V453, P687, DOI 10.1038/453687a; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; Chae JC, 2008, FEMS MICROBIOL LETT, V281, P203, DOI 10.1111/j.1574-6968.2008.01106.x; Chang CCJ, 1999, NAT BIOTECHNOL, V17, P793, DOI 10.1038/11737; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Cherry JR, 2003, CURR OPIN BIOTECH, V14, P438, DOI 10.1016/S0958-1669(03)00099-5; Christians FC, 1999, NAT BIOTECHNOL, V17, P259, DOI 10.1038/7003; Coco WM, 2001, NAT BIOTECHNOL, V19, P354, DOI 10.1038/86744; Cohen N, 2001, TRENDS BIOTECHNOL, V19, P507, DOI 10.1016/S0167-7799(01)01869-8; Cottrell MT, 2005, APPL ENVIRON MICROB, V71, P8506, DOI 10.1128/AEM.71.12.8506-8513.2005; Cowan D, 2005, TRENDS BIOTECHNOL, V23, P321, DOI 10.1016/j.tibtech.2005.04.001; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Ferrer M, 2005, CURR OPIN BIOTECH, V16, P588, DOI 10.1016/j.copbio.2005.09.001; Ferrer M, 2000, J CHEM TECHNOL BIOT, V75, P569, DOI 10.1002/1097-4660(200007)75:7<569::AID-JCTB258>3.0.CO;2-S; Fischer M, 2003, NUCLEIC ACIDS RES, V31, P319, DOI 10.1093/nar/gkg015; Griswold KE, 2005, P NATL ACAD SCI USA, V102, P10082, DOI 10.1073/pnas.0504556102; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Jiang CJ, 2007, BIOCHEM BIOPH RES CO, V357, P421, DOI 10.1016/j.bbrc.2007.03.159; Joern JM, 2002, J MOL BIOL, V316, P643, DOI 10.1006/jmbi.2001.5349; LeCleir GR, 2007, ENVIRON MICROBIOL, V9, P197, DOI 10.1111/j.1462-2920.2006.01128.x; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; Lutz S, 2001, P NATL ACAD SCI USA, V98, P11248, DOI 10.1073/pnas.201413698; Moore JC, 1996, NAT BIOTECHNOL, V14, P458, DOI 10.1038/nbt0496-458; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; Roh C, 2007, LETT APPL MICROBIOL, V44, P475, DOI 10.1111/j.1472-765X.2007.02118.x; Schmidt M, 2005, BIOMOL ENG, V22, P51, DOI 10.1016/j.bioeng.2004.09.004; Sieber V, 2001, NAT BIOTECHNOL, V19, P456, DOI 10.1038/88129; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tao HY, 2002, CURR OPIN CHEM BIOL, V6, P858, DOI 10.1016/S1367-5931(02)00396-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8	38	27	30	0	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41509	41516		10.1074/jbc.M110.139659	http://dx.doi.org/10.1074/jbc.M110.139659			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20962349	hybrid, Green Published			2022-12-27	WOS:000285622600037
J	Albin, JS; LaRue, RS; Weaver, JA; Brown, WL; Shindo, K; Harjes, E; Matsuo, H; Harris, RS				Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.			A Single Amino Acid in Human APOBEC3F Alters Susceptibility to HIV-1 Vif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIRETROVIRAL ACTIVITY; RESTRICTION; SENSITIVITY; VARIANTS; HOST; DNA; IDENTIFICATION; DEAMINATION; INHIBITION; REPERTOIRE	Human APOBEC3F (huA3F) potently restricts the infectivity of HIV-1 in the absence of the viral accessory protein virion infectivity factor (Vif). Vif functions to preserve viral infectivity by triggering the degradation of huA3F but not rhesus macaque A3F (rhA3F). Here, we use a combination of deletions, chimeras, and systematic mutagenesis between huA3F and rhA3F to identify Glu(324) as a critical determinant of huA3F susceptibility to HIV-1 Vif-mediated degradation. A structural model of the C-terminal deaminase domain of huA3F indicates that Glu(324) is a surface residue within the alpha 4 helix adjacent to residues corresponding to other known Vif susceptibility determinants in APOBEC3G and APOBEC3H. This structural clustering suggests that Vif may bind a conserved surface present in multiple APOBEC3 proteins.	[Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harjes, Elena; Matsuo, Hiroshi; Harris, Reuben S.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Albin, John S.; LaRue, Rebecca S.; Weaver, Jessalyn A.; Brown, William L.; Shindo, Keisuke; Harris, Reuben S.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	rsh@umn.edu	Brown, William/GXN-2777-2022	Harjes, Elena/0000-0002-3643-9432; Shindo, Keisuke/0000-0001-8793-8189	National Institutes of Health through the NIAID [R01 AI064046]; National Institute on Drug Abuse [F30 DA026310]; University of Minnesota [T32 GM008244]; Minnesota Agricultural Experiment Station; College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073167, R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026310] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); University of Minnesota(University of Minnesota System); Minnesota Agricultural Experiment Station; College of Veterinary Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health Grant R01 AI064046 through the NIAID (to R.S.H.).; Supported by the National Institute on Drug Abuse (F30 DA026310) and the University of Minnesota Medical Scientist Training Program (T32 GM008244).; Supported in part by a studentship from the Minnesota Agricultural Experiment Station and the College of Veterinary Medicine.	Albin JS, 2010, J VIROL, V84, P10209, DOI 10.1128/JVI.00632-10; Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Browne EP, 2009, VIROLOGY, V387, P313, DOI 10.1016/j.virol.2009.02.026; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; GIBBS JS, 1994, AIDS RES HUM RETROV, V10, P343, DOI 10.1089/aid.1994.10.343; Hache G, 2008, CURR BIOL, V18, P819, DOI 10.1016/j.cub.2008.04.073; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Henriet S, 2009, MICROBIOL MOL BIOL R, V73, P211, DOI 10.1128/MMBR.00040-08; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Larue RS, 2010, J VIROL, V84, P8193, DOI 10.1128/JVI.00685-10; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lassen KG, 2010, J BIOL CHEM, V285, P29326, DOI 10.1074/jbc.M110.154054; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Romani B, 2009, ARCH VIROL, V154, P1579, DOI 10.1007/s00705-009-0481-y; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Virgen CA, 2007, J VIROL, V81, P13932, DOI 10.1128/JVI.01760-07; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	36	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40785	40792		10.1074/jbc.M110.173161	http://dx.doi.org/10.1074/jbc.M110.173161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971849	Green Published, hybrid			2022-12-27	WOS:000285414400043
J	Bakkes, PJ; Jenewein, S; Smits, SHJ; Holland, IB; Schmitt, L				Bakkes, Patrick J.; Jenewein, Stefan; Smits, Sander H. J.; Holland, I. Barry; Schmitt, Lutz			The Rate of Folding Dictates Substrate Secretion by the Escherichia coli Hemolysin Type 1 Secretion System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; MEMBRANE TRANSLOCATION; ANTIFOLDING ACTIVITY; SECB CHAPERONE; IN-VIVO; SIGNAL; EXPORT; TRANSPORTER; EXPRESSION; PATHWAY	Secretion of the Escherichia coli toxin hemolysin A (HlyA) is catalyzed by the membrane protein complex HlyB-HlyD-TolC and requires a secretion sequence located within the last 60 amino acids of HlyA. The Hly translocator complex exports a variety of passenger proteins when fused N-terminal to this secretion sequence. However, not all fusions are secreted efficiently. Here, we demonstrate that the maltose binding protein (MalE) lacking its natural export signal and fused to the HlyA secretion signal is poorly secreted by the Hly system. We anticipated that folding kinetics might be limiting secretion, and we therefore introduced the "folding" mutation Y283D. Indeed this mutant fusion protein was secreted at a much higher level. This level was further enhanced by the introduction of a second MalE folding mutation (V8G or A276G). Secretion did not require the molecular chaperone SecB. Folding analysis revealed that all mutations reduced the refolding rate of the substrate, whereas the unfolding rate was unaffected. Thus, the efficiency of secretion by the Hly system is dictated by the folding rate of the substrate. Moreover, we demonstrate that fusion proteins defective in export can be engineered for secretion while still retaining function.	[Bakkes, Patrick J.; Jenewein, Stefan; Smits, Sander H. J.; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Holland, I. Barry; Schmitt, Lutz] Univ Paris 11, Inst Genet & Microbiol, UMR Bat 1354 409, F-91405 Orsay, France	Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Universite Paris Saclay	Schmitt, L (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	lutz.schmitt@uni-duesseldorf.de		Bakkes, Patrick/0000-0003-1876-7384	CNRS at the University of Paris-Sud; Heinrich Heine University of Duesseldorf;  [SFB 628]	CNRS at the University of Paris-Sud; Heinrich Heine University of Duesseldorf; 	This work was supported by the CNRS at the University of Paris-Sud (to I. B. H.) and in part by the SFB 628 and the Heinrich Heine University of Duesseldorf (to L. S.).	Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Benabdelhak H, 2003, J MOL BIOL, V327, P1169, DOI 10.1016/S0022-2836(03)00204-3; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; BLIGHT MA, 1994, TRENDS BIOTECHNOL, V12, P450, DOI 10.1016/0167-7799(94)90020-5; Blight Mark A., 1994, Current Opinion in Biotechnology, V5, P468, DOI 10.1016/0958-1669(94)90059-0; CHERVAUX C, 1995, MOL GEN GENET, V249, P237, DOI 10.1007/BF00290371; CHUN SY, 1993, J BIOL CHEM, V268, P20855; COLLIER DN, 1989, J BACTERIOL, V171, P4640, DOI 10.1128/jb.171.9.4640-4647.1989; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; COVER WH, 1987, J BACTERIOL, V169, P1794, DOI 10.1128/jb.169.5.1794-1800.1987; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Debarbieux L, 2001, EMBO J, V20, P4657, DOI 10.1093/emboj/20.17.4657; Delepelaire P, 1998, EMBO J, V17, P936, DOI 10.1093/emboj/17.4.936; DIAMOND DL, 1995, PROTEIN SCI, V4, P1118, DOI 10.1002/pro.5560040610; Driessen AJM, 2001, TRENDS MICROBIOL, V9, P193, DOI 10.1016/S0966-842X(01)01980-1; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fernandez LA, 2000, APPL ENVIRON MICROB, V66, P5024, DOI 10.1128/AEM.66.11.5024-5029.2000; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; GENTSCHEV I, 1990, MOL GEN GENET, V222, P211, DOI 10.1007/BF00633820; Gentschev I, 2002, TRENDS MICROBIOL, V10, P39, DOI 10.1016/S0966-842X(01)02259-4; Gentschev I, 1996, GENE, V179, P133, DOI 10.1016/S0378-1119(96)00424-6; GRAY L, 1986, MOL GEN GENET, V205, P127, DOI 10.1007/BF02428042; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HESS J, 1990, MOL GEN GENET, V224, P201, DOI 10.1007/BF00271553; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; HOLLAND IB, 1990, J BIOENERG BIOMEMBR, V22, P473, DOI 10.1007/BF00763178; JOBLING MG, 1990, NUCLEIC ACIDS RES, V18, P5315, DOI 10.1093/nar/18.17.5315; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; KENNY B, 1991, MOL MICROBIOL, V5, P2557, DOI 10.1111/j.1365-2958.1991.tb02102.x; KENNY B, 1994, MOL MICROBIOL, V11, P99, DOI 10.1111/j.1365-2958.1994.tb00293.x; KENNY B, 1992, MOL MICROBIOL, V6, P1477, DOI 10.1111/j.1365-2958.1992.tb00868.x; KHISTY VJ, 1995, J BACTERIOL, V177, P3277, DOI 10.1128/jb.177.11.3277-3282.1995; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Labadia ME, 1998, J IMMUNOL, V161, P836; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LIU G, 1988, J BIOL CHEM, V263, P14790; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; MACKMAN N, 1987, EMBO J, V6, P2835, DOI 10.1002/j.1460-2075.1987.tb02580.x; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; NAKANO H, 1992, APPL MICROBIOL BIOT, V37, P765; NICAUD JM, 1986, FEBS LETT, V204, P331, DOI 10.1016/0014-5793(86)80838-9; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; Prakash S, 2004, TRENDS BIOCHEM SCI, V29, P593, DOI 10.1016/j.tibs.2004.09.011; STANLEY P, 1991, MOL MICROBIOL, V5, P2391, DOI 10.1111/j.1365-2958.1991.tb02085.x; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tomikiewicz D, 2008, J MOL BIOL, V377, P83, DOI 10.1016/j.jmb.2008.01.014; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200	58	51	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40573	40580		10.1074/jbc.M110.173658	http://dx.doi.org/10.1074/jbc.M110.173658			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971850	Green Published, hybrid			2022-12-27	WOS:000285414400020
J	Cheng, C; Xia, CH; Huang, QL; Ding, LL; Horwitz, J; Gong, XH				Cheng, Catherine; Xia, Chun-hong; Huang, Qingling; Ding, Linlin; Horwitz, Joseph; Gong, Xiaohua			Altered Chaperone-like Activity of alpha-Crystallins Promotes Cataractogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-D-CRYSTALLIN; A-CRYSTALLIN; B-CRYSTALLIN; MUTATION; MECHANISM; MUTANT; MODEL	Despite the enormous number of studies demonstrating changes in the chaperone-like activity of alpha-crystallins in vitro, little is known about how these changes influence life-long lens transparency in vivo. Using the gamma B-crystallin I4F mutant protein as a target for alpha A-crystallins, we examined how cataract phenotypes are modulated by interactions between alpha-crystallins with altered chaperone-like activities and gamma B-I4F proteins in vivo. Double heterozygous alpha-crystallin knock-out alpha A(+/-) alpha B(+/-) mice with a decreased amount of alpha-crystallins were used to simulate reduced total alpha-crystallin chaperone-like activity in vivo. We found that triple heterozygous alpha A(+/-) alpha B(+/-) gamma B(I4F/+) mice developed more severe whole cataracts than heterozygous gamma B(I4F/+) mice. Thus, total chaperone-like activity of alpha-crystallins is important for maintaining lens transparency. We further tested whether mutant alpha A-crystallin Y118D proteins with increased chaperone-like activity influenced the whole cataract caused by the gamma B-I4F mutation. Unexpectedly, compound alpha A(Y118D/+) gamma B(I4F/+) mutant lenses displayed severe nuclear cataracts, whereas the lens cortex remained unaffected. Thus, the synergistic effect of alpha A-Y118D and gamma B-I4F mutant proteins is detrimental to the transparency only in the lens core. alpha-Crystallins with different chaperone-like activities are likely required in the lens cortex and nucleus for maintaining transparency.	[Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Huang, Qingling; Ding, Linlin; Horwitz, Joseph] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Gong, XH (corresponding author), Univ Calif Berkeley, Sch Optometry, 693 Minor Hall, Berkeley, CA 94720 USA.	xgong@berkeley.edu			National Institutes of Health from NEI [EY013849]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER	National Institutes of Health from NEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY013849 (to X.G.) from NEI.	Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Benedek GB, 1997, INVEST OPHTH VIS SCI, V38, P1911; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Derham BK, 1999, PROG RETIN EYE RES, V18, P463, DOI 10.1016/S1350-9462(98)00030-5; Duncan M.K., 2004, DEV OCULAR LENS; Ghosh JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000498; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gu F, 2008, HUM MUTAT, V29, P769, DOI 10.1002/humu.20724; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; Huang QL, 2009, INVEST OPHTH VIS SCI, V50, P2919, DOI 10.1167/iovs.08-3070; Li H, 2008, BBA-MOL BASIS DIS, V1782, P303, DOI 10.1016/j.bbadis.2008.01.011; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Mayer Marcus, 2004, Methods Mol Med, V94, P239; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; Murugesan R, 2007, MOL VIS, V13, P2301; Pande A, 2009, BIOCHEM BIOPH RES CO, V382, P196, DOI 10.1016/j.bbrc.2009.03.007; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Sanderson J, 2000, INVEST OPHTH VIS SCI, V41, P2255; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Singh D, 2006, MOL VIS, V12, P1372; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Wang K, 2007, INVEST OPHTH VIS SCI, V48, P3719, DOI 10.1167/iovs.06-1487; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178	34	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41187	41193		10.1074/jbc.M110.154534	http://dx.doi.org/10.1074/jbc.M110.154534			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959464	Green Published, hybrid			2022-12-27	WOS:000285414400080
J	Gaines, WA; Sehorn, MG; Marcotte, WR				Gaines, William A.; Sehorn, Michael G.; Marcotte, William R., Jr.			Spidroin N-terminal Domain Promotes a pH-dependent Association of Silk Proteins during Self-assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIDER DRAGLINE SILK; NEPHILA-CLAVIPES; FIBER; GLAND; TRANSITION; FLOW	Spider silks are spun from concentrated solutions of spidroin proteins. The appropriate timing of spidroin assembly into organized fibers must be highly regulated to avoid premature fiber formation. Chemical and physical signals presented to the silk proteins as they pass from the ampulle and through the tapered duct include changes in ionic environment and pH as well as the introduction of shear forces. Here, we show that the N-terminal domain of spidroins from the major ampullate gland (MaSp-NTDs) for both Nephila and Latrodectus spiders associate noncovalently as homodimers. The MaSp-NTDs are highly pH-responsive and undergo a structural transition in the physiological pH range of the spider duct. Tryptophan fluorescence of the MaSp-NTDs reveals a change in conformation when pH is decreased, and the pH at which the transition occurs is determined by the amount and type of salt present. Size exclusion chromatography and pull-down assays both indicate that the lower pH conformation is associated with a significantly increased MaSp-NTD homodimer stability. By transducing the duct pH signal into specific protein-protein interactions, this conserved spidroin domain likely contributes significantly to the silk-spinning process. Based on these results, we propose a model of spider silk assembly dynamics as mediated through the MaSp-NTD.	[Marcotte, William R., Jr.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Marcotte, William R., Jr.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA	Clemson University; Clemson University	Marcotte, WR (corresponding author), Clemson Univ, Dept Biochem & Genet, 51 New Cherry Rd,Biosyst Res Complex,Rm 216, Clemson, SC 29634 USA.	marcotw@clemson.edu	Marcotte, William/AAD-8354-2019	Marcotte, William/0000-0003-4580-1939	National Institutes of Health [EB007403]; Sigma Xi; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R15EB007403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigma Xi; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant EB007403 (to W.R.M.). This work was also supported by a Sigma Xi grant-in-aid for research (to W.A.G.). This is Technical Contribution 5829 of the Clemson University Experiment Station.	Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Breslauer DN, 2009, BIOMACROMOLECULES, V10, P49, DOI 10.1021/bm800752x; Chen X, 2004, CHEM J CHINESE U, V25, P1160; Chen X, 2002, BIOMACROMOLECULES, V3, P644, DOI 10.1021/bm0156126; Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Eisoldt L, 2010, J STRUCT BIOL, V170, P413, DOI 10.1016/j.jsb.2009.12.027; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883; Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Knight DP, 1999, P ROY SOC B-BIOL SCI, V266, P519, DOI 10.1098/rspb.1999.0667; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Knight DP, 2000, INT J BIOL MACROMOL, V27, P205, DOI 10.1016/S0141-8130(00)00124-0; Lefevre T, 2008, BIOMACROMOLECULES, V9, P2399, DOI 10.1021/bm800390j; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x; Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120	31	80	87	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40745	40753		10.1074/jbc.M110.163121	http://dx.doi.org/10.1074/jbc.M110.163121			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959449	Green Published, hybrid			2022-12-27	WOS:000285414400038
J	Matthias, LJ; Azimi, I; Tabrett, CA; Hogg, PJ				Matthias, Lisa J.; Azimi, Iman; Tabrett, Catherine A.; Hogg, Philip J.			Reduced Monomeric CD4 Is the Preferred Receptor for HIV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN DISULFIDE-ISOMERASE; CLASS-II MHC; MONOCLONAL-ANTIBODY; MEDIATED FUSION; TYPE-1 ENVELOPE; BINDING-SITE; INFECTION; THIOREDOXIN; ASSOCIATION	CD4 is a co-receptor for binding of T cells to antigen-presenting cells and the primary receptor for the human immunodeficiency virus type 1 (HIV). CD4 exists in three different forms on the cell surface defined by the state of the domain 2 cysteine residues: an oxidized monomer, a reduced monomer, and a covalent dimer linked through the domain 2 cysteines. The disulfide-linked dimer is the preferred immune co-receptor. The form of CD4 that is preferred by HIV was examined in this study. HIV entry and envelope-mediated cell-cell fusion were tested using cells expressing comparable levels of wildtype or disulfide bond mutant CD4 in which the domain 2 cysteines were mutated to alanine. Eliminating the domain 2 disulfide bond increased entry of HIV reporter viruses and enhanced HIV envelope-mediated cell-cell fusion 2-4-fold. These observations suggest that HIV enters susceptible cells preferably through monomeric reduced CD4, whereas dimeric CD4 is the preferred receptor for binding to antigen-presenting cells. Cleavage of the domain 2 disulfide bond is possibly involved in the conformational change in CD4 associated with fusion of the HIV and cell membranes.	[Hogg, Philip J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Level 2, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au	Azimi, Iman/E-2043-2011; Hill, Andrew/B-4527-2009	Azimi, Iman/0000-0001-9477-9999; Hill, Andrew/0000-0001-5581-2354; Hogg, Philip/0000-0001-6486-2863	Australian Research Council; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian Research Council and the National Health and Medical Research Council of Australia.	ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BACHELDER RE, 1995, J VIROL, V69, P5734, DOI 10.1128/JVI.69.9.5734-5742.1995; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Brady RL, 1996, CURR TOP MICROBIOL, V205, P1; BURKLY LC, 1992, J IMMUNOL, V149, P1779; CELADA F, 1990, J EXP MED, V172, P1143, DOI 10.1084/jem.172.4.1143; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Einfeld D, 1996, CURR TOP MICROBIOL, V214, P133; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; JAMESON BA, 1988, SCIENCE, V240, P1335, DOI 10.1126/science.2453925; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Lynch GW, 2003, EXP DERMATOL, V12, P700, DOI 10.1034/j.1600-0625.2003.00078.x; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Maerz AL, 2001, J VIROL, V75, P6635, DOI 10.1128/JVI.75.14.6635-6644.2001; Marsh M, 1996, CURR TOP MICROBIOL, V205, P107; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MIZUKAMI T, 1988, P NATL ACAD SCI USA, V85, P9273, DOI 10.1073/pnas.85.23.9273; MOORE JP, 1992, J VIROL, V66, P4784, DOI 10.1128/JVI.66.8.4784-4793.1992; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; Poumbourios P, 2003, J BIOL CHEM, V278, P42149, DOI 10.1074/jbc.M305223200; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; Schmidt B, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-49; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schwertassek U., 2007, SCI STKE, pl8; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; TAGAYA Y, 1989, EMBO J, V8, P757, DOI 10.1002/j.1460-2075.1989.tb03436.x; Vandegraaff N, 2001, ANTIMICROB AGENTS CH, V45, P2510, DOI 10.1128/AAC.45.9.2510-2516.2001; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wong J. W., 2010, MOL BIOL EV IN PRESS; Wouters MA, 2004, BIOESSAYS, V26, P73, DOI 10.1002/bies.10413	42	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40793	40799		10.1074/jbc.M110.190579	http://dx.doi.org/10.1074/jbc.M110.190579			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20974843	Green Published, hybrid			2022-12-27	WOS:000285414400044
J	Parent, A; Roy, SJ; Iorio-Morin, C; Lepine, MC; Labrecque, P; Gallant, MA; Slipetz, D; Parent, JL				Parent, Audrey; Roy, Sebastien J.; Iorio-Morin, Christian; Lepine, Marie-Claude; Labrecque, Pascale; Gallant, Maxime A.; Slipetz, Deborah; Parent, Jean-Luc			ANKRD13C Acts as a Molecular Chaperone for G Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN HOMOLOG NINAA; PROSTAGLANDIN D-2; ANKYRIN REPEAT; CRTH2; TRANSPORT; DP; TRAFFICKING; ROLES; MOTIF	Although the mechanisms that regulate folding and maturation of newly synthesized G protein-coupled receptors are crucial for their function, they remain poorly characterized. By yeast two-hybrid screening, we have isolated ANKRD13C, a protein of unknown function, as an interacting partner for the DP receptor for prostaglandin D-2. In the present study we report the characterization of this novel protein as a regulator of DP biogenesis and trafficking in the biosynthetic pathway. Co-localization by confocal microscopy with an endoplasmic reticulum (ER) marker, subcellular fractionation experiments, and demonstration of the interaction between ANKRD13C and the cytoplasmic C terminus of DP suggest that ANKRD13C is a protein associated with the cytosolic side of ER membranes. Co-expression of ANKRD13C with DP initially increased receptor protein levels, whereas siRNA-mediated knockdown of endogenous ANKRD13C decreased them. Pulse-chase experiments indicated that ANKRD13C can promote the biogenesis of DP by inhibiting the degradation of newly synthesized receptors. However, a prolonged interaction between ANKRD13C and DP resulted in ER retention of misfolded/unassembled forms of the receptor and to their proteasome-mediated degradation. ANKRD13C also regulated the expression of other GPCRs tested (CRTH2, thromboxane A(2) (TP alpha), and beta 2-adrenergic receptor), whereas it did not affect the expression of green fluorescent protein, GRK2 (G protein-coupled receptor kinase 2), and VSVG (vesicular stomatitis virus glycoprotein), showing specificity toward G protein-coupled receptors. Altogether, these results suggest that ANKRD13C acts as a molecular chaperone for G protein-coupled receptors, regulating their biogenesis and exit from the ER.	[Gallant, Maxime A.; Parent, Jean-Luc] Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante,Ctr Rech Clin Etienne Lebel, Sherbrooke, PQ J1H 5N4, Canada; [Gallant, Maxime A.; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada; [Slipetz, Deborah] Merck Res Labs, BRIE Program, Boston, MA 02115 USA	University of Sherbrooke; Merck & Company	Parent, JL (corresponding author), Univ Sherbrooke, Serv Rhumatol, Dept Med, Fac Med & Sci Sante,Ctr Rech Clin Etienne Lebel, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	jean-luc.parent@usherbrooke.ca	Iorio-Morin, Christian/I-8696-2019	Iorio-Morin, Christian/0000-0003-2995-7255	Canadian Institutes of Health Research; Natural Science and Engineering Research Council; Fonds de la Recherche en Sante du Quebec; Andre Lussier Research Chair in Rheumatology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Andre Lussier Research Chair in Rheumatology	This work was supported by a grant from the Canadian Institutes of Health Research (to J.-L.P.).; Recipients of studentships from the Natural Science and Engineering Research Council.; Recipients of studentships from the Fonds de la Recherche en Sante du Quebec.; Holds a "Chercheur boursier-Senior" salary award from the Fonds de la Recherche en Sante du Quebec and the Andre Lussier Research Chair in Rheumatology.	Achour L, 2008, TRENDS PHARMACOL SCI, V29, P528, DOI 10.1016/j.tips.2008.07.009; Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bouschet T, 2005, J CELL SCI, V118, P4709, DOI 10.1242/jcs.02598; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Durand M, 2008, J BONE MINER RES, V23, P1097, DOI [10.1359/jbmr.080228, 10.1359/JBMR.080228]; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hayaishi O, 2002, NEUROSCIENTIST, V8, P12, DOI 10.1177/107385840200800105; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Kostenis E, 2006, TRENDS MOL MED, V12, P148, DOI 10.1016/j.molmed.2006.02.005; Laroche G, 2005, CELL SIGNAL, V17, P1373, DOI 10.1016/j.cellsig.2005.02.008; LeClerc PC, 2002, ENDOCRINOLOGY, V143, P4702, DOI 10.1210/en.2002-220679; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Oguma Tsuyoshi, 2008, Allergol Int, V57, P307, DOI 10.2332/allergolint.08-RAI-0033; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546	35	20	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40838	40851		10.1074/jbc.M110.142257	http://dx.doi.org/10.1074/jbc.M110.142257			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959461	Green Published, hybrid			2022-12-27	WOS:000285414400049
J	Pierce, E; Becker, DF; Ragsdale, SW				Pierce, Elizabeth; Becker, Donald F.; Ragsdale, Stephen W.			Identification and Characterization of Oxalate Oxidoreductase, a Novel Thiamine Pyrophosphate-dependent 2-Oxoacid Oxidoreductase That Enables Anaerobic Growth on Oxalate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; 2 2-OXOACID-FERREDOXIN OXIDOREDUCTASES; SULFOLOBUS SP STRAIN-7; CLOSTRIDIUM-THERMOACETICUM; OXALOBACTER-FORMIGENES; MOORELLA-THERMOACETICA; RADICAL INTERMEDIATE; HYPERTHERMOPHILIC ARCHAEON; HALOBACTERIUM-HALOBIUM; CARBON ASSIMILATION	Moorella thermoacetica is an anaerobic acetogen, a class of bacteria that is found in the soil, the animal gastrointestinal tract, and the rumen. This organism engages the Wood-Ljungdahl pathway of anaerobic CO2 fixation for heterotrophic or autotrophic growth. This paper describes a novel enzyme, oxalate oxidoreductase (OOR), that enables M. thermoacetica to grow on oxalate, which is produced in soil and is a common component of kidney stones. Exposure to oxalate leads to the induction of three proteins that are subunits of OOR, which oxidizes oxalate coupled to the production of two electrons and CO2 or bicarbonate. Like other members of the 2-oxoacid: ferredoxin oxidoreductase family, OOR contains thiamine pyrophosphate and three [Fe4S4] clusters. However, unlike previously characterized members of this family, OOR does not use coenzyme A as a substrate. Oxalate is oxidized with a kcat of 0.09 s(-1) and a K-m of 58 mu M at pH 8. OOR also oxidizes a few other 2-oxoacids (which do not induce OOR) also without any requirement for CoA. The enzyme transfers its reducing equivalents to a broad range of electron acceptors, including ferredoxin and the nickel-dependent carbon monoxide dehydrogenase. In conjunction with the well characterized Wood-Ljungdahl pathway, OOR should be sufficient for oxalate metabolism by M. thermoacetica, and it constitutes a novel pathway for oxalate metabolism.	[Ragsdale, Stephen W.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Becker, Donald F.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; University of Nebraska System; University of Nebraska Lincoln	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Pierce, Elizabeth/0000-0003-4693-5883	National Institutes of Health (NIH) [GM39451]; NIH, NCRR [P20 RR-017675]; National Science Foundation [DBI-0619764]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039451, R01GM039451, R29GM039451] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant GM39451 (to S. W. R.) and NIH, NCRR, Grant P20 RR-017675 (to D. F. B.) (for the ultracentrifugation studies). This work was also supported by National Science Foundation Grant DBI-0619764.	Abe K, 1996, J BIOL CHEM, V271, P6789, DOI 10.1074/jbc.271.12.6789; ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; ANANTHARAM V, 1989, J BIOL CHEM, V264, P7244; Arendsen AF, 1999, J BACTERIOL, V181, P1489, DOI 10.1128/JB.181.5.1489-1495.1999; Astashkin AV, 2006, J AM CHEM SOC, V128, P3888, DOI 10.1021/ja0585275; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; Barent RL, 1992, PLANT MOL BIOL REP, V10, P338, DOI 10.1007/BF02668910; CAMMACK R, 1980, FEBS LETT, V118, P271, DOI 10.1016/0014-5793(80)80236-5; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Cornick NA, 1996, CAN J MICROBIOL, V42, P1219, DOI 10.1139/m96-157; Cornick NA, 1996, APPL ENVIRON MICROB, V62, P3011, DOI 10.1128/AEM.62.8.3011-3013.1996; Costelloe SJ, 2008, J MOL EVOL, V66, P36, DOI 10.1007/s00239-007-9056-2; Daniel SL, 2004, FEMS MICROBIOL LETT, V231, P39, DOI 10.1016/S0378-1097(03)00924-8; DANIEL SL, 1993, APPL ENVIRON MICROB, V59, P3062, DOI 10.1128/AEM.59.9.3062-3069.1993; Dorner E, 2002, J BACTERIOL, V184, P3975, DOI 10.1128/JB.184.14.3975-3983.2002; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V190, P351, DOI 10.1016/0003-9861(78)90285-0; Frostl JM, 1996, J BACTERIOL, V178, P4597; Fukuda E, 2002, BBA-PROTEIN STRUCT M, V1597, P74, DOI 10.1016/S0167-4838(02)00280-7; Fukuda E, 2001, EUR J BIOCHEM, V268, P5639, DOI 10.1046/j.1432-1033.2001.02504.x; Furdui C, 2002, BIOCHEMISTRY-US, V41, P9921, DOI 10.1021/bi0257641; Guo FS, 1998, BIOCHEMISTRY-US, V37, P13379, DOI 10.1021/bi9807097; KERSCHER L, 1981, EUR J BIOCHEM, V116, P587, DOI 10.1111/j.1432-1033.1981.tb05376.x; LUNDIE LL, 1984, J BACTERIOL, V159, P700, DOI 10.1128/JB.159.2.700-703.1984; Ma K, 1997, P NATL ACAD SCI USA, V94, P9608, DOI 10.1073/pnas.94.18.9608; MATHEWS R, 1974, J BIOL CHEM, V249, P4326; MEINECKE B, 1989, ARCH MICROBIOL, V152, P244, DOI 10.1007/BF00409658; Menon S, 1997, BIOCHEMISTRY-US, V36, P8484, DOI 10.1021/bi970403k; Nishizawa Y, 2005, FEBS LETT, V579, P2319, DOI 10.1016/j.febslet.2004.11.117; ORMEJOHN.WH, 1969, BIOCHEM BIOPH RES CO, V36, P337, DOI 10.1016/0006-291X(69)90569-5; Park YJ, 2006, J BIOCHEM MOL BIOL, V39, P46; Penttinen H K, 1979, Methods Enzymol, V62, P58, DOI 10.1016/0076-6879(79)62190-0; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; QUAYLE JR, 1963, BIOCHEM J, V89, P492, DOI 10.1042/bj0890492; QUAYLE JR, 1959, BIOCHEM J, V72, P623, DOI 10.1042/bj0720623; Ragsdale SW, 2003, CHEM REV, V103, P2333, DOI 10.1021/cr020423e; Seifritz C, 1999, FEMS MICROBIOL LETT, V170, P399, DOI 10.1111/j.1574-6968.1999.tb13400.x; Seifritz C, 2002, ARCH MICROBIOL, V178, P457, DOI 10.1007/s00203-002-0475-6; Seravalli J, 2000, BIOCHEMISTRY-US, V39, P1274, DOI 10.1021/bi991812e; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Tittmann K, 2005, BIOCHEMISTRY-US, V44, P13291, DOI 10.1021/bi051058z; WEAST RC, 1981, CRC HDB CHEM PHYSICS, pD166; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Yamamoto M, 2003, BIOCHEM BIOPH RES CO, V312, P1297, DOI 10.1016/j.bbrc.2003.11.078; Zhang Q, 1996, J BIOCHEM-TOKYO, V120, P587; [No title captured]	48	16	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40515	40524		10.1074/jbc.M110.155739	http://dx.doi.org/10.1074/jbc.M110.155739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956531	Green Published, hybrid			2022-12-27	WOS:000285414400014
J	Shelton, SN; Dillard, CD; Robertson, JD				Shelton, Shary N.; Dillard, Cindy D.; Robertson, John D.			Activation of Caspase-9, but Not Caspase-2 or Caspase-8, Is Essential for Heat-induced Apoptosis in Jurkat Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; INITIATOR CASPASES; GENOTOXIC STRESS; COMPLEX; DEATH; HYPERTHERMIA; CLEAVAGE; PROTEIN; REQUIREMENT	Exposure of cells to hyperthermia is known to induce apoptosis, although the underlying mechanisms are only partially understood. Here, we examine the molecular requirements necessary for heat-induced apoptosis using genetically modified Jurkat T-lymphocytes. Cells stably overexpressing Bcl-2/Bcl-xL or stably depleted of Apaf-1 were completely resistant to heat-induced apoptosis, implicating the involvement of the mitochondria-mediated pathway. Pretreatment of wild-type cells with the cell-permeable biotinylated general caspase inhibitor b-VAD-fmk (biotin-Val-Ala-Asp(OMe)-CH2F) both inhibited heat-induced apoptosis and affinity-labeled activated initiator caspase-2, -8, and -9. Despite this finding, however, cells engineered to be deficient in caspase-8, caspase-2, or the caspase-2 adaptor protein RAIDD (receptor-interacting protein (RIP)-associated Ich-1/CED homologous protein with death domain) remained susceptible to heat-induced apoptosis. Additionally, b-VAD-fmk failed to label any activated initiator caspase in Apaf-1-deficient cells exposed to hyperthermia. Cells lacking Apaf-1 or the pro-apoptotic BH3-only protein Bid exhibited lower levels of heat-induced Bak activation, cytochrome c release, and loss of mitochondrial membrane potential, although cleavage of Bid to truncated Bid (tBid) occurred downstream of caspase-9 activation. Combined, the data suggest that caspase-9 is the critical initiator caspase activated during heat-induced apoptosis and that tBid may function to promote cytochrome c release during this process as part of a feed-forward amplification loop.	[Robertson, John D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Robertson, JD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jrobertson3@kumc.edu			National Institutes of Health [K22 ES011647, P20 RR016475, P20 RR016443]; IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR; National Center for Research Resources (NCRR);  [T32 ES007079]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES011647, T32ES007079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants K22 ES011647 (to J. D. R.), P20 RR016475 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the NCRR, and T32 ES007079.; We thank Dr. Joyce Slusser for invaluable assistance with flow cytometry, the late Dr. Stanley Korsmeyer for the pSFFV-neo, pSFFV-Bcl-2, and pSFFV-Bcl-xL mammalian expression vectors, and Drs. Shawn Bratton and Wen-Xing Ding for helpful discussion. The Flow Cytometry Core is supported in part by National Institutes of Health Grant P20 RR016443 from the National Center for Research Resources (NCRR).	Bao Q, 2007, CELL DEATH DIFFER, V14, P56, DOI 10.1038/sj.cdd.4402028; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2009, MOL CELL, V35, P830, DOI 10.1016/j.molcel.2009.07.023; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cippitelli M, 2005, J IMMUNOL, V174, P223, DOI 10.4049/jimmunol.174.1.223; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Franklin EE, 2007, BIOCHEM J, V405, P115, DOI 10.1042/BJ20061576; Ito A, 2006, CANCER IMMUNOL IMMUN, V55, P320, DOI 10.1007/s00262-005-0049-y; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Kouloulias V, 2005, AM J CLIN ONCOL-CANC, V28, P91, DOI 10.1097/01.coc.0000139939.60056.42; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Milleron RS, 2007, CELL MOL LIFE SCI, V64, P2329, DOI 10.1007/s00018-007-7135-6; Milleron RS, 2006, J BIOL CHEM, V281, P16991, DOI 10.1074/jbc.M512754200; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; PARSELL DA, 1993, PHILOS T R SOC B, V339, P279, DOI 10.1098/rstb.1993.0026; Pissuwan D, 2006, TRENDS BIOTECHNOL, V24, P62, DOI 10.1016/j.tibtech.2005.12.004; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Shawgo ME, 2009, J BIOL CHEM, V284, P33447, DOI 10.1074/jbc.M109.032359; Shawgo ME, 2008, J BIOL CHEM, V283, P35532, DOI 10.1074/jbc.M807656200; Shelton SN, 2009, J BIOL CHEM, V284, P11247, DOI 10.1074/jbc.M809392200; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	42	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40525	40533		10.1074/jbc.M110.167635	http://dx.doi.org/10.1074/jbc.M110.167635			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978129	hybrid, Green Published			2022-12-27	WOS:000285414400015
J	Furrer, M; Balbi, M; Albarca-Aguilera, M; Gallant, M; Herr, W; Gallant, P				Furrer, Michael; Balbi, Mirjam; Albarca-Aguilera, Monica; Gallant, Maria; Herr, Winship; Gallant, Peter			Drosophila Myc Interacts with Host Cell Factor (dHCF) to Activate Transcription and Control Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE COMPLEX; C-MYC; INDEPENDENT FUNCTIONS; PROTEIN; DMYC; MAX; METHYLTRANSFERASE; PROLIFERATION; ASSOCIATION; APOPTOSIS	The Myc proto-oncoproteins are transcription factors that recognize numerous target genes through hexameric DNA sequences called E-boxes. The mechanism by which they then activate the expression of these targets is still under debate. Here, we use an RNAi screen in Drosophila S2 cells to identify Drosophila host cell factor (dHCF) as a novel co-factor for Myc that is functionally required for the activation of a Myc-dependent reporter construct. dHCF is also essential for the full activation of endogenous Myc target genes in S2 cells, and for the ability of Myc to promote growth in vivo. Myc and dHCF physically interact, and they colocalize on common target genes. Furthermore, down-regulation of dHCF-associated histone acetyltransferase and histone methyltransferase complexes in vivo interferes with the Myc biological activities. We therefore propose that dHCF recruits such chromatin-modifying complexes and thereby contributes to the expression of Myc targets and hence to the execution of Myc biological activities.	[Furrer, Michael; Balbi, Mirjam; Gallant, Maria; Gallant, Peter] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; [Albarca-Aguilera, Monica; Herr, Winship] Univ Lausanne, CIG, CH-1015 Lausanne, Switzerland	University of Zurich; University of Lausanne	Gallant, P (corresponding author), Univ Wurzburg, Inst Physiol Chem 2, D-97074 Wurzburg, Germany.	peter.gallant@biozentrum.uni-wuerzburg.de	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	Swiss National Science Foundation; DFG; University of Lausanne	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DFG(German Research Foundation (DFG)); University of Lausanne	These studies were supported by grants from the Swiss National Science Foundation (to P. G. and W. H.), from the DFG (to P. G.), and by the University of Lausanne (W. H.).	Bellosta P, 2005, P NATL ACAD SCI USA, V102, P11799, DOI 10.1073/pnas.0408945102; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; Benassayag C, 2005, MOL CELL BIOL, V25, P9897, DOI 10.1128/MCB.25.22.9897-9909.2005; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Cowling VH, 2006, SEMIN CANCER BIOL, V16, P242, DOI 10.1016/j.semcancer.2006.08.001; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Gallant P, 1996, SCIENCE, V274, P1523, DOI 10.1126/science.274.5292.1523; Gallant P, 2009, ADV CANCER RES, V103, P111, DOI 10.1016/S0065-230X(09)03005-X; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Hulf T, 2005, MOL CELL BIOL, V25, P3401, DOI 10.1128/MCB.25.9.3401-3410.2005; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Maines JZ, 2004, DEVELOPMENT, V131, P775, DOI 10.1242/dev.00932; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Montero L, 2008, GENESIS, V46, P104, DOI 10.1002/dvg.20373; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Pierce SB, 2004, DEVELOPMENT, V131, P2317, DOI 10.1242/dev.01108; Pirity M, 2006, CURR TOP MICROBIOL, V302, P205; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Schwinkendorf D, 2009, GENE, V436, P90, DOI 10.1016/j.gene.2009.02.009; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Steiger D, 2008, NAT GENET, V40, P1084, DOI 10.1038/ng.178; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu M, 2005, ONCOGENE, V24, P1982, DOI 10.1038/sj.onc.1208410	45	11	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39623	39636		10.1074/jbc.M110.140467	http://dx.doi.org/10.1074/jbc.M110.140467			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937797	Green Published, hybrid			2022-12-27	WOS:000285185500006
J	Muiznieks, LD; Keeley, FW				Muiznieks, Lisa D.; Keeley, Fred W.			Proline Periodicity Modulates the Self-assembly Properties of Elastin-like Polypeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPROLINE-II STRUCTURE; HUMAN TROPOELASTIN; HYDROPHOBIC DOMAINS; IN-VITRO; PROTEIN; AGGREGATION; SEQUENCE; C-13; MOBILITY; DETERMINANTS	Elastin is a self-assembling protein of the extracellular matrix that provides tissues with elastic extensibility and recoil. The monomeric precursor, tropoelastin, is highly hydrophobic yet remains substantially disordered and flexible in solution, due in large part to a high combined threshold of proline and glycine residues within hydrophobic sequences. In fact, proline-poor elastin-like sequences are known to form amyloid-like fibrils, rich in beta-structure, from solution. On this basis, it is clear that hydrophobic elastin sequences are in general optimized to avoid an amyloid fate. However, a small number of hydrophobic domains near the C terminus of tropoelastin are substantially depleted of proline residues. Here we investigated the specific contribution of proline number and spacing to the structure and self-assembly propensities of elastin-like polypeptides. Increasing the spacing between proline residues significantly decreased the ability of polypeptides to reversibly self-associate. Real-time imaging of the assembly process revealed the presence of smaller colloidal droplets that displayed enhanced propensity to cluster into dense networks. Structural characterization showed that these aggregates were enriched in beta-structure but unable to bind thioflavin-T. These data strongly support a model where proline-poor regions of the elastin monomer provide a unique contribution to assembly and suggest a role for localized beta-sheet in mediating self-assembly interactions.	[Muiznieks, Lisa D.; Keeley, Fred W.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Keeley, Fred W.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Keeley, FW (corresponding author), 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fwk@sickkids.ca			Heart and Stroke Foundation of Ontario [T6725]; Canadian Institutes of Health Research [MOP84496]; Heart and Stroke/Richard Lewar Centre	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke/Richard Lewar Centre	This project was supported by grants from the Heart and Stroke Foundation of Ontario (Operating Grant T6725) and the Canadian Institutes of Health Research (Operating Grant MOP84496) (to F. W. K.). and a Heart and Stroke/Richard Lewar Centre of Excellence Fellowship (to L. D. M.).	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; Bochicchio B, 2004, BIOPOLYMERS, V73, P484, DOI 10.1002/bip.10552; Bochicchio B, 2007, BIOMACROMOLECULES, V8, P3478, DOI 10.1021/bm700636a; Cheung MS, 2002, P NATL ACAD SCI USA, V99, P685, DOI 10.1073/pnas.022387699; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Cirulis JT, 2010, BIOCHEMISTRY-US, V49, P5726, DOI 10.1021/bi100468v; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d; DEBELLE L, 1995, J MOL STRUCT, V348, P321, DOI 10.1016/0022-2860(95)08653-D; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Hall D, 2005, J MOL BIOL, V351, P195, DOI 10.1016/j.jmb.2005.05.013; INDIK Z, 1987, P NATL ACAD SCI USA, V84, P5680, DOI 10.1073/pnas.84.16.5680; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200; Kozel BA, 2004, MATRIX BIOL, V23, P23, DOI 10.1016/j.matbio.2004.02.004; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Kumashiro KK, 2001, BIOPOLYMERS, V59, P266, DOI 10.1002/1097-0282(20011005)59:4<266::AID-BIP1023>3.0.CO;2-2; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; LYERLA JR, 1975, BIOCHEMISTRY-US, V14, P5175, DOI 10.1021/bi00694a024; Martino M, 2000, J MOL STRUCT, V519, P173, DOI 10.1016/S0022-2860(99)00299-9; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018; Monsellier E, 2007, BIOPHYS J, V93, P4382, DOI 10.1529/biophysj.107.111336; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k; Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/O09-161, 10.1139/o09-161]; Nikolic A, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.22854; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; Pedersen JS, 2004, J MOL BIOL, V341, P575, DOI 10.1016/j.jmb.2004.06.020; Pepe A, 2007, NANOMEDICINE-UK, V2, P203, DOI 10.2217/17435889.2.2.203; Perry A, 2002, J AM CHEM SOC, V124, P6832, DOI 10.1021/ja017711x; Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4; Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Renault A, 2009, LANGMUIR, V25, P8170, DOI 10.1021/la900475q; Reumers J, 2009, HUM MUTAT, V30, P431, DOI 10.1002/humu.20905; ROBSON P, 1993, J BIOL CHEM, V268, P1440; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200; TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Toonkool P, 2001, J BIOL CHEM, V276, P28042, DOI 10.1074/jbc.M103391200; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; Torchia D A, 1977, Adv Exp Med Biol, V79, P655; TORCHIA DA, 1973, J MOL BIOL, V76, P419, DOI 10.1016/0022-2836(73)90514-7; Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003; URRY D W, 1976, Critical Reviews in Biochemistry, V4, P1, DOI 10.3109/10409237609102557; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	61	58	60	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39779	39789		10.1074/jbc.M110.164467	http://dx.doi.org/10.1074/jbc.M110.164467			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947499	hybrid, Green Published			2022-12-27	WOS:000285185500022
J	Radnai, L; Rapali, P; Hodi, Z; Suveges, D; Molnar, T; Kiss, B; Becsi, B; Erdodi, F; Buday, L; Kardos, J; Kovacs, M; Nyitray, L				Radnai, Laszlo; Rapali, Peter; Hodi, Zsuzsa; Sueveges, Daniel; Molnar, Tamas; Kiss, Bence; Becsi, Balint; Erdoedi, Ferenc; Buday, Laszlo; Kardos, Jozsef; Kovacs, Mihaly; Nyitray, Laszlo			Affinity, Avidity, and Kinetics of Target Sequence Binding to LC8 Dynein Light Chain Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; COILED-COIL DOMAIN; SPLICED EXON-B; CYTOPLASMIC DYNEIN; INTERMEDIATE CHAIN; MOTOR COMPLEX; MYOSIN-VA; PROTEIN INHIBITOR; BCL-2 FAMILY; PHOSPHORYLATION	LC8 dynein light chain (DYNLL) is a highly conserved eukaryotic hub protein with dozens of binding partners and various functions beyond being a subunit of dynein and myosin Va motor proteins. Here, we compared the kinetic and thermodynamic parameters of binding of both mammalian isoforms, DYNLL1 and DYNLL2, to two putative consensus binding motifs (KXTQTX and XG(I/V)QVD) and report only subtle differences. Peptides containing either of the above motifs bind to DYNLL2 with micromolar affinity, whereas a myosin Va peptide (lacking the conserved Gln) and the noncanonical Pak1 peptide bind with K-d values of 9 and 40 mu M, respectively. Binding of the KXTQTX motif is enthalpy-driven, although that of all other peptides is both enthalpy- and entropy-driven. Moreover, the KXTQTX motif shows strikingly slower off-rate constant than the other motifs. As most DYNLL partners are homodimeric, we also assessed the binding of bivalent ligands to DYNLL2. Compared with monovalent ligands, a significant avidity effect was found as follows: K-d values of 37 and 3.5 nM for a dimeric myosin Va fragment and a Leu zipper dimerized KXTQTX motif, respectively. Ligand binding kinetics of DYNLL can best be described by a conformational selection model consisting of a slow isomerization and a rapid binding step. We also studied the binding of the phosphomimetic S88E mutant of DYNLL2 to the dimeric myosin Va fragment, and we found a significantly lower apparent K-d value (3 mu M). We conclude that the thermodynamic and kinetic fine-tuning of binding of various ligands to DYNLL could have physiological relevance in its interaction network.	[Kardos, Jozsef; Kovacs, Mihaly; Nyitray, Laszlo] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Becsi, Balint; Erdoedi, Ferenc] Univ Debrecen, Dept Med Chem, Med & Hlth Sci Ctr, H-4032 Debrecen, Hungary; [Buday, Laszlo] Hungarian Acad Sci, Inst Enzymol, Biol Res Ctr, H-1113 Budapest, Hungary; [Buday, Laszlo] Semmelweis Univ Med Sch, Dept Med Chem, H-1094 Budapest, Hungary	Eotvos Lorand University; University of Debrecen; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Semmelweis University	Nyitray, L (corresponding author), Pazmany Peter Setany 1-C, H-1117 Budapest, Hungary.	nyitray@elte.hu	Kardos, József/J-1035-2017; Kiss, Bence/AAF-1808-2020; Kovacs, Mihaly/A-6841-2011; Nyitray, László/AAE-5910-2020; Erdődi, Ferenc/B-3383-2011	Kardos, József/0000-0002-2135-2932; Nyitray, László/0000-0003-4717-5994; Kiss, Bence/0000-0001-5810-5858; Radnai, Laszlo/0000-0001-6843-3740; Rapali, Peter/0000-0003-1422-6660; Kovacs, Mihaly/0000-0002-1200-4741; Suveges, Daniel/0000-0003-4133-0447	Hungarian Scientific Research Fund OTKA [K61784, NI68466, NK81950, K71915, NNF78783]; National Development Agency [TAMOP-4.2.1.B-09/1/KMR]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency	This work was supported by Hungarian Scientific Research Fund OTKA K61784, NI68466, and NK81950 (L. N.), K71915, NNF78783 (M. K.), and National Development Agency Grant TAMOP-4.2.1.B-09/1/KMR. M. K. is a Bolyai Fellow of the Hungarian Academy of Sciences.	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2009, BIOCHEMISTRY-US, V48, P11381, DOI 10.1021/bi901589w; Benison G, 2008, J MOL BIOL, V384, P954, DOI 10.1016/j.jmb.2008.09.083; Benison G, 2009, METHOD ENZYMOL, V455, P237, DOI 10.1016/S0076-6879(08)04209-2; Day CL, 2004, BIOCHEM J, V377, P597, DOI 10.1042/BJ20031251; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fan JS, 2002, J BIOMOL NMR, V23, P103, DOI 10.1023/A:1016332918178; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; HODI Z, 2007, FEBS J S1, V274, P106; Hodi Z, 2006, BIOCHEMISTRY-US, V45, P12582, DOI 10.1021/bi060991e; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lajoix AD, 2004, MOL DIVERS, V8, P281, DOI 10.1023/B:MODI.0000036242.01129.27; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lightcap CM, 2008, J BIOL CHEM, V283, P27314, DOI 10.1074/jbc.M800758200; Lightcap CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006025; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Lu JQ, 2005, BIOCHEM BIOPH RES CO, V331, P153, DOI 10.1016/j.bbrc.2005.03.128; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pabbisetty KB, 2007, PROTEIN SCI, V16, P355, DOI 10.1110/ps.062608807; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Rodriguez-Crespo I, 1998, ARCH BIOCHEM BIOPHYS, V359, P297, DOI 10.1006/abbi.1998.0928; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Song CY, 2008, J BIOL CHEM, V283, P4004, DOI 10.1074/jbc.M704512200; Song YJ, 2007, J BIOL CHEM, V282, P17272, DOI 10.1074/jbc.M610445200; Su Y, 2010, CELL MICROBIOL, V12, P1098, DOI 10.1111/j.1462-5822.2010.01453.x; Tochio H, 1998, NAT STRUCT BIOL, V5, P965, DOI 10.1038/2940; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Yang PF, 2009, J BIOL CHEM, V284, P31412, DOI 10.1074/jbc.M109.050666; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200; Zhou HX, 2006, BIOPHYS J, V91, P3170, DOI 10.1529/biophysj.106.090258; Zhou HX, 2003, J MOL BIOL, V329, P1, DOI 10.1016/S0022-2836(03)00372-3	59	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38649	38657		10.1074/jbc.M110.165894	http://dx.doi.org/10.1074/jbc.M110.165894			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889982	hybrid, Green Published			2022-12-27	WOS:000284625600069
J	Chen, YH; Wendt-Pienkowski, E; Ju, JH; Lin, SJ; Rajski, SR; Shen, B				Chen, Yihua; Wendt-Pienkowski, Evelyn; Ju, Jianhua; Lin, Shuangjun; Rajski, Scott R.; Shen, Ben			Characterization of FdmV as an Amide Synthetase for Fredericamycin A Biosynthesis in Streptomyces griseus ATCC 43944	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYTETRACYCLINE POLYKETIDE SYNTHASE; GENE-CLUSTER; PHYSICOCHEMICAL PROPERTIES; FUNCTIONAL-ANALYSIS; SKELETAL TYPE; CLONING; IDENTIFICATION; ASPARAGINE; ANTIBIOTICS; PURIFICATION	Fredericamycin (FDM) A is a pentadecaketide natural product that features an amide linkage. Analysis of the fdm cluster from Streptomyces griseus ATCC 43944, however, failed to reveal genes encoding the types of amide synthetases commonly seen in natural product biosynthesis. Here, we report in vivo and in vitro characterizations of FdmV, an asparagine synthetase (AS) B-like protein, as an amide synthetase that catalyzes the amide bond formation in FDM A biosynthesis. This is supported by the findings that (i) inactivation of fdmV in vivo afforded the Delta fdmV mutant strain SB4027 that abolished FDM A and FDM E production but accumulated FDM C, a biosynthetic intermediate devoid of the characteristic amide linkage; (ii) FdmV in vitro catalyzes conversion of FDM C to FDM B, a known intermediate for FDM A biosynthesis (apparent K-m = 162 +/- 67 mu M and k(cat) = 0.11 +/- 0.02 min(-1)); and (iii) FdmV also catalyzes the amidation of FDM M-3, a structural analog of FDM C, to afford amide FDM M-6 in vitro, albeit at significantly reduced efficiency. Preliminary enzymatic studies revealed that, in addition to the common nitrogen sources (L-Gln and free amine) of class II glutamine amidotransferases (to which AS B belongs), FdmV can also utilize L-Asn as a nitrogen donor. The amide bond formation in FDM A biosynthesis is proposed to occur after C-8 hydroxylation but before the carbaspirocycle formation.	[Shen, Ben] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Natl Cooperat Drug Discovery Grp, Madison, WI 53705 USA; [Shen, Ben] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shen, B (corresponding author), Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.	bshen@pharmacy.wisc.edu	Chen, Yihua/B-3550-2012		National Institutes of Health [CA113297]; NATIONAL CANCER INSTITUTE [U19CA113297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113297.	Anderle C, 2007, CHEM BIOL, V14, P955, DOI 10.1016/j.chembiol.2007.07.014; BYRNE KM, 1985, BIOCHEMISTRY-US, V24, P478, DOI 10.1021/bi00323a035; Chen Y, 2008, J BACTERIOL, V190, P5587, DOI 10.1128/JB.00592-08; Chen YH, 2008, J NAT PROD, V71, P431, DOI 10.1021/np070664n; Chen YH, 2009, J BIOL CHEM, V284, P24735, DOI 10.1074/jbc.M109.014191; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Fortin PD, 2007, NATURE, V448, P824, DOI 10.1038/nature06068; Hornung A, 2007, CHEMBIOCHEM, V8, P757, DOI 10.1002/cbic.200600375; Hu Y, 2007, CHEM BIOL, V14, P691, DOI 10.1016/j.chembiol.2007.05.009; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Madduri K, 1998, NAT BIOTECHNOL, V16, P69, DOI 10.1038/nbt0198-69; Magarvey NA, 2008, ACS CHEM BIOL, V3, P542, DOI 10.1021/cb800085g; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Miller MT, 2003, J BIOL CHEM, V278, P40996, DOI 10.1074/jbc.M307901200; Miller MT, 2001, NAT STRUCT BIOL, V8, P684, DOI 10.1038/90394; MISRA R, 1982, J AM CHEM SOC, V104, P4478, DOI 10.1021/ja00380a025; MISRA R, 1987, J ANTIBIOT, V40, P786; Nakano T, 2004, BIOSCI BIOTECH BIOCH, V68, P1345, DOI 10.1271/bbb.68.1345; Ogasawara Y, 2004, CHEM BIOL, V11, P79, DOI 10.1016/j.chembiol.2003.12.010; PANDEY RC, 1981, J ANTIBIOT, V34, P1389, DOI 10.7164/antibiotics.34.1389; Pompeo F, 2002, PROTEIN EXPRES PURIF, V24, P138, DOI 10.1006/prep.2001.1550; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; SAMBROOK J, 2000, MOL CLONING LAB MANU; Sontag B, 2004, J ANTIBIOT, V57, P823, DOI 10.7164/antibiotics.57.823; TOMITA K, 1990, J ANTIBIOT, V43, P755, DOI 10.7164/antibiotics.43.755; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Yunt Z, 2009, J AM CHEM SOC, V131, P2297, DOI 10.1021/ja807827k; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; Zhang WJ, 2006, J NAT PROD, V69, P1633, DOI 10.1021/np060290i; Zhang WJ, 2006, APPL ENVIRON MICROB, V72, P2573, DOI 10.1128/AEM.72.4.2573-2580.2006; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Ziermann R, 1999, BIOTECHNIQUES, V26, P106, DOI 10.2144/99261st05	40	16	17	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38853	38860		10.1074/jbc.M110.147744	http://dx.doi.org/10.1074/jbc.M110.147744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926388	hybrid, Green Published			2022-12-27	WOS:000284941300014
J	Luanpitpong, S; Talbott, SJ; Rojanasakul, Y; Nimmannit, U; Pongrakhananon, V; Wang, LY; Chanvorachote, P				Luanpitpong, Sudjit; Talbott, Siera Jo; Rojanasakul, Yon; Nimmannit, Ubonthip; Pongrakhananon, Varisa; Wang, Liying; Chanvorachote, Pithi			Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED P53 ACTIVATION; OXIDATIVE STRESS; PROSTATE-CANCER; HYDROGEN-PEROXIDE; BREAST-CANCER; TUMOR PROGRESSION; POOR-PROGNOSIS; EXPRESSION; GROWTH; METASTASIS	The acquired capability of tumor cells to migrate and invade neighboring tissues is associated with high metastatic potential and advanced stage of cancers. Recently, signaling molecules such as reactive oxygen species (ROS) and caveolin-1 (Cav-1) have been implicated in the aggressive behavior of cancer cells. However, the roles of specific ROS in cancer cell migration and Cav-1 regulation are unclear. We demonstrate here that Cav-1 plays an important role in the migration and invasion of human lung carcinoma H460 cells and that these effects are differentially regulated by cellular ROS. Using various known inhibitors and donors of ROS, we found that different ROS have different effects on Cav-1 expression and cell migration and invasion. Superoxide anion and hydrogen peroxide down-regulated Cav-1 expression and inhibited cell migration and invasion, whereas hydroxyl radical up-regulated the Cav-1 expression and promoted cell migration and invasion. The down-regulating effect of superoxide anion and hydrogen peroxide on Cav-1 is mediated through a transcription-independent mechanism that involves protein degradation via the ubiquitin-proteasome pathway. These results indicate the essential role of different ROS in cancer cell motility and through Cav-1 expression, which may provide a key mechanism controlling tumor progression and metastasis. The upregulation of Cav-1 and cell motility by hydroxyl free radical suggests an important role of this ROS as a positive regulator of tumor progression.	[Rojanasakul, Yon] W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; Chulalongkorn Univ, Pharmaceut Technol Int Program, Bangkok 10330, Thailand; [Chanvorachote, Pithi] Chulalongkorn Univ, Dept Physiol & Pharmacol, Bangkok 10330, Thailand; [Talbott, Siera Jo] W Virginia Univ, Canc Cell Biol Program, Morgantown, WV 26506 USA; [Nimmannit, Ubonthip] Natl Nanotechnol Ctr, Pathum Thani 12120, Thailand; [Wang, Liying] NIOSH, Morgantown, WV 26505 USA	West Virginia University; Chulalongkorn University; Chulalongkorn University; West Virginia University; National Science & Technology Development Agency - Thailand; National Nanotechnology Center (NANOTEC); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Rojanasakul, Y (corresponding author), W Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA.	yrojan@hsc.wvu.edu; pithi_chan@yahoo.com	Luanpitpong, Sudjit/ABF-1962-2021	chanvorachote, pithi/0000-0002-3103-3249; Rojanasakul, Yon/0000-0002-8839-6462; Luanpitpong, Sudjit/0000-0002-1639-4935	National Institutes of Health [R01-HL076340]; Thailand Research Fund [5.Q.CU/49/A.1]; Ratchadaphiseksomphot Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Ratchadaphiseksomphot Endowment Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL076340. This work was also supported by Thailand Research Fund Grant 5.Q.CU/49/A.1 and Ratchadaphiseksomphot Endowment Fund.	Alexandrova AY, 2006, EXP CELL RES, V312, P2066, DOI 10.1016/j.yexcr.2006.03.004; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Ben Mahdi MH, 2000, IUBMB LIFE, V50, P291, DOI 10.1080/15216540051081038; Brenneisen P, 1998, J BIOL CHEM, V273, P5279, DOI 10.1074/jbc.273.9.5279; Brown NS, 2001, BREAST CANCER RES, V3, P323, DOI 10.1186/bcr315; Cassoni P, 2009, HISTOPATHOLOGY, V55, P20, DOI 10.1111/j.1365-2559.2009.03326.x; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen DB, 2005, BIOL REPROD, V73, P761, DOI 10.1095/biolreprod.105.040881; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; CHUNGMAN HJ, 2001, CANCER RES, V61, P8578; Dokka S, 2001, AM J PHYSIOL-LUNG C, V280, pL1196, DOI 10.1152/ajplung.2001.280.6.L1196; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Esme H, 2008, RESPIROLOGY, V13, P112, DOI 10.1111/j.1440-1843.2007.01212.x; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han F, 2010, J SURG RES, V159, P443, DOI 10.1016/j.jss.2009.03.079; Herr B, 2007, CELL MOL LIFE SCI, V64, P3295, DOI 10.1007/s00018-007-7371-9; Hileman EO, 2004, CANCER CHEMOTH PHARM, V53, P209, DOI 10.1007/s00280-003-0726-5; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Ishihara Y, 2006, TOXICOL APPL PHARM, V214, P109, DOI 10.1016/j.taap.2005.12.003; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Laurent A, 2005, CANCER RES, V65, P948; Lee KJ, 2008, CANCER LETT, V268, P233, DOI 10.1016/j.canlet.2008.03.058; Li LK, 2009, MOL CANCER RES, V7, P1781, DOI 10.1158/1541-7786.MCR-09-0255; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Misthos P, 2005, EUR J CARDIO-THORAC, V27, P379, DOI 10.1016/j.ejcts.2004.12.023; Moon KC, 2005, ANTICANCER RES, V25, P4631; Nelson KK, 2004, FREE RADICAL BIO MED, V37, P768, DOI 10.1016/j.freeradbiomed.2004.06.008; Novo E, 2006, GUT, V55, P90, DOI 10.1136/gut.2005.069633; Oka N, 1997, J BIOL CHEM, V272, P33416, DOI 10.1074/jbc.272.52.33416; OToole EA, 1996, DERMATOL SURG, V22, P525, DOI 10.1111/j.1524-4725.1996.tb00368.x; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Shatz M, 2008, INT J RADIAT BIOL, V84, P177, DOI 10.1080/09553000701745293; Shim E, 2007, BIOTECHNOL LETT, V29, P141, DOI 10.1007/s10529-006-9213-5; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Steiling H, 1999, EXP CELL RES, V247, P484, DOI 10.1006/excr.1998.4366; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Svensk AM, 2004, AM J CLIN PATHOL, V122, P395, DOI 10.1309/A45QHB0QRRX6CT9A; Svineng G, 2008, CONNECT TISSUE RES, V49, P197, DOI 10.1080/03008200802143166; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Urbich C, 2002, CIRCULATION, V106, P981, DOI 10.1161/01.CIR.0000027107.54614.1A; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Volonte D, 2002, MOL BIOL CELL, V13, P2502, DOI 10.1091/mbc.01-11-0529; Wang SW, 2004, MOL CELL BIOCHEM, V255, P119, DOI 10.1023/B:MCBI.0000007268.42733.53; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Yoo SH, 2003, LUNG CANCER, V42, P195, DOI 10.1016/S0169-5002(03)00287-3; Zhang W, 2000, J BIOL CHEM, V275, P20717, DOI 10.1074/jbc.M909895199	59	143	145	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38832	38840		10.1074/jbc.M110.124958	http://dx.doi.org/10.1074/jbc.M110.124958			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923773	Green Published, hybrid			2022-12-27	WOS:000284941300012
J	Shannon, LA; Calloway, PA; Welch, TP; Vines, CM				Shannon, Laura A.; Calloway, Psachal A.; Welch, T. Paul; Vines, Charlotte M.			CCR7/CCL21 Migration on Fibronectin Is Mediated by Phospholipase C gamma 1 and ERK1/2 in Primary T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; LYMPH-NODE; INTEGRIN; CHEMOTAXIS; ADHESION; ACTIVATION; RECEPTORS; PLC-GAMMA-1; PATHWAYS; PROMOTES	CCR7 binds to its cognate ligand, CCL21, to mediate the migration of circulating naive T lymphocytes to the lymph nodes. T lymphocytes can bind to fibronectin, a constituent of lymph nodes, via their beta 1 integrins, which is a primary mechanism of T lymphocyte migration; however, the signaling pathways involved are unclear. We report that rapid (within 2 min) and transient phosphorylation of ERK1/2 is required for T cell migration on fibronectin in response to CCL21. Conversely, prevention of ERK1/2 phosphorylation by inhibition of its kinase, MAPK/MEK, prevented T lymphocyte migration. Previous studies have suggested that phospholipase C gamma 1 (PLC gamma 1) can mediate phosphorylation of ERK1/2, which is required for beta 1 integrin activation. Paradoxically, we found that inhibition of PLC gamma 1 phosphorylation by the general PLC inhibitor U73122 was associated with a delayed and reduced phosphorylation of ERK1/2 and reduced migration of T lymphocytes on fibronectin. To further characterize the relationship between ERK1/2 and PLC gamma 1, we reduced PLC gamma 1 levels by 85% using shRNA and observed a reduced phosphorylation of ERK1/2 and a significant loss of CCR7-mediated migration of T lymphocytes on fibronectin. In addition, we found that inhibition of ERK1/2 phosphorylation by U0126 resulted in a decreased phosphorylation of PLC gamma 1, suggesting a feedback loop between ERK1/2 and PLC gamma 1. Overall, these results suggest that the CCR7 signaling pathway leading to T lymphocyte migration on fibronectin is a beta 1 integrin-dependent pathway involving transient ERK1/2 phosphorylation, which is modulated by PLC gamma 1.	[Shannon, Laura A.; Calloway, Psachal A.; Welch, T. Paul; Vines, Charlotte M.] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Vines, CM (corresponding author), 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	cvines@kumc.edu			National Institutes of Health, National Center for Research Resources [P20 RO16443]; National Institutes of Health, NIAID [K22AIP60815]; University of Kansas Medical Center Research Institute; Hall Foundation; National Institutes of Health [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI060815] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Kansas Medical Center Research Institute; Hall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported, in whole or in part, by National Institutes of Health Grant P20 RO16443 from the National Center for Research Resources and National Institutes of Health Grant K22AIP60815 from NIAID (to C. M. V.). This work was also supported by a University of Kansas Medical Center Research Institute bridging award and biomedical research training award (to L. A. S.). Flow cytometry was carried out at the University of Kansas Medical Center flow cytometry core laboratory, which is supported by a generous endowment from the Hall Foundation and by National Institutes of Health Grant P20 RR016443.	Bach TL, 2007, J IMMUNOL, V179, P2223, DOI 10.4049/jimmunol.179.4.2223; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Cheung R, 2009, J LEUKOCYTE BIOL, V86, P833, DOI 10.1189/jlb.0908551; Faull RJ, 1996, J AM SOC NEPHROL, V7, P1091; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; GUTKIND JS, 2000, SCI STKE, V40, pRE1; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Jones NP, 2005, J CELL SCI, V118, P2695, DOI 10.1242/jcs.02374; Kaiser A, 2005, J IMMUNOL, V175, P2349, DOI 10.4049/jimmunol.175.4.2349; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Kranenburg O, 2001, ONCOGENE, V20, P1540, DOI 10.1038/sj.onc.1204187; Liu E, 2005, MOL CELL BIOL, V25, P11145, DOI 10.1128/MCB.25.24.11145-11155.2005; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Mu H, 2009, AM J PHYSIOL-HEART C, V297, pH400, DOI 10.1152/ajpheart.01254.2008; Otero C, 2008, J CELL SCI, V121, P2759, DOI 10.1242/jcs.029074; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rong R, 2003, J BIOL CHEM, V278, P52497, DOI 10.1074/jbc.M306744200; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; SZEKANECZ Z, 1992, J CELL SCI, V101, P885; Szekeres CK, 2000, J BIOL CHEM, V275, P38831, DOI 10.1074/jbc.M002673200; Tvorogov D, 2005, J CELL SCI, V118, P601, DOI 10.1242/jcs.01643; Vossmeyer D, 2002, J BIOL CHEM, V277, P4636, DOI 10.1074/jbc.M105415200; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Yang JM, 2001, MOL PHARMACOL, V60, P674; Yopp AC, 2005, J IMMUNOL, V175, P2913, DOI 10.4049/jimmunol.175.5.2913	31	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38781	38787		10.1074/jbc.M110.152173	http://dx.doi.org/10.1074/jbc.M110.152173			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889506	Green Published, hybrid			2022-12-27	WOS:000284941300007
J	Shimura, K; Nameki, D; Kajiwara, K; Watanabe, K; Sakagami, Y; Oishi, S; Fujii, N; Matsuoka, M; Sarafianos, SG; Kodama, EN				Shimura, Kazuya; Nameki, Daisuke; Kajiwara, Keiko; Watanabe, Kentaro; Sakagami, Yasuko; Oishi, Shinya; Fujii, Nobutaka; Matsuoka, Masao; Sarafianos, Stefan G.; Kodama, Eiichi N.			Resistance Profiles of Novel Electrostatically Constrained HIV-1 Fusion Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENV-MEDIATED FUSION; ANTIRETROVIRAL ACTIVITY; ENFUVIRTIDE RESISTANCE; BASE-LINE; HIV-1-INFECTED PATIENTS; PHENOTYPIC RESISTANCE; ENVELOPE GLYCOPROTEIN; HEPTAD REPEAT; GP41 GENOTYPE	Human immunodeficiency virus (HIV) gp41 plays a key role in viral fusion; the N- and C-terminal heptad repeats (N-HR and C-HR) of gp41 form a stable 6-helical conformation for fusion. Therefore, HR-derived peptides, such as enfuvirtide (T-20), inhibit HIV-1 fusion by acting as decoys, and have been used for the treatment of HIV-1 infection. However, the efficacy of T-20 is attenuated by resistance mutations in gp41, including V38A and N43D. To suppress the resistant variants, we previously developed electrostatically constrained peptides, SC34 and SC34EK, and showed that both exhibited potent anti-HIV-1 activity against wild-type and T-20-resistant variants. In this study, to clarify the resistance mechanism to this next generation of fusion inhibitors, we selected variants with resistance to SC34 and SC34EK in vitro. The resistant variants had multiple mutations in gp41. All of these mutations individually caused less than 6-fold resistance to SC34 and SC34EK, indicating that there is a significant genetic barrier for high-level resistance. Cross-resistance to SC34 and SC34EK was reduced by a simple difference in the polarity of two intramolecular electrostatic pairs. Furthermore, the selected mutations enhanced the physicochemical interactions with N-HR variants and restored activities of the parental peptide, C34, even to resistant variants. These results demonstrate that our approach of designing gp41-binding inhibitors using electrostatic constraints and information derived from resistance studies produces inhibitors with enhanced activity, high genetic barrier, and distinct resistance profile from T-20 and other inhibitors. Hence, this is a promising approach for the design of future generation peptide fusion inhibitors.	[Matsuoka, Masao; Kodama, Eiichi N.] Kyoto Univ, Inst Virus Res, Lab Virus Control, Kyoto 6068507, Japan; [Watanabe, Kentaro; Oishi, Shinya; Fujii, Nobutaka] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto 6068507, Japan; [Kodama, Eiichi N.] Tohoku Univ, Sch Med, Div Emerging Infect Dis, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Sarafianos, Stefan G.] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	Kyoto University; Kyoto University; Tohoku University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Shimura, K (corresponding author), 53 Shogoin Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	kshimura@virus.kyoto-u.ac.jp; kodama515@med.tohoku.ac.jp	Kodama, Eiichi N/C-4032-2009; Oishi, Shinya/C-1350-2011	Kodama, Eiichi N/0000-0002-6622-2752; Oishi, Shinya/0000-0002-2833-2539; Matsuoka, Masao/0000-0002-0473-754X; Sarafianos, Stefan G/0000-0002-5840-154X; SHIMURA, Kazuya/0000-0001-7819-5184	National Institutes of Health [AI076119, AI074389, AI079801]; Ministry of Health and Welfare of Japan; Japan Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076119, R33AI079801, R01AI074389, R21AI079801] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, and AI079801 (to S. G. S.), in part by a grant for Promotion of AIDS Research from the Ministry of Health and Welfare of Japan (to E. N. K. and M. M.), a grant for Research on Health Science Focusing on Drug Innovation from the Japan Health Science Foundation (to E. N. K. and M. M.), and a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. N. K.).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aquaro S, 2006, J ANTIMICROB CHEMOTH, V58, P714, DOI 10.1093/jac/dkl306; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Cabrera C, 2006, AIDS, V20, P2075, DOI 10.1097/QAD.0b013e3280102377; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chibo D, 2007, AIDS, V21, P1974, DOI 10.1097/QAD.0b013e3282ef1bc8; Derdeyn CA, 2001, J VIROL, V75, P8605, DOI 10.1128/JVI.75.18.8605-8614.2001; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104; Eggink D, 2008, J VIROL, V82, P6678, DOI 10.1128/JVI.00352-08; Eggink D, 2009, J BIOL CHEM, V284, P26941, DOI 10.1074/jbc.M109.004416; Epand RM, 2003, BBA-BIOMEMBRANES, V1614, P116, DOI 10.1016/S0005-2736(03)00169-X; Eron JJ, 2004, J INFECT DIS, V189, P1075, DOI 10.1086/381707; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; Izumi K, 2009, J BIOL CHEM, V284, P4914, DOI 10.1074/jbc.M807169200; Kuiken C, 2008, HIV SEQUENCE COMPEND; Lalezari JP, 2005, J INFECT DIS, V191, P1155, DOI 10.1086/427993; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lu J, 2006, JAIDS-J ACQ IMM DEF, V43, P60, DOI 10.1097/01.qai.0000234083.34161.55; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Naito T, 2009, ANTIMICROB AGENTS CH, V53, P1013, DOI 10.1128/AAC.01211-08; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Nishikawa H, 2009, INT J BIOCHEM CELL B, V41, P891, DOI 10.1016/j.biocel.2008.08.039; Oishi S, 2008, J MED CHEM, V51, P388, DOI 10.1021/jm701109d; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Pan C, 2009, AIDS, V23, P639, DOI 10.1097/QAD.0b013e328325a4cd; Qi Z, 2008, J BIOL CHEM, V283, P30376, DOI 10.1074/jbc.M804672200; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; Ryser HJP, 2005, DRUG DISCOV TODAY, V10, P1085, DOI 10.1016/S1359-6446(05)03550-6; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Sista PR, 2004, AIDS, V18, P1787, DOI 10.1097/00002030-200409030-00007; Tolstrup M, 2007, AIDS, V21, P519, DOI 10.1097/QAD.0b013e3280187558; Watabe T, 2009, J MOL BIOL, V392, P657, DOI 10.1016/j.jmb.2009.07.027; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	49	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39471	39480		10.1074/jbc.M110.145789	http://dx.doi.org/10.1074/jbc.M110.145789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937812	Green Published, hybrid			2022-12-27	WOS:000284941300073
J	Guo, HT; Mi, ZY; Bowles, DE; Bhattacharya, SD; Kuo, PC				Guo, Hongtao; Mi, Zhiyong; Bowles, Dawn E.; Bhattacharya, Syamal D.; Kuo, Paul C.			Osteopontin and Protein Kinase C Regulate PDLIM2 Activation and STAT1 Ubiquitination in LPS-treated Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; TUMOR-CELLS; TRANSCRIPTION; PATHWAY; MIGRATION; DOMAIN; SHP-1; GENE	The molecular pathways regulating signal transducer and activator of transcription 1 (STAT1) levels in states of inflammation are incompletely understood. The suppressor of cytokine signaling, protein inhibitor of STAT, and SHP-1/2 tyrosine phosphatases ultimately regulate activity of STAT molecules. However, these mechanisms do not degrade STAT proteins. In this regard, using a murine macrophage model of LPS stimulation, we previously demonstrated that osteopontin (OPN) increased STAT1 ubiquitination and 26 S proteasome degradation via the ubiquitin E3 ligase, PDLIM2. In this study, we further characterize OPN-dependent activation of PDLIM2 in a model of LPS-stimulated RAW264.7 murine macrophages. We identify serine 137 as a protein kinase C-phosphorylation site in PDLIM2 that is required for ubiquitination of STAT1. PDLIM2 phosphorylation requires OPN expression. Using phospho-mutants and phospho-mimetic constructs of PDLIM2, our in vivo and in vitro ubiquitination studies confirm the role of PDLIM2 in formation and degradation of Ub-STAT1. The functional consequences of PDLIM2-mediated STAT1 degradation were confirmed using an IFN-gamma-regulated transcription factor STAT1 alpha reporter construct and chromatin immunoprecipitation assay for the inducible nitric-oxide synthase promoter. In a murine cecal ligation and puncture model of sepsis in wild-type and OPN (-/-) animals, OPN was necessary for PDLIM2 serine phosphorylation and STAT1 ubiquitination in bone marrow macrophages. We conclude that OPN and PDLIM2 are important regulators of STAT1-mediated inflammatory responses.	[Guo, Hongtao; Mi, Zhiyong; Bowles, Dawn E.; Bhattacharya, Syamal D.; Kuo, Paul C.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA	Duke University	Kuo, PC (corresponding author), Duke Univ, Med Ctr 3522, 224 Hanes House, Durham, NC 27710 USA.	pkuo@lumc.edu	Bowles, Dawn/R-6153-2019		National Institutes of Health [R01-GM065113, T32-GM069331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM069331, R01GM065113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM065113 (to P. C. K.) and T32-GM069331 (to P. C. K.).	Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boushaba K, 2009, MATH BIOSCI, V220, P131, DOI 10.1016/j.mbs.2009.05.006; Bousquet C, 1999, J CLIN INVEST, V104, P1277, DOI 10.1172/JCI7924; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Doursout MF, 2000, J CRIT CARE, V15, P22, DOI 10.1053/jcrc.2000.0150022; Endo TA, 1997, NATURE, V387, P921, DOI 10.1038/43213; Gao CJ, 2007, NEOPLASIA, V9, P699, DOI 10.1593/neo.07463; Gao CJ, 2007, J IMMUNOL, V178, P1870, DOI 10.4049/jimmunol.178.3.1870; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Guo H, 2008, J BIOL CHEM, V283, P25209, DOI 10.1074/jbc.M804062200; Guo HT, 2001, J IMMUNOL, V166, P1079, DOI 10.4049/jimmunol.166.2.1079; Haque SJ, 1998, J BIOL CHEM, V273, P33893, DOI 10.1074/jbc.273.51.33893; Healy NC, 2009, J LEUKOCYTE BIOL, V85, P481, DOI 10.1189/jlb.0408238; Hullinger TG, 2000, J CELL BIOCHEM, V78, P607, DOI 10.1002/1097-4644(20000915)78:4<607::AID-JCB10>3.0.CO;2-F; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Loughran G, 2005, MOL BIOL CELL, V16, P1811, DOI 10.1091/mbc.E04-12-1052; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Noti JD, 2000, INT J ONCOL, V17, P1237; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tanaka T, 2005, IMMUNITY, V22, P729, DOI 10.1016/j.immuni.2005.04.008; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Ungureanu D., 2005, SCI STKE, V2005, pe49; You M, 1999, MOL CELL BIOL, V19, P2416, DOI 10.1128/mcb.19.3.2416; Zhou H, 2009, BASIC CLIN PHARMACOL, V104, P164, DOI 10.1111/j.1742-7843.2008.00348.x	28	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37787	37796		10.1074/jbc.M110.161869	http://dx.doi.org/10.1074/jbc.M110.161869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20889505	Green Published, hybrid			2022-12-27	WOS:000284424000070
J	Kresge, N; Simoni, RD; Hill, RL				Kresge, Nicole; Simoni, Robert D.; Hill, Robert L.			Mercury Detoxification and Natural Product Synthesis: the Work of Christopher T. Walsh	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material														Kresge, Nicole/0000-0003-1551-6627				BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P2017, DOI 10.1021/bi00222a002; WALSH CT, 1965, NATURE, V207, P320, DOI 10.1038/207320b0	2	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	2010	285	42							e14	10.1074/jbc.O110.000237	http://dx.doi.org/10.1074/jbc.O110.000237			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	660XZ	20954296	hybrid, Green Published			2022-12-27	WOS:000282683000001
J	Hale, M; Oyler, G; Swaminathan, S; Ahmed, SA				Hale, Martha; Oyler, George; Swaminathan, Subramanyam; Ahmed, S. Ashraf			Basic Tetrapeptides as Potent Intracellular Inhibitors of Type A Botulinum Neurotoxin Protease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MAP KINASE PATHWAY; LIGHT-CHAIN; INTERNALIZATION MECHANISMS; PROTEOLYTIC ACTIVITY; SNAP-25 SUBSTRATE; PEPTIDE DRUGS; SEROTYPE-A; T-CELLS; IDENTIFICATION	Botulinum neurotoxins (BoNT) are the most potent of all toxins that cause flaccid muscle paralysis leading to death. They are also potential biothreat agents. A systematic investigation of various short peptide inhibitors of the BoNT protease domain with a 17-residue peptide substrate led to arginine-arginine-glycine-cysteine having a basic tetrapeptide structure as the most potent inhibitor. When assayed in the presence of dithiothreitol (DTT), the inhibitory effect was drastically reduced. Replacing the terminal cysteine with one hydrophobic residue eliminated the DTT effect but with two hydrophobic residues made the pentapeptide a poor inhibitor. Replacing the first arginine with cysteine or adding an additional cysteine at the N terminus did not improve inhibition. When assessed using mouse brain lysates, the tetrapeptides also inhibited BoNT/A cleavage of the endogenous SNAP-25. The peptides penetrated the neuronal cell lines, N2A and BE(2)-M17, without adversely affecting metabolic functions as measured by ATP production and P-38 phosphorylation. Biological activity of the peptides persisted within cultured chick motor neurons and rat and mouse cerebellar neurons for more than 40 h and inhibited BoNT/A protease action inside the neurons in a dose- and time-dependent fashion. Our results define a tetrapeptide as the smallest peptide inhibitor in the backdrop of a large substrate protein of 200+ amino acids having multiple interaction regions with its cognate enzyme. The inhibitors should also be valuable candidates for drug development.	USA, Med Res Inst Infect Dis, Dept Biochem & Cell Biol, Integrated Toxicol Div, Ft Detrick, MD 21702 USA; [Oyler, George] Synapt Res LLC, Baltimore, MD 21227 USA; [Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Ahmed, SA (corresponding author), USAMRIID, Integrated Toxicol Div, 1425 Porter St, Ft Detrick, MD 21702 USA.	syed.ahmed@amedd.army.mil		Hale, Martha/0000-0002-1108-9202	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense [CBS. MEDBIO.01.10.RD.002, JSTOCBD3.10012_06_RD_B]	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grants CBS. MEDBIO.01.10.RD.002 and JSTOCBD3.10012_06_RD_B (to S.A.A.).	Agarwal R, 2008, J BIOL CHEM, V283, P25944, DOI 10.1074/jbc.M803756200; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2000, J PROTEIN CHEM, V19, P475, DOI 10.1023/A:1026549431380; Awasthi V, 2000, AM J PHYSIOL-LUNG C, V279, pL942, DOI 10.1152/ajplung.2000.279.5.L942; Ayoub M, 2006, CHIM OGGI, V24, P46; Boldt GE, 2006, ORG LETT, V8, P1729, DOI 10.1021/ol0603211; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Boldt GE, 2006, CHEM COMMUN, P3063, DOI 10.1039/b603099h; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; Capkova K, 2007, BIOORG MED CHEM LETT, V17, P6463, DOI 10.1016/j.bmcl.2007.09.103; Capkova K, 2009, TOXICON, V54, P575, DOI 10.1016/j.toxicon.2009.03.016; Doherty DG, 1999, J IMMUNOL, V163, P2314; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Gilsdorf J, 2006, PROTEIN EXPRES PURIF, V46, P256, DOI 10.1016/j.pep.2005.09.024; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; Gul N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012872; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Kuo CL, 2010, TOXICON, V55, P619, DOI 10.1016/j.toxicon.2009.10.019; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lee SY, 2005, MOL BRAIN RES, V140, P45, DOI 10.1016/j.molbrainres.2005.07.009; LUDIVICO M, 2006, 43 ANN M INT BOT RES, P67; Ludivico M., 2009, BOTULINUM J, V1, P297; MATHEWS CK, 1990, BIOCHEMISTRY-US, P382; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007730; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Roxas-Duncan V, 2009, ANTIMICROB AGENTS CH, V53, P3478, DOI 10.1128/AAC.00141-09; Saikh KU, 2002, IMMUNOLOGY, V106, P363, DOI 10.1046/j.1365-2567.2002.01446.x; Schmidt JJ, 2005, BIOCHEMISTRY-US, V44, P4067, DOI 10.1021/bi0477642; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2002, FEBS LETT, V532, P423, DOI 10.1016/S0014-5793(02)03738-9; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Sheridan RE, 1997, TOXICON, V35, P1439, DOI 10.1016/S0041-0101(96)00208-5; SHOEMAKER B, 2009, NIAID FOOD WATERBORN; Sikorra S, 2006, J MOL BIOL, V357, P574, DOI 10.1016/j.jmb.2005.12.075; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Tang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000761; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Vylkova S, 2007, PURINERG SIGNAL, V3, P91, DOI 10.1007/s11302-006-9040-0; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011; 2005, CHEM ENG NEWS, V83, P17	59	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1802	1811		10.1074/jbc.M110.146464	http://dx.doi.org/10.1074/jbc.M110.146464			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20961849	hybrid, Green Published			2022-12-27	WOS:000286191500020
J	Kim, HJ; Lv, P; Sihn, CR; Yamoah, EN				Kim, Hyo Jeong; Lv, Ping; Sihn, Choong-Ryoul; Yamoah, Ebenezer N.			Cellular and Molecular Mechanisms of Autosomal Dominant Form of Progressive Hearing Loss, DFNA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; POTASSIUM CHANNELS; KCNQ4 GENE; ROMANO-WARD; PORE-REGION; INNER-EAR; HOT-SPOT; SALICYLATE; MUTATIONS; EXPRESSION	Despite advances in identifying deafness genes, determination of the underlying cellular and functional mechanisms for auditory diseases remains a challenge. Mutations of the human K+ channel hKv7.4 lead to post-lingual progressive hearing loss (DFNA2), which affects world-wide population with diverse racial backgrounds. Here, we have generated the spectrum of point mutations in the hKv7.4 that have been identified as diseased mutants. We report that expression of five point mutations in the pore region, namely L274H, W276S, L281S, G285C, and G296S, as well as the C-terminal mutant G321S in the heterologous expression system, yielded nonfunctional channels because of endoplasmic reticulum retention of the mutant channels. We mimicked the dominant diseased conditions by co-expressing the wild-type and mutant channels. As compared with expression of wild-type channel alone, the blend of wild-type and mutant channel subunits resulted in reduced currents. Moreover, the combinatorial ratios of wild type: mutant and the ensuing current magnitude could not be explained by the predictions of a tetrameric channel and a dominant negative effect of the mutant subunits. The results can be explained by the dependence of cell surface expression of the mutant on the wild-type subunit. Surprisingly, a transmembrane mutation F182L, which has been identified in a pre-lingual progressive hearing loss patient in Taiwan, yielded cell surface expression and functional features that were similar to that of the wild type, suggesting that this mutation may represent redundant polymorphism. Collectively, these findings provide traces of the cellular mechanisms for DFNA2.	[Kim, Hyo Jeong; Lv, Ping; Sihn, Choong-Ryoul; Yamoah, Ebenezer N.] Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Dept Anesthesiol & Pain Med, Program Commun Sci, Sch Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu			National Institutes of Health, NIDCD [DC010386, DC007592]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010386, R01DC007592] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants through DC010386 and DC007592 the NIDCD (to E.N.Y.).	Abbott GW, 2002, FASEB J, V16, DOI 10.1096/fj.01-0520hyp; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akita J, 2001, J HUM GENET, V46, P355, DOI 10.1007/s100380170053; Beisel KW, 2005, J NEUROSCI, V25, P9285, DOI 10.1523/JNEUROSCI.2110-05.2005; Campbell CA, 2010, AM J MED GENET A, V152A, P67, DOI 10.1002/ajmg.a.33114; Casimiro MC, 2004, GENOMICS, V84, P555, DOI 10.1016/j.ygeno.2004.06.007; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Cooper EC, 2001, EPILEPSIA, V42, P49, DOI 10.1046/j.1528-1157.2001.0420s5049.x; COUCKE P, 1994, NEW ENGL J MED, V331, P425, DOI 10.1056/NEJM199408183310702; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Davis H, 1972, Ann Otol Rhinol Laryngol, V81, P750; Diaz RC, 2007, JARO-J ASSOC RES OTO, V8, P422, DOI 10.1007/s10162-007-0089-4; Ehrlich JR, 2004, J BIOL CHEM, V279, P1233, DOI 10.1074/jbc.M309087200; Guitton MJ, 2003, J NEUROSCI, V23, P3944; Hallworth R, 1997, HEARING RES, V114, P204, DOI 10.1016/S0378-5955(97)00167-6; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Lv P, 2010, J BIOL CHEM, V285, P34699, DOI 10.1074/jbc.M110.136192; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Ohyama H, 2001, PFLUG ARCH EUR J PHY, V442, P329, DOI 10.1007/s004240100547; Oliver D, 2003, J NEUROSCI, V23, P2141; Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Talebizadeh Z, 1999, HUM MUTAT, V14, P493, DOI 10.1002/(SICI)1098-1004(199912)14:6<493::AID-HUMU8>3.0.CO;2-P; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; Topsakal V, 2005, OTOL NEUROTOL, V26, P52, DOI 10.1097/00129492-200501000-00009; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Hauwe P, 2000, AM J MED GENET, V93, P184, DOI 10.1002/1096-8628(20000731)93:3<184::AID-AJMG4>3.0.CO;2-5; VanCamp G, 1997, GENOMICS, V41, P70, DOI 10.1006/geno.1997.4624; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wu T, 2010, J NEUROPHYSIOL, V103, P1969, DOI 10.1152/jn.01057.2009; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200	43	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1517	1527		10.1074/jbc.M110.179010	http://dx.doi.org/10.1074/jbc.M110.179010			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966080	hybrid, Green Published			2022-12-27	WOS:000286005000064
J	Zou, XQ; Gao, YG; Ruvolo, VR; Gardner, TL; Ruvolo, PP; Brown, RE				Zou, Xianqiong; Gao, Yongguang; Ruvolo, Vivian R.; Gardner, Tawnya L.; Ruvolo, Peter P.; Brown, Rhoderick E.			Human Glycolipid Transfer Protein Gene (GLTP) Expression Is Regulated by Sp1 and Sp3 INVOLVEMENT OF THE BIOACTIVE SPHINGOLIPID CERAMIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE PROMOTER; GLUCOSYLCERAMIDE SYNTHASE; DIHYDROFOLATE-REDUCTASE; DOWN-REGULATION; CELL; BINDING; FAMILY; MECHANISMS; GLYCOSPHINGOLIPIDS; AMPLIFICATION	Glycolipid transfer protein (GLTP) accelerates glycolipid intermembrane transfer via a unique lipid transfer/binding fold (GLTP fold) that defines the GLTP superfamily and is the prototype for functional GLTP-like domains in larger proteins, i.e. FAPP2. Human GLTP is encoded by the single-copy GLTP gene on chromosome 12 (12q24.11 locus), but regulation of GLTP gene expression remains completely unexplored. Herein, the ability of glycosphingolipids (and their sphingolipid metabolites) to regulate the transcriptional expression of GLTP via its promoter has been evaluated. Using luciferase and GFP reporters in concert with deletion mutants, the constitutive and basal (225 bp; similar to 78% G + C) human GLTP promoters have been defined along with adjacent regulatory elements. Despite high G + C content, translational regulation was not evident by the mammalian target of rapamycin pathway. Four GC-boxes were shown to be functional Sp1/Sp3 transcription factor binding sites. Mutation of one GC-box was particularly detrimental to GLTP transcriptional activity. Sp1/Sp3 RNA silencing and mithramycin A treatment significantly inhibited GLTP promoter activity. Among tested sphingolipid analogs of glucosylceramide, sulfatide, ganglioside GM1, ceramide 1-phosphate, sphingosine 1-phosphate, dihydroceramide, sphingosine, only ceramide, a nonglycosylated precursor metabolite unable to bind to GLTP protein, induced GLTP promoter activity and raised transcript levels in vivo. Ceramide treatment partially blocked promoter activity decreases induced by Sp1/Sp3 knockdown. Ceramide treatment also altered the in vivo binding affinity of Sp1 and Sp3 for the GLTP promoter and decreased Sp3 acetylation. This study represents the first characterization of any Gltp gene promoter and links human GLTP expression to sphingolipid homeostasis through ceramide.	[Zou, Xianqiong; Gao, Yongguang; Ruvolo, Vivian R.; Gardner, Tawnya L.; Ruvolo, Peter P.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252; Brown, Rhoderick/0000-0002-7337-3604	National Institutes of Health/NIGMS [45928]; National Institutes of Health/NCI [121493]; Hormel Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health/NIGMS Grant 45928 and National Institutes of Health/NCI Grant 121493. This work was also supported by The Hormel Foundation.	ABE A, 1995, J LIPID RES, V36, P611; Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Ammanamanchi S, 2003, J BIOL CHEM, V278, P35775, DOI 10.1074/jbc.M305961200; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Chakrabarti R, 2001, GENE, V274, P293, DOI 10.1016/S0378-1119(01)00621-7; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Debret R, 2008, BBA-MOL CELL RES, V1783, P1718, DOI 10.1016/j.bbamcr.2008.06.001; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Gross P, 2006, BIOCHEM SOC SYMP, V73, P225; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; MARUYAMA K, 1994, GENE, V138, P171; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; Muller F, 2007, J BIOL CHEM, V282, P14685, DOI 10.1074/jbc.R700012200; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Sparkman L, 2006, AM J PHYSIOL-LUNG C, V290, pL351, DOI 10.1152/ajplung.00275.2005; Stockmann-Juvala H, 2008, HUM EXP TOXICOL, V27, P799, DOI 10.1177/0960327108099525; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008; Tuuf J., 2007, BIOCHIM BIOPHYS ACTA, V1711, P1353; Uchida Y, 2004, CANCER RES, V64, P6271, DOI 10.1158/0008-5472.CAN-03-1476; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; WANG E, 1991, J BIOL CHEM, V266, P14486; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Wooten LG, 2005, J BIOL CHEM, V280, P28867, DOI 10.1074/jbc.M413444200; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	60	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1301	1311		10.1074/jbc.M110.127837	http://dx.doi.org/10.1074/jbc.M110.127837			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20974858	hybrid, Green Published			2022-12-27	WOS:000286005000042
J	Grassian, AR; Schafer, ZT; Brugge, JS				Grassian, Alexandra R.; Schafer, Zachary T.; Brugge, Joan S.			ErbB2 Stabilizes Epidermal Growth Factor Receptor (EGFR) Expression via Erk and Sprouty2 in Extracellular Matrix-detached Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL ACINI; DOWN-REGULATION; TISSUE ARCHITECTURE; ANOIKIS RESISTANCE; TUMOR PROGRESSION; KINASE PATHWAY; CANCER CELLS; MECHANISMS; PHOSPHORYLATION; INHIBITION	Epithelial cells are dependent on extracellular matrix (ECM) attachment for maintenance of metabolic activity and suppression of apoptosis. Here we show that loss of ECM attachment causes down-regulation of epidermal growth factor receptor (EGFR) and beta 1 integrin protein and mRNA expression and that ErbB2, which is amplified in 25% of breast tumors, reverses these effects of ECM deprivation. ErbB2 rescue of beta 1 integrin mRNA and protein in suspended cells is dependent on EGFR, however, the rescue of EGFR expression does not require beta 1 integrin. We show that there is a significant decrease in the stability of EGFR in ECM-detached cells that is reversed by ErbB2 overexpression. Rescue of both EGFR and beta 1 integrin protein by ErbB2 is dependent on Erk activity and induction of its downstream target Sprouty2, a protein known to regulate EGFR protein stability. Interestingly, expression of EGFR and beta 1 integrin protein is more dependent on Erk/Sprouty2 in ECM-detached ErbB2-overexpressing cells when compared with ECM-attached cells. These results provide further insight into the ErbB2-driven anchorage independence of tumor cells and provide a new mechanism for regulation of EGFR and beta 1 integrin expression in ECM-detached cells.	[Grassian, Alexandra R.; Schafer, Zachary T.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu			NCI; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA105134] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant from the NCI (to J. S. B.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to A. R. G.).	Barbachano A, 2010, ONCOGENE, V29, P4800, DOI 10.1038/onc.2010.225; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brandt B, 2006, CLIN CANCER RES, V12, P7252, DOI 10.1158/1078-0432.CCR-06-0626; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Carraway KL, 2009, FUTURE ONCOL, V5, P1631, DOI 10.2217/FON.09.125; Carraway KL, 2006, CANCER CELL, V10, P93, DOI 10.1016/j.ccr.2006.07.015; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Feng YH, 2010, CANCER SCI, V101, P2033, DOI 10.1111/j.1349-7006.2010.01637.x; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris J, 1999, DIS BREAST; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Ivaska J, 2010, CELL TISSUE RES, V339, P111, DOI 10.1007/s00441-009-0857-z; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kim LT, 1997, P SOC EXP BIOL MED, V214, P123; Koziczak M, 2004, ONCOGENE, V23, P3501, DOI 10.1038/sj.onc.1207331; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lito P, 2008, J BIOL CHEM, V283, P2002, DOI 10.1074/jbc.M709046200; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Miin Wong Esther Sook, 2006, V327, P61; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Ozaki K, 2001, BIOCHEM BIOPH RES CO, V285, P1084, DOI 10.1006/bbrc.2001.5295; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Rubin C, 2005, J BIOL CHEM, V280, P9735, DOI 10.1074/jbc.M408308200; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Spangenberg C, 2006, CANCER RES, V66, P3715, DOI 10.1158/0008-5472.CAN-05-2823; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Workman HC, 2009, CANCER RES, V69, P2845, DOI 10.1158/0008-5472.CAN-08-2089; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yu X, 2000, J CELL SCI, V113, P2139; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200	69	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					79	90		10.1074/jbc.M110.169821	http://dx.doi.org/10.1074/jbc.M110.169821			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956544	hybrid, Green Published			2022-12-27	WOS:000285782800009
J	Sathish, N; Zhu, FX; Golub, EE; Liang, QM; Yuan, Y				Sathish, Narayanan; Zhu, Fan Xiu; Golub, Ellis E.; Liang, Qiming; Yuan, Yan			Mechanisms of Autoinhibition of IRF-7 and a Probable Model for Inactivation of IRF-7 by Kaposi's Sarcoma-associated Herpesvirus Protein ORF45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON REGULATORY FACTOR-7; POSITIVE FEEDBACK; MEDIATED DEGRADATION; PATTERN-RECOGNITION; CRYSTAL-STRUCTURE; I INTERFERON; DNA-BINDING; INDUCTION; LOCALIZATION; DISTINCT	IRF-7 is the master regulator of type I interferon-dependent immune responses controlling both innate and adaptive immunity. Given the significance of IRF-7 in the induction of immune responses, many viruses have developed strategies to inhibit its activity to evade or antagonize host antiviral responses. We previously demonstrated that ORF45, a KSHV immediate-early protein as well as a tegument protein of virions, interacts with IRF-7 and inhibits virus-mediated type I interferon induction by blocking IRF-7 phosphorylation and nuclear translocation (Zhu, F. X., King, S. M., Smith, E. J., Levy, D. E., and Yuan, Y. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5573-5578). In this report, we sought to reveal the mechanism underlying the ORF45-mediated inactivation of IRF-7. We found that ORF45 interacts with the inhibitory domain of IRF-7. The most striking feature in the IRF-7 inhibitory domain is two alpha-helices H3 and H4 that contain many hydrophobic residues and two beta-sheets located between the helices that are also very hydrophobic. These hydrophobic subdomains mediate intramolecular interactions that keep the molecule in a closed (inactive) form. Mutagenesis studies confirm the contribution of the hydrophobic helices and sheets to the autoinhibition of IRF-7 in the absence of viral signal. The binding of ORF45 to the critical domain of IRF-7 leads to a hypothesis that ORF45 may maintain the IRF-7 molecule in the closed form and prevent it from being activated in response to viral infection.	[Sathish, Narayanan; Yuan, Yan] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Golub, Ellis E.] Univ Penn, Sch Dent Med, Dept Biochem, Philadelphia, PA 19104 USA; [Zhu, Fan Xiu; Liang, Qiming] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of Pennsylvania; University of Pennsylvania; State University System of Florida; Florida State University	Yuan, Y (corresponding author), 240 S 40th St, Philadelphia, PA 19104 USA.	yuan2@pobox.upenn.edu			National Institutes of Health [R01CA86839, R01DE016680]; NATIONAL CANCER INSTITUTE [R01CA086839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA86839 (to Y. Y.) and R01DE016680 (to F. X. Z.).	Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hahn AM, 2005, J VIROL, V79, P10040, DOI 10.1128/JVI.79.15.10040-10052.2005; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Joo CH, 2007, J VIROL, V81, P8282, DOI 10.1128/JVI.00235-07; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Lau JF, 2000, P NATL ACAD SCI USA, V97, P7278, DOI 10.1073/pnas.97.13.7278; Levy DE, 2002, J INTERF CYTOK RES, V22, P87, DOI 10.1089/107999002753452692; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Servant MJ, 2002, J INTERF CYTOK RES, V22, P49, DOI 10.1089/107999002753452656; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Wu L, 2009, J VIROL, V83, P1140, DOI 10.1128/JVI.00602-08; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700; Zhu FX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010573; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	43	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					746	756		10.1074/jbc.M110.150920	http://dx.doi.org/10.1074/jbc.M110.150920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980251	hybrid, Green Published			2022-12-27	WOS:000285782800074
J	Wei, RR; Hughes, H; Boucher, S; Bird, JJ; Guziewicz, N; Van Patten, SM; Qiu, HW; Pan, CQ; Edmunds, T				Wei, Ronnie R.; Hughes, Heather; Boucher, Susan; Bird, Julie J.; Guziewicz, Nicholas; Van Patten, Scott M.; Qiu, Huawei; Pan, Clark Qun; Edmunds, Tim			X-ray and Biochemical Analysis of N370S Mutant Human Acid beta-Glucosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; GAUCHER-DISEASE TYPE-1; IMINOSUGAR ISOFAGOMINE; CHEMICAL CHAPERONES; CATALYTIC-ACTIVITY; DEFECTIVE ENZYME; GLUCOCEREBROSIDASE; MUTATIONS; FIBROBLASTS; DEFICIENCY	Gaucher disease is caused by mutations in the enzyme acid beta-glucosidase (GCase), the most common of which is the substitution of serine for asparagine at residue 370 (N370S). To characterize the nature of this mutation, we expressed human N370S GCase in insect cells and compared the x-ray structure and biochemical properties of the purified protein with that of the recombinant human GCase (imiglucerase, Cerezyme (R)). The x-ray structure of N370S mutant acid beta-glucosidase at acidic and neutral pH values indicates that the overall folding of the N370S mutant is identical to that of recombinant GCase. Subtle differences were observed in the conformation of a flexible loop at the active site and in the hydrogen bonding ability of aromatic residues on this loop with residue 370 and the catalytic residues Glu-235 and Glu-340. Circular dichroism spectroscopy showed a pH-dependent change in the environment of tryptophan residues in imiglucerase that is absent in N370S GCase. The mutant protein was catalytically deficient with reduced V-max and increased Km values for the substrate p-nitrophenyl-beta-D-glucopyranoside and reduced sensitivity to competitive inhibitors. N370S GCase was more stable to thermal denaturation and had an increased lysosomal half-life compared with imiglucerase following uptake into macrophages. The competitive inhibitor N-(n-nonyl) deoxynojirimycin increased lysosomal levels of both N370S and imiglucerase 2-3-fold by reducing lysosomal degradation. Overall, these data indicate that the N370S mutation results in a normally folded but less flexible protein with reduced catalytic activity compared with imiglucerase.	[Wei, Ronnie R.; Hughes, Heather; Boucher, Susan; Bird, Julie J.; Guziewicz, Nicholas; Van Patten, Scott M.; Qiu, Huawei; Pan, Clark Qun; Edmunds, Tim] Genzyme Corp, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Wei, RR (corresponding author), Genzyme Corp, 1 Mt Rd, Framingham, MA 01701 USA.	ronnie.wei@genzyme.com		Jaworski, Julie/0000-0002-0633-287X				BASU A, 1985, J BIOL CHEM, V260, P3067; BERGMANN JE, 1989, AM J HUM GENET, V44, P741; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; BLONDER E, 1976, BIOCHIM BIOPHYS ACTA, V431, P45, DOI 10.1016/0005-2760(76)90258-7; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; DALE GL, 1976, BIOCHEM BIOPH RES CO, V71, P1048, DOI 10.1016/0006-291X(76)90760-9; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grabowski GA, 2006, METABOLIC MOL BASES; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GRACE ME, 1994, J BIOL CHEM, V269, P2283; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Michelin K, 2005, CLIN CHIM ACTA, V362, P101, DOI 10.1016/j.cccn.2005.06.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHASHI T, 1991, J BIOL CHEM, V266, P3661; PETERS SP, 1977, J BIOL CHEM, V252, P563; Piepenhagen PA, 2010, MICROSC RES TECHNIQ, V73, P694, DOI 10.1002/jemt.20810; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Salvioli R, 2005, BIOCHEM J, V390, P95, DOI 10.1042/BJ20050325; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Shen JS, 2008, BIOCHEM BIOPH RES CO, V369, P1071, DOI 10.1016/j.bbrc.2008.02.125; Steet R, 2007, BIOCHEM PHARMACOL, V73, P1376, DOI 10.1016/j.bcp.2006.12.015; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684	37	51	51	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					299	308		10.1074/jbc.M110.150433	http://dx.doi.org/10.1074/jbc.M110.150433			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980263	hybrid, Green Published			2022-12-27	WOS:000285782800033
J	Zeng, ZH; Cortes-Ledesma, F; El Khamisy, SF; Caldecott, KW				Zeng, Zhihong; Cortes-Ledesma, Felipe; El Khamisy, Sherif F.; Caldecott, Keith W.			TDP2/TTRAP Is the Major 5 '-Tyrosyl DNA Phosphodiesterase Activity in Vertebrate Cells and Is Critical for Cellular Resistance to Topoisomerase II-induced DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED FACTORS; TTRAP; PROTEIN; REPAIR; BREAKS; BETA; CD40	Topoisomerase II (Top2) activity involves an intermediate in which the topoisomerase is covalently bound to a DNA double-strand break via a 5' -phosphotyrosyl bond. Although these intermediates are normally transient, they can be stabilized by antitumor agents that act as Top2 "poisons," resulting in the induction of cytotoxic double-strand breaks, and they are implicated in the formation of site-specific translocations that are commonly associated with cancer. Recently, we revealed that TRAF and TNF receptor-associated protein (TTRAP) is a 5' -tyrosyl DNA phosphodiesterase (5' -TDP) that can cleave 5' -phosphotyrosyl bonds, and we denoted this protein tyrosyl DNA phosphodiesterase-2 (TDP2). Here, we have generated TDP2-deleted DT40 cells, and we show that TDP2 is the major if not the only 5' -TDP activity present in vertebrate cells. We also show that TDP2-deleted DT40 cells are highly sensitive to the anticancer Top2 poison, etoposide, but are not hypersensitive to the Top1 poison camptothecin or the DNA-alkyating agent methyl methanesulfonate. These data identify an important mechanism for resistance to Top2-induced chromosome breakage and raise the possibility that TDP2 is a significant factor in cancer development and treatment.	[Zeng, Zhihong; Cortes-Ledesma, Felipe; El Khamisy, Sherif F.; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Cortes-Ledesma, F (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat, Ave Americo Vespucio S-N, Seville 41092, Spain.	felipe.cortes@cabimer.es; s.f.el-khamisy@sussex.ac.uk; k.w.caldecott@sussex.ac.uk	Ledesma, Felipe Cortés/F-4803-2014; Zeng, Zhihong/HEV-8703-2022; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; Caldecott, Keith/0000-0003-4255-9016; , Sherif/0000-0003-2721-7763	Medical Research Council [G0600776, G0901606]; Marie Curie IntraEuropean Fellowship [2007-2-1-IEF-221222]; Wellcome Trust [085284]; MRC [G0600776, G0901606] Funding Source: UKRI; Cancer Research UK [13078] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie IntraEuropean Fellowship(European Commission); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grants G0600776 and G0901606 (to K. W. C.), Marie Curie IntraEuropean Fellowship 2007-2-1-IEF-221222 (to F. C.-L.), and a Wellcome Trust grant (085284) (to S. F. E. K.).	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wilson-Sali T, 2002, P NATL ACAD SCI USA, V99, P7974, DOI 10.1073/pnas.122007999; Wilson-Sali T, 2002, J BIOL CHEM, V277, P26865, DOI 10.1074/jbc.M204641200; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	17	117	121	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					403	409		10.1074/jbc.M110.181016	http://dx.doi.org/10.1074/jbc.M110.181016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030584	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000285782800043
J	Nunez, A; Franco, A; Soto, T; Vicente, J; Gacto, M; Cansado, J				Nunez, Andres; Franco, Alejandro; Soto, Teresa; Vicente, Jero; Gacto, Mariano; Cansado, Jose			Fission Yeast Receptor of Activated C Kinase (RACK1) Ortholog Cpc2 Regulates Mitotic Commitment through Wee1 Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; CELL-CYCLE; EUKARYOTIC TRANSLATION; NEGATIVE REGULATION; SCAFFOLD PROTEIN; TYROSINE KINASE; MITOSIS; STRESS; PROGRESSION	In the fission yeast Schizosaccharomyces pombe, Wee1-dependent inhibitory phosphorylation of the highly conserved Cdc2/Cdk1 kinase determines the mitotic onset when cells have reached a defined size. The receptor of activated C kinase (RACK1) is a scaffolding protein strongly conserved among eukaryotes which binds to other proteins to regulate multiple processes in mammalian cells, including the modulation of cell cycle progression during G1/S transition. We have recently described that Cpc2, the fission yeast ortholog to RACK1, controls from the ribosome the activation of MAPK cascades and the cellular defense against oxidative stress by positively regulating the translation of specific genes whose products participate in the above processes. Intriguingly, mutants lacking Cpc2 display an increased cell size at division, suggesting the existence of a specific cell cycle defect at the G2/M transition. In this work we show that protein levels of Wee1 mitotic inhibitor are increased in cells devoid of Cpc2, whereas the levels of Cdr2, a Wee1 inhibitor, are down-regulated in the above mutant. On the contrary, the kinetics of G1/S transition was virtually identical both in control and Cpc2-less strains. Thus, our results suggest that in fission yeast Cpc2/RACK1 positively regulates from the ribosome the mitotic onset by modulating both the protein levels and the activity of Wee1. This novel mechanism of translational control of cell cycle progression might be conserved in higher eukaryotes.	[Nunez, Andres; Franco, Alejandro; Soto, Teresa; Vicente, Jero; Gacto, Mariano; Cansado, Jose] Univ Murcia, Yeast Physiol Grp, Dept Genet & Microbiol, Fac Biol, E-30071 Murcia, Spain	University of Murcia	Cansado, J (corresponding author), Univ Murcia, Yeast Physiol Grp, Dept Genet & Microbiol, Fac Biol, E-30071 Murcia, Spain.	jcansado@um.es	Pino, Teresa Soto/AAC-6096-2020; Cansado, Jose/K-5212-2014; Nunez-Hernandez, Andres/AAZ-3900-2020; Franco, Alejandro/ABG-6823-2020; Vicente-Soler, Jerónima/ABF-6293-2020; Cansado, Jose/ABC-6872-2020	Pino, Teresa Soto/0000-0003-2965-318X; Nunez-Hernandez, Andres/0000-0002-0781-0001; Franco, Alejandro/0000-0001-7461-3414; Vicente-Soler, Jerónima/0000-0001-8759-6545; Cansado, Jose/0000-0002-2342-8152	MICINN [BFU2008-01653]; Fundacion Seneca (Region de Murcia), Spain [08725/PI/08]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Fundacion Seneca (Region de Murcia), Spain(Fundacion Seneca)	This work was supported by MICINN Grants BFU2008-01653 and Fundacion Seneca (Region de Murcia), Spain, Grant 08725/PI/08 (to J. C.).	Alfa C., 1993, EXPT FISSION YEAST; Aligue R, 1997, J BIOL CHEM, V272, P13320, DOI 10.1074/jbc.272.20.13320; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Breeding CS, 1998, MOL BIOL CELL, V9, P3399, DOI 10.1091/mbc.9.12.3399; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FEILOTTER H, 1991, GENETICS, V127, P309; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Grallert B, 2000, J CELL SCI, V113, P1447; He DY, 2010, J BIOL CHEM, V285, P19043, DOI 10.1074/jbc.M110.100693; Ishii K, 1996, EMBO J, V15, P6629, DOI 10.1002/j.1460-2075.1996.tb01053.x; Kanoh J, 1998, MOL BIOL CELL, V9, P3321, DOI 10.1091/mbc.9.12.3321; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; MacNeil S. A., 1997, MOL CELLULAR BIOL YE, V3, P697; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2007, BIOCHEM BIOPH RES CO, V352, P423, DOI 10.1016/j.bbrc.2006.11.034; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McInerny CJ, 1995, NUCLEIC ACIDS RES, V23, P4761; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Paul SK, 2009, FEBS J, V276, P5076, DOI 10.1111/j.1742-4658.2009.07204.x; Petersen J, 2009, BIOCHEM SOC T, V37, P273, DOI 10.1042/BST0370273; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Soto T, 2002, EUR J BIOCHEM, V269, P5056, DOI 10.1046/j.1432-1033.2002.03214.x; Soto T, 2010, J BIOL CHEM, V285, P11516, DOI 10.1074/jbc.M109.071027; Suda M, 2000, FEBS LETT, V486, P305, DOI 10.1016/S0014-5793(00)02299-7; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	52	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41366	41373		10.1074/jbc.M110.173815	http://dx.doi.org/10.1074/jbc.M110.173815			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974849	Green Published, hybrid			2022-12-27	WOS:000285622600022
J	Chini, CCS; Escande, C; Nin, V; Chini, EN				Chini, Claudia C. S.; Escande, Carlos; Nin, Veronica; Chini, Eduardo N.			HDAC3 Is Negatively Regulated by the Nuclear Protein DBC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASES; SIRT1; SMRT; TRANSCRIPTION; COREPRESSOR; REPRESSION; DISEASE; CANCER; ROLES	HDAC3 is a member of the class I histone deacetylase family that regulates gene expression by deacetylation of histones and non-histone proteins. HDAC3 activity has been shown to be modulated by interaction with the co-repressors NCoR and SMRT. Here, we present evidence that the nuclear protein DBC1 is an endogenous inhibitor of HDAC3. DBC1 has been previously identified as a regulator of some nuclear receptors, the methyltransferase SUV39H1, and the NAD-dependent deacetylase SIRT1. Furthermore, DBC1 has been shown to influence transcription regulation and apoptosis, and it may also act as a tumor suppressor. We found that DBC1 interacts and specifically inhibits the deacetylase HDAC3. This interaction depends on the N terminus of DBC1 and the C terminus of HDAC3. Expression of DBC1 not only inhibited HDAC3 activity but also altered its subcellular distribution. In addition, knockdown of endogenous DBC1 in cells and knock-out in mouse tissues increased HDAC3 deacetylase activity. Together, these results identify DBC1 as a new regulator of HDAC3 and demonstrate that DBC1 is a negative regulator of two key distinct deacetylases, SIRT1 and HDAC3. These findings may lead to a better understanding of the biological roles of DBC1 and HDAC3 in metabolic diseases and cancer.	[Chini, Claudia C. S.; Escande, Carlos; Nin, Veronica; Chini, Eduardo N.] Mayo Clin, Coll Med, Dept Anesthesiol, Lab Signal Transduct, Rochester, MN 55905 USA	Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Coll Med, Dept Anesthesiol, 200 1st St SW, Rochester, MN 55902 USA.	chini.eduardo@mayo.edu			National Institutes of Health, NIDDK [DK-084055]; American Federation for Aging Research; Mayo Foundation; Strickland Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084055] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation for Aging Research; Mayo Foundation; Strickland Career Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-084055 from NIDDK. This work was supported by grants from the American Federation for Aging Research and from the Mayo Foundation and by the Strickland Career Development Award.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kim EJ, 2008, BMB REP, V41, P751, DOI 10.5483/BMBRep.2008.41.11.751; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JE, 2009, CELL CYCLE, V8, P2932; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Sundararajan R, 2005, ONCOGENE, V24, P4908, DOI 10.1038/sj.onc.1208681; Trauernicht AM, 2007, MOL ENDOCRINOL, V21, P1526, DOI 10.1210/me.2007-0064; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	29	64	69	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40830	40837		10.1074/jbc.M110.153270	http://dx.doi.org/10.1074/jbc.M110.153270			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	21030595	hybrid, Green Published			2022-12-27	WOS:000285414400048
J	Figueiredo, RT; Fernandez, PL; Dutra, FF; Gonzalez, Y; Lopes, LC; Bittencourt, VCB; Sassaki, GL; Barreto-Bergter, E; Bozza, MT				Figueiredo, Rodrigo T.; Fernandez, Patricia L.; Dutra, Fabianno F.; Gonzalez, Yissett; Lopes, Livia Cristina; Bittencourt, Vera Carolina B.; Sassaki, Guilherme L.; Barreto-Bergter, Eliana; Bozza, Marcelo T.			TLR4 Recognizes Pseudallescheria boydii Conidia and Purified Rhamnomannans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; TOLL-LIKE RECEPTOR-2; CANDIDA-ALBICANS; FUNGAL PATHOGENS; HOST-DEFENSE; INFECTIONS; FUMIGATUS; DECTIN-1; ALPHA; SCEDOSPORIUM	Pseudallescheria boydii (Scedosporium apiospermum) is a saprophytic fungus widespread in the environment, and has recently emerged as an agent of localized as well as disseminated infections, particularly mycetoma, in immunocompromised and immunocompetent hosts. We have previously shown that highly purified alpha-glucan from P. boydii activates macrophages through Toll-like receptor TLR2, however, the mechanism of P. boydii recognition by macrophage is largely unknown. In this work, we investigated the role of innate immune receptors in the recognition of P. boydii. Macrophages responded to P. boydii conidia and hyphae with secretion of proinflammatory cytokines. The activation of macrophages by P. boydii conidia required functional MyD88, TLR4, and CD14, whereas stimulation by hyphae was independent of TLR4 and TLR2 signaling. Removal of peptidorhamnomannans from P. boydii conidia abolished induction of cytokines by macrophages. A fraction highly enriched in rhamnomannans was obtained and characterized by NMR, high performance TLC, and GC-MS. Preparation of rhamnomannans derived from P. boydii triggered cytokine release by macrophages, as well as MAPKs phosphorylation and I kappa B alpha degradation. Cytokine release induced by P. boydii-derived rhamnomannans was dependent on TLR4 recognition and required the presence of non-reducing end units of rhamnose of the rhamnomannan, but not O-linked oligosaccharides from the peptidorhamnomannan. These results imply that TLR4 recognizes P. boydii conidia and this recognition is at least in part due to rhamnomannans expressed on the surface of P. boydii.	[Bozza, Marcelo T.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Imunol, Lab Inflamacao & Imunidade, BR-941902 Rio De Janeiro, Brazil; [Figueiredo, Rodrigo T.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-941902 Rio De Janeiro, Brazil; [Fernandez, Patricia L.; Gonzalez, Yissett] Inst Sci Invest & High Technol Serv, INDICASAT, Ciudad De Panama 84301103, Panama; [Lopes, Livia Cristina; Bittencourt, Vera Carolina B.; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Dept Microbiol Geral, Inst Microbiol, BR-941902 Rio De Janeiro, Brazil; [Bittencourt, Vera Carolina B.] Univ Fed Estado Rio de Janeiro, BR-20211040 Rio De Janeiro, Brazil; [Sassaki, Guilherme L.] Univ Fed Parana, Dept Bioquim, BR-81531990 Curitiba, Parana, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidade Federal do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Parana	Bozza, MT (corresponding author), Univ Fed Rio de Janeiro, CCS Bloco 1,Ave Carlos Chagas Filho,373 Cidade Un, BR-21941902 Rio de Janeiro, Brazil.	mbozza@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Ferreira Dutra, Fabianno/AAE-2895-2022; Sassaki, Guilherme/AAM-1112-2020; Dutra, Fabianno F/C-1387-2015; Bittencourt, Vera CB/A-7921-2019; Figueiredo, Rodrigo/F-5176-2016	Ferreira Dutra, Fabianno/0000-0003-3106-7585; Sassaki, Guilherme/0000-0001-7420-168X; Dutra, Fabianno F/0000-0003-3106-7585; Figueiredo, Rodrigo/0000-0002-7551-8782; Llanes Fernandez, Patricia/0000-0002-0762-0566; Bozza, Marcelo/0000-0003-3683-7550; bittencourt, vera/0000-0002-7403-9747	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (Pronex); Universidade Federal do Rio de Janeiro	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (Pronex)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Rio de Janeiro	The work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Nucleos de Excelencia (Pronex), and Universidade Federal do Rio de Janeiro.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Barbosa FM, 2007, CLIN VACCINE IMMUNOL, V14, P94, DOI 10.1128/CVI.00296-06; BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247; BELCHER R, 1954, ANALYST, V79, P201, DOI 10.1039/an9547900201; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Gilgado F, 2005, J CLIN MICROBIOL, V43, P4930, DOI 10.1128/JCM.43.10.4930-4942.2005; Gorin P. A. J., 1981, ADV CARBOHYD CHEM BI, VV38, P13, DOI DOI 10.1016/S0065-2318(08)60309-1; Hohl TM, 2006, CURR OPIN IMMUNOL, V18, P465, DOI 10.1016/j.coi.2006.05.003; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Lopes LCL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000853; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mambula SS, 2002, J BIOL CHEM, V277, P39320, DOI 10.1074/jbc.M201683200; Meier A, 2003, CELL MICROBIOL, V5, P561, DOI 10.1046/j.1462-5822.2003.00301.x; Netea MG, 2004, EUR J CLIN MICROBIOL, V23, P672, DOI 10.1007/s10096-004-1192-7; Netea MG, 2003, J INFECT DIS, V188, P320, DOI 10.1086/376456; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; O'Bryan Thomas A, 2005, Expert Rev Anti Infect Ther, V3, P765, DOI 10.1586/14787210.3.5.765; Peter E, 2002, CLIN INFECT DIS, V35, pE54, DOI 10.1086/341971; Pinto MR, 2001, MICROBIOL-SGM, V147, P1499, DOI 10.1099/00221287-147-6-1499; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Roilides E, 2009, MED MYCOL, V47, P433, DOI 10.1080/13693780902738006; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Villamon E, 2004, MICROBES INFECT, V6, P1, DOI 10.1016/j.micinf.2003.09.020; Warris A, 2001, NEW ENGL J MED, V344, P1099, DOI 10.1056/NEJM200104053441415; Wieland CW, 2007, MICROBES INFECT, V9, P134, DOI 10.1016/j.micinf.2006.10.018; Zelante T, 2007, ADV EXP MED BIOL, V590, P209	46	28	29	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40714	40723		10.1074/jbc.M110.181255	http://dx.doi.org/10.1074/jbc.M110.181255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959459	Green Published, hybrid			2022-12-27	WOS:000285414400035
J	Noh, OJ; Park, YH; Chung, YW; Kim, IY				Noh, Ok Jeong; Park, Yong Hwan; Chung, Youn Wook; Kim, Ick Young			Transcriptional Regulation of Selenoprotein W by MyoD during Early Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOGENIC DIFFERENTIATION; OXIDATIVE STRESS; BINDING PROTEIN; MYOBLAST CELLS; DNA-BINDING; STEM-CELLS; EXPRESSION; GENE; THIOREDOXIN; ACTIVATION	Selenoprotein W (SelW) is expressed in various tissues, but it is especially high in the skeletal muscle of mammals. Such tissue-specific protein expression implies regulation by a tissue-specific factor. In this study, we investigated SelW expression during myogenic C2C12 cell differentiation using RTPCR, quantitative PCR, and Western blot analysis. Both the protein and mRNA levels of SelW were increased during C2C12 cell differentiation, particularly during the early stage. Sequence analysis of the SelW promoter revealed four putative E-boxes, E1, E2, E3, and E4, which are known binding sites for MyoD, a myogenic transcriptional factor. Luciferase reporter assay showed that E1 and E4 were crucial for MyoD-dependent promoter activity. Using EMSA analysis, we observed that MyoD bound directly to E1 but not to E4, even though E4 mutation reduced SelW promoter activity in the luciferase reporter assay. Binding of MyoD to E1 was further investigated by ChIP assay. These results suggest that the SelW gene was activated by the binding of MyoD to a specific E-box during early skeletal muscle differentiation.	[Noh, Ok Jeong; Park, Yong Hwan; Kim, Ick Young] Korea Univ, Lab Cellular & Mol Biochem, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Chung, Youn Wook] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA	Korea University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, IY (corresponding author), Korea Univ, Lab Cellular & Mol Biochem, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	ickkim@korea.ac.kr		Chung, Youn Wook/0000-0002-4382-1410	Korean Government (MOEHRD) [KRF-2005-070-C00086]; Korea University	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea University	This work was authored, in whole or in part, by National Institutes of Health staff. This work was funded by Korea Research Foundation Grant from the Korean Government (MOEHRD) KRF-2005-070-C00086 (to I. Y. K.) and in part by a Korea University grant.	Aachmann FL, 2007, J BIOL CHEM, V282, P37036, DOI 10.1074/jbc.M705410200; Amantana A, 2004, J INORG BIOCHEM, V98, P1513, DOI 10.1016/j.jinorgbio.2004.06.003; Amantana A, 2002, J INORG BIOCHEM, V91, P356, DOI 10.1016/S0162-0134(02)00453-1; ASAKURA A, 1993, MOL CELL BIOL, V13, P7153, DOI 10.1128/MCB.13.11.7153; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Castets P, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-46; Catani MV, 2004, FREE RADICAL BIO MED, V37, P1024, DOI 10.1016/j.freeradbiomed.2004.06.021; Chung YW, 2009, MOL CELLS, V27, P609, DOI 10.1007/s10059-009-0074-3; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Flohe L, 2009, BBA-GEN SUBJECTS, V1790, P1389, DOI 10.1016/j.bbagen.2009.03.031; Fujita H, 2010, BIOTECHNOL BIOENG, V107, P894, DOI 10.1002/bit.22865; Gao Y, 2006, CYTOKINE, V33, P246, DOI 10.1016/j.cyto.2006.02.005; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; Huang J, 1996, MOL CELL BIOL, V16, P3893; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; Jeong DW, 2004, MOL CELLS, V17, P156; Kaspar P, 2005, EXP CELL RES, V309, P419, DOI 10.1016/j.yexcr.2005.06.016; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776; Loflin J, 2006, J INORG BIOCHEM, V100, P1679, DOI 10.1016/j.jinorgbio.2006.05.018; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sengupta A, 2009, BIOCHEM CELL BIOL, V87, P953, DOI [10.1139/O09-064, 10.1139/o09-064]; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Stoytcheva ZR, 2010, BBA-GEN SUBJECTS, V1800, P416, DOI 10.1016/j.bbagen.2009.11.003; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Thisse C, 2003, GENE EXPR PATTERNS, V3, P525, DOI 10.1016/S1567-133X(03)00054-1; Walter PL, 2008, BIOCHEM BIOPH RES CO, V365, P316, DOI 10.1016/j.bbrc.2007.10.171; Whanger PD, 2000, CELL MOL LIFE SCI, V57, P1846, DOI 10.1007/PL00000666; Wimmer U, 2005, NUCLEIC ACIDS RES, V33, P5715, DOI 10.1093/nar/gki881; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; YEH JY, 1995, FASEB J, V9, P392, DOI 10.1096/fasebj.9.5.7896009	41	25	25	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40496	40507		10.1074/jbc.M110.152934	http://dx.doi.org/10.1074/jbc.M110.152934			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956524	Green Published, hybrid			2022-12-27	WOS:000285414400012
J	Rinaldo-Matthis, A; Wetterholm, A; Molina, DM; Holm, J; Niegowski, D; Ohlson, E; Nordlund, P; Morgenstern, R; Haeggstrom, JZ				Rinaldo-Matthis, Agnes; Wetterholm, Anders; Molina, Daniel Martinez; Holm, Johanna; Niegowski, Damian; Ohlson, Eva; Nordlund, Par; Morgenstern, Ralf; Haeggstrom, Jesper Z.			Arginine 104 Is a Key Catalytic Residue in Leukotriene C-4 Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL GLUTATHIONE TRANSFERASE; PROSTAGLANDIN-E SYNTHASE-1; THIOLATE ANION; ACTIVE-SITE; OXIDATIVE STRESS; STRUCTURAL BASIS; S-TRANSFERASE; ENZYME; IDENTIFICATION; PURIFICATION	Human leukotriene C-4 synthase (hLTC(4)S) is an integral membrane enzyme that conjugates leukotriene (LT) A(4) with glutathione to form LTC4, a precursor to the cysteinyl leukotrienes (LTC4, LTD4, and LTE4) that are involved in the pathogenesis of human bronchial asthma. From the crystal structure of hLTC(4)S, Arg-104 and Arg-31 have been implicated in the conjugation reaction. Here, we used site-directed mutagenesis, UV spectroscopy, and x-ray crystallography to examine the catalytic role of Arg-104 and Arg-31. Exchange of Arg-104 with Ala, Ser, Thr, or Lys abolished 94.3-99.9% of the specific activity against LTA(4). Steady-state kinetics of R104A and R104S revealed that the K-m for GSH was not significantly affected. UV difference spectra of the binary enzyme-GSH complex indicated that GSH ionization depends on the presence of Arg-104 because no thiolate signal, with lambda(max) at 239 nm, could be detected using R104A or R104S hLTC(4)S. Apparently, the interaction of Arg-104 with the thiol group of GSH reduces its pK(a) to allow formation of a thiolate anion and subsequent nucleophilic attack at C6 of LTA(4). On the other hand, exchange of Arg-31 with Ala or Glu reduced the catalytic activity of hLTC4S by 88 and 70%, respectively, without significantly affecting the k(cat)/K-m values for GSH, and a crystal structure of R31Q hLTC(4)S (2.1 angstrom) revealed a Gln-31 side chain pointing away from the active site. We conclude that Arg-104 plays a critical role in the catalytic mechanism of hLTC(4)S, whereas a functional role of Arg-31 seems more elusive. Because Arg-104 is a conserved residue, our results pertain to other homologous membrane proteins and represent a structure-function paradigm probably common to all microsomal GSH transferases.	[Haeggstrom, Jesper Z.] Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Molina, Daniel Martinez; Nordlund, Par] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Morgenstern, Ralf] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se	Morgenstern, Ralf/GZH-0158-2022	Holm, Johanna/0000-0002-0220-3288	Swedish Research Council [10350, 80429191, 20854]; CERIC; CIDaT; European Commission [005033, 201668]; Soderbergs Foundation; Vinnova SAMPOST; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); CERIC; CIDaT; European Commission(European CommissionEuropean Commission Joint Research Centre); Soderbergs Foundation; Vinnova SAMPOST(Vinnova); Karolinska Institutet(Karolinska Institutet)	This work was supported by Swedish Research Council Grants 10350, 80429191, and 20854 and Linneus Grant CERIC, the CIDaT, European Commission Projects FP6 and FP7 (Grants 005033 and 201668), Soderbergs Foundation, a Vinnova SAMPOST position (to D.N.), and a Distinguished Professor Award from the Karolinska Institutet (to J.Z.H.).	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Alander J, 2009, ARCH BIOCHEM BIOPHYS, V487, P42, DOI 10.1016/j.abb.2009.04.009; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; Caccuri AM, 2001, J BIOL CHEM, V276, P5427, DOI 10.1074/jbc.M002819200; CHEN WJ, 1988, BIOCHEMISTRY-US, V27, P647, DOI 10.1021/bi00402a023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P6252, DOI 10.1021/bi00441a017; GRAMINSKI GF, 1989, BIOCHEMISTRY-US, V28, P3562, DOI 10.1021/bi00434a062; Hammarberg T, 2009, J BIOL CHEM, V284, P301, DOI 10.1074/jbc.M808365200; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; IZUMI T, 1988, BIOCHIM BIOPHYS ACTA, V959, P305; Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jakobsson PJ, 1997, J LIPID MEDIAT CELL, V17, P15, DOI 10.1016/S0929-7855(97)00013-8; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kim DC, 2006, J IMMUNOL, V176, P4440, DOI 10.4049/jimmunol.176.7.4440; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lynch KR, 1999, NATURE, V399, P789; Molina DM, 2008, CURR OPIN STRUC BIOL, V18, P442, DOI 10.1016/j.sbi.2008.04.005; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Morgenstern R, 2001, BIOCHEMISTRY-US, V40, P3378, DOI 10.1021/bi0023394; MORGENSTERN R, 1983, EUR J BIOCHEM, V134, P591, DOI 10.1111/j.1432-1033.1983.tb07607.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Patskovsky YV, 2000, J BIOL CHEM, V275, P3296, DOI 10.1074/jbc.275.5.3296; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rinaldo-Matthis A, 2010, BIOCHIMIE, V92, P676, DOI 10.1016/j.biochi.2010.01.010; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Siritantikorn A, 2007, BIOCHEM BIOPH RES CO, V355, P592, DOI 10.1016/j.bbrc.2007.02.018; Svensson R, 2004, BIOCHEMISTRY-US, V43, P8869, DOI 10.1021/bi0492511; Thoren S, 2003, J BIOL CHEM, V278, P22199, DOI 10.1074/jbc.M303227200; YOSHIMOTO T, 1988, J CLIN INVEST, V81, P866, DOI 10.1172/JCI113396	37	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40771	40776		10.1074/jbc.M110.105940	http://dx.doi.org/10.1074/jbc.M110.105940			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20980252	hybrid, Green Published			2022-12-27	WOS:000285414400041
J	Schupp, M; Lazar, MA				Schupp, Michael; Lazar, Mitchell A.			Endogenous Ligands for Nuclear Receptors: Digging Deeper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							REV-ERB-ALPHA; PROLIFERATOR-ACTIVATED RECEPTORS; RETINOIC ACID RECEPTOR; PPAR-GAMMA; ROR-ALPHA; FATTY-ACIDS; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; BINDING DOMAIN; CIRCADIAN TRANSCRIPTION	Nuclear receptors (NRs) are hormone-sensing transcription factors that translate dietary or endocrine signals into changes in gene expression. Therefore, the adoption of orphan NRs through the identification of their endogenous ligands is a key element for our understanding of their biology. In this minireview, we give an update on recent progress in regard to endogenous ligands for a cluster of NRs with high sequence homology, namely peroxisome proliferator-activated receptors alpha and gamma, Rev-erb alpha, and related receptors. This knowledge about the nature and physiology of these ligands may create new opportunities for therapeutic drug development.	[Schupp, Michael] Charite, Dept Endocrinol Diabet & Nutr, D-10115 Berlin, Germany; [Schupp, Michael] Charite, Cardiovasc Res Ctr, Inst Pharmacol, D-10115 Berlin, Germany; [Lazar, Mitchell A.] Univ Penn, Sch Med, Div Endocrinol Diabet & Metab, Dept Med,Dept Genet, Philadelphia, PA 19104 USA; [Lazar, Mitchell A.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Pennsylvania; University of Pennsylvania	Schupp, M (corresponding author), Charite, Dept Endocrinol Diabet & Nutr, D-10115 Berlin, Germany.	michael.schupp@charite.de; lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019	Schupp, Michael/0000-0003-3720-1052	National Institutes of Health [DK45586, DK49780, DK062434]; Deutsche Forschungsgemeinschaft [SCHU 2546/1-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R01DK045586, R01DK049780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45586, DK49780, and DK062434 (Nuclear Receptor Signaling Atlas; to M. A. L.). This work was also supported by an Emmy-Noether grant from the Deutsche Forschungsgemeinschaft (SCHU 2546/1-1; to M. S.). This is the third article in the Thematic Minireview Series on Nuclear Receptors in Biology and Diseases. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexander RL, 2009, BIOCHEMISTRY-US, V48, P492, DOI 10.1021/bi8016747; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Auwerx J, 2002, AM J PHYSIOL-GASTR L, V282, pG581, DOI 10.1152/ajpgi.00508.2001; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Barter PJ, 2008, ARTERIOSCL THROM VAS, V28, P39, DOI 10.1161/ATVBAHA.107.148817; BECKERANDRE M, 1993, BIOCHEM BIOPH RES CO, V194, P1371, DOI 10.1006/bbrc.1993.1976; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bitsch F, 2003, ANAL BIOCHEM, V323, P139, DOI 10.1016/j.ab.2003.08.029; BRUMBAUGH PF, 1973, LIFE SCI, V13, P1737, DOI 10.1016/0024-3205(73)90120-3; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; CHEN JJ, 1981, CELL, V26, P117, DOI 10.1016/0092-8674(81)90039-8; Cheung KJ, 2007, CELL METAB, V5, P115, DOI 10.1016/j.cmet.2007.01.005; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; GIGUERE V, 1995, MOL CELL BIOL, V15, P2517; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Hallenborg P, 2010, MOL CELL BIOL, V30, P4077, DOI 10.1128/MCB.01806-08; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kallen J, 2004, J BIOL CHEM, V279, P14033, DOI 10.1074/jbc.M400302200; Kallen JA, 2002, STRUCTURE, V10, P1697, DOI 10.1016/S0969-2126(02)00912-7; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LAZAR MA, 1990, DNA CELL BIOL, V9, P77, DOI 10.1089/dna.1990.9.77; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; LoVerme J, 2006, J BIOL CHEM, V281, P22815, DOI 10.1074/jbc.M604751200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Moise AR, 2010, FASEB J, V24, P1261, DOI 10.1096/fj.09-147207; Nagaoka-Yasuda R, 2007, FREE RADICAL BIO MED, V43, P781, DOI 10.1016/j.freeradbiomed.2007.05.008; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Narala VR, 2010, J BIOL CHEM, V285, P22067, DOI 10.1074/jbc.M109.085118; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rogers PM, 2008, BIOCHEM BIOPH RES CO, V368, P955, DOI 10.1016/j.bbrc.2008.02.031; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; SAMUELS HH, 1974, SCIENCE, V184, P1188, DOI 10.1126/science.184.4142.1188; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Schopfer FJ, 2010, J BIOL CHEM, V285, P12321, DOI 10.1074/jbc.M109.091512; Schupp M, 2009, P NATL ACAD SCI USA, V106, P1105, DOI 10.1073/pnas.0812065106; Solt LA, 2010, CURR OPIN LIPIDOL, V21, P204, DOI 10.1097/MOL.0b013e328338ca18; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsukahara T, 2006, J BIOL CHEM, V281, P3398, DOI 10.1074/jbc.M510843200; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; van der Meer DLM, 2010, NUCLEIC ACIDS RES, V38, P2839, DOI 10.1093/nar/gkq012; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Wang YJ, 2010, BBA-MOL CELL BIOL L, V1801, P917, DOI 10.1016/j.bbalip.2010.02.012; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; YAMAMOTO KR, 1972, P NATL ACAD SCI USA, V69, P2105, DOI 10.1073/pnas.69.8.2105; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yin L, 2005, MOL ENDOCRINOL, V19, P1452, DOI 10.1210/me.2005-0057; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	100	122	129	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40409	40415		10.1074/jbc.R110.182451	http://dx.doi.org/10.1074/jbc.R110.182451			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956526	hybrid, Green Published			2022-12-27	WOS:000285414400003
J	Chen, HJ; Anagnostou, G; Chai, A; Withers, J; Morris, A; Adhikaree, J; Pennetta, G; de Belleroche, JS				Chen, Han-Jou; Anagnostou, Georgia; Chai, Andrea; Withers, James; Morris, Alex; Adhikaree, Jason; Pennetta, Giuseppa; de Belleroche, Jackie S.			Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SUPEROXIDE-DISMUTASE PROTEINS; ENDOPLASMIC-RETICULUM STRESS; OXYSTEROL-BINDING PROTEIN; MEMBRANE-PROTEIN; FFAT MOTIF; HAPLOTYPE RECONSTRUCTION; DROSOPHILA-MELANOGASTER; NEUROMUSCULAR-JUNCTIONS; DEPENDENT MANNER	Following the mutation screening of genes known to cause amyotrophic lateral sclerosis (ALS) in index cases from 107 familial ALS (FALS) kindred, a point mutation was identified in vesicle-associated membrane protein-associated protein B (VAPB), or VAMP-associated protein B, causing an amino acid change from threonine to isoleucine at codon 46 (T46I) in one FALS case but not in 257 controls. This is an important finding because it is only the second mutation identified in this gene that causes ALS. In order to investigate the pathogenic effects of this mutation, we have used a motor neuron cell line and tissue-specific expression of the mutant protein in Drosophila. We provide substantial evidence for the pathogenic effects of this mutation in abolishing the effect of wild type VAPB in the unfolded protein response, promoting ubiquitin aggregate formation, and activating neuronal cell death. We also report that expression of the mutant protein in the Drosophila motor system induces aggregate deposition, endoplasmic reticulum disorganization, and chaperone up-regulation both in neurons and in muscles. Our integrated analysis of the pathogenic effect of the T46I mutation and the previously identified P56S mutation indicate extensive commonalities in the disease mechanism for these two mutations. In summary, we show that this newly identified mutation in human FALS has a pathogenic effect, supporting and reinforcing the role of VAPB as a causative gene of ALS.	[Chen, Han-Jou; Anagnostou, Georgia; Morris, Alex; Adhikaree, Jason; de Belleroche, Jackie S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Expt Med,Ctr Neurosci, London W12 0NN, England; [Chai, Andrea; Withers, James; Pennetta, Giuseppa] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh EH8 9XD, Midlothian, Scotland	Imperial College London; University of Edinburgh	de Belleroche, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Div Expt Med,Ctr Neurosci, London W12 0NN, England.	j.belleroche@imperial.ac.uk		Withers, James/0000-0002-5974-3728	ALS Association; Motor Neurone Disease Association; Wellcome Trust	ALS Association; Motor Neurone Disease Association; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the ALS Association, Motor Neurone Disease Association and Wellcome Trust.	Acharya U, 2005, CELL MOL LIFE SCI, V62, P128, DOI 10.1007/s00018-004-4254-1; Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Anagnostou G, 2010, NEUROBIOL AGING, V31, P969, DOI 10.1016/j.neurobiolaging.2008.07.005; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bradley M, 2005, NEUROLOGY, V64, P1628, DOI 10.1212/01.WNL.0000160395.43761.AC; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Conforti FL, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-7; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fleiss JL., 2003, STAT METHODS RATES P; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; HARALICK R, 1992, COMPUTER ROBOT VISIO, V1, P168; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kim S, 2010, J BIOL CHEM, V285, P13839, DOI 10.1074/jbc.M109.097345; KONG TY, 1996, TOPOLOGICAL ALGORITH, P99; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Marques VD, 2006, MUSCLE NERVE, V34, P731, DOI 10.1002/mus.20657; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; NIKAWA J, 1995, J BIOCHEM, V118, P39, DOI 10.1093/oxfordjournals.jbchem.a124889; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Oyanagi K, 2008, NEUROPATH APPL NEURO, V34, P650, DOI 10.1111/j.1365-2990.2008.00941.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; PRATT WK, 2007, DIGITAL IMAGE PROCES, P431; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Ratnaparkhi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002334; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryoo HD, 2007, CELL CYCLE, V6, P830, DOI 10.4161/cc.6.7.4064; Sanyal S, 2005, GENETICS, V169, P737, DOI 10.1534/genetics.104.031930; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Watson MR, 2008, J BIOL CHEM, V283, P24972, DOI 10.1074/jbc.M804817200; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; YAO KM, 1994, J NEUROCHEM, V63, P41; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	77	121	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40266	40281		10.1074/jbc.M110.161398	http://dx.doi.org/10.1074/jbc.M110.161398			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940299	hybrid, Green Published			2022-12-27	WOS:000285185500070
J	Driscoll, MD; McLean, KJ; Levy, C; Mast, N; Pikuleva, IA; Lafite, P; Rigby, SEJ; Leys, D; Munro, AW				Driscoll, Max D.; McLean, Kirsty J.; Levy, Colin; Mast, Natalia; Pikuleva, Irina A.; Lafite, Pierre; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.			Structural and Biochemical Characterization of Mycobacterium tuberculosis CYP142	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; HEME IRON; CHOLESTEROL DEGRADATION; CYTOCHROME-P450; P450; REDUCTION; PROTEINS; SITE; IDENTIFICATION; REVEALS	The Mycobacterium tuberculosis cytochrome P450 enzyme CYP142 is encoded in a large gene cluster involved in metabolism of host cholesterol. CYP142 was expressed and purified as a soluble, low spin P450 hemoprotein. CYP142 binds tightly to cholesterol and its oxidized derivative cholest-4-en-3-one, with extensive shift of the heme iron to the high spin state. High affinity for azole antibiotics was demonstrated, highlighting their therapeutic potential. CYP142 catalyzes either 27- hydroxylation of cholesterol/cholest-4-en-3-one or generates 5-cholestenoic acid/cholest-4-en-3-one-27-oic acid from these substrates by successive sterol oxidations, with the catalytic outcome dependent on the redox partner system used. The CYP142 crystal structure was solved to 1.6A angstrom, revealing a similar active site organization to the cholesterol-metabolizing M. tuberculosis CYP125, but having a near-identical organization of distal pocket residues to the branched fatty acid oxidizing M. tuberculosis CYP124. The cholesterol oxidizing activity of CYP142 provides an explanation for previous findings that del CYP125 strains of Mycobacterium bovis and M. bovis BCG cannot grow on cholesterol, because these strains have a defective CYP142 gene. CYP142 is revealed as a cholesterol 27-oxidase with likely roles in host response modulation and cholesterol metabolism.	[Driscoll, Max D.; McLean, Kirsty J.; Levy, Colin; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs M1 7DN, England; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Lafite, Pierre] Univ Orleans, CNRS, ICOA, UMR 6005, F-45067 Orleans, France; [Leys, David] Royal Soc Univ, London, England	University of Manchester; Case Western Reserve University; CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Orleans	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester, Lancs M1 7DN, England.	Andrew.Munro@Manchester.ac.uk	Lafite, Pierre/F-6806-2011; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Lafite, Pierre/0000-0003-1637-4966; Munro, Andrew/0000-0002-4642-180X; Pikuleva, Irina/0000-0001-9742-6232; McLean, Kirsty/0000-0002-7193-5044	National Institutes of Health [GM062882]; European Union [NM4TB]; BBSRC [BB/E013007/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E013007/1] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062882 (to I. A. P.). This work was also supported by European Union FPVI Project NM4TB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Aoyama Y, 1998, J BIOCHEM-TOKYO, V124, P694; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BATIE CJ, 1981, J BIOL CHEM, V256, P7756; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Campbell IA, 2006, BRIT MED J, V332, P1194, DOI 10.1136/bmj.332.7551.1194; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DRISCOLL MD, 2010, BIOCHIM BIO IN PRESS; Dunford AJ, 2007, J BIOL CHEM, V282, P24816, DOI 10.1074/jbc.M702958200; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Girvan HM, 2010, BIOCHEM J, V427, P455, DOI 10.1042/BJ20091603; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Javitt NB, 2002, J LIPID RES, V43, P665; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lafite P, 2007, BIOCHEMISTRY-US, V46, P10237, DOI 10.1021/bi700876a; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2010, FUTURE MED CHEM, V2, P1339, DOI [10.4155/fmc.10.216, 10.4155/FMC.10.216]; McLean KJ, 2009, J BIOL CHEM, V284, P35524, DOI 10.1074/jbc.M109.032706; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2003, BIOCHEM J, V372, P317, DOI 10.1042/BJ20021692; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Ogura H, 2004, BIOCHEMISTRY-US, V43, P14712, DOI 10.1021/bi048980d; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ouellet H, 2010, MOL MICROBIOL, V77, P730, DOI 10.1111/j.1365-2958.2010.07243.x; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Rivers EC, 2008, DRUG DISCOV TODAY, V13, P1090, DOI 10.1016/j.drudis.2008.09.004; Rosloniec KZ, 2009, MOL MICROBIOL, V74, P1031, DOI 10.1111/j.1365-2958.2009.06915.x; Shenoi S, 2009, CURR OPIN INFECT DIS, V22, P11, DOI 10.1097/QCO.0b013e3283210020; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; STOMBAUGH NA, 1976, BIOCHEMISTRY-US, V15, P2633, DOI 10.1021/bi00657a024; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104	60	78	83	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38270	38282		10.1074/jbc.M110.164293	http://dx.doi.org/10.1074/jbc.M110.164293			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889498	hybrid, Green Published			2022-12-27	WOS:000284625600085
J	Kulkarni, MV; Tettamanzi, MC; Murphy, JW; Keeler, C; Myszka, DG; Chayen, NE; Lolis, EJ; Hodsdon, ME				Kulkarni, Mandar V.; Tettamanzi, M. Cristina; Murphy, James W.; Keeler, Camille; Myszka, David G.; Chayen, Naomi E.; Lolis, Elias J.; Hodsdon, Michael E.			Two Independent Histidines, One in Human Prolactin and One in Its Receptor, Are Critical for pH-dependent Receptor Recognition and Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-RECEPTOR; POSTMENOPAUSAL BREAST-CANCER; TRAFFICKING DYNAMICS; BINDING-SITE; POSTENDOCYTIC TRAFFICKING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; CELL-SURFACE; UCSF CHIMERA; FAMILY	Human prolactin (hPRL), a member of the family of hematopoietic cytokines, functions as both an endocrine hormone and autocrine/paracrine growth factor. We have previously demonstrated that recognition of the hPRL.receptor depends strongly on solution acidity over the physiologic range from pH 6 to pH 8. The hPRL.receptor binding interface contains four histidines whose protonation is hypothesized to regulate pH-dependent receptor recognition. Here, we systematically dissect its molecular origin by characterizing the consequences of His to Ala mutations on pH-dependent receptor binding kinetics, site-specific histidine protonation, and high resolution structures of the intermolecular interface. Thermodynamic modeling of the pH dependence to receptor binding affinity reveals large changes in site-specific protonation constants for a majority of interface histidines upon complexation. Removal of individual His imidazoles reduces these perturbations in protonation constants, which is most likely explained by the introduction of solvent-filled, buried cavities in the crystallographic structures without inducing significant conformational rearrangements.	[Kulkarni, Mandar V.; Tettamanzi, M. Cristina; Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Murphy, James W.; Lolis, Elias J.; Hodsdon, Michael E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Myszka, David G.] Univ Utah, Sch Med, Ctr Biomol Interact Anal, Salt Lake City, UT 84132 USA; [Chayen, Naomi E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Fac Med, London SW7 2AZ, England	Yale University; Yale University; Utah System of Higher Education; University of Utah; Imperial College London	Hodsdon, ME (corresponding author), Yale Univ, Sch Med, Dept Lab Med, POB 208035, New Haven, CT 06520 USA.	michael.hodsdon@yale.edu		Lolis, Elias/0000-0002-7902-7868	National Institutes of Health [RO1 CA 108992, T32-HL007974-07, P41 RR-01081]; NATIONAL CANCER INSTITUTE [R01CA108992] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082295, R01AI065029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA 108992 (to M. E. H.).; Supported by National Institutes of Health Training Grant T32-HL007974-07.; We are thankful to Dr. B. R. Smith for insight and critical comments on the manuscript. The UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, used for creating the molecular graphics images, was supported by National Institutes of Health Grant P41 RR-01081 grant.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Balbis A, 2004, J BIOL CHEM, V279, P12777, DOI 10.1074/jbc.M311493200; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BIGNON C, 1994, J BIOL CHEM, V269, P3318; Broutin I, 2010, J BIOL CHEM, V285, P8422, DOI 10.1074/jbc.M109.089128; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clevenger Charles V, 2003, Breast Dis, V18, P75; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Das R, 1996, ONCOGENE, V13, P1139; Deller MC, 2000, CURR OPIN STRUC BIOL, V10, P213, DOI 10.1016/S0959-440X(00)00072-5; Eliassen AH, 2007, INT J CANCER, V120, P1536, DOI 10.1002/ijc.22482; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; French AR, 1997, ANN BIOMED ENG, V25, P690, DOI 10.1007/BF02684846; FRENCH AR, 1994, J BIOL CHEM, V269, P15749; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; GOFFIN V, 1992, MOL ENDOCRINOL, V6, P1381, DOI 10.1210/me.6.9.1381; Gutzman JH, 2007, ONCOGENE, V26, P6341, DOI 10.1038/sj.onc.1210454; HERBST JJ, 1994, J BIOL CHEM, V269, P12865; Horn JR, 2009, P NATL ACAD SCI USA, V106, P2559, DOI 10.1073/pnas.0809800106; Keeler C, 2007, BIOCHEMISTRY-US, V46, P2398, DOI 10.1021/bi061958v; Keeler C, 2009, PROTEIN SCI, V18, P909, DOI 10.1002/pro.100; Kinet S, 1996, J BIOL CHEM, V271, P14353, DOI 10.1074/jbc.271.24.14353; Kline JB, 2001, MOL ENDOCRINOL, V15, P832, DOI 10.1210/me.15.5.832; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Lauffenburger DA, 1998, CHEM BIOL, V5, pR257, DOI 10.1016/S1074-5521(98)90110-7; LUCK DN, 1991, MOL ENDOCRINOL, V5, P1880, DOI 10.1210/mend-5-12-1880; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pezet A, 1997, J BIOL CHEM, V272, P25043, DOI 10.1074/jbc.272.40.25043; Sarkar CA, 2003, BIOTECHNOL PROGR, V19, P955, DOI 10.1021/bp020017g; STARBUCK C, 1992, BIOTECHNOL PROGR, V8, P132, DOI 10.1021/bp00014a007; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Tettamanzi MC, 2008, BIOCHEMISTRY-US, V47, P8638, DOI 10.1021/bi800444t; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Tworoger SS, 2006, CANCER LETT, V243, P160, DOI 10.1016/j.canlet.2006.01.032; Tworoger SS, 2004, CANCER RES, V64, P6814, DOI 10.1158/0008-5472.CAN-04-1870; Voorhees JL, 2010, J BIOL CHEM, V285, P20022, DOI 10.1074/jbc.M109.084988; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	48	24	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38524	38533		10.1074/jbc.M110.172072	http://dx.doi.org/10.1074/jbc.M110.172072			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889499	Green Published, hybrid			2022-12-27	WOS:000284625600058
J	Liu, L; Luo, Y; Chen, L; Shen, T; Xu, BS; Chen, WX; Zhou, HY; Han, XZ; Huang, SL				Liu, Lei; Luo, Yan; Chen, Long; Shen, Tao; Xu, Baoshan; Chen, Wenxing; Zhou, Hongyu; Han, Xiuzhen; Huang, Shile			Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICTOR-MTOR COMPLEX; MAMMALIAN TARGET; PROTEIN-KINASE; MOTIF PHOSPHORYLATION; BINDING PARTNER; RAPTOR; ACTIVATION; CANCER; GROWTH; MIGRATION	The mammalian target of rapamycin (mTOR) functions in cells at least as two complexes, mTORC1 and mTORC2. Intensive studies have focused on the roles of mTOR in the regulation of cell proliferation, growth, and survival. Recently we found that rapamycin inhibits type I insulin-like growth factor (IGF-1)-stimulated lamellipodia formation and cell motility, indicating involvement of mTOR in regulating cell motility. This study was set to further elucidate the underlying mechanism. Here we show that rapamycin inhibited protein synthesis and activities of small GTPases (RhoA, Cdc42, and Rac1), crucial regulatory proteins for cell migration. Disruption of mTORC1 or mTORC2 by down-regulation of raptor or rictor, respectively, inhibited the activities of these proteins. However, only disruption of mTORC1 mimicked the effect of rapamycin, inhibiting their protein expression. Ectopic expression of rapamycin-resistant and constitutively active S6K1 partially prevented rapamycin inhibition of RhoA, Rac1, and Cdc42 expression, whereas expression of constitutively hypophosphorylated 4E-BP1 (4EBP1-5A) or down-regulation of S6K1 by RNA interference suppressed expression of the GTPases, suggesting that both mTORC1-mediated S6K1 and 4E-BP1 pathways are involved in protein synthesis of the GTPases. Expression of constitutively active RhoA, but not Cdc42 and Rac1, conferred resistance to rapamycin inhibition of IGF-1-stimulated lamellipodia formation and cell migration. The results suggest that rapamycin inhibits cell motility at least in part by down-regulation of RhoA protein expression and activity through mTORC1-mediated S6K1 and 4E-BP1-signaling pathways.	[Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Shreveport, LA 71130 USA; [Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71130 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Huang, SL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1501 Kings Highway, Shreveport, LA 71130 USA.	shuan1@lsuhsc.edu	luo, yan/I-5305-2015; Chen, Wenxing/GSI-9910-2022; Xu, Baoshan/H-6435-2011; Huang, Shile/I-1632-2019	Huang, Shile/0000-0002-3239-1072; Chen, Wenxing/0000-0003-4571-7622; Xu, Baoshan/0000-0001-8902-1243	National Institutes of Health [CA115414]; American Cancer Society [RSG-08-135-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115414 (to S. H.). This work was also supported by American Cancer Society Grant RSG-08-135-01-CNE (to S. H.).	Abecassis I, 2003, EXP CELL RES, V291, P363, DOI 10.1016/j.yexcr.2003.08.006; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fasolo A, 2008, EXPERT OPIN INV DRUG, V17, P1717, DOI [10.1517/13543784.17.11.1717, 10.1517/13543784.17.11.1717 ]; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Guerin P, 2005, J VASC RES, V42, P21, DOI 10.1159/000082873; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo FK, 2004, MOL CELL BIOL, V24, P1426, DOI 10.1128/MCB.24.3.1426-1438.2004; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Liu L, 2008, ONCOGENE, V27, P4998, DOI 10.1038/onc.2008.137; Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2005, J BIOL CHEM, V280, P11101, DOI 10.1074/jbc.M413995200; Shu LL, 2002, J BIOL CHEM, V277, P16726, DOI 10.1074/jbc.M112285200; Sunavala-Dossabhoy G, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-1; Tsang CK, 2007, CELL CYCLE, V6, P25, DOI 10.4161/cc.6.1.3675; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	52	103	113	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38362	38373		10.1074/jbc.M110.141168	http://dx.doi.org/10.1074/jbc.M110.141168			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937815	Green Published, hybrid			2022-12-27	WOS:000284625600042
J	Sun, TT; Yang, XM; Wang, W; Zhang, XJ; Xu, QB; Zhu, SC; Kuchta, R; Chen, GJ; Liu, XD				Sun, Tingting; Yang, Xiaomei; Wang, Wei; Zhang, Xiaojuan; Xu, Quanbin; Zhu, Songcheng; Kuchta, Robert; Chen, Guanjun; Liu, Xuedong			Cellular Abundance of Mps1 and the Role of Its Carboxyl Terminal Tail in Substrate Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; SMALL-MOLECULE INHIBITOR; DUPLICATION GENE MPS1; MITOTIC CHECKPOINT; PROTEIN-KINASE; CENTROSOME DUPLICATION; CANCER-CELLS; CHROMOSOMAL INSTABILITY; CRYSTAL-STRUCTURE; DROSOPHILA MPS1	Mps1 is a protein kinase that regulates normal mitotic progression and the spindle checkpoint in response to spindle damage. The levels of Mps1 are relatively low in cells during interphase but elevated in mitosis or upon activation of the spindle checkpoint, although the dynamic range of Mps1 expression and the Mps1 catalytic mechanism have not been carefully characterized. Our recent structural studies of the Mps1 kinase domain revealed that the carboxyl-terminal tail region of Mps1 is unstructured, raising the question of whether this region has any functional role in Mps1 catalysis. Here we first determined the cellular abundance of Mps1 during cell cycle progression and found that Mps1 levels vary between 60,000 per cell in early G(1) and 110,000 per cell during mitosis. We studied phosphorylation of a number of Mps1 substrates in vitro and in culture cells. Unexpectedly, we found that the unstructured carboxyl-terminal region of Mps1 plays an essential role in substrate recruitment. Kinetics studies using the purified recombinant wild type and mutant kinases indicate that the carboxyl-terminal tail is largely dispensable for autophosphorylation of Mps1 but critical for trans-phosphorylation of substrates in vitro and in cultured cells. Mps1 mutant without the unstructured tail region is defective in mediating spindle assembly checkpoint activation. Our results underscore the importance of the unstructured tail region of Mps1 in kinase activation.	[Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA; [Sun, Tingting; Chen, Guanjun] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Yang, Xiaomei] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China; [Xu, Quanbin] Beijing Inst Biotechnol, Beijing 100850, Peoples R China	University of Colorado System; University of Colorado Boulder; Shandong University; Shandong University	Liu, XD (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	liux@colorado.edu	Xu, Quanbin/K-1904-2019	LIU, XUEDONG/0000-0001-7209-4964; Xu, Quanbin/0000-0002-2833-9773	National Institutes of Health [R01CA107098]; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA107098 (to X. L.).	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bourhis E, 2009, BIOCHEMISTRY-US, V48, P6783, DOI 10.1021/bi900530v; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; DOUVILLE EMJ, 1992, MOL CELL BIOL, V12, P2681, DOI 10.1128/MCB.12.6.2681; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; Fisk HA, 2004, CELL CYCLE, V3, P439; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Frisa PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007064; Gilliland WD, 2005, CURR BIOL, V15, P672; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HOGG D, 1994, ONCOGENE, V9, P89; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Jelluma N, 2008, CELL, V132, P233, DOI 10.1016/j.cell.2007.11.046; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Kanatsu-Shinohara M, 2000, BIOL REPROD, V63, P1610, DOI 10.1095/biolreprod63.6.1610; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; KOBAYASHI H, 1991, J CELL BIOL, V114, P755, DOI 10.1083/jcb.114.4.755; Kops GJPL, 2004, P NATL ACAD SCI USA, V101, P8699, DOI 10.1073/pnas.0401142101; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; LINDBERG RA, 1993, ONCOGENE, V8, P351; Mattison CP, 2007, J BIOL CHEM, V282, P30553, DOI 10.1074/jbc.M707063200; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Poss KD, 2004, GENE DEV, V18, P1527, DOI 10.1101/gad.1182604; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Schmidt M, 2006, CELL CYCLE, V5, P159, DOI 10.4161/cc.5.2.2309; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tighe A, 2001, EMBO REP, V2, P609, DOI 10.1093/embo-reports/kve127; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xu NH, 2007, CELL CYCLE, V6, P1639, DOI 10.4161/cc.6.13.4385; Xu QB, 2009, MOL BIOL CELL, V20, P10, DOI 10.1091/mbc.E08-03-0324; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhu SC, 2007, J BIOL CHEM, V282, P18327, DOI 10.1074/jbc.M700636200; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	53	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38730	38739		10.1074/jbc.M110.177642	http://dx.doi.org/10.1074/jbc.M110.177642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884615	Green Published, hybrid			2022-12-27	WOS:000284625600078
J	Feng, XY; Tang, KH; Blankenship, RE; Tang, YJ				Feng, Xueyang; Tang, Kuo-Hsiang; Blankenship, Robert E.; Tang, Yinjie J.			Metabolic Flux Analysis of the Mixotrophic Metabolisms in the Green Sulfur Bacterium Chlorobaculum tepidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; COMPLETE GENOME SEQUENCE; CHLOROBIUM-TEPIDUM; SACCHAROMYCES-CEREVISIAE; PATHWAYS; STRAIN; ACID; MS; PURIFICATION; PYRUVATE	The photosynthetic green sulfur bacterium Chlorobaculum tepidum assimilates CO2 and organic carbon sources (acetate or pyruvate) during mixotrophic growth conditions through a unique carbon and energy metabolism. Using a C-13-labeling approach, this study examined biosynthetic pathways and flux distributions in the central metabolism of C. tepidum. The isotopomer patterns of proteinogenic amino acids revealed an alternate pathway for isoleucine synthesis (via citramalate synthase, CimA, CT0612). A C-13-assisted flux analysis indicated that carbons in biomass were mostly derived from CO2 fixation via three key routes: the reductive tricarboxylic acid (RTCA) cycle, the pyruvate synthesis pathway via pyruvate: ferredoxin oxidoreductase, and the CO2-anaplerotic pathway via phosphoenolpyruvate carboxylase. During mixotrophic growth with acetate or pyruvate as carbon sources, acetyl-CoA was mainly produced from acetate (via acetyl-CoA synthetase) or citrate (via ATP citrate lyase). Pyruvate: ferredoxin oxidoreductase converted acetyl-CoA and CO2 to pyruvate, and this growth-rate control reaction is driven by reduced ferredoxin generated during phototrophic growth. Most reactions in the RTCA cycle were reversible. The relative fluxes through the RTCA cycle were 80 similar to 100 units for mixotrophic cultures grown on acetate and 200 similar to 230 units for cultures grown on pyruvate. Under the same light conditions, the flux results suggested a trade-off between energy-demanding CO2 fixation and biomass growth rate; C. tepidum fixed more CO2 and had a higher biomass yield (Y-X/S, mole carbon in biomass/mole substrate) in pyruvate culture (Y-X/S = 9.2) than in acetate culture (Y-X/S = 6.4), but the biomass growth rate was slower in pyruvate culture than in acetate culture.	Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO 63130 USA; [Tang, Kuo-Hsiang; Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)		yinjie.tang@seas.wustl.edu	Tang, Yinjie/AAI-5584-2020; Feng, Xueyang/G-1295-2015	Feng, Xueyang/0000-0003-4426-5732	National Science Foundation [MCB0954016]; NASA [NNX08AP62G]	National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported in part by National Science Foundation Career Grant MCB0954016 (to Y. J. T.). This work was also supported by Grant NNX08AP62G from the Exobiology program of NASA (to R. E. B.).	Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Feng XY, 2010, MICROBIOL-SGM, V156, P2566, DOI 10.1099/mic.0.038232-0; Feng XY, 2009, APPL ENVIRON MICROB, V75, P5001, DOI 10.1128/AEM.00715-09; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Furdui C, 2000, J BIOL CHEM, V275, P28494, DOI 10.1074/jbc.M003291200; HOWELL BF, 1979, CLIN CHEM, V25, P269; Kleijn RJ, 2007, FEMS YEAST RES, V7, P216, DOI 10.1111/j.1567-1364.2006.00180.x; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; Sauer U, 1999, J BACTERIOL, V181, P6679, DOI 10.1128/JB.181.21.6679-6688.1999; Seo D, 2002, BBA-PROTEIN STRUCT M, V1597, P123, DOI 10.1016/S0167-4838(02)00269-8; Sonderegger M, 2004, APPL ENVIRON MICROB, V70, P2307, DOI 10.1128/AEM.70.4.2307-2317.2004; Stephanopoulos G. N., 1998, METABOLIC ENG PRINCI, P119; Tan YJ, 2009, BIOTECHNOL BIOENG, V102, P1161, DOI 10.1002/bit.22129; Tang KH, 2010, J BIOL CHEM, V285, P35848, DOI 10.1074/jbc.M110.157834; Tang KH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-150; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P3859, DOI 10.1128/AEM.02986-06; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJ, 2007, J BACTERIOL, V189, P894, DOI 10.1128/JB.00926-06; Tang YJ, 2009, MASS SPECTROM REV, V28, P362, DOI 10.1002/mas.20191; Tang YJ, 2009, BIOTECHNOL BIOENG, V102, P1377, DOI 10.1002/bit.22181; Voet D., 2008, FUNDAMENTALS BIOCH, P586; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Wahlund TM, 1997, J BACTERIOL, V179, P4859, DOI 10.1128/jb.179.15.4859-4867.1997; Wu B, 2010, MICROBIOL-SGM, V156, P596, DOI 10.1099/mic.0.031799-0; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Zhao J, 2003, J BIOTECHNOL, V101, P101, DOI 10.1016/S0168-1656(02)00316-4	31	42	43	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39544	39550		10.1074/jbc.M110.162958	http://dx.doi.org/10.1074/jbc.M110.162958			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937805	Green Published, hybrid			2022-12-27	WOS:000284941300080
J	Simon, F; Leiva-Salcedo, E; Armisen, R; Riveros, A; Cerda, O; Varela, D; Eguiguren, AL; Olivero, P; Stutzin, A				Simon, Felipe; Leiva-Salcedo, Elias; Armisen, Ricardo; Riveros, Ana; Cerda, Oscar; Varela, Diego; Luisa Eguiguren, Ana; Olivero, Pablo; Stutzin, Andres			Hydrogen Peroxide Removes TRPM4 Current Desensitization Conferring Increased Vulnerability to Necrotic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; REGULATORY VOLUME DECREASE; PROTEIN-SULFENIC ACIDS; SMOOTH-MUSCLE-CELLS; MEMBRANE DEPOLARIZATION; OXIDATIVE STRESS; ACTIVATION; EXPRESSION; CA2+; NECROSIS	Necrosis is associated with an increase in plasma membrane permeability, cell swelling, and loss of membrane integrity with subsequent release of cytoplasmic constituents. Severe redox imbalance by overproduction of reactive oxygen species is one of the main causes of necrosis. Here we demonstrate that H2O2 induces a sustained activity of TRPM4, a Ca2+-activated, Ca2+-impermeant nonselective cation channel resulting in an increased vulnerability to cell death. In HEK 293 cells overexpressing TRPM4, H2O2 was found to eliminate in a dose-dependent manner TRPM4 desensitization. Site-directed mutagenesis experiments revealed that the Cys(1093) residue is crucial for the H2O2-mediated loss of desensitization. In HeLa cells, which endogenously express TRPM4, H2O2 elicited necrosis as well as apoptosis. H2O2-mediated necrosis but not apoptosis was abolished by replacement of external Na+ ions with sucrose or the non-permeant cation N-methyl-D-glucamine and by knocking down TRPM4 with a shRNA directed against TRPM4. Conversely, transient overexpression of TRPM4 in HeLa cells in which TRPM4 was previously silenced re-established vulnerability to H2O2-induced necrotic cell death. In addition, HeLa cells exposed to H2O2 displayed an irreversible loss of membrane potential, which was prevented by TRPM4 knockdown.	[Stutzin, Andres] Univ Chile, Fac Med, Ctr Estudios Mol Celula, Santiago 7, Chile; Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 7, Chile	Universidad de Chile; Universidad de Chile	Stutzin, A (corresponding author), Univ Chile, Fac Med, Ctr Estudios Mol Celula, Av Independencia 1027,Independencia 838-0543, Santiago 7, Chile.	astutzin@bitmed.med.uchile.cl	Varela, Diego/AAG-7489-2019; Cerda, Oscar/N-3895-2018; Stutzin, Andrés/I-7605-2013; Armisen, Ricardo/A-7409-2012; riveros, ana/AAD-2134-2020; Olivero, Pablo/AAS-5076-2021	Varela, Diego/0000-0002-9352-414X; Cerda, Oscar/0000-0003-2873-5722; Stutzin, Andrés/0000-0002-7264-066X; Armisen, Ricardo/0000-0003-2567-0521; Olivero, Pablo/0000-0001-8886-7706; Riveros, Ana Luisa/0000-0002-1926-4562; Simon, Felipe/0000-0002-2653-9798	FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile [15010006]	FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work was supported by Grant 15010006 from FONDAP (Fondo de Financiamiento de Centros de Excelencia en Investigacion), Chile.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Barros LF, 2001, COMP BIOCHEM PHYS A, V130, P401, DOI 10.1016/S1095-6433(01)00438-X; Barros LF, 2001, HEPATOLOGY, V33, P114, DOI 10.1053/jhep.2001.20530; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; CROWE WE, 1995, NEUROSCIENCE, V69, P283, DOI 10.1016/0306-4522(95)00219-9; Fonfria E, 2006, J RECEPT SIG TRANSD, V26, P159, DOI 10.1080/10799890600637506; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Guinamard R, 2006, HYPERTENSION, V48, P587, DOI 10.1161/01.HYP.0000237864.65019.a5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Herson PS, 1997, J PHYSIOL-LONDON, V501, P59, DOI 10.1111/j.1469-7793.1997.059bo.x; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Inoue M, 1999, J PHYSIOL-LONDON, V519, P385, DOI 10.1111/j.1469-7793.1999.0385m.x; Jeulin C, 2002, PFLUG ARCH EUR J PHY, V443, P574, DOI 10.1007/s00424-001-0733-5; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Koliwad SK, 1996, J PHYSIOL-LONDON, V491, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Petersen OH, 2002, CURR BIOL, V12, pR520, DOI 10.1016/S0960-9822(02)01027-8; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Salsbury FR, 2008, PROTEIN SCI, V17, P299, DOI 10.1110/ps.073096508; Schlenker T, 2000, GASTROENTEROLOGY, V118, P395, DOI 10.1016/S0016-5085(00)70222-8; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simon F, 2004, AM J PHYSIOL-CELL PH, V287, pC963, DOI 10.1152/ajpcell.00041.2004; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200	42	52	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37150	37158		10.1074/jbc.M110.155390	http://dx.doi.org/10.1074/jbc.M110.155390			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20884614	hybrid, Green Published			2022-12-27	WOS:000284424000008
J	Li, XP; Grela, P; Krokowski, D; Tchorzewski, M; Tumer, NE				Li, Xiao-Ping; Grela, Przemyslaw; Krokowski, Dawid; Tchorzewski, Marek; Tumer, Nilgun E.			Pentameric Organization of the Ribosomal Stalk Accelerates Recruitment of Ricin A Chain to the Ribosome for Depurination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR-G; N-GLYCOSIDASE ACTIVITY; IN-VITRO; P-PROTEINS; INACTIVATING PROTEIN; INTERACTION SITES; STRUCTURAL BASIS; BINDING-SITES; A-CHAIN; TRICHOSANTHIN	Ribosome inactivating proteins (RIPs) depurinate a universally conserved adenine in the alpha-sarcin/ricin loop (SRL) and inhibit protein synthesis at the translation elongation step. We previously showed that ribosomal stalk is required for depurination of the SRL by ricin toxin A chain (RTA). The interaction between RTA and ribosomes was characterized by a two-step binding model, where the stalk structure could be considered as an important interacting element. Here, using purified yeast ribosomal stalk complexes assembled in vivo, we show a direct interaction between RTA and the isolated stalk complex. Detailed kinetic analysis of these interactions in real time using surface plasmon resonance (SPR) indicated that there is only one type of interaction between RTA and the ribosomal stalk, which represents one of the two binding steps of the interaction with ribosomes. Interactions of RTA with the isolated stalk were relatively insensitive to salt, indicating that nonelectrostatic interactions were dominant. We compared the interaction of RTA with the full pentameric stalk complex containing two pairs of P1/P2 proteins with its interaction with the trimeric stalk complexes containing only one pair of P1/P2 and found that the rate of association of RTA with the pentamer was higher than with either trimer. These results demonstrate that the stalk is the main landing platform for RTA on the ribosome and that pentameric organization of the stalk accelerates recruitment of RTA to the ribosome for depurination. Our results suggest that multiple copies of the stalk proteins might also increase the scavenging ability of the ribosome for the translational GTPases.	[Li, Xiao-Ping; Tumer, Nilgun E.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA; [Grela, Przemyslaw; Krokowski, Dawid; Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, PL-20033 Lublin, Poland	Rutgers State University New Brunswick; Maria Curie-Sklodowska University	Tumer, NE (corresponding author), Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	tumer@aesop.rutgers.edu		Tchorzewski, Marek/0000-0002-0718-4223; Grela, Przemyslaw/0000-0002-5930-416X	National Institutes of Health [AI072425]; FOGARTY INTERNATIONAL CENTER [R03TW008418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI072425 (to N. E. T.).	Ayub MJ, 2008, BIOCHEM BIOPH RES CO, V369, P314, DOI 10.1016/j.bbrc.2008.01.170; Ballesta JPG, 1996, PROG NUCLEIC ACID RE, V55, P157, DOI 10.1016/S0079-6603(08)60193-2; Bernado P, 2010, BIOPHYS J, V98, P2374, DOI 10.1016/j.bpj.2010.02.012; CAWLEY DB, 1979, BIOCHEMISTRY-US, V18, P2648, DOI 10.1021/bi00579a034; Chan DSB, 2007, NUCLEIC ACIDS RES, V35, P1660, DOI 10.1093/nar/gkm065; Chan SH, 2001, EUR J BIOCHEM, V268, P2107, DOI 10.1046/j.1432-1327.2001.02091.x; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Clementi N, 2010, NAT CHEM BIOL, V6, P344, DOI 10.1038/nchembio.341; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; ENDO Y, 1988, J BIOL CHEM, V263, P8735; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FERNANDEZPUENTES C, 1976, EUR J BIOCHEM, V64, P437, DOI 10.1111/j.1432-1033.1976.tb10320.x; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gonzalo P, 2001, J BIOL CHEM, V276, P19762, DOI 10.1074/jbc.M101398200; Grela P, 2008, J BIOCHEM, V143, P169, DOI 10.1093/jb/mvm207; Grela P, 2010, BIOCHEMISTRY-US, V49, P924, DOI 10.1021/bi901811s; Grela P, 2007, BIOCHEMISTRY-US, V46, P1988, DOI 10.1021/bi0616450; Guarinos E, 2003, MOL MICROBIOL, V50, P703, DOI 10.1046/j.1365-2958.2003.03733.x; Guarinos E, 2001, J BIOL CHEM, V276, P32474, DOI 10.1074/jbc.M103229200; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; HOLMBERG L, 1994, BIOCHEMISTRY-US, V33, P15159, DOI 10.1021/bi00254a027; Huang CH, 2010, J MOL BIOL, V399, P145, DOI 10.1016/j.jmb.2010.04.009; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Korennykh AV, 2007, RNA, V13, P1391, DOI 10.1261/rna.619707; Korennykh AV, 2006, NAT STRUCT MOL BIOL, V13, P436, DOI 10.1038/nsmb1082; Krokowski D, 2006, MOL MICROBIOL, V60, P386, DOI 10.1111/j.1365-2958.2006.05117.x; Krokowski D, 2005, BBA-GEN SUBJECTS, V1724, P59, DOI 10.1016/j.bbagen.2005.03.009; Krokowski D, 2007, BIOCHEM BIOPH RES CO, V355, P575, DOI 10.1016/j.bbrc.2007.02.024; Lalioti VS, 2002, MOL MICROBIOL, V46, P719, DOI 10.1046/j.1365-2958.2002.03179.x; Li XP, 2009, BIOCHEMISTRY-US, V48, P3853, DOI 10.1021/bi802371h; Lord Michael J., 2003, Toxicological Reviews, V22, P53, DOI 10.2165/00139709-200322010-00006; Maki Y, 2007, J BIOL CHEM, V282, P32827, DOI 10.1074/jbc.M705412200; Martinez-Azorin F, 2008, FEBS LETT, V582, P3029, DOI 10.1016/j.febslet.2008.07.039; McCluskey AJ, 2008, J MOL BIOL, V378, P375, DOI 10.1016/j.jmb.2008.02.014; Miyoshi T, 2009, J BIOL CHEM, V284, P85, DOI 10.1074/jbc.M806024200; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Naganuma T, 2010, J BIOL CHEM, V285, P4747, DOI 10.1074/jbc.M109.068098; NOLAN RD, 1976, EUR J BIOCHEM, V64, P69, DOI 10.1111/j.1432-1033.1976.tb10275.x; Nomura T, 2008, J BIOCHEM, V144, P665, DOI 10.1093/jb/mvn113; OLSNES S, 1972, FEBS LETT, V20, P327, DOI 10.1016/0014-5793(72)80098-X; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Shimizu T, 2002, NUCLEIC ACIDS RES, V30, P2620, DOI 10.1093/nar/gkf379; SPERTI S, 1973, BIOCHEM J, V136, P813, DOI 10.1042/bj1360813; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Too PHM, 2009, NUCLEIC ACIDS RES, V37, P602, DOI 10.1093/nar/gkn922; VILELLA MD, 1991, EUR J BIOCHEM, V196, P407, DOI 10.1111/j.1432-1033.1991.tb15831.x; WAHL MC, 2002, CURR PROTEIN PEPT SC, V3, pNIL2; Yang YH, 2010, J MOL BIOL, V395, P897, DOI 10.1016/j.jmb.2009.10.051	48	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41463	41471		10.1074/jbc.M110.171793	http://dx.doi.org/10.1074/jbc.M110.171793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974854	Green Published, hybrid			2022-12-27	WOS:000285622600032
J	Mok, WWK; Patel, NH; Li, YF				Mok, Wendy W. K.; Patel, Nirav H.; Li, Yingfu			Decoding Toxicity DEDUCING THE SEQUENCE REQUIREMENTS OF IbsC, A TYPE I TOXIN IN ESCHERICHIA COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOS-INDUCED TOXIN; SMALL RNAS; GEF GENE; COMPARATIVE GENOMICS; PLASMID MAINTENANCE; ANTITOXIN SYSTEMS; CELL-DEATH; MEMBRANE; INDUCTION; IDENTIFICATION	Bacterial genomes encode a collection of small peptides that are deleterious to their hosts when overexpressed. The physiological relevance of the majority of these peptides is unknown at present, although many of them have been implicated in regulatory processes important for cell survival and adaptability. One peptide that is of particular interest to us is a 19-amino acid proteic toxin, coined IbsC, whose production is repressed by SibC, an RNA antitoxin. Together, IbsC and SibC constitute a type I toxin-antitoxin (TA) pair. To better understand the function of IbsC and to decipher the sequence determinants for its toxic phenotype, we carried out extensive sequence analyses of the peptide. We generated a series of truncation and single amino acid deletion mutants to determine the minimal sequence required for toxicity. We further probed into functionally relevant amino acids with a comprehensive set of IbsC mutants produced using a systematic sequence randomization strategy. We found that IbsC remained toxic in the presence of multiple deletions and single amino acid substitutions, despite being well-conserved in Escherichia coli and across other Gram-negative bacteria. The toxicity of this peptide was determined to be dependent on a stretch of highly hydrophobic residues near its center. Our results defined sequence-function relationship of IbsC and offered additional insights into properties common to membrane-targeting type I toxins in E. coli and related species.	McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	Li, YF (corresponding author), Hlth Sci Ctr 4H31, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	liying@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).; An NSERC CGS Doctoral Scholarship recipient.; Supported by the Canada Research Chairs program. To whom correspondence should be addressed: 1200 Main St. West, Health Sciences Centre 4H31, Hamilton, ON L8N 3Z5, Canada. Tel.: 905-525-9140, ext. 22462; Fax: 905-522-9033; E-mail: liying@mcmaster.ca.	Alix E, 2009, MOL MICROBIOL, V72, P5, DOI 10.1111/j.1365-2958.2009.06626.x; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Boulaiz H, 2008, BRIT J DERMATOL, V159, P370, DOI 10.1111/j.1365-2133.2008.08688.x; Boulaiz H, 2003, BRIT J CANCER, V89, P192, DOI 10.1038/sj.bjc.6601064; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; Darfeuille F, 2007, MOL CELL, V26, P381, DOI 10.1016/j.molcel.2007.04.003; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Fozo EM, 2008, MOL MICROBIOL, V70, P1076, DOI 10.1111/j.1365-2958.2008.06394.x; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200; Han K, 2010, NUCLEIC ACIDS RES, V38, P5851, DOI 10.1093/nar/gkq292; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Kawano M, 2007, MOL MICROBIOL, V64, P738, DOI 10.1111/j.1365-2958.2007.05688.x; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Mok WWK, 2009, CHEMBIOCHEM, V10, P238, DOI 10.1002/cbic.200800591; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Prados J, 2008, INT J ONCOL, V33, P121; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Unoson C, 2008, MOL MICROBIOL, V70, P258, DOI 10.1111/j.1365-2958.2008.06416.x; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439	35	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41627	41636		10.1074/jbc.M110.149179	http://dx.doi.org/10.1074/jbc.M110.149179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980267	Green Published, hybrid			2022-12-27	WOS:000285622600050
J	Prunetti, L; Infossi, P; Brugna, M; Ebel, C; Giudici-Orticoni, MT; Guiral, M				Prunetti, Laurence; Infossi, Pascale; Brugna, Myriam; Ebel, Christine; Giudici-Orticoni, Marie-Therese; Guiral, Marianne			New Functional Sulfide Oxidase-Oxygen Reductase Supercomplex in the Membrane of the Hyperthermophilic Bacterium Aquifex aeolicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; RESPIRATORY-CHAIN; QUINONE REDUCTASE; ELECTRON-TRANSFER; C-OXIDASE; PARACOCCUS-DENITRIFICANS; RHODOBACTER-SPHAEROIDES; NATIVE ELECTROPHORESIS; PROTEIN COMPLEXES; TERMINAL OXIDASE	Aquifex aeolicus, a hyperthermophilic and microaerophilic bacterium, obtains energy for growth from inorganic compounds alone. It was previously proposed that one of the respiratory pathways in this organism consists of the electron transfer from hydrogen sulfide (H2S) to molecular oxygen. H2S is oxidized by the sulfide quinone reductase, a membrane-bound flavoenzyme, which reduces the quinone pool. We have purified and characterized a novel membrane-bound multienzyme supercomplex that brings together all the molecular components involved in this bioenergetic chain. Our results indicate that this purified structure consists of one dimeric bc(1) complex (complex III), one cytochrome c oxidase (complex IV), and one or two sulfide quinone reductases as well as traces of the monoheme cytochrome c(555) and quinone molecules. In addition, this work strongly suggests that the cytochrome c oxidase in the supercomplex is a ba(3)-type enzyme. The supercomplex has a molecular mass of about 350 kDa and is enzymatically functional, reducing O-2 in the presence of the electron donor, H2S. This is the first demonstration of the existence of such a respirasome carrying a sulfide oxidase-oxygen reductase activity. Moreover, the kinetic properties of the sulfide quinone reductase change slightly when integrated in the supercomplex, compared with the free enzyme. We previously purified a complete respirasome involved in hydrogen oxidation and sulfur reduction from Aquifex aeolicus. Thus, two different bioenergetic pathways (sulfur reduction and sulfur oxidation) are organized in this bacterium as supramolecular structures in the membrane. A model for the energetic sulfur metabolism of Aquifex aeolicus is proposed.	[Prunetti, Laurence; Infossi, Pascale; Brugna, Myriam; Giudici-Orticoni, Marie-Therese; Guiral, Marianne] CNRS, IMM IFR88, Lab Bioenerget & Ingn Prot, UPR 9036, F-13402 Marseille 20, France; [Brugna, Myriam] Univ Aix Marseille 1, F-13331 Marseille 3, France; [Ebel, Christine] CEA, IBS, F-38027 Grenoble 1, France; [Ebel, Christine] Univ Grenoble 1, F-3800 Grenoble, France; [Ebel, Christine] CNRS, UMR 5075, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Guiral, M (corresponding author), CNRS, IMM IFR88, Lab Bioenerget & Ingn Prot, UPR 9036, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	guiral@ifr88.cnrs-mrs.fr		BRUGNA, Myriam/0000-0002-4017-3294; Ebel, Christine/0000-0002-6912-500X	CNRS; Region-Provence-Alpes Cote d'Azur; Marseille Metropole	CNRS(Centre National de la Recherche Scientifique (CNRS)); Region-Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Marseille Metropole	This work was supported in part by CNRS, Region-Provence-Alpes Cote d'Azur, and Marseille Metropole.	Aubert C, 2001, BIOCHEMISTRY-US, V40, P13690, DOI 10.1021/bi011202q; Baymann F, 2001, BIOCHEMISTRY-US, V40, P13681, DOI 10.1021/bi011201y; BERRY EA, 1985, J BIOL CHEM, V260, P2458; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Cherney MM, 2010, J MOL BIOL, V398, P292, DOI 10.1016/j.jmb.2010.03.018; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DEVRIES S, 1979, BIOCHIM BIOPHYS ACTA, V546, P334; DISPIRITO AA, 1986, J BIOL CHEM, V261, P7048; Ebel C., 2007, PROTEIN STRUCTURES M, P229; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Eubel H, 2004, PLANT PHYSIOL BIOCH, V42, P937, DOI 10.1016/j.plaphy.2004.09.010; Farver O, 2006, FEBS LETT, V580, P3417, DOI 10.1016/j.febslet.2006.05.013; FEE JA, 1980, P NATL ACAD SCI-BIOL, V77, P147, DOI 10.1073/pnas.77.1.147; Genova ML, 2008, BBA-BIOENERGETICS, V1777, P740, DOI 10.1016/j.bbabio.2008.04.007; GRIESBECK C, 2000, RRD MICROBIOL 1, V4, P179; Guiral M, 2005, J BIOL CHEM, V280, P42004, DOI 10.1074/jbc.M508034200; Guiral M, 2009, J PROTEOME RES, V8, P1717, DOI 10.1021/pr8007946; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Huber R., 1999, EMBRYONIC ENCY LIFE; Infossi P, 2010, INT J HYDROGEN ENERG, V35, P10778, DOI 10.1016/j.ijhydene.2010.02.054; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; KEEFE RG, 1993, BIOCHIM BIOPHYS ACTA, V1183, P91, DOI 10.1016/0005-2728(93)90008-4; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebreton S, 2003, J BIOL CHEM, V278, P12078, DOI 10.1074/jbc.M213096200; Marcia M, 2010, BBA-BIOMEMBRANES, V1798, P2114, DOI 10.1016/j.bbamem.2010.07.033; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; MCCURLEY JP, 1990, BIOCHIM BIOPHYS ACTA, V1020, P176, DOI 10.1016/0005-2728(90)90049-A; Megehee JA, 2006, MICROBIOL-SGM, V152, P823, DOI 10.1099/mic.0.28723-0; Montoya G, 1999, EUR J BIOCHEM, V259, P709, DOI 10.1046/j.1432-1327.1999.00094.x; Niebisch A, 2003, J BIOL CHEM, V278, P4339, DOI 10.1074/jbc.M210499200; Nubel T, 2000, ARCH MICROBIOL, V173, P233, DOI 10.1007/s002030000135; Pelletier N, 2008, EXTREMOPHILES, V12, P205, DOI 10.1007/s00792-007-0119-5; SALERNO JC, 1984, J BIOL CHEM, V259, P2331; Salvay AG, 2006, PROG COLL POL SCI S, V131, P74, DOI 10.1007/2882_006; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scharf B, 1997, BIOCHEMISTRY-US, V36, P4471, DOI 10.1021/bi962312d; Schutz M, 1999, J BACTERIOL, V181, P6516; Schutz M, 1997, J BIOL CHEM, V272, P9890; Schutz M, 2003, BIOCHEMISTRY-US, V42, P10800, DOI 10.1021/bi034452a; SONE N, 1987, J BIOL CHEM, V262, P15386; SONE N, 1984, BIOCHEM J, V223, P809, DOI 10.1042/bj2230809; Sousa FL, 2008, BIOPHYS J, V94, P2434, DOI 10.1529/biophysj.107.122614; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stuart RA, 2009, METHOD ENZYMOL, V456, P191, DOI 10.1016/S0076-6879(08)04411-X; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; VANGELDE.BF, 1969, BIOCHIM BIOPHYS ACTA, V189, P1, DOI 10.1016/0005-2728(69)90219-9; Vermeglio A, 2002, BBA-BIOENERGETICS, V1555, P60, DOI 10.1016/S0005-2728(02)00255-4; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	56	29	29	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41815	41826		10.1074/jbc.M110.167841	http://dx.doi.org/10.1074/jbc.M110.167841			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971847	hybrid, Green Published			2022-12-27	WOS:000285622600069
J	Sakwe, AM; Koumangoye, R; Goodwin, SJ; Ochieng, J				Sakwe, Amos M.; Koumangoye, Rainelli; Goodwin, Shawn J.; Ochieng, Josiah			Fetuin-A (alpha 2HS-Glycoprotein) Is a Major Serum Adhesive Protein That Mediates Growth Signaling in Breast Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER CELLS; CARCINOMA CELLS; CYSTATIN SUPERFAMILY; MUSCLE-CELLS; CALCIFICATION; FIBRONECTIN; PROLIFERATION; GLYCOPROTEIN; MODULATION; MECHANISMS	The identity of the cell adhesive factors in fetal bovine serum, commonly used to supplement growth media, remains a mystery due to the plethora of serum proteins. In the present analyses, we showed that fetuin-A, whose function in cellular attachment in tissue culture has been debated for many years, is indeed a major serum cell attachment factor particularly for tumor cells. We are able to report this because of a new purification strategy that has for the first time given us a homogeneous protein band in colloidal Coomassie-stained gels that retains biological activity. The tumor cells adhered to immobilized fetuin-A and not alpha(2)-macroglobulin, its major contaminant. The interaction of cells with fetuin-A was driven mainly by Ca2+ ions, and cells growing in regular medium supplemented with fetal bovine serum were just as sensitive to loss of extracellular Ca2+ ions as cells growing in fetuin-A. Fractionation of human serum revealed that cell attachment was confined to the fractions that had fetuin-A. Interestingly, the tumor cells also took up fetuin-A and secreted it back to the medium using an unknown mechanism that can be observed in live cells. The attachment of tumor cells to fetuin-A was accompanied by phosphatidylinositol 3-kinase/Akt activation that was down-regulated in cells that lack annexin-A6, one of the cell surface receptors for fetuin-A. Taken together, our data show the significance of fetuin-A in tumor cell growth mechanisms in vitro and open new research vistas for this protein.	[Sakwe, Amos M.; Koumangoye, Rainelli; Goodwin, Shawn J.; Ochieng, Josiah] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Ochieng, Josiah] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Ochieng, J (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.	jochieng@mmc.edu	Sakwe, Amos/AAU-7639-2020	Sakwe, Amos/0000-0002-2283-794X	National Institutes of Health [1SC1CA134018-01, G12RR03032-19, 5U54NS041071]; Department of Defense [W81XWH-07-1-0254]; NATIONAL CANCER INSTITUTE [SC1CA134018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, S10RR025497, G12RR003032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1SC1CA134018-01 (to J. O.), G12RR03032-19 (to J. O.), and 5U54NS041071 (to S. J. G.). This work was also supported by Department of Defense Grant W81XWH-07-1-0254 (to J. O.).	Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BROWN WM, 1992, EUR J BIOCHEM, V205, P321, DOI 10.1111/j.1432-1033.1992.tb16783.x; BROWN WM, 1992, BIOESSAYS, V14, P749, DOI 10.1002/bies.950141105; BURRILL PH, 1981, J SUPRAMOL STR CELL, V16, P385, DOI 10.1002/jsscb.1981.380160409; Cartellieri S, 2002, BIOTECHNOL APPL BIOC, V35, P83, DOI 10.1042/BA20010067; Chen NX, 2007, AM J PHYSIOL-RENAL, V292, pF599, DOI 10.1152/ajprenal.00303.2006; Chiang YP, 1999, MOL CELL BIOCHEM, V199, P139, DOI 10.1023/A:1006942128672; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Dy Grace K, 2009, Proc Am Thorac Soc, V6, P218, DOI 10.1513/pats.200808-099LC; Dziegielewska KM, 2001, HISTOCHEM J, V33, P443, DOI 10.1023/A:1014412013445; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; FISHER HW, 1958, P NATL ACAD SCI USA, V44, P4, DOI 10.1073/pnas.44.1.4; HAM RG, 1988, IN VITRO CELL DEV B, V24, P833; HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948; Hetzel M, 2005, LUNG, V183, P225, DOI 10.1007/s00408-004-2534-z; Ivaska J., CELL TISSUE RES, V339, P111; KOHN EC, 1995, CANCER RES, V55, P1856; Kojima K, 1996, J BIOL CHEM, V271, P7679, DOI 10.1074/jbc.271.13.7679; Kundranda MN, 2005, CANCER RES, V65, P499; Kundranda MN, 2004, BBA-MOL CELL RES, V1693, P111, DOI 10.1016/j.bbamcr.2004.06.005; MCINNES C, 1987, J CELL SCI, V88, P623; Mellgren RL, 2007, J BIOL CHEM, V282, P35868, DOI 10.1074/jbc.M706929200; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Mould AP, 1996, J CELL SCI, V109, P2613; NIE Z, 1991, BIOCHEM BIOPH RES CO, V178, P959, DOI 10.1016/0006-291X(91)90985-G; NIE ZT, 1992, AM J PHYSIOL, V263, pC551, DOI 10.1152/ajpcell.1992.263.3.C551; Ochieng J, 1999, J CELL BIOCHEM, V75, P505, DOI 10.1002/(SICI)1097-4644(19991201)75:3<505::AID-JCB14>3.0.CO;2-I; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Padmasekar M, 2007, CARDIOVASC RES, V75, P118, DOI 10.1016/j.cardiores.2007.03.003; Ray S, 2003, BBA-PROTEINS PROTEOM, V1652, P91, DOI 10.1016/j.bbapap.2003.08.004; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; RIZZINO A, 1978, P NATL ACAD SCI USA, V75, P1844, DOI 10.1073/pnas.75.4.1844; Rodan SB, 1997, J ENDOCRINOL, V154, pS47; SALOMON DS, 1982, J BIOL CHEM, V257, P4093; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; Suva LJ, 2009, ENDOCR-RELAT CANCER, V16, P703, DOI 10.1677/ERC-09-0012; Takagi H, 2002, J CELL SCI, V115, P3309; Wang HC, 1998, P NATL ACAD SCI USA, V95, P14429, DOI 10.1073/pnas.95.24.14429; Yu CH, 2008, CANCER SCI, V99, P2467, DOI 10.1111/j.1349-7006.2008.00966.x; Yu CL, 2001, CANCER LETT, V166, P173, DOI 10.1016/S0304-3835(01)00417-7	45	49	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41827	41835		10.1074/jbc.M110.128926	http://dx.doi.org/10.1074/jbc.M110.128926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956534	hybrid, Green Published			2022-12-27	WOS:000285622600070
J	Zhou, H; Qiao, KJ; Gao, ZZ; Vederas, JC; Tang, Y				Zhou, Hui; Qiao, Kangjian; Gao, Zhizeng; Vederas, John C.; Tang, Yi			Insights into Radicicol Biosynthesis via Heterologous Synthesis of Intermediates and Analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESORCYLIC ACID LACTONES; POLYKETIDE SYNTHASE GENES; NATURAL-PRODUCT BIOSYNTHESIS; FLAVIN-DEPENDENT HALOGENASE; GIBBERELLA-ZEAE; 6-DEOXYERYTHRONOLIDE-B SYNTHASE; FUNCTIONAL-CHARACTERIZATION; POCHONIA-CHLAMYDOSPORIA; KETOREDUCTASE DOMAINS; CHAETOMIUM-CHIVERSII	Resorcylic acid lactones are fungal polyketides that display diverse biological activities, with the potent Hsp90 inhibitor radicicol being an important representative member. Two fungal iterative polyketide synthases (IPKSs), Rdc5, the highly reducing IPKS, and Rdc1, the nonreducing IPKS, are required for the biosynthesis of radicicol in Pochonia chlamydosporia. In this study, the complete reconstitution of Rdc5 and Rdc1 activities both in vitro and in Saccharomyces cerevisiae uncovered the earliest resorcylic acid lactone intermediate of the radicicol biosynthetic pathway, (R)-monocillin II. The enzymatic synthesis of (R)-monocillin II confirmed the exquisite timing of the Rdc5 enoyl reductase domain. Using precursor-directed biosynthesis, the chemical modularity of the dual IPKS system was determined. Rdc1 readily accepted an N-acetylcysteamine thioester mimic of the reduced pentaketide product of Rdc5 to synthesize (R)-monocillin II with four additional iterations of polyketide elongation, indicating the C2' ketone group found in (R)-monocillin II is incorporated via the functions of Rdc1 instead of Rdc5. The involvement of the thioesterase domain in Rdc1 in macrolactonization was confirmed through both site-directed mutagenesis and domain deletion. The Rdc1 thioesterase domain was also shown to be tolerant of the opposite stereochemistry of the terminal hydroxyl nucleophile, demonstrated in the precursor-directed synthesis of the enantiomeric (S)-monocillin II. Finally, reconstitution of the halogenase Rdc2 was demonstrated both in vivo and in vitro in the synthesis of pochonin D and a new halogenated analog 6-chloro, 7', 8'-dehydrozearalenol.	[Gao, Zhizeng; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Zhou, Hui; Qiao, Kangjian; Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Tang, Yi] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Vederas, JC (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.	john.vederas@ualberta.ca; yitang@ucla.edu	Gao, Zhizeng/E-2963-2019	Gao, Zhizeng/0000-0002-8176-0727; Vederas, John/0000-0002-2996-0326	National Institutes of Health [1R01GM085128, 1R01GM092217]; David and Lucile Packard Fellowship in Science and Engineering; Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Bioorganic and Medicinal Chemistry; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092217, R01GM085128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Lucile Packard Fellowship in Science and Engineering(The David & Lucile Packard Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM085128 and 1R01GM092217. This work was also supported by a David and Lucile Packard Fellowship in Science and Engineering (to Y.T.) and by the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Bioorganic and Medicinal Chemistry (to J.C.V.).	Agatsuma T, 2002, BIOORGAN MED CHEM, V10, P3445, DOI 10.1016/S0968-0896(02)00260-2; Akey DL, 2010, STRUCTURE, V18, P94, DOI 10.1016/j.str.2009.10.018; Barluenga S, 2008, ANGEW CHEM INT EDIT, V47, P4432, DOI 10.1002/anie.200800233; Barluenga S, 2009, CHEMBIOCHEM, V10, P2753, DOI 10.1002/cbic.200900494; Brase S, 2009, CHEM REV, V109, P3903, DOI 10.1021/cr050001f; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Castonguay R, 2008, J AM CHEM SOC, V130, P11598, DOI 10.1021/ja804453p; Castonguay R, 2007, J AM CHEM SOC, V129, P13758, DOI 10.1021/ja0753290; Chiang YM, 2009, J AM CHEM SOC, V131, P2965, DOI 10.1021/ja8088185; Chooi YH, 2010, CHEM BIOL, V17, P483, DOI 10.1016/j.chembiol.2010.03.015; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; Crawford JM, 2008, SCIENCE, V320, P243, DOI 10.1126/science.1154711; Crawford JM, 2006, P NATL ACAD SCI USA, V103, P16728, DOI 10.1073/pnas.0604112103; Dakas PY, 2007, ANGEW CHEM INT EDIT, V46, P6899, DOI 10.1002/anie.200702406; Day JEH, 2010, CHEM-EUR J, V16, P2758, DOI 10.1002/chem.200902766; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Gaffoor I, 2006, APPL ENVIRON MICROB, V72, P1793, DOI 10.1128/AEM.72.3.1793-1799.2006; Hellwig V, 2003, J NAT PROD, V66, P829, DOI 10.1021/np020556v; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Ikuina Y, 2003, J MED CHEM, V46, P2534, DOI 10.1021/jm030110r; JONES EW, 1991, METHOD ENZYMOL, V194, P428; Kashima T, 2009, BIOSCI BIOTECH BIOCH, V73, P1118, DOI 10.1271/bbb.80878; Keatinge-Clay A, 2008, J MOL BIOL, V384, P941, DOI 10.1016/j.jmb.2008.09.084; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kim YT, 2005, MOL MICROBIOL, V58, P1102, DOI 10.1111/j.1365-2958.2005.04884.x; Korman TP, 2010, P NATL ACAD SCI USA, V107, P6246, DOI 10.1073/pnas.0913531107; Lee KKM, 2009, ANAL BIOCHEM, V394, P75, DOI 10.1016/j.ab.2009.07.010; Ma SM, 2007, J AM CHEM SOC, V129, P10642, DOI 10.1021/ja074865p; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Menzella HG, 2005, NAT BIOTECHNOL, V23, P1171, DOI 10.1038/nbt1128; Mootz HD, 2002, FEMS MICROBIOL LETT, V213, P51, DOI 10.1016/S0378-1097(02)00760-7; Moulin E, 2005, J AM CHEM SOC, V127, P6999, DOI 10.1021/ja043101w; Neumann CS, 2008, CHEM BIOL, V15, P99, DOI 10.1016/j.chembiol.2008.01.006; Neumann CS, 2010, P NATL ACAD SCI USA, V107, P5798, DOI 10.1073/pnas.1001681107; O'Hare HM, 2006, CHEM BIOL, V13, P287, DOI 10.1016/j.chembiol.2006.01.003; Reeves CD, 2008, APPL ENVIRON MICROB, V74, P5121, DOI 10.1128/AEM.00478-08; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Schulte TW, 1998, CELL STRESS CHAPERON, V3, P100, DOI 10.1379/1466-1268(1998)003<0100:ARBTTN>2.3.CO;2; Soga S, 2003, CURR CANCER DRUG TAR, V3, P359, DOI 10.2174/1568009033481859; Wang CH, 2009, BIOORG MED CHEM LETT, V19, P3836, DOI 10.1016/j.bmcl.2009.04.030; Wang M, 2009, BIOCHEMISTRY-US, V48, P6288, DOI 10.1021/bi9009049; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Watanabe CMH, 2002, CHEM BIOL, V9, P981, DOI 10.1016/S1074-5521(02)00213-2; Wicklow DT, 2009, MYCOL RES, V113, P1433, DOI 10.1016/j.mycres.2009.10.001; Wijeratne EMK, 2006, TETRAHEDRON, V62, P8439, DOI 10.1016/j.tet.2006.06.089; Winssinger N, 2007, CHEM COMMUN, P22, DOI 10.1039/b610344h; Workman P, 2003, CURR CANCER DRUG TAR, V3, P297, DOI 10.2174/1568009033481868; Xie XK, 2009, J AM CHEM SOC, V131, P8388, DOI 10.1021/ja903203g; Yang ZQ, 2004, J AM CHEM SOC, V126, P7881, DOI 10.1021/ja0484348; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105; Zhou H, 2010, J AM CHEM SOC, V132, P4530, DOI 10.1021/ja100060k	55	73	73	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41412	41421		10.1074/jbc.M110.183574	http://dx.doi.org/10.1074/jbc.M110.183574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961859	Green Published, hybrid			2022-12-27	WOS:000285622600027
J	Briffotaux, J; Kobryn, K				Briffotaux, Julien; Kobryn, Kerri			Preventing Broken Borrelia Telomeres ResT COUPLES DUAL HAIRPIN TELOMERE FORMATION WITH PRODUCT RELEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC RECOMBINATION; BIDIRECTIONAL REPLICATION; STRAND EXCHANGE; RESOLVASE REST; LINEAR DNA; BURGDORFERI; PROTELOMERASE; RESOLUTION; MECHANISMS; SYNAPSIS	Spirochetes of the genus Borrelia include the tick-transmitted causative agents of Lyme disease and relapsing fever. They possess unusual genomes composed mainly of linear replicons terminated by closed DNA hairpins. Hairpin telomeres are formed from inverted repeat replicated telomere junctions (rTels) by the telomere resolvase ResT. ResT uses a reaction mechanism similar to that of the type IB topoisomerases and tyrosine recombinases. ResT can catalyze three distinct reactions: telomere resolution, telomere fusion, and Holliday junction (HJ) formation. HJ formation is known to occur only in the context of a synapsed pair of rTels. To test whether telomere resolution was synapsis-dependent, we performed experiments with rTel substrates immobilized on streptavidin-coated beads. We report that telomere resolution by ResT is synapsis-independent, indicating that alternative complexes are formed for telomere resolution and HJ formation. We also present evidence that dual hairpin telomere formation precedes product release. This mechanism of telomere resolution prevents the appearance of broken telomeres. We compare and contrast this mechanism with that proposed for TelK, the telomere resolvase of phi KO2.	[Briffotaux, Julien; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	kerri.kobryn@usask.ca	Briffotaux, Julien/AAG-2189-2021	Briffotaux, Julien/0000-0002-0084-5818	Canadian Institutes for Health Research [MOP 79344]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Grant MOP 79344.	Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; Allingham JS, 2001, EMBO J, V20, P2931, DOI 10.1093/emboj/20.11.2931; Bankhead T, 2004, P NATL ACAD SCI USA, V101, P13768, DOI 10.1073/pnas.0405762101; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Barbour AG, 2001, EMERGING INFECTIONS 5, P153; BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BARIL C, 1989, RES MICROBIOL, V140, P507, DOI 10.1016/0923-2508(89)90083-1; Barre F.-X., 2002, MOBILE DNA, P149; Beaurepaire C, 2005, MOL MICROBIOL, V57, P132, DOI 10.1111/j.1365-2958.2005.04688.x; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Casjens S, 1999, CURR OPIN MICROBIOL, V2, P529, DOI 10.1016/S1369-5274(99)00012-0; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Deneke J, 2004, J BIOL CHEM, V279, P53699, DOI 10.1074/jbc.M409001200; Deneke J, 2000, P NATL ACAD SCI USA, V97, P7721, DOI 10.1073/pnas.97.14.7721; Dworkin MS, 2002, MED CLIN N AM, V86, P417, DOI 10.1016/S0025-7125(03)00095-6; FERDOWS MS, 1989, P NATL ACAD SCI USA, V86, P5969, DOI 10.1073/pnas.86.15.5969; Grindley NDF, 1997, CURR BIOL, V7, pR608, DOI 10.1016/S0960-9822(06)00314-9; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; HAASNOOT CAG, 1983, J BIOMOL STRUCT DYN, V1, P115, DOI 10.1080/07391102.1983.10507429; HANIFORD DB, 2002, MOBILE DNA, V2, P457; Huang WM, 2004, J MOL BIOL, V337, P77, DOI 10.1016/j.jmb.2004.01.012; Kobryn K, 2005, J BIOL CHEM, V280, P26788, DOI 10.1074/jbc.M504530200; Kobryn K, 2005, MOL CELL, V17, P783, DOI 10.1016/j.molcel.2005.02.025; Kobryn K, 2002, MOL CELL, V9, P195, DOI 10.1016/S1097-2765(01)00433-6; Kobryn K, 2009, MOL MICROBIOL, V71, P1117, DOI 10.1111/j.1365-2958.2008.06584.x; Kobryn Kerri, 2007, V7, P117, DOI 10.1007/7171_2007_093; Marshall JJT, 2007, J MOL BIOL, V367, P419, DOI 10.1016/j.jmb.2006.12.070; Moriarty TJ, 2009, J BIOL CHEM, V284, P23293, DOI 10.1074/jbc.M109.023549; NASH HA, 1989, EMBO J, V8, P3523, DOI 10.1002/j.1460-2075.1989.tb08518.x; NunesDuby SE, 1997, J MOL BIOL, V272, P493, DOI 10.1006/jmbi.1997.1260; Picardeau M, 2000, GENOME RES, V10, P1594, DOI 10.1101/gr.124000; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; Picardeau M, 2000, MICROBIOL-UK, V146, P305, DOI 10.1099/00221287-146-2-305; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Ravin NV, 2003, FEMS MICROBIOL LETT, V221, P1, DOI 10.1016/S0378-1097(03)00125-3; SCHWAN TG, 1999, MANUAL CLIN MICROBIO, P746; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Tourand Y, 2007, MOL MICROBIOL, V64, P580, DOI 10.1111/j.1365-2958.2007.05691.x; Tourand Y, 2006, J BACTERIOL, V188, P7378, DOI 10.1128/JB.00760-06; Tourand Y, 2009, J BIOL CHEM, V284, P7264, DOI 10.1074/jbc.M808918200; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000; ZHU XD, 1995, J BIOL CHEM, V270, P11646, DOI 10.1074/jbc.270.19.11646	44	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41010	41018		10.1074/jbc.M110.150060	http://dx.doi.org/10.1074/jbc.M110.150060			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952394	Green Published, hybrid			2022-12-27	WOS:000285414400064
J	Hirakawa, J; Tsuboi, K; Sato, K; Kobayashi, M; Watanabe, S; Takakura, A; Imai, Y; Ito, Y; Fukuda, M; Kawashima, H				Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Kobayashi, Motohiro; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Ito, Yuki; Fukuda, Minoru; Kawashima, Hiroto			Novel Anti-carbohydrate Antibodies Reveal the Cooperative Function of Sulfated N- and O-Glycans in Lymphocyte Homing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-ENDOTHELIAL VENULES; L-SELECTIN LIGANDS; VASCULAR ADDRESSIN; NODE ADDRESSIN; FUC-TVII; EXPRESSION; RECRUITMENT; ANTIGEN; INFLAMMATION; MECA-79	Cell surface glycans play pivotal roles in immune cell trafficking and immunity. Here we present an efficient method for generating anti-carbohydrate monoclonal antibodies (mAbs) using gene-targeted mice and describe critical glycans in lymphocyte homing. We immunized sulfotransferase GlcNAc6ST-1 and GlcNAc6ST-2 doubly deficient mice with sulfotransferase-overexpressing Chinese hamster ovary cells and generated two mAbs, termed S1 and S2. Both S1 and S2 bound high endothelial venules (HEVs) in the lymphoid organs of humans and wild-type mice, but not in those of doubly deficient mice. Glycan array analysis indicated that both S1 and S2 specifically bound 6-sulfo sialyl Lewis X and its defuco-sylated structure. Interestingly, S2 inhibited lymphocyte homing to peripheral lymph nodes by 95%, whereas S1 inhibited it by only 25%. S2 also significantly inhibited contact hypersensitivity responses and L-selectin-dependent leukocyte adhesion to HEVs. Immunohistochemical and Western blot analyses indicated that S1 preferentially bound sulfated O-glycans, whereas S2 bound both sulfated N- and O-glycans in HEVs. Furthermore, S2 strongly inhibited the N-glycan-dependent residual lymphocyte homing in mutant mice lacking sulfated O-glycans, indicating the importance of both sulfated N- and O-glycans in lymphocyte homing. Thus, the two mAbs generated by a novel method revealed the cooperative function of sulfated N- and O-glycans in lymphocyte homing and immune surveillance.	[Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Hirakawa, Jotaro; Tsuboi, Koichiro; Sato, Kaori; Watanabe, Sota; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Global Ctr Excellence Program, Shizuoka 4228526, Japan; [Kobayashi, Motohiro] Shinshu Univ, Grad Sch Med, Dept Mol Pathol, Matsumoto, Nagano 3908621, Japan; [Ito, Yuki; Fukuda, Minoru] Sanford Burnham Med Res Inst, Glycobiol Unit, La Jolla, CA 92037 USA; [Kawashima, Hiroto] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Shizuoka; University of Shizuoka; Shinshu University; Sanford Burnham Prebys Medical Discovery Institute; Japan Science & Technology Agency (JST)	Kawashima, H (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, 52-1 Yada, Shizuoka 4228526, Japan.	kawashih@u-shizuoka-ken.ac.jp	Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	National Institutes of Health [PO1CA71932, U54GM62116]; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390023, 20057022]; Takeda Science Foundation; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant PO1CA71932 (to M. F.). This work was also supported by Grant-in-Aid for Scientific Research, Category (B) 21390023 and Grant-in-Aid for Scientific Research on Priority Areas, Dynamics of Extracellular Environments 20057022 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to H. K.), by the Takeda Science Foundation (to H. K.), and by a research fellowship from the Japan Society for the Promotion of Science (to J. H.).; We thank Drs. John B. Lowe (Genentech) for providing the FucT-IV and FucT-VII DKO mice, Eugene Butcher (Stanford University, School of Medicine) for providing the MECA-79 hybridomas, and Pamela Stanley (Albert Einstein College of Medicine) for providing the Lec1 and Lec2 cells. We also thank Dr. Yuki Tobisawa and Ryuji Matsumura (University of Shizuoka, School of Pharmaceutical Sciences) for technical support and Core H of the Consortium for Functional Glycomics (funded by National Institutes of Health Grant U54GM62116) for the glycan array analysis.	ARATAKAWAI H, 2010, AM J PATHOL IN PRESS; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Bruehl RE, 2000, J BIOL CHEM, V275, P32642, DOI 10.1074/jbc.M001703200; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; Clark RA, 1998, J CELL BIOL, V140, P721, DOI 10.1083/jcb.140.3.721; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; HEMMERICH S, 1994, J EXP MED, V180, P2219, DOI 10.1084/jem.180.6.2219; Hiraoka N, 2004, J BIOL CHEM, V279, P3058, DOI 10.1074/jbc.M311150200; Hiraoka N, 1999, IMMUNITY, V11, P79, DOI 10.1016/S1074-7613(00)80083-7; HOKE D, 1995, CURR BIOL, V5, P670, DOI 10.1016/S0960-9822(95)00132-1; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; IMAI Y, 1993, NATURE, V361, P555; Kannagi R, 2009, GLYCOCONJUGATE J, V26, P923, DOI 10.1007/s10719-008-9122-z; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; KAWANO T, 1995, J BIOL CHEM, V270, P16458, DOI 10.1074/jbc.270.27.16458; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kawashima H, 2006, BIOL PHARM BULL, V29, P2343, DOI 10.1248/bpb.29.2343; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Lee J, 2002, GLYCOCONJUGATE J, V19, P211, DOI 10.1023/A:1024205925263; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MICHIE SA, 1993, AM J PATHOL, V143, P1688; Mitoma J, 2007, NAT IMMUNOL, V8, P409, DOI 10.1038/ni1442; Mitoma J, 2009, GLYCOCONJUGATE J, V26, P511, DOI 10.1007/s10719-008-9207-8; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Smithson G, 2001, J EXP MED, V194, P601, DOI 10.1084/jem.194.5.601; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Suzawa K, 2007, AM J GASTROENTEROL, V102, P1499, DOI 10.1111/j.1572-0241.2007.01189.x; Tahara H, 2010, J IMMUNOL, V184, P3269, DOI 10.4049/jimmunol.0902857; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; Uchimura K, 2004, J BIOL CHEM, V279, P35001, DOI 10.1074/jbc.M404456200; Varki A., 2009, ESSENTIALS GLYCOBIOL; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	44	41	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40864	40878		10.1074/jbc.M110.167296	http://dx.doi.org/10.1074/jbc.M110.167296			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20929857	Green Published, hybrid			2022-12-27	WOS:000285414400051
J	Porter, JR; Burg, JS; Espenshade, PJ; Iglesias, PA				Porter, Joshua R.; Burg, John S.; Espenshade, Peter J.; Iglesias, Pablo A.			Ergosterol Regulates Sterol Regulatory Element Binding Protein (SREBP) Cleavage in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SENSING DOMAIN; SCAP; CHOLESTEROL; OXYGEN; INSIG; ER; DEGRADATION; TRANSPORT; MEMBRANES	In fission yeast, the endoplasmic reticulum membrane-bound proteins Sre1 and Scp1, orthologs of mammalian sterol regulatory element binding protein (SREBP) and Scap, monitor sterol synthesis as an indirect measure of oxygen supply. When cellular oxygen levels are low, sterol synthesis is inhibited, and the Sre1-Scp1 complex responds by increasing transcription of genes required for adaptation to hypoxia. Sre1 and Scp1 are believed to detect a blockage in sterol synthesis by monitoring levels of particular sterols, but the evidence concerning which sterol signals this condition is unclear. Here, we demonstrate that Sre1-Scp1 senses ergosterol. Processing experimental data with a mathematical model of Sre1 and Scp1 function reveals a clear quantitative relationship between ergosterol concentration in the endoplasmic reticulum and Sre1 activation. Based on this relationship, we predict that the Sre1-Scp1 complex exists under "active" and "inactive" states and that the transition between these states is cooperatively mediated by ergosterol.	[Burg, John S.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Iglesias, Pablo A.] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu; pi@jhu.edu	Iglesias, Pablo A/A-5202-2008	Iglesias, Pablo A/0000-0002-0840-155X	National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Adams CM, 2003, P NATL ACAD SCI USA, V100, P10647, DOI 10.1073/pnas.1534833100; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Moler C. B., 2004, NUMERICAL COMPUTING, P99; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Sokolov A, 2010, J BIOL CHEM, V285, P29480, DOI 10.1074/jbc.M110.148254; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Tomlin CJ, 2005, P NATL ACAD SCI USA, V102, P4219, DOI 10.1073/pnas.0500276102; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; ZINSER E, 1993, J BACTERIOL, V175, P2853, DOI 10.1128/JB.175.10.2853-2858.1993; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x	31	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41051	41061		10.1074/jbc.M110.144337	http://dx.doi.org/10.1074/jbc.M110.144337			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959444	Green Published, hybrid			2022-12-27	WOS:000285414400068
J	Vazquez-Novelle, MD; Mailand, N; Ovejero, S; Bueno, A; Sacristan, MP				Vazquez-Novelle, Maria D.; Mailand, Niels; Ovejero, Sara; Bueno, Avelino; Sacristan, Maria P.			Human Cdc14A Phosphatase Modulates the G2/M Transition through Cdc25A and Cdc25B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; FISSION YEAST; MITOTIC EXIT; CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE; DNA-DAMAGE; MITOSIS; PHOSPHORYLATION; ACTIVATION; CENTROSOME	The Cdc14 family of serine-threonine phosphatases antagonizes CDK activity by reversing CDK-dependent phosphorylation events. It is well established that the yeast members of this family bring about the M/G1 transition. Budding yeast Cdc14 is essential for CDK inactivation at the end of mitosis and fission yeast Cdc14 homologue Flp1/Clp1 down-regulates Cdc25 to ensure the inactivation of mitotic CDK complexes to trigger cell division. However, the functions of human Cdc14 homologues remain poorly understood. Here we have tested the hypothesis that Cdc14A might regulate Cdc25 mitotic inducers in human cells. We found that increasing levels of Cdc14A delay entry into mitosis by inhibiting Cdk1-cyclin B1 activity. By contrast, lowering the levels of Cdc14A accelerates mitotic entry. Biochemical analyses revealed that Cdc14A acts through key Cdk1-cyclin B1 regulators. We observed that Cdc14A directly bound to and dephosphorylated Cdc25B, inhibiting its catalytic activity. Cdc14A also regulated the activity of Cdc25A at the G2/M transition. Our results indicate that Cdc14A phosphatase prevents premature activation of Cdk1 regulating Cdc25A and Cdc25B at the entry into mitosis.	[Vazquez-Novelle, Maria D.; Ovejero, Sara; Bueno, Avelino; Sacristan, Maria P.] Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain; [Mailand, Niels] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Danish Cancer Society	Sacristan, MP (corresponding author), Campus Miguel de Unamuno, Salamanca 37007, Spain.	msacristan@usal.es	Bueno, Avelino/A-9505-2016; Sacristan, Maria/Y-4923-2019; Sacristán, María P/A-9587-2016	Bueno, Avelino/0000-0002-0362-4391; Sacristan, Maria/0000-0003-2314-8430; Sacristán, María P/0000-0003-2314-8430; Ovejero, Sara/0000-0002-8354-856X	Spanish Ministerio de Educacion y Ciencia (MEC) [BFU2006-05878/BFU2008-04293]; Junta Castilla y Leon [SAN196/SA32/07]; MEC	Spanish Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Junta Castilla y Leon(Junta de Castilla y Leon); MEC(European Commission)	This work was supported by Grants BFU2006-05878/BFU2008-04293 from Spanish Ministerio de Educacion y Ciencia (MEC) and SAN196/SA32/07 from Junta Castilla y Leon.; Supported by a FPU fellowship from MEC. Present address: Cancer Research UK London Research Institute, Clare Hall Laboratories, South Mimms, Herts EN6 3LD, UK.	Andersen SSL, 1999, BIOESSAYS, V21, P53, DOI 10.1002/(SICI)1521-1878(199901)21:1<53::AID-BIES7>3.0.CO;2-L; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675, DOI 10.1128/MCB.13.3.1675; Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bembenek J, 2001, J BIOL CHEM, V276, P48237, DOI 10.1074/jbc.M108126200; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; De Souza CPC, 2000, EXP CELL RES, V257, P11, DOI 10.1006/excr.2000.4872; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Dutertre S, 2004, J CELL SCI, V117, P2523, DOI 10.1242/jcs.01108; Esteban V, 2004, J CELL SCI, V117, P2461, DOI 10.1242/jcs.01107; Esteban V, 2008, CELL CYCLE, V7, P1269, DOI 10.4161/cc.7.9.5947; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Gabrielli BG, 1997, J BIOL CHEM, V272, P28607, DOI 10.1074/jbc.272.45.28607; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; IZUMI T, 1992, MOL BIOL CELL, V3, P927, DOI 10.1091/mbc.3.8.927; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jensen S, 2002, CURR BIOL, V12, pR221, DOI 10.1016/S0960-9822(02)00756-X; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Lammer C, 1998, J CELL SCI, V111, P2445; Li LW, 1997, J BIOL CHEM, V272, P29403, DOI 10.1074/jbc.272.47.29403; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Neely KE, 2003, CELL CYCLE, V2, P455, DOI 10.4161/cc.2.5.488; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Nurse P, 1998, NAT MED, V4, P1103, DOI 10.1038/2594; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Theis-Febvre N, 2003, ONCOGENE, V22, P220, DOI 10.1038/sj.onc.1206107; Trautmann S, 2001, CURR BIOL, V11, P931, DOI 10.1016/S0960-9822(01)00268-8; Vazquez-Novelle MD, 2005, J BIOL CHEM, V280, P29144, DOI 10.1074/jbc.M413328200; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	52	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40544	40553		10.1074/jbc.M110.133009	http://dx.doi.org/10.1074/jbc.M110.133009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956543	Green Published, hybrid			2022-12-27	WOS:000285414400017
J	Lee, HJ; Joo, M; Abdolrasulnia, R; Young, DG; Choi, I; Ware, LB; Blackwell, TS; Christman, BW				Lee, Hye Jeong; Joo, Myungsoo; Abdolrasulnia, Rasul; Young, David G.; Choi, Inyeong; Ware, Lorraine B.; Blackwell, Timothy S.; Christman, Brian W.			Peptidylarginine Deiminase 2 Suppresses Inhibitory kappa B Kinase Activity in Lipopolysaccharide-stimulated RAW 264.7 Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEIMINATION; POSTTRANSLATIONAL MODIFICATION; DEVELOPMENTALLY IMMATURE; ARGININE METHYLATION; TISSUE INFLAMMATION; MULTIPLE-SCLEROSIS; PROSTAGLANDIN D-2; STRUCTURAL BASIS; KERATIN K1; HUMAN PAD4	Peptidylarginine deiminases (PADs) are enzymes that convert arginine to citrulline in proteins. In this study, we examined PAD-mediated citrullination and its effect on pro-inflammatory activity in the macrophage cell line RAW 264.7. Citrullination of 45-65-kDa proteins was induced when cells were treated with lipopolysaccharide (LPS; 1 mu g/ml). Protein citrullination was suppressed by the intracellular calcium chelator BAPTA/AM (30 mu M). LPS treatment up-regulated COX-2 levels in cells. Interestingly, overexpressing PAD2 reduced LPS-mediated COX-2 up-regulation by 50%. PAD2 overexpression also reduced NF-kappa B activity, determined by NF-kappa B-driven luciferase activity. The effect of PAD2 on NF-kappa B activity was further examined by using HEK 293 cells transfected with NF-kappa B luciferase, I kappa B beta/gamma kinase (IKK beta/gamma) subunits, and PAD2. IKK beta increased NF-kappa B activity, but this increase was markedly suppressed when PAD2 was present in cells. IKK kappa-mediated NF-kappa B activation was further enhanced by IKK beta in the presence of calcium ionophore A23187. However, this stimulatory effect of IKK beta/gamma was abolished by PAD2. Coimmunoprecipitation of cell lysates showed that IKK gamma and PAD2 can coimmunoprecipitate in the presence of the Ca2+ ionophore. IKK gamma coimmunoprecipitated truncation mutants, PAD2(1-385) and PAD2(355-672). The substitution of Gln-358 (a putative ligand for Ca2+ binding) with an Ala abolished coimmunoprecipitation. Conversely, PAD2 coimmunoprecipitated truncation mutants IKK gamma(1-196) and IKK gamma(197419). In other experiments, treating RAW 264.7 cells with LPS induced citrullination in the immunoprecipitates of IKK gamma. In vitro citrullination assay showed that incubation of purified PAD2 and IKK gamma proteins in the presence of Ca2+ citrullinated IKK gamma. These results demonstrate that PAD2 interacts with IKK gamma and suppresses NF-kappa B activity.	[Lee, Hye Jeong; Joo, Myungsoo; Abdolrasulnia, Rasul; Young, David G.; Ware, Lorraine B.; Blackwell, Timothy S.; Christman, Brian W.] Vanderbilt Univ, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Christman, Brian W.] Dept Vet Affairs, Nashville, TN 37232 USA; [Choi, Inyeong] Emory Univ, Dept Physiol, Atlanta, GA 30033 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Lee, HJ (corresponding author), Dept Radiol & Radiol Sci, 1161 21st Ave S,CCC 1121 MCN, Nashville, TN 37232 USA.	hye-jeong.lee@vanderbilt.edu	Ware, Lorraine/AAJ-9307-2021; choi, inyeong/AAM-4826-2021	Ware, Lorraine/0000-0002-9429-4702; 	National Institutes of Health [PO1 HL66196, R01-GM078502, HL81332, HL088263]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081332, K24HL103836, P01HL066196, R01HL088263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL66196 (to B. W. C., M. J., and T. S. B.), R01-GM078502 (to I. C.), and HL81332 (to L. B. W.) and HL088263 (to L. B. W.). This work was also supported by an American Heart Association Established Investigator Award (L. B. W.).	Arita K, 2006, P NATL ACAD SCI USA, V103, P5291, DOI 10.1073/pnas.0509639103; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Asaga H, 2001, J LEUKOCYTE BIOL, V70, P46; BENBARUCH A, 1995, J BIOL CHEM, V270, P11703, DOI 10.1074/jbc.270.20.11703; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2002, CURR TOP MICROBIOL, V270, P109; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Ishida-Yamamoto A, 2000, J INVEST DERMATOL, V114, P701, DOI 10.1046/j.1523-1747.2000.00936.x; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; LEE HJ, 2006, P AM THRAC SOC, V3, pA232; Liu GY, 2006, APOPTOSIS, V11, P183, DOI 10.1007/s10495-006-3715-4; Loos T, 2008, BLOOD, V112, P2648, DOI 10.1182/blood-2008-04-149039; Makrygiannakis D, 2008, ANN RHEUM DIS, V67, P1488, DOI 10.1136/ard.2007.075192; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MOSCARELLO MA, 1994, J CLIN INVEST, V94, P146, DOI 10.1172/JCI117300; Nakashima K, 1999, J BIOL CHEM, V274, P27786, DOI 10.1074/jbc.274.39.27786; Nakashima K, 2002, J BIOL CHEM, V277, P49562, DOI 10.1074/jbc.M208795200; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Proost P, 2008, J EXP MED, V205, P2085, DOI 10.1084/jem.20080305; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; ROGERS GE, 1962, NATURE, V194, P1149, DOI 10.1038/1941149a0; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Senshu T, 1999, J DERMATOL SCI, V21, P113, DOI 10.1016/S0923-1811(99)00026-2; Shifera AS, 2010, BIOCHEM BIOPH RES CO, V396, P585, DOI 10.1016/j.bbrc.2010.05.012; Shifera AS, 2010, J CELL PHYSIOL, V223, P558, DOI 10.1002/jcp.22105; Shirai H, 2001, TRENDS BIOCHEM SCI, V26, P465, DOI 10.1016/S0968-0004(01)01906-5; Struyf S, 2009, J IMMUNOL, V182, P666, DOI 10.4049/jimmunol.182.1.666; Tanaka Y, 2004, BIOL PHARM BULL, V27, P985, DOI 10.1248/bpb.27.985; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, pR142, DOI 10.1186/ar1149; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; WATANABE K, 1988, BIOCHIM BIOPHYS ACTA, V966, P375, DOI 10.1016/0304-4165(88)90088-8; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106	42	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39655	39662		10.1074/jbc.M110.170290	http://dx.doi.org/10.1074/jbc.M110.170290			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937835	hybrid, Green Published			2022-12-27	WOS:000285185500009
J	Mendes, AI; Matos, P; Moniz, S; Jordan, P				Mendes, Ana Isabel; Matos, Paulo; Moniz, Sonia; Jordan, Peter			Protein Kinase WNK1 Promotes Cell Surface Expression of Glucose Transporter GLUT1 by Regulating a Tre-2/USP6-BUB2-Cdc16 Domain Family Member 4 (TBC1D4)-Rab8A Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING-PROTEIN; EPITHELIAL SODIUM-CHANNEL; SIGNALING PATHWAY; CL-COTRANSPORTER; MOLECULAR-BASIS; BLOOD-PRESSURE; AKT SUBSTRATE; MUSCLE-CELLS; RAB-GAP; TRANSLOCATION	One mechanism by which mammalian cells regulate the uptake of glucose is the number of glucose transporter proteins (GLUT) present at the plasma membrane. In insulin-responsive cells types, GLUT4 is released from intracellular stores through inactivation of the Rab GTPase activating protein Tre-2/USP6-BUB2-Cdc16 domain family member 4 (TBC1D4) (also known as AS160). Here we describe that TBC1D4 forms a protein complex with protein kinase WNK1 in human embryonic kidney (HEK293) cells. We show that WNK1 phosphorylates TBC1D4 in vitro and that the expression levels of WNK1 in these cells regulate surface expression of the constitutive glucose transporter GLUT1. WNK1 was found to increase the binding of TBC1D4 to regulatory 14-3-3 proteins while reducing its interaction with the exocytic small GTPase Rab8A. These effects were dependent on the catalytic activity because expression of a kinase-dead WNK1 mutant had no effect on binding of 14-3-3 and Rab8A, or on surface GLUT1 levels. Together, the data describe a pathway regulating constitutive glucose uptake via GLUT1, the expression level of which is related to several human diseases.	[Mendes, Ana Isabel; Matos, Paulo; Moniz, Sonia; Jordan, Peter] Natl Inst Hlth, Dept Genet, P-1649016 Lisbon, Portugal		Jordan, P (corresponding author), Ave Padre Cruz, P-1649016 Lisbon, Portugal.	peter.jordan@insa.min-saude.pt	Matos, Paulo/P-3012-2019; Jordan, Peter/G-9335-2012; Matos, Paulo/F-5245-2012	Matos, Paulo/0000-0002-9379-9696; Jordan, Peter/0000-0002-1425-9211; Matos, Paulo/0000-0002-9379-9696	Portuguese Fundacao para a Ciencia e Tecnologia [POCI_PPCDT/SAU-MMO/56439/04]; Programa de Financiamento Plurianual do CIGMH;  [BD 23001/05]	Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa de Financiamento Plurianual do CIGMH; 	This work was supported by Portuguese Fundacao para a Ciencia e Tecnologia through Grant POCI_PPCDT/SAU-MMO/56439/04, Programa de Financiamento Plurianual do CIGMH, and Fellowship BD 23001/05 (to A. I. M.).	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cope G, 2006, J AM SOC NEPHROL, V17, P1867, DOI 10.1681/ASN.2005111224; Delaloy C, 2008, HYPERTENSION, V52, P1149, DOI 10.1161/HYPERTENSIONAHA.108.120899; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Gnudi L, 2003, HYPERTENSION, V42, P19, DOI 10.1161/01.HYP.0000075949.19968.EF; Hadchouel J, 2006, J AM SOC NEPHROL, V17, P208, DOI 10.1681/ASN.2005030314; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; Koumanov Francoise, 2007, Biochem J, V403, pe9; Lee BH, 2004, MOL CELL, V15, P741, DOI 10.1016/j.molcel.2004.07.018; Lee BH, 2007, J BIOL CHEM, V282, P17985, DOI 10.1074/jbc.M702664200; Lenertz LY, 2005, J BIOL CHEM, V280, P26653, DOI 10.1074/jbc.M502598200; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Liang XB, 2010, MOL BIOL CELL, V21, P2024, DOI 10.1091/mbc.E10-01-0042; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moniz S, 2007, ONCOGENE, V26, P6071, DOI 10.1038/sj.onc.1210706; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Ngo S, 2009, MOL CELL ENDOCRINOL, V302, P33, DOI 10.1016/j.mce.2008.10.020; Oh E, 2007, J BIOL CHEM, V282, P32613, DOI 10.1074/jbc.M706591200; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Vitari AC, 2004, BIOCHEM J, V378, P257, DOI 10.1042/BJ20031692; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, J BIOL CHEM, V280, P34218, DOI 10.1074/jbc.M505735200; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2002, J BIOL CHEM, V277, P48456, DOI 10.1074/jbc.M207917200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Zagorska A, 2007, J CELL BIOL, V176, P89, DOI 10.1083/jcb.200605093; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; ZHAO FQ, 1993, INT J BIOCHEM, V25, P1897, DOI 10.1016/0020-711X(88)90322-9	62	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39117	39126		10.1074/jbc.M110.159418	http://dx.doi.org/10.1074/jbc.M110.159418			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937822	hybrid, Green Published			2022-12-27	WOS:000284941300042
J	Hussain, KM; Leong, KLJ; Ng, MML; Chu, JJH				Hussain, Khairunnisa' Mohamed; Leong, Kim Lian Janet; Ng, Mary Mah-Lee; Chu, Justin Jang Hann			The Essential Role of Clathrin-mediated Endocytosis in theInfectious Entry of Human Enterovirus 71	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; ACTIN-FILAMENTS; VIRUS ENTRY; CYTOPLASMIC DOMAIN; POLIOVIRUS TYPE-1; ARP2/3 COMPLEX; H+-ATPASE; RECEPTOR; MEMBRANE; CELLS	Little is currently known about the infectious entry process of human enterovirus 71 (HEV71) into host cells, which may represent potential anti-viral targeting sites. In this study a targeted small-interfering RNA (siRNA) screening platform assay was established and validated to identify and profile key cellular genes involved in processes of endocytosis, cytoskeletal dynamics, and endosomal trafficking essential for HEV71 infection. Screen evaluation was conducted via the expression of well characterized dominant-negative mutants, bioimaging studies (double-labeled immunofluorescence assays, transmission electron microscopy analysis), secondary siRNA-based dosage dependence studies, and drug inhibition assays. The infectious entry of HEV71 into rhabdomyosarcoma cells was shown to be significantly inhibited by siRNAs targeting genes associated with clathrin-mediated endocytosis (CME) that include AP2A1, ARRB1, CLTC, CLTCL1, SYNJ1, ARPC5, PAK1, ROCK1, and WASF1. The functional role of CME was verified by the observation of strong co-localization between HEV71 particles and clathrin as well as dose-dependent inhibition of HEV71 infection upon siRNA knockdown of CME-associated genes. HEV71 entry by CME was further confirmed via inhibition by dominant-negative EPS15 mutants and treatment of CME drug inhibitors, with more than 80% inhibition observed at 20 mu M chlorpromazine. Furthermore, HEV71 infection was shown to be sensitive to the disruption of human genes in regulating early to late endosomal trafficking as well as endosomal acidic pH. The identification of clathrin-mediated endocytosis as the entry pathway for HEV71 infection of susceptible host cells contributes to a better understanding of HEV71 pathogenesis and enables future development of anti-viral strategies against HEV71 infection.	[Hussain, Khairunnisa' Mohamed; Leong, Kim Lian Janet; Ng, Mary Mah-Lee; Chu, Justin Jang Hann] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore	National University of Singapore	Chu, JJH (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol, 5 Sci Dr 2, Singapore 117597, Singapore.	miccjh@nus.edu.sg	Chu, Justin Jang Hann/ABA-8297-2021; Ng, Mei Li/Q-3704-2016	Chu, Justin Jang Hann/0000-0002-1673-6819; Ng, Mei Li/0000-0001-9917-4534	Ministry of Education Academic Research Fund [R182-000-165-133]; National Medical Research Council (Singapore) [NMRC/NIG/0012/2007]; Defense Science and Technology Agency [POD0713895]; National University of Singapore	Ministry of Education Academic Research Fund; National Medical Research Council (Singapore)(National Medical Research Council, Singapore); Defense Science and Technology Agency; National University of Singapore(National University of Singapore)	This work was supported by The Ministry of Education Academic Research Fund Grant R182-000-165-133), National Medical Research Council (Singapore) Grant (Project no. NMRC/NIG/0012/2007), Defense Science and Technology Agency Grant POD0713895, and an Infectious Diseases Program grant (National University of Singapore) (to J. H. C.).	Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Bergelson JM, 2008, TRENDS MICROBIOL, V16, P44, DOI 10.1016/j.tim.2007.12.004; Buss F, 2001, FEBS LETT, V508, P295, DOI 10.1016/S0014-5793(01)03065-4; CARRASCO L, 1994, FEBS LETT, V350, P151, DOI 10.1016/0014-5793(94)00780-2; Chu JJH, 2007, P NATL ACAD SCI USA, V104, P3520, DOI 10.1073/pnas.0611681104; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Durrbach A, 1996, J CELL SCI, V109, P457; Eckhardt ERM, 2006, J BIOL CHEM, V281, P4348, DOI 10.1074/jbc.M513154200; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; Gagliardi S, 1999, CURR MED CHEM, V6, P1197; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; Greber UF, 2002, CELL MOL LIFE SCI, V59, P608, DOI 10.1007/s00018-002-8453-3; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; Harrison DN, 2008, J VIROL, V82, P1465, DOI 10.1128/JVI.01374-07; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Isaacson MK, 2008, CURR TOP MICROBIOL, V325, P85; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Kolokoltsov AA, 2007, J VIROL, V81, P7786, DOI 10.1128/JVI.02780-06; MADSHUS IH, 1984, J CELL BIOL, V98, P1194, DOI 10.1083/jcb.98.4.1194; MADSHUS IH, 1984, EMBO J, V3, P1945, DOI 10.1002/j.1460-2075.1984.tb02074.x; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; MAUPIN P, 1983, J CELL BIOL, V96, P51, DOI 10.1083/jcb.96.1.51; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; Monier S, 2002, TRAFFIC, V3, P289, DOI 10.1034/j.1600-0854.2002.030406.x; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Nolan MA, 2003, NEUROLOGY, V60, P1651, DOI 10.1212/01.WNL.0000066810.62490.FF; Opdam FJM, 2000, J CELL SCI, V113, P2725; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; PEREZ L, 1993, J VIROL, V67, P4543; Pietiainen V, 2004, MOL BIOL CELL, V15, P4911, DOI 10.1091/mbc.E04-01-0070; Qualmann B, 2002, INT REV CYTOL, V220, P93; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; SETIADI H, 1995, J BIOL CHEM, V270, P26818, DOI 10.1074/jbc.270.45.26818; Setiadi H, 2003, J CELL BIOL, V163, P1385, DOI 10.1083/jcb.200307178; Setiadi H, 1998, J CELL BIOL, V142, P859, DOI 10.1083/jcb.142.3.859; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Tung WH, 2007, CELL SIGNAL, V19, P2127, DOI 10.1016/j.cellsig.2007.06.009; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yang B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-141; Yarar D, 2005, MOL BIOL CELL, V16, P964, DOI 10.1091/mbc.e04-09-0774; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006; ZEICHHARDT H, 1985, J GEN VIROL, V66, P483, DOI 10.1099/0022-1317-66-3-483; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	66	95	104	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					309	321		10.1074/jbc.M110.168468	http://dx.doi.org/10.1074/jbc.M110.168468			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956521	Green Published, hybrid			2022-12-27	WOS:000285782800034
J	Li, HR; Mapolelo, DT; Dingra, NN; Keller, G; Riggs-Gelasco, PJ; Winge, DR; Johnson, MK; Outten, CE				Li, Haoran; Mapolelo, Daphne T.; Dingra, Nin N.; Keller, Greg; Riggs-Gelasco, Pamela J.; Winge, Dennis R.; Johnson, Michael K.; Outten, Caryn E.			Histidine 103 in Fra2 Is an Iron-Sulfur Cluster Ligand in the [2Fe-2S] Fra2-Grx3 Complex and Is Required for in Vivo Iron Signaling in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION-SPECTROSCOPY; BOLA-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; MONOTHIOL GLUTAREDOXINS; SCAFFOLD PROTEINS; OXIDATIVE STRESS; TRANSCRIPTION; MITOCHONDRIAL; RIESKE; AFT1	The BolA homologue Fra2 and the cytosolic monothiol glutaredoxins Grx3 and Grx4 together play a key role in regulating iron homeostasis in Saccharomyces cerevisiae. Genetic studies indicate that Grx3/4 and Fra2 regulate activity of the iron-responsive transcription factors Aft1 and Aft2 in response to mitochondrial Fe-S cluster biosynthesis. We have previously shown that Fra2 and Grx3/4 form a [2Fe-2S](2+)-bridged heterodimeric complex with iron ligands provided by the active site cysteine of Grx3/4, glutathione, and a histidine residue. To further characterize this unusual Fe-S-binding complex, site-directed mutagenesis was used to identify specific residues in Fra2 that influence Fe-S cluster binding and regulation of Aft1 activity in vivo. Here, we present spectroscopic evidence that His-103 in Fra2 is an Fe-S cluster ligand in the Fra2-Grx3 complex. Replacement of this residue does not abolish Fe-S cluster binding, but it does lead to a change in cluster coordination and destabilization of the [2Fe-2S] cluster. In vivo genetic studies further confirm that Fra2 His-103 is critical for control of Aft1 activity in response to the cellular iron status. Using CD spectroscopy, we find that similar to 1 mol eq of apo-Fra2 binds tightly to the [2Fe-2S] Grx3 homodimer to form the [2Fe-2S] Fra2-Grx3 heterodimer, suggesting a mechanism for formation of the [2Fe-2S] Fra2-Grx3 heterodimer in vivo. Taken together, these results demonstrate that the histidine coordination and stability of the [2Fe-2S] cluster in the Fra2-Grx3 complex are essential for iron regulation in yeast.	[Li, Haoran; Dingra, Nin N.; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Mapolelo, Daphne T.; Johnson, Michael K.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Mapolelo, Daphne T.; Johnson, Michael K.] Univ Georgia, Ctr Metalloenzyme Studies, Athens, GA 30602 USA; [Keller, Greg; Winge, Dennis R.] Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; [Keller, Greg; Winge, Dennis R.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; [Riggs-Gelasco, Pamela J.] Coll Charleston, Dept Chem & Biochem, Charleston, SC 29424 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; College of Charleston	Outten, CE (corresponding author), Univ S Carolina, Dept Chem & Biochem, 631 Sumter St, Columbia, SC 29208 USA.	caryn.outten@chem.sc.edu	Outten, Caryn E./I-9433-2019; Li, Haoran/J-6618-2013	Outten, Caryn E./0000-0003-0335-6531; Li, Haoran/0000-0002-6158-2345	National Institutes of Health [ES13780, GM62524, ES03817, P20 RR016461]; Camille and Henry Dreyfus Foundation; United States Department of Energy, Office of Basic Energy Sciences; Department of Energy; National Institutes of Health-NCRR; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, K22ES013780, R37ES003817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062524, R01GM083292, R01GM062524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camille and Henry Dreyfus Foundation; United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES13780 (to C.E.O.), GM62524 (to M.K.J.), ES03817 (to D. R. W.), and P20 RR016461 (P.J.R.-G.). This work was also supported by The Camille and Henry Dreyfus Foundation Scholar Award (to P.J.R.-G.).; We thank F. Wayne Outten (University of South Carolina) for helpful discussions and Jerry Kaplan (University of Utah) for Fra2 antibodies. The Stanford Synchrotron Radiation Laboratory is a national user facility supported by the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by Department of Energy and the National Institutes of Health-NCRR Biomedical Technology Program.	Bak DW, 2009, BIOCHEMISTRY-US, V48, P10193, DOI 10.1021/bi9016445; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; BERTRAND P, 1979, BIOCHIM BIOPHYS ACTA, V579, P107, DOI 10.1016/0005-2795(79)90091-6; BERTRAND P, 1980, BIOCHIM BIOPHYS ACTA, V625, P337, DOI 10.1016/0005-2795(80)90298-6; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Broderick JB, 2000, BIOCHEM BIOPH RES CO, V269, P451, DOI 10.1006/bbrc.2000.2313; Chin KH, 2005, J BIOMOL NMR, V31, P167, DOI 10.1007/s10858-004-7804-9; Clark-Baldwin K, 1998, J AM CHEM SOC, V120, P8401, DOI 10.1021/ja980580o; Cosper MM, 2004, BIOCHEMISTRY-US, V43, P2007, DOI 10.1021/bi0356653; Cosper NJ, 2002, PROTEIN SCI, V11, P2969, DOI 10.1110/ps.0222402; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson LM, 2008, ACTA CRYSTALLOGR D, V64, P927, DOI 10.1107/S0907444908021641; Huynen MA, 2005, FEBS LETT, V579, P591, DOI 10.1016/j.febslet.2004.11.111; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Kasai T, 2004, PROTEIN SCI, V13, P545, DOI 10.1110/ps.03401004; Kim KD, 2010, BIOCHEM BIOPH RES CO, V392, P467, DOI 10.1016/j.bbrc.2010.01.051; Kounosu A, 2004, J BIOL CHEM, V279, P12519, DOI 10.1074/jbc.M305923200; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Link TA, 1999, ADV INORG CHEM, V47, P83, DOI 10.1016/S0898-8838(08)60077-X; MEYER J, 1994, BIOCHEMISTRY-US, V33, P13642, DOI 10.1021/bi00250a014; Molina MM, 2004, J BIOL CHEM, V279, P51923, DOI 10.1074/jbc.M410219200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; TSANG HT, 1989, BIOCHEMISTRY-US, V28, P7233, DOI 10.1021/bi00444a015; Ueta R, 2007, MOL BIOL CELL, V18, P2980, DOI 10.1091/mbc.E06-11-1054; WERTH MT, 1990, P NATL ACAD SCI USA, V87, P8965, DOI 10.1073/pnas.87.22.8965; WERTH MT, 1992, FEBS LETT, V299, P1, DOI 10.1016/0014-5793(92)80086-V; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372	43	89	90	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					867	876		10.1074/jbc.M110.184176	http://dx.doi.org/10.1074/jbc.M110.184176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978135	hybrid, Green Published			2022-12-27	WOS:000285782800086
J	Mittal, MK; Singh, K; Misra, S; Chaudhuri, G				Mittal, Mukul K.; Singh, Kshipra; Misra, Smita; Chaudhuri, Gautam			SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR; TRANSCRIPTION FACTORS; CONJUGATING ENZYMES; GENE-EXPRESSION; IN-VIVO; DEGRADATION; PROTEIN; OVEREXPRESSION; ACTIVATION; TAMOXIFEN	UbcH5c, a member of the UbcH5 family of protein ubiquitin conjugase E2 enzymes, is a critical component of biological processes in human cells, being the initial ubiquitinating enzyme of substrates like I kappa B, TP53, and cyclin D1. We report here that the metastasis regulator protein SLUG inhibits the expression of UbcH5c directly through chromatin remodeling and thus, among other downstream effects, elevates the level of cyclin D1, thus enhancing the growth rates of breast cancer cells. Overexpression of SLUG in the SLUG-deficient breast cancer cells significantly decreased the levels of mRNA and protein of UbcH5c but only elevated the protein levels of cyclin D1. On the contrary, knockdown of SLUG in SLUG-high breast cancer cells elevated the levels of UbcH5c while decreasing the level of cyclin D1 protein. SLUG is recruited at the E2-box sequence at the UbcH5c gene promoter along with the corepressor CtBP1 and the effector HDAC1 to silence the expression of this gene. Knockdown of UbcH5c in the SLUG-deficient human breast cells elevated the level of cyclin D1 as well as the rates of proliferation and invasiveness of these cells. Whereas the growth rates of the cells are enhanced due to overexpression of SLUG or knockdown of UbcH5c in the breast cancer cells tested, ER+ cells also acquire resistance to the anti-estrogen 4 -hydroxytamoxifen due to the rise of cyclin D1 levels in these cells. This study thus implicates high levels of SLUG and low levels of UbcH5c as a determinant in the progression of metastatic breast cancer.	[Mittal, Mukul K.; Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Singh, Kshipra] Vanderbilt Univ, Med Ctr, Div Gastroenterol, Nashville, TN 37232 USA	Meharry Medical College; Vanderbilt University	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd,Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Mittal, Mukul/0000-0002-9795-7372	Department of Defense [W81XWH-06-1-0466]; Susan G. Komen Breast Cancer Foundation [BCTR0707627]; National Institutes of Health [U54NS041071]; NCRR, National Institutes of Health [UL1 RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by Department of Defense Congressionally Directed Medical Research Program IDEA Grant W81XWH-06-1-0466 and Susan G. Komen Breast Cancer Foundation Grant BCTR0707627 (to G.C.). Confocal microscopy was performed through the use of the Meharry Medical College Morphology Core, which is supported in part by National Institutes of Health Grant U54NS041071. Other core facility research was supported in part by Vanderbilt Clinical and Translational Science Award Grant UL1 RR024975 from NCRR, National Institutes of Health.	Ahnstrom M, 2005, BREAST CANCER RES TR, V91, P145, DOI 10.1007/s10549-004-6457-4; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Conkright MD, 2001, J BIOL CHEM, V276, P29299, DOI 10.1074/jbc.M103670200; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Fournier AK, 2008, J CELL SCI, V121, P226, DOI 10.1242/jcs.017012; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gao F, 2006, NAT CELL BIOL, V8, P1171, DOI 10.1038/ncb1483; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; GILLETT C, 1994, CANCER RES, V54, P1812; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Hattori H, 2007, BLOOD, V110, P640, DOI 10.1182/blood-2006-11-059048; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Klein EA, 2007, CELL CYCLE, V6, P1115, DOI 10.4161/cc.6.9.4147; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lambertini E, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-13; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Lin DI, 2008, ONCOGENE, V27, P1231, DOI 10.1038/sj.onc.1210738; Lopez-Otin C, 2010, NAT REV CANCER, V10, P278, DOI 10.1038/nrc2823; Maeda I, 2001, FEBS LETT, V494, P181, DOI 10.1016/S0014-5793(01)02343-2; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2010, MOL BIOL REP, V37, P1221, DOI 10.1007/s11033-009-9492-8; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Piscopo DM, 2008, CANCER RES, V68, P5581, DOI 10.1158/0008-5472.CAN-07-6346; Prasad CP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-325; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Watanabe H, 1998, P NATL ACAD SCI USA, V95, P1392, DOI 10.1073/pnas.95.4.1392; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Yuan YH, 2007, CANCER RES, V67, P8032, DOI 10.1158/0008-5472.CAN-07-0083; Zhang XD, 2005, NAT CELL BIOL, V7, P12, DOI 10.1038/ncb0105-12; Zwart W, 2009, MOL ENDOCRINOL, V23, P1335, DOI 10.1210/me.2008-0268; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	58	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					469	479		10.1074/jbc.M110.164384	http://dx.doi.org/10.1074/jbc.M110.164384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044962	Green Published, hybrid			2022-12-27	WOS:000285782800050
J	Shang, FF; Rynkiewicz, MJ; McCormack, FX; Wu, HX; Cafarella, TM; Head, JF; Seaton, BA				Shang, Feifei; Rynkiewicz, Michael J.; McCormack, Francis X.; Wu, Huixing; Cafarella, Tanya M.; Head, James F.; Seaton, Barbara A.			Crystallographic Complexes of Surfactant Protein A and Carbohydrates Reveal Ligand-induced Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY INNATE IMMUNITY; MANNOSE-BINDING PROTEINS; BACTERIAL LIPOPOLYSACCHARIDES; STRUCTURAL-CHANGES; LUNG COLLECTINS; HOST-DEFENSE; RECOGNITION; DOMAIN; DETERMINANTS; INSIGHTS	Surfactant protein A (SP-A), a C-type lectin, plays an important role in innate lung host defense against inhaled pathogens. Crystallographic SP-A.ligand complexes have not been reported to date, limiting available molecular information about SP-A interactions with microbial surface components. This study describes crystal structures of calcium-dependent complexes of the C-terminal neck and carbohydrate recognition domain of SP-A with D-mannose, D-alpha-methylmannose, and glycerol, which represent subdomains of glycans on pathogen surfaces. Comparison of these complexes with the unliganded SP-A neck and carbohydrate recognition domain revealed an unexpected ligand-associated conformational change in the loop region surrounding the lectin site, one not previously reported for the lectin homologs SP-D and mannan-binding lectin. The net result of the conformational change is that the SP-A lectin site and the surrounding loop region become more compact. The Glu-202 side chain of unliganded SP-A extends out into the solvent and away from the calcium ion; however, in the complexes, the Glu-202 side chain translocates 12.8 angstrom to bind the calcium. The availability of Glu-202, together with positional changes involving water molecules, creates a more favorable hydrogen bonding environment for carbohydrate ligands. The Lys-203 side chain reorients as well, extending outward into the solvent in the complexes, thereby opening up a small cation-friendly cavity occupied by a sodium ion. Binding of this cation brings the large loop, which forms one wall of the lectin site, and the adjacent small loop closer together. The ability to undergo conformational changes may help SP-A adapt to different ligand classes, including microbial glycolipids and surfactant lipids.	[Shang, Feifei; Rynkiewicz, Michael J.; Cafarella, Tanya M.; Head, James F.; Seaton, Barbara A.] Boston Univ, Dept Physiol & Biophys, Sch Med, Boston, MA 02118 USA; [McCormack, Francis X.; Wu, Huixing] Univ Cincinnati, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45267 USA	Boston University; University System of Ohio; University of Cincinnati	Seaton, BA (corresponding author), Boston Univ, Dept Physiol & Biophys, Sch Med, 72 E Concord St, Boston, MA 02118 USA.	seatonba@bu.edu	shang, feifei/AAH-8592-2019; McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464; Seaton, Barbara/0000-0003-4654-7709; Rynkiewicz, Michael/0000-0002-4717-5700; Head, James/0000-0002-6226-4146	National Institutes of Health, NIAID [AI083222]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI083222 from NIAID (to B. A. S.). This work was also supported by a Department of Veterans Affairs merit award (to F. X. M.).	BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cason C., 2005, PERSISTENCE VISION R; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; Crouch E, 2000, IMMUNOL REV, V173, P52, DOI 10.1034/j.1600-065X.2000.917311.x; Crouch E, 2007, BIOCHEMISTRY-US, V46, P5160, DOI 10.1021/bi700037x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haagsman HP, 2008, NEONATOLOGY, V93, P288, DOI 10.1159/000121454; Hartshorn Kevan L, 2010, Front Biosci (Schol Ed), V2, P527; Hartshorn KL, 2000, BIOCHEM J, V351, P449, DOI 10.1042/0264-6021:3510449; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Head JF, 2003, J BIOL CHEM, V278, P43254, DOI 10.1074/jbc.M305628200; Hsin K, 2008, J APPL CRYSTALLOGR, V41, P963, DOI 10.1107/S002188980802476X; Jones T. A., 1992, MANUAL; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; KUAN SF, 1992, J CLIN INVEST, V90, P97, DOI 10.1172/JCI115861; MALHOTRA R, 1994, BIOCHEM J, V304, P455, DOI 10.1042/bj3040455; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P13963, DOI 10.1021/bi970745q; McCormack FX, 2002, J CLIN INVEST, V109, P707, DOI 10.1172/JCI200215293; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Ng KKS, 2002, J BIOL CHEM, V277, P16088, DOI 10.1074/jbc.M200493200; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; Seaton BA, 2010, INNATE IMMUN-LONDON, V16, P143, DOI 10.1177/1753425910368716; Shrive AK, 2009, J MOL BIOL, V394, P776, DOI 10.1016/j.jmb.2009.09.057; Shrive AK, 2003, J MOL BIOL, V331, P509, DOI 10.1016/S0022-2836(03)00761-7; Somers WS, 2000, CELL, V103, P467, DOI 10.1016/S0092-8674(00)00138-0; VANIWAARDEN JF, 1994, BIOCHEM J, V303, P407, DOI 10.1042/bj3030407; Wang H, 2008, BIOCHEMISTRY-US, V47, P710, DOI 10.1021/bi7020553; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Whitsett JA, 2005, BIOL NEONATE, V88, P175, DOI 10.1159/000087580; Wright JR, 2004, BIOL NEONATE, V85, P326, DOI 10.1159/000078172; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	37	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					757	765		10.1074/jbc.M110.175265	http://dx.doi.org/10.1074/jbc.M110.175265			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047777	Green Published, hybrid			2022-12-27	WOS:000285782800075
J	Cui, S; Ho, WK; Kim, ST; Cho, H				Cui, Shanyu; Ho, Won-Kyung; Kim, Seong-Tae; Cho, Hana			Agonist-induced Localization of Gq-coupled Receptors and G Protein-gated Inwardly Rectifying K+ (GIRK) Channels to Caveolae Determines Receptor Specificity of Phosphatidylinositol 4,5-Bisphosphate Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ATRIAL-FIBRILLATION; ADENYLYL-CYCLASE; CARDIAC MYOCYTES; CA2+ CHANNELS; LIPID RAFTS; MODULATION; BRADYKININ; INHIBITION; HEART	G protein-gated inwardly rectifying K+ (GIRK) channels are parasympathetic effectors in cardiac myocytes that act as points of integration of signals from diverse pathways. Neurotransmitters and hormones acting on the Gq protein regulate GIRK channels by phosphatidylinositol 4,5-bisphosphate (PIP2) depletion. In previous studies, we found that endothelin- 1, but not bradykinin, inhibited GIRK channels, even though both of them hydrolyze PIP2 in cardiac myocytes, showing receptor specificity. The present study assessed whether the spatial organization of the PIP2 signal into caveolar microdomains underlies the specificity of PIP2-mediated signaling. Using biochemical analysis, we examined the localization of GIRK and Gq protein-coupled receptors (GqPCRs) in mouse atrial myocytes. Agonist stimulation induced a transient co-localization of GIRK channels with endothelin receptors in the caveolae, excluding bradykinin receptors. Such redistribution was eliminated by caveolar disruption with methyl-beta-cyclodextrin (M beta CD). Patch clamp studies showed that the specific response of GIRK channels to GqPCR agonists was abolished by M beta CD, indicating the functional significance of the caveolae-dependent spatial organization. To assess whether low PIP2 mobility is essential for PIP2-mediated signaling, we blocked the cytoskeletal restriction of PIP2 diffusion by latrunculin B. This abolished the GIRK channel regulation by GqPCRs without affecting their targeting to caveolae. These data suggest that without the hindered diffusion of PIP2 from microdomains, PIP2 loses its signaling efficacy. Taken together, these data suggest that specific targeting combined with restricted diffusion of PIP2 allows the PIP2 signal to be compartmentalized to the targets localized closely to the GqPCRs, enabling cells to discriminate between identical PIP2 signaling that is triggered by different receptors.	[Kim, Seong-Tae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Cui, Shanyu; Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; [Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Ho, Won-Kyung] Biomed Plast Res Ctr, Seoul 110799, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU)	Kim, ST (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea.	stkim@med.skku.ac.kr; hanacho@med.skku.ac.kr	Kim, Seong-Tae/A-9917-2013; Ho, Won-Kyung/J-2798-2012		Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A080604]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grant A080604 from the Korea Healthcare area, so that the activation of a given GqPCR affects only Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea.	Bae GU, 2008, J BIOL CHEM, V283, P8301, DOI 10.1074/jbc.M706730200; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; Calaghan S, 2006, CARDIOVASC RES, V69, P816, DOI 10.1016/j.cardiores.2005.10.006; Chen PS, 2007, HEART RHYTHM, V4, pS61, DOI 10.1016/j.hrthm.2006.12.006; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2001, BRIT J PHARMACOL, V134, P1066, DOI 10.1038/sj.bjp.0704347; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Delmas P, 2005, NEURON, V47, P179, DOI 10.1016/j.neuron.2005.07.001; Dobrzynski H, 2001, J HISTOCHEM CYTOCHEM, V49, P1221, DOI 10.1177/002215540104901004; Feron O, 2006, CARDIOVASC RES, V69, P788, DOI 10.1016/j.cardiores.2005.12.014; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Garg V, 2009, CARDIOVASC RES, V82, P51, DOI 10.1093/cvr/cvp039; Haasemann M, 1998, J CELL SCI, V111, P917; Horstmeyer A, 1996, J BIOL CHEM, V271, P20811, DOI 10.1074/jbc.271.34.20811; Kitakaze M, 2000, HYPERTENS RES, V23, P253, DOI 10.1291/hypres.23.253; Kolettis TM, 2008, J INTERV CARD ELECTR, V21, P203, DOI 10.1007/s10840-008-9206-5; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; MINSHALL RD, 1995, CIRC RES, V76, P773, DOI 10.1161/01.RES.76.5.773; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2004, J BIOL CHEM, V279, P19846, DOI 10.1074/jbc.M313440200; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sbaa E, 2005, TRENDS CARDIOVAS MED, V15, P157, DOI 10.1016/j.tcm.2005.05.006; Schoemaker RG, 2000, AM J PHYSIOL-HEART C, V278, pH1571, DOI 10.1152/ajpheart.2000.278.5.H1571; Sharifov OF, 2004, J AM COLL CARDIOL, V43, P483, DOI 10.1016/j.jacc.2003.09.030; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Yamaguchi H, 1997, AM J PHYSIOL-HEART C, V273, pH1745, DOI 10.1152/ajpheart.1997.273.4.H1745	38	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41732	41739		10.1074/jbc.M110.153312	http://dx.doi.org/10.1074/jbc.M110.153312			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041306	Green Published, hybrid			2022-12-27	WOS:000285622600060
J	Fernandez, CA; Roy, R; Lee, S; Yang, JA; Panigrahy, D; Van Vliet, KJ; Moses, MA				Fernandez, Cecilia A.; Roy, Roopali; Lee, Sunyoung; Yang, Jiang; Panigrahy, Dipak; Van Vliet, Krystyn J.; Moses, Marsha A.			The Anti-angiogenic Peptide, Loop 6, Binds Insulin-like Growth Factor-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; CELL-SURFACE BINDING; TISSUE INHIBITOR; CROSS-TALK; IGF-I; 1-MATRIX METALLOPROTEINASE; CATALYTIC DOMAIN; TUMOR INVASION; CANCER GROWTH; TIMP-2	Tissue inhibitors of metalloproteinases (TIMPs), the endogenous inhibitors of matrix metalloproteinases, have been shown to possess biological functions that are independent of their ability to inhibit matrix metalloproteinases. We have previously shown that the C-terminal domain of TIMP-2 and, in particular, Loop 6 inhibit capillary endothelial cell proliferation and angiogenesis both in vitro and in vivo. To elucidate the mechanism by which Loop 6 inhibits angiogenesis, we sought to determine whether its biological effects were the result of a known TIMP-2 protein-protein interaction or of a receptor-mediated event. In this study, we identify insulin-like growth factor-1 receptor as a binding partner of Loop 6/TIMP-2 and characterize this interaction on the endothelial cell surface and the consequences of this interaction on downstream receptor signaling.	[Moses, Marsha A.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Fernandez, Cecilia A.; Roy, Roopali; Yang, Jiang; Panigrahy, Dipak; Moses, Marsha A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Lee, Sunyoung; Van Vliet, Krystyn J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Van Vliet, Krystyn J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Moses, MA (corresponding author), Childrens Hosp, Vasc Biol Program, Karp Family Res Bldg,300 Longwood Ave, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu			National Institutes of Health [1 RO1 CA118764-01, P01 CA045548]; S. Elizabeth O'Brien Trust Charitable Foundation; Nancy and Neal Foster Research Fund; Arnold and Mabel Beckman Young award; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA118764, P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); S. Elizabeth O'Brien Trust Charitable Foundation; Nancy and Neal Foster Research Fund; Arnold and Mabel Beckman Young award; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1 RO1 CA118764-01 and P01 CA045548 (to M. A. M.). The S. Elizabeth O'Brien Trust Charitable Foundation, the Nancy and Neal Foster Research Fund (to M. A. M.), an Arnold and Mabel Beckman Young award (to K.J.V.), and a National Science Foundation career award (to K.J.V.).	Beattie J, 2010, J CELL PHYSIOL, V224, P605, DOI 10.1002/jcp.22183; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bjorndahl M, 2005, P NATL ACAD SCI USA, V102, P15593, DOI 10.1073/pnas.0507865102; Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745; Corcoran ML, 1996, ADV EXP MED BIOL, V389, P295; Danielpour D, 2006, CYTOKINE GROWTH F R, V17, P59, DOI 10.1016/j.cytogfr.2005.09.007; EMMERTBUCK MR, 1995, FEBS LETT, V364, P28, DOI 10.1016/0014-5793(95)00345-A; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; Fernandez CA, 2006, BIOCHEM BIOPH RES CO, V345, P523, DOI 10.1016/j.bbrc.2006.04.083; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Goel HL, 2004, J CELL BIOL, V166, P407, DOI 10.1083/jcb.200403003; Goetsch L, 2005, INT J CANCER, V113, P316, DOI 10.1002/ijc.20543; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; Hu YP, 2008, CANCER RES, V68, P8004, DOI 10.1158/0008-5472.CAN-08-0280; Itoh Y, 1998, J BIOL CHEM, V273, P24360, DOI 10.1074/jbc.273.38.24360; Ko YC, 1997, BIOCHEM BIOPH RES CO, V236, P100, DOI 10.1006/bbrc.1997.6859; Laviola L, 2007, CURR PHARM DESIGN, V13, P663, DOI 10.2174/138161207780249146; Lee S, 2007, P NATL ACAD SCI USA, V104, P9609, DOI 10.1073/pnas.0702668104; Li S, 2009, MOL ENDOCRINOL, V23, P2013, DOI 10.1210/me.2009-0197; Long L, 1998, CANCER RES, V58, P3243; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Roy R, 2004, J BIOL CHEM, V279, P51323, DOI 10.1074/jbc.M409565200; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Stroh C, 2004, P NATL ACAD SCI USA, V101, P12503, DOI 10.1073/pnas.0403538101; Tai YT, 2003, CANCER RES, V63, P5850; Tuuttila A, 1998, J MOL BIOL, V284, P1133, DOI 10.1006/jmbi.1998.2223; Walton EB, 2008, BIOPHYS J, V94, P2621, DOI 10.1529/biophysj.107.114454; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yoon A, 2001, MOL CELL BIOCHEM, V223, P1, DOI 10.1023/A:1017549222677; Zhang D, 2003, HORM METAB RES, V35, P802; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	43	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41886	41895		10.1074/jbc.M110.166439	http://dx.doi.org/10.1074/jbc.M110.166439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20940305	hybrid, Green Published			2022-12-27	WOS:000285622600076
J	Zhang, ZY; Lowry, SF; Guarente, L; Haimovich, B				Zhang, Zhiyong; Lowry, Stephen F.; Guarente, Leonard; Haimovich, Beatrice			Roles of SIRT1 in the Acute and Restorative Phases following Induction of Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR-1; UBIQUITIN-PROTEASOME PATHWAY; PERIPHERAL-BLOOD LEUKOCYTES; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; FACTOR 1-ALPHA; FACTOR-I	Endotoxin is a potent inducer of systemic inflammatory responses in human and rodents. Here, we show that in vivo endotoxin triggers a rapid and transient decline in ATP concentration in human peripheral blood leukocytes and murine peripheral blood leukocytes and liver, which is associated with a brief increase in expression of the autophagy indicator LC3-II. In both of these tissues, the ATP concentration reaches a nadir, and autophagy is induced between 2 and 4 h post-endotoxin infusion, and homeostasis is restored within 12 h. Mouse liver SIRT1 and AMP-activated protein kinase (AMPK) protein expression levels decline precipitously within 10 min and remain below detection levels for up to 12 h post-endotoxin administration. In marked contrast, the expression of HIF-1 alpha is induced within 90 min and remains elevated for up to 12 h. The ATP recovery is delayed, and the increases in both HIF-1 alpha expression and autophagy are prolonged in endotoxin-challenged SIRT1 liver knock-out mice. Resveratrol prevents the decline in ATP concentration and SIRT1 expression, as well as the increase in HIF-1 alpha expression and autophagy in liver of endotoxin-challenged wild type mice but not in SIRT1 liver knock-out mice. These results provide novel insight into the state of both cellular bioenergetics and metabolic networks during the acute phase of systemic inflammation and suggest a role for SIRT1 in acute metabolic decline, as well as the restoration of metabolic homeostasis during an inflammatory challenge.	[Haimovich, Beatrice] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08902 USA; [Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Haimovich, B (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, CAB Rm 7018,125 Paterson St, New Brunswick, NJ 08902 USA.	haimovic@umdnj.edu		zhang, zhiyong/0000-0003-4061-7374; ZHANG, ZHIYONG/0000-0001-8576-1607	National Institutes of Health [R21GM079255]; NIGMS [RO1 GM 034695]; NIEHS Center for Excellence [ES005022]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM079255, R01GM034695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS Center for Excellence; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21GM079255 (to B. H.) and RO1 GM 034695 (to S. F. L.) from NIGMS and Grant ES005022 from NIEHS Center for Excellence (to B. H.).	Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brealey D, 2002, LANCET, V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buryanovskyy L, 2004, BIOCHEMISTRY-US, V43, P11417, DOI 10.1021/bi049162o; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Crouser ED, 2006, CRIT CARE MED, V34, P2439, DOI 10.1097/01.CCM.0000230240.02216.21; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Haimovich B, 2010, CRIT CARE, V14, DOI 10.1186/cc9283; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Izaguirre G, 1999, J BIOL CHEM, V274, P37012, DOI 10.1074/jbc.274.52.37012; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kim HY, 2007, EXP CELL RES, V313, P1866, DOI 10.1016/j.yexcr.2007.03.009; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; Lowry SF, 2005, SHOCK, V24, P94, DOI 10.1097/01.shk.0000191340.23907.a1; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murias M, 2004, BIOORGAN MED CHEM, V12, P5571, DOI 10.1016/j.bmc.2004.08.008; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nguyen HB, 2004, CRIT CARE MED, V32, P1637, DOI 10.1097/01.CCM.0000132904.35713.A7; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sebai H, 2009, ARCH TOXICOL, V83, P335, DOI 10.1007/s00204-008-0348-0; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Singer M, 2007, CRIT CARE MED, V35, pS441, DOI 10.1097/01.CCM.0000278049.48333.78; Talwar S, 2006, PHYSIOL GENOMICS, V25, P203, DOI 10.1152/physiolgenomics.00192.2005; Thiel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000853; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WANG GL, 1995, BIOCHEM BIOPH RES CO, V212, P550, DOI 10.1006/bbrc.1995.2005; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshida K, 2008, INT J HEMATOL, V88, P43, DOI 10.1007/s12185-008-0091-6; Zang MW, 2006, DIABETES, V55, pA13; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	84	77	89	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41391	41401		10.1074/jbc.M110.174482	http://dx.doi.org/10.1074/jbc.M110.174482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966076	Green Published, hybrid			2022-12-27	WOS:000285622600025
J	Butler, TM; Mooers, SU; Narayan, SR; Siegman, MJ				Butler, Thomas M.; Mooers, Susan U.; Narayan, Srinivasa R.; Siegman, Marion J.			The N-terminal Region of Twitchin Binds Thick and Thin Contractile Filaments REDUNDANT MECHANISMS OF CATCH FORCE MAINTENANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN KINASE; INVERTEBRATE SMOOTH-MUSCLE; BYSSUS RETRACTOR MUSCLE; F-ACTIN; PROTEIN-C; PEVK DOMAIN; REGULATORY DOMAIN; MOLLUSCAN MUSCLES; MYTILUS-EDULIS; IN-VITRO	Catch force maintenance in invertebrate smooth muscles is probably mediated by a force-bearing tether other than myosin cross-bridges between thick and thin filaments. The phosphorylation state of the mini-titin twitchin controls catch. The C-terminal phosphorylation site (D2) of twitchin with its flanking Ig domains forms a phosphorylation-sensitive complex with actin and myosin, suggesting that twitchin is the tether (Funabara, D., Osawa, R., Ueda, M., Kanoh, S., Hartshorne, D.J., and Watabe, S. (2009) J. Biol. Chem. 284, 18015-18020). Here we show that a region near the N terminus of twitchin also interacts with thick and thin filaments from Mytilus anterior byssus retractor muscles. Both a recombinant protein, including the D1 and DX phosphorylation sites with flanking 7th and 8th Ig domains, and a protein containing just the linker region bind to thin filaments with about a 1: 1 mol ratio to actin and K-d values of 1 and 15 mu M, respectively. Both proteins show a decrease in binding when phosphorylated. The unphosphorylated proteins increase force in partially activated permeabilized muscles, suggesting that they are sufficient to tether thick and thin filaments. There are two sites of thin filament interaction in this region because both a 52-residue peptide surrounding the DX site and a 47-residue peptide surrounding the D1 site show phosphorylation-dependent binding to thin filaments. The peptides relax catch force, confirming the region's central role in the mechanism of catch. The multiple sites of thin filament interaction in the N terminus of twitchin in addition to those in the C terminus provide an especially secure and redundant mechanical link between thick and thin filaments in catch.	[Butler, Thomas M.; Mooers, Susan U.; Narayan, Srinivasa R.; Siegman, Marion J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA	Jefferson University	Butler, TM (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, 1020 Locust St, Philadelphia, PA 19107 USA.	thomas.butler@jefferson.edu			National Institutes of Health, NIAMS [R01AR042758]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042758] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant R01AR042758. This project was also supported in part under a grant with the Pennsylvania Department of Health.	Avrova SV, 2010, BIOCHEM BIOPH RES CO, V394, P126, DOI 10.1016/j.bbrc.2010.02.128; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; Bianco P, 2007, BIOPHYS J, V93, P2102, DOI [10.1529/biophysj.107.106153, 10.1529/biophysj.l07.106153]; Butler TM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/725207; Butler TM, 2006, BIOPHYS J, V90, P3193, DOI 10.1529/biophysj.105.077453; Butler TM, 1998, BIOPHYS J, V75, P1904, DOI 10.1016/S0006-3495(98)77631-3; CASTELLANI L, 1987, SCIENCE, V235, P334, DOI 10.1126/science.3026049; COLE RA, 1972, COMP BIOCHEM PHYSIOL, V43, P321, DOI 10.1016/0300-9629(72)90191-0; Erickson FL, 2003, MOL BIOL CELL, V14, P4173, DOI 10.1091/mbc.e02-10-0656; Franke AS, 2007, BIOPHYS J, V93, P554, DOI 10.1529/biophysj.107.105577; Funabara D, 2003, J BIOL CHEM, V278, P29308, DOI 10.1074/jbc.M303272200; Funabara D, 2001, BIOCHEMISTRY-US, V40, P2087, DOI 10.1021/bi0022691; Funabara D, 2007, J EXP BIOL, V210, P4399, DOI 10.1242/jeb.008722; Funabara D, 2009, J BIOL CHEM, V284, P18015, DOI 10.1074/jbc.M109.016485; Galler S, 2005, PFLUG ARCH EUR J PHY, V449, P372, DOI 10.1007/s00424-004-1350-x; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Hatch V, 2001, J CELL BIOL, V154, P611, DOI 10.1083/jcb.200105079; ISHII N, 1989, SCIENCE, V243, P1367, DOI 10.1126/science.2922614; JEWELL BR, 1959, J PHYSIOL-LONDON, V149, P154, DOI 10.1113/jphysiol.1959.sp006332; Kulke M, 2001, CIRC RES, V89, P874, DOI 10.1161/hh2201.099453; LEHMAN W, 1975, J GEN PHYSIOL, V66, P1, DOI 10.1085/jgp.66.1.1; Leonard TR, 2010, AM J PHYSIOL-CELL PH, V299, pC14, DOI 10.1152/ajpcell.00049.2010; Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468; LOWY J, 1963, PHILOS T ROY SOC B, V246, P105, DOI 10.1098/rstb.1963.0003; Nagy A, 2004, J CELL SCI, V117, P5781, DOI 10.1242/jcs.01501; Rode C, 2009, J THEOR BIOL, V259, P350, DOI 10.1016/j.jtbi.2009.03.015; RUEGG J. C., 1961, PROC ROY SOC SER B BIOL SCI, V154, P224, DOI 10.1098/rspb.1961.0030; RUEGG JC, 1971, PHYSIOL REV, V51, P201, DOI 10.1152/physrev.1971.51.1.201; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Shelud'ko NS, 2004, ARCH BIOCHEM BIOPHYS, V432, P269, DOI 10.1016/j.abb.2004.10.006; Siegman MJ, 1997, J MUSCLE RES CELL M, V18, P655, DOI 10.1023/A:1018683823020; Siegman MJ, 1998, P NATL ACAD SCI USA, V95, P5383, DOI 10.1073/pnas.95.9.5383; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; TWAROG BM, 1954, J CELL COMPAR PHYSL, V44, P141, DOI 10.1002/jcp.1030440112; VIBERT P, 1993, J MUSCLE RES CELL M, V14, P598, DOI 10.1007/BF00141557; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; YAMADA A, 1989, J MUSCLE RES CELL M, V10, P124, DOI 10.1007/BF01739968; Yamada A, 2001, P NATL ACAD SCI USA, V98, P6635, DOI 10.1073/pnas.111585098; Yamasaki R, 2001, BIOPHYS J, V81, P2297, DOI 10.1016/S0006-3495(01)75876-6	42	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52								10.1074/jbc.M110.166041	http://dx.doi.org/10.1074/jbc.M110.166041			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971853	hybrid, Green Published			2022-12-27	WOS:000285414400028
J	Simboeck, E; Sawicka, A; Zupkovitz, G; Senese, S; Winter, S; Dequiedt, F; Ogris, E; Di Croce, L; Chiocca, S; Seiser, C				Simboeck, Elisabeth; Sawicka, Anna; Zupkovitz, Gordin; Senese, Silvia; Winter, Stefan; Dequiedt, Franck; Ogris, Egon; Di Croce, Luciano; Chiocca, Susanna; Seiser, Christian			A Phosphorylation Switch Regulates the Transcriptional Activation of Cell Cycle Regulator p21 by Histone Deacetylase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Poetry							DEPENDENT KINASE INHIBITOR; WAF1/CIP1 GENE PROMOTER; H3 PHOSPHORYLATION; P21(WAF1/CIP1) EXPRESSION; CHROMATIN MODIFICATION; POTENTIAL MEDIATOR; CANCER-CELLS; MAP KINASE; ACETYLATION; PHOSPHATASE	Histone deacetylase inhibitors induce cell cycle arrest and apoptosis in tumor cells and are, therefore, promising anticancer drugs. The cyclin-dependent kinase inhibitor p21 is activated in histone deacetylase (HDAC) inhibitor-treated tumor cells, and its growth-inhibitory function contributes to the anti-tumorigenic effect of HDAC inhibitors. We show here that induction of p21 by trichostatin A involves MAP kinase signaling. Activation of the MAP kinase signaling pathway by growth factors or stress signals results in histone H3 serine 10 phosphorylation at the p21 promoter and is crucial for acetylation of the neighboring lysine 14 and recruitment of activated RNA polymerase II in response to trichostatin A treatment. In non-induced cells, the protein phosphatase PP2A is associated with the p21 gene and counteracts its activation. Induction of p21 is linked to simultaneous acetylation and phosphorylation of histone H3. The dual modification mark H3S10phK14ac at the activated p21 promoter is recognized by the phospho-binding protein 14-3-3 zeta, which protects the phosphoacetylation mark from being processed by PP2A. Taken together we have revealed a cross-talk of reversible phosphorylation and acetylation signals that controls the activation of p21 by HDAC inhibitors and identify the phosphatase PP2A as chromatin-associated transcriptional repressor in mammalian cells.	[Simboeck, Elisabeth; Sawicka, Anna; Zupkovitz, Gordin; Winter, Stefan; Ogris, Egon; Seiser, Christian] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria; [Simboeck, Elisabeth; Di Croce, Luciano] Ctr Regulacio Genom, Barcelona 08003, Spain; [Senese, Silvia; Chiocca, Susanna] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Dequiedt, Franck] FUSAGx, Cellular & Mol Biol Unit, B-5030 Gembloux, Belgium; [Dequiedt, Franck] Univ Liege, CHU Sart Tilman, Interdisciplinary Cluster Appl Genoprote GIGA R, B-4000 Liege, Belgium	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); IRCCS European Institute of Oncology (IEO); University of Liege; University of Liege	Seiser, C (corresponding author), Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Med Biochem, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	christian.seiser@univie.ac.at	Chiocca, Susanna/AAC-8863-2019; qiao, zhixin/I-3408-2012; Chiocca, Susanna/K-5233-2016; Di Croce, Luciano/E-7759-2015	Chiocca, Susanna/0000-0002-9721-0850; Di Croce, Luciano/0000-0003-3488-6228; Seiser, Christian/0000-0002-7046-9352; Zupkovitz, Gordin/0000-0001-8101-4524; Dequiedt, Franck/0000-0003-1234-7477; Ogris, Egon/0000-0001-5950-9264	Austrian Science Fund (FWF) [P18746, P22340]; Herzfelder Family Foundation; Italian Association for Cancer Research; Austrian Ministry of Science and Research; Austrian Science Fund (FWF) [P 22340] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Herzfelder Family Foundation; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF P18746 and P22340), the GEN-AU project "Epigenetic Plasticity of the Mammalian Genome" (Austrian Ministry of Science and Research), the Herzfelder Family Foundation (to C. S.), and by the Italian Association for Cancer Research (to S. C.).	Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Ballestar E, 2008, ADV GENET, V61, P247, DOI 10.1016/S0065-2660(07)00009-0; Brunmeir R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000927; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; Drobic B, 2010, NUCLEIC ACIDS RES, V38, P3196, DOI 10.1093/nar/gkq030; Dunn KL, 2005, BIOCHEM CELL BIOL, V83, P1, DOI 10.1139/O04-121; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Espino PS, 2006, CANCER RES, V66, P4610, DOI 10.1158/0008-5472.CAN-05-4251; Gartel AL, 2006, BIOMOL ENG, V23, P17, DOI 10.1016/j.bioeng.2006.01.002; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; Gartel AL, 2000, ONCOGENE, V19, P961, DOI 10.1038/sj.onc.1203411; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hauser C, 2002, MOL CELL BIOL, V22, P7820, DOI 10.1128/MCB.22.22.7820-7830.2002; Hazzalin CA, 2005, PLOS BIOL, V3, P2111, DOI 10.1371/journal.pbio.0030393; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karam CS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000975; Kobayashi H, 2004, INT J CANCER, V109, P207, DOI 10.1002/ijc.11697; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lagger G, 2003, MOL CELL BIOL, V23, P2669, DOI 10.1128/MCB.23.8.2669-2679.2003; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Liu Y, 2007, EMBO J, V26, P4683, DOI 10.1038/sj.emboj.7601886; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MAHADEVAN LC, 1991, NATURE, V349, P747, DOI 10.1038/349747c0; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Martin M, 2008, P NATL ACAD SCI USA, V105, P4727, DOI 10.1073/pnas.0708455105; MICHIELI P, 1994, CANCER RES, V54, P3391; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Mottet D, 2009, ONCOGENE, V28, P243, DOI 10.1038/onc.2008.371; Mottet D, 2008, CLIN EXP METASTAS, V25, P183, DOI 10.1007/s10585-007-9131-5; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2003, MOL CELL BIOL, V23, P6129, DOI 10.1128/MCB.23.17.6129-6138.2003; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Vaziri C, 1998, CELL GROWTH DIFFER, V9, P465; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang J, 2005, J BIOL CHEM, V280, P37725, DOI 10.1074/jbc.M507976200; Wharton W, 2000, J BIOL CHEM, V275, P33981, DOI 10.1074/jbc.M005600200; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	74	47	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41062	41073		10.1074/jbc.M110.184481	http://dx.doi.org/10.1074/jbc.M110.184481			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952396	hybrid, Green Published			2022-12-27	WOS:000285414400069
J	Spevak, CC; Ivanov, IP; Sachs, MS				Spevak, Christina C.; Ivanov, Ivaylo P.; Sachs, Matthew S.			Sequence Requirements for Ribosome Stalling by the Arginine Attenuator Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; PROLYL-TRANSFER-RNA; NEUROSPORA-CRASSA; LEADER PEPTIDE; TRANSLATIONAL REGULATION; A-SITE; UPSTREAM; GENE; CPA1; MECHANISMS	The 5 ' regions of eukaryotic mRNAs often contain upstream open reading frames (uORFs). The Neurospora crassa arg-2 uORF encodes the 24-residue arginine attenuator peptide (AAP). This regulatory uORF-encoded peptide, which is evolutionarily conserved in fungal transcripts specifying an arginine biosynthetic enzyme, functions as a nascent peptide within the ribosomal tunnel and negatively regulates gene expression. The nascent AAP causes ribosomes to stall at the uORF stop codon in response to arginine, thus, blocking ribosomes from reaching the ARG-2 initiation codon. Here scanning mutagenesis with alanine and proline was performed to systematically determine which AAP residues were important for conferring regulation. Changing many of the most highly conserved residues (Asp-12, Tyr-13, Lys-14, and Trp-19) abolished regulatory function. The minimal functional domain of the AAP was determined by positioning AAP sequences internally within a large polypeptide. Pulse-chase analyses revealed that residues 9-20 of the AAP composed the minimal domain that was sufficient to confer regulatory function. An extensive analysis of predicted fungal AAPs revealed that the minimal functional domain of the N. crassa AAP corresponded closely to the region that was most highly conserved among the fungi. We also observed that the tripeptide RGD could function similarly to arginine in triggering AAP-mediated ribosome stalling. These studies provide a better understanding of the elements required for a nascent peptide and a small regulatory molecule to control translational processes.	[Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Ivanov, Ivaylo P.] Univ Coll Cork, BioSci Inst, Cork, Ireland; [Ivanov, Ivaylo P.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Texas A&M University System; Texas A&M University College Station; Scripps Research Institute; University College Cork; Utah System of Higher Education; University of Utah	Sachs, MS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	msachs@mail.bio.tamu.edu		Ivanov, Ivaylo/0000-0002-4793-5466; Ivanov, Ivaylo/0000-0002-6008-3261; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [R01GM47498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM47498 (to M. S. S.).	Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Cao JH, 1996, MOL CELL BIOL, V16, P7109; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; DAVIS RH, 1986, MICROBIOL REV, V50, P280, DOI 10.1128/MMBR.50.3.280-313.1986; Delbecq P, 2000, CURR GENET, V38, P105, DOI 10.1007/s002940000140; DELBECQ P, 1994, MOL CELL BIOL, V14, P2378, DOI 10.1128/MCB.14.4.2378; Fang P, 2000, J BIOL CHEM, V275, P26710; Fang P, 2004, P NATL ACAD SCI USA, V101, P4059, DOI 10.1073/pnas.0400554101; Fang P, 2002, FUNGAL GENET BIOL, V36, P167, DOI 10.1016/S1087-1845(02)00014-2; Freitag M, 1996, GENETICS, V142, P117; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gaba A, 2001, EMBO J, V20, P6453, DOI 10.1093/emboj/20.22.6453; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Geballe AP, 2000, COLD SPRING HARBOR M, V39, P595; HONG J, 1994, J MOL BIOL, V243, P131, DOI 10.1006/jmbi.1994.1638; Hood HM, 2007, FUNGAL GENET BIOL, V44, P93, DOI 10.1016/j.fgb.2006.07.009; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LUO ZG, 1995, MOL CELL BIOL, V15, P5235; Luo ZL, 1996, J BACTERIOL, V178, P2172, DOI 10.1128/jb.178.8.2172-2177.1996; McLaughlin DJ, 2009, TRENDS MICROBIOL, V17, P488, DOI 10.1016/j.tim.2009.08.001; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Radford A, 2004, ADV GENET, V52, P165, DOI 10.1016/S0065-2660(04)52005-9; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Spevak CC, 2006, BIOCHEM BIOPH RES CO, V350, P834, DOI 10.1016/j.bbrc.2006.09.128; TAYLOR A, 1993, FASEB J, V7, P290, DOI 10.1096/fasebj.7.2.8440407; vandenHoff MJB, 1995, J MOL EVOL, V41, P813, DOI 10.1007/BF00173161; Wang Z, 1997, J BIOL CHEM, V272, P255; Wang Z, 1998, MOL CELL BIOL, V18, P7528, DOI 10.1128/MCB.18.12.7528; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; Wang Z, 1999, J BIOL CHEM, V274, P37565, DOI 10.1074/jbc.274.53.37565; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yasothornsrikul S, 1998, J NEUROCHEM, V70, P153	41	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40933	40942		10.1074/jbc.M110.164152	http://dx.doi.org/10.1074/jbc.M110.164152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20884617	hybrid, Green Published			2022-12-27	WOS:000285414400057
J	Suthammarak, W; Morgan, PG; Sedensky, MM				Suthammarak, Wichit; Morgan, Phil G.; Sedensky, Margaret M.			Mutations in Mitochondrial Complex III Uniquely Affect Complex I in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; CYTOCHROME BC(1) COMPLEX; IRON-SULFUR PROTEIN; CONSERVED CHARGED RESIDUES; BOVINE HEART-MITOCHONDRIA; RESPIRATORY-CHAIN; ESCHERICHIA-COLI; ELECTRON-TRANSPORT; C-OXIDASE; LIFE-SPAN	Mitochondrial supercomplexes containing complexes I, III, and IV of the electron transport chain are now regarded as an established entity. Supercomplex I.III.IV has been theorized to improve respiratory chain function by allowing quinone channeling between complexes I and III. Here, we show that the role of the supercomplexes extends beyond channeling. Mutant analysis in Caenorhabditis elegans reveals that complex III affects supercomplex I.III.IV formation by acting as an assembly or stabilizing factor. Also, a complex III mtDNA mutation, ctb-1, inhibits complex I function by weakening the interaction of complex IV in supercomplex I.III.IV. Other complex III mutations inhibit complex I function either by decreasing the amount of complex I (isp-1), or decreasing the amount of complex I in its most active form, the I.III.IV supercomplex (isp-1; ctb-1). ctb-1 suppresses a nuclear encoded complex III defect, isp-1, without improving complex III function. Allosteric interactions involve all three complexes within the supercomplex and are necessary for maximal enzymatic activities.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98101 USA; [Morgan, Phil G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Seattle, WA 98101 USA; [Suthammarak, Wichit] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Biochem, Bangkok 10700, Thailand	Case Western Reserve University; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Mahidol University	Sedensky, MM (corresponding author), Childrens Res Inst, 1900 9th Ave, Seattle, WA 98101 USA.	margaret.sedensky@seattlechildrens.org			National Institutes of Health [GM58881, AG026273]; American Recovery and Reinvestment Act Supplement [3R01GM58881-12S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Supplement; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health Grants GM58881 and AG026273 and American Recovery and Reinvestment Act Supplement 3R01GM58881-12S1.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; BENECKE R, 1993, BRAIN, V116, P1451, DOI 10.1093/brain/116.6.1451; Bianchi C, 2004, J BIOL CHEM, V279, P36562, DOI 10.1074/jbc.M405135200; Blakely EL, 2005, FEBS J, V272, P3583, DOI 10.1111/j.1742-4658.2005.04779.x; Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brass EP, 2001, AM J PHYSIOL-HEART C, V280, pH603, DOI 10.1152/ajpheart.2001.280.2.H603; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Budde SMS, 2000, BIOCHEM BIOPH RES CO, V275, P63, DOI 10.1006/bbrc.2000.3257; CHANCE B, 1955, NATURE, V176, P250, DOI 10.1038/176250a0; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; De Meirleir L, 2003, AM J MED GENET A, V121A, P126, DOI 10.1002/ajmg.a.20171; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Fernandez-Vizarra E, 2007, HUM MOL GENET, V16, P1241, DOI 10.1093/hmg/ddm072; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HATEFI Y, 1962, J BIOL CHEM, V237, P1676; Higdon R, 2005, OMICS, V9, P364, DOI 10.1089/omi.2005.9.364; HOPPEL C, 1979, J BIOL CHEM, V254, P4164; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Iwata S, 1996, STRUCTURE, V4, P567, DOI 10.1016/S0969-2126(96)00062-7; Kadenbach B, 1997, MOL CELL BIOCHEM, V174, P131, DOI 10.1023/A:1006819416358; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; KORENKE GC, 1990, EUR J PEDIATR, V150, P104, DOI 10.1007/BF02072049; KROGER A, 1973, EUR J BIOCHEM, V39, P313, DOI 10.1111/j.1432-1033.1973.tb03129.x; Lamantea E, 2002, NEUROMUSCULAR DISORD, V12, P49, DOI 10.1016/S0960-8966(01)00244-9; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Napiwotzki J, 1998, BIOL CHEM, V379, P335, DOI 10.1515/bchm.1998.379.3.335; NOBREGA FG, 1992, EMBO J, V11, P3821, DOI 10.1002/j.1460-2075.1992.tb05474.x; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schafer E, 2007, BIOCHEMISTRY-US, V46, P12579, DOI 10.1021/bi700983h; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Smits P, 2010, EUR J HUM GENET, V18, P324, DOI 10.1038/ejhg.2009.169; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; van Straaten HLM, 2005, NEUROPEDIATRICS, V36, P193, DOI 10.1055/s-2005-865713; Vempati UD, 2009, J BIOL CHEM, V284, P4383, DOI 10.1074/jbc.M805972200; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x	54	43	47	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40724	40731		10.1074/jbc.M110.159608	http://dx.doi.org/10.1074/jbc.M110.159608			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20971856	hybrid, Green Published			2022-12-27	WOS:000285414400036
J	Chun, KS; Lao, HC; Langenbach, R				Chun, Kyung-Soo; Lao, Huei-Chen; Langenbach, Robert			The Prostaglandin E-2 Receptor, EP2, Stimulates Keratinocyte Proliferation in Mouse Skin by G Protein-dependent and beta-Arrestin1-dependent Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SRC FAMILY KINASES; COUPLED RECEPTORS; EGF RECEPTOR; EPITHELIAL CARCINOGENESIS; PROSTANOID RECEPTORS; TUMOR-DEVELOPMENT; KNOCKOUT MICE; ACTIVATION	The prostaglandin E-2 (PGE2) G protein-coupled receptor (GPCR), EP2, plays important roles in mouse skin tumor development (Chun, K. S., Lao, H. C., Trempus, C. S., Okada, M., and Langenbach, R. (2009) Carcinogenesis 30, 1620-1627). Because keratinocyte proliferation is essential for skin tumor development, EP2-mediated signaling pathways that contribute to keratinocyte proliferation were investigated. A single topical application of the EP2 agonist, butaprost, dose-dependently increased keratinocyte replication via activation of epidermal growth factor receptor (EGFR) and PKA signaling. Because GPCR-mediated activation of EGFR can involve the formation of a GPCR-beta-arrestin-Src signaling complex, the possibility of a beta-arrestin1-Src complex contributing to EP2-mediated signaling in keratinocytes was investigated. Butaprost induced beta-arrestin1-Src complex formation and increased both Src and EGFR activation. A role for beta-arrestin1 in EP2-mediated Src and EGFR activation was demonstrated by the observation that beta-arrestin1 deficiency significantly reduced Src and EGFR activation. In agreement with a beta-arrestin1-Src complex contributing to EGFR activation, Src and EGFR inhibition (PP2 and AG1478, respectively) indicated that Src was upstream of EGFR. Butaprost also induced the activation of Akt, ERK1/2, and STAT3, and both beta-arrestin1 deficiency and EGFR inhibition (AG1478 or gefitinib) decreased their activation. In addition to beta-arrestin1-dependent EGFR activation, butaprost increased PKA activation, as measured by phospho-GSK3 beta (p-GSK3 beta) and p-cAMP-response element-binding protein formation. PKA inhibition (H89 or R-P-adenosine-3',5'-cyclic monophosphorothioate (R-P-cAMPS)) decreased butaprost-induced cAMP-response element-binding protein and ERK activation but did not affect EGFR activation, whereas beta-arrestin1 deficiency decreased EGFR activation but did not affect butaprost-induced PKA activation, thus indicating that they were independent EP2-mediated pathways. Therefore, the results indicate that EP2 contributed to mouse keratinocyte proliferation by G protein-independent, beta-arrestin1- dependent activation of EGFR and G protein-dependent activation of PKA.	[Chun, Kyung-Soo; Lao, Huei-Chen; Langenbach, Robert] NIEHS, NIH, Lab Toxicol & Pharmacol, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Langenbach, R (corresponding author), NIEHS, NIH, Lab Toxicol & Pharmacol, MD C4-09,POB 12233, Res Triangle Pk, NC 27709 USA.	langenb1@niehs.nih.gov			NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102145] Funding Source: NIH RePORTER	NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the Intramural Research Program of the NIEHS/National Institutes of Health.	Ansari KM, 2007, CARCINOGENESIS, V28, P2063, DOI 10.1093/carcin/bgm011; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bourcier C, 2006, CANCER RES, V66, P2700, DOI 10.1158/0008-5472.CAN-05-3129; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Bruce JIE, 2002, J BIOL CHEM, V277, P1340, DOI 10.1074/jbc.M106609200; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chang SH, 2005, PROSTAG OTH LIPID M, V76, P48, DOI 10.1016/j.prostaglandins.2004.12.001; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Chun KS, 2007, CANCER RES, V67, P2015, DOI 10.1158/0008-5472.CAN-06-3617; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Conner DA, 1997, CIRC RES, V81, P1021; Dajani OF, 2008, J CELL PHYSIOL, V214, P371, DOI 10.1002/jcp.21205; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Desai S, 2000, MOL PHARMACOL, V58, P1279, DOI 10.1124/mol.58.6.1279; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Egeblad M, 2001, BIOCHEM BIOPH RES CO, V281, P25, DOI 10.1006/bbrc.2001.4302; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Fischer Susan M., 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P183; Fujino H, 2003, TRENDS PHARMACOL SCI, V24, P335, DOI 10.1016/S0165-6147(03)00162-7; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; Kendall RT, 2009, CELL MOL LIFE SCI, V66, P2953, DOI 10.1007/s00018-009-0088-1; Kim DJ, 2007, MOL CARCINOGEN, V46, P725, DOI 10.1002/mc.20342; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Penn RB, 2001, J BIOL CHEM, V276, P32648, DOI 10.1074/jbc.M104143200; PENTLAND AP, 1986, J CLIN INVEST, V77, P246, DOI 10.1172/JCI112283; Pierce KL, 2001, J BIOL CHEM, V276, P23155, DOI 10.1074/jbc.M101303200; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Regan JW, 2003, LIFE SCI, V74, P143, DOI 10.1016/j.lfs.2003.09.031; Segrelles C, 2007, CANCER RES, V67, P10879, DOI 10.1158/0008-5472.CAN-07-2564; Seno H, 2002, CANCER RES, V62, P506; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109136200; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Sung YM, 2006, ONCOGENE, V25, P5507, DOI 10.1038/sj.onc.1209538; Sung YM, 2005, CANCER RES, V65, P9304, DOI 10.1158/0008-5472.CAN-05-1015; Tiano HF, 2002, CANCER RES, V62, P3395; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415	54	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39672	39681		10.1074/jbc.M110.117689	http://dx.doi.org/10.1074/jbc.M110.117689			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959465	hybrid, Green Published			2022-12-27	WOS:000285185500011
J	Dong, H; Fillingame, RH				Dong, Hui; Fillingame, Robert H.			Chemical Reactivities of Cysteine Substitutions in Subunit a of ATP Synthase Define Residues Gating H+ Transport from Each Side of the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AQUEOUS ACCESS PATHWAYS; ESCHERICHIA-COLI; PROTON TRANSLOCATION; C-RING; OXIDATIVE-PHOSPHORYLATION; MUTAGENIC ANALYSIS; ALPHA-SUBUNIT; CROSS-LINKING; ROTARY MOTOR; ROTOR RING	Subunit a plays a key role in coupling H+ transport to rotations of the subunit c-ring in F1Fo ATP synthase. In Escherichia coli, H+ binding and release occur at Asp-61 in the middle of the second transmembrane helix (TMH) of F-o subunit c. Based upon the Ag+ sensitivity of Cys substituted into subunit a, H+ are thought to reach Asp-61 via aqueous pathways mapping to surfaces of TMH 2-5. In this study we have extended characterization of the most Ag+-sensitive residues in subunit a with cysteine reactive methanethiosulfonate (MTS) reagents and Cd2+. The effect of these reagents on ATPase-coupled H+ transport was measured using inside-out membrane vesicles. Cd2+ inhibited the activity of all Ag+-sensitive Cys on the cytoplasmic side of the TMHs, and three of these substitutions were also sensitive to inhibition by MTS reagents. On the other hand, Cd2+ did not inhibit the activities of substitutions at residues 119 and 120 on the periplasmic side of TMH2, and residues 214 and 215 in TMH4 and 252 in TMH5 at the center of the membrane. When inside-out membrane vesicles from each of these substitutions were sonicated during Cd2+ treatment to expose the periplasmic surface, the ATPase-coupled H+ transport activity was strongly inhibited. The periplasmic access to N214C and Q252C, and their positioning in the protein at the a-c interface, is consistent with previous proposals that these residues may be involved in gating H+ access from the periplasmic half-channel to Asp-61 during the protonation step.	[Dong, Hui; Fillingame, Robert H.] Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fillingame, RH (corresponding author), Univ Wisconsin, Dept Biomol Chem, Sch Med & Publ Hlth, 1300 Univ Ave, Madison, WI 53706 USA.	rhfillin@wisc.edu			National Institutes of Health [GM23105]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023105, R37GM023105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by United States Public Health Service Grant GM23105 from the National Institutes of Health.	Angevine CM, 2007, J BIOL CHEM, V282, P9001, DOI 10.1074/jbc.M610848200; Angevine CM, 2003, P NATL ACAD SCI USA, V100, P13179, DOI 10.1073/pnas.2234364100; Angevine CM, 2003, J BIOL CHEM, V278, P6066, DOI 10.1074/jbc.M210199200; Barik S, 1996, Methods Mol Biol, V57, P203; CAIN BD, 1986, J BIOL CHEM, V261, P43; CAIN BD, 1989, J BIOL CHEM, V264, P3292; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; FILLINGAME RH, 1975, J BACTERIOL, V124, P870, DOI 10.1128/JB.124.2.870-883.1975; Fillingame RH, 2003, FEBS LETT, V555, P29, DOI 10.1016/S0014-5793(03)01101-3; HARTZOG PE, 1994, J BIOL CHEM, V269, P32313; HATCH LP, 1995, J BIOL CHEM, V270, P29407, DOI 10.1074/jbc.270.49.29407; Hicks DB, 2010, BBA-BIOENERGETICS, V1797, P1362, DOI 10.1016/j.bbabio.2010.02.028; HOWITT SM, 1988, BIOCHIM BIOPHYS ACTA, V936, P74, DOI 10.1016/0005-2728(88)90253-8; Jiang WP, 1998, P NATL ACAD SCI USA, V95, P6607, DOI 10.1073/pnas.95.12.6607; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; Jones PC, 1998, J BIOL CHEM, V273, P17178, DOI 10.1074/jbc.273.27.17178; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Kuo PH, 1998, FEBS LETT, V426, P217, DOI 10.1016/S0014-5793(98)00337-8; Long JC, 1998, J BIOL CHEM, V273, P16235, DOI 10.1074/jbc.273.26.16235; McMillan DGG, 2007, J BIOL CHEM, V282, P17395, DOI 10.1074/jbc.M611709200; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Moore KJ, 2008, J BIOL CHEM, V283, P31726, DOI 10.1074/jbc.M803848200; Moore KJ, 2008, J BIOL CHEM, V283, P13044, DOI 10.1074/jbc.M800900200; MOSHER ME, 1985, J BIOL CHEM, V260, P4807; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P415, DOI 10.1016/j.bbabio.2006.04.023; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; Steed PR, 2008, J BIOL CHEM, V283, P12365, DOI 10.1074/jbc.M800901200; Steed PR, 2009, J BIOL CHEM, V284, P23243, DOI 10.1074/jbc.M109.002501; Valiyaveetil FI, 1997, J BIOL CHEM, V272, P32635, DOI 10.1074/jbc.272.51.32635; Valiyaveetil FI, 1998, J BIOL CHEM, V273, P16241, DOI 10.1074/jbc.273.26.16241; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wada T, 1999, J BIOL CHEM, V274, P17353, DOI 10.1074/jbc.274.24.17353; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Wang ZX, 2004, J BIOL CHEM, V279, P26546, DOI 10.1074/jbc.M401206200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	43	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39811	39818		10.1074/jbc.M110.175844	http://dx.doi.org/10.1074/jbc.M110.175844			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943664	hybrid, Green Published			2022-12-27	WOS:000285185500025
J	Tillotson, B; Slocum, K; Coco, J; Whitebread, N; Thomas, B; West, KA; MacDougall, J; Ge, J; Ali, JA; Palombella, VJ; Normant, E; Adams, J; Fritz, CC				Tillotson, Bonnie; Slocum, Kelly; Coco, John; Whitebread, Nigel; Thomas, Brian; West, Kip A.; MacDougall, John; Ge, Jie; Ali, Janid A.; Palombella, Vito J.; Normant, Emmanuel; Adams, Julian; Fritz, Christian C.			Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTROINTESTINAL STROMAL TUMOR; PHASE-I; HEAT-SHOCK-PROTEIN-90 INHIBITION; CHAPERONE MACHINERY; CANCER CHAPERONE; GELDANAMYCIN; IPI-504; ASSAY; HYDROQUINONE; KINASE	Several Hsp90 (heat shock protein 90) inhibitors are currently under clinical evaluation as anticancer agents. However, the correlation between the duration and magnitude of Hsp90 inhibition and the downstream effects on client protein degradation and cancer cell growth inhibition has not been thoroughly investigated. To investigate the relationship between Hsp90 inhibition and cellular effects, we developed a method that measures drug occupancy on Hsp90 after treatment with the Hsp90 inhibitor IPI-504 in living cells and in tumor xenografts. In cells, we find the level of Hsp90 occupancy to be directly correlated with cell growth inhibition. At the molecular level, the relationship between Hsp90 occupancy and Hsp90 client protein degradation was examined for different client proteins. For sensitive Hsp90 clients (e. g. HER2 (human epidermal growth factor receptor 2), client protein levels directly mirror Hsp90 occupancy at all time points after IPI-504 administration. For insensitive client proteins, we find that protein abundance matches Hsp90 occupancy only after prolonged incubation with drug. Additionally, we investigate the correlation between plasma pharmacokinetics (PK), tumor PK, pharmacodynamics (PD) (client protein degradation), tumor growth inhibition, and Hsp90 occupancy in a xenograft model of human cancer. Our results indicate Hsp90 occupancy to be a better predictor of PD than either plasma PK or tumor PK. In the nonsmall cell lung cancer xenograft model studied, a linear correlation between Hsp90 occupancy and tumor growth inhibition was found. This novel binding assay was evaluated both in vitro and in vivo and could be used as a pharmacodynamic readout in the clinic.	[Tillotson, Bonnie; Slocum, Kelly; Coco, John; Whitebread, Nigel; Thomas, Brian; West, Kip A.; MacDougall, John; Ge, Jie; Ali, Janid A.; Palombella, Vito J.; Normant, Emmanuel; Adams, Julian; Fritz, Christian C.] Infin Pharmaceut, Cambridge, MA 02139 USA		Tillotson, B (corresponding author), Infin Pharmaceut, 780 Mem Dr, Cambridge, MA 02139 USA.	bonnie.tillotson@infi.com						Abramson JS, 2009, BRIT J HAEMATOL, V144, P358, DOI 10.1111/j.1365-2141.2008.07484.x; Aherne Wynne, 2003, Methods Mol Med, V85, P149; Avila C, 2006, BIOORG MED CHEM LETT, V16, P3005, DOI 10.1016/j.bmcl.2006.02.063; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Carreras CW, 2003, ANAL BIOCHEM, V317, P40, DOI 10.1016/S0003-2697(03)00060-5; Chan CT, 2008, CANCER RES, V68, P216, DOI 10.1158/0008-5472.CAN-07-2268; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dewaele B, 2008, CLIN CANCER RES, V14, P5749, DOI 10.1158/1078-0432.CCR-08-0533; Dittmar KD, 1997, J BIOL CHEM, V272, P21213, DOI 10.1074/jbc.272.34.21213; Douglas M, 2009, MOL CANCER THER, V8, P3369, DOI 10.1158/1535-7163.MCT-09-0568; Galam L, 2007, BIOORGAN MED CHEM, V15, P1939, DOI 10.1016/j.bmc.2007.01.004; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Gooljarsingh LT, 2006, P NATL ACAD SCI USA, V103, P7625, DOI 10.1073/pnas.0602650103; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Mahalingam D, 2009, BRIT J CANCER, V100, P1523, DOI 10.1038/sj.bjc.6605066; Maroney AC, 2006, BIOCHEMISTRY-US, V45, P5678, DOI 10.1021/bi0524969; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; Neckers L, 2007, J BIOSCIENCES, V32, P517, DOI 10.1007/s12038-007-0051-y; Park H, 2007, BIOORG MED CHEM LETT, V17, P6345, DOI 10.1016/j.bmcl.2007.08.069; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Ramanathan RK, 2005, CLIN CANCER RES, V11, P3385, DOI 10.1158/1078-0432.CCR-04-2322; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; SCHUMACHER RJ, 1994, J BIOL CHEM, V269, P9493; Smith-Jones PM, 2004, NAT BIOTECHNOL, V22, P701, DOI 10.1038/nbt968; Song D, 2008, MOL CANCER THER, V7, P3275, DOI 10.1158/1535-7163.MCT-08-0508; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Sydor JR, 2006, P NATL ACAD SCI USA, V103, P17408, DOI 10.1073/pnas.0608372103; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xu L, 2003, J PHARMACOKINET PHAR, V30, P185, DOI 10.1023/A:1025542026488; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200	42	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39835	39843		10.1074/jbc.M110.141580	http://dx.doi.org/10.1074/jbc.M110.141580			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940293	hybrid, Green Published			2022-12-27	WOS:000285185500028
J	Bockelmann, S; Menche, D; Rudolph, S; Bender, T; Grond, S; von Zezschwitz, P; Muench, SP; Wieczorek, H; Huss, M				Bockelmann, Svenja; Menche, Dirk; Rudolph, Sven; Bender, Tobias; Grond, Stephanie; von Zezschwitz, Paultheo; Muench, Stephen P.; Wieczorek, Helmut; Huss, Markus			Archazolid A Binds to the Equatorial Region of the c-Ring of the Vacuolar H+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASES; CONCANAMYCIN-A; SUBUNIT-C; P-TYPE; INHIBITORS; SITE; MYXOBACTERIA; PURIFICATION; ELUCIDATION; MEMBRANE	The macrolactone archazolid is a novel, highly specific V-ATPase inhibitor with an IC50 value in the low nanomolar range. The binding site of archazolid is presumed to overlap with the binding site of the established plecomacrolide V-ATPase inhibitors bafilomycin and concanamycin in subunit c of the membrane-integral V-O complex. Using a semi-synthetic derivative of archazolid for photoaffinity labeling of the V1VO holoenzyme we confirmed binding of archazolid to the V-O subunit c. For the plecomacrolide binding site a model has been published based on mutagenesis studies of the c subunit of Neurospora crassa, revealing 11 amino acids that are part of the binding pocket at the interface of two adjacent c subunits (Bowman, B. J., McCall, M. E., Baertsch, R., and Bowman, E. J. (2006) J. Biol. Chem. 281, 31885-31893). To investigate the contribution of these amino acids to the binding of archazolid, we established in Saccharomyces cerevisiae mutations that in N. crassa had changed the IC50 value for bafilomycin 10-fold or more and showed that out of the amino acids forming the plecomacrolide binding pocket only one amino acid (tyrosine 142) contributes to the binding of archazolid. Using a fluorescent derivative of N, N'-dicyclohexylcarbodiimide, we found that the binding site for archazolid comprises the essential glutamate within helix 4 of subunit c. In conclusion the archazolid binding site resides within the equatorial region of the V-O rotor subunit c. This hypothesis was supported by an additional subset of mutations within helix 4 that revealed that leucine 144 plays a role in archazolid binding.	[Wieczorek, Helmut; Huss, Markus] Univ Osnabruck, Fachbereich Biolo Chem, Abt Tierphysiol, D-49069 Osnabruck, Germany; [Menche, Dirk; Rudolph, Sven] Heidelberg Univ, Inst Organ Chem, D-69120 Heidelberg, Germany; [Bender, Tobias; von Zezschwitz, Paultheo] Univ Marburg, Fachbereich Chem, D-35032 Marburg, Germany; [Grond, Stephanie] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany; [Muench, Stephen P.] Univ Leeds, Inst Membrane & Syst Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University Osnabruck; Ruprecht Karls University Heidelberg; Philipps University Marburg; Eberhard Karls University of Tubingen; University of Leeds	Huss, M (corresponding author), Univ Osnabruck, Fachbereich Biolo Chem, Abt Tierphysiol, Barbarastr 11, D-49069 Osnabruck, Germany.	huss@biologie.uni-osnabrueck.de	Muench, Stephen/AAI-9529-2020	Muench, Stephen/0000-0001-6869-4414; Grond, Stephanie/0000-0002-7549-4936	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [SFB 431]; BMBF [0313105]; Medical Research Council; Medical Research Council [G1000567] Funding Source: researchfish; MRC [G1000567] Funding Source: UKRI	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants of the VolkswagenStiftung (Funding Initiative "Interplay between Molecular Conformations and Biological Function" (to D. M., H. W., and M. H.), Deutsche Forschungsgemeinschaft Grant SFB 431 (H. W. and M. H.) and BMBF MetabolitGenoMik Grant 0313105 (to S. G.).; Recipient of a Medical Research Council Career Development fellowship.	Bender T, 2007, EUR J ORG CHEM, V2007, P3870, DOI 10.1002/ejoc.200700194; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; CHADWICK CC, 1983, BIOCHIM BIOPHYS ACTA, V730, P201, DOI 10.1016/0005-2736(83)90334-6; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Drose S, 2001, BIOCHEMISTRY-US, V40, P2816, DOI 10.1021/bi001759q; FINBOW ME, 1992, PROTEIN ENG, V5, P7, DOI 10.1093/protein/5.1.7; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Harrison M, 2000, BIOCHEMISTRY-US, V39, P7531, DOI 10.1021/bi000159o; Hassfeld J, 2006, ORG LETT, V8, P4751, DOI 10.1021/ol061831y; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; Huss Markus, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-13; Jansen R, 2000, EUR J ORG CHEM, V2000, P913, DOI 10.1002/(SICI)1099-0690(200003)2000:6<913::AID-EJOC913>3.0.CO;2-L; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Menche D, 2007, J AM CHEM SOC, V129, P6100, DOI 10.1021/ja071461o; Menche D, 2007, EUR J ORG CHEM, V2007, P1196, DOI 10.1002/ejoc.200600912; Menche D, 2007, BIOORG MED CHEM LETT, V17, P1732, DOI 10.1016/j.bmcl.2006.12.073; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; NOUMI T, 1991, P NATL ACAD SCI USA, V88, P1938, DOI 10.1073/pnas.88.5.1938; Pali T, 2004, BIOCHEMISTRY-US, V43, P12297, DOI 10.1021/bi0493867; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Sasse F, 2003, J ANTIBIOT, V56, P520, DOI 10.7164/antibiotics.56.520; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; WIECZOREK H, 1990, METHOD ENZYMOL, V192, P608	33	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38304	38314		10.1074/jbc.M110.137539	http://dx.doi.org/10.1074/jbc.M110.137539			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20884613	Green Published, hybrid			2022-12-27	WOS:000284625600037
J	Chakraborty, S; Li, M; Chatterjee, C; Sivaraman, J; Leung, KY; Mok, YK				Chakraborty, Smarajit; Li, Mo; Chatterjee, Chiradip; Sivaraman, J.; Leung, Ka Yin; Mok, Yu-Keung			Temperature and Mg2+ Sensing by a Novel PhoP-PhoQ Two-component System for Regulation of Virulence in Edwardsiella tarda	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; SENSOR DOMAIN; MOLECULAR CHARACTERIZATION; SECRETION SYSTEM; SIGNAL-DETECTION; GENE-EXPRESSION; SALMONELLA; IDENTIFICATION; PATHOGENESIS	The PhoP-PhoQ two-component system is commonly used by bacteria to sense environmental factors. Here we show that the PhoP-PhoQ system of Edwardsiella tarda detects changes in environmental temperature and Mg2+ concentration as well as regulates the type III and VI secretion systems through direct activation of esrB. Protein secretion is activated from 23 to 35 degrees C or at low Mg2+ concentrations, but it is suppressed at or below 20 degrees C, at or above 37 C, or at high Mg2+ concentrations. The effects of temperature and Mg2+ concentration are additive. The PhoQ sensor domain has a low T-m of 37.9 degrees C, and it detects temperatures through a conformational change of its secondary structure. Mutation of specific Pro or Thr residues increased the stability of the PhoQ sensor drastically, altering its temperature-sensing ability. The PhoQ sensor detects Mg2+ concentration through the direct binding of Mg2+ to a cluster of acidic residues (DDDSAD) and through changes that likely affect its tertiary structure. Here, we describe for the first time the use of PhoP-PhoQ as a temperature sensor for bacterial virulence control.	[Chakraborty, Smarajit; Li, Mo; Chatterjee, Chiradip; Sivaraman, J.; Mok, Yu-Keung] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; [Leung, Ka Yin] Trinity Western Univ, Fac Nat & Appl Sci, Dept Biol, Langley, BC V2Y 1T1, Canada	National University of Singapore; Trinity Western University	Mok, YK (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore.	dbsmokh@nus.edu.sg	Mok, Yu Keung/H-8019-2012; Sivaraman, J/H-8028-2012	Mok, Yu Keung/0000-0002-2829-4878; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore [07/1/21/19/495]	Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Biomedical Research Council of the Agency for Science Technology and Research (A*STAR) of Singapore Grant 07/1/21/19/495 (to Y.-K.M.).	Aguirre A, 2006, J BACTERIOL, V188, P6889, DOI 10.1128/JB.00804-06; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cybulski LE, 2002, MOL MICROBIOL, V45, P1379, DOI 10.1046/j.1365-2958.2002.03103.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Hargreaves J. A., 2004, BIOL CULTURE CHANNEL, P42; Hunger K, 2004, FEMS MICROBIOL LETT, V230, P41, DOI 10.1016/S0378-1097(03)00852-8; JANDA JM, 1993, CLIN INFECT DIS, V17, P742, DOI 10.1093/clinids/17.4.742; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kato A, 1999, J BACTERIOL, V181, P5516, DOI 10.1128/JB.181.17.5516-5520.1999; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Lesley JA, 2001, J BIOL CHEM, V276, P30827, DOI 10.1074/jbc.M104262200; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; LODGE J, 1992, FEMS MICROBIOL LETT, V95, P271; Martin-Orozco N, 2006, MOL BIOL CELL, V17, P498, DOI 10.1091/mbc.E04-12-1096; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Minagawa S, 2003, J BACTERIOL, V185, P3696, DOI 10.1128/JB.185.13.3696-3702.2003; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; Mok YK, 1996, PROTEIN SCI, V5, P310; Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Prajapati RS, 2007, PROTEINS, V66, P480, DOI 10.1002/prot.21215; Prost LR, 2008, MOL MICROBIOL, V69, P503, DOI 10.1111/j.1365-2958.2008.06303.x; Prost LR, 2008, CELL MICROBIOL, V10, P576, DOI 10.1111/j.1462-5822.2007.01111.x; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, INFECT IMMUN, V71, P1343, DOI 10.1128/IAI.71.3.1343-1351.2003; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thune Ronald L., 1993, Annual Review of Fish Diseases, V3, P37, DOI 10.1016/0959-8030(93)90028-A; Vescovi EG, 1997, J BIOL CHEM, V272, P1440, DOI 10.1074/jbc.272.3.1440; Waldburger CD, 1996, J BIOL CHEM, V271, P26630, DOI 10.1074/jbc.271.43.26630; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Zheng J, 2005, INFECT IMMUN, V73, P4127, DOI 10.1128/IAI.73.7.4127-4137.2005; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	42	55	55	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38876	38888		10.1074/jbc.M110.179150	http://dx.doi.org/10.1074/jbc.M110.179150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937832	Green Published, hybrid			2022-12-27	WOS:000284941300017
J	Moriyama, K; Sitkovsky, MV				Moriyama, Kengo; Sitkovsky, Michail V.			Adenosine A2A Receptor Is Involved in Cell Surface Expression of A2B Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUTEINIZING-HORMONE RECEPTOR; PROTEIN-COUPLED RECEPTORS; NEPHROGENIC DIABETES-INSIPIDUS; ENDOPLASMIC-RETICULUM; TRAFFICKING; MEMBRANE; EXPORT; UBIQUITINATION; DEGRADATION; MATURATION	The A2A and A2B adenosine receptors (A2AR and A2BR) are implicated in many physiological processes. However, the mechanisms of their intracellular maturation and trafficking are poorly understood. In comparative studies of A2AR versus A2BR expression in transfected cells, we noticed that the levels of cell surface expression of A2BR were significantly lower than those of A2AR. A large portion of the A2BR was degraded by the proteasome. Studies of cell surface expression of A2BR chimeric molecules in transfectants suggested that A2BR does not have the dominant forward transport signal for export from the endoplasmic reticulum to the cell surface. A2BR surface expression was increased in A2BR chimeras where the A2BR carboxyl terminus (CT) was replaced or fused with the A2AR CT. Co-transfection of A2AR with A2BR enhanced surface expression of A2BR though the F(X)(6)LL motif in the A2AR CT. The requirements of A2AR expression for better A2BR cell surface expression was not only established in transfectants but also confirmed by observations of much lower levels of A2BR-induced intracellular cAMP accumulation in response to A2BR-activating ligand in splenocytes from A2AR(-/-) mice than in wild type mice. The results of mechanistic studies suggested that poor A2BR expression at the cell surface might be accounted for mainly by the lack of a dominant forward transport signal from the endoplasmic reticulum to the plasma membrane; it is likely that A2BR forms a heterooligomer complex for better function.	[Sitkovsky, Michail V.] Northeastern Univ, Dept Pharmaceut Sci, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; Northeastern Univ, Dept Biol, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Sitkovsky, MV (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, New England Inflammat & Tissue Protect Inst, 360 Huntington Ave,134 Mugar Sci Bldg, Boston, MA 02115 USA.	m.sitkovsky@neu.edu			National Institutes of Health [R01 CA111985, R01 CA112561]; NATIONAL CANCER INSTITUTE [R01CA112561, R01CA111985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA111985 and R01 CA112561 (to M. V. S.).	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Apaja PM, 2006, MOL BIOL CELL, V17, P2243, DOI 10.1091/mbc.E05-09-0875; Apaja PM, 2005, ENDOCRINOLOGY, V146, P3224, DOI 10.1210/en.2005-0073; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cook LB, 2003, MOL ENDOCRINOL, V17, P1777, DOI 10.1210/me.2003-0073; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Duvernay MT, 2004, J BIOL CHEM, V279, P30741, DOI 10.1074/jbc.M313881200; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Fredholm BB, 2007, ACTA PHYSIOL, V190, P3, DOI 10.1111/j.1365-201X.2007.01689.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Gelman MS, 2002, J CLIN INVEST, V110, P1591, DOI 10.1172/JCI200216786; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HIPKIN RW, 1992, MOL ENDOCRINOL, V6, P2210, DOI 10.1210/me.6.12.2210; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Lee CM, 2009, ONCOGENE, V28, P1694, DOI 10.1038/onc.2009.12; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Mohammad S, 2007, J BIOL CHEM, V282, P4963, DOI [10.1074/jbc.m608283200, 10.1074/jbc.M608283200]; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; OMORCHOE CCC, 1984, J CELL BIOL, V98, P629, DOI 10.1083/jcb.98.2.629; Pankevych H, 2003, J BIOL CHEM, V278, P30283, DOI 10.1074/jbc.M212918200; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sitaraman SV, 2002, J BIOL CHEM, V277, P33188, DOI 10.1074/jbc.M202522200; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sun CX, 2006, J CLIN INVEST, V116, P2173, DOI 10.1172/JCI27303; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tan CM, 2003, J BIOL CHEM, V278, P35678, DOI 10.1074/jbc.M301888200; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Ulloa-Aguirre A, 2006, ACS CHEM BIOL, V1, P631, DOI 10.1021/cb600360h; Vannier B, 1996, BIOCHEMISTRY-US, V35, P1358, DOI 10.1021/bi952290f; VUHAILUUTHI MT, 1992, BIOCHEMISTRY-US, V31, P8377, DOI 10.1021/bi00150a035; WADA I, 1994, J BIOL CHEM, V269, P7464; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yang D, 2008, P NATL ACAD SCI USA, V105, P792, DOI 10.1073/pnas.0705563105; Yang M, 1998, J EXP MED, V187, P835, DOI 10.1084/jem.187.6.835	64	56	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39271	39288		10.1074/jbc.M109.098293	http://dx.doi.org/10.1074/jbc.M109.098293			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926384	hybrid, Green Published			2022-12-27	WOS:000284941300056
J	Zarrabi, T; Cervenka, R; Sandtner, W; Lukacs, P; Koenig, X; Hilber, K; Mille, M; Lipkind, GM; Fozzard, HA; Todt, H				Zarrabi, Touran; Cervenka, Rene; Sandtner, Walter; Lukacs, Peter; Koenig, Xaver; Hilber, Karlheinz; Mille, Markus; Lipkind, Gregory M.; Fozzard, Harry A.; Todt, Hannes			A Molecular Switch between the Outer and the Inner Vestibules of the Voltage-gated Na+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE-INACTIVATION; SHAKER K+ CHANNEL; ULTRA-SLOW INACTIVATION; CARDIAC SODIUM-CHANNELS; POTASSIUM CHANNELS; LOCAL-ANESTHETICS; SELECTIVITY FILTER; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; CELLULAR PLASTICITY	Voltage-gated ion channels are transmembrane proteins that undergo complex conformational changes during their gating transitions. Both functional and structural data from K+ channels suggest that extracellular and intracellular parts of the pore communicate with each other via a trajectory of interacting amino acids. No crystal structures are available for voltage-gated Na+ channels, but functional data suggest a similar intramolecular communication involving the inner and outer vestibules. However, the mechanism of such communication is unknown. Here, we report that amino acid Ile-1575 in the middle of transmembrane segment 6 of domain IV (DIV-S6) in the adult rat skeletal muscle isoform of the voltage-gated sodium channel (rNa(V)1.4) may act as molecular switch allowing for interaction between outer and inner vestibules. Cysteine scanning mutagenesis of the internal part of DIV-S6 revealed that only mutations at site 1575 rescued the channel from a unique kinetic state ("ultra-slow inactivation," I-US) produced by the mutation K1237E in the selectivity filter. A similar effect was seen with I1575A. Previously, we reported that conformational changes of both the internal and the external vestibule are involved in the generation of I-US. The fact that mutations at site 1575 modulate I-US produced by K1237E strongly suggests an interaction between these sites. Our data confirm a previously published molecular model in which Ile-1575 of DIV-S6 is in close proximity to Lys-1237 of the selectivity filter. Furthermore, these functional data define the position of the selectivity filter relative to the adjacent DIV-S6 segment within the ionic permeation pathway.	[Todt, Hannes] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Lipkind, Gregory M.; Fozzard, Harry A.] Univ Chicago, Dept Med, Cardiac Electrophysiol Labs, Chicago, IL 60637 USA	Medical University of Vienna; University of Chicago	Todt, H (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	hannes.todt@meduniwien.ac.at	Koenig, Xaver/Y-5588-2019	Koenig, Xaver/0000-0002-2423-4966; Hilber, Karlheinz/0000-0002-3033-0874	National Institutes of Health [1R01 HL096476-01]; Austrian Science Fund [P21006-B11, P17509-B11, P13961-B05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01 HL096476-01. This work was also supported by Austrian Science Fund Grants P21006-B11, P17509-B11, and P13961-B05.	Balser JR, 1996, J PHYSIOL-LONDON, V494, P431, DOI 10.1113/jphysiol.1996.sp021503; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Bett GCL, 2004, J PHYSIOL-LONDON, V556, P109, DOI 10.1113/jphysiol.2003.055012; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Carr DB, 2003, NEURON, V39, P793, DOI 10.1016/S0896-6273(03)00531-2; Chancey JH, 2007, AM J PHYSIOL-CELL PH, V293, pC1895, DOI 10.1152/ajpcell.00377.2007; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Chen ZH, 2000, J PHYSIOL-LONDON, V524, P37, DOI 10.1111/j.1469-7793.2000.t01-1-00037.x; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Creighton T. E., 1993, PROTEINS STRUCTURES, P141; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Cuello LG, 2009, BIOPHYS J, V96, p381A, DOI 10.1016/j.bpj.2008.12.2852; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eriksson MAL, 2002, BIOPHYS J, V83, P2595, DOI 10.1016/S0006-3495(02)75270-3; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Fukuda K, 2005, J PHYSIOL-LONDON, V564, P21, DOI 10.1113/jphysiol.2004.081646; Hilber K, 2005, BIOCHEMISTRY-US, V44, P13874, DOI 10.1021/bi0511944; Hilber K, 2002, J BIOL CHEM, V277, P37105, DOI 10.1074/jbc.M205661200; Hilber K, 2001, J BIOL CHEM, V276, P27831, DOI 10.1074/jbc.M101933200; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CJ, 2000, J GEN PHYSIOL, V115, P435, DOI 10.1085/jgp.115.4.435; Huang CJ, 2001, BIOPHYS J, V80, P1262, DOI 10.1016/S0006-3495(01)76102-4; Jiang XJ, 2003, J PHYSIOL-LONDON, V549, P683, DOI 10.1113/jphysiol.2002.034660; Kambouris NG, 1998, J PHYSIOL-LONDON, V512, P693, DOI 10.1111/j.1469-7793.1998.693bd.x; Lee PJ, 2001, CIRC RES, V89, P1014, DOI 10.1161/hh2301.100002; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; LIPKIND GM, 1994, BIOPHYS J, V66, P1, DOI 10.1016/S0006-3495(94)80746-5; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Meyer R, 1997, EUR BIOPHYS J BIOPHY, V26, P433, DOI 10.1007/s002490050098; O'Leary ME, 2003, MOL PHARMACOL, V64, P1575, DOI 10.1124/mol.64.6.1575; O'Reilly JP, 2000, BIOPHYS J, V78, P773, DOI 10.1016/S0006-3495(00)76635-5; O'Reilly JP, 2001, BIOPHYS J, V81, P2100, DOI 10.1016/S0006-3495(01)75858-4; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Olcese R, 2001, J GEN PHYSIOL, V117, P149, DOI 10.1085/jgp.117.2.149; Ong BH, 2000, J GEN PHYSIOL, V116, P653, DOI 10.1085/jgp.116.5.653; Panyi G, 2007, J GEN PHYSIOL, V129, P403, DOI 10.1085/jgp.200709758; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; RAGSDALE DS, 1994, SCIENCE, V265, P1724, DOI 10.1126/science.8085162; Ramos E, 2004, J PHYSIOL-LONDON, V560, P37, DOI 10.1113/jphysiol.2004.065003; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Sandtner W, 2004, MOL PHARMACOL, V66, P648; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Struyk AF, 2002, J GEN PHYSIOL, V120, P509, DOI 10.1085/jgp.20028672; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Sunami A, 2001, MOL PHARMACOL, V59, P684, DOI 10.1124/mol.59.4.684; Szendroedi J, 2007, BIOPHYS J, V93, P4209, DOI 10.1529/biophysj.107.104794; Takahashi MP, 1999, BIOPHYS J, V76, P861, DOI 10.1016/S0006-3495(99)77249-8; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Todt H, 1999, BIOPHYS J, V76, P1335, DOI 10.1016/S0006-3495(99)77296-6; TOMASELLI GF, 1995, BIOPHYS J, V68, P1814, DOI 10.1016/S0006-3495(95)80358-9; Townsend C, 1997, J GEN PHYSIOL, V110, P23, DOI 10.1085/jgp.110.1.23; Tsushima RG, 1997, J GEN PHYSIOL, V109, P463, DOI 10.1085/jgp.109.4.463; Tsushima RG, 1997, J GEN PHYSIOL, V110, P59, DOI 10.1085/jgp.110.1.59; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Vilin YY, 2001, BIOPHYS J, V80, p21A; Wang GK, 1998, PFLUG ARCH EUR J PHY, V435, P293; Wang SY, 2005, BIOPHYS J, V88, P3991, DOI 10.1529/biophysj.105.059352; Wang SY, 1997, BIOPHYS J, V72, P1633, DOI 10.1016/S0006-3495(97)78809-X; Xiong W, 2003, J GEN PHYSIOL, V122, P323, DOI 10.1085/jgp.200308881; Xiong W, 2006, J PHYSIOL-LONDON, V576, P739, DOI 10.1113/jphysiol.2006.115105; Yamagishi T, 2009, MOL PHARMACOL, V76, P861, DOI 10.1124/mol.109.055863; Yang YC, 2009, J GEN PHYSIOL, V134, P95, DOI 10.1085/jgp.200810158; YELLEN G, 1994, BIOPHYS J, V66, pA23; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; YOOL AJ, 1995, BIOPHYS J, V68, P448, DOI 10.1016/S0006-3495(95)80206-7; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	75	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39458	39470		10.1074/jbc.M110.132886	http://dx.doi.org/10.1074/jbc.M110.132886			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926383	hybrid, Green Published			2022-12-27	WOS:000284941300072
J	Adak, S; DeAndrade, D; Pike, LJ				Adak, Sangeeta; DeAndrade, Diana; Pike, Linda J.			The Tethering Arm of the EGF Receptor Is Required for Negative Cooperativity and Signal Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-BINDING; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; LIPID RAFTS; PHORBOL ESTERS; ACTIVATION; AFFINITY; ECTODOMAIN; SURFACE	The EGF receptor is a classical receptor-tyrosine kinase. In the absence of ligand, the receptor adopts a closed conformation in which the dimerization arm of subdomain II interacts with the tethering arm in subdomain IV. Following the binding of EGF, the receptor opens to form a symmetric, back-to-back dimer. Although it is clear that the dimerization arm of subdomain II is central to the formation of receptor dimers, the role of the tethering arm of subdomain IV (residues 561-585) in this configuration is not known. Here we use I-125-EGF binding studies to assess the functional role of the tethering arm in the EGF receptor dimer. Mutation of the three major residues that contribute to tethering (D563A, H566A, K585A-EGF receptor) did not significantly alter either the ligand binding properties or the signaling properties of the EGF receptor. By contrast, breaking the Cys(558)-Cys(567) disulfide bond through double alanine replacements or deleting the loop entirely led to a decrease in the negative cooperativity in EGF binding and was associated with small changes in downstream signaling. Deletion of the Cys(571)-Cys(593) disulfide bond abrogated cooperativity, resulting in a high affinity receptor and increased sensitivity of downstream signaling pathways to EGF. Releasing the Cys(571)-Cys(593) disulfide bond resulted in extreme negative cooperativity, ligand-independent kinase activity, and impaired downstream signaling. These data demonstrate that the tethering arm plays an important role in supporting cooperativity in ligand binding. Because cooperativity implies subunit-subunit interactions, these results also suggest that the tethering arm contributes to intersubunit interactions within the EGF receptor dimer.	[Adak, Sangeeta; DeAndrade, Diana; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu		ADAK, SANGEETA/0000-0003-3855-9099	National Institutes of Health [R01 GM064491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM064491 (to L.J.P.).	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; BAJAJ M, 1987, BIOCHIM BIOPHYS ACTA, V916, P220, DOI 10.1016/0167-4838(87)90112-9; BREMER EG, 1986, J BIOL CHEM, V261, P2434; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kastner J, 2009, J STRUCT BIOL, V167, P117, DOI 10.1016/j.jsb.2009.04.007; KING AC, 1982, J BIOL CHEM, V257, P3053; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; Liu YH, 2008, GLYCOBIOLOGY, V18, P593, DOI 10.1093/glycob/cwn039; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 1998, J BIOL CHEM, V273, P22298, DOI 10.1074/jbc.273.35.22298; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Ringerike T, 2002, J CELL SCI, V115, P1331; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Saxon ML, 1999, J BIOL CHEM, V274, P28356, DOI 10.1074/jbc.274.40.28356; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; SOROKIN A, 1995, ONCOGENE, V11, P1531; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang XQ, 2001, J INVEST DERMATOL, V116, P69, DOI 10.1046/j.1523-1747.2001.00222.x; Wyman J., 1990, BINDING LINKAGE FUNC, P203; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411	51	15	15	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1545	1555		10.1074/jbc.M110.182899	http://dx.doi.org/10.1074/jbc.M110.182899			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047778	Green Published, hybrid			2022-12-27	WOS:000286005000067
J	Maity, B; Yang, JQ; Huang, J; Askeland, RW; Bera, S; Fisher, RA				Maity, Biswanath; Yang, Jianqi; Huang, Jie; Askeland, Ryan W.; Bera, Soumen; Fisher, Rory A.			Regulator of G Protein Signaling 6 (RGS6) Induces Apoptosis via a Mitochondrial-dependent Pathway Not Involving Its GTPase-activating Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; RETINOBLASTOMA PROTEIN; ADENYLYL-CYCLASE; PHOSPHOLIPASE-C; GGL DOMAIN; CANCER; PHOSPHORYLATION; SUBUNIT	Regulator of G protein signaling 6 (RGS6) is a member of a family of proteins called RGS proteins, which function as GTPase-activating proteins (GAPs) for G alpha subunits. Given the role of RGS6 as a G protein GAP, the link between G protein activation and cancer, and a reduction of cancer risk in humans expressing a RGS6 SNP leading to its increased translation, we hypothesized that RGS6 might function to inhibit growth of cancer cells. Here, we show a marked down-regulation of RGS6 in human mammary ductal epithelial cells that correlates with the progression of their transformation. RGS6 exhibited impressive anti-proliferative actions in breast cancer cells, including inhibition of cell growth and colony formation and induction of cell cycle arrest and apoptosis by mechanisms independent of p53. RGS6 activated the intrinsic pathway of apoptosis involving regulation of Bax/Bcl-2, mitochondrial outer membrane permeabilization (MOMP), cytochrome c release, activation of caspases-3 and -9, and poly(ADP-ribose) polymerase cleavage. RGS6 promoted loss of mitochondrial membrane potential (Delta Psi(m)) and increases in reactive oxygen species (ROS). RGS6-induced caspase activation and loss of Delta Psi(m) was mediated by ROS, suggesting an amplification loop in which ROS provided a feed forward signal to induce MOMP, caspase activation, and cell death. Loss of RGS6 in mouse embryonic fibroblasts dramatically impaired doxorubicin-induced growth suppression and apoptosis. Surprisingly, RGS6-induced apoptosis in both breast cancer cells and mouse embryonic fibroblasts does not require its GAP activity toward G proteins. This work demonstrates a novel signaling action of RGS6 in cell death pathways and identifies it as a possible therapeutic target for treatment of breast cancer.	[Maity, Biswanath; Yang, Jianqi; Huang, Jie; Fisher, Rory A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Askeland, Ryan W.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Bera, Soumen] Univ Iowa, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Fisher, RA (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA.	rory-fisher@uiowa.edu	Bera, Soumen/ABG-1233-2021	Fisher, Rory/0000-0003-3108-4836; Maity, Biswanath/0000-0002-3239-3764	National Institutes of Health [GM075033, GM075033-03S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM075033 and GM075033-03S1 (to R.A.F.).	Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; DOHLMAN HG, 1995, MOL CELL BIOL, V15, P3635; Dohlman HG, 1996, MOL CELL BIOL, V16, P5194; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Dulin NO, 2000, J BIOL CHEM, V275, P21317, DOI 10.1074/jbc.M910079199; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Gabrielli BG, 1999, J BIOL CHEM, V274, P13961, DOI 10.1074/jbc.274.20.13961; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; James MA, 2009, CANCER RES, V69, P2108, DOI 10.1158/0008-5472.CAN-08-3495; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kato Jun-Ya, 1997, Leukemia (Basingstoke), V11, P347; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; Khleif SN, 1996, P NATL ACAD SCI USA, V93, P4350, DOI 10.1073/pnas.93.9.4350; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Liu ZY, 2004, J BIOL CHEM, V279, P14120, DOI 10.1074/jbc.M309547200; Liu ZY, 2002, J BIOL CHEM, V277, P37832, DOI 10.1074/jbc.M205908200; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nuydens R, 1999, J NEUROSCI METH, V92, P153, DOI 10.1016/S0165-0270(99)00107-7; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Shishodia S, 2003, CANCER RES, V63, P4375; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391	41	41	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1409	1419		10.1074/jbc.M110.186700	http://dx.doi.org/10.1074/jbc.M110.186700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21041304	hybrid, Green Published			2022-12-27	WOS:000286005000053
J	Xiong, Y; Song, D; Cai, YF; Yu, WF; Yeung, YG; Stanley, ER				Xiong, Ying; Song, Da; Cai, Yunfei; Yu, Wenfeng; Yeung, Yee-Guide; Stanley, E. Richard			A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL FACTOR; C-CBL; GROWTH-FACTOR; MONOCLONAL-ANTIBODIES; JUXTAMEMBRANE DOMAIN; ONCOGENE PRODUCT; STRUCTURAL BASIS; DOWN-REGULATION; PDGF RECEPTOR; BINDING-SITE	Receptor tyrosine kinase (RTK) activation involves ligand-induced receptor dimerization and transphosphorylation on tyrosine residues. Colony-stimulating factor-1 (CSF-1)-induced CSF-1 receptor (CSF-1R) tyrosine phosphorylation and ubiquitination were studied in mouse macrophages. Phosphorylation of CSF-1R Tyr-559, required for the binding of Src family kinases (SFKs), was both necessary and sufficient for these responses and for c-Cbl tyrosine phosphorylation and all three responses were inhibited by SFK inhibitors. In c-Cbl-deficient macrophages, CSF-1R ubiquitination and tyrosine phosphorylation were substantially inhibited. Reconstitution with wild-type, but not ubiquitin ligase-defective C381A c-Cbl rescued these responses, while expression of C381A c-Cbl in wild-type macrophages suppressed them. Analysis of site-directed mutations in the CSF-1R further suggests that activated c-Cbl-mediated CSF-1R ubiquitination is required for a conformational change in the major kinase domain that allows amplification of receptor tyrosine phosphorylation and full receptor activation. Thus the results indicate that CSF-1-mediated receptor dimerization leads to a Tyr-559/SFK/c-Cbl pathway resulting in receptor ubiquitination that permits full receptor tyrosine phosphorylation of this class III RTK in macrophages.	[Xiong, Ying; Song, Da; Cai, Yunfei; Yu, Wenfeng; Yeung, Yee-Guide; Stanley, E. Richard] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@aecom.yu.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	National Institutes of Health [CA26504, P01 CA 100324]; Albert Einstein College of Medicine Cancer Center [5P30-CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330, R37CA026504, R01CA026504, P01CA100324] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA26504, P01 CA 100324 (to E. R. S.), and the Albert Einstein College of Medicine Cancer Center Grant 5P30-CA13330.	ALONSO G, 1995, J BIOL CHEM, V270, P9840, DOI 10.1074/jbc.270.17.9840; Baccarini M, 1991, Receptor, V1, P243; BLAKE TJ, 1991, ONCOGENE, V6, P653; BLECHMAN JM, 1993, J BIOL CHEM, V268, P4399; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bourette RP, 2000, GROWTH FACTORS, V17, P155, DOI 10.3109/08977190009001065; CARLBERG K, 1994, MOL BIOL CELL, V5, P81, DOI 10.1091/mbc.5.1.81; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gu TL, 2007, BLOOD, V110, P323, DOI 10.1182/blood-2006-10-052282; Hamilton JA, 1997, J LEUKOCYTE BIOL, V62, P145, DOI 10.1002/jlb.62.2.145; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAWLEY RG, 1994, GENE THER, V1, P136; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Hunter T, 1998, Harvey Lect, V94, P81; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Joos H, 1996, J BIOL CHEM, V271, P24476, DOI 10.1074/jbc.271.40.24476; Kiyoi H, 2002, LEUKEMIA LYMPHOMA, V43, P1541, DOI 10.1080/1042819021000002866; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lasota J, 2006, SEMIN DIAGN PATHOL, V23, P91, DOI 10.1053/j.semdp.2006.08.006; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI W, 1991, MOL CELL BIOL, V11, P3756, DOI 10.1128/MCB.11.7.3756; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; Lokker NA, 1997, J BIOL CHEM, V272, P33037, DOI 10.1074/jbc.272.52.33037; Masson K, 2006, BIOCHEM J, V399, P59, DOI 10.1042/BJ20060464; MEISNER H, 1995, MOL CELL BIOL, V15, P3571; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Mol CD, 2003, J BACTERIOL, V185, P4152, DOI 10.1128/JB.185.14.4152-4162.2003; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Pakuts B, 2007, J BIOL CHEM, V282, P17953, DOI 10.1074/jbc.M701182200; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Stanley E. R., 1998, ANIMAL CELL CULTURE, P301; Stomski FC, 1996, MOL CELL BIOL, V16, P3035; Takeshita S, 2007, J BIOL CHEM, V282, P18980, DOI 10.1074/jbc.M610938200; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Walter M, 2007, J MOL BIOL, V367, P839, DOI 10.1016/j.jmb.2007.01.036; Wang Y, 1999, J CELL BIOCHEM, V72, P119; Wang Y, 1996, J BIOL CHEM, V271, P17, DOI 10.1074/jbc.271.1.17; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wilhelmsen K, 2002, ONCOGENE, V21, P1079, DOI 10.1038/sj.onc.1205166; Yeung YG, 1998, J BIOL CHEM, V273, P17128, DOI 10.1074/jbc.273.27.17128; Yu WF, 2008, J LEUKOCYTE BIOL, V84, P852, DOI 10.1189/jlb.0308171; ZE W, 1993, MOL CELL BIOL, V13, P5348, DOI 10.1128/MCB.13.9.5348; Zhang Y, 1999, J BIOL CHEM, V274, P33072, DOI 10.1074/jbc.274.46.33072	61	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					952	960		10.1074/jbc.M110.166702	http://dx.doi.org/10.1074/jbc.M110.166702			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21041311	Green Published, hybrid			2022-12-27	WOS:000286005000006
J	Kashlan, OB; Adelman, JL; Okumura, S; Blobner, BM; Zuzek, Z; Hughey, RP; Kleyman, TR; Grabe, M				Kashlan, Ossama B.; Adelman, Joshua L.; Okumura, Sora; Blobner, Brandon M.; Zuzek, Zachary; Hughey, Rebecca P.; Kleyman, Thomas R.; Grabe, Michael			Constraint-based, Homology Model of the Extracellular Domain of the Epithelial Na+ Channel alpha Subunit Reveals a Mechanism of Channel Activation by Proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; STRUCTURE PREDICTION; SODIUM-CHANNELS; ION CHANNELS; 3-DIMENSIONAL STRUCTURES; INHIBITORY DOMAIN; GAMMA-SUBUNIT; ENAC; PEPTIDE; FURIN	The epithelial Na+ channel (ENaC) mediates Na+ transport across high resistance epithelia. This channel is assembled from three homologous subunits with the majority of the protein's mass found in the extracellular domains. Acid-sensing ion channel 1 (ASIC1) is homologous to ENaC, but a key functional domain is highly divergent. Here we present molecular models of the extracellular region of alpha ENaC based on a large data set of mutations that attenuate inhibitory peptide binding in combination with comparative modeling based on the resolved structure of ASIC1. The models successfully rationalized the data from the peptide binding screen. We engineered new mutants that had not been tested based on the models and successfully predict sites where mutations affected peptide binding. Thus, we were able to confirm the overall general fold of our structural models. Further analysis suggested that the alpha subunit-derived inhibitory peptide affects channel gating by constraining motions within two major domains in the extracellular region, the thumb and finger domains.	[Kashlan, Ossama B.; Okumura, Sora; Blobner, Brandon M.; Zuzek, Zachary; Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Adelman, Joshua L.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Grabe, Michael] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Renal Electrolyte Div, A919 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu			National Institutes of Health [DK078734, DK051391, DK065161, DK079307]; American Heart Association; National Science Foundation [MCB0845286]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161, K01DK078734, R37DK051391, R01DK051391, R01DK065161, P30DK079307] Funding Source: NIH RePORTER; Direct For Biological Sciences [0845286] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants DK078734 (to O. B. K.), DK051391 (to T. R. K.), DK065161 (to T. R. K. and R. P. H.), and DK079307 (to the Pittsburgh Center for Kidney Research). This work was also supported by a Scientist Development Grant from the American Heart Association (to O. B. K.) and a National Science Foundation Career Award MCB0845286 (to M. G.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2010, J GEN PHYSIOL, V135, P563, DOI 10.1085/jgp.200910368; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2008, AM J PHYSIOL-RENAL, V294, pF47, DOI 10.1152/ajprenal.00399.2007; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kastner C, 2009, AM J PHYSIOL-RENAL, V296, pF902, DOI 10.1152/ajprenal.90451.2008; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Myerburg MM, 2008, AM J PHYSIOL-LUNG C, V294, pL932, DOI 10.1152/ajplung.00437.2007; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Passero CJ, 2010, AM J PHYSIOL-RENAL, V299, pF854, DOI 10.1152/ajprenal.00316.2010; Passero CJ, 2010, CURR OPIN NEPHROL HY, V19, P13, DOI 10.1097/MNH.0b013e3283330fb2; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Reddy BVB, 2007, J BIOSCIENCES, V32, P929, DOI 10.1007/s12038-007-0093-1; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng S., 2008, KIDNEY PHYSL PATHOPH, P743; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151	52	55	56	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					649	660		10.1074/jbc.M110.167098	http://dx.doi.org/10.1074/jbc.M110.167098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974852	hybrid, Green Published			2022-12-27	WOS:000285782800066
J	Stenson, BM; Ryden, M; Venteclef, N; Dahlman, I; Pettersson, AML; Mairal, A; Astrom, G; Blomqvist, L; Wang, V; Jocken, JWE; Clement, K; Langin, D; Arner, P; Laurencikiene, J				Stenson, Britta M.; Ryden, Mikael; Venteclef, Nicolas; Dahlman, Ingrid; Pettersson, Annie M. L.; Mairal, Aline; Astrom, Gaby; Blomqvist, Lennart; Wang, Victoria; Jocken, Johan W. E.; Clement, Karine; Langin, Dominique; Arner, Peter; Laurencikiene, Jurga			Liver X Receptor (LXR) Regulates Human Adipocyte Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; CHOLESTEROL EFFLUX; TISSUE EXPRESSION; GENE-EXPRESSION; LIPID DROPLETS; PERILIPIN; ALPHA; MOUSE; DIFFERENTIATION	The Liver X receptor (LXR) is an important regulator of carbohydrate and lipid metabolism in humans and mice. We have recently shown that activation of LXR regulates cellular fuel utilization in adipocytes. In contrast, the role of LXR in human adipocyte lipolysis, the major function of human white fat cells, is not clear. In the present study, we stimulated in vitro differentiated human and murine adipocytes with the LXR agonist GW3965 and observed an increase in basal lipolysis. Microarray analysis of human adipocyte mRNA following LXR activation revealed an altered gene expression of several lipolysis- regulating proteins, which was also confirmed by quantitative real-time PCR. We show that expression and intracellular localization of perilipin1 (PLIN1) and hormone-sensitive lipase (HSL) are affected by GW3965. Although LXR activation does not influence phosphorylation status of HSL, HSL activity is required for the lipolytic effect of GW3965. This effect is abolished by PLIN1 knockdown. In addition, we demonstrate that upon activation, LXR binds to the proximal regions of the PLIN1 and HSL promoters. By selective knockdown of either LXR isoform, we show that LXR proportional to is the major isoform mediating the lipolysis-related effects of LXR. In conclusion, the present study demonstrates that activation of LXR proportional to up-regulates basal human adipocyte lipolysis. This is at least partially mediated through LXR binding to the PLIN1 promoter and down-regulation of PLIN1 expression.	[Stenson, Britta M.; Ryden, Mikael; Dahlman, Ingrid; Pettersson, Annie M. L.; Astrom, Gaby; Blomqvist, Lennart; Wang, Victoria; Jocken, Johan W. E.; Arner, Peter; Laurencikiene, Jurga] Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden; [Venteclef, Nicolas; Clement, Karine] INSERM, U872, Nutri Team 7, F-75006 Paris, France; [Venteclef, Nicolas; Clement, Karine] Univ Paris 06, Cordeliers Res Ctr, F-75006 Paris, France; [Clement, Karine] Hop La Pitie Salpetriere, AP HP, F-75013 Paris, France; [Mairal, Aline; Langin, Dominique] INSERM, U858, Lab Rech Obes, F-31432 Toulouse, France; [Mairal, Aline; Langin, Dominique] Univ Toulouse, UPS, IFR150, Inst Med Mol Rangueil, F-31432 Toulouse, France; [Langin, Dominique] CHU Toulouse, Biochim Lab, Inst Federatif Biol Purpan, F-31059 Toulouse, France	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Laurencikiene, J (corresponding author), Karolinska Inst, Dept Med Huddinge, NVS, Halsovagen 7,4th Floor, S-14186 Stockholm, Sweden.	jurga.laurencikiene@ki.se	Clément, karine/R-1120-2017; Venteclef, Nicolas/K-8484-2017	Arner, Peter/0000-0002-6208-6220; Venteclef, Nicolas/0000-0002-6313-1214; Dahlman, Ingrid/0000-0003-3819-5977; Langin, Dominique/0000-0002-2669-7825; , Jurga/0000-0002-7032-2924	Swedish Research Council; NovoNordisk; Swedish Diabetes Association; Swedish Heart and Lung Foundation; EndoMet; Karolinska Institutet; Ake Wiberg Foundation; Magn Bergvalls Foundation; ADAPT [HEALTH-F2-2008-201100]; NordForsk [SYSDIET-070014]; COST action [BM 0602]; NWO Rubicon [825.07.025]; European Union [HEPADIP] [LSHM-CT-2005-018734]	Swedish Research Council(Swedish Research CouncilEuropean Commission); NovoNordisk(Novo Nordisk); Swedish Diabetes Association; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); EndoMet; Karolinska Institutet(Karolinska Institutet); Ake Wiberg Foundation; Magn Bergvalls Foundation; ADAPT; NordForsk; COST action(European Cooperation in Science and Technology (COST)); NWO Rubicon(Netherlands Organization for Scientific Research (NWO)); European Union [HEPADIP]	This study was supported in part by the Swedish Research Council, NovoNordisk, Swedish Diabetes Association, Swedish Heart and Lung Foundation, EndoMet, Karolinska Institutet, Ake Wiberg Foundation, Magn Bergvalls Foundation, the European Union [HEPADIP (LSHM-CT-2005-018734), ADAPT (HEALTH-F2-2008-201100], NordForsk (SYSDIET-070014), COST action BM 0602, and NWO Rubicon (825.07.025).	Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; Arner P, 2007, CURR OPIN LIPIDOL, V18, P246, DOI 10.1097/MOL.0b013e32811e16fb; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Bezaire V, 2009, FEBS LETT, V583, P3045, DOI 10.1016/j.febslet.2009.08.019; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Commerford SR, 2007, MOL ENDOCRINOL, V21, P3002, DOI 10.1210/me.2007-0156; Dahlman I, 2006, PHARMACOGENET GENOM, V16, P881, DOI 10.1097/01.fpc.0000236334.49422.48; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Dicker A, 2005, INT J OBESITY, V29, P1413, DOI 10.1038/sj.ijo.0803042; Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029; Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; HELLMER J, 1989, ANAL BIOCHEM, V177, P132, DOI 10.1016/0003-2697(89)90027-4; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; KRAUSE BR, 1984, J LIPID RES, V25, P97; Krintel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003756; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Laurencikiene J, 2007, J LIPID RES, V48, P1069, DOI 10.1194/jlr.M600471-JLR200; Le Lay S, 2003, J LIPID RES, V44, P1499, DOI 10.1194/jlr.M200466-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe DB, 2004, BIOORG MED CHEM LETT, V14, P3155, DOI 10.1016/j.bmcl.2004.04.015; Magnusson B, 2008, METABOLISM, V57, P1307, DOI 10.1016/j.metabol.2008.04.028; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottagui-Tabar S, 2003, DIABETOLOGIA, V46, P789, DOI 10.1007/s00125-003-1112-x; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Ryden M, 2002, J BIOL CHEM, V277, P1085, DOI 10.1074/jbc.M109498200; Ryden M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1847, DOI 10.1152/ajpendo.00040.2007; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Shimizu M, 1996, PHARMACOL TOXICOL, V78, P254, DOI 10.1111/j.1600-0773.1996.tb00214.x; Stenson BM, 2009, ENDOCRINOLOGY, V150, P4104, DOI 10.1210/en.2009-0676; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulven SM, 2004, J LIPID RES, V45, P2052, DOI 10.1194/jlr.M400119-JLR200; van Harmelen Vanessa, 2005, Methods Mol Med, V107, P125; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200	48	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					370	379		10.1074/jbc.M110.179499	http://dx.doi.org/10.1074/jbc.M110.179499			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030586	Green Published, hybrid			2022-12-27	WOS:000285782800040
J	Uniewicz, KA; Cross, MJ; Fernig, DG				Uniewicz, Katarzyna A.; Cross, Michael J.; Fernig, David G.			Exogenous Recombinant Dimeric Neuropilin-1 Is Sufficient to Drive Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-CELLS; STEM-CELLS; VEGF; RECEPTOR; EXPRESSION; VEGF(165); BINDING; ORGANIZATION; APOPTOSIS	Neuropilin-1 (NRP-1) is present on the cell surface of endothelial cells, or as a soluble truncated variant. Membrane NRP-1 is proposed to enhance angiogenesis by promoting the formation of a signaling complex between vascular endothelial growth factor-A(165) (VEGF-A(165)), VEGF receptor-2 (VEGFR-2) and heparan sulfate, whereas the soluble NRP-1 is thought to act as an antagonist of signaling complex formation. We have analyzed the angiogenic potential of a chimera comprising the entire extracellular NRP-1 region dimerized through an Fc IgG domain and a monomeric truncated NRP-1 variant. Both NRP-1 proteins stimulated tubular morphogenesis and cell migration in HDMECs and HUVECs. Fc rNRP-1 was able to induce VEGFR-2 phosphorylation and expression of the VEGFR-2 specific target, regulator of calcineurin-1 (RCAN1.4). siRNA mediated gene silencing of VEGFR-2 revealed that VEGFR-2 was required for Fc rNRP-1 mediated activation of the intracellular signaling proteins PLC-gamma, AKT, and MAPK and tubular morphogenesis. The stimulatory activity was independent of VEGF-A(165). This was evidenced by depleting the cell culture of exogenous VEGF-A(165), and using instead for routine culture VEGF-A(121), which does not interact with NRP-1, and by the inability of VEGF-A sequestering antibodies to inhibit the angiogenic activity of the NRP proteins. Analysis of angiogenesis over a period of 6 days in an in vitro fibroblast/ endothelial co-culture model revealed that Fc rNRP-1 could induce endothelial cell tubular morphogenesis. Thus, we conclude that soluble Fc rNRP-1 is a VEGF-A(165)-independent agonist of VEGFR-2 and stimulates angiogenesis in endothelial cells.	[Cross, Michael J.] Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L69 3GE, Merseyside, England; [Uniewicz, Katarzyna A.; Fernig, David G.] Univ Liverpool, Dept Chem & Struct Biol, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Cross, MJ (corresponding author), Univ Liverpool, Dept Mol & Clin Pharmacol, Inst Translat Med, Liverpool L69 3GE, Merseyside, England.	m.j.cross@liv.ac.uk; Dgfernig@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293	European Commission; North West Cancer Research Fund; Cancer and Polio Research Fund	European Commission(European CommissionEuropean Commission Joint Research Centre); North West Cancer Research Fund; Cancer and Polio Research Fund	This work was supported by the European Commission (Marie Curie Early Stage Training Fellowship, to K.A.U.), the North West Cancer Research Fund, and the Cancer and Polio Research Fund.	Abcouwer SF, 2002, INVEST OPHTH VIS SCI, V43, P2791; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Barr MP, 2005, BRIT J CANCER, V92, P328, DOI 10.1038/sj.bjc.6602308; Bartoli M, 2003, FASEB J, V17, P1562, DOI 10.1096/fj.02-1084fje; Bartsch G, 2008, J UROLOGY, V179, P326, DOI 10.1016/j.juro.2007.08.086; Bechet D, 2010, PHARM RES-DORDR, V27, P468, DOI 10.1007/s11095-009-0035-8; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Chitteti BR, 2010, BLOOD, V115, P3239, DOI 10.1182/blood-2009-09-246173; Cristofaro B, 2009, CURR OPIN PHARMACOL, V9, P102, DOI 10.1016/j.coph.2008.11.006; da Silva AJ, 2002, J IMMUNOL, V168, P4462, DOI 10.4049/jimmunol.168.9.4462; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Ferrara N, 1999, KIDNEY INT, V56, P794, DOI 10.1046/j.1523-1755.1999.00610.x; Fiocco U, 2008, AUTOIMMUN REV, V8, P76, DOI 10.1016/j.autrev.2008.07.035; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Geretti E, 2007, CELL ADHES MIGR, V1, DOI 10.4161/cam.1.2.4490; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Gualandris A, 2009, FASEB J, V23, P68, DOI 10.1096/fj.08-112847; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holmes K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011435; Hong TM, 2007, CLIN CANCER RES, V13, P4759, DOI 10.1158/1078-0432.CCR-07-0001; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Jarvis A, 2010, J MED CHEM, V53, P2215, DOI 10.1021/jm901755g; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Lambert S, 2009, BLOOD, V113, P5176, DOI 10.1182/blood-2008-04-150342; Lee TY, 2008, CLIN CANCER RES, V14, P1487, DOI 10.1158/1078-0432.CCR-07-1530; Liang WC, 2007, J MOL BIOL, V366, P815, DOI 10.1016/j.jmb.2006.11.021; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; SEDMAK DD, 1991, AM J PATHOL, V138, P175; Slimani H, 2006, J DRUG TARGET, V14, P694, DOI 10.1080/10611860600947607; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; UCHIDA K, 1994, AM J PHYSIOL, V266, pF81, DOI 10.1152/ajprenal.1994.266.1.F81; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Yamada Y, 2001, BLOOD, V97, P1671, DOI 10.1182/blood.V97.6.1671; Zachary IC, 2009, BIOCHEM SOC T, V37, P1171, DOI 10.1042/BST0371171	72	18	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					12	23		10.1074/jbc.M110.190801	http://dx.doi.org/10.1074/jbc.M110.190801			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956519	Green Published, hybrid			2022-12-27	WOS:000285782800002
J	Christian, J; Vier, J; Paschen, SA; Hacker, G				Christian, Jan; Vier, Juliane; Paschen, Stefan A.; Haecker, Georg			Cleavage of the NF-kappa B Family Protein p65/RelA by the Chlamydial Protease-like Activity Factor (CPAF) Impairs Proinflammatory Signaling in Cells Infected with Chlamydiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-SPECIFIC PROTEASE; SECRETED PROTEASE; DEGRADATION; ACTIVATION; PATHWAY; GENE	Chlamydiae are obligate intracellular bacteria that frequently cause human disease. Chlamydiae replicate in a membranous vacuole in the cytoplasm termed inclusion but have the ability to transport proteins into the host cell cytosol. Chlamydial replication is associated with numerous changes of host cell functions, and these changes are often linked to proteolytic events. It has been shown earlier that the member of the NF-kappa B family of inflammation-associated transcription factors, p65/RelA, is cleaved during chlamydial infection, and a chlamydial protease has been implicated. We here provide evidence that the chlamydial protease chlamydial protease-like activity factor (CPAF) is responsible for degradation of p65/RelA during infection. This degradation was seen in human and in mouse cells infected with either Chlamydia trachomatis or Chlamydia pneumoniae where it correlated with the expression of CPAF and CPAF activity. Isolated expression of active C. trachomatis or C. pneumoniae CPAF in human or mouse cells yielded a p65 fragment of indistinguishable size from the one generated during infection. Expression of active CPAF in human cells caused a mild reduction in I kappa B alpha phosphorylation but a strong reduction in NF-kappa B reporter activity in response to interleukin-1 beta. Infection with C. trachomatis likewise reduced this responsiveness. IL-1 beta-dependent secretion of IL-8 was further reduced by CPAF expression. Secretion of CPAF is, thus, a mechanism that reduces host cell sensitivity to a proinflammatory stimulus, which may facilitate bacterial growth in vivo.	[Christian, Jan; Paschen, Stefan A.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Christian, Jan; Vier, Juliane; Paschen, Stefan A.; Haecker, Georg] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, D-79104 Freiburg, Germany	Technical University of Munich; University of Freiburg	Hacker, G (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.haecker@uniklinik-freiburg.de			Else-Kromer-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft	Else-Kromer-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Else-Kromer-Fresenius-Stiftung and the Deutsche Forschungsgemeinschaft (to G.H.).	Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Belland RJ, 2004, CELL MICROBIOL, V6, P117, DOI 10.1046/j.1462-5822.2003.00352.x; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Dong F, 2004, MOL MICROBIOL, V52, P1487, DOI 10.1111/j.1365-2958.2004.04072.x; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; HARA H, 1991, J BACTERIOL, V173, P4799, DOI 10.1128/jb.173.15.4799-4813.1991; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Huang ZW, 2008, CELL HOST MICROBE, V4, P529, DOI 10.1016/j.chom.2008.10.005; Kawana K, 2007, J BIOL CHEM, V282, P7368, DOI 10.1074/jbc.M610754200; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Lad SP, 2007, J BACTERIOL, V189, P6619, DOI 10.1128/JB.00429-07; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Le Negrate G, 2008, CELL MICROBIOL, V10, P1879, DOI 10.1111/j.1462-5822.2008.01178.x; Liao DI, 2000, NAT STRUCT BIOL, V7, P749, DOI 10.1038/78973; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Ostberg Y, 2004, J BACTERIOL, V186, P2074, DOI 10.1128/JB.186.7.2074-2084.2004; Paetzel M, 1997, TRENDS BIOCHEM SCI, V22, P28, DOI 10.1016/S0968-0004(96)10065-7; Paschen SA, 2008, J CELL BIOL, V182, P117, DOI 10.1083/jcb.200804023; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; SILBER KR, 1992, P NATL ACAD SCI USA, V89, P295, DOI 10.1073/pnas.89.1.295; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2009, TRENDS MICROBIOL, V17, P467, DOI 10.1016/j.tim.2009.07.007	29	46	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41320	41327		10.1074/jbc.M110.152280	http://dx.doi.org/10.1074/jbc.M110.152280			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041296	hybrid, Green Published			2022-12-27	WOS:000285622600017
J	Popkie, AP; Zeidner, LC; Albrecht, AM; D'Ippolito, A; Eckardt, S; Newsom, DE; Groden, J; Doble, BW; Aronow, B; McLaughlin, KJ; White, P; Phiel, CJ				Popkie, Anthony P.; Zeidner, Leigh C.; Albrecht, Ashley M.; D'Ippolito, Anthony; Eckardt, Sigrid; Newsom, David E.; Groden, Joanna; Doble, Bradley W.; Aronow, Bruce; McLaughlin, K. John; White, Peter; Phiel, Christopher J.			Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; PROTEIN-KINASE; VALPROIC ACID; SELF-RENEWAL; ES CELLS; MOUSE; PHOSPHORYLATION; PLURIPOTENCY; EXPRESSION	Glycogen synthase kinase-3 (Gsk-3) isoforms, Gsk-3 alpha and Gsk-3 beta, are constitutively active, largely inhibitory kinases involved in signal transduction. Underscoring their biological significance, altered Gsk-3 activity has been implicated in diabetes, Alzheimer disease, schizophrenia, and bipolar disorder. Here, we demonstrate that deletion of both Gsk-3 alpha and Gsk-3 beta in mouse embryonic stem cells results in reduced expression of the de novo DNA methyltransferase Dnmt3a2, causing misexpression of the imprinted genes Igf2, H19, and Igf2r and hypomethylation of their corresponding imprinted control regions. Treatment of wild-type embryonic stem cells and neural stem cells with the Gsk-3 inhibitor, lithium, phenocopies the DNA hypomethylation at these imprinted loci. We show that inhibition of Gsk-3 by phosphatidylinositol 3-kinase (PI3K)-mediated activation of Akt also results in reduced DNA methylation at these imprinted loci. Finally, we find that N-Myc is a potent Gsk-3-dependent regulator of Dnmt3a2 expression. In summary, we have identified a signal transduction pathway that is capable of altering the DNA methylation of imprinted loci.	[Zeidner, Leigh C.; Albrecht, Ashley M.; D'Ippolito, Anthony; Eckardt, Sigrid; McLaughlin, K. John; Phiel, Christopher J.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; [Popkie, Anthony P.; Phiel, Christopher J.] Ohio State Univ, Grad Program Mol Cellular & Dev Biol, Columbus, OH 43210 USA; [Newsom, David E.; White, Peter] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Doble, Bradley W.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Aronow, Bruce] Cincinnati Childrens Hosp, Div Biomed Informat, Cincinnati, OH 45229 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; McMaster University; Cincinnati Children's Hospital Medical Center	Phiel, CJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, 700 Childrens Dr,W432, Columbus, OH 43205 USA.	phiel.1@osu.edu	Aronow, Bruce J/F-8438-2012; Doble, Brad/L-7551-2016; Doble, Bradley/V-7848-2019; McLaughlin, Kenneth/E-3648-2011; White, Peter/E-4301-2011	Doble, Brad/0000-0002-0260-2983; Doble, Bradley/0000-0002-0260-2983; White, Peter/0000-0002-5218-5903	National Institutes of Health [P30 DK078392, U54RR025216, R01CA63517, R01AG031833]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 DK078392 and U54RR025216 (to B. A.), R01CA63517 (to J. G.), and R01AG031833 (to C. J. P.).	BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; BUDOWLE B, 1990, Applied and Theoretical Electrophoresis, V1, P181; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dean W, 1998, DEVELOPMENT, V125, P2273; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Horsthemke B, 2008, AM J MED GENET A, V146A, P2041, DOI 10.1002/ajmg.a.32364; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Ng SS, 2009, J BIOL CHEM, V284, P35308, DOI 10.1074/jbc.M109.078261; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	59	69	72	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41337	41347		10.1074/jbc.M110.170704	http://dx.doi.org/10.1074/jbc.M110.170704			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047779	Green Published, hybrid			2022-12-27	WOS:000285622600019
J	Zhang, MH; Lu, SQ; Li, GW; Mao, ZL; Yu, X; Sun, WN; Tang, ZC; Long, MA; Su, WA				Zhang, Minhua; Lue, Shouqin; Li, Guowei; Mao, Zhilei; Yu, Xin; Sun, Weining; Tang, Zhangcheng; Long, Mian; Su, Weiai			Identification of a Residue in Helix 2 of Rice Plasma Membrane Intrinsic Proteins That Influences Water Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; AQUAPORIN NTAQP1; CHANNEL ACTIVITY; STRUCTURAL BASIS; TRANSPORT; FAMILY; ARABIDOPSIS; SELECTIVITY; PERMEATION; GLYCEROL	Molecular selection, ion exclusion, and water permeation are well known regulatory mechanisms in aquaporin. Water permeability was found to be diverse in different subgroups of plasma membrane intrinsic proteins (PIPs), even though the residues surrounding the water holes remained the same across the subgroups. Upon homology modeling and structural comparison, a conserved Ala/Ile(Val) residue difference was identified in helix 2 that affected the conformation of the NPA region and consequently influenced the water permeability. The residue difference was found to be conservative within the two subgroups of PIPs in rice as well as in other plants. Functional tests further confirmed the prediction via site-directed mutagenesis where replacement of Ala(103) or Ala(102) in respective OsPIP1; 1 or OsPIP1; 3 with Val yielded 7.0- and 2.2-fold increases in water transportation, and substitution of Ile(98) or Val(95) in respective OsPIP2; 3 or OsPIP2; 7 with Ala resulted in 73 or 52% reduction of water transportation. Based on structural analyses and molecular dynamics simulations, we proposed that the difference in water permeability was attributed to the orientation variations of helix 2 that modified water-water and water-protein interactions.	[Su, Weiai] Chinese Acad Sci, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Lue, Shouqin; Long, Mian] Chinese Acad Sci, Key Lab Micrograv, Natl Micrograv Lab, Beijing 100190, Peoples R China; [Lue, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Inst Mech, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS	Long, MA (corresponding author), 15 N 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn; zstressc@online.sh.cn		Mao, Zhi-Lei/0000-0002-7071-8048	National Natural Science Foundation of China [30670172, 30730032, 10332060]; National Key Basic Research Foundation of China [2006CB910303]; Chinese Academy of Science [KSCX2-YW-N-011, KJCX2-YW-L08]; National High Technology Research and Development Program of China [2007AA100603, 2007AA02Z306]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30670172, 30730032, and 10332060, National Key Basic Research Foundation of China Grant 2006CB910303, Knowledge Innovation Program of Chinese Academy of Science Grants KSCX2-YW-N-011 and KJCX2-YW-L08, and National High Technology Research and Development Program of China Grants 2007AA100603 and 2007AA02Z306.	Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dixit R, 2001, PLANT MOL BIOL, V45, P51, DOI 10.1023/A:1006428007826; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X; Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503; Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321; Han BG, 2006, J MOL BIOL, V360, P285, DOI 10.1016/j.jmb.2006.04.039; Hashido M, 2005, FEBS LETT, V579, P5549, DOI 10.1016/j.febslet.2005.09.018; Hashido M, 2007, BIOPHYS J, V93, P373, DOI 10.1529/biophysj.106.101170; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; Jensen MO, 2008, P NATL ACAD SCI USA, V105, P14430, DOI 10.1073/pnas.0802401105; Kitson David H, 2002, Brief Bioinform, V3, P32, DOI 10.1093/bib/3.1.32; Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7; Kong YF, 2001, P NATL ACAD SCI USA, V98, P14345, DOI 10.1073/pnas.251507998; Lee JK, 2005, P NATL ACAD SCI USA, V102, P18932, DOI 10.1073/pnas.0509469102; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nyirenda TE, 2004, INT J TUBERC LUNG D, V8, P1089; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Sakurai J, 2008, PLANT CELL PHYSIOL, V49, P30, DOI 10.1093/pcp/pcm162; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smolin N, 2008, BIOPHYS J, V95, P1089, DOI 10.1529/biophysj.107.125187; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; Wallace IS, 2004, PLANT PHYSIOL, V135, P1059, DOI 10.1104/pp.103.033415; Weig A, 1997, PLANT PHYSIOL, V114, P1347, DOI 10.1104/pp.114.4.1347; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhu FQ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.224501	41	12	15	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41982	41992		10.1074/jbc.M110.101790	http://dx.doi.org/10.1074/jbc.M110.101790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20926385	hybrid, Green Published			2022-12-27	WOS:000285622600084
J	Bousquet, SM; Monet, M; Boulay, G				Bousquet, Simon M.; Monet, Michael; Boulay, Guylain			Protein Kinase C-dependent Phosphorylation of Transient Receptor Potential Canonical 6 (TRPC6) on Serine 448 Causes Channel Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-ENTRY; CA2+ OSCILLATIONS; CATION CHANNEL; ACTIVATION; STORE; GENERATION; EXPRESSION; DECREASES; HOMOLOG; CLONING	TRPC6 is a cation channel in the plasma membrane that plays a role in Ca2+ entry following the stimulation of a G(q)-protein coupled or tyrosine kinase receptor. A dysregulation of TRPC6 activity causes abnormal proliferation of smooth muscle cells and glomerulosclerosis. In the present study, we investigated the regulation of TRPC6 activity by protein kinase C (PKC). We showed that inhibiting PKC with GF1 or activating it with phorbol 12-myristate 13-acetate potentiated and inhibited agonist-induced Ca2+ entry, respectively, into cells expressing TRPC6. Similar results were obtained when TRPC6 was directly activated with 1-oleyl-2-acetyl-sn-glycerol. Activation of the cells with carbachol increased the phosphorylation of TRPC6, an effect that was prevented by the inhibition of PKC. The target residue of PKC was identified by an alanine screen of all canonical PKC sites on TRPC6. Unexpectedly, all the mutants, including TRPC6(S768A) (a residue previously proposed to be a target for PKC), displayed PKC-dependent inhibition of channel activity. Phosphorylation prediction software suggested that Ser(448), in a non-canonical PKC consensus sequence, was a potential target for PKC delta. Ba2+ and Ca2+ entry experiments revealed that GF1 did not potentiate TRPC6(S448A) activity. Moreover, activation of PKC did not enhance the phosphorylation state of TRPC6(S448A). Using A7r5 vascular smooth muscle cells, which endogenously express TRPC6, we observed that a novel PKC isoform is involved in the inhibition of the vasopressin-induced Ca2+ entry. Furthermore, knocking down PKC delta in A7r5 cells potentiated vasopressin-induced Ca2+ entry. In summary, we provide evidence that PKC delta exerts a negative feedback effect on TRPC6 through the phosphorylation of Ser(448).	[Boulay, Guylain] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Boulay, G (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, 3001-12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Guylain.Boulay@USherbrooke.ca	Boulay, Guylain/D-9773-2010	MONET, Michael/0000-0002-7864-862X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Quebec Heart & Stroke Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Quebec Heart & Stroke Foundation	This work was supported by grants from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Quebec Heart & Stroke Foundation.	Arguin G, 2007, J ENDOCRINOL, V192, P659, DOI 10.1677/JOE-06-0179; AUSUBEL FM, 2002, CURRENT PROTOCOLS MO; Basora N, 2003, J BIOL CHEM, V278, P31709, DOI 10.1074/jbc.M304437200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Caron AZ, 2007, CELL CALCIUM, V42, P323, DOI 10.1016/j.ceca.2007.01.002; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Estacion M, 2004, J BIOL CHEM, V279, P22047, DOI 10.1074/jbc.M402320200; Fujii K, 2004, P NATL ACAD SCI USA, V101, P13744, DOI 10.1073/pnas.0401881101; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Jung S, 2002, AM J PHYSIOL-CELL PH, V282, pC347, DOI 10.1152/ajpcell.00283.2001; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Kim JY, 2005, J BIOL CHEM, V280, P32035, DOI 10.1074/jbc.M500429200; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Li MX, 2008, PHARMACOL RES, V58, P308, DOI 10.1016/j.phrs.2008.09.004; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lussier MP, 2005, J BIOL CHEM, V280, P19393, DOI 10.1074/jbc.M500391200; Mani BK, 2009, CELL CALCIUM, V45, P400, DOI 10.1016/j.ceca.2009.01.004; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Maruyama Y, 2006, CIRC RES, V98, P1520, DOI 10.1161/01.RES.0000226495.34949.28; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rey O, 2006, J BIOL CHEM, V281, P38730, DOI 10.1074/jbc.M605956200; Saleh SN, 2006, J PHYSIOL-LONDON, V577, P479, DOI 10.1113/jphysiol.2006.119305; Saleh SN, 2009, J PHYSIOL-LONDON, V587, P531, DOI 10.1113/jphysiol.2008.166678; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Miranda E, 2010, BIOCHEM BIOPH RES CO, V391, P1714, DOI 10.1016/j.bbrc.2009.12.139; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; Sel S, 2008, CLIN EXP ALLERGY, V38, P1548, DOI 10.1111/j.1365-2222.2008.03043.x; Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051; Snetkov VA, 2008, HYPERTENSION, V51, P239, DOI 10.1161/HYPERTENSIONAHA.107.104802; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Venkatachalam K, 2003, J BIOL CHEM, V278, P29031, DOI 10.1074/jbc.M302751200; Wang YJ, 2008, CLIN EXP PHARMACOL P, V35, P1127, DOI 10.1111/j.1440-1681.2008.05018.x; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu Y, 2004, P NATL ACAD SCI USA, V101, P13861, DOI 10.1073/pnas.0405908101; Yu Y, 2009, CIRCULATION, V119, P2313, DOI 10.1161/CIRCULATIONAHA.108.782458; Zhang L, 2006, J BIOCHEM, V139, P459, DOI 10.1093/jb/mvj065; Zhu MH, 2005, AM J PHYSIOL-CELL PH, V289, pC591, DOI 10.1152/ajpcell.00440.2004; ZHU X, 1995, FEBS LETT, V373, P193, DOI 10.1016/0014-5793(95)01038-G; Zhu X, 1996, CELL, V85, P661, DOI 10.1016/S0092-8674(00)81233-7	57	36	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40534	40543		10.1074/jbc.M110.160051	http://dx.doi.org/10.1074/jbc.M110.160051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961851	hybrid, Green Published			2022-12-27	WOS:000285414400016
J	Okamoto, F; Saeki, K; Sumimoto, H; Yamasaki, S; Yokomizo, T				Okamoto, Fuyuki; Saeki, Kazuko; Sumimoto, Hideki; Yamasaki, Sho; Yokomizo, Takehiko			Leukotriene B-4 Augments and Restores Fc gamma Rs-dependent Phagocytosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; BLT1-DEFICIENT MICE; SIGNAL-TRANSDUCTION; ANTAGONIST IL-1RA; HUMAN NEUTROPHILS; CELL RECRUITMENT; BONE-MARROW; ACTIVATION; MECHANISMS; IDENTIFICATION	Phagocytosis by macrophages is essential for host defense, i.e. preventing invasion of pathogens and foreign materials. Macrophages engulf immunoglobulin G (IgG)-opsonized particles through the action of the receptors for the Fc of IgG (Fc gamma Rs). Leukotriene B-4 (LTB4) is a classical lipid chemoattractant derived from arachidonic acid. Leukotriene B-4 receptor 1 (BLT1), a high affinity LTB4 receptor, is expressed in a variety of immune cells such as neutrophils, macrophages, and dendritic cells. Although LTB4 has been shown to enhance macrophage phagocytosis, few studies have investigated the intracellular mechanisms involved in this in detail. Furthermore, there have been no reports of the direct cross-talk between LTB4-BLT1 and IgG-Fc gamma Rs signaling. Here, we show that Fc gamma Rs-dependent phagocytosis was attenuated in BLT1-deficient macrophages as compared with wild-type (WT) cells. Moreover, cross-talk between LTB4-BLT1 and IgG-Fc gamma Rs signaling was identified at the level of phosphatidylinositol 3-OH kinase (PI3K) and Rac, downstream of Syk. In addition, the trimeric G(i) protein (G(i)) was found to be essential for BLT1-dependent phagocytosis. Surprisingly, we found that LTB4-BLT1 signaling restores phagocytosis in the absence of Fc gamma Rs signaling. These data indicate that LTB4-BLT1 signaling plays a pivotal role in macrophage phagocytosis and innate immunity.	[Yokomizo, Takehiko] Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Higashi Ku, Fukuoka 8128582, Japan; [Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Yokomizo, Takehiko] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1028666, Japan	Kyushu University; Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Yokomizo, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med Biochem, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yokomizo@biochem1.med.kyushu-u.ac.jp	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21390083, 22116001, 22116002, 22790320]; Takeda Science Foundation; Mitsubishi Foundation; Uehara Memorial Foundation; Sankyo Foundation of Life Science; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Sankyo Foundation of Life Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 21390083, 22116001, and 22116002 (to T. Y.) and 22790320 (to K. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and grants from the Takeda Science Foundation, Mitsubishi Foundation, Uehara Memorial Foundation, Sankyo Foundation of Life Science, and Japan Society for the Promotion of Science (Global COE Program) (to T. Y.).; Supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahluwalia N, 2007, J IMMUNOL, V179, P691, DOI 10.4049/jimmunol.179.1.691; AHMADZADEH N, 1991, INFLAMMATION, V15, P497, DOI 10.1007/BF00923346; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; ANTONELLI M, 1989, INTENS CARE MED, V15, P296, DOI 10.1007/BF00263864; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Christmas P, 2006, J BIOL CHEM, V281, P7189, DOI 10.1074/jbc.M513101200; CONTI P, 1993, CLIN EXP IMMUNOL, V91, P526; CONTI P, 1992, AGENTS ACTIONS, pC93; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; Dostert C, 2007, NAT IMMUNOL, V8, P17, DOI 10.1038/ni0107-17; DUELL EA, 1988, J INVEST DERMATOL, V91, P446, DOI 10.1111/1523-1747.ep12476562; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gijon MA, 2007, J LIPID RES, V48, P716, DOI 10.1194/jlr.M600508-JLR200; Goodarzi K, 2003, NAT IMMUNOL, V4, P965, DOI 10.1038/ni972; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Heller EA, 2005, CIRCULATION, V112, P578, DOI 10.1161/CIRCULATIONAHA.105.545616; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; Kuniyeda K, 2007, J BIOL CHEM, V282, P3998, DOI 10.1074/jbc.M610540200; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Montuschi P, 2002, J ALLERGY CLIN IMMUN, V109, P615, DOI 10.1067/mai.2002.122461; NEU I, 1992, ACTA NEUROL SCAND, V86, P586, DOI 10.1111/j.1600-0404.1992.tb05491.x; Ott VL, 2003, NAT IMMUNOL, V4, P974, DOI 10.1038/ni971; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Pinto AK, 2007, J VIROL, V81, P12564, DOI 10.1128/JVI.01328-07; Sakurai D, 2004, J IMMUNOL, V172, P2374, DOI 10.4049/jimmunol.172.4.2374; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Serezani CH, 2009, BLOOD, V114, P3316, DOI 10.1182/blood-2009-01-199919; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tedeschi A, 2004, BIOCHEM PHARMACOL, V67, P385, DOI 10.1016/j.bcp.2003.09.019; Terawaki K, 2005, J IMMUNOL, V175, P4217, DOI 10.4049/jimmunol.175.7.4217; Toda A, 2010, BIOCHIMIE, V92, P682, DOI 10.1016/j.biochi.2009.12.002; Weller CL, 2005, J EXP MED, V201, P1961, DOI 10.1084/jem.20042407; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	47	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41113	41121		10.1074/jbc.M110.175497	http://dx.doi.org/10.1074/jbc.M110.175497			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959460	Green Published, hybrid			2022-12-27	WOS:000285414400073
J	Pence, MG; Choi, JY; Egli, M; Guengerich, FP				Pence, Matthew G.; Choi, Jeong-Yun; Egli, Martin; Guengerich, F. Peter			Structural Basis for Proficient Incorporation of dTTP Opposite O-6-Methylguanine by Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATSON-CRICK; PAIRING PROPERTIES; IOTA; REPLICATION; HOOGSTEEN; KINETICS; BYPASS; MUTAGENICITY; ALKYLATION; REFINEMENT	O-6-Methylguanine (O-6-methylG) is highly mutagenic and is commonly found in DNA exposed to methylating agents, even physiological ones (e.g. S-adenosylmethionine). The efficiency of a truncated, catalytic DNA polymerase i core enzyme was determined for nucleoside triphosphate incorporation opposite O-6-methylG, using steady-state kinetic analyses. The results presented here corroborate previous work from this laboratory using full-length pol i, which showed that dTTP incorporation occurs with high efficiency opposite O-6-methylG. Misincorporation of dTTP opposite O-6-methylG occurred with similar to 6-fold higher efficiency than incorporation of dCTP. Crystal structures of the truncated form of pol i with O-6-methylG as the template base and incoming dCTP or dTTP were solved and showed that O-6-methylG is rotated into the syn conformation in the pol i active site and that dTTP misincorporation by pol i is the result of Hoogsteen base pairing with the adduct. Both dCTP and dTTP base paired with the Hoogsteen edge of O-6-methylG. A single, short hydrogen bond formed between the N3 atom of dTTP and the N7 atom of O-6-methylG. Protonation of the N3 atom of dCTP and bifurcation of the N3 hydrogen between the N7 and O-6 atoms of O-6-methylG allow base pairing of the lesion with dCTP. We conclude that differences in the Hoogsteen hydrogen bonding between nucleotides is the main factor in the preferential selectivity of dTTP opposite O-6-methylG by human pol i, in contrast to the mispairing modes observed previously for O-6-methylG in the structures of the model DNA polymerases Sulfolobus solfataricus Dpo4 and Bacillus stearothermophilus DNA polymerase I.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Choi, Jeong-Yun; Guengerich, F. Peter] Ewha Womans Univ, Dept Pharmacol, Sch Med, Seoul 158710, South Korea	Vanderbilt University; Vanderbilt University; Ewha Womans University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X	National Institutes of Health [R01 ES010375, P01 ES005355, P30 ES000267, T32 ES007028]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375, P30ES000267, T32ES007028, P01ES005355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 (to F.P.G.), P01 ES005355 (to M.E.), P30 ES000267 (to F.P.G. and M.E.), and T32 ES007028 (to F.P.G. and M.G.P.). Vanderbilt University is a member institution of LS-CAT at the Advanced Photon Source (APS), Argonne, Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-06CH11357.	Afonin AV, 2010, MAGN RESON CHEM, V48, P309, DOI 10.1002/mrc.2579; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Carpio RVD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005766; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; DAWSON RMC, 1986, DATA BIOCH RES, P80; DeLano W.L, PYMOL MOL GRAPHICS S; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eoff RL, 2007, J BIOL CHEM, V282, P13573, DOI 10.1074/jbc.M700656200; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; GAFFNEY BL, 1984, BIOCHEMISTRY-US, V23, P5686, DOI 10.1021/bi00319a004; GAFFNEY BL, 1989, BIOCHEMISTRY-US, V28, P5881, DOI 10.1021/bi00440a026; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GINELL SL, 1990, BIOCHEMISTRY-US, V29, P10461, DOI 10.1021/bi00498a005; GRAY DM, 1984, NUCLEIC ACIDS RES, V12, P7565, DOI 10.1093/nar/12.19.7565; Haracska L, 2000, MOL CELL BIOL, V20, P8001, DOI 10.1128/MCB.20.21.8001-8007.2000; Hwang HS, 2005, BIOCHEMISTRY-US, V44, P4850, DOI 10.1021/bi048244+; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1027, DOI 10.1021/bi00353a012; PATEL DJ, 1986, BIOCHEMISTRY-US, V25, P1036, DOI 10.1021/bi00353a013; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; SHANK RC, 1987, ARCH TOXICOL, P204; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SNOW ET, 1984, J BIOL CHEM, V259, P8095; TAN HB, 1994, BIOCHEMISTRY-US, V33, P5335, DOI 10.1021/bi00183a042; Tissier A, 2000, GENE DEV, V14, P1642; Warren JJ, 2006, P NATL ACAD SCI USA, V103, P19701, DOI 10.1073/pnas.0609580103; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; WILLIAMS LD, 1987, P NATL ACAD SCI USA, V84, P1779, DOI 10.1073/pnas.84.7.1779; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolfle WT, 2005, MOL CELL BIOL, V25, P7137, DOI 10.1128/MCB.25.16.7137-7143.2005; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1027, DOI 10.1021/bi011495n; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	44	44	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40666	40672		10.1074/jbc.M110.183665	http://dx.doi.org/10.1074/jbc.M110.183665			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961860	Green Published, hybrid			2022-12-27	WOS:000285414400029
J	Takata, K; Kitamura, Y; Saeki, M; Terada, M; Kagitani, S; Kitamura, R; Fujikawa, Y; Maelicke, A; Tomimoto, H; Taniguchi, T; Shimohama, S				Takata, Kazuyuki; Kitamura, Yoshihisa; Saeki, Mana; Terada, Maki; Kagitani, Sachiko; Kitamura, Risa; Fujikawa, Yasuhiro; Maelicke, Alfred; Tomimoto, Hidekazu; Taniguchi, Takashi; Shimohama, Shun			Galantamine-induced Amyloid-beta Clearance Mediated via Stimulation of Microglial Nicotinic Acetylcholine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; ALLOSTERIC MODULATION; CHOLINERGIC NEURONS; TREATMENT STRATEGY; SELECTIVE LOSS; MOUSE MODEL; RAT-BRAIN; IN-VIVO	Reduction of brain amyloid-beta (A beta) has been proposed as a therapeutic target for Alzheimer disease (AD), and microglial A beta phagocytosis is noted as an A beta clearance system in brains. Galantamine is an acetylcholinesterase inhibitor approved for symptomatic treatment of AD. Galantamine also acts as an allosterically potentiating ligand (APL) for nicotinic acetylcholine receptors (nAChRs). APL-binding site is located close to but distinct from that for acetylcholine on nAChRs, and FK1 antibody specifically binds to the APL-binding site without interfering with the acetylcholine-binding site. We found that in human AD brain, microglia accumulated on A beta deposits and expressed alpha 7 nAChRs including the APL-binding site recognized with FK1 antibody. Treatment of rat microglia with galantamine significantly enhanced microglial A beta phagocytosis, and acetylcholine competitive antagonists as well as FK1 antibody inhibited the enhancement. Thus, the galantamine-enhanced microglial A beta phagocytosis required the combined actions of an acetylcholine competitive agonist and the APL for nAChRs. Indeed, depletion of choline, an acetylcholine-competitive alpha 7 nAChR agonist, from the culture medium impeded the enhancement. Similarly, Ca2+ depletion or inhibition of the calmodulin-dependent pathways for the actin reorganization abolished the enhancement. These results suggest that galantamine sensitizes microglial alpha 7 nAChRs to choline and induces Ca2+ influx into microglia. The Ca2+-induced intracellular signaling cascades may then stimulate A beta phagocytosis through the actin reorganization. We further demonstrated that galantamine treatment facilitated A beta clearance in brains of rodent AD models. In conclusion, we propose a further advantage of galantamine in clinical AD treatment and microglial nAChRs as a new therapeutic target.	[Takata, Kazuyuki; Kitamura, Yoshihisa; Saeki, Mana; Terada, Maki; Kagitani, Sachiko; Kitamura, Risa; Fujikawa, Yasuhiro; Taniguchi, Takashi] Kyoto Pharmaceut Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan; [Maelicke, Alfred] Galantos Pharma GmbH, D-55131 Mainz, Germany; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 5148507, Japan; [Shimohama, Shun] Sapporo Med Univ, Sch Med, Dept Neurol, Chuo Ku, Sapporo, Hokkaido 0608543, Japan	Kyoto Pharmaceutical University; Mie University; Sapporo Medical University	Kitamura, Y (corresponding author), Kyoto Pharmaceut Univ, Dept Neurobiol, Yamashina Ku, Kyoto 6078414, Japan.	yo-kita@mb.kyoto-phu.ac.jp; shimoha@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Frontier Research Program, grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for Promotion of Science.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Cordero-Erausquin M, 2000, TRENDS PHARMACOL SCI, V21, P211, DOI 10.1016/S0165-6147(00)01489-9; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DAVIES P, 1976, LANCET, V2, P1403; Elsaraj SM, 2008, BBA-MOL CELL RES, V1783, P770, DOI 10.1016/j.bbamcr.2008.01.022; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartmann J, 2008, NEUROCHEM INT, V52, P972, DOI 10.1016/j.neuint.2007.10.008; Hellstrom-Lindahl E, 2004, EUR J NEUROSCI, V19, P2703, DOI 10.1111/j.1460-9568.2004.03377.x; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kihara T, 2004, BIOCHEM BIOPH RES CO, V325, P976, DOI 10.1016/j.bbrc.2004.10.132; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitamura Y, 2003, J PHARMACOL SCI, V92, P115; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Maelicke A, 2001, BIOL PSYCHIAT, V49, P279, DOI 10.1016/S0006-3223(00)01109-4; Maelicke A, 1997, J RECEPT SIGNAL TR R, V17, P11, DOI 10.3109/10799899709036592; MANDELZYS A, 1995, J NEUROPHYSIOL, V74, P1212, DOI 10.1152/jn.1995.74.3.1212; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nordberg A, 2002, J NEUROCHEM, V81, P655, DOI 10.1046/j.1471-4159.2002.00874.x; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Papke RL, 1996, NEUROSCI LETT, V213, P201; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Ramsden M, 2003, J NEUROCHEM, V87, P1052, DOI 10.1046/j.1471-4159.2003.02114.x; Raskind MA, 2004, ARCH NEUROL-CHICAGO, V61, P252, DOI 10.1001/archneur.61.2.252; Raskind MA, 2003, NEUROLOGIST, V9, P235, DOI 10.1097/01.nrl.0000087722.46430.c4; Raskind MA, 2001, MED CLIN N AM, V85, P803, DOI 10.1016/S0025-7125(05)70341-2; Raskind MA, 2000, NEUROLOGY, V54, P2261, DOI 10.1212/WNL.54.12.2261; Sala C, 1996, NEUROSCI LETT, V215, P71, DOI 10.1016/0304-3940(96)12923-2; Samochocki M, 2003, J PHARMACOL EXP THER, V305, P1024, DOI 10.1124/jpet.102.045773; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schrattenholz A, 1996, MOL PHARMACOL, V49, P1; SCHRATTENHOLZ A, 1993, EUR J BIOCHEM, V216, P671, DOI 10.1111/j.1432-1033.1993.tb18187.x; SCHRODER B, 1994, J BIOL CHEM, V269, P10407; Shimizu E, 2008, J IMMUNOL, V181, P6503, DOI 10.4049/jimmunol.181.9.6503; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Takata K, 2004, J NEUROSCI RES, V78, P880, DOI 10.1002/jnr.20340; Takata K, 2007, EUR J NEUROSCI, V26, P2458, DOI 10.1111/j.1460-9568.2007.05852.x; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Unger C, 2006, J PHARMACOL EXP THER, V317, P30, DOI 10.1124/jpet.105.098566; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Wisniewski T, 2008, LANCET NEUROL, V7, P805, DOI 10.1016/S1474-4422(08)70170-4; Yanagida T, 2008, NEUROSCI RES, V62, P254, DOI 10.1016/j.neures.2008.09.003; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	55	122	129	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40180	40191		10.1074/jbc.M110.142356	http://dx.doi.org/10.1074/jbc.M110.142356			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947502	Green Published, hybrid			2022-12-27	WOS:000285185500063
J	Todi, SV; Scaglione, KM; Blount, JR; Basrur, V; Conlon, KP; Pastore, A; Elenitoba-Johnson, K; Paulson, HL				Todi, Sokol V.; Scaglione, K. Matthew; Blount, Jessica R.; Basrur, Venkatesha; Conlon, Kevin P.; Pastore, Annalisa; Elenitoba-Johnson, Kojo; Paulson, Henry L.			Activity and Cellular Functions of the Deubiquitinating Enzyme and Polyglutamine Disease Protein Ataxin-3 Are Regulated by Ubiquitination at Lysine 117	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACHADO-JOSEPH-DISEASE; CRYSTAL-STRUCTURE; BRAZILIAN FAMILIES; STATISTICAL-MODEL; GENE-PRODUCT; MECHANISM; BINDING; CHAINS; RETROTRANSLOCATION; LOCALIZATION	Deubiquitinating enzymes (DUbs) play important roles in many ubiquitin-dependent pathways, yet how DUbs themselves are regulated is not well understood. Here, we provide insight into the mechanism by which ubiquitination directly enhances the activity of ataxin-3, a DUb implicated in protein quality control and the disease protein in the polyglutamine neurodegenerative disorder, Spinocerebellar Ataxia Type 3. We identify Lys-117, which resides near the catalytic triad, as the primary site of ubiquitination in wild type and pathogenic ataxin-3. Further studies indicate that ubiquitin-dependent activation of ataxin-3 at Lys-117 is important for its ability to reduce high molecular weight ubiquitinated species in cells. Ubiquitination at Lys-117 also facilitates the ability of ataxin-3 to induce aggresome formation in cells. Finally, structure-function studies support a model of activation whereby ubiquitination at Lys-117 enhances ataxin-3 activity independent of the known ubiquitin-binding sites in ataxin-3, most likely through a direct conformational change in or near the catalytic domain.	[Todi, Sokol V.; Scaglione, K. Matthew; Blount, Jessica R.; Paulson, Henry L.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Conlon, Kevin P.; Elenitoba-Johnson, Kojo] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Pastore, Annalisa] Natl Inst Med Res, MRC, London NW7 1AA, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; MRC National Institute for Medical Research	Todi, SV (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, 540 E Canfield,Scott Hall 6374, Detroit, MI 48201 USA.	sokolt@umich.edu; henryp@umich.edu		Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [K99NS064097, R01 NS038712]; NRSA through the NINDS [1F32NS064596]; MRC [MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712, K99NS064097, F32NS064596] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants K99NS064097 (Pathway to Independence Award to S. V. T.), R01 NS038712 (to H. L. P.), and NRSA 1F32NS064596 (to K. M. S.) through the NINDS.	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Costa MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011728; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Fernandez-Montalvan A, 2007, FEBS J, V274, P4256, DOI 10.1111/j.1742-4658.2007.05952.x; Fischer JA, 2003, INT REV CYTOL, V229, P43, DOI 10.1016/S0074-7696(03)29002-1; Fujigasaki H, 2000, EXP NEUROL, V165, P248, DOI 10.1006/exnr.2000.7479; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Marfany G, 2008, BIOCHEM SOC T, V36, P833, DOI 10.1042/BST0360833; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nicastro G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012430; Nicastro G, 2009, BIOPOLYMERS, V91, P1203, DOI 10.1002/bip.21210; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Paulson HL, 1997, ANN NEUROL, V41, P453, DOI 10.1002/ana.410410408; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Seilhean D, 2004, ACTA NEUROPATHOL, V108, P81, DOI 10.1007/s00401-004-0855-x; Shen CL, 2005, J BIOL CHEM, V280, P35967, DOI 10.1074/jbc.M505220200; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STEVANIN G, 1995, AM J HUM GENET, V57, P1247; STEVANIN G, 1995, J MED GENET, V32, P827, DOI 10.1136/jmg.32.10.827; Takahashi J, 2001, J NEUROPATH EXP NEUR, V60, P369, DOI 10.1093/jnen/60.4.369; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wada K, 2006, BIOCHEM BIOPH RES CO, V342, P253, DOI 10.1016/j.bbrc.2006.01.144; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	51	72	74	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39303	39313		10.1074/jbc.M110.181610	http://dx.doi.org/10.1074/jbc.M110.181610			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20943656	hybrid, Green Published			2022-12-27	WOS:000284941300058
J	Wickstrom, D; Wagner, S; Baars, L; Ytterberg, AJ; Klepsch, M; van Wijk, KJ; Luirink, J; de Gier, JW				Wickstrom, David; Wagner, Samuel; Baars, Louise; Ytterberg, A. Jimmy; Klepsch, Mirjam; van Wijk, Klaas J.; Luirink, Joen; de Gier, Jan-Willem			Consequences of Depletion of the Signal Recognition Particle in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; HEAT-SHOCK PROTEINS; CYTOPLASMIC MEMBRANE; TRIGGER FACTOR; 4.5S RNA; PATHWAY; INNER; INSERTION; TRANSLOCATION; TRANSLATION	Thus far, the role of the Escherichia coli signal recognition particle (SRP) has only been studied using targeted approaches. It has been shown for a handful of cytoplasmic membrane proteins that their insertion into the cytoplasmic membrane is at least partially SRP-dependent. Furthermore, it has been proposed that the SRP plays a role in preventing toxic accumulation of mistargeted cytoplasmic membrane proteins in the cytoplasm. To complement the targeted studies on SRP, we have studied the consequences of the depletion of the SRP component Fifty-four homologue (Ffh) in E. coli using a global approach. The steady-state proteomes and the proteome dynamics were evaluated using one- and two-dimensional gel analysis, followed by mass spectrometry-based protein identification and immunoblotting. Our analysis showed that depletion of Ffh led to the following: (i) impaired kinetics of the biogenesis of the cytoplasmic membrane proteome; (ii) lowered steady-state levels of the respiratory complexes NADH dehydrogenase, succinate dehydrogenase, and cytochrome bo(3) oxidase and lowered oxygen consumption rates; (iii) increased levels of the chaperones DnaK and GroEL at the cytoplasmic membrane; (iv) a sigma(32) stress response and protein aggregation in the cytoplasm; and (v) impaired protein synthesis. Our study shows that in E. coli SRP-mediated protein targeting is directly linked to maintaining protein homeostasis and the general fitness of the cell.	[Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [de Gier, Jan-Willem] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Ytterberg, A. Jimmy; van Wijk, Klaas J.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Vrije Universiteit Amsterdam; Stockholm University; Cornell University	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, De Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl; degier@dbb.su.se	Luirink, Joen/AAB-8658-2021; Ytterberg, Anders/E-1773-2016	Ytterberg, Anders/0000-0002-1485-2314; Luirink, J./0000-0001-8431-0804	National Institutes of Health [5R01GM081827-03]; Swedish Research Council; Carl Tryggers Stiftelse; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for Strategic Research; Swedish Foundation for International Cooperation in Research and Higher Education; Wenner Foundation; Gren Foundation; NYSTAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Foundation for International Cooperation in Research and Higher Education; Wenner Foundation; Gren Foundation; NYSTAR; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01GM081827-03. This work was also supported by the Swedish Research Council, Carl Tryggers Stiftelse, Marianne and Marcus Wallenberg Foundation, Swedish Foundation for Strategic Research-supported Center for Biomembrane Research (to J.-W. d. G.), grants from the Swedish Foundation for International Cooperation in Research and Higher Education (to J.-W. d. G. and K. J. v. W.), and the Wenner-Gren Foundations (to K. J. v. W.).; Proteomics infrastructure was supported by a grant from NYSTAR (to K. J. v. W.).	Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Avdeeva ON, 2002, FEBS LETT, V514, P70, DOI 10.1016/S0014-5793(02)02332-3; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; BALZER D, 1992, NUCLEIC ACIDS RES, V20, P1851, DOI 10.1093/nar/20.8.1851; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bernstein KD, 2001, J BACTERIOL, V183, P2187, DOI 10.1128/JB.183.7.2187-2197.2001; Bochkareva E, 1996, J BIOL CHEM, V271, P22256, DOI 10.1074/jbc.271.36.22256; Bochkareva ES, 1998, P NATL ACAD SCI USA, V95, P478, DOI 10.1073/pnas.95.2.478; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bowers CW, 2003, J BACTERIOL, V185, P5697, DOI 10.1128/JB.185.19.5697-5705.2003; Burk J, 2009, J BACTERIOL, V191, P7017, DOI 10.1128/JB.00208-09; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen Y, 2003, PROTEIN EXPRES PURIF, V32, P221, DOI 10.1016/S1046-5928(03)00233-X; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; Dalbey RE, 2004, BBA-MOL CELL RES, V1694, P37, DOI 10.1016/j.bbamcr.2004.03.009; Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; du Plessis DJF, 2006, J BIOL CHEM, V281, P12248, DOI 10.1074/jbc.M600048200; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; Froderberg L, 2001, FEBS LETT, V498, P52, DOI 10.1016/S0014-5793(01)02494-2; Funes S, 2009, P NATL ACAD SCI USA, V106, P6656, DOI 10.1073/pnas.0809951106; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Hasona A, 2007, J BACTERIOL, V189, P1219, DOI 10.1128/JB.01146-06; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Hewitt CJ, 2004, ADV BIOCHEM ENG BIOT, V89, P197; JENSEN CG, 1994, J BACTERIOL, V176, P7148, DOI 10.1128/JB.176.23.7148-7154.1994; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Klepsch M, 2008, METHODS, V46, P48, DOI 10.1016/j.ymeth.2008.06.017; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; LUIRINK J, 1992, NATURE, V359, P741, DOI 10.1038/359741a0; MACFARLANE J, 1995, EUR J BIOCHEM, V233, P766, DOI 10.1111/j.1432-1033.1995.766_3.x; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Nicchitta CV, 2002, CURR OPIN CELL BIOL, V14, P412, DOI 10.1016/S0955-0674(02)00353-8; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; PHILLIPS GJ, 1990, NATURE, V344, P882, DOI 10.1038/344882a0; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Raine A, 2003, BIOCHIMIE, V85, P659, DOI 10.1016/S0300-9084(03)00130-5; Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1189, DOI 10.1046/j.1365-2958.2003.03772.x; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; Santos JM, 2002, MOL MICROBIOL, V45, P1729, DOI 10.1046/j.1365-2958.2002.03131.x; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Stenberg F, 2005, J BIOL CHEM, V280, P34409, DOI 10.1074/jbc.M506479200; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; WIKSTROM PM, 1988, J BACTERIOL, V170, P3025, DOI 10.1128/jb.170.7.3025-3031.1988; Wu CC, 2003, NAT BIOTECHNOL, V21, P262, DOI 10.1038/nbt0303-262; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	74	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4598	4609		10.1074/jbc.M109.081935	http://dx.doi.org/10.1074/jbc.M109.081935			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20923772	Green Published, hybrid			2022-12-27	WOS:000286975700060
J	Wu, KM; Jiao, XM; Li, ZM; Katiyar, S; Casimiro, MC; Yang, WC; Zhang, QO; Willmarth, NE; Chepelev, I; Crosariol, M; Wei, Z; Hu, JB; Zhao, K; Pestell, RG				Wu, Kongming; Jiao, Xuanmao; Li, Zhaoming; Katiyar, Sanjay; Casimiro, Mathew C.; Yang, Wancai; Zhang, Qiong; Willmarth, Nicole E.; Chepelev, Iouri; Crosariol, Marco; Wei, Zhang; Hu, Junbo; Zhao, Keji; Pestell, Richard G.			Cell Fate Determination Factor Dachshund Reprograms Breast Cancer Stem Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERMINATION FACTOR DACH1; EPITHELIAL-MESENCHYMAL TRANSITION; CYCLIN D1; ANDROGEN RECEPTOR; EXPRESSION; GROWTH; BINDING; IDENTIFICATION; ACETYLATION; COACTIVATOR	The cell fate determination factor Dachshund was cloned as a dominant inhibitor of the hyperactive epidermal growth factor receptor ellipse. The expression of Dachshund is lost in human breast cancer associated with poor prognosis. Breast tumor-initiating cells (TIC) may contribute to tumor progression and therapy resistance. Here, endogenous DACH1 was reduced in breast cancer cell lines with high expression of TIC markers and in patient samples of the basal breast cancer phenotype. Re-expression of DACH1 reduced new tumor formation in serial transplantations in vivo, reduced mammosphere formation, and reduced the proportion of CD44(high)/CD24(low) breast tumor cells. Conversely, lentiviral shRNA to DACH1 increased the breast (B) TIC population. Genome-wide expression studies of mammary tumors demonstrated DACH1 repressed a molecular signature associated with stem cells (SOX2, Nanog, and KLF4) and genome-wide ChIP-seq analysis identified DACH1 binding to the promoter of the Nanog, KLF4, and Lin28 genes. KLF4/c-Myc and Oct4/Sox2 antagonized DACH1 repression of BTIC. Mechanistic studies demonstrated DACH1 directly repressed the Nanog and Sox2 promoters via a conserved domain. Endogenous DACH1 regulates BTIC in vitro and in vivo.	[Wu, Kongming; Zhang, Qiong; Willmarth, Nicole E.; Crosariol, Marco; Wei, Zhang; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wu, Kongming; Li, Zhaoming; Hu, Junbo] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430030, Peoples R China; [Yang, Wancai] Univ Illinois, Dept Pathol, Chicago, IL 60612 USA; [Chepelev, Iouri; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Jefferson University; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Wu, KM (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	kmwu2005@gmail.com; director@kimmelcancercenter.org	Yang, Wancai/O-7655-2019; Zhang, Qiong/F-8172-2015	Yang, Wancai/0000-0001-7437-9197; Katiyar, Sanjay/0000-0003-1622-5661; Chepelev, Iouri/0000-0002-2121-8805; Li, Zhaoming/0000-0002-2876-5182	National Institutes of Health [R01CA70896, R01CA75503, R01CA86072, P30CA56036]; Dr. Ralph and Marian C. Falk Medical Research Trust; Margaret Q. Landenberger Research Foundation; Pennsylvania Department of Health; National Natural Science Foundation of China [81072169]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA075503, R01CA086072, R01CA070896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Margaret Q. Landenberger Research Foundation; Pennsylvania Department of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA86072 (to R. G. P.) and Grant P30CA56036 (Kimmel Cancer Center Core grant to R. G. P.).; This work was also supported by a grant from Dr. Ralph and Marian C. Falk Medical Research Trust (to R. G. P.), Margaret Q. Landenberger Research Foundation (to K. W.), in part by a grant from the Pennsylvania Department of Health (to R. G. P.), and in part by National Natural Science Foundation of China Grant 81072169 (to K. W.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2007, CURR OPIN ONCOL, V19, P61; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Edelman E, 2006, BIOINFORMATICS, V22, pE108, DOI 10.1093/bioinformatics/btl231; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Fu MF, 2002, MOL CELL BIOL, V22, P3373, DOI 10.1128/MCB.22.10.3373-3388.2002; Fu MF, 2000, J BIOL CHEM, V275, P20853, DOI 10.1074/jbc.M000660200; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hulit J, 2004, MOL CELL BIOL, V24, P7598, DOI 10.1128/MCB.24.17.7598-7611.2004; Jiao XM, 2010, J BIOL CHEM, V285, P8218, DOI 10.1074/jbc.M110.100792; Laflamme C, 2003, CANCER RES, V63, P449; Li X, 2002, SCIENCE, V297, P1180; Li Z, 2008, J BIOL CHEM, V283, P7007, DOI 10.1074/jbc.M706992200; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Noveen A, 2000, DEVELOPMENT, V127, P3475; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Winchester C, 2000, J CLIN PATHOL, V53, P212, DOI 10.1136/jcp.53.3.212; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	44	69	73	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2132	2142		10.1074/jbc.M110.148395	http://dx.doi.org/10.1074/jbc.M110.148395			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20937839	hybrid, Green Published			2022-12-27	WOS:000286191500055
J	Nyarko, A; Barbar, E				Nyarko, Afua; Barbar, Elisar			Light Chain-dependent Self-association of Dynein Intermediate Chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL DOMAIN; CYTOPLASMIC DYNEIN; FUNCTIONAL INTERACTION; RHODAMINE DIMERS; PROTEIN; LC8; FLUORESCENCE; DIMERIZATION; COMPLEX; BINDING	Dynein light chains are bivalent dimers that bind two copies of dynein intermediate chain IC to form a cargo attachment subcomplex. The interaction of light chain LC8 with the natively disordered N-terminal domain of IC induces helix formation at distant IC sites in or near a region predicted to form a coiled-coil. This fostered the hypothesis that LC8 binding promotes IC self-association to form a coiled-coil or other interchain helical structure. However, recent studies show that the predicted coiled-coil sequence partially overlaps the light chain LC7 recognition sequence on IC, raising questions about the apparently contradictory effects of LC8 and LC7. Here, we use NMR and fluorescence quenching to localize IC self-association to residues within the predicted coiled-coil that also correspond to helix 1 of the LC7 recognition sequence. LC8 binding promotes IC self-association of helix 1 from each of two IC chains, whereas LC7 binding reverses self-association by incorporating the same residues into two symmetrical, but distant, helices of the LC7-IC complex. Isothermal titration experiments confirm the distinction of LC8 enhancement of IC self-association and LC7 binding effects. When all three light chains are bound, IC self-association is shifted to another region. Such flexibility in association modes may function in maintaining a stable and versatile light chain-intermediate chain assembly under changing cellular conditions.	[Nyarko, Afua; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu	Nyarko, Afua/R-9872-2019	Barbar, Elisar/0000-0003-4892-5259	National Institutes of Health [GM 084276]; NIEHS, National Institutes of Health [00210]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 084276.; We thank Clare Woodward and Yujuan Song for valuable discussions and Michael Hare at the mass spectrometry facilities and services core in the Oregon State University Environmental Health Sciences Center (NIEHS, National Institutes of Health Grant 00210.	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Ashokkumar B, 2009, AM J PHYSIOL-GASTR L, V297, pG480, DOI 10.1152/ajpgi.00154.2009; Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Burghardt TP, 1996, BIOPHYS CHEM, V59, P119, DOI 10.1016/0301-4622(95)00118-2; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Grama L, 2001, P NATL ACAD SCI USA, V98, P14362, DOI 10.1073/pnas.191494098; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hall J, 2008, BIOCHEMISTRY-US, V47, P11940, DOI 10.1021/bi801093k; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Karki S, 2002, MOL BIOL CELL, V13, P1722, DOI 10.1091/mbc.02-02-0011; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794; Lakowicz JR, 2003, ANAL BIOCHEM, V320, P13, DOI 10.1016/S0003-2697(03)00351-8; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Wagner W, 2006, BIOCHEMISTRY-US, V45, P11564, DOI 10.1021/bi061142u; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wanschers B, 2008, CELL MOTIL CYTOSKEL, V65, P183, DOI 10.1002/cm.20254; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Ye GJ, 2000, J VIROL, V74, P1355, DOI 10.1128/JVI.74.3.1355-1363.2000; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	46	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1556	1566		10.1074/jbc.M110.171686	http://dx.doi.org/10.1074/jbc.M110.171686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20974845	Green Published, hybrid			2022-12-27	WOS:000286005000068
J	Lai, Y; Oslund, RC; Bollinger, JG; Henderson, WR; Santana, LF; Altemeier, WA; Gelb, MH; Hallstrand, TS				Lai, Ying; Oslund, Rob C.; Bollinger, James G.; Henderson, William R., Jr.; Santana, Luis F.; Altemeier, William A.; Gelb, Michael H.; Hallstrand, Teal S.			Eosinophil Cysteinyl Leukotriene Synthesis Mediated by Exogenous Secreted Phospholipase A(2) Group X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; EXERCISE-INDUCED BRONCHOCONSTRICTION; ARACHIDONIC-ACID METABOLISM; GROUP-V; MAMMALIAN-CELLS; ASTHMA; LYSOPHOSPHATIDYLCHOLINE; TRANSLOCATION; ACTIVATION; INHIBITOR	Secreted phospholipase A(2) group X (sPLA(2)-X) has recently been identified in the airways of patients with asthma and may participate in cysteinyl leukotriene (CysLT; C-4, D-4, and E-4) synthesis. We examined CysLT synthesis and arachidonic acid (AA) and lysophospholipid release by eosinophils mediated by recombinant human sPLA(2)-X. We found that recombinant sPLA(2)-X caused marked AA release and a rapid onset of CysLT synthesis in human eosinophils that was blocked by a selective sPLA(2)-X inhibitor. Exogenous sPLA(2)-X released lysophospholipid species that arise from phospholipids enriched in AA in eosinophils, including phosphatidylcholine, phosphatidylinositol, and phosphatidylethanolamine as well as plasmenyl phosphatidylcholine and phosphatidylethanolamine. CysLT synthesis mediated by sPLA(2)-X but not AA release could be suppressed by inhibition of cPLA(2)alpha. Exogenous sPLA(2)-X initiated Ser(505) phosphorylation of cPLA(2)alpha, an intracellular Ca2+ flux, and translocation of cPLA(2)alpha and 5-lipoxygenase in eosinophils. Synthesis of CysLTs in response to sPLA(2)-X or lysophosphatidylcholine was inhibited by p38 or JNK inhibitors but not by a MEK 1/2 inhibitor. A further increase in CysLT synthesis was induced by the addition of sPLA(2)-X to eosinophils under conditions of N-formyl-methionyl-leucyl-phenylalanine-mediated cPLA(2)alpha activation. These results indicate that sPLA(2)-X participates in AA and lysophospholipid release, resulting in CysLT synthesis in eosinophils through a mechanism involving p38 and JNK MAPK, cPLA(2)alpha, and 5-lipoxygenase activation and resulting in the amplification of CysLT synthesis during cPLA(2)alpha activation. Transactivation of eosinophils by sPLA(2)-X may be an important mechanism leading to CysLT formation in the airways of patients with asthma.	[Oslund, Rob C.; Bollinger, James G.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Lai, Ying; Altemeier, William A.; Hallstrand, Teal S.] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA; [Henderson, William R., Jr.] Univ Washington, Div Allergy & Infect Dis, Dept Med, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Santana, Luis F.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gelb, MH (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	gelb@chem.washington.edu; tealh@u.washington.edu		gelb, michael/0000-0001-7000-5219; Santana, Luis/0000-0002-4297-8029; Hallstrand, Teal/0000-0002-5059-6872; Altemeier, William/0000-0001-8860-405X	National Institutes of Health [R01HL089215, R01HL50040, R37HL036235]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235, R01HL085870, R01HL086883, R01HL089215, R01HL050040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089215 (to T.S.H.), R01HL50040 (to M.H.G.), and R37HL036235 (to M.H.G.). Some of the results of this study have been previously reported in abstract form (25).	Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Balboa MA, 2003, J BIOL CHEM, V278, P48059, DOI 10.1074/jbc.M305904200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Blom M, 1998, BLOOD, V91, P3037; Bollinger JG, 2010, J LIPID RES, V51, P440, DOI 10.1194/jlr.D000885; Bowton DL, 1997, AM J RESP CRIT CARE, V155, P421, DOI 10.1164/ajrccm.155.2.9032172; Calabrese C, 2000, ALLERGY, V55, P27, DOI 10.1034/j.1398-9995.2000.00504.x; Casas J, 2009, J IMMUNOL, V183, P2767, DOI 10.4049/jimmunol.0901530; CHILTON FH, 1989, J APPL PHYSIOL, V66, P2763, DOI 10.1152/jappl.1989.66.6.2763; Chilton FH, 1996, J EXP MED, V183, P2235, DOI 10.1084/jem.183.5.2235; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Fang XJ, 1997, J BIOL CHEM, V272, P13683, DOI 10.1074/jbc.272.21.13683; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Frasch SC, 2007, J IMMUNOL, V178, P6540, DOI 10.4049/jimmunol.178.10.6540; Geijsen N, 2000, FEBS LETT, V471, P83, DOI 10.1016/S0014-5793(00)01373-9; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hallstrand TS, 2009, AM J RESP CRIT CARE, V179; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2010, CURR OPIN ALLERGY CL, V10, P60, DOI 10.1097/ACI.0b013e32833489c3; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P586, DOI 10.1016/j.jaci.2005.04.035; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; Lamothe J, 2008, CLIN IMMUNOL, V127, pS89, DOI 10.1016/j.clim.2008.03.250; Mandal AK, 2008, P NATL ACAD SCI USA, V105, P20434, DOI 10.1073/pnas.0808211106; MEHTA D, 1990, AM REV RESPIR DIS, V142, P157, DOI 10.1164/ajrccm/142.1.157; Misso NLA, 2008, THORAX, V63, P21, DOI 10.1136/thx.2006.074112; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Mounier CM, 2004, J BIOL CHEM, V279, P25024, DOI 10.1074/jbc.M313019200; Munoz NM, 2006, J IMMUNOL, V177, P574, DOI 10.4049/jimmunol.177.1.574; Munoz NM, 2003, J BIOL CHEM, V278, P38813, DOI 10.1074/jbc.M302476200; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Myou S, 2003, J IMMUNOL, V171, P4399, DOI 10.4049/jimmunol.171.8.4399; Nishiyama O, 2004, CLIN EXP PHARMACOL P, V31, P179, DOI 10.1111/j.1440-1681.2004.03973.x; OJIMAUCHIYAMA A, 1988, LIPIDS, V23, P815, DOI 10.1007/BF02536227; Oslund RC, 2008, J MED CHEM, V51, P4708, DOI 10.1021/jm800422v; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Romagnoli M, 2002, EUR RESPIR J, V20, P1370, DOI 10.1183/09031936.02.00029202; Sano A, 2001, AM J PHYSIOL-LUNG C, V281, pL844, DOI 10.1152/ajplung.2001.281.4.L844; Santana LF, 2002, J PHYSIOL-LONDON, V544, P57, DOI 10.1113/jphysiol.2002.020552; Satake Y, 2004, J BIOL CHEM, V279, P16488, DOI 10.1074/jbc.M313748200; Seno K, 2001, BIOORG MED CHEM LETT, V11, P587, DOI 10.1016/S0960-894X(01)00003-8; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; STADEL JM, 1994, AM J RESP CELL MOL, V11, P108, DOI 10.1165/ajrcmb.11.1.8018333; Triggiani M, 2003, J IMMUNOL, V170, P3279, DOI 10.4049/jimmunol.170.6.3279; Triggiani M, 2009, J ALLERGY CLIN IMMUN, V124, P558, DOI 10.1016/j.jaci.2009.04.035; Xing FY, 2009, J CELL MOL MED, V13, P1136, DOI 10.1111/j.1582-4934.2008.00394.x; Zhu XD, 2001, J IMMUNOL, V167, P461, DOI 10.4049/jimmunol.167.1.461; Zhu XD, 2007, AM J RESP CELL MOL, V36, P585, DOI 10.1165/rcmb.2006-0391OC	53	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41491	41500		10.1074/jbc.M110.153338	http://dx.doi.org/10.1074/jbc.M110.153338			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974857	Green Published, hybrid			2022-12-27	WOS:000285622600035
J	Sun, M; Lariviere, L; Dengl, S; Mayer, A; Cramer, P				Sun, Mai; Lariviere, Laurent; Dengl, Stefan; Mayer, Andreas; Cramer, Patrick			A Tandem SH2 Domain in Transcription Elongation Factor Spt6 Binds the Phosphorylated RNA Polymerase II C-terminal Repeat Domain (CTD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; 3'-END FORMATION; STRUCTURAL BASIS; IN-VIVO; PROTEIN; YEAST; INHIBITION; ELEMENTS; ZAP-70	Spt6 is an essential transcription elongation factor and histone chaperone that binds the C-terminal repeat domain (CTD) of RNA polymerase II. We show here that Spt6 contains a tandem SH2 domain with a novel structure and CTD-binding mode. The tandem SH2 domain binds to a serine 2-phosphorylated CTD peptide in vitro, whereas its N-terminal SH2 subdomain, which we previously characterized, does not. CTD binding requires a positively charged crevice in the C-terminal SH2 subdomain, which lacks the canonical phospho-binding pocket of SH2 domains and had previously escaped detection. The tandem SH2 domain is apparently required for transcription elongation in vivo as its deletion in cells is lethal in the presence of 6-azauracil.	[Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@LMB.uni-muenchen.de	Mayer, Andreas/AAA-5173-2021; Sun, Mai/A-3837-2010	Sun, Mai/0000-0003-2824-7964; Mayer, Andreas/0000-0002-4532-9382	Deutsche Forschungsgemeinschaft [SFB646]; Transregio 5; Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern; Fonds der Chemischen Industrie; Jung Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Transregio 5; Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Jung Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Nanosystems Initiative Munich (NIM) the Elitenetzwerk Bayern, the Fonds der Chemischen Industrie, and the Jung Stiftung.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bucheli ME, 2005, EMBO J, V24, P2150, DOI 10.1038/sj.emboj.7600687; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; CLARKADAMS CD, 1987, MOL CELL BIOL, V7, P679, DOI 10.1128/MCB.7.2.679; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Futterer K, 1998, J MOL BIOL, V281, P523, DOI 10.1006/jmbi.1998.1964; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; HATADA MH, 1995, NATURE, V377, P32, DOI 10.1038/377032a0; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Johnson SJ, 2008, J MOL BIOL, V377, P1460, DOI 10.1016/j.jmb.2008.01.096; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan CD, 2000, GENE DEV, V14, P2623, DOI 10.1101/gad.831900; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Labarga A, 2007, NUCLEIC ACIDS RES, V35, pW6, DOI 10.1093/nar/gkm291; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Liu PD, 2010, MOL BIOL EVOL, V27, P2628, DOI 10.1093/molbev/msq151; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; MACLENNAN AJ, 1993, TRENDS BIOCHEM SCI, V18, P464; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2003, J BIOL CHEM, V278, P48267, DOI 10.1074/jbc.M307874200; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; SWANSON MS, 1990, MOL CELL BIOL, V10, P4935, DOI 10.1128/MCB.10.9.4935; SWANSON MS, 1992, GENETICS, V132, P325; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WANGE RL, 1993, J BIOL CHEM, V268, P19797; WEINER MP, 1994, PCR METH APPL, V4, pS131; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	43	63	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41597	41603		10.1074/jbc.M110.144568	http://dx.doi.org/10.1074/jbc.M110.144568			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20926372	Green Published, hybrid			2022-12-27	WOS:000285622600047
J	Schaedler, S; Krause, J; Himmelsbach, K; Carvajal-Yepes, M; Lieder, F; Klingel, K; Nassal, M; Weiss, TS; Werner, S; Hildt, E				Schaedler, Stephanie; Krause, Janis; Himmelsbach, Kiyoshi; Carvajal-Yepes, Monica; Lieder, Franziska; Klingel, Karin; Nassal, Michael; Weiss, Thomas S.; Werner, Sabine; Hildt, Eberhard			Hepatitis B Virus Induces Expression of Antioxidant Response Element-regulated Genes by Activation of Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE SURFACE PROTEIN; TRANSGENIC MICE; HBX PROTEIN; LIVER-REGENERATION; HUMAN HEPATOCYTES; X PROTEIN; IN-VITRO; HEPATOCELLULAR-CARCINOMA; HEPATOTROPHIC FACTOR; PROTEASOME COMPLEX	The expression of a variety of cytoprotective genes is regulated by short cis-acting elements in their promoters, called antioxidant response elements (AREs). A central regulator of ARE-mediated gene expression is the NF-E2-related factor 2 (Nrf2). Human hepatitis B virus (HBV) induces a strong activation of Nrf2/ARE-regulated genes in vitro and in vivo. This is triggered by the HBV-regulatory proteins (HBx and LHBs) via c-Raf and MEK. The Nrf2/ARE-mediated induction of cytoprotective genes by HBV results in a better protection of HBV-positive cells against oxidative damage as compared with control cells. Furthermore, there is a significantly increased expression of the Nrf2/ARE-regulated proteasomal subunit PSMB5 in HBV-positive cells that is associated with a decreased level of the immunoproteasome subunit PSMB5i. In accordance with this finding, HBV-positive cells display a higher constitutive proteasome activity and a decreased activity of the immunoproteasome as compared with control cells even after interferon alpha/gamma treatment. The HBV-dependent induction of Nrf2/ARE-regulated genes might ensure survival of the infected cell, shape the immune response to HBV, and thereby promote establishment of the infection.	[Hildt, Eberhard] Univ Kiel, UKSH, Inst Infect Med Mol Med Virol, D-24105 Kiel, Germany; [Schaedler, Stephanie; Krause, Janis; Himmelsbach, Kiyoshi; Carvajal-Yepes, Monica; Nassal, Michael; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Schaedler, Stephanie; Carvajal-Yepes, Monica] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, D-72076 Tubingen, Germany; [Lieder, Franziska; Werner, Sabine] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Weiss, Thomas S.] Univ Regensburg, Ctr Liver Cell Res, D-93053 Regensburg, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Regensburg	Hildt, E (corresponding author), Univ Kiel, UKSH, Inst Infect Med Mol Med Virol, Brunswiker Str 10, D-24105 Kiel, Germany.	hildt@infmed.uni-kiel.de	Weiss, Thomas S./G-3989-2012; Hildt, Eberhard/A-1040-2015; Nassal, Michael/U-4529-2019	Weiss, Thomas S./0000-0003-0336-0581; Nassal, Michael/0000-0003-2204-9158; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft; Studienstiftung des Deutschen Volkes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes	This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft Excellence Cluster "Inflammation at Interfaces" (to E. H.).; Supported by a fellowship from the Studienstiftung des Deutschen Volkes.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Bandi P, 2010, ANTIMICROB AGENTS CH, V54, P749, DOI 10.1128/AAC.01101-09; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Bea F, 2003, CIRC RES, V92, P386, DOI 10.1161/01.RES.0000059561.65545.16; BEASLEY RP, 1981, LANCET, V2, P1129; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; BRUSS V, 1995, J VIROL, V69, P6652, DOI 10.1128/JVI.69.11.6652-6657.1995; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chemin I, 2009, CANCER LETT, V286, P52, DOI 10.1016/j.canlet.2008.12.003; Dayoub R, 2006, BIOCHEM BIOPH RES CO, V345, P181, DOI 10.1016/j.bbrc.2006.04.040; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Durchdewald M, 2007, J INVEST DERMATOL, V127, P646, DOI 10.1038/sj.jid.5700585; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; FAVREAU LV, 1995, J BIOL CHEM, V270, P24468, DOI 10.1074/jbc.270.41.24468; Friedrich B, 2005, J HEPATOL, V43, P696, DOI 10.1016/j.jhep.2005.02.026; Hafner A, 2003, EMBO REP, V4, P767, DOI 10.1038/sj.embor.embor903; HAGEN TM, 1994, P NATL ACAD SCI USA, V91, P12808, DOI 10.1073/pnas.91.26.12808; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Higuchi A, 2004, J BIOMED MATER RES A, V71A, P470, DOI 10.1002/jbm.a.30169; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hildt E, 2002, EMBO J, V21, P525, DOI 10.1093/emboj/21.4.525; Hu ZY, 1999, J VIROL, V73, P7231, DOI 10.1128/JVI.73.9.7231-7240.1999; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jung T, 2009, MOL ASPECTS MED, V30, P191, DOI 10.1016/j.mam.2009.04.001; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008649; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Lupberger J, 2006, J HEPATOL, V45, P547, DOI 10.1016/j.jhep.2006.05.012; Melegari M, 2005, J VIROL, V79, P9810, DOI 10.1128/JVI.79.15.9810-9820.2005; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Severi T, 2007, CHEM-BIOL INTERACT, V168, P128, DOI 10.1016/j.cbi.2007.03.006; Shen GX, 2004, J BIOL CHEM, V279, P23052, DOI 10.1074/jbc.M401368200; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Sprinzl MF, 2001, J VIROL, V75, P5108, DOI 10.1128/JVI.75.11.5108-5118.2001; Stockl L, 2003, ONCOGENE, V22, P2604, DOI 10.1038/sj.onc.1206320; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Thasler WE, 2006, J PHARMACOL EXP THER, V316, P822, DOI 10.1124/jpet.105.094201; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Ying CX, 2003, BIOCHEM BIOPH RES CO, V309, P482, DOI 10.1016/j.bbrc.2003.08.021; Zhang ZS, 2000, J BIOL CHEM, V275, P15157, DOI 10.1074/jbc.M910378199; Zhang ZS, 2004, J VIROL, V78, P4566, DOI 10.1128/JVI.78.9.4566-4572.2004; Zhu HZ, 2004, EXP MOL PATHOL, V76, P44, DOI 10.1016/j.yexmp.2003.09.001	60	69	74	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41074	41086		10.1074/jbc.M110.145862	http://dx.doi.org/10.1074/jbc.M110.145862			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956535	hybrid, Green Published			2022-12-27	WOS:000285414400070
J	Mehta, M; Braberg, H; Wang, SY; Lozsa, A; Shales, M; Solache, A; Krogan, NJ; Keogh, MC				Mehta, Monika; Braberg, Hannes; Wang, Shuyi; Lozsa, Anita; Shales, Michael; Solache, Alejandra; Krogan, Nevan J.; Keogh, Michael-Christopher			Individual Lysine Acetylations on the N Terminus of Saccharomyces cerevisiae H2A.Z Are Highly but Not Differentially Regulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL CHARGE PATCH; HISTONE H2A.Z; GENE ACTIVITY; VARIANT HTZ1; YEAST; CHROMATIN; COMPLEX; GENOME; HETEROCHROMATIN; NUCLEOSOMES	The multi-functional histone variant Htz1 (Saccharomyces cerevisiae H2A.Z) is acetylated on up to four N-terminal lysines at positions 3, 8, 10, and 14. It has thus been posited that specific acetylated forms of the histone could regulate distinct roles. Antibodies against Htz1-K8(Ac), -K10(Ac), and -K14(Ac) show that all three modifications are added by Esa1 acetyltransferase and removed by Hda1 deacetylase. Completely unacetylatable htz1 alleles exhibit widespread interactions in genome scale genetic screening. However, singly mutated (e. g. htz1-K8R) or singly acetylable (e. g. the triple mutant htz1-K3R/K10R/K14R) alleles show no significant defects in these analyses. This suggests that the N-terminal acetylations on Htz1 are internally redundant. Further supporting this proposal, each acetylation decays with similar kinetics when Htz1 transcription is repressed, and proteomic screening did not find a single condition in which one Htz1(Ac) was differentially regulated. However, whereas the individual acetylations on Htz1 may be redundant, they are not dispensable. Completely unacetylatable htz1 alleles display genetic interactions and phenotypes in common with and distinct from htz1 Delta. In addition, each Htz1 N-terminal lysine is deacetylated by Hda1 in response to benomyl and reacetylated when this agent is removed. Such active regulation suggests that acetylation plays a significant role in Htz1 function.	[Mehta, Monika; Keogh, Michael-Christopher] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Braberg, Hannes; Wang, Shuyi; Shales, Michael; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Lozsa, Anita; Solache, Alejandra] Millipore Corp, Temecula, CA 92590 USA	Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck KGaA; MilliporeSigma	Keogh, MC (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Chanin 415A,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.keogh@einstein.yu.edu		Mehta, Monika/0000-0003-3928-3733	National Institutes of Health; Searle Foundation; Keck Foundation; National Cancer Institute Cancer Centre [2P30CA013330]; Speaker's Fund for Biomedical Research; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Foundation; Keck Foundation(W.M. Keck Foundation); National Cancer Institute Cancer Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Speaker's Fund for Biomedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the National Institutes of Health. This work was also supported by the Searle and Keck Foundations, by National Cancer Institute Cancer Centre Grant 2P30CA013330 to Albert Einstein College of Medicine, and by the Speaker's Fund for Biomedical Research: Toward the Science of Patient Care awarded by the City of New York.	Babiarz JE, 2006, GENE DEV, V20, P700, DOI 10.1101/gad.1386306; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Caterino TL, 2007, NAT STRUCT MOL BIOL, V14, P1056, DOI 10.1038/nsmb1107-1056; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Kanta H, 2006, GENETICS, V173, P435, DOI 10.1534/genetics.105.050559; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Mateus C, 2000, YEAST, V16, P1313, DOI 10.1002/1097-0061(200010)16:14<1313::AID-YEA626>3.0.CO;2-O; Mehta Monika, 2010, J Biol, V9, P3, DOI 10.1186/jbiol214; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Raisner RM, 2006, CURR OPIN GENET DEV, V16, P119, DOI 10.1016/j.gde.2006.02.005; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ren QH, 2003, MOL CELL BIOL, V23, P2778, DOI 10.1128/MCB.23.8.2778-2789.2003; Ren QH, 2001, MOL CELL, V7, P1329, DOI 10.1016/S1097-2765(01)00269-6; Schneider J, 2004, METHOD ENZYMOL, V377, P227; Schuldiner M, 2006, METHODS, V40, P344, DOI 10.1016/j.ymeth.2006.07.034; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Straube K, 2010, TRAFFIC, V11, P185, DOI 10.1111/j.1600-0854.2009.01010.x; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Tanabe M, 2008, GENES CELLS, V13, P1279, DOI 10.1111/j.1365-2443.2008.01244.x; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Thambirajah AA, 2009, BIOCHEM CELL BIOL, V87, P7, DOI 10.1139/O08-103; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	53	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39855	39865		10.1074/jbc.M110.185967	http://dx.doi.org/10.1074/jbc.M110.185967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952395	Green Published, hybrid			2022-12-27	WOS:000285185500030
J	Muradov, H; Boyd, KK; Artemyev, NO				Muradov, Hakim; Boyd, Kimberly K.; Artemyev, Nikolai O.			Rod phosphodiesterase-6 PDE6A and PDE6B Subunits Are Enzymatically Equivalent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY GAMMA-SUBUNIT; CGMP-PHOSPHODIESTERASE; PHOTORECEPTOR PHOSPHODIESTERASE; BINDING-SITES; BETA-SUBUNIT; TRANSDUCIN; PROTEIN; ALPHA; PHOTOTRANSDUCTION; ACTIVATION	Phosphodiesterase-6 (PDE6) is the key effector enzyme of the phototransduction cascade in rods and cones. The catalytic core of rod PDE6 is a unique heterodimer of PDE6A and PDE6B catalytic subunits. The functional significance of rod PDE6 heterodimerization and conserved differences between PDE6AB and cone PDE6C and the individual properties of PDE6A and PDE6B are unknown. To address these outstanding questions, we expressed chimeric homodimeric enzymes, enhanced GFP (EGFP)-PDE6C-A and EGFP-PDE6C-B, containing the PDE6A and PDE6B catalytic domains, respectively, in transgenic Xenopus laevis. Similar to EGFP-PDE6C, EGFP-PDE6C-A and EGFP-PDE6C-B were targeted to the rod outer segments and concentrated at the disc rims. PDE6C, PDE6C-A, and PDE6C-B were isolated following selective immunoprecipitation of the EGFP fusion proteins. All three enzymes, PDE6C, PDE6C-A, and PDE6C-B, hydrolyzed cGMP with similar K-m (20-23 mu M) and k(cat) (4200-5100 s(-1)) values. Likewise, the K-i values for PDE6C, PDE6C-A, and PDE6C-B inhibition by the cone-and rod-specific PDE6 gamma-subunits (P gamma) were comparable. Recombinant cone transducin-alpha (G alpha(t2)) and native rod G alpha(t1) fully and potently activated PDE6C, PDE6C-A, and PDE6C-B. In contrast, the half-maximal activation of bovine rod PDE6 required markedly higher concentrations of G alpha(t2) or G alpha(t1). Our results suggest that PDE6A and PDE6B are enzymatically equivalent. Furthermore, PDE6A and PDE6B are similar to PDE6C with respect to catalytic properties and the interaction with P gamma but differ in the interaction with transducin. This study significantly limits the range of mechanisms by which conserved differences between PDE6A, PDE6B, and PDE6C may contribute to remarkable differences in rod and cone physiology.	[Muradov, Hakim; Boyd, Kimberly K.; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu		Artemyev, Nikolai/0000-0002-5266-6854	National Institutes of Health [EY-10843, EY-12682]; NATIONAL EYE INSTITUTE [R01EY010843, R01EY012682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY-10843 and EY-12682 (to N.O.A.).	Artemyev NO, 1996, P NATL ACAD SCI USA, V93, P5407, DOI 10.1073/pnas.93.11.5407; Barren B, 2009, EMBO J, V28, P3613, DOI 10.1038/emboj.2009.284; Berger AL, 1999, BIOCHEMISTRY-US, V38, P1293, DOI 10.1021/bi981683m; BRUCKERT F, 1994, BIOCHEMISTRY-US, V33, P12625, DOI 10.1021/bi00208a013; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GILLESPIE PG, 1988, J BIOL CHEM, V263, P8133; Granovsky AE, 1997, J BIOL CHEM, V272, P11686, DOI 10.1074/jbc.272.18.11686; Guo LW, 2006, J BIOL CHEM, V281, P15412, DOI 10.1074/jbc.M600595200; HAMILTON SE, 1993, FEBS LETT, V318, P157, DOI 10.1016/0014-5793(93)80012-J; HAMILTON SE, 1990, J BIOL CHEM, V265, P11259; Huang DM, 2004, J BIOL CHEM, V279, P48143, DOI 10.1074/jbc.M404338200; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; Korschen HG, 1999, NATURE, V400, P761, DOI 10.1038/23468; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lamb TD, 2006, INVEST OPHTH VIS SCI, V47, P5138, DOI 10.1167/iovs.06-0849; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Liu YT, 2009, J BIOL CHEM, V284, P31541, DOI 10.1074/jbc.M109.018606; MALINSKI JA, 1992, BIOCHEMISTRY-US, V31, P9502, DOI 10.1021/bi00154a024; Melia TJ, 2000, J BIOL CHEM, V275, P3535, DOI 10.1074/jbc.275.5.3535; Mou HM, 2001, J BIOL CHEM, V276, P27527, DOI 10.1074/jbc.M103316200; Muradov H, 2006, VISION RES, V46, P860, DOI 10.1016/j.visres.2005.09.015; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Muradov H, 2009, J BIOL CHEM, V284, P32662, DOI 10.1074/jbc.M109.049916; Muradov KG, 2003, J BIOL CHEM, V278, P10594, DOI 10.1074/jbc.M208456200; Muradov KG, 2002, BIOCHEMISTRY-US, V41, P3884, DOI 10.1021/bi015935m; Natochin M, 1999, J BIOL CHEM, V274, P7865, DOI 10.1074/jbc.274.12.7865; Norton AW, 2000, J BIOL CHEM, V275, P38611, DOI 10.1074/jbc.M004606200; Pentia DC, 2006, J BIOL CHEM, V281, P5500, DOI 10.1074/jbc.M507488200; Piri N, 2003, J BIOL CHEM, V278, P36999, DOI 10.1074/jbc.M303710200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SUGIMOTO Y, 1991, P NATL ACAD SCI USA, V88, P3116, DOI 10.1073/pnas.88.8.3116; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003; Zhang XJ, 2005, FRONT BIOSCI-LANDMRK, V10, P1191, DOI 10.2741/1612	42	36	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39828	39834		10.1074/jbc.M110.170068	http://dx.doi.org/10.1074/jbc.M110.170068			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940301	hybrid, Green Published			2022-12-27	WOS:000285185500027
J	Franco, M; Muratori, C; Corso, S; Tenaglia, E; Bertotti, A; Capparuccia, L; Trusolino, L; Comoglio, PM; Tamagnone, L				Franco, Melanie; Muratori, Claudia; Corso, Simona; Tenaglia, Enrico; Bertotti, Andrea; Capparuccia, Lorena; Trusolino, Livio; Comoglio, Paolo M.; Tamagnone, Luca			The Tetraspanin CD151 Is Required for Met-dependent Signaling and Tumor Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANCHORAGE-INDEPENDENT GROWTH; BREAST-CANCER CELLS; C-MET; FACTOR RECEPTORS; IN-VIVO; CLINICAL-SIGNIFICANCE; INTEGRIN; MOTILITY; ALPHA-6-BETA-4; TUMORIGENESIS	CD151, a transmembrane protein of the tetraspanin family, is implicated in the regulation of cell-substrate adhesion and cell migration through physical and functional interactions with integrin receptors. In contrast, little is known about the potential role of CD151 in controlling cell proliferation and survival. We have previously shown that beta 4 integrin, a major CD151 partner, not only acts as an adhesive receptor for laminins but also as an intracellular signaling platform promoting cell proliferation and invasive growth upon interaction with Met, the tyrosine kinase receptor for hepatocyte growth factor (HGF). Here we show that RNAi-mediated silencing of CD151 expression in cancer cells impairs HGF-driven proliferation, anchorage-independent growth, protection from anoikis, and tumor progression in xenograft models in vivo. Mechanistically, we found that CD151 is crucially implicated in the formation of signaling complexes between Met and beta 4 integrin, a known amplifier of HGF-induced tumor cell growth and survival. CD151 depletion hampered HGF-induced phosphorylation of beta 4 integrin and the ensuing Grb2-Gab1 association, a signaling pathway leading to MAPK stimulation and cell growth. Accordingly, CD151 knockdown reduced HGF-triggered activation of MAPK but not AKT signaling cascade. These results indicate that CD151 controls Met-dependent neoplastic growth by enhancing receptor signaling through beta 4 integrin-mediated pathways, independent of cell-substrate adhesion.	[Franco, Melanie; Muratori, Claudia; Corso, Simona; Tenaglia, Enrico; Bertotti, Andrea; Capparuccia, Lorena; Trusolino, Livio; Comoglio, Paolo M.; Tamagnone, Luca] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, I-10060 Turin, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	Tamagnone, L (corresponding author), Univ Turin, IRCC, SP 142, I-10060 Candiolo, TO, Italy.	luca.tamagnone@ircc.it	Trusolino, Livio/A-3896-2011; FRANCO, Melanie/I-1612-2015; Tamagnone, Luca/J-8948-2018	FRANCO, Melanie/0000-0001-6519-4131; Tamagnone, Luca/0000-0002-2884-7946; Trusolino, Livio/0000-0002-6379-3365; Bertotti, Andrea/0000-0001-8196-7608; Muratori, Claudia/0000-0002-3359-164X; Comoglio, Paolo/0000-0002-7056-5328; CORSO, Simona/0000-0002-5069-1503	Italian Association for Cancer Research (AIRC); Regione Piemonte	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Regione Piemonte(Regione Piemonte)	This work was supported by grants from the Italian Association for Cancer Research (AIRC) and Regione Piemonte (grants to L. Trusolino, L. Tamagnone, and P.M.C.).	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Chometon G, 2006, EXP CELL RES, V312, P983, DOI 10.1016/j.yexcr.2005.12.034; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Fiucci G, 2002, ONCOGENE, V21, P2365, DOI 10.1038/sj.onc.1205300; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; Geary SM, 2001, TISSUE ANTIGENS, V58, P141, DOI 10.1034/j.1399-0039.2001.580301.x; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Israels SJ, 2007, THROMB HAEMOSTASIS, V98, P1081, DOI 10.1160/TH06-08-0455; Klosek SK, 2009, BIOCHEM BIOPH RES CO, V379, P1097, DOI 10.1016/j.bbrc.2009.01.023; Klosek SK, 2005, BIOCHEM BIOPH RES CO, V336, P408, DOI 10.1016/j.bbrc.2005.08.106; Lazo PA, 2007, CANCER SCI, V98, P1666, DOI 10.1111/j.1349-7006.2007.00584.x; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Murayama Y, 2008, J CELL PHYSIOL, V216, P135, DOI 10.1002/jcp.21384; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; PRAT M, 1991, MOL CELL BIOL, V11, P5954, DOI 10.1128/MCB.11.12.5954; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sincock PM, 1999, J CELL SCI, V112, P833; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Sterk LMT, 2002, J CELL SCI, V115, P1161; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Takahashi M, 2007, INT J CANCER, V121, P1919, DOI 10.1002/ijc.22887; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Todeschini AR, 2008, P NATL ACAD SCI USA, V105, P1925, DOI 10.1073/pnas.0709619104; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	46	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38756	38764		10.1074/jbc.M110.145417	http://dx.doi.org/10.1074/jbc.M110.145417			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937830	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000284941300004
J	Ma, D; Li, SM; Lucas, EK; Cowell, RM; Lin, JD				Ma, Di; Li, Siming; Lucas, Elizabeth K.; Cowell, Rita M.; Lin, Jiandie D.			Neuronal Inactivation of Peroxisome Proliferator-activated Receptor gamma Coactivator 1 alpha (PGC-1 alpha) Protects Mice from Diet-induced Obesity and Leads to Degenerative Lesions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; HEPATIC GLUCONEOGENESIS; MONITORING AUTOPHAGY; LIPID-METABOLISM; NERVOUS-SYSTEM; RAT-BRAIN; PGC-1	Peroxisome proliferator-activated receptor alpha coactivator 1 alpha (PGC-1 alpha) is a transcriptional coactivator that regulates diverse aspects of energy metabolism in peripheral tissues. Mice deficient in PGC-1 alpha have elevated metabolic rate and are resistant to diet-induced obesity. However, it remains unknown whether this alteration in energy balance is due to the action of PGC-1 alpha in peripheral tissues or the central nervous system. In this study, we generated neuronal PGC-1 alpha knock-out mice (B alpha KO) using calcium/calmodulin-dependent protein kinase II alpha(CaMKII alpha)-Cre to address its role in the regulation of energy balance and neuronal function. Unlike whole body PGC-1 alpha null mice, B alpha KO mice have normal adaptive metabolic response to starvation and cold exposure in peripheral tissues. In contrast, B alpha KO mice are hypermetabolic, and similar to whole body PGC-1 alpha null mice, are also resistant to diet-induced obesity, resulting in significantly improved metabolic profiles. Neuronal inactivation of PGC-1 alpha leads to striatal lesions that are reminiscent of neurodegeneration in whole body PGC-1 alpha null brain and impairs nutritional regulation of hypothalamic expression of genes that regulate systemic energy balance. Together, these studies have demonstrated a physiological role for neuronal PGC-1 alpha in the control of energy balance. Our results also implicate CaMKII alpha-positive neurons as an important part of the neural circuitry that governs energy expenditure in vivo.	[Ma, Di; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ma, Di; Li, Siming; Lin, Jiandie D.] Univ Michigan, Med Ctr, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Lucas, Elizabeth K.; Cowell, Rita M.] Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Alabama System; University of Alabama Birmingham	Lin, JD (corresponding author), Univ Michigan, Life Sci Inst 5437, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	jdlin@umich.edu	Cowell, Rita/J-5083-2013	Cowell, Rita/0000-0001-5814-9412; Lucas, Elizabeth/0000-0002-0632-4538	National Institutes of Health; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant (to J. D. L.).; Supported by a predoctoral fellowship from the American Heart Association.	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Draper S, 2010, BRAIN RES, V1350, P139, DOI 10.1016/j.brainres.2010.03.082; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lin JD, 2009, MOL ENDOCRINOL, V23, P2, DOI 10.1210/me.2008-0344; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tritos NA, 2003, BRAIN RES, V961, P255, DOI 10.1016/S0006-8993(02)03961-6; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	57	59	62	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39087	39095		10.1074/jbc.M110.151688	http://dx.doi.org/10.1074/jbc.M110.151688			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20947495	Green Published, hybrid			2022-12-27	WOS:000284941300039
J	D'Avanzo, N; Cheng, WWL; Doyle, DA; Nichols, CG				D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Doyle, Declan A.; Nichols, Colin G.			Direct and Specific Activation of Human Inward Rectifier K+ Channels by Membrane Phosphatidylinositol 4,5-Bisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANIONIC PHOSPHOLIPIDS; POTASSIUM CHANNELS; KIR CHANNELS; CRYSTAL-STRUCTURE; PIP2 REGULATION; ATP CHANNELS; ION CHANNELS; CHANNELOPATHIES; DETERMINANTS; SENSITIVITY	Many ion channels are modulated by phosphatidylinositol 4,5-bisphosphate (PIP2), but studies examining the PIP2 dependence of channel activity have been limited to cell expression systems, which present difficulties for controlling membrane composition. We have characterized the PIP2 dependence of purified human Kir2.1 and Kir2.2 activity using Rb-86(+) flux and patch clamp assays in liposomes of defined composition. We definitively show that these channels are directly activated by PIP2 and that PIP2 is absolutely required in the membrane for channel activity. The results provide the first quantitative description of the dependence of eukaryotic Kir channel function on PIP2 levels in the membrane; Kir2.1 shows measureable activity in as little as 0.01% PIP2, and open probability increases to similar to 0.4 at 1% PIP2. Activation of Kir2.1 by phosphatidylinositol phosphates is also highly selective for PIP2; PI, PI(4) P, and PI(5) P do not activate channels, and PI(3,4,5)P-3 causes minimal activity. The PIP2 dependence of eukaryotic Kir activity is almost exactly opposite that of KirBac1.1, which shows marked inhibition by PIP2. This raises the interesting hypothesis that PIP2 activation of eukaryotic channels reflects an evolutionary adaptation of the channel to the appearance of PIP2 in the eukaryotic cell membrane.	[D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [D'Avanzo, Nazzareno; Cheng, Wayland W. L.; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Doyle, Declan A.] Trinity Coll Dublin, Sch Biochem & Immunol, Coll Green, Dublin 2, Ireland	Washington University (WUSTL); Washington University (WUSTL); Trinity College Dublin	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@wustl.edu	Nichols, Colin/D-6336-2012	Cheng, Wayland/0000-0002-9529-9820	National Institutes of Health [HL54171]; American Heart Association [0810196Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54171 (to C. G. N.). This work was also supported by American Heart Association Fellowship 0810196Z (to W. W. L. C.).	Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cukras CA, 2002, J GEN PHYSIOL, V119, P581, DOI 10.1085/jgp.20028562; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; D'Avanzo N, 2010, PROTEIN EXPRES PURIF, V71, P115, DOI 10.1016/j.pep.2010.01.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rosenhouse-Dantsker A, 2010, CHANNELS, V4, P63, DOI 10.4161/chan.4.1.10366; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Shen W, 2007, NAT NEUROSCI, V10, P1458, DOI 10.1038/nn1972; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; VANPHUNG L, 1995, MICROBIOL IMMUNOL, V39, P105, DOI 10.1111/j.1348-0421.1995.tb02176.x; Xie LH, 2008, J PHYSIOL-LONDON, V586, P1833, DOI 10.1113/jphysiol.2007.147868; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	37	54	55	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37129	37132		10.1074/jbc.C110.186692	http://dx.doi.org/10.1074/jbc.C110.186692			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20921230	Green Published, hybrid			2022-12-27	WOS:000284424000005
J	Siddiqua, A; Margittai, M				Siddiqua, Ayisha; Margittai, Martin			Three- and Four-repeat Tau Coassemble into Heterogeneous Filaments AN IMPLICATION FOR ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN-TAU; STRAIN VARIATION; AMYLOID FIBRILS; SPIN; AGGREGATION; PARALLEL; BRAIN; CORE; TRANSMISSION	Tau filaments are the pathological hallmark of numerous neurodegenerative diseases including Alzheimer disease, Pick disease, and progressive supranuclear palsy. In the adult human brain, six isoforms are expressed that differ by the presence or absence of the second of four semiconserved repeats. As a consequence, half of the tau isoforms have three repeats (3R tau), whereas the other half of the isoforms have four repeats (4R tau). Tauopathies can be characterized based on the isoform composition of their filaments. Alzheimer disease filamentous inclusions contain all isoforms. Pick disease filaments contain 3R tau. Progressive supranuclear palsy filaments contain 4R tau. Here, we used site-directed spin labeling of recombinant tau in conjunction with electron paramagnetic resonance spectroscopy to obtain structural insights into these filaments. We find that filaments of 4R tau and 3R tau share a highly ordered core structure in the third repeat with parallel, in-register arrangement of beta-strands. This structure is conserved regardless of whether full-length isoforms (htau40 and htau23) or truncated constructs (K18 and K19) are used. When mixed, 3R tau and 4R tau coassemble into heterogeneous filaments. These filaments share the highly ordered core in the third repeat; however, they differ in their overall composition. Our findings indicate that at least three distinct types of filaments exist: homogeneous 3R tau, homogeneous 4R tau, and heterogeneous 3R/4R tau. These results suggest that individual filaments found in Alzheimer disease are structurally distinct from those in the 3R and 4R tauopathies.	[Siddiqua, Ayisha; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, 2190 E Iliff Ave, Denver, CO 80208 USA.	martin.margittai@du.edu	Siddiqua, Ayisha/AGZ-8093-2022; Margittai, Martin/D-5039-2014	Siddiqua, Ayisha/0000-0002-9241-204X; Margittai, Martin/0000-0003-1903-5927	CurePSP - Society for Progressive Supranuclear Palsy	CurePSP - Society for Progressive Supranuclear Palsy	This work was supported by grants from CurePSP - Society for Progressive Supranuclear Palsy (to M. M.).	Adams SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010810; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Bretteville A, 2008, J ALZHEIMERS DIS, V14, P431; Brunden KR, 2008, J ALZHEIMERS DIS, V14, P393; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Chen M, 2007, J BIOL CHEM, V282, P24970, DOI 10.1074/jbc.M700368200; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P227, DOI 10.1016/0022-2836(77)90214-5; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, J BIOL CHEM, V281, P37820, DOI 10.1074/jbc.M605336200; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; NOVAK M, 1993, EMBO J, V12, P365, DOI 10.1002/j.1460-2075.1993.tb05665.x; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	59	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37920	37926		10.1074/jbc.M110.185728	http://dx.doi.org/10.1074/jbc.M110.185728			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20921227	Green Published, hybrid			2022-12-27	WOS:000284424000081
J	de Lucas-Cerrillo, AM; Maldifassi, MC; Arnalich, F; Renart, J; Atienza, G; Serantes, R; Cruces, J; Sanchez-Pacheco, A; Andres-Mateos, E; Montiel, C				de Lucas-Cerrillo, Ana M.; Constanza Maldifassi, M.; Arnalich, Francisco; Renart, Jaime; Atienza, Gema; Serantes, Rocio; Cruces, Jesus; Sanchez-Pacheco, Aurora; Andres-Mateos, Eva; Montiel, Carmen			Function of Partially Duplicated Human alpha 7 Nicotinic Receptor Subunit CHRFAM7A Gene POTENTIAL IMPLICATIONS FOR THE CHOLINERGIC ANTI-INFLAMMATORY RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATION; PERIPHERAL-BLOOD LYMPHOCYTES; ACETYLCHOLINE-RECEPTOR; MESSENGER-RNA; XENOPUS-OOCYTES; VAGUS NERVE; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; GABA(A) RECEPTORS; BIPOLAR DISORDER	The neuronal alpha 7 nicotinic receptor subunit gene (CHRNA7) is partially duplicated in the human genome forming a hybrid gene (CHRFAM7A) with the novel FAM7A gene. The hybrid gene transcript, dup alpha 7, has been identified in brain, immune cells, and the HL-60 cell line, although its translation and function are still unknown. In this study, dup alpha 7 cDNA has been cloned and expressed in GH4C1 cells and Xenopus oocytes to study the pattern and functional role of the expressed protein. Our results reveal that dup alpha 7 transcript was natively translated in HL-60 cells and heterologously expressed in GH4C1 cells and oocytes. Injection of dup alpha 7 mRNA into oocytes failed to generate functional receptors, but when co-injected with alpha 7 mRNA at alpha 7/dup alpha 7 ratios of 5:1, 2:1, 1:1, 1:5, and 1: 10, it reduced the nicotine-elicited alpha 7 current generated in control oocytes (alpha 7 alone) by 26, 53, 75, 93, and 94%, respectively. This effect is mainly due to a reduction in the number of functional alpha 7 receptors reaching the oocyte membrane, as deduced from alpha-bungarotoxin binding and fluorescent confocal assays. Two additional findings open the possibility that the dominant negative effect of dup alpha 7 on alpha 7 receptor activity observed in vitro could be extrapolated to in vivo situations. (i) Compared with alpha 7 mRNA, basal dup alpha 7 mRNA levels are substantial in human cerebral cortex and higher in macrophages. (ii) dup alpha 7 mRNA levels in macrophages are down-regulated by IL-1 beta, LPS, and nicotine. Thus, dup alpha 7 could modulate alpha 7 receptor-mediated synaptic transmission and cholinergic anti-inflammatory response.	[de Lucas-Cerrillo, Ana M.; Constanza Maldifassi, M.; Atienza, Gema; Serantes, Rocio; Montiel, Carmen] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Farmacol & Terapeut, E-28029 Madrid, Spain; [Arnalich, Francisco; Serantes, Rocio] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Med Interna, E-28029 Madrid, Spain; [Cruces, Jesus; Sanchez-Pacheco, Aurora] Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Bioquim, E-28029 Madrid, Spain; [Renart, Jaime; Cruces, Jesus; Sanchez-Pacheco, Aurora] Inst Invest Biomed Alberto Sols, Consejo Super Invest Cient, Madrid 28029, Spain; [Andres-Mateos, Eva] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Sch Med, Baltimore, MD 21205 USA	Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Johns Hopkins University	Montiel, C (corresponding author), Univ Autonoma Madrid, Fac Med, Hosp La Paz,IdiPAZ, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28029 Madrid, Spain.	carmen.montiel@uam.es	Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/J-8184-2017; Arnalich, Francisco/AAF-5924-2021; Renart, Jaime/B-7661-2009; Montiel, Carmen/L-1407-2017	Arnalich, Francisco/0000-0003-2943-0373; Renart, Jaime/0000-0001-6620-3706; Montiel, Carmen/0000-0003-4845-0484; Sanchez Pacheco, Aurora/0000-0002-7776-2594	Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain [SAF2008-05347]; Ministerio de Ciencia e Innovacion, Spain; CONICYT, Ministerio de Educacion, Chile	Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICYT, Ministerio de Educacion, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Grant SAF2008-05347 (to C. M. and F. A.) from the Ministerio de Ciencia y Tecnologia and Fundacion Mutua Madrilena, Spain.; Recipient of fellowship from Programa de Formacion de Personal Investigador (Ministerio de Ciencia e Innovacion, Spain).; Recipient of fellowship from Beca Chile (CONICYT, Ministerio de Educacion, Chile.	Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Balduzzi R, 2001, BBA-MOL CELL RES, V1539, P93, DOI 10.1016/S0167-4889(01)00097-0; Bertrand D, 2008, MOL PHARMACOL, V74, P1407, DOI 10.1124/mol.107.042820; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; de Almeida MC, 2000, MEM I OSWALDO CRUZ, V95, P221, DOI 10.1590/S0074-02762000000200014; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036; Flomen RH, 2006, AM J MED GENET B, V141B, P571, DOI 10.1002/ajmg.b.30306; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Garcia-Guzman M., 1994, BIOCHEMISTRY-US, V33, P15198; Gault J, 2003, AM J MED GENET B, V123B, P39, DOI 10.1002/ajmg.b.20061; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Groot Kormelink P. J., 1997, FEBS LETT, V400, P309; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Herrero CJ, 1999, BRIT J PHARMACOL, V127, P1375, DOI 10.1038/sj.bjp.0702692; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Li DP, 2001, BRAIN RES, V920, P151, DOI 10.1016/S0006-8993(01)03055-4; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; PENG X, 1994, MOL PHARMACOL, V45, P546; Perl O, 2006, NEUROPSYCHOBIOLOGY, V53, P88, DOI 10.1159/000091725; Pintado AJ, 2000, BRIT J PHARMACOL, V130, P1893, DOI 10.1038/sj.bjp.0703519; Pradet-Balade B, 2001, BIOTECHNIQUES, V30, P1352, DOI 10.2144/01306rr03; Pradet-Balade B, 2001, TRENDS BIOCHEM SCI, V26, P225, DOI 10.1016/S0968-0004(00)01776-X; Raux G, 2002, MOL PSYCHIATR, V7, P1006, DOI 10.1038/sj.mp.4001140; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Severance EG, 2008, GENES BRAIN BEHAV, V7, P37, DOI 10.1111/j.1601-183X.2007.00323.x; Severance EG, 2009, J NEURAL TRANSM, V116, P213, DOI 10.1007/s00702-008-0164-y; Sharma G, 2008, CURR MED CHEM, V15, P2921, DOI 10.2174/092986708786848703; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Sweileh W, 2000, MOL BRAIN RES, V75, P293, DOI 10.1016/S0169-328X(99)00302-2; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P1272, DOI 10.1002/art.24470; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578; Zwart R, 2002, NEUROPHARMACOLOGY, V43, P374, DOI 10.1016/S0028-3908(02)00094-1	58	87	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					594	606		10.1074/jbc.M110.180067	http://dx.doi.org/10.1074/jbc.M110.180067			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047781	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000285782800062
J	Giulivi, C; Ross-Inta, C; Omanska-Klusek, A; Napoli, E; Sakaguchi, D; Barrientos, G; Allen, PD; Pessah, IN				Giulivi, Cecilia; Ross-Inta, Catherine; Omanska-Klusek, Alicja; Napoli, Eleonora; Sakaguchi, Danielle; Barrientos, Genaro; Allen, Paul D.; Pessah, Isaac N.			Basal Bioenergetic Abnormalities in Skeletal Muscle from Ryanodine Receptor Malignant Hyperthermia-susceptible R163C Knock-in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-CORE DISEASE; ACTIVATED PROTEIN-KINASE; SATURATED FATTY-ACIDS; RAT SKELETAL; OXIDATIVE-PHOSPHORYLATION; GENE-EXPRESSION; FIBER-TYPE; SUBCELLULAR-FRACTIONS; CALCIUM-HOMEOSTASIS; DIABETES-MELLITUS	Malignant hyperthermia (MH) and central core disease in humans have been associated with mutations in the skeletal ryanodine receptor (RyR1). Heterozygous mice expressing the human MH/central core disease RyR1 R163C mutation exhibit MH when exposed to halothane or heat stress. Considering that many MH symptoms resemble those that could ensue from a mitochondrial dysfunction (e.g. metabolic acidosis and hyperthermia) and that MH-susceptible mice or humans have a higher than normal cytoplasmic Ca2+ concentration at rest, we evaluated the role of mitochondria in skeletal muscle from R163C compared with wild type mice under basal (untriggered) conditions. R163C skeletal muscle exhibited a significant increase in matrix Ca2+, increased reactive oxygen species production, lower expression of mitochondrial proteins, and higher mtDNA copy number. These changes, in conjunction with lower myoglobin and glycogen contents, Myh4 and GAPDH transcript levels, GAPDH activity, and lower glucose utilization suggested a switch to a compromised bioenergetic state characterized by both low oxidative phosphorylation and glycolysis. The shift in bioenergetic state was accompanied by a dysregulation of Ca2+-esponsive signaling pathways regulated by calcineurin and ERK1/2. Chronically elevated resting Ca2+ in R163C skeletal muscle elicited the maintenance of a fast-twitch fiber program and the development of insulin resistance-like phenotype as part of a metabolic adaptation to the R163C RyR1 mutation.	[Giulivi, Cecilia; Ross-Inta, Catherine; Omanska-Klusek, Alicja; Napoli, Eleonora; Sakaguchi, Danielle; Barrientos, Genaro; Pessah, Isaac N.] Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, Davis, CA 95616 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital	Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, Sch Vet Med, 1120 Haring Hall,1 Shields Ave, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/AAV-6774-2021; Pessah, Isaac N/K-7985-2017; Giulivi, Cecilia/ABB-7809-2020; Napoli, Eleonora/AAQ-6079-2021; Barrientos, Genaro/I-2778-2013	Pessah, Isaac N/0000-0002-8149-588X; Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; 	National Institutes of Health [012691, RC1DK087307]; NIEHS;  [2R0 AR043140];  [1P01 AR052354]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 012691 (to C. G.) and RC1DK087307 (to C. G.) from NIEHS and 2R0 AR043140 and 1P01 AR052354.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Aleman M, 2004, MUSCLE NERVE, V30, P356, DOI 10.1002/mus.20084; ALMARAZ L, 1989, FEBS LETT, V244, P417, DOI 10.1016/0014-5793(89)80575-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrienko T, 2003, J EXP BIOL, V206, P2059, DOI 10.1242/jeb.00242; Argaud L, 2008, AM J PHYSIOL-HEART C, V294, pH386, DOI 10.1152/ajpheart.01035.2007; Ashcroft S. J. H., 2002, Biochemical Society Transactions, V30, pA114; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Bina S, 2006, ANESTHESIOLOGY, V104, P90, DOI 10.1097/00000542-200601000-00015; Bizeau ME, 1998, J APPL PHYSIOL, V85, P1279, DOI 10.1152/jappl.1998.85.4.1279; BOCEK RM, 1966, AM J PHYSIOL, V210, P1108, DOI 10.1152/ajplegacy.1966.210.5.1108; BOCEK RM, 1966, AM J PHYSIOL, V210, P1101, DOI 10.1152/ajplegacy.1966.210.5.1101; BOCEK RM, 1966, J HISTOCHEM CYTOCHEM, V14, P549, DOI 10.1177/14.7.549; BOLENDER RP, 1978, J CELL BIOL, V77, P565, DOI 10.1083/jcb.77.2.565; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; BOOKELMAN H, 1978, BIOCHEM MED METAB B, V20, P404, DOI 10.1016/0006-2944(78)90090-X; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Britt B. A., 1973, INT S MALIGNANT HYPE, P387; BRITT BA, 1973, CAN ANAESTH SOC J, V20, P431, DOI 10.1007/BF03026208; Bruton JD, 1999, P NATL ACAD SCI USA, V96, P3281, DOI 10.1073/pnas.96.6.3281; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; BULLOCK GR, 1973, BIOCHIM BIOPHYS ACTA, V292, P350, DOI 10.1016/0005-2728(73)90041-8; BYRNE E, 1985, J NEUROL SCI, V69, P319, DOI 10.1016/0022-510X(85)90143-1; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; CAMPBELL IT, 1981, ANESTHESIOLOGY, V55, P46, DOI 10.1097/00000542-198107000-00010; Mulero M, 2007, BBA-MOL CELL RES, V1773, P330, DOI 10.1016/j.bbamcr.2006.12.007; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0; CHANCE B, 1959, CIBA F S REGULATION, P91; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Cherednichenko G, 2004, P NATL ACAD SCI USA, V101, P15793, DOI 10.1073/pnas.0403485101; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Cross HR, 2002, J MOL CELL CARDIOL, V34, P361, DOI 10.1006/jmcc.2001.1518; Crossthwaite AJ, 2002, J NEUROCHEM, V80, P24, DOI 10.1046/j.0022-3042.2001.00637.x; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; Delp MD, 1996, J APPL PHYSIOL, V80, P261, DOI 10.1152/jappl.1996.80.1.261; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DENBOROUGH MA, 1970, LANCET, V1, P1137; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DUBOWITZ V, 1960, LANCET, V2, P23; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Elfering SL, 2004, AM J PHYSIOL-HEART C, V286, pH22, DOI 10.1152/ajpheart.00766.2003; ELLIS FR, 1973, P ROY SOC MED, V66, P66, DOI 10.1177/00359157730661P132; Engstrom I, 1996, SCAND J CLIN LAB INV, V56, P345, DOI 10.3109/00365519609090586; Espinosa A, 2004, J ENDOCRINOL, V182, P339, DOI 10.1677/joe.0.1820339; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; EVERTS ME, 1993, ACTA PHYSIOL SCAND, V147, P357, DOI 10.1111/j.1748-1716.1993.tb09512.x; FENG L, 1992, CELL CALCIUM, V13, P79, DOI 10.1016/0143-4160(92)90001-9; FENOGLIO JJ, 1977, AM J PATHOL, V89, P51; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FOSTER PS, 1989, MUSCLE NERVE, V12, P390, DOI 10.1002/mus.880120509; Fujisawa Y, 2009, BIOCHEM J, V423, P219, DOI 10.1042/BJ20090594; GAZZOTTI P, 1985, BIOCHEM BIOPH RES CO, V127, P358, DOI 10.1016/S0006-291X(85)80167-4; Gellerich FN, 2002, BBA-BIOENERGETICS, V1556, P41, DOI 10.1016/S0005-2728(02)00305-5; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; GIULIVI C, 2003, SIGNAL TRANSDUCTION, P311; Gubern C, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-57; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1287, DOI 10.1152/ajpcell.00567.2004; Hannken T, 2000, J AM SOC NEPHROL, V11, P1387, DOI 10.1681/ASN.V1181387; HARIGAYA S, 1968, J BIOCHEM-TOKYO, V63, P324; Hatefi Y, 1978, Methods Enzymol, V53, P21; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HEDMAN R, 1962, BIOCHEM BIOPH RES CO, V8, P314, DOI 10.1016/0006-291X(62)90285-1; Hollander AS, 2003, PEDIATRICS, V111, P1447, DOI 10.1542/peds.111.6.1447; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Imai K, 2006, BIOCHEM BIOPH RES CO, V351, P595, DOI 10.1016/j.bbrc.2006.10.056; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Jungbluth Heinz, 2004, Neuromuscul Disord, V14, P754, DOI 10.1016/j.nmd.2004.07.007; Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D; Kilbane BJ, 2006, PEDIATR CRIT CARE ME, V7, P169, DOI 10.1097/01.PCC.0000192340.09136.82; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; LEBARON FN, 1959, J NEUROCHEM, V4, P1, DOI 10.1111/j.1471-4159.1959.tb13168.x; Leblondel G, 2001, BIOL TRACE ELEM RES, V83, P191, DOI 10.1385/BTER:83:3:191; LEBLONDEL G, 1988, BIOL TRACE ELEM RES, V16, P115, DOI 10.1007/BF02797096; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9; Long YC, 2007, J BIOL CHEM, V282, P1607, DOI 10.1074/jbc.M609208200; Lopez JR, 2005, AM J PHYSIOL-CELL PH, V288, pC606, DOI 10.1152/ajpcell.00297.2004; MANNESCHI L, 1995, J NEUROL SCI, V128, P151, DOI 10.1016/0022-510X(94)00227-F; MARBAN E, 1980, NATURE, V286, P845, DOI 10.1038/286845a0; MAX SR, 1972, ANAL BIOCHEM, V46, P576, DOI 10.1016/0003-2697(72)90328-4; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Mezin P, 1997, BRIT J ANAESTH, V79, P327, DOI 10.1093/bja/79.3.327; MEZON BJ, 1974, CAN J BIOCHEM CELL B, V52, P1024, DOI 10.1139/o74-143; MICKELSON JR, 1980, ANAL BIOCHEM, V109, P255, DOI 10.1016/0003-2697(80)90645-4; Missihoun C, 2009, MOL CELL BIOCHEM, V321, P45, DOI 10.1007/s11010-008-9908-0; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mu XD, 2007, PHYSIOL GENOMICS, V30, P300, DOI 10.1152/physiolgenomics.00286.2006; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; NISHIYAMA A, 1966, ACTA MED OKAYAMA, V20, P137; OBRIEN PJ, 1990, RES VET SCI, V48, P124, DOI 10.1016/S0034-5288(18)31522-4; OBRIEN PJ, 1990, CAN J VET RES, V54, P83; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; PAYEN JF, 1993, ANESTHESIOLOGY, V78, P848, DOI 10.1097/00000542-199305000-00007; PAYEN JF, 1991, LANCET, V337, P1550, DOI 10.1016/0140-6736(91)93247-7; PETER JB, 1967, BIOCHEM BIOPH RES CO, V29, P430, DOI 10.1016/0006-291X(67)90475-5; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Rasmussen HN, 1997, ANAL BIOCHEM, V252, P153, DOI 10.1006/abio.1997.2304; Rasmussen HN, 1997, MOL CELL BIOCHEM, V174, P55, DOI 10.1023/A:1006851705996; Ritov VB, 2010, AM J PHYSIOL-ENDOC M, V298, pE49, DOI 10.1152/ajpendo.00317.2009; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Robinson RL, 2002, HUM MUTAT, V20, P88, DOI 10.1002/humu.10098; Ross-Inta C, 2008, BIOSCIENCE REP, V28, P239, DOI 10.1042/BSR20080090; Rueffert H, 2004, AM J MED GENET A, V124A, P248, DOI 10.1002/ajmg.a.20404; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sahlin K, 2002, J PHYSIOL-LONDON, V541, P569, DOI 10.1113/jphysiol.2002.016683; Sambuughin N, 2001, AM J HUM GENET, V69, P204, DOI 10.1086/321270; Sarkela TM, 2001, J BIOL CHEM, V276, P6945, DOI 10.1074/jbc.M007625200; SCHILLER HH, 1974, J NEUROL SCI, V21, P93, DOI 10.1016/0022-510X(74)90109-9; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shi H, 2007, AM J PHYSIOL-CELL PH, V292, pC1681, DOI 10.1152/ajpcell.00466.2006; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004; SHY GM, 1956, BRAIN, V79, P610, DOI 10.1093/brain/79.4.610; SMITH MJH, 1956, BIOCHEM J, V63, P524, DOI 10.1042/bj0630524; Szalai G, 2000, J BIOL CHEM, V275, P15305, DOI 10.1074/jbc.275.20.15305; TAYLOR WM, 1980, BIOCHEM J, V188, P443, DOI 10.1042/bj1880443; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005; VALLIERES J, 1975, ARCH BIOCHEM BIOPHYS, V170, P659, DOI 10.1016/0003-9861(75)90162-9; Venkatraman R., 2006, Indian Journal of Pediatrics, V73, P55, DOI 10.1007/BF02758261; WANG JK, 1969, ANESTHESIOLOGY, V30, P439, DOI 10.1097/00000542-196904000-00015; Wappler F, 2001, EUR J ANAESTH, V18, P632, DOI 10.1046/j.1365-2346.2001.00888.x; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390; WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764; WILSON RD, 1971, SOUTHERN MED J, V64, P411, DOI 10.1097/00007611-197104000-00006; Wright DC, 2004, LIFE SCI, V74, P815, DOI 10.1016/j.lfs.2003.06.041; WROGEMANN K, 1973, ARCH BIOCHEM BIOPHYS, V159, P267, DOI 10.1016/0003-9861(73)90453-0; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yang TZ, 2003, J BIOL CHEM, V278, P25722, DOI 10.1074/jbc.M302165200; Yoshida M, 2006, AM J PHYSIOL-REG I, V290, pR449, DOI 10.1152/ajpregu.00684.2004; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhao P, 2008, EXP BIOL MED, V233, P1289, DOI 10.3181/0803-RM-84; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N; Zimmermann P, 2000, LIFE SCI, V67, P949, DOI 10.1016/S0024-3205(00)00688-3	160	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					99	113		10.1074/jbc.M110.153247	http://dx.doi.org/10.1074/jbc.M110.153247			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978128	hybrid, Green Published			2022-12-27	WOS:000285782800011
J	Lin, DYW; Diao, JB; Zhou, DG; Chen, J				Lin, David Yin-wei; Diao, Jianbo; Zhou, Daoguo; Chen, Jue			Biochemical and Structural Studies of a HECT-like Ubiquitin Ligase from Escherichia coli O157:H7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III SECRETION EFFECTORS; PROTEIN-KINASE; HOST; INSIGHTS; MECHANISMS; VIRULENCE; FAMILY; ENZYME	Many microbial pathogens deliver effector proteins via the type III secretion system into infected host cells. Elucidating the function of these effectors is essential for our understanding of pathogenesis. Here, we describe biochemical and structural characterization of an effector protein (NleL) from Escherichia coli O157:H7, a widespread pathogen causing severe foodborne diseases. We show that NleL functionally and structurally mimics eukaryotic HECT E3 ligases and catalyzes formation of unanchored polyubiquitin chains using Lys(6) and Lys(48) linkage. The catalytic cysteine residue forms a thioester intermediate with ubiquitin. The structure of NleL contains two domains, a beta-helix domain formed by pentapeptide repeats and a bilobed catalytic domain reminiscent of the N- and C-lobe architecture of HECT E3s. Six structures of NleL observed in two crystal forms revealed a large range of different positions of the C-lobe relative to the N-lobe, indicating that the helix linking the two lobes is extremely flexible. Comparing the structure of NleL with that of the Salmonella homolog SopA showed that the orientation of the C-lobes differ by as much as 108, suggesting that large movements of the C-lobe may be required to facilitate the transfer of ubiquitin from E2 to the substrate. These results provide critical knowledge toward understanding the molecular mechanism by which pathogens utilize the host ubiquitination system during infection.	[Lin, David Yin-wei; Zhou, Daoguo; Chen, Jue] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Chen, Jue] Howard Hughes Med Inst, W Lafayette, IN 47907 USA; [Diao, Jianbo] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Howard Hughes Medical Institute; Fudan University	Chen, J (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	chenjue@purdue.edu		Lin, David/0000-0001-6149-5236	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Howard Hughes Medical Institute.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 1998, PROTEIN SCI, V7, P1477, DOI 10.1002/pro.5560070625; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; DeLano W.L, PYMOL MOL GRAPHICS S; Deng WY, 2010, J BIOL CHEM, V285, P6790, DOI 10.1074/jbc.M109.086603; Diao J, 2008, NAT STRUCT MOL BIOL, V15, P65, DOI 10.1038/nsmb1346; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREEMONT PS, 1993, ANN NY ACAD SCI, V684, P174, DOI 10.1111/j.1749-6632.1993.tb32280.x; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hicks SW, 2010, CURR OPIN MICROBIOL, V13, P41, DOI 10.1016/j.mib.2009.11.008; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munro P, 2007, CURR OPIN MICROBIOL, V10, P39, DOI 10.1016/j.mib.2006.11.002; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Porwollik S, 2003, MICROBES INFECT, V5, P977, DOI 10.1016/S1286-4579(03)00186-2; Quezada CM, 2009, P NATL ACAD SCI USA, V106, P4864, DOI 10.1073/pnas.0811058106; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Rosebrock TR, 2007, NATURE, V448, P370, DOI 10.1038/nature05966; Singer AU, 2008, NAT STRUCT MOL BIOL, V15, P1293, DOI 10.1038/nsmb.1511; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vetting MW, 2006, BIOCHEMISTRY-US, V45, P1, DOI 10.1021/bi052130w; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Zhang Y, 2006, ACTA CRYSTALLOGR E, V62, pM490, DOI 10.1107/S1600536806004442; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	44	56	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					441	449		10.1074/jbc.M110.167643	http://dx.doi.org/10.1074/jbc.M110.167643			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980253	hybrid, Green Published			2022-12-27	WOS:000285782800047
J	Shi, YJ; Frost, P; Hoang, B; Benavides, A; Gera, J; Lichtenstein, A				Shi, Yijiang; Frost, Patrick; Hoang, Bao; Benavides, Angelica; Gera, Joseph; Lichtenstein, Alan			IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells CRITICAL ROLE OF CYTOPLASMIC LOCALIZATION OF THE RNA-BINDING PROTEIN hnRNP A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-A1; TRANS-ACTING FACTOR; HNRNP A1; SITE FUNCTION; PROTEINS; RELOCALIZATION; ACTIVATION; INITIATION; EXPRESSION	Prior work indicates that IL-6 can stimulate c-Myc expression in multiple myeloma (MM) cells, which is independent of effects on transcription and due to enhanced translation mediated by an internal ribosome entry site in the 5'-UTR of the c-Myc RNA. The RNA-binding protein hnRNP A1 (A1) was also critical to IL-6-stimulated translation. Because A1 shuttles between nucleus and cytoplasm, we investigated whether the ability of IL-6 to enhance Myc translation was mediated by stimulation of A1 shuttling. In MM cell lines and primary specimens, IL-6 increased A1 cytoplasmic localization. In contrast, there was no effect on the total cellular levels of A1. Use of a dominant negative A1 construct, which prevents endogenous A1 from nucleus-to-cytoplasm transit, prevented the ability of IL-6 to enhance Myc internal ribosome entry site activity, Myc protein expression, and MM cell growth. IL-6-stimulated cytoplasmic localization was mediated by alterations in the C-terminal M9 peptide of A1, and this correlated with the ability of IL-6 to induce serine phosphorylation of this domain. A p38 kinase inhibitor prevented IL-6-induced A1 phosphorylation. Thus, IL-6 activates c-Myc translation in MM cells by inducing A1 phosphorylation and cytoplasmic localization in a p38-dependent fashion. These data suggest A1 as a potential therapeutic target in MM.	[Shi, Yijiang; Frost, Patrick; Hoang, Bao; Benavides, Angelica; Gera, Joseph; Lichtenstein, Alan] Univ Calif Los Angeles, Div Hematol Oncol, Greater Los Angeles Vet Affairs Healthcare Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90073 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Lichtenstein, A (corresponding author), W Los Angeles VA Hosp, W111H,11301 Wilshire Blvd, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Frost, Patrick/0000-0003-3348-5983; Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [RO1 CA109312, RO1 CA111448]; Department of Defense; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA111448, R01CA109312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA109312 and RO1 CA111448. This work was also supported by research funds from the Department of Defense and the Department of Veterans Affairs.	Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Avet-Loiseau H, 2001, BLOOD, V98, P3082, DOI 10.1182/blood.V98.10.3082; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Cammas A, 2007, MOL BIOL CELL, V18, P5048, DOI 10.1091/mbc.E07-06-0603; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Cheung WC, 2002, LEUKEMIA, V16, P1182, DOI 10.1038/sj.leu.2402481; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; David CJ, 2010, NATURE, V463, P364, DOI 10.1038/nature08697; Greco C, 2006, INT J IMMUNOPATH PH, V19, P67; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; HAMILTON BJ, 1993, J BIOL CHEM, V268, P8881; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Matter N, 2000, J BIOL CHEM, V275, P35353, DOI 10.1074/jbc.M004692200; MELAMED D, 1993, MOL CELL BIOL, V13, P5255, DOI 10.1128/MCB.13.9.5255; MICHAEL WM, 1995, CELL, V83, P415; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Patry C, 2004, MOL CANCER THER, V3, P1193; Patry C, 2003, CANCER RES, V63, P7679; Paulin FEM, 1996, ONCOGENE, V13, P505; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shi YY, 2002, J BIOL CHEM, V277, P15712, DOI 10.1074/jbc.M200043200; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vincent T, 2004, LEUKEMIA, V18, P967, DOI 10.1038/sj.leu.2403333; Zhang J, 2009, CANCER RES, V69, P5082, DOI 10.1158/0008-5472.CAN-08-4603; Zinszner H, 1997, J CELL SCI, V110, P1741	38	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					67	78		10.1074/jbc.M110.153221	http://dx.doi.org/10.1074/jbc.M110.153221			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974848	Green Published, hybrid			2022-12-27	WOS:000285782800008
J	Swenerton, RK; Zhang, SY; Sajid, M; Medzihradszky, KF; Craik, CS; Kelly, BL; McKerrow, JH				Swenerton, Ryan K.; Zhang, Shuyi; Sajid, Mohammed; Medzihradszky, Katalin F.; Craik, Charles S.; Kelly, Ben L.; McKerrow, James H.			The Oligopeptidase B of Leishmania Regulates Parasite Enolase and Immune Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED GENE DELETION; CYSTEINE PROTEASES; TRYPANOSOMA-CRUZI; MOLECULAR-CLONING; CELL INVASION; PLASMINOGEN; IDENTIFICATION; PROMASTIGOTES; INHIBITORS; PEPTIDASE	Proteases are a ubiquitous group of enzymes that play key roles in the life cycle of parasites, in the host-parasite relationship, and in the pathogenesis of parasitic diseases. Furthermore, proteases are targets for the development of new antiparasitic therapy. Protozoan parasites like Leishmania predominantly express Clan CA cysteine proteases for key life cycle functions. It was therefore unexpected to find a high level of serine protease activity expressed by Leishmania donovani. Purification of this activity followed by mass spectrometry identified oligopeptidase B (OPB; Clan SC, family S9A) as the responsible enzyme. This was confirmed by gene knock-out of OPB, which resulted in the disappearance of the detected serine protease activity of Leishmania extracts. To delineate the specific role of OPB in parasite physiology, proteomic analysis was carried out on OPB(-/-) versus wild type parasites. Four protein species were significantly elevated in OPB(-/-) parasites, and all four were identified by mass spectrometry as enolase. This increased enolase was enzymatically inactive and associated with the parasite membrane. Aside from its classic role in carbohydrate metabolism, enolase was recently found to localize to membranes, where it binds host plasminogen and functions as a virulence factor for several pathogens. As expected, there was a striking alteration in macrophage responses to Leishmania when OPB was deleted. Whereas wild type parasites elicited little, if any, response from infected macrophages, OPB(-/-) parasites induced a massive up-regulation in gene transcription. Additionally, these OPB(-/-) parasites displayed decreased virulence in the murine footpad infection model.	[Swenerton, Ryan K.; Zhang, Shuyi; Sajid, Mohammed; Kelly, Ben L.; McKerrow, James H.] Univ Calif San Francisco, Dept Pathol, Sandler Ctr Drug Discovery, San Francisco, CA 94158 USA; [Medzihradszky, Katalin F.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Sajid, Mohammed] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Kelly, Ben L.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA 70112 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	McKerrow, JH (corresponding author), 1700 4th St,Box 2550,UCSF QB3, San Francisco, CA 94158 USA.	James.McKerrow@ucsf.edu		Swenerton, Ryan/0000-0002-0994-752X	National Institutes of Health (NIH) [AI35707]; National Science Foundation; Sandler Foundation; NIH National Center for Research Resources (NCRR), NIH NCRR [P41RR001614, RR012961]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR012961, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035707] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Sandler Foundation; NIH National Center for Research Resources (NCRR), NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant AI35707. This work was also supported by a National Science Foundation graduate research fellowship and the Sandler Foundation. Mass spectrometry analysis was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California (San Francisco, CA) (A. L. Burlingame, Director), supported by the Biomedical Research Technology Program of the NIH National Center for Research Resources (NCRR), NIH NCRR Grant P41RR001614, and NIH NCRR Grant RR012961.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Avilan L, 2000, MOL BIOCHEM PARASIT, V110, P183, DOI 10.1016/S0166-6851(00)00269-3; Bal G, 2003, BIOORG MED CHEM LETT, V13, P2875, DOI 10.1016/S0960-894X(03)00579-1; Bogdan C, 1998, INT J PARASITOL, V28, P121, DOI 10.1016/S0020-7519(97)00169-0; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; BUTTON LL, 1989, MOL BIOCHEM PARASIT, V32, P271, DOI 10.1016/0166-6851(89)90076-5; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Guedes HLD, 2007, PARASITOL RES, V101, P853, DOI [10.1007/s00436-007-0630-8, 10.1007/s00436-007-0552-5]; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; Guedes HLM, 2007, Z NATURFORSCH C, V62, P373; Hansell E, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000262; Hide M, 2008, PARASITOL RES, V103, P989, DOI 10.1007/s00436-008-1062-9; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Joshi PB, 1998, MOL MICROBIOL, V27, P519, DOI 10.1046/j.1365-2958.1998.00689.x; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; LACALLE RA, 1989, GENE, V79, P375, DOI 10.1016/0378-1119(89)90220-5; Maldonado J, 2006, EXP MOL PATHOL, V80, P289, DOI 10.1016/j.yexmp.2005.06.005; MANIATIS T, 1982, MOL CLONING LAB MANU; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McKerrow JH, 2008, CURR OPIN INFECT DIS, V21, P668, DOI 10.1097/QCO.0b013e328315cca9; MEDINAACOSTA E, 1993, MOL BIOCHEM PARASIT, V59, P327, DOI 10.1016/0166-6851(93)90231-L; Morty RE, 1999, J BIOL CHEM, V274, P26149, DOI 10.1074/jbc.274.37.26149; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Mottram JC, 2004, CURR OPIN MICROBIOL, V7, P375, DOI 10.1016/j.mib.2004.06.010; O'Brien TC, 2008, J BIOL CHEM, V283, P28934, DOI 10.1074/jbc.M805824200; Pal-Bhowmick I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-45; Polgar L, 1997, PROTEINS, V28, P375; Que XC, 2000, CLIN MICROBIOL REV, V13, P196, DOI 10.1128/CMR.13.2.196-206.2000; Quinones W, 2007, EXP PARASITOL, V116, P241, DOI 10.1016/j.exppara.2007.01.008; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; SACKS DL, 1985, J IMMUNOL, V135, P564; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Silva-Lopez RE, 2007, PARASITOL RES, V101, P1627, DOI 10.1007/s00436-007-0706-5; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; WALLIS AE, 1987, J EXP MED, V166, P1814, DOI 10.1084/jem.166.6.1814; Yoshida N, 2006, AN ACAD BRAS CIENC, V78, P87, DOI 10.1590/S0001-37652006000100010; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	44	69	70	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					429	440		10.1074/jbc.M110.138313	http://dx.doi.org/10.1074/jbc.M110.138313			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20961853	hybrid, Green Published			2022-12-27	WOS:000285782800046
J	Abdul-Sater, AA; Said-Sadier, N; Lam, VM; Singh, B; Pettengill, MA; Soares, F; Tattoli, I; Lipinski, S; Girardin, SE; Rosenstiel, P; Ojcius, DM				Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Soares, Fraser; Tattoli, Ivan; Lipinski, Simone; Girardin, Stephen E.; Rosenstiel, Philip; Ojcius, David M.			Enhancement of Reactive Oxygen Species Production and Chlamydial Infection by the Mitochondrial Nod-like Family Member NLRX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH OXIDASE; TRACHOMATIS INCLUSION; MURIDARUM INFECTION; ACTIVATION; PNEUMONIAE; RECEPTOR; CELLS; MEMBRANE; PATHWAYS; SURVIVAL	Chlamydia trachomatis infections cause severe and irreversible damage that can lead to infertility and blindness in both males and females. Following infection of epithelial cells, Chlamydia induces production of reactive oxygen species (ROS). Unconventionally, Chlamydiae use ROS to their advantage by activating caspase-1, which contributes to chlamydial growth. NLRX1, a member of the Nod-like receptor family that translocates to the mitochondria, can augment ROS production from the mitochondria following Shigella flexneri infections. However, in general, ROS can also be produced by membrane-bound NADPH oxidases. Given the importance of ROS-induced caspase-1 activation in growth of the chlamydial vacuole, we investigated the sources of ROS production in epithelial cells following infection with C. trachomatis. In this study, we provide evidence that basal levels of ROS are generated during chlamydial infection by NADPH oxidase, but ROS levels, regardless of their source, are enhanced by an NLRX1-dependent mechanism. Significantly, the presence of NLRX1 is required for optimal chlamydial growth.	[Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Ojcius, David M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Abdul-Sater, Ali A.; Said-Sadier, Najwane; Lam, Verissa M.; Singh, Bhavni; Pettengill, Matthew A.; Ojcius, David M.] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA; [Soares, Fraser; Tattoli, Ivan; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lipinski, Simone; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of California System; University of California Merced; University of California System; University of California Merced; University of Toronto; University of Kiel	Ojcius, DM (corresponding author), Univ Calif, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	david.ojcius@gmail.com	Ojcius, David/ABE-6557-2020; Rosenstiel, Philip/A-5137-2009; Lipinski, Simone/L-9818-2017; Lipinski, Simone/HHY-9238-2022; Tattoli, Ivan/H-2600-2017	Rosenstiel, Philip/0000-0002-9692-8828; Lipinski, Simone/0000-0002-9322-7372; Tattoli, Ivan/0000-0001-7925-4609; Pettengill, Matthew/0000-0002-4579-0187; Ojcius, David/0000-0003-1461-4495	NIAID NIH HHS [R01 AI079004] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079004] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Azenabor AA, 2005, MED MICROBIOL IMMUN, V194, P91, DOI 10.1007/s00430-004-0223-4; Bavoil PM, 2000, MICROBIOL-UK, V146, P2723, DOI 10.1099/00221287-146-11-2723; Belland R, 2004, NAT REV MICROBIOL, V2, P530, DOI 10.1038/nrmicro931; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buss C, 2010, J IMMUNOL, V184, P3072, DOI 10.4049/jimmunol.0902947; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Kalvegren H, 2005, THROMB HAEMOSTASIS, V94, P327, DOI 10.1160/TH04-06-0360; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; McClarty Grant, 1994, Trends in Microbiology, V2, P157, DOI 10.1016/0966-842X(94)90665-3; Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Ojcius DM, 1996, RES IMMUNOL, V147, P175, DOI 10.1016/0923-2494(96)83169-5; Ojcius DM, 1998, J BIOL CHEM, V273, P7052, DOI 10.1074/jbc.273.12.7052; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Perfettini JL, 2003, J BIOL CHEM, V278, P9496, DOI 10.1074/jbc.M211275200; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Shinohara M, 2010, J BIOL CHEM, V285, P4481, DOI 10.1074/jbc.M109.071779; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Takeya R, 2006, METHOD ENZYMOL, V406, P456, DOI 10.1016/S0076-6879(06)06034-4; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wyrick PB, 2000, CELL MICROBIOL, V2, P275, DOI 10.1046/j.1462-5822.2000.00059.x; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	40	102	106	4	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41637	41645		10.1074/jbc.M110.137885	http://dx.doi.org/10.1074/jbc.M110.137885			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959452	hybrid, Green Published			2022-12-27	WOS:000285622600051
J	Bolourani, P; Spiegelman, G; Weeks, G				Bolourani, Parvin; Spiegelman, George; Weeks, Gerald			Determinants of RasC Specificity during Dictyostelium Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RELAY; ACTIVATION; TRANSFORMATION; CHEMOTAXIS; DISCOIDEUM; EXPRESSION; KINASE	RasC is required for optimum activation of adenylyl cyclase A and for aggregate stream formation during the early differentiation of Dictyostelium discoideum. RasG is unable to substitute for this requirement despite its sequence similarity to RasC. A critical question is which amino acids in RasC are required for its specific function. Each of the amino acids within the switch 1 and 2 domains in the N-terminal portion of RasG was changed to the corresponding amino acid from RasC, and the ability of the mutated RasG protein to reverse the phenotype of rasC(-) cells was determined. Only the change from aspartate at position 30 of RasG to alanine (the equivalent position 31 in RasC) resulted in a significant increase in adenylyl cyclase A activation and a partial reversal of the aggregation-deficient phenotype of rasC(-) cells. All other single amino acid changes were without effect. Expression of a chimeric protein, RasG(1-77)-RasC(79-189), also resulted in a partial reversal of the rasC(-) cell phenotype, indicating the importance of the C-terminal portion of RasC. Furthermore, expression of the chimeric protein, with alanine changed to aspartate (RasG(1-77(D30A))-RasC(79-189)), resulted in a full rescue the rasC(-) aggregation-deficient phenotype. Finally, the expression of either a mutated RasC, with the aspartate 31 replaced by alanine, or the chimeric protein, RasC(1-78)-RasG(78-189), only generated a partial rescue. These results emphasize the importance of both the single amino acid at position 31 and the C-terminal sequence for the specific function of RasC during Dictyostelium aggregation.	[Bolourani, Parvin; Spiegelman, George; Weeks, Gerald] Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Weeks, G (corresponding author), Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	gerwee@interchange.ubc.ca			Canadian Institute of Health Research	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute of Health Research (to G. W.).	Alibaud L, 2003, BIOTECHNIQUES, V35, P78, DOI 10.2144/03351st03; Biou V, 2004, BIOCHEMISTRY-US, V43, P6833, DOI 10.1021/bi049630u; Bolourani P, 2008, J BIOL CHEM, V283, P10232, DOI 10.1074/jbc.M707459200; Bolourani P, 2006, MOL BIOL CELL, V17, P4543, DOI 10.1091/mbc.E05-11-1019; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Chubb JR, 2001, BBA-GEN SUBJECTS, V1525, P262, DOI 10.1016/S0304-4165(01)00111-8; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; KHOSLA M, 1990, MOL CELL BIOL, V10, P918, DOI 10.1128/MCB.10.3.918; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997, DOI 10.1128/MCB.11.8.3997; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Reuther GW, 2000, CURR OPIN CELL BIOL, V12, P157, DOI 10.1016/S0955-0674(99)00071-X; ROBBINS SM, 1989, P NATL ACAD SCI USA, V86, P938, DOI 10.1073/pnas.86.3.938; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; SAMBROOK J, 1989, MOL CLONING LAB MANU, V18, P47; THIERY R, 1992, BIOCHEM CELL BIOL, V70, P1193, DOI 10.1139/o92-165; Tuxworth RI, 1997, J CELL BIOL, V138, P605, DOI 10.1083/jcb.138.3.605; VANHAASTERT PJM, 1984, J GEN MICROBIOL, V130, P2559; Weeks G., 2005, DICTYOSTELIUM GENOMI, P211; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	27	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41374	41379		10.1074/jbc.M110.181115	http://dx.doi.org/10.1074/jbc.M110.181115			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971846	hybrid, Green Published			2022-12-27	WOS:000285622600023
J	Ferreira, R; Xapelli, S; Santos, T; Silva, AP; Cristovao, A; Cortes, L; Malva, JO				Ferreira, Raquel; Xapelli, Sara; Santos, Tiago; Silva, Ana Paula; Cristovao, Armando; Cortes, Luisa; Malva, Joao O.			Neuropeptide Y Modulation of Interleukin-1 beta (IL-1 beta)-induced Nitric Oxide Production in Microglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; MESSENGER-RNA EXPRESSION; TOLL-LIKE RECEPTORS; NF-KAPPA-B; INFLAMMATORY NEURODEGENERATION; GENE-TRANSCRIPTION; BRAIN INFLAMMATION; IL-1-BETA RELEASE; NPY	Given the modulatory role of neuropeptide Y (NPY) in the immune system, we investigated the effect of NPY on the production of NO and IL-1 beta in microglia. Upon LPS stimulation, NPY treatment inhibited NO production as well as the expression of inducible nitric-oxide synthase (iNOS). Pharmacological studies with a selective Y-1 receptor agonist and selective antagonists for Y-1, Y-2, and Y-5 receptors demonstrated that inhibition of NO production and iNOS expression was mediated exclusively through Y-1 receptor activation. Microglial cells stimulated with LPS and ATP responded with a massive release of IL-1 beta, as measured by ELISA. NPY inhibited this effect, suggesting that it can strongly impair the release of IL-1 beta. Furthermore, we observed that IL-1 beta stimulation induced NO production and that the use of a selective IL-1 receptor antagonist prevented NO production upon LPS stimulation. Moreover, NPY acting through Y1 receptor inhibited LPS-stimulated release of IL-1 beta, inhibiting NO synthesis. IL-1 beta activation of NF-kappa B was inhibited by NPY treatment, as observed by confocal microscopy and Western blotting analysis of nuclear translocation of NF-kappa B p65 subunit, leading to the decrease of NO synthesis. Our results showed that upon LPS challenge, microglial cells release IL-1 beta, promoting the production of NO through a NF-kappa B-dependent pathway. Also, NPY was able to strongly inhibit NO synthesis through Y1 receptor activation, which prevents IL-1 beta release and thus inhibits nuclear translocation of NF-kappa B. The role of NPY in key inflammatory events may contribute to unravel novel gateways to modulate inflammation associated with brain pathology.	[Malva, Joao O.] Univ Coimbra, Inst Biochem, Fac Med, P-3004504 Coimbra, Portugal; [Malva, Joao O.] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004504 Coimbra, Portugal; [Silva, Ana Paula] Univ Coimbra, Inst Pharmacol & Expt Therapeut, P-3004504 Coimbra, Portugal; [Silva, Ana Paula] Univ Coimbra, Inst Biomed Res Light & Image, P-3004504 Coimbra, Portugal; [Cristovao, Armando] Univ Coimbra, Dept Life Sci, P-3004504 Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Malva, JO (corresponding author), Univ Coimbra, Inst Biochem, Fac Med, P-3004504 Coimbra, Portugal.	jomalva@fmed.uc.pt	Ferreira, Raquel/AAA-7401-2021; Silva, Ana Paula/L-4184-2014; Cortes, Luisa/F-7349-2014; Cristóvão, Armando J/N-2612-2013; Malva, Joao/L-3557-2014	Ferreira, Raquel/0000-0003-1014-0499; Silva, Ana Paula/0000-0002-7802-8690; Cortes, Luisa/0000-0001-5292-4369; Cristóvão, Armando J/0000-0002-4090-3269; Santos, Tiago/0000-0003-0237-499X; Xapelli, Sara/0000-0001-6854-2509; Malva, Joao/0000-0002-5438-4447	Fundacao para a Ciencia e a Tecnologia Portugal; Fundo-Europeu-De-Desenvolvimento-Regional Grants [PTDC/SAU-NEU/68465/2006, PTDC/SAU-OSM/101469/2008, SFRH/BD/23595/2005]	Fundacao para a Ciencia e a Tecnologia Portugal(Portuguese Foundation for Science and Technology); Fundo-Europeu-De-Desenvolvimento-Regional Grants	This work was supported by the Fundacao para a Ciencia e a Tecnologia Portugal and Fundo-Europeu-De-Desenvolvimento-Regional Grants PTDC/SAU-NEU/68465/2006, PTDC/SAU-OSM/101469/2008 and SFRH/BD/23595/2005.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Agasse F, 2008, STEM CELLS, V26, P1636, DOI 10.1634/stemcells.2008-0056; Akama KT, 2000, J BIOL CHEM, V275, P7918, DOI 10.1074/jbc.275.11.7918; Allan SM, 2004, METH MOLEC MED, V104, P333; Allan SM, 2003, PHILOS T R SOC B, V358, P1669, DOI 10.1098/rstb.2003.1358; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; Bal-Price A, 2001, J NEUROSCI, V21, P6480; BALL HJ, 1995, J BIOL CHEM, V270, P27272, DOI 10.1074/jbc.270.45.27272; Bedoui S, 2004, TRENDS IMMUNOL, V25, P508, DOI 10.1016/j.it.2004.08.005; Bedoui S, 2003, J NEUROIMMUNOL, V134, P1, DOI 10.1016/S0165-5728(02)00424-1; Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451; Bedoui S, 2007, PEPTIDES, V28, P373, DOI 10.1016/j.peptides.2006.07.029; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bernardino Lifiana, 2007, P3; Bernardino L, 2008, J NEUROCHEM, V106, P271, DOI 10.1111/j.1471-4159.2008.05387.x; Bianco F, 2006, J NEUROCHEM, V99, P745, DOI 10.1111/j.1471-4159.2006.04101.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Brakch N, 2002, J NEUROCHEM, V81, P1166, DOI 10.1046/j.1471-4159.2002.00919.x; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Cervin A, 1999, AM J RESP CRIT CARE, V160, P1724, DOI 10.1164/ajrccm.160.5.9902102; Choi J, 2008, YONSEI MED J, V49, P1, DOI 10.3349/ymj.2008.49.1.1; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; De la Fuente M, 2001, J NEUROIMMUNOL, V116, P156, DOI 10.1016/S0165-5728(01)00297-1; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P527, DOI 10.1016/0306-4522(86)90056-4; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P545, DOI 10.1016/0306-4522(86)90057-6; Dimayuga FO, 2007, J NEUROIMMUNOL, V182, P89, DOI 10.1016/j.jneuroim.2006.10.003; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Ferrari D, 1997, J IMMUNOL, V159, P1451; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI DOI 10.1002/CBER.187901201117; GRIFFITHS RJ, 1995, J IMMUNOL, V154, P2821; Hagberg H, 2005, CURR OPIN NEUROL, V18, P117, DOI 10.1097/01.wco.0000162851.44897.8f; Hassani H, 2005, AM J PHYSIOL-GASTR L, V288, pG550, DOI 10.1152/ajpgi.00182.2004; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hernanz A, 2003, REGUL PEPTIDES, V115, P19, DOI 10.1016/S0167-0115(03)00127-7; Howell OW, 2003, J NEUROCHEM, V86, P646, DOI 10.1046/j.1471-4159.2003.01895.x; Hu SX, 1999, J NEUROSCI, V19, P6468; HUYGEN IC, 1970, ANAL CHEM, V42, P407; Inoue K, 1998, PHARMACOL RES, V38, P323, DOI 10.1006/phrs.1998.0382; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; Liu B, 2002, ANN NY ACAD SCI, V962, P318, DOI 10.1111/j.1749-6632.2002.tb04077.x; Minghetti L, 2005, BRAIN RES REV, V48, P251, DOI 10.1016/j.brainresrev.2004.12.015; Mollace V, 1997, BIOCHEM BIOPH RES CO, V238, P916, DOI 10.1006/bbrc.1997.7155; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Mukaida N, 1996, J LEUKOCYTE BIOL, V59, P145, DOI 10.1002/jlb.59.2.145; Murphy S, 1996, NEUROSCIENTIST, V2, P90, DOI 10.1177/107385849600200210; Musso R, 1997, MOL PHARMACOL, V51, P27, DOI 10.1124/mol.51.1.27; Nave H, 2004, J NEUROIMMUNOL, V155, P1, DOI 10.1016/j.jneuroim.2004.05.009; Naveilhan P, 1998, NEUROSCIENCE, V87, P289, DOI 10.1016/S0306-4522(98)00141-9; Ohtani Y, 2000, NEUROSCI LETT, V293, P72, DOI 10.1016/S0304-3940(00)01478-6; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PETITTO JM, 1994, J NEUROIMMUNOL, V54, P81, DOI 10.1016/0165-5728(94)90234-8; Pinheiro PS, 2005, NEUROCHEM INT, V47, P309, DOI 10.1016/j.neuint.2005.05.007; Pinteaux E, 2009, CYTOKINE, V45, P1, DOI 10.1016/j.cyto.2008.10.008; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Santos AE, 2001, J NEUROSCI RES, V66, P643, DOI 10.1002/jnr.10036; Schroeder RA, 1999, AM J PHYSIOL-CELL PH, V277, pC523, DOI 10.1152/ajpcell.1999.277.3.C523; Silva AP, 2003, FASEB J, V17, P1118, DOI 10.1096/fj.02-0885fje; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Teixeira L, 2009, J CELL BIOCHEM, V107, P908, DOI 10.1002/jcb.22194; Teng XW, 2002, AM J PHYSIOL-CELL PH, V282, pC144, DOI 10.1152/ajpcell.2002.282.1.C144; Thorsell A, 2002, NEUROPEPTIDES, V36, P182, DOI 10.1054/npep.2002.0897; Turrin NP, 2006, MOL NEUROBIOL, V34, P221, DOI 10.1385/MN:34:3:221; Vetvicka V, 1999, CLIN EXP IMMUNOL, V115, P229, DOI 10.1046/j.1365-2249.1999.00800.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Watterson DM, 2001, NEUROCHEM INT, V39, P459, DOI 10.1016/S0197-0186(01)00053-5; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Wheway J, 2007, PEPTIDES, V28, P453, DOI 10.1016/j.peptides.2006.09.030; Xapelli S, 2008, EUR J NEUROSCI, V27, P2089, DOI 10.1111/j.1460-9568.2008.06172.x	77	89	92	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41921	41934		10.1074/jbc.M110.164020	http://dx.doi.org/10.1074/jbc.M110.164020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959451	Green Published, hybrid			2022-12-27	WOS:000285622600079
J	Greene, MW; Burrington, CM; Ruhoff, MS; Johnson, AK; Chongkrairatanakul, T; Kangwanpornsiri, A				Greene, Michael W.; Burrington, Christine M.; Ruhoff, Mary S.; Johnson, Andrew K.; Chongkrairatanakul, Tepsiri; Kangwanpornsiri, Atipon			PKC delta Is Activated in a Dietary Model of Steatohepatitis and Regulates Endoplasmic Reticulum Stress and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; FATTY LIVER-DISEASE; HEPATIC INSULIN-RESISTANCE; CHOLINE-DEFICIENT DIET; NONALCOHOLIC STEATOHEPATITIS; CHEMICAL CHAPERONES; ER STRESS; PHOSPHATIDYLINOSITOL 3-KINASE; RAT HEPATOCYTES; METHIONINE	Hepatic steatosis can progress to the clinical condition of non-alcoholic steatohepatitis (NASH), which is a precursor of more serious liver diseases. The novel PKC isoforms delta and epsilon are activated by lipid metabolites and have been implicated in lipid-induced hepatic disease. Using a methionine-and choline- deficient (MCD) dietary model of NASH, we addressed the question of whether hepatic PKC delta and PKC epsilon are activated. With progression from steatosis to steatohepatitis, there was activation and increased PKC delta protein content coincident with hepatic endoplasmic reticulum (ER) stress parameters. To examine whether similar changes could be induced in vitro, McA-RH 7777 (McA) hepatoma cells were used. We observed that McA cells stored triglyceride and released alanine aminotransferase (ALT) when treated with MCD medium in the presence of fatty acids. Further, MCD medium with palmitic acid, but not oleic or linoleic acids, maximally activated PKC delta and stimulated ER stress. In PKC delta knockdown McA cells, MCD/fatty acid medium-induced ALT release and ER stress induction were completely blocked, but triglyceride storage was not. In addition, a reduction in the uptake of propidium iodide and the number of apoptotic nuclei and a significant increase in cell viability and DNA content were observed in PKC delta knockdown McA cells incubated in MCD medium with palmitic acid. Our studies show that PKC delta activation and protein levels are elevated in an animal model of steatohepatitis, which was recapitulated in a cell model, supporting the conclusion that PKC delta plays a role in ALT release, the ER stress signal, and cell death.	[Greene, Michael W.] Bassett Res Inst, Cooperstown, NY 13326 USA; [Chongkrairatanakul, Tepsiri; Kangwanpornsiri, Atipon] Bassett Healthcare Network, Dept Internal Med, Bassett Med Ctr, Cooperstown, NY 13326 USA		Greene, MW (corresponding author), Bassett Res Inst, 1 Atwell Rd, Cooperstown, NY 13326 USA.	michael.greene@bassett.org	Greene, Michael/L-6174-2019	Greene, Michael/0000-0002-6443-8269	Stephen C.Clark Fund; E.Donnall Thomas Resident Research Fund	Stephen C.Clark Fund; E.Donnall Thomas Resident Research Fund	This work was supported by the Stephen C.Clark Fund (to M. W. G.) and the E.Donnall Thomas Resident Research Fund (to A. K. and T. C.).	Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Chang YC, 2010, BIOCHEMISTRY-US, V49, P5086, DOI 10.1021/bi100222h; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Greene MW, 2010, CELL SIGNAL, V22, P274, DOI 10.1016/j.cellsig.2009.09.029; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hansson PK, 2004, BBA-MOL CELL BIOL L, V1684, P54, DOI 10.1016/j.bbalip.2004.06.005; Henkel AS, 2009, J BIOL CHEM, V284, P31807, DOI 10.1074/jbc.M109.017970; Itani S, 2002, DIABETES, V51, pA300; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kirsch R, 2003, J GASTROEN HEPATOL, V18, P1272, DOI 10.1046/j.1440-1746.2003.03198.x; Kohli R, 2007, J BIOL CHEM, V282, P21327, DOI 10.1074/jbc.M701759200; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Lin SL, 2009, PROTEIN SCI, V18, P526, DOI 10.1002/pro.52; Medkova M, 1998, BIOCHEMISTRY-US, V37, P4892, DOI 10.1021/bi972495j; Melowic HR, 2007, J BIOL CHEM, V282, P21467, DOI 10.1074/jbc.M700119200; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohmori S, 1998, MOL CELL BIOL, V18, P5263, DOI 10.1128/MCB.18.9.5263; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Qi X, 2007, J MOL CELL CARDIOL, V43, P420, DOI 10.1016/j.yjmcc.2007.07.061; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rizki G, 2006, J LIPID RES, V47, P2280, DOI 10.1194/jlr.M600198-JLR200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sahai A, 2006, AM J PHYSIOL-GASTR L, V291, pG55, DOI 10.1152/ajpgi.00360.2005; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Shepshelovich J, 2005, J CELL SCI, V118, P1577, DOI 10.1242/jcs.02294; Shin OH, 1997, J CELL BIOCHEM, V64, P196, DOI 10.1002/(SICI)1097-4644(199702)64:2<196::AID-JCB3>3.0.CO;2-S; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570; Wei H, 2008, HUM MOL GENET, V17, P469, DOI 10.1093/hmg/ddm324; Wei Y, 2007, MOL CELL BIOCHEM, V303, P105, DOI 10.1007/s11010-007-9461-2; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yen CLE, 2002, J NUTR, V132, P1840, DOI 10.1093/jn/132.7.1840	55	41	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42115	42129		10.1074/jbc.M110.168575	http://dx.doi.org/10.1074/jbc.M110.168575			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20971848	Green Published, hybrid			2022-12-27	WOS:000285622600096
J	Deng, WH; Garrett, C; Dombert, B; Soura, V; Bank, G; Fishe, EMC; van der Brug, MP; Hafezparast, M				Deng, Wenhan; Garrett, Caroline; Dombert, Benjamin; Soura, Violetta; Bank, Gareth; Fishe, Elizabeth M. C.; van der Brug, Marcel P.; Hafezparast, Majid			Neurodegenerative Mutation in Cytoplasmic Dynein Alters Its Organization and Dynein-Dynactin and Dynein-Kinesin Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT INTERMEDIATE CHAIN; MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; IN-VIVO; SUBUNIT; PROTEIN; PHOSPHORYLATION; MICROTUBULES; BINDING; LC8	A single amino acid change, F580Y (Legs at odd angles (Loa), Dync1h1(Loa)), in the highly conserved and overlapping homodimerization, intermediate chain, and light intermediate chain binding domain of the cytoplasmic dynein heavy chain can cause severe motor and sensory neuron loss in mice. The mechanism by which the Loa mutation impairs the neuron-specific functions of dynein is not understood. To elucidate the underlying molecular mechanisms of neurodegeneration arising from this mutation, we applied a cohort of biochemical methods combined with in vivo assays to systemically study the effects of the mutation on the assembly of dynein and its interaction with dynactin. We found that the Loa mutation in the heavy chain leads to increased affinity of this subunit of cytoplasmic dynein to light intermediate and a population of intermediate chains and a suppressed association of dynactin to dynein. These data suggest that the Loa mutation drives the assembly of cytoplasmic dynein toward a complex with lower affinity to dynactin and thus impairing transport of cargos that tether to the complex via dynactin. In addition, we detected up-regulation of kinesin light chain 1 (KLC1) and its increased association with dynein but reduced microtubule-associated KLC1 in the Loa samples. We provide a model describing how up-regulation of KLC1 and its interaction with cytoplasmic dynein in Loa could play a regulatory role in restoring the retrograde and anterograde transport in the Loa neurons.	[Deng, Wenhan; Garrett, Caroline; Dombert, Benjamin; Soura, Violetta; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England; [Bank, Gareth; Fishe, Elizabeth M. C.] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [van der Brug, Marcel P.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA	University of Sussex; University of London; University College London; Scripps Research Institute	Hafezparast, M (corresponding author), Univ Sussex, Sch Life Sci, Brighton BN1 9QG, E Sussex, England.	M.Hafezparast@sussex.ac.uk	Hafezparast, Majid/H-6728-2018; Hafezparast, Majid/N-8292-2019; Fisher, Elizabeth MC/C-2168-2008	Hafezparast, Majid/0000-0002-5262-7150; Fisher, Elizabeth MC/0000-0003-2850-9936; Banks, Gareth/0000-0002-8647-667X	European Union; University of Sussex; BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [G0500288] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0500288] Funding Source: researchfish	European Union(European Commission); University of Sussex; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (to M. H., W. D., and C. G.), the Wellcome Trust (to G. B.), the ENDOCYTE Research and Training Network funded by the European Union (to E. M. C. F.), and the University of Sussex (to V.S.).	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cai DW, 2007, J CELL BIOL, V176, P51, DOI 10.1083/jcb.200605097; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; Dell KR, 2000, TRAFFIC, V1, P38, DOI 10.1034/j.1600-0854.2000.010107.x; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; DILLMAN JF, 1994, J CELL BIOL, V127, P1671, DOI 10.1083/jcb.127.6.1671; El-Kadi AM, 2010, J BIOL CHEM, V285, P18627, DOI 10.1074/jbc.M110.129320; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Eyckerman Sven, 2002, Sci STKE, V2002, ppl18; GILL SR, 1994, MOL BIOL CELL, V5, P645, DOI 10.1091/mbc.5.6.645; Hackney DD, 2008, BIOCHEMISTRY-US, V47, P7770, DOI 10.1021/bi8006687; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; King SM, 2000, J CELL SCI, V113, P2521; Kuta A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011682; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; NEELY MD, 1990, J BIOL CHEM, V265, P8691; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Pfister KK, 1999, MOL NEUROBIOL, V20, P81, DOI 10.1007/BF02742435; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Susalka SJ, 2000, J NEUROCYTOL, V29, P819, DOI 10.1023/A:1010995408343; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; WOYNIAK MJ, 2006, EMBO J, V25, P5457; Yamada M, 2010, EMBO J, V29, P517, DOI 10.1038/emboj.2009.378	51	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39922	39934		10.1074/jbc.M110.178087	http://dx.doi.org/10.1074/jbc.M110.178087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20889981	Green Published, hybrid			2022-12-27	WOS:000285185500037
J	Perrotta, C; Bizzozero, L; Cazzato, D; Morlacchi, S; Assi, E; Simbari, F; Zhang, Y; Gulbins, E; Bassi, MT; Rosa, P; Clementi, E				Perrotta, Cristiana; Bizzozero, Laura; Cazzato, Denise; Morlacchi, Sara; Assi, Emma; Simbari, Fabio; Zhang, Yang; Gulbins, Erich; Bassi, Maria Teresa; Rosa, Patrizia; Clementi, Emilio			Syntaxin 4 Is Required for Acid Sphingomyelinase Activity and Apoptotic Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; DENDRITIC CELLS; T-LYMPHOCYTES; LIPID RAFTS; MOUSE MODEL; ACTIVATION; CERAMIDE; PATHWAY; INHIBITION; DEATH	Acid sphingomyelinase (A-SMase) is an important enzyme in sphingolipid metabolism and plays key roles in apoptosis, immunity, development, and cancer. In addition, it mediates cytotoxicity of cisplatin and some other chemotherapeutic drugs. The mechanism of A-SMase activation is still undefined. We now demonstrate that, upon CD95 stimulation, A-SMase is activated through translocation from intracellular compartments to the plasma membrane in an exocytic pathway requiring the t-SNARE protein syntaxin 4. Indeed, down-regulation of syntaxin 4 inhibits A-SMase translocation and activation induced by CD95 stimulation. This leads to inhibition of the CD95-triggered signaling events, including caspase 3 and 9 activation and apoptosis, activation of the survival pathway involving the protein kinase Akt, and important changes in cell cycle and proliferation. The molecular interaction between A-SMase and syntaxin 4 was not known and clarifies the mechanism of A-SMase activation. The novel actions of syntaxin 4 in sphingolipid metabolism and exocytosis we describe here define signaling mechanisms of broad relevance in cell pathophysiology.	[Perrotta, Cristiana; Bizzozero, Laura; Morlacchi, Sara; Assi, Emma; Clementi, Emilio] Univ Milan, Dept Clin Sci, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, I-20157 Milan, Italy; [Cazzato, Denise; Bassi, Maria Teresa; Clementi, Emilio] E Medea Sci Inst, I-23842 Bosisio Parini, Lecco, Italy; [Simbari, Fabio] Inst Adv Chem Catalonia CSIC, Dept Biomed Chem, Barcelona, Spain; [Zhang, Yang; Gulbins, Erich] Univ Duisburg Essen, Ctr Med Biol, D-45122 Essen, Germany; [Zhang, Yang; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, D-45122 Essen, Germany; [Rosa, Patrizia] CNR, Inst Neurosci, Dept Med Pharmacol, I-20129 Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; Consejo Superior de Investigaciones Cientificas (CSIC); University of Duisburg Essen; University of Duisburg Essen; Consiglio Nazionale delle Ricerche (CNR)	Clementi, E (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	emilio.clementi@unimi.it	Perrotta, Cristiana/I-2835-2016; Bassi, Maria Teresa T/A-3517-2014; Gulbins, Erich/L-6989-2014; PERROTTA, CRISTIANA/A-9179-2010	Perrotta, Cristiana/0000-0001-6680-4536; Bassi, Maria Teresa T/0000-0002-8236-1197; Gulbins, Erich/0000-0002-3117-1342; Bizzozero, Laura/0000-0003-2038-7356; Rosa, Patrizia/0000-0002-2590-6955	Italian Association of Cancer Research; Italian Ministry of Research; Fondazione Cariplo; Fondazione Romeo and Enrica Invernizzi; Deutsche Forschungsgemeinschaft [GU335/21-1]; Italian Ministry of Health	Italian Association of Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo(Fondazione Cariplo); Fondazione Romeo and Enrica Invernizzi; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by grants from the Italian Association of Cancer Research (to E.C.), the Italian Ministry of Research Programmi di Ricerca di Rilevante Interesse Nazionale 2007 (to E.C.), Fondazione Cariplo (to E.C.), Fondazione Romeo and Enrica Invernizzi (to E.C.), Deutsche Forschungsgemeinschaft Grant GU335/21-1 (to E.G.), Italian Ministry of Health Ricerca Finalizzata 2007 (to M.T.B. and E.C.), and Ricerca Corrente 2010 (to M.T.B. and E.C.).	Algeciras-Schimnich A, 2002, MOL CELL BIOL, V22, P207, DOI 10.1128/MCB.22.1.207-220.2002; Band AM, 2002, FEBS LETT, V531, P513, DOI 10.1016/S0014-5793(02)03605-0; Barsacchi R, 2002, CELL DEATH DIFFER, V9, P1248, DOI 10.1038/sj.cdd.4401095; Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Calegari F, 1999, J BIOL CHEM, V274, P22539, DOI 10.1074/jbc.274.32.22539; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Degli Esposti M, 2009, MOL BIOL CELL, V20, P600, DOI 10.1091/mbc.E08-09-0925; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Faustino RS, 2008, J LIPID RES, V49, P654, DOI 10.1194/jlr.M700464-JLR200; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Henriques-Pons A, 2009, J CARDIOVASC PHARM, V53, P94, DOI 10.1097/FJC.0b013e318198fe46; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Hong WJ, 2005, TRENDS CELL BIOL, V15, P644, DOI 10.1016/j.tcb.2005.10.003; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Marchesini N, 2004, BIOCHEM CELL BIOL, V82, P27, DOI 10.1139/o03-091; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Ng CG, 2006, J VIROL, V80, P10989, DOI 10.1128/JVI.01154-06; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peraud A, 1999, LAB INVEST, V79, P123; Perrotta C, 2004, CANCER RES, V64, P3767, DOI 10.1158/0008-5472.CAN-04-0668; Perrotta C, 2007, CANCER RES, V67, P7559, DOI 10.1158/0008-5472.CAN-07-0309; Pizzo P, 2007, TRENDS CELL BIOL, V17, P511, DOI 10.1016/j.tcb.2007.07.011; Poonia B, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-91; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schubert KM, 2000, J BIOL CHEM, V275, P13330, DOI 10.1074/jbc.275.18.13330; Sciorati C, 1997, J BIOL CHEM, V272, P23211, DOI 10.1074/jbc.272.37.23211; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Wiegmann K, 1999, J BIOL CHEM, V274, P5267, DOI 10.1074/jbc.274.9.5267; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	40	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40240	40251		10.1074/jbc.M110.139287	http://dx.doi.org/10.1074/jbc.M110.139287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956541	hybrid, Green Published			2022-12-27	WOS:000285185500068
J	Zhou, Q; Fan, JJ; Ding, XB; Peng, WX; Yu, XQ; Chen, YQ; Nie, J				Zhou, Qin; Fan, Jinjin; Ding, Xuebing; Peng, Wenxing; Yu, Xueqing; Chen, Yueqin; Nie, Jing			TGF-beta-induced MiR-491-5p Expression Promotes Par-3 Degradation in Rat Proximal Tubular Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL TRANSITION; TIGHT JUNCTIONS; MICRORNAS; INHIBITION; MECHANISM; FIBROSIS; POLARITY; RNA; MICROARRAY	Par-3 is a component of Par complex, which is critical for the integrity of tight junction. We previously reported that TGF-beta down-regulated Par-3 expression in rat proximal tubular epithelial cells, but the underlying mechanism remains unknown. In the present study, we demonstrated by a luciferase reporter assay that miR-491-5p down-regulated the luciferase activity through a binding site in the 3' UTR of Par-3. Overexpression of miR-491-5p dramatically decreased the expression of endogenous Par-3, disrupted tight junction, and resulted in decreased transepithelial resistance. Moreover, miR-491-5p expression was induced by TGF-beta 1 through the MEK/p38 MAPK pathway. Importantly, miR-491-5p levels were increased significantly in a rat model of obstructive nephropathy, in parallel with decreased Par-3 levels. Taken together, we conclude that up-regulation of miR-491-5p contributes to TGF-beta-regulated Par-3 expression. Our study uncovered a novel mechanism by which TGF-beta disrupts cell junction.	Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Yueqin] Sun Yat Sen Univ, State Key Lab Biocontrol, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Nie, J (corresponding author), Zhongshan 2nd Rd 58, Guangzhou 510080, Guangdong, Peoples R China.	niejing@mail.sysu.edu.cn		Zhou, Qin/0000-0002-7205-082X	National Science Foundation of China [30871033]; Natural Science Foundation of Guangdong province [8251008901000014]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by National Science Foundation of China Grant 30871033 and Natural Science Foundation of Guangdong province Grant 8251008901000014.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO;2-M; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen XY, 2006, J CELL BIOL, V172, P671, DOI 10.1083/jcb.200510061; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Iden S, 2006, EMBO REP, V7, P1239, DOI 10.1038/sj.embor.7400819; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kojima R, 2010, J IMMUNOL, V184, P5253, DOI 10.4049/jimmunol.0901298; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; NAKANO H, 2009, INT J CANCER, V27, P1072; Ooshio' T, 2007, J CELL SCI, V120, P2352, DOI 10.1242/jcs.03470; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vidyasagar A, 2008, AM J PHYSIOL-RENAL, V295, pF707, DOI 10.1152/ajprenal.90240.2008; Wang XY, 2008, BBA-MOL BASIS DIS, V1782, P51, DOI 10.1016/j.bbadis.2007.11.002; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Zavadil J, 2007, CELLS TISSUES ORGANS, V185, P157, DOI 10.1159/000101316; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	36	46	50	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40019	40027		10.1074/jbc.M110.141341	http://dx.doi.org/10.1074/jbc.M110.141341			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20966078	hybrid, Green Published			2022-12-27	WOS:000285185500047
J	Minagawa, H; Watanabe, A; Akatsu, H; Adachi, K; Ohtsuka, C; Terayama, Y; Hosono, T; Takahashi, S; Wakita, H; Jung, CG; Komano, H; Michikawa, M				Minagawa, Hirohisa; Watanabe, Atsushi; Akatsu, Hiroyasu; Adachi, Kayo; Ohtsuka, Chigumi; Terayama, Yasuo; Hosono, Takashi; Takahashi, Satoshi; Wakita, Hideaki; Jung, Cha-Gyun; Komano, Hiroto; Michikawa, Makoto			Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCK-IN MICE; PLASMA HOMOCYSTEINE; LIPID RELEASE; A-BETA; APOE; BRAIN; HYPERHOMOCYSTEINEMIA; ASTROCYTES; NEURONS; TRANSTHYRETIN	Apolipoprotein E (apoE) epsilon 4 and hyperhomocysteinemia are risk factors for Alzheimer disease (AD). The dimerization of apoE3 by disulfide bonds between cysteine residues enhances apoE3 function to generate HDL. Because homocysteine (Hcy) harbors a thiol group, we examined whether Hcy interferes with the dimerization of apoE3 and thereby impairs apoE3 function. We found that Hcy inhibits the dimerization of apoE3 and reduces apoE3-mediated HDL generation to a level similar to that by apoE4, whereas Hcy does not affect apoE4 function. Western blot analysis of cerebrospinal fluid showed that the ratio of apoE3 dimers was significantly lower in the samples from the patients with hyperhomocysteinemia than in those that from control subjects. Hyperhomocysteinemia induced by subcutaneous injection of Hcy to apoE3 knock-in mice decreased the level of the apoE3 dimer in the brain homogenate. Because apoE-HDL plays a role in amyloid beta-protein clearance, these results suggest that two different risk factors, apoE4 and hyperhomocysteinemia, may share a common mechanism that accelerates the pathogenesis of AD in terms of reduced HDL generation.	[Hosono, Takashi; Jung, Cha-Gyun] Natl Ctr Geriatr & Gerontol, Dept Alzheimer Dis Res, Aichi 4748511, Japan; [Watanabe, Atsushi; Adachi, Kayo; Wakita, Hideaki] Natl Ctr Geriatr & Gerontol, Dept Cognit Brain Sci, Aichi 4748511, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Ohtsuka, Chigumi; Terayama, Yasuo; Takahashi, Satoshi] Iwate Med Univ, Sch Med, Dept Neurol & Gerontol, Shiwa, Iwate 0283694, Japan; [Komano, Hiroto] Iwate Med Univ, Sch Pharm, Dept Neurosci, Shiwa, Iwate 0283694, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Iwate Medical University; Iwate Medical University		michi@ncgg.go.jp	Watanabe, Atsushi/AAU-8018-2020	Jung, Cha-Gyun/0000-0002-0225-0658	Ministry of Health, Labor and Welfare of Japan [H20-007]; National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science and Technology of Japan [20023040]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Health, Labor and Welfare of Japan Comprehensive Research on Aging and Health Grant H20-007, the Program for Promotion of Fundamental Studies in Health of the National Institute of Biomedical Innovation (NIBIO), and Grant-in-aid for Scientific Research on Priority Areas 20023040 (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Altenburg M, 2007, J BIOL CHEM, V282, P7817, DOI 10.1074/jbc.M610712200; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9; Gong JS, 2002, J BIOL CHEM, V277, P29919, DOI 10.1074/jbc.M203934200; Guthikonda S, 1999, CURR OPIN CARDIOL, V14, P283, DOI 10.1097/00001573-199907000-00002; Hamanaka H, 2000, HUM MOL GENET, V9, P353, DOI 10.1093/hmg/9.3.353; Hara M, 2003, ARTERIOSCL THROM VAS, V23, P269, DOI 10.1161/01.ATV.0000054199.78458.4B; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Isobe C, 2005, LIFE SCI, V77, P1836, DOI 10.1016/j.lfs.2005.02.014; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kamath AF, 2006, BLOOD, V107, P591, DOI 10.1182/blood-2005-06-2506; Kim NK, 2003, NEUROLOGY, V61, P1595, DOI 10.1212/01.WNL.0000096010.98989.49; Kolovou GD, 2007, AGEING RES REV, V6, P94, DOI 10.1016/j.arr.2006.11.001; Krimbou L, 2004, J LIPID RES, V45, P839, DOI 10.1194/jlr.M300418-JLR200; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Lim A, 2003, J BIOL CHEM, V278, P49707, DOI 10.1074/jbc.M306748200; Luchsinger JA, 2004, NEUROLOGY, V62, P1972, DOI 10.1212/01.WNL.0000129504.60409.88; Maler JM, 2003, NEUROSCI LETT, V347, P85, DOI 10.1016/S0304-3940(03)00655-4; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; Michikawa M, 2000, J NEUROCHEM, V74, P1008, DOI 10.1046/j.1471-4159.2000.0741008.x; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35; Pacheco-Quinto J, 2006, NEUROBIOL DIS, V22, P651, DOI 10.1016/j.nbd.2006.01.005; Perry IJ, 1999, J CARDIOVASC RISK, V6, P235; Ravaglia G, 2005, AM J CLIN NUTR, V82, P636, DOI 10.1093/ajcn/82.3.636; Sass JO, 2003, BIOCHEM BIOPH RES CO, V310, P242, DOI 10.1016/j.bbrc.2003.08.089; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; STARKEBAUM G, 1986, J CLIN INVEST, V77, P1370, DOI 10.1172/JCI112442; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Xu Q, 2004, J BIOL CHEM, V279, P25511, DOI 10.1074/jbc.M311256200; Zhang CE, 2009, AM J PATHOL, V174, P1481, DOI 10.2353/ajpath.2009.081036	35	30	32	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38382	38388		10.1074/jbc.M110.146258	http://dx.doi.org/10.1074/jbc.M110.146258			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889503	hybrid, Green Published			2022-12-27	WOS:000284625600044
J	Sadakata, T; Shinoda, Y; Sekine, Y; Saruta, C; Itakura, M; Takahashi, M; Furuichi, T				Sadakata, Tetsushi; Shinoda, Yo; Sekine, Yukiko; Saruta, Chihiro; Itakura, Makoto; Takahashi, Masami; Furuichi, Teiichi			Interaction of Calcium-dependent Activator Protein for Secretion 1 (CAPS1) with the Class II ADP-ribosylation Factor Small GTPases Is Required for Dense-core Vesicle Trafficking in the trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; ARF FAMILY; EXOCYTOSIS; MEMBRANE; LOCALIZATION; EXPRESSION; REGULATORS; RELEASE; DOMAINS; GROWTH	Ca2+-dependent activator protein for secretion (CAPS) regulates exocytosis of catecholamine-or neuropeptide-containing dense-core vesicles (DCVs) at secretion sites, such as nerve terminals. However, large amounts of CAPS protein are localized in the cell soma, and the role of somal CAPS protein remains unclear. The present study shows that somal CAPS1 plays an important role in DCV trafficking in the trans-Golgi network. The anti-CAPS1 antibody appeared to pull down membrane fractions, including many Golgi-associated proteins, such as ADP-ribosylation factor (ARF) small GTPases. Biochemical analyses of the protein-protein interaction showed that CAPS1 interacted specifically with the class II ARF4/ARF5, but not with other classes of ARFs, via the pleckstrin homology domain in a GDP-bound ARF form-specific manner. The pleckstrin homology domain of CAPS1 showed high affinity for the Golgi membrane, thereby recruiting ARF4/ARF5 to the Golgi complex. Knockdown of either CAPS1 or ARF4/ARF5 expression caused accumulation of chromogranin, a DCV marker protein, in the Golgi, thereby reducing its DCV secretion. In addition, the overexpression of CAPS1 binding-deficient ARF5 mutants induced aberrant chromogranin accumulation in the Golgi and consequently reduced its DCV secretion. These findings implicate a functional role for CAPS1 protein in the soma, a major subcellular localization site of CAPS1 in many cell types, in regulating DCV trafficking in the trans-Golgi network; this activity occurs via protein-protein interaction with ARF4/ARF5 in a GDP-dependent manner.	[Sadakata, Tetsushi; Shinoda, Yo; Sekine, Yukiko; Saruta, Chihiro; Furuichi, Teiichi] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Itakura, Makoto; Takahashi, Masami; Furuichi, Teiichi] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Itakura, Makoto; Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Kanagawa 2288555, Japan	RIKEN; Japan Science & Technology Agency (JST); Kitasato University	Furuichi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan.	tfuruichi@brain.riken.jp	Shinoda, Yo/H-3091-2019; Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888	Takeda Science Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kao Foundation for Arts and Sciences; Life Science Foundation of Japan; Japanese Ministry of Education, Culture, Sports, Science, and Technology [21700421]; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Institute of Physical and Chemical Research	Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kao Foundation for Arts and Sciences; Life Science Foundation of Japan(Life Science Foundation of Japan); Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Physical and Chemical Research	This work was supported by grants-in-aid for Scientific Research from the Takeda Science Foundation; the Naito Foundation; the Mochida Memorial Foundation for Medical and Pharmaceutical Research; the Kao Foundation for Arts and Sciences; the Life Science Foundation of Japan; the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grant 21700421), the Japan Science and Technology Agency; the Japan Society for the Promotion of Science; and the Institute of Physical and Chemical Research.	Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Brunk I, 2009, J BIOL CHEM, V284, P1050, DOI 10.1074/jbc.M805328200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Donaldson Julie G, 2002, Methods Mol Biol, V189, P191; Fujita Y, 2007, J BIOL CHEM, V282, P21392, DOI 10.1074/jbc.M703699200; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Grishanin RN, 2002, J BIOL CHEM, V277, P22025, DOI 10.1074/jbc.M201614200; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Jockusch WJ, 2007, CELL, V131, P796, DOI 10.1016/j.cell.2007.11.002; JOHN J, 1993, J BIOL CHEM, V268, P923; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Liu YY, 2008, J NEUROSCI, V28, P5594, DOI 10.1523/JNEUROSCI.5672-07.2008; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Renden R, 2001, NEURON, V31, P421, DOI 10.1016/S0896-6273(01)00382-8; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Sadakata T, 2006, J COMP NEUROL, V495, P735, DOI 10.1002/cne.20947; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Speidel D, 2003, J BIOL CHEM, V278, P52802, DOI 10.1074/jbc.M304727200; Speidel D, 2008, CELL METAB, V7, P57, DOI 10.1016/j.cmet.2007.11.009; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719	38	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38710	38719		10.1074/jbc.M110.137414	http://dx.doi.org/10.1074/jbc.M110.137414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921225	Green Published, hybrid			2022-12-27	WOS:000284625600076
J	Bhattacharyya, S; Dudeja, PK; Tobacman, JK				Bhattacharyya, Sumit; Dudeja, Pradeep K.; Tobacman, Joanne K.			Tumor Necrosis Factor alpha-induced Inflammation Is Increased but Apoptosis Is Inhibited by Common Food Additive Carrageenan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; DEATH DOMAIN; SIGNAL-TRANSDUCTION; PROTEIN; ACTIVATION; KINASE; RIP; PATHWAY; BCL10	Tumor necrosis factor (TNF)-alpha, a homotrimeric, pleiotropic cytokine, is secreted in response to inflammatory stimuli in diseases such as rheumatoid arthritis and inflammatory bowel disease. TNF-alpha mediates both apoptosis and inflammation, stimulating an inflammatory cascade through the non-canonical pathway of NF-kappa B activation, leading to increased nuclear RelB and p52. In contrast, the common food additive carrageenan (CGN) stimulates inflammation through both the canonical and non-canonical pathways of NF-kappa B activation and utilizes the adaptor molecule BCL10 (B-cell leukemia/lymphoma 10). In a series of experiments, colonic epithelial cells and mouse embryonic fibroblasts were treated with TNF-alpha and carrageenan in order to simulate the possible effects of exposure to dietary CGN in the setting of a TNF-alpha-mediated inflammatory disease process. A marked increase in secretion of IL-8 occurred, attributable to synergistic effects on phosphorylated NF-kappa B-inducing kinase (NIK) in the non-canonical pathway. TNF-alpha induced the ubiquitination of TRAF2 (TNF receptor-associated factor 2), which interacts with NIK, and CGN induced phosphorylation of BCL10, leading to increased NIK phosphorylation. These results suggest that TNF-alpha and CGN in combination act to increase NIK phosphorylation, thereby increasing activation of the non-canonical pathway of NF-kappa B activation. In contrast, the apoptotic effects of TNF-alpha, including activation of caspase-8 and PARP-1 (poly(ADP-ribose) polymerase 1) fragmentation, were markedly reduced in the presence of CGN, and CGN caused reduced expression of Fas. These findings demonstrate that exposure to CGN drives TNF-alpha-stimulated cells toward inflammation rather than toward apoptotic cell death and suggest that CGN exposure may compromise the effectiveness of anti-TNF-alpha/therapy.	[Bhattacharyya, Sumit; Dudeja, Pradeep K.; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Tobacman, Joanne K.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, 840 S Wood St,CSN 440 M-C 718, Chicago, IL 60612 USA.	jkt@uic.edu			Veterans Affairs Merit funds	Veterans Affairs Merit funds	This work was supported by Veterans Affairs Merit funds (to J. K. T.).	[Anonymous], 1983, IARC Monogr Eval Carcinog Risk Chem Hum, V31, P79; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Behm BW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006893; BENITZ KF, 1973, FOOD COSMET TOXICOL, V11, P565, DOI 10.1016/S0015-6264(73)80327-X; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, J IMMUNOASS IMMUNOCH, V28, P173, DOI 10.1080/15321810701454573; Bhattacharyya S, 2010, EXP CELL RES, V316, P3317, DOI 10.1016/j.yexcr.2010.05.004; Bhattacharyya S, 2010, J NUTR BIOCHEM, V21, P906, DOI 10.1016/j.jnutbio.2009.07.002; Bhattacharyya S, 2010, J BIOL CHEM, V285, P522, DOI 10.1074/jbc.M109.050815; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Ceccarelli M, 2009, J CELL MOL MED, V13, P2704, DOI 10.1111/j.1582-4934.2009.00658.x; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Chung JY, 2002, J CELL SCI, V115, P679; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; FAO/WHO, 2007, SUMM CONCL 68 M UN; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kollias G, 2002, CYTOKINE GROWTH F R, V13, P315, DOI 10.1016/S1359-6101(02)00019-9; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; MARCUS R, 1969, LANCET, V2, P489; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X; Mohamed AAA, 2002, BIOCHEM J, V366, P145, DOI 10.1042/BJ20020527; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Sfikakis PP, 2010, CURR DIR AUTOIMMUN, V11, P180, DOI 10.1159/000289205; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; TOBACMAN JK, 2003, REV FOOD NUTR TOXICI, V1, P204; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Weinlich R, 2010, CELL MOL LIFE SCI, V67, P1631, DOI 10.1007/s00018-010-0289-7; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; West J., 2001, AGAROPHYTES CARRAGEE, P286; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5	55	28	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39511	39522		10.1074/jbc.M110.159681	http://dx.doi.org/10.1074/jbc.M110.159681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937806	Green Published, hybrid			2022-12-27	WOS:000284941300077
J	Olafsen, T; Young, SG; Davies, BSJ; Beigneux, AP; Kenanova, VE; Voss, C; Young, G; Wong, KP; Barnes, RH; Tu, YP; Weinstein, MM; Nobumori, C; Huang, SC; Goldberg, IJ; Bensadoun, A; Wu, AM; Fong, LG				Olafsen, Tove; Young, Stephen G.; Davies, Brandon S. J.; Beigneux, Anne P.; Kenanova, Vania E.; Voss, Constance; Young, Glen; Wong, Koon-Pong; Barnes, Richard H., II; Tu, Yiping; Weinstein, Michael M.; Nobumori, Chika; Huang, Sung-Cheng; Goldberg, Ira J.; Bensadoun, Andre; Wu, Anna M.; Fong, Loren G.			Unexpected Expression Pattern for Glycosylphosphatidylinositol-anchored HDL-binding Protein 1 (GPIHBP1) in Mouse Tissues Revealed by Positron Emission Tomography Scanning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; LIPASE-DEFICIENT MICE; FC ANTIBODY FRAGMENTS; SEVERE HYPERTRIGLYCERIDEMIA; PHARMACOKINETICS; RELEASE; PLASMA; MUSCLE; LIVER	Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1), a GPI-anchored endothelial cell protein, binds lipoprotein lipase (LPL) and transports it into the lumen of capillaries where it hydrolyzes triglycerides in lipoproteins. GPIHBP1 is assumed to be expressed mainly within the heart, skeletal muscle, and adipose tissue, the sites where most lipolysis occurs, but the tissue pattern of GPIHBP1 expression has never been evaluated systematically. Because GPIHBP1 is found on the luminal face of capillaries, we predicted that it would be possible to define GPIHBP1 expression patterns with radiolabeled GPIHBP1-specific antibodies and positron emission tomography (PET) scanning. In Gpihbp1(-/-) mice, GPIHBP1-specific antibodies were cleared slowly from the blood, and PET imaging showed retention of the antibodies in the blood pools (heart and great vessels). In Gpihbp1(+/+) mice, the antibodies were cleared extremely rapidly from the blood and, to our surprise, were taken up mainly by lung and liver. Immunofluorescence microscopy confirmed the presence of GPIHBP1 in the capillary endothelium of both lung and liver. In most tissues with high levels of Gpihbp1 expression, Lpl expression was also high, but the lung was an exception (very high Gpihbp1 expression and extremely low Lpl expression). Despite low Lpl transcript levels, however, LPL protein was readily detectable in the lung, suggesting that some of that LPL originates elsewhere and then is captured by GPIHBP1 in the lung. In support of this concept, lung LPL levels were significantly lower in Gpihbp1(-/-) mice than in Gpihbp1(+/+) mice. In addition, Lpl(-/-) mice expressing human LPL exclusively in muscle contained high levels of human LPL in the lung.	[Olafsen, Tove; Kenanova, Vania E.; Wong, Koon-Pong; Huang, Sung-Cheng; Wu, Anna M.] Calif NanoSyst Inst, Crump Inst Mol Imaging, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Young, Stephen G.; Davies, Brandon S. J.; Beigneux, Anne P.; Voss, Constance; Young, Glen; Barnes, Richard H., II; Tu, Yiping; Nobumori, Chika; Fong, Loren G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Young, Stephen G.; Weinstein, Michael M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Huang, Sung-Cheng] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Goldberg, Ira J.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Cornell University	Young, SG (corresponding author), 675 Charles Young Dr S, Los Angeles, CA 90095 USA.	sgyoung@mednet.ucla.edu; lfong@mednet.ucla.edu	Wong, Koon-Pong/AAI-3780-2020	Young, Stephen/0000-0001-7270-3176; Davies, Brandon/0000-0002-7168-8522; Wu, Anna/0000-0001-8487-823X; Wong, Koon-Pong/0000-0002-6095-4645	National Institutes of Health [1RC1 HL100008, R01 HL094732, P01 HL090553, RO1 HL086683, R01 HL087228, R01 EB001943, P30 CA016042, U24 CA092865, R25 CA098010]; American Heart Association, Western States Affiliate; NATIONAL CANCER INSTITUTE [P30CA016042, R25CA098010, U24CA092865] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045095, P01HL090553, RC1HL100008, R01HL094732, R01HL087228, R01HL086683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association, Western States Affiliate(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC1 HL100008, R01 HL094732, P01 HL090553, RO1 HL086683, R01 HL087228, R01 EB001943, P30 CA016042, U24 CA092865, and R25 CA098010 and a grant from the American Heart Association, Western States Affiliate.	Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; BRUNZELL JD, 2001, METABOLIC MOL BASES; Cai WB, 2007, J NUCL MED, V48, P304; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; DOOLITTLE MH, 1987, J LIPID RES, V28, P1326; Ginzinger DG, 1999, EUR J CLIN INVEST, V29, P17, DOI 10.1046/j.1365-2362.1999.00435.x; Havel R.J., 2001, METABOLIC MOL BASES; Ioka RX, 2003, J BIOL CHEM, V278, P7344, DOI 10.1074/jbc.M211932200; Kenanova V, 2005, CANCER RES, V65, P622; Kenanova V, 2007, CANCER RES, V67, P718, DOI 10.1158/0008-5472.CAN-06-0454; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Olafsen T, 2005, CANCER RES, V65, P5907, DOI 10.1158/0008-5472.CAN-04-4472; Olafsen T, 2006, NAT PROTOC, V1, P2048, DOI 10.1038/nprot.2006.322; Strauss JG, 2001, J BIOL CHEM, V276, P36083, DOI 10.1074/jbc.M104430200; VILARO S, 1988, BIOCHIM BIOPHYS ACTA, V959, P106, DOI 10.1016/0005-2760(88)90021-5; WALLINDER L, 1984, BIOCHIM BIOPHYS ACTA, V795, P513, DOI 10.1016/0005-2760(84)90181-4; Weinstein MM, 2010, ARTERIOSCL THROM VAS, V30, P20, DOI 10.1161/ATVBAHA.109.196329; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Zhang XH, 2008, CIRC RES, V102, P250, DOI 10.1161/CIRCRESAHA.107.156554	23	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39239	39248		10.1074/jbc.M110.171041	http://dx.doi.org/10.1074/jbc.M110.171041			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889497	hybrid, Green Published			2022-12-27	WOS:000284941300053
J	Pardo, PS; Mohamed, JS; Lopez, MA; Boriek, AM				Pardo, Patricia S.; Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.			Induction of Sirt1 by Mechanical Stretch of Skeletal Muscle through the Early Response Factor EGR1 Triggers an Antioxidative Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; REACTIVE OXYGEN; FREE-RADICALS; EXERCISE; LONGEVITY; PROTEIN; PATHWAY; COMPLEX	Mechanical loading of muscles by intrinsic muscle activity or passive stretch leads to an increase in the production of reactive oxygen species (1, 2). The NAD-dependent protein deacetylase SIRT1 is involved in the protection against oxidative stress by enhancing FOXO-driven Sod2 transcription (3-5). In this report, we unravel a mechanism triggered by mechanical stretch of skeletal muscle cells that leads to an EGR1-dependent transcriptional activation of the Sirt1 gene. The resulting transient increase in SIRT1 expression generates an antioxidative response that contributes to reactive oxygen species scavenging.	[Pardo, Patricia S.; Mohamed, Junaith S.; Lopez, Michael A.; Boriek, Aladin M.] Baylor Coll Med, Dept Med, Div Pulm Crit Care Med & Sleep, Houston, TX 77030 USA	Baylor College of Medicine	Boriek, AM (corresponding author), 1 Baylor Plaza 825E, Houston, TX 77030 USA.	boriek@bcm.edu	Lopez, Michael A./AAT-2145-2021; Mohamed, Junaith/AAC-4050-2020	Lopez, Michael A./0000-0002-3029-0761; 	National Institutes of Health [HL63134]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL63134. This work was also supported by a grant from the National Science Foundation.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281; Hollander J, 2001, PFLUG ARCH EUR J PHY, V442, P426, DOI 10.1007/s004240100539; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Javesghani D, 2002, AM J RESP CRIT CARE, V165, P412, DOI 10.1164/ajrccm.165.3.2103028; Ji LL, 2008, FREE RADICAL BIO MED, V44, P142, DOI 10.1016/j.freeradbiomed.2007.02.031; JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kumar A, 2002, J BIOL CHEM, V277, P46493, DOI 10.1074/jbc.M203654200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Marfe Gabriella, 2010, BMC Physiology, V10, P7, DOI 10.1186/1472-6793-10-7; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nethery D, 2000, J APPL PHYSIOL, V89, P72, DOI 10.1152/jappl.2000.89.1.72; Pardo PS, 2008, AM J PHYSIOL-CELL PH, V294, pC1056, DOI 10.1152/ajpcell.00270.2007; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Reid MB, 2002, ANN NY ACAD SCI, V959, P108, DOI 10.1111/j.1749-6632.2002.tb02087.x; Reid MB, 2008, FREE RADICAL BIO MED, V44, P169, DOI 10.1016/j.freeradbiomed.2007.03.002; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468	35	59	64	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 28	2011	286	4					2559	2566		10.1074/jbc.M110.149153	http://dx.doi.org/10.1074/jbc.M110.149153			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	709TM	20971845	Green Published, hybrid			2022-12-27	WOS:000286464300021
J	Thompson, D; Whistler, JL				Thompson, Dawn; Whistler, Jennifer L.			Dopamine D-3 Receptors Are Down-regulated following Heterologous Endocytosis by a Specific Interaction with G Protein-coupled Receptor-associated Sorting Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; D2 RECEPTORS; DIFFERENTIAL REGULATION; BINDING; TRAFFICKING; PHOSPHORYLATION; DESENSITIZATION; SCHIZOPHRENIA; TOLERANCE; DISEASE	The D-3 dopamine receptor is endocytosed through a heterologous mechanism mediated by phorbol esters. Here, we show that following this endocytosis the D-3 dopamine receptors fail to recycle and are instead targeted for degradation through an interaction with the G protein-coupled receptor (GPCR)-associated sorting protein-1 (GASP-1). Furthermore, we identified a specific binding motif in the C terminus common to the D-3 and D-2 that confers GASP-1 binding. shRNA knockdown of GASP-1 delayed post-endocytic degradation of both the D-2 and D-3 dopamine receptors. In addition, mutation of the D-2 and D-3 receptor C termini to resemble the D-4, which does not interact with GASP-1, not only inhibited GASP-1 binding but slowed degradation after endocytosis. Conversely, mutation of the C terminus of the D-4 to resemble that of the D-2 and D-3 facilitated GASP-1 binding and promoted post-endocytic degradation of the mutant D-4 receptor. Thus, we have identified a motif that is both necessary and sufficient to promote GASP-1 binding and receptor degradation. In addition, these data demonstrated that GASP-1 can mediate post-endocytic degradation of dopamine receptors that have been endocytosed not only as a consequence of dopamine activation but also as a consequence of activation by phorbol esters.	[Thompson, Dawn; Whistler, Jennifer L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; [Whistler, Jennifer L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Ste 200, Emeryville, CA 94608 USA.	jwhistler@gallo.ucsf.edu			National Institutes of Health [R01MH068442]; State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01MH068442. This work was also supported by funds provided by the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (to J.L.W.).	Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Boileau I, 2009, BRAIN, V132, P1366, DOI 10.1093/brain/awn337; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Enquist J, 2007, MOL PHARMACOL, V71, P494, DOI 10.1124/mol.106.030858; Finn AK, 2001, NEURON, V32, P829, DOI 10.1016/S0896-6273(01)00517-7; FRIEDMAN E, 1993, BIOL PSYCHIAT, V33, P520, DOI 10.1016/0006-3223(93)90006-Y; Heydorn A, 2004, J BIOL CHEM, V279, P54291, DOI 10.1074/jbc.M406169200; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Martini L, 2010, NEUROPSYCHOPHARMACOL, V35, P1363, DOI 10.1038/npp.2010.6; Nader MA, 2006, NAT NEUROSCI, V9, P1050, DOI 10.1038/nn1737; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Quik M, 2000, NEUROSCIENCE, V98, P263, DOI 10.1016/S0306-4522(00)00130-5; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Seneca N, 2006, SYNAPSE, V59, P260, DOI 10.1002/syn.20238; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; Suhara T, 2002, ARCH GEN PSYCHIAT, V59, P25, DOI 10.1001/archpsyc.59.1.25; Talvik M, 2003, INT J NEUROPSYCHOPH, V6, P361, DOI 10.1017/S1461145703003699; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Tschische P, 2010, TRAFFIC, V11, P660, DOI 10.1111/j.1600-0854.2010.1045.x; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V116, P163, DOI 10.1016/S0925-4927(02)00087-2; Volkow ND, 2001, AM J PSYCHIAT, V158, P2015, DOI 10.1176/appi.ajp.158.12.2015; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	33	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1598	1608		10.1074/jbc.M110.158345	http://dx.doi.org/10.1074/jbc.M110.158345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030592	Green Published, hybrid			2022-12-27	WOS:000286005000072
J	Kienitz, MC; Bender, K; Dermietzel, R; Pott, L; Zoidl, G				Kienitz, Marie-Cecile; Bender, Kirsten; Dermietzel, Rolf; Pott, Lutz; Zoidl, Georg			Pannexin 1 Constitutes the Large Conductance Cation Channel of Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEINS; VENTRICULAR MYOCYTES; P2X(7) RECEPTOR; PLASMA-MEMBRANE; HEMICHANNELS; ATP; ACTIVATION; INHIBITION; EXPRESSION; RELEASE	A large conductance (similar to 300 picosiemens) channel (LCC) of unknown molecular identity, activated by Ca2+ release from the sarcoplasmic reticulum, particularly when augmented by caffeine, has been described previously in isolated cardiac myocytes. A potential candidate for this channel is pannexin 1 (Panx1), which has been shown to form large ion channels when expressed in Xenopus oocytes and mammalian cells. Panx1 function is implicated in ATP-mediated auto-/paracrine signaling, and a crucial role in several cell death pathways has been suggested. Here, we demonstrate that after culturing for 4 days LCC activity is no longer detected in myocytes but can be rescued by adenoviral gene transfer of Panx1. Endogenous LCCs and those related to expression of Panx1 share key pharmacological properties previously used for identifying and characterizing Panx1 channels. These data demonstrate that Panx1 constitutes the LCC of cardiac myocytes. Sporadic openings of single Panx1 channels in the absence of Ca2+ release can trigger action potentials, suggesting that Panx1 channels potentially promote arrhythmogenic activities.	[Kienitz, Marie-Cecile; Bender, Kirsten; Pott, Lutz] Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany; [Dermietzel, Rolf; Zoidl, Georg] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kienitz, MC (corresponding author), Ruhr Univ Bochum, Dept Cellular Physiol, D-44780 Bochum, Germany.	cecile-kienitz@rub.de; georg.zoidl@rub.de	Pott, Lutz/E-5304-2011	Pott, Lutz/0000-0002-4000-4132				Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Bargiotas P, 2009, CURR MOL MED, V9, P186, DOI 10.2174/156652409787581646; BECHEM M, 1983, EUR J CELL BIOL, V31, P366; Bhalla-Gehi R, 2010, J BIOL CHEM, V285, P9147, DOI 10.1074/jbc.M109.082008; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; FABIATO A, 1975, J PHYSIOL-LONDON, V249, P497, DOI 10.1113/jphysiol.1975.sp011027; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Gurung IS, 2009, J MOL CELL CARDIOL, V47, P622, DOI 10.1016/j.yjmcc.2009.08.001; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kondo RP, 2000, PFLUG ARCH EUR J PHY, V440, P125, DOI 10.1007/s004240051029; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MECHMANN S, 1986, NATURE, V319, P597, DOI 10.1038/319597a0; Musa H, 2009, N-S ARCH PHARMACOL, V379, P541, DOI 10.1007/s00210-009-0403-2; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POTT L, 1990, J MEMBRANE BIOL, V117, P189, DOI 10.1007/BF01868685; Prochnow N, 2009, NEUROSCIENCE, V162, P1039, DOI 10.1016/j.neuroscience.2009.04.064; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Ray A, 2005, EUR J NEUROSCI, V21, P3277, DOI 10.1111/j.1460-9568.2005.04139.x; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Vessey DA, 2010, J CARDIOVASC PHARM T, V15, P190, DOI 10.1177/1074248409360356; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Volk T, 2003, CARDIOVASC RES, V58, P76, DOI 10.1016/S0008-6363(02)00858-1; Zhang YA, 2007, AM J PHYSIOL-HEART C, V293, pH2448, DOI 10.1152/ajpheart.00032.2007; Zoidl G, 2007, NEUROSCIENCE, V146, P9, DOI 10.1016/j.neuroscience.2007.01.061	44	57	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					290	298		10.1074/jbc.M110.163477	http://dx.doi.org/10.1074/jbc.M110.163477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041301	Green Published, hybrid			2022-12-27	WOS:000285782800032
J	Lee, Y; Smith, RS; Jordan, W; King, BL; Won, J; Valpuesta, JM; Naggert, JK; Nishina, PM				Lee, YongSuk; Smith, Richard S.; Jordan, Wanda; King, Benjamin L.; Won, Jungyeon; Valpuesta, Jose M.; Naggert, Jurgen K.; Nishina, Patsy M.			Prefoldin 5 Is Required for Normal Sensory and Neuronal Development in a Murine Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; POLYCYSTIC KIDNEY-DISEASE; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; SACCHAROMYCES-CEREVISIAE; UNFOLDED PROTEINS; GENE CAUSES; C-ELEGANS; IN-VIVO; ACTIN	Molecular chaperones and co-chaperones are crucial for cellular development and maintenance as they assist in protein folding and stabilization of unfolded or misfolded proteins. Prefoldin (PFDN), a ubiquitously expressed heterohexameric co-chaperone, is necessary for proper folding of nascent proteins, in particular, tubulin and actin. Here we show that a genetic disruption in the murine Pfdn5 gene, a subunit of prefoldin, causes a syndrome characterized by photoreceptor degeneration, central nervous system abnormalities, and male infertility. Our data indicate that a missense mutation in Pfdn5, may cause these phenotypes through a reduction in formation of microtubules and microfilaments, which are necessary for the development of cilia and cytoskeletal structures, respectively. The diversity of phenotypes demonstrated by models carrying mutations in different PFDN subunits suggests that each PFDN subunit must confer a distinct substrate specificity to the prefoldin holocomplex.	[Lee, YongSuk; Smith, Richard S.; Jordan, Wanda; King, Benjamin L.; Won, Jungyeon; Naggert, Jurgen K.; Nishina, Patsy M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Valpuesta, Jose M.] Univ Autonoma Madrid, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Jackson Laboratory; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Nishina, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	patsy.nishina@jax.org	Valpuesta, José M/T-1977-2017; King, Benjamin/AAI-1492-2019; Valpuesta, Jose M/AAA-6002-2019	Valpuesta, José M/0000-0001-7468-8053; King, Benjamin/0000-0001-6463-1336	Institutional Cancer Core grant [CA-24190]; NEI, National Institutes of Health [EY016501, EY11996]; NATIONAL EYE INSTITUTE [R01EY016501, R01EY011996] Funding Source: NIH RePORTER	Institutional Cancer Core grant; NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Drs. Susan Ackerman and Gregory Cox for critical review of the manuscript, Adrienne Mehalow for initiating the mapping crosses, Dr. Robert Braun for testis analysis, Jeanie Hansen for mouse colony care, and Douglas Howell for ERG measurement. Shared scientific services were supported by an Institutional Cancer Core grant (CA-24190).; This work was supported, in whole or in part, by NEI, National Institutes of Health Grants EY016501 and EY11996.	Andreu J. M., 2007, MICROTUBULE PROTOCOL; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Bouhouche A, 2006, J MED GENET, V43, P441, DOI 10.1136/jmg.2005.039230; Buchner DA, 2004, MAMM GENOME, V15, P344, DOI 10.1007/s00335-004-2332-1; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; Gu Y, 2008, P NATL ACAD SCI USA, V105, P18064, DOI 10.1073/pnas.0808652105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Lacefield S, 2003, GENETICS, V165, P531; Lacefield S, 2006, GENETICS, V173, P635, DOI 10.1534/genetics.105.055160; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lee Y, 2005, MOL CELL NEUROSCI, V30, P160, DOI 10.1016/j.mcn.2005.07.009; Leroux MR, 1999, EMBO J, V18, P6730, DOI 10.1093/emboj/18.23.6730; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Lundin VF, 2008, DEV BIOL, V313, P320, DOI 10.1016/j.ydbio.2007.10.022; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Micheva KD, 1998, EUR J NEUROSCI, V10, P3785, DOI 10.1046/j.1460-9568.1998.00391.x; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; MOYER JH, 1994, SCIENCE, V264, P1329, DOI 10.1126/science.8191288; Ohtaki A, 2008, J MOL BIOL, V376, P1130, DOI 10.1016/j.jmb.2007.12.010; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Stenson PD, 2008, J MED GENET, V45, P124, DOI 10.1136/jmg.2007.055210; Tsuchiya H, 1996, CANCER RES, V56, P2881; URSIC D, 1991, MOL CELL BIOL, V11, P2629, DOI 10.1128/MCB.11.5.2629; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zhang J, 2006, J NEUROL, V253, P1255, DOI 10.1007/s00415-006-0245-5; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	42	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					726	736		10.1074/jbc.M110.177352	http://dx.doi.org/10.1074/jbc.M110.177352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20956523	Green Published, hybrid			2022-12-27	WOS:000285782800072
J	Dupouy, C; Zhang, C; Padilla, A; Pochet, S; Kaminski, PA				Dupouy, Christelle; Zhang, Chi; Padilla, Andre; Pochet, Sylvie; Kaminski, Pierre Alexandre			Probing the Active Site of the Deoxynucleotide N-Hydrolase Rcl Encoded by the Rat Gene c6orf108	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSIDE 2-DEOXYRIBOSYLTRANSFERASE; MASS-SPECTROMETRY; DNA-DAMAGE; IN-VIVO; METABOLISM; IDENTIFICATION; CELLS; PHOSPHORYLATION; EXPRESSION; ENZYME	Rcl is a potential anti-angiogenic therapeutic target that hydrolyzes the N-glycosidic bond of 2'-deoxyribonucleoside 5'-monophosphate, yielding 2-deoxyribose 5-phosphate and the corresponding base. Its recently elucidated solution structure provided the first insight into the molecular basis for the substrate recognition. To facilitate the development of potent and specific inhibitors of Rcl, the active site was probed by site-directed mutagenesis and by the use of substrate analogs. The nucleobase shows weak interactions with the protein, and the deoxyribose binding pocket includes the catalytic triad Tyr-13, Asp-69, and Glu-93 and the phosphate binding site Ser-87 and Ser-117. The phosphomimetic mutation of Ser-17 to Glu prevents substrate binding and, thus, abolishes the activity of Rcl. The synthetic ligand-based analysis of the Rcl binding site shows that substitutions at positions 2 and 6 of the nucleobase as well as large heterocycles are well tolerated. The phosphate group at position 5 of the (deoxy) ribose moiety is the critical binding determinant. This study provides the roadmap for the design of small molecules inhibitors with pharmacological properties.	[Kaminski, Pierre Alexandre] Inst Pasteur, Unite Chim & Biocatalyse, F-75724 Paris 15, France; [Zhang, Chi; Pochet, Sylvie; Kaminski, Pierre Alexandre] CNRS, URA2128, F-75724 Paris 15, France; [Padilla, Andre] CNRS, Ctr Biochim Struct, UMR5048, F-34090 Montpellier, France; [Padilla, Andre] INSERM, U554, F-34090 Montpellier, France; [Padilla, Andre] Univ Montpellier 1 & 2, IFR3, F-34090 Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, 28 Rue Dr Roux, F-75724 Paris 15, France.	pierre-alexandre.kaminski@pasteur.fr		Dupouy, Christelle/0000-0002-4508-838X; Kaminski, Pierre Alexandre/0000-0001-9841-6837; PADILLA, ANDRE/0000-0001-9702-4612	Institut Pasteur (Direction des applications de la recherche et des relations industrielles); CNRS	Institut Pasteur (Direction des applications de la recherche et des relations industrielles); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Institut Pasteur (Direction des applications de la recherche et des relations industrielles) and CNRS.	Almon RR, 2007, ENDOCRINOLOGY, V148, P2209, DOI 10.1210/en.2006-0790; Armstrong SR, 1996, STRUCTURE, V4, P97, DOI 10.1016/S0969-2126(96)00013-5; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Brown NS, 1998, BIOCHEM J, V334, P1; Burcham PC, 1999, MUTAT RES-GEN TOX EN, V443, P11, DOI 10.1016/S1383-5742(99)00008-3; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Doddapaneni K, 2009, J MOL BIOL, V394, P423, DOI 10.1016/j.jmb.2009.08.054; Epp JB, 1999, J ORG CHEM, V64, P293, DOI 10.1021/jo981316g; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fyrberg A, 2007, BIOCHEM BIOPH RES CO, V357, P847, DOI 10.1016/j.bbrc.2007.03.176; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gorgun G, 2009, P NATL ACAD SCI USA, V106, P6250, DOI 10.1073/pnas.0901166106; Hah SS, 2007, P NATL ACAD SCI USA, V104, P11203, DOI 10.1073/pnas.0701733104; Hirsch AKH, 2007, ANGEW CHEM INT EDIT, V46, P338, DOI 10.1002/anie.200603420; HOLGUIN J, 1975, EUR J BIOCHEM, V54, P515, DOI 10.1111/j.1432-1033.1975.tb04164.x; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pD80; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Jullig M, 2001, J BIOL CHEM, V276, P24000, DOI 10.1074/jbc.M100435200; Kaminski PA, 2002, J BIOL CHEM, V277, P14400, DOI 10.1074/jbc.M111995200; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lewis BC, 2000, CANCER RES, V60, P6178; Liu YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002722; Loeb LA, 2001, CANCER RES, V61, P3230; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Miki Y, 2005, CANCER LETT, V220, P197, DOI 10.1016/j.canlet.2004.07.024; MIZUNO Y, 1963, J ORG CHEM, V28, P3329, DOI 10.1021/jo01047a012; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; PORTER DJT, 1995, J BIOL CHEM, V270, P15551, DOI 10.1074/jbc.270.26.15551; Rhodes DR, 2002, CANCER RES, V62, P4427; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Smal C, 2006, J BIOL CHEM, V281, P4887, DOI 10.1074/jbc.M512129200; TENER GM, 1961, J AM CHEM SOC, V83, P159, DOI 10.1021/ja01462a032; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Yang YS, 2009, J MOL BIOL, V394, P435, DOI 10.1016/j.jmb.2009.10.004	43	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41806	41814		10.1074/jbc.M110.181594	http://dx.doi.org/10.1074/jbc.M110.181594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20962348	Green Published, hybrid			2022-12-27	WOS:000285622600068
J	Jeanguenin, L; Lara-Nunez, A; Pribat, A; Mageroy, MH; Gregory, JF; Rice, KC; de Crecy-Lagard, V; Hanson, AD				Jeanguenin, Linda; Lara-Nunez, Aurora; Pribat, Anne; Mageroy, Melissa Hamner; Gregory, Jesse F., III; Rice, Kelly C.; de Crecy-Lagard, Valerie; Hanson, Andrew D.			Moonlighting Glutamate Formiminotransferases Can Functionally Replace 5-Formyltetrahydrofolate Cycloligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; METHENYLTETRAHYDROFOLATE SYNTHETASE; METHANOSARCINA-BARKERI; STAPHYLOCOCCUS-AUREUS; METHANOGENIC ARCHAEON; MOLECULAR-CLONING; FOLIC-ACID; FOLATE; STREPTOCOCCUS; ENZYMES	5-Formyltetrahydrofolate (5-CHO-THF) is formed by a side reaction of serine hydroxymethyltransferase. Unlike other folates, it is not a one-carbon donor but a potent inhibitor of folate enzymes and must therefore be metabolized. Only 5-CHO-THF cycloligase (5-FCL) is generally considered to do this. However, comparative genomic analysis indicated (i) that certain prokaryotes lack 5-FCL, implying that they have an alternative 5-CHO-THF-metabolizing enzyme, and (ii) that the histidine breakdown enzyme glutamate formiminotransferase (FT) might moonlight in this role. A functional complementation assay for 5-CHO-THF metabolism was developed in Escherichia coli, based on deleting the gene encoding 5-FCL (ygfA). The deletion mutant accumulated 5-CHO-THF and, with glycine as sole nitrogen source, showed a growth defect; both phenotypes were complemented by bacterial or archaeal genes encoding FT. Furthermore, utilization of supplied 5-CHO-THF by Streptococcus pyogenes was shown to require expression of the native FT. Recombinant bacterial and archaeal FTs catalyzed formyl transfer from 5-CHO-THF to glutamate, with k(cat) values of 0.1-1.2 min(-1) and K-m values for 5-CHO-THF and glutamate of 0.4-5 mu M and 0.03-1 mM, respectively. Although the formyltransferase activities of these proteins were far lower than their formiminotransferase activities, the K-m values for both substrates relative to their intracellular levels in prokaryotes are consistent with significant in vivo flux through the formyltransferase reaction. Collectively, these data indicate that FTs functionally replace 5-FCL in certain prokaryotes.	[Jeanguenin, Linda; Pribat, Anne; Mageroy, Melissa Hamner; Hanson, Andrew D.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Lara-Nunez, Aurora; Gregory, Jesse F., III] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA; [Rice, Kelly C.; de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Hanson, AD (corresponding author), Univ Florida, Dept Hort Sci, POB 110690, Gainesville, FL 32611 USA.	adha@ufl.edu	de Crecy-Lagard, Valerie/AAN-8995-2020; Nunez, Aurora Lara/G-3485-2019; Mageroy, Melissa H/H-5879-2019	Nunez, Aurora Lara/0000-0003-4056-9501; Mageroy, Melissa H/0000-0001-7801-1007; Gregory, Jesse/0000-0002-9976-2085	United States (U.S.) National Science Foundation [MCB-0839926]; U.S. Dept. of Energy [FG02-07ER64498]; National Institutes of Health [R03-DE019179]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE019179] Funding Source: NIH RePORTER	United States (U.S.) National Science Foundation(National Science Foundation (NSF)); U.S. Dept. of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by United States (U.S.) National Science Foundation Award MCB-0839926 (to A.D.H.), by U.S. Dept. of Energy award FG02-07ER64498 (to V. de C.L.), by National Institutes of Health Award R03-DE019179 (to K.C.R.), and by an endowment from the C.V. Griffin, Sr. Foundation.	ANDERSON CB, 1982, APPL ENVIRON MICROB, V43, P1501, DOI 10.1128/AEM.43.6.1501-1503.1982; Anguera MC, 2003, J BIOL CHEM, V278, P29856, DOI 10.1074/jbc.M302883200; Arnold RJ, 2000, ANAL BIOCHEM, V281, P45, DOI 10.1006/abio.2000.4527; Baba Tomoya, 2006, Mol Syst Biol, V2; Baggott JE, 2000, BIOCHEMISTRY-US, V39, P14647, DOI 10.1021/bi001362m; Bagley PJ, 2000, CLIN CHEM, V46, P404; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Benkovic S. J., 1984, FOLATES PTERINS, V1, P61; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V4, P2285; Biswas I, 2003, J BACTERIOL, V185, P3081, DOI 10.1128/JB.185.10.3081-3090.2003; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; BORTOLUZZI LC, 1983, CAN J BIOCHEM CELL B, V61, P248, DOI 10.1139/o83-035; Brabban AD, 1999, APPL ENVIRON MICROB, V65, P1222; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchenau B, 2004, ARCH MICROBIOL, V182, P313, DOI 10.1007/s00203-004-0714-0; CHASIN LA, 1968, J BIOL CHEM, V243, P5165; de Crecy-Lagard V., 2007, BMC GENOMICS, V8, P245; Field MS, 2007, ARCH BIOCHEM BIOPHYS, V458, P194, DOI 10.1016/j.abb.2006.12.023; FINDLAY WA, 1987, BIOCHEMISTRY-US, V26, P1948, DOI 10.1021/bi00381a024; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; Goyer A, 2005, J BIOL CHEM, V280, P26137, DOI 10.1074/jbc.M503106200; GREGORY JF, 1984, J NUTR, V114, P341, DOI 10.1093/jn/114.2.341; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Holmes WB, 2002, J BIOL CHEM, V277, P20205, DOI 10.1074/jbc.M201242200; HU L, 1987, J BACTERIOL, V169, P4696, DOI 10.1128/jb.169.10.4696-4702.1987; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; KRUSCHWITZ HL, 1994, J BIOL CHEM, V269, P28757; Lee HH, 2004, J BIOL CHEM, V279, P50514, DOI 10.1074/jbc.M409672200; MATTHEWS RG, 1996, ESCHERICHIA COLI SAL, V1, P600; MIYAKE M, 1983, BIOCHIM BIOPHYS ACTA, V760, P206, DOI 10.1016/0304-4165(83)90165-4; MURLEY LL, 1995, BIOCHEMISTRY-US, V34, P10358, DOI 10.1021/bi00033a006; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NEWMAN EB, 1976, BIOCHIM BIOPHYS ACTA, V421, P97, DOI 10.1016/0304-4165(76)90173-2; OHMURA E, 1957, J BIOL CHEM, V227, P181; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pelletier JN, 1996, BIOORG CHEM, V24, P220, DOI 10.1006/bioo.1996.0020; Pfeiffer CM, 1997, J AGR FOOD CHEM, V45, P407, DOI 10.1021/jf960633q; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Rodionov DA, 2009, J BACTERIOL, V191, P42, DOI 10.1128/JB.01208-08; Roje S, 2002, J BIOL CHEM, V277, P42748, DOI 10.1074/jbc.M205632200; Sambrook J., 1989, MOL CLONING LAB MANU; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; SILVERMAN M, 1957, J BIOL CHEM, V226, P83; SIMON D, 1991, FEMS MICROBIOL LETT, V82, P219, DOI 10.1016/0378-1097(91)90336-9; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; STOVER P, 1993, TRENDS BIOCHEM SCI, V18, P102, DOI 10.1016/0968-0004(93)90162-G; STOVER P, 1992, BIOCHEMISTRY-US, V31, P2155, DOI 10.1021/bi00122a037; STOVER P, 1990, J BIOL CHEM, V265, P14227; TABOR H, 1954, J BIOL CHEM, V210, P559; Tabor H., 1957, BIOCHEM PREP, V5, P100; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson HR, 2001, AM J PHYSIOL-GASTR L, V280, pG873, DOI 10.1152/ajpgi.2001.280.5.G873; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRIEUCUOT P, 1990, NUCLEIC ACIDS RES, V18, P4296, DOI 10.1093/nar/18.14.4296; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; WHITE RH, 1991, J BACTERIOL, V173, P1987, DOI 10.1128/jb.173.6.1987-1991.1991; WORRELL VE, 1988, J BACTERIOL, V170, P4420, DOI 10.1128/jb.170.9.4420-4423.1988; WRAY LV, 1994, J BACTERIOL, V176, P1894, DOI 10.1128/jb.176.7.1894-1902.1994	63	23	31	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41557	41566		10.1074/jbc.M110.190504	http://dx.doi.org/10.1074/jbc.M110.190504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952389	Green Published, hybrid			2022-12-27	WOS:000285622600043
J	Kikani, CK; Antonysamy, SA; Bonanno, JB; Romero, R; Zhang, FF; Russell, M; Gheyi, T; Iizuka, M; Emtage, S; Sauder, JM; Turk, BE; Burley, SK; Rutter, J				Kikani, Chintan K.; Antonysamy, Stephen A.; Bonanno, Jeffrey B.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Turk, Benjamin E.; Burley, Stephen K.; Rutter, Jared			Structural Bases of PAS Domain-regulated Kinase (PASK) Activation in the Absence of Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; TRANSLATION; MTOR; ERK2; AMPK	Per-Arnt-Sim (PAS) domain-containing protein kinase (PASK) is an evolutionary conserved protein kinase that coordinates cellular metabolism with metabolic demand in yeast and mammals. The molecular mechanisms underlying PASK regulation, however, remain unknown. Herein, we describe a crystal structure of the kinase domain of human PASK, which provides insights into the regulatory mechanisms governing catalysis. We show that the kinase domain adopts an active conformation and has catalytic activity in vivo and in vitro in the absence of activation loop phosphorylation. Using site-directed mutagenesis and structural comparison with active and inactive kinases, we identified several key structural features in PASK that enable activation loop phosphorylation-independent activity. Finally, we used combinatorial peptide library screening to determine that PASK prefers basic residues at the P-3 and P-5 positions in substrate peptides. Our results describe the key features of the PASK structure and how those features are important for PASK activity and substrate selection.	[Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Antonysamy, Stephen A.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Burley, Stephen K.] Eli Lilly & Co, San Diego, CA 92121 USA; [Antonysamy, Stephen A.; Romero, Rich; Zhang, Feiyu Fred; Russell, Marijane; Gheyi, Tarun; Iizuka, Miyo; Emtage, Spencer; Sauder, J. Michael; Burley, Stephen K.] New York SGX Res Ctr Struct Genom NYSGXRC, San Diego, CA 92121 USA; [Bonanno, Jeffrey B.] Yeshiva Univ, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Utah System of Higher Education; University of Utah; Eli Lilly; Yeshiva University; Albert Einstein College of Medicine; Yale University	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, 15 N Med Dr E,Rm 5200J, Salt Lake City, UT 84112 USA.	Rutter@biochem.utah.edu		Kikani, Chintan/0000-0003-1140-0192; Sauder, J Michael/0000-0002-0254-4955; Burley, Stephen K./0000-0002-2487-9713	National Institutes of Health [U54 GM074945, DK071962, GM079498]; United States Dept. of Energy, Office of Basic Energy Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK071962, R01DK071962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498, U54GM074945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Dept. of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health Grants U54 GM074945 (to New York SGX Research Center for Structural Genomics, principal investigator, S. K. Burley), DK071962 (to J. R.) and GM079498 (to B. E. T.). Use of the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Basic Energy Sciences. Use of the LRL-CAT beam line facilities at Sector 31 of the APS (formerly SGX-CAT) was provided by Eli Lilly and Company, which operates the beamline (formerly SGX Pharmaceuticals).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Grose JH, 2007, EMBO J, V26, P4824, DOI 10.1038/sj.emboj.7601914; Grose JH, 2009, CELL CYCLE, V8, P1824, DOI 10.4161/cc.8.12.8799; Hao HX, 2008, IUBMB LIFE, V60, P204, DOI 10.1002/iub.32; Hao HX, 2007, P NATL ACAD SCI USA, V104, P15466, DOI 10.1073/pnas.0705407104; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Komander D, 2005, J BIOL CHEM, V280, P18797, DOI 10.1074/jbc.M500977200; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; Mazanka E, 2008, PLOS BIOL, V6, P1778, DOI 10.1371/journal.pbio.0060203; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Rutter J, 2002, CELL, V111, P17, DOI 10.1016/S0092-8674(02)00974-1; Rutter J, 2001, P NATL ACAD SCI USA, V98, P8991, DOI 10.1073/pnas.161284798; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Smith TL, 2007, MOL CELL, V26, P491, DOI 10.1016/j.molcel.2007.03.025; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; XAVIER GD, 2004, P NATL ACAD SCI USA, V101, P8319; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0	39	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41034	41043		10.1074/jbc.M110.157594	http://dx.doi.org/10.1074/jbc.M110.157594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943661	Green Published, hybrid			2022-12-27	WOS:000285414400066
J	Rani, SH; Krishna, THA; Saha, S; Negi, AS; Rajasekharan, R				Rani, Sapa Hima; Krishna, T. H. Anantha; Saha, Saikat; Negi, Arvind Singh; Rajasekharan, Ram			Defective in Cuticular Ridges (DCR) of Arabidopsis thaliana, a Gene Associated with Surface Cutin Formation, Encodes a Soluble Diacylglycerol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIACYLGLYCEROL SYNTHESIS; MICROSOMAL PREPARATIONS; BIOSYNTHESIS; EXPRESSION; SUBERIN; YEAST; ACID; IDENTIFICATION; CLONING; MONOMERS	A key step in the triacylglycerol (TAG) biosynthetic pathway is the final acylation of diacylglycerol (DAG) by DAG acyltransferase. In silico analysis has revealed that the DCR (defective in cuticular ridges) (At5g23940) gene has a typical HX4D acyltransferase motif at the N-terminal end and a lipid binding motif VX(2)GF at the middle of the sequence. To understand the biochemical function, the gene was overexpressed in Escherichia coli, and the purified recombinant protein was found to acylate DAG specifically in an acyl-CoA-dependent manner. Overexpression of At5g23940 in a Saccharomyces cerevisiae quadruple mutant deficient in DAG acyltransferases resulted in TAG accumulation. At5g23940 rescued the growth of this quadruple mutant in the oleate-containing medium, whereas empty vector control did not. Lipid particles were localized in the cytosol of At5g23940-transformed quadruple mutant cells, as observed by oil red O staining. There was an incorporation of 16-hydroxyhexadecanoic acid into TAG in At5g23940-transformed cells of quadruple mutant. Here we report a soluble acyl-CoA-dependent DAG acyltransferase from Arabidopsis thaliana. Taken together, these data suggest that a broad specific DAG acyltransferase may be involved in the cutin as well as in the TAG biosynthesis by supplying hydroxy fatty acid.	[Rani, Sapa Hima; Krishna, T. H. Anantha; Saha, Saikat; Rajasekharan, Ram] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Negi, Arvind Singh; Rajasekharan, Ram] CSIR, Cent Inst Med & Aromat Plants, Lucknow 220015, Uttar Pradesh, India	Indian Institute of Science (IISC) - Bangalore; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Rajasekharan, R (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	lipid@biochem.iisc.ernet.in	Rajasekharan, Ram/R-2257-2019; Negi, arvind singh/AAS-1530-2021; Sapa, Hima/K-1134-2019	Sapa, Hima/0000-0003-4749-7600; Rajasekharan, Ram/0000-0002-2124-6013; Ram, Rajasekharan/0000-0002-4114-0654	Department of Biotechnology (New Delhi, India); Council of Scientific and Industrial Research (New Delhi, India)	Department of Biotechnology (New Delhi, India)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (New Delhi, India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology (New Delhi, India) under the program "Support for Nonconventional Yeasts" and the Council of Scientific and Industrial Research (New Delhi, India).	BAFOR M, 1991, BIOCHEM J, V280, P507, DOI 10.1042/bj2800507; Beisson F, 2007, PLANT CELL, V19, P351, DOI 10.1105/tpc.106.048033; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CROTEAU R, 1974, BIOCHEMISTRY-US, V13, P3193, DOI 10.1021/bi00712a030; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; GERARD HC, 1992, PHYTOCHEM ANALYSIS, V3, P139, DOI 10.1002/pca.2800030310; Ghosh AK, 2008, J BIOL CHEM, V283, P9768, DOI 10.1074/jbc.M708418200; Hobbs DH, 1999, FEBS LETT, V452, P145, DOI 10.1016/S0014-5793(99)00646-8; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; KENNEDY EP, 1961, FED PROC, V20, P934; Kurdyukov S, 2006, PLANT CELL, V18, P321, DOI 10.1105/tpc.105.036079; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Li RZ, 2010, LIPIDS, V45, P145, DOI 10.1007/s11745-010-3385-4; Li YH, 2007, P NATL ACAD SCI USA, V104, P18339, DOI 10.1073/pnas.0706984104; Li YH, 2007, PLANT PHYSIOL, V144, P1267, DOI 10.1104/pp.107.099432; Li YH, 2009, BIOCHIMIE, V91, P685, DOI 10.1016/j.biochi.2009.03.016; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; MARTIN BA, 1984, LIPIDS, V19, P117, DOI 10.1007/BF02534501; Mavraganis I, 2010, APPL ENVIRON MICROB, V76, P1135, DOI 10.1128/AEM.02297-09; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Nykiforuk CL, 2002, BBA-MOL CELL BIOL L, V1580, P95, DOI 10.1016/S1388-1981(01)00200-1; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; OHLROGGE JB, 1991, BIOCHIM BIOPHYS ACTA, V1082, P1, DOI 10.1016/0005-2760(91)90294-R; Panikashvili D, 2009, PLANT PHYSIOL, V151, P1773, DOI 10.1104/pp.109.143388; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Reddy VS, 2010, BBA-MOL CELL BIOL L, V1801, P455, DOI 10.1016/j.bbalip.2009.12.005; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Stobart K, 1997, PLANTA, V203, P58, DOI 10.1007/s004250050165; Tumaney AW, 2001, J BIOL CHEM, V276, P10847, DOI 10.1074/jbc.M100005200; Valencia-Turcotte L, 2001, BBA-MOL CELL BIOL L, V1534, P14, DOI 10.1016/S1388-1981(01)00170-6; WALTON TJ, 1972, BIOCHEMISTRY-US, V11, P1885, DOI 10.1021/bi00760a025; WALTON TJ, 1972, BIOCHEM BIOPH RES CO, V46, P16, DOI 10.1016/0006-291X(72)90623-7; WILSON RF, 1986, BIOCHIM BIOPHYS ACTA, V877, P231, DOI 10.1016/0005-2760(86)90299-7; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang M, 2009, PLANT CELL, V21, P3885, DOI 10.1105/tpc.109.071795; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	43	63	67	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38337	38347		10.1074/jbc.M110.133116	http://dx.doi.org/10.1074/jbc.M110.133116			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921218	Green Published, hybrid			2022-12-27	WOS:000284625600040
J	Cui, JG; Li, YY; Zhao, YH; Bhattacharjee, S; Lukiw, WJ				Cui, Jian Guo; Li, Yuan Yuan; Zhao, Yuhai; Bhattacharjee, Surjyadipta; Lukiw, Walter J.			Differential Regulation of Interleukin-1 Receptor-associated Kinase-1 (IRAK-1) and IRAK-2 by MicroRNA-146a and NF-kappa B in Stressed Human Astroglial Cells and in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON GENE-TRANSCRIPTION; EXPRESSION; CYCLOOXYGENASE-2; NEUROINFLAMMATION; DEMENTIA; FETAL	Specific microRNAs (miRNAs), small non-coding RNAs that support homeostatic gene expression, are significantly altered in abundance in human neurological disorders. In monocytes, increased expression of an NF-kappa B-regulated miRNA-146a down-regulates expression of the interleukin-1 receptor-associated kinase-1 (IRAK-1), an essential component of Toll-like/IL-1 receptor signaling. Here we extend those observations to the hippocampus and neocortex of Alzheimer disease (AD) brain and to stressed human astroglial (HAG) cells in primary culture. In 66 control and AD samples we note a significant up-regulation of miRNA-146a coupled to down-regulation of IRAK-1 and a compensatory up-regulation of IRAK-2. Using miRNA-146a-, IRAK-1-, or IRAK-2 promoter-luciferase reporter constructs, we observe decreases in IRAK-1 and increases in miRNA-146a and IRAK-2 expression in interleukin-1 beta (IL-1 beta) and amyloid-beta-42 (A beta 42) peptide-stressed HAG cells. NF-kappa B-mediated transcriptional control of human IRAK-2 was localized to between -119 and -12 bp of the immediate IRAK-2 promoter. The NF-kappa B inhibitors curcumin, pyrrolidine dithiocarbamate or CAY10512 abrogated both IRAK-2 and miRNA-146a expression, whereas IRAK-1 was up-regulated. Incubation of a protected antisense miRNA-146a was found to inhibit miRNA-146a and restore IRAK-1, whereas IRAK-2 remained unaffected. These data suggest a significantly independent regulation of IRAK-1 and IRAK-2 in AD and in IL-1 beta+A beta 42 peptide-stressed HAG cells and that an inducible, NF-kappa B-sensitive, miRNA-146a-mediated down-regulation of IRAK-1 coupled to an NF-kappa B-induced up-regulation of IRAK-2 expression drives an extensively sustained inflammatory response. The interactive signaling of NF-kappa B and miRNA-146a further illustrate interplay between inducible transcription factors and pro-inflammatory miRNAs that regulate brain IRAK expression. The combinatorial use of NF-kappa B inhibitors with miRNA-146a or antisense miRNA-146a may have potential as a bi-pronged therapeutic strategy directed against IRAK-2-driven pathogenic signaling.	[Cui, Jian Guo; Li, Yuan Yuan; Bhattacharjee, Surjyadipta; Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Louisiana State Univ Neurosci Ctr, New Orleans, LA 70112 USA; [Cui, Jian Guo; Li, Yuan Yuan; Bhattacharjee, Surjyadipta; Lukiw, Walter J.] Louisiana State Univ, Hlth Sci Ctr, Dept Ophthalmol, New Orleans, LA 70112 USA; [Zhao, Yuhai; Lukiw, Walter J.] Univ Pittsburgh, Dept Biol Struct, Pittsburgh, PA 15260 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lukiw, WJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, LSU Neurosci Ctr Excellence, 2020 Gravier St,Rm 904, New Orleans, LA 70112 USA.	wlukiw@lsuhsc.edu	Bhattacharjee, Surjyadipta/I-5354-2016; Bhattacharjee, Surjyadipta/AAD-7586-2021	Bhattacharjee, Surjyadipta/0000-0003-0185-553X; Bhattacharjee, Surjyadipta/0000-0003-0185-553X	National Institutes of Health [AG18031]; Louisiana State University; Alzheimer Association [IIRG-09-131729]; NIA, National Institutes of Health [P50 AG16573]; NATIONAL INSTITUTE ON AGING [R01AG018031, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG18031 (NIA; to W. J. L.). This work was supported in part by a Translational Research Initiative grant from Louisiana State University (to W. J. L.) and by Alzheimer Association Investigator Initiated Research Grant IIRG-09-131729 (to W. J. L.).; Thanks are extended to the many families and physicians who contributed to the human brain bank resources used in these studies and especially to Drs. P. Alexandrov, L. Carver, E. Head, H. LeBlanc, W. Poon, and T. Saing for human brain tissues. Some of the brain tissues used in this project were provided by the Institute for Memory Impairments and Neurological Disorders and the University of California at Irvine Alzheimer Disease Research Center (UCI-ADRC); funding for the UCI-ADRC was provided by NIA, National Institutes of Health Grant P50 AG16573. Thanks are also extended to Yuan Yuan Li and Darlene Guillot for expert technical assistance and statistical analysis and to Drs. K. Taganov and D. Baltimore for the use of the NF-kappa B-containing pre-miRNA-146a promoter-luciferase reporter vector (A547; Addgene, Cambridge, MA) and expression controls.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Birdsill A. C., 2010, CELL TISSUE IN PRESS; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Cui JG, 2005, CELL MOL NEUROBIOL, V25, P789, DOI 10.1007/s10571-005-4035-x; Cui JG, 2007, NEUROREPORT, V18, P115, DOI 10.1097/WNR.0b013e32801198bc; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Forlenza OV, 2009, DEMENT GERIATR COGN, V28, P507, DOI 10.1159/000255051; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Jellinger KA, 2006, J ALZHEIMERS DIS, V9, P61; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kuzmin I, 2005, J MOL BIOL, V346, P411, DOI 10.1016/j.jmb.2004.11.066; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Letiembre M, 2007, NEUROSCIENCE, V146, P248, DOI 10.1016/j.neuroscience.2007.01.004; Li L, 2010, SCAND J IMMUNOL, V71, P227, DOI 10.1111/j.1365-3083.2010.02383.x; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2010, NEUROREPORT, V21, P922, DOI 10.1097/WNR.0b013e32833da51a; Lukiw WJ, 2000, ALZHEIMERS REP, V3, P233; Lukiw WJ, 1998, J MOL NEUROSCI, V11, P67, DOI 10.1385/JMN:11:1:67; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Lukiw WJ, 1998, P NATL ACAD SCI USA, V95, P3914, DOI 10.1073/pnas.95.7.3914; Lukiw WJ, 1998, J NEUROSCI RES, V53, P583, DOI 10.1002/(SICI)1097-4547(19980901)53:5<583::AID-JNR8>3.3.CO;2-B; Martino S, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/654346; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Ringwood L, 2008, CYTOKINE, V42, P1, DOI 10.1016/j.cyto.2007.12.012; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sethi P, 2009, NEUROSCI LETT, V459, P100, DOI 10.1016/j.neulet.2009.04.052; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tan LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003966; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Yang I, 2010, J CLIN NEUROSCI, V17, P6, DOI 10.1016/j.jocn.2009.05.006; Zhao YH, 2006, MOL NEUROBIOL, V34, P181, DOI 10.1385/MN:34:3:181	46	198	211	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38951	38960		10.1074/jbc.M110.178848	http://dx.doi.org/10.1074/jbc.M110.178848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937840	hybrid, Green Published			2022-12-27	WOS:000284941300025
J	Kaur, S; Martin-Manso, G; Pendrak, ML; Garfield, SH; Isenberg, JS; Roberts, DD				Kaur, Sukhbir; Martin-Manso, Gema; Pendrak, Michael L.; Garfield, Susan H.; Isenberg, Jeff S.; Roberts, David D.			Thrombospondin-1 Inhibits VEGF Receptor-2 Signaling by Disrupting Its Association with CD47	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; CELL RESPONSES; VASCULAR HOMEOSTASIS; DEPENDENT ACTIVATION; ISCHEMIC TISSUE; TYPE-1 REPEATS; IN-VITRO; ANGIOGENESIS; MIGRATION	Thrombospondin-1 (TSP1) can inhibit angiogenic responses directly by interacting with VEGF and indirectly by engaging several endothelial cell TSP1 receptors. We now describe a more potent mechanism by which TSP1 inhibits VEGF receptor-2 (VEGFR2) activation through engaging its receptor CD47. CD47 ligation is known to inhibit downstream signaling targets of VEGFR2, including endothelial nitric-oxide synthase and soluble guanylate cyclase, but direct effects on VEGFR2 have not been examined. Based on FRET and co-immunoprecipitation, CD47 constitutively associated with VEGFR2. Ligation of CD47 by TSP1 abolished resonance energy transfer with VEGFR2 and inhibited phosphorylation of VEGFR2 and its downstream target Akt without inhibiting VEGF binding to VEGFR2. The inhibitory activity of TSP1 in large vessel and microvascular endothelial cells was replicated by a recombinant domain of the protein containing its CD47-binding site and by a CD47-binding peptide derived from this domain but not by the CD36-binding domain of TSP1. Inhibition of VEGFR2 phosphorylation was lost when CD47 expression was suppressed in human endothelial cells and in murine CD47-null cells. These results reveal that anti-angiogenic signaling through CD47 is highly redundant and extends beyond inhibition of nitric oxide signaling to global inhibition of VEGFR2 signaling.	[Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Garfield, Susan H.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Vasc Med Inst, Dept Med, Pittsburgh, PA 15260 USA; [Isenberg, Jeff S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, DD (corresponding author), NCI, Pathol Lab, Ctr Canc Res, NIH, Bldg 10,Rm 2A33,10 Ctr Dr,MSC1500, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Martin Manso, Maria Gema/D-4612-2013; Kaur, Sukhbir/ADW-6023-2022	Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225	National Institutes of Health/NCI; National Institutes of Health [CA128616]; NATIONAL CANCER INSTITUTE [K22CA128616, ZIASC009172] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health/NCI (to D. D. R.) and by National Institutes of Health Grant CA128616 (to J. S. I.).	BAGAVANDOSS P, 1990, BIOCHEM BIOPH RES CO, V170, P867, DOI 10.1016/0006-291X(90)92171-U; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Bauer E. M., 2010, CARDIOVASC IN PRESS; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Calzada MJ, 2004, CIRC RES, V94, P462, DOI 10.1161/01.RES.0000115555.05668.93; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Curwen JO, 2008, CLIN CANCER RES, V14, P3124, DOI 10.1158/1078-0432.CCR-07-4783; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Dimmeler S, 2000, FEBS LETT, V477, P258, DOI 10.1016/S0014-5793(00)01657-4; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Gupta K, 1999, Angiogenesis, V3, P147, DOI 10.1023/A:1009018702832; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, ANN SURG, V247, P860, DOI 10.1097/SLA.0b013e31816c4006; Isenberg JS, 2008, ANN SURG, V247, P180, DOI 10.1097/SLA.0b013e31815685dc; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; KU DD, 1993, AM J PHYSIOL, V265, pH586, DOI 10.1152/ajpheart.1993.265.2.H586; Laklai H, 2009, P NATL ACAD SCI USA, V106, P17769, DOI 10.1073/pnas.0908674106; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Misenheimer TM, 2000, J BIOL CHEM, V275, P40938, DOI 10.1074/jbc.M007022200; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; Sun J, 2009, AM J PHYSIOL-HEART C, V296, pH43, DOI 10.1152/ajpheart.00613.2008; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200	55	154	162	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38923	38932		10.1074/jbc.M110.172304	http://dx.doi.org/10.1074/jbc.M110.172304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923780	Green Published, hybrid			2022-12-27	WOS:000284941300022
J	Wen, WH; Zhu, F; Zhang, JS; Keum, YS; Zykova, T; Yao, K; Peng, C; Zheng, D; Cho, YY; Ma, WY; Bode, AM; Dong, ZG				Wen, Weihong; Zhu, Feng; Zhang, Jishuai; Keum, Young-Sam; Zykova, Tatyana; Yao, Ke; Peng, Cong; Zheng, Duo; Cho, Yong-Yeon; Ma, Wei-ya; Bode, Ann M.; Dong, Zigang			MST1 Promotes Apoptosis through Phosphorylation of Histone H2AX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE-MEDIATED ACTIVATION; STE20-LIKE PROTEIN-KINASE; PROTEOLYTIC ACTIVATION; CHROMATIN CONDENSATION; DNA FRAGMENTATION; DEPENDENT MANNER; UV-IRRADIATION; CELL-DEATH; SERINE 139; C DELTA	MST1 (mammalian STE20-like kinase 1) is a serine/threonine kinase that is cleaved and activated by caspases during apoptosis. Overexpression of MST1 induces apoptotic morphological changes such as chromatin condensation, but the mechanism is not clear. Here we show that MST1 induces apoptotic chromatin condensation through its phosphorylation of histone H2AX at Ser-139. During etoposide-induced apoptosis in Jurkat cells, the cleavage of MST1 directly corresponded with strong H2AX phosphorylation. In vitro kinase assay results showed that MST1 strongly phosphorylates histone H2AX. Western blot and kinase assay results with a mutant S139A H2AX confirmed that MST1 phosphorylates H2AX at Ser-139. Direct binding of MST1 and H2AX can be detected when co-expressed in HEK293 cells and was also confirmed by an endogenous immunoprecipitation study. When overexpressed in HeLa cells, both the MST1 full-length protein and the MST1 kinase domain (MST1-NT), but not the kinase-negative mutant (MST1-NT-KN), could induce obvious endogenous histone H2AX phosphorylation. The caspase-3 inhibitor benzyloxycarbonyl-DEVD-fluoromethyl ketone (Z-DEVD-fmk) attenuates phosphorylation of H2AX by MST1 but cannot inhibit MST1-NT-induced histone H2AX phosphorylation, indicating that cleaved MST1 is responsible for H2AX phosphorylation during apoptosis. Histone H2AX phosphorylation and DNA fragmentation were suppressed in MST1 knockdown Jurkat cells after etoposide treatment. Taken together, our data indicated that H2AX is a substrate of MST1, which functions to induce apoptotic chromatin condensation and DNA fragmentation.	[Wen, Weihong; Zhu, Feng; Zhang, Jishuai; Keum, Young-Sam; Zykova, Tatyana; Yao, Ke; Peng, Cong; Zheng, Duo; Cho, Yong-Yeon; Ma, Wei-ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010; Cho, Yong-Yeon/AAD-4263-2020; ZHU, Feng/G-3567-2010; peng, cong/A-9454-2012; 温, 家琦/GYV-3177-2022	Cho, Yong-Yeon/0000-0003-1107-2651; Zhu, Feng/0000-0003-1172-0102	National Institutes of Health [CA077646, CA027502, CA111536, CA120388, R37CA081064, ES017548]; Hormel Foundation; NATIONAL CANCER INSTITUTE [R01CA120388, R37CA081064, R01CA077646, R01CA111536, P01CA027502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA077646, CA027502, CA111536, CA120388, R37CA081064, and ES017548 (to Z. D.) and by The Hormel Foundation.	Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Creasy CL, 1995, GENE, V167, P303, DOI 10.1016/0378-1119(95)00653-2; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Huang X, 2004, CYTOM PART A, V58A, P99, DOI 10.1002/cyto.a.20018; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kakeya H, 1998, CANCER RES, V58, P4888; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lu ML, 1996, P NATL ACAD SCI USA, V93, P8977, DOI 10.1073/pnas.93.17.8977; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Park EJ, 2003, NUCLEIC ACIDS RES, V31, P6819, DOI 10.1093/nar/gkg921; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reszka AA, 1999, J BIOL CHEM, V274, P34967, DOI 10.1074/jbc.274.49.34967; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Solier S, 2009, CELL CYCLE, V8, P1853, DOI 10.4161/cc.8.12.8865; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200; Watabe M, 1999, ONCOGENE, V18, P5211, DOI 10.1038/sj.onc.1202901; Watabe M, 2000, J BIOL CHEM, V275, P8766, DOI 10.1074/jbc.275.12.8766; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9	44	52	52	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39108	39116		10.1074/jbc.M110.151753	http://dx.doi.org/10.1074/jbc.M110.151753			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921231	hybrid, Green Published			2022-12-27	WOS:000284941300041
J	Keller, CW; Fokken, C; Turville, SG; Lunemann, A; Schmidt, J; Munz, C; Lunemann, JD				Keller, Christian W.; Fokken, Claudia; Turville, Stuart G.; Luenemann, Anna; Schmidt, Jens; Muenz, Christian; Luenemann, Jan D.			TNF-alpha Induces Macroautophagy and Regulates MHC Class II Expression in Human Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCLUSION-BODY MYOSITIS; NECROSIS-FACTOR-ALPHA; IDIOPATHIC INFLAMMATORY MYOPATHIES; T-CELLS; INDUCED AUTOPHAGY; LIGAND TRAIL; APOPTOSIS; POLYMYOSITIS; DEATH; IMMUNOBIOLOGY	Macroautophagy, a homeostatic process that shuttles cytoplasmic constituents into endosomal and lysosomal compartments, has recently been shown to deliver antigens for presentation on major histocompatibility complex (MHC) class II molecules. Skeletal muscle fibers show a high level of constitutive macroautophagy and express MHC class II molecules upon immune activation. We found that tumor necrosis factor-alpha (TNF-alpha), a monokine overexpressed in inflammatory myopathies, led to a marked up-regulation of macroautophagy in skeletal myocytes. Furthermore, TNF-alpha augmented surface expression of MHC class II molecules in interferon-gamma (IFN-gamma)-treated myoblasts. The synergistic effect of TNF-alpha and IFN-gamma on the induction of MHC class II surface expression was not reflected by higher intracellular human leukocyte antigen (HLA)-DR levels and was reversed by macroautophagy inhibition, suggesting that TNF-alpha facilitates antigen processing via macroautophagy for more efficient MHC class II loading. Muscle biopsies from patients with sporadic inclusion body myositis, a well defined myopathy with chronic inflammation, showed that over 20% of fibers that contained autophagosomes costained for MHC class II molecules and that more than 40% of double-positive muscle fibers had contact with CD4(+) and CD8(+) immune cells. These findings establish a mechanism through which TNF-alpha regulates both macroautophagy and MHC class II expression and suggest that macroautophagy-mediated antigen presentation contributes to the immunological environment of the inflamed human skeletal muscle.	[Luenemann, Anna; Muenz, Christian; Luenemann, Jan D.] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Keller, Christian W.; Luenemann, Anna; Muenz, Christian; Luenemann, Jan D.] Rockefeller Univ, Lab Viral Immunobiol, Christopher H Browne Ctr Immunol & Immune Dis, New York, NY 10065 USA; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Inst Multiple Sclerosis Res, Dept Neurol, D-37073 Gottingen, Germany; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Inst Multiple Sclerosis Res, Dept Neuroimmunol, D-37073 Gottingen, Germany; [Keller, Christian W.; Fokken, Claudia; Schmidt, Jens] Univ Med Ctr, Hertie Fdn, D-37073 Gottingen, Germany; [Turville, Stuart G.] Westmead Hosp, Ctr Virus Res, Westmead Millennium Inst, Sydney, NSW 2145, Australia; [Turville, Stuart G.] Univ Sydney, Sydney, NSW 2145, Australia	University of Zurich; Rockefeller University; University of Gottingen; University of Gottingen; University of Gottingen; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Lunemann, JD (corresponding author), Univ Zurich, Inst Expt Immunol, Campus Irchel,Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jan.luenemann@usz.ch	Münz, Christian/W-4881-2017; Schmidt, Jens/B-5791-2013; Lunemann, Jan D/G-8729-2011	Lunemann, Jan D/0000-0002-3007-708X; Keller, Christian Wolfgang/0000-0003-2276-0003; Munz, Christian/0000-0001-6419-1940; Turville, Stuart/0000-0003-1918-5343	National Institutes of Health, NCI [R01CA108609, R01CA101741]; Foundation for National Institutes of Health Grand Challenges in Global Health; Boehringer Ingelheim; University of Gottingen; Swiss National Science Foundation [310030_126995]; Deutsche Forschungsgemeinschaft [SCHM 1669/2-1]; Fritz Thyssen Stiftung [Az 10.08.2.168]; Swiss National Research Foundation; Gemeinnutzige Hertie Stiftung; Swiss Multiple Sclerosis Foundation; Betty and David Koetser Foundation; Ernst Schering Foundation; Baxter Research Grant Program; NATIONAL CANCER INSTITUTE [R01CA108609, R01CA101741] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for National Institutes of Health Grand Challenges in Global Health; Boehringer Ingelheim(Boehringer Ingelheim); University of Gottingen; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fritz Thyssen Stiftung; Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Gemeinnutzige Hertie Stiftung; Swiss Multiple Sclerosis Foundation; Betty and David Koetser Foundation; Ernst Schering Foundation; Baxter Research Grant Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA108609 and R01CA101741 from NCI and Foundation for National Institutes of Health Grand Challenges in Global Health.; Supported by Boehringer Ingelheim Fonds Travel Allowance and funds from the University of Gottingen.; Supported by the Marie-Heim Vogtlin Program of the Swiss National Science Foundation.; Supported by Deutsche Forschungsgemeinschaft Grant SCHM 1669/2-1 and Fritz Thyssen Stiftung Grant Az 10.08.2.168.; Supported by Swiss National Science Foundation Grant 310030_126995.; Recipient of grant support from Swiss National Research Foundation, Gemeinnutzige Hertie Stiftung, Swiss Multiple Sclerosis Foundation, Betty and David Koetser Foundation, Ernst Schering Foundation, and Baxter Research Grant Program. To whom correspondence should be addressed: Institute of Experimental Immunology, University of Zurich, Campus Irchel, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland. Tel.: 41-44-635-3701; Fax: 41-44-635-6883; E-mail: jan.luenemann@usz.ch.	Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Arancibia-Carcamo CV, 2004, EUR J IMMUNOL, V34, P471, DOI 10.1002/eji.200324195; Curnow J, 2001, J NEUROIMMUNOL, V115, P127, DOI 10.1016/S0165-5728(01)00272-7; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Dalakas MC, 2006, NAT CLIN PRACT RHEUM, V2, P219, DOI 10.1038/ncprheum0140; De Bleecker JL, 1999, NEUROMUSCULAR DISORD, V9, P239, DOI 10.1016/S0960-8966(98)00126-6; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Englund P, 2007, ARTHRITIS RHEUM-US, V56, P372, DOI 10.1002/art.22293; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Fyhr IM, 2002, ACTA NEUROL SCAND, V105, P403, DOI 10.1034/j.1600-0404.2002.01198.x; GOEBELS N, 1992, J IMMUNOL, V149, P661; Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HOHLFELD R, 1994, IMMUNOL TODAY, V15, P269, DOI 10.1016/0167-5699(94)90006-X; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Klein L, 2010, FEBS LETT, V584, P1405, DOI 10.1016/j.febslet.2010.01.008; Kumamoto T, 2004, ACTA NEUROPATHOL, V107, P59, DOI 10.1007/s00401-003-0774-2; Kuru S, 2000, ACTA NEUROPATHOL, V99, P585, DOI 10.1007/s004010051165; Lepidi H, 1998, NEUROPATH APPL NEURO, V24, P73, DOI 10.1046/j.1365-2990.1998.00092.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lundberg I, 1995, J NEUROIMMUNOL, V63, P9, DOI 10.1016/0165-5728(95)00122-0; Lunemann JD, 2007, AUTOPHAGY, V3, P384; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Lunemann JD, 2002, J IMMUNOL, V168, P4881, DOI 10.4049/jimmunol.168.10.4881; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nikcevich KM, 1999, J NEUROIMMUNOL, V99, P195, DOI 10.1016/S0165-5728(99)00117-4; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pandya JM, 2010, ARTHRITIS RHEUM-US, V62, P3457, DOI 10.1002/art.27665; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148; Schmidt J, 2008, BRAIN, V131, P1228, DOI 10.1093/brain/awn053; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Thorburn J, 2005, MOL BIOL CELL, V16, P1189, DOI 10.1091/mbc.E04-10-0906; Wang YJ, 2008, J BIOL CHEM, V283, P4766, DOI 10.1074/jbc.M706666200; WARRENS AN, 1994, INT IMMUNOL, V6, P847, DOI 10.1093/intimm/6.6.847; Wiendl H, 2005, TRENDS IMMUNOL, V26, P373, DOI 10.1016/j.it.2005.05.003; Wiendl H, 2003, BRAIN, V126, P176, DOI 10.1093/brain/awg017	51	95	100	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3970	3980		10.1074/jbc.M110.159392	http://dx.doi.org/10.1074/jbc.M110.159392			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20980264	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000286653200077
J	Brahmbhatt, VV; Albert, CJ; Anbukumar, DS; Cunningham, BA; Neumann, WL; Ford, DA				Brahmbhatt, Viral V.; Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Neumann, William L.; Ford, David A.			omega-Oxidation of alpha-Chlorinated Fatty Acids IDENTIFICATION OF alpha-CHLORINATED DICARBOXYLIC ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINYL ETHER BOND; HEREDITARY MYELOPEROXIDASE DEFICIENCY; CORONARY-ARTERY-DISEASE; DENSITY-LIPOPROTEIN; MASS-SPECTROMETRY; LIVER-MICROSOMES; LIPID-METABOLISM; PLASMALOGENS; TARGET; BIOSYNTHESIS	Myeloperoxidase-derived HOCl targets tissue-and lipoprotein-associated plasmalogens to generate alpha-chlorinated fatty aldehydes, including 2-chlorohexadecanal. Under physiological conditions, 2-chlorohexadecanal is oxidized to 2-chlorohexadecanoic acid (2-ClHA). This study demonstrates the catabolism of 2-ClHA by omega-oxidation and subsequent beta-oxidation from the omega-end. Mass spectrometric analyses revealed that 2-ClHA is omega-oxidized in the presence of liver microsomes with initial omega-hydroxylation of 2-ClHA. Subsequent oxidation steps were examined in a human hepatocellular cell line (HepG2). Three different alpha-chlorinated dicarboxylic acids, 2-chlorohexadecane-(1,16)-dioic acid, 2-chlorotetradecane-(1,14)-dioic acid, and 2-chloroadipic acid (2-ClAdA), were identified. Levels of 2-chlorohexadecane-(1,16)-dioic acid, 2-chlorotetradecane-(1,14)-dioic acid, and 2-ClAdA produced by HepG2 cells were dependent on the concentration of 2-ClHA and the incubation time. Synthetic stable isotope-labeled 2-ClHA was used to demonstrate a precursor-product relationship between 2-ClHA and the alpha-chlorinated dicarboxylic acids. We also report the identification of endogenous 2-ClAdA in human and rat urine and elevations in stable isotope-labeled urinary 2-ClAdA in rats subjected to intraperitoneal administration of stable isotope-labeled 2-ClHA. Furthermore, urinary 2-ClAdA and plasma 2-ClHA levels are increased in LPS-treated rats. Taken together, these data show that 2-ClHA is omega-oxidized to generate alpha-chlorinated dicarboxylic acids, which include alpha-chloroadipic acid that is excreted in the urine.	[Brahmbhatt, Viral V.; Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Ford, David A.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Albert, Carolyn J.; Anbukumar, Dhanalakshmi S.; Cunningham, Bryce A.; Ford, David A.] St Louis Univ, Cardiovasc Res Ctr, St Louis, MO 63104 USA; [Neumann, William L.] So Illinois Univ, Dept Pharmaceut Sci, Edwardsville Sch Pharm, Edwardsville, IL 62026 USA	Saint Louis University; Saint Louis University; Southern Illinois University System; Southern Illinois University Edwardsville	Ford, DA (corresponding author), Dept Biochem & Mol Biol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	fordda@slu.edu	Ford, David/D-1819-2018	Ford, David/0000-0002-0029-1560	National Institutes of Health [HL074214, HL088073, HL098907, RR019232]; American Heart Association [0650044Z, 0710121Z, 0710163Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019232] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074214, R21HL098907, R21HL088073] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL074214 (to D.A.F.), HL088073 (to D.A.F.), HL098907 (to D.A.F.), and RR019232 (to D.A.F.). This work was also supported by Grant-in-aid 0650044Z (to D.A.F.) and Predoctoral Fellowship Grants 0710121Z (to V.V.B.) and 0710163Z (to D.S.A.) from the American Heart Association.	Albert CJ, 2002, J BIOL CHEM, V277, P4694, DOI 10.1074/jbc.M110875200; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Albert CJ, 2001, J BIOL CHEM, V276, P23733, DOI 10.1074/jbc.M101447200; Anbukumar DS, 2010, J LIPID RES, V51, P1085, DOI 10.1194/jlr.M003673; Asselbergs FW, 2004, AM J MED, V116, P429, DOI 10.1016/j.amjmed.2003.10.025; BERGSETH S, 1988, BIOCHIM BIOPHYS ACTA, V961, P103, DOI 10.1016/0005-2760(88)90135-X; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; BJORKHEM I, 1976, J BIOL CHEM, V251, P5259; BJORKHEM I, 1978, J LIPID RES, V19, P585; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CECH P, 1979, BLOOD, V53, P403; CHASE JFA, 1972, BIOCHEM J, V129, P55, DOI 10.1042/bj1290055; GREGERSEN N, 1983, CLIN CHIM ACTA, V132, P181, DOI 10.1016/0009-8981(83)90246-2; Grossert JS, 2005, CAN J CHEM, V83, P1878, DOI 10.1139/V05-214; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Hsu FF, 1999, INT J MASS SPECTROM, V185, P795, DOI 10.1016/S1387-3806(98)14105-2; Jemal M, 1998, J CHROMATOGR B, V709, P233, DOI 10.1016/S0378-4347(98)00080-2; KAIKAUS RM, 1993, J BIOL CHEM, V268, P9593; Kakola J, 2006, J SEP SCI, V29, P1996, DOI 10.1002/jssc.200600106; Kerwin JL, 1996, ANAL BIOCHEM, V237, P56, DOI 10.1006/abio.1996.0200; KITAHARA M, 1981, BLOOD, V57, P888; Komen JC, 2004, J LIPID RES, V45, P1341, DOI 10.1194/jlr.M400064-JLR200; LAMPERT MB, 1983, BLOOD, V62, P645; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; LU AYH, 1968, J BIOL CHEM, V243, P1331; Marsche G, 2004, ARTERIOSCL THROM VAS, V24, P2302, DOI 10.1161/01.ATV.0000148703.43429.25; McMillen TS, 2005, CIRCULATION, V111, P2798, DOI 10.1161/CIRCULATIONAHA.104.516278; MORTENSEN PB, 1984, DAN MED BULL, V31, P121; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V666, P394, DOI 10.1016/0005-2760(81)90298-8; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nikpoor B, 2001, AM HEART J, V142, P336, DOI 10.1067/mhj.2001.116769; Okita RT, 2001, CURR DRUG METAB, V2, P265; Panneels V, 1996, J BIOL CHEM, V271, P23006, DOI 10.1074/jbc.271.38.23006; PASSI S, 1984, BIOCHEM PHARMACOL, V33, P103, DOI 10.1016/0006-2952(84)90376-9; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Skaff O, 2008, BIOCHEMISTRY-US, V47, P8237, DOI 10.1021/bi800786q; STAROSTIN EK, 1992, SYNTHESIS-STUTTGART, P917; Sugiyama S, 2001, AM J PATHOL, V158, P879, DOI 10.1016/S0002-9440(10)64036-9; Thukkani AK, 2005, AM J PHYSIOL-HEART C, V288, pH2955, DOI 10.1152/ajpheart.00834.2004; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Thukkani AK, 2002, J BIOL CHEM, V277, P3842, DOI 10.1074/jbc.M109489200; TONSGARD JH, 1985, J PEDIATR-US, V107, P79, DOI 10.1016/S0022-3476(85)80619-3; TONSGARD JH, 1985, J CLIN INVEST, V76, P816, DOI 10.1172/JCI112039; VAMECQ J, 1985, BIOCHEM J, V230, P683, DOI 10.1042/bj2300683; WAKABAYASHI K, 1963, BIOCHIM BIOPHYS ACTA, V70, P132, DOI 10.1016/0006-3002(63)90733-9; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wildsmith KR, 2006, CHEM PHYS LIPIDS, V139, P157, DOI 10.1016/j.chemphyslip.2005.12.003; Wildsmith KR, 2006, J BIOL CHEM, V281, P16849, DOI 10.1074/jbc.M602505200; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	51	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41255	41269		10.1074/jbc.M110.147157	http://dx.doi.org/10.1074/jbc.M110.147157			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956542	Green Published, hybrid			2022-12-27	WOS:000285622600011
J	Cheng, SW; Li, LX; He, ST; Liu, J; Sun, YN; He, MC; Grasing, K; Premont, RT; Suo, WZ				Cheng, Shaowu; Li, Longxuan; He, Shuangteng; Liu, Jun; Sun, Yuning; He, Minchao; Grasing, Kenneth; Premont, Richard T.; Suo, William Z.			GRK5 Deficiency Accelerates beta-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR KINASES; PRECURSOR PROTEIN-METABOLISM; M1 MUSCARINIC AGONISTS; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; HYPOTHESIS; PHOSPHORYLATION; ACTIVATION; DESENSITIZATION; PERSPECTIVE	Membrane G protein-coupled receptor kinase 5 (GRK5) deficiency is linked to Alzheimer disease, yet its precise roles in the disease pathogenesis remain to be delineated. We have previously demonstrated that GRK5 deficiency selectively impairs desensitization of presynaptic M2 autoreceptors, which causes presynaptic M2 hyperactivity and inhibits acetylcholine release. Here we report that inactivation of one copy of Grk5 gene in transgenic mice overexpressing beta-amyloid precursor protein (APP) carrying Swedish mutations (Tg2576 or APPsw) resulted in significantly increased beta-amyloid (A beta) accumulation, including increased A beta(+) plaque burdens and soluble A beta in brain lysates and interstitial fluid (ISF). In addition, secreted beta-APP fragment (sAPP beta) also increased, whereas full-length APP level did not change, suggesting an alteration in favor of beta-amyloidogenic APP processing in these animals. Reversely, perfusion of methoctramine, a selective M2 antagonist, fully corrected the difference between the control and GRK5-deficient APPsw mice for ISF A beta. In contrast, a cholinesterase inhibitor, eserine, although significantly decreasing the ISF A beta in both control and GRK5-deficient APPsw mice, failed to correct the difference between them. However, combining eserine with methoctramine additively reduced the ISF A beta further in both animals. Altogether, these findings indicate that GRK5 deficiency accelerates beta-amyloidogenic APP processing and A beta accumulation in APPsw mice via impaired cholinergic activity and that presynaptic M2 hyperactivity is the specific target for eliminating the pathologic impact of GRK5 deficiency. Moreover, a combination of an M2 antagonist and a cholinesterase inhibitor may reach the maximal disease-modifying effect for both amyloid pathology and cholinergic dysfunction.	[Suo, William Z.] Univ Kansas, Coll Med, Dept Neurol, Kansas City, KS 66170 USA; [Suo, William Z.] Univ Kansas, Coll Med, Dept Physiol, Kansas City, KS 66170 USA; [He, Shuangteng; Grasing, Kenneth] Kansas City Vet Affairs Med Ctr, Subst Abuse Res Lab, Kansas City, MO 64128 USA; [Li, Longxuan] Guangdong Med Coll Affiliated Hosp, Dept Neurol, Zhanjiang 524001, Peoples R China; [Liu, Jun] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China; [He, Minchao] Ningxia Med Univ, Dept Biochem & Mol Biol, Ningxia 750004, Peoples R China; [Premont, Richard T.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Cheng, Shaowu; Li, Longxuan; Liu, Jun; Sun, Yuning; He, Minchao; Suo, William Z.] Kansas City Vet Affairs Med Ctr, Lab Alzheimers Dis & Aging Res, Kansas City, MO 64128 USA	University of Kansas; University of Kansas; Guangdong Medical University; Sun Yat Sen University; Ningxia Medical University; Duke University	Suo, WZ (corresponding author), Vet Adm Med Ctr, Lab Alzheimers Dis & Aging Res, 4801 Linwood Blvd, Kansas City, MO 64128 USA.	William.Suo@va.gov	cheng, shaowu/C-1622-2013	cheng, shaowu/0000-0001-6148-9565; Premont, Richard/0000-0002-8053-5026; cheng, shaowu/0000-0001-9059-4727; Grasing, Kenneth/0000-0002-6464-5700	Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research; Midwest Biomedical Research Foundation	Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research(US Department of Veterans Affairs); Midwest Biomedical Research Foundation	This work was supported by grants from the Medical Research and Development Service, Department of Veterans Affairs, the American Federation for Aging Research, and the Midwest Biomedical Research Foundation (to W. Z. S.).	BARTUS RT, 1985, ANN NY ACAD SCI, V444, P332, DOI 10.1111/j.1749-6632.1985.tb37600.x; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bartus RT, 1999, JAMA-J AM MED ASSOC, V282, P2208, DOI 10.1001/jama.282.23.2208; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Cirrito JR, 2003, J NEUROSCI, V23, P8844; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; DeLapp N, 1998, BIOCHEM BIOPH RES CO, V244, P156, DOI 10.1006/bbrc.1998.8235; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; FARBER SA, 1995, J NEUROSCI, V15, P7442; Fisher A, 2003, J MOL NEUROSCI, V20, P349, DOI 10.1385/JMN:20:3:349; Fisher A, 2008, NEUROTHERAPEUTICS, V5, P433, DOI 10.1016/j.nurt.2008.05.002; Fisher A, 2008, NEURODEGENER DIS, V5, P237, DOI 10.1159/000113712; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Imahori K, 1997, J BIOCHEM, V121, P179; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; King DL, 1999, BEHAV BRAIN RES, V103, P145, DOI 10.1016/S0166-4328(99)00037-6; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Ladner CJ, 1998, J NEUROPATH EXP NEUR, V57, P719, DOI 10.1097/00005072-199808000-00001; LEE RKK, 1995, P NATL ACAD SCI USA, V92, P8083, DOI 10.1073/pnas.92.17.8083; Levey AI, 1996, P NATL ACAD SCI USA, V93, P13541, DOI 10.1073/pnas.93.24.13541; Li LX, 2009, BRAIN RES BULL, V78, P145, DOI 10.1016/j.brainresbull.2008.09.019; Li L, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-24; Lin L, 1999, P NATL ACAD SCI USA, V96, P12108, DOI 10.1073/pnas.96.21.12108; Liskowsky W, 2006, INT J DEV NEUROSCI, V24, P149, DOI 10.1016/j.ijdevneu.2005.11.010; Liu J, 2009, J BIOL CHEM, V284, P19564, DOI 10.1074/jbc.M109.005959; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Nitsch RM, 1996, J BIOL CHEM, V271, P4188; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Roberson MR, 1997, BRAIN RES REV, V25, P50, DOI 10.1016/S0165-0173(97)00016-7; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Sadot E, 1996, J NEUROCHEM, V66, P877; Small DH, 2006, J NEUROCHEM, V99, P708, DOI 10.1111/j.1471-4159.2006.04212.x; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Suo WZ, 2010, THESCIENTIFICWORLDJO, V10, P1667, DOI 10.1100/tsw.2010.154; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Suo ZM, 2004, J NEUROSCI, V24, P3444, DOI 10.1523/JNEUROSCI.4856-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Trojanowski JQ, 1995, FASEB J, V9, P1570, DOI 10.1096/fasebj.9.15.8529836; Uezu K, 2005, BRAIN RES, V1050, P118, DOI 10.1016/j.brainres.2005.05.044; Walker JKL, 2004, AM J PHYSIOL-LUNG C, V286, pL312, DOI 10.1152/ajplung.00255.2003; Wang J, 2003, NEUROBIOL DIS, V14, P318, DOI 10.1016/j.nbd.2003.08.009; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Woolf NJ, 1996, NEUROBIOL LEARN MEM, V66, P258, DOI 10.1006/nlme.1996.0068; Zhang WL, 2002, J NEUROSCI, V22, P1709, DOI 10.1523/JNEUROSCI.22-05-01709.2002; Zhang XY, 1999, AM J PHYSIOL-LUNG C, V276, pL769, DOI 10.1152/ajplung.1999.276.5.L769; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07	59	30	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41541	41548		10.1074/jbc.M110.170894	http://dx.doi.org/10.1074/jbc.M110.170894			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041302	hybrid, Green Published			2022-12-27	WOS:000285622600041
J	Delekta, PC; Apel, IJ; Gu, SF; Siu, K; Hattori, Y; McAllister-Lucas, LM; Lucas, PC				Delekta, Phillip C.; Apel, Ingrid J.; Gu, Shufang; Siu, Katy; Hattori, Yoshiyuki; McAllister-Lucas, Linda M.; Lucas, Peter C.			Thrombin-dependent NF-kappa B Activation and Monocyte/Endothelial Adhesion Are Mediated by the CARMA3.Bcl10.MALT1 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELA/P65 NUCLEAR TRANSLOCATION; INDUCED ICAM-1 EXPRESSION; ENDOTHELIAL-CELLS; PROTEIN-KINASE; MOLECULE-1 EXPRESSION; CARMA3/BCL10/MALT1 COMPLEX; SIGNALING PATHWAYS; EPITHELIAL-CELLS; GENE-EXPRESSION; CANCER CELLS	Thrombin is a potent modulator of endothelial function and, through stimulation of NF-kappa B, induces endothelial expression of intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). These cell surface adhesion molecules recruit inflammatory cells to the vessel wall and thereby participate in the development of atherosclerosis, which is increasingly recognized as an inflammatory condition. The principal receptor for thrombin on endothelial cells is protease-activated receptor-1 (PAR-1), a member of the G protein-coupled receptor superfamily. Although it is known that PAR-1 signaling to NF-kappa B depends on initial PKC activation, the subsequent steps leading to stimulation of the canonical NF-kappa B machinery have remained unclear. Here, we demonstrate that a complex of proteins containing CARMA3, Bcl10, and MALT1 links PAR-1 activation to stimulation of the I kappa B kinase complex. I kappa B kinase in turn phosphorylates I kappa B, leading to its degradation and the release of active NF-kappa B. Further, we find that although this CARMA3.Bcl10.MALT1 signalosome shares features with a CARMA1-containing signalosome found in lymphocytes, there are significant differences in how the signalosomes communicate with their cognate receptors. Specifically, whereas the CARMA1-containing lymphocyte complex relies on 3-phosphoinositide-dependent protein kinase 1 for assembly and activation, the CARMA3-containing endothelial signalosome functions completely independent of 3-phosphoinositide-dependent protein kinase 1 and instead relies on beta-arrestin 2 for assembly. Finally, we show that thrombin-dependent adhesion of monocytes to endothelial cells requires an intact endothelial CARMA3.Bcl10.MALT1 signalosome, underscoring the importance of the signalosome in mediating one of the most significant pro-atherogenic effects of thrombin.	[Apel, Ingrid J.; Gu, Shufang; Siu, Katy; Lucas, Peter C.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Delekta, Phillip C.; Lucas, Peter C.] Univ Michigan, Sch Med, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [McAllister-Lucas, Linda M.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Hattori, Yoshiyuki] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi 3210293, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Dokkyo Medical University	Lucas, PC (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 3510 MSRB I,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu		Lucas, Peter/0000-0003-4880-7172	National Institutes of Health [R01-HL082914, R01-DK079973]; Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shirley K. Schlafer Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-HL082914 and R01-DK079973 (to P.C.L.). This work was also supported by Shirley K. Schlafer Foundation (to L.M.M.-L.).	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Anwar KN, 2004, J IMMUNOL, V173, P6965, DOI 10.4049/jimmunol.173.11.6965; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Bijli KM, 2007, AM J PHYSIOL-LUNG C, V292, pL396, DOI 10.1152/ajplung.00163.2006; Blonska M, 2009, IMMUNOL REV, V228, P199, DOI 10.1111/j.1600-065X.2008.00749.x; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Borthakur A, 2010, INFLAMM BOWEL DIS, V16, P593, DOI 10.1002/ibd.21092; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Gustin JA, 2006, J BIOL CHEM, V281, P16473, DOI 10.1074/jbc.M507373200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Inohara N, 2000, J BIOL CHEM, V275, P27823; Kalmes A, 2001, ANN NY ACAD SCI, V947, P42; Kang KW, 2003, J BIOL CHEM, V278, P17368, DOI 10.1074/jbc.M300471200; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Major C, 2003, ARTERIOSCL THROM VAS, V23, pA48; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Martorell L, 2008, THROMB HAEMOSTASIS, V99, P305, DOI 10.1160/TH07-08-0481; Matsumoto R, 2005, IMMUNITY, V23, P575, DOI 10.1016/j.immuni.2005.10.007; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Miho N, 2005, CARDIOVASC RES, V68, P289, DOI 10.1016/j.cardiores.2005.05.029; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; Minami T, 2003, J BIOL CHEM, V278, P6976, DOI 10.1074/jbc.M208974200; Minami T, 2001, J BIOL CHEM, V276, P47632, DOI 10.1074/jbc.M108363200; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Nakano A, 2009, HYPERTENS RES, V32, P765, DOI 10.1038/hr.2009.95; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Ozes ON, 1999, NATURE, V401, P82; Pantano C, 2006, ANTIOXID REDOX SIGN, V8, P1791, DOI 10.1089/ars.2006.8.1791; Park SG, 2009, NAT IMMUNOL, V10, P158, DOI 10.1038/ni.1687; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Tantivejkul K, 2005, J CELL BIOCHEM, V96, P641, DOI 10.1002/jcb.20533; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; WEGENER E, 2007, SCI STKE, pPE21; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839	68	60	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41432	41442		10.1074/jbc.M110.158949	http://dx.doi.org/10.1074/jbc.M110.158949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041303	Green Published, hybrid			2022-12-27	WOS:000285622600029
J	Ghanam, RH; Fernandez, TF; Fledderman, EL; Saad, JS				Ghanam, Ruba H.; Fernandez, Timothy F.; Fledderman, Emily L.; Saad, Jamil S.			Binding of Calmodulin to the HIV-1 Matrix Protein Triggers Myristate Exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SIZE-DISTRIBUTION ANALYSIS; GAG MEMBRANE-BINDING; PLASMA-MEMBRANE; ANALYTICAL ULTRACENTRIFUGATION; INTRACELLULAR TRAFFICKING; TARGET RECOGNITION; CALCIUM-BINDING; ENVELOPE GLYCOPROTEIN; STRUCTURAL BIOLOGY	Steady progress has been made in defining both the viral and cellular determinants of retroviral assembly and release. Although it is widely accepted that targeting of the Gag polypeptide to the plasma membrane is critical for proper assembly of HIV-1, the intracellular interactions and trafficking of Gag to its assembly sites in the infected cell are poorly understood. HIV-1 Gag was shown to interact and co-localize with calmodulin (CaM), a ubiquitous and highly conserved Ca2+-binding protein expressed in all eukaryotic cells, and is implicated in a variety of cellular functions. Binding of HIV-1 Gag to CaM is dependent on calcium and is mediated by the N-terminally myristoylated matrix (myr(+)MA) domain. Herein, we demonstrate that CaM binds to myr(+) MA with a dissociation constant (K-d) of similar to 2 mu M and 1: 1 stoichiometry. Strikingly, our data revealed that CaM binding to MA induces the extrusion of the myr group. However, in contrast to all known examples of CaM-binding myristoylated proteins, our data show that the myr group is exposed to solvent and not involved in CaM binding. The interactions between CaM and myr(+) MA are endothermic and entropically driven, suggesting that hydrophobic contacts are critical for binding. As revealed by NMR data, both CaM and MA appear to engage substantial regions and/or undergo significant conformational changes upon binding. We believe that our findings will provide new insights on how Gag may interact with CaM during the HIV replication cycle.	[Ghanam, Ruba H.; Fernandez, Timothy F.; Fledderman, Emily L.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101]; University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center [NCI CA13148-35]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI087101. This work was also supported by intramural funding from the University of Alabama at Birmingham Center for AIDS Research and Comprehensive Cancer Center Grant NCI CA13148-35.	Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Dou J, 2009, VIROLOGY, V387, P341, DOI 10.1016/j.virol.2009.02.037; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Faurobert E, 1996, J BIOL CHEM, V271, P10256, DOI 10.1074/jbc.271.17.10256; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FOLKERS PJM, 1993, J AM CHEM SOC, V115, P3798, DOI 10.1021/ja00062a065; FRANKE EK, 1994, J VIROL, V68, P5300, DOI 10.1128/JVI.68.8.5300-5305.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hermida-Matsumoto L, 2000, J VIROL, V74, P8670, DOI 10.1128/JVI.74.18.8670-8679.2000; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; Matsuda S, 1998, J BIOL CHEM, V273, P20223, DOI 10.1074/jbc.273.32.20223; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Morikawa Y, 2000, J VIROL, V74, P16, DOI 10.1128/JVI.74.1.16-23.2000; Morikawa Y, 1998, J VIROL, V72, P7659, DOI 10.1128/JVI.72.9.7659-7663.1998; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Ono A, 2010, BIOL CELL, V102, P335, DOI 10.1042/BC20090165; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; PUTKEY JA, 1985, J BIOL CHEM, V260, P4704; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; VOGEL HJ, 1994, BIOCHEM CELL BIOL, V72, P357, DOI 10.1139/o94-049; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	94	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41911	41920		10.1074/jbc.M110.179093	http://dx.doi.org/10.1074/jbc.M110.179093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20956522	Green Published, hybrid			2022-12-27	WOS:000285622600078
J	Hunter, GA; Ferreira, GC				Hunter, Gregory A.; Ferreira, Gloria C.			Identification and Characterization of an Inhibitory Metal Ion-binding Site in Ferrochelatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS FERROCHELATASE; MITOCHONDRIAL CARRIER PROTEINS; HEME-BIOSYNTHESIS; PRODUCT RELEASE; IRON; FRATAXIN; CHELATION; BUFFERS; ENZYME	Ferrochelatase catalyzes the insertion of ferrous iron into protoporphyrin IX to form heme. The severe metal ion substrate inhibition observed during in vitro studies of the purified enzyme is almost completely eliminated by mutation of an active site histidine residue (His-287, murine ferrochelatase numbering) to leucine and reduced over 2 orders of magnitude by mutation of a nearby conserved phenylalanine residue (Phe-283) to leucine. Elimination of substrate inhibition had no effect on the apparent V-max for Ni2+, but the apparent K-m was increased 100-fold, indicating that the integrity of the inhibitory binding site is important for the enzyme to turn over substrates rapidly at low micromolar metal ion concentrations. The inhibitory site was observed to have a pK(a) value of 8.0, and this value was reduced to 7.5 by the F283L mutation and to 7.4 in a naturally occurring positional variant observed in most bacterial ferrochelatases, murine ferrochelatase H287C. A H287N variant was also found to be substrate-inhibited, but unlike the H287C variant, pH dependence of substrate inhibition was largely eliminated. The data indicate that the inhibitory metal ion-binding site is composed of multiple residues but primarily defined by His-287 and Phe-283 and is crucial for optimal activity at low metal ion concentrations. It is proposed that this binding site may be important for ferrous iron acquisition and desolvation in vivo.	[Hunter, Gregory A.] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Hunter, GA (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, MDC 7, Tampa, FL 33612 USA.	ghunter@health.usf.edu; gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	National Institutes of Health [GM080270]; American Heart Association Florida [0655091B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Florida(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080270 (to G. C. F.). This work was also supported by the American Heart Association Florida Affiliate 0655091B (to G. C. F.).	Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; [Anonymous], 2010, HDB PORPHYRIN SCI, V15; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Cleland W W, 1977, Adv Enzymol Relat Areas Mol Biol, V45, P273; Davidson RE, 2009, J BIOL CHEM, V284, P33795, DOI 10.1074/jbc.M109.030205; FERREIRA GC, 1994, J BIOL CHEM, V269, P4396; FISCHER BE, 1979, EUR J BIOCHEM, V94, P523, DOI 10.1111/j.1432-1033.1979.tb12921.x; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Hansson MD, 2007, BIOCHEMISTRY-US, V46, P87, DOI 10.1021/bi061760a; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hoggins M, 2007, BIOCHEMISTRY-US, V46, P8121, DOI 10.1021/bi602418e; Hunter GA, 2008, J BIOL CHEM, V283, P23685, DOI 10.1074/jbc.M803372200; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Lecerof D, 2003, J BIOL INORG CHEM, V8, P452, DOI 10.1007/s00775-002-0436-1; Lecha M, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-19; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Mash HE, 2003, ANAL CHEM, V75, P671, DOI 10.1021/ac0261101; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock AE, 2009, J MOL BIOL, V393, P308, DOI 10.1016/j.jmb.2009.08.042; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yu QY, 1997, ANAL BIOCHEM, V253, P50, DOI 10.1006/abio.1997.2349; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200	28	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41836	41842		10.1074/jbc.M110.174243	http://dx.doi.org/10.1074/jbc.M110.174243			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966079	hybrid, Green Published			2022-12-27	WOS:000285622600071
J	Jesch, SA; Gaspar, ML; Stefan, CJ; Aregullin, MA; Henry, SA				Jesch, Stephen A.; Gaspar, Maria L.; Stefan, Christopher J.; Aregullin, Manuel A.; Henry, Susan A.			Interruption of Inositol Sphingolipid Synthesis Triggers Stt4p-dependent Protein Kinase C Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; SAC1 LIPID PHOSPHATASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; MAP-KINASE; PHOSPHATIDYLINOSITOL 4-KINASE; PHOSPHOLIPID-METABOLISM; BUDDING YEAST; 1,3-BETA-D-GLUCAN SYNTHASE; ACTIN CYTOSKELETON	The protein kinase C (PKC)-MAPK signaling cascade is activated and is essential for viability when cells are starved for the phospholipid precursor inositol. In this study, we report that inhibiting inositol-containing sphingolipid metabolism, either by inositol starvation or treatment with agents that block sphingolipid synthesis, triggers PKC signaling independent of sphingoid base accumulation. Under these same growth conditions, a fluorescent biosensor that detects the necessary PKC signaling intermediate, phosphatidylinositol (PI)-4-phosphate (PI4P), is enriched on the plasma membrane. The appearance of the PI4P biosensor on the plasma membrane correlates with PKC activation and requires the PI 4-kinase Stt4p. Like other mutations in the PKC-MAPK pathway, mutants defective in Stt4p and the PI4P 5-kinase Mss4p, which generates phosphatidylinositol 4,5-bisphosphate, exhibit inositol auxotrophy, yet fully derepress INO1, encoding inositol-3-phosphate synthase. These observations suggest that inositol-containing sphingolipid metabolism controls PKC signaling by regulating access of the signaling lipids PI4P and phosphatidylinositol 4,5-bisphosphate to effector proteins on the plasma membrane.	[Henry, Susan A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Stefan, Christopher J.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Henry, SA (corresponding author), Cornell Univ, Dept Mol Biol & Genet, 249 Biotechnol Bldg, Ithaca, NY 14853 USA.	sah42@cornell.edu	Henry, Susan/K-5464-2014	Stefan, Christopher/0000-0002-4118-5721	National Institutes of Health [GM-19629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019629, F32GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-19629 (to S.A.H.).	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balasubramanian K, 1996, EUR J BIOCHEM, V240, P798, DOI 10.1111/j.1432-1033.1996.0798h.x; BECKER GW, 1977, J BIOL CHEM, V252, P8684; Becker KP, 2005, CELL MOL LIFE SCI, V62, P1448, DOI 10.1007/s00018-005-4531-7; Brachmann CB, 1998, YEAST, V14, P115; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; CERBON J, 1995, BBA-BIOMEMBRANES, V1235, P100, DOI 10.1016/0005-2736(94)00311-C; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; Faulhammer F, 2005, J CELL BIOL, V168, P185, DOI 10.1083/jcb.200407118; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gaspar ML, 2007, BBA-MOL CELL BIOL L, V1771, P241, DOI 10.1016/j.bbalip.2006.06.011; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HANSON BA, 1980, J LIPID RES, V21, P309; HAWKINS PT, 1986, BIOCHEM J, V238, P507, DOI 10.1042/bj2380507; HECHTBERGER P, 1994, EUR J BIOCHEM, V225, P641, DOI 10.1111/j.1432-1033.1994.00641.x; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; INOUE SB, 1995, EUR J BIOCHEM, V231, P845, DOI 10.1111/j.1432-1033.1995.tb20770.x; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jin H, 2008, J CELL BIOL, V180, P813, DOI 10.1083/jcb.200705076; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kobayashi T, 2005, J BIOL CHEM, V280, P18087, DOI 10.1074/jbc.M414138200; LEE KS, 1993, MOL CELL BIOL, V13, P3067, DOI 10.1128/MCB.13.5.3067; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; MAZZONI C, 1993, J CELL BIOL, V123, P1821, DOI 10.1083/jcb.123.6.1821; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; NIKAWA J, 1984, EUR J BIOCHEM, V143, P251, DOI 10.1111/j.1432-1033.1984.tb08366.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Perera NM, 2004, J BIOL CHEM, V279, P5216, DOI 10.1074/jbc.M305068200; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Roelants FM, 2010, P NATL ACAD SCI USA, V107, P34, DOI 10.1073/pnas.0912497106; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Sawai H, 1999, CHEM PHYS LIPIDS, V102, P141, DOI 10.1016/S0009-3084(99)00082-1; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Stock SD, 2000, ANTIMICROB AGENTS CH, V44, P1174, DOI 10.1128/AAC.44.5.1174-1180.2000; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Torres J, 2002, J BIOL CHEM, V277, P43495, DOI 10.1074/jbc.M205408200; Villa-Garcia M., 2011, MOL GENET G IN PRESS; WHITTERS EA, 1993, J CELL BIOL, V122, P79, DOI 10.1083/jcb.122.1.79; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	92	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41947	41960		10.1074/jbc.M110.188607	http://dx.doi.org/10.1074/jbc.M110.188607			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20972263	Green Published, hybrid			2022-12-27	WOS:000285622600081
J	Lin, CY; Meng, SX; Zhu, TN; Wang, XZ				Lin, Chengyi; Meng, Shuxia; Zhu, Tina; Wang, Xiaozhong			PDCD10/CCM3 Acts Downstream of gamma-Protocadherins to Regulate Neuronal Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; ACTIVATED PROTEIN-KINASE; APOPTOSIS-RELATED GENE; PROGRAMMED CELL-DEATH; NERVOUS-SYSTEM; HOMOPHILIC INTERACTION; SPINAL INTERNEURONS; MOLECULAR-GENETICS; RECENT INSIGHTS; ENCODING KRIT1	gamma-Protocadherins (PCDH-gamma) regulate neuronal survival in the vertebrate central nervous system. The molecular mechanisms of how PCDH-gamma mediates this function are still not understood. In this study, we show that through their common cytoplasmic domain, different PCDH-gamma isoforms interact with an intracellular adaptor protein named PDCD10 (programmed cell death 10). PDCD10 is also known as CCM3, a causative genetic defect for cerebral cavernous malformations in humans. Using RNAi-mediated knockdown, we demonstrate that PDCD10 is required for the occurrence of apoptosis upon PCDH-gamma depletion in developing chicken spinal neurons. Moreover, overexpression of PDCD10 is sufficient to induce neuronal apoptosis. Taken together, our data reveal a novel function for PDCD10/CCM3, acting as a critical regulator of neuronal survival during development.	[Lin, Chengyi; Meng, Shuxia; Zhu, Tina; Wang, Xiaozhong] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Wang, XZ (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	awang@northwestern.edu			National Institutes of Health [5R01NS051253]; 3M Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051253] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 3M Fellowship(3M); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grant 5R01NS051253 (to X. W.).; Supported in part by a 3M Fellowship.	Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Chan AC, 2010, FEBS J, V277, P1076, DOI 10.1111/j.1742-4658.2009.07536.x; Chen J, 2009, J BIOL CHEM, V284, P2880, DOI 10.1074/jbc.M807417200; Cheng AW, 2001, J BIOL CHEM, V276, P43320, DOI 10.1074/jbc.M107698200; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Emond MR, 2008, DEV BIOL, V321, P175, DOI 10.1016/j.ydbio.2008.06.011; Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Fong B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-2; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Han MH, 2010, MOL CELL PROTEOMICS, V9, P71, DOI 10.1074/mcp.M900343-MCP200; Harada J, 1999, JPN J PHARMACOL, V79, P369, DOI 10.1254/jjp.79.369; Harel L, 2009, NEURON, V63, P585, DOI 10.1016/j.neuron.2009.08.020; Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142; Horstmann S, 1998, J NEUROSCI RES, V52, P483, DOI 10.1002/(SICI)1097-4547(19980515)52:4<483::AID-JNR12>3.3.CO;2-Y; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kummer JL, 1997, J BIOL CHEM, V272, P20490, DOI 10.1074/jbc.272.33.20490; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Linseman DA, 2001, J BIOL CHEM, V276, P39123, DOI 10.1074/jbc.M103959200; Liquori Christina L, 2006, Hum Mutat, V27, P118, DOI 10.1002/humu.9389; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lowrie MB, 2000, PROG NEUROBIOL, V61, P543, DOI 10.1016/S0301-0082(99)00065-9; Lu YY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp686; Ma X, 2007, MOL BIOL CELL, V18, P1965, DOI 10.1091/mbc.E06-07-0608; Mennerick S, 2000, MOL NEUROBIOL, V22, P41; Nakamura H, 2001, METHODS, V24, P43, DOI 10.1006/meth.2001.1155; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nogueira E, 2008, J BIOL CHEM, V283, P16248, DOI 10.1074/jbc.M709724200; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Petit N, 2006, GENE EXPR PATTERNS, V6, P495, DOI 10.1016/j.modgep.2005.11.001; Phillips GR, 2003, J NEUROSCI, V23, P5096; Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8; Prasad T, 2008, DEVELOPMENT, V135, P4153, DOI 10.1242/dev.026807; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Silos-Santiago Inmaculada, 1995, Current Opinion in Neurobiology, V5, P42, DOI 10.1016/0959-4388(95)80085-9; Su H, 2010, DEV BIOL, V339, P38, DOI 10.1016/j.ydbio.2009.12.010; Tanriover G, 2008, NEUROSURGERY, V62, P930, DOI 10.1227/01.neu.0000318179.02912.ca; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wang YG, 1999, SCI CHINA SER C, V42, P323, DOI 10.1007/BF03183610; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu HY, 2008, APOPTOSIS, V13, P283, DOI 10.1007/s10495-007-0161-x; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	70	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41675	41685		10.1074/jbc.M110.179895	http://dx.doi.org/10.1074/jbc.M110.179895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041308	Green Published, hybrid			2022-12-27	WOS:000285622600055
J	Ooms, LS; Kobayashi, T; Dermody, TS; Chappell, JD				Ooms, Laura S.; Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.			A Post-entry Step in the Mammalian Orthoreovirus Replication Cycle Is a Determinant of Cell Tropism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEMPERATURE-SENSITIVE MUTANTS; REVERSE GENETICS SYSTEM; DOUBLE-STRANDED-RNA; CORE PROTEIN MU-2; REOVIRUS TYPE 3; M1 GENE; INFLUENZA-VIRUS; TRIPHOSPHATASE ACTIVITIES; INDUCED APOPTOSIS; STRAIN	Mammalian reoviruses replicate in a broad range of hosts, cells, and tissues. These viruses display strain-dependent variation in tropism for different types of cells in vivo and ex vivo. Early steps in the reovirus life cycle, attachment, entry, and disassembly, have been identified as pivotal points of virus-cell interaction that determine the fate of infection, either productive or abortive. However, in studies of the differential capacity of reovirus strains type 1 Lang and type 3 Dearing to replicate in Madin-Darby canine kidney (MDCK) cells, we found that replication efficiency is regulated at a late point in the viral life cycle following primary transcription and translation. Results of genetic studies using recombinant virus strains show that reovirus tropism for MDCK cells is primarily regulated by replication protein mu 2 and further influenced by the viral RNA-dependent RNA polymerase protein, mu 3, depending on the viral genetic background. Furthermore, mu 2 residue 347 is a critical determinant of replication efficiency in MDCK cells. These findings indicate that components of the reovirus replication complex are mediators of cell-selective viral replication capacity at a post-entry step. Thus, reovirus cell tropism may be determined at early and late points in the viral replication program.	[Ooms, Laura S.; Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA; [Ooms, Laura S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Kobayashi, Takeshi; Dermody, Terence S.; Chappell, James D.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Chappell, JD (corresponding author), Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, D7235 MCN, Nashville, TN 37232 USA.	jim.chappell@vanderbilt.edu			United States Public Health Service [K08 AI62862, R01 AI32539]; Vanderbilt Department of Pathology; Naito Foundation; Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI062862, R01AI032539] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Vanderbilt Department of Pathology; Naito Foundation(Naito Memorial Foundation); Elizabeth B. Lamb Center for Pediatric Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 AI62862 (to J.D.C.) and R01 AI32539 (to T.S.D.) from the United States Public Health Service. This work was supported by the Vanderbilt Department of Pathology (to L.S.O.), a fellowship from the Naito Foundation (to T.K.), and the Elizabeth B. Lamb Center for Pediatric Research.	ANDERSON N, 1966, J PATHOL BACTERIOL, V92, P433, DOI 10.1002/path.1700920222; Arnold MM, 2008, VIROLOGY, V375, P412, DOI 10.1016/j.virol.2008.02.024; Attoui H, 2001, BIOCHEM BIOPH RES CO, V287, P583, DOI 10.1006/bbrc.2001.5612; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Berry JM, 1999, BIOTECHNOL BIOENG, V62, P12, DOI 10.1002/(SICI)1097-0290(19990105)62:1<12::AID-BIT2>3.0.CO;2-G; Brentano L, 1998, J VIROL, V72, P8354, DOI 10.1128/JVI.72.10.8354-8357.1998; Campbell JA, 2005, J VIROL, V79, P7967, DOI 10.1128/JVI.79.13.7967-7978.2005; Carvalho J, 2007, VIROLOGY, V364, P301, DOI 10.1016/j.virol.2007.03.037; Clarke P, 2005, APOPTOSIS, V10, P513, DOI 10.1007/s10495-005-1881-4; Coombs KM, 1996, J VIROL, V70, P4237, DOI 10.1128/JVI.70.7.4237-4245.1996; Coombs KM, 1998, CURR TOP MICROBIOL, V233, P69; Coombs KM, 1998, VIROLOGY, V243, P218, DOI 10.1006/viro.1998.9061; DALES S, 1965, VIROLOGY, V25, P193, DOI 10.1016/0042-6822(65)90199-6; DERMODY TS, 1990, J VIROL, V64, P5173, DOI 10.1128/JVI.64.10.5173-5176.1990; FIELDS BN, 1971, VIROLOGY, V46, P142, DOI 10.1016/0042-6822(71)90013-4; Forrest JC, 2003, J VIROL, V77, P9109, DOI 10.1128/JVI.77.17.9109-9115.2003; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GOMATOS PJ, 1962, VIROLOGY, V17, P441, DOI 10.1016/0042-6822(62)90139-3; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Ishii K, 2002, VIROLOGY, V302, P433, DOI 10.1006/viro.2002.1622; KAYE KM, 1986, J VIROL, V59, P90, DOI 10.1128/JVI.59.1.90-97.1986; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; MATOBA Y, 1991, J CLIN INVEST, V87, P1628, DOI 10.1172/JCI115177; MATOBA Y, 1993, J CLIN INVEST, V92, P2883, DOI 10.1172/JCI116910; Mbisa JL, 2000, VIROLOGY, V272, P16, DOI 10.1006/viro.2000.0362; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nibert ML, 1996, J VIROL, V70, P7295, DOI 10.1128/JVI.70.10.7295-7300.1996; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Rodgers SE, 1997, J VIROL, V71, P2540, DOI 10.1128/JVI.71.3.2540-2546.1997; ROSEN L, 1962, ANN NY ACAD SCI, V101, P461, DOI 10.1111/j.1749-6632.1962.tb18886.x; SABIN AB, 1959, SCIENCE, V130, P1387, DOI 10.1126/science.130.3386.1387; SCHIFF LA, 2007, FIELDS VIROLOGY, P1853; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; SHARPE AH, 1982, VIROLOGY, V122, P381, DOI 10.1016/0042-6822(82)90237-9; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; SHERRY B, 1994, J VIROL, V68, P8461, DOI 10.1128/JVI.68.12.8461-8465.1994; Sherry B, 2002, VIRAL IMMUNOL, V15, P17, DOI 10.1089/088282402317340206; SHERRY B, 1989, J VIROL, V63, P4840, DOI 10.1128/JVI.63.11.4840-4849.1989; SILVERST.SC, 1970, VIROLOGY, V41, P564, DOI 10.1016/0042-6822(70)90178-9; SILVERSTEIN SC, 1968, J CELL BIOL, V36, P197, DOI 10.1083/jcb.36.1.197; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; TYLER KL, 1986, SCIENCE, V233, P770, DOI 10.1126/science.3016895; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; WEINER HL, 1977, P NATL ACAD SCI USA, V74, P5744, DOI 10.1073/pnas.74.12.5744; YIN BY, 1995, FREE RADICAL BIO MED, V18, P1023, DOI 10.1016/0891-5849(95)00003-G; Yin P, 1996, J VIROL, V70, P1223, DOI 10.1128/JVI.70.2.1223-1227.1996; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zou S, 1996, VIROLOGY, V217, P42, DOI 10.1006/viro.1996.0091; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08; ZWEERINK HJ, 1970, VIROLOGY, V41, P501, DOI 10.1016/0042-6822(70)90171-6	60	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41604	41613		10.1074/jbc.M110.176255	http://dx.doi.org/10.1074/jbc.M110.176255			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978124	Green Published, hybrid			2022-12-27	WOS:000285622600048
J	Pohl, M; Kaminski, H; Castrop, H; Bader, M; Himmerkus, N; Bleich, M; Bachmann, S; Theilig, F				Pohl, Marcus; Kaminski, Henriette; Castrop, Hayo; Bader, Michael; Himmerkus, Nina; Bleich, Markus; Bachmann, Sebastian; Theilig, Franziska			Intrarenal Renin Angiotensin System Revisited ROLE OF MEGALIN-DEPENDENT ENDOCYTOSIS ALONG THE PROXIMAL NEPHRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-KIDNEY; TUBULE TRANSPORT; TRANSGENIC MICE; APICAL SURFACE; BLOOD-PRESSURE; OK CELLS; EXPRESSION; HYPERTENSION; GENE; PROTEIN	The existence of a local renin angiotensin system (RAS) of the kidney has been established. Angiotensinogen (AGT), renin, angiotensin-converting enzyme (ACE), angiotensin receptors, and high concentrations of luminal angiotensin II have been found in the proximal tubule. Although functional data have documented the relevance of a local RAS, the dualism between biosynthesis and endocytotic uptake of its components and their cellular processing has been incompletely understood. To resolve this, we have selectively analyzed their distribution, endocytosis, transcytosis, and biosynthesis in the proximal tubule. The presence of immunoreactive AGT, restricted to the early proximal tubule, was due to its retrieval from the ultrafiltrate and storage in endosomal and lysosomal compartments. Cellular uptake was demonstrated by autoradiography of radiolabeled AGT and depended on intact endocytosis. AGT was identified as a ligand of the multiple ligand-binding repeats of megalin. AGT biosynthesis was restricted to the proximal straight tubule, revealing substantial AGT mRNA expression. Transgenic AGT overexpression under the control of an endogenous promoter was also restricted to the late proximal tubule. Proximal handling of renin largely followed the patterns of AGT, whereas its local biosynthesis was not significant. Transcytotic transport of AGT in a proximal cell line revealed a 5% recovery rate after 1 h. ACE was expressed along late proximal brush-border membrane, whereas ACE2 was present along the entire segment. Surface expression of ACE and ACE2 differed as a function of endocytosis. Our data on the localization and cellular processing of RAS components provide new aspects of the functional concept of a "self-contained" renal RAS.	[Pohl, Marcus; Kaminski, Henriette; Bachmann, Sebastian; Theilig, Franziska] Charite, Inst Anat, D-10115 Berlin, Germany; [Castrop, Hayo] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Bader, Michael] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Himmerkus, Nina; Bleich, Markus] Inst Physiol, D-24118 Kiel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bachmann, S (corresponding author), Charite, Inst Vegetat Anat, Philippstr 12, D-10115 Berlin, Germany.	sbachm@charite.de; franziska.theilig@unifr.ch	Theilig, Franziska/K-9566-2015; Bleich, Markus/A-2812-2010; Bader, Michael/K-2124-2013	Theilig, Franziska/0000-0001-8810-4717; Bleich, Markus/0000-0002-1745-2295; Bader, Michael/0000-0003-4780-4164; Himmerkus, Nina/0000-0002-2910-6728				Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Bachmann S, 2004, J AM SOC NEPHROL, V15, P892, DOI 10.1097/01.ASN.0000120389.09938.21; BACHMANN S, 1992, KIDNEY INT, V41, P24, DOI 10.1038/ki.1992.4; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Baum M, 1997, AM J PHYSIOL-RENAL, V273, pF595, DOI 10.1152/ajprenal.1997.273.4.F595; BIBER J, 1981, BIOCHIM BIOPHYS ACTA, V647, P169, DOI 10.1016/0005-2736(81)90243-1; Bohlender J, 1996, HYPERTENSION, V27, P535, DOI 10.1161/01.HYP.27.3.535; BRAAM B, 1993, AM J PHYSIOL, V264, pF891, DOI 10.1152/ajprenal.1993.264.5.F891; Burns KD, 2007, CURR OPIN NEPHROL HY, V16, P116, DOI 10.1097/MNH.0b013e3280123c0e; CHAN JSD, 1992, J AM SOC NEPHROL, V2, P1360; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christensen E, 2007, KIDNEY INT, V72, P1192, DOI 10.1038/sj.ki.5002526; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; COGAN MG, 1990, HYPERTENSION, V15, P451, DOI 10.1161/01.HYP.15.5.451; DARBY IA, 1994, KIDNEY INT, V46, P1557, DOI 10.1038/ki.1994.445; EVERETT AD, 1992, HYPERTENSION, V19, P70, DOI 10.1161/01.HYP.19.1.70; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GEIBEL J, 1990, P NATL ACAD SCI USA, V87, P7917, DOI 10.1073/pnas.87.20.7917; Gociman B, 2004, KIDNEY INT, V65, P2153, DOI 10.1111/j.1523-1755.2004.00635.x; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; He WZ, 2008, NATURE, V455, P542, DOI 10.1038/nature07255; HILGENFELDT U, 1982, BIOCHIM BIOPHYS ACTA, V708, P335, DOI 10.1016/0167-4838(82)90446-0; IKEMOTO F, 1990, NEPHRON, V55, P3; IWAO H, 1983, J HISTOCHEM CYTOCHEM, V31, P776, DOI 10.1177/31.6.6341461; Kobori H, 2003, HYPERTENSION, V41, P42, DOI 10.1161/01.HYP.0000050102.90932.CF; Kobori H, 2002, KIDNEY INT, V61, P579, DOI 10.1046/j.1523-1755.2002.00155.x; Kobori H, 2001, J AM SOC NEPHROL, V12, P431, DOI 10.1681/ASN.V123431; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Le TH, 2008, CURR OPIN NEPHROL HY, V17, P57, DOI 10.1097/MNH.0b013e3282f2fd39; Leheste JR, 2002, FASEB J, V16, P247, DOI 10.1096/fj.02-0578fje; LEYSSAC PP, 1986, KIDNEY INT, V30, P332, DOI 10.1038/ki.1986.189; Marino M, 2001, J AM SOC NEPHROL, V12, P637, DOI 10.1681/ASN.V124637; MOE OW, 1993, J CLIN INVEST, V91, P774, DOI 10.1172/JCI116296; NASJLETTI A, 1971, CAN J PHYSIOL PHARM, V49, P292, DOI 10.1139/y71-032; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Navar LG, 2002, HYPERTENSION, V39, P316, DOI 10.1161/hy0202.103821; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Park S, 2010, AM J PHYSIOL-RENAL, V298, pF37, DOI 10.1152/ajprenal.00519.2009; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Quan A, 1996, J CLIN INVEST, V97, P2878, DOI 10.1172/JCI118745; Quan A, 2000, NEPHRON, V84, P103, DOI 10.1159/000045556; RICHOUX JP, 1983, CELL TISSUE RES, V233, P439; Riquier-Brison ADM, 2010, AM J PHYSIOL-RENAL, V298, pF177, DOI 10.1152/ajprenal.00464.2009; Rohrwasser A, 1999, HYPERTENSION, V34, P1265, DOI 10.1161/01.HYP.34.6.1265; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Saftig P, 2008, AUTOPHAGY, V4, P510, DOI 10.4161/auto.5724; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Satou R, 2008, AM J PHYSIOL-RENAL, V295, pF283, DOI 10.1152/ajprenal.00047.2008; SEIKALY MG, 1990, J CLIN INVEST, V86, P1352, DOI 10.1172/JCI114846; Singh I, 1996, AM J PHYSIOL-RENAL, V270, pF1027, DOI 10.1152/ajprenal.1996.270.6.F1027; TAUGNER R, 1982, HISTOCHEMISTRY, V75, P473; TAUGNER R, 1982, KIDNEY INT, pS33; TERADA Y, 1993, KIDNEY INT, V43, P1251, DOI 10.1038/ki.1993.177; Theilig F, 2001, J AM SOC NEPHROL, V12, P2209, DOI 10.1681/ASN.V12112209; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Warner FJ, 2005, J BIOL CHEM, V280, P39353, DOI 10.1074/jbc.M508914200; Willmann JK, 1997, PFLUG ARCH EUR J PHY, V434, P173, DOI 10.1007/s004240050380; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; YANAGAWA N, 1991, KIDNEY INT, V39, P938, DOI 10.1038/ki.1991.117; YANG GY, 1994, J BIOL CHEM, V269, P32497	62	111	113	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41935	41946		10.1074/jbc.M110.150284	http://dx.doi.org/10.1074/jbc.M110.150284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966072	Green Published, hybrid			2022-12-27	WOS:000285622600080
J	Erez, E; Stjepanovic, G; Zelazny, AM; Brugger, B; Sinning, I; Bibi, E				Erez, Elinor; Stjepanovic, Goran; Zelazny, Adrian M.; Brugger, Britta; Sinning, Irmgard; Bibi, Eitan			Genetic Evidence for Functional Interaction of the Escherichia coli Signal Recognition Particle Receptor with Acidic Lipids in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLGLYCEROPHOSPHATE SYNTHASE; MEMBRANE ASSOCIATION; BINDING DOMAIN; SRP RECEPTOR; NULL MUTANT; NG DOMAIN; FTSY; PHOSPHOLIPIDS; CHLOROPLASTS; CARDIOLIPIN	The mechanism underlying the interaction of the Escherichia coli signal recognition particle receptor FtsY with the cytoplasmic membrane has been studied in detail. Recently, we proposed that FtsY requires functional interaction with inner membrane lipids at a late stage of the signal recognition particle pathway. In addition, an essential lipid-binding alpha-helix was identified in FtsY of various origins. Theoretical considerations and in vitro studies have suggested that it interacts with acidic lipids, but this notion is not yet fully supported by in vivo experimental evidence. Here, we present an unbiased genetic clue, obtained by serendipity, supporting the involvement of acidic lipids. Utilizing a dominant negative mutant of FtsY (termed NG), which is defective in its functional interaction with lipids, we screened for E. coli genes that suppress the negative dominant phenotype. In addition to several unrelated phenotype-suppressor genes, we identified pgsA, which encodes the enzyme phosphatidylglycerophosphate synthase (PgsA). PgsA is an integral membrane protein that catalyzes the committed step to acidic phospholipid synthesis, and we show that its overexpression increases the contents of cardiolipin and phosphatidylglycerol. Remarkably, expression of PgsA also stabilizes NG and restores its biological function. Collectively, our results strongly support the notion that FtsY functionally interacts with acidic lipids.	[Erez, Elinor; Zelazny, Adrian M.; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Stjepanovic, Goran; Brugger, Britta; Sinning, Irmgard] Univ Heidelberg, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; Ruprecht Karls University Heidelberg	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	azelazny@mail.nih.gov; e.bibi@weizmann.ac.il	Stjepanovic, Goran/A-7902-2010	Stjepanovic, Goran/0000-0002-4841-9949; Bibi, Eitan/0000-0003-3700-2707	German-Israeli Foundation for Scientific Research and Development; Israel Science Foundation; Deutsche Forschungsgemeinschaft [GRK 1188]	German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German-Israeli Foundation for Scientific Research and Development (to I. S. and E. B.), by the Israel Science Foundation (to E. B.), and by Deutsche Forschungsgemeinschaft Collaborative Research Grant GRK 1188 (to I. S.).	Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bibi E, 2001, TRENDS BIOCHEM SCI, V26, P15, DOI 10.1016/S0968-0004(00)01711-4; Bohn C, 1998, J BACTERIOL, V180, P6072, DOI 10.1128/JB.180.22.6072-6075.1998; Braig D, 2009, J MOL BIOL, V390, P401, DOI 10.1016/j.jmb.2009.04.061; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; deLeeuw E, 1997, FEBS LETT, V416, P225, DOI 10.1016/S0014-5793(97)01238-6; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lam VQ, 2010, J CELL BIOL, V190, P623, DOI 10.1083/jcb.201004129; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Millman JS, 1999, J BIOL CHEM, V274, P33227, DOI 10.1074/jbc.274.47.33227; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Suzuki H, 1999, J BIOL CHEM, V274, P31020, DOI 10.1074/jbc.274.43.31020; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; USUI M, 1994, J BACTERIOL, V176, P3389, DOI 10.1128/jb.176.11.3389-3392.1994; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	30	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40508	40514		10.1074/jbc.M110.140921	http://dx.doi.org/10.1074/jbc.M110.140921			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20956528	hybrid, Green Published			2022-12-27	WOS:000285414400013
J	Borza, CM; Chen, XW; Mathew, S; Mont, S; Sanders, CR; Zent, R; Pozzi, A				Borza, Corina M.; Chen, Xiwu; Mathew, Sijo; Mont, Stacey; Sanders, Charles R.; Zent, Roy; Pozzi, Ambra			Integrin alpha 1 beta 1 Promotes Caveolin-1 Dephosphorylation by Activating T Cell Protein-tyrosine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; ENDOTHELIAL-CELLS; MESANGIAL CELLS; GLOMERULAR INJURY; PHOSPHORYLATION; GROWTH; KINASE; TRAFFICKING; EXPRESSION; TCPTP	Integrin alpha 1 beta 1 is a collagen receptor that down-regulates collagen and reactive oxygen species (ROS) production, and mice lacking this receptor show increased ROS levels and exacerbated glomerular sclerosis following injury. Caveolin-1 (Cav-1) is a multifunctional protein that is tyrosine-phosphorylated in response to injury and has been implicated in ROS-mediated injury. Cav-1 interacts with integrins, and integrin alpha 1 beta 1 binds/activates T cell protein-tyrosine phosphatase (TCPTP), which is homologous to the tyrosine phosphatase PTP1B known to dephosphorylate Cav-1. In this study, we analyzed whether phosphorylated Cav-1 (pCav-1) is a substrate of TCPTP and if integrin alpha 1 beta 1 is essential for promoting TCPTP-mediated Cav-1 dephosphorylation. We found that Cav-1 phosphorylation is significantly higher in cells lacking integrin alpha 1 beta 1 at base line and following oxidative stress. Overexpression of TCPTP leads to reduced pCav-1 levels only in cells expressing integrin alpha 1 beta 1. Using solid phase binding assays, we demonstrated that 1) purified Cav-1 directly interacts with TCPTP and the integrin alpha 1 subunit, 2) pCav-1 is a substrate of TCPTP, and 3) TCPTP-mediated Cav-1 dephosphorylation is highly increased by the addition of purified integrin alpha 1 beta 1 or an integrin alpha 1 cytoplasmic peptide to which TCPTP has been shown to bind. Thus, our results demonstrate that pCav-1 is a new substrate of TCPTP and that integrin alpha 1 beta 1 acts as a negative regulator of Cav-1 phosphorylation by activating TCPTP. This could explain the protective function of integrin alpha 1 beta 1 in oxidative stress-mediated damage and why integrin alpha 1-null mice are more susceptible to fibrosis following injury.	[Borza, Corina M.; Chen, Xiwu; Mathew, Sijo; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37212 USA; [Mont, Stacey; Zent, Roy; Pozzi, Ambra] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37212 USA; [Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37212 USA; [Zent, Roy; Pozzi, Ambra] Vet Affairs Hosp, Dept Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Borza, CM (corresponding author), Vanderbilt Univ, Med Ctr N, Dept Med, B3115, Nashville, TN 37232 USA.	corina.borza@vanderbilt.edu; ambra.pozzi@vanderbilt.edu	Borza, Corina/AAF-5292-2020; Borza, Corina/A-1603-2013	Borza, Corina/0000-0001-9113-110X	National Institutes of Health [2P01DK065123, DK075594, DK65123, DK083187]; Department of Veterans Affairs; American Heart Association; O'Brien Center [P30DK79341-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075594, R01DK083187, P30DK079341, P01DK065123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); O'Brien Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2P01DK065123 (to A.P. and R.Z.), DK075594 and DK65123 (to R.Z.), and DK083187 (to R.Z. and C.R.S.). These studies were also supported by a Merit Review from the Department of Veterans Affairs (to A.P. and R.Z.) and an American Heart Association established investigator award (to R.Z.); and O'Brien Center Grant P30DK79341-01 (to A.P. and R.Z.).	Abair TD, 2008, BLOOD, V112, P3242, DOI 10.1182/blood-2007-12-126433; Aoki J, 1999, BIOCHEM J, V340, P365, DOI 10.1042/0264-6021:3400365; Caselli A, 2001, J BIOL CHEM, V276, P18849, DOI 10.1074/jbc.M100705200; Caselli A, 2007, BIOCHEMISTRY-US, V46, P6383, DOI 10.1021/bi0620858; Chen DB, 2005, BIOL REPROD, V73, P761, DOI 10.1095/biolreprod.105.040881; Chen XW, 2007, MOL CELL BIOL, V27, P3313, DOI 10.1128/MCB.01476-06; Chen XW, 2010, MOL CELL BIOL, V30, P3048, DOI 10.1128/MCB.00892-09; Chen XW, 2004, AM J PATHOL, V165, P617, DOI 10.1016/S0002-9440(10)63326-3; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chretien A, 2008, FEBS LETT, V582, P1685, DOI 10.1016/j.febslet.2008.04.026; Del Galdo F, 2008, CURR OPIN RHEUMATOL, V20, P713, DOI 10.1097/BOR.0b013e3283103d27; DELAURENTIIS A, 2007, BIOCHEM J, V1, P12; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004; Hao LN, 1997, J BIOL CHEM, V272, P29322, DOI 10.1074/jbc.272.46.29322; IVARSSON M, 1993, J INVEST DERMATOL, V101, P216, DOI 10.1111/1523-1747.ep12364810; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kim H, 2006, NEUROSCI LETT, V402, P76, DOI 10.1016/j.neulet.2006.04.008; Krepinsky JC, 2005, J AM SOC NEPHROL, V16, P1661, DOI 10.1681/ASN.2004100897; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lam MHC, 2001, J BIOL CHEM, V276, P37700, DOI 10.1074/jbc.M105128200; Lee H, 2006, BIOCHEMISTRY-US, V45, P234, DOI 10.1021/bi051560j; Lee H, 2000, MOL ENDOCRINOL, V14, P1750, DOI 10.1210/me.14.11.1750; LORENZEN JA, 1995, J CELL BIOL, V131, P631, DOI 10.1083/jcb.131.3.631; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mattila E, 2008, J CELL SCI, V121, P3570, DOI 10.1242/jcs.031898; Mattila E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-7; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Ostalska-Nowicka D, 2007, HISTOPATHOLOGY, V51, P611, DOI 10.1111/j.1365-2559.2007.02844.x; Parat MO, 2002, BIOCHEM J, V361, P681, DOI 10.1042/0264-6021:3610681; Park DS, 2003, BIOCHEMISTRY-US, V42, P15124, DOI 10.1021/bi0356348; Park JH, 2011, J CELL PHYSIOL, V226, P267, DOI 10.1002/jcp.22338; Percy CJ, 2008, PATHOLOGY, V40, P694, DOI 10.1080/00313020802436402; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Sanguinetti AR, 2003, BIOCHEM J, V376, P159, DOI 10.1042/BJ20030336; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; SETTY S, 1995, CELL ADHES COMMUN, V3, P187, DOI 10.3109/15419069509081286; Shajahan AN, 2007, J BIOL CHEM, V282, P5934, DOI 10.1074/jbc.M608857200; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Shin J, 2006, BIOCHEM BIOPH RES CO, V339, P737, DOI 10.1016/j.bbrc.2005.11.077; Stuible M, 2008, CANCER METAST REV, V27, P215, DOI 10.1007/s10555-008-9115-1; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Thomas CM, 2008, J CELL MOL MED, V12, P796, DOI 10.1111/j.1582-4934.2008.00295.x; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Xia H, 2010, AM J PATHOL, V176, P2626, DOI 10.2353/ajpath.2010.091117; Zent R, 2006, KIDNEY INT, V70, P460, DOI 10.1038/sj.ki.5000359; Zhang BF, 2007, CELL SIGNAL, V19, P1690, DOI 10.1016/j.cellsig.2007.03.005	51	30	30	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40114	40124		10.1074/jbc.M110.156729	http://dx.doi.org/10.1074/jbc.M110.156729			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940300	Green Published, hybrid			2022-12-27	WOS:000285185500057
J	Leal-Pinto, E; Gomez-Llorente, Y; Sundaram, S; Tang, QY; Ivanova-Nikolova, T; Mahajan, R; Baki, L; Zhang, Z; Chavez, J; Ubarretxena-Belandia, I; Logothetis, DE				Leal-Pinto, Edgar; Gomez-Llorente, Yacob; Sundaram, Shobana; Tang, Qiong-Yao; Ivanova-Nikolova, Tatyana; Mahajan, Rahul; Baki, Lia; Zhang, Zhe; Chavez, Jose; Ubarretxena-Belandia, Iban; Logothetis, Diomedes E.			Gating of a G protein-sensitive Mammalian Kir3.1 Prokaryotic Kir Channel Chimera in Planar Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING K+ CHANNELS; MUSCARINIC POTASSIUM CHANNEL; HIGH-AFFINITY INHIBITOR; GTP-BINDING PROTEINS; INWARD-RECTIFIER; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; ADENYLYL-CYCLASE	Kir3 channels control heart rate and neuronal excitability through GTP-binding (G) protein and phosphoinositide signaling pathways. These channels were the first characterized effectors of the beta gamma subunits of G proteins. Because we currently lack structures of complexes between G proteins and Kir3 channels, their interactions leading to modulation of channel function are not well understood. The recent crystal structure of a chimera between the cytosolic domain of a mammalian Kir3.1 and the transmembrane region of a prokaryotic KirBac1.3 (Kir3.1 chimera) has provided invaluable structural insight. However, it was not known whether this chimera could form functional K+ channels. Here, we achieved the functional reconstitution of purified Kir3.1 chimera in planar lipid bilayers. The chimera behaved like a bona fide Kir channel displaying an absolute requirement for PIP2 and Mg2+-dependent inward rectification. The channel could also be blocked by external tertiapin Q. The three-dimensional reconstruction of the chimera by single particle electron microscopy revealed a structure consistent with the crystal structure. Channel activity could be stimulated by ethanol and activated G proteins. Remarkably, the presence of both activated G alpha and G beta gamma subunits was required for gating of the channel. These results confirm the Kir3.1 chimera as a valid structural and functional model of Kir3 channels.	[Gomez-Llorente, Yacob; Chavez, Jose; Ubarretxena-Belandia, Iban] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Leal-Pinto, Edgar; Sundaram, Shobana; Tang, Qiong-Yao; Ivanova-Nikolova, Tatyana; Mahajan, Rahul; Baki, Lia; Zhang, Zhe; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Icahn School of Medicine at Mount Sinai; Virginia Commonwealth University	Ubarretxena-Belandia, I (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.	Iban.Ubarretxena@mssm.edu; delogothetis@vcu.edu	Ubarretxena-Belandia, Iban/AAA-8939-2019; Gomez-Llorente, Yacob/E-5631-2013; Zhang, Zhe/C-2685-2011; Tang, Qiong-Yao/G-6051-2012; Mahajan, Rahul/AAS-5971-2021	Mahajan, Rahul/0000-0002-9613-2870; Chavez, Jose/0000-0003-4351-1516	National Institutes of Health [R01 HL59949, F30]; National Science Foundation [MCB-0546087]; Ministerio de Educacion y Ciencia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia(Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL59949 (to D. E. L.) and National Science Foundation Grant MCB-0546087 (to I. U.-B.).; Supported by a postdoctoral fellowship from the Ministerio de Educacion y Ciencia.; Supported by an National Institutes of Health F30 award.	Aleksandrov A, 1996, BIOPHYS J, V70, P2680, DOI 10.1016/S0006-3495(96)79837-5; Aryal P, 2009, NAT NEUROSCI, V12, P988, DOI 10.1038/nn.2358; Chan KW, 1996, J GEN PHYSIOL, V107, P381, DOI 10.1085/jgp.107.3.381; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P6596, DOI 10.1073/pnas.90.14.6596; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GAO BN, 1991, P NATL ACAD SCI USA, V88, P10178, DOI 10.1073/pnas.88.22.10178; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LEALPINTO E, 1995, J MEMBRANE BIOL, V146, P123; LealPinto E, 1997, J BIOL CHEM, V272, P617; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LESAGE F, 1994, FEBS LETT, V353, P37, DOI 10.1016/0014-5793(94)01007-2; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Logothetis DE, 2010, PFLUG ARCH EUR J PHY, V460, P321, DOI 10.1007/s00424-010-0828-y; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mirshahi T, 2004, J BIOL CHEM, V279, P11890, DOI 10.1074/jbc.M313322200; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rubinstein JL, 2007, METHODS, V41, P409, DOI 10.1016/j.ymeth.2006.07.019; Rubinstein M, 2007, J PHYSIOL-LONDON, V581, P17, DOI 10.1113/jphysiol.2006.125864; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2007, STRUCTURE, V15, P1167, DOI 10.1016/j.str.2007.09.003; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; TANG WJ, 1991, SCIENCE, V254, P1500, DOI 10.1126/science.1962211; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Yamada M, 1998, PHARMACOL REV, V50, P723	59	31	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39790	39800		10.1074/jbc.M110.151373	http://dx.doi.org/10.1074/jbc.M110.151373			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937804	Green Published, hybrid			2022-12-27	WOS:000285185500023
J	Peterson, JM; Wei, ZK; Wong, GW				Peterson, Jonathan M.; Wei, Zhikui; Wong, G. William			C1q/TNF-related Protein-3 (CTRP3), a Novel Adipokine That Regulates Hepatic Glucose Output	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; GENE-EXPRESSION; ADIPONECTIN; KINASE; MICE; MUSCLE; FAMILY; ACTIVATION	Adipose tissue-derived adipokines play important roles in controlling systemic insulin sensitivity and energy balance. Our recent efforts to identify novel metabolic mediators produced by adipose tissue have led to the discovery of a highly conserved family of secreted proteins, designated as C1q/TNF-related proteins 1-10 (CTRP1 to -10). However, physiological functions regulated by CTRPs are largely unknown. Here we provide the first in vivo functional characterization of CTRP3. We show that circulating levels of CTRP3 are inversely correlated with leptin levels; CTRP3 increases with fasting, decreases in diet-induced obese mice with high leptin levels, and increases in leptin-deficient ob/ob mice. A modest 3-fold elevation of plasma CTRP3 levels by recombinant protein administration is sufficient to lower glucose levels in normal and insulin-resistant ob/ob mice, without altering insulin or adiponectin levels. The glucose-lowering effect in mice is linked to activation of the Akt signaling pathway in liver and a marked suppression of hepatic gluconeogenic gene expression. Consistent with its effects in mice, CTRP3 acts directly and independently of insulin to regulate gluconeogenesis in cultured hepatocytes. In humans, alternative splicing generates two circulating CTRP3 isoforms differing in size and glycosylation pattern. The two human proteins form hetero-oligomers, an association that does not require interdisulfide bond formation and appears to protect the longer isoform from proteolytic cleavage. Recombinant human CTRP3 also reduces glucose output in hepatocytes by suppressing gluconeogenic enzyme expression. This study provides the first functional evidence linking CTRP3 to hepatic glucose metabolism and establishes CTRP3 as a novel adipokine.	[Wong, G. William] Johns Hopkins Univ, Dept Physiol, Sch Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Ctr Metab & Obes Res, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wong, GW (corresponding author), Johns Hopkins Univ, Dept Physiol, Sch Med, 855 N Wolfe St, Baltimore, MD 21205 USA.	gwwong@jhmi.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880; Wong, G. William/0000-0002-5286-6506; Wei, Zhikui/0000-0002-2311-9800	National Institutes of Health [DK084171]; American Heart Association [SDG2260721, PRE3790034]; Baltimore Diabetes Research and Training Center [P60DK079637]; National Institutes of Health National Research Service [F32DK084607]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK084607, R01DK084171, P60DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Baltimore Diabetes Research and Training Center; National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK084171 (to G. W. W.). This work was also supported in part by American Heart Association Grant SDG2260721 and Baltimore Diabetes Research and Training Center Grant P60DK079637.; Supported by National Institutes of Health National Research Service Award F32DK084607.; Supported by a American Heart Association Fellowship PRE3790034.	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Akiyama H, 2006, FEBS J, V273, P2257, DOI 10.1111/j.1742-4658.2006.05240.x; Akiyama H, 2007, MOL CELL BIOCHEM, V304, P243, DOI 10.1007/s11010-007-9506-6; Akiyama H, 2009, ONCOL REP, V21, P1477, DOI 10.3892/or_00000377; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Davis Kathryn E, 2008, Biochem J, V416, pe7, DOI 10.1042/BJ20082033; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Govorko D, 2007, AM J PHYSIOL-ENDOC M, V293, pE1503, DOI 10.1152/ajpendo.00420.2007; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; KLIP A, 1984, AM J PHYSIOL, V247, pE291, DOI 10.1152/ajpendo.1984.247.3.E291; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Maeda T, 2001, J BIOL CHEM, V276, P3628, DOI 10.1074/jbc.M007898200; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ono H, 2003, DIABETES, V52, pA301; Perrot V, 2003, J BIOL CHEM, V278, P26111, DOI 10.1074/jbc.M212750200; Peterson JM, 2009, BIOCHEM BIOPH RES CO, V388, P360, DOI 10.1016/j.bbrc.2009.08.014; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yano W, 2008, ENDOCR J, V55, P515, DOI 10.1507/endocrj.K08E-093; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	48	195	211	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39691	39701		10.1074/jbc.M110.180695	http://dx.doi.org/10.1074/jbc.M110.180695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952387	hybrid, Green Published			2022-12-27	WOS:000285185500013
J	Pi, M; Parrill, AL; Quarles, LD				Pi, Min; Parrill, Abby L.; Quarles, L. Darryl			GPRC6A Mediates the Non-genomic Effects of Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; PROSTATE-CANCER CELLS; AMINO-ACID RECEPTOR; ANDROGEN RECEPTOR; CRYSTAL-STRUCTURE; TESTOSTERONE RECEPTORS; EXPRESSION; ESTROGEN; CLONING; GROWTH	The identity of the putative G-protein coupled receptor (GPCR) that mediates the non-genomic effects of androgens is unknown. We present in vitro and in vivo evidence that the orphan GPRC6A receptor, a widely expressed calcium and amino acid sensing GPCR, transduces the non-genomic effects of testosterone and other steroids. Overexpression of GPRC6A imparts the ability of extracellular testosterone to illicit a rapid, non-genomic signaling response in HEK-293 cells lacking the androgen receptor. Conversely, testosterone-stimulated rapid signaling and phosphorylation of ERK is attenuated in bone marrow stromal cells derived from GPRC6A(-/-) mice and in 22Rv1 prostate cancer cells after siRNA-mediated knockdown of GPRC6A. Compared with wild-type controls, GPRC6A(-/-) null mice exhibit significantly less ERK activation and Egr-1 expression in both bone marrow and testis in response to pharmacological doses of testosterone in vivo. In addition, testosterone administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice. These results suggest that GPRC6A is functionally important in regulating non-genomic effects of androgens in multiple tissues.	[Pi, Min; Quarles, L. Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38103 USA; [Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis	Pi, M (corresponding author), 19 S Manassas St, Memphis, TN 38103 USA.	mpi@uthsc.edu; dquarles@uthsc.edu		Parrill, Abby/0000-0003-1658-8497; Pi, Min/0000-0002-0319-8003; Quarles, L. Darryl/0000-0002-5082-7896	National Institutes of Health [R01-AR37308]; Center of Biomedical Research Excellence [P20 RR017686]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR37308 (to L. D. Q.) and Center of Biomedical Research Excellence, Epithelial Function in Health and Disease Grant P20 RR017686 (to M. P.).	Armen TA, 2000, J CELL BIOCHEM, V79, P620, DOI 10.1002/1097-4644(20001215)79:4<620::AID-JCB110>3.3.CO;2-8; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Benten WPM, 2004, STEROIDS, V69, P585, DOI 10.1016/j.steroids.2004.05.007; Benten WPM, 1999, MOL BIOL CELL, V10, P3113, DOI 10.1091/mbc.10.10.3113; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernauer S, 2001, DNA SEQUENCE, V12, P13, DOI 10.3109/10425170109042047; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bhasin S, 1998, J CLIN ENDOCR METAB, V83, P3435, DOI 10.1210/jc.83.10.3440; Braun AM, 2004, BIOL REPROD, V71, P146, DOI 10.1095/biolreprod.103.025825; Cato A.C., 2002, SCI STKE, V2002, pre9, DOI [10.1126/stke.2002.138.re9, DOI 10.1126/STKE.2002.138.RE9]; Chen JG, 2006, J CLIN ENDOCR METAB, V91, P4387, DOI 10.1210/jc.2006-0284; Chen Min, 2008, Zhonghua Yi Xue Za Zhi, V88, P1488; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christiansen B, 2007, BRIT J PHARMACOL, V150, P798, DOI 10.1038/sj.bjp.0707121; Dong Y, 2005, MOL CANCER THER, V4, P1047, DOI 10.1158/1535-7163.MCT-05-0124; Dos Santos EG, 2002, ENDOCRINOLOGY, V143, P930; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Falkenstein E, 2000, PHARMACOL REV, V52, P513; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Gerdes D, 1998, BIOL CHEM, V379, P907; GOLDSTEIN JL, 1972, J CLIN INVEST, V51, P1647, DOI 10.1172/JCI106966; Gruenewald DA, 2003, J AM GERIATR SOC, V51, P101, DOI 10.1034/j.1601-5215.2002.51018.x; Heinlein CA, 2002, MOL ENDOCRINOL, V16, P2181, DOI 10.1210/me.2002-0070; ISWARI S, 1986, STEROIDS, V47, P189, DOI 10.1016/0039-128X(86)90088-7; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kampa M, 2002, FASEB J, V16, P1429, DOI 10.1096/fj.02-0131fje; Kang HY, 2004, J BONE MINER RES, V19, P1181, DOI 10.1359/JBMR.040306; Koeneman KS, 1999, PROSTATE, V39, P246; Kuang DH, 2005, J NEUROCHEM, V93, P383, DOI 10.1111/j.1471-4159.2005.03025.x; LAMBERT JJ, 1995, TRENDS PHARMACOL SCI, V16, P295, DOI 10.1016/S0165-6147(00)89058-6; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Liao XB, 2003, ENDOCRINOLOGY, V144, P1656, DOI 10.1210/en.2002-0157; LIEBERHERR M, 1994, J BIOL CHEM, V269, P7217; Liu DM, 2002, J BIOL CHEM, V277, P21379, DOI 10.1074/jbc.M200491200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Losel RM, 2003, PHYSIOL REV, V83, P965, DOI 10.1152/physrev.00003.2003; MENDELSON CR, 1984, MOL CELL ENDOCRINOL, V37, P61, DOI 10.1016/0303-7207(84)90128-X; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; MOGER WH, 1974, BIOL REPROD, V11, P1, DOI 10.1095/biolreprod11.1.1; Morgentaler A, 2006, EUR UROL, V50, P935, DOI 10.1016/j.eururo.2006.06.034; Omwancha J, 2006, CURR OPIN INVEST DR, V7, P873; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Pi M, 2010, J BONE MINER RES, V25, P1092, DOI 10.1359/jbmr.091037; Pi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003858; Pike CJ, 2008, HORM BEHAV, V53, P693, DOI 10.1016/j.yhbeh.2007.11.006; Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P784, DOI 10.1210/jc.2007-2156; Raynaud JP, 2006, J STEROID BIOCHEM, V102, P261, DOI 10.1016/j.jsbmb.2006.09.032; Riedmaier I, 2009, J STEROID BIOCHEM, V114, P167, DOI 10.1016/j.jsbmb.2009.01.019; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Saidak Z, 2009, MOL PHARMACOL, V76, P1131, DOI 10.1124/mol.109.058784; Schmidt BMW, 2003, HYPERTENSION, V42, P156, DOI 10.1161/01.HYP.0000083298.23119.16; Somjen D, 2004, J ENDOCRINOL, V180, P97, DOI 10.1677/joe.0.1800097; Sutters M, 2001, KIDNEY INT, V60, P484, DOI 10.1046/j.1523-1755.2001.060002484.x; TADDEI S, 1993, HYPERTENSION, V21, P929, DOI 10.1161/01.HYP.21.6.929; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Tokumoto M, 2005, THER APHER DIAL, V9, pS27, DOI 10.1111/j.1744-9987.2005.00302.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Watson CS, 2002, STEROIDS, V67, P429, DOI 10.1016/S0039-128X(01)00172-6; Wellendorph P, 2005, MOL PHARMACOL, V67, P589, DOI 10.1124/mol.104.007559; Wellendorph P, 2004, GENE, V335, P37, DOI 10.1016/j.gene.2004.03.003; WEST RE, 1985, J BIOL CHEM, V260, P4428; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Wunderlich F, 2002, STEROIDS, V67, P535, DOI 10.1016/S0039-128X(01)00175-1; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Yialamas MA, 2007, J CLIN ENDOCR METAB, V92, P4254, DOI 10.1210/jc.2007-0454; Zagar Y, 2004, J BIOL CHEM, V279, P2403, DOI 10.1074/jbc.M309132200; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	74	126	137	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39953	39964		10.1074/jbc.M110.158063	http://dx.doi.org/10.1074/jbc.M110.158063			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947496	hybrid, Green Published			2022-12-27	WOS:000285185500040
J	Gong, P; Vetrivel, KS; Nguyen, PD; Meckler, X; Cheng, HP; Kounnas, MZ; Wagner, SL; Parent, AT; Thinakaran, G				Gong, Ping; Vetrivel, Kulandaivelu S.; Nguyen, Phuong D.; Meckler, Xavier; Cheng, Haipeng; Kounnas, Maria Z.; Wagner, Steven L.; Parent, Angeele T.; Thinakaran, Gopal			Mutation Analysis of the Presenilin 1 N-terminal Domain Reveals a Broad Spectrum of gamma-Secretase Activity toward Amyloid Precursor Protein and Other Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; BETA-SECRETASE; CELL-SURFACE; IN-VIVO; A-BETA; TRANSMEMBRANE DOMAIN-4; INTRACELLULAR DOMAIN; CATALYTIC PORE; COMPLEX; NICASTRIN	The gamma-secretase protein complex executes the intramembrane proteolysis of amyloid precursor protein (APP), which releases Alzheimer disease beta-amyloid peptide. In addition to APP, gamma-secretase also cleaves several other type I membrane protein substrates including Notch1 and N-cadherin. gamma-Secretase is made of four integral transmembrane protein subunits: presenilin (PS), nicastrin, APH1, and PEN2. Multiple lines of evidence indicate that a heteromer of PS-derived N- and C-terminal fragments functions as the catalytic subunit of gamma-secretase. Only limited information is available on the domains within each subunit involved in the recognition and recruitment of diverse substrates and the transfer of substrates to the catalytic site. Here, we performed mutagenesis of two domains of PS1, namely the first luminal loop domain (LL1) and the second transmembrane domain (TM2), and analyzed PS1 endoproteolysis as well as the catalytic activities of PS1 toward APP, Notch, and N-cadherin. Our results show that distinct residues within LL1 and TM2 domains as well as the length of the LL1 domain are critical for PS1 endoproteolysis, but not for PS1 complex formation with nicastrin, APH1, and PEN2. Furthermore, our experimental PS1 mutants formed gamma-secretase complexes with distinct catalytic properties toward the three substrates examined in this study; however, the mutations did not affect PS1 interaction with the substrates. We conclude that the N-terminal LL1 and TM2 domains are critical for PS1 endoproteolysis and the coordination between the putative substrate-docking site and the catalytic core of the gamma-secretase.	[Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Gong, Ping; Vetrivel, Kulandaivelu S.; Meckler, Xavier; Cheng, Haipeng; Parent, Angeele T.; Thinakaran, Gopal] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Nguyen, Phuong D.; Wagner, Steven L.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA; [Kounnas, Maria Z.] Neurogenet Pharmaceut Inc, San Diego, CA 92121 USA	University of Chicago; University of Chicago; University of Chicago; University of California System; University of California San Diego	Thinakaran, G (corresponding author), Univ Chicago, Dept Neurobiol, Knapp R212,924 E 57th St, Chicago, IL 60637 USA.	gopal@uchicago.edu			National Institutes of Health [AG021495, AG019070, NS055223]; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019070, R01AG021495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG021495 (to G.T.), AG019070 (to G.T.), and NS055223 (to A.T.P.). This work was also supported by grants from the Alzheimer's Association (to G.T. and K.S.V.).	Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; DE SB, 1999, NATURE, V398, P518; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hecimovic S, 2004, NEUROBIOL DIS, V17, P205, DOI 10.1016/j.nbd.2004.04.018; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Iwatsubo T, 2004, CURR OPIN NEUROBIOL, V14, P379, DOI 10.1016/j.conb.2004.05.010; Iwatsubo T, 2004, MOL PSYCHIATR, V9, P8, DOI 10.1038/sj.mp.4001438; Kaether C, 2004, EMBO J, V23, P4738, DOI 10.1038/sj.emboj.7600478; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kim J, 2007, J CELL BIOL, V179, P951, DOI 10.1083/jcb.200709012; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Leem JY, 2002, NEUROBIOL DIS, V11, P64, DOI 10.1006/nbdi.2002.0546; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Steiner H, 2008, CURR ALZHEIMER RES, V5, P147, DOI 10.2174/156720508783954677; Tesco G, 2005, J NEUROCHEM, V95, P446, DOI 10.1111/j.1471-4159.2005.03381.x; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tolia A, 2008, J BIOL CHEM, V283, P19793, DOI 10.1074/jbc.M802461200; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wanngren J, 2010, J BIOL CHEM, V285, P8527, DOI 10.1074/jbc.M109.055590; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yamasaki A, 2006, J NEUROSCI, V26, P3821, DOI 10.1523/JNEUROSCI.5354-05.2006; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zhao GJ, 2010, J NEUROSCI, V30, P1648, DOI 10.1523/JNEUROSCI.3826-09.2010	62	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38042	38052		10.1074/jbc.M110.132613	http://dx.doi.org/10.1074/jbc.M110.132613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921220	Green Published, hybrid			2022-12-27	WOS:000284625600012
J	Hong, J; Cho, IH; Kwak, KI; Suh, EC; Seo, J; Min, HJ; Choi, SY; Kim, CH; Park, SH; Jo, EK; Lee, S; Lee, KE; Lee, SJ				Hong, Jinpyo; Cho, Ik-Hyun; Kwak, Kyung Il; Suh, Eun Cheng; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Kim, Chong-Hyun; Park, Seung Hwa; Jo, Eun-Kyeong; Lee, Soojin; Lee, Kyung Eun; Lee, Sung Joong			Microglial Toll-like Receptor 2 Contributes to Kainic Acid-induced Glial Activation and Hippocampal Neuronal Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN-INJURY; RAT HIPPOCAMPUS; WALLERIAN DEGENERATION; STATUS EPILEPTICUS; CEREBRAL-ISCHEMIA; ENDOGENOUS LIGAND; EXPRESSION; SEIZURES; DISEASE	Recent studies indicate that Toll-like receptors (TLRs), originally identified as infectious agent receptors, also mediate sterile inflammatory responses during tissue damage. In this study, we investigated the role of TLR2 in excitotoxic hippocampal cell death using TLR2 knock-out (KO) mice. TLR2 expression was up-regulated in microglia in the ipsilateral hippocampus of kainic acid (KA)-injected mice. KA-mediated hippocampal cell death was significantly reduced in TLR2 KO mice compared with wild-type (WT) mice. Similarly, KA-induced glial activation and proinflammatory gene expression in the hippocampus were compromised in TLR2 KO mice. In addition, neurons in organotypic hippocampal slice cultures (OHSCs) from TLR2 KO mouse brains were less susceptible to KA excitotoxicity than WT OHSCs. This protection is partly attributed to decreased expression of proinflammatory genes, such as TNF-alpha and IL-1 beta in TLR2 KO mice OHSCs. These data demonstrate conclusively that TLR2 signaling in microglia contributes to KA-mediated innate immune responses and hippocampal excitotoxicity.	[Hong, Jinpyo; Kwak, Kyung Il; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, BK21, Program Mol & Cellular Neurosci,DRI, Seoul 110749, South Korea; [Hong, Jinpyo; Kwak, Kyung Il; Seo, Jinsoo; Min, Hyun Jung; Choi, Se-Young; Jo, Eun-Kyeong; Lee, Sung Joong] Seoul Natl Univ, Sch Dent, Dept Oral Physiol, Seoul 110749, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Coll Oriental Med, Dept Anat, Seoul 130701, South Korea; [Cho, Ik-Hyun] Kyung Hee Univ, Inst Oriental Med, Seoul 130701, South Korea; [Suh, Eun Cheng; Lee, Kyung Eun] Ewha Womans Univ, Sch Med, Dept Pharmacol, Seoul 158710, South Korea; [Kim, Chong-Hyun] Univ Sci & Technol, Korea Inst Sci & Technol, Ctr Neural Sci, Seoul 130722, South Korea; [Park, Seung Hwa] Konkuk Univ, Coll Med, Dept Anat, Chungju 380701, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Dept Microbiol, Taejon 301747, South Korea; [Jo, Eun-Kyeong] Chungnam Natl Univ, Coll Med, Infect Signaling Network Res Ctr, Taejon 301747, South Korea; [Lee, Soojin] Chungnam Natl Univ, Sch Syst Biol, Dept Microbiol, Taejon 305764, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Korea Institute of Oriental Medicine (KIOM); Kyung Hee University; Ewha Womans University; Korea Institute of Science & Technology (KIST); Konkuk University; Konkuk University Medical Center; Chungnam National University; Chungnam National University; Chungnam National University	Lee, SJ (corresponding author), 28 Yeongun Dong, Seoul 110749, South Korea.	sjlee87@snu.ac.kr	Cho, Ik-Hyun/A-9348-2014; Seo, Jinsoo/AAD-4950-2019; Min, Hyunjung/ABA-8709-2020	Seo, Jinsoo/0000-0001-6432-6964; Lee, Soojin/0000-0002-0383-5025; Choi, Se-Young/0000-0001-7534-5167; Eun-Kyeong, Jo/0000-0001-7191-0587	Ministry of Education, Science and Technology (MEST), the Republic of Korea [2009-0081467, 2009-0063285, 2009-0053167]; Korea Science and Engineering Foundation through the Infection Signaling Network Research Center at Chungnam National University [R13-2007-020-01000-0]	Ministry of Education, Science and Technology (MEST), the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation through the Infection Signaling Network Research Center at Chungnam National University(Korea Science and Engineering Foundation)	This work was supported by the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (MEST) (No. 2009-0081467, 2009-0063285, 2009-0053167), the Republic of Korea, and the Korea Science and Engineering Foundation through the Infection Signaling Network Research Center (R13-2007-020-01000-0) at Chungnam National University.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Ananth C, 2003, HIPPOCAMPUS, V13, P375, DOI 10.1002/hipo.10090; ANDERSSON PB, 1991, NEUROSCIENCE, V42, P201, DOI 10.1016/0306-4522(91)90159-L; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Boivin A, 2007, J NEUROSCI, V27, P12565, DOI 10.1523/JNEUROSCI.3027-07.2007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Cho IH, 2008, BRAIN, V131, P3019, DOI 10.1093/brain/awn230; Cho IH, 2006, J NEUROSCI RES, V84, P1505, DOI 10.1002/jnr.21052; COYLE JT, 1983, NEUROBEH TOXICOL TER, V5, P617; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Downen M, 1999, GLIA, V28, P114, DOI 10.1002/(SICI)1098-1136(199911)28:2<114::AID-GLIA3>3.0.CO;2-O; Dumas TC, 2000, EXP NEUROL, V166, P180, DOI 10.1006/exnr.2000.7500; Franklin K. B. J., 2001, MOUSE BRAIN STEREOTA; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Hsieh CH, 2008, TOXICOL SCI, V101, P112, DOI 10.1093/toxsci/kfm258; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kielian T, 2006, J NEUROSCI RES, V83, P711, DOI 10.1002/jnr.20767; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kristensen BW, 2001, BRAIN RES, V917, P21, DOI 10.1016/S0006-8993(01)02900-6; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MITCHELL J, 1993, EXP NEUROL, V121, P224, DOI 10.1006/exnr.1993.1089; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Park C, 2008, NEUROSCI LETT, V431, P123, DOI 10.1016/j.neulet.2007.11.057; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Rizzi M, 2003, NEUROBIOL DIS, V14, P494, DOI 10.1016/j.nbd.2003.08.001; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Song LY, 2007, J NEUROSCI RES, V85, P2186, DOI 10.1002/jnr.21367; SPERK G, 1985, BRAIN RES, V338, P289, DOI 10.1016/0006-8993(85)90159-3; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Thornton P, 2006, J NEUROCHEM, V98, P258, DOI 10.1111/j.1471-4159.2006.03872.x; Turrin NP, 2004, NEUROBIOL DIS, V16, P321, DOI 10.1016/j.nbd.2004.03.010; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	51	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39447	39457		10.1074/jbc.M110.132522	http://dx.doi.org/10.1074/jbc.M110.132522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923777	hybrid, Green Published			2022-12-27	WOS:000284941300071
J	Ziebell, A; Gracom, K; Katahira, R; Chen, F; Pu, YQ; Ragauskas, A; Dixon, RA; Davis, M				Ziebell, Angela; Gracom, Kristen; Katahira, Rui; Chen, Fang; Pu, Yunqiao; Ragauskas, Art; Dixon, Richard A.; Davis, Mark			Increase in 4-Coumaryl Alcohol Units during Lignification in Alfalfa (Medicago sativa) Alters the Extractability and Molecular Weight of Lignin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOLIGNOL BIOSYNTHESIS; DOWN-REGULATION; MAGNETIC-RESONANCE; FORAGE QUALITY; ACID BRIDGES; NMR; INTERNODES; CELLULOSE; WHEAT; CRYSTALLINITY	The lignin content of biomass can impact the ease and cost of biomass processing. Lignin reduction through breeding and genetic modification therefore has potential to reduce costs in biomass-processing industries (e. g. pulp and paper, forage, and lignocellulosic ethanol). We investigated compositional changes in two low-lignin alfalfa (Medicago sativa) lines with antisense down-regulation of p-coumarate 3-hydroxylase (C3H) or hydroxycinnamoyl-CoA:shikimate hydroxycinnamoyltransferase (HCT). We investigated whether the difference in reactivity during lignification of 4-coumaryl alcohol (H) monomers versus the naturally dominant sinapyl alcohol and coniferyl alcohol lignin monomers alters the lignin structure. Sequential base extraction readily reduced the H monomer content of the transgenic lines, leaving a residual lignin greatly enriched in H subunits; the extraction profile highlighted the difference between the control and transgenic lines. Gel permeation chromatography of isolated ball-milled lignin indicated significant changes in the weight average molecular weight distribution of the control versus transgenic lines (CTR1a, 6000; C3H4a, 5500; C3H9a, 4000; and HCT30a, 4000).	[Ziebell, Angela; Gracom, Kristen; Katahira, Rui; Davis, Mark] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Ziebell, Angela; Gracom, Kristen; Davis, Mark] Natl Renewable Energy Lab, Bioenergy Sci Ctr, Golden, CO 80401 USA; [Chen, Fang; Dixon, Richard A.] Samuel Roberts Noble Fdn Inc, Ardmore, OK 73401 USA; [Chen, Fang; Dixon, Richard A.] Bioenergy Sci Ctr, Ardmore, OK 73401 USA; [Pu, Yunqiao; Ragauskas, Art] Georgia Tech, Inst Paper Sci & Technol, Atlanta, GA 30318 USA; [Pu, Yunqiao; Ragauskas, Art] Georgia Tech, Bioenergy Sci Ctr, Atlanta, GA 30318 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Noble Research Institute; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Davis, M (corresponding author), Natl Renewable Energy Lab, Natl Bioenergy Ctr, 1617 Cole Blvd, Golden, CO 80401 USA.	mark.davis@nrel.gov	Ziebell, Angela/AAO-1551-2020; Ragauskas, Art/J-7486-2016; Davis, Mark/F-7341-2017; Pu, Yunqiao/H-3206-2016	Ragauskas, Art/0000-0002-3536-554X; Davis, Mark/0000-0003-4541-9852; Pu, Yunqiao/0000-0003-2554-1447; Ziebell, Angela/0000-0002-9940-2194	Bioenergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	Bioenergy Science Center; Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by the Bioenergy Science Center, which is a United States Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	Bjorkman A., 1956, SVEN PAPPERSTIDN, V59, P477, DOI DOI 10.1016/J.CHROMA.2003.08.046; Buranov AU, 2008, IND CROP PROD, V28, P237, DOI 10.1016/j.indcrop.2008.03.008; CHANG HM, 1975, HOLZFORSCHUNG, V29, P153, DOI 10.1515/hfsg.1975.29.5.153; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen F, 2006, PLANT J, V48, P113, DOI 10.1111/j.1365-313X.2006.02857.x; Chiang VL, 2006, ENVIRON CHEM LETT, V4, P143, DOI 10.1007/s10311-006-0067-9; Crestini C, 1997, J AGR FOOD CHEM, V45, P1212, DOI 10.1021/jf960568k; Freudenberg K., 1968, CONSTITUTION BIOSYNT, P95; Hult EL, 2002, CARBOHYD POLYM, V49, P231, DOI 10.1016/S0144-8617(01)00309-5; IIYAMA K, 1994, PHYTOCHEMISTRY, V35, P959, DOI 10.1016/S0031-9422(00)90647-2; IIYAMA K, 1990, PHYTOCHEMISTRY, V29, P733, DOI 10.1016/0031-9422(90)80009-6; Joseleau JP, 1997, PLANT PHYSIOL, V114, P1123, DOI 10.1104/pp.114.3.1123; LAM TBT, 1992, PHYTOCHEMISTRY, V31, P1179, DOI 10.1016/0031-9422(92)80256-E; LAPIERRE C, 1983, HOLZFORSCHUNG, V37, P189, DOI 10.1515/hfsg.1983.37.4.189; MCDOUGALL GJ, 1994, PLANTA, V194, P9, DOI 10.1007/BF00201028; Monties B., 2001, LIGNIN HUMIC SUBSTAN, P1; Nakashima J, 2008, NEW PHYTOL, V179, P738, DOI 10.1111/j.1469-8137.2008.02502.x; O'Connell A, 2002, TRANSGENIC RES, V11, P495, DOI 10.1023/A:1020362705497; Park S, 2009, CELLULOSE, V16, P641, DOI 10.1007/s10570-009-9321-1; Pu YQ, 2009, BIOENERG RES, V2, P198, DOI 10.1007/s12155-009-9056-8; Ralph J, 2006, J BIOL CHEM, V281, P8843, DOI 10.1074/jbc.M511598200; Ralph J, 1996, J NAT PROD, V59, P341, DOI 10.1021/np960143s; RALPH J, 1994, J AM CHEM SOC, V116, P9448, DOI 10.1021/ja00100a006; Ralph S. A., 2004, NMR DATABASE LIGNIN; Reddy MSS, 2005, P NATL ACAD SCI USA, V102, P16573, DOI 10.1073/pnas.0505749102; Robert D, 1992, METHODS LIGNIN CHEM; Russell WR, 2006, BIOMACROMOLECULES, V7, P268, DOI 10.1021/bm050636o; Russell WR, 2000, J BIOTECHNOL, V79, P73, DOI 10.1016/S0168-1656(00)00212-1; Russell WR, 1996, ARCH BIOCHEM BIOPHYS, V332, P357, DOI 10.1006/abbi.1996.0353; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; TEEAAR R, 1987, POLYM BULL, V17, P231; Wadenback J, 2004, HOLZFORSCHUNG, V58, P107, DOI 10.1515/HF.2004.015; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585; Wikberg H, 2004, CARBOHYD POLYM, V58, P461, DOI 10.1016/j.carbpol.2004.08.008	36	90	91	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38961	38968		10.1074/jbc.M110.137315	http://dx.doi.org/10.1074/jbc.M110.137315			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921228	Green Published, hybrid			2022-12-27	WOS:000284941300026
J	Park, UH; Yoon, SK; Park, T; Kim, EJ; Um, SJ				Park, Ui-Hyun; Yoon, Seung Kew; Park, Taesun; Kim, Eun-Joo; Um, Soo-Jong			Additional Sex Comb-like (ASXL) Proteins 1 and 2 Play Opposite Roles in Adipogenesis via Reciprocal Regulation of Peroxisome Proliferator-activated Receptor gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; RESPONSIVE ELEMENT; TRANSCRIPTIONAL COACTIVATOR; METABOLIC PATHWAYS; GENE-EXPRESSION; TARGET GENES; HISTONE H3; LYSINE 9; IDENTIFICATION	Our previous studies have suggested that the mammalian additional sex comb-like 1 protein functions as a coactivator or repressor of retinoic acid receptors in a cell-specific manner. Here, we investigated the roles of additional sex comb-like 1 proteins in regulating peroxisome proliferator-activated receptors (PPARs). In pulldown assays in vitro and in immuno-precipitation assays in vivo, ASXL1 and its paralog, ASXL2, interacted with PPAR alpha and PPAR gamma. In 3T3-L1 preadipocyte cells, overexpression of ASXL1 inhibited the induction of PPAR gamma activity by rosiglitazone, as shown by transcription assays, and completely suppressed adipogenesis, as shown by Oil Red O staining. In contrast, overexpression of ASXL2 greatly enhanced rosiglitazone-induced PPAR gamma activity and enhanced adipogenesis. Deletion of the heterochromatin protein 1 (HP1)-binding domain from ASXL1 caused the mutant protein to enhance adipogenesis similarly to ASXL2, indicating that HP1 binding is required for the adipogenesis-suppressing activity of ASXL1. Adipocyte differentiation was associated with a gradual decrease in ASXL1 expression but did not affect ASXL2 expression. Knockdown of ASXL1 and ASXL2 had reciprocal effects on adipogenesis. In chromatin immuno-precipitation assays in 3T3-L1 cells, ASXL1 occupied the promoter of the PPAR gamma target gene aP2 together with HP1 alpha and Lys-9-methylated histone H3, whereas ASXL2 occupied the aP2 promoter together with histone-lysine N-methyltransferase MLL1 and Lys-9-acetylated and Lys-4-methylated H3 histones. Finally, microarray analysis demonstrated that ASXL1 represses, whereas ASXL2 increases, the expression of adipogenic genes, most of which are PPAR gamma targets. These results suggest that members of the additional sex comb-like family provide complex regulation of adipogenesis via differential modulation of PPAR gamma activity.	[Kim, Eun-Joo] Dankook Univ, Grad Program BK21, Dept Mol Biol, Yongin 448701, Gyeonggi Do, South Korea; [Park, Ui-Hyun; Um, Soo-Jong] Sejong Univ, Grad Program BK21, Dept Biosci & Biotechnol, Seoul 143747, South Korea; [Yoon, Seung Kew] Catholic Univ Korea, Dept Internal Med, Seoul 137701, South Korea; [Park, Taesun] Yonsei Univ, Dept Food & Nutr, Seoul 120749, South Korea	Dankook University; Sejong University; Catholic University of Korea; Yonsei University	Kim, EJ (corresponding author), Dankook Univ, Grad Program BK21, Dept Mol Biol, 126 Jukjeon Dong, Yongin 448701, Gyeonggi Do, South Korea.	nbrejk@dankook.ac.kr; umsj@sejong.ac.kr		Park, Taesun/0000-0002-9752-9407	MEST [2007-0053438, 2008-0057731, 2009-0079104, 2008-0059055]; Ministry of Health, Welfare, and Family Affairs, Republic of Korea [A090282]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported in part by Basic Science Research Program NRF Grants 2007-0053438, 2008-0057731, and 2009-0079104 (to S.-J. U.) and 2008-0059055 (to E.-J. K.) from MEST and in part by Health 21 R & D Project Grant A090282 (to S.-J. U.) from the Ministry of Health, Welfare, and Family Affairs, Republic of Korea.	Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baskind HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004750; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Biscetti F, 2009, NUTR METAB CARDIOVAS, V19, P751, DOI 10.1016/j.numecd.2009.04.011; Chen JG, 2006, BIOCHEM BIOPH RES CO, V347, P821, DOI 10.1016/j.bbrc.2006.06.170; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Deng T, 2006, ENDOCRINOLOGY, V147, P875, DOI 10.1210/en.2005-0623; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Katoh M, 2004, INT J ONCOL, V24, P1617; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leader JE, 2006, BIOCHEM PHARMACOL, V72, P1589, DOI 10.1016/j.bcp.2006.05.024; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Louet JF, 2007, CELL CYCLE, V6, P2448, DOI 10.4161/cc.6.20.4777; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Musri MM, 2007, BIOCHEM CELL BIOL, V85, P397, DOI 10.1139/O07-068; Musri MM, 2006, J BIOL CHEM, V281, P17180, DOI 10.1074/jbc.M601295200; Musri MM, 2010, ORGANOGENESIS, V6, P15, DOI 10.4161/org.6.1.10226; Nagai S, 2004, ENDOCRINOLOGY, V145, P2346, DOI 10.1210/en.2003-1180; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Shimizu M, 2006, J BIOCHEM, V139, P563, DOI 10.1093/jb/mvj053; Sinclair DAR, 1998, DEVELOPMENT, V125, P1207; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang L, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/67297; Yadav N, 2008, EMBO REP, V9, P193, DOI 10.1038/sj.embor.7401151; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu ST, 2007, BBA-MOL CELL BIOL L, V1771, P936, DOI 10.1016/j.bbalip.2007.01.008; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636	53	57	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1354	1363		10.1074/jbc.M110.177816	http://dx.doi.org/10.1074/jbc.M110.177816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047783	hybrid, Green Published			2022-12-27	WOS:000286005000047
J	Du, H; Wolf, J; Schafer, B; Moldoveanu, T; Chipuk, JE; Kuwana, T				Du, Han; Wolf, Jacob; Schafer, Blanca; Moldoveanu, Tudor; Chipuk, Jerry E.; Kuwana, Tomomi			BH3 Domains other than Bim and Bid Can Directly Activate Bax/Bak	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; APOPTOTIC PROTEIN BAK; BCL-2 FAMILY-MEMBERS; CELL-DEATH; ANTAGONIST ABT-737; BH3-ONLY PROTEINS; MIMETIC ABT-737; MCL-1; OLIGOMERIZATION; SENSITIVITY	Bcl-2 family proteins regulate a critical step in apoptosis referred to as mitochondrial outer membrane permeabilization (MOMP). Members of a subgroup of the Bcl-2 family, known as the BH3-only proteins, activate pro-apoptotic effectors (Bax and Bak) to initiate MOMP. They do so by neutralizing pro-survival Bcl-2 proteins and/or directly activating Bax/Bak. Bim and Bid are reported to be direct activators; however, here we show that BH3 peptides other than Bim and Bid exhibited various degrees of direct activation of the effector Bax or Bak, including Bmf and Noxa BH3s. In the absence of potent direct activators, such as Bim and Bid, we unmasked novel direct activator BH3 ligands capable of inducing effector-mediated cytochrome c release and liposome permeabilization, even when both Bcl-xL- and Mcl-1-type anti-apoptotic proteins were inhibited. The ability of these weaker direct activator BH3 peptides to cause MOMP correlated with that of the corresponding full-length proteins to induce apoptosis in the absence of Bim and Bid. We propose that, in certain contexts, direct activation by BH3-only proteins other than Bim and Bid may significantly contribute to MOMP and apoptosis.	[Moldoveanu, Tudor; Chipuk, Jerry E.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA; [Du, Han; Wolf, Jacob; Schafer, Blanca; Kuwana, Tomomi] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA	St Jude Children's Research Hospital; University of Iowa	Kuwana, T (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, 1161ML, Ia City, IA 52242 USA.	t-kuwana@uiowa.edu	Moldoveanu, Tudor/N-8173-2018	Moldoveanu, Tudor/0000-0003-0791-318X; Chipuk, Jerry Edward/0000-0002-1337-842X; Du, Han/0000-0002-8488-6755	National Institutes of Health; Dept. of Pathology, University of Iowa Carver College of Medicine; NATIONAL CANCER INSTITUTE [R01CA157740, F32CA101444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Pathology, University of Iowa Carver College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health and the start-up funds from the Dept. of Pathology, University of Iowa Carver College of Medicine (to T. K.).	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2008, P NATL ACAD SCI USA, V105, P20327, DOI 10.1073/pnas.0808036105; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Khaled AR, 1999, P NATL ACAD SCI USA, V96, P14476, DOI 10.1073/pnas.96.25.14476; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Mason KD, 2008, P NATL ACAD SCI USA, V105, P17961, DOI 10.1073/pnas.0809957105; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sharpe JC, 1999, J MEMBRANE BIOL, V171, P209, DOI 10.1007/s002329900572; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	44	118	120	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					491	501		10.1074/jbc.M110.167148	http://dx.doi.org/10.1074/jbc.M110.167148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041309	Green Published, hybrid			2022-12-27	WOS:000285782800052
J	Sajid, W; Kulahin, N; Schluckebier, G; Ribel, U; Henderson, HR; Tatar, M; Hansen, BF; Svendsen, AM; Kiselyov, VV; Norgaard, P; Wahlund, PO; Brandt, J; Kohanski, RA; Andersen, AS; De Meyts, P				Sajid, Waseem; Kulahin, Nikolaj; Schluckebier, Gerd; Ribel, Ulla; Henderson, Hope Rosalind; Tatar, Marc; Hansen, Bo Falck; Svendsen, Angela Manegold; Kiselyov, Vladislav V.; Norgaard, Per; Wahlund, Per-Olof; Brandt, Jakob; Kohanski, Ronald A.; Andersen, Asser Sloth; De Meyts, Pierre			Structural and Biological Properties of the Drosophila Insulin-like Peptide 5 Show Evolutionary Conservation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING REGION; NEGATIVE COOPERATIVITY; LIFE-SPAN; GROWTH; PROTEIN; EXPRESSION; AFFINITY; ISOFORM; CELLS; MUTAGENESIS	We report the crystal structure of two variants of Drosophila melanogaster insulin-like peptide 5 (DILP5) at a resolution of 1.85 angstrom. DILP5 shares the basic fold of the insulin peptide family (T conformation) but with a disordered B-chain C terminus. DILP5 dimerizes in the crystal and in solution. The dimer interface is not similar to that observed in vertebrates, i.e. through an anti-parallel beta-sheet involving the B-chain C termini but, in contrast, is formed through an anti-parallel beta-sheet involving the B-chain N termini. DILP5 binds to and activates the human insulin receptor and lowers blood glucose in rats. It also lowers trehalose levels in Drosophila. Reciprocally, human insulin binds to the Drosophila insulin receptor and induces negative cooperativity as in the human receptor. DILP5 also binds to insect insulin-binding proteins. These results show high evolutionary conservation of the insulin receptor binding properties despite divergent insulin dimerization mechanisms.	[Sajid, Waseem; Kulahin, Nikolaj; Svendsen, Angela Manegold; Kiselyov, Vladislav V.; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Schluckebier, Gerd; Ribel, Ulla; Hansen, Bo Falck; Norgaard, Per; Wahlund, Per-Olof; Brandt, Jakob; Andersen, Asser Sloth] Novo Nordisk AS, Diabet Res Unit, DK-2760 Malov, Denmark; [Henderson, Hope Rosalind; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Kohanski, Ronald A.] NIA, NIH, Bethesda, MD 20892 USA	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; Brown University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sajid, W (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark.	wsaj@hagedorn.dk	Schluckebier, Gerd/A-5045-2009	Schluckebier, Gerd/0000-0003-0725-4081; Tatar, Marc/0000-0003-3232-6884; De Meyts, Pierre/0000-0001-6214-0824; Henderson, Hope/0000-0002-1373-296X				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Andersen AS, 2000, J BIOL CHEM, V275, P16948, DOI 10.1074/jbc.M001578200; Arquier N, 2008, CELL METAB, V7, P333, DOI 10.1016/j.cmet.2008.02.003; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Bonnesen C, 2010, CELL BIOL TOXICOL, V26, P293, DOI 10.1007/s10565-009-9142-x; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Chan SJ, 2000, AM ZOOL, V40, P213; Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0; CUTFIELD JF, 1979, J MOL BIOL, V132, P85, DOI 10.1016/0022-2836(79)90497-2; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 1976, METHODS RECEPTOR RES, V1, P301; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1976, J BIOL CHEM, V251, P1877; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; GARBE JC, 1993, DEVELOPMENT, V119, P1237; Gauguin L., 2008, THESIS U COPENHAGEN; Gauguin L, 2008, J BIOL CHEM, V283, P2604, DOI 10.1074/jbc.M709220200; Glaser RW, 1925, J GEN PHYSIOL, V7, P599, DOI 10.1085/jgp.7.5.599; Glendorf T., 1995, THESIS DANISH TU LYN; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hernandez-Sanchez C, 2008, MOL BIOL EVOL, V25, P1043, DOI 10.1093/molbev/msn036; HONEGGER B, 2008, J BIOL-LONDON, V7, pNIL1, DOI DOI 10.1186/jbiol72; Hua QX, 2003, GENE DEV, V17, P826, DOI 10.1101/gad.1058003; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; KADOWAKI H, 1990, J BIOL CHEM, V265, P21285; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 1998, PROTEIN EXPRES PURIF, V14, P309, DOI 10.1006/prep.1998.0977; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MENESES P, 1975, COMP BIOCHEM PHYS A, V51, P483, DOI 10.1016/0300-9629(75)90398-9; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; MUGGEO M, 1979, DIABETES, V28, P175, DOI 10.2337/diab.28.3.175; MURRAYRUST J, 1992, BIOESSAYS, V14, P325, DOI 10.1002/bies.950140507; NAGATA K, 1995, J MOL BIOL, V253, P749, DOI 10.1006/jmbi.1995.0588; NORMANN TC, 1975, NATURE, V254, P259, DOI 10.1038/254259a0; OSTERBUR DL, 1988, DEV BIOL, V129, P439, DOI 10.1016/0012-1606(88)90391-0; PETRUZZELLI L, 1985, J BIOL CHEM, V260, P6072; Petruzzelli L., 1985, CANC CELLS, P115; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Renteria ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003667; RUAN YM, 1995, J BIOL CHEM, V270, P4236, DOI 10.1074/jbc.270.9.4236; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sajid W, 2009, BIOCHEMISTRY-US, V48, P11283, DOI 10.1021/bi901269j; Satake S, 1997, COMP BIOCHEM PHYS B, V118, P349, DOI 10.1016/S0305-0491(97)00166-1; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Wilkinson TN, 2007, ADV EXP MED BIOL, V612, P1; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011	70	43	45	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					661	673		10.1074/jbc.M110.156018	http://dx.doi.org/10.1074/jbc.M110.156018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20974844	Green Published, hybrid			2022-12-27	WOS:000285782800067
J	Batchelor, R; Windle, CJ; Buchoux, S; Lorch, M				Batchelor, Rebecca; Windle, Christopher J.; Buchoux, Sebastien; Lorch, Mark			Cholesterol and Lipid Phases Influence the Interactions between Serotonin Receptor Agonists and Lipid Bilayers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; NOESY NMR CROSSPEAKS; ANGLE-SPINNING NMR; SOLID-STATE NMR; HYDROCARBON CHAINS; H-2 NMR; DIPALMITOYL PHOSPHATIDYLCHOLINE; MEMBRANE INTERACTIONS; MOLECULAR DISORDER; ACYL CHAINS	Solid state NMR techniques have been used to investigate the effect that two serotonin receptor 1a agonists (quipazine and LY-165,163) have on the phase behavior of, and interactions within, cholesterol/phosphocholine lipid bilayers. The presence of agonist, and particularly LY-165,163, appears to widen the phase transitions, an effect that is much more pronounced in the presence of cholesterol. It was found that both agonists locate close to the cholesterol, and their interactions with the lipids are modulated by the lipid phases. As the membrane condenses into mixed liquid-ordered/disordered phases, quipazine is pushed up toward the surface of the bilayer, whereas LY-165,163 moves deeper into the lipid chain region. In light of our results, we discuss the role of lipid/drug interactions on drug efficacy.	[Batchelor, Rebecca; Windle, Christopher J.; Lorch, Mark] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England; [Buchoux, Sebastien] Univ Picardie Jules Verne, F-80000 Amiens, France	University of Hull; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Lorch, M (corresponding author), Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England.	M.Lorch@hull.ac.uk	Buchoux, Sébastien/B-1822-2010	Buchoux, Sébastien/0000-0002-1544-2093	Royal Society; Engineering and Physical Sciences Research Council; Research Councils UK; Engineering and Physical Sciences Research Council [EP/C508912/1] Funding Source: researchfish	Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Research Councils UK(UK Research & Innovation (UKRI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by a Royal Society project grant and an Engineering and Physical Sciences Research Council doctoral training account.; Supported by a Research Councils UK academic fellowship. To whom correspondence should be addressed. Tel.: 44-1482-465687; E-mail: M. Lorch@hull.ac.uk.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; AMMANN C, 1982, J MAGN RESON, V46, P319, DOI 10.1016/0022-2364(82)90147-0; Bjork K, 2010, EXP CELL RES, V316, P1351, DOI 10.1016/j.yexcr.2010.02.034; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Castanho MARB, 2006, EUR BIOPHYS J BIOPHY, V35, P92, DOI 10.1007/s00249-005-0007-9; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Clarke JA, 2006, BIOPHYS J, V90, P2383, DOI 10.1529/biophysj.104.056499; DAVIS JH, 1979, BIOPHYS J, V27, P339, DOI 10.1016/S0006-3495(79)85222-4; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Eisensamer B, 2005, J NEUROSCI, V25, P10198, DOI 10.1523/JNEUROSCI.2460-05.2005; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; Holte LL, 1997, BIOCHEMISTRY-US, V36, P4669, DOI 10.1021/bi9626416; HUANG TH, 1993, BIOCHEMISTRY-US, V32, P13277, DOI 10.1021/bi00211a041; Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h; Huster D, 1999, J AM CHEM SOC, V121, P1992, DOI 10.1021/ja9838413; Huster D, 1999, BIOPHYS J, V76, pA354; Jones E., 2001, SCIPY OPEN SOURCE SC; Karmakar S, 2005, J PHYS-CONDENS MAT, V17, pS1177, DOI 10.1088/0953-8984/17/14/006; Keller R., 2004, COMPUTER AIDED RESON, V1; Lombardi D, 2009, EUR J PHARM SCI, V38, P533, DOI 10.1016/j.ejps.2009.10.001; Lopez JJ, 2008, J BIOL CHEM, V283, P7813, DOI 10.1074/jbc.M707480200; Lucio M, 2010, CURR MED CHEM, V17, P1795, DOI 10.2174/092986710791111233; McCabe MA, 1997, SOLID STATE NUCL MAG, V10, P53, DOI 10.1016/S0926-2040(97)00024-6; Meyer HH., 1899, ARCH EXP PATH PHARMA, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; MILLAN MJ, 1995, J PHARMACOL EXP THER, V273, P1418; OLDFIELD E, 1978, BIOCHEMISTRY-US, V17, P2727, DOI 10.1021/bi00607a006; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; PEROUTKA SJ, 1988, EUR J PHARMACOL, V148, P297, DOI 10.1016/0014-2999(88)90579-1; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Polozov IV, 2006, BIOPHYS J, V90, P2051, DOI 10.1529/biophysj.105.070441; REINL H, 1992, BIOPHYS J, V61, P1025, DOI 10.1016/S0006-3495(92)81910-0; SALMON A, 1987, J AM CHEM SOC, V109, P2600, DOI 10.1021/ja00243a010; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10676, DOI 10.1021/bi00499a015; Scheidt HA, 2005, BIOPHYS J, V89, P2504, DOI 10.1529/biophysj.105.062018; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Siarheyeva A, 2006, BIOCHEMISTRY-US, V45, P6203, DOI 10.1021/bi0524870; Soubias O, 2004, CHEM-EUR J, V10, P6005, DOI 10.1002/chem.200400246; Vauquelin G, 2009, MOL CELL ENDOCRINOL, V311, P1, DOI 10.1016/j.mce.2009.07.022; Veatch SL, 2004, BIOPHYS J, V86, p201A; VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	44	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41402	41411		10.1074/jbc.M110.155176	http://dx.doi.org/10.1074/jbc.M110.155176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961857	Green Published, hybrid			2022-12-27	WOS:000285622600026
J	Legiewicz, M; Zolotukhin, AS; Pilkington, GR; Purzycka, KJ; Mitchell, M; Uranishi, H; Bear, J; Pavlakis, GN; Le Grice, SFJ; Felber, BK				Legiewicz, Michal; Zolotukhin, Andrei S.; Pilkington, Guy R.; Purzycka, Katarzyna J.; Mitchell, Michelle; Uranishi, Hiroaki; Bear, Jenifer; Pavlakis, George N.; Le Grice, Stuart F. J.; Felber, Barbara K.			The RNA Transport Element of the Murine musD Retrotransposon Requires Long-range Intramolecular Interactions for Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KISSING-LOOP INTERACTION; SELECTIVE 2'-HYDROXYL ACYLATION; REV PROTEIN; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL CONTROL; MUTATIONAL ANALYSIS; SECONDARY STRUCTURE; TARGET SEQUENCE; VIRUS GENOME; HIV-1	Retrovirus replication requires specialized transport mechanisms to export genomic mRNA from the nucleus to the cytoplasm of the infected cell. This regulation is mediated by a combination of viral and/or cellular factors that interact with cis-acting RNA export elements linking the viral RNA to the cellular CRM1 or NXF1 nuclear export pathways. Endogenous type D murine LTR retrotransposons (musD) were reported to contain an RNA export element located upstream of the 3'-LTR. Although functionally equivalent, the musD export element, termed the musD transport element, is distinct from the other retroviral RNA export elements, such as the constitutive transport element of simian/Mason-Pfizer monkey retroviruses and the RNA transport element found in rodent intracisternal A-particle LTR retrotransposons. We demonstrate here that the minimal RNA transport element (musD transport element) of musD comprises multiple secondary structure elements that presumably serve as recognition signals for the cellular export machinery. We identified two classes of tertiary interactions, namely kissing loops and a pseudoknot. This work constitutes the first example of an RNA transport element requiring such structural motifs to mediate nuclear export.	[Le Grice, Stuart F. J.] NCI, RT Biochem Sect, HIV Drug Resistance Program, Vaccine Branch,Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Zolotukhin, Andrei S.; Pilkington, Guy R.; Bear, Jenifer; Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, NIH, Frederick, MD 21702 USA; [Uranishi, Hiroaki; Pavlakis, George N.] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Le Grice, SFJ (corresponding author), NCI, RT Biochem Sect, HIV Drug Resistance Program, Vaccine Branch,Ctr Canc Res,NIH, POB B,Bldg 535,Rm 206, Frederick, MD 21702 USA.	legrices@mail.nih.gov; felberb@mail.nih.gov		Purzycka, Katarzyna J./0000-0002-0271-9161	National Institutes of Health of the NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750, ZIABC010334] Funding Source: NIH RePORTER	National Institutes of Health of the NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NCI Center for Cancer Research.	Badorrek CS, 2006, BIOCHEMISTRY-US, V45, P12664, DOI 10.1021/bi060521k; BARTEL DP, 1991, CELL, V67, P529, DOI 10.1016/0092-8674(91)90527-6; BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Concepcion D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000484; COOK KS, 1991, NUCLEIC ACIDS RES, V19, P1577, DOI 10.1093/nar/19.7.1577; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Ernst RK, 1997, RNA, V3, P210; Felber BK, 2007, ADV PHARMACOL, V55, P161, DOI 10.1016/S1054-3589(07)55005-2; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Friebe P, 2005, J VIROL, V79, P380, DOI 10.1128/JVI.79.1.380-392.2005; Gago S, 2005, RNA, V11, P1073, DOI 10.1261/rna.2230605; Gruter P, 1998, MOL CELL, V1, P649, DOI 10.1016/S1097-2765(00)80065-9; Haddrick M, 1996, J MOL BIOL, V259, P58, DOI 10.1006/jmbi.1996.0301; HEAPHY S, 1990, CELL, V60, P685, DOI 10.1016/0092-8674(90)90671-Z; Hiriart E, 2005, J BIOL CHEM, V280, P36935, DOI 10.1074/jbc.M501725200; HOLLAND SM, 1990, J VIROL, V64, P5966, DOI 10.1128/JVI.64.12.5966-5975.1990; Ishihara H, 2004, J RADIAT RES, V45, P25, DOI 10.1269/jrr.45.25; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kang YB, 1999, VIROLOGY, V262, P200, DOI 10.1006/viro.1999.9906; Legiewicz M, 2008, P NATL ACAD SCI USA, V105, P14365, DOI 10.1073/pnas.0804461105; Lindtner S, 2006, J BIOL CHEM, V281, P36915, DOI 10.1074/jbc.M608745200; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; MANS RMW, 1991, EUR J BIOCHEM, V201, P303, DOI 10.1111/j.1432-1033.1991.tb16288.x; MARINO JP, 1995, SCIENCE, V268, P1448, DOI 10.1126/science.7539549; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mitra S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn267; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Nappi F, 2001, J VIROL, V75, P4558, DOI 10.1128/JVI.75.10.4558-4569.2001; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; REUSS FU, 1992, J VIROL, V66, P1915, DOI 10.1128/JVI.66.4.1915-1923.1992; Ribet D, 2004, GENOME RES, V14, P2261, DOI 10.1101/gr.2924904; Ribet D, 2008, GENOME RES, V18, P597, DOI 10.1101/gr.073486.107; Ribet D, 2007, J VIROL, V81, P1888, DOI 10.1128/JVI.02051-06; Seol Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158103; Smulevitch S, 2005, J VIROL, V79, P2356, DOI 10.1128/JVI.79.4.2356-2365.2005; Sung D, 1998, NUCLEIC ACIDS RES, V26, P1369, DOI 10.1093/nar/26.6.1369; Tabernero C, 1997, J VIROL, V71, P95, DOI 10.1128/JVI.71.1.95-101.1997; Tabernero C, 1996, J VIROL, V70, P5998, DOI 10.1128/JVI.70.9.5998-6011.1996; Townsend HL, 2008, RNA BIOL, V5, P263, DOI 10.4161/rna.7165; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Uranishi H, 2009, J BIOL CHEM, V284, P26106, DOI 10.1074/jbc.M109.040113; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilkinson KA, 2009, RNA, V15, P1314, DOI 10.1261/rna.1536209; Zolotukhin AS, 2008, VIROLOGY, V377, P88, DOI 10.1016/j.virol.2008.04.002; Zolotukhin AS, 2009, NUCLEIC ACIDS RES, V37, P7151, DOI 10.1093/nar/gkp782; Zolotukhin AS, 2001, J VIROL, V75, P5567, DOI 10.1128/JVI.75.12.5567-5575.2001	49	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42097	42104		10.1074/jbc.M110.182840	http://dx.doi.org/10.1074/jbc.M110.182840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978285	hybrid, Green Published			2022-12-27	WOS:000285622600094
J	Caulfield, MJ; Dudkin, VY; Ottinger, EA; Getty, KL; Zuck, PD; Kaufhold, RM; Hepler, RW; McGaughey, GB; Citron, M; Hrin, RC; Wang, YJ; Miller, MD; Joyce, JG				Caulfield, Michael J.; Dudkin, Vadim Y.; Ottinger, Elizabeth A.; Getty, Krista L.; Zuck, Paul D.; Kaufhold, Robin M.; Hepler, Robert W.; McGaughey, Georgia B.; Citron, Michael; Hrin, Renee C.; Wang, Ying-Jie; Miller, Michael D.; Joyce, Joseph G.			Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; DESIGN; EPITOPE; BINDING; POTENT; DIVERSITY; GP120; PEPTIDOMIMETICS; IMMUNOGENICITY; HYPERMUTATION	We describe here a novel platform technology for the discovery of small molecule mimetics of conformational epitopes on protein antigens. As a model system, we selected mimetics of a conserved hydrophobic pocket within the N-heptad repeat region of the HIV-1 envelope protein, gp41. The human monoclonal antibody, D5, binds to this target and exhibits broadly neutralizing activity against HIV-1. We exploited the antigen-binding property of D5 to select complementary small molecules using a high throughput screen of a diverse chemical collection. The resulting small molecule leads were rendered immunogenic by linking them to a carrier protein and were shown to elicit N-heptad repeat-binding antibodies in a fraction of immunized mice. Plasma from HIV-1-infected subjects shown previously to contain broadly neutralizing antibodies was found to contain antibodies capable of binding to haptens represented in the benzylpiperidine leads identified as a result of the high throughput screen, further validating these molecules as vaccine leads. Our results suggest a new paradigm for vaccine discovery using a medicinal chemistry approach to identify lead molecules that, when optimized, could become vaccine candidates for infectious diseases that have been refractory to conventional vaccine development.	[Caulfield, Michael J.; Ottinger, Elizabeth A.; Kaufhold, Robin M.; Hepler, Robert W.; Citron, Michael; Joyce, Joseph G.] Merck Res Labs, Dept Vaccine Basic Res, West Point, PA 19486 USA; [Dudkin, Vadim Y.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Getty, Krista L.; Zuck, Paul D.] Merck Res Labs, Dept Automated Biotechnol, West Point, PA 19486 USA; [McGaughey, Georgia B.] Merck Res Labs, Dept Chem Modeling & Informat, West Point, PA 19486 USA; [Hrin, Renee C.; Wang, Ying-Jie; Miller, Michael D.] Merck Res Labs, Dept Antiviral Res, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Joyce, JG (corresponding author), WP16-101,770 Sumneytown Pike, West Point, PA 19486 USA.	joseph_joyce@merck.com						Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Crooks ET, 2007, VIROLOGY, V366, P245, DOI 10.1016/j.virol.2007.04.033; DATTA SK, 1987, J EXP MED, V165, P1252, DOI 10.1084/jem.165.5.1252; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dias RLA, 2006, J AM CHEM SOC, V128, P2726, DOI 10.1021/ja057513w; Falciani C, 2005, CHEM BIOL, V12, P417, DOI 10.1016/j.chembiol.2005.02.009; Freeman C, 2005, J BIOL CHEM, V280, P8842, DOI 10.1074/jbc.M410769200; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Harvey AJ, 2005, BIOORG MED CHEM LETT, V15, P3193, DOI 10.1016/j.bmcl.2005.05.014; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Joyce JG, 2008, P NATL ACAD SCI USA, V105, P15684, DOI 10.1073/pnas.0807837105; Kelso MJ, 2004, J AM CHEM SOC, V126, P4828, DOI 10.1021/ja037980i; KieberEmmons T, 1997, CURR OPIN BIOTECH, V8, P435, DOI 10.1016/S0958-1669(97)80065-1; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; Miller MD, 2005, P NATL ACAD SCI USA, V102, P14759, DOI 10.1073/pnas.0506927102; MILLER MD, 1994, J COMPUT AID MOL DES, V8, P153, DOI 10.1007/BF00119865; Nahas DD, 2008, BIOCONJUGATE CHEM, V19, P322, DOI 10.1021/bc700232z; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Qiao ZS, 2005, J BIOL CHEM, V280, P23138, DOI 10.1074/jbc.M414515200; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Saphire EO, 2007, J MOL BIOL, V369, P696, DOI 10.1016/j.jmb.2007.01.060; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Yang LH, 1998, J MED CHEM, V41, P2439, DOI 10.1021/jm9800191; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	34	3	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40604	40611		10.1074/jbc.M110.172197	http://dx.doi.org/10.1074/jbc.M110.172197			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943652	hybrid, Green Published			2022-12-27	WOS:000285414400023
J	Ding, PG; Huang, JA; Battiprolu, PK; Hill, JA; Kamm, KE; Stull, JT				Ding, Peiguo; Huang, Jian; Battiprolu, Pavan K.; Hill, Joseph A.; Kamm, Kristine E.; Stull, James T.			Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CONTRACTION; INTERACTING PROTEIN-KINASE; HYPERTROPHIC CARDIOMYOPATHY; CA2+ SENSITIVITY; TRANSGENIC MICE; FORCE DEVELOPMENT; STRIATED-MUSCLE; THIN-FILAMENTS; KNOCKOUT MICE; HEART	In contrast to studies on skeletal and smooth muscles, the identity of kinases in the heart that are important physiologically for direct phosphorylation of myosin regulatory light chain (RLC) is not known. A Ca2+/calmodulin-activated myosin light chain kinase is expressed only in cardiac muscle (cMLCK), similar to the tissue-specific expression of skeletal muscle MLCK and in contrast to the ubiquitous expression of smooth muscle MLCK. We have ablated cMLCK expression in male mice to provide insights into its role in RLC phosphorylation in normally contracting myocardium. The extent of RLC phosphorylation was dependent on the extent of cMLCK expression in both ventricular and atrial muscles. Attenuation of RLC phosphorylation led to ventricular myocyte hypertrophy with histological evidence of necrosis and fibrosis. Echocardiography showed increases in left ventricular mass as well as end-diastolic and end-systolic dimensions. Cardiac performance measured as fractional shortening decreased proportionally with decreased cMLCK expression culminating in heart failure in the setting of no RLC phosphorylation. Hearts from female mice showed similar responses with loss of cMLCK associated with diminished RLC phosphorylation and cardiac hypertrophy. Isoproterenol infusion elicited hypertrophic cardiac responses in wild type mice. In mice lacking cMLCK, the hypertrophic hearts showed no additional increases in size with the isoproterenol treatment, suggesting a lack of RLC phosphorylation blunted the stress response. Thus, cMLCK appears to be the predominant protein kinase that maintains basal RLC phosphorylation that is required for normal physiological cardiac performance in vivo.	[Ding, Peiguo; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Stull, JT (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	james.stull@utsouthwestern.edu			National Institutes of Health [HL080536, HL-075173, HL-080144, HL-090842]; American Heart Association [0640084N]; American Diabetes Association [7-08-MN-21-ADA]; American Heart Association-Jon Holden DeHaan Foundation [0970518N]; Moss Heart Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075173, R01HL080536, R01HL080144, R01HL090842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); Moss Heart Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536, HL-075173, HL-080144, and HL-090842. This work was also supported by American Heart Association Grant 0640084N, American Diabetes Association Grant 7-08-MN-21-ADA, the American Heart Association-Jon Holden DeHaan Foundation Grant 0970518N, and the Moss Heart Fund.	Abraham TP, 2009, CARDIOVASC RES, V82, P84, DOI 10.1093/cvr/cvp016; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2010, J BIOL CHEM, V285, P5122, DOI 10.1074/jbc.C109.076489; Collins JH, 2006, J MUSCLE RES CELL M, V27, P69, DOI 10.1007/s10974-006-9057-6; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Davis JS, 2001, CELL, V107, P631, DOI 10.1016/S0092-8674(01)00586-4; Dias FAL, 2006, J MOL CELL CARDIOL, V41, P330, DOI 10.1016/j.yjmcc.2006.05.012; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dudnakova TV, 2006, CELL MOTIL CYTOSKEL, V63, P375, DOI 10.1002/cm.20127; Ferrari MB, 2006, CELL BIOCHEM BIOPHYS, V45, P317, DOI 10.1385/CBB:45:3:317; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Graves PR, 2005, J BIOL CHEM, V280, P9363, DOI 10.1074/jbc.M412538200; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; HERRING BP, 1986, BIOCHEM J, V240, P205, DOI 10.1042/bj2400205; HIGH CW, 1980, AM J PHYSIOL, V239, pH756, DOI 10.1152/ajpheart.1980.239.6.H756; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huang GJ, 2006, J CELL SCI, V119, P153, DOI 10.1242/jcs.02731; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; JABBOUR A, 2010, EUR J HEART IN PRESS; Kerrick WGL, 2009, FASEB J, V23, P855, DOI 10.1096/fj.08-118182; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Li HY, 2004, DEV DYNAM, V229, P231, DOI 10.1002/dvdy.10428; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Lin PJ, 1997, J BIOL CHEM, V272, P7412, DOI 10.1074/jbc.272.11.7412; Ma XF, 2009, CIRC RES, V105, P1102, DOI 10.1161/CIRCRESAHA.109.200303; MacDonald JA, 2001, P NATL ACAD SCI USA, V98, P2419, DOI 10.1073/pnas.041331498; Maillet M, 2010, J BIOL CHEM, V285, P6716, DOI 10.1074/jbc.M109.056143; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Mizutani H, 2010, CIRC J, V74, P120, DOI 10.1253/circj.CJ-09-0462; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; NUNNALLY MH, 1984, J BIOL CHEM, V259, P1776; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Rayment I, 1996, J BIOL CHEM, V271, P15850, DOI 10.1074/jbc.271.27.15850; Rosenkranz S, 2002, AM J PHYSIOL-HEART C, V283, pH1253, DOI 10.1152/ajpheart.00578.2001; Rottbauer W, 2006, CIRC RES, V99, P323, DOI 10.1161/01.RES.0000234807.16034.fe; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Saucerman JJ, 2008, BIOPHYS J, V95, P4597, DOI 10.1529/biophysj.108.128728; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; SILVER PJ, 1986, J MOL CELL CARDIOL, V18, P31, DOI 10.1016/S0022-2828(86)80980-4; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Smith L, 2002, J BIOL CHEM, V277, P35597, DOI 10.1074/jbc.M206483200; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Song QJ, 2008, J BIOL CHEM, V283, P31531, DOI 10.1074/jbc.M804902200; Stull JT, 1998, ACTA PHYSIOL SCAND, V164, P471, DOI 10.1111/j.1365-201X.1998.tb10699.x; STULL JT, 1986, ENZYMES, V17, P113; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; SWEENEY HL, 1993, AM J PHYSIOL, V264, pC1085, DOI 10.1152/ajpcell.1993.264.5.C1085; Szczesna D, 2002, J APPL PHYSIOL, V92, P1661, DOI 10.1152/japplphysiol.00858.2001; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna-Cordary D, 2005, J CELL SCI, V118, P3675, DOI 10.1242/jcs.02492; van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Xiang W, 2005, AM J PHYSIOL-ENDOC M, V288, pE125, DOI 10.1152/ajpendo.00224.2004; Zhang WC, 2010, J BIOL CHEM, V285, P5522, DOI 10.1074/jbc.M109.062836; Zhi G, 2005, P NATL ACAD SCI USA, V102, P17519, DOI 10.1073/pnas.0506846102	68	89	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40819	40829		10.1074/jbc.M110.160499	http://dx.doi.org/10.1074/jbc.M110.160499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943660	Green Published, hybrid			2022-12-27	WOS:000285414400047
J	Pal, K; Swaminathan, K; Xu, HE; Pioszak, AA				Pal, Kuntal; Swaminathan, Kunchithapadam; Xu, H. Eric; Pioszak, Augen A.			Structural Basis for Hormone Recognition by the Human CRFR2 alpha G Protein-coupled Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING-FACTOR; 1ST EXTRACELLULAR DOMAIN; MOLECULAR RECOGNITION; PARATHYROID-HORMONE; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SOLUBLE FORM; TUMOR-GROWTH; CRF; UROCORTINS	The mammalian corticotropin releasing factor (CRF)/urocortin (Ucn) peptide hormones include four structurally similar peptides, CRF, Ucn1, Ucn2, and Ucn3, that regulate stress responses, metabolism, and cardiovascular function by activating either of two related class B G protein-coupled receptors, CRFR1 and CRFR2. CRF and Ucn1 activate both receptors, whereas Ucn2 and Ucn3 are CRFR2-selective. The molecular basis for selectivity is unclear. Here, we show that the purified N-terminal extracellular domains (ECDs) of human CRFR1 and the CRFR2 alpha isoform are sufficient to discriminate the peptides, and we present three crystal structures of the CRFR2 alpha ECD bound to each of the Ucn peptides. The CRFR2 alpha ECD forms the same fold observed for the CRFR1 and mouse CRFR2 alpha ECDs but contains a unique N-terminal alpha-helix formed by its pseudo signal peptide. The CRFR2 alpha ECD peptide-binding site architecture is similar to that of CRFR1, and binding of the alpha-helical Ucn peptides closely resembles CRF binding to CRFR1. Comparing the electrostatic surface potentials of the ECDs suggests a charge compatibility mechanism for ligand discrimination involving a single amino acid difference in the receptors (CRFR1 Glu104/CRFR2 alpha Pro-100) at a site proximate to peptide residue 35 (Arg in CRF/Ucn1, Ala in Ucn2/3). CRFR1 Glu-104 acts as a selectivity filter preventing Ucn2/3 binding because the nonpolar Ala-35 is incompatible with the negatively charged Glu-104. The structures explain the mechanisms of ligand recognition and discrimination and provide a molecular template for the rational design of therapeutic agents selectively targeting these receptors.	[Pal, Kuntal; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	National University of Singapore; Van Andel Institute	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; eric.xu@vai.org; augen-pioszak@ouhsc.edu	Pal, Kuntal/W-6348-2019; Xu, H. Eric/ABD-7487-2021; sarkar, sabyasachi/A-9896-2010	sarkar, sabyasachi/0000-0002-8954-4375; Xu, H. Eric/0000-0002-6829-8144; PAL, KUNTAL/0000-0001-7094-2456	Michigan Economic Development Corp; Michigan Technology Tri-Corridor [085P1000817]; National Institutes of Health [GM087413]; Jay and Betty Van Andel Foundation; Ministry of Education, Singapore, and Biomedical Research Council; National University of Singapore; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087413] Funding Source: NIH RePORTER	Michigan Economic Development Corp; Michigan Technology Tri-Corridor; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Ministry of Education, Singapore, and Biomedical Research Council(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Brunzelle for assistance with data collection at sector 21 (LS-CAT) of the Advanced Photon Source, which is partly funded by the Michigan Economic Development Corp. and Michigan Technology Tri-Corridor Grant 085P1000817. Use of the Advanced Photon Source was supported by the Office of Science of the United States Department of Energy.; This work was supported, in whole or in part, by National Institutes of Health Grant GM087413 (to H. E. X. and A. A. P.). This work was also supported in part by the Jay and Betty Van Andel Foundation (to H. E. X., A. A. P., and K. P.), grants from the Ministry of Education, Singapore, and Biomedical Research Council (to K. S.), and a Research Scholarship from the National University of Singapore (to K.P.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Bale TL, 2003, TRENDS CARDIOVAS MED, V13, P68, DOI 10.1016/S1050-1738(02)00214-1; Chen A, 2006, P NATL ACAD SCI USA, V103, P16580, DOI 10.1073/pnas.0607337103; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; Dautzenberg FM, 1999, J NEUROCHEM, V73, P821, DOI 10.1046/j.1471-4159.1999.0730821.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dieterle T, 2009, HYPERTENSION, V53, P739, DOI 10.1161/HYPERTENSIONAHA.108.125211; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; Grace CRR, 2007, J AM CHEM SOC, V129, P16102, DOI 10.1021/ja0760933; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Grammatopoulos DK, 2002, TRENDS ENDOCRIN MET, V13, P436, DOI 10.1016/S1043-2760(02)00670-7; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Hauger Richard L., 2006, CNS & Neurological Disorders-Drug Targets, V5, P453, DOI 10.2174/187152706777950684; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Klose J, 2005, BIOCHEMISTRY-US, V44, P1614, DOI 10.1021/bi049022e; Kuperman Y, 2008, TRENDS ENDOCRIN MET, V19, P122, DOI 10.1016/j.tem.2007.12.002; Kuperman Y, 2010, P NATL ACAD SCI USA, V107, P8393, DOI 10.1073/pnas.1003969107; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Li C, 2007, P NATL ACAD SCI USA, V104, P4206, DOI 10.1073/pnas.0611641104; Mazur AW, 2004, J MED CHEM, V47, P3450, DOI 10.1021/jm049883l; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; PERRIN M, 1995, P NATL ACAD SCI USA, V92, P2969, DOI 10.1073/pnas.92.7.2969; Perrin MH, 2003, J BIOL CHEM, V278, P15595, DOI 10.1074/jbc.M210476200; Perrin MH, 2001, J BIOL CHEM, V276, P31528, DOI 10.1074/jbc.M101838200; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Pioszak AA, 2009, J BIOL CHEM, V284, P28382, DOI 10.1074/jbc.M109.022905; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Rutz C, 2006, J BIOL CHEM, V281, P24910, DOI 10.1074/jbc.M601554200; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Wang JJ, 2008, CANCER INVEST, V26, P359, DOI 10.1080/07357900701788106; Yang LZ, 2010, EUR J PHARMACOL, V632, P1, DOI 10.1016/j.ejphar.2010.01.027; Zmijewski MA, 2010, ACTA BIOCHIM POL, V57, P1	44	64	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40351	40361		10.1074/jbc.M110.186072	http://dx.doi.org/10.1074/jbc.M110.186072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20966082	hybrid, Green Published			2022-12-27	WOS:000285185500078
J	Sekine, O; Love, DC; Rubenstein, DS; Hanover, JA				Sekine, Osamu; Love, Dona C.; Rubenstein, David S.; Hanover, John A.			Blocking O-Linked GlcNAc Cycling in Drosophila Insulin-producing Cells Perturbs Glucose-Insulin Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINE; TETRATRICOPEPTIDE REPEATS; SIGNAL-TRANSDUCTION; SKELETAL-MUSCLE; X-CHROMOSOME; BETA-CELLS; RESISTANCE; GLYCOSYLATION; TRANSFERASE; PROTEIN	A dynamic cycle of O-linked GlcNAc (O-GlcNAc) addition and removal is catalyzed by O-GlcNAc transferase and O-GlcNAcase, respectively, in a process that serves as the final step in a nutrient-driven "hexosamine-signaling pathway." Evidence points to a role for O-GlcNAc cycling in diabetes and insulin resistance. We have used Drosophila melanogaster to determine whether O-GlcNAc metabolism plays a role in modulating Drosophila insulin-like peptide (dilp) production and insulin signaling. We employed transgenesis to either overexpress or knock down Drosophila Ogt(sxc) and Oga in insulin-producing cells (IPCs) or fat bodies using the GAL4-UAS system. Knockdown of Ogt decreased Dilp2, Dilp3, and Dilp5 production, with reduced body size and decreased phosphorylation of Akt in vivo. In contrast, knockdown of Oga increased Dilp2, Dilp3, and Dilp5 production, increased body size, and enhanced phosphorylation of Akt in vivo. However, knockdown of either Ogt(sxc) or Oga in the IPCs increased the hemolymph carbohydrate concentration. Furthermore, phosphorylation of Akt stimulated by extraneous insulin in an ex vivo cultured fat body of third instar larvae was diminished in strains subjected to IPC knockdown of Ogt or Oga. Knockdown of O-GlcNAc cycling enzymes in the fat body dramatically reduced neutral lipid stores. These results demonstrate that altered O-GlcNAc cycling in Drosophila IPCs modulates insulin production and influences the insulin responsiveness of peripheral tissues. The observed phenotypes in O-GlcNAc cycling mimic pancreatic beta-cell dysfunction and glucose toxicity related to sustained hyperglycemia in mammals.	[Sekine, Osamu] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Rubenstein, David S.] Univ N Carolina, Dept Dermatol, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of North Carolina; University of North Carolina Chapel Hill	Hanover, JA (corresponding author), NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov			National Institutes of Health NIDDK; Cell Science Research Foundation in Japan; Manpei Suzuki Diabetes Foundation in Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060103, ZIADK060101] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cell Science Research Foundation in Japan; Manpei Suzuki Diabetes Foundation in Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health NIDDK Intramural Research Program. This work was also supported by a scholarship from the Cell Science Research Foundation in Japan and the Manpei Suzuki Diabetes Foundation in Japan.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Comtesse N, 2001, BIOCHEM BIOPH RES CO, V283, P634, DOI 10.1006/bbrc.2001.4815; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Egawa K, 1999, J BIOL CHEM, V274, P14306, DOI 10.1074/jbc.274.20.14306; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hartweck LM, 2002, GENETICS, V161, P1279; Heckel D, 1998, HUM MOL GENET, V7, P1859, DOI 10.1093/hmg/7.12.1859; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; KELLY WG, 1989, CELL, V57, P243, DOI 10.1016/0092-8674(89)90962-8; Konrad RJ, 2000, BIOCHEM BIOPH RES CO, V267, P26, DOI 10.1006/bbrc.1999.1895; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Lizcano JM, 2003, BIOCHEM J, V374, P297, DOI 10.1042/BJ20030577; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Lubas WA, 1997, J BIOL CHEM, V272, P9316; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Miles PDG, 1998, J CLIN INVEST, V101, P202, DOI 10.1172/JCI1256; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; ROSSETTI L, 1990, DIABETES CARE, V13, P610, DOI 10.2337/diacare.13.6.610; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tang JP, 2000, DIABETES, V49, P1492, DOI 10.2337/diabetes.49.9.1492; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Thornton TM, 1999, TRENDS PLANT SCI, V4, P424, DOI 10.1016/S1360-1385(99)01485-5; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Toleman CA, 2006, J BIOL CHEM, V281, P3918, DOI 10.1074/JBC.m510485200; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zhang HF, 2009, P NATL ACAD SCI USA, V106, pE27, DOI 10.1073/pnas.0900125106; Zierath JR, 2000, DIABETOLOGIA, V43, P821, DOI 10.1007/s001250051457	47	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38684	38691		10.1074/jbc.M110.155192	http://dx.doi.org/10.1074/jbc.M110.155192			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926386	Green Published, hybrid			2022-12-27	WOS:000284625600073
J	Higashi, K; Sakamaki, Y; Herai, E; Demizu, R; Uemura, T; Saroj, SD; Zenda, R; Terui, Y; Nishimura, K; Toida, T; Kashiwagi, K; Igarashi, K				Higashi, Kyohei; Sakamaki, Yoshiharu; Herai, Emiko; Demizu, Risa; Uemura, Takeshi; Saroj, Sunil D.; Zenda, Risa; Terui, Yusuke; Nishimura, Kazuhiro; Toida, Toshihiko; Kashiwagi, Keiko; Igarashi, Kazuei			Identification and Functions of Amino Acid Residues in PotB and PotC Involved in Spermidine Uptake Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREFERENTIAL UPTAKE SYSTEM; BINDING CASSETTE TRANSPORTER; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; POLYAMINE TRANSPORT; ABC TRANSPORTER; MALTOSE TRANSPORT; PROTEIN; ATP; MALK	Amino acid residues on PotB and PotC involved in spermidine uptake were identified by random and site-directed mutagenesis. It was found that Trp(8), Tyr(43), Trp(100), Leu(110), and Tyr(261) in PotB and Trp(46), Asp(108), Glu(169), Ser(196), Asp(198), and Asp(199) in PotC were strongly involved in spermidine uptake and that Tyr(160), Glu(172), and Leu(274) in PotB and Tyr(19), Tyr(88), Tyr(148), Glu(160), Leu(195), and Tyr(211) in PotC were moderately involved in spermidine uptake. Among 11 amino acid residues that were strongly involved in spermidine uptake, Trp(8) in PotB was important for insertion of PotB and PotC into membranes. Tyr(43), Trp(100), and Leu(110) in PotB and Trp(46), Asp(108), Ser(196), and Asp(198) in PotC were found to be involved in the interaction with PotD. Leu(110) and Tyr(261) in PotB and Asp(108), Asp(198), and Asp(199) in PotC were involved in the recognition of spermidine, and Trp(100) and Tyr(261) in PotB and Asp(108), Glu(169), and Asp(198) in PotC were involved in ATPase activity of PotA. Accordingly, Trp(100) in PotB was involved in both PotD recognition and ATPase activity, Leu(110) in PotB was involved in both PotD and spermidine recognition, and Tyr(261) in PotB was involved in both spermidine recognition and ATPase activity. Asp(108) and Asp(198) in PotC were involved in PotD and spermidine recognition as well as ATPase activity. These results suggest that spermidine passage from PotD to the cytoplasm is coupled to the ATPase activity of PotA through a structural change of PotA by its ATPase activity.	[Zenda, Risa; Nishimura, Kazuhiro; Toida, Toshihiko; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Amine Pharma Res Inst, Chuo Ku, Chiba 2600856, Japan; [Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Chiba 2880025, Japan	Chiba University; Chiba University	Igarashi, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	iga16077@faculty.chiba-u.jp	Saroj, Sunil/R-8113-2019	Saroj, Sunil D/0000-0002-8071-2731; Nishimura, Kazuhiro/0000-0002-6209-5522; Higashi, Kyohei/0000-0002-2622-4825; Igarashi, Kazuei/0000-0003-3751-3187	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; CUNNINGHAMRUNDLES S, 1975, J BACTERIOL, V124, P791, DOI 10.1128/JB.124.2.791-799.1975; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Eitinger T., 2010, FEMS MICROB IN PRESS; FURUCHI T, 1991, J BIOL CHEM, V266, P20928; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOUNG HS, 1986, J BACTERIOL, V168, P1040, DOI 10.1128/jb.168.2.1040-1044.1986; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; Igarashi K, 2010, PLANT PHYSIOL BIOCH, V48, P506, DOI 10.1016/j.plaphy.2010.01.017; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KANG CH, 1991, J BIOL CHEM, V266, P23893; KASHIWAGI K, 1990, J BIOL CHEM, V265, P20893; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; KASHIWAGI K, 1993, J BIOL CHEM, V268, P19358; Kashiwagi K, 1996, J BIOL CHEM, V271, P12205, DOI 10.1074/jbc.271.21.12205; KASHIWAGI K, 1986, J BACTERIOL, V165, P972, DOI 10.1128/jb.165.3.972-977.1986; KASHIWAGI K, 1988, J BACTERIOL, V170, P3131, DOI 10.1128/jb.170.7.3131-3135.1988; Kashiwagi K, 2002, J BIOL CHEM, V277, P24212, DOI 10.1074/jbc.M202849200; KASHIWAGI K, 1995, J BIOL CHEM, V270, P25377, DOI 10.1074/jbc.270.43.25377; Koizume S, 2006, NEUROSCIENCE, V141, P1861, DOI 10.1016/j.neuroscience.2006.05.067; KUHNAU S, 1991, J BACTERIOL, V173, P2180; Kurihara S, 2005, J BIOL CHEM, V280, P4602, DOI 10.1074/jbc.M411114200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Leng XH, 1998, J BIOL CHEM, V273, P6717, DOI 10.1074/jbc.273.12.6717; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; LINDEROTH N, 1983, BIOCHEM BIOPH RES CO, V117, P616, DOI 10.1016/0006-291X(83)91245-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING LAB MANU, P250; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; PEGG AE, 1988, CANCER RES, V48, P759; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Sugiyama S, 1996, J BIOL CHEM, V271, P9519, DOI 10.1074/jbc.271.16.9519; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; YAMAGUCHI K, 1985, MOL GEN GENET, V200, P362, DOI 10.1007/BF00425718; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	50	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39061	39069		10.1074/jbc.M110.186536	http://dx.doi.org/10.1074/jbc.M110.186536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937813	hybrid, Green Published			2022-12-27	WOS:000284941300036
J	Hofman, EG; Bader, AN; Voortman, J; van den Heuvel, DJ; Sigismund, S; Verkleij, AJ; Gerritsen, HC; Henegouwen, PMPVE				Hofman, Erik G.; Bader, Arjen N.; Voortman, Jarno; van den Heuvel, Dave J.; Sigismund, Sara; Verkleij, Arie J.; Gerritsen, Hans C.; Henegouwen, Paul M. P. van Bergen En			Ligand-induced EGF Receptor Oligomerization Is Kinase-dependent and Enhances Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN CLUSTER SIZES; LIVING CELLS; ACTIVATION; DOMAIN; ENDOCYTOSIS; MICROSCOPY; SURFACE; TRAFFICKING; MECHANISM	The current activation model of the EGF receptor (EGFR) predicts that binding of EGF results in dimerization and oligomerization of the EGFR, leading to the allosteric activation of the intracellular tyrosine kinase. Little is known about the regulatory mechanism of receptor oligomerization. In this study, we have employed FRET between identical fluorophores (homo-FRET) to monitor the dimerization and oligomerization state of the EGFR before and after receptor activation. Our data show that, in the absence of ligand, similar to 40% of the EGFR molecules were present as inactive dimers or predimers. The monomer/predimer ratio was not affected by deletion of the intracellular domain. Ligand binding induced the formation of receptor oligomers, which were found in both the plasma membrane and intracellular structures. Ligand-induced oligomerization required tyrosine kinase activity and nine different tyrosine kinase substrate residues. This indicates that the binding of signaling molecules to activated EGFRs results in EGFR oligomerization. Induction of EGFR predimers or pre-oligomers using the EGFR fused to the FK506-binding protein did not affect signaling but was found to enhance EGF-induced receptor internalization. Our data show that EGFR oligomerization is the result of EGFR signaling and enhances EGFR internalization.	[Henegouwen, Paul M. P. van Bergen En] Univ Utrecht, Fac Sci, Inst Biomembranes, Dept Cellular Dynam, NL-3584 CH Utrecht, Netherlands; [Bader, Arjen N.; van den Heuvel, Dave J.; Gerritsen, Hans C.] Univ Utrecht, Fac Sci, Dept Mol Biophys, NL-3584 CH Utrecht, Netherlands; [Sigismund, Sara] FIRC Inst Mol Oncol Fdn IFOM, I-20139 Milan, Italy	Utrecht University; Utrecht University; IFOM - FIRC Institute of Molecular Oncology	Henegouwen, PMPVE (corresponding author), Univ Utrecht, Fac Sci, Inst Biomembranes, Dept Cellular Dynam, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.vanbergen@uu.nl	van Bergen en Henegouwen, Paul/B-8870-2011; Sigismund, Sara/H-3687-2017; Gerritsen, Hans c/B-6303-2008	van Bergen en Henegouwen, Paul/0000-0001-6050-9042; Sigismund, Sara/0000-0002-1396-4453; 	Dutch Organization for Scientific Research (NWO) [805.47.084]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by Dutch Organization for Scientific Research (NWO) Grant 805.47.084 (to E. G. H. and A. N. B.).	Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; de Grauw CJ, 2001, APPL SPECTROSC, V55, P670, DOI 10.1366/0003702011952587; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Martin-Fernandez M, 2002, BIOPHYS J, V82, P2415, DOI 10.1016/S0006-3495(02)75585-9; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Rappoport JZ, 2009, J CELL SCI, V122, P1301, DOI 10.1242/jcs.040030; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Stoorvogel W, 2004, J BIOL CHEM, V279, P11562, DOI 10.1074/jbc.M308449200; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VANBELZEN N, 1988, J CELL PHYSIOL, V134, P413, DOI 10.1002/jcp.1041340312; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhu HJ, 2003, GROWTH FACTORS, V21, P15, DOI 10.1080/0897719031000096424	30	72	72	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39481	39489		10.1074/jbc.M110.164731	http://dx.doi.org/10.1074/jbc.M110.164731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20940297	Green Published, hybrid			2022-12-27	WOS:000284941300074
J	Islam, MR; Jimenez, T; Pelham, C; Rodova, M; Puri, S; Magenheimer, BS; Maser, RL; Widmann, C; Calvet, JP				Islam, M. Rafiq; Jimenez, Tamara; Pelham, Christopher; Rodova, Marianna; Puri, Sanjeev; Magenheimer, Brenda S.; Maser, Robin L.; Widmann, Christian; Calvet, James P.			MAP/ERK Kinase Kinase 1 (MEKK1) Mediates Transcriptional Repression by Interacting with Polycystic Kidney Disease-1 (PKD1) Promoter-bound p53 Tumor Suppressor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; N-TERMINAL KINASE; WILD-TYPE P53; C-JUN; P53-MEDIATED REPRESSION; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; DOWN-REGULATION; GENE; UBIQUITINATION	Mitogen-activated protein kinase (MAPK) cascades regulate a wide variety of cellular processes that ultimately depend on changes in gene expression. We have found a novel mechanism whereby one of the key MAP3 kinases, Mekk1, regulates transcriptional activity through an interaction with p53. The tumor suppressor protein p53 down-regulates a number of genes, including the gene most frequently mutated in autosomal dominant polycystic kidney disease (PKD1). We have discovered that Mekk1 translocates to the nucleus and acts as a co-repressor with p53 to down-regulate PKD1 transcriptional activity. This repression does not require Mekk1 kinase activity, excluding the need for an Mekk1 phosphorylation cascade. However, this PKD1 repression can also be induced by the stress-pathway stimuli, including TNF alpha, suggesting that Mekk1 activation induces both JNK-dependent and JNK-independent pathways that target the PKD1 gene. An Mekk1-p53 interaction at the PKD1 promoter suggests a new mechanism by which abnormally elevated stress-pathway stimuli might directly down-regulate the PKD1 gene, possibly causing haploinsufficiency and cyst formation.	[Islam, M. Rafiq; Jimenez, Tamara; Pelham, Christopher] NW Missouri State Univ, Dept Chem Phys, Maryville, MO 64468 USA; [Islam, M. Rafiq; Rodova, Marianna; Puri, Sanjeev; Magenheimer, Brenda S.; Calvet, James P.] Univ Kansas, Med Ctr, Kidney Inst, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Maser, Robin L.] Univ Kansas, Med Ctr, Kidney Inst, Dept Clin Lab Sci, Kansas City, KS 66160 USA; [Widmann, Christian] Univ Lausanne, Dept Physiol, Biol & Med Fac, CH-1005 Lausanne, Switzerland	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Lausanne	Islam, MR (corresponding author), NW Missouri State Univ, Dept Chem Phys, Maryville, MO 64468 USA.	islamr@nwmissouri.edu; jcalvet@kumc.edu	Widmann, Christian/N-9851-2013	Widmann, Christian/0000-0002-6881-0363; Puri, Sanjeev/0000-0002-3967-987X; Puri, Sanjeev/0000-0002-4314-9871	National Institutes of Health [R15 DK069897, P50 DK057301]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057301, R15DK069897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R15 DK069897 (to M. R. I.) and P50 DK057301 (to J. P. C.).	Arnould T, 1998, J BIOL CHEM, V273, P6013, DOI 10.1074/jbc.273.11.6013; Banchio C, 2007, J BIOL CHEM, V282, P14827, DOI 10.1074/jbc.M700527200; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Boehme KA, 2009, CRIT REV BIOCHEM MOL, V44, P367, DOI 10.3109/10409230903401507; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Das KC, 2010, MOL CELL BIOCHEM, V337, P53, DOI 10.1007/s11010-009-0285-0; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Harris PC, 2009, J AM SOC NEPHROL, V20, P1188, DOI 10.1681/ASN.2009010014; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Innocente SA, 2005, FEBS LETT, V579, P1001, DOI 10.1016/j.febslet.2004.12.073; Islam MR, 2008, AM J PHYSIOL-RENAL, V295, pF1845, DOI 10.1152/ajprenal.90355.2008; Islam MR, 1999, J BIOL CHEM, V274, P23451, DOI 10.1074/jbc.274.33.23451; Kim JW, 2001, J BIOL CHEM, V276, P27064, DOI 10.1074/jbc.M009364200; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lee CK, 2008, INT IMMUNOPHARMACOL, V8, P362, DOI 10.1016/j.intimp.2007.10.020; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Li H, 2009, BIOINFORMATICS, V25, P358, DOI 10.1093/bioinformatics/btn635; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Maillet M, 2009, J CLIN INVEST, V119, P3079, DOI 10.1172/JCI37694; Maki CG, 1997, MOL CELL BIOL, V17, P355, DOI 10.1128/MCB.17.1.355; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Maser RL, 2003, METH MOLEC MED, V86, P205; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; Patel V, 2009, CURR OPIN NEPHROL HY, V18, P99, DOI 10.1097/MNH.0b013e3283262ab0; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Puri S, 2006, BIOCHEM BIOPH RES CO, V342, P1005, DOI 10.1016/j.bbrc.2006.02.045; Rodova M, 2002, J BIOL CHEM, V277, P29577, DOI 10.1074/jbc.M203570200; Sandford RN, 2009, KIDNEY INT, V75, P765, DOI 10.1038/ki.2009.17; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Shats I, 2004, J BIOL CHEM, V279, P50976, DOI 10.1074/jbc.M402502200; Shimada J, 2001, MOL ENDOCRINOL, V15, P1677, DOI 10.1210/me.15.10.1677; Takatori A, 2008, DEVELOPMENT, V135, P23, DOI 10.1242/dev.007120; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Van Bodegom D, 2006, J BIOL CHEM, V281, P31234, DOI 10.1074/jbc.M606510200; van Bodegom D, 2010, BBA-GENE REGUL MECH, V1799, P502, DOI 10.1016/j.bbagrm.2010.04.001; Wang DZ, 2001, J BIOL CHEM, V276, P3650, DOI 10.1074/jbc.M006115200; WANG Y, 1995, MOL CELL BIOL, V15, P2157; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Xu DW, 2000, ONCOGENE, V19, P5123, DOI 10.1038/sj.onc.1203890; Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6; Zebrowski DC, 2006, J MOL CELL CARDIOL, V40, P605, DOI 10.1016/j.yjmcc.2005.11.012; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	64	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38818	38831		10.1074/jbc.M110.145284	http://dx.doi.org/10.1074/jbc.M110.145284			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923779	Green Published, hybrid			2022-12-27	WOS:000284941300011
J	Awayda, MS; Awayda, KL; Pochynyuk, O; Bugaj, V; Stockand, JD; Ortiz, RM				Awayda, Mouhamed S.; Awayda, Karen L.; Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.; Ortiz, Rudy M.			Acute Cholesterol-induced Anti-natriuretic Effects ROLE OF EPITHELIAL Na+ CHANNEL ACTIVITY, PROTEIN LEVELS, AND PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; GAMMA-SUBUNIT; LIPID RAFTS; MEMBRANE CHOLESTEROL; SERUM-CHOLESTEROL; PLASMA-MEMBRANE; RAT-KIDNEY; ACTIVATION; ENAC; PROSTASIN	The epithelial Na+ channel (ENaC) is modulated by membrane lipid composition. However, the effect of an in vivo change of membrane composition is unknown. We examined the effect of a 70-day enhanced cholesterol diet (ECD) on ENaC and renal Na+ handling. Rats were fed a standard chow or one supplemented with 1% cholesterol and 0.5% cholic acid (ECD). ECD animals exhibited marked anti-diuresis and anti-natriuresis (40 and 47%), which peaked at 1-3 weeks. Secondary compensation returned urine output and urinary Na+ excretion to control levels by week 10. During these initial changes, there were no accompanying effects on systolic blood pressure, serum creatinine, or urinary creatinine excretion, indicating that the these effects of ECD preceded those which modify renal filtration and blood pressure. The effects of ECD on ENaC were evaluated by measuring the relative protein content of alpha, beta, and gamma subunits. alpha and gamma blots were further examined for subunit cleavage (a process that activates ENaC). No significant changes were observed in alpha and beta levels throughout the study. However, levels of cleaved gamma were elevated, suggesting that ENaC was activated. The changes of gamma persisted at week 10 and were accompanied by additional subunit fragments, indicating potential changes of gamma-cleaving proteases. Enhanced protease activity, and specifically that which could act on the second identified cleavage site in gamma, was verified in a newly developed urinary protease assay. These results predict enhanced ENaC activity, an effect that was confirmed in patch clamp experiments of principal cells of split open collecting ducts, where ENaC open probability was increased by 40% in the ECD group. These data demonstrate a complex series of events and a new regulatory paradigm that is initiated by ECD prior to the onset of elevated blood pressure. These events lead to changes of renal Na+ handling, which occur in part by effects on extracellular gamma-ENaC cleavage.	[Awayda, Mouhamed S.; Awayda, Karen L.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Pochynyuk, Oleh; Bugaj, Vladislav; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Ortiz, Rudy M.] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Merced	Awayda, MS (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall,3435 Main St, Buffalo, NY 14214 USA.	awayda@buffalo.edu		Stockand, James/0000-0002-3817-4319	National Institutes of Health [DK55626]; John R. Oishei Foundation; University of California; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John R. Oishei Foundation; University of California(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55626. This work was also supported by the John R. Oishei Foundation and University of California start-up funds.	Awayda MS, 2004, J GEN PHYSIOL, V123, P709, DOI 10.1085/jgp.200308983; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE; Belli S, 2009, J PHARM SCI-US, V98, P1905, DOI 10.1002/jps.21558; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borghi C, 2007, J HYPERTENS, V25, P2051, DOI 10.1097/HJH.0b013e32827759a6; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Christian AE, 1997, J LIPID RES, V38, P2264; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF389, DOI 10.1152/ajprenal.90528.2008; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hinzpeter A, 2007, J BIOL CHEM, V282, P2423, DOI 10.1074/jbc.M608251200; Hu JC, 2009, J BIOL CHEM, V284, P36334, DOI 10.1074/jbc.M109.032870; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; JACOB MP, 1982, ARTERY, V10, P310; Koda A, 2009, HYPERTENS RES, V32, P276, DOI 10.1038/hr.2009.6; Kopkan L, 2009, AM J PHYSIOL-RENAL, V297, pF1606, DOI 10.1152/ajprenal.90743.2008; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; Levitan I, 2009, IUBMB LIFE, V61, P781, DOI 10.1002/iub.192; MOLITORIS BA, 1985, AM J PHYSIOL, V249, pF12, DOI 10.1152/ajprenal.1985.249.1.F12; MORRIS MD, 1957, J BIOL CHEM, V224, P1039; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF139, DOI 10.1152/ajprenal.00504.2006; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Sampson Laura J., 2008, V491, P91, DOI 10.1007/978-1-59745-526-8_7; Singh DK, 2009, J BIOL CHEM, V284, P30727, DOI 10.1074/jbc.M109.011221; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; TSAI AC, 1975, J NUTR, V105, P939, DOI 10.1093/jn/105.7.939; Wang J, 2009, AM J PHYSIOL-RENAL, V296, pF284, DOI 10.1152/ajprenal.90647.2008; Wei SP, 2007, J MEMBRANE BIOL, V220, P21, DOI 10.1007/s00232-007-9071-7; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; YU JX, 1994, J BIOL CHEM, V269, P18843	46	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1683	1695		10.1074/jbc.M110.159194	http://dx.doi.org/10.1074/jbc.M110.159194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21041305	Green Published, hybrid			2022-12-27	WOS:000286191500008
J	Daniel, C; Wahlstedt, H; Ohlson, J; Bjork, P; Ohman, M				Daniel, Chammiran; Wahlstedt, Helene; Ohlson, Johan; Bjork, Petra; Ohman, Marie			Adenosine-to-Inosine RNA Editing Affects Trafficking of the gamma-Aminobutyric Acid Type A (GABA(A)) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT MESSENGER-RNAS; ALPHA-SUBUNITS; RAT-BRAIN; GABA(A)-RECEPTOR SUBTYPES; SYNAPTIC-TRANSMISSION; ENDOPLASMIC-RETICULUM; POSTNATAL-DEVELOPMENT; GLUR-B; EXPRESSION; EPILEPSY	Recoding by adenosine-to-inosine RNA editing plays an important role in diversifying proteins involved in neurotransmission. We have previously shown that the Gabra-3 transcript, coding for the alpha 3 subunit of the GABA(A) receptor is edited in mouse, causing an isoleucine to methionine (I/M) change. Here we show that this editing event is evolutionarily conserved from human to chicken. Analyzing recombinant GABA(A) receptor subunits expressed in HEK293 cells, our results suggest that editing at the I/M site in alpha 3 has functional consequences on receptor expression. We demonstrate that I/M editing reduces the cell surface and the total number of alpha 3 subunits. The reduction in cell surface levels is independent of the subunit combination as it is observed for alpha in combination with either the beta 2 or the beta 3 subunit. Further, an amino acid substitution at the corresponding I/M site in the alpha 1 subunit has a similar effect on cell surface presentation, indicating the importance of this site for receptor trafficking. We show that the I/M editing during brain development is inversely related to the alpha 3 protein abundance. Our results suggest that editing controls trafficking of alpha 3-containing receptors and may therefore facilitate the switch of subunit compositions during development as well as the subcellular distribution of alpha subunits in the adult brain.	[Daniel, Chammiran; Wahlstedt, Helene; Ohlson, Johan; Bjork, Petra; Ohman, Marie] Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden	Stockholm University	Ohman, M (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, SE-10691 Stockholm, Sweden.	marie.ohman@molbio.su.se	Ãhman, Marie/N-8561-2015	Ãhman, Marie/0000-0002-6636-5841	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council.	ARAKI T, 1992, NEUROSCIENCE, V51, P583, DOI 10.1016/0306-4522(92)90298-G; Aruscavage PJ, 2000, RNA, V6, P257, DOI 10.1017/S1355838200991921; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BENKE D, 1991, J BIOL CHEM, V266, P4478; Bohme I, 2004, J BIOL CHEM, V279, P35193, DOI 10.1074/jbc.M405653200; Bosman LWJ, 2002, J PHYSIOL-LONDON, V545, P169, DOI 10.1113/jphysiol.2002.026534; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Enstero M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-6; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Gallagher MJ, 2004, J NEUROSCI, V24, P5570, DOI 10.1523/JNEUROSCI.1301-04.2004; Gingrich KJ, 1995, J PHYSIOL-LONDON, V489, P529, DOI 10.1113/jphysiol.1995.sp021070; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Guzman JN, 2003, J NEUROSCI, V23, P8931; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Jepson JEC, 2008, BBA-GENE REGUL MECH, V1779, P459, DOI 10.1016/j.bbagrm.2007.11.009; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; KORPI ER, 1993, MOL PHARMACOL, V44, P87; Kung SS, 2001, FEBS LETT, V509, P277, DOI 10.1016/S0014-5793(01)03183-0; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liu QL, 2006, BRAIN RES, V1098, P129, DOI 10.1016/j.brainres.2006.05.001; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Nimmich ML, 2009, NEUROSCI RES, V63, P288, DOI 10.1016/j.neures.2009.01.003; Ohlson J, 2007, RNA, V13, P698, DOI 10.1261/rna.349107; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; Ramadan E, 2003, J NEUROPHYSIOL, V89, P128, DOI 10.1152/jn.00700.2002; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Tian N, 2008, RNA, V14, P211, DOI 10.1261/rna.797108; VERDOORN TA, 1994, MOL PHARMACOL, V45, P475; Wahlstedt H, 2009, GENOME RES, V19, P978, DOI 10.1101/gr.089409.108; WISDEN W, 1992, J NEUROSCI, V12, P1040; Wu YM, 1996, DNA CELL BIOL, V15, P717, DOI 10.1089/dna.1996.15.717	49	53	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2031	2040		10.1074/jbc.M110.130096	http://dx.doi.org/10.1074/jbc.M110.130096			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21030585	Green Published, hybrid			2022-12-27	WOS:000286191500045
J	Nicholson, AM; Methner, DNR; Ferreira, A				Nicholson, Alexandra M.; Methner, D. Nicole Riherd; Ferreira, Adriana			Membrane Cholesterol Modulates beta-Amyloid-dependent Tau Cleavage by Inducing Changes in the Membrane Content and Localization of N-Methyl-D-aspartic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATURE HIPPOCAMPAL-NEURONS; COATED VESICLE FORMATION; SUBUNIT MESSENGER-RNAS; ALZHEIMERS-DISEASE; NMDA-RECEPTOR; LIPID RAFTS; RAT-BRAIN; A-BETA; DEVELOPMENTAL-CHANGES; POSTNATAL-DEVELOPMENT	We have previously shown that beta-amyloid (A beta) treatment resulted in an age-dependent calpain activation leading to Tau cleavage into a neurotoxic 17-kDa fragment in a cellular model of Alzheimer disease. This detrimental cellular response was mediated by a developmentally regulated increase in membrane cholesterol levels. In this study, we assessed the molecular mechanisms by which cholesterol modulated A beta-induced Tau cleavage in cultured hippocampal neurons. Our results indicated that these mechanisms did not involve the regulation of the binding of A beta aggregates to the plasma membrane. On the other hand, experiments using N-methyl-D-aspartic acid receptor inhibitors suggested that these receptors played an essential role in cholesterol-mediated A beta-dependent calpain activity and 17-kDa Tau production. Biochemical and immunocytochemical analyses demonstrated that decreasing membrane cholesterol levels in mature neurons resulted in a significant reduction of the NR1 subunit at the membrane as well as an increase in the number of large NR1, NR2A, and NR2B subunit clusters. Moreover, the majority of these larger N-methyl-D-aspartic acid receptor subunit immunoreactive spots was not juxtaposed to presynaptic sites in cholesterol-reduced neurons. These data suggested that changes at the synaptic level underlie the mechanism by which membrane cholesterol modulates developmental changes in the susceptibility of hippocampal neurons to A beta-induced toxicity.	[Nicholson, Alexandra M.; Methner, D. Nicole Riherd; Ferreira, Adriana] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ferreira, A (corresponding author), Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, 303 E Chicago Ave,Ward Bldg,Rm 8-140, Chicago, IL 60611 USA.	a-ferreira@northwestern.edu		Ferreira, Adriana/0000-0003-3705-3918	National Institutes of Health [RO1 NS39080]; Alzheimer's Association [57869]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 NS39080. This work was also supported byAlzheimer's Association Grant 57869 (to A. F.).	Abulrob A, 2005, J NEUROCHEM, V92, P1477, DOI 10.1111/j.1471-4159.2005.03001.x; ARIOKA M, 1993, J NEUROCHEM, V60, P461, DOI 10.1111/j.1471-4159.1993.tb03173.x; Avdulov NA, 1997, J NEUROCHEM, V69, pS102; BENKE D, 1995, J RECEPT SIGNAL TR R, V15, P393, DOI 10.3109/10799899509045229; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Besshoh S, 2007, J NEUROSCI RES, V85, P1876, DOI 10.1002/jnr.21336; Bharadwaj PR, 2009, J CELL MOL MED, V13, P412, DOI 10.1111/j.1582-4934.2009.00609.x; Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Christian AE, 1997, J LIPID RES, V38, P2264; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Curtain CC, 2003, J BIOL CHEM, V278, P2977, DOI 10.1074/jbc.M205455200; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Dante S, 2006, EUR BIOPHYS J BIOPHY, V35, P523, DOI 10.1007/s00249-006-0062-x; Dunah AW, 1996, J NEUROCHEM, V67, P2335; Ferreira A, 1997, MOL CELL NEUROSCI, V9, P220, DOI 10.1006/mcne.1997.0615; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Foradori CD, 2007, NEUROSCIENCE, V149, P155, DOI 10.1016/j.neuroscience.2007.06.054; Frank C, 2004, FEBS LETT, V566, P25, DOI 10.1016/j.febslet.2004.03.113; Fritschy JM, 1998, J COMP NEUROL, V390, P194; FYKSE EM, 1993, J NEUROSCI, V13, P4997; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Goslin K., 1998, CULTURING NERVE CELL, P339; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Harkany T, 2000, REV NEUROSCIENCE, V11, P329; Hering H, 2003, J NEUROSCI, V23, P3262; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; Hou QM, 2008, MOL CELL NEUROSCI, V38, P213, DOI 10.1016/j.mcn.2008.02.010; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; ISHII T, 1993, J BIOL CHEM, V268, P2836; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert D, 2005, BIOCHEM J, V387, P553, DOI 10.1042/BJ20041377; Law AJ, 2003, EUR J NEUROSCI, V18, P1197, DOI 10.1046/j.1460-9568.2003.02850.x; Lee VMY, 1996, ANN NY ACAD SCI, V777, P107, DOI 10.1111/j.1749-6632.1996.tb34408.x; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Lipton Stuart A., 2005, Current Alzheimer Research, V2, P155, DOI 10.2174/1567205053585846; Liu P, 2008, SYNAPSE, V62, P834, DOI 10.1002/syn.20563; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnusson KR, 1997, J GERONTOL A-BIOL, V52, pB291, DOI 10.1093/gerona/52A.6.B291; Magnusson KR, 1998, MECH AGEING DEV, V104, P227, DOI 10.1016/S0047-6374(98)00076-1; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mitter D, 2003, J NEUROCHEM, V84, P35, DOI 10.1046/j.1471-4159.2003.01258.x; Mizuno T, 1999, J BIOL CHEM, V274, P15110, DOI 10.1074/jbc.274.21.15110; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; MURPHY SN, 1989, MOL PHARMACOL, V35, P671; Nagler K, 2001, J PHYSIOL-LONDON, V533, P665, DOI 10.1111/j.1469-7793.2001.00665.x; Nicholson AM, 2009, J NEUROSCI, V29, P4640, DOI 10.1523/JNEUROSCI.0862-09.2009; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Oshima N, 2001, AM J PATHOL, V158, P2209, DOI 10.1016/S0002-9440(10)64693-7; Park SY, 2005, J NEUROSCI, V25, P5365, DOI 10.1523/JNEUROSCI.1125-05.2005; Pevalova M, 2006, Bratisl Lek Listy, V107, P346; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Resende R, 2007, BRAIN RES, V1143, P11, DOI 10.1016/j.brainres.2007.01.071; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Shah WA, 2006, J GEN VIROL, V87, P673, DOI 10.1099/vir.0.81444-0; Sun DA, 2004, CELL CALCIUM, V35, P155, DOI 10.1016/j.ceca.2003.09.003; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Torp R, 2000, NEUROSCIENCE, V96, P495, DOI 10.1016/S0306-4522(99)00568-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsai LH, 2004, BBA-PROTEINS PROTEOM, V1697, P137, DOI 10.1016/j.bbapap.2003.11.019; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Wenk GL, 2006, J CLIN PSYCHIAT, V67, P3; Wenzel A, 1997, J NEUROCHEM, V68, P469; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512290-00010; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yakunin AF, 1998, ANAL BIOCHEM, V258, P146, DOI 10.1006/abio.1998.2571; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yu WD, 2008, J NEUROCHEM, V104, P830, DOI 10.1111/j.1471-4159.2007.05014.x	82	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					976	986		10.1074/jbc.M110.154138	http://dx.doi.org/10.1074/jbc.M110.154138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047784	hybrid, Green Published			2022-12-27	WOS:000286005000008
J	Choveau, FS; Rodriguez, N; Ali, FA; Labro, AJ; Rose, T; Dahimene, S; Boudin, H; Le Henaff, C; Escande, D; Snyders, DJ; Charpentier, F; Merot, J; Baro, I; Loussouarn, G				Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Labro, Alain J.; Rose, Thierry; Dahimene, Shehrazade; Boudin, Helene; Le Henaff, Carole; Escande, Denis; Snyders, Dirk J.; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas			KCNQ1 Channels Voltage Dependence through a Voltage-dependent Binding of the S4-S5 Linker to the Pore Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; POTASSIUM CHANNEL; ACTIVATION GATE; SENSOR; PROTEINS; CONDUCTION; MOVEMENT; K(V)LQT1; KCNE1; STATE	Voltage-dependent potassium (Kv) channels are tetramers of six transmembrane domain (S1-S6) proteins. Crystallographic data demonstrate that the tetrameric pore (S5-S6) is surrounded by four voltage sensor domains (S1-S4). One key question remains: how do voltage sensors (S4) regulate pore gating? Previous mutagenesis data obtained on the Kv channel KCNQ1 highlighted the critical role of specific residues in both the S4-S5 linker (S4S5(L)) and S6 C terminus (S6(T)). From these data, we hypothesized that S4S5(L) behaves like a ligand specifically interacting with S6(T) and stabilizing the closed state. To test this hypothesis, we designed plasmid-encoded peptides corresponding to portions of S4S5(L) and S6(T) of the voltage-gated potassium channel KCNQ1 and evaluated their effects on the channel activity in the presence and absence of the ancillary subunit KCNE1. We showed that S4S5(L) peptides inhibit KCNQ1, in a reversible and state-dependent manner. S4S5(L) peptides also inhibited a voltage-independent KCNQ1 mutant. This inhibition was competitively prevented by a peptide mimicking S6(T), consistent with S4S5(L) binding to S6(T). Val(254) in S4S5(L) is known to contact Leu(353) in S6(T) when the channel is closed, and mutations of these residues alter the coupling between the two regions. The same mutations introduced in peptides altered their effects, further confirming S4S5(L) binding to S6(T). Our results suggest a mechanistic model in which S4S5(L) acts as a voltage-dependent ligand bound to its receptor on S6 at rest. This interaction locks the channel in a closed state. Upon plasma membrane depolarization, S4 pulls S4S5(L) away from S6(T), allowing channel opening.	[Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] INSERM, U915, F-44000 Nantes, France; [Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] CNRS, ERL3147, F-44035 Nantes, France; [Choveau, Frank S.; Rodriguez, Nicolas; Ali, Fayal Abderemane; Dahimene, Shehrazade; Boudin, Helene; Le Henaff, Carole; Escande, Denis; Charpentier, Flavien; Merot, Jean; Baro, Isabelle; Loussouarn, Gildas] Univ Nantes, Fac Med, Inst Thorax, F-44000 Nantes, France; [Labro, Alain J.; Snyders, Dirk J.] Univ Antwerp, Lab Mol Biophys Physiol & Pharmacol, Dept Biomed Sci, B-2610 Antwerp, Belgium; [Rose, Thierry] Inst Pasteur, F-75724 Paris 15, France; [Boudin, Helene] INSERM, U643, F-44000 Nantes, France; [Boudin, Helene] CHU Nantes, Inst Transplantat & Rech Transplantat, F-44000 Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Nantes Universite; CHU de Nantes; University of Antwerp; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Loussouarn, G (corresponding author), INSERM, U915, 8 Quai Moncousu,BP 70721, F-44007 Nantes, France.	gildas.loussouarn@inserm.fr	Loussouarn, Gildas/D-3590-2015; Baró, Isabelle/D-3604-2015; MEROT, Jean/D-5741-2015; Snyders, Dirk/A-2713-2013; Choveau, Frank/AFI-6500-2022; Charpentier, Flavien/D-3586-2015; Baró, Isabelle/ABH-5667-2020; Choveau, Frank/AAF-3858-2022; Boudin, Helene/K-2400-2015; Loussouarn, Gildas/ABH-6043-2020	Loussouarn, Gildas/0000-0001-8007-5931; Baró, Isabelle/0000-0003-4850-4171; Snyders, Dirk/0000-0001-7142-6672; Charpentier, Flavien/0000-0002-5057-0998; Baró, Isabelle/0000-0003-4850-4171; Loussouarn, Gildas/0000-0001-8007-5931; VAL, Thierry/0000-0002-5749-8570; Rodriguez, Nicolas/0000-0003-1079-6041; Boudin, Helene/0000-0002-9714-2384; ROSE, Thierry/0000-0001-8863-0207; Labro, Alain J/0000-0002-0871-7511	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche [ANR-05-JCJC-0160-01]; Hubert Curien Program; Association Francaise contre les Myopathies [14120]; Vaincre La Mucoviscidose; Fondation Genavie; Fondation pour la Recherche Medicale; Federation Francaise de Cardiologie; French Ministere de la Recherche	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Hubert Curien Program; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Vaincre La Mucoviscidose; Fondation Genavie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Federation Francaise de Cardiologie; French Ministere de la Recherche(Ministry of Research, France)	This work was supported in part by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM), from the Agence Nationale de la Recherche (ANR-05-JCJC-0160-01), the Hubert Curien Program (Tournesol program), and the Association Francaise contre les Myopathies (Grant 14120 to G. L.), and from Vaincre La Mucoviscidose (to J. M.).; Supported by the Fondation Genavie, the Fondation pour la Recherche Medicale, and the Federation Francaise de Cardiologie.; Recipient of a grant from the French Ministere de la Recherche.	Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bellocq C, 2004, MOL PHARMACOL, V66, P1093, DOI 10.1124/mol.104.001065; Boulet IR, 2007, J PHYSIOL-LONDON, V585, P325, DOI 10.1113/jphysiol.2007.145813; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; COLE KS, 1960, BIOPHYS J, V1, P1, DOI 10.1016/S0006-3495(60)86871-3; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gilchrist A., 2002, SCI STKE, pPL1; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; John SA, 2003, J PHYSIOL-LONDON, V552, P23, DOI 10.1113/jphysiol.2003.048843; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Le Maout S, 2001, P NATL ACAD SCI USA, V98, P10475, DOI 10.1073/pnas.181481098; Lin PJ, 1999, J BIOL CHEM, V274, P5987, DOI 10.1074/jbc.274.9.5987; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Loussouarn Gildas, 2006, V337, P167; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Park KH, 2005, CIRC RES, V96, P730, DOI 10.1161/01.RES.0000161451.04649.a8; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rex TS, 2005, MOL VIS, V11; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; Wang WY, 1998, J BIOL CHEM, V273, P34069, DOI 10.1074/jbc.273.51.34069; Zheng RJ, 2010, BIOCHEM J, V428, P75, DOI 10.1042/BJ20090977	31	42	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					707	716		10.1074/jbc.M110.146324	http://dx.doi.org/10.1074/jbc.M110.146324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940310	Green Published, hybrid			2022-12-27	WOS:000285782800070
J	Chen, YC; Weinreich, M				Chen, Ying-Chou; Weinreich, Michael			Dbf4 Regulates the Cdc5 Polo-like Kinase through a Distinct Non-canonical Binding Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; BOX DOMAIN; DNA-REPLICATION; BUDDING YEAST; PROTEIN-KINASE; MITOTIC EXIT; MEIOTIC RECOMBINATION; CANCER-THERAPY; CELL-DIVISION; S PHASE	Cdc7-Dbf4 is a conserved, two-subunit kinase required for initiating eukaryotic DNA replication. Recent studies have shown that Cdc7-Dbf4 also regulates the mitotic exit network (MEN) and monopolar homolog orientation in meiosis I (Matos, J., Lipp, J. J., Bogdanova, A., Guillot, S., Okaz, E., Junqueira, M., Shevchenko, A., and Zachariae, W. (2008) Cell 135, 662-678 and Miller, C. T., Gabrielse, C., Chen, Y. C., and Weinreich, M. (2009) PLoS Genet. 5, e1000498). Both activities likely involve a Cdc7-Dbf4 interaction with Cdc5, the single Polo-like kinase in budding yeast. We previously showed that Dbf4 binds the Cdc5 polo-box domain (PBD) via an similar to 40-residue N-terminal sequence, which lacks a PBD consensus binding site (S(pS/pT)(P/X)), and that Dbf4 inhibits Cdc5 function during mitosis. Here we identify a non-consensus PBD binding site within Dbf4 and demonstrate that the PBD-Dbf4 interaction occurs via a distinct PBD surface from that used to bind phosphoproteins. Genetic and biochemical analysis of multiple dbf4 mutants indicate that Dbf4 inhibits Cdc5 function through direct binding. Surprisingly, mutation of invariant Cdc5 residues required for binding phosphorylated substrates has little effect on yeast viability or growth rate. Instead, cdc5 mutants defective for binding phosphoproteins exhibit enhanced resistance to microtubule disruption and an increased rate of spindle elongation. This study, therefore, details the molecular nature of a new type of PBD binding and reveals that Cdc5 targeting to phosphorylated substrates likely regulates spindle dynamics.	Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Chen, Ying-Chou] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA	Van Andel Institute; Michigan State University	Weinreich, M (corresponding author), 333 Bostwick Ave NE, Grand Rapids, MI 49503 USA.	michael.weinreich@vai.org	Weinreich, Michael/D-2310-2014		Van Andel Research Institute; American Cancer Society [RSG-0506301GMC]	Van Andel Research Institute; American Cancer Society(American Cancer Society)	This work was supported by the Van Andel Research Institute and American Cancer Society Grant RSG-0506301GMC.	Archambault V, 2008, GENE DEV, V22, P2707, DOI 10.1101/gad.486808; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bin OY, 1997, J BIOL CHEM, V272, P28646, DOI 10.1074/jbc.272.45.28646; Blow JJ, 2005, EMBO REP, V6, P1028, DOI 10.1038/sj.embor.7400557; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Garcia-Alvarez B, 2007, P NATL ACAD SCI USA, V104, P3107, DOI 10.1073/pnas.0609131104; Geymonat M, 2003, J BIOL CHEM, V278, P14591, DOI 10.1074/jbc.C300059200; Hardy CFJ, 1996, MOL CELL BIOL, V16, P6775; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Johnston LH, 1999, TRENDS CELL BIOL, V9, P249, DOI 10.1016/S0962-8924(99)01586-X; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; KITADA K, 1993, MOL CELL BIOL, V13, P4445, DOI 10.1128/MCB.13.7.4445; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Lee KS, 1998, P NATL ACAD SCI USA, V95, P9301, DOI 10.1073/pnas.95.16.9301; Lee KS, 1997, MOL CELL BIOL, V17, P3408, DOI 10.1128/MCB.17.6.3408; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; Liang FS, 2007, MOL CELL BIOL, V27, P5067, DOI 10.1128/MCB.00095-07; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2004, CELL CYCLE, V3, P128; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Miller CT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000498; Park CJ, 2003, GENETICS, V163, P21; Pereira G, 2005, MOL CELL, V19, P209, DOI 10.1016/j.molcel.2005.05.030; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Pintard L, 2001, MOL CELL, V8, P1155, DOI 10.1016/S1097-2765(01)00422-1; Rahal R, 2008, CELL CYCLE, V7, P3262, DOI 10.4161/cc.7.20.6852; Reindl WG, 2008, CHEM BIOL, V15, P459, DOI 10.1016/j.chembiol.2008.03.013; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Sherman F., 1986, METHODS YEAST GENETI, P523; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Soues S, 1998, J CELL SCI, V111, P2809; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sullivan M, 2008, MOL CELL BIOL, V28, P5328, DOI 10.1128/MCB.00235-08; SUNKEL CE, 1988, J CELL SCI, V89, P25; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Watanabe N, 2009, J BIOL CHEM, V284, P2344, DOI 10.1074/jbc.M805308200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747	66	27	28	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41244	41254		10.1074/jbc.M110.155242	http://dx.doi.org/10.1074/jbc.M110.155242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036905	Green Published, hybrid			2022-12-27	WOS:000285622600010
J	Escola, JM; Kuenzi, G; Gaertner, H; Foti, M; Hartley, O				Escola, Jean-Michel; Kuenzi, Gabriel; Gaertner, Hubert; Foti, Michelangelo; Hartley, Oliver			CC Chemokine Receptor 5 (CCR5) Desensitization CYCLING RECEPTORS ACCUMULATE IN THE TRANS-GOLGI NETWORK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHLY POTENT; HIV; INHIBITION; PROTEIN; TRAFFICKING; RANTES; CELLS; ENDOCYTOSIS; ENDOSOMES; INTERNALIZATION	CC chemokine receptor 5 (CCR5), the major HIV coreceptor, is a G protein-coupled receptor (GPCR) involved in cell activation and migration in response to chemokines. Blockade of CCR5 is an effective anti-HIV strategy, and potent anti-HIV chemokine analogs such as PSC-RANTES have been developed. These inhibitors act by interfering with receptor trafficking, thereby inducing prolonged intracellular sequestration of CCR5. Like many GPCRs, CCR5 is desensitized following agonist activation. The initial steps in this process are well understood, but later stages, including where CCR5 is sequestered during desensitization, and how anti-HIV chemokine analogs intervene to achieve prolonged sequestration, have yet to be elucidated in detail. In this study we demonstrate that CCR5 cycles to and from the cell surface via the endosome recycling compartment and the trans-Golgi network during desensitization, accumulating in the trans-Golgi network following internalization by both PSC-RANTES and CCL5, the native ligand from which it was derived. In addition, we show that unlike CCR5 sequestered by CCL5, CCR5 sequestered by PSC-RANTES cannot be induced to return to the cell surface by addition of the small molecule CCR5 inhibitor, TAK-779, and that association of PSC-RANTES with CCR5 is more durable than that of native CCL5 during desensitization. Our findings reconcile the previously conflicting descriptions of the location of sequestered CCR5 during desensitization, as well as providing more general insights into potential trafficking routes for endocytosed GPCRs and further elucidation of the unusual inhibitory mechanism of chemokine analogs with potent anti-HIV activity.	[Escola, Jean-Michel; Kuenzi, Gabriel; Gaertner, Hubert; Hartley, Oliver] Univ Geneva, Fac Med, Dept Struct Biol & Bioinformat, CH-1211 Geneva 4, Switzerland; [Foti, Michelangelo] Univ Geneva, Fac Med, Dept Cellular Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Hartley, O (corresponding author), 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.	oliver.hartley@unige.ch		Foti, Michelangelo/0000-0001-7199-4135	Swiss National Science Foundation [3100A0-110042, 310000-120280/1]; NIH/NIAID [U19 AI076981]; Swedish International Development Agency [7500037313]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076981] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish International Development Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Swiss National Science Foundation (3100A0-110042 to O. H.; 310000-120280/1 to M. F.), NIH/NIAID (U19 AI076981), and the Swedish International Development Agency (7500037313 to O. H.).	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Csaba Z, 2007, TRAFFIC, V8, P820, DOI 10.1111/j.1600-0854.2007.00580.x; GAERTNER HF, 1994, J BIOL CHEM, V269, P7224; Gaertner H, 2008, PROTEIN ENG DES SEL, V21, P65, DOI 10.1093/protein/gzm079; Gaertner H, 2008, P NATL ACAD SCI USA, V105, P17706, DOI 10.1073/pnas.0805098105; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kiss DL, 2009, CELL MOL BIOL LETT, V14, P537, DOI 10.2478/s11658-009-0017-1; Kuhmann SE, 2008, ANNU REV PHARMACOL, V48, P425, DOI 10.1146/annurev.pharmtox.48.113006.094847; LEDERMAN MM, 1995, ANN INTERN MED, V122, P218, DOI 10.7326/0003-4819-122-3-199502010-00010; Lelouvier B, 2008, J NEUROSCI, V28, P4336, DOI 10.1523/JNEUROSCI.4379-07.2008; Longden J, 2008, BRIT J PHARMACOL, V153, P1513, DOI 10.1038/sj.bjp.0707691; Mack M, 1998, J EXP MED, V187, P1215, DOI 10.1084/jem.187.8.1215; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Neubrand VE, 2005, EMBO J, V24, P1122, DOI 10.1038/sj.emboj.7600600; Offord RE, 1997, METHOD ENZYMOL, V287, P348; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Signoret N, 2004, TRAFFIC, V5, P529, DOI 10.1111/j.1600-0854.2004.00200.x; Signoret N, 2000, J CELL BIOL, V151, P1281, DOI 10.1083/jcb.151.6.1281; Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276; Trkola A, 1998, J VIROL, V72, P396, DOI 10.1128/JVI.72.1.396-404.1998	31	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41772	41780		10.1074/jbc.M110.153460	http://dx.doi.org/10.1074/jbc.M110.153460			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041313	Green Published, hybrid			2022-12-27	WOS:000285622600065
J	Hyvarinen, J; Parikka, M; Sormunen, R; Ramet, M; Tryggvason, K; Kivirikko, KI; Myllyharju, J; Koivunen, P				Hyvarinen, Jaana; Parikka, Mataleena; Sormunen, Raija; Ramet, Mika; Tryggvason, Karl; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi			Deficiency of a Transmembrane Prolyl 4-Hydroxylase in the Zebrafish Leads to Basement Membrane Defects and Compromised Kidney Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; LYSYL OXIDASE; KAPPA-B; HIF-1-ALPHA; INHIBITION; HIF; OVEREXPRESSION; DIOXYGENASES; HIF-2-ALPHA	Prolyl 4-hydroxylases (P4Hs) catalyze the hydroxylation of collagens and hypoxia-inducible factor (HIF)-alpha subunits. We studied the zebrafish homologue of the recently characterized human transmembrane P4H (P4H-TM) that can hydroxylate HIF-alpha, but not collagens, in vitro and influence HIF-alpha levels in cellulo. The zebrafish P4H-TM mRNA had its highest expression in the eye and brain and lower levels in other tissues, including the kidney. Morpholino knockdown of P4H-TM in embryos resulted in a reduction in the size of the eye and head and morphological alterations in the head from 2 days postfertilization onward. In addition, pericardial edema, regarded as a sign of kidney dysfunction, developed from 3 days postfertilization onward. The phenotype was dependent on the P4H-TM catalytic activity because similar results were obtained with morpholinos targeting either translation initiation or catalytic residues of the enzyme. Structural and functional analyses of the morphant pronephric kidneys revealed fragmented glomerular basement membranes (BMs), disorganized podocyte foot processes, and severely compromised pronephric kidney function leading to proteinuria. The opacity of the eye lens was increased due to the presence of extra nuclei and deposits, and the structure of the lens capsule BM was altered.	[Hyvarinen, Jaana; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Dept Med Biochem & Mol Biol, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, FIN-90014 Oulu, Finland; [Hyvarinen, Jaana; Sormunen, Raija; Kivirikko, Kari I.; Myllyharju, Johanna; Koivunen, Peppi] Univ Oulu, Bioctr Oulu, FIN-90014 Oulu, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, FIN-90014 Oulu, Finland; [Parikka, Mataleena; Ramet, Mika] Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; [Parikka, Mataleena] Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; [Ramet, Mika] Tampere Univ Hosp, Dept Pediat, FIN-33521 Tampere, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; Tampere University; Karolinska Institutet; Tampere University; Tampere University Hospital	Koivunen, P (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, Aapistie 7,POB 5000, FIN-90014 Oulu, Finland.	Peppi.Koivunen@oulu.fi	Parikka, Mataleena/D-4364-2014	Parikka, Mataleena/0000-0001-5555-3815	Academy of Finland [120156, 200471, 202469, 118431]; S. Juselius Foundation; FibroGen Inc.; Knut and Alice Wallenberg Foundation; Swedish Research Council; Swedish Foundation for Strategic Research; Soderberg's Foundation; Biocenter Finland; Pirkanmaa Hospital district	Academy of Finland(Academy of Finland); S. Juselius Foundation; FibroGen Inc.; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Soderberg's Foundation; Biocenter Finland; Pirkanmaa Hospital district	This work was supported by Academy of Finland Grants 120156 (to P. K.), 200471 and 202469 (to J.M.), and 118431 (to M. R.); the S. Juselius Foundation (to P. K., J.M., and M. R.); FibroGen Inc. (to J.M.); the Knut and Alice Wallenberg Foundation; the Swedish Research Council; the Swedish Foundation for Strategic Research; and Soderberg's Foundation (to K. T.). The Tampere Zebrafish facility is supported by the Biocenter Finland. K. I. K. is a scientific founder and consultant of FibroGen Inc., which is developing HIF-P4H inhibitors as potential therapeutic agents. J.M. and K. I. K. own equity in this company, and the company itself has supported research in the laboratory headed by K. I. K. in the past and currently supports research in the laboratory of J.M. K. T. is co-founder of Nephro-Genex, Inc., and BioLamina AB Inc. but receives no research support from those companies.; Supported by the Competitive Research Funds of the Pirkanmaa Hospital district.	Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Cooper ME, 2002, SEMIN NEPHROL, V22, P393, DOI 10.1053/snep.2002.34724; Corey DR, 2001, GENOME BIOL, V2; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Koivunen P, 2007, J BIOL CHEM, V282, P30544, DOI 10.1074/jbc.M704988200; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee J, 2007, INVEST OPHTH VIS SCI, V48, P2483, DOI 10.1167/iovs.06-1211; Majumdar A, 2000, DEV BIOL, V222, P147, DOI 10.1006/dbio.2000.9642; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Myllyharju J, 1999, EMBO J, V18, P306, DOI 10.1093/emboj/18.2.306; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Raschperger E, 2008, DEV BIOL, V313, P455, DOI 10.1016/j.ydbio.2007.10.049; Reynaud C, 2008, MATRIX BIOL, V27, P547, DOI 10.1016/j.matbio.2008.03.002; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Serluca FC, 2002, CURR BIOL, V12, P492, DOI 10.1016/S0960-9822(02)00694-2; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Rooijen E, 2009, BLOOD, V113, P6449, DOI 10.1182/blood-2008-07-167890; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Zhang Q, 2009, CANCER CELL, V16, P413, DOI 10.1016/j.ccr.2009.09.029	47	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42023	42032		10.1074/jbc.M110.145904	http://dx.doi.org/10.1074/jbc.M110.145904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952382	Green Published, hybrid			2022-12-27	WOS:000285622600088
J	Sarell, CJ; Wilkinson, SR; Viles, JH				Sarell, Claire J.; Wilkinson, Shane R.; Viles, John H.			Substoichiometric Levels of Cu2+ Ions Accelerate the Kinetics of Fiber Formation and Promote Cell Toxicity of Amyloid-beta from Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; TRANSGENIC MICE; IN-VIVO; COORDINATION GEOMETRY; COPPER(II) BINDING; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; FIBRILLAR FORMS; PRION PROTEIN; ZINC-BINDING	A role for Cu2+ ions in Alzheimer disease is often disputed, as it is believed that Cu2+ ions only promote nontoxic amorphous aggregates of amyloid-beta (A beta). In contrast with currently held opinion, we show that the presence of substoichiometric levels of Cu2+ ions in fact doubles the rate of production of amyloid fibers, accelerating both the nucleation and elongation of fiber formation. We suggest that binding of Cu2+ ions at a physiological pH causes A beta to approach its isoelectric point, thus inducing self-association and fiber formation. We further show that Cu2+ ions bound to A beta are consistently more toxic to neuronal cells than A beta in the absence of Cu2+ ions, whereas Cu2+ ions in the absence of A beta are not cytotoxic. The degree of Cu-A beta cytotoxicity correlates with the levels of Cu2+ ions that accelerate fiber formation. We note the effect appears to be specific for Cu2+ ions as Zn2+ ions inhibit the formation of fibers. An active role for Cu2+ ions in accelerating fiber formation and promoting cell death suggests impaired copper homeostasis may be a risk factor in Alzheimer disease.	[Sarell, Claire J.; Wilkinson, Shane R.; Viles, John H.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Viles, JH (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC) [BBD0050271]; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish; BBSRC [BB/D005027/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Project Grant BBD0050271 and a BBSRC quota studentship.	Antzutkin ON, 2004, MAGN RESON CHEM, V42, P231, DOI 10.1002/mrc.1341; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Crouch PJ, 2007, FEBS J, V274, P3775, DOI 10.1111/j.1742-4658.2007.05918.x; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Damante CA, 2008, INORG CHEM, V47, P9669, DOI 10.1021/ic8006052; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Dorlet P, 2009, ANGEW CHEM INT EDIT, V48, P9273, DOI 10.1002/anie.200904567; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Faller P, 2009, DALTON T, P1080, DOI 10.1039/b813398k; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hou LM, 2006, J AM CHEM SOC, V128, P9260, DOI 10.1021/ja046032u; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Innocenti M, 2010, J ALZHEIMERS DIS, V19, P1323, DOI 10.3233/JAD-2010-1338; Jun S, 2009, BIOCHEMISTRY-US, V48, P10724, DOI 10.1021/bi9012935; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murray IVJ, 2005, BIOCHEMISTRY-US, V44, P12606, DOI 10.1021/bi050926p; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Raman B, 2005, J BIOL CHEM, V280, P16157, DOI 10.1074/jbc.M500309200; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Shin BK, 2008, BIOCHEMISTRY-US, V47, P9117, DOI 10.1021/bi801014x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Streltsov VA, 2008, BIOPHYS J, V95, P3447, DOI 10.1529/biophysj.108.134429; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Urbanc B, 2002, P NATL ACAD SCI USA, V99, P13990, DOI 10.1073/pnas.222433299; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; VIGOPELFREY C, 1993, J NEUROCHEM, V61, P1965, DOI 10.1111/j.1471-4159.1993.tb09841.x; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200	66	154	157	1	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41533	41540		10.1074/jbc.M110.171355	http://dx.doi.org/10.1074/jbc.M110.171355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974842	hybrid, Green Published			2022-12-27	WOS:000285622600040
J	Yang, JH; Wada, A; Yoshida, K; Miyoshi, Y; Sayano, T; Esaki, K; Kinoshita, MO; Tomonaga, S; Azuma, N; Watanabe, M; Hamase, K; Zaitsu, K; Machida, T; Messing, A; Itohara, S; Hirabayashi, Y; Furuya, S				Yang, Jung Hoon; Wada, Akira; Yoshida, Kazuyuki; Miyoshi, Yurika; Sayano, Tomoko; Esaki, Kayoko; Kinoshita, Masami O.; Tomonaga, Shozo; Azuma, Norihiro; Watanabe, Masahiko; Hamase, Kenji; Zaitsu, Kiyoshi; Machida, Takeo; Messing, Albee; Itohara, Shigeyoshi; Hirabayashi, Yoshio; Furuya, Shigeki			Brain-specific Phgdh Deletion Reveals a Pivotal Role for L-Serine Biosynthesis in Controlling the Level of D-Serine, an N-methyl-D-aspartate Receptor Co-agonist, in Adult Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-PHOSPHOGLYCERATE DEHYDROGENASE GENE; CENTRAL-NERVOUS-SYSTEM; ENDOGENOUS D-SERINE; MOUSE-BRAIN; NMDA-RECEPTORS; RAT-BRAIN; AMINO-ACIDS; TARGETED DISRUPTION; RACEMASE; EXPRESSION	In mammalian brain, D-serine is synthesized from L-serine by serine racemase, and it functions as an obligatory co-agonist at the glycine modulatory site of N-methyl-D-aspartate (NMDA)-selective glutamate receptors. Although diminution in D-serine level has been implicated in NMDA receptor hypofunction, which is thought to occur in schizophrenia, the source of the precursor L-serine and its role in D-serine metabolism in adult brain have yet to be determined. We investigated whether L-serine synthesized in brain via the phosphorylated pathway is essential for D-serine synthesis by generating mice with a conditional deletion of D-3-phosphoglycerate dehydrogenase (Phgdh; EC 1.1.1.95). This enzyme catalyzes the first step in L-serine synthesis via the phosphorylated pathway. HPLC analysis of serine enantiomers demonstrated that both L-and D-serine levels were markedly decreased in the cerebral cortex and hippocampus of conditional knock-out mice, whereas the serine deficiency did not alter protein expression levels of serine racemase and NMDA receptor subunits in these regions. The present study provides definitive proof that L-serine-synthesized endogenously via the phosphorylated pathway is a key rate-limiting factor for maintaining steady-state levels of D-serine in adult brain. Furthermore, NMDA-evoked transcription of Arc, an immediate early gene, was diminished in the hippocampus of conditional knock-out mice. Thus, this study demonstrates that in mature neuronal circuits L-serine availability determines the rate of D-serine synthesis in the forebrain and controls NMDA receptor function at least in the hippocampus.	[Furuya, Shigeki] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan; [Yang, Jung Hoon; Wada, Akira; Sayano, Tomoko; Esaki, Kayoko; Furuya, Shigeki] Kyushu Univ, Lab Metab Regulat Res, Bioarchitecture Ctr, Fukuoka 8128581, Japan; [Miyoshi, Yurika; Hamase, Kenji; Zaitsu, Kiyoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128581, Japan; [Yoshida, Kazuyuki; Azuma, Norihiro] Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 3218505, Japan; [Yoshida, Kazuyuki; Kinoshita, Masami O.; Itohara, Shigeyoshi; Hirabayashi, Yoshio; Furuya, Shigeki] RIKEN Brain Sci Inst, Wako, Saitama 3510198, Japan; [Kinoshita, Masami O.; Machida, Takeo] Saitama Univ, Dept Regulat Biol, Saitama 3388570, Japan; [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Messing, Albee] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Messing, Albee] Univ Wisconsin, Dept Comparat Biosci, Madison, WI 53705 USA	Kyushu University; Kyushu University; Kyushu University; Utsunomiya University; RIKEN; Saitama University; Hokkaido University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Furuya, S (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	shigekifur@brs.kyuhsu-u.ac.jp	Itohara, Shigeyoshi/I-8769-2012; Watanabe, Masahiko/S-3614-2019; Tomonaga, Shozo/S-3307-2018; WATANABE, Masahiko/A-4055-2012	Itohara, Shigeyoshi/0000-0002-2410-9989; Watanabe, Masahiko/0000-0001-5037-7138; Tomonaga, Shozo/0000-0003-0888-1407; WATANABE, Masahiko/0000-0001-5037-7138; Hirabayashi, Yoshio/0000-0002-5774-7354; Wada, Akira/0000-0003-4037-5766; Furuya, Shigeki/0000-0001-9020-3597	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18300125, 22380078]; TOYOTA Physical and Chemical Research Institute; Grants-in-Aid for Scientific Research [22780240] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); TOYOTA Physical and Chemical Research Institute(Toyota Physical and Chemical Research Institute); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Scientific Research Areas (B) 18300125 and 22380078 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. F.) and a grant from the research fund of the TOYOTA Physical and Chemical Research Institute (to S. F.).	Abe M, 2004, J NEUROSCI, V24, P7292, DOI 10.1523/JNEUROSCI.1261-04.2004; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Bendikov I, 2007, SCHIZOPHR RES, V90, P41, DOI 10.1016/j.schres.2006.10.010; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; Cho HM, 2000, GENE, V245, P193, DOI 10.1016/S0378-1119(00)00009-3; Coba MP, 2008, J BIOL CHEM, V283, P34101, DOI 10.1074/jbc.M804951200; CONTRERAS PC, 1990, NEUROPHARMACOLOGY, V29, P291, DOI 10.1016/0028-3908(90)90015-J; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Danysz W, 1998, PHARMACOL REV, V50, P597; de Koning TJ, 2006, J INHERIT METAB DIS, V29, P347, DOI 10.1007/s10545-006-0269-0; DE MJ, 2002, P NATL ACAD SCI USA, V99, P14542; Dunlop DS, 1997, BIOCHEM BIOPH RES CO, V235, P26, DOI 10.1006/bbrc.1997.6724; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Fuchs SA, 2006, ANN NEUROL, V60, P476, DOI 10.1002/ana.20977; Furuya S, 2000, P NATL ACAD SCI USA, V97, P11528, DOI 10.1073/pnas.200364497; Furuya S, 2008, FUNCT INTEGR GENOMIC, V8, P235, DOI 10.1007/s10142-007-0072-5; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1993, J NEUROCHEM, V60, P783, DOI 10.1111/j.1471-4159.1993.tb03219.x; HASHIMOTO A, 1992, FEBS LETT, V296, P33, DOI 10.1016/0014-5793(92)80397-Y; Hashimoto K, 2005, PROG NEURO-PSYCHOPH, V29, P767, DOI 10.1016/j.pnpbp.2005.04.023; Heresco-Levy U, 2005, BIOL PSYCHIAT, V57, P577, DOI 10.1016/j.biopsych.2004.12.037; Hirabayashi Y, 2008, PROG LIPID RES, V47, P188, DOI 10.1016/j.plipres.2008.01.003; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Kawakami Y, 2009, NEUROSCI RES, V63, P184, DOI 10.1016/j.neures.2008.12.002; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MATSUI T, 1995, J NEUROCHEM, V65, P454; Menniti FS, 2000, NEUROPHARMACOLOGY, V39, P1147, DOI 10.1016/S0028-3908(99)00211-7; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Morikawa A, 2003, ANAL BIOCHEM, V312, P66, DOI 10.1016/S0003-2697(02)00432-3; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Mustafa AK, 2010, J NEUROSCI, V30, P1413, DOI 10.1523/JNEUROSCI.4297-09.2010; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neidle A, 2002, NEUROCHEM RES, V27, P1719, DOI 10.1023/A:1021607715824; Nishikawa T, 2005, BIOL PHARM BULL, V28, P1561, DOI 10.1248/bpb.28.1561; OLDENDORF WH, 1971, AM J PHYSIOL, V221, P1629, DOI 10.1152/ajplegacy.1971.221.6.1629; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; Schell MJ, 1997, J NEUROSCI, V17, P1604; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; Strisovsky K, 2003, FEBS LETT, V535, P44, DOI 10.1016/S0014-5793(02)03855-3; Takasaki C, 2007, BIOMED RES-TOKYO, V28, P61, DOI 10.2220/biomedres.28.61; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; Tsai GC, 1998, BIOL PSYCHIAT, V44, P1081, DOI 10.1016/S0006-3223(98)00279-0; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; WOOD PL, 1989, J NEUROCHEM, V53, P979, DOI 10.1111/j.1471-4159.1989.tb11803.x; Yamasaki M, 2001, J NEUROSCI, V21, P7691, DOI 10.1523/JNEUROSCI.21-19-07691.2001; Yoshida K, 2004, J BIOL CHEM, V279, P3573, DOI 10.1074/jbc.C300507200; Yoshikawa M, 2008, J PHARMACOL SCI, V107, P270, DOI 10.1254/jphs.08030FP; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	62	88	89	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41380	41390		10.1074/jbc.M110.187443	http://dx.doi.org/10.1074/jbc.M110.187443			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966073	hybrid, Green Published			2022-12-27	WOS:000285622600024
J	Capp, C; Qian, YS; Sage, H; Huber, H; Hsieh, TS				Capp, Christopher; Qian, Yushen; Sage, Harvey; Huber, Harald; Hsieh, Tao-shih			Separate and Combined Biochemical Activities of the Subunits of a Naturally Split Reverse Gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE-LIKE DOMAIN; NANOARCHAEUM-EQUITANS; DNA; TOPOISOMERASE; HYPERTHERMOPHILES; INSIGHTS; ASSOCIATION; EVOLUTION; TOPOLOGY; MACHINE	Reverse gyrase reanneals denatured DNA and induces positive supercoils in DNA, an activity that is critical for life at very high temperatures. Positive supercoiling occurs by a poorly understood mechanism involving the coordination of a topoisomerase domain and a helicase-like domain. In the parasitic archaeon Nanoarchaeum equitans, these domains occur as separate subunits. We express the subunits, and characterize them both in isolation and as a heterodimer. Each subunit tightly associates and interacts with the other. The topoisomerase subunit enhances the catalytic specificity of the DNA-dependent ATPase activity of the helicase-like subunit, and the helicase-like subunit inhibits the relaxation activity of the topoisomerase subunit while promoting positive supercoiling. DNA binding preference for both single-and double-stranded DNA is partitioned between the subunits. Based on a sensitive topological shift assay, the binding preference of helicase-like subunit for underwound DNA is modulated by its binding with ATP cofactor. These results provide new insight into the mechanism of positive supercoil induction by reverse gyrase.	[Capp, Christopher; Qian, Yushen; Sage, Harvey; Hsieh, Tao-shih] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Huber, Harald] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; [Huber, Harald] Univ Regensburg, Archaeal Ctr, D-93053 Regensburg, Germany	Duke University; University of Regensburg; University of Regensburg	Hsieh, TS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 3711, Durham, NC 27710 USA.	hsieh@biochem.duke.edu	Wu, Wan-lin/G-8937-2012; Hsieh, Tao-shih/G-9305-2012		National Institutes of Health [GM29006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported, in whole or in part, by National Institutes of Health Grant GM29006.	Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004; Brochier-Armanet Celine, 2007, Archaea, V2, P83; Capp C, 2009, J BIOL CHEM, V284, P30845, DOI 10.1074/jbc.M109.008052; CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753; Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199; Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Grogan DW, 1998, MOL MICROBIOL, V28, P1043, DOI 10.1046/j.1365-2958.1998.00853.x; Heine M, 2009, J MICROBIOL, V47, P229, DOI 10.1007/s12275-009-0019-8; Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200; Hsieh TS, 2005, J BIOL CHEM, V280, P20467, DOI 10.1074/jbc.M502739200; Jahn U, 2008, J BACTERIOL, V190, P1743, DOI 10.1128/JB.01731-07; Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683; KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Krah R, 1996, P NATL ACAD SCI USA, V93, P106, DOI 10.1073/pnas.93.1.106; Lopez-Garcia P, 1999, MOL MICROBIOL, V33, P766, DOI 10.1046/j.1365-2958.1999.01524.x; Lopez-Garcia P, 2000, J BACTERIOL, V182, P4998, DOI 10.1128/JB.182.17.4998-5000.2000; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Stetter KO, 2006, EXTREMOPHILES, V10, P357, DOI 10.1007/s00792-006-0012-7; Valenti A, 2008, NUCLEIC ACIDS RES, V36, P4587, DOI 10.1093/nar/gkn418; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100	26	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39637	39645		10.1074/jbc.M110.173989	http://dx.doi.org/10.1074/jbc.M110.173989			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929866	hybrid, Green Published			2022-12-27	WOS:000285185500007
J	Dennis, EA; Deems, RA; Harkewicz, R; Quehenberger, O; Brown, HA; Milne, SB; Myers, DS; Glass, CK; Hardiman, G; Reichart, D; Merrill, AH; Sullards, MC; Wang, E; Murphy, RC; Raetz, CRH; Garrett, TA; Guan, ZQ; Ryan, AC; Russell, DW; McDonald, JG; Thompson, BM; Shaw, WA; Sud, M; Zhao, YH; Gupta, S; Maurya, MR; Fahy, E; Subramaniam, S				Dennis, Edward A.; Deems, Raymond A.; Harkewicz, Richard; Quehenberger, Oswald; Brown, H. Alex; Milne, Stephen B.; Myers, David S.; Glass, Christopher K.; Hardiman, Gary; Reichart, Donna; Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine; Murphy, Robert C.; Raetz, Christian R. H.; Garrett, Teresa A.; Guan, Ziqiang; Ryan, Andrea C.; Russell, David W.; McDonald, Jeffrey G.; Thompson, Bonne M.; Shaw, Walter A.; Sud, Manish; Zhao, Yihua; Gupta, Shakti; Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar			A Mouse Macrophage Lipidome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITION; ENDOTOXIN; CELLS	We report the lipidomic response of the murine macrophage RAW cell line to Kdo(2)-lipid A, the active component of an inflammatory lipopolysaccharide functioning as a selective TLR4 agonist and compactin, a statin inhibitor of cholesterol biosynthesis. Analyses of lipid molecular species by dynamic quantitative mass spectrometry and concomitant transcriptomic measurements define the lipidome and demonstrate immediate responses in fatty acid metabolism represented by increases in eicosanoid synthesis and delayed responses characterized by sphingolipid and sterol biosynthesis. Lipid remodeling of glycerolipids, glycerophospholipids, and prenols also take place, indicating that activation of the innate immune system by inflammatory mediators leads to alterations in a majority of mammalian lipid categories, including unanticipated effects of a statin drug. Our studies provide a systems-level view of lipid metabolism and reveal significant connections between lipid and cell signaling and biochemical pathways that contribute to innate immune responses and to pharmacological perturbations.	[Dennis, Edward A.; Deems, Raymond A.; Subramaniam, Shankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dennis, Edward A.; Harkewicz, Richard] Univ Calif San Diego, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; [Quehenberger, Oswald; Glass, Christopher K.; Hardiman, Gary] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Brown, H. Alex; Milne, Stephen B.; Myers, David S.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Glass, Christopher K.; Reichart, Donna; Subramaniam, Shankar] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Chem, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Sch Biochem, Atlanta, GA 30332 USA; [Merrill, Alfred H., Jr.; Sullards, M. Cameron; Wang, Elaine] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Raetz, Christian R. H.; Garrett, Teresa A.; Guan, Ziqiang; Ryan, Andrea C.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Russell, David W.; McDonald, Jeffrey G.; Thompson, Bonne M.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Shaw, Walter A.] Avanti Polar Lipids Inc, Alabaster, AL 35007 USA; [Sud, Manish; Zhao, Yihua; Gupta, Shakti; Maurya, Mano R.; Fahy, Eoin; Subramaniam, Shankar] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Vanderbilt University; University of California System; University of California San Diego; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego; University of California System; University of California San Diego	Dennis, EA (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr, La Jolla, CA 92093 USA.	edennis@ucsd.edu; shankar@ucsd.edu	Guan, Ziqiang/AAE-5110-2019; Murphy, Robert/AAO-5349-2020; Dennis, Edward A./M-5554-2019; Glass, Christopher/AAI-3933-2021	Murphy, Robert/0000-0002-9430-6515; Dennis, Edward A./0000-0003-3738-3140; Glass, Christopher/0000-0003-4344-3592; Merrill, Alfred/0000-0002-6673-968X; Russell, David/0000-0002-0277-403X; Thompson, Bonne/0000-0001-7563-8330; Hardiman, Gary/0000-0003-4558-0400	National Institutes of Health through NIGMS [U54 GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	National Institutes of Health through NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant through the NIGMS Large Scale Collaborative "Glue" Grant U54 GM069338 (to E. A. D.).	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Brown HA, 2007, METHOD ENZYMOL, V432, P1; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Buczynski MW, 2007, J BIOL CHEM, V282, P22834, DOI 10.1074/jbc.M701831200; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; BYRNES RW, 2007, JALA, V12, P230; Dennis E.A., 2005, FUNCTIONAL LIPIDOMIC, P1; Dennis EA, 2009, P NATL ACAD SCI USA, V106, P2089, DOI 10.1073/pnas.0812636106; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Gilman AG, 2002, NATURE, V420, P703, DOI 10.1038/nature01304; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Harkewicz R, 2007, J BIOL CHEM, V282, P2899, DOI 10.1074/jbc.M610067200; Ivanova PT, 2010, J LIPID RES, V51, P1581, DOI 10.1194/jlr.D003715; Ivanova PT, 2001, P NATL ACAD SCI USA, V98, P7152, DOI 10.1073/pnas.131195098; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Kim JK, 2006, CELL METAB, V4, P417, DOI 10.1016/j.cmet.2006.11.008; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Popovic ZV, 2007, J IMMUNOL, V179, P6770, DOI 10.4049/jimmunol.179.10.6770; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wu HFM, 2005, AM J PHYSIOL-LUNG C, V288, pL585, DOI 10.1152/ajplung.00305.2004	32	203	208	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39976	39985		10.1074/jbc.M110.182915	http://dx.doi.org/10.1074/jbc.M110.182915			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20923771	hybrid, Green Published			2022-12-27	WOS:000285185500042
J	Gao, JL; Nguyen, KA; Hunter, N				Gao, Jin-Long; Nguyen, Ky-Anh; Hunter, Neil			Characterization of a Hemophore-like Protein from Porphyromonas gingivalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE-SPECIFIC GINGIPAIN; OUTER-MEMBRANE PROTEIN; HEMIN-BINDING-PROTEIN; INFLUENZAE TYPE-B; HAEMOPHILUS-INFLUENZAE; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; TRAFFICKING PROTEIN; CONTAINING PIGMENT	The porphyrin auxotrophic pathogen Porphyromonas gingivalis obtains the majority of essential iron and porphyrin from host hemoproteins. To achieve this, the organism expresses outer membrane gingipains containing cysteine proteinase domains linked to hemagglutinin domains. Heme mobilized in this way is taken up by P. gingivalis through a variety of potential portals where HmuY/HmuR of the hmu locus are best described. These receptors have relatively low binding affinities for heme. In this report, we describe a novel P. gingivalis protein, HusA, the product of PG2227, which rapidly bound heme with a high binding constant at equilibrium of 7 x 10(-10) M. HusA is both expressed on the outer membrane and released from the organism. Spectral analysis indicated an unusual pattern of binding where heme was ligated preferentially as a dimer. Further, the presence of dimeric heme induced protein dimer formation. Deletional inactivation of husA showed that expression of this moiety was essential for growth of P. gingivalis under conditions of heme limitation. This finding was in accord with the pronounced increase in gene expression levels for husA with progressive reduction of heme supplementation. Antibodies reactive against HusA were detected in patients with chronic periodontitis, suggesting that the protein is expressed during the course of infection by P. gingivalis. It is predicted that HusA efficiently sequesters heme from gingipains and fulfills the function of a high affinity hemophore-like protein to meet the heme requirement for growth of P. gingivalis during establishment of infection.	Westmead Millennium Inst, Inst Dent Res, Sydney, NSW 2145, Australia; Westmead Hosp, Ctr Oral Hlth, Sydney, NSW 2145, Australia; [Gao, Jin-Long; Nguyen, Ky-Anh] Univ Sydney, Fac Dent, Sydney, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney	Nguyen, KA (corresponding author), POB 533, Wentworthville, NSW 2145, Australia.	kyanhn@gmail.com	Nguyen, Ky-Anh/A-4971-2010	Nguyen, Ky-Anh/0000-0002-1643-6576; Gao, Jinlong/0000-0002-5153-5393	Australian Research Council [LP0562660]; Ramaciotti Foundation [RN38/08]; New South Wales Dental Board; University of Sydney; Australia and Bela Schwartz Foundation	Australian Research Council(Australian Research Council); Ramaciotti Foundation; New South Wales Dental Board; University of Sydney(University of Sydney); Australia and Bela Schwartz Foundation	This work was supported by Grant LP0562660 from the Australian Research Council (to N. H.) and Establishment Grant RN38/08 from the Ramaciotti Foundation (to K.-A. N.).; Supported by Ph.D. scholarship from the New South Wales Dental Board, Australia and Bela Schwartz Foundation, and the University of Sydney.	AduseOpoku J, 1997, J BACTERIOL, V179, P4778, DOI 10.1128/jb.179.15.4778-4788.1997; Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08; Anaya-Bergman C, 2010, INFECT IMMUN, V78, P688, DOI 10.1128/IAI.00108-09; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; BRAMANTI TE, 1992, MICROB PATHOGENESIS, V13, P61, DOI 10.1016/0882-4010(92)90032-J; BRAMANTI TE, 1993, J PERIODONTAL RES, V28, P464, DOI 10.1111/j.1600-0765.1993.tb02103.x; Caldwell RB, 2004, APPL ENVIRON MICROB, V70, P610, DOI 10.1128/AEM.70.1.610-612.2004; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; COPE LD, 1994, MOL MICROBIOL, V13, P863, DOI 10.1111/j.1365-2958.1994.tb00478.x; Crosson S, 2005, P NATL ACAD SCI USA, V102, P8018, DOI 10.1073/pnas.0503022102; Czjzek M, 2007, J MOL BIOL, V365, P1176, DOI 10.1016/j.jmb.2006.10.063; Dashper SG, 2000, J BACTERIOL, V182, P6456, DOI 10.1128/JB.182.22.6456-6462.2000; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Fujise O, 2006, J PERIODONTOL, V77, P1333, DOI 10.1902/jop.2006.050225; Ghosh K, 2005, BIOCHEMISTRY-US, V44, P16729, DOI 10.1021/bi0511585; Gibson FC, 2008, FRONT BIOSCI-LANDMRK, V13, P2041, DOI 10.2741/2822; HANSON MS, 1992, P NATL ACAD SCI USA, V89, P1973, DOI 10.1073/pnas.89.5.1973; HANSON MS, 1992, INFECT IMMUN, V60, P2257, DOI 10.1128/IAI.60.6.2257-2266.1992; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Liu XY, 2006, INFECT IMMUN, V74, P1222, DOI 10.1128/IAI.74.2.1222-1232.2006; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; Nguyen KA, 2004, INFECT IMMUN, V72, P1374, DOI 10.1128/IAI.72.3.1374-1382.2004; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Periasamy S, 2009, J BACTERIOL, V191, P6804, DOI 10.1128/JB.01006-09; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; Rungrassamee W, 2009, J BACTERIOL, V191, P6709, DOI 10.1128/JB.00932-09; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Shibata Y, 2003, BIOCHEM BIOPH RES CO, V300, P351, DOI 10.1016/S0006-291X(02)02826-7; SHIZUKUISHI S, 1995, FEMS MICROBIOL LETT, V131, P313; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Smalley JW, 2006, MICROBIOL-SGM, V152, P1839, DOI 10.1099/mic.0.28835-0; Smalley JW, 2008, BIOL CHEM, V389, P1235, DOI 10.1515/BC.2008.140; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; SMALLEY JW, 1993, J GEN MICROBIOL, V139, P2145, DOI 10.1099/00221287-139-9-2145; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Tompkins GR, 1997, J BACTERIOL, V179, P620, DOI 10.1128/jb.179.3.620-626.1997; Troese MJ, 2009, INFECT IMMUN, V77, P1746, DOI 10.1128/IAI.01530-08; Vermeiren CL, 2006, BIOCHEMISTRY-US, V45, P12867, DOI 10.1021/bi0607711; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984	61	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40028	40038		10.1074/jbc.M110.163535	http://dx.doi.org/10.1074/jbc.M110.163535			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940309	Green Published, hybrid			2022-12-27	WOS:000285185500048
J	Robbins, RD; Tersey, SA; Ogihara, T; Gupta, D; Farb, TB; Ficorilli, J; Bokvist, K; Maier, B; Mirmira, RG				Robbins, Reiesha D.; Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Farb, Thomas B.; Ficorilli, James; Bokvist, Krister; Maier, Bernhard; Mirmira, Raghavendra G.			Inhibition of Deoxyhypusine Synthase Enhances Islet beta Cell Function and Survival in the Setting of Endoplasmic Reticulum Stress and Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 5A; UNFOLDED PROTEIN RESPONSE; INSULIN-SECRETION; NUCLEAR EXPORT; MESSENGER-RNA; TRANSLATION INITIATION; ABDOMINAL OBESITY; MICE; INFLAMMATION; EXPRESSION	Islet beta cell dysfunction resulting from inflammation, ER stress, and oxidative stress is a key determinant in the progression from insulin resistance to type 2 diabetes mellitus. It was recently shown that the enzyme deoxyhypusine synthase (DHS) promotes early cytokine-induced inflammation in the beta cell. DHS catalyzes the conversion of lysine to hypusine, an amino acid that is unique to the translational elongation factor eIF5A. Here, we sought to determine whether DHS activity contributes to beta cell dysfunction in models of type 2 diabetes in mice and beta cell lines. A 2-week treatment of obese diabetic C57BLKS/J-db/db mice with the DHS inhibitor GC7 resulted in improved glucose tolerance, increased insulin release, and enhanced beta cell mass. Thapsigargin treatment of beta cells in vitro induces a picture of ER stress and apoptosis similar to that seen in db/db mice; in this setting, DHS inhibition led to a block in CHOP (CAAT/enhancer binding protein homologous protein) production despite >30-fold activation of Chop gene transcription. Blockage of CHOP translation resulted in reduction of downstream caspase-3 cleavage and near-complete protection of cells from apoptotic death. DHS inhibition appeared to prevent the cytoplasmic co-localization of eIF5A with the ER, possibly precluding the participation of eIF5A in translational elongation at ER-based ribosomes. We conclude that hypusination by DHS is required for the ongoing production of proteins, particularly CHOP, in response to ER stress in the beta cell.	[Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Tersey, Sarah A.; Ogihara, Takeshi; Gupta, Dhananjay; Maier, Bernhard; Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Robbins, Reiesha D.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22904 USA; [Farb, Thomas B.; Ficorilli, James; Bokvist, Krister] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Mirmira, Raghavendra G.] Indiana Univ, Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Virginia; Eli Lilly; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Maier, B (corresponding author), Indiana Univ, Sch Med, Dept Pediat, 635 Barnhill Dr,MS2021, Indianapolis, IN 46202 USA.	bfmaier@iupui.edu; rmirmira@iupui.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Tersey, Sarah/0000-0003-0667-2361	National Institutes of Health [R01 DK60581, F31 DK079420]; Ball Brothers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK079420, R01DK060581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball Brothers Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK60581 (to R. G. M.) and F31 DK079420 (to R. D. R.). This work was also supported by a grant from the Ball Brothers Foundation (to R.G.M.).	BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Bergman RN, 2007, AM J MED, V120, pS3, DOI 10.1016/j.amjmed.2006.11.012; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chatterjee I, 2006, MOL GENET GENOMICS, V275, P264, DOI 10.1007/s00438-005-0086-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Elfgang C, 1999, P NATL ACAD SCI USA, V96, P6229, DOI 10.1073/pnas.96.11.6229; Evans-Molina C, 2009, MOL CELL BIOL, V29, P2053, DOI 10.1128/MCB.01179-08; GOTOH M, 1990, HORM METAB RES, V25, P10; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hostens K, 1999, J CLIN INVEST, V104, P67, DOI 10.1172/JCI6438; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Laedtke T, 2000, AM J PHYSIOL-ENDOC M, V279, pE520, DOI 10.1152/ajpendo.2000.279.3.E520; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lebrun P, 2010, DIABETOLOGIA, V53, P1935, DOI 10.1007/s00125-010-1786-9; LEITER EH, 1981, DIABETES, V30, P30, DOI 10.2337/diabetes.30.1.30; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Lipowsky G, 2000, EMBO J, V19, P4362, DOI 10.1093/emboj/19.16.4362; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moore CC, 2008, J INFECT DIS, V198, P1407, DOI 10.1086/592222; Ogihara T, 2010, J DIABETES INVEST, V1, P123, DOI 10.1111/j.2040-1124.2010.00021.x; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; ROE MW, 1994, J BIOL CHEM, V269, P18279; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shao CL, 2010, J BIOL CHEM, V285, P19710, DOI 10.1074/jbc.M109.087486; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Umland TC, 2004, J BIOL CHEM, V279, P28697, DOI 10.1074/jbc.M404095200; Wolff EC, 2000, J BIOL CHEM, V275, P9170, DOI 10.1074/jbc.275.13.9170; Xu AG, 2001, J BIOL CHEM, V276, P2555, DOI 10.1074/jbc.M008982200; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	44	34	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39943	39952		10.1074/jbc.M110.170142	http://dx.doi.org/10.1074/jbc.M110.170142			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956533	hybrid, Green Published			2022-12-27	WOS:000285185500039
J	Noonan, J; Tanveer, R; Klompas, A; Gowran, A; McKiernan, J; Campbell, VA				Noonan, Janis; Tanveer, Riffat; Klompas, Allan; Gowran, Aoife; McKiernan, Joanne; Campbell, Veronica A.			Endocannabinoids Prevent beta-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CB1 CANNABINOID RECEPTORS; ALZHEIMERS-DISEASE; CELL-DEATH; CORTICAL-NEURONS; CATHEPSIN-D; MEMBRANE PERMEABILIZATION; MOUSE MODEL; OXIDATIVE-METABOLISM; INDUCED APOPTOSIS; NERVOUS-SYSTEM	Neuronal cell loss underlies the pathological decline in cognition and memory associated with Alzheimer disease (AD). Recently, targeting the endocannabinoid system in AD has emerged as a promising new approach to treatment. Studies have identified neuroprotective roles for endocannabinoids against key pathological events in the AD brain, including cell death by apoptosis. Elucidation of the apoptotic pathway evoked by beta-amyloid (A beta) is thus important for the development of therapeutic strategies that can thwart A beta toxicity and preserve cell viability. We have previously reported that lysosomal membrane permeabilization plays a distinct role in the apoptotic pathway initiated by A beta. In the present study, we provide evidence that the endocannabinoid system can stabilize lysosomes against A beta-induced permeabilization and in turn sustain cell survival. We report that endocannabinoids stabilize lysosomes by preventing the A beta-induced up-regulation of the tumor suppressor protein, p53, and its interaction with the lysosomal membrane. We also provide evidence that intracellular cannabinoid type 1 receptors play a role in stabilizing lysosomes against A beta toxicity and thus highlight the functionality of these receptors. Given the deleterious effect of lysosomal membrane permeabilization on cell viability, stabilization of lysosomes with endocannabinoids may represent a novel mechanism by which these lipid modulators confer neuroprotection.	[Campbell, Veronica A.] Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland; Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin	Campbell, VA (corresponding author), Trinity Coll Dublin, Dept Physiol, Sch Med, Dublin 2, Ireland.	vacmpbll@tcd.ie	Gowran, Aoife/K-6671-2016	Klompas, Allan/0000-0001-8852-4666	Health Research Board Ireland	Health Research Board Ireland	This work was supported by the Health Research Board Ireland.	Ahn K, 2002, TRAFFIC, V3, P147, DOI 10.1034/j.1600-0854.2002.030207.x; Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Benito C, 2003, J NEUROSCI, V23, P11136; Bidere N, 2003, J BIOL CHEM, V278, P31401, DOI 10.1074/jbc.M301911200; Boland B, 2003, NEUROBIOL AGING, V24, P179, DOI 10.1016/S0197-4580(02)00060-X; Boland B, 2004, NEUROBIOL AGING, V25, P83, DOI 10.1016/S0197-4580(03)00034-4; Bouaboula M, 2005, EUR J PHARMACOL, V517, P174, DOI 10.1016/j.ejphar.2005.05.032; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Campbell VA, 2007, BRIT J PHARMACOL, V152, P655, DOI 10.1038/sj.bjp.0707446; Campillo NE, 2009, MINI-REV MED CHEM, V9, P539, DOI 10.2174/138955709788167628; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Chen B, 2010, CURR ALZHEIMER RES, V7, P255, DOI 10.2174/156720510791050948; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Colak A, 2009, NEUROCIRUGIA, V20, P245; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734; Dinamarca MC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-4; Ditaranto K, 2001, NEUROBIOL DIS, V8, P19, DOI 10.1006/nbdi.2000.0364; Dodd GT, 2010, J NEUROSCI, V30, P7369, DOI 10.1523/JNEUROSCI.5455-09.2010; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Ehrhart J, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-29; Esposito G, 2006, J MOL MED, V84, P253, DOI 10.1007/s00109-005-0025-1; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Fowler CJ, 2010, EXP NEUROL, V224, P37, DOI 10.1016/j.expneurol.2010.03.021; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Gomes I, 2009, FASEB J, V23, P3020, DOI 10.1096/fj.09-132142; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Heimann AS, 2007, P NATL ACAD SCI USA, V104, P20588, DOI 10.1073/pnas.0706980105; Iuvone T, 2004, J NEUROCHEM, V89, P134, DOI 10.1111/j.1471-4159.2003.02327.x; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Joy B, 2010, MOL CARCINOGEN, V49, P324, DOI 10.1002/mc.20599; Kagedal K, 2005, INT J EXP PATHOL, V86, P309, DOI 10.1111/j.0959-9673.2005.00442.x; Karanian DA, 2005, EUR J PHARMACOL, V508, P47, DOI 10.1016/j.ejphar.2004.12.009; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Kozak KR, 2002, J BIOL CHEM, V277, P23278, DOI 10.1074/jbc.M201084200; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Li N, 2007, CANCER RES, V67, P11176, DOI 10.1158/0008-5472.CAN-07-2333; Liu Q, 2009, J PHARMACOL EXP THER, V331, P1062, DOI 10.1124/jpet.109.156216; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MACKIE K, 1995, J NEUROSCI, V15, P6552; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Mendiguren A, 2009, BRIT J PHARMACOL, V158, P1579, DOI 10.1111/j.1476-5381.2009.00434.x; Milton NGN, 2002, NEUROSCI LETT, V332, P127, DOI 10.1016/S0304-3940(02)00936-9; Mirnikjoo B, 2009, J BIOL CHEM, V284, P6918, DOI 10.1074/jbc.M805288200; NADLER V, 1993, NEUROSCI LETT, V162, P43, DOI 10.1016/0304-3940(93)90555-Y; Neumar RW, 2003, J BIOL CHEM, V278, P14162, DOI 10.1074/jbc.M212255200; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Palotas A, 2002, BRAIN RES BULL, V58, P203, DOI 10.1016/S0361-9230(02)00773-6; Pertwee RG, 2007, BRIT J PHARMACOL, V152, P984, DOI 10.1038/sj.bjp.0707464; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Roberg K, 2002, AM J PATHOL, V161, P89, DOI 10.1016/S0002-9440(10)64160-0; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Sagredo O, 2009, GLIA, V57, P1154, DOI 10.1002/glia.20838; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Shimohama S, 1999, BIOCHEM BIOPH RES CO, V256, P381, DOI 10.1006/bbrc.1999.0344; SMALE G, 1995, EXP NEUROL, V133, P225, DOI 10.1006/exnr.1995.1025; SU JH, 1994, NEUROREPORT, V5, P2529, DOI 10.1097/00001756-199412000-00031; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Van der Stelt M, 2006, CELL MOL LIFE SCI, V63, P1410, DOI 10.1007/s00018-006-6037-3; WESTLAKE TM, 1994, NEUROSCIENCE, V63, P637, DOI 10.1016/0306-4522(94)90511-8; Yacoub A, 2008, MOL CANCER THER, V7, P297, DOI 10.1158/1535-7163.MCT-07-2166; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Yang HW, 2008, MOL CELL NEUROSCI, V37, P682, DOI 10.1016/j.mcn.2007.12.019; Yap YW, 2006, J NEUROCHEM, V98, P1597, DOI 10.1111/j.1471-4159.2006.03996.x; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zheng L, 2006, NEUROSCI LETT, V394, P184, DOI 10.1016/j.neulet.2005.10.035; Zhuang SY, 2005, NEUROPHARMACOLOGY, V48, P1086, DOI 10.1016/j.neuropharm.2005.01.005	88	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38543	38554		10.1074/jbc.M110.162040	http://dx.doi.org/10.1074/jbc.M110.162040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923768	hybrid, Green Published			2022-12-27	WOS:000284625600060
J	Kazemi, Z; Chang, HN; Haserodt, S; McKen, C; Zachara, NE				Kazemi, Zahra; Chang, Hana; Haserodt, Sarah; McKen, Cathrine; Zachara, Natasha E.			O-Linked beta-N-acetylglucosamine (O-GlcNAc) Regulates Stress-induced Heat Shock Protein Expression in a GSK-3 beta-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE KINASE 3-BETA; ISCHEMIA-REPERFUSION INJURY; TARGETED GENE DISRUPTION; FACTOR-I EXPRESSION; RNA-POLYMERASE-II; NEONATAL CARDIOMYOCYTES; HEXOSAMINE BIOSYNTHESIS; MOLECULAR CHAPERONES; CYTOSOLIC PROTEINS; NUCLEOCYTOPLASMIC GLYCOSYLATION	To investigate the mechanisms by which O-linked beta-N-acetylglucosamine modification of nucleocytoplasmic proteins (O-GlcNAc) confers stress tolerance to multiple forms of cellular injury, we explored the role(s) of O-GlcNAc in the regulation of heat shock protein (HSP) expression. Using a cell line in which deletion of the O-GlcNAc transferase (OGT; the enzyme that adds O-GlcNAc) can be induced by 4-hydroxytamoxifen, we screened the expression of 84 HSPs using quantitative reverse transcriptase PCR. In OGT null cells the stress-induced expression of 18 molecular chaperones, including HSP72, were reduced. GSK-3 beta promotes apoptosis through numerous pathways, including phosphorylation of heat shock factor 1 (HSF1) at Ser(303) (Ser(P)(303) HSF1), which inactivates HSF1 and inhibits HSP expression. In OGT null cells we observed increased Ser(P)(303) HSF1; conversely, in cells in which O-GlcNAc levels had been elevated, reduced Ser(P)(303) HSF1 was detected. These data, combined with those showing that inhibition of GSK-3 beta in OGT null cells recovers HSP72 expression, suggests that O-GlcNAc regulates the activity of GSK-3 beta. In OGT null cells, stress-induced inactivation of GSK-3 beta by phosphorylation at Ser(9) was ablated providing a molecular basis for these findings. Together, these data suggest that stress-induced GlcNAcylation increases HSP expression through inhibition of GSK-3 beta	[Kazemi, Zahra; Chang, Hana; Haserodt, Sarah; McKen, Cathrine; Zachara, Natasha E.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Zachara, NE (corresponding author), 725 N Wolfe St, Baltimore, MD 21205 USA.	nzachara@jhmi.edu			American Heart Association [SDG 0930162N]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant SDG 0930162N (to N. E. Z.).	BECKER J, 1994, EUR J BIOCHEM, V219, P11, DOI 10.1111/j.1432-1033.1994.tb19910.x; Beurel E, 2006, PROG NEUROBIOL, V79, P173, DOI 10.1016/j.pneurobio.2006.07.006; Boglarka L, 2010, AM J PHYSIOL-HEART C, V299, pH1715, DOI 10.1152/ajpheart.00337.2010; Champattanachai V, 2008, AM J PHYSIOL-CELL PH, V294, pC1509, DOI 10.1152/ajpcell.00456.2007; Champattanachai V, 2007, AM J PHYSIOL-CELL PH, V292, pC178, DOI 10.1152/ajpcell.00162.2006; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Curi R, 2005, J CELL PHYSIOL, V204, P392, DOI 10.1002/jcp.20339; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dugo L, 2007, SHOCK, V27, P113, DOI 10.1097/01.shk.0000238059.23837.68; Eliasen MM, 2006, J MOL MED, V84, P147, DOI 10.1007/s00109-005-0004-6; Eom TY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-14; Farook VS, 2002, MOL GENET METAB, V77, P189, DOI 10.1016/S1096-7192(02)00127-0; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fulop N, 2007, AM J PHYSIOL-HEART C, V292, pH2227, DOI 10.1152/ajpheart.01091.2006; Fulop N, 2007, CARDIOVASC RES, V73, P288, DOI 10.1016/j.cardiores.2006.07.018; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart G. W., 1995, NIH CATALYST, V3, P8; Hartigan JA, 2001, BIOCHEM BIOPH RES CO, V284, P485, DOI 10.1006/bbrc.2001.4986; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; Hayashida N, 2006, EMBO J, V25, P4773, DOI 10.1038/sj.emboj.7601370; Heese-Peck A, 1998, PLANT CELL, V10, P599, DOI 10.1105/tpc.10.4.599; HEESEPECK A, 1995, PLANT CELL, V7, P1459, DOI 10.1105/tpc.7.9.1459; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Huang JB, 2007, CELL IMMUNOL, V245, P1, DOI 10.1016/j.cellimm.2007.03.006; Huang L, 2001, MOL CELL BIOL, V21, P8575, DOI 10.1128/MCB.21.24.8575-8591.2001; Imahori K, 1997, J BIOCHEM, V121, P179; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kannoji A, 2008, EXPERT OPIN THER TAR, V12, P1443, DOI 10.1517/14728222.12.11.1443 ; KEARSE KP, 1991, P NATL ACAD SCI USA, V88, P1701, DOI 10.1073/pnas.88.5.1701; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Konrad RJ, 2002, INT J MOL MED, V10, P535; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Laczy B, 2009, AM J PHYSIOL-HEART C, V296, pH13, DOI 10.1152/ajpheart.01056.2008; Lee SH, 2001, STROKE, V32, P2905, DOI 10.1161/hs1201.099604; Lefebvre T, 1999, BBA-GEN SUBJECTS, V1472, P71, DOI 10.1016/S0304-4165(99)00105-1; Lefebvre T, 2004, J CELL BIOCHEM, V93, P999, DOI 10.1002/jcb.20242; Lim KH, 2006, FEBS LETT, V580, P4645, DOI 10.1016/j.febslet.2006.07.040; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Majumdar G, 2003, AM J PHYSIOL-ENDOC M, V285, pE584, DOI 10.1152/ajpendo.00140.2003; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Miura T, 2009, CIRC J, V73, P1184, DOI 10.1253/circj.CJ-09-0284; Morrison AL, 2006, AM J PHYSIOL-CELL PH, V290, pC1625, DOI 10.1152/ajpcell.00635.2005; Musicki B, 2005, P NATL ACAD SCI USA, V102, P11870, DOI 10.1073/pnas.0502488102; Nagy T, 2006, AM J PHYSIOL-CELL PH, V290, pC57, DOI 10.1152/ajpcell.00263.2005; Ngoh GA, 2008, J PHARMACOL EXP THER, V327, P602, DOI 10.1124/jpet.108.143263; Ngoh GA, 2008, J MOL CELL CARDIOL, V45, P313, DOI 10.1016/j.yjmcc.2008.04.009; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Nollen EAA, 2002, J CELL SCI, V115, P2809; Not L. G., 2010, CRIT CARE MED, V38, P562; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Oh KH, 2004, TRANSPL IMMUNOL, V13, P273, DOI 10.1016/j.trim.2004.08.003; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Park SY, 2005, EXP MOL MED, V37, P220, DOI 10.1038/emm.2005.30; Peng ZY, 2006, JPEN-PARENTER ENTER, V30, P373, DOI 10.1177/0148607106030005373; Peng ZY, 2006, JPEN-PARENTER ENTER, V30, P400, DOI 10.1177/0148607106030005400; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Santoro M G, 1996, EXS, V77, P337; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shim EH, 2002, EMBO REP, V3, P857, DOI 10.1093/embo-reports/kvf175; Singleton KD, 2008, JPEN-PARENTER ENTER, V32, P371, DOI 10.1177/0148607108320661; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2002, BBA-GEN SUBJECTS, V1573, P121, DOI 10.1016/S0304-4165(02)00369-0; Slawson C, 2008, MOL BIOL CELL, V19, P4130, DOI 10.1091/mbc.E07-11-1146; Soesanto YA, 2008, AM J PHYSIOL-ENDOC M, V295, pE974, DOI 10.1152/ajpendo.90366.2008; Sohn KC, 2004, BIOCHEM BIOPH RES CO, V322, P1045, DOI 10.1016/j.bbrc.2004.08.023; Tannour-Louet M, 2002, HEPATOLOGY, V35, P1072, DOI 10.1053/jhep.2002.33164; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wang XZ, 2004, J BIOL CHEM, V279, P49460, DOI 10.1074/jbc.M406059200; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, J BIOL CHEM, V277, P1755, DOI 10.1074/jbc.M109656200; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Xavier IJ, 2000, J BIOL CHEM, V275, P29147, DOI 10.1074/jbc.M002169200; Xi JK, 2009, EUR J PHARMACOL, V604, P111, DOI 10.1016/j.ejphar.2008.12.024; Yang SL, 2006, SHOCK, V25, P600, DOI 10.1097/01.shk.0000209563.07693.db; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zou LY, 2009, AM J PHYSIOL-HEART C, V296, pH515, DOI 10.1152/ajpheart.01025.2008	106	115	116	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39096	39107		10.1074/jbc.M110.131102	http://dx.doi.org/10.1074/jbc.M110.131102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926391	Green Published, hybrid			2022-12-27	WOS:000284941300040
J	Burschowsky, D; Rudolf, F; Rabut, G; Herrmann, T; Matthias, P; Wider, G				Burschowsky, Daniel; Rudolf, Fabian; Rabut, Gwenael; Herrmann, Torsten; Matthias, Peter; Wider, Gerhard			Structural Analysis of the Conserved Ubiquitin-binding Motifs (UBMs) of the Translesion Polymerase iota in Complex with Ubiquitin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; NMR STRUCTURE DETERMINATION; TORSION ANGLE DYNAMICS; DNA-DAMAGE TOLERANCE; POLYUBIQUITIN CHAINS; UBA DOMAIN; PROTEIN; RECOGNITION; REV1; DETERMINANTS	Ubiquitin-binding domains (UBDs) provide specificity to the ubiquitin system, which is also involved in translesion synthesis (TLS) in eukaryotic cells. Upon DNA damage, the UBDs (UBM domains) of polymerase iota (Pol iota) interact with ubiquitinated proliferating cell nuclear antigen to regulate the interchange between processive DNA polymerases and TLS. We report a biophysical analysis and solution structures of the two conserved UBM domains located in the C-terminal tail of murine Pol iota in complex with ubiquitin. The 35-amino acid core folds into a helix-turn-helix motif, which belongs to a novel domain fold. Similar to other UBDs, UBMs bind to ubiquitin on the hydrophobic surface delineated by Leu-8, Ile-44, and Val-70, however, slightly shifted toward the C terminus. In addition, UBMs also use electrostatic interactions to stabilize binding. NMR and fluorescence spectroscopy measurements revealed that UBMs bind monoubiquitin, and Lys-63-but not Lys-48-linked chains. Importantly, these biophysical data are supported by functional studies. Indeed, yeast cells expressing ubiquitin mutants specifically defective for UBM binding are viable but sensitive to DNA damaging conditions that require TLS for repair.	[Rudolf, Fabian; Rabut, Gwenael; Matthias, Peter] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Burschowsky, Daniel; Wider, Gerhard] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Rudolf, Fabian; Matthias, Peter] Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Herrmann, Torsten] Univ Lyon, CNRS ENS Lyon UCB, Ctr Europeen RMN Tres Hauts Champs, F-69100 Villeurbanne, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ecole Normale Superieure de Lyon (ENS de LYON)	Matthias, P (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	matthias.peter@bc.biol.ethz.ch; gsw@mol.biol.ethz.ch	Rabut, Gwenaël/E-7257-2011; Herrmann, Torsten/B-9978-2008	Rabut, Gwenaël/0000-0003-2658-2769; Burschowsky, Daniel/0000-0002-7782-5508; Herrmann, Torsten/0000-0003-2115-4781; Wider, Gerhard/0000-0001-9366-7645; Peter, Matthias/0000-0002-2160-6824	Swiss National Science Foundation; Oncosuisse; INSERM; ETH Zurich [TH-42/04-2, TH-3307-3]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ETH Zurich(ETH Zurich)	This work was supported by grants from the Swiss National Science Foundation, Oncosuisse, INSERM (to G. R.), and the ETH Zurich (TH-42/04-2 and TH-3307-3).	BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Bomar MG, 2010, MOL CELL, V37, P408, DOI 10.1016/j.molcel.2009.12.038; Case D. A., 2006, AMBER9; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Groemping Y., 2005, CURR PROTOC PROTEIN, V39, P202821; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2009, CELL MOL LIFE SCI, V66, P2363, DOI 10.1007/s00018-009-0024-4; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Lehmann AR, 2006, DNA REPAIR, V5, P404, DOI 10.1016/j.dnarep.2005.12.005; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sato Y, 2009, EMBO J, V28, P3903, DOI 10.1038/emboj.2009.345; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vermeulen W, 2004, PROTEIN SCI, V13, P1276, DOI 10.1110/ps.03518104; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yin LM, 2006, ISR J CHEM, V46, P159, DOI 10.1560/46F8-EDWB-6QXP-CB14; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	55	32	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1364	1373		10.1074/jbc.M110.135038	http://dx.doi.org/10.1074/jbc.M110.135038			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20929865	Green Published, hybrid			2022-12-27	WOS:000286005000048
J	Moore, F; Naamane, N; Colli, ML; Bouckenooghe, T; Ortis, F; Gurzov, EN; Igoillo-Esteve, M; Mathieu, C; Bontempi, G; Thykjaer, T; Orntoft, TF; Eizirik, DL				Moore, Fabrice; Naamane, Najib; Colli, Maikel L.; Bouckenooghe, Thomas; Ortis, Fernanda; Gurzov, Esteban N.; Igoillo-Esteve, Mariana; Mathieu, Chantal; Bontempi, Gianluca; Thykjaer, Thomas; Orntoft, Torben F.; Eizirik, Decio L.			STAT1 Is a Master Regulator of Pancreatic beta-Cell Apoptosis and Islet Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; INSULIN-PRODUCING CELLS; IFN-GAMMA; DIABETES-MELLITUS; SIGNAL TRANSDUCER; INDUCED GENES; DEATH; TYPE-1; EXPRESSION; ACTIVATION	Cytokines produced by islet-infiltrating immune cells induce beta-cell apoptosis in type 1 diabetes. The IFN-gamma-regulated transcription factors STAT1/IRF-1 have apparently divergent effects on beta-cells. Thus, STAT1 promotes apoptosis and inflammation, whereas IRF-1 down-regulates inflammatory mediators. To understand the molecular basis for these differential outcomes within a single signal transduction pathway, we presently characterized the gene networks regulated by STAT1 and IRF-1 in beta-cells. This was done by using siRNA approaches coupled to microarray analysis of insulin-producing cells exposed or not to IL-1 beta and IFN-gamma. Relevant microarray findings were further studied in INS-1E cells and primary rat beta-cells. STAT1, but not IRF-1, mediates the cytokine-induced loss of the differentiated beta-cell phenotype, as indicated by decreased insulin, Pdx1, MafA, and Glut2. Furthermore, STAT1 regulates cytokine-induced apoptosis via up-regulation of the proapoptotic protein DP5. STAT1 and IRF-1 have opposite effects on cytokine-induced chemokine production, with IRF-1 exerting negative feedback inhibition on STAT1 and downstream chemokine expression. The present study elucidates the transcriptional networks through which the IFN-gamma/STAT1/IRF-1 axis controls beta-cell function/differentiation, demise, and islet inflammation.	[Moore, Fabrice; Naamane, Najib; Colli, Maikel L.; Bouckenooghe, Thomas; Ortis, Fernanda; Gurzov, Esteban N.; Igoillo-Esteve, Mariana; Eizirik, Decio L.] Univ Libre Bruxelles, Expt Med Lab, B-1070 Brussels, Belgium; [Bontempi, Gianluca] Univ Libre Bruxelles, Machine Learning Grp, B-1070 Brussels, Belgium; [Mathieu, Chantal] Katholieke Univ Leuven, LEGENDO, B-3000 Louvain, Belgium; [Thykjaer, Thomas; Orntoft, Torben F.] CMO Aros Appl Biotechnol AS, Aarhus, Denmark; [Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark	Universite Libre de Bruxelles; Universite Libre de Bruxelles; KU Leuven; Aarhus University	Moore, F (corresponding author), Univ Libre Bruxelles, Expt Med Lab, Route Lennik 808,CP618, B-1070 Brussels, Belgium.	fmoore@ulb.ac.be	Bontempi, Gianluca/J-7121-2012; mathieu, chantal/ABD-5505-2021; Ortis, Fernanda/K-7917-2014; Bontempi, Gianluca/ABE-4365-2020; Ortis, Fernanda/M-7190-2019	Bontempi, Gianluca/0000-0001-8621-316X; mathieu, chantal/0000-0002-4055-5233; Bontempi, Gianluca/0000-0001-8621-316X; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839	Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium; Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union (NAIMIT) [Health F22009-241447]; Fonds National de la Recherche Scientifique, Belgium; European Molecular Biology Organization; Belgian government [IUAP P6/40]	Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium(Fonds de la Recherche Scientifique - FNRS); Communaute Francaise de Belgique (Actions de Recherche Concertees); European Union (NAIMIT)(European Commission); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Belgian government	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS-FRSM) Belgium, the Communaute Francaise de Belgique (Actions de Recherche Concertees), the European Union (NAIMIT, Health F22009-241447; in the Framework Programme 7 of the European Community) and the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian government (IUAP P6/40).; Recipient of a postdoctoral fellowship from Fonds National de la Recherche Scientifique, Belgium. To whom correspondence should be addressed: Laboratory of Experimental Medicine, Universite Libre de Bruxelles, Route de Lennik, 808, CP618, B-1070 Brussels, Belgium. E-mail: fmoore@ulb.ac.be.; Supported by a long term fellowship from the European Molecular Biology Organization.	Allagnat F, 2010, DIABETOLOGIA, V53, P1120, DOI 10.1007/s00125-010-1699-7; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Callewaert HI, 2007, DIABETES, V56, P2169, DOI 10.2337/db07-0052; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cardozo AK, 2001, DIABETES, V50, P909, DOI 10.2337/diabetes.50.5.909; Chong MMW, 2004, J IMMUNOL, V172, P5714, DOI 10.4049/jimmunol.172.9.5714; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Darville MI, 2006, BIOCHEM BIOPH RES CO, V339, P1063, DOI 10.1016/j.bbrc.2005.11.111; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Flodstrom-Tullberg M, 2003, DIABETES, V52, P2696, DOI 10.2337/diabetes.52.11.2696; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Gysemans C, 2009, DIABETOLOGIA, V52, P2374, DOI 10.1007/s00125-009-1514-5; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Gysemans C, 2008, BIOCHEM SOC T, V36, P328, DOI 10.1042/BST0360328; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Imaizumi K, 2004, J NEUROSCI, V24, P3721, DOI 10.1523/JNEUROSCI.5101-03.2004; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanazawa K, 1998, MOL BRAIN RES, V54, P316, DOI 10.1016/S0169-328X(97)00360-4; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Kim S, 2007, DIABETES, V56, P2561, DOI 10.2337/db06-1372; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Liu L, 2001, BRIT J PHARMACOL, V134, P1629, DOI 10.1038/sj.bjp.0704404; Ma C, 2007, J BIOL CHEM, V282, P30901, DOI 10.1074/jbc.M608694200; Magnusson NE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-311; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Ortis F, 2008, DIABETOLOGIA, V51, P1213, DOI 10.1007/s00125-008-0999-7; Ortis F, 2006, MOL ENDOCRINOL, V20, P1867, DOI 10.1210/me.2005-0268; Ortis F, 2010, DIABETES, V59, P358, DOI 10.2337/db09-1159; Perez-Arana G, 2010, ENDOCRINOLOGY, V151, P2538, DOI 10.1210/en.2009-1113; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Saito H, 2000, J IMMUNOL, V164, P5833, DOI 10.4049/jimmunol.164.11.5833; SIBLEY RK, 1985, LAB INVEST, V53, P132; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tajima K, 2010, J ORTHOP RES, V28, P937, DOI 10.1002/jor.21086; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	50	125	127	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					929	941		10.1074/jbc.M110.162131	http://dx.doi.org/10.1074/jbc.M110.162131			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20980260	Green Published, hybrid			2022-12-27	WOS:000286005000004
J	Mekler, V; Pavlova, O; Severinov, K				Mekler, Vladimir; Pavlova, Olga; Severinov, Konstantin			Interaction of Escherichia coli RNA Polymerase sigma(70) Subunit with Promoter Elements in the Context of Free sigma(70), RNA Polymerase Holoenzyme, and the beta '-sigma(70) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRANDED-DNA BUBBLE; NONTEMPLATE STRAND; BETA' SUBUNIT; TRANSCRIPTION INITIATION; STRUCTURAL ORGANIZATION; CRYSTAL-STRUCTURE; BINDING; RECOGNITION; REGION; SIGMA-70	Promoter recognition by RNA polymerase is a key point in gene expression and a target of regulation. Bacterial RNA polymerase binds promoters in the form of the holoenzyme, with the sigma specificity subunit being primarily responsible for promoter recognition. Free sigma, however, does not recognize promoter DNA, and it has been proposed that the intrinsic DNA binding ability is masked in free sigma but becomes unmasked in the holoenzyme. Here, we use a newly developed fluorescent assay to quantitatively study the interactions of free sigma 70 from Escherichia coli, the beta '-sigma complex, and the sigma(70) RNA polymerase (RNAP) holoenzyme with non-template strand of the open promoter complex transcription bubble in the context of model non-template oligonucleotides and fork junction templates. We show that sigma(70), free or in the context of the holoenzyme, recognizes the - 10 promoter element with the same efficiency and specificity. The result implies that there is no need to invoke a conformational change in sigma for recognition of the - 10 element in the single-stranded form. In the holoenzyme, weak but specific interactions of sigma are increased by contacts with DNA downstream of the - 10 element. We further show that region 1 of sigma(70) is required for stronger interaction with non-template oligonucleotides in the holoenzyme but not in free sigma. Finally, we show that binding of the beta ' RNAP subunit is sufficient to allow specific recognition of the TG motif of the extended - 10 promoter element by sigma(70). The new fluorescent assay, which we call a protein beacon assay, will be instrumental in quantitative dissection of fine details of RNAP interactions with promoters.	[Mekler, Vladimir; Pavlova, Olga; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet & Gene Biol, Moscow 119334, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Mekler, V (corresponding author), Rutgers State Univ, Waksman Inst, 190 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu	Severinov, Konstantin/C-8545-2016		National Institutes of Health [R01 GM64530]; Charles and Johanna Busch postdoctoral fellowship; Russian Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Johanna Busch postdoctoral fellowship; Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64530 (to K. S.). This work was also supported by a Charles and Johanna Busch postdoctoral fellowship (to O. P.) and Russian Academy of Sciences Presidium Program in Molecular and Cellular Biology (to K. S.).	Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; Auner H, 2003, J MOL BIOL, V331, P331, DOI 10.1016/S0022-2836(03)00727-7; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Callaci S, 1999, MOL CELL, V3, P229, DOI 10.1016/S1097-2765(00)80313-5; Callaci S, 1998, BIOCHEMISTRY-US, V37, P3312, DOI 10.1021/bi972041m; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; DeHaseth PL, 2003, METHOD ENZYMOL, V370, P553; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Doose S, 2005, CHEMPHYSCHEM, V6, P2277, DOI 10.1002/cphc.200500191; Feklistov A, 2008, P NATL ACAD SCI USA, V105, P14820, DOI 10.1073/pnas.0802822105; Feklistov A, 2006, MOL CELL, V23, P97, DOI 10.1016/j.molcel.2006.06.010; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; Fenton MS, 2003, J BIOL CHEM, V278, P39669, DOI 10.1074/jbc.M307412200; Figueroa-Bossi N, 1998, EMBO J, V17, P2359, DOI 10.1093/emboj/17.8.2359; Gries TJ, 2010, P NATL ACAD SCI USA, V107, P10418, DOI 10.1073/pnas.1000967107; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; Kulbachinskiy A, 1999, FEBS LETT, V454, P71, DOI 10.1016/S0014-5793(99)00778-4; Kuznedelov K, 2002, SCIENCE, V295, P855, DOI 10.1126/science.1066303; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Matlock DL, 2000, BIOCHEMISTRY-US, V39, P12274, DOI 10.1021/bi001433h; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Nickels BE, 2005, P NATL ACAD SCI USA, V102, P4488, DOI 10.1073/pnas.0409850102; Oh KJ, 2007, BIOCONJUGATE CHEM, V18, P607, DOI 10.1021/bc060319u; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Roberts CW, 1996, CELL, V86, P495; Rogozina A, 2009, NUCLEIC ACIDS RES, V37, P5390, DOI 10.1093/nar/gkp560; Schroeder LA, 2009, J MOL BIOL, V385, P339, DOI 10.1016/j.jmb.2008.10.023; Sun L, 2004, J MOL BIOL, V343, P1171, DOI 10.1016/j.jmb.2004.09.025; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zaychikov E, 1997, J BIOL CHEM, V272, P2259; Zenkin N, 2007, EMBO J, V26, P955, DOI 10.1038/sj.emboj.7601555	48	28	29	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					270	279		10.1074/jbc.M110.174102	http://dx.doi.org/10.1074/jbc.M110.174102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20952386	Green Published, hybrid			2022-12-27	WOS:000285782800030
J	Akiyama, H; Kamiguchi, H				Akiyama, Hiroki; Kamiguchi, Hiroyuki			Phosphatidylinositol 3-Kinase Facilitates Microtubule-dependent Membrane Transport for Neuronal Growth Cone Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; ADENOMATOUS POLYPOSIS-COLI; NERVE GROWTH; AXON GUIDANCE; TRPC CHANNELS; PROTEIN; CALCIUM; BINDING; PHOSPHATASE; ACTIVATION	The activity of PI3K is necessary for polarized cell motility. To guide extending axons, environmental cues polarize the growth cone via asymmetric generation of Ca2+ signals and subsequent intracellular mechanical events, including membrane trafficking and cytoskeletal reorganization. However, it remains unclear how PI3K is involved in such events for axon guidance. Here, we demonstrate that PI3K plays a permissive role in growth cone turning by facilitating microtubule (MT)dependent membrane transport. Using embryonic chick dorsal root ganglion neurons in culture, attractive axon turning was induced by Ca2+ elevations on one side of the growth cone by photolyzing caged Ca2+ or caged inositol 1,4,5-trisphosphate. We show that PI3K activity was required downstream of Ca2+ signals for growth cone turning. Attractive Ca2+ signals, generated with caged Ca2+ or caged inositol 1,4,5-trisphosphate, triggered asymmetric transport of membrane vesicles from the center to the periphery of growth cones in a MT-dependent manner. This centrifugal vesicle transport was abolished by PI3K inhibitors, suggesting that PI3K is involved in growth cone attraction at the level of membrane trafficking. Consistent with this observation, immunocytochemistry showed that PI3K inhibitors reduced MTs in the growth cone peripheral domain. Time-lapse imaging of EB1 on the plus-end of MTs revealed that MT advance into the growth cone peripheral domain was dependent on PI3K activity: inhibition of the PI3K signaling pathway attenuated MT advance, whereas exogenous phosphatidylinositol 3,4,5-trisphosphate, the product of PI3K-catalyzed reactions, promoted MT advance. This study demonstrates the importance of PI3K-dependent membrane trafficking in chemotactic cell migration.	[Akiyama, Hiroki; Kamiguchi, Hiroyuki] RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, Wako, Saitama 3510198, Japan	RIKEN	Kamiguchi, H (corresponding author), RIKEN Brain Sci Inst, Lab Neuronal Growth Mech, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kamiguchi@brain.riken.jp	Kamiguchi, Hiroyuki/N-5409-2015	Kamiguchi, Hiroyuki/0000-0003-1802-6324				Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akiyama H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000196; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dunn GA, 1997, J CELL SCI, V110, P3091; FORCE T, 2007, SCI STKE, pPE41, DOI DOI 10.1126/STKE.3972007PE41; Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Kollins KM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-26; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Medeiros NA, 2006, NAT CELL BIOL, V8, P215, DOI 10.1038/ncb1367; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Nishiyama M, 2008, NAT NEUROSCI, V11, P762, DOI 10.1038/nn.2130; Ooashi N, 2005, J CELL BIOL, V170, P1159, DOI 10.1083/jcb.200503157; Orlova I, 2007, DEV NEUROBIOL, V67, P1843, DOI 10.1002/dneu.20558; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shim S, 2005, NAT NEUROSCI, V8, P730, DOI 10.1038/nn1459; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Takeda K, 2007, J BIOL CHEM, V282, P11874, DOI 10.1074/jbc.M610984200; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Tojima T, 2007, NAT NEUROSCI, V10, P58, DOI 10.1038/nn1814; Tojima T, 2010, NEURON, V66, P370, DOI 10.1016/j.neuron.2010.04.007; Tojima T, 2009, J NEUROSCI, V29, P7886, DOI 10.1523/JNEUROSCI.0087-09.2009; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Veale EL, 2010, J BIOL CHEM, V285, P29295, DOI 10.1074/jbc.M110.108423; von Philipsborn A, 2007, INT REV CYTOL, V263, P1, DOI 10.1016/S0074-7696(07)63001-0; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Wolf AM, 2008, J NEUROSCI, V28, P3456, DOI 10.1523/JNEUROSCI.0029-08.2008; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	58	34	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41740	41748		10.1074/jbc.M110.156489	http://dx.doi.org/10.1074/jbc.M110.156489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041312	Green Published, hybrid			2022-12-27	WOS:000285622600061
J	Eken, C; Martin, PJ; Sadallah, S; Treves, S; Schaller, M; Schifferli, JA				Eken, Ceylan; Martin, Perrine J.; Sadallah, Salima; Treves, Susan; Schaller, Monica; Schifferli, Juerg A.			Ectosomes Released by Polymorphonuclear Neutrophils Induce a MerTK-dependent Anti-inflammatory Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; APOPTOTIC CELLS; DENDRITIC CELLS; TYROSINE KINASE; TYRO-3 FAMILY; RESPONSES; RECOGNITION; RECEPTORS; MEDIATORS; MICROPARTICLES	At the earliest stage of activation, human polymorphonuclear neutrophils release vesicles derived directly from the cell surface. These vesicles, called ectosomes (PMN-Ect), expose phosphatidylserine in the outer membrane leaflet. They inhibit the inflammatory response of human monocyte-derived macrophages and dendritic cells to zymosan A (ZymA) and LPS and induce TGF-beta 1 release, suggesting a reprogramming toward a tolerogenic phenotype. The receptors and signaling pathways involved have not yet been defined. Here, we demonstrate that PMN-Ect interfered with ZymA activation of macrophages via inhibition of NF kappa B p65 phosphorylation and NF kappa B translocation. The MerTK (Mer receptor tyrosine kinase) and PI3K/Akt pathways played a key role in this immunomodulatory effect as shown using specific MerTK-blocking antibodies and PI3K inhibitors LY294002 and wortmannin. As a result, PMN-Ect reduced the transcription of many proinflammatory genes in ZymA-activated macrophages. In sum, PMN-Ect interacted with the macrophages by activation of the MerTK pathway responsible for down-modulation of the proinflammatory signals generated by ZymA.	[Eken, Ceylan; Martin, Perrine J.; Sadallah, Salima; Schifferli, Juerg A.] Univ Basel Hosp, Immunonephrol Lab, CH-4031 Basel, Switzerland; [Schaller, Monica] Univ Basel Hosp, Clin Immunol Lab, Dept Biomed, CH-4031 Basel, Switzerland; [Schaller, Monica] Univ Basel Hosp, Clin Immunol Lab, Dept Med, CH-4031 Basel, Switzerland; [Treves, Susan] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Eken, C (corresponding author), Univ Basel Hosp, Immunonephrol Lab, CH-4031 Basel, Switzerland.	ceylan.eken@unibas.ch	Poubelle, Patrice E/G-6537-2013	Treves, Susan/0000-0002-0007-9631; Schaller, Monica/0000-0002-5002-2238; Eken, Ceylan/0000-0002-9172-6581; Martin, Perrine/0000-0003-4439-5078	Swiss National Science Foundation [32000-116839]; Roche Foundation for Anemia Research (RoFAR); Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Nora van Meeuwen Stiftung	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Foundation for Anemia Research (RoFAR); Fondazione per la Ricerca sulla Trasfusione e sui Trapianti; Nora van Meeuwen Stiftung	This work was supported by Swiss National Science Foundation Grant 32000-116839, the Roche Foundation for Anemia Research (RoFAR), the Fondazione per la Ricerca sulla Trasfusione e sui Trapianti, and the Nora van Meeuwen Stiftung.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bowers-Morrow VM, 2004, BIOL REV, V79, P611, DOI 10.1017/S1464793103006389; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Gasser O, 2003, EXP CELL RES, V285, P243, DOI 10.1016/S0014-4827(03)00055-7; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Hess C, 1999, J IMMUNOL, V163, P4564; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Koppler B, 2006, EUR J IMMUNOL, V36, P648, DOI 10.1002/eji.200535435; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; McDonald PP, 1999, J IMMUNOL, V163, P6164; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Pawson T, 2000, GENE DEV, V14, P1027; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003	35	95	97	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39914	39921		10.1074/jbc.M110.126748	http://dx.doi.org/10.1074/jbc.M110.126748			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959443	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000285185500036
J	Gohl, C; Banovic, D; Grevelhorster, A; Bogdan, S				Gohl, Christina; Banovic, Daniel; Grevelhoerster, Astrid; Bogdan, Sven			WAVE Forms Hetero- and Homo-oligomeric Complexes at Integrin Junctions in Drosophila Visualized by Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTIONS; BIFC ANALYSIS; IN-SITU; ACTIN; KETTE; WASP; ABI; INTERACTS; SCAR/WAVE; SYSTEM	Dynamic actin polymerization drives a variety of morphogenetic events during metazoan development. Members of the WASP/WAVE protein family are central nucleation-promoting factors. They are embedded within regulatory networks of macromolecular complexes controlling Arp2/3-mediated actin nucleation in time and space. WAVE (Wiskott-Aldrich syndrome protein family verprolin-homologous protein) proteins are found in a conserved pentameric heterocomplex that contains Abi, Kette/Nap1, Sra-1/CYFIP, and HSPC300. Formation of the WAVE complex contributes to the localization, activity, and stability of the various WAVE proteins. Here, we established the Bimolecular Fluorescence Complementation (BiFC) technique in Drosophila to determine the subcellular localization of the WAVE complex in living flies. Using different split-YFP combinations, we are able to visualize the formation of the WAVE-Abi complex in vivo. We found that WAVE also forms dimers that are capable of forming higher order clusters with endogenous WAVE complex components. The N-terminal WAVE homology domain (WHD) of the WAVE protein mediates both WAVE-Abi and WAVE-WAVE interactions. Detailed localization analyses show that formation of WAVE complexes specifically takes place at basal cell compartments promoting actin polymerization. In the wing epithelium, hetero- and homooligomeric WAVE complexes co-localize with Integrin and Talin suggesting a role in integrin-mediated cell adhesion. RNAi mediated suppression of single components of the WAVE and the Arp2/3 complex in the wing further suggests that WAVE-dependent Arp2/3-mediated actin nucleation is important for the maintenance of stable integrin junctions.	[Gohl, Christina; Banovic, Daniel; Grevelhoerster, Astrid; Bogdan, Sven] Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Bogdan, S (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	sbogdan@uni-muenster.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants (to S.B.) from the Deutsche Forschungsgemeinschaft.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Bogdan S, 2003, DEVELOPMENT, V130, P4427, DOI 10.1242/dev.00663; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Cole KC, 2007, EUKARYOT CELL, V6, P378, DOI 10.1128/EC.00368-06; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fricke R, 2009, CURR BIOL, V19, P1429, DOI 10.1016/j.cub.2009.07.058; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HARTLEY JL, 2003, CURR PROTOC PROTEIN, pCH5; Hiatt SM, 2008, METHODS, V45, P185, DOI 10.1016/j.ymeth.2008.06.003; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin TY, 2009, DEVELOPMENT, V136, P3099, DOI 10.1242/dev.033324; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Robida AM, 2009, J MOL BIOL, V394, P391, DOI 10.1016/j.jmb.2009.08.069; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tayler TD, 2003, CURR OPIN NEUROBIOL, V13, P90, DOI 10.1016/S0959-4388(03)00004-7; Torgler CN, 2004, DEV CELL, V6, P357, DOI 10.1016/S1534-5807(04)00055-3; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Zallen JA, 2002, J CELL BIOL, V156, P689, DOI 10.1083/jcb.200109057	41	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40171	40179		10.1074/jbc.M110.139337	http://dx.doi.org/10.1074/jbc.M110.139337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937809	Green Published, hybrid			2022-12-27	WOS:000285185500062
J	Jong, WSP; ten Hagen-Jongman, CM; Ruijter, E; Orru, RVA; Genevaux, P; Luirink, J				Jong, Wouter S. P.; ten Hagen-Jongman, Corinne M.; Ruijter, Eelco; Orru, Romano V. A.; Genevaux, Pierre; Luirink, Joen			YidC Is Involved in the Biogenesis of the Secreted Autotransporter Hemoglobin Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI YIDC; MEMBRANE-PROTEIN; CYTOPLASMIC MEMBRANE; PERIPLASMIC DOMAIN; INNER MEMBRANE; TRIGGER FACTOR; DEPENDENT TRANSLOCATION; PRESECRETORY PROTEINS; CRYSTAL-STRUCTURE	Autotransporters (ATs) constitute an important family of virulence factors secreted by Gram-negative bacteria. Following their translocation across the inner membrane (IM), ATs temporarily reside in the periplasmic space after which they are secreted into the extracellular environment. Previous studies have shown that the AT hemoglobin protease (Hbp) of Escherichia coli requires a functional signal recognition particle pathway and Sec translocon for optimal targeting to and translocation across the IM. Here, we analyzed the mode of IM translocation of Hbp in more detail. Using site-directed photocross-linking, we found that the Hbp signal peptide is adjacent to YidC early during biogenesis. Notably, YidC is in part associated with the Sec translocon but has until now primarily been implicated in the biogenesis of IM proteins. In vivo, YidC appeared critical for the biogenesis of the ATs Hbp and EspC. For Hbp, depletion of YidC resulted in the formation of secretion-incompetent intermediates that were sensitive to degradation by the periplasmic protease DegP, indicating that YidC activity affects Hbp biogenesis at a late stage, after translocation across the IM. This is the first demonstration of a role for YidC in the biogenesis of an extracellular protein. We propose that YidC is required for maintenance of the translocation-competent state of certain ATs in the periplasm. The large periplasmic domain of YidC is not critical for this novel functionality as it can be deleted without affecting Hbp biogenesis.	[Jong, Wouter S. P.; ten Hagen-Jongman, Corinne M.; Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Ruijter, Eelco; Orru, Romano V. A.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, NL-1081 HV Amsterdam, Netherlands; [Genevaux, Pierre] Univ Toulouse 3, LMGM, CNRS, F-31062 Toulouse, France	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Luirink, J (corresponding author), Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Genevaux, Pierre/A-4851-2015; Ruijter, Eelco/A-7613-2011; Luirink, Joen/AAB-8658-2021	Jong, Wouter/0000-0002-4132-4605; Luirink, J./0000-0001-8431-0804; Jong, W.S.P./0000-0002-8907-6954; Orru, Romano V.A./0000-0003-1142-6798; Ruijter, Eelco/0000-0002-1105-3947; GENEVAUX, Pierre/0000-0001-7539-3126	Netherlands Organization for Scientific Research (NWO); FEBS	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); FEBS	This work was supported by an "ALW Open Program" grant from the Netherlands Organization for Scientific Research (NWO) and a FEBS short term fellowship (to W. S. P. J.).	Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; BRUNNER J, 1989, METHOD ENZYMOL, V172, P628; Chevalier N, 2004, J MOL MICROB BIOTECH, V8, P7, DOI 10.1159/000082076; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; Desvaux M, 2007, MICROBIOL-SGM, V153, P59, DOI 10.1099/mic.0.29091-0; Desvaux M, 2006, FEMS MICROBIOL LETT, V264, P22, DOI 10.1111/j.1574-6968.2006.00425.x; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Froderberg L, 2004, J BIOL CHEM, V279, P31026, DOI 10.1074/jbc.M403229200; Giacalone MJ, 2006, BIOTECHNIQUES, V40, P355, DOI 10.2144/000112112; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Houben ENG, 2004, EMBO REP, V5, P970, DOI 10.1038/sj.embor.7400261; Houben ENG, 2002, J BIOL CHEM, V277, P35880, DOI 10.1074/jbc.M205556200; Houben ENG, 2000, FEBS LETT, V476, P229, DOI 10.1016/S0014-5793(00)01735-X; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; Jong WSP, 2008, BIOCHEM BIOPH RES CO, V368, P522, DOI 10.1016/j.bbrc.2008.01.122; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; KUSTERS R, 1989, J BIOL CHEM, V264, P20827; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; Martoglio B, 1996, TRENDS CELL BIOL, V6, P142, DOI 10.1016/0962-8924(96)10001-5; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Oliver DC, 2008, J BIOL CHEM, V283, P5208, DOI 10.1074/jbc.M708936200; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Peterson JH, 2006, J BIOL CHEM, V281, P9038, DOI 10.1074/jbc.M508681200; Pop OI, 2009, FEBS J, V276, P4891, DOI 10.1111/j.1742-4658.2009.07188.x; Pradel N, 2005, BIOCHIMIE, V87, P191, DOI 10.1016/j.biochi.2004.11.001; Ravaud S, 2008, J BIOL CHEM, V283, P9350, DOI 10.1074/jbc.M710493200; Ruiz N, 2005, CURR OPIN MICROBIOL, V8, P122, DOI 10.1016/j.mib.2005.02.013; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Shimohata N, 2005, J BACTERIOL, V187, P3997, DOI 10.1128/JB.187.12.3997-4004.2005; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; Sijbrandi R, 2003, J BIOL CHEM, V278, P4654, DOI 10.1074/jbc.M211630200; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Ullers RS, 2006, J BIOL CHEM, V281, P13999, DOI 10.1074/jbc.M600638200; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van Bloois E, 2008, FEBS LETT, V582, P1419, DOI 10.1016/j.febslet.2008.02.082; van Bloois E, 2007, BIOCHEM BIOPH RES CO, V362, P727, DOI 10.1016/j.bbrc.2007.08.053; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; WAGNER S, 2008, J BIOL CHEM; Wang P, 2010, J BACTERIOL, V192, P2193, DOI 10.1128/JB.00484-09; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z	52	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39682	39690		10.1074/jbc.M110.167650	http://dx.doi.org/10.1074/jbc.M110.167650			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20959450	Green Published, hybrid			2022-12-27	WOS:000285185500012
J	Kitazume, S; Tachida, Y; Kato, M; Yamaguchi, Y; Honda, T; Hashimoto, Y; Wada, Y; Saito, T; Iwata, N; Saido, T; Taniguchi, N				Kitazume, Shinobu; Tachida, Yuriko; Kato, Masaki; Yamaguchi, Yoshiki; Honda, Takashi; Hashimoto, Yasuhiro; Wada, Yoshinao; Saito, Takashi; Iwata, Nobuhisa; Saido, Takaomi; Taniguchi, Naoyuki			Brain Endothelial Cells Produce Amyloid beta from Amyloid Precursor Protein 770 and Preferentially Secrete the O-Glycosylated Form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INHIBITOR DOMAIN; APP; ANGIOPATHY; ACID; CLEARANCE; CLEAVAGE; NEURONS; MATRIX; DIMER	Deposition of amyloid beta(A beta) in the brain is closely associated with Alzheimer disease (AD). A beta is generated from amyloid precursor protein (APP) by the actions of beta- and gamma-secretases. In addition to A beta deposition in the brain parenchyma, deposition of A beta in cerebral vessel walls, termed cerebral amyloid angiopathy, is observed in more than 80% of AD individuals. The mechanism for how A beta accumulates in blood vessels remains largely unknown. In the present study, we show that brain endothelial cells expressed APP770, a differently spliced APP mRNA isoform from neuronal APP695, and produced A beta 40 and A beta 42. Furthermore, we found that the endothelial APP770 had sialylated core 1 type O-glycans. Interestingly, O-glycosylated APP770 was preferentially processed by both alpha- and beta-cleavage and secreted into the media, suggesting that O-glycosylation and APP processing involved related pathways. By immunostaining human brain sections with an anti-APP770 antibody, we found that APP770 was expressed in vascular endothelial cells. Because we were able to detect O-glycosylated sAPP770 beta in human cerebrospinal fluid, this unique soluble APP770 beta has the potential to serve as a marker for cortical dementias such as AD and vascular dementia.	[Kitazume, Shinobu; Tachida, Yuriko; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Dis Glyc Team, Wako, Saitama 3510198, Japan; [Kato, Masaki; Yamaguchi, Yoshiki; Taniguchi, Naoyuki] RIKEN, Adv Sci Inst, Struct Glycobiol Team, Wako, Saitama 3510198, Japan; [Hashimoto, Yasuhiro] Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima 9601295, Japan; [Honda, Takashi] Fukushima Med Univ, Sch Nursing, Dept Human Life Sci, Fukushima 9601295, Japan; [Wada, Yoshinao] Osaka Med Ctr, Izumi 5941101, Japan; [Saito, Takashi; Iwata, Nobuhisa; Saido, Takaomi] RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Taniguchi, Naoyuki] Osaka Univ, Inst Sci & Ind Res, Dept Dis Glyc, Ibaraki, Osaka 5670047, Japan; [Wada, Yoshinao] Res Inst Maternal & Child Hlth, Izumi 5941101, Japan	RIKEN; RIKEN; Fukushima Medical University; Fukushima Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; RIKEN; Osaka University	Taniguchi, N (corresponding author), RIKEN, Adv Sci Inst, Dis Glyc Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tani52@wd5.so-net.ne.jp	Saido, Takaomi C/N-5472-2015; Yamaguchi, Yoshiki/N-5246-2015; Sado, Takaomi/AAN-2759-2021; Taniguchi, Naoyuki/A-7086-2016; Saito, Takashi/G-2563-2015; Taniguchi, Naoyuki/I-4182-2014	Saido, Takaomi C/0000-0003-1970-6903; Yamaguchi, Yoshiki/0000-0003-0100-5439; Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Taniguchi, Naoyuki/0000-0001-5889-5968	Systems Glycobiology research project; Ministry of Education, Science, Sports, and Culture of Japan [21570154]	Systems Glycobiology research project; Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Systems Glycobiology research project (to N.T.) and Grant 21570154 from the Ministry of Education, Science, Sports, and Culture of Japan (to S.K.).	AROETI B, 1994, EMBO J, V13, P2297, DOI 10.1002/j.1460-2075.1994.tb06513.x; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Dahms SO, 2010, P NATL ACAD SCI USA, V107, P5381, DOI 10.1073/pnas.0911326107; DE SB, 1999, NATURE, V398, P518; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Hama E, 2001, J BIOCHEM-TOKYO, V130, P721, DOI 10.1093/oxfordjournals.jbchem.a003040; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; HYNES TR, 1990, BIOCHEMISTRY-US, V29, P10018, DOI 10.1021/bi00495a002; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato Y, 1999, BBA-GEN SUBJECTS, V1472, P344, DOI 10.1016/S0304-4165(99)00140-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SMALL DH, 1992, J NEUROSCI, V12, P4143; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu F, 2005, P NATL ACAD SCI USA, V102, P18135, DOI 10.1073/pnas.0507798102; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	35	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40097	40103		10.1074/jbc.M110.144626	http://dx.doi.org/10.1074/jbc.M110.144626			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952385	Green Published, hybrid			2022-12-27	WOS:000285185500055
J	Kimura, T; Fukuda, T; Sahara, N; Yamashita, S; Murayama, M; Mizoroki, T; Yoshiike, Y; Lee, B; Sotiropoulos, I; Maeda, S; Takashima, A				Kimura, Tetsuya; Fukuda, Tetsuya; Sahara, Naruhiko; Yamashita, Shunji; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Lee, Boyoung; Sotiropoulos, Ioannis; Maeda, Sumihiro; Takashima, Akihiko			Aggregation of Detergent-insoluble Tau Is Involved in Neuronal Loss but Not in Synaptic Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROFIBRILLARY TANGLE FORMATION; PAIRED HELICAL FILAMENTS; TRANSGENIC ANIMAL-MODELS; FRONTOTEMPORAL DEMENTIA; ALZHEIMERS-DISEASE; MOUSE MODEL; MUTATIONS; TAUOPATHY; PROTEIN; MICE	Neurofibrillary tangles (NFTs), which consist of highly phosphorylated tau, are hallmarks of neurodegenerative diseases including Alzheimer disease (AD). In neurodegenerative diseases, neuronal dysfunction due to neuronal loss and synaptic loss accompanies NFT formation, suggesting that a process associated with NFT formation may be involved in neuronal dysfunction. To clarify the relationship between the tau aggregation process and synapse and neuronal loss, we compared two lines of mice expressing human tau with or without an aggregation-prone P301L mutation. P301L tau transgenic (Tg) mice exhibited neuronal loss and produced sarcosyl-insoluble tau in old age but did not exhibit synaptic loss and memory impairment. By contrast, wild-type tau Tg mice neither exhibited neuronal loss nor produced sarcosyl-insoluble tau but did exhibit synaptic loss and memory impairment. Moreover, P301L tau was less phosphorylated than wild-type tau, suggesting that the tau phosphorylation state is involved in synaptic loss, whereas the tau aggregation state is involved in neuronal loss. Finally, increasing concentrations of insoluble tau aggregates leads to the formation of fibrillar tau, which causes NFTs to form.	[Kimura, Tetsuya; Fukuda, Tetsuya; Sahara, Naruhiko; Yamashita, Shunji; Murayama, Miyuki; Mizoroki, Tatsuya; Yoshiike, Yuji; Lee, Boyoung; Sotiropoulos, Ioannis; Maeda, Sumihiro; Takashima, Akihiko] RIKEN, Lab Alzheimers Dis, Brain Sci Inst, Wako, Saitama 3510198, Japan	RIKEN	Takashima, A (corresponding author), RIKEN, Lab Alzheimers Dis, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kenneth@brain.riken.jp	Maeda, Sumihiro/W-9146-2019; Sotiropoulos, Ioannis/B-3316-2010	Sotiropoulos, Ioannis/0000-0003-0115-0038	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work supported in part by a grant-in-aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; Boekhoorn K, 2006, J NEUROSCI, V26, P3514, DOI 10.1523/JNEUROSCI.5425-05.2006; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Goedert M, 2000, BBA-MOL BASIS DIS, V1502, P110, DOI 10.1016/S0925-4439(00)00037-5; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gotz J, 2004, MOL PSYCHIATR, V9, P664, DOI 10.1038/sj.mp.4001508; Gotz J, 2001, BRAIN RES REV, V35, P266, DOI 10.1016/S0165-0173(01)00055-8; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Head E, 2007, J ALZHEIMERS DIS, V11, P61; Hutton M, 2000, ANN NY ACAD SCI, V920, P63; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Lee S, 2009, J ALZHEIMERS DIS, V16, P99, DOI 10.3233/JAD-2009-0954; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Miyasaka T, 2001, AM J PATHOL, V158, P373, DOI 10.1016/S0002-9440(10)63979-X; Nacharaju P, 1999, FEBS LETT, V447, P195, DOI 10.1016/S0014-5793(99)00294-X; Perez M, 2005, NEUROSCIENCE, V130, P339, DOI 10.1016/j.neuroscience.2004.09.029; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sato S, 2002, J BIOL CHEM, V277, P42060, DOI 10.1074/jbc.M202241200; Shiarli AM, 2006, NEUROPATH APPL NEURO, V32, P374, DOI 10.1111/j.1365-2990.2006.00736.x; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Tanemura K, 2001, NEUROBIOL DIS, V8, P1036, DOI 10.1006/nbdi.2001.0439; Taniguchi T, 2005, FEBS LETT, V579, P5704, DOI 10.1016/j.febslet.2005.09.047; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200	33	72	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38692	38699		10.1074/jbc.M110.136630	http://dx.doi.org/10.1074/jbc.M110.136630			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20921222	hybrid, Green Published			2022-12-27	WOS:000284625600074
J	Kozaili, JM; Leek, D; Tobacman, LS				Kozaili, Julie Mouannes; Leek, Daniel; Tobacman, Larry S.			Dual Regulatory Functions of the Thin Filament Revealed by Replacement of the Troponin I Inhibitory Peptide with a Linker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CARDIAC TROPONIN; COOPERATIVE EQUILIBRIUM BINDING; AMINO-ACID-SEQUENCE; PHOTO-CROSS-LINKING; MYOSIN SUBFRAGMENT-1; SKELETAL-MUSCLE; HYPERTROPHIC CARDIOMYOPATHY; TROPOMYOSIN COMPLEX; ACTIN-TROPOMYOSIN; CA2+ SENSITIVITY	Striated muscles are relaxed under low Ca2+ concentration conditions due to actions of the thin filament protein troponin. To investigate this regulatory mechanism, an 11-residue segment of cardiac troponin I previously termed the inhibitory peptide region was studied by mutagenesis. Several mutant troponin complexes were characterized in which specific effects of the inhibitory peptide region were abrogated by replacements of 4-10 residues with Gly-Ala linkers. The mutations greatly impaired two of troponin's actions under low Ca2+ concentration conditions: inhibition of myosin subfragment 1 (S1)-thin filament MgATPase activity and cooperative suppression of myosin S1-ADP binding to thin filaments with low myosin saturation. Inhibitory peptide replacement diminished but did not abolish the Ca2+ dependence of the ATPase rate; ATPase rates were at least 2-fold greater when Ca2+ rather than EGTA was present. This residual regulation was highly cooperative as a function of Ca2+ concentration, similar to the degree of cooperativity observed with WT troponin present. Other effects of the mutations included 2-fold or less increases in the apparent affinity of the thin filament regulatory Ca2+ sites, similar decreases in the affinity of troponin for actin-tropomyosin regardless of Ca2+, and increases in myosin S1-thin filament ATPase rates in the presence of saturating Ca2+. The overall results indicate that cooperative myosin binding to Ca2+-free thin filaments depends upon the inhibitory peptide region but that a cooperatively activating effect of Ca2+ binding does not. The findings suggest that these two processes are separable and involve different conformational changes in the thin filament.	[Leek, Daniel; Tobacman, Larry S.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Kozaili, Julie Mouannes; Tobacman, Larry S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tobacman, LS (corresponding author), Univ Illinois, Dept Med, 1853 W Polk St,MC 784, Chicago, IL 60612 USA.	lst@uic.edu			National Institutes of Health [HL063774, HL038834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038834, R01HL038834, R01HL063774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL063774 and HL038834.	Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Foster DB, 2003, CIRC RES, V93, P917, DOI 10.1161/01.RES.0000099889.35340.6F; Galinska A, 2010, CIRC RES, V106, P705, DOI 10.1161/CIRCRESAHA.109.210047; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GREENE L, 1982, J BIOL CHEM, V257, P3993; Heeley DH, 2006, J BIOL CHEM, V281, P668, DOI 10.1074/jbc.M505549200; Heeley DH, 2002, P NATL ACAD SCI USA, V99, P16731, DOI 10.1073/pnas.252236399; Heller MJ, 2003, J BIOL CHEM, V278, P41742, DOI 10.1074/jbc.M303408200; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P60, DOI 10.1073/pnas.80.1.60; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; Huynh Q, 1996, BIOPHYS J, V70, P1447, DOI 10.1016/S0006-3495(96)79704-7; Jin JP, 2001, BIOCHEMISTRY-US, V40, P2623, DOI 10.1021/bi002423j; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; Kobayashi T, 2009, J BIOL CHEM, V284, P20052, DOI 10.1074/jbc.M109.001396; Kowlessur D, 2010, J BIOL CHEM, V285, P2686, DOI 10.1074/jbc.M109.062349; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Lin D, 1996, J CLIN INVEST, V97, P2842, DOI 10.1172/JCI118740; Lu QW, 2010, J BIOL CHEM, V285, P11810, DOI 10.1074/jbc.M109.055657; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Mathur MC, 2009, BIOPHYS J, V96, P2237, DOI 10.1016/j.bpj.2008.12.3909; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MEHEGAN JP, 1991, J BIOL CHEM, V266, P966; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Mudalige WAKA, 2009, J MOL BIOL, V389, P575, DOI 10.1016/j.jmb.2009.04.027; NAGASHIMA H, 1982, J MOL BIOL, V155, P409, DOI 10.1016/0022-2836(82)90479-X; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; Rosol M, 2000, BIOPHYS J, V78, P908, DOI 10.1016/S0006-3495(00)76648-3; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strand J, 2001, J BIOL CHEM, V276, P34832, DOI 10.1074/jbc.M104750200; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2374; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; TRYBUS KM, 1980, P NATL ACAD SCI-BIOL, V77, P7209, DOI 10.1073/pnas.77.12.7209; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; WILKINSON JM, 1978, NATURE, V271, P31, DOI 10.1038/271031a0; WILLIAMS DL, 1983, BIOCHEMISTRY-US, V22, P2770, DOI 10.1021/bi00280a027; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3	63	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38034	38041		10.1074/jbc.M110.165753	http://dx.doi.org/10.1074/jbc.M110.165753			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889978	Green Published, hybrid			2022-12-27	WOS:000284625600011
J	Galocha, B; de Castro, JAL				Galocha, Begona; Lopez de Castro, Jose A.			Mutational Analysis Reveals a Complex Interplay of Peptide Binding and Multiple Biological Features of HLA-B27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; CELL-SURFACE EXPRESSION; C-TERMINAL ANCHOR; ANKYLOSING-SPONDYLITIS; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODY; HEAVY-CHAINS; ANTIGENIC DETERMINANTS; SUBTYPES; POLYMORPHISM	Molecular polymorphism influences the strong association of HLA-B27 with ankylosing spondylitis through an unknown mechanism. Natural subtypes and site-directed mutants were used to analyze the effect of altering the peptide-binding site of this molecule on its stability, interaction with tapasin, folding, and export. The disease-associated subtypes B*2705, B*2702, and B*2704 showed higher thermostability at 50 degrees C than all other subtypes and mutants, except some mimicking B*2702 polymorphism. The lowest values were found among pocket B mutants, most of which interacted strongly with tapasin, but otherwise there was no correlation between thermostability and tapasin interaction. Mutants resulting in increased hydrophobicity frequently acquired their maximal thermostability faster than those with increased polarity, suggesting that this process is largely driven by the thermodynamics of peptide binding. Folding, export, and tendency to misfold were influenced by polymorphism all along the peptide-binding site and were not specifically dependent on any particular region or structural feature. Frequent uncoupling of thermostability, folding/misfolding, and export can be explained by the distinct effect of mutations on the acquisition of a folded conformation, the optimization rate of B27-peptide complexes, and their quality control in the endoplasmic reticulum, all of which largely depend on the ways in which mutations alter peptide binding, without excluding additional effects on interactions with tapasin or other proteins involved in folding and export. The similarity of the generally disease-associated B*2707 to nondisease-associated subtypes in all the features analyzed suggests that molecular properties other than antigen presentation may not currently explain the relationship between HLA-B27 polymorphism and ankylosing spondylitis.	[Lopez de Castro, Jose A.] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Galocha, Begona] Inst Salud Carlos III, Madrid 28007, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Instituto de Salud Carlos III	de Castro, JAL (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	aldecastro@cbm.uam.es			Ministry of Science and Innovation of Spain [SAF2008/00461]; Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa	This work was supported by Grant SAF2008/00461 from the Ministry of Science and Innovation of Spain and an institutional grant of the Fundacion Ramon Areces to the Centro de Biolog a Molecular Severo Ochoa.	Allen RL, 1999, J IMMUNOL, V162, P5045; Barnden MJ, 2000, J IMMUNOL, V165, P322, DOI 10.4049/jimmunol.165.1.322; Ben Dror L, 2010, ARTHRITIS RHEUM-US, V62, P420, DOI 10.1002/art.27257; BENJAMIN R, 1990, IMMUNOL TODAY, V11, P137, DOI 10.1016/0167-5699(90)90051-A; Bird LA, 2003, EUR J IMMUNOL, V33, P748, DOI 10.1002/eji.200323678; Blanco-Gelaz MA, 2009, MOL IMMUNOL, V46, P1304, DOI 10.1016/j.molimm.2008.11.023; BOUVIER M, 1994, SCIENCE, V265, P398, DOI 10.1126/science.8023162; Bowness P, 2002, RHEUMATOLOGY, V41, P857, DOI 10.1093/rheumatology/41.8.857; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; CALVO V, 1990, J IMMUNOL, V144, P4038; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Colbert RA, 2000, MOL MED TODAY, V6, P224, DOI 10.1016/S1357-4310(00)01699-3; Cragnolini JJ, 2008, MOL CELL PROTEOMICS, V7, P170, DOI 10.1074/mcp.M700386-MCP200; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; de Castro JAL, 2004, TISSUE ANTIGENS, V63, P424, DOI 10.1111/j.0001-2815.2004.00220.x; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Edwards JCW, 2000, IMMUNOL TODAY, V21, P256, DOI 10.1016/S0167-5699(00)01625-X; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; FAHNESTOCK ML, 1992, SCIENCE, V258, P1658, DOI 10.1126/science.1360705; Fiorillo MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200; FIORILLO MT, 1995, IMMUNOGENETICS, V41, P38, DOI 10.1007/BF00188430; Galocha B, 2008, ARTHRITIS RHEUM-US, V58, P401, DOI 10.1002/art.23164; Garstka M, 2007, J BIOL CHEM, V282, P30680, DOI 10.1074/jbc.M701721200; Gomez P, 2006, EUR J IMMUNOL, V36, P1867, DOI 10.1002/eji.200635896; Goodall JC, 2006, ARTHRITIS RHEUM, V54, P138, DOI 10.1002/art.21552; Hildebrand WH, 2002, HUM IMMUNOL, V63, P248, DOI 10.1016/S0198-8859(02)00364-6; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Howe C, 2009, EMBO J, V28, P3730, DOI 10.1038/emboj.2009.296; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Marcilla M, 2008, TISSUE ANTIGENS, V71, P495, DOI 10.1111/j.1399-0039.2008.01051.x; Mear JP, 1999, J IMMUNOL, V163, P6665; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Neisig A, 1996, J IMMUNOL, V156, P3196; Paulsson KM, 2006, J IMMUNOL, V176, P7482, DOI 10.4049/jimmunol.176.12.7482; Paulsson KM, 2002, J BIOL CHEM, V277, P18266, DOI 10.1074/jbc.M201388200; Raine T, 2006, RHEUMATOLOGY, V45, P1338, DOI 10.1093/rheumatology/kel305; Ramos M, 2002, J BIOL CHEM, V277, P28749, DOI 10.1074/jbc.M204155200; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; ROTZSCHKE O, 1994, IMMUNOGENETICS, V39, P74; Ruckert C, 2006, J BIOL CHEM, V281, P2306, DOI 10.1074/jbc.M508528200; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; Sesma L, 2002, J BIOL CHEM, V277, P16744, DOI 10.1074/jbc.M200371200; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; STAM NJ, 1986, J IMMUNOL, V137, P2299; Thammavongsa V, 2009, IMMUNOGENETICS, V61, P703, DOI 10.1007/s00251-009-0399-2; Thammavongsa V, 2006, J IMMUNOL, V177, P3150, DOI 10.4049/jimmunol.177.5.3150; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Tran TM, 2001, IMMUNOGENETICS, V53, P440, DOI 10.1007/s002510100353; Tran TM, 2000, HUM IMMUNOL, V61, P1197, DOI 10.1016/S0198-8859(00)00220-2; Turnquist HR, 2000, EUR J IMMUNOL, V30, P3021, DOI 10.1002/1521-4141(200010)30:10<3021::AID-IMMU3021>3.0.CO;2-U; Uchanska-Ziegler B, 2003, TRENDS IMMUNOL, V24, P73, DOI 10.1016/S1471-4906(02)00028-5; Varnavidou-Nicolaidou A, 2004, HUM IMMUNOL, V65, P1451, DOI 10.1016/j.humimm.2004.08.177; Vazquez MN, 2005, ARTHRITIS RHEUM-US, V52, P3290, DOI 10.1002/art.21284; VILLADANGOS JA, 1994, J IMMUNOL, V152, P2317; VILLADANGOS JA, 1995, EUR J IMMUNOL, V25, P2370, DOI 10.1002/eji.1830250837; VILLADANGOS JA, 1992, J IMMUNOL, V149, P505; VILLADANGOS JA, 1994, EUR J IMMUNOL, V24, P2548, DOI 10.1002/eji.1830241043; WANG J, 1994, J IMMUNOL, V152, P1197; WEN J, 1994, IMMUNOGENETICS, V39, P444; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zernich D, 2004, J EXP MED, V200, P13, DOI 10.1084/jem.20031680; Ziegler A, 2009, ADV EXP MED BIOL, V649, P177	64	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39180	39190		10.1074/jbc.M110.149906	http://dx.doi.org/10.1074/jbc.M110.149906			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889980	Green Published, hybrid			2022-12-27	WOS:000284941300048
J	Stratigopoulos, G; LeDuc, CA; Cremona, ML; Chung, WK; Leibel, RL				Stratigopoulos, George; LeDuc, Charles A.; Cremona, Maria L.; Chung, Wendy K.; Leibel, Rudolph L.			Cut-like Homeobox 1 (CUX1) Regulates Expression of the Fat Mass and Obesity-associated and Retinitis Pigmentosa GTPase Regulator-interacting Protein-1-like (RPGRIP1L) Genes and Coordinates Leptin Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARDET-BIEDL-SYNDROME; GENOME-WIDE ASSOCIATION; FTO GENE; PRIMARY CILIA; SYNDROME PROTEINS; RETINAL DEGENERATION; HOMEODOMAIN PROTEIN; ENERGY-INTAKE; DNA-BINDING; FOOD-INTAKE	The first intron of FTO contains common single nucleotide polymorphisms associated with body weight and adiposity in humans. In an effort to identify the molecular basis for this association, we discovered that FTO and RPGRIP1L (a ciliary gene located in close proximity to the transcriptional start site of FTO) are regulated by isoforms P200 and P110 of the transcription factor, CUX1. This regulation occurs via a single AATAAATA regulatory site (conserved in the mouse) within the FTO intronic region associated with adiposity in humans. Single nucleotide polymorphism rs8050136 (located in this regulatory site) affects binding affinities of P200 and P110. Promoter-probe analysis revealed that binding of P200 to this site represses FTO, whereas binding of P110 increases transcriptional activity from the FTO as well as RPGRIP1L minimal promoters. Reduced expression of Fto or Rpgrip1l affects leptin receptor isoform b trafficking and leptin signaling in N41 mouse hypothalamic or N2a neuroblastoma cells in vitro. Leptin receptor clusters in the vicinity of the cilium of arcuate hypothalamic neurons in C57BL/6J mice treated with leptin, but not in fasted mice, suggesting a potentially important role of the cilium in leptin signaling that is, in part, regulated by FTO and RPGRIP1L. Decreased Fto/Rpgrip1l expression in the arcuate hypothalamus coincides with decreased nuclear enzymatic activity of a protease (cathepsin L) that has been shown to cleave full-length CUX1 (P200) to P110. P200 disrupts (whereas P110 promotes) leptin receptor isoform b clustering in the vicinity of the cilium in vitro. Clustering of the receptor coincides with increased leptin signaling as reflected in protein levels of phosphorylated Stat3 (p-Stat3). Association of the FTO locus with adiposity in humans may reflect functional consequences of A/C alleles at rs8050136. The obesity-risk (A) allele shows reduced affinity for the FTO and RPGRIP1L transcriptional activator P110, leading to the following: 1) decreased FTO and RPGRIP1L mRNA levels; 2) reduced LEPR trafficking to the cilium; and, as a consequence, 3) a diminished cellular response to leptin.	Columbia Univ, Div Mol Genet, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Stratigopoulos, G (corresponding author), 1150 St Nicholas Ave,Rm 620, New York, NY 10032 USA.	GS2172@columbia.edu; RL232@columbia.edu	Stratigopoulos, G/D-4159-2015	Stratigopoulos, G/0000-0003-4752-9123; LeDuc, Charles/0000-0002-2073-5050	National Institutes of Health [RO1 DK52431-15, P30 DK26687-30, P30 DK63608-08]; American Diabetes Association; Russell Berrie Foundation; Lasky Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052431, P30DK063608, P30DK026687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Russell Berrie Foundation; Lasky Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants RO1 DK52431-15, P30 DK26687-30, and P30 DK63608-08, an American Diabetes Association-mentored fellowship award, a grant from the Russell Berrie Foundation, and a gift from the Lasky Foundation.	Alcalay NI, 2008, AM J PHYSIOL-RENAL, V295, pF1725, DOI 10.1152/ajprenal.90420.2008; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Belouzard S, 2004, J BIOL CHEM, V279, P28499, DOI 10.1074/jbc.M400508200; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Cadieux C, 2008, J BIOL CHEM, V283, P13817, DOI 10.1074/jbc.M709332200; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Collette J, 2004, INT REV CYTOL, V241, P1, DOI 10.1016/S0074-7696(04)41001-8; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Devuyst O, 2008, NEPHROL DIAL TRANSPL, V23, P1500, DOI 10.1093/ndt/gfn033; Diano S, 1998, J NEUROENDOCRINOL, V10, P647, DOI 10.1046/j.1365-2826.1998.00261.x; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Ellis T, 2001, GENE DEV, V15, P2307, DOI 10.1101/gad.200101; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Goossens GH, 2009, INT J OBESITY, V33, P669, DOI 10.1038/ijo.2009.59; Gorivodsky M, 2009, DEV BIOL, V325, P24, DOI 10.1016/j.ydbio.2008.09.019; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Harada R, 2008, NUCLEIC ACIDS RES, V36, P189, DOI 10.1093/nar/gkm970; Hardie LJ, 1996, BIOCHEM BIOPH RES CO, V223, P660, DOI 10.1006/bbrc.1996.0951; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Herwig A, 2008, OBESITY FACTS, V1, P71, DOI 10.1159/000123428; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; KAMBERI IA, 1970, J NEUROCHEM, V17, P261, DOI 10.1111/j.1471-4159.1970.tb02209.x; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Khanna-Gupta A, 2003, BLOOD, V101, P3460, DOI 10.1182/blood-2002-09-2767; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Mailly F, 1996, MOL CELL BIOL, V16, P5346; Marshall WF, 2008, CURR TOP DEV BIOL, V85, P1, DOI 10.1016/S0070-2153(08)00801-6; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Moon NS, 2000, J BIOL CHEM, V275, P31325, DOI 10.1074/jbc.M002912200; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Mukhopadhyay S, 2008, DEV CELL, V14, P762, DOI 10.1016/j.devcel.2008.03.002; Overton JM, 2004, PHYSIOL BEHAV, V81, P749, DOI 10.1016/j.physbeh.2004.04.025; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Sansregret L, 2008, GENE, V412, P84, DOI 10.1016/j.gene.2008.01.017; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Schwartz MW, 2003, DIABETES, V52, P232, DOI 10.2337/diabetes.52.2.232; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Sinclair AM, 2001, BLOOD, V98, P3658, DOI 10.1182/blood.V98.13.3658; Slotnick B.M., 1975, STEREOTAXIC ATLAS AL; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Truscott M, 2004, J BIOL CHEM, V279, P49787, DOI 10.1074/jbc.M409484200; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Wang ZS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006979; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	74	92	97	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2155	2170		10.1074/jbc.M110.188482	http://dx.doi.org/10.1074/jbc.M110.188482			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21037323	hybrid, Green Published			2022-12-27	WOS:000286191500057
J	Faxen, K; Andersen, JL; Gourdon, P; Fedosova, N; Morth, JP; Nissen, P; Moller, JV				Faxen, Kristina; Andersen, Jacob Lauwring; Gourdon, Pontus; Fedosova, Natalya; Morth, Jens Preben; Nissen, Poul; Moller, Jesper Vuust			Characterization of a Listeria monocytogenes Ca2+ Pump A SERCA-TYPE ATPase WITH ONLY ONE Ca2+-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA-2+-ATPASE; CALCIUM-TRANSPORT; H+ COUNTERTRANSPORT; MEMBRANE-PROTEINS; HIGH-AFFINITY; RECONSTITUTION; ELECTROGENICITY; CA2+-ATPASE; EXPRESSION; STRONTIUM	We have characterized a putative Ca2+-ATPase from the pathogenic bacterium Listeria monocytogenes with the locus tag lmo0841. The purified and detergent-solubilized protein, which we have named Listeria monocytogenes Ca2+-ATPase 1 (LMCA1), performs a Ca2+-dependent ATP hydrolysis and actively transports Ca2+ after reconstitution in dioleoylphosphatidyl-choline vesicles. Despite a high sequence similarity to the sarcoplasmic reticulum Ca2+-ATPase (SERCA1a) and plasma membrane Ca2+-ATPase (PMCA), LMCA1 exhibits important biochemical differences such as a low Ca2+ affinity (K-0.5 similar to 80 mu M) and a high pH optimum (pH similar to 9). Mutational studies indicate that the unusually high pH optimum can be partially ascribed to the presence of an arginine residue (Arg-795), corresponding in sequence alignments to the Glu-908 position at Ca2+ binding site I of rabbit SERCA1a, but probably with an exposed position in LMCA1. The arginine is characteristic of a large group of putative bacterial Ca2+-ATPases. Moreover, we demonstrate that H+ is countertransported with a transport stoichiometry of 1 Ca2+ out and 1 H+ in per ATP hydrolyzed. The ATPase may serve an important function by removing Ca2+ from the microorganism in environmental conditions when e.g. stressed by high Ca2+ and alkaline pH.	[Faxen, Kristina; Andersen, Jacob Lauwring; Gourdon, Pontus; Morth, Jens Preben; Nissen, Poul] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol, DK-8000 Aarhus, Denmark; [Fedosova, Natalya; Moller, Jesper Vuust] Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Physiol & Biophys, DK-8000 Aarhus, Denmark	Aarhus University; Danmarks Grundforskningsfond; Aarhus University; Danmarks Grundforskningsfond	Nissen, P (corresponding author), Aarhus Univ, Danish Natl Res Fdn, PUMPKIN, Dept Mol Biol, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	pn@mb.au.dk; jvm@biophys.au.dk	Johnson, Michael D. L./B-4352-2012; Morth, Jens Preben/AAP-7834-2021; Gourdon, Pontus/E-1076-2014; Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Gourdon, Pontus/HCI-8898-2022	Morth, Jens Preben/0000-0003-4077-0192; Gourdon, Pontus/0000-0002-8631-3539; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Andersen, Jacob Lauwring/0000-0002-6062-7740; Fedosova, Natalya U./0000-0002-1706-6108	Danish National Research Foundation; Swedish Research Council; Novo Nordisk Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by a Center of Excellence grant from the Danish National Research Foundation, a post-doctoral fellowship from The Swedish Research Council (to P.G.), and a Hallas-Moller research stipend from the Novo Nordisk Foundation (to P.N.).	AMBUDKAR SV, 1986, J BIOL CHEM, V261, P5596; Andersen JP, 1995, BIOSCIENCE REP, V15, P243, DOI 10.1007/BF01788358; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; BERKELMAN T, 1994, J BACTERIOL, V176, P4430, DOI 10.1128/jb.176.14.4430-4436.1994; BERMAN MC, 1990, BIOCHIM BIOPHYS ACTA, V1029, P235, DOI 10.1016/0005-2736(90)90159-L; Campbell A.K, 1983, INTRACELLULAR CALCIU; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CORNELIUS F, 1991, FEBS LETT, V284, P46, DOI 10.1016/0014-5793(91)80758-U; DACOSTA AG, 1986, ARCH BIOCHEM BIOPHYS, V249, P199, DOI 10.1016/0003-9861(86)90575-8; DeSantiago J, 2007, FRONT BIOSCI, V12, P4641, DOI 10.2741/2414; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; GEISLER M, 1993, J MOL BIOL, V234, P1284, DOI 10.1006/jmbi.1993.1684; Geisler Markus, 1998, Biol Proced Online, V1, P70, DOI 10.1251/bpo9; Giotis ES, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-102; GMAJ P, 1983, EUR J BIOCHEM, V136, P71, DOI 10.1111/j.1432-1033.1983.tb07706.x; Guerini D, 1996, BIOCHEMISTRY-US, V35, P3290, DOI 10.1021/bi952572f; Guerini D, 1998, CELL TISSUE RES, V292, P191, DOI 10.1007/s004410051050; HASSELBACH W, 1983, ANNU REV PHYSIOL, V45, P325, DOI 10.1146/annurev.ph.45.030183.001545; HEEGAARD CW, 1990, J BIOL CHEM, V265, P12020; Inesi G, 1978, Ann N Y Acad Sci, V307, P224, DOI 10.1111/j.1749-6632.1978.tb41947.x; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LEIMEISTERWACHTER M, 1989, INFECT IMMUN, V57, P2350; LEVY D, 1990, J BIOL CHEM, V265, P19524; LONDON E, 1978, ANAL BIOCHEM, V88, P203, DOI 10.1016/0003-2697(78)90412-8; LUND S, 1988, J BIOL CHEM, V263, P1654; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; MELTZER S, 1984, J BIOL CHEM, V259, P4244; MERMIER P, 1976, EUR J BIOCHEM, V69, P79, DOI 10.1111/j.1432-1033.1976.tb10860.x; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Preiano BS, 1996, BIOCHEMISTRY-US, V35, P7946; Raeymaekers L, 2002, CELL CALCIUM, V32, P93, DOI 10.1016/S0143-4160(02)00125-2; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x; ROSEN BP, 1987, BIOCHIM BIOPHYS ACTA, V906, P101, DOI 10.1016/0304-4157(87)90007-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvador JM, 1998, J BIOL CHEM, V273, P18230, DOI 10.1074/jbc.273.29.18230; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Thomas RC, 2009, J PHYSIOL-LONDON, V587, P315, DOI 10.1113/jphysiol.2008.162453; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TSUCHIYA T, 1976, J BIOL CHEM, V251, P962; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; YU X, 1993, BIOPHYS J, V64, pA334	46	29	30	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1609	1617		10.1074/jbc.M110.176784	http://dx.doi.org/10.1074/jbc.M110.176784			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21047776	hybrid, Green Published			2022-12-27	WOS:000286005000073
J	Rebres, RA; Roach, TIA; Fraser, IDC; Philip, F; Moon, C; Lin, KM; Liu, J; Santat, L; Cheadle, L; Ross, EM; Simon, MI; Seaman, WE				Rebres, Robert A.; Roach, Tamara I. A.; Fraser, Iain D. C.; Philip, Finly; Moon, Christina; Lin, Keng-Mean; Liu, Jamie; Santat, Leah; Cheadle, Lucas; Ross, Elliott M.; Simon, Melvin I.; Seaman, William E.			Synergistic Ca2+ Responses by G alpha(i)- and G alpha(q)-coupled G-protein-coupled Receptors Require a Single PLC beta Isoform That Is Sensitive to Both G beta gamma and G alpha(q)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-BETA; ADENOSINE A(1) RECEPTORS; ALPHA-SUBUNIT; CROSS-TALK; MEDIATED ACTIVATION; CELLS; CALCIUM; DOMAIN; STIMULATION; IDENTIFICATION	Cross-talk between G alpha(i)- and G alpha(q)-linked G-protein-coupled receptors yields synergistic Ca2+ responses in a variety of cell types. Prior studies have shown that synergistic Ca2+ responses from macrophage G-protein-coupled receptors are primarily dependent on phospholipase C beta 3 (PLC beta 3), with a possible contribution of PLC beta 2, whereas signaling through PLC beta 4 interferes with synergy. We here show that synergy can be induced by the combination of G beta gamma and G alpha(q) activation of a single PLC beta isoform. Synergy was absent in macrophages lacking both PLC beta 2 and PLC beta 3, but it was fully reconstituted following transduction with PLC beta 3 alone. Mechanisms of PLC beta mediated synergy were further explored in NIH-3T3 cells, which express little if any PLC beta 2. RNAi-mediated knockdown of endogenous PLC beta s demonstrated that synergy in these cells was dependent on PLC beta 3, but PLC beta 1 and PLC beta 4 did not contribute, and overexpression of either isoform inhibited Ca2+ synergy. When synergy was blocked by RNAi of endogenous PLC beta 3, it could be reconstituted by expression of either human PLC beta 3 or mouse PLC beta 2. In contrast, it could not be reconstituted by human PLC beta 3 with a mutation of the Y box, which disrupted activation by G beta gamma, and it was only partially restored by human PLC beta 3 with a mutation of the C terminus, which partly disrupted activation by G alpha(q). Thus, both G beta gamma and G alpha(q) contribute to activation of PLC beta 3 in cells for Ca2+ synergy. We conclude that Ca2+ synergy between G alpha(i)-coupled and G alpha(q)-coupled receptors requires the direct action of both G beta gamma and G alpha(q) on PLC beta and is mediated primarily by PLC beta 3, although PLC beta 2 is also competent.	[Rebres, Robert A.; Roach, Tamara I. A.; Moon, Christina; Simon, Melvin I.] Univ Calif San Francisco, Vet Affairs Med Ctr, No Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Seaman, William E.] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Fraser, Iain D. C.; Liu, Jamie; Santat, Leah; Cheadle, Lucas] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Philip, Finly; Lin, Keng-Mean; Ross, Elliott M.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Northern California Institute for Research & Education; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); California Institute of Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas	Rebres, RA (corresponding author), Univ Calif San Francisco, Vet Affairs Med Ctr, No Calif Inst Res & Educ, 111R,4150 Clement St, San Francisco, CA 94121 USA.	rarebres@yahoo.com; tiaroach@gmail.com; bseaman@medicine.ucsf.edu	Fraser, Iain DC/L-4735-2017	Fraser, Iain DC/0000-0003-2272-3907	National Institutes of Health [GM 62114, GM 30355]; Welch Foundation [I-0982]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062114, R37GM030355, R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 62114 and GM 30355 (to E. M. R.). This work was also supported by Welch Foundation Grant I-0982 (to E. M. R.).	Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; BOYER JL, 1994, J BIOL CHEM, V269, P2814; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; CARROLL RC, 1995, CURR BIOL, V5, P536, DOI 10.1016/S0960-9822(95)00106-0; Cilluffo MC, 2000, AM J PHYSIOL-CELL PH, V279, pC734, DOI 10.1152/ajpcell.2000.279.3.C734; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Delmas P, 2004, TRENDS NEUROSCI, V27, P41, DOI 10.1016/j.tins.2003.10.013; DICKENSON JM, 1994, INT J BIOCHEM, V26, P959, DOI 10.1016/0020-711X(94)90066-3; Dickenson JM, 1996, EUR J PHARMACOL, V302, P141, DOI 10.1016/0014-2999(96)00039-8; DICKENSON JM, 1993, BIOCHEM SOC T, V21, P1124, DOI 10.1042/bst0211124; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; JHON DY, 1993, J BIOL CHEM, V268, P6654; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jimenez AI, 1999, GLIA, V26, P119, DOI 10.1002/(SICI)1098-1136(199904)26:2<119::AID-GLIA3>3.0.CO;2-D; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; LEE CW, 1994, J BIOL CHEM, V269, P25335; LEE SB, 1993, J BIOL CHEM, V268, P25952; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; OKAJIMA F, 1989, FEBS LETT, V248, P145, DOI 10.1016/0014-5793(89)80450-8; OKAJIMA F, 1993, BIOCHEM J, V290, P241, DOI 10.1042/bj2900241; PARK DG, 1993, J BIOL CHEM, V268, P4573; PARK DG, 1993, J BIOL CHEM, V268, P3710; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Roach TIA, 2008, J BIOL CHEM, V283, P17351, DOI 10.1074/jbc.M800907200; Sankaran B, 1998, J BIOL CHEM, V273, P7148, DOI 10.1074/jbc.273.12.7148; Shah BH, 1999, EXP MOL MED, V31, P42, DOI 10.1038/emm.1999.7; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STERNWEIS PC, 1993, CIBA F SYMP, V176, P96; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Toms NJ, 1999, NEUROPHARMACOLOGY, V38, P1511, DOI 10.1016/S0028-3908(99)00090-8; UEDA N, 1994, J BIOL CHEM, V269, P4388; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Werry TD, 2003, J PHARMACOL EXP THER, V307, P661, DOI 10.1124/jpet.103.055632; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; WU DQ, 1993, J BIOL CHEM, V268, P3704; Wu J, 2000, J EXP MED, V192, P1059, DOI 10.1084/jem.192.7.1059; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zavzavadjian JR, 2007, MOL CELL PROTEOMICS, V6, P413, DOI 10.1074/mcp.M600437-MCP200	52	39	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					942	951		10.1074/jbc.M110.198200	http://dx.doi.org/10.1074/jbc.M110.198200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21036901	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000286005000005
J	Stierl, M; Stumpf, P; Udwari, D; Gueta, R; Hagedorn, R; Losi, A; Gartner, W; Petereit, L; Efetova, M; Schwarzel, M; Oertner, TG; Nagel, G; Hegemann, P				Stierl, Manuela; Stumpf, Patrick; Udwari, Daniel; Gueta, Ronnie; Hagedorn, Rolf; Losi, Aba; Gaertner, Wolfgang; Petereit, Linda; Efetova, Marina; Schwarzel, Martin; Oertner, Thomas G.; Nagel, Georg; Hegemann, Peter			Light Modulation of Cellular cAMP by a Small Bacterial Photoactivated Adenylyl Cyclase, bPAC, of the Soil Bacterium Beggiatoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUGLENA-GRACILIS; NEURAL CIRCUITS; IN-VIVO; MAT; PHOTORECEPTOR; TRANSDUCTION; PHOTOTROPIN; ACTIVATION; MECHANISM; BINDING	The recent success of channelrhodopsin in optogenetics has also caused increasing interest in enzymes that are directly activated by light. We have identified in the genome of the bacterium Beggiatoa a DNA sequence encoding an adenylyl cyclase directly linked to a BLUF (blue light receptor using FAD) type light sensor domain. In Escherichia coli and Xenopus oocytes, this photoactivated adenylyl cyclase (bPAC) showed cyclase activity that is low in darkness but increased 300-fold in the light. This enzymatic activity decays thermally within 20 s in parallel with the red-shifted BLUF photointermediate. bPAC is well expressed in pyramidal neurons and, in combination with cyclic nucleotide gated channels, causes efficient light-induced depolarization. In the Drosophila central nervous system, bPAC mediates light-dependent cAMP increase and behavioral changes in freely moving animals. bPAC seems a perfect optogenetic tool for light modulation of cAMP in neuronal cells and tissues and for studying cAMP-dependent processes in live animals.	[Stierl, Manuela; Hagedorn, Rolf; Hegemann, Peter] Humboldt Univ, D-10115 Berlin, Germany; [Stumpf, Patrick; Gueta, Ronnie; Nagel, Georg] Univ Wurzburg, Dept Bot 1, D-97082 Wurzburg, Germany; [Udwari, Daniel; Oertner, Thomas G.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Losi, Aba] Univ Parma, Dept Phys, I-43121 Parma, Italy; [Gaertner, Wolfgang] Max Planck Inst Bioinorgan Chem, D-45410 Mulheim, Germany; [Petereit, Linda; Efetova, Marina; Schwarzel, Martin] Free Univ Berlin, Dept Biol, D-14195 Berlin, Germany	Humboldt University of Berlin; University of Wurzburg; Friedrich Miescher Institute for Biomedical Research; University of Parma; Max Planck Society; Free University of Berlin	Hegemann, P (corresponding author), Humboldt Univ, Invalidenstr 42, D-10115 Berlin, Germany.	Hegemann@rz.hu-berlin.de	Oertner, Thomas/F-2214-2010; Stumpf, Patrick/AAK-1895-2020; Losi, Aba/M-8709-2015	Oertner, Thomas/0000-0002-2312-7528; Stumpf, Patrick/0000-0003-0862-0290; Losi, Aba/0000-0003-0497-2723; Nagel, Georg/0000-0001-8174-8712; Gartner, Wolfgang/0000-0002-6898-7011	National Institutes of Health [RO1-MH-086415-01]; Deutsche Forschungsgemeinschaft [FOR526/1279]; Cluster of Excellence Unifying Concepts in Catalysis [SFB 567, SCHW1410/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Unifying Concepts in Catalysis(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-MH-086415-01 (to M. S.). This work was also supported by Deutsche Forschungsgemeinschaft Grants FOR526/1279 and the Cluster of Excellence Unifying Concepts in Catalysis (to P. H.), Grant SFB 567 (to G. N.), and Grant SCHW1410/1-1 (to M. S.).	Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bonetti C, 2009, BIOCHEMISTRY-US, V48, P11458, DOI 10.1021/bi901196x; Chen CF, 1997, J NEUROSCI, V17, P8687; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Dunn TA, 2008, DEV NEUROBIOL, V68, P835, DOI 10.1002/dneu.20619; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Hinck S, 2007, APPL ENVIRON MICROB, V73, P7013, DOI 10.1128/AEM.00548-07; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Linder JU, 2003, CELL SIGNAL, V15, P1081, DOI 10.1016/S0898-6568(03)00130-X; Looser J, 2009, BIOL CHEM, V390, P1105, DOI 10.1515/BC.2009.132; Makhinson M, 1999, J NEUROSCI, V19, P2500; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Matsuoka D, 2005, P NATL ACAD SCI USA, V102, P13337, DOI 10.1073/pnas.0506402102; Miller G, 2006, SCIENCE, V314, P1674, DOI 10.1126/science.314.5806.1674; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Moglich A, 2009, J MOL BIOL, V385, P1433, DOI 10.1016/j.jmb.2008.12.017; MOLLER MM, 1985, APPL ENVIRON MICROB, V50, P373; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Schoenenberger P, 2011, EXP PHYSIOL, V96, P34, DOI 10.1113/expphysiol.2009.051219; Schoenenberger P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008185; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Weinreich F, 1997, PFLUG ARCH EUR J PHY, V434, P484, DOI 10.1007/s004240050424; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zhang F, 2008, NAT NEUROSCI, V11, P631, DOI 10.1038/nn.2120	33	250	258	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1181	1188		10.1074/jbc.M110.185496	http://dx.doi.org/10.1074/jbc.M110.185496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030594	Green Published, hybrid			2022-12-27	WOS:000286005000029
J	Ilioaia, C; Johnson, MP; Duffy, CDP; Pascal, AA; van Grondelle, R; Robert, B; Ruban, AV				Ilioaia, Cristian; Johnson, Matthew P.; Duffy, Christopher D. P.; Pascal, Andrew A.; van Grondelle, Rienk; Robert, Bruno; Ruban, Alexander V.			Origin of Absorption Changes Associated with Photoprotective Energy Dissipation in the Absence of Zeaxanthin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; ABSORBED EXCITATION-ENERGY; PH-DEPENDENT DISSIPATION; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; PHOTOSYNTHETIC MEMBRANES; CONFORMATIONAL-CHANGES; SPECTROSCOPIC ANALYSIS; PHOTOOXIDATIVE STRESS	To prevent photo-oxidative damage to the photosynthetic membrane in strong light, plants dissipate excess absorbed light energy as heat in a mechanism known as non-photochemical quenching (NPQ). NPQ is triggered by the transmembrane proton gradient (Delta pH), which causes the protonation of the photosystem II light-harvesting antenna (LHCII) and the PsbS protein, as well as the de-epoxidation of the xanthophyll violaxanthin to zeaxanthin. The combination of these factors brings about formation of dissipative pigment interactions that quench the excess energy. The formation of NPQ is associated with certain absorption changes that have been suggested to reflect a conformational change in LHCII brought about by its protonation. The light-minus-dark recovery absorption difference spectrum is characterized by a series of positive and negative bands, the best known of which is Delta A(535). Light-minus-dark recovery resonance Raman difference spectra performed at the wavelength of the absorption change of interest allows identification of the pigment responsible from its unique vibrational signature. Using this technique, the origin of Delta A(535) was previously shown to be a subpopulation of red-shifted zeaxanthin molecules. In the absence of zeaxanthin (and antheraxanthin), a proportion of NPQ remains, and the Delta A(535) change is blue-shifted to 525 nm (Delta A(525)). Using resonance Raman spectroscopy, it is shown that the Delta A(525) absorption change in Arabidopsis leaves lacking zeaxanthin belongs to a red-shifted subpopulation of violaxanthin molecules formed during NPQ. The presence of the same Delta A(535) and Delta A(525) Raman signatures in vitro in aggregated LHCII, containing zeaxanthin and violaxanthin, respectively, leads to a new proposal for the origin of the xanthophyll red shifts associated with NPQ.	[Ilioaia, Cristian; van Grondelle, Rienk] Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands; [Robert, Bruno] CEA, Inst Biol & Technol Saclay iBiTecS, F-91191 Gif Sur Yvette, France; [Robert, Bruno] CENS, Lab Leon Brillouin, CNRS, Unite Rech Associee 2096, F-91191 Gif Sur Yvette, France; [Johnson, Matthew P.; Duffy, Christopher D. P.; Ruban, Alexander V.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	Vrije Universiteit Amsterdam; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of London; Queen Mary University London	Ilioaia, C (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron, Fac Sci, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	cristian.ilioaia@cea.fr; a.ruban@qmul.ac.uk	Robert, Bruno/D-1264-2012; pascal, andrew a/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew a/0000-0002-1844-6065; Johnson, Matthew/0000-0002-1663-0205; ILIOAIA, Cristian/0000-0001-7505-1900	United Kingdom Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union (EU) [ERG 224796]; Engineering and Physical Sciences Research Council [EP/H024697/1] Funding Source: researchfish; EPSRC [EP/H024697/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences; European Union (EU)(CGIAREuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by research and equipment grants from the United Kingdom Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council, The Netherlands Organization for Scientific Research via the Foundation of Earth and Life Sciences (to C. I. and R. v. G.), the European Union (EU) FP7 Marie Curie Reintegration Grant (ERG 224796) (to C. I.), and an EU FP7 Marie Curie HARVEST Network grant.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; BAYLISS NS, 1950, J CHEM PHYS, V18, P292, DOI 10.1063/1.1747621; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BILGER W, 1989, PLANT PHYSIOL, V91, P542, DOI 10.1104/pp.91.2.542; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; Billsten HH, 2005, J PHYS CHEM A, V109, P1521, DOI 10.1021/jp044847j; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2007, PHOTOSYNTH RES, V91, P292; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Davydov A.S., 1962, THEORY MOL EXCITONS; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; GILMORE AM, 1995, P NATL ACAD SCI USA, V92, P2273, DOI 10.1073/pnas.92.6.2273; GOTTFRIED DS, 1991, BIOCHIM BIOPHYS ACTA, V1059, P76, DOI 10.1016/S0005-2728(05)80189-6; HEBER U, 1969, BIOCHIM BIOPHYS ACTA, V180, P302, DOI 10.1016/0005-2728(69)90116-9; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Johnson MP, 2010, PLANT J, V61, P283, DOI 10.1111/j.1365-313X.2009.04051.x; Johnson MP, 2009, J BIOL CHEM, V284, P23592, DOI 10.1074/jbc.M109.013557; Johnson MP, 2009, PLANT PHYSIOL, V149, P1061, DOI 10.1104/pp.108.129957; KRAUSE GH, 1973, BIOCHIM BIOPHYS ACTA, V292, P715, DOI 10.1016/0005-2728(73)90019-4; Ledford HK, 2005, PLANT CELL ENVIRON, V28, P1037, DOI 10.1111/j.1365-3040.2005.01374.x; LEROSEN AL, 1952, J CHEM PHYS, V20, P233, DOI 10.1063/1.1700384; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Li ZR, 2009, PLANT CELL, V21, P1798, DOI 10.1105/tpc.109.066571; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Ma YZ, 2003, P NATL ACAD SCI USA, V100, P4377, DOI 10.1073/pnas.0736959100; Muller MG, 2010, CHEMPHYSCHEM, V11, P1289, DOI 10.1002/cphc.200900852; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; NOCTOR G, 1993, BIOCHIM BIOPHYS ACTA, V1183, P339, DOI 10.1016/0005-2728(93)90237-A; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REICH R, 1977, PHOTOCHEM PHOTOBIOL, V26, P11, DOI 10.1111/j.1751-1097.1977.tb07442.x; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban A. V., 2009, CAROTENOIDS PHYS CHE; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P39, DOI 10.1016/0167-4838(92)90496-Z; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Ruban AV, 1997, BIOCHEMISTRY-US, V36, P7855, DOI 10.1021/bi9630725; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; RUBAN AV, 1993, J PHOTOCH PHOTOBIO B, V21, P229, DOI 10.1016/1011-1344(93)80188-F; WALTERS RG, 1994, EUR J BIOCHEM, V226, P1063, DOI 10.1111/j.1432-1033.1994.01063.x	59	21	23	1	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					91	98		10.1074/jbc.M110.184887	http://dx.doi.org/10.1074/jbc.M110.184887			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036900	Green Published, hybrid			2022-12-27	WOS:000285782800010
J	Mosnier, LO				Mosnier, Laurent O.			Platelet Factor 4 Inhibits Thrombomodulin-dependent Activation of Thrombin-activatable Fibrinolysis Inhibitor (TAFI) by Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-C; FACTOR-XI; ANTICOAGULANT ACTIVITY; CARBOXYPEPTIDASE-U; PLATELET FACTOR-4; PREMATURE LYSIS; PLASMA; COAGULATION; GENERATION; HEPARIN	Thrombomodulin (TM) is a cofactor for thrombin-mediated activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI) and thereby helps coordinate coagulation, anticoagulation, fibrinolysis, and inflammation. Platelet factor 4 (PF4), a platelet alpha-granule protein and a soluble cofactor for TM-dependent protein C activation, stimulates protein C activation in vitro and in vivo. In contrast to stimulation of protein C activation, PF4 is shown here to inhibit activation of TAFI by thrombin-TM. Consequences of inhibition of TAFI activation by PF4 included loss of TM-dependent prolongation of clot lysis times in hemophilia A plasma and loss of TM-stimulated conversion of bradykinin (BK) to des-Arg(9)-BK by TAFIa in normal plasma. Thus, PF4 modulates the substrate specificity of the thrombin-TM complex by selectively enhancing protein C activation while inhibiting TAFI activation, thereby preventing the generation of the antifibrinolytic and anti-inflammatory activities of TAFIa. To block the inhibitory effects of PF4 on TAFI activation, heparin derivatives were tested for their ability to retain high affinity binding to PF4 despite having greatly diminished anticoagulant activity. N-acetylated heparin (NAc-Hep) lacked detectable anticoagulant activity in activated partial thromboplastin time clotting assays but retained high affinity binding to PF4 and effectively reversed PF4 binding to immobilized TM. NAc-Hep permitted BK conversion to des-Arg(9)-BK by TAFIa in the presence of PF4. In a clot lysis assay on TM-expressing cells using hemophilia A plasma, NAc-Hep prevented PF4-mediated inhibition of TAFI activation and the antifibrinolytic functions of TAFIa. Accordingly, NAc-Hep or similar heparin derivatives might provide therapeutic benefits by diminishing bleeding complications in hemophilia A via restoration of TAFIa-mediated protection of clots against premature lysis.	[Mosnier, Laurent O.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Mosnier, LO (corresponding author), Scripps Res Inst, Dept Mol & Expt Med MEM 180, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	lmosnier@scripps.edu			National Institutes of Health, NHLBI [HL087618]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104165, R01HL130678, K99HL087618, R00HL087618] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI Grant HL087618.	ALMONDHIRY H, 1987, THROMB HAEMOSTASIS, V57, P294; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; BAJZAR L, 1993, J BIOL CHEM, V268, P8608; Bajzar L, 1998, J BIOL CHEM, V273, P2792, DOI 10.1074/jbc.273.5.2792; Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BOCK PE, 1980, BIOCHEM J, V191, P769, DOI 10.1042/bj1910769; Bouma BN, 1999, THROMB HAEMOSTASIS, V82, P1703; Broze GJ, 1996, BLOOD, V88, P3815, DOI 10.1182/blood.V88.10.3815.bloodjournal88103815; Butenas S, 2006, J THROMB HAEMOST, V4, P2411, DOI 10.1111/j.1538-7836.2006.02226.x; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cazenave Jean-Pierre, 2004, Methods Mol Biol, V272, P13; Chan MY, 2008, CIRCULATION, V118, P2286, DOI 10.1161/CIRCULATIONAHA.108.778837; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; De Nanteuil G, 2006, J MED CHEM, V49, P5047, DOI 10.1021/jm0606950; Dehmer GJ, 1996, CIRCULATION, V94, P347; Dudek AZ, 1997, J BIOL CHEM, V272, P31785, DOI 10.1074/jbc.272.50.31785; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Foley JH, 2009, J THROMB HAEMOST, V7, P453, DOI 10.1111/j.1538-7836.2008.03261.x; FRIEDRICHS GS, 1994, CIRC RES, V75, P701, DOI 10.1161/01.RES.75.4.701; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; Kokame K, 1998, J BIOL CHEM, V273, P12135, DOI 10.1074/jbc.273.20.12135; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; Leurs J, 2004, J THROMB HAEMOST, V2, P416, DOI 10.1111/j.1538-7836.2004.00605.x; Levi M, 2001, SEMIN THROMB HEMOST, V27, P569, DOI 10.1055/s-2001-18862; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; MEDICI I, 1989, THROMB RES, V54, P277, DOI 10.1016/0049-3848(89)90086-8; Mosnier LO, 2007, J BIOL CHEM, V282, P33022, DOI 10.1074/jbc.M705824200; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mosnier LO, 2006, FRONT BIOSCI-LANDMRK, V11, P2381, DOI 10.2741/1977; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Mosnier LO, 1998, THROMB HAEMOSTASIS, V80, P829; Mosnier LO, 2001, THROMB HAEMOSTASIS, V86, P1035; Mosnier LO, 2001, THROMB HAEMOSTASIS, V85, P5; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; Shetty S, 2007, BRIT J HAEMATOL, V138, P541, DOI 10.1111/j.1365-2141.2007.06693.x; SLUNGAARD A, 1994, J BIOL CHEM, V269, P25549; Slungaard A, 2004, CRIT CARE MED, V32, pS331, DOI 10.1097/01.CCM.0000126359.92825.E9; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; STUCKEY JA, 1992, PROTEINS, V14, P277, DOI 10.1002/prot.340140213; Van de Wouwer M, 2004, ARTERIOSCL THROM VAS, V24, P1374, DOI 10.1161/01.ATV.0000134298.25489.92; VONDEMBORNE PAK, 1995, BLOOD, V86, P3035; VondemBorne PAK, 1997, J CLIN INVEST, V99, P2323, DOI 10.1172/JCI119412; Walker JB, 2004, J BIOL CHEM, V279, P27896, DOI 10.1074/jbc.M401027200; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x	50	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					502	510		10.1074/jbc.M110.147959	http://dx.doi.org/10.1074/jbc.M110.147959			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21041299	Green Published, hybrid			2022-12-27	WOS:000285782800053
J	Brameshuber, M; Weghuber, J; Ruprecht, V; Gombos, I; Horvath, I; Vigh, L; Eckerstorfer, P; Kiss, E; Stockinger, H; Schutz, GJ				Brameshuber, Mario; Weghuber, Julian; Ruprecht, Verena; Gombos, Imre; Horvath, Ibolya; Vigh, Laszlo; Eckerstorfer, Paul; Kiss, Endre; Stockinger, Hannes; Schuetz, Gerhard J.			Imaging of Mobile Long-lived Nanoplatforms in the Live Cell Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; HEAT-SHOCK RESPONSE; LIPID RAFTS; DETERGENT RESISTANCE; LATERAL MOBILITY; CHOLESTEROL; MOLECULES; SURFACE; ACTIN; ORGANIZATION	The plasma membrane has been hypothesized to contain nanoscopic lipid platforms, which are discussed in the context of "lipid rafts" or "membrane rafts." Based on biochemical and cell biological studies, rafts are believed to play a crucial role in many signaling processes. However, there is currently not much information on their size, shape, stability, surface density, composition, and heterogeneity. We present here a method that allows for the first time the direct imaging of nanoscopic long-lived platforms with raft-like properties diffusing in the live cell plasma membrane. Our method senses these platforms by their property to assemble a characteristic set of fluorescent marker proteins or lipids on a time scale of seconds. A special photobleaching protocol was used to reduce the surface density of labeled mobile platforms down to the level of well isolated diffraction-limited spots without altering the single spot brightness. The statistical distribution of probe molecules per platform was determined by single molecule brightness analysis. For demonstration, we used the consensus raft marker glycosylphosphatidylinositol-anchored monomeric GFP and the fluorescent lipid analog BODIPY-G(M1), which preferentially partitions into liquid-ordered phases. For both markers, we found cholesterol-dependent homo-association in the plasma membrane of living CHO and Jurkat T cells in the resting state, thereby demonstrating the existence of small, mobile, long-lived platforms containing these probes. We further applied the technology to address structural changes in the plasma membrane during fever-type heat shock: at elevated temperatures, the glycosylphosphatidylinositol- anchored monomeric GFP homo-association disappeared, accompanied by an increase in the expression of the small heat shock protein Hsp27.	[Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Gombos, Imre; Horvath, Ibolya; Vigh, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Eckerstorfer, Paul; Kiss, Endre; Stockinger, Hannes] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Mol Immunol, A-1090 Vienna, Austria	Johannes Kepler University Linz; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Medical University of Vienna	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Stockinger, Hannes/E-5173-2011; Schuetz, Gerhard/B-1243-2008; Ruprecht, Verena/H-7563-2017	Stockinger, Hannes/0000-0001-6404-4430; Schuetz, Gerhard/0000-0003-1542-1089; Ruprecht, Verena/0000-0003-4088-8633; Weghuber, Julian/0000-0001-6312-4666; Brameshuber, Mario/0000-0001-8672-2255	Austrian Science Fund [Y250-B03, I301-B12]; Austrian Federal Ministry for Science and Research; European Union [HEALTH-F4-2008-202272]; Hungarian National Scientific Research Foundation [NK 68379, NN 76716]; Austrian Science Fund (FWF) [Y 250, I 300, I 301] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry for Science and Research; European Union(European Commission); Hungarian National Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects Y250-B03 and I301-B12, the GEN-AU Project of the Austrian Federal Ministry for Science and Research and the European Union Project LipidomicNet (HEALTH-F4-2008-202272), and Hungarian National Scientific Research Foundation Grants NK 68379 and NN 76716.	BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Giocondi MC, 2007, J MOL RECOGNIT, V20, P531, DOI 10.1002/jmr.835; Gombos I, 2004, CYTOM PART A, V61A, P117, DOI 10.1002/cyto.a.20080; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Krishnan J, 2006, EXP NEUROL, V200, P301, DOI 10.1016/j.expneurol.2006.02.135; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lebreton S, 2008, J BIOL CHEM, V283, P29545, DOI 10.1074/jbc.M803819200; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Metzner C, 2008, FASEB J, V22, P2734, DOI 10.1096/fj.08-108217; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Muhammad A, 2009, J IMMUNOL, V182, P7672, DOI 10.4049/jimmunol.0800691; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Ruprecht V, 2010, SOFT MATTER, V6, P568, DOI 10.1039/b916734j; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Saidi Y, 2009, PLANT CELL, V21, P2829, DOI 10.1105/tpc.108.065318; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; von Haller PD, 2001, PROTEOMICS, V1, P1010; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	48	88	89	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41765	41771		10.1074/jbc.M110.182121	http://dx.doi.org/10.1074/jbc.M110.182121			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20966075	Green Published, hybrid			2022-12-27	WOS:000285622600064
J	Madl, J; Weghuber, J; Fritsch, R; Derler, I; Fahrner, M; Frischauf, I; Lackner, B; Romanin, C; Schutz, GJ				Madl, Josef; Weghuber, Julian; Fritsch, Reinhard; Derler, Isabella; Fahrner, Marc; Frischauf, Irene; Lackner, Barbara; Romanin, Christoph; Schuetz, Gerhard J.			Resting State Orai1 Diffuses as Homotetramer in the Plasma Membrane of Live Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ STORE DEPLETION; ACTIVATES CRAC CHANNELS; CALCIUM-CHANNEL; LIVING CELLS; SINGLE; STOICHIOMETRY; PROTEINS; STIM1; MOLECULES; SUBUNIT	Store-operated calcium entry is essential for many signaling processes in nonexcitable cells. The best studied store-operated calcium current is the calcium release-activated calcium (CRAC) current in T-cells and mast cells, with Orai1 representing the essential pore forming subunit. Although it is known that functional CRAC channels in store-depleted cells are composed of four Orai1 subunits, the stoichiometric composition in quiescent cells is still discussed controversially: both a tetrameric and a dimeric stoichiometry of resting state Orai1 have been reported. We obtained here robust and similar FRET values on labeled tandem repeat constructs of Orai1 before and after store depletion, suggesting an unchanged tetrameric stoichiometry. Moreover, we directly visualized the stoichiometry of mobile Orai1 channels in live cells using a new single molecule recording modality that combines single molecule tracking and brightness analysis. By alternating imaging and photobleaching pulses, we recorded trajectories of single, fluorescently labeled Orai1 channels, with each trajectory consisting of bright and dim segments, corresponding to higher and lower numbers of colocalized active GFP label. The according brightness values were used for global fitting and statistical analysis, yielding a tetrameric subunit composition of mobile Orai1 channels in resting cells.	[Madl, Josef; Weghuber, Julian; Fritsch, Reinhard; Derler, Isabella; Fahrner, Marc; Frischauf, Irene; Lackner, Barbara; Romanin, Christoph; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Johannes Kepler University Linz	Schutz, GJ (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	gerhard.schuetz@jku.at	Schuetz, Gerhard/B-1243-2008; Fahrner, Marc/AAI-7927-2021; Romanin, Christoph/D-5399-2009; Frischauf, Irene/AAG-2007-2019; Derler, Isabella/B-7871-2019	Schuetz, Gerhard/0000-0003-1542-1089; Romanin, Christoph/0000-0003-3756-4136; Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Weghuber, Julian/0000-0001-6312-4666; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund [W1201, Y250-B3, P2118, T466-B09]; Austrian Research Promotion Agency; Austrian Academy of Sciences; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Research Promotion Agency; Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (Ph.D. Program W1201 "Molecular Bioanalytics" and project Y250-B3 to G. J. S.; Project P2118 to C. R.: and Hertha Firnberg T466-B09 to I. D.) and the GEN-AU project of the Austrian Research Promotion Agency.; Recipient of a DOC-forte scholarship of the Austrian Academy of Sciences.	Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Garcia-Parajo MF, 2000, P NATL ACAD SCI USA, V97, P7237, DOI 10.1073/pnas.97.13.7237; Goulian M, 2000, BIOPHYS J, V79, P2188, DOI 10.1016/S0006-3495(00)76467-8; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hesse J, 2004, ANAL CHEM, V76, P5960, DOI 10.1021/ac049300f; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Maruyama Y, 2009, J BIOL CHEM, V284, P13676, DOI 10.1074/jbc.M900812200; Mashanov GI, 2010, J BIOL CHEM, V285, P3664, DOI 10.1074/jbc.M109.039974; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mignen O, 2009, J PHYSIOL-LONDON, V587, P4181, DOI 10.1113/jphysiol.2009.174193; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Ruprecht V, 2010, SOFT MATTER, V6, P568, DOI 10.1039/b916734j; Schmidt T, 1996, ANAL CHEM, V68, P4397, DOI 10.1021/ac960710g; Schwarzenbacher M, 2008, NAT METHODS, V5, P1053, DOI 10.1038/nmeth.1268; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wieser S, 2008, BIOPHYS J, V95, P5988, DOI 10.1529/biophysj.108.141655; Woodard GE, 2008, AM J PHYSIOL-CELL PH, V294, pC1323, DOI 10.1152/ajpcell.00071.2008; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	37	78	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41135	41142		10.1074/jbc.M110.177881	http://dx.doi.org/10.1074/jbc.M110.177881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961852	hybrid, Green Published			2022-12-27	WOS:000285414400075
J	Ozga, M; Dolot, R; Janicka, M; Kaczmarek, R; Krakowiak, A				Ozga, Magdalena; Dolot, Rafal; Janicka, Magdalena; Kaczmarek, Renata; Krakowiak, Agnieszka			Histidine Triad Nucleotide-binding Protein 1 (HINT-1) Phosphoramidase Transforms Nucleoside 5 '-O-Phosphorothioates to Nucleoside 5 '-O-Phosphates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-GROWTH; PHOSPHOROTHIOATE; OLIGONUCLEOTIDES; METABOLISM; BIODISTRIBUTION; PHOSPHODIESTER; PRONUCLEOTIDES; STABILITY; HYDROLASE; MECHANISM	Nucleoside 5'-O-phosphorothioates are formed in vivo as primary products of hydrolysis of oligo(nucleoside phosphorothioate)s (PS-oligos) that are applied as antisense therapeutic molecules. The biodistribution of PS-oligos and their pharmacokinetics have been widely reported, but little is known about their subsequent decay inside the organism. We suggest that the enzyme responsible for nucleoside 5'-O-monophosphorothioate ((d)NMPS) metabolism could be histidine triad nucleotide-binding protein 1 (Hint-1), a phosphoramidase belonging to the histidine triad (HIT) superfamily that is present in all forms of life. An additional, but usually ignored, activity of Hint-1 is its ability to catalyze the conversion of adenosine 5'-O-monophosphorothioate (AMPS) to 5'-O-monophosphate (AMP). By mutagenetic and biochemical studies, we defined the active site of Hint-1 and the kinetic parameters of the desulfuration reaction (P-S bond cleavage). Additionally, crystallographic analysis (resolution from 1.08 to 1.37 angstrom) of three engineered cysteine mutants showed the high similarity of their structures, which were not very different from the structure of WT Hint-1. Moreover, we found that not only AMPS but also other ribonucleoside and 2'-deoxyribonucleoside phosphorothioates are desulfurated by Hint-1 at the following relative rates: GMPS > AMPS > dGMPS >= CMPS > UMPS > dAMPS >> dCMPS > TMPS, and during the reaction, hydrogen sulfide, which is thought to be the third gaseous mediator, was released.	[Ozga, Magdalena; Dolot, Rafal; Janicka, Magdalena; Kaczmarek, Renata; Krakowiak, Agnieszka] Polish Acad Sci, Ctr Mol & Macromol Studies, Dept Bioorgan Chem, PL-90363 Lodz, Poland	Polish Academy of Sciences; Centre of Molecular & Macromolecular Studies of the Polish Academy of Sciences	Krakowiak, A (corresponding author), Sienkiewicza 112, PL-90363 Lodz, Poland.	akrakow@bio.cbmm.lodz.pl	Krakowiak, Agnieszka/ABC-8848-2020	Krakowiak, Agnieszka/0000-0002-0273-2972; Dolot, Rafal/0000-0002-2300-5264	Polish Ministry of Science and Higher Education [NN204130137, PBZ-MNiSW-07/I/2007]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Polish Ministry of Science and Higher Education Grants NN204130137 (to A.K.) and PBZ-MNiSW-07/I/2007 (2008-2010).	Abraham TW, 1996, J MED CHEM, V39, P4569, DOI 10.1021/jm9603680; AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baraniak J, 2002, J ORG CHEM, V67, P7267, DOI 10.1021/jo026027d; Beltowski Jerzy, 2004, Postepy Hig Med Dosw (Online), V58, P285; Bieganowski P, 2002, J BIOL CHEM, V277, P10852, DOI 10.1074/jbc.M111480200; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Brenner C, 1997, NAT STRUCT BIOL, V4, P231, DOI 10.1038/nsb0397-231; BRESLOW R, 1968, J AM CHEM SOC, V90, P7376, DOI 10.1021/ja01028a054; Cahard D, 2004, MINI-REV MED CHEM, V4, P371; CHLEBOWSKI JF, 1974, J BIOL CHEM, V249, P7192; Chou TF, 2007, MOL PHARMACEUT, V4, P208, DOI 10.1021/mp060070y; DeLano W.L, PYMOL MOL GRAPHICS S; Dias N, 2002, MOL CANCER THER, V1, P347; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gilar M, 1997, NUCLEIC ACIDS RES, V25, P3615, DOI 10.1093/nar/25.18.3615; Guranowski A, 2010, NEW J CHEM, V34, P888, DOI 10.1039/b9nj00660e; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Koziolkiewicz M, 1997, ANTISENSE NUCLEIC A, V7, P43, DOI 10.1089/oli.1.1997.7.43; Koziolkiewicz M, 2001, BLOOD, V98, P995, DOI 10.1182/blood.V98.4.995; Krakowiak A, 2004, J BIOL CHEM, V279, P18711, DOI 10.1074/jbc.M314271200; Krakowiak A, 2007, CHEM COMMUN, P2163, DOI 10.1039/b615160d; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li H, 2006, ONCOGENE, V25, P713, DOI 10.1038/sj.onc.1209111; Lima CD, 1996, P NATL ACAD SCI USA, V93, P5357, DOI 10.1073/pnas.93.11.5357; Lowicka E, 2007, PHARMACOL REP, V59, P4; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mirandola P, 2007, J CELL PHYSIOL, V213, P826, DOI 10.1002/jcp.21151; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SANDS H, 1994, MOL PHARMACOL, V45, P932; Su T, 2003, P NATL ACAD SCI USA, V100, P7824, DOI 10.1073/pnas.1332160100; Temsamani J, 1997, ANTISENSE NUCLEIC A, V7, P159, DOI 10.1089/oli.1.1997.7.159; Vaerman JL, 1997, BLOOD, V90, P331; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wagner CR, 2000, MED RES REV, V20, P417, DOI 10.1002/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang LR, 2007, NAT CHEM BIOL, V3, P709, DOI 10.1038/nchembio.2007.39; Weiske J, 2006, J BIOL CHEM, V281, P27356, DOI 10.1074/jbc.M513452200; Wojcik M, 2007, OLIGONUCLEOTIDES, V17, P134, DOI 10.1089/oli.2007.0021; Yuan BZ, 2004, NEOPLASIA, V6, P412, DOI 10.1593/neo.03490; Zemlicka J, 2002, BBA-MOL BASIS DIS, V1587, P276, DOI 10.1016/S0925-4439(02)00090-X; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; ZON G, 1988, PHARM RES-DORDR, V5, P539, DOI 10.1023/A:1015985728434	50	30	35	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40809	40818		10.1074/jbc.M110.162065	http://dx.doi.org/10.1074/jbc.M110.162065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20940308	hybrid, Green Published			2022-12-27	WOS:000285414400046
J	Prasad, R; Shock, DD; Beard, WA; Wilson, SH				Prasad, Rajendra; Shock, David D.; Beard, William A.; Wilson, Samuel H.			Substrate Channeling in Mammalian Base Excision Repair Pathways: Passing the Baton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-BETA; DEOXYRIBOSE PHOSPHATE LYASE; LIGASE-I; BOVINE TESTIS; IDENTIFICATION; MECHANISM; CELLS; RECONSTITUTION; BINDING; PROTEIN	The current model for base excision repair (BER) involves two general sub-pathways termed single-nucleotide BER and long patch BER that are distinguished by their repair patch sizes and the enzymes/co-factors involved. Both sub-pathways involve a series of sequential steps from initiation to completion of repair. The BER sub-pathways are designed to sequester the various intermediates, passing them along from one step to the next without allowing these toxic molecules to trigger cell cycle arrest, necrotic cell death, or apoptosis. Although a variety of DNA-protein and protein-protein interactions are known for the BER intermediates and enzymes/co-factors, the molecular mechanisms accounting for step-to-step coordination are not well understood. In the present study we designed an in vitro assay to explore the question of whether there is a channeling or "hand-off" of the repair intermediates during BER in vitro. The results show that when BER enzymes are pre-bound to the initial single-nucleotide BER intermediate, the DNA is channeled from apurinic/apyrimidinic endonuclease 1 to DNA polymerase beta and then to DNA ligase. In the long patch BER subpathway, where the 5'-end of the incised strand is blocked, the intermediate after DNA polymerase beta gap filling is not channeled to the subsequent enzyme, flap endonuclease 1. Instead, flap endonuclease 1 must recognize and bind to the intermediate in competition with other molecules.	[Prasad, Rajendra; Shock, David D.; Beard, William A.; Wilson, Samuel H.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293	National Institutes of Health Research [Z01-ES050158, Z01-ES050159]; NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, ZIAES050158, Z01ES050158, Z01ES050159] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Research Projects Z01-ES050158 and Z01-ES050159 in the Intramural Research Program of the NIEHS.	Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; Beard WA, 1995, METHOD ENZYMOL, V262, P98; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; CASASFINET JR, 1991, J BIOL CHEM, V266, P19618; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; DIANOV G, 1992, MOL CELL BIOL, V12, P1605, DOI 10.1128/MCB.12.4.1605; DIANOV G, 1994, CURR BIOL, V4, P1069, DOI 10.1016/S0960-9822(00)00245-1; DOETSCH PW, 1986, BIOCHEMISTRY-US, V25, P2212, DOI 10.1021/bi00356a054; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; Frosina G, 1996, J BIOL CHEM, V271, P9573, DOI 10.1074/jbc.271.16.9573; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; KUMAR A, 1990, J BIOL CHEM, V265, P2124; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Parikh Sudip S., 1999, Current Opinion in Structural Biology, V9, P37, DOI 10.1016/S0959-440X(99)80006-2; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 2005, DNA REPAIR, V4, P1347, DOI 10.1016/j.dnarep.2005.08.009; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; PRIGENT C, 1994, MOL CELL BIOL, V14, P310, DOI 10.1128/MCB.14.1.310; SINGHAL RK, 1995, J BIOL CHEM, V270, P949, DOI 10.1074/jbc.270.2.949; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; WANG YCJ, 1994, J BIOL CHEM, V269, P31923; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Zolghadr K, 2008, MOL CELL PROTEOMICS, V7, P2279, DOI 10.1074/mcp.M700548-MCP200	44	110	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40479	40488		10.1074/jbc.M110.155267	http://dx.doi.org/10.1074/jbc.M110.155267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20952393	Green Published, hybrid			2022-12-27	WOS:000285414400010
J	Zhou, J; Liu, Y; Zhang, W; Popov, VM; Wang, M; Pattabiraman, N; Sune, C; Cvekl, A; Wu, KM; Jiang, J; Wang, CG; Pestell, RG				Zhou, Jie; Liu, Yang; Zhang, Wei; Popov, Vladimir M.; Wang, Min; Pattabiraman, Nagarajan; Sune, Carlos; Cvekl, Ales; Wu, Kongming; Jiang, Jie; Wang, Chenguang; Pestell, Richard G.			Transcription Elongation Regulator 1 Is a Co-integrator of the Cell Fate Determination Factor Dachshund Homolog 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DETERMINATION FACTOR DACH1; ECTOPIC EYE DEVELOPMENT; CYCLIN D1; ALTERED EXPRESSION; BREAST-CANCER; PROTEIN; CA150; DROSOPHILA; GROWTH	DACH1 (Dachshund homolog 1) is a key component of the retinal determination gene network and regulates gene expression either indirectly as a co-integrator or through direct DNA binding. The current studies were conducted to understand, at a higher level of resolution, the mechanisms governing DACH1-mediated transcriptional repression via DNA sequence- specific binding. DACH1 repressed gene transcription driven by the DACH1-responsive element (DRE). Recent genome- wide ChIP-Seq analysis demonstrated DACH1 binding sites co-localized with Forkhead protein (FOX) binding sites. Herein, DACH1 repressed, whereas FOX proteins enhanced, both DRE and FOXA-responsive element-driven gene expression. Reduced DACH1 expression using a shRNA approach enhanced FOX protein activity. As DACH1 antagonized FOX target gene expression and attenuated FOX signaling, we sought to identify limiting co-integrator proteins governing DACH1 signaling. Proteomic analysis identified transcription elongation regulator 1 (TCERG1) as the transcriptional coregulator of DACH1 activity. The FF2 domain of TCERG1 was required for DACH1 binding, and the deletion of FF2 abolished DACH1 trans-repression function. The carboxyl terminus of DACH1 was necessary and sufficient for TCERG1 binding. Thus, DACH1 represses gene transcription through direct DNA binding to the promoter region of target genes by recruiting the transcriptional co-regulator, TCERG1.	[Zhou, Jie; Liu, Yang; Zhang, Wei; Popov, Vladimir M.; Wang, Min; Pattabiraman, Nagarajan; Wu, Kongming; Wang, Chenguang; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Wu, Kongming; Pestell, Richard G.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Wang, Chenguang] Thomas Jefferson Univ, Dept Stem Cell Biol & Regenerat Med, Philadelphia, PA 19107 USA; [Sune, Carlos] CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Mol Biol, Granada 18100, Spain; [Cvekl, Ales] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Liu, Yang; Jiang, Jie] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250012, Shandong, Peoples R China	Jefferson University; Jefferson University; Jefferson University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Yeshiva University; Albert Einstein College of Medicine; Shandong University	Wang, CG (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	chenguang.wang@jefferson.edu; richard.pestell@jefferson.edu	Cvekl, Ales/B-2427-2013; Pattabiraman, Nagarjan/A-9347-2011; Suñé, Carlos/AAA-8198-2019	Suñé, Carlos/0000-0002-7991-0458	National Institutes of Health [R01CA70896, R01CA75503, R01CA86072]; National Institutes of Health Cancer Center [P30CA56036]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Spanish Ministry of Science and Innovation [BFU2008-01599]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA070896, R01CA086072, R01CA075503] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA86072 (to R. G. P.). Work conducted at the Kimmel Cancer Center was supported by National Institutes of Health Cancer Center Core Grant P30CA56036 (to R. G. P.). This work was also supported by the Dr. Ralph and Marian C. Falk Medical Research Trust and a grant from Pennsylvania Department of Health (to R. G. P. and C. W.) and Spanish Ministry of Science and Innovation Grant BFU2008-01599 (C.S.).	Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Carty SM, 2000, P NATL ACAD SCI USA, V97, P9015, DOI 10.1073/pnas.160266597; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Dalgin GS, 2008, J UROLOGY, V180, P1126, DOI 10.1016/j.juro.2008.04.137; Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; Li X, 2002, SCIENCE, V297, P1180; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; MARDON G, 1994, DEVELOPMENT, V120, P3473; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Pearson JL, 2008, J BIOL CHEM, V283, P7949, DOI 10.1074/jbc.M709402200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sanchez-Alvarez M, 2006, MOL CELL BIOL, V26, P4998, DOI 10.1128/MCB.01991-05; Shen WP, 1997, DEVELOPMENT, V124, P45; Sunde JS, 2006, CANCER RES, V66, P8404, DOI 10.1158/0008-5472.CAN-06-0683; Sune C, 1999, MOL CELL BIOL, V19, P4719; Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang CG, 2001, MOL CELL BIOL, V21, P3057, DOI 10.1128/MCB.21.9.3057-3070.2001; Wawersik S, 2000, HUM MOL GENET, V9, P917, DOI 10.1093/hmg/9.6.917; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Yamada Y, 2008, CANCER SCI, V99, P2193, DOI 10.1111/j.1349-7006.2008.00935.x; Zhou J, 2010, P NATL ACAD SCI USA, V107, P6864, DOI 10.1073/pnas.1002746107	29	21	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40342	40350		10.1074/jbc.M110.156141	http://dx.doi.org/10.1074/jbc.M110.156141			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956529	Green Published, hybrid			2022-12-27	WOS:000285185500077
J	Eltit, JM; Feng, W; Lopez, JR; Padilla, IT; Pessah, IN; Molinski, TF; Fruen, BR; Allen, PD; Perez, CF				Eltit, Jose M.; Feng, Wei; Lopez, Jose R.; Padilla, Isela T.; Pessah, Isaac N.; Molinski, Tadeusz F.; Fruen, Bradley R.; Allen, Paul D.; Perez, Claudio F.			Ablation of Skeletal Muscle Triadin Impairs FKBP12/RyR1 Channel Interactions Essential for Maintaining Resting Cytoplasmic Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC RYANODINE RECEPTOR; JUNCTIONAL FOOT PROTEIN; CALCIUM-RELEASE CHANNEL; FK506-BINDING PROTEIN; DIHYDROPYRIDINE RECEPTOR; INTRACELLULAR CA2+; BINDING; MYOTUBES; CALSEQUESTRIN; RYR1	Previously, we have shown that lack of expression of triadins in skeletal muscle cells results in significant increase of myoplasmic resting free Ca2+ ([Ca2+](rest)), suggesting a role for triadins in modulating global intracellular Ca2+ homeostasis. To understand this mechanism, we study here how triadin alters [Ca2+](rest), Ca2+ release, and Ca2+ entry pathways using a combination of Ca2+ microelectrodes, channels reconstituted in bilayer lipid membranes (BLM), Ca2+, and Mn2+ imaging analyses of myotubes and RyR1 channels obtained from triadin-null mice. Unlike WT cells, triadin-null myotubes had chronically elevated [Ca2+](rest) that was sensitive to inhibition with ryanodine, suggesting that triadin-null cells have increased basal RyR1 activity. Consistently, BLM studies indicate that, unlike WT-RyR1, triadin-null channels more frequently display atypical gating behavior with multiple and stable subconductance states. Accordingly, pulldown analysis and fluorescent FKBP12 binding studies in triadin-null muscles revealed a significant impairment of the FKBP12/RyR1 interaction. Mn2+ quench rates under resting conditions indicate that triadin-null cells also have higher Ca2+ entry rates and lower sarcoplasmic reticulum Ca2+ load than WT cells. Overexpression of FKBP12.6 reverted the null phenotype, reducing resting Ca2+ entry, recovering sarcoplasmic reticulum Ca2+ content levels, and restoring near normal [Ca2+](rest). Exogenous FKBP12.6 also reduced the RyR1 channel P-o but did not rescue subconductance behavior. In contrast, FKBP12 neither reduced P-o nor recovered multiple subconductance gating. These data suggest that elevated [Ca2+](rest) in triadin-null myotubes is primarily driven by dysregulated RyR1 channel activity that results in part from impaired FKBP12/RyR1 functional interactions and a secondary increased Ca2+ entry at rest.	[Eltit, Jose M.; Lopez, Jose R.; Allen, Paul D.; Perez, Claudio F.] Brigham & Womens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Feng, Wei; Padilla, Isela T.; Pessah, Isaac N.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Molinski, Tadeusz F.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Fruen, Bradley R.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Harvard University; Brigham & Women's Hospital; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Perez, CF (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol, 75 Francis St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu	Pessah, Isaac N/K-7985-2017; Molinski, Tadeusz F/P-2125-2018	Pessah, Isaac N/0000-0002-8149-588X; 	National Institute of Health [5K01AR054818, P01AR47605, R01HL076433]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054818, P01AR052354, R03AR047605] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institute of Health Grants 5K01AR054818 (to C. F. P.), P01AR47605 (to P. D. A. and I. N. P.), and R01HL076433 (to B. R. F.).	Avila G, 2003, J BIOL CHEM, V278, P22600, DOI 10.1074/jbc.M205866200; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Buck ED, 1997, J BIOL CHEM, V272, P7360, DOI 10.1074/jbc.272.11.7360; Chen L, 1999, J BIOL CHEM, V274, P32603, DOI 10.1074/jbc.274.46.32603; Cornea RL, 2010, J BIOL CHEM, V285, P19219, DOI 10.1074/jbc.M109.066944; Eltit JM, 2010, BIOPHYS J, V98, p509A, DOI 10.1016/j.bpj.2009.12.2774; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Goonasekera SA, 2007, J GEN PHYSIOL, V130, P365, DOI 10.1085/jgp.200709790; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; Gu W, 1996, SOC GEN PHY, V51, P19; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb GD, 1996, J PHYSIOL-LONDON, V494, P569, DOI 10.1113/jphysiol.1996.sp021514; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; LOPEZ JR, 1986, MUSCLE NERVE, V9, P85; MACK MM, 1994, J BIOL CHEM, V269, P23236; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; Masuno MN, 2006, J MED CHEM, V49, P4497, DOI 10.1021/jm050708u; MAYRLEITNER M, 1994, CELL CALCIUM, V15, P99, DOI 10.1016/0143-4160(94)90048-5; MOTOIKE HK, 1994, J MUSCLE RES CELL M, V15, P493, DOI 10.1007/BF00121156; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Pessah IN, 1997, AM J PHYSIOL-CELL PH, V272, pC601, DOI 10.1152/ajpcell.1997.272.2.C601; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Tang W, 2004, FASEB J, V18, P1597, DOI 10.1096/fj.04-1587fje; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006	40	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38453	38462		10.1074/jbc.M110.164525	http://dx.doi.org/10.1074/jbc.M110.164525			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926377	hybrid, Green Published			2022-12-27	WOS:000284625600051
J	Sheu, JJC; Guan, B; Choi, JH; Lin, A; Lee, CH; Hsiao, YT; Wang, TL; Tsai, FJ; Shih, IM				Sheu, Jim Jinn-Chyuan; Guan, Bin; Choi, Jung-Hye; Lin, Athena; Lee, Chia-Huei; Hsiao, Yi-Ting; Wang, Tian-Li; Tsai, Fuu-Jen; Shih, Ie-Ming			Rsf-1, a Chromatin Remodeling Protein, Induces DNA Damage and Promotes Genomic Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAK REPAIR PATHWAYS; FUNCTIONAL-ANALYSIS; DOWNSTREAM TARGET; CELL-GROWTH; C-MYC; EXPRESSION; ONCOGENES; CANCER; GENE; AMPLIFICATION	Rsf-1 (HBXAP) has been reported as an amplified gene in human cancer, including the highly aggressive ovarian serous carcinoma. Rsf-1 protein interacts with SNF2H to form an ISWI chromatin remodeling complex, RSF. In this study, we investigated the functional role of Rsf-1 by observing phenotypes after expressing it in nontransformed cells. Acute expression of Rsf-1 resulted in DNA damage as evidenced by DNA strand breaks, nuclear gamma H2AX foci, and activation of the ATM-CHK2-p53-p21 pathway, leading to growth arrest and apoptosis. Deletion mutation and gene knockdown assays revealed that formation of a functional RSF complex with SNF2H was required for Rsf-1 to trigger DNA damage response (DDR). Gene knock-out of TP53 alleles, TP53 mutation, or treatment with an ATM inhibitor abolished up-regulation of p53 and p21 and prevented Rsf-1-induced growth arrest. Chronic induction of Rsf-1 expression resulted in chromosomal aberration and clonal selection for cells with c-myc amplification and CDKN2A/B deletion. Co-culture assays indicated Rsf-1-induced DDR as a selecting barrier that favored outgrowth of cell clones with a TP53 mutation. The above findings suggest that increased Rsf-1 expression and thus excessive RSF activity, which occurs in tumors harboring Rsf-1 amplification, can induce chromosomal instability likely through DDR.	[Shih, Ie-Ming] Johns Hopkins Med Inst, Dept Pathol & Oncol, Baltimore, MD 21231 USA; [Sheu, Jim Jinn-Chyuan; Hsiao, Yi-Ting; Tsai, Fuu-Jen] China Med Univ Hosp, Ctr Human Genet, Taichung 40447, Taiwan; [Sheu, Jim Jinn-Chyuan; Hsiao, Yi-Ting; Tsai, Fuu-Jen] China Med Univ, Sch Chinese Med, Taichung 40447, Taiwan; [Choi, Jung-Hye] Kyung Hee Univ, Dept Oriental Pharm, Seoul 130701, South Korea; [Lin, Athena] Touro Univ, Dept Basic Sci & Int Hlth, Vallejo, CA 94592 USA; [Lee, Chia-Huei] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan 35053, Taiwan	Johns Hopkins University; Johns Hopkins Medicine; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kyung Hee University; Touro University California; National Health Research Institutes - Taiwan	Sheu, JJC (corresponding author), 2 Yuh Der Rd, Taichung 40447, Taiwan.	jimsheu@mail.cmu.edu.tw; ishih@jhmi.edu	Choi, Jung-Hye/AAI-9922-2020; sdsd, shihieih/ABE-6190-2020; Tsai, Fuu-Jen/J-4140-2015; Lee, Chia-Huei/B-1063-2010	Guan, Bin/0000-0001-5986-5189; Lee, Chia-Huei/0000-0002-8847-3288; Choi, Jung-Hye/0000-0001-5178-6814	NCI, National Institutes of Health [RO1CA129080, RO1CA103937]; Johns Hopkins-China Medical University [DMR-98-104]; National Science Council (Taiwan) [NSC 98-2320-B-039-033-MY3]; NATIONAL CANCER INSTITUTE [R01CA129080, R01CA103937] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Johns Hopkins-China Medical University; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants RO1CA129080 and RO1CA103937. This work was also supported by Johns Hopkins-China Medical University Research Collaboration Fund (DMR-98-104) and National Science Council Grant NSC 98-2320-B-039-033-MY3 (Taiwan).	Bao YH, 2007, CURR OPIN GENET DEV, V17, P126, DOI 10.1016/j.gde.2007.02.010; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bommer GT, 2005, J BIOL CHEM, V280, P7962, DOI 10.1074/jbc.M412593200; Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Choi JH, 2005, J CLIN ENDOCR METAB, V90, P207, DOI 10.1210/jc.2004-0297; Choi JH, 2009, CANCER RES, V69, P1407, DOI 10.1158/0008-5472.CAN-08-3602; Davidson B, 2006, GYNECOL ONCOL, V103, P814, DOI 10.1016/j.ygyno.2006.05.042; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Downey M, 2006, NAT CELL BIOL, V8, P9, DOI 10.1038/ncb0106-9; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Komiya T, 2006, ONCOGENE, V25, P6128, DOI 10.1038/sj.onc.1209627; Lafon-Hughes L, 2008, MUTAT RES-REV MUTAT, V658, P191, DOI 10.1016/j.mrrev.2008.01.008; Leitao MM, 2004, GYNECOL ONCOL, V93, P301, DOI 10.1016/j.ygyno.2004.01.043; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Loyola A, 2001, GENE DEV, V15, P2837; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Salani R, 2008, INT J GYNECOL CANCER, V18, P487, DOI 10.1111/j.1525-1438.2007.01039.x; Schwab M, 1998, BIOESSAYS, V20, P473, DOI 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.3.CO;2-N; Sehdev AES, 2010, MODERN PATHOL, V23, p264A; Shen JJC, 2008, CANCER RES, V68, P4050, DOI 10.1158/0008-5472.CAN-07-3240; Shih LM, 2005, P NATL ACAD SCI USA, V102, P14004, DOI 10.1073/pnas.0504195102; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang GG, 2007, TRENDS MOL MED, V13, P373, DOI 10.1016/j.molmed.2007.07.004; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	49	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38260	38269		10.1074/jbc.M110.138735	http://dx.doi.org/10.1074/jbc.M110.138735			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923775	Green Published, hybrid			2022-12-27	WOS:000284625600034
J	Carlucci, A; Porpora, M; Garbi, C; Galgani, M; Santoriello, M; Mascolo, M; di Lorenzo, D; Altieri, V; Quarto, M; Terracciano, L; Gottesman, ME; Insabato, L; Feliciello, A				Carlucci, Annalisa; Porpora, Monia; Garbi, Corrado; Galgani, Mario; Santoriello, Margherita; Mascolo, Massimo; di Lorenzo, Domenico; Altieri, Vincenzo; Quarto, Maria; Terracciano, Luigi; Gottesman, Max E.; Insabato, Luigi; Feliciello, Antonio			PTPD1 Supports Receptor Stability and Mitogenic Signaling in Bladder Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GENE-EXPRESSION; OXIDATIVE-METABOLISM; ENDOCYTOSIS; KINESIN; TARGETS; KINASE; CLASSIFICATION; TRAFFICKING; REGULATOR	PTPD1, a cytosolic non-receptor protein-tyrosine phosphatase, stimulates the Src-EGF transduction pathway. Localization of PTPD1 at actin cytoskeleton and adhesion sites is required for cell scattering and migration. Here, we show that during EGF stimulation, PTPD1 is rapidly recruited to endocytic vesicles containing the EGF receptor. Endosomal localization of PTPD1 is mediated by interaction with KIF16B, an endosomal kinesin that modulates receptor recycling at the plasma membrane. Silencing of PTPD1 promotes degradation of EGF receptor and inhibits downstream ERK signaling. We also found that PTPD1 is markedly increased in bladder cancer tissue samples. PTPD1 levels positively correlated with the grading and invasiveness potential of these tumors. Transgenic expression of an inactive PTPD1 mutant or genetic knockdown of the endogenous PTPD1 severely inhibited both growth and motility of human bladder cancer cells. These findings identify PTPD1 as a novel component of the endocytic machinery that impacts on EGF receptor stability and on growth and motility of bladder cancer cells.	[Quarto, Maria] Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare, Naples, Italy; [Mascolo, Massimo; Insabato, Luigi] Univ Naples Federico II, Dipartimento Sci Biomorfol & Funz, Naples, Italy; [di Lorenzo, Domenico; Altieri, Vincenzo] Univ Naples Federico II, Dipartimento Urol, Naples, Italy; [Terracciano, Luigi] Univ Hosp, Inst Pathol, Basel, Switzerland; [Gottesman, Max E.] Columbia Univ, Inst Canc Res, New York, NY 10032 USA	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Columbia University		feliciel@unina.it	Mascolo, Massimo/AAE-3547-2021; Galgani, Mario/AAC-3298-2022; Terracciano, Luigi M./AAB-5335-2022	Mascolo, Massimo/0000-0002-2576-220X; Terracciano, Luigi M./0000-0002-9393-9660; Quarto, Maria/0000-0003-0119-2393; Feliciello, Antonio/0000-0002-7932-2170; Galgani, Mario/0000-0001-8414-1676	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of University and Research MIUR [2007KS47FW_002]; Union for International Cancer Control [YY1/09/012]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research MIUR(Ministry of Education, Universities and Research (MIUR)); Union for International Cancer Control	This work was supported by a grant from Associazione Italiana per la Ricerca sul Cancro and Italian Ministry of University and Research MIUR 2008-2009 Grant 2007KS47FW_002, and Union for International Cancer Control Study Grant YY1/09/012 (to A. F.).	Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Baffa R, 2006, J EXP CLIN CANC RES, V25, P145; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Black Peter C, 2008, Curr Urol Rep, V9, P55, DOI 10.1007/s11934-008-0011-6; Blanchet P, 2001, EUR UROL, V40, P169, DOI 10.1159/000049768; Blatner NR, 2007, EMBO J, V26, P3709, DOI 10.1038/sj.emboj.7601800; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Carlucci A, 2008, J BIOL CHEM, V283, P10919, DOI 10.1074/jbc.M707248200; Carlucci A, 2008, TRENDS CELL BIOL, V18, P604, DOI 10.1016/j.tcb.2008.09.006; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dorner C, 1998, J BIOL CHEM, V273, P20267, DOI 10.1074/jbc.273.32.20267; Dunican DS, 2002, ONCOGENE, V21, P3253, DOI 10.1038/sj.onc.1205431; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Eden ER, 2009, BIOCHEM SOC T, V37, P173, DOI 10.1042/BST0370173; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jui HY, 2000, J BIOL CHEM, V275, P41124, DOI 10.1074/jbc.M007772200; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Liedberg F, 2008, UROL ONCOL-SEMIN ORI, V26, P17, DOI 10.1016/j.urolonc.2006.08.021; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; MOLLER NPH, 1994, P NATL ACAD SCI USA, V91, P7477, DOI 10.1073/pnas.91.16.7477; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Sanchez-Carbayo M, 2006, AM J PATHOL, V168, P93, DOI 10.2353/ajpath.2006.050601; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sandilands E, 2008, TRENDS CELL BIOL, V18, P322, DOI 10.1016/j.tcb.2008.05.004; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Wallerand H, 2008, CURR OPIN UROL, V18, P524, DOI 10.1097/MOU.0b013e3283097889; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	38	38	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39260	39270		10.1074/jbc.M110.174706	http://dx.doi.org/10.1074/jbc.M110.174706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923765	Green Published, hybrid			2022-12-27	WOS:000284941300055
J	Wang, YL; Kuo, JH; Lee, SC; Liu, JS; Hsieh, YC; Shih, YT; Chen, CJ; Chiu, JJ; Wu, WG				Wang, Yu-Ling; Kuo, Je-Hung; Lee, Shao-Chen; Liu, Jai-Shin; Hsieh, Yin-Cheng; Shih, Yu-Tsung; Chen, Chun-Jung; Chiu, Jeng-Jiann; Wu, Wen-guey			Cobra CRISP Functions as an Inflammatory Modulator via a Novel Zn2+- and Heparan Sulfate-dependent Transcriptional Regulation of Endothelial Cell Adhesion Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH SECRETORY PROTEIN-3; GATED ION CHANNELS; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CRYSTAL-STRUCTURE; HUMAN NEUTROPHILS; NATRIN TOXIN; SNAKE-VENOM; E-SELECTIN; FAMILY	Cysteine-rich secretory proteins (CRISPs) have been identified as a toxin family in most animal venoms with biological functions mainly associated with the ion channel activity of cysteine-rich domain (CRD). CRISPs also bind to Zn2+ at their N-terminal pathogenesis-related (PR-1) domain, but their function remains unknown. Interestingly, similar the Zn2+-binding site exists in all CRISP family, including those identified in a wide range of organisms. Here, we report that the CRISP from Naja atra (natrin) could induce expression of vascular endothelial cell adhesion molecules, i.e. intercellular adhesion molecule-1, vascular adhesion molecule-1, and E-selectin, to promote monocytic cell adhesion in a heparan sulfate (HS)- and Zn2+-dependent manner. Using specific inhibitors and small interfering RNAs, the activation mechanisms are shown to involve both mitogen-activated protein kinases and nuclear factor-kappa B. Biophysical characterization of natrin by using fluorescence, circular dichroism, and x-ray crystallographic methods further reveals the presence of two Zn2+-binding sites for natrin. The strong binding site is located near the putative Ser-His-Glucatalytic triad of the N-terminal domain. The weak binding site remains to be characterized, but it may modulate HS binding by enhancing its interaction with long chain HS. Our results strongly suggest that natrin may serve as an inflammatory modulator that could perturb the wound-healing process of the bitten victim by regulating adhesion molecule expression in endothelial cells. Our finding uncovers a new aspect of the biological role of CRISP family in immune response and is expected to facilitate future development of new therapeutic strategy for the envenomed victims.	[Wang, Yu-Ling; Shih, Yu-Tsung; Chiu, Jeng-Jiann] Natl Hlth Res Inst, Div Med Engn Res, Miaoli 35053, Taiwan; [Wang, Yu-Ling; Kuo, Je-Hung; Liu, Jai-Shin; Hsieh, Yin-Cheng; Wu, Wen-guey] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Lee, Shao-Chen] FuJen Catholic Univ, Sch Med, Hsinchuang 24205, Taiwan; [Hsieh, Yin-Cheng; Chen, Chun-Jung] Natl Synchrotron Radiat Res Ctr, Sci Res Div, Life Sci Grp, Hsinchu 30076, Taiwan	National Health Research Institutes - Taiwan; National Tsing Hua University; Fu Jen Catholic University; National Synchrotron Radiation Research Center	Chiu, JJ (corresponding author), Natl Hlth Res Inst, Div Med Engn Res, Miaoli 35053, Taiwan.	jjchiu@nhri.org.tw; wgwu@life.nthu.edu.tw	Chen, Chun-Jung/A-6880-2011; Chiu, Jeng-Jiann/E-3980-2010	Chen, Chun-Jung/0000-0002-5157-4288; Kuo, Je-Hung/0000-0002-5499-8027	Ministry of Economic Affairs [98_EC_17_A_17_S2_0101]; National Science Council [99-3112-B-400-008, 99-2321-B-400-002]	Ministry of Economic Affairs; National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Ministry of Economic Affairs Grant 98_EC_17_A_17_S2_0101 (to W.-g. W.) and National Science Council Grants 99-3112-B-400-008 and 99-2321-B-400-002 (to J.-J. C.).	ALBELDA SM, 1994, FASEB J, V8, P504, DOI 10.1096/fasebj.8.8.8181668; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Asmann YW, 2002, CANCER RES, V62, P3308; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Brown RL, 1999, P NATL ACAD SCI USA, V96, P754, DOI 10.1073/pnas.96.2.754; Brunger AT, 1998, CURR OPIN STRUC BIOL, V8, P606, DOI 10.1016/S0959-440X(98)80152-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; CHEN CC, 1995, AGENT ACTION SUPPL, V47, P135; Chiu JJ, 2004, ARTERIOSCL THROM VAS, V24, P73, DOI 10.1161/01.ATV.0000106321.63667.24; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Giese A, 2002, GENE, V299, P101, DOI 10.1016/S0378-1119(02)01018-1; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; HAENDLER B, 1993, ENDOCRINOLOGY, V133, P192, DOI 10.1210/en.133.1.192; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; Horne AW, 2009, MOL HUM REPROD, V15, P287, DOI 10.1093/molehr/gap019; Hung DZ, 2003, TOXICON, V41, P409, DOI 10.1016/S0041-0101(02)00336-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kjeldsen L, 1996, FEBS LETT, V380, P246, DOI 10.1016/0014-5793(96)00030-0; Kratzschmar J, 1996, EUR J BIOCHEM, V236, P827, DOI 10.1111/j.1432-1033.1996.t01-1-00827.x; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kuvibidila SR, 2006, J NATL MED ASSOC, V98, P1263; Laine M, 2007, ARTHRITIS RHEUM, V56, P2575, DOI 10.1002/art.22828; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Liao Q, 2003, HISTOL HISTOPATHOL, V18, P425, DOI 10.14670/HH-18.425; Lin YH, 1999, FEBS LETT, V453, P395, DOI 10.1016/S0014-5793(99)00760-7; Modur V, 1996, J BIOL CHEM, V271, P13094, DOI 10.1074/jbc.271.22.13094; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; O'Bryan MK, 1998, MOL REPROD DEV, V50, P313, DOI 10.1002/(SICI)1098-2795(199807)50:3&lt;313::AID-MRD7&gt;3.0.CO;2-M; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Patel HV, 1997, J BIOL CHEM, V272, P1484, DOI 10.1074/jbc.272.32.20185; PECK EJ, 1971, J BIOL CHEM, V246, P1160; Pfisterer P, 1996, MOL CELL BIOL, V16, P6160; SCHULTZ RM, 1982, INT J PEPT PROT RES, V19, P454; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; SIMONS TJB, 1991, J MEMBRANE BIOL, V123, P63, DOI 10.1007/BF01993964; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Suzuki N, 2008, ACTA CRYSTALLOGR D, V64, P1034, DOI 10.1107/S0907444908023512; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Udby L, 2004, BIOCHEMISTRY-US, V43, P12877, DOI 10.1021/bi048823e; Udby L, 2002, J IMMUNOL METHODS, V263, P43, DOI 10.1016/S0022-1759(02)00033-9; Udby L, 2002, J LEUKOCYTE BIOL, V72, P462; VandenBerg E, 2004, J CELL BIOCHEM, V91, P926, DOI 10.1002/jcb.20011; Vinay DS, 2009, CELL BIOL INT, V33, P453, DOI 10.1016/j.cellbi.2009.02.001; Wang F, 2006, BIOCHEM BIOPH RES CO, V351, P443, DOI 10.1016/j.bbrc.2006.10.067; Wang J, 2005, BIOCHEMISTRY-US, V44, P10145, DOI 10.1021/bi050614m; Wang YQ, 2004, ACTA CRYSTALLOGR E, V60, pM876, DOI 10.1107/S1600536804012565; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Yamazaki Y, 2002, BIOCHEMISTRY-US, V41, P11331, DOI 10.1021/bi026132h; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224	64	69	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 26	2010	285	48					37872	37883		10.1074/jbc.M110.146290	http://dx.doi.org/10.1074/jbc.M110.146290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	682ST	20889969	Green Published, hybrid			2022-12-27	WOS:000284424000077
J	Rishavy, MA; Usubalieva, A; Hallgren, KW; Berkner, KL				Rishavy, Mark A.; Usubalieva, Aisulu; Hallgren, Kevin W.; Berkner, Kathleen L.			Novel Insight into the Mechanism of the Vitamin K Oxidoreductase (VKOR) ELECTRON RELAY THROUGH Cys(43) AND Cys(51) REDUCES VKOR TO ALLOW VITAMIN K REDUCTION AND FACILITATION OF VITAMIN K-DEPENDENT PROTEIN CARBOXYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-CARBOXYLASE; BLOOD-COAGULATION FACTORS; EPOXIDE-REDUCTASE; COMBINED DEFICIENCY; PHARMACODYNAMIC RESISTANCE; 2,3-EPOXIDE REDUCTASE; ENDOPLASMIC-RETICULUM; WARFARIN RESISTANCE; ACTIVE-SITE; FACTOR-IX	The vitamin K oxidoreductase (VKOR) reduces vitamin K to support the carboxylation and consequent activation of vitamin K-dependent proteins, but the mechanism of reduction is poorly understood. VKOR is an integral membrane protein that reduces vitamin K using membrane-embedded thiols (Cys-132 and Cys-135), which become oxidized with concomitant VKOR inactivation. VKOR is subsequently reactivated by an unknown redox protein that is currently thought to act directly on the Cys132-Cys135 residues. However, VKOR contains evolutionarily conserved Cys residues (Cys-43 and Cys-51) that reside in a loop outside of the membrane, raising the question of whether they mediate electron transfer from a redox protein to Cys-132/Cys-135. To assess a possible role, the activities of mutants with Ala substituted for Cys (C43A and C51A) were analyzed in intact membranes using reductants that were either membrane-permeable or -impermeable. Both reductants resulted in wild type VKOR reduction of vitamin K epoxide; however, the C43A and C51A mutants only showed activity with the membrane-permeant reductant. We obtained similar results when testing the ability of wild type and mutant VKORs to support carboxylation, using intact membranes from cells coexpressing VKOR and carboxylase. These results indicate a role for Cys-43 and Cys-51 in catalysis, suggesting a relay mechanism in which a redox protein transfers electrons to these loop residues, which in turn reduce the membrane-embedded Cys132-Cys135 disulfide bond to activate VKOR. The results have implications for the mechanism of warfarin resistance, the topology of VKOR in the membrane, and the interaction of VKOR with the carboxylase.	[Rishavy, Mark A.; Usubalieva, Aisulu; Hallgren, Kevin W.; Berkner, Kathleen L.] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Usubalieva, Aisulu; Berkner, Kathleen L.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University	Berkner, KL (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave,NB50, Cleveland, OH 44195 USA.	berknek@ccf.org		Berkner, Kathleen/0000-0001-8054-8081	National Institutes of Health [5RO1HL081093]; American Heart Association [0735317N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081093, R01HL055666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant 5RO1HL081093 (to K. L. B.).; Supported by Scientist Development Grant 0735317N from the American Heart Association.	Berkner KL, 2008, VITAM HORM, V78, P131, DOI 10.1016/S0083-6729(07)00007-6; Berkner KL, 1997, METHOD ENZYMOL, V282, P313; Berkner KL, 2005, ANNU REV NUTR, V25, P127, DOI 10.1146/annurev.nutr.25.050304.092713; Bodin L, 2008, J THROMB HAEMOST, V6, P1436, DOI 10.1111/j.1538-7836.2008.03049.x; Brenner B, 1998, BLOOD, V92, P4554, DOI 10.1182/blood.V92.12.4554.424k42_4554_4559; D'Ambrosio RL, 2007, J THROMB HAEMOST, V5, P191, DOI 10.1111/j.1538-7836.2006.02261.x; Darghouth D, 2006, BLOOD, V108, P1925, DOI 10.1182/blood-2005-12-010660; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; FASCO MJ, 1982, J BIOL CHEM, V257, P4894; FASCO MJ, 1983, BIOCHEMISTRY-US, V22, P5655, DOI 10.1021/bi00293a031; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Hallgren KW, 2006, BIOCHEMISTRY-US, V45, P5587, DOI 10.1021/bi051986y; Harrington DJ, 2008, J THROMB HAEMOST, V6, P1663, DOI 10.1111/j.1538-7836.2008.03116.x; Harrington DJ, 2005, THROMB HAEMOSTASIS, V93, P23, DOI 10.1160/TH04-08-0540; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; KREIBICH G, 1973, J CELL BIOL, V58, P436, DOI 10.1083/jcb.58.2.436; LEE JJ, 1984, BIOCHEMISTRY-US, V23, P2246, DOI 10.1021/bi00305a024; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Loebstein R, 2007, BLOOD, V109, P2477, DOI 10.1182/blood-2006-08-038984; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Morris DP, 1995, J BIOL CHEM, V270, P30491, DOI 10.1074/jbc.270.51.30491; Oldenburg J, 2000, THROMB HAEMOSTASIS, V84, P937; Rishavy MA, 2008, BIOCHEMISTRY-US, V47, P9836, DOI 10.1021/bi800296r; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, BRIT J HAEMATOL, V126, P546, DOI 10.1111/j.1365-2141.2004.05071.x; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; ROTH DA, 1993, P NATL ACAD SCI USA, V90, P8372, DOI 10.1073/pnas.90.18.8372; Schmeits PCJ, 2010, BRIT J HAEMATOL, V148, P955, DOI 10.1111/j.1365-2141.2009.08017.x; SOUTE BAM, 1992, BIOCHEM J, V281, P255, DOI 10.1042/bj2810255; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Spronk HMH, 2000, BLOOD, V96, P3650; Stenina O, 2001, BIOCHEMISTRY-US, V40, P10301, DOI 10.1021/bi0107039; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; VANHAARLEM JL, 1987, FEBS LETT, V222, P353; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wallin R, 2002, THROMB RES, V108, P221, DOI 10.1016/S0049-3848(03)00060-4; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003; Wilms EB, 2008, J THROMB HAEMOST, V6, P1224, DOI 10.1111/j.1538-7836.2008.02975.x; Zhu AH, 2007, BLOOD, V109, P5270, DOI 10.1182/blood-2006-12-064188	45	64	72	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7267	7278		10.1074/jbc.M110.172213	http://dx.doi.org/10.1074/jbc.M110.172213			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	20978134	Green Published, hybrid			2022-12-27	WOS:000287737300043
J	Wu, LM; Ma, CA; Zhao, YG; Jain, A				Wu, Liming; Ma, Chi A.; Zhao, Yongge; Jain, Ashish			Aurora B Interacts with NIR-p53, Leading to p53 Phosphorylation in Its DNA-binding Domain and Subsequent Functional Suppression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; CHROMOSOMAL PASSENGERS; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; IN-VIVO; KINASE; ACETYLATION; ACTIVATION; APOPTOSIS; DEGRADATION	NIR (novel INHAT repressor) is a transcriptional co-repressor with inhibitor of histone acetyltransferase (INHAT) activity and has previously been shown to physically interact with and suppress p53 transcriptional activity and function. However, the mechanism by which NIR suppresses p53 is not completely understood. Using a proteomic approach, we have identified the Aurora kinase B as a novel binding partner of NIR. We show that Aurora B, NIR and p53 exist in a protein complex in which Aurora B binds to NIR, thus also indirectly associates with p53. Functionally, overexpression of Aurora B or NIR suppresses p53 transcriptional activity, and depletion of Aurora B or NIR causes p53-dependent apoptosis and cell growth arrest, due to the up-regulation of p21 and Bax. We then demonstrate that Aurora B phosphorylates multiple sites in the p53 DNA-binding domain in vitro, and this phosphorylation probably also occurs in cells. Importantly, the Aurora B-mediated phosphorylation on Ser(269) or Thr(284) significantly compromises p53 transcriptional activity. Taken together, these results provide novel insight into NIR-mediated p53 suppression and also suggest an additional way for p53 regulation.	[Wu, Liming; Ma, Chi A.; Zhao, Yongge; Jain, Ashish] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, A (corresponding author), NIAID, Host Def Lab, NIH, 10 Ctr Dr,CRC,Rm 5W3950, Bethesda, MD 20892 USA.	ajain@niaid.nih.gov	Wu, liming/AAH-5415-2019; Wu, Liming/C-4004-2011		National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000924] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the intramural Research Program from National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health.	Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bross L, 2000, IMMUNITY, V13, P589, DOI 10.1016/S1074-7613(00)00059-5; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; Ikezoe T, 2010, INT J HEMATOL, V91, P69, DOI 10.1007/s12185-009-0462-7; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Katayama H, 1999, J NATL CANCER I, V91, P1160, DOI 10.1093/jnci/91.13.1160; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lee EM, 2006, NEUROLOGY, V66, pA89; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	38	56	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					2236	2244		10.1074/jbc.M110.174755	http://dx.doi.org/10.1074/jbc.M110.174755			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	20959462	Green Published, hybrid			2022-12-27	WOS:000286191500064
J	Alvarez, C; Lozano-Juste, J; Romero, LC; Garcia, I; Gotor, C; Leon, J				Alvarez, Consolacion; Lozano-Juste, Jorge; Romero, Luis C.; Garcia, Irene; Gotor, Cecilia; Leon, Jose			Inhibition of Arabidopsis O-Acetylserine(thiol)lyase A1 by Tyrosine Nitration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ACETYLSERINE SULFHYDRYLASE; NITRIC-OXIDE; SERINE ACETYLTRANSFERASE; GENE FAMILY; CYSTEINE BIOSYNTHESIS; ABSCISIC-ACID; FUNCTIONAL-ANALYSIS; CADMIUM TOLERANCE; PROTEIN OXIDATION; THALIANA	The last step of sulfur assimilation is catalyzed by O-acetyl-serine(thiol) lyase (OASTL) enzymes. OASTLs are encoded by a multigene family in the model plant Arabidopsis thaliana. Cytosolic OASA1 enzyme is the main source of OASTL activity and thus crucial for cysteine homeostasis. We found that nitrating conditions after exposure to peroxynitrite strongly inhibited OASTL activity. Among OASTLs, OASA1 was markedly sensitive to nitration as demonstrated by the comparative analysis of OASTL activity in nitrated crude protein extracts from wild type and different oastl mutants. Furthermore, nitration assays on purified recombinant OASA1 protein led to 90% reduction of the activity due to inhibition of the enzyme, as no degradation of the protein occurred under these conditions. The reduced activity was due to nitration of the protein because selective scavenging of peroxynitrite with epicatechin impaired OASA1 nitration and the concomitant inhibition of OASTL activity. Inhibition of OASA1 activity upon nitration correlated with the identification of a modified OASA1 protein containing 3-nitroTyr(302) residue. The essential role of the Tyr(302) residue for the catalytic activity was further demonstrated by the loss of OASTL activity of a Y302A-mutated version of OASA1. Inhibition caused by Tyr(302) nitration on OASA1 activity seems to be due to a drastically reduced O-acetylserine substrate binding to the nitrated protein, and also to reduced stabilization of the pyridoxal-5'-phosphate cofactor through hydrogen bonds. This is the first report identifying a Tyr nitration site of a plant protein with functional effect and the first post-translational modification identified in OASA1 enzyme.	[Lozano-Juste, Jorge; Leon, Jose] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; [Alvarez, Consolacion; Romero, Luis C.; Garcia, Irene; Gotor, Cecilia] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Leon, J (corresponding author), Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, CPI Ed 8E,Camino Vera S-N, Valencia 46022, Spain.	jleon@ibmcp.upv.es	León, José/C-4756-2016; García, Irene/C-8334-2011; Romero, Luis C./B-7138-2012; Gotor, Cecilia/B-7173-2012; Lozano-Juste, Jorge/K-3066-2017; Alvarez Nunez, Consolacion/I-3342-2018	León, José/0000-0002-7332-1572; García, Irene/0000-0001-7586-5664; Romero, Luis C./0000-0002-2414-4813; Gotor, Cecilia/0000-0003-4272-7446; Lozano-Juste, Jorge/0000-0001-7034-566X; Alvarez Nunez, Consolacion/0000-0002-2893-3545	CONSOLIDER TRANSPLANTA [CSD2007-00057];  [BIO2008-00839];  [BIO2010- 15201]	CONSOLIDER TRANSPLANTA; ; 	This work was supported by Grants BIO2008-00839 and CONSOLIDER TRANSPLANTA CSD2007-00057 (to J. L.) and BIO2010- 15201 (to C. G.).	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Atanassov II, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-14; Barroso C, 1999, PLANT MOL BIOL, V40, P729, DOI 10.1023/A:1006285016296; BARROSO C, 1995, FEBS LETT, V363, P1, DOI 10.1016/0014-5793(95)00255-8; Bonner ER, 2005, J BIOL CHEM, V280, P38803, DOI 10.1074/jbc.M505313200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Corpas FJ, 2009, PLANT SIGNAL BEHAV, V4, P920, DOI 10.4161/psb.4.10.9466; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Dominguez-Solis JR, 2001, J BIOL CHEM, V276, P9297, DOI 10.1074/jbc.M009574200; Dominguez-Solis JR, 2004, PLANT BIOTECHNOL J, V2, P469, DOI 10.1111/j.1467-7652.2004.00092.x; Droux M, 2004, PHOTOSYNTH RES, V79, P331, DOI 10.1023/B:PRES.0000017196.95499.11; Durzan DJ, 2002, BIOTECHNOL GENET ENG, V19, P293, DOI 10.1080/02648725.2002.10648032; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Heeg C, 2008, PLANT CELL, V20, P168, DOI 10.1105/tpc.107.056747; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Lindermayr C, 2009, J PROTEOMICS, V73, P1, DOI 10.1016/j.jprot.2009.07.002; Lopez-Martin MC, 2008, PLANT PHYSIOL, V147, P562, DOI 10.1104/pp.108.117408; Lozano-Juste J, 2010, PLANT PHYSIOL, V152, P891, DOI 10.1104/pp.109.148023; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Rinalducci S, 2008, J EXP BOT, V59, P3781, DOI 10.1093/jxb/ern252; Schroeder P, 2001, BIOCHEM BIOPH RES CO, V285, P782, DOI 10.1006/bbrc.2001.5210; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Tai CH, 2001, ACCOUNTS CHEM RES, V34, P49, DOI 10.1021/ar990169l; Thomas DD, 2002, P NATL ACAD SCI USA, V99, P12691, DOI 10.1073/pnas.202312699; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; Watanabe M, 2008, PLANT CELL, V20, P2484, DOI 10.1105/tpc.108.060335; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2004, J EXP BOT, V55, P1785, DOI 10.1093/jxb/erh201; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang Y, 2009, INT J BIOCHEM CELL B, V41, P907, DOI 10.1016/j.biocel.2008.08.040	41	40	40	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					578	586		10.1074/jbc.M110.147678	http://dx.doi.org/10.1074/jbc.M110.147678			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21047785	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-27	WOS:000285782800060
J	Brady, RO				Brady, Roscoe O.			Benefits from Unearthing "a Biochemical Rosetta Stone"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							INHERITED ENZYME DEFICIENCY; NIEMANN-PICK DISEASE; GLUCOCEREBROSIDE-CLEAVING ENZYME; IN-UTERO DIAGNOSIS; GAUCHERS-DISEASE; REPLACEMENT THERAPY; FABRYS-DISEASE; PURIFIED GLUCOCEREBROSIDASE; FATTY ACIDS; METABOLISM		NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Brady, RO (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	bradyr@ninds.nih.gov						Aghion A, 1934, THESIS U PARIS PARIS; AGRANOFF BW, 1954, J BIOL CHEM, V211, P773; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; BRADY R O, 1952, Brookhaven Symp Biol, V5, P162; Brady R. O, 1971, CHEM ENG NEWS   0222; BRADY RO, 1960, J BIOL CHEM, V235, P3099; BRADY RO, 1958, P NATL ACAD SCI USA, V44, P993, DOI 10.1073/pnas.44.10.993; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; BRADY RO, 1971, AM J MED, V51, P423, DOI 10.1016/0002-9343(71)90249-X; BRADY RO, 1951, J BIOL CHEM, V189, P371; BRADY RO, 1950, J BIOL CHEM, V186, P461; BRADY RO, 1952, J BIOL CHEM, V199, P421; BRADY RO, 1957, J AM CHEM SOC, V79, P2648, DOI 10.1021/ja01567a079; BRADY RO, 1971, SCIENCE, V172, P174, DOI 10.1126/science.172.3979.174; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; BRADY RO, 1974, NEW ENGL J MED, V291, P989, DOI 10.1056/NEJM197411072911901; BRADY RO, 1966, J CLIN INVEST, V45, P1112, DOI 10.1172/JCI105417; BRADY RO, 1966, NEW ENGL J MED, V275, P312, DOI 10.1056/NEJM196608112750606; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; BRADY RO, 1973, NEW ENGL J MED, V289, P9, DOI 10.1056/NEJM197307052890103; BRADY RO, 1953, P SOC EXP BIOL MED, V84, P634; BRADY RO, 1951, J BIOL CHEM, V193, P459; BRADY RO, 1954, J BIOL CHEM, V211, P621; BRADY RO, 1950, J BIOL CHEM, V187, P589; BRADY RO, 1951, ARCH BIOCHEM BIOPHYS, V34, P221, DOI 10.1016/S0003-9861(51)80030-4; BRADY RO, 1965, J BIOL CHEM, V240, P39; Brady RO, 1982, MEMBRANES TRANSPORT, V2, P587; Buton R.M., 1958, J BIOL CHEM, V233, P1053; EPSTEIN CJ, 1971, AM J HUM GENET, V23, P533; FURBISH FS, 1977, P NATL ACAD SCI USA, V74, P3560, DOI 10.1073/pnas.74.8.3560; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; HO MW, 1972, AM J HUM GENET, V24, P37; JOHNSON WG, 1972, METHOD ENZYMOL, V28, P849; KAMPINE JP, 1967, SCIENCE, V155, P86, DOI 10.1126/science.155.3758.86; KOLODNY EH, 1969, BIOCHEM BIOPH RES CO, V37, P526, DOI 10.1016/0006-291X(69)90947-4; Lieb H, 1924, H-S Z PHYSIOL CHEM, V140, P305, DOI 10.1515/bchm2.1924.140.5-6.305; PENTCHEV PG, 1975, J MOL MED, V1, P73; PENTCHEV PG, 1973, J BIOL CHEM, V248, P5256; SCHNEIDER EL, 1972, J PEDIATR-US, V81, P1134; SHAPIRO D, 1962, J AM CHEM SOC, V84, P1047, DOI 10.1021/ja00865a036; TALLMAN JF, 1972, J CLIN INVEST, V51, P2339, DOI 10.1172/JCI107045; Thannhauser S. J., 1950, LIPIDOSES DIS CELLUL; Thudicum J. L. W., 1884, TREATISE CHEM COMPOS; TRAMS EG, 1960, J CLIN INVEST, V39, P1546, DOI 10.1172/JCI104175; WEINREB NJ, 1968, BIOCHIM BIOPHYS ACTA, V159, P141, DOI 10.1016/0005-2744(68)90251-9	46	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41216	41221		10.1074/jbc.X110.197954	http://dx.doi.org/10.1074/jbc.X110.197954			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21030589	Green Published, hybrid			2022-12-27	WOS:000285622600007
J	Machiya, Y; Hara, S; Arawaka, S; Fukushima, S; Sato, H; Sakamoto, M; Koyama, S; Kato, T				Machiya, Youhei; Hara, Susumu; Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sakamoto, Masahiro; Koyama, Shingo; Kato, Takeo			Phosphorylated alpha-Synuclein at Ser-129 Is Targeted to the Proteasome Pathway in a Ubiquitin-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; COUPLED RECEPTOR KINASES; PARKINSONS-DISEASE; NEURONAL CELLS; MOUSE-BRAIN; DEGRADATION; AGGREGATION; PATHOGENESIS; INCLUSIONS; BINDING	alpha-Synuclein (a-Syn) is a major component of fibrillar aggregates in Lewy bodies (LBs), a characteristic hallmark of Parkinson disease. Almost 90% of a-Syn deposited in LBs is phosphorylated at Ser-129. However, the role of Ser-129-phosphorylated a-Syn in the biogenesis of LBs remains unclear. Here, we investigated the metabolism of Ser-129-phosphorylated a-Syn. In SH-SY5Y cells, inhibition of protein phosphatase 2A/1 by okadaic acid, and inhibition of the proteasome pathway by MG132 or lactacystin accumulated Ser129-phosphorylated a-Syn. However, these inhibitions did not alter the amounts of total a-Syn within the observation time. Inhibition of the autophagy-lysosome pathway by 3-methyladenine or chloroquine accumulated Ser-129-phosphorylated a-Syn in parallel to total a-Syn during longer incubations. Experiments using cycloheximide showed that Ser-129-phosphorylated a-Syn diminished rapidly (t1/2 = 54.9 +/- 6.4 min), in contrast to the stably expressed total a-Syn. The short half-life of Ser-129-phosphorylated a-Syn was blocked by MG132 to a greater extent than okadaic acid. In rat primary cortical neurons, either MG132, lactacystin, or okadaic acid accumulated Ser-129-phosphorylated a-Syn. Additionally, we did not find that phosphorylated a-Syn was ubiquitinated in the presence of proteasome inhibitors. These data show that Ser-129-phosphorylated a-Syn is targeted to the proteasome pathway in a ubiquitin-independent manner, in addition to undergoing dephosphorylation. The proteasome pathway may play a role in the biogenesis of Ser-129-phosphorylated a-Syn-rich LBs.	[Machiya, Youhei; Hara, Susumu; Arawaka, Shigeki; Fukushima, Shingo; Sato, Hiroyasu; Sakamoto, Masahiro; Koyama, Shingo; Kato, Takeo] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata 9909585, Japan	Yamagata University	Arawaka, S (corresponding author), 2-2-2 Iida Nishi, Yamagata 9908585, Japan.	arawaka@med.id.yamagata-u.ac.jp		Arawaka, Shigeki/0000-0002-1505-3012	Japan Society for the Promotion of Science [F03]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid from the Global COE Program (F03) of the Japan Society for the Promotion of Science (to T.K.).	Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chen L, 2009, J CLIN INVEST, V119, P3257, DOI 10.1172/JCI39088; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600	38	80	83	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40732	40744		10.1074/jbc.M110.141952	http://dx.doi.org/10.1074/jbc.M110.141952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959456	Green Published, hybrid			2022-12-27	WOS:000285414400037
J	Moller, C; Melaun, C; Castillo, C; Diaz, ME; Renzelman, CM; Estrada, O; Kuch, U; Lokey, S; Mari, F				Moeller, Carolina; Melaun, Christian; Castillo, Cecilia; Diaz, Mary E.; Renzelman, Chad M.; Estrada, Omar; Kuch, Ulrich; Lokey, Scott; Mari, Frank			Functional Hypervariability and Gene Diversity of Cardioactive Neuropeptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAB CARCINUS-MAENAS; D-AMINO-ACID; PEPTIDE CCAP; MANDUCA-SEXTA; SHORE CRAB; CARDIOACCELERATORY PEPTIDE; GAMMA-CARBOXYGLUTAMATE; DECAPOD CRUSTACEANS; LOCUSTA-MIGRATORIA; ALPHA-AMYLASE	Crustacean cardioactive peptide (CCAP) and related peptides are multifunctional regulatory neurohormones found in invertebrates. We isolated a CCAP-related peptide (conoCAP-a, for cone snail CardioActive Peptide) and cloned the cDNA of its precursor from venom of Conus villepinii. The precursor of conoCAP-a encodes for two additional CCAP-like peptides: conoCAP-b and conoCAP-c. This multi-peptide precursor organization is analogous to recently predicted molluscan CCAP-like preprohormones, and suggests a mechanism for the generation of biological diversification without gene amplification. While arthropod CCAP is a cardio-accelerator, we found that conoCAP-a decreases the heart frequency in Drosophila larvae, demonstrating that conoCAP-a and CCAP have opposite effects. Intravenous injection of conoCAP-a in rats caused decreased heart frequency and blood pressure in contrast to the injection of CCAP, which did not elicit any cardiac effect. Perfusion of rat ventricular cardiac myocytes with conoCAP-a decreased systolic calcium, indicating that conoCAP-a cardiac negative inotropic effects might be mediated via impairment of intracellular calcium trafficking. The contrasting cardiac effects of conoCAP-a and CCAP indicate that molluscan CCAP-like peptides have functions that differ from those of their arthropod counterparts. Molluscan CCAP-like peptides sequences, while homologous, differ between taxa and have unique sequences within a species. This relates to the functional hypervariability of these peptides as structure activity relationship studies demonstrate that single amino acids variations strongly affect cardiac activity. The discovery of conoCAPs in cone snail venom emphasizes the significance of their gene plasticity to have mutations as an adaptive evolution in terms of structure, cellular site of expression, and physiological functions.	[Mari, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Melaun, Christian; Kuch, Ulrich] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Castillo, Cecilia] Inst Estudios Avanzados IDEA, Ctr Biociencias & Med Mol, Caracas 1015A, Venezuela; [Diaz, Mary E.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Renzelman, Chad M.; Lokey, Scott] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; Inst Venezolano Invest Cient, Biophys & Biochem Ctr, Caracas 1020A, Venezuela	State University System of Florida; Florida Atlantic University; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Edinburgh; University of California System; University of California Santa Cruz; Venezuelan Institute Science Research	Mari, F (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, 777 Glades Rd, Boca Raton, FL 33431 USA.	mari@fau.edu	Castillo, Cecilia/AAH-1903-2020; Kuch, Ulrich/C-6656-2013; Estrada, Omar/G-9953-2018	Castillo, Cecilia/0000-0003-3978-2866; Kuch, Ulrich/0000-0002-5091-7752; Diaz, Mary/0000-0001-8946-8563; Estrada, Omar/0000-0001-9214-5183	National Institutes of Health [1R21NS066371-01]; Florida Seagrant program [R/LR-MB-28]; Hesse's Ministry of Higher Education, Research, and the Arts (UK); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Seagrant program; Hesse's Ministry of Higher Education, Research, and the Arts (UK); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21NS066371-01 (to F.M.), Florida Seagrant program Grant R/LR-MB-28 (to F.M.), LOEWE-Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of Hesse's Ministry of Higher Education, Research, and the Arts (UK).	Aguilar MB, 2008, PEPTIDES, V29, P186, DOI 10.1016/j.peptides.2007.09.022; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bayrhuber M, 2005, J BIOL CHEM, V280, P23766, DOI 10.1074/jbc.C500064200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; CARPINO LA, 1986, J ORG CHEM, V51, P3732, DOI 10.1021/jo00369a042; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Chung JS, 2004, DEVELOPMENT, V131, P4751, DOI 10.1242/dev.01312; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Cruz-Bermudez ND, 2007, J EXP BIOL, V210, P2873, DOI 10.1242/jeb.002949; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Donini A, 2002, PEPTIDES, V23, P1915, DOI 10.1016/S0196-9781(02)00174-2; Donini A, 2002, PEPTIDES, V23, P683, DOI 10.1016/S0196-9781(01)00662-3; Ducancel F, 2002, TOXICON, V40, P1541, DOI 10.1016/S0041-0101(02)00159-9; Dulcis D, 2005, J NEUROBIOL, V64, P259, DOI 10.1002/neu.20136; Dulcis D, 2001, J COMP PHYSIOL A, V187, P837, DOI 10.1007/s00359-001-0254-x; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; EIPPER BA, 1985, ENDOCRINOLOGY, V116, P2497, DOI 10.1210/endo-116-6-2497; Fort TJ, 2007, J NEUROPHYSIOL, V97, P3407, DOI 10.1152/jn.00939.2006; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; FURUYA K, 1993, BIOL CHEM H-S, V374, P1065, DOI 10.1515/bchm3.1993.374.7-12.1065; Gammie SC, 1997, J NEUROSCI, V17, P4389; Honegger HW, 2002, J COMP NEUROL, V452, P163, DOI 10.1002/cne.10357; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; LEHMAN HK, 1993, PEPTIDES, V14, P735, DOI 10.1016/0196-9781(93)90106-Q; Lirazan M, 2002, TOXICON, V40, P901, DOI 10.1016/S0041-0101(02)00079-X; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; Minakata H., 1992, PEPTIDE CHEM; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Muneoka Y., 1994, PERSPECTIVES COMP EN; Nagata K., 2005, PEPTIDE SCI, V44, P441; Nichols R, 1999, PEPTIDES, V20, P1153, DOI 10.1016/S0196-9781(99)00118-7; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; OLIVERA BM, 1995, TRENDS BIOTECHNOL, V13, P422, DOI 10.1016/S0167-7799(00)88996-9; Phlippen MK, 2000, J EXP BIOL, V203, P521; Pimenta AMC, 2005, J PEPT SCI, V11, P670, DOI 10.1002/psc.701; Sakai T, 2004, ENDOCRINOLOGY, V145, P5671, DOI 10.1210/en.2004-0722; Sakai T, 2006, PEPTIDES, V27, P2157, DOI 10.1016/j.peptides.2006.04.009; SCHWARTZ TW, 1986, FEBS LETT, V200, P1, DOI 10.1016/0014-5793(86)80500-2; STANGIER J, 1987, P NATL ACAD SCI USA, V84, P575, DOI 10.1073/pnas.84.2.575; STANGIER J, 1989, GEN COMP ENDOCR, V74, P271; TAM JP, 1991, J AM CHEM SOC, V113, P6657, DOI 10.1021/ja00017a044; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; THORNDYKE MC, 1988, BIOL J LINN SOC, V34, P249, DOI 10.1111/j.1095-8312.1988.tb01962.x; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; TUBLITZ NJ, 1986, J NEUROSCI, V6, P2451; Veelaert D, 1997, ENDOCRINOLOGY, V138, P138, DOI 10.1210/en.138.1.138; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; WILKENS JL, 1993, PHYSIOL ZOOL, V66, P237, DOI 10.1086/physzool.66.2.30163688	57	20	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40673	40680		10.1074/jbc.M110.171397	http://dx.doi.org/10.1074/jbc.M110.171397			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20923766	Green Published, hybrid			2022-12-27	WOS:000285414400030
J	Su, SC; Maxwell, SA; Bayless, KJ				Su, Shih-Chi; Maxwell, Steve A.; Bayless, Kayla J.			Annexin 2 Regulates Endothelial Morphogenesis by Controlling AKT Activation and Junctional Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL COLLAGEN MATRICES; SPHINGOSINE 1-PHOSPHATE; LUMEN FORMATION; IN-VIVO; TYROSINE PHOSPHORYLATION; VASCULAR MATURATION; SIGNAL-TRANSDUCTION; ADHERENS JUNCTIONS; BARRIER INTEGRITY; CAPILLARY LUMEN	Sprouting angiogenesis is a multistep process that involves endothelial cell activation, basement membrane degradation, proliferation, lumen formation, and stabilization. In this study, we identified annexin 2 as a regulator of endothelial morphogenesis using a three-dimensional in vitro model where sprouting angiogenesis was driven by sphingosine 1-phosphate and angiogenic growth factors. We observed that sphingosine 1-phosphate triggered annexin 2 translocation from the cytosol to the plasma membrane and its association with vascular endothelial (VE)-cadherin. In addition, annexin 2 depletion attenuated Akt activation, which was associated with increased phosphorylation of VE-cadherin and endothelial barrier leakage. Disrupting homotypic VE-cadherin interactions with EGTA, antibodies to the extracellular domain of VE-cadherin, or gene silencing all resulted in decreased Akt (but not Erk1/2) activation. Furthermore, expression of constitutively active Akt restored reduced endothelial sprouting responses observed with annexin 2 and VE-cadherin knockdown. Collectively, we report that annexin 2 regulates endothelial morphogenesis through an adherens junction-mediated pathway upstream of Akt.	[Su, Shih-Chi; Maxwell, Steve A.; Bayless, Kayla J.] Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Bayless, KJ (corresponding author), Texas A&M Hlth Sci Ctr, Dept Mol & Cellular Med, 440 Reynolds Med Bldg, College Stn, TX 77843 USA.	kbayless@medicine.tamhsc.edu			National Institutes of Health from the NHLBI [RO1HL095786]; Texas A&M Health Science Center [134403-20605]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095786] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Texas A&M Health Science Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL095786 from the NHLBI (to K. J. B.). This work was also supported by Texas A&M Health Science Center Research Development Grant 134403-20605 to (K. J. B. and S. A. M.).	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ancellin N, 1999, J BIOL CHEM, V274, P18997, DOI 10.1074/jbc.274.27.18997; Babiychuk EB, 2002, FASEB J, V16, DOI 10.1096/fj.02-0070com; Bayless KJ, 2009, NAT PROTOC, V4, P1888, DOI 10.1038/nprot.2009.221; Bayless KJ, 2003, BIOCHEM BIOPH RES CO, V312, P903, DOI 10.1016/j.bbrc.2003.11.017; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; Berridge MJ, 2000, SCIENCE, V287, P1604, DOI 10.1126/science.287.5458.1604; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Donati C, 2006, BBA-BIOMEMBRANES, V1758, P2037, DOI 10.1016/j.bbamem.2006.06.015; Dossumbekova A, 2008, AM J PHYSIOL-HEART C, V295, pH2417, DOI 10.1152/ajpheart.00501.2008; Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174; Endo A, 2002, J BIOL CHEM, V277, P23747, DOI 10.1074/jbc.M111794200; English D, 2002, BBA-MOL CELL BIOL L, V1582, P228, DOI 10.1016/S1388-1981(02)00176-2; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; HARDER T, 1993, J CELL BIOL, V123, P1119, DOI 10.1083/jcb.123.5.1119; Hayes MJ, 2006, EMBO J, V25, P1816, DOI 10.1038/sj.emboj.7601078; Heyraud S, 2008, MOL CELL BIOL, V28, P1657, DOI 10.1128/MCB.00695-07; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kang HJ, 2008, AM J PHYSIOL-HEART C, V295, pH2087, DOI 10.1152/ajpheart.00281.2008; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Krump-Konvalinkova V, 2005, ARTERIOSCL THROM VAS, V25, P546, DOI 10.1161/01.ATV.0000154360.36106.d9; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Merrifield CJ, 2001, CURR BIOL, V11, P1136, DOI 10.1016/S0960-9822(01)00321-9; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Montesano R, 1992, EXS, V61, P129; Muraki K, 2001, J PHYSIOL-LONDON, V537, P431, DOI 10.1111/j.1469-7793.2001.00431.x; Nicosia RF, 1999, INT REV CYTOL, V185, P1; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, J CELL SCI, V121, P2177, DOI 10.1242/jcs.028415; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Su SC, 2008, AM J PHYSIOL-CELL PH, V295, pC1215, DOI 10.1152/ajpcell.00336.2008; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Tsunezumi J, 2008, FEBS J, V275, P4810, DOI 10.1111/j.1742-4658.2008.06620.x; VERNON RB, 1995, AM J PATHOL, V147, P873; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Yamada A, 2006, ONCOGENE, V25, P5085, DOI 10.1038/sj.onc.1209525; Zhao J, 2009, CELL SIGNAL, V21, P1945, DOI 10.1016/j.cellsig.2009.09.002	74	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52								10.1074/jbc.M110.157271	http://dx.doi.org/10.1074/jbc.M110.157271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947498	Green Published, hybrid			2022-12-27	WOS:000285414400025
J	Mayer, PR; Huang, NA; Dewey, CM; Dries, DR; Zhang, H; Yu, G				Mayer, Paul R.; Huang, Nian; Dewey, Colleen M.; Dries, Daniel R.; Zhang, Hong; Yu, Gang			Expression, Localization, and Biochemical Characterization of Nicotinamide Mononucleotide Adenylyltransferase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEINS; DELAYS AXONAL DEGENERATION; GTP-BINDING PROTEINS; SYNAPTIC VESICLES; BETA-COP; NMN/NAMN ADENYLYLTRANSFERASE; NAD BIOSYNTHESIS; TRITON X-114; IN-VIVO; BRAIN	Nicotinamide mononucleotide (NMN) adenylyltransferase 2 (Nmnat2) catalyzes the synthesis of NAD from NMN and ATP. The Nmnat2 transcript is expressed predominately in the brain; we report here that Nmnat2 is a low abundance protein expressed in neurons. Previous studies indicate that Nmnat2 localizes to Golgi. As Nmnat2 is not predicted to contain a signal sequence, lipid-binding domain, or transmembrane domain, we investigated the nature of this interaction. These experiments reveal that Nmnat2 is palmitoylated in vitro, and this modification is required for membrane association. Surprisingly, exogenous Nmnat2 is toxic to neurons, indicating that protein levels must be tightly regulated. To analyze Nmnat2 localization in neurons (previous experiments relied on exogenous expression in HeLa cells), mouse brains were fractionated, showing that Nmnat2 is enriched in numerous membrane compartments including synaptic terminals. In HeLa cells, in addition to Golgi, Nmnat2 localizes to Rab7-containing late endosomes. These studies show that Nmnat2 is a neuronal protein peripherally attached to membranes via palmitoylation and suggest that Nmnat2 is transported to synaptic terminals via an endosomal pathway.	[Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Huang, Nian; Zhang, Hong] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [R01 AG029547]; Ruth K. Broad Biomedical Research Foundation; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING [R01AG029547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth K. Broad Biomedical Research Foundation; Ted Nash Long Life Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG029547. This work was also supported by the Ruth K. Broad Biomedical Research Foundation and the Ted Nash Long Life Foundation.	Abuin A, 2007, Handb Exp Pharmacol, P129; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; DEHOOP MJ, 1994, NEURON, V13, P11, DOI 10.1016/0896-6273(94)90456-1; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; El-Husseini AE, 2001, J BIOL CHEM, V276, P44984, DOI 10.1074/jbc.M103049200; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; Hegyi J, 2004, INT J DERMATOL, V43, P1, DOI 10.1111/j.1365-4632.2004.01959.x; HOGEBOOM GH, 1952, J BIOL CHEM, V197, P611; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KINSELLA BT, 1991, J BIOL CHEM, V266, P8540; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KNAUS P, 1986, J NEUROCHEM, V47, P1302; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kurnasov OV, 2002, J BACTERIOL, V184, P6906, DOI 10.1128/JB.184.24.6906-6917.2002; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Ponnambalam S, 1996, J CELL SCI, V109, P675; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; SALMON P, 2006, CURR PROTOC NEUROSCI, V37; Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schweiger M, 2001, FEBS LETT, V492, P95, DOI 10.1016/S0014-5793(01)02180-9; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; Spies TD, 1939, ANN INTERN MED, V12, P1830, DOI 10.7326/0003-4819-12-11-1830; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; VONMOLLARD GF, 1994, EUR J CELL BIOL, V65, P319; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 1998, DEV DYNAM, V212, P258; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; WHITTAKER VP, 1993, J NEUROCYTOL, V22, P735, DOI 10.1007/BF01181319; WHITTAKER VP, 1964, BIOCHEM J, V90, P293, DOI 10.1042/bj0900293; Yalowitz JA, 2004, BIOCHEM J, V377, P317, DOI 10.1042/BJ20030518; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	67	51	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40387	40396		10.1074/jbc.M110.178913	http://dx.doi.org/10.1074/jbc.M110.178913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20943658	Green Published, hybrid			2022-12-27	WOS:000285185500081
J	Smith-Pearson, PS; Greuber, EK; Yogalingam, G; Pendergast, AM				Smith-Pearson, Pameeka S.; Greuber, Emileigh K.; Yogalingam, Gouri; Pendergast, Ann Marie			Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; EXTRACELLULAR-MATRIX DEGRADATION; SRC-DEPENDENT PHOSPHORYLATION; ALDRICH-SYNDROME PROTEIN; ROUS-SARCOMA-VIRUS; TYROSINE-KINASE; C-ABL; TRANSFORMING ACTIVITY; FAMILY KINASES; N-WASP	The Abl tyrosine kinases, Abl and Arg, play a role in the regulation of the actin cytoskeleton by modulating cell-cell adhesion and cell motility. Deregulation of both the actin cytoskeleton and Abl kinases have been implicated in cancers. Abl kinase activity is elevated in a number of metastatic cancers and these kinases are activated downstream of several oncogenic growth factor receptor signaling pathways. However, the role of Abl kinases in regulation of the actin cytoskeleton during tumor progression and invasion remains elusive. Here we identify the Abl kinases as essential regulators of invadopodia assembly and function. We show that Abl kinases are activated downstream of the chemokine receptor, CXCR4, and are required for cancer cell invasion and matrix degradation induced by SDF1 alpha, serum growth factors, and activated Src kinase. Moreover, Abl kinases are readily detected at invadopodia assembly sites and their inhibition prevents the assembly of actin and cortactin into organized invadopodia structures. We show that active Abl kinases form complexes with membrane type-1 matrix metalloproteinase (MT1-MMP), a critical invadopodia component required for matrix degradation. Further, loss of Abl kinase signaling induces internalization of MT1-MMP from the cell surface, promotes its accumulation in the perinuclear compartment and inhibits MT1-MMP tyrosine phosphorylation. Our findings reveal that Abl kinase signaling plays a critical role in invadopodia formation and function, and have far-reaching implications for the treatment of metastatic carcinomas.	[Smith-Pearson, Pameeka S.; Greuber, Emileigh K.; Yogalingam, Gouri; Pendergast, Ann Marie] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Pendergast, AM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, 308 Res Dr,DUMC Box 3813, Durham, NC 27710 USA.	pende014@mc.duke.edu		Pendergast, Ann Marie/0000-0002-1250-6880	National Institutes of Health [CA 70940, HL 084102]; American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship; Molecular Cancer Biology Postdoctoral Fellowship; PhRMA Predoctoral Fellowship; NATIONAL CANCER INSTITUTE [R01CA070940] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship(American Cancer Society); Molecular Cancer Biology Postdoctoral Fellowship; PhRMA Predoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 70940 and HL 084102 (to A.M.P.).; Supported by the American Cancer Society New England Division-Spin Odyssey Postdoctoral Fellowship and by the Molecular Cancer Biology Postdoctoral Fellowship Training Grant.; Supported by a PhRMA Predoctoral Fellowship.	Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2009, AM J PATHOL, V174, P602, DOI 10.2353/ajpath.2009.080636; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Burton EA, 2005, MOL CELL BIOL, V25, P8834, DOI 10.1128/MCB.25.20.8834-8843.2005; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chen WS, 1999, INT J CANCER, V83, P579, DOI 10.1002/(SICI)1097-0215(19991126)83:5<579::AID-IJC1>3.0.CO;2-R; CHEN WT, 1985, NATURE, V316, P156, DOI 10.1038/316156a0; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; Clark ES, 2008, EUR J CELL BIOL, V87, P581, DOI 10.1016/j.ejcb.2008.01.008; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; DAI ZH, 1995, GENE DEV, V9, P2569, DOI 10.1101/gad.9.21.2569; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Jallal H, 2007, CANCER RES, V67, P1580, DOI 10.1158/0008-5472.CAN-06-2027; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Leng Y, 2005, P NATL ACAD SCI USA, V102, P1098, DOI 10.1073/pnas.0409120102; Li YS, 2001, CANCER RES, V61, P6906; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; McLaughlin J, 2007, P NATL ACAD SCI USA, V104, P20501, DOI 10.1073/pnas.0710532105; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mizutani K, 2002, CANCER RES, V62, P669; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Oikawa T, 2008, J CELL BIOL, V182, P157, DOI 10.1083/jcb.200801042; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schade B, 2007, CANCER RES, V67, P7579, DOI 10.1158/0008-5472.CAN-06-4724; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Srinivasan D, 2008, ONCOGENE, V27, P1095, DOI 10.1038/sj.onc.1210714; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Sun XL, 2009, CARCINOGENESIS, V30, P2109, DOI 10.1093/carcin/bgp251; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zou DH, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2332	68	63	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40201	40211		10.1074/jbc.M110.147330	http://dx.doi.org/10.1074/jbc.M110.147330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937825	Green Published, hybrid			2022-12-27	WOS:000285185500065
J	Soundararajan, R; Wang, JA; Melters, D; Pearce, D				Soundararajan, Rama; Wang, Jian; Melters, Daniel; Pearce, David			Glucocorticoid-induced Leucine Zipper 1 Stimulates the Epithelial Sodium Channel by Regulating Serum- and Glucocorticoid-induced Kinase 1 Stability and Subcellular Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DEGRADATION; ALDOSTERONE; PROTEIN; TRANSPORT; SGK-1; UBIQUITYLATION; EXPRESSION; ISOFORMS; NEDD4-2	Serum-and glucocorticoid-induced kinase 1 (SGK1) is a multifunctional protein kinase that markedly influences various cellular processes such as proliferation, apoptosis, glucose metabolism, and sodium (Na+) transport via the epithelial Na+ channel, ENaC. SGK1 is a short-lived protein, which is predominantly targeted to the endoplasmic reticulum (ER) to undergo rapid proteasome-mediated degradation through the ER-associated degradation (ERAD) system. We show here that the aldosterone-induced chaperone, GILZ1 (glucocorticoid-induced leucine zipper protein-1) selectively decreases SGK1 localization to ER as well as its interaction with ER-associated E3 ubiquitin ligases, HRD1 and CHIP. GILZ1 inhibits SGK1 ubiquitinylation and subsequent proteasome-mediated degradation, thereby prolonging its half-life and increasing its steady-state expression. Furthermore, comparison of the effect of GILZ1 with that of proteasome inhibition (by MG-132) supports the idea that these effects of GILZ1 are secondary to physical interaction of GILZ1 with SGK1 and enhanced recruitment of SGK1 to targets within an "ENaC regulatory complex," thus making less SGK1 available to the ERAD machinery. Finally, effects of GILZ1 knockdown and overexpression strongly support the idea that these effects of GILZ1 are functionally important for ENaC regulation. These data provide new insight into how the manifold activities of SGK1 are selectively deployed and strengthened through modulation of its molecular interactions, subcellular localization, and stability.	[Soundararajan, Rama; Wang, Jian; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Melters, Daniel] Univ Calif Davis, Cell & Dev Biol Grad Grp, Dept Plant Biol, Davis, CA 95616 USA; [Melters, Daniel] Univ Calif Davis, Cell & Dev Biol Grad Grp, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Pearce, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Francisco	Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, 600 16th St,N274H,Box 2140,Genentech Hall, San Francisco, CA 94143 USA.	dpearce@medsfgh.ucsf.edu	wang, jian/GVS-0711-2022	Melters, Daniel/0000-0003-4809-0562	National Institutes of Health [K01-DK078679, R01-DK56695, R01-DK85101]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078679, R01DK085101, R01DK056695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants K01-DK078679 (to R. S.), R01-DK56695 (to D. P.), and R01-DK85101 (to D. P.).	Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; Belova L, 2006, BIOCHEM J, V400, P235, DOI 10.1042/BJ20060905; Bhargava A, 2004, MOL CELL ENDOCRINOL, V217, P189, DOI 10.1016/j.mce.2003.10.020; Bogusz AM, 2006, FEBS J, V273, P2913, DOI 10.1111/j.1742-4658.2006.05304.x; Brickley DR, 2002, J BIOL CHEM, V277, P43064, DOI 10.1074/jbc.M207604200; Feng L, 2007, P NATL ACAD SCI USA, V104, P14348, DOI 10.1073/pnas.0701298104; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; KENDALL JM, 1994, ANAL BIOCHEM, V221, P173, DOI 10.1006/abio.1994.1394; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lee EJ, 2009, EXP MOL MED, V41, P555, DOI 10.3858/emm.2009.41.8.061; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; LU M, J AM SOC NEPHROL, V21, P811; McCormick JA, 2005, PHYSIOLOGY, V20, P134, DOI 10.1152/physiol.00053.2004; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Morice C, 1999, EUR J NEUROSCI, V11, P1995, DOI 10.1046/j.1460-9568.1999.00609.x; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Paolino M, 2009, EUR J IMMUNOL, V39, P2337, DOI 10.1002/eji.200939662; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Vallon V, 2005, AM J PHYSIOL-REG I, V288, pR4, DOI 10.1152/ajpregu.00369.2004; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	30	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39905	39913		10.1074/jbc.M110.161133	http://dx.doi.org/10.1074/jbc.M110.161133			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947508	Green Published, hybrid			2022-12-27	WOS:000285185500035
J	Spoerner, M; Hozsa, C; Poetzl, JA; Reiss, K; Ganser, P; Geyer, M; Kalbitzer, HR				Spoerner, Michael; Hozsa, Constantin; Poetzl, Johann A.; Reiss, Kerstin; Ganser, Petra; Geyer, Matthias; Kalbitzer, Hans Robert			Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-31 NMR-SPECTROSCOPY; BINDING DOMAIN; H-RAS; EXCHANGE PROCESSES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; P21(RAS); P21; MOLECULES; MECHANISM	The guanine nucleotide-binding protein Ras exists in solution in two different conformational states when complexed with different GTP analogs such as GppNHp or GppCH(2)p. State 1 has only a very low affinity to effectors and seems to be recognized by guanine nucleotide exchange factors, whereas state 2 represents the high affinity effector binding state. In this work we investigate Ras in complex with the physiological nucleoside triphosphate GTP. By polarization transfer P-31 NMR experiments and effector binding studies we show that Ras(wt)center dot Mg2+center dot GTP also exists in a dynamical equilibrium between the weakly populated conformational state 1 and the dominant state 2.At 278 K the equilibrium constant between state 1 and state 2 of C-terminal truncated wild-type Ras(1166) K-12 is 11.3. K-12 of full-length Ras is > 20, suggesting that the C terminus may also have a regulatory effect on the conformational equilibrium. The exchange rate (k(ex)) for Ras(wt)center dot Mg2+center dot GTP is 7 s(-1) and thus 18-fold lower compared with that found for the Ras. GppNHp complex. The intrinsic GTPase activity substantially increases after effector binding for the switch I mutants Ras(Y32F), (Y32R), (Y32W), (Y32C/C118S), (T35S), and the switch II mutant Ras(G60A) by stabilizing state 2, with the largest effect on Ras(Y32R) with a 13-fold increase compared with wild-type. In contrast, no acceleration was observed in Ras(T35A). Thus Ras in conformational state 2 has a higher affinity to effectors as well as a higher GTPase activity. These observations can be used to explain why many mutants have a low GTPase activity but are not oncogenic.	[Spoerner, Michael; Hozsa, Constantin; Poetzl, Johann A.; Reiss, Kerstin; Ganser, Petra; Kalbitzer, Hans Robert] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany	University of Regensburg; Max Planck Society	Kalbitzer, HR (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.	hans-robert.kalbitzer@biologie.uni-regensburg.de	Spörner, Michael/B-9018-2012; Spoerner, Michael/C-9035-2012	Hozsa, Constantin/0000-0001-7766-3644; Kalbitzer, Hans Robert/0000-0002-6514-2355; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft; Volkswagenstiftung; Fonds der Chemischen Industrie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Volkswagenstiftung(Volkswagen); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Deutsche Forschungsgemeinschaft, the Volkswagenstiftung, and the Fonds der Chemischen Industrie.	Buhrman G, 2007, STRUCTURE, V15, P1618, DOI 10.1016/j.str.2007.10.011; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Geyer M, 1999, BIOCHEMISTRY-US, V38, P11250, DOI 10.1021/bi9904306; Geyer M, 1997, NAT STRUCT BIOL, V4, P694, DOI 10.1038/nsb0997-694; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Gronwald W, 2001, STRUCTURE, V9, P1029, DOI 10.1016/S0969-2126(01)00671-2; HAUSSER KH, 1991, NMR MED BIOL STRUCTU; Herrmann C, 1996, J BIOL CHEM, V271, P6794, DOI 10.1074/jbc.271.12.6794; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Iuga A, 2004, J MOL BIOL, V342, P1033, DOI 10.1016/j.jmb.2004.07.077; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JOHN J, 1993, J BIOL CHEM, V268, P923; Kalbitzer HR, 2009, J AM CHEM SOC, V131, P16714, DOI 10.1021/ja904314q; Kotting C, 2007, CHEMBIOCHEM, V8, P781, DOI 10.1002/cbic.200600552; Linnemann T, 1999, J BIOL CHEM, V274, P13556, DOI 10.1074/jbc.274.19.13556; Maurer T, 1996, J MAGN RESON SER B, V113, P177, DOI 10.1006/jmrb.1996.0172; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; Rosnizeck IC, 2010, ANGEW CHEM INT EDIT, V49, P3830, DOI 10.1002/anie.200907002; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; Schweins T, 1996, BIOCHEMISTRY-US, V35, P14225, DOI 10.1021/bi961118o; SCHWEINS T, 1995, NAT STRUCT BIOL, V2, P36, DOI 10.1038/nsb0195-36; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spangler C, 2009, ANAL BIOANAL CHEM, V394, P989, DOI 10.1007/s00216-008-2517-7; Spoerner M, 2005, BIOCHEM BIOPH RES CO, V334, P709, DOI 10.1016/j.bbrc.2005.06.144; Spoerner M, 2005, BIOCHEMISTRY-US, V44, P2225, DOI 10.1021/bi0488000; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Stumber M, 2002, J MOL BIOL, V323, P899, DOI 10.1016/S0022-2836(02)01010-0; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	42	94	94	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39768	39778		10.1074/jbc.M110.145235	http://dx.doi.org/10.1074/jbc.M110.145235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937837	hybrid, Green Published			2022-12-27	WOS:000285185500021
J	Durr, KL; Seuffert, I; Friedrich, T				Duerr, Katharina L.; Seuffert, Ina; Friedrich, Thomas			Deceleration of the E1P-E2P Transition and Ion Transport by Mutation of Potentially Salt Bridge-forming Residues Lys-791 and Glu-820 in Gastric H+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-CLAMP FLUOROMETRY; K+-COMPETITIVE INHIBITOR; SWISS-MODEL WORKSPACE; RAT DISTAL COLON; ADENOSINE-TRIPHOSPHATE; ESCHERICHIA-COLI; LACTOSE PERMEASE; INORGANIC-PHOSPHATE; STATE STABILIZATION; CRYSTAL-STRUCTURE	A lysine residue within the highly conserved center of the fifth transmembrane segment in P-IIC-type ATPase alpha-subunits is uniquely found in H,K-ATPases instead of a serine in all Na,K-ATPase isoforms. Because previous studies suggested a prominent role of this residue in determining the electrogenicity of non-gastric H,K-ATPase and in pK(a) modulation of the proton-translocating residues in the gastric H,K-ATPases as well, we investigated its functional significance for ion transport by expressing several Lys-791 variants of the gastric H,K-ATPase in Xenopus oocytes. Although the mutant proteins were all detected at the cell surface, none of the investigated mutants displayed any measurable K+-induced stationary currents. In Rb+ uptake measurements, replacement of Lys-791 by Arg, Ala, Ser, and Glu substantially impaired transport activity and reduced the sensitivity toward the E-2-specific inhibitor SCH28080. Furthermore, voltage clamp fluorometry using a reporter site in the TM5/TM6 loop for labeling with tetramethylrhodamine-6-maleimide revealed markedly changed fluorescence signals. All four investigated mutants exhibited a strong shift toward the E1P state, in agreement with their reduced SCH28080 sensitivity, and an about 5-10-fold decreased forward rate constant of the E1P <-> E2P conformational transition, thus explaining the E1P shift and the reduced Rb+ transport activity. When Glu-820 in TM6 adjacent to Lys-791 was replaced by non-charged or positively charged amino acids, severe effects on fluorescence signals and Rb+ transport were also observed, whereas substitution by aspartate was less disturbing. These results suggest that formation of an E2P-stabilizing interhelical salt bridge is essential to prevent futile proton exchange cycles of H+ pumping P-type ATPases.	[Duerr, Katharina L.; Seuffert, Ina; Friedrich, Thomas] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany	Technical University of Berlin	Durr, KL (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	duerr@ohsu.edu	Friedrich, Thomas/AAA-3418-2022; Duerr, Katharina/A-6975-2015	Duerr, Katharina/0000-0002-3245-4088	Deutsche Forschungsgemeinschaft [SFB 740]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SFB 740 and Cluster of Excellence Unifying Concepts in Catalysis).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asano S, 1997, J BIOL CHEM, V272, P17668, DOI 10.1074/jbc.272.28.17668; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BuffinMeyer B, 1997, AM J PHYSIOL-RENAL, V272, pF124, DOI 10.1152/ajprenal.1997.272.1.F124; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Burnay M, 2001, AM J PHYSIOL-RENAL, V281, pF869, DOI 10.1152/ajprenal.2001.281.5.F869; CHIESI M, 1984, BIOCHEMISTRY-US, V23, P2595, DOI 10.1021/bi00307a009; CHMOULIO.M, 1974, PFLUG ARCH EUR J PHY, V350, P309, DOI 10.1007/BF00592639; Cougnon M, 1998, P NATL ACAD SCI USA, V95, P6516, DOI 10.1073/pnas.95.11.6516; Cougnon M, 1996, J BIOL CHEM, V271, P7277, DOI 10.1074/jbc.271.13.7277; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; De Pont JJHHM, 2003, ANN NY ACAD SCI, V986, P175; DEWEER P, 1984, NATURE, V309, P450, DOI 10.1038/309450a0; Durr KL, 2009, J BIOL CHEM, V284, P20147, DOI 10.1074/jbc.M109.005769; Durr KL, 2009, J BIOL CHEM, V284, P3842, DOI 10.1074/jbc.M808101200; DUNTEN RL, 1993, BIOCHEMISTRY-US, V32, P3139, DOI 10.1021/bi00063a028; Durr KL, 2008, BIOCHEMISTRY-US, V47, P4288, DOI 10.1021/bi800092k; EFTHYMIADIS A, 1991, BIOCHIM BIOPHYS ACTA, V1068, P73, DOI 10.1016/0005-2736(91)90062-D; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P237, DOI 10.1113/jphysiol.1967.sp008298; GARRAHAN PJ, 1966, NATURE, V211, P1414, DOI 10.1038/2111414a0; Geering K, 2001, J BIOENERG BIOMEMBR, V33, P425, DOI 10.1023/A:1010623724749; Geibel S, 2003, ANN NY ACAD SCI, V986, P31, DOI 10.1111/j.1749-6632.2003.tb07136.x; Geibel S, 2003, P NATL ACAD SCI USA, V100, P964, DOI 10.1073/pnas.0337336100; GOTTARDI CJ, 1993, J BIOL CHEM, V268, P14342; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; HELMICHDEJONG ML, 1985, BIOCHIM BIOPHYS ACTA, V821, P377, DOI 10.1016/0005-2736(85)90041-0; Hermsen HPH, 2001, BIOCHEMISTRY-US, V40, P6527, DOI 10.1021/bi002456z; Hermsen HPH, 1999, BBA-BIOMEMBRANES, V1416, P251, DOI 10.1016/S0005-2736(98)00227-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAISSER F, 1993, J CELL BIOL, V123, P1421, DOI 10.1083/jcb.123.6.1421; KING SC, 1991, BIOCHIM BIOPHYS ACTA, V1062, P177, DOI 10.1016/0005-2736(91)90390-T; KNOWLES AF, 1975, J BIOL CHEM, V250, P1949; Koenderink JB, 2004, J BIOL CHEM, V279, P16417, DOI 10.1074/jbc.M400020200; Lew V L, 1970, Nature, V225, P865, DOI 10.1038/225865a0; LORENTZON P, 1988, J BIOL CHEM, V263, P10705; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; MENDLEIN J, 1990, J BIOL CHEM, V265, P5030; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Munson K, 2005, BIOCHEMISTRY-US, V44, P5267, DOI 10.1021/bi047761p; Nissen P, 2009, EMBO J, V28, P1535, DOI 10.1038/emboj.2009.137; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Rajendran VM, 2000, J BIOL CHEM, V275, P13035, DOI 10.1074/jbc.275.17.13035; SACHS G, 1976, J BIOL CHEM, V251, P7690; SAHINTOTH M, 1992, P NATL ACAD SCI USA, V89, P10547, DOI 10.1073/pnas.89.21.10547; Shin JM, 2009, PFLUG ARCH EUR J PHY, V457, P609, DOI 10.1007/s00424-008-0495-4; STEKHOVEN FMAHS, 1986, BIOCHIM BIOPHYS ACTA, V854, P21; STENGELIN M, 1993, J MEMBRANE BIOL, V132, P211; Swarts HGP, 1998, EMBO J, V17, P3029, DOI 10.1093/emboj/17.11.3029; Swarts HGP, 1999, MOL PHARMACOL, V55, P541; Swarts HGP, 2001, J BIOL CHEM, V276, P36909, DOI 10.1074/jbc.M103945200; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; THOMAS RC, 1969, J PHYSIOL-LONDON, V201, P495, DOI 10.1113/jphysiol.1969.sp008769; Vagin O, 2001, BIOCHEMISTRY-US, V40, P7480, DOI 10.1021/bi0105328; VANDERHIJDEN HTWM, 1990, J MEMBRANE BIOL, V114, P245, DOI 10.1007/BF01869218; WALLMARK B, 1983, BIOCHIM BIOPHYS ACTA, V728, P31, DOI 10.1016/0005-2736(83)90433-9; WUTHRICH A, 1979, EXPERIENTIA, V35, P1589	60	11	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39366	39379		10.1074/jbc.M110.133470	http://dx.doi.org/10.1074/jbc.M110.133470			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921224	Green Published, hybrid			2022-12-27	WOS:000284941300064
J	Lee, GT; Kwon, SJ; Lee, JH; Jeon, SS; Jang, KT; Choi, HY; Lee, HM; Kim, WJ; Kim, SJ; Kim, IY				Lee, Geun Taek; Kwon, Seok Joo; Lee, Jae-Ho; Jeon, Seong Soo; Jang, Kee Taek; Choi, Han Yong; Lee, Hyun Moo; Kim, Wun-Jae; Kim, Seong Jin; Kim, Isaac Yi			Induction of Interleukin-6 Expression by Bone Morphogenetic Protein-6 in Macrophages Requires Both SMAD and p38 Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTOR; REGULATORS; KINASE; ACTS	Unlike the prototype transforming growth factor-beta (TGF-beta), bone morphogenetic protein-6 (BMP-6) activates macrophages. Here, we report that BMP-6 induces the expression of IL-6 in macrophages. Using overexpression and knockdown experiments, we demonstrate that BMP receptor type II and activin-like kinase-2 are necessary for IL-6 induction by BMP-6. At the intracellular level, both Smad and p38 signaling pathways are required for the induction of IL-6. The cross-talk between the two pathways occurs at the level of transcription factor GATA4 and Smad 1/4. These results, taken together, demonstrate a novel BMP-6 signaling mechanism in which both the Smad and non-Smad pathways directly interact to activate the transcription of a target gene.	[Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dean & Betty Gallo Prostate Canc Ctr, Sect Urol Oncol,Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Lee, Geun Taek; Kwon, Seok Joo; Lee, Jae-Ho; Jeon, Seong Soo; Kim, Isaac Yi] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Urol, Sect Urol Oncol,Canc Inst New Jersey,Dept Surg, New Brunswick, NJ 08903 USA; [Jeon, Seong Soo; Choi, Han Yong; Lee, Hyun Moo] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Urol, Seoul 135710, South Korea; [Jang, Kee Taek] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea; [Kim, Wun-Jae] Chungbuk Natl Univ, Coll Med, Dept Urol, Chonju 361711, South Korea; [Kim, Seong Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 401840, South Korea	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Chungbuk National University; Gachon University	Kim, IY (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dean & Betty Gallo Prostate Canc Ctr, Sect Urol Oncol,Canc Inst New Jersey, 195 Little Albany St,4560, New Brunswick, NJ 08903 USA.	kimiy@umdnj.edu			Ruth Estrin Goldberg Memorial Foundation; Tanzman Foundation; Jon Runyan Score for the Cure; Korean government Ministry of Education, Science, and Technology [09-1975-CCR-EO, PC 080209, R11-2008-014-00001-0]	Ruth Estrin Goldberg Memorial Foundation; Tanzman Foundation; Jon Runyan Score for the Cure; Korean government Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work has been supported in part by grants from the Ruth Estrin Goldberg Memorial Foundation, the Tanzman Foundation, and the Jon Runyan Score for the Cure, and by New Jersey Commission on Cancer Research Grant 09-1975-CCR-EO, Department of Defense Grant PC 080209, and Korea Science and Engineering Foundation Grant R11-2008-014-00001-0 funded by the Korean government Ministry of Education, Science, and Technology.	Belaguli NS, 2007, AM J PHYSIOL-GASTR L, V292, pG1520, DOI 10.1152/ajpgi.00236.2006; Brewer Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000093; Dawes LJ, 2009, INVEST OPHTH VIS SCI, V50, P5318, DOI 10.1167/iovs.08-3223; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hong JH, 2009, IMMUNOLOGY, V128, pe442, DOI 10.1111/j.1365-2567.2008.02998.x; Hsu MY, 2005, CANCER METAST REV, V24, P251, DOI 10.1007/s10555-005-1575-y; Hu MC, 2004, J BIOL CHEM, V279, P12051, DOI 10.1074/jbc.M310526200; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; LIU F, 1995, MOL CELL BIOL, V15, P3479; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Plaisance S, 1997, MOL CELL BIOL, V17, P3733, DOI 10.1128/MCB.17.7.3733; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Sivertsen EA, 2007, EUR J IMMUNOL, V37, P2937, DOI 10.1002/eji.200636759; Tokuda H, 2003, AM J PHYSIOL-ENDOC M, V284, pE1202, DOI 10.1152/ajpendo.00300.2002; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	23	26	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39401	39408		10.1074/jbc.M110.103705	http://dx.doi.org/10.1074/jbc.M110.103705			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20889504	hybrid, Green Published			2022-12-27	WOS:000284941300067
J	Ghoshal, S; Trivedi, DB; Graf, GA; Loftin, CD				Ghoshal, Sarbani; Trivedi, Darshini B.; Graf, Gregory A.; Loftin, Charles D.			Cyclooxygenase-2 Deficiency Attenuates Adipose Tissue Differentiation and Inflammation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); UP-REGULATION; 3T3-L1 CELLS; IN-VIVO; PROSTAGLANDIN; EXPRESSION; OBESITY	Obesity is associated with a variety of disorders and is a significant health problem in developed countries. One factor controlling the level of adiposity is the differentiation of cells into adipocytes. Adipocyte differentiation requires expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), which is activated by ligands to regulate expression of genes involved in adipocyte differentiation. Although 15-deoxy-Delta(12,14)-prostaglandin (PG) J(2) (15d-PGJ(2)) has long been known to be a potent activator of PPAR gamma, the importance of its synthesis in adipose tissue in vivo is not clear. The current study utilized mice deficient in cyclooxygenase-2 (COX-2) to examine the role of COX-2-derived PGs as in vivo modulators of adiposity. As compared with strain- and age-matched wildtype controls, the genetic deficiency of COX-2 resulted in a significant reduction in total body weight and percent body fat. Although there were no significant differences in food consumption between groups, COX-2-deficient mice showed increased metabolic activity. Epididymal adipose tissue from wild-type mice produced a significantly greater level of 15d-PGJ(2), as compared with adipose tissue isolated from mice deficient in COX-2. Furthermore, production of the precursor required for 15d-PGJ(2) formation, PGD(2), was also significantly reduced in COX-2-deficient adipose tissue. The expression of markers for differentiated adipocytes was significantly reduced in adipose tissue from COX-2-deficient mice, whereas preadipocyte marker expression was increased. Macrophage-dependent inflammation was also significantly reduced in adipose tissue of COX-2-deficient mice. These findings suggest that reduced adiposity in COX-2-deficient mice results from attenuated PPAR gamma ligand production and adipocyte differentiation.	[Ghoshal, Sarbani; Graf, Gregory A.; Loftin, Charles D.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Trivedi, Darshini B.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Loftin, CD (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Bio Pharm Complex,Rm 347,789 S Limestone St, Lexington, KY 40536 USA.	cdloft2@email.uky.edu		Graf, Gregory/0000-0002-0130-9929	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR024598] Funding Source: Medline; NIDDK NIH HHS [R01 DK080874-01A2, R01 DK080874-02, R01 DK080874-03, R01 DK080874] Funding Source: Medline; NIGMS NIH HHS [P20 GM103527] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bell-Parikh LC, 2003, J CLIN INVEST, V112, P945, DOI 10.1172/JCI200318012; Bosetti F, 2004, J NEUROCHEM, V91, P1389, DOI 10.1111/j.1471-4159.2004.02829.x; Bosetti F, 2007, J NEUROCHEM, V102, P577, DOI 10.1111/j.1471-4159.2007.04558.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Chu X, 2010, PROSTAG OTH LIPID M, V91, P1, DOI 10.1016/j.prostaglandins.2009.10.002; Cuzzocrea S, 2002, MOL PHARMACOL, V61, P997, DOI 10.1124/mol.61.5.997; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Granado M, 2009, EUR J PHARMACOL, V608, P97, DOI 10.1016/j.ejphar.2009.02.030; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Hsieh PS, 2010, EUR J CLIN INVEST, V40, P164, DOI 10.1111/j.1365-2362.2009.02239.x; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Kageyama H, 2003, BIOCHEM BIOPH RES CO, V305, P22, DOI 10.1016/S0006-291X(03)00663-6; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kirtikara K, 1998, J EXP MED, V187, P517, DOI 10.1084/jem.187.4.517; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Lijnen HR, 2008, THROMB HAEMOSTASIS, V100, P338, DOI 10.1160/TH08-02-0114; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mazid MA, 2006, FEBS LETT, V580, P6885, DOI 10.1016/j.febslet.2006.11.049; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Negrel R, 1999, PROSTAG LEUKOTR ESS, V60, P383, DOI 10.1016/S0952-3278(99)80017-9; Nishimura S, 2008, J CLIN INVEST, V118, P710, DOI 10.1172/JCI33328; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Scher JU, 2005, CLIN IMMUNOL, V114, P100, DOI 10.1016/j.clim.2004.09.008; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Sonoda E, 2008, ENDOCRINOLOGY, V149, P4794, DOI 10.1210/en.2008-0525; SUGIHARA H, 1988, J LIPID RES, V29, P691; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; VASSAUX G, 1992, J BIOL CHEM, V267, P11092; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wang HB, 2004, J BIOL CHEM, V279, P10649, DOI 10.1074/jbc.M312203200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu DY, 2007, J IMMUNOL, V179, P4829, DOI 10.4049/jimmunol.179.7.4829; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200	51	66	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					889	898		10.1074/jbc.M110.139139	http://dx.doi.org/10.1074/jbc.M110.139139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20961858	Green Published, hybrid			2022-12-27	WOS:000285782800088
J	Boukalova, S; Marsakova, L; Teisinger, J; Vlachova, V				Boukalova, Stepana; Marsakova, Lenka; Teisinger, Jan; Vlachova, Viktorie			Conserved Residues within the Putative S4-S5 Region Serve Distinct Functions among Thermosensitive Vanilloid Transient Receptor Potential (TRPV) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; CAPSAICIN RECEPTOR; SUBTYPE-1 CHANNEL; VOLTAGE SENSOR; PORE REGION; SENSITIVITY; ACTIVATION; DETERMINANTS; MUTATION	The vanilloid transient receptor potential channel TRPV1 is a tetrameric six-transmembrane segment (S1-S6) channel that can be synergistically activated by various proalgesic agents such as capsaicin, protons, heat, or highly depolarizing voltages, and also by 2-aminoethoxydiphenyl borate (2-APB), a common activator of the related thermally gated vanilloid TRP channels TRPV1, TRPV2, and TRPV3. In these channels, the conserved charged residues in the intracellular S4-S5 region have been proposed to constitute part of a voltage sensor that acts in concert with other stimuli to regulate channel activation. The molecular basis of this gating event is poorly understood. We mutated charged residues all along the S4 and the S4-S5 linker of TRPV1 and identified four potential voltage-sensing residues (Arg(557), Glu(570), Asp(576), and Arg(579)) that, when specifically mutated, altered the functionality of the channel with respect to voltage, capsaicin, heat, 2-APB, and/or their interactions in different ways. The nonfunctional charge-reversing mutations R557E and R579E were partially rescued by the charge-swapping mutations R557E/E570R and D576R/R579E, indicating that electrostatic interactions contribute to allosteric coupling between the voltage-, temperature- and capsaicin-dependent activation mechanisms. The mutant K571E was normal in all aspects of TRPV1 activation except for 2-APB, revealing the specific role of Lys(571) in chemical sensitivity. Surprisingly, substitutions at homologous residues in TRPV2 or TRPV3 had no effect on temperature- and 2-APB-induced activity. Thus, the charged residues in S4 and the S4-S5 linker contribute to voltage sensing in TRPV1 and, despite their highly conserved nature, regulate the temperature and chemical gating in the various TRPV channels in different ways.	[Boukalova, Stepana; Marsakova, Lenka; Teisinger, Jan; Vlachova, Viktorie] Acad Sci Czech Republic, Inst Physiol, Dept Cellular Neurophysiol, CR-14220 Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Vlachova, V (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Cellular Neurophysiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	vlachova@biomed.cas.cz	Boukalova, Stepana/H-2610-2014; Teisinger, Jan/B-7122-2012; Marsakova, Lenka/F-8637-2014; Boukalova, Stepana/AAM-3541-2020; Vlachova, Viktorie/A-4380-2012; Vlachova, Viktorie/Q-2040-2019	Boukalova, Stepana/0000-0002-6478-4604; Boukalova, Stepana/0000-0002-6478-4604; Vlachova, Viktorie/0000-0002-8621-0935; Vlachova, Viktorie/0000-0002-8621-0935; Vyklicka, Lenka/0000-0003-4108-5701	Czech Science Foundation [305/09/0081, 301/10/1159]; Academy of Science of the Czech Republic [AV0Z50110509, GAAV IAA600110701]; Ministry of Education, Youth and Sports of the Czech Republic [1M0517, LC554, GAUK 26110]	Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Science of the Czech Republic(Czech Academy of Sciences); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by Czech Science Foundation Grants 305/09/0081 and 301/10/1159, Research Project Fund of the Academy of Science of the Czech Republic Grants AV0Z50110509 and GAAV IAA600110701, and by the Ministry of Education, Youth and Sports of the Czech Republic Grants 1M0517, LC554, and GAUK 26110.	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Bezanilla F, 2008, NAT REV MOL CELL BIO, V9, P323, DOI 10.1038/nrm2376; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nilius B, 2005, J PHYSIOL-LONDON, V567, P35, DOI 10.1113/jphysiol.2005.088377; Novakova-Tousova K, 2007, NEUROSCIENCE, V149, P144, DOI 10.1016/j.neuroscience.2007.07.039; Susankova K, 2007, J NEUROSCI, V27, P7578, DOI 10.1523/JNEUROSCI.1956-07.2007; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046	32	53	53	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41455	41462		10.1074/jbc.M110.145466	http://dx.doi.org/10.1074/jbc.M110.145466			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044960	hybrid, Green Published			2022-12-27	WOS:000285622600031
J	Lee, SH; Park, Y; Yoon, SK; Yoon, JB				Lee, Seung-Hoon; Park, Yoon; Yoon, Sungjoo Kim; Yoon, Jong-Bok			Osmotic Stress Inhibits Proteasome by p38 MAPK-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOMES; 26S PROTEASOME; MASS-SPECTROMETRY; SUBSTRATE ENTRY; CORE PARTICLE; S PROTEASOME; ATPASE; ACTIVATION; PROTEINS; COMPLEXES	Osmotic stress causes profound perturbations of cell functions. Although the adaptive responses required for cell survival upon osmotic stress are being unraveled, little is known about the effects of osmotic stress on ubiquitin-dependent proteolysis. We now report that hyperosmotic stress inhibits proteasome activity by activating p38 MAPK. Osmotic stress increased the level of polyubiquitinated proteins in the cell. The selective p38 inhibitor SB202190 decreased osmotic stress-associated accumulation of polyubiquitinated proteins, indicating that p38 MAPK plays an inhibitory role in the ubiquitin proteasome system. Activated p38 MAPK stabilized various substrates of the proteasome and increased polyubiquitinated proteins. Proteasome preparations purified from cells expressing activated p38 MAPK had substantially lower peptidase activities than control proteasome samples. Proteasome phosphorylation sites dependent on p38 were identified by measuring changes in the extent of proteasome phosphorylation in response to p38 MAPK activation. The residue Thr-273 of Rpn2 is the major phosphorylation site affected by p38 MAPK. The mutation T273A in Rpn2 blocked the proteasome inhibition that is mediated by p38 MAPK. These results suggest that p38 MAPK negatively regulates the proteasome activity by phosphorylating Thr-273 of Rpn2.	[Lee, Seung-Hoon] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; Yonsei Univ, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Yoon, Sungjoo Kim] Catholic Univ Korea, Dept Biomed Sci, Seoul 137040, South Korea	Yonsei University; Yonsei University; Catholic University of Korea	Yoon, JB (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, 262 Seongsanno, Seoul 120749, South Korea.	yoonj@yonsei.ac.kr		Yoon, Jong-Bok/0000-0002-3563-0702	MEST [2009-0081317]; Korean Ministry of Science and Technology; Translational Research Center for Protein Function Control, National Research Foundation of Korea [2009-0081489]	MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Translational Research Center for Protein Function Control, National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported in part by the Mid-Career Researcher Program supported by National Research Foundation of Korea Grant 2009-0081317 funded by the MEST and grants from the Korean Ministry of Science and Technology supporting the Studies on Ubiquitome Functions Project and from the Translational Research Center for Protein Function Control, National Research Foundation of Korea Grant 2009-0081489.	Bode JG, 1999, J BIOL CHEM, V274, P30222, DOI 10.1074/jbc.274.42.30222; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Min KW, 2003, J BIOL CHEM, V278, P15905, DOI 10.1074/jbc.M213070200; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nickell S, 2007, FEBS LETT, V581, P2751, DOI 10.1016/j.febslet.2007.05.028; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sachon E, 2006, RAPID COMMUN MASS SP, V20, P1127, DOI 10.1002/rcm.2427; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shibatani T, 2006, MOL BIOL CELL, V17, P4962, DOI 10.1091/mbc.E06-04-0311; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	39	51	52	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41280	41289		10.1074/jbc.M110.182188	http://dx.doi.org/10.1074/jbc.M110.182188			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044959	hybrid, Green Published			2022-12-27	WOS:000285622600013
J	Oh, YT; Liu, XG; Yue, P; Kang, SM; Chen, J; Taunton, J; Khuri, FR; Sun, SY				Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Taunton, Jack; Khuri, Fadlo R.; Sun, Shi-Yong			ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; LUNG-CANCER CELLS; CCAAT/ENHANCER-BINDING-PROTEIN; CELECOXIB-INDUCED APOPTOSIS; DEPENDENT DEATH-RECEPTOR-5 INDUCTION; LIGAND-INDUCED APOPTOSIS; TRAIL-INDUCED APOPTOSIS; DRUG-INDUCED APOPTOSIS; NF-KAPPA-B; UP-REGULATION	Death receptor 5 (DR5) is a death domain-containing transmembrane receptor that triggers apoptosis upon binding to its ligand or when overexpressed. Its expression is induced by certain small molecule drugs, including celecoxib, through mechanisms that have not been fully elucidated. The current study has revealed a novel ERK/ribosomal S6 kinase (RSK)-dependent mechanism that regulates DR5 expression primarily using celecoxib as a DR5 inducer. Both C/EBP homologous protein (CHOP) and Elk1 are required for celecoxib-induced DR5 expression based on promoter deletion and mutation analysis and siRNA-mediated gene silencing results. Co-expression of both CHOP and Elk1 exhibited enhanced effects on increasing DR5 promoter activity and DR5 expression, indicating that CHOP and Elk1 co-operatively regulate DR5 expression. Because Elk1 is an ERK-regulated protein, we accordingly found that celecoxib increased the levels of phosphorylated ERK1/2, RSK2, and Elk1. Inhibition of either ERK signaling with a MEK inhibitor or ERK1/2 siRNA, or RSK2 signaling with an RSK2 inhibitor or RSK2 siRNA abrogated DR5 up-regulation by celecoxib as well as other agents. Moreover, these inhibitions suppressed celecoxib-induced CHOP up-regulation. Thus, ERK/RSK-dependent, CHOP and Elk1-mediated mechanisms are critical for DR5 induction. Additionally, celecoxib increased CHOP promoter activity in an ATF4-dependent manner, and siRNA-mediated blockade of ATF4 abrogated both CHOP induction and DR5 up-regulation, indicating that ATF4 is involved in celecoxib-induced CHOP and DR5 expression. Collectively, we conclude that small molecules such as celecoxib induce DR5 expression through activating ERK/RSK signaling and subsequent Elk1 activation and ATF4-dependent CHOP induction.	[Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Khuri, Fadlo R.; Sun, Shi-Yong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Oh, You-Take; Liu, Xiangguo; Yue, Ping; Kang, Sumin; Chen, Jing; Khuri, Fadlo R.; Sun, Shi-Yong] Winship Canc Inst, Atlanta, GA 30322 USA; [Liu, Xiangguo] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94117 USA	Emory University; Shandong University; University of California System; University of California San Francisco	Sun, SY (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, 1365-C Clifton Rd NE,Suite C3088, Atlanta, GA 30322 USA.	ssun@emory.edu	Liu, Xiangguo/G-1091-2010; Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618; Liu, Xiangguo/0000-0002-1879-3817	National Institutes of Health/NCI [SPORE P50, CA128613]; Georgia Cancer Coalition Distinguished Cancer Scholar award; Department of Defense [W81XWH-04-1-0142]; NATIONAL CANCER INSTITUTE [P50CA128613] Funding Source: NIH RePORTER	National Institutes of Health/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Cancer Scholar award; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health/NCI SPORE P50 Grant CA128613 (to S.-Y. S. for Project 2). This work was also supported by a Georgia Cancer Coalition Distinguished Cancer Scholar award (to S.-Y. S.) and Department of Defense VITAL Grant W81XWH-04-1-0142 (to S.-Y. S. for Project 4).	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Arai K, 2004, J NEUROCHEM, V89, P232, DOI 10.1111/j.1471-4159.2004.02317.x; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen SZ, 2007, MOL PHARMACOL, V72, P1269, DOI 10.1124/mol.107.037465; Chen ST, 2010, LEUKEMIA RES, V34, P250, DOI 10.1016/j.leukres.2009.09.028; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Drosopoulos KG, 2005, J BIOL CHEM, V280, P22856, DOI 10.1074/jbc.M412483200; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; He Q, 2008, ONCOGENE, V27, P2656, DOI 10.1038/sj.onc.1210894; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hung CC, 2003, J BIOL CHEM, V278, P29317, DOI 10.1074/jbc.M302368200; Jiang CC, 2007, CANCER RES, V67, P9750, DOI 10.1158/0008-5472.CAN-07-2047; Kim Su-Hyeong, 2007, Carcinogenesis, V28, P223, DOI 10.1093/carcin/bgl227; Kurnaz IA, 2004, BIOTECHNOL BIOENG, V88, P890, DOI 10.1002/bit.20322; Lawrence MC, 2007, P NATL ACAD SCI USA, V104, P11518, DOI 10.1073/pnas.0704618104; Lin YD, 2008, CANCER RES, V68, P5335, DOI 10.1158/0008-5472.CAN-07-6209; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu X, 2006, CANCER RES, V66, P11115, DOI 10.1158/0008-5472.CAN-06-2471; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Pyrko P, 2008, BIOCHEM PHARMACOL, V75, P395, DOI 10.1016/j.bcp.2007.08.029; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Ravi R, 2001, NAT CELL BIOL, V3, P409, DOI 10.1038/35070096; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal Axel H, 2006, Neurosurg Focus, V20, pE21, DOI 10.3171/foc.2006.20.4.14; Scott DW, 2008, DNA CELL BIOL, V27, P607, DOI 10.1089/dna.2008.0773; Shetty S, 2005, MOL CELL BIOL, V25, P5404, DOI 10.1128/MCB.25.13.5404-5416.2005; Suganuma M, 2006, INT J CANCER, V119, P33, DOI 10.1002/ijc.21809; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2005, APOPTOSIS, V10, P1203, DOI 10.1007/s10495-005-2274-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Tanaka K, 2005, J BIOL CHEM, V280, P31059, DOI 10.1074/jbc.M502956200; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; van der Sanden MHM, 2004, J BIOL CHEM, V279, P52007, DOI 10.1074/jbc.M405577200; Wang AB, 2009, J IMMUNOL, V183, P3268, DOI 10.4049/jimmunol.0900894; Woo KJ, 2007, BIOCHEM PHARMACOL, V73, P68, DOI 10.1016/j.bcp.2006.09.015; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zhang LJ, 2009, CANCER LETT, V274, P40, DOI 10.1016/j.canlet.2008.08.030; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	62	54	55	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41310	41319		10.1074/jbc.M110.153775	http://dx.doi.org/10.1074/jbc.M110.153775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21044953	Green Published, hybrid			2022-12-27	WOS:000285622600016
J	Sekiya, M; Hosokawa, H; Nakanishi-Matsui, M; Al-Shawi, MK; Nakamoto, RK; Futai, M				Sekiya, Mizuki; Hosokawa, Hiroyuki; Nakanishi-Matsui, Mayumi; Al-Shawi, Marwan K.; Nakamoto, Robert K.; Futai, Masamitsu			Single Molecule Behavior of Inhibited and Active States of Escherichia coli ATP Synthase F-1 Rotation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-SUBUNIT; BETA-SUBUNIT; CATALYTIC SITE; GAMMA-SUBUNIT; NUCLEOTIDE-BINDING; F0F1-ATP SYNTHASE; ROTARY MECHANISM; TRANSITION-STATE; C-RING; F-1-ATPASE	ATP hydrolysis-dependent rotation of the F-1 sector of the ATP synthase is a successive cycle of catalytic dwells (similar to 0.2 ms at 24 degrees C) and 120 degrees rotation steps (similar to 0.6 ms) when observed under V-max conditions using a low viscous drag 60-nm bead attached to the gamma subunit (Sekiya, M., Nakamoto, R. K., AlShawi, M. K., Nakanishi-Matsui, M., and Futai, M. (2009) J. Biol. Chem. 284, 22401-22410). During the normal course of observation, the gamma subunit pauses in a stochastic manner to a catalytically inhibited state that averages similar to 1 s in duration. The rotation behavior with adenosine 5'-O-(3-thiotriphosphate) as the substrate or at a low ATP concentration (4 mu M) indicates that the rotation is inhibited at the catalytic dwell when the bound ATP undergoes reversible hydrolysis/synthesis. The temperature dependence of rotation shows that F-1 requires similar to 2-fold higher activation energy for the transition from the active to the inhibited state compared with that for normal steady-state rotation during the active state. Addition of superstoichiometric gamma subunit, the inhibitor of F-1-ATPase, decreases the rotation rate and at the same time increases the duration time of the inhibited state. Arrhenius analysis shows that the gamma subunit has little effect on the transition between active and inhibited states. Rather, the gamma subunit confers lower activation energy of steady-state rotation. These results suggest that the gamma subunit plays a role in guiding the enzyme through the proper and efficient catalytic and transport rotational pathway but does not influence the transition to the inhibited state.	[Futai, Masamitsu] Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan; [Futai, Masamitsu] Iwate Med Univ, Futai Special Lab, Yahaba, Iwate 0283694, Japan; [Al-Shawi, Marwan K.; Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	Iwate Medical University; Iwate Medical University; University of Virginia	Futai, M (corresponding author), Iwate Med Univ, Dept Biochem, Fac Pharmaceut Sci, Yahaba, Iwate 0283694, Japan.	futaim@iwate-med.ac.jp			United States Public Health Service [RO1 GM50957, RO1 GM52502]; Ministry of Science and Culture of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052502, R01GM050957] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Ministry of Science and Culture of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was support, in whole or in part, by United States Public Health Service Grants RO1 GM50957 (to R. K.N.) and RO1 GM52502 (to M. K. A.-S.). This work was also supported by a grant from Ministry of Science and Culture of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AlShawi MK, 1997, J BIOL CHEM, V272, P2300; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12954, DOI 10.1021/bi971477z; AlShawi MK, 1997, BIOCHEMISTRY-US, V36, P12961, DOI 10.1021/bi971478r; Andrews SH, 2001, BIOCHEMISTRY-US, V40, P10664, DOI 10.1021/bi0155697; Bowler MW, 2006, P NATL ACAD SCI USA, V103, P8646, DOI 10.1073/pnas.0602915103; Boyer P. D., 1979, MEMBRANE BIOENERGETI, P461; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; KANAZAWA H, 1980, J BIOCHEM-TOKYO, V88, P695, DOI 10.1093/oxfordjournals.jbchem.a133022; Kashiwagi S, 2008, BIOCHEM BIOPH RES CO, V365, P227, DOI 10.1016/j.bbrc.2007.10.157; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Mao HZ, 2007, P NATL ACAD SCI USA, V104, P18478, DOI 10.1073/pnas.0709322104; Monkos K, 1996, INT J BIOL MACROMOL, V18, P61, DOI 10.1016/0141-8130(95)01057-2; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nakanishi-Matsui M, 2010, BBA-BIOENERGETICS, V1797, P1343, DOI 10.1016/j.bbabio.2010.02.014; Nakanishi-Matsui M, 2010, BIOCHEM BIOPH RES CO, V395, P173, DOI 10.1016/j.bbrc.2010.03.127; Nishio K, 2002, P NATL ACAD SCI USA, V99, P13448, DOI 10.1073/pnas.202149599; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Okuno D, 2008, P NATL ACAD SCI USA, V105, P20722, DOI 10.1073/pnas.0805828106; Omote H, 1999, P NATL ACAD SCI USA, V96, P7780, DOI 10.1073/pnas.96.14.7780; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Scanlon JAB, 2008, J BIOL CHEM, V283, P26228, DOI 10.1074/jbc.M804858200; Scanlon JAB, 2007, BIOCHEMISTRY-US, V46, P8785, DOI 10.1021/bi700610m; Sekiya M, 2009, J BIOL CHEM, V284, P22401, DOI 10.1074/jbc.M109.009019; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Sun-Wada GH, 2002, J BIOL CHEM, V277, P18098, DOI 10.1074/jbc.M111567200; Tanabe M, 2001, J BIOL CHEM, V276, P15269, DOI 10.1074/jbc.M100289200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; WEBER J, 1993, J BIOL CHEM, V268, P20126; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	43	39	40	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42058	42067		10.1074/jbc.M110.176701	http://dx.doi.org/10.1074/jbc.M110.176701			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974856	hybrid, Green Published			2022-12-27	WOS:000285622600091
J	Yamano, K; Tanaka-Yamano, S; Endo, T				Yamano, Koji; Tanaka-Yamano, Sachiko; Endo, Toshiya			Tom7 Regulates Mdm10-mediated Assembly of the Mitochondrial Import Channel Protein Tom40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BARREL MEMBRANE-PROTEINS; OUTER-MEMBRANE; BIOGENESIS; COMPLEX; MACHINERY; MDM10; TRANSLOCASE	beta-Barrel membrane proteins in the mitochondrial outer membrane use the TOM40 complex to enter mitochondria and then the TOB/SAM complex to be assembled into the outer membrane. Tom7, a subunit of the TOM40 complex, regulates association of Mdm10 with the TOB complex. Here, we analyzed the role of Tom7 in assembly of beta-barrel proteins, including Tom40, a central channel subunit of the TOM40 complex, and porin. Depletion of Tom7 decreased transient accumulation of Tom40 at the level of the TOB complex and retarded assembly of porin in vitro. On the other hand, overexpression of Tom7 resulted in enhanced accumulation of in vitro imported Tom40 in the TOB complex, yet it did not affect the in vitro assembly of porin. Site-specific photocross-linking in vivo revealed that Tom7 directly interacts with Tom40 through its transmembrane segment and with Mdm10. These results collectively show that Tom7 recruits Mdm10, enhancing its association with the MMM1 complex, to regulate timing of the release of Tom40 from the TOB complex for subsequent assembly into the TOM40 complex.	[Yamano, Koji; Tanaka-Yamano, Sachiko; Endo, Toshiya] Nagoya Univ, Dept Chem, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Endo, T (corresponding author), Nagoya Univ, Dept Chem, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Esaki M, 2004, J BIOL CHEM, V279, P45701, DOI 10.1074/jbc.M404591200; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; GRATZER S, 1995, J CELL BIOL, V129, P25, DOI 10.1083/jcb.129.1.25; Honlinger A, 1996, EMBO J, V15, P2125, DOI 10.1002/j.1460-2075.1996.tb00566.x; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Maaev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Nakai M, 1995, J BIOL CHEM, V270, P30571, DOI 10.1074/jbc.270.51.30571; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Paschen SA, 2005, TRENDS BIOCHEM SCI, V30, P575, DOI 10.1016/j.tibs.2005.08.009; Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283	32	79	80	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41222	41231		10.1074/jbc.M110.163238	http://dx.doi.org/10.1074/jbc.M110.163238			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036907	Green Published, hybrid			2022-12-27	WOS:000285622600008
J	Benjannet, S; Saavedra, YGL; Hamelin, J; Asselin, MC; Essalmani, R; Pasquato, A; Lemaire, P; Duke, G; Miao, B; Duclos, F; Parker, R; Mayer, G; Seidah, NG				Benjannet, Suzanne; Saavedra, Yascara Grisel Luna; Hamelin, Josee; Asselin, Marie-Claude; Essalmani, Rachid; Pasquato, Antonella; Lemaire, Peter; Duke, Gerald; Miao, Bowman; Duclos, Franck; Parker, Rex; Mayer, Gaetan; Seidah, Nabil G.			Effects of the Prosegment and pH on the Activity of PCSK9 EVIDENCE FOR ADDITIONAL PROCESSING EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; PROPROTEIN CONVERTASE PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; SECRETED PCSK9; LDL-RECEPTOR; HEPG2 CELLS; DEGRADATION; CHOLESTEROL; BINDING	PCSK9, a target for the treatment of dyslipidemia, enhances the degradation of the LDL receptor (LDLR) in endosomes/lysosomes, up-regulating LDL-cholesterol levels. Whereas the targeting and degradation of the PCSK9-LDLR complex are under scrutiny, the roles of the N- and C-terminal domains of PCSK9 are unknown. Although autocatalytic zymogen processing of PCSK9 occurs at Gln(152)down arrow, here we show that human PCSK9 can be further cleaved in its N-terminal prosegment at Arg(46)down arrow by an endogenous enzyme of insect High Five cells and by a cellular mammalian protease, yielding an similar to 4-fold enhanced activity. Removal of the prosegment acidic stretch resulted in similar to 3-fold higher binding to LDLR in vitro, in >= 4-fold increased activity on cellular LDLR, and faster cellular internalization in endosome/lysosome-like compartments. Finally, swapping the acidic stretch of PCSK9 with a similar one found in the glycosylphosphatidylinositol-anchored hepa-rin-binding protein 1 does not impair PCSK9 autoprocessing, secretion, or activity and confirmed that the acidic stretch acts as an inhibitor of PCSK9 function. We also show that upon short exposure to pH values 6.5 to 5.5, an similar to 2.5-fold increase in PCSK9 activity on total and cell surface LDLR occurs, and PCSK9 undergoes a second cleavage at Arg(248), generating a two-chain PCSK9-Delta N-248. At pH values below 5.5, PCSK9 dissociates from its prosegment and loses its activity. This pH-dependent activation of PCSK9 represents a novel pathway to further activate PCSK9 in acidic endosomes. These data enhance our understanding of the functional role of the acidic prosegment and on the effect of pH in the regulation of PCSK9 activity.	[Benjannet, Suzanne; Saavedra, Yascara Grisel Luna; Hamelin, Josee; Asselin, Marie-Claude; Essalmani, Rachid; Pasquato, Antonella; Mayer, Gaetan; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Lemaire, Peter; Duke, Gerald; Miao, Bowman; Duclos, Franck; Parker, Rex] Bristol Myers Squibb Co, Princeton, NJ 08543 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Bristol-Myers Squibb	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Strauss Foundation; Bristol-Myers Squibb; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Canada Chair	This work was supported by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946 (to N. G. S.), Strauss Foundation grant (to N. G. S.), Bristol-Myers Squibb collaborative research grant, and Canada Chair 216684 (to N. G. S.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Berge KE, 2006, ARTERIOSCL THROM VAS, V26, P1094, DOI 10.1161/01.ATV.0000204337.81286.1c; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; BROWN MS, 1974, P NATL ACAD SCI USA, V71, P788, DOI 10.1073/pnas.71.3.788; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; Dewpura T, 2008, FEBS J, V275, P3480, DOI 10.1111/j.1742-4658.2008.06495.x; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Fan D, 2008, BIOCHEMISTRY-US, V47, P1631, DOI 10.1021/bi7016359; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; LLOYDJONES D, 2009, Y Circulation, V119, pE21; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Miao B, 2002, METHOD ENZYMOL, V357, P180; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Noguchi T, 2010, ATHEROSCLEROSIS, V210, P166, DOI 10.1016/j.atherosclerosis.2009.11.018; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, BRAIN RES, V848, pA14; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Teupser D, 1996, BBA-LIPID LIPID MET, V1303, P193, DOI 10.1016/0005-2760(96)00094-X; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	50	53	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40965	40978		10.1074/jbc.M110.154815	http://dx.doi.org/10.1074/jbc.M110.154815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20937814	hybrid, Green Published			2022-12-27	WOS:000285414400060
J	van Lith, M; McEwen-Smith, RM; Benham, AM				van Lith, Marcel; McEwen-Smith, Rosanna M.; Benham, Adam M.			HLA-DP, HLA-DQ, and HLA-DR Have Different Requirements for Invariant Chain and HLA-DM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II HISTOCOMPATIBILITY ANTIGENS; CELL-SURFACE EXPRESSION; PEPTIDE-BINDING; INTRACELLULAR-TRANSPORT; MHC MOLECULES; HEPATITIS-B; T-CELLS; COMPLEX; HLA-DP2; ALPHA	The MHC is central to the adaptive immune response. The human MHC class II is encoded by three different isotypes, HLA-DR, -DQ, and -DP, each being highly polymorphic. In contrast to HLA-DR, the intracellular assembly and trafficking of HLA-DP molecules have not been studied extensively. However, different HLA-DP variants can be either protective or risk factors for infectious diseases (e.g. hepatitis B), immune dysfunction (e.g. berylliosis), and autoimmunity (e.g. myasthenia gravis). Here, we establish a system to analyze the chaperone requirements for HLA-DP and to compare the assembly and trafficking of HLA-DP, -DQ, and -DR directly. Unlike HLA-DR1, HLA-DQ5 and HLA-DP4 can form SDS-stable dimers supported by invariant chain (Ii) in the absence of HLA-DM. Uniquely, HLA-DP also forms dimers in the presence of HLA-DM alone. In model antigen-presenting cells, SDS-stable HLA-DP complexes are resistant to treatments that prevent formation of SDS-stable HLA-DR complexes. The unexpected properties of HLA-DP molecules may help explain why they bind to a more restricted range of peptides than other human MHC class II proteins and frequently present viral peptides.	[van Lith, Marcel; McEwen-Smith, Rosanna M.; Benham, Adam M.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England	Durham University	Benham, AM (corresponding author), Univ Durham, Sch Biol & Biomed Sci, South Rd, Durham DH1 3LE, England.	adam.benham@durham.ac.uk	Benham, Adam/AAC-6606-2019	Benham, Adam/0000-0002-0919-7431; Van Lith, Marcel/0000-0003-0225-5501	Biotechnology and Biological Sciences Research Council [BBC509582]; Biotechnology and Biological Sciences Research Council [BB/C509582/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BBC509582.	ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; AUSTIN P, 1985, NATURE, V313, P61, DOI 10.1038/313061a0; BIKOFF EK, 1995, IMMUNITY, V2, P301, DOI 10.1016/1074-7613(95)90054-3; Bontrop RE, 1999, IMMUNOL REV, V167, P339, DOI 10.1111/j.1600-065X.1999.tb01403.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; CELIS E, 1990, J IMMUNOL, V145, P305; Chicz RM, 1997, J IMMUNOL, V159, P4935; COTNER T, 1995, J BIOL CHEM, V270, P2379, DOI 10.1074/jbc.270.5.2379; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; Dai SD, 2010, P NATL ACAD SCI USA, V107, P7425, DOI 10.1073/pnas.1001772107; Diaz G, 2005, IMMUNOGENETICS, V56, P754, DOI 10.1007/s00251-004-0735-5; ECKELS DD, 1983, NATURE, V301, P716, DOI 10.1038/301716a0; El Fakhry Y, 2004, J BIOL CHEM, V279, P18472, DOI 10.1074/jbc.M401159200; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Ettinger RA, 1998, J IMMUNOL, V161, P6439; FALK K, 1994, IMMUNOGENETICS, V39, P230; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GIACOMINI P, 1989, J IMMUNOGENET, V16, P203; GORGA JC, 1987, J BIOL CHEM, V262, P16087; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; HAMMOND SA, 1991, J IMMUNOL, V146, P1470; Hiltbold EM, 2002, CURR OPIN IMMUNOL, V14, P30, DOI 10.1016/S0952-7915(01)00295-3; HORIKI T, 1994, AUTOIMMUNITY, V19, P49, DOI 10.3109/08916939409008008; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; KARLSSON L, 1994, SCIENCE, V266, P1569, DOI 10.1126/science.7985028; Kenty G, 1999, J IMMUNOL, V163, P232; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; MOMBURG F, 1988, IMMUNOLOGY, V63, P551; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Reed AM, 1997, J IMMUNOL, V159, P6260; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Robinson J, 2009, NUCLEIC ACIDS RES, V37, pD1013, DOI 10.1093/nar/gkn662; Sato AK, 2000, J BIOL CHEM, V275, P2165, DOI 10.1074/jbc.275.3.2165; SEKALY RP, 1986, J EXP MED, V164, P1490, DOI 10.1084/jem.164.5.1490; SHACKELFORD DA, 1983, J IMMUNOL, V130, P274; Sidney J, 2010, J IMMUNOL, V184, P2492, DOI 10.4049/jimmunol.0903655; Toussaint H, 2008, J VIROL, V82, P8373, DOI 10.1128/JVI.00670-08; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; van Lith M, 2006, J IMMUNOL, V177, P5430, DOI 10.4049/jimmunol.177.8.5430; VIDARD L, 1991, J IMMUNOL, V147, P1786; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	49	43	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40800	40808		10.1074/jbc.M110.148155	http://dx.doi.org/10.1074/jbc.M110.148155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20959457	Green Published, hybrid			2022-12-27	WOS:000285414400045
J	Glantschnig, H; Hampton, RA; Lu, P; Zhao, JZ; Vitelli, S; Huang, LY; Haytko, P; Cusick, T; Ireland, C; Jarantow, SW; Ernst, R; Wei, N; Nantermet, P; Scott, KR; Fisher, JE; Talamo, F; Orsatti, L; Reszka, AA; Sandhu, P; Kimmel, D; Flores, O; Strohl, W; An, ZQ; Wang, FB				Glantschnig, Helmut; Hampton, Richard A.; Lu, Ping; Zhao, Jing Z.; Vitelli, Salvatore; Huang, Lingyi; Haytko, Peter; Cusick, Tara; Ireland, Cheryl; Jarantow, Stephen W.; Ernst, Robin; Wei, Nan; Nantermet, Pascale; Scott, Kevin R.; Fisher, John E.; Talamo, Fabio; Orsatti, Laura; Reszka, Alfred A.; Sandhu, Punam; Kimmel, Donald; Flores, Osvaldo; Strohl, William; An, Zhiqiang; Wang, Fubao			Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERAPEUTIC TARGETS; MISSENSE MUTATIONS; CELL-LINE; LRP5; RECEPTOR; EXPRESSION; DISEASE; MECHANISM; REGULATOR; DENSITY	Wnt/LRP5 signaling is a central regulatory component of bone formative and resorptive activities, and the pathway inhibitor DKK1 is a suppressor of bone formation and bone mass accrual in mice. In addition, augmented DKK1 levels are associated with high bone turnover in diverse low bone mass states in rodent models and disease etiologies in human. However, examination of the precise role of DKK1 in the normal skeleton and in higher species requires the development of refined DKK1-specific pharmacological tools. Here, we report the strategy resulting in isolation of a panel of fully human anti-DKK1 antibodies applicable to studies interrogating the roles of mouse, rhesus, and human DKK1. Selected anti-DKK1 antibodies bind primate and human DKK-1 with picomolar affinities yet do not appreciably bind to DKK2 or DKK4. Epitopes mapped within the DKK1 C-terminal domain necessary for interaction with LRP5/6 and consequently effectively neutralized DKK1 function in vitro. When introduced into naive normal growing female mice, IgGs significantly improved trabecular bone volume and structure and increased both trabecular and cortical bone mineral densities in a dose-related fashion. Furthermore, fully human DKK1-IgG displayed favorable pharmacokinetic parameters in non-human primates. In summary, we demonstrate here a rate-limiting function of physiologic DKK1 levels in the regulation of bone mass in intact female mice, amendable to specific pharmacologic neutralization by newly identified DKK1-IgGs. Importantly the fully human IgGs display a profile of attributes that recommends their testing in higher species and their use in evaluating DKK1 function in relevant disease models.	[Glantschnig, Helmut; Cusick, Tara; Wei, Nan; Nantermet, Pascale; Scott, Kevin R.; Fisher, John E.; Reszka, Alfred A.; Kimmel, Donald; Flores, Osvaldo] Merck Res Labs, Mol Endocrinol & Bone Biol, West Point, PA 19486 USA; [Hampton, Richard A.; Lu, Ping; Zhao, Jing Z.; Vitelli, Salvatore; Huang, Lingyi; Haytko, Peter; Ireland, Cheryl; Jarantow, Stephen W.; Ernst, Robin; Strohl, William; An, Zhiqiang; Wang, Fubao] Merck Res Labs, Biol Res, West Point, PA 19486 USA; [Sandhu, Punam] Merck Res Labs, Preclin DMPK, West Point, PA 19486 USA; [Talamo, Fabio; Orsatti, Laura] Merck Res Labs, Ist Ric Biol Mol P Angeletti, Dept Biochem, I-00040 Rome, Italy	Merck & Company; Merck & Company; Merck & Company; Merck & Company	Wang, FB (corresponding author), 700 Sumneytownpike, West Point, PA 19486 USA.	fubao_wang@merck.com		Strohl, William/0000-0002-8271-6875; An, Zhiqiang/0000-0001-9309-2335				Ai M, 2005, MOL CELL BIOL, V25, P4946, DOI 10.1128/MCB.25.12.4946-4955.2005; An ZQ, 2009, MABS-AUSTIN, V1, P572, DOI 10.4161/mabs.1.6.10185; [Anonymous], 2001, PHAGE DISPLAY LAB MA; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bajada S, 2009, BONE, V45, P726, DOI 10.1016/j.bone.2009.06.015; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Chen LJ, 2008, J BIOL CHEM, V283, P23364, DOI 10.1074/jbc.M802375200; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; Darling RJ, 2002, BIOCHEMISTRY-US, V41, P14524, DOI 10.1021/bi0265022; Deal C, 2009, CURR OPIN RHEUMATOL, V21, P380, DOI 10.1097/BOR.0b013e32832cbc2a; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Ellwanger K, 2008, MOL CELL BIOL, V28, P4875, DOI 10.1128/MCB.00222-08; Fleury D, 2010, PROTEIN EXPRES PURIF, V70, P39, DOI 10.1016/j.pep.2009.08.012; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gavriatopoulou M, 2009, EXPERT OPIN THER TAR, V13, P839, DOI 10.1517/14728220903025770; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hager-Braun C, 2005, EXPERT REV PROTEOMIC, V2, P745, DOI 10.1586/14789450.2.5.745; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kaiser M, 2008, EUR J HAEMATOL, V80, P490, DOI 10.1111/j.1600-0609.2008.01065.x; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Komatsu DE, 2010, J ORTHOP RES, V28, P928, DOI 10.1002/jor.21078; Leucht P, 2008, SEMIN CELL DEV BIOL, V19, P434, DOI 10.1016/j.semcdb.2008.09.002; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; McCarthy HS, 2010, EXPERT OPIN THER TAR, V14, P221, DOI 10.1517/14728220903525720; Minear S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000231; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rodan G, 2002, PRINCIPLES BONE BIOL, P1275; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; van Tilbeurgh H, 1999, BBA-MOL CELL BIOL L, V1441, P173, DOI 10.1016/S1388-1981(99)00149-3; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Wang K, 2008, J BIOL CHEM, V283, P23371, DOI 10.1074/jbc.M802376200; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712	59	69	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40135	40147		10.1074/jbc.M110.166892	http://dx.doi.org/10.1074/jbc.M110.166892			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20929859	Green Published, hybrid			2022-12-27	WOS:000285185500059
J	Jayapal, S; Lee, KL; Ji, P; Kaldis, P; Lim, B; Lodish, HF				Jayapal, Senthil; Lee, Kian Leong; Ji, Peng; Kaldis, Philipp; Lim, Bing; Lodish, Harvey F.			Down-regulation of Myc Is Essential for Terminal Erythroid Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-X-L; C-MYC; CELL-CYCLE; MICE LACKING; DIFFERENTIATION; ERYTHROPOIETIN; ERYTHROBLASTS; KINASE; P27(KIP1); APOPTOSIS	Terminal differentiation of mammalian erythroid progenitors involves 4-5 cell divisions and induction of many erythroid important genes followed by chromatin and nuclear condensation and enucleation. The protein levels of c-Myc (Myc) are reduced dramatically during late stage erythroid maturation, coinciding with cell cycle arrest in G(1) phase and enucleation, suggesting possible roles for c-Myc in either or both of these processes. Here we demonstrate that ectopic Myc expression affects terminal erythroid maturation in a dose-dependent manner. Expression of Myc at physiological levels did not affect erythroid differentiation or cell cycle shutdown but specifically blocked erythroid nuclear condensation and enucleation. Continued Myc expression prevented deacetylation of several lysine residues in histones H3 and H4 that are normally deacetylated during erythroid maturation. The histone acetyltransferase Gcn5 was up-regulated by Myc, and ectopic Gcn5 expression partially blocked enucleation and inhibited the late stage erythroid nuclear condensation and histone deacetylation. When overexpressed at levels higher than the physiological range, Myc blocked erythroid differentiation, and the cells continued to proliferate in cytokine-free, serum-containing culture medium with an early erythroblast morphology. Gene expression analysis demonstrated the dysregulation of erythropoietin signaling pathway and the up-regulation of several positive regulators of G(1)-S cell cycle checkpoint by supraphysiological levels of Myc. These results reveal an important dose-dependent function of Myc in regulating terminal maturation in mammalian erythroid cells.	[Jayapal, Senthil; Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Jayapal, Senthil; Lim, Bing; Lodish, Harvey F.] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Lee, Kian Leong] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Ji, Peng; Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ji, Peng; Lodish, Harvey F.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Kaldis, Philipp] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lim, B (corresponding author), Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore.	limb1@gis.a-star.edu.sg; lodish@wi.mit.edu	Kaldis, Philipp/G-2714-2010; LEE, Kian Leong/E-3584-2013	Kaldis, Philipp/0000-0002-7247-7591; LEE, Kian Leong/0000-0002-0443-2746; Jayapal, Senthil Raja/0000-0002-0670-7766	National Institutes of Health [DK047636, AI54973, P01 HL32262]; Singapore-MIT alliance [C-382-641-001-091]; A*STAR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); A*STAR(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047636 and AI54973 (to B.L.) and P01 HL32262 (to H.F.L.). This study was also supported by Singapore-MIT alliance Grant C-382-641-001-091 (to B.L. and H.F.L.).; Supported by a Singapore-MIT Alliance graduate fellowship.; Supported by A*STAR funds in Genome Institute of Singapore.	Acosta JC, 2008, MOL CELL BIOL, V28, P7286, DOI 10.1128/MCB.00752-08; Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; CORY S, 1991, CELL GROWTH DIFFER, V2, P165; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dolznig H, 2002, CURR BIOL, V12, P1076, DOI 10.1016/S0960-9822(02)00930-2; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eshghi S, 2007, J CELL BIOL, V177, P871, DOI 10.1083/jcb.200702080; Fang J, 2007, BLOOD, V110, P2361, DOI 10.1182/blood-2006-12-063503; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Ghaffari S, 2006, BLOOD, V107, P1888, DOI 10.1182/blood-2005-06-2304; Gregoli PA, 1997, BLOOD, V90, P630, DOI 10.1182/blood.V90.2.630.630_630_640; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Hsieh FF, 2000, BLOOD, V96, P2746, DOI 10.1182/blood.V96.8.2746.h8002746_2746_2754; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Janz S, 2005, ONCOGENE, V24, P3541, DOI 10.1038/sj.onc.1208473; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2013, DOI 10.3324/haematol.2010.029827; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; KOURY ST, 1988, EXP HEMATOL, V16, P758; Krauss SW, 2005, BLOOD, V106, P2200, DOI 10.1182/blood-2005-04-1357; LENG L, 1993, CANCER RES, V53, P5554; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Ray D, 2007, CELL CYCLE, V6, P3039, DOI 10.4161/cc.6.24.5104; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SIMPSON CF, 1967, J CELL BIOL, V35, P237, DOI 10.1083/jcb.35.1.237; SKUTELSKY E, 1967, J CELL BIOL, V33, P625, DOI 10.1083/jcb.33.3.625; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; SPANGLER R, 1992, BLOOD, V79, P52; SPOTTS GD, 1990, MOL CELL BIOL, V10, P3952, DOI 10.1128/MCB.10.8.3952; VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Yang W, 2001, ONCOGENE, V20, P1688, DOI 10.1038/sj.onc.1204245; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang WZ, 1998, EMBO J, V17, P3155, DOI 10.1093/emboj/17.11.3155; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhao W, 2006, BLOOD, V107, P907, DOI 10.1182/blood-2005-06-2516	52	49	61	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40252	40265		10.1074/jbc.M110.181073	http://dx.doi.org/10.1074/jbc.M110.181073			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940306	Green Published, hybrid			2022-12-27	WOS:000285185500069
J	Lokareddy, RK; Lunelli, M; Eilers, B; Wolter, V; Kolbe, M				Lokareddy, Ravi Kumar; Lunelli, Michele; Eilers, Bjoern; Wolter, Vivien; Kolbe, Michael			Combination of Two Separate Binding Domains Defines Stoichiometry between Type III Secretion System Chaperone IpgC and Translocator Protein IpaB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHIGELLA-FLEXNERI; YERSINIA-ENTEROCOLITICA; EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; BACTERIAL PATHOGENS; VIRULENCE GENES; HOST-CELLS; YOPE; PLASMID; INVASINS	Type III secretion systems (TTSSs) utilized by enteropathogenic bacteria require the presence of small, acidic virulence-associated chaperones for effective host cell infection. We adopted a combination of biochemical and cellular techniques to define the chaperone binding domains (CBDs) in the translocators IpaB and IpaC associated with the chaperone IpgC from Shigella flexneri. We identified a novel CBD in IpaB and furthermore precisely mapped the boundaries of the CBDs in both translocator proteins. In IpaC a single binding domain associates with IpgC. In IpaB, we show that the binding of the newly characterized CBD is essential in maintaining the ternary arrangement of chaperone-translocator complex. This hitherto unknown function is reflected in the co-crystal structure as well, with an IpgC dimer bound to an IpaB fragment comprising both CBDs. Moreover, in the absence of this novel CBD the IpaB/IpgC complex aggregates. This dual-recognition of a domain in the protein by the chaperone in facilitating the correct chaperone-substrate organization describes a new function for the TTSS associated chaperone-substrate complexes.	[Lokareddy, Ravi Kumar; Lunelli, Michele; Eilers, Bjoern; Wolter, Vivien; Kolbe, Michael] Max Planck Inst Infect Biol, Dept Cellular Microbiol, D-10117 Berlin, Germany; [Lokareddy, Ravi Kumar] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Eilers, Bjoern] Inst Lab Med, D-10627 Berlin, Germany	Max Planck Society; Jefferson University	Kolbe, M (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Charite Pl 1, D-10117 Berlin, Germany.	kolbe@mpiib-berlin.mpg.de						Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner CR, 2008, J MOL BIOL, V375, P997, DOI 10.1016/j.jmb.2007.11.009; Cambronne ED, 2000, MOL MICROBIOL, V37, P263, DOI 10.1046/j.1365-2958.2000.01974.x; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Cornelis GR, 2003, MOL MICROBIOL, V50, P1091, DOI 10.1046/j.1365-2958.2003.03812.x; Darwin KH, 2000, MOL MICROBIOL, V35, P949, DOI 10.1046/j.1365-2958.2000.01772.x; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Harrington AT, 2003, INFECT IMMUN, V71, P1255, DOI 10.1128/IAI.71.3.1255-1264.2003; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lunelli M, 2009, P NATL ACAD SCI USA, V106, P9661, DOI 10.1073/pnas.0812900106; MAURELLI AT, 1985, INFECT IMMUN, V49, P164, DOI 10.1128/IAI.49.1.164-171.1985; MENARD R, 1993, J BACTERIOL, V175, P5899; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; Page AL, 2001, MOL MICROBIOL, V42, P1133, DOI 10.1046/j.1365-2958.2001.02715.x; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Penno C, 2005, MOL MICROBIOL, V56, P204, DOI 10.1111/j.1365-2958.2004.04530.x; Picking WL, 1996, PROTEIN EXPRES PURIF, V8, P401, DOI 10.1006/prep.1996.0117; Russmann H, 2000, EUR J IMMUNOL, V30, P1375; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SASAKAWA C, 1989, MOL MICROBIOL, V3, P1191, DOI 10.1111/j.1365-2958.1989.tb00269.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; WATARAI M, 1995, EMBO J, V14, P2461, DOI 10.1002/j.1460-2075.1995.tb07243.x; WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x; ZYCHLINSKY A, 1994, MOL MICROBIOL, V11, P619, DOI 10.1111/j.1365-2958.1994.tb00341.x	42	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39965	39975		10.1074/jbc.M110.135616	http://dx.doi.org/10.1074/jbc.M110.135616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937829	Green Published, hybrid			2022-12-27	WOS:000285185500041
J	Paris, LL; Hu, JJ; Galan, J; Ong, SS; Martin, VA; Ma, HY; Tao, WA; Harrison, ML; Geahlen, RL				Paris, Leela L.; Hu, Jianjie; Galan, Jacob; Ong, Su Sien; Martin, Victoria A.; Ma, Haiyan; Tao, W. Andy; Harrison, Marietta L.; Geahlen, Robert L.			Regulation of Syk by Phosphorylation on Serine in the Linker Insert	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; GREEN FLUORESCENT PROTEIN; B-CELL DEVELOPMENT; ANTIGEN RECEPTOR; STRUCTURAL BASIS; PHORBOL ESTER; ACTIVATION; LYMPHOCYTES; PROHIBITIN; ZAP-70	The Syk protein-tyrosine kinase is phosphorylated on multiple tyrosines after the aggregation of the B cell antigen receptor. However, metabolic labeling experiments indicate that Syk is inducibly phosphorylated to an even greater extent on serine after receptor ligation. A combination of phosphopeptide mapping and mass spectrometric analyses indicates that serine 291 is a major site of phosphorylation. Serine 291 lies within a 23-amino acid insert located within the linker B region that distinguishes Syk from SykB and Zap-70. The phosphorylation of serine-291 by protein kinase C enhances the ability of Syk to couple the antigen receptor to the activation of the transcription factors NFAT and Elk-1. Protein interaction studies indicate a role for the phosphorylated linker insert in promoting an interaction between Syk and the chaperone protein, prohibitin.	[Harrison, Marietta L.; Geahlen, Robert L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Galan, Jacob; Tao, W. Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Tao, W. Andy; Harrison, Marietta L.; Geahlen, Robert L.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Hansen Life Sci Res Bldg,201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu	Tao, Andy/N-1290-2019; ma, haiyan/GWQ-7425-2022; Tao, Weiguo/AAL-2777-2020; Ong, Su Sien/I-2245-2012	Tao, Weiguo/0000-0002-5535-5517; Geahlen, Robert/0000-0001-8400-2924; Galan, Jacob/0000-0003-3304-0474	National Institutes of Health [CA037372]; National Science Foundation;  [CA115465]; NATIONAL CANCER INSTITUTE [R01CA037372, R01CA115465] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA037372 (NCI; to R. L. G. and M. L. H.). This work was also supported by a National Science Foundation Career Award (to W. A. T.).; Supported by a Research Supplement to Promote Diversity in Health-related Research to National Institutes of Health CA115465 (to R. L. G. and W. A. T.).	CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; GEAHLEN RL, 2009, L BIOCHIM BIOPHYS AC, V1793, P1115; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; Hitomi T, 2001, GENES CELLS, V6, P475, DOI 10.1046/j.1365-2443.2001.00434.x; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Keshvara LM, 1998, J IMMUNOL, V161, P5276; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Latour S, 1998, EMBO J, V17, P2584, DOI 10.1093/emboj/17.9.2584; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matthews SA, 2000, J EXP MED, V191, P2075, DOI 10.1084/jem.191.12.2075; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Papp E, 2007, BIOCHEMISTRY-US, V46, P15103, DOI 10.1021/bi701596u; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rasmussen RK, 1997, ELECTROPHORESIS, V18, P588, DOI 10.1002/elps.1150180342; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; ROWLEY RB, 1995, J BIOL CHEM, V270, P12659, DOI 10.1074/jbc.270.21.12659; SEVERSON CD, 1987, IMMUNOL LETT, V15, P291, DOI 10.1016/0165-2478(87)90130-1; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; SloanLancaster J, 1997, J EXP MED, V186, P1713, DOI 10.1084/jem.186.10.1713; Sun LG, 2004, J CELL SCI, V117, P3021, DOI 10.1242/jcs.01142; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Wang L, 2003, CANCER RES, V63, P4724; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang Sheng, 2008, Transl Oncogenomics, V3, P23; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xia K, 1999, MOL CELL BIOL, V19, P4819; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409; Zhang J, 1998, J IMMUNOL, V161, P4366; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006	38	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39844	39854		10.1074/jbc.M110.164509	http://dx.doi.org/10.1074/jbc.M110.164509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956537	Green Published, hybrid			2022-12-27	WOS:000285185500029
J	Donald, JE; Zhu, H; Litvinov, RI; DeGrado, WF; Bennett, JS				Donald, Jason E.; Zhu, Hua; Litvinov, Rustem I.; DeGrado, William F.; Bennett, Joel S.			Identification of Interacting Hot Spots in the beta 3 Integrin Stalk Using Comprehensive Interface Design	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSIDE-OUT ACTIVATION; CYTOPLASMIC FACE; STRUCTURAL BASIS; BINDING-ENERGY; FIBRINOGEN; DOMAIN; ALPHA-IIB-BETA-3; ALPHA(V)BETA(3); MECHANISM; AFFINITY	Protein-protein interfaces are usually large and complementary surfaces, but specific side chains, representing energetic "hot spots," often contribute disproportionately to binding free energy. We used a computational method, comprehensive interface design, to identify hot spots in the interface between the stalk regions of the beta 3 and the complementary alpha IIb and alpha v integrin subunits. Using the Rosetta alanine-scanning and design algorithms to predict destabilizing, stabilizing, and neutral mutations in the beta 3 region extending from residues Lys(532) through Gly(690), we predicted eight alanine mutations that would destabilize the alpha IIb beta 3 interface as well as nine predicted to destabilize the alpha v beta 3 interface, by at least 0.3 kcal/mol. The mutations were widely and unevenly distributed, with four between residues 552 and 563 and five between 590 and 610, but none between 565 and 589, and 611 and 655. Further, mutations destabilizing the alpha v beta 3 and alpha IIb beta 3 interfaces were not identical. The predictions were then tested by introducing selected mutations into the full-length integrins expressed in Chinese hamster ovary cells. Five mutations predicted to destabilize alpha IIb and beta 3 caused fibrinogen binding to alpha IIb beta 3, whereas three of four predicted to be neutral or stabilizing did not. Conversely, a mutation predicted to destabilize alpha v beta 3, but not alpha IIb beta 3 (D552A), caused osteopontin binding to alpha v beta 3, but not fibrinogen binding to alpha IIb beta 3. These results indicate that stability of the distal stalk interface is involved in constraining integrins in stable, inactive conformations. Further, they demonstrate the ability of comprehensive interface design to identify functionally significant integrin mutations.	[Zhu, Hua; Bennett, Joel S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Litvinov, Rustem I.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bennett, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	bennetts@mail.med.upenn.edu	Litvinov, Rustem/E-5291-2011	Litvinov, Rustem/0000-0003-0643-1496	National Institutes of Health [HL40387, HL81012, T32 HL107971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL040387, P50HL081012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL40387 and HL81012.; Supported in part by the National Institutes of Health Training Grant T32 HL107971.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li W, 2005, P NATL ACAD SCI USA, V102, P1424, DOI 10.1073/pnas.0409334102; Litvinov RI, 2006, BIOCHEMISTRY-US, V45, P4957, DOI 10.1021/bi0526581; Litvinov RI, 2003, J BIOL CHEM, V278, P51285, DOI 10.1074/jbc.M304581200; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Litvinov RI, 2002, P NATL ACAD SCI USA, V99, P7426, DOI 10.1073/pnas.112194999; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Luo BH, 2009, J BIOL CHEM, V284, P3917, DOI 10.1074/jbc.M806312200; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Zang Q, 2001, J BIOL CHEM, V276, P6922, DOI 10.1074/jbc.M005868200; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	35	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38658	38665		10.1074/jbc.M110.170670	http://dx.doi.org/10.1074/jbc.M110.170670			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20929856	Green Published, hybrid			2022-12-27	WOS:000284625600070
J	Gakh, O; Bedekovics, T; Duncan, SF; Smith, DY; Berkholz, DS; Isaya, G				Gakh, Oleksandr; Bedekovics, Tibor; Duncan, Samantha F.; Smith, Douglas Y.; Berkholz, Donald S.; Isaya, Grazia			Normal and Friedreich Ataxia Cells Express Different Isoforms of Frataxin with Complementary Roles in Iron-Sulfur Cluster Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST FRATAXIN; MITOCHONDRIAL LOCALIZATION; BINDING PROPERTIES; DEFICIENCY; MECHANISM; PROTEINS; CYAY; DETOXIFICATION; BIOGENESIS; MATURATION	Friedreich ataxia (FRDA) is an autosomal recessive degenerative disease caused by insufficient expression of frataxin (FXN), a mitochondrial iron-binding protein required for Fe-S cluster assembly. The development of treatments to increase FXN levels in FRDA requires elucidation of the steps involved in the biogenesis of functional FXN. The FXN mRNA is translated to a precursor polypeptide that is transported to the mitochondrial matrix and processed to at least two forms, FXN42-210 and FXN81-210. Previous reports suggested that FXN42-210 is a transient processing intermediate, whereas FXN81-210 represents the mature protein. However, we find that both FXN42-210 and FXN81-210 are present in control cell lines and tissues at steady-state, and that FXN42-210 is consistently more depleted than FXN81-210 in samples from FRDA patients. Moreover, FXN42-210 and FXN81-210 have strikingly different biochemical properties. A shorter N terminus correlates with monomeric configuration, labile iron binding, and dynamic contacts with components of the Fe-S cluster biosynthetic machinery, i.e. the sulfur donor complex NFS1 center dot ISD11 and the scaffold ISCU. Conversely, a longer N terminus correlates with the ability to oligomerize, store iron, and form stable contacts with NFS1 center dot ISD11 and ISCU. Monomeric FXN81-210 donates Fe2+ for Fe-S cluster assembly on ISCU, whereas oligomeric FXN42-210 donates either Fe2+ or Fe3+. These functionally distinct FXN isoforms seem capable to ensure incremental rates of Fe-S cluster synthesis from different mitochondrial iron pools. We suggest that the levels of both isoforms are relevant to FRDA pathophysiology and that the FXN81-210/FXN42-210 molar ratio should provide a useful parameter to optimize FXN augmentation and replacement therapies.	Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance, Muscular Dystrophy Association; Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance, Muscular Dystrophy Association(Muscular Dystrophy Association); Mayo Clinic Department of Pediatric & Adolescent Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709, and grants from the Friedreich Ataxia Research Alliance, Muscular Dystrophy Association (to G. I.), and the Mayo Clinic Department of Pediatric & Adolescent Medicine (to T. B. and D. S. B.). Mayo Clinic has a financial interest associated with technology used in this research (rec-FXN<SUP>56-210</SUP>), which has been licensed to MitoSciences, Inc. Mayo Clinic, but not the investigators, has received royalties of less than the federal threshold for significant financial interest.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; Bou-Abdallah F, 2004, J MOL BIOL, V341, P605, DOI 10.1016/j.jmb.2004.05.072; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2002, HUM MOL GENET, V11, P217, DOI 10.1093/hmg/11.3.217; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Karlberg T, 2006, STRUCTURE, V14, P1535, DOI 10.1016/j.str.2006.08.010; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Kearney M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub2; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Lu CY, 2009, BBA-MOL BASIS DIS, V1792, P1052, DOI 10.1016/j.bbadis.2009.07.011; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Park S, 2002, J BIOL CHEM, V277, P38589, DOI 10.1074/jbc.M206711200; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Pianese L, 2002, HUM MOL GENET, V11, P2989, DOI 10.1093/hmg/11.23.2989; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Whitnall M, 2008, P NATL ACAD SCI USA, V105, P9757, DOI 10.1073/pnas.0804261105; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	52	61	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38486	38501		10.1074/jbc.M110.145144	http://dx.doi.org/10.1074/jbc.M110.145144			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889968	Green Published, hybrid			2022-12-27	WOS:000284625600054
J	Wang, YN; Yamaguchi, H; Huo, LF; Du, Y; Lee, HJ; Lee, HH; Wang, HM; Hsu, JM; Hung, MC				Wang, Ying-Nai; Yamaguchi, Hirohito; Huo, Longfei; Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Wang, Hongmei; Hsu, Jung-Mao; Hung, Mien-Chie			The Translocon Sec61 beta Localized in the Inner Nuclear Membrane Transports Membrane-embedded EGF Receptor to the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL-SURFACE RECEPTORS; PROTEIN TRANSLOCATION; ENDOPLASMIC-RETICULUM; PROGNOSTIC VALUE; BREAST-CANCER; EXPRESSION; IMPORTIN; BIOLOGY; PATHWAY	Accumulating evidence indicates that endocytosis plays an essential role in the nuclear transport of the ErbB family members, such as epidermal growth factor receptor (EGFR) and ErbB-2. Nevertheless, how full-length receptors embedded in the endosomal membrane pass through the nuclear pore complexes and function as non-membrane-bound receptors in the nucleus remains unclear. Here we show that upon EGF treatment, the biotinylated cell surface EGFR is trafficked to the inner nuclear membrane (INM) through the nuclear pore complexes, remaining in a membrane-bound environment. We further find that importin beta regulates EGFR nuclear transport to the INM in addition to the nucleus/nucleoplasm. Unexpectedly, the well known endoplasmic reticulum associated translocon Sec61 beta is found to reside in the INM and associate with EGFR. Knocking down Sec61 beta expression reduces EGFR level in the nucleoplasm portion and accumulates it in the INM portion. Thus, the Sec61 beta translocon plays an unrecognized role in the release of the membrane- anchored EGFR from the lipid bilayer of the INM to the nucleus. The newly identified Sec61 beta function provides an alternative pathway for nuclear transport that can be utilized by membrane- embedded proteins such as full-length EGFR.	[Wang, Ying-Nai; Yamaguchi, Hirohito; Huo, Longfei; Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Wang, Hongmei; Hsu, Jung-Mao; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Du, Yi; Lee, Hong-Jen; Lee, Heng-Huan; Hsu, Jung-Mao; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Hung, MC (corresponding author), 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Huo, Longfei/F-9233-2010; Hsu, Jung-Mao/AAC-9527-2019; Hsu, Jung-Mao/AAP-8045-2020	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Wang, Ying-Nai/0000-0002-5275-6729; Wang, Hongmei/0000-0002-5881-2488	National Institutes of Health [RO1 109311, PO1 099031]; National Breast Cancer Foundation, Inc.; China Medical University Hospital; MD Anderson Cancer Center; Taiwan Cancer Research Center of Excellence Grant [DOH99-TD-C-111-005]; High Resolution Electron Microscopy Facility [CA 16672]; National Science Council Taiwan [TMS-94-2B-001]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Breast Cancer Foundation, Inc.; China Medical University Hospital; MD Anderson Cancer Center; Taiwan Cancer Research Center of Excellence Grant; High Resolution Electron Microscopy Facility; National Science Council Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 109311 and PO1 099031 (to M.-C. H.). This work was also supported by the National Breast Cancer Foundation, Inc. and the Sister Institutional fund from China Medical University Hospital and MD Anderson Cancer Center (to M.-C. H.); the Taiwan Cancer Research Center of Excellence Grant DOH99-TD-C-111-005; the Institutional Core Grant CA 16672 High Resolution Electron Microscopy Facility; and the National Science Council Taiwan Merit Postdoctoral Scholarship TMS-94-2B-001 (to Y.-N. W.).	Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; Das AK, 2007, CANCER RES, V67, P5267, DOI 10.1158/0008-5472.CAN-07-0242; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Edwards J, 2006, CLIN CANCER RES, V12, P123, DOI 10.1158/1078-0432.CCR-05-1445; Feng YY, 1999, BIOCHEM BIOPH RES CO, V256, P192, DOI 10.1006/bbrc.1998.9790; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Greenfield JJA, 1999, J CELL SCI, V112, P1477; Hadzisejdic I, 2010, MODERN PATHOL, V23, P392, DOI 10.1038/modpathol.2009.166; Hoelz A, 2004, NATURE, V432, P815, DOI 10.1038/432815a; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Klein C, 2004, BIOCHEMISTRY-US, V43, P15873, DOI 10.1021/bi048604t; Kutay U, 2006, NATURE, V442, P991, DOI 10.1038/nature05173; Liao HJ, 2007, MOL BIOL CELL, V18; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Offterdinger M, 2002, J CELL BIOL, V157, P929, DOI 10.1083/jcb.200109033; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rexach MF, 2006, NAT STRUCT MOL BIOL, V13, P476, DOI 10.1038/nsmb0606-476; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Romisch K, 1999, J CELL SCI, V112, P4185; Saksena S, 2006, NAT STRUCT MOL BIOL, V13, P500, DOI 10.1038/nsmb1098; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504	52	87	92	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38720	38729		10.1074/jbc.M110.158659	http://dx.doi.org/10.1074/jbc.M110.158659			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20937808	Green Published, hybrid			2022-12-27	WOS:000284625600077
J	Nishitani, Y; Yoshida, S; Fujihashi, M; Kitagawa, K; Doi, T; Atomi, H; Imanaka, T; Miki, K				Nishitani, Yuichi; Yoshida, Shosuke; Fujihashi, Masahiro; Kitagawa, Kazuya; Doi, Takashi; Atomi, Haruyuki; Imanaka, Tadayuki; Miki, Kunio			Structure-based Catalytic Optimization of a Type III Rubisco from a Hyperthermophile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; ACTIVE-SITE; RIBULOSEBISPHOSPHATE CARBOXYLASE; CO2/O2 SPECIFICITY; ARCHAEAL RUBISCO; PROTEIN	The Calvin-Benson-Bassham cycle is responsible for carbon dioxide fixation in all plants, algae, and cyanobacteria. The enzyme that catalyzes the carbon dioxide-fixing reaction is ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco). Rubisco from a hyperthermophilic archaeon Thermococcus kodakarensis (Tk-Rubisco) belongs to the type III group, and shows high activity at high temperatures. We have previously found that replacement of the entire alpha-helix 6 of Tk-Rubisco with the corresponding region of the spinach enzyme (SP6 mutant) results in an improvement of catalytic performance at mesophilic temperatures, both in vivo and in vitro, whereas the former and latter half-replacements of the alpha-helix 6 (SP4 and SP5 mutants) do not yield such improvement. We report here the crystal structures of the wild-type Tk-Rubisco and the mutants SP4 and SP6, and discuss the relationships between their structures and enzymatic activities. A comparison among these structures shows the movement and the increase of temperature factors of alpha-helix 6 induced by four essential factors. We thus supposed that an increase in the flexibility of the alpha-helix 6 and loop 6 regions was important to increase the catalytic activity of Tk-Rubisco at ambient temperatures. Based on this structural information, we constructed a new mutant, SP5-V330T, which was designed to have significantly greater flexibility in the above region, and it proved to exhibit the highest activity among all mutants examined to date. The thermostability of the SP5-V330T mutant was lower than that of wild-type Tk-Rubisco, providing further support on the relationship between flexibility and activity at ambient temperatures.	[Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Yoshida, Shosuke; Atomi, Haruyuki; Imanaka, Tadayuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan	Kyoto University; Kyoto University	Miki, K (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan.	miki@kuchem.kyoto-u.ac.jp		Atomi, Haruyuki/0000-0001-9687-6426	Ministry of Education, Culture, Sports, Science and Technology, Japan [B-29]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Targeted Proteins Research Program (B-29) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The synchrotron radiation experiments were performed at the Photon Factory and SPring-8 with the approval of the Photon Factory Advisory Committee (proposals 2008S2-001 and 2008G149) and the Japan Synchrotron Radiation Research Institute (JASRI) (proposals 2008A1511, 2008A1973, 2008A2001, 2008A2048, 2009A1012, and 2009A1013).	Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Atomi Haruyuki, 2004, Archaea, V1, P263, DOI 10.1155/2004/204953; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; CHEN ZX, 1991, BIOCHEMISTRY-US, V30, P8846, DOI 10.1021/bi00100a017; CHEN ZX, 1989, J BIOL CHEM, V264, P3051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaki S, 1999, J BIOL CHEM, V274, P5078, DOI 10.1074/jbc.274.8.5078; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; FUJII T, 1983, AGR BIOL CHEM TOKYO, V47, P2747; GATENBY AA, 1988, PHOTOSYNTH RES, V17, P145, DOI 10.1007/BF00047686; GATENBY AA, 1985, NATURE, V314, P617, DOI 10.1038/314617a0; GUTTERIDGE S, 1984, EMBO J, V3, P2737, DOI 10.1002/j.1460-2075.1984.tb02204.x; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HARPEL MR, 1995, TECH PROT CHEM, V6, P357, DOI 10.1016/S1080-8914(06)80044-X; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Karkehabadi S, 2007, BIOCHEMISTRY-US, V46, P11080, DOI 10.1021/bi701063f; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; KNIGHT S, 1990, J MOL BIOL, V215, P113, DOI 10.1016/S0022-2836(05)80100-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Maeda N, 1999, J MOL BIOL, V293, P57, DOI 10.1006/jmbi.1999.3145; Maeda N, 2002, J BIOL CHEM, V277, P31656, DOI 10.1074/jbc.M203117200; MORIKAWA M, 1994, APPL ENVIRON MICROB, V60, P4559, DOI 10.1128/AEM.60.12.4559-4566.1994; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; READ BA, 1994, ARCH BIOCHEM BIOPHYS, V312, P210, DOI 10.1006/abbi.1994.1301; Sambrook J., 2001, MOL CLONING LAB MANU; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; SCHNEIDER G, 1992, ANNU REV BIOPH BIOM, V21, P119, DOI 10.1146/annurev.bb.21.060192.001003; SCHNEIDER G, 1986, EMBO J, V5, P3409, DOI 10.1002/j.1460-2075.1986.tb04662.x; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; SCHREUDER HA, 1993, P NATL ACAD SCI USA, V90, P9968, DOI 10.1073/pnas.90.21.9968; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOMERVILLE CR, 1984, MOL GEN GENET, V193, P214, DOI 10.1007/BF00330670; Taylor TC, 1996, NAT STRUCT BIOL, V3, P95, DOI 10.1038/nsb0196-95; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; Yoshida S, 2006, J BIOTECHNOL, V124, P532, DOI 10.1016/j.jbiotec.2006.02.001	48	17	18	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39339	39347		10.1074/jbc.M110.147587	http://dx.doi.org/10.1074/jbc.M110.147587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926376	Green Published, hybrid			2022-12-27	WOS:000284941300061
J	York, B; O'Malley, BW				York, Brian; O'Malley, Bert W.			Steroid Receptor Coactivator (SRC) Family: Masters of Systems Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							THYROID-HORMONE RECEPTOR; LIGAND-BINDING DOMAIN; TRANSCRIPTIONAL COACTIVATOR; ESTROGEN-RECEPTOR; GLUCOCORTICOID-RECEPTOR; REPRODUCTIVE FUNCTION; P160 COACTIVATORS; ACTIVATION DOMAIN; GENE ACTIVATION; MESSENGER-RNA	The three members of the p160 family of steroid receptor coactivators (SRC-1, SRC-2, and SRC-3) steer the functional output of numerous genetic programs and serve as pleiotropic rheostats for diverse physiological processes. Since their discovery similar to 15 years ago, the extraordinary sum of examination of SRC function has shaped the foundation of our knowledge for the now 350+ coregulators that have been identified to date. In this perspective, we retrace our steps into the field of coregulators and provide a summary of selected seminal work that helped define the SRCs as masters of systems biology.	[York, Brian; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu						ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Anafi M, 2000, MOL ENDOCRINOL, V14, P718, DOI 10.1210/me.14.5.718; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Auboeuf D, 2004, P NATL ACAD SCI USA, V101, P2270, DOI 10.1073/pnas.0308133100; BANIAHMAD A, 1995, MOL CELL BIOL, V15, P76, DOI 10.1128/MCB.15.1.76; BANIAHMAD C, 1995, MOL ENDOCRINOL, V9, P34, DOI 10.1210/me.9.1.34; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Carapeti M, 1998, BLOOD, V91, P3127, DOI 10.1182/blood.V91.9.3127.3127_3127_3133; Cavarretta ITR, 2002, MOL ENDOCRINOL, V16, P253, DOI 10.1210/me.16.2.253; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; Chopra AR, 2008, SCIENCE, V322, P1395, DOI 10.1126/science.1164847; Coste A, 2008, P NATL ACAD SCI USA, V105, P17187, DOI 10.1073/pnas.0808207105; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Guan XY, 1996, CANCER RES, V56, P3446; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; JACKSON DA, 1972, P NATL ACAD SCI USA, V69, P2904, DOI 10.1073/pnas.69.10.2904; JENSEN EV, 1962, RECENT PROG HORM RES, V18, P387; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; KUROKAWA R, 1995, NATURE, V377, P451, DOI 10.1038/377451a0; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Li H, 1997, P NATL ACAD SCI USA, V94, P8479, DOI 10.1073/pnas.94.16.8479; Liang J, 1998, BLOOD, V92, P2118, DOI 10.1182/blood.V92.6.2118.418k09_2118_2122; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lonard DM, 2010, MOL ENDOCRINOL, V24, P279, DOI 10.1210/me.2009-0276; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Louet J. F., 2011, CELL METAB IN PRESS; Louet JF, 2007, CELL CYCLE, V6, P2448, DOI 10.4161/cc.6.20.4777; Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; LUNDBLAD JR, 1995, NATURE, V374, P85, DOI 10.1038/374085a0; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; Malovannaya A, 2010, P NATL ACAD SCI USA, V107, P2431, DOI 10.1073/pnas.0912599106; MCDONNELL DP, 1992, P NATL ACAD SCI USA, V89, P10563, DOI 10.1073/pnas.89.22.10563; MCGRATH ME, 1994, J MOL BIOL, V237, P236, DOI 10.1006/jmbi.1994.1224; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; MEANS AR, 1972, P NATL ACAD SCI USA, V69, P1146, DOI 10.1073/pnas.69.5.1146; Modder UIL, 2004, ENDOCRINOLOGY, V145, P913, DOI 10.1210/en.2003-1089; Modder UI, 2009, J BIOL CHEM, V284, P18767, DOI 10.1074/jbc.M109.000836; Molenda HA, 2003, BIOL REPROD, V69, P1449, DOI 10.1095/biolreprod.103.019364; Mukherjee A., 2007, J NUCL RECEPT SIGNAL, V5, pe011; Mukherjee A, 2006, MOL CELL BIOL, V26, P6571, DOI 10.1128/MCB.00654-06; MURRAY MB, 1989, MOL ENDOCRINOL, V3, P1434, DOI 10.1210/mend-3-9-1434; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; OMALLEY BW, 1968, P NATL ACAD SCI USA, V60, P1527, DOI 10.1073/pnas.60.4.1527; ONATE SA, 1995, SCIENCE, V270, P1354; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; PAYVAR F, 1982, J CELL BIOCHEM, V19, P241, DOI 10.1002/jcb.240190305; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Planas-Silva MD, 2001, CANCER RES, V61, P3858; PUCA GA, 1974, P NATL ACAD SCI USA, V71, P979, DOI 10.1073/pnas.71.3.979; Pugh BF, 2006, MOL CELL, V23, P776, DOI 10.1016/j.molcel.2006.08.022; Redmond AM, 2009, CLIN CANCER RES, V15, P2098, DOI 10.1158/1078-0432.CCR-08-1649; Reiter R, 2004, ONCOGENE, V23, P403, DOI 10.1038/sj.onc.1207202; Reiter R, 2001, J BIOL CHEM, V276, P39736, DOI 10.1074/jbc.M104744200; SMITH RG, 1975, NATURE, V253, P271, DOI 10.1038/253271a0; SPELSBERG TC, 1971, J BIOL CHEM, V246, P4188; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Tai H, 2000, BIOCHEM BIOPH RES CO, V267, P311, DOI 10.1006/bbrc.1999.1954; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tyteca S, 2006, MOL CELL, V24, P807, DOI 10.1016/j.molcel.2006.12.005; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang H., 2011, J HISTOCHEM IN PRESS; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Wang ZY, 2006, CELL METAB, V3, P111, DOI 10.1016/j.cmet.2006.01.002; WOO SLC, 1976, J BIOL CHEM, V251, P3868; WRANGE O, 1984, J BIOL CHEM, V259, P4534; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; York B, 2010, P NATL ACAD SCI USA, V107, P11122, DOI 10.1073/pnas.1005262107; YOSHINAGA SK, 1992, SCIENCE, V258, P1598, DOI 10.1126/science.1360703; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	98	163	170	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38743	38750		10.1074/jbc.R110.193367	http://dx.doi.org/10.1074/jbc.R110.193367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20956538	Green Published, hybrid			2022-12-27	WOS:000284941300002
J	Maezawa, I; Zimin, PI; Wulff, H; Jin, LW				Maezawa, Izumi; Zimin, Pavel I.; Wulff, Heike; Jin, Lee-Way			Amyloid-beta Protein Oligomer at Low Nanomolar Concentrations Activates Microglia and Induces Microglial Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MILD COGNITIVE IMPAIRMENT; CA2+-ACTIVATED K+ CHANNEL; SMALL-MOLECULE INHIBITORS; NECROSIS-FACTOR-ALPHA; ALZHEIMERS-DISEASE; A-BETA; POTASSIUM CHANNELS; INTERFERON-GAMMA; MOUSE MODEL	Neuroinflammation and associated neuronal dysfunction mediated by activated microglia play an important role in the pathogenesis of Alzheimer disease (AD). Microglia are activated by aggregated forms of amyloid-beta protein (A beta), usually demonstrated in vitro by stimulating microglia with micromolar concentrations of fibrillar A beta, a major component of amyloid plaques in AD brains. Here we report that amyloid-beta oligomer (A beta O), at 5-50 nM, induces a unique pattern of microglia activation that requires the activity of the scavenger receptor A and the Ca2+-activated potassium channel KCa3.1. A beta O treatment induced an activated morphological and biochemical profile of microglia, including activation of p38 MAPK and nuclear factor kappa B. Interestingly, although increasing nitric oxide (NO) production, A beta O did not increase several proinflammatory mediators commonly induced by lipopolyliposacharides or fibrillar A beta, suggesting that A beta O stimulates both common and divergent pathways of microglia activation. A beta O at low nanomolar concentrations, although not neurotoxic, induced indirect, microglia-mediated damage to neurons in dissociated cultures and in organotypic hippocampal slices. The indirect neurotoxicity was prevented by (i) doxycycline, an inhibitor of microglia activation; (ii) TRAM-34, a selective KCa3.1 blocker; and (iii) two inhibitors of inducible NO synthase, indicating that KCa3.1 activity and excessive NO release are required for A beta O-induced microglial neurotoxicity. Our results suggest that A beta O, generally considered a neurotoxin, may more potently cause neuronal damage indirectly by activating microglia in AD.	Univ Calif Davis, Med Invest Neurodev Disorders Inst, Davis, CA 95618 USA; [Maezawa, Izumi; Jin, Lee-Way] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95618 USA; [Zimin, Pavel I.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95618 USA; [Jin, Lee-Way] Univ Calif Davis, Alzheimers Dis Ctr, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Jin, LW (corresponding author), Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, 2805 50th St, Sacramento, CA 95817 USA.	Lee-Way.Jin@ucdmc.ucdavis.edu	wulff, Heike/Z-2056-2019		National Institutes of Health [AG025500, AG031362]; University of California Davis Alzheimer's Disease Center [AG010129]; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG025500, R21AG031362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Davis Alzheimer's Disease Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG025500 and AG031362. This work was also supported by University of California Davis Alzheimer's Disease Center Grant AG010129.	Bahr BA, 1998, J COMP NEUROL, V397, P139; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bernardino ALF, 2009, J INFECT DIS, V199, P1379, DOI 10.1086/597807; Bernardino L, 2005, J NEUROSCI, V25, P6734, DOI 10.1523/JNEUROSCI.1510-05.2005; Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Carson MJ, 1998, GLIA, V22, P72, DOI 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DAVIS JB, 1992, BIOCHEM BIOPH RES CO, V189, P1096, DOI 10.1016/0006-291X(92)92317-Q; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; EDER C, 1995, J MEMBRANE BIOL, V147, P137; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; ElKhoury J, 1996, NATURE, V382, P716; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Franciosi S, 2006, J NEUROSCI, V26, P11652, DOI 10.1523/JNEUROSCI.2490-06.2006; GALLIN EK, 1984, BIOPHYS J, V46, P821, DOI 10.1016/S0006-3495(84)84080-1; Gasic-Milenkovic J, 2003, EUR J NEUROSCI, V17, P813, DOI 10.1046/j.1460-9568.2003.02506.x; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashioka S, 2005, NEUROCHEM INT, V47, P369, DOI 10.1016/j.neuint.2005.05.001; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hoogenraad CC, 2005, NAT NEUROSCI, V8, P906, DOI 10.1038/nn1487; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jantzie LL, 2005, J CEREBR BLOOD F MET, V25, P314, DOI 10.1038/sj.jcbfm.9600025; Jimenez S, 2008, J NEUROSCI, V28, P11650, DOI 10.1523/JNEUROSCI.3024-08.2008; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lai AY, 2006, GLIA, V53, P809, DOI 10.1002/glia.20335; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li M, 2004, J NEUROCHEM, V91, P623, DOI 10.1111/j.1471-4159.2004.02765.x; Lindberg C, 2005, J MOL NEUROSCI, V27, P1, DOI 10.1385/JMN:27:1:001; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; Maezawa I, 2006, FASEB J, V20, P797, DOI 10.1096/fj.05-5423fje; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Muehlhauser F, 2001, CLIN CHEM LAB MED, V39, P313, DOI 10.1515/CCLM.2001.048; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Ohana L, 2009, CHANNELS, V3, P129, DOI 10.4161/chan.3.2.8609; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Parvathy S, 2009, NEUROBIOL AGING, V30, P1792, DOI 10.1016/j.neurobiolaging.2008.01.011; Reich EP, 2005, EUR J IMMUNOL, V35, P1027, DOI 10.1002/eji.200425954; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2003, PFLUG ARCH EUR J PHY, V447, P312, DOI 10.1007/s00424-003-1155-3; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Takata K, 2003, J PHARMACOL SCI, V91, P330; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tamagno E, 2008, J NEUROCHEM, V104, P683, DOI 10.1111/j.1471-4159.2007.05072.x; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; van Helmond Z, 2010, BRAIN PATHOL, V20, P468, DOI 10.1111/j.1750-3639.2009.00321.x; Veerhuis R, 2003, ACTA NEUROPATHOL, V105, P135, DOI 10.1007/s00401-002-0624-7; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Xiang H, 1998, J NEUROSCI, V18, P1363; Xie Z, 2002, J NEUROSCI, V22, P3484; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	88	198	204	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3693	3706		10.1074/jbc.M110.135244	http://dx.doi.org/10.1074/jbc.M110.135244			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20971854	Green Published, hybrid			2022-12-27	WOS:000286653200052
J	Nagle, MA; Truong, DM; Dnyanmote, AV; Ahn, SY; Eraly, SA; Wu, W; Nigam, SK				Nagle, Megha A.; Truong, David M.; Dnyanmote, Ankur V.; Ahn, Sun-Young; Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.			Analysis of Three-dimensional Systems for Developing and Mature Kidneys Clarifies the Role of OAT1 and OAT3 in Antiviral Handling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGANIC ANION TRANSPORTERS; SLC22A FAMILY-MEMBERS; MOLECULAR-CLONING; ION TRANSPORTERS; NEPHROTOXICITY; EXPRESSION; TENOFOVIR; DRUG; RAT; IMMUNOLOCALIZATION	The organic anion transporters OAT1 (SLC22A6, originally identified by us as NKT) and OAT3 (SLC22A8) are critical for handling many toxins, metabolites, and drugs, including antivirals (Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) J. Biol. Chem. 283, 8654-8663). Although microinjected Xenopus oocytes and/or transfected cells indicate overlapping specificities, the individual contributions of these transporters in the three-dimensional context of the tissues in which they normally function remain unclear. Here, handling of HIV antivirals (stavudine, tenofovir, lamivudine, acyclovir, and zidovudine) was analyzed with three-dimensional ex vivo functional assays using knock-out tissue. To investigate the contribution of OAT1 and OAT3 in various nephron segments, the OAT-selective fluorescent tracer substrates 5-carboxyfluorescein and 6-carboxyfluorescein were used. Although OAT1 function (uptake in oat3(-/-) tissue) was confined to portions of the cortex, consistent with a proximal tubular localization, OAT3 function (uptake in oat1(-/-) tissue) was apparent throughout the cortex, indicating localization in the distal as well as proximal nephron. This functional localization indicates a complex three-dimensional context, which needs to be considered for metabolites, toxins, and drugs (e. g. antivirals) handled by both transporters. These results also raise the possibility of functional differences in the relative importance of OAT1 and OAT3 in antiviral handling in developing and mature tissue. Because the HIV antivirals are used in pregnant women, the results may also help in understanding how these drugs are handled by developing organs.	[Eraly, Satish A.; Wu, Wei; Nigam, Sanjay K.] Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, La Jolla, CA 92093 USA; [Nagle, Megha A.; Dnyanmote, Ankur V.; Ahn, Sun-Young; Nigam, Sanjay K.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Nigam, Sanjay K.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Truong, David M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Austin	Nigam, SK (corresponding author), Univ Calif San Diego, Dept Med, Div Nephrol & Hypertens, 9500 Gilman Dr, La Jolla, CA 92093 USA.	snigam@ucsd.edu		Ahn, Sun-Young/0000-0001-5571-6901; Truong, David/0000-0002-5121-5111	National Institutes of Health [AI057695, DK079784, GM88824, HL094728]; Society of Toxicology and Colgate Palmolive; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Toxicology and Colgate Palmolive; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI057695, DK079784, and GM88824 (to S. K. N.) and HL094728 (to S. A. E.). This work was also supported by a postdoctoral fellowship from the Society of Toxicology and Colgate Palmolive (to A. V. D.).	Ahn SY, 2009, MOL PHARMACOL, V76, P481, DOI 10.1124/mol.109.056564; Cihlar T, 2001, NUCLEOS NUCLEOT NUCL, V20, P641, DOI 10.1081/NCN-100002341; Eraly SA, 2006, J BIOL CHEM, V281, P5072, DOI 10.1074/jbc.M508050200; Eraly SA, 2003, CURR OPIN NEPHROL HY, V12, P551, DOI 10.1097/00041552-200309000-00011; Hasegawa M, 2003, J PHARMACOL EXP THER, V305, P1087, DOI 10.1124/jpet.102.046847; Hussain S, 2006, PEDIATR NEPHROL, V21, P1034, DOI 10.1007/s00467-006-0109-3; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Kaler G, 2007, J BIOL CHEM, V282, P23841, DOI 10.1074/jbc.M703467200; Kojima R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134848; Laitinen L, 1987, J HISTOCHEM CYTOCHEM, V35, P55, DOI 10.1177/35.1.3794309; LopezNieto CE, 1997, J BIOL CHEM, V272, P6471, DOI 10.1074/jbc.272.10.6471; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Nigam SK, 2007, NAT CLIN PRACT NEPHR, V3, P443, DOI 10.1038/ncpneph0558; Pavlova A, 2000, AM J PHYSIOL-RENAL, V278, pF635, DOI 10.1152/ajprenal.2000.278.4.F635; Ray AS, 2006, ANTIMICROB AGENTS CH, V50, P3297, DOI 10.1128/AAC.00251-06; Servais Aude, 2005, Nephrol Ther, V1, P296, DOI 10.1016/j.nephro.2005.06.011; Servais A, 2006, EUR J PHARMACOL, V540, P168, DOI 10.1016/j.ejphar.2006.04.047; Sweet DH, 2005, TOXICOL APPL PHARM, V204, P198, DOI 10.1016/j.taap.2004.10.016; Sweet DH, 2006, KIDNEY INT, V69, P837, DOI 10.1038/sj.ki.5000170; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sykes D, 2004, AM J PHYSIOL-RENAL, V286, pF972, DOI 10.1152/ajprenal.00356.2003; Tahara H, 2005, PHARM RES-DORDR, V22, P647, DOI 10.1007/s11095-005-2503-0; Takeda M, 2002, J PHARMACOL EXP THER, V300, P918, DOI 10.1124/jpet.300.3.918; Trifillis AL, 1999, EXP NEPHROL, V7, P353; Truong DM, 2008, J BIOL CHEM, V283, P8654, DOI 10.1074/jbc.M708615200; Uwai Y, 2007, PHARM RES, V24, P811, DOI 10.1007/s11095-006-9196-x; Vallon V, 2008, J AM SOC NEPHROL, V19, P1732, DOI 10.1681/ASN.2008020180; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Wada S, 2000, J PHARMACOL EXP THER, V294, P844	29	52	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					243	251		10.1074/jbc.M110.139949	http://dx.doi.org/10.1074/jbc.M110.139949			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20921221	Green Published, hybrid			2022-12-27	WOS:000285782800027
J	Chen, W; Dong, QH; Shin, KH; Kim, RH; Oh, JE; Park, NH; Kang, MK				Chen, Wei; Dong, Qinghua; Shin, Ki-Hyuk; Kim, Reuben H.; Oh, Ju-Eun; Park, No-Hee; Kang, Mo K.			Grainyhead-like 2 Enhances the Human Telomerase Reverse Transcriptase Gene Expression by Inhibiting DNA Methylation at the 5 '-CpG Island in Normal Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ORAL KERATINOCYTES; PROMOTER ACTIVITY; IMMORTAL CELLS; DROSOPHILA; HTERT; DIFFERENTIATION; SENESCENCE; MECHANISM; BINDING; HEAD	We recently identified Grainyhead-like 2 (GRHL2) as a novel transcription factor that binds to and regulates the activity of the human telomerase reverse transcriptase (hTERT) gene promoter. In this study, we investigated the biological functions of GRHL2 and the molecular mechanism underlying hTERT gene regulation by GRHL2. Retroviral transduction of GRHL2 in normal human keratinocytes (NHK) led to a significant extension of replicative life span, whereas GRHL2 knockdown notably repressed telomerase activity and cell proliferation. Using promoter magnetic precipitation coupled with Western blotting, we confirmed the binding of GRHL2 to the hTERT promoter and mapped the minimal binding region at -53 to -13 of the promoter. Furthermore, mutation analysis revealed the three nucleotides from -21 to -19 to be critical for GRHL2 binding. Because hTERT expression is regulated in part by DNA methylation, we determined the effects of GRHL2 on the methylation status of the hTERT promoter. Senescent NHK exhibited hypermethylation of the CpG island, which occurred with the loss of hTERT expression. On the contrary, the promoter remained hypomethylated in GRHL2-transduced NHK, irrespective of cell proliferation status. Also, knockdown of endogenous GRHL2 led to hypermethylation of the promoter. These results indicate that GRHL2 regulates the hTERT expression through an epigenetic mechanism and controls the cellular life span.	[Kang, Mo K.] Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Los Angeles, CA 90095 USA; [Shin, Ki-Hyuk; Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Dent Res Inst, Los Angeles, CA 90095 USA; [Shin, Ki-Hyuk; Kim, Reuben H.; Park, No-Hee; Kang, Mo K.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Park, No-Hee] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kang, MK (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Hlth Sci, Rm 43-009,10833 Le Conte Ave, Los Angeles, CA 90095 USA.	mkang@dentistry.ucla.edu			National Institutes of Health, NIDCR [R01DE18295, K02DE18959]; Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K02DE018959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018295] Funding Source: NIH RePORTER	National Institutes of Health, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Jack A. Weichman Endowed Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DE18295 and K02DE18959 from NIDCR.; Supported by the Jack A. Weichman Endowed Fund.	Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; Boldrini L, 2006, INT J ONCOL, V28, P1555; BRAY SJ, 1991, GENE DEV, V5, P1672, DOI 10.1101/gad.5.9.1672; Cann JR, 1998, ELECTROPHORESIS, V19, P127, DOI 10.1002/elps.1150190202; Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dessain SK, 2000, CANCER RES, V60, P537; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hayashi Y, 1999, J BIOL CHEM, V274, P35080, DOI 10.1074/jbc.274.49.35080; Horikawa I, 2004, CYTOTECHNOLOGY, V45, P23, DOI 10.1007/s10616-004-5122-4; Horikawa I, 1999, CANCER RES, V59, P826; Huang JD, 1995, GENE DEV, V9, P3177, DOI 10.1101/gad.9.24.3177; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kang MK, 2000, EXP CELL RES, V258, P288, DOI 10.1006/excr.2000.4943; Kang MK, 2004, J CELL PHYSIOL, V199, P364, DOI 10.1002/jcp.10410; Kang MK, 1998, CELL GROWTH DIFFER, V9, P85; Kang Mo K, 2007, Methods Mol Biol, V371, P151; Kang X, 2009, ONCOGENE, V28, P565, DOI 10.1038/onc.2008.404; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kim RH, 2007, EXP CELL RES, V313, P462, DOI 10.1016/j.yexcr.2006.10.025; Kristensen LS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-453; Kyo S, 1999, INT J CANCER, V80, P60, DOI 10.1002/(SICI)1097-0215(19990105)80:1<60::AID-IJC12>3.3.CO;2-5; Lo YMD, 1999, CANCER RES, V59, P3899; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Shin KH, 2003, BRIT J CANCER, V89, P1473, DOI 10.1038/sj.bjc.6601291; Stramer B, 2005, CURR BIOL, V15, pR425, DOI 10.1016/j.cub.2005.05.034; Svedruzic ZM, 2008, CURR MED CHEM, V15, P92, DOI 10.2174/092986708783330700; Tanaka Y, 2008, J HEPATOL, V49, P746, DOI 10.1016/j.jhep.2008.06.019; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, BIOCHEM J, V370, P953, DOI 10.1042/BJ20021476; UV AE, 1994, MOL CELL BIOL, V14, P4020, DOI 10.1128/MCB.14.6.4020; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Wilanowski T, 2008, EMBO J, V27, P886, DOI 10.1038/emboj.2008.24; Wooten LG, 2005, J BIOL CHEM, V280, P28867, DOI 10.1074/jbc.M413444200; Yu ZQ, 2006, DEV BIOL, V299, P122, DOI 10.1016/j.ydbio.2006.07.015	41	40	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40852	40863		10.1074/jbc.M110.103812	http://dx.doi.org/10.1074/jbc.M110.103812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20938050	Green Published, hybrid			2022-12-27	WOS:000285414400050
J	Lee, KP; Yuan, JP; So, I; Worley, PF; Muallem, S				Lee, Kyu Pil; Yuan, Joseph P.; So, Insuk; Worley, Paul F.; Muallem, Shmuel			STIM1-dependent and STIM1-independent Function of Transient Receptor Potential Canonical (TRPC) Channels Tunes Their Store-operated Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; PLASMA-MEMBRANE; CRAC CHANNELS; CA2+ ENTRY; ORAI CHANNELS; STIM1; DOMAIN; DEPLETION; OLIGOMERIZATION	Ca(2+)influx by store-operated Ca2+ channels is a key component of the receptor-evoked Ca2+ signal. In all cells examined, transient receptor potential canonical (TRPC) channels mediate a significant portion of the receptor-stimulated Ca2+ influx. Recent studies have revealed how STIM1 activates TRPC1 in response to store depletion; however, the role of STIM1 in TRPC channel activation by receptor stimulation is not fully understood. Here, we established mutants of TRPC channels that could not be activated by STIM1 but were activated by the "charge-swap" mutant STIM1(K684E,K685E). Significantly, WT but not mutant TRPC channels were inhibited by scavenging STIM1 with Orai1(R91W), indicating the STIM1 dependence and independence of WT and mutant TRPC channels, respectively. Importantly, mutant TRPC channels were robustly activated by receptor stimulation. Moreover, STIM1 and STIM1(K684E, K685E) reciprocally affected receptor-activated WT and mutant TRPC channels. Together, these findings indicate that TRPC channels can function as STIM1-dependent and STIM1-independent channels, which increases the versatility of TRPC channel function and their role in receptor-stimulated Ca2+ influx.	[Lee, Kyu Pil; Yuan, Joseph P.; Muallem, Shmuel] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Lee, Kyu Pil; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; [Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci & Neurol, Baltimore, MD 21205 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Seoul National University (SNU); Johns Hopkins University	Muallem, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	shmuel.muallem@nih.gov	So, Insuk/J-2762-2012	lee, kyu pil/0000-0002-7192-4791	National Institutes of Health [DE12302, DK38938]; NIDCR/DIR; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR/DIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DE12302 and DK38938 and by NIDCR/DIR.	DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020	26	57	57	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38666	38673		10.1074/jbc.M110.155036	http://dx.doi.org/10.1074/jbc.M110.155036			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20926378	Green Published, hybrid			2022-12-27	WOS:000284625600071
J	Habib, LK; Lee, MTC; Yang, J				Habib, Lila K.; Lee, Michelle T. C.; Yang, Jerry			Inhibitors of Catalase-Amyloid Interactions Protect Cells from beta-Amyloid-Induced Oxidative Stress and Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-RADICAL GENERATION; ANTIOXIDANT ENZYME-ACTIVITY; ALZHEIMERS-DISEASE BRAIN; A-BETA; HYDROGEN-PEROXIDE; PRECURSOR PROTEIN; THIOFLAVIN-T; COLORIMETRIC ASSAY; SURFACE-AREA; PEPTIDE	Compelling evidence shows a strong correlation between accumulation of neurotoxic beta-amyloid (A beta) peptides and oxidative stress in the brains of patients afflicted with Alzheimer disease (AD). One hypothesis for this correlation involves the direct and harmful interaction of aggregated A beta peptides with enzymes responsible for maintaining normal, cellular levels of reactive oxygen species (ROS). Identification of specific, destructive interactions of A beta peptides with cellular anti-oxidant enzymes would represent an important step toward understanding the pathogenicity of A beta peptides in AD. This report demonstrates that exposure of human neuroblastoma cells to cytotoxic preparations of aggregated A beta peptides results in significant intracellular co-localization of A beta with catalase, an anti-oxidant enzyme responsible for catalyzing the degradation of the ROS intermediate hydrogen peroxide (H2O2). These catalase-A beta interactions deactivate catalase, resulting in increased cellular levels of H2O2. Furthermore, small molecule inhibitors of catalase-amyloid interactions protect the hydrogen peroxide-degrading activity of catalase in A beta-rich environments, leading to reduction of the co-localization of catalase and A beta in cells, inhibition of A beta-induced increases in cellular levels of H2O2, and reduction of the toxicity of A beta peptides. These studies, thus, provide evidence for the important role of intracellular catalase-amyloid interactions in A beta-induced oxidative stress and propose a novel molecular strategy to inhibit such harmful interactions in AD.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lee, Michelle T. C.; Yang, Jerry] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Yang, J (corresponding author), 9500 Gilman Dr,MC 0358, La Jolla, CA 92093 USA.	jerryyang@ucsd.edu			Hellman Foundation; Alzheimer Disease Research Center [3P50 AG005131]; Alzheimer Association [NIRG-08-91651]; National Science Foundation [CHE-0847530, CHE-0116662]; Kuwait University; UCSD Cancer Center Microscopy Shared Facility [P30 CA23100]; UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	Hellman Foundation; Alzheimer Disease Research Center; Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); National Science Foundation(National Science Foundation (NSF)); Kuwait University; UCSD Cancer Center Microscopy Shared Facility; UCSD Neuroscience Microscopy Shared Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Hellman Foundation, the Alzheimer Disease Research Center (3P50 AG005131), the Alzheimer Association (NIRG-08-91651), and the National Science Foundation (CAREER Award CHE-0847530, to J. Y.).; Supported by a Kuwait University fellowship.; We thank Jennifer Meerloo and Dr. Kersi Pestonjamasp for technical assistance. We thank Neal Sekiya of the UCSD Flow Cytometry Research Core for acquiring the flow cytometry data and Valentina Matlachova for preliminary work in developing the catalase activity assay. We acknowledge the UCSD Cancer Center Microscopy Shared Facility supported by Grant P30 CA23100 and the UCSD Neuroscience Microscopy Shared Facility supported by Grant P30 NS047101. We also acknowledge the National Science Foundation for support of the mass spectrometry facility at UCSD (CHE-0116662).	Aksenov MY, 2001, NEUROSCIENCE, V103, P373, DOI 10.1016/S0306-4522(00)00580-7; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Bhatia R, 2000, FASEB J, V14, P1233, DOI 10.1096/fasebj.14.9.1233; Bieschke J, 2008, BIOCHEMISTRY-US, V47, P50, DOI 10.1021/bi701757v; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Casley CS, 2002, J NEUROCHEM, V80, P91, DOI 10.1046/j.0022-3042.2001.00681.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Clifford PM, 2007, BRAIN RES, V1142, P223, DOI 10.1016/j.brainres.2007.01.070; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; FOSSATI P, 1980, CLIN CHEM, V26, P227; GAUNT GL, 1976, J NEUROCHEM, V26, P749, DOI 10.1111/j.1471-4159.1976.tb04448.x; Gibson GE, 1998, J NEURAL TRANSM, V105, P855, DOI 10.1007/s007020050099; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GSELL W, 1995, J NEUROCHEM, V64, P1216; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Halliwell B.G.J.M.C., 2007, FREE RADICALS BIOL M; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; Hensley K, 1996, ANN NY ACAD SCI, V786, P120, DOI 10.1111/j.1749-6632.1996.tb39057.x; HENSLEY K, 1994, P NATL ACAD SCI USA, V91, P3270, DOI 10.1073/pnas.91.8.3270; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Huang XD, 2004, ANN NY ACAD SCI, V1012, P153, DOI 10.1196/annals.1306.012; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Inbar P, 2006, BIOORG MED CHEM LETT, V16, P1076, DOI 10.1016/j.bmcl.2005.10.067; Inbar P, 2008, ANAL CHEM, V80, P3502, DOI 10.1021/ac702592f; Inbar P, 2006, CHEMBIOCHEM, V7, P1563, DOI 10.1002/cbic.200600119; Kagan BL, 2004, J MEMBRANE BIOL, V202, P1, DOI 10.1007/s00232-004-0709-4; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kaminsky YG, 2008, FREE RADICAL RES, V42, P564, DOI 10.1080/10715760802159057; KNAUER MF, 1992, P NATL ACAD SCI USA, V89, P7437, DOI 10.1073/pnas.89.16.7437; Kuo YM, 1996, J BIOL CHEM, V271, P4077; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lal R, 2007, BBA-BIOMEMBRANES, V1768, P1966, DOI 10.1016/j.bbamem.2007.04.021; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lockhart A, 2005, J BIOL CHEM, V280, P7677, DOI 10.1074/jbc.M412056200; Lomakin A, 1999, METHOD ENZYMOL, V309, P429; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; LOVELL MA, 1995, NEUROLOGY, V45, P1594, DOI 10.1212/WNL.45.8.1594; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MARGOLIASH E, 1960, BIOCHEM J, V74, P339, DOI 10.1042/bj0740339; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; MARTTILA RJ, 1988, J NEURAL TRANSM, V74, P87, DOI 10.1007/BF01245142; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Milton NGN, 1999, BIOCHEM J, V344, P293, DOI 10.1042/0264-6021:3440293; Milton NGN, 2004, DRUG AGING, V21, P81, DOI 10.2165/00002512-200421020-00002; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; PAPPOLLA MA, 1992, AM J PATHOL, V140, P621; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reddy PH, 2006, J NEUROCHEM, V96, P1, DOI 10.1111/j.1471-4159.2005.03530.x; Rensink AAM, 2002, BRAIN RES, V952, P111, DOI 10.1016/S0006-8993(02)03218-3; Rottkamp CA, 2001, FREE RADICAL BIO MED, V30, P447, DOI 10.1016/S0891-5849(00)00494-9; Sagara Y, 1996, J NEUROSCI, V16, P497; SCHUBERT D, 1995, BIOCHEM BIOPH RES CO, V216, P702, DOI 10.1006/bbrc.1995.2678; SCHUBERT D, 1995, P NATL ACAD SCI USA, V92, P1989, DOI 10.1073/pnas.92.6.1989; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Slaughter MR, 2000, CLIN BIOCHEM, V33, P525, DOI 10.1016/S0009-9120(00)00158-2; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; SUBBARAO KV, 1990, J NEUROCHEM, V55, P342, DOI 10.1111/j.1471-4159.1990.tb08858.x; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; TOMSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V294, P630, DOI 10.1016/0003-9861(92)90735-F; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walters WP, 1999, CURR OPIN CHEM BIOL, V3, P384, DOI 10.1016/S1367-5931(99)80058-1; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Zhang ZY, 1996, J NEUROCHEM, V67, P1595	100	65	69	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38933	38943		10.1074/jbc.M110.132860	http://dx.doi.org/10.1074/jbc.M110.132860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923778	Green Published, hybrid			2022-12-27	WOS:000284941300023
J	Nagy, K; Pilbat, AM; Groma, G; Szalontai, B; Cuisinier, FJG				Nagy, Krisztina; Pilbat, Ana-Maria; Groma, Geza; Szalontai, Balazs; Cuisinier, Frederic J. G.			Casein Aggregates Built Step-by-Step on Charged Polyelectrolyte Film Surfaces Are Calcium Phosphate-cemented	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; INTRINSICALLY UNSTRUCTURED PROTEINS; MULTILAYERS; MICELLES; BOVINE	The possible mechanism of casein aggregation and micelle buildup was studied in a new approach by letting alpha-casein adsorb from low concentration (0.1 mg.ml(-1)) solutions onto the charged surfaces of polyelectrolyte films. It was found that alpha-casein could adsorb onto both positively and negatively charged surfaces. However, only when its negative phosphoseryl clusters remained free, i.e. when it adsorbed onto a negative surface, could calcium phosphate (CaP) nanoclusters bind to the casein molecules. Once the CaP clusters were in place, step-by-step building of multilayered casein architectures became possible. The presence of CaP was essential; neither Ca2+ nor phosphate could alone facilitate casein aggregation. Thus, it seems that CaP is the organizing motive in the casein micelle formation. Atomic force microscopy revealed that even a single adsorbed casein layer was composed of very small (in the range of tens of nanometers) spherical forms. The stiffness of the adsorbed casein layer largely increased in the presence of CaP. On this basis, we can imagine that casein micelles emerge according to the following scheme. The amphipathic casein monomers aggregate into oligomers via hydrophobic interactions even in the absence of CaP. Full scale, CaP-carrying micelles could materialize by interlocking these casein oligomers with CaP nanoclusters. Such a mechanism would not contradict former experimental results and could offer a synthesis between the submicelle and the block copolymer models of casein micelles.	Hungarian Acad Sci, Inst Biophys, Biol Res Ctr, H-6071 Szeged, Hungary; [Cuisinier, Frederic J. G.] Univ Montpellier 1, Fac Chirurg Dent, Montpellier 5, France	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Universite de Montpellier		balazs@brc.hu	Cuisinier, Frédéric/ABD-4152-2020	Cuisinier, Frédéric/0000-0001-6870-0490	Hungarian Research Foundation [75818]; ECO-NET program (France) [16203RK]	Hungarian Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ECO-NET program (France)	This work was supported by Grant 75818 from Hungarian Research Foundation and by Grant 16203RK from ECO-NET program (France).	Balint Z, 2007, EUR BIOPHYS J BIOPHY, V36, P113, DOI 10.1007/s00249-006-0112-4; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Coifman R. R., 1995, WAVELETS STAT, P125; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Farrell H.M., 2006, ACS S SERIES AM CHEM, VVolume 935, P52; Farrell HM, 2006, CURR OPIN COLLOID IN, V11, P135, DOI 10.1016/j.cocis.2005.11.005; Farrell HM, 2003, J PROTEIN CHEM, V22, P259, DOI 10.1023/A:1025020503769; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; HERTZ M, 1982, J REINE ANGEWANDTE M, V92, P156; Heuvingh J, 2005, LANGMUIR, V21, P3165, DOI 10.1021/la047388m; Horne D. S., 2006, Current Opinion in Colloid and Interface Science, V11, P148, DOI 10.1016/j.cocis.2005.11.004; Horne DS, 2002, CURR OPIN COLLOID IN, V7, P456, DOI 10.1016/S1359-0294(02)00082-1; Horne DS, 1998, INT DAIRY J, V8, P171, DOI 10.1016/S0958-6946(98)00040-5; Ladam G, 2000, LANGMUIR, V16, P1249, DOI 10.1021/la990650k; MALLAT S, 1998, WAVELET TOUR SIGNAL, P248; Martin P., 2003, ADV DAIRY CHEM, V1, P277; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; MORAGUTIERREZ A, 1993, J AGR FOOD CHEM, V41, P372, DOI 10.1021/jf00027a007; Muller-Buschbaum P, 2007, BIOPHYS J, V93, P960, DOI 10.1529/biophysj.107.106385; Saab MB, 2009, LANGMUIR, V25, P5159, DOI 10.1021/la9002274; Schwinte P, 2002, BIOMACROMOLECULES, V3, P1135, DOI 10.1021/bm025547f; Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4; Walstra P, 1999, INT DAIRY J, V9, P189, DOI 10.1016/S0958-6946(99)00059-X	28	10	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38811	38817		10.1074/jbc.M110.151167	http://dx.doi.org/10.1074/jbc.M110.151167			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20921229	Green Published, hybrid			2022-12-27	WOS:000284941300010
J	Jahani-Asl, A; Pilon-Larose, K; Xu, W; MacLaurin, JG; Park, DS; McBride, HM; Slack, RS				Jahani-Asl, Arezu; Pilon-Larose, Karine; Xu, William; MacLaurin, Jason G.; Park, David S.; McBride, Heidi M.; Slack, Ruth S.			The Mitochondrial Inner Membrane GTPase, Optic Atrophy 1 (Opa1), Restores Mitochondrial Morphology and Promotes Neuronal Survival following Excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; CELL-DEATH; ENDOPLASMIC-RETICULUM; RHO-GTPASES; MOLECULAR-MECHANISMS; THERAPEUTIC TARGET; CYTOCHROME-C; FISSION; KINASE; BAX	Mitochondrial dynamics have been extensively studied in the context of classical cell death models involving Bax-mediated cytochrome c release. Excitotoxic neuronal loss is a nonclassical death signaling pathway that occurs following overactivation of glutamate receptors independent of Bax activation. Presently, the role of mitochondrial dynamics in the regulation of excitotoxicity remains largely unknown. Here, we report that NMDA-induced excitotoxicity results in defects in mitochondrial morphology as evident by the presence of excessive fragmented mitochondria, cessation of mitochondrial fusion, and cristae dilation. Up-regulation of the mitochondrial inner membrane GTPase, Opa1, is able to restore mitochondrial morphology and protect neurons against excitotoxic injury. Opa1 functions downstream of the calcium-dependent protease, calpain. Inhibition of calpain activity by calpastatin, an endogenous calpain inhibitor, significantly rescued mitochondrial defects and maintained neuronal survival. Opa1 was required for calpastatin-mediated neuroprotection because the enhanced survival found following NMDA-induced toxicity was significantly reduced upon loss of Opa1. Our results define a mechanism whereby breakdown of the mitochondrial network mediated through loss of Opa1 function contributes to neuronal death following excitotoxic neuronal injury. These studies suggest Opa1 as a potential therapeutic target to promote neuronal survival following acute brain damage and neurodegenerative diseases.	[Jahani-Asl, Arezu; Pilon-Larose, Karine; Xu, William; MacLaurin, Jason G.; Park, David S.; Slack, Ruth S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [McBride, Heidi M.] Univ Ottawa, Dept Biochem, Ottawa, ON K1H 8M5, Canada; [McBride, Heidi M.] Univ Ottawa, Inst Heart, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Slack, RS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	rslack@uottawa.ca	McBride, Heidi M/C-1162-2008; McBride, Heidi M./ABD-5774-2021	McBride, Heidi M/0000-0003-4666-2280; McBride, Heidi M./0000-0003-4666-2280; Park, David/0000-0002-4490-3784; Jahani-Asl, Arezu/0000-0003-4002-3381; Slack, Ruth/0000-0002-1552-2835	Heart and Stroke Foundation of Canada [NA6030]; Canadian Institutes of Health Research (CIHR)	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Canada Grant NA6030 and a grant from the Canadian Institutes of Health Research (CIHR) (to R. S. S.).	Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Aznar S, 2004, CANCER LETT, V206, P181, DOI 10.1016/j.canlet.2003.08.035; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2006, DEV CELL, V11, P592, DOI 10.1016/j.devcel.2006.10.009; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Cregan SP, 1999, J NEUROSCI, V19, P7860; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dargusch R, 2001, J NEUROCHEM, V76, P295, DOI 10.1046/j.1471-4159.2001.00035.x; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Forder JP, 2009, NEUROSCIENCE, V158, P293, DOI 10.1016/j.neuroscience.2008.10.021; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herlan M, 2003, J BIOL CHEM, V278, P27781, DOI 10.1074/jbc.M211311200; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200; Jahani-Asl A, 2010, BBA-MOL BASIS DIS, V1802, P162, DOI 10.1016/j.bbadis.2009.09.006; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kloog Y, 2000, MOL MED TODAY, V6, P398, DOI 10.1016/S1357-4310(00)01789-5; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kume H, 2008, CURR MED CHEM, V15, P2876, DOI 10.2174/092986708786242831; Marchioni F, 2009, CURR PHARM DESIGN, V15, P2481, DOI 10.2174/138161209788682334; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; O'Hare MJ, 2005, J NEUROSCI, V25, P8954, DOI 10.1523/JNEUROSCI.2899-05.2005; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rashidian J, 2005, P NATL ACAD SCI USA, V102, P14080, DOI 10.1073/pnas.0500099102; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Seo SY, 1999, J NEUROSCI, V19, P8849, DOI 10.1523/JNEUROSCI.19-20-08849.1999; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Wakino S, 2005, DRUG NEWS PERSPECT, V18, P639, DOI 10.1358/dnp.2005.18.10.959578; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Xing XQ, 2006, DRUG NEWS PERSPECT, V19, P517, DOI 10.1358/dnp.2006.19.9.1050426; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	43	88	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4772	4782		10.1074/jbc.M110.167155	http://dx.doi.org/10.1074/jbc.M110.167155			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21041314	Green Published, hybrid			2022-12-27	WOS:000286975700075
J	Lakhal, S; Schodel, J; Townsend, ARM; Pugh, CW; Ratcliffe, PJ; Mole, DR				Lakhal, Samira; Schoedel, Johannes; Townsend, Alain R. M.; Pugh, Christopher W.; Ratcliffe, Peter J.; Mole, David R.			Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors NEW LINK BETWEEN HYPOXIA SIGNALING AND IRON HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE MATRIPTASE-2 TMPRSS6; TRANSFERRIN RECEPTOR; HEPCIDIN EXPRESSION; MUTATIONS; ANEMIA; GENE; HFE; BINDING; HEMOJUVELIN; INHIBITION	Hepcidin is a liver-derived hormone with a key role in iron homeostasis. In addition to iron, it is regulated by inflammation and hypoxia, although mechanisms of hypoxic regulation remain unclear. In hepatocytes, hepcidin is induced by bone morphogenetic proteins (BMPs) through a receptor complex requiring hemojuvelin (HJV) as a co-receptor. Type II transmembrane serine proteinase (TMPRSS6) antagonizes hepcidin induction by BMPs by cleaving HJV from the cell membrane. Inactivating mutations in TMPRSS6 lead to elevated hepcidin levels and consequent iron deficiency anemia. Here we demonstrate that TMPRSS6 is up-regulated in hepatic cell lines by hypoxia and by other activators of hypoxia-inducible factor (HIF). We show that TMPRSS6 expression is regulated by both HIF-1 alpha and HIF-2 alpha. This HIF-dependent up-regulation of TMPRSS6 increases membrane HJV shedding and decreases hepcidin promoter responsiveness to BMP signaling in hepatocytes. Our results reveal a potential role for TMPRSS6 in hepcidin regulation by hypoxia and provide a new molecular link between oxygen sensing and iron homeostasis.	[Lakhal, Samira; Schoedel, Johannes; Pugh, Christopher W.; Ratcliffe, Peter J.; Mole, David R.] Univ Oxford, Oxford OX3 7BN, England; [Townsend, Alain R. M.] Univ Oxford, Weatherall Inst Mol Med, John Radcliffe Hosp, Oxford OX4 9DS, England	University of Oxford; University of Oxford	Lakhal, S (corresponding author), Univ Oxford, Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England.	samira.lakhal@well.ox.ac.uk; drmole@well.ox.ac.uk		Schodel, Johannes/0000-0002-3587-8839; Mole, David/0000-0002-0984-300X; Townsend, Alain/0000-0002-3702-0107; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X				Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Beutler E, 2010, BLOOD CELL MOL DIS, V44, P16, DOI 10.1016/j.bcmd.2009.09.001; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Giannetti AM, 2004, J BIOL CHEM, V279, P25866, DOI 10.1074/jbc.M401467200; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Island ML, 2009, HAEMATOL-HEMATOL J, V94, P720, DOI 10.3324/haematol.2008.001784; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Leung PS, 2005, GUT, V54, P1391, DOI 10.1136/gut.2004.062083; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; McMahon S, 2005, J BIOL CHEM, V280, P6561, DOI 10.1074/jbc.M413248200; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Parr C, 2007, CLIN CANCER RES, V13, P3568, DOI 10.1158/1078-0432.CCR-06-2357; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Sanders AJ, 2008, J CELL PHYSIOL, V216, P780, DOI 10.1002/jcp.21460; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Volke M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007875; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045; Yamaji S, 2004, BLOOD, V104, P2178, DOI 10.1182/blood-2004-03-0829	41	79	88	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4090	4097		10.1074/jbc.M110.173096	http://dx.doi.org/10.1074/jbc.M110.173096			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	20966077	Green Published, hybrid			2022-12-27	WOS:000286975700007
J	Eissa, A; Amodeo, V; Smith, CR; Diamandis, EP				Eissa, Azza; Amodeo, Vanessa; Smith, Christopher R.; Diamandis, Eleftherios P.			Kallikrein-related Peptidase-8 (KLK8) Is an Active Serine Protease in Human Epidermis and Sweat and Is Involved in a Skin Barrier Proteolytic Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; HUMAN STRATUM-CORNEUM; NEUROPSIN MESSENGER-RNA; NETHERTON-SYNDROME; TRYPSIN-LIKE; ENZYMATIC CHARACTERIZATION; MOLECULAR-CLONING; SEMINAL PLASMA; GENE FAMILY; EXPRESSION	Kallikrein-related peptidase-8 (KLK8) is a relatively uncharacterized epidermal protease. Although proposed to regulate skin-barrier desquamation and recovery, the catalytic activity of KLK8 was never demonstrated in human epidermis, and its regulators and targets remain unknown. Herein, we elucidated for the first time KLK8 activity in human non-palmoplantar stratum corneum and sweat ex vivo. The majority of stratum corneum and sweat KLK8 was catalytically active, displaying optimal activity at pH 8.5 and considerable activity at pH 5. We also showed that KLK8 is a keratinocyte-specific protease, not secreted by human melanocytes or dermal fibroblasts. KLK8 secretion increased significantly upon calcium induction of terminal keratinocyte differentiation, suggesting an active role for this protease in upper epidermis. Potential activators, regulators, and targets of KLK8 activity were identified by in vitro kinetic assays using pro-KLK8 and mature KLK8 recombinant proteins produced in Pichia pastoris. Mature KLK8 activity was enhanced by calcium and magnesium ions and attenuated by zinc ions and by autocleavage after Arg(164). Upon screening KLK8 cleavage of a library of FRET-quenched peptides, trypsin-like specificity was observed with the highest preference for (R/K)(S/T)(A/V) at P1-P1'-P2'. We also demonstrated that KLK5 and lysyl endopeptidase activate latent pro-KLK8, whereas active KLK8 targets pro-KLK11, pro-KLK1, and LL-37 antimicrobial peptide activation in vitro. Together, our data identify KLK8 as a new active serine protease in human stratum corneum and sweat, and we propose regulators and targets that augment its involvement in a skin barrier proteolytic cascade. The implications of KLK8 elevation and hyperactivity in desquamatory and inflammatory skin disease conditions remain to be studied.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Dept Pathol & Lab Med, Toronto, ON M5T 3L9, Canada; [Eissa, Azza; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Smith, Christopher R.; Diamandis, Eleftherios P.] Univ Hlth Network, Dept Clin Biochem, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Joseph & Wolf Lebov Ctr, Dept Pathol & Lab Med, 6th Fl,Rm 6-201,60 Murray St, Toronto, ON M5T 3L9, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Bernard D, 2003, J INVEST DERMATOL, V120, P592, DOI 10.1046/j.1523-1747.2003.12086.x; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Borgono CA, 2007, J BIOL CHEM, V282, P2405, DOI 10.1074/jbc.M608348200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Brattsand M, 2009, J INVEST DERMATOL, V129, P1656, DOI 10.1038/jid.2008.448; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Crew A, 2008, TALANTA, V75, P1221, DOI 10.1016/j.talanta.2008.01.043; Denda M, 1999, ARCH DERMATOL RES, V291, P560, DOI 10.1007/s004030050454; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; EGELRUD T, 1991, ARCH DERMATOL RES, V283, P108, DOI 10.1007/BF00371618; EGELRUD T, 1988, ACTA DERM-VENEREOL, V68, P93; Eissa A, 2008, BIOL CHEM, V389, P669, DOI 10.1515/BC.2008.079; Emami N, 2008, J BIOL CHEM, V283, P3031, DOI 10.1074/jbc.M707253200; Gallo RL, 2002, J ALLERGY CLIN IMMUN, V110, P823, DOI 10.1067/mai.2002.129801; Hachem JP, 2006, J INVEST DERMATOL, V126, P1609, DOI 10.1038/sj.jid.5700288; Hachem JP, 2010, J INVEST DERMATOL, V130, P500, DOI 10.1038/jid.2009.249; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; HIBINO T, 1994, J INVEST DERMATOL, V102, P214, DOI 10.1111/1523-1747.ep12371765; Inoue N, 1998, J INVEST DERMATOL, V110, P923, DOI 10.1046/j.1523-1747.1998.00212.x; Ishida-Yamamoto A, 2004, J INVEST DERMATOL, V122, P1137, DOI 10.1111/j.0022-202X.2004.22515.x; Jayakumar A, 2005, ARCH BIOCHEM BIOPHYS, V435, P89, DOI 10.1016/j.abb.2004.12.012; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; Kirihara T, 2003, BRIT J DERMATOL, V149, P700, DOI 10.1046/j.1365-2133.2003.05484.x; Kishi T, 2006, BIOL CHEM, V387, P723, DOI 10.1515/BC.2006.091; Kishibe M, 2007, J BIOL CHEM, V282, P5834, DOI 10.1074/jbc.M607998200; Kitayoshi H, 1999, ARCH DERMATOL RES, V291, P333, DOI 10.1007/s004030050418; Komatsu N, 2007, BRIT J DERMATOL, V156, P875, DOI 10.1111/j.1365-2133.2006.07743.x; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2005, BRIT J DERMATOL, V153, P274, DOI 10.1111/j.1365-2133.2005.06754.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Komatsu N, 2007, EXP DERMATOL, V16, P513, DOI 10.1111/j.1600-0625.2007.00562.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P925, DOI 10.1038/sj.jid.5700146; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Kuwae K, 2002, J CLIN PATHOL-MOL PA, V55, P235, DOI 10.1136/mp.55.4.235; Lee PHA, 2005, P NATL ACAD SCI USA, V102, P3750, DOI 10.1073/pnas.0500268102; LUNDSTROM A, 1991, ACTA DERM-VENEREOL, V71, P471; LUNDSTROM A, 1994, ARCH DERMATOL RES, V286, P369, DOI 10.1007/BF00371795; Luo LY, 2006, BIOL CHEM, V387, P813, DOI 10.1515/BC.2006.103; Luo LY, 2006, CLIN CANCER RES, V12, P742, DOI 10.1158/1078-0432.CCR-05-1696; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; MENON GK, 1994, BRIT J DERMATOL, V130, P139, DOI 10.1111/j.1365-2133.1994.tb02892.x; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Michael IP, 2005, J BIOL CHEM, V280, P14628, DOI 10.1074/jbc.M408132200; Milstone LM, 2004, J DERMATOL SCI, V36, P131, DOI 10.1016/j.jdermsci.2004.05.004; Murakami M, 2002, J INVEST DERMATOL, V119, P1090, DOI 10.1046/j.1523-1747.2002.19507.x; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; Nitzan YB, 2004, J HISTOCHEM CYTOCHEM, V52, P529, DOI 10.1177/002215540405200411; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Okabe A, 1996, BRAIN RES, V728, P116, DOI 10.1016/S0006-8993(96)00473-8; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yoshida S, 1998, GENE, V213, P9, DOI 10.1016/S0378-1119(98)00232-7; Yousef GM, 2000, GENOMICS, V65, P184, DOI 10.1006/geno.2000.6159; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184	61	79	79	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					687	706		10.1074/jbc.M110.125310	http://dx.doi.org/10.1074/jbc.M110.125310			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20940292	Green Published, hybrid			2022-12-27	WOS:000285782800069
J	Oyama, M; Nagashima, T; Suzuki, T; Kozuka-Hata, H; Yumoto, N; Shiraishi, Y; Ikeda, K; Kuroki, Y; Gotoh, N; Ishida, T; Inoue, S; Kitano, H; Okada-Hatakeyama, M				Oyama, Masaaki; Nagashima, Takeshi; Suzuki, Takashi; Kozuka-Hata, Hiroko; Yumoto, Noriko; Shiraishi, Yuichi; Ikeda, Kazuhiro; Kuroki, Yoko; Gotoh, Noriko; Ishida, Takanori; Inoue, Satoshi; Kitano, Hiroaki; Okada-Hatakeyama, Mariko			Integrated Quantitative Analysis of the Phosphoproteome and Transcriptome in Tamoxifen-resistant Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; GLYCOGEN-SYNTHASE KINASE-3; DNA-BINDING ACTIVITY; ENDOCRINE RESISTANCE; ELEVATED LEVELS; CROSS-TALK; C-JUN; CELLS; PHOSPHORYLATION	Quantitative phosphoproteome and transcriptome analysis of ligand-stimulated MCF-7 human breast cancer cells was performed to understand the mechanisms of tamoxifen resistance at a system level. Phosphoproteome data revealed that WT cells were more enriched with phospho-proteins than tamoxifen-resistant cells after stimulation with ligands. Surprisingly, decreased phosphorylation after ligand perturbation was more common than increased phosphorylation. In particular, 17 beta-estradiol induced down-regulation in WT cells at a very high rate. 17 beta-Estradiol and the ErbB ligand heregulin induced almost equal numbers of up-regulated phospho-proteins in WT cells. Pathway and motif activity analyses using transcriptome data additionally suggested that deregulated activation of GSK3 beta (glycogen-synthase kinase 3 beta) and MAPK1/3 signaling might be associated with altered activation of cAMP-responsive element-binding protein and AP-1 transcription factors in tamoxifen-resistant cells, and this hypothesis was validated by reporter assays. An examination of clinical samples revealed that inhibitory phosphorylation of GSK3 beta at serine 9 was significantly lower in tamoxifen-treated breast cancer patients that eventually had relapses, implying that activation of GSK3 beta may be associated with the tamoxifen-resistant phenotype. Thus, the combined phosphoproteome and transcriptome data set analyses revealed distinct signal transcription programs in tumor cells and provided a novel molecular target to understand tamoxifen resistance.	[Oyama, Masaaki; Kozuka-Hata, Hiroko] Univ Tokyo, Inst Med Sci, Med Prote Lab, Minato Ku, Tokyo 1088639, Japan; [Nagashima, Takeshi; Yumoto, Noriko; Shiraishi, Yuichi; Okada-Hatakeyama, Mariko] RIKEN Res Ctr Allergy & Immunol, Lab Cellular Syst Modeling, Tsurumi Ku, Kanagawa 2300045, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Histotechnol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Ikeda, Kazuhiro; Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan; [Kuroki, Yoko] RIKEN Adv Sci Inst, Computat Syst Biol Res Grp, Tsurumi Ku, Kanagawa 2300045, Japan; [Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Minato Ku, Tokyo 1088639, Japan; [Ishida, Takanori] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1130033, Japan; [Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kitano, Hiroaki] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan	University of Tokyo; RIKEN; Tohoku University; Tohoku University; Saitama Medical University; RIKEN; University of Tokyo; Tohoku University; University of Tokyo; University of Tokyo	Oyama, M (corresponding author), 4-6-1 Shirokanedai,Minato Ku, Tokyo 1088639, Japan.	moyama@ims.u-tokyo.ac.jp; marikoh@rcai.riken.jp	GOTOH, Noriko/D-8430-2015; Okada, Mariko/N-6933-2015	Kozuka-Hata, Hiroko/0000-0002-9286-6594; Oyama, Masaaki/0000-0001-6478-3735	Ministry of Education, Culture, Sports, Science and Technology, Japan; National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [22591016] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Genome Network Project and Cell Innovation Program, Ministry of Education, Culture, Sports, Science and Technology, Japan and the Program for Promotion of Fundamental Studies in Health Sciences, National Institute of Biomedical Innovation, Japan.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOUCAS V, 1991, EMBO J, V10, P2237, DOI 10.1002/j.1460-2075.1991.tb07760.x; Dumont JA, 1996, CELL GROWTH DIFFER, V7, P351; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnston SRD, 1999, CLIN CANCER RES, V5, P251; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Mai L, 2002, J NEUROCHEM, V82, P75, DOI 10.1046/j.1471-4159.2002.00939.x; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mendez P, 2006, ENDOCRINOLOGY, V147, P3027, DOI 10.1210/en.2005-1224; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nagashima T, 2009, FEBS J, V276, P5239, DOI 10.1111/j.1742-4658.2009.07220.x; Nahta R, 2006, NAT CLIN PRACT ONCOL, V3, P269, DOI 10.1038/ncponc0509; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHEMSHEDINI L, 1991, EMBO J, V10, P3839, DOI 10.1002/j.1460-2075.1991.tb04953.x; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sithanandam G, 2003, CARCINOGENESIS, V24, P1581, DOI 10.1093/carcin/bgg125; Speirs V, 1999, CANCER RES, V59, P5421; STEWART AJ, 1990, J BIOL CHEM, V265, P21172; Teyssier C, 2001, J BIOL CHEM, V276, P36361, DOI 10.1074/jbc.M101806200; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; TZUKERMAN M, 1991, MOL ENDOCRINOL, V5, P1983, DOI 10.1210/mend-5-12-1983; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; [No title captured], DOI DOI 10.1126/STKE.2882005PE27	51	33	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					818	829		10.1074/jbc.M110.156877	http://dx.doi.org/10.1074/jbc.M110.156877			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044952	Green Published, hybrid			2022-12-27	WOS:000285782800081
J	Wang, XF; Gulhati, P; Li, J; Dobner, PR; Weiss, H; Townsend, CM; Evers, BM				Wang, Xiaofu; Gulhati, Pat; Li, Jing; Dobner, Paul R.; Weiss, Heidi; Townsend, Courtney M., Jr.; Evers, B. Mark			Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SMALL-INTESTINE; TYROSINE-HYDROXYLASE GENE; ORPHAN NUCLEAR RECEPTOR; ENDOCRINE CELL-LINE; NEUROMEDIN-N; PANCREATIC-SECRETION; NEOPLASTIC TISSUES; STIMULATES GROWTH; MESSENGER-RNA; TRANSCRIPTION	Expression of the gene encoding neurotensin/neuromedin N (NT/N) is mostly limited to the brain and specialized enteroendocrine N cells in the distal small intestine. We have identified key regulatory elements in the promoter region that are involved in human NT/N (hNT/N) gene expression in the novel human endocrine cell line, BON, which resembles intestinal N cells in several important aspects including NT/N precursor protein processing, ratios of different NT/N mRNA isoforms, and high levels of constitutive expression of the NT/N gene. In this study, we demonstrated multiple cis-regulatory elements including a proximal region containing a cAMP-responsive element (CRE)/AP-1-like element that binds both the AP-1 and CRE-binding protein (CREB)/ATF proteins (c-Jun, ATF-1, ATF-2, JunD, and CREB). Similar to the rat NT/N gene, this region is critical for constitutive hNT/N gene expression. Moreover, we identified a novel region that binds the orphan hormone receptor, NR2F2. We have demonstrated that the C terminus of NR2F2 strongly represses hNT/N transcription, whereas an N-terminal domain antagonizes this repressive effect. Regulation of NT/N expression by NR2F2 may have important consequences for lipid metabolism. We speculate that a complex interplay between the proximal CRE/AP-1-like motif and NR2F2 binding region exists to regulate hNT/N expression, which is critical for the high level of constitutive expression of NT/N in enteroendocrine cells. Finally, the BON cell line provides a unique model to characterize the factors regulating expression of the hNT/N gene and to better understand the mechanisms responsible for terminal differentiation of the N cell lineage in the gut.	[Gulhati, Pat; Li, Jing; Weiss, Heidi; Evers, B. Mark] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Gulhati, Pat; Li, Jing; Weiss, Heidi; Evers, B. Mark] Univ Kentucky, Dept Surg, Lexington, KY 40536 USA; [Gulhati, Pat] Univ Texas Galveston, Med Branch, MD PhD Program, Galveston, TX 77555 USA; [Wang, Xiaofu; Townsend, Courtney M., Jr.] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77555 USA; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; [Dobner, Paul R.] Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA	University of Kentucky; University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Evers, BM (corresponding author), Univ Kentucky, Lucille P Markey Canc Ctr, 800 Rose St,CC140, Lexington, KY 40536 USA.	mark.evers@uky.edu			National Institutes of Health [R37 AG10855, R01 DK48489]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK048489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 AG10855 and R01 DK48489.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; ANDERSSON S, 1977, ACTA PHYSIOL SCAND, V100, P231, DOI 10.1111/j.1748-1716.1977.tb05941.x; ARMSTRONG MJ, 1986, AM J PHYSIOL, V251, pG823, DOI 10.1152/ajpgi.1986.251.6.G823; BACA I, 1982, DIGESTION, V23, P174, DOI 10.1159/000198725; BEAN AJ, 1992, NEUROSCIENCE, V50, P259, DOI 10.1016/0306-4522(92)90421-W; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; CARRAWAY RE, 1994, REGUL PEPTIDES, V53, P17, DOI 10.1016/0167-0115(94)90155-4; CHUNG DH, 1992, GASTROENTEROLOGY, V103, P1254, DOI 10.1016/0016-5085(92)91512-3; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Everett LM, 1999, J STEROID BIOCHEM, V70, P197, DOI 10.1016/S0960-0760(99)00109-0; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; EVERS BM, 1995, J CLIN INVEST, V95, P2822, DOI 10.1172/JCI117987; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; EVERS BM, 1994, AM J PHYSIOL, V267, pG180, DOI 10.1152/ajpgi.1994.267.2.G180; EVERS BM, 1991, ANN SURG, V214, P448, DOI 10.1097/00000658-199110000-00009; EVERS BM, 1994, AM J PHYSIOL-GASTR L, V267, pG875, DOI 10.1152/ajpgi.1994.267.5.G875; EVERS BM, 1993, AM J PHYSIOL, V265, pG482, DOI 10.1152/ajpgi.1993.265.3.G482; EVERS BM, 1992, GASTROENTEROLOGY, V103, P86, DOI 10.1016/0016-5085(92)91099-P; EVERS BM, 1992, DIGEST DIS SCI, V37, P426, DOI 10.1007/BF01307738; EVERS BM, 1995, MOL CELL BIOL, V15, P3870; FERRIS CF, 1985, REGUL PEPTIDES, V12, P101, DOI 10.1016/0167-0115(85)90191-0; FEURLE GE, 1987, GUT, V28, P19, DOI 10.1136/gut.28.Suppl.19; HABENER JF, 1990, MOL ENDOCRINOL, V4, P1087, DOI 10.1210/mend-4-8-1087; HALL C V, 1983, Journal of Molecular and Applied Genetics, V2, P101; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Haus-Seuffert P, 2000, MOL CELL BIOCHEM, V212, P5, DOI 10.1023/A:1007111818628; Jin H, 2006, J CELL PHYSIOL, V207, P49, DOI 10.1002/jcp.20534; Jordan EM, 2003, BIOCHEMISTRY-US, V42, P2656, DOI 10.1021/bi0268347; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kim KS, 2003, J NEUROCHEM, V85, P622, DOI 10.1046/j.1471-4159.2003.01671.x; KIMURA A, 1993, J BIOL CHEM, V268, P11125; KISLAUSKIS E, 1990, NEURON, V4, P783, DOI 10.1016/0896-6273(90)90205-T; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEE KAW, 1992, J CELL SCI, V103, P9; Li J, 2008, J BIOL CHEM, V283, P2614, DOI 10.1074/jbc.M707513200; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; MIETUSSNYDER M, 1992, MOL CELL BIOL, V12, P1708, DOI 10.1128/MCB.12.4.1708; MURAKI K, 1993, PEPTIDES, V14, P1095, DOI 10.1016/0196-9781(93)90161-9; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; POLAK JM, 1977, NATURE, V270, P183, DOI 10.1038/270183a0; ROTTMAN JN, 1993, J BIOL CHEM, V268, P11994; SAKAMOTO T, 1984, SURGERY, V96, P146; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; Shibata H, 1997, RECENT PROG HORM RES, V52, P141; Slogoff M., 2003, ENCY HORMONES, P19; Thomas RP, 2003, ENDOCR REV, V24, P571, DOI 10.1210/er.2002-0028; THOR K, 1986, GASTROENTEROLOGY, V90, P27, DOI 10.1016/0016-5085(86)90070-3; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; WOOD JG, 1988, AM J PHYSIOL, V255, pG813, DOI 10.1152/ajpgi.1988.255.6.G813; WOOD JG, 1988, PANCREAS, V3, P332, DOI 10.1097/00006676-198805000-00015; Zetterstrom R. H., 1997, SCIENCE, V276, P248	54	9	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					542	554		10.1074/jbc.M110.145664	http://dx.doi.org/10.1074/jbc.M110.145664			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21030593	Green Published, hybrid			2022-12-27	WOS:000285782800057
J	Belyaev, ND; Kellett, KAB; Beckett, C; Makova, NZ; Revett, TJ; Nalivaeva, NN; Hooper, NM; Turner, AJ				Belyaev, Nikolai D.; Kellett, Katherine A. B.; Beckett, Caroline; Makova, Natalia Z.; Revett, Timothy J.; Nalivaeva, Natalia N.; Hooper, Nigel M.; Turner, Anthony J.			The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a beta-Secretase-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; DEGRADING ENZYME NEPRILYSIN; ALZHEIMERS-DISEASE; ALPHA-SECRETASE; LIPID RAFTS; GENE-EXPRESSION; TARGET GENES; HUMAN-BRAIN; INHIBITOR; NEURONS	Amyloidogenic processing of the amyloid precursor protein (APP) by beta- and gamma-secretases generates several biologically active products, including amyloid-beta (A beta) and the APP intracellular domain (AICD). AICD regulates transcription of several neuronal genes, especially the A beta-degrading enzyme, neprilysin (NEP). APP exists in several alternatively spliced isoforms, APP(695), APP(751), and APP(770). We have examined whether each isoform can contribute to AICD generation and hence up-regulation of NEP expression. Using SH-SY5Y neuronal cells stably expressing each of the APP isoforms, we observed that only APP(695) up-regulated nuclear AICD levels (9-fold) and NEP expression (6-fold). Increased NEP expression was abolished by a beta- or gamma-secretase inhibitor but not an alpha-secretase inhibitor. This correlated with a marked increase in both A beta(1-40) and A beta(1-42) in APP(695) cells as compared with APP(751) or APP(770) cells. Similar phenomena were observed in Neuro2a but not HEK293 cells. SH-SY5Y cells expressing the Swedish mutant of APP(695) also showed an increase in A beta levels and NEP expression as compared with wild-type APP(695) cells. Chromatin immunoprecipitation revealed that AICD was associated with the NEP promoter in APP(695), Neuro2a, and APP(Swe) cells but not APP(751) nor APP(770) cells where AICD was replaced by histone deacetylase 1 (HDAC1). AICD occupancy of the NEP promoter was replaced by HDAC1 after treatment of the APP(695) cells with a beta- but not an alpha-secretase inhibitor. The increased AICD and NEP levels were significantly reduced in cholesterol-depleted APP(695) cells. In conclusion, A beta and functional AICD appear to be preferentially synthesized through beta-secretase action on APP(695).	[Belyaev, Nikolai D.; Kellett, Katherine A. B.; Beckett, Caroline; Makova, Natalia Z.; Revett, Timothy J.; Nalivaeva, Natalia N.; Hooper, Nigel M.; Turner, Anthony J.] Univ Leeds, Proteolysis Res Grp, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Hooper, NM (corresponding author), Univ Leeds, Proteolysis Res Grp, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.m.hooper@leeds.ac.uk; a.j.turner@leeds.ac.uk	Nalivaeva, Natalia/K-6522-2018	Nalivaeva, Natalia/0000-0002-7134-3540; Hooper, Nigel/0000-0002-5811-3484; Kellett, Katherine/0000-0002-2802-0615	United Kingdom Medical Research Council [G9824728, G0501565, G0802189]; Alzheimer's Research Trust [ART/PG2008/2, ART/PhD2009/4]; Alzheimers Research UK [ART-PG2008-2, ART-PhD2009-4] Funding Source: researchfish; Medical Research Council [G0802189, G9824728, G0000701, G0501565] Funding Source: researchfish; MRC [G0802189, G0501565, G9824728] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the United Kingdom Medical Research Council (Grants G9824728, G0501565, and G0802189) and the Alzheimer's Research Trust (Grants ART/PG2008/2 and ART/PhD2009/4).	Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen AC, 2007, NEURON, V53, P479, DOI 10.1016/j.neuron.2007.01.023; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Forman MS, 1997, J BIOL CHEM, V272, P32247, DOI 10.1074/jbc.272.51.32247; Frigerio CS, 2010, FEBS J, V277, P1503, DOI 10.1111/j.1742-4658.2010.07579.x; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Goto JJ, 2002, J MOL NEUROSCI, V19, P37, DOI 10.1007/s12031-002-0008-4; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Haugabook SJ, 2001, J NEUROSCI METH, V108, P171, DOI 10.1016/S0165-0270(01)00388-0; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Henriques AG, 2007, J ALZHEIMERS DIS, V11, P85; Hersh LB, 2008, CURR ALZHEIMER RES, V5, P225, DOI 10.2174/156720508783954703; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; ISHIMARU F, 1995, BLOOD, V85, P3199, DOI 10.1182/blood.V85.11.3199.bloodjournal85113199; KAMETANI F, 1993, BIOCHEM BIOPH RES CO, V191, P392, DOI 10.1006/bbrc.1993.1230; Kennedy Hilary, 1992, Neurodegeneration, V1, P59; Knauer MF, 1996, BRAIN RES, V740, P6, DOI 10.1016/S0006-8993(96)00711-1; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; LI CW, 1995, GENE, V164, P363, DOI 10.1016/0378-1119(95)00464-H; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moir RD, 1998, J BIOL CHEM, V273, P5013, DOI 10.1074/jbc.273.9.5013; MUCKE L, 1995, J EXP MED, V181, P1551, DOI 10.1084/jem.181.4.1551; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nalivaeva NN, 2008, CURR ALZHEIMER RES, V5, P212, DOI 10.2174/156720508783954785; Nalivaeva NN, 2009, TRENDS PHARMACOL SCI, V30, P509, DOI 10.1016/j.tips.2009.07.002; Nili E, 2001, J CELL SCI, V114, P3297; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Panegyres PK, 1998, J NEURAL TRANSM, V105, P463, DOI 10.1007/s007020050070; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parvathy S, 1999, BIOCHEMISTRY-US, V38, P9728, DOI 10.1021/bi9906827; Parvathy S, 1998, BIOCHEMISTRY-US, V37, P1680, DOI 10.1021/bi972034y; Postuma RB, 1998, FEBS LETT, V428, P13, DOI 10.1016/S0014-5793(98)00475-X; Sandbrink R, 1996, ANN NY ACAD SCI, V777, P281, DOI 10.1111/j.1749-6632.1996.tb34433.x; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SMITH RP, 1990, SCIENCE, V248, P1126, DOI 10.1126/science.2111585; SPILLANTINI MG, 1989, MOL BRAIN RES, V6, P143, DOI 10.1016/0169-328X(89)90048-X; TANAKA S, 1989, BIOCHEM BIOPH RES CO, V165, P1406, DOI 10.1016/0006-291X(89)92760-5; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Willoughby DA, 1995, J MOL NEUROSCI, V6, P257, DOI 10.1007/BF02736785; Zhang XZ, 2010, BRAIN RES BULL, V81, P3, DOI 10.1016/j.brainresbull.2009.09.003; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	55	144	146	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41443	41454		10.1074/jbc.M110.141390	http://dx.doi.org/10.1074/jbc.M110.141390			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961856	Green Published, hybrid			2022-12-27	WOS:000285622600030
J	Goodall, MH; Wardlow, RD; Goldblum, RR; Ziman, A; Lederer, WJ; Randall, W; Rogers, TB				Goodall, Mariah H.; Wardlow, Robert D., II; Goldblum, Rebecca R.; Ziman, Andrew; Lederer, W. Jonathan; Randall, William; Rogers, Terry B.			Novel Function of Cardiac Protein Kinase D1 as a Dynamic Regulator of Ca2+ Sensitivity of Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAY; ELEMENT-BINDING PROTEIN; TROPONIN-I; C-MU; HEART-FAILURE; G(Q)-COUPLED RECEPTORS; HISTONE DEACETYLASE-5; MEDIATED REGULATION; D ACTIVATION; D PKD	Although the function of protein kinase D1 (PKD) in cardiac cells has remained enigmatic, recent work has shown that PKD phosphorylates the nuclear regulators HDAC5/7 (histone deacetylase 5/7) and CREB, implicating this kinase in the development of dysfunction seen in heart failure. Additional studies have shown that PKD also phosphorylates multiple sarcomeric substrates to regulate myofilament function. Initial studies examined PKD through adenoviral vector expression of wild type PKD, constitutively active PKD (caPKD), or dominant negative PKD in cultured adult rat ventricular myocytes. Confocal immunofluorescent images of these cells reveal a predominant distribution of all PKD forms in a non-nuclear, Z-line localized, striated reticular pattern, suggesting the importance of PKD in Ca2+ signaling in heart. Consistent with an established role of PKD in targeting cardiac troponin I (cTnI), caPKD expression led to a marked decrease in contractile myofilament Ca2+ sensitivity with an unexpected electrical stimulus dependence to this response. This desensitization was accompanied by stimulus-dependent increases in cTnI phosphorylation in control and caPKD cells with a more pronounced effect in the latter. Electrical stimulation also provoked phosphorylation of regulatory site Ser(916) on PKD. The functional importance of this phospho-Ser(916) event is demonstrated in experiments with a phosphorylation-defective mutant, caPKD-S916A, which is functionally inactive and blocks stimulus-dependent increases in cTnI phosphorylation. Dominant negative PKD expression resulted in sensitization of the myofilaments to Ca2+ and blocked stimulus-dependent increases in cTnI phosphorylation. Taken together, these data reveal that localized PKD may play a role as a dynamic regulator of Ca2+ sensitivity of contraction in cardiac myocytes.	[Rogers, Terry B.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Randall, William] Univ Maryland, Sch Med, Dept Pharmacol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Ziman, Andrew; Lederer, W. Jonathan] Univ Maryland, Sch Med, Dept Physiol, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Rogers, TB (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Ctr Biomed Engn & Technol, 108 N Greene St, Baltimore, MD 21201 USA.	trogers@som.umaryland.edu		Wardlow, Robert D/0000-0002-0309-9769	National Institutes of Health [P01 HL070709, T32-GM-008181, T32-AR-07592]; MARC U*STAR [T34-08663, T32-HL-072751]; Economic Development Corporation of Maryland; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751, P01HL070709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181, T34GM008663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MARC U*STAR; Economic Development Corporation of Maryland; Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL070709 (to T. B. R.), T32-GM-008181 (to M. H. G. and A. Z.), T32-AR-07592 (to M. H. G.), MARC U*STAR T34-08663 (to R. D. W.), and T32-HL-072751 (to A. Z.). This work was also supported by an Economic Development Corporation of Maryland stem cell grant (to T. B. R. and W. J. L.) and the Leducq Foundation (to W. J. L.).	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Avner BS, 2010, AM J PHYSIOL-HEART C, V299, pH723, DOI 10.1152/ajpheart.00050.2010; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Bowman AL, 2007, FEBS LETT, V581, P1549, DOI 10.1016/j.febslet.2007.03.011; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; DuBell WH, 2000, AM J PHYSIOL-HEART C, V278, pH886, DOI 10.1152/ajpheart.2000.278.3.H886; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Goodall M. H., 2009, J MOL CELL CARDIOL, V46, pS29; Goodall MH, 2009, BIOPHYS J, V96, p622A, DOI 10.1016/j.bpj.2008.12.3290; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2007, J MOL CELL CARDIOL, V43, P686, DOI 10.1016/j.yjmcc.2007.09.013; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Iwata M, 2005, BIOCHEM BIOPH RES CO, V327, P1105, DOI 10.1016/j.bbrc.2004.12.128; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kim MS, 2008, CIRC RES, V103, P252, DOI 10.1161/CIRCRESAHA.108.178681; Kirk JA, 2009, CIRC RES, V105, P1232, DOI 10.1161/CIRCRESAHA.109.205427; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Liu YW, 2009, J PHYSIOL-LONDON, V587, P1101, DOI 10.1113/jphysiol.2008.164566; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luiken JJFP, 2008, CELL SIGNAL, V20, P543, DOI 10.1016/j.cellsig.2007.11.007; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McKinsey TA, 2007, CARDIOVASC RES, V73, P667, DOI 10.1016/j.cardiores.2006.11.036; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Oancea E, 2003, DEV CELL, V4, P561, DOI 10.1016/S1534-5807(03)00087-X; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Pi YQ, 2003, J PHYSIOL-LONDON, V552, P845, DOI 10.1113/jphysiol.2003.045260; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Rey O, 2001, J BIOL CHEM, V276, P32616, DOI 10.1074/jbc.M101649200; Rey O, 2001, BIOCHEM BIOPH RES CO, V287, P21, DOI 10.1006/bbrc.2001.5530; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Rybin VO, 2003, J BIOL CHEM, V278, P14555, DOI 10.1074/jbc.M212644200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Spitaler M, 2006, IMMUNITY, V24, P535, DOI 10.1016/j.immuni.2006.02.013; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wood CD, 2005, J BIOL CHEM, V280, P6245, DOI 10.1074/jbc.M411564200; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	58	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41686	41700		10.1074/jbc.M110.179648	http://dx.doi.org/10.1074/jbc.M110.179648			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041300	Green Published, hybrid			2022-12-27	WOS:000285622600056
J	Kumar, B; LeCompte, KG; Klein, JM; Haas, AL				Kumar, Brajesh; LeCompte, Kimberly G.; Klein, Jennifer M.; Haas, Arthur L.			Ser(120) of Ubc2/Rad6 Regulates Ubiquitin-dependent N-end Rule Targeting by E3 alpha/Ubr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIUBIQUITIN CHAIN; CONJUGATING ENZYMES; H2B UBIQUITYLATION; ACTIVATING ENZYME; HISTONE H2B; PROTEIN; PATHWAY; DEGRADATION; PROTEOLYSIS; MECHANISM	In CHO cells, CDK1/2-dependent phosphorylation of Ubc2/Rad6 at Ser(120) stimulates its ubiquitin conjugating activity and can be replicated by a S120D point mutant (Sarcevic, B., Mawson, A., Baker, R. T., and Sutherland, R. L. (2002) EMBO J. 21, 2009-2018). In contrast, we find that ectopic expression of wild type Ubc2b but not Ubc2bS120D or Ubc2bS120A in T47D human breast cancer cells specifically stimulates N-end rule-dependent degradation but not the Ubc2-independent unfolded protein response pathway, indicating that the former is E2 limiting in vivo and likely down-regulated by Ser(120) phosphorylation, as modeled by the S120D point mutation. In vitro kinetic analysis shows the in vivo phenotype of Ubc2bS120D and Ubc2bS120A is not due to differences in activating enzyme-catalyzed E2 transthiolation. However, the Ser(120) mutants possess marked differences in their abilities to support in vitro conjugation by the N-end rule-specific E3 alpha/Ubr1 ligase that presumably accounts for their in vivo effects. Initial rate kinetics of human E3 alpha-catalyzed conjugation of the human alpha-lactalbumin N-end rule substrate shows Ubc2bS120D is 20-fold less active than wild type E2, resulting from an 8-fold increase in K-m and a 2.5-fold decrease in V-max, the latter reflecting a decreased ability to support the initial step in target protein conjugation; Ubc2bS120A is 8-fold less active than wild type E2 due almost exclusively to a decrease in V-max, reflecting a defect in polyubiquitin chain elongation. These studies suggest a mechanism for the integrated regulation of diverse ubiquitin-dependent signaling pathways through E2 phosphorylation that yields differential effects on its cognate ligases.	[Haas, Arthur L.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health (NIGMS) [R01GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM034009 (NIGMS; to A. L. H.).	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Bohnsack RN, 2003, J BIOL CHEM, V278, P26823, DOI 10.1074/jbc.M303177200; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Froese N, 2006, MOL CELL BIOL, V26, P293, DOI 10.1128/MCB.26.1.293-302.2006; Gilon T, 1998, EMBO J, V17, P2759, DOI 10.1093/emboj/17.10.2759; HAAS AL, 1982, J BIOL CHEM, V257, P2543; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1981, P NATL ACAD SCI-BIOL, V78, P6845, DOI 10.1073/pnas.78.11.6845; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HAAS AL, 1991, ADV EXP MED BIOL, V307, P191; HAAS AL, 1991, J BIOL CHEM, V266, P5104; HAAS AL, 1995, J BIOL CHEM, V270, P9407, DOI 10.1074/jbc.270.16.9407; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kume K, 2010, GENES CELLS, V15, P339, DOI 10.1111/j.1365-2443.2010.01385.x; LOEB KR, 1992, J BIOL CHEM, V267, P7806; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; MENENDEZBENI, 2005, METHODS, V399, P490; Monaco EA, 2004, CURR ALZHEIMER RES, V1, P33, DOI 10.2174/1567205043480519; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; OGUNJOBI O, 1990, BIOCHEM SOC T, V18, P1322, DOI 10.1042/bst0181322; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; REISS Y, 1988, J BIOL CHEM, V263, P2693; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Salomons FA, 2005, ESSAYS BIOCHEM, V41, P113, DOI 10.1042/EB0410113; Sarcevic B, 2002, EMBO J, V21, P2009, DOI 10.1093/emboj/21.8.2009; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Streich FC, 2010, SUBCELL BIOCHEM, V54, P1, DOI 10.1007/978-1-4419-6676-6_1; Tokgoz Z, 2006, J BIOL CHEM, V281, P14729, DOI 10.1074/jbc.M513562200; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WIEBEL FF, 1992, NATURE, V359, P73, DOI 10.1038/359073a0; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	54	13	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41300	41309		10.1074/jbc.M110.169136	http://dx.doi.org/10.1074/jbc.M110.169136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041297	Green Published, hybrid			2022-12-27	WOS:000285622600015
J	Westphal, D; Sytnyk, V; Schachner, M; Leshchyns'ka, I				Westphal, Doreen; Sytnyk, Vladimir; Schachner, Melitta; Leshchyns'ka, Iryna			Clustering of the Neural Cell Adhesion Molecule (NCAM) at the Neuronal Cell Surface Induces Caspase-8- and -3-dependent Changes of the Spectrin Meshwork Required for NCAM-mediated Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-CAM; BETA-SPECTRIN; LIPID RAFTS; RPTP-ALPHA; ACTIVATION; MEMBRANE; RECEPTOR; DEGRADATION; ASSOCIATION; MECHANISMS	Changes in neuronal morphology underlying neuronal differentiation depend on rapid and sustained cytoskeleton rearrangements in the growing neurites. Whereas cell adhesion molecules are well established as regulators of neuronal differentiation, less is known about the signaling mechanisms by which they influence the cytoskeleton. Here we show that the neural cell adhesion molecule (NCAM) associates with the active form of caspase-8 and that clustering of NCAM at the neuronal cell surface leads to activation of caspase-8 and -3 followed by the cleavage of the sub-membranous brain spectrin meshwork, but not of the actin or tubulin cytoskeleton. Inhibitors of caspase-8 and -3 specifically block the NCAM-dependent spectrin cleavage and abolish NCAM-dependent neurite outgrowth. NCAM-dependent rearrangements of the membrane associated spectrin meshwork via caspase-8 dependent caspase-3 activation are thus indispensable for NCAM-mediated neurite outgrowth.	[Sytnyk, Vladimir; Leshchyns'ka, Iryna] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Westphal, Doreen; Sytnyk, Vladimir; Schachner, Melitta; Leshchyns'ka, Iryna] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA	University of New South Wales Sydney; University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Leshchyns'ka, I (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	iryna.leshchynska@unsw.edu.au	Sytnyk, Vladimir/A-3878-2010	Leshchyns'ka, Iryna/0000-0002-2025-5831; Sytnyk, Vladimir/0000-0003-1927-2199	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (to I. L.,V.S., and M.S.).	Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Berg CP, 2001, CELL DEATH DIFFER, V8, P1197, DOI 10.1038/sj.cdd.4400905; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Bukalo O, 2004, J NEUROSCI, V24, P1565, DOI 10.1523/JNEUROSCI.3298-03.2004; Buttner B, 2003, BIOCHEM BIOPH RES CO, V310, P967, DOI 10.1016/j.bbrc.2003.09.105; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Christensen C, 2006, FEBS LETT, V580, P3386, DOI 10.1016/j.febslet.2006.05.008; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; GENNARINI G, 1984, EUR J BIOCHEM, V142, P57, DOI 10.1111/j.1432-1033.1984.tb08250.x; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Hulsmeier J, 2007, DEVELOPMENT, V134, P713, DOI 10.1242/dev.02758; Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987; Korshunova I, 2007, J NEUROCHEM, V100, P1599, DOI 10.1111/j.1471-4159.2006.04316.x; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MILEV P, 1995, J BIOL CHEM, V270, P24650, DOI 10.1074/jbc.270.42.24650; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Muzio M, 1997, J BIOL CHEM, V272, P2952, DOI 10.1074/jbc.272.5.2952; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; PFENNINGER KH, 1983, CELL, V35, P573, DOI 10.1016/0092-8674(83)90191-5; POLLERBERG GE, 1986, NATURE, V324, P462, DOI 10.1038/324462a0; POLLERBERG GE, 1987, CELL TISSUE RES, V250, P227, DOI 10.1007/BF00214676; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rolf B, 2003, J NEUROSCI RES, V71, P835, DOI 10.1002/jnr.10533; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; SOBUE K, 1989, NEURON, V3, P311, DOI 10.1016/0896-6273(89)90255-9; Spira ME, 2001, CELL MOL NEUROBIOL, V21, P591, DOI 10.1023/A:1015135617557; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Sytnyk V, 2006, J CELL BIOL, V174, P1071, DOI 10.1083/jcb.200604145; THOR G, 1986, NEUROSCI LETT, V66, P121, DOI 10.1016/0304-3940(86)90176-X; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490	56	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42046	42057		10.1074/jbc.M110.177147	http://dx.doi.org/10.1074/jbc.M110.177147			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20961848	Green Published, hybrid			2022-12-27	WOS:000285622600090
J	Yao, SH; Qian, ML; Deng, SY; Xie, LF; Yang, HS; Xiao, C; Zhang, T; Xu, H; Zhao, X; Wei, YQ; Mo, XM				Yao, Shaohua; Qian, Meilin; Deng, Senyi; Xie, Lifang; Yang, Hanshuo; Xiao, Chun; Zhang, Ting; Xu, Hong; Zhao, Xia; Wei, Yu-quan; Mo, Xianming			Kzp Controls Canonical wnt8 Signaling to Modulate Dorsoventral Patterning during Zebrafish Gastrulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; TRANSCRIPTIONAL REPRESSOR; MESODERM FORMATION; AXIS FORMATION; PARTNER KAISO; DNA-BINDING; EXTENSION; PROTEINS; CATENIN; CONVERGENCE	During vertebrate embryonic development, the body axis formation requires the action of Wnt signals and their antagonists. Zygotic canonical wnt8 expression appears exclusively at the ventrolateral margin and mediates Wnt/beta-catenin activities to promote posterior and ventral cell fate. However, the mechanisms involved in the initiation of zygotic wnt8 signals are poorly understood. Here, we identify a novel, maternally derived transcription factor, Kzp ((K) under bar aiso (z) under bar inc finger-containing protein), as an important determinant for the initiation of zygotic Wnt signals in zebrafish. Kzp is a DNA-binding transcription factor that recognizes specific consensus DNA sequences, 5'-(t/a/g)t(a/t/g)nctgcca-3', through zinc fingers and controls the initiation of zygotic wnt8 expression by directly binding to the wnt8 promoter during zebrafish embryonic development. Depletion of Kzp strongly dorsalized embryos, which was characterized by the expansion of dorsal gene expression. Overexpression of Kzp caused posteriorization. These phenotypes were highly similar to ones induced by wnt8 depletion or overexpression and were rescued by alteration of wnt8 activity. Thus, our results provide the first insight into the mechanism involved in the initiation of zygotic canonical Wnt signals by a maternally derived transcription factor.	[Wei, Yu-quan] Sichuan Univ, State Key Lab Biotherapy, Chengdu 610041, Peoples R China; Sichuan Univ, Ctr Canc, W China Hosp, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University	Wei, YQ (corresponding author), Sichuan Univ, State Key Lab Biotherapy, Keyuan 4 Lu, Chengdu 610041, Peoples R China.	yuquawei@sina.vip.com; xmingmo@yahoo.cn	Mo, Xianming/AAM-2167-2021	Wei, Yu-quan/0000-0002-6211-3217; Yao, Shaohua/0000-0002-0191-4889	National Basic Research Program of China [2009CB941200, 2010CB529900]; Nature Science Foundation of China [30771228, 30771227]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2009CB941200 and 2010CB529900 and Nature Science Foundation of China Grants 30771228 (to H. X.) and 30771227 (to X. M.).	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Daniel JM, 2002, NUCLEIC ACIDS RES, V30, P2911, DOI 10.1093/nar/gkf398; Erter CE, 2001, DEVELOPMENT, V128, P3571; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hild M, 1999, DEVELOPMENT, V126, P2149; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; Kim SW, 2004, NAT CELL BIOL, V6, P1212, DOI 10.1038/ncb1191; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Li HY, 2006, DEV BIOL, V290, P470, DOI 10.1016/j.ydbio.2005.11.020; Little SC, 2004, DEVELOPMENT, V131, P5825, DOI 10.1242/dev.01464; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Ragland JW, 2004, DEV BIOL, V276, P16, DOI 10.1016/j.ydbio.2004.08.017; Ramel MC, 2004, DEV DYNAM, V231, P441, DOI 10.1002/dvdy.20141; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yamamoto Y, 2004, NATURWISSENSCHAFTEN, V91, P519, DOI 10.1007/s00114-004-0575-z; Yao J, 2001, DEVELOPMENT, V128, P2975; Yao SH, 2008, FEBS LETT, V582, P2325, DOI 10.1016/j.febslet.2008.05.036	37	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42086	42096		10.1074/jbc.M110.161554	http://dx.doi.org/10.1074/jbc.M110.161554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20978132	Green Published, hybrid			2022-12-27	WOS:000285622600093
J	Maasch, C; Vater, A; Buchner, K; Purschke, WG; Eulberg, D; Vonhoff, S; Klussmann, S				Maasch, Christian; Vater, Axel; Buchner, Klaus; Purschke, Werner G.; Eulberg, Dirk; Vonhoff, Stefan; Klussmann, Sven			Polyetheylenimine-Polyplexes of Spiegelmer NOX-A50 Directed against Intracellular High Mobility Group Protein A1 (HMGA1) Reduce Tumor Growth in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE DELIVERY-SYSTEMS; POLYETHYLENIMINE/DNA COMPLEXES; PANCREATIC ADENOCARCINOMA; POLY(ETHYLENE IMINE); CHROMOSOMAL-PROTEINS; MOLECULAR-WEIGHT; C-MYC; EXPRESSION; MICE; RNA	High mobility group A1 (HMGA1) proteins belong to a group of architectural transcription factors that are overexpressed in a range of human malignancies, including pancreatic adenocarcinoma. They promote anchorage-independent growth and epithelial-mesenchymal transition and are therefore suggested as potential therapeutic targets. Employing in vitro selection techniques against a chosen fragment of HMGA1, we have generated biostable L-RNA oligonucleotides, so-called Spiegelmers, that specifically bind HMGA1b with low nanomolar affinity. We demonstrate that the best binding Spiegelmers, NOX-A50 and NOX-f33, compete HMGA1b from binding to its natural binding partner, AT-rich double-stranded DNA. We describe a formulation method based on polyplex formation with branched polyethylenimine for efficient delivery of polyethylene glycol-modified Spiegelmers and show improved tissue distribution and persistence in mice. In a xenograft mouse study using the pancreatic cancer cell line PSN-1, subcutaneous administration of 2 mg/kg per day NOX-A50 formulated in polyplexes showed an enhanced delivery of NOX-A50 to the tumor and a significant reduction of tumor volume. Our results demonstrate that intracellular targets can be successfully addressed with a Spiegelmer using polyethylenimine-based delivery and underline the importance of HMGA1 as a therapeutic target in pancreatic cancer.	[Maasch, Christian; Vater, Axel; Buchner, Klaus; Purschke, Werner G.; Eulberg, Dirk; Vonhoff, Stefan; Klussmann, Sven] NOXXON Pharma AG, D-10589 Berlin, Germany	NOXXON Pharma	Klussmann, S (corresponding author), NOXXON Pharma AG, Max Dohrn Str 8-10, D-10589 Berlin, Germany.	sklussmann@noxxon.com		Vater, Axel/0000-0003-4166-982X	State of Berlin/Investitionsbank Berlin [10018314]	State of Berlin/Investitionsbank Berlin	This work was supported by the State of Berlin/Investitionsbank Berlin Grant 10018314. All authors are employees of NOXXON Pharma AG, a company that has a commercial interest in Spiegelmers.	Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Eulberg D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni044; EULBERG D, 2006, APTAMER HDB, P417; Evans A, 2004, J SURG ONCOL, V88, P86, DOI 10.1002/jso.20136; Famulok M, 2001, CHEM BIOL, V8, P931, DOI 10.1016/S1074-5521(01)00070-9; FASHENA SJ, 1992, MOL CELL BIOL, V12, P894, DOI 10.1128/MCB.12.2.894; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fedele M, 2006, CANCER RES, V66, P2536, DOI 10.1158/0008-5472.CAN-05-1889; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Fischer D, 2004, DRUG METAB DISPOS, V32, P983; GIANCOTTI V, 1987, EMBO J, V6, P1981, DOI 10.1002/j.1460-2075.1987.tb02461.x; Goula D, 2000, GENE THER, V7, P499, DOI 10.1038/sj.gt.3301113; Helmling S, 2004, P NATL ACAD SCI USA, V101, P13174, DOI 10.1073/pnas.0404175101; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; Jeong JH, 2003, J CONTROL RELEASE, V93, P183, DOI 10.1016/j.jconrel.2003.07.002; JOHNSON KR, 1990, EXP CELL RES, V187, P69, DOI 10.1016/0014-4827(90)90118-T; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Kunath K, 2002, PHARMACEUT RES, V19, P810, DOI 10.1023/A:1016152831963; Liau SS, 2008, CANCER-AM CANCER SOC, V113, P302, DOI 10.1002/cncr.23560; Lungwitz U, 2005, EUR J PHARM BIOPHARM, V60, P247, DOI 10.1016/j.ejpb.2004.11.011; Masciullo V, 2003, CARCINOGENESIS, V24, P1191, DOI 10.1093/carcin/bgg075; Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773; Ogris M, 2002, DRUG DISCOV TODAY, V7, P479, DOI 10.1016/S1359-6446(02)02243-2; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Ogris M, 2003, J CONTROL RELEASE, V91, P173, DOI 10.1016/S0168-3659(03)00230-X; Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Petersen H, 2002, BIOMACROMOLECULES, V3, P926, DOI 10.1021/bm025539z; Proske D, 2002, CHEMBIOCHEM, V3, P717, DOI 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C; Purschke WG, 2006, P NATL ACAD SCI USA, V103, P5173, DOI 10.1073/pnas.0509663103; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; REEVES R, 1990, J BIOL CHEM, V265, P8573; Reeves Raymond, 2003, Prog Cell Cycle Res, V5, P279; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Sayyed SG, 2009, DIABETOLOGIA, V52, P2445, DOI 10.1007/s00125-009-1493-6; Scala S, 2000, P NATL ACAD SCI USA, V97, P4256, DOI 10.1073/pnas.070029997; Sirsi SR, 2005, HUM GENE THER, V16, P1307, DOI 10.1089/hum.2005.16.1307; Sonawane ND, 2003, J BIOL CHEM, V278, P44826, DOI 10.1074/jbc.M308643200; Trapasso F, 2004, CANCER GENE THER, V11, P633, DOI 10.1038/sj.cgt.7700745; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Wlotzka B, 2002, P NATL ACAD SCI USA, V99, P8898, DOI 10.1073/pnas.132067399; Xu W, 1996, P NATL ACAD SCI USA, V93, P7475, DOI 10.1073/pnas.93.15.7475; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; Zou SM, 2000, J GENE MED, V2, P128, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<128::AID-JGM95>3.0.CO;2-W; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	28	33	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40012	40018		10.1074/jbc.M110.178533	http://dx.doi.org/10.1074/jbc.M110.178533			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20961861	Green Published, hybrid			2022-12-27	WOS:000285185500046
J	Wu, BH; Song, J; Beitz, E				Wu, Binghua; Song, Jie; Beitz, Eric			Novel Channel Enzyme Fusion Proteins Confer Arsenate Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PLASMODIUM-FALCIPARUM; ARSENITE TRANSPORT; GENE ENCODES; REDUCTASE; DETOXIFICATION; BACTERIA; GLYCEROL; AQUAGLYCEROPORINS	Steady exposure to environmental arsenic has led to the evolution of vital cellular detoxification mechanisms. Under aerobic conditions, a two-step process appears most common among microorganisms involving reduction of predominant, oxidized arsenate ((H2AsO4-)-O-V/(HAsO42-)-O-V) to arsenite (As-III(OH)(3)) by a cytosolic enzyme (ArsC; Escherichia coli type arsenate reductase) and subsequent extrusion via ArsB (E. coli type arsenite transporter)/ACR3 (yeast type arsenite transporter). Here, we describe novel fusion proteins consisting of an aquaglyceroporin-derived arsenite channel with a C-terminal arsenate reductase domain of phosphotyrosine-phosphatase origin, providing transposable, single gene-encoded arsenate resistance. The fusion occurred in actinobacteria from soil, Frankia alni, and marine environments, Salinispora tropica; Mycobacterium tuberculosis encodes an analogous ACR3-ArsC fusion. Mutations rendered the aquaglyceroporin channel more polar resulting in lower glycerol permeability and enhanced arsenite selectivity. The arsenate reductase domain couples to thioredoxin and can complement arsenate-sensitive yeast strains. A second isoform with a nonfunctional channel may use the mycothiol/mycoredoxin cofactor pool. These channel enzymes constitute prototypes of a novel concept in metabolism in which a substrate is generated and compartmentalized by the same molecule. Immediate diffusion maintains the dynamic equilibrium and prevents toxic accumulation of metabolites in an energy-saving fashion.	[Beitz, Eric] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany	University of Kiel	Beitz, E (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			Deutsche Forschungsgemeinschaft [Be2253/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Be2253/3 (to E. B.).	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; ADAMSON SR, 1981, BIOCHEMISTRY-US, V20, P3418, DOI 10.1021/bi00515a018; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Bertl A, 2007, FEBS LETT, V581, P5413, DOI 10.1016/j.febslet.2007.10.034; Brachmann CB, 1998, YEAST, V14, P115; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; MOORE SA, 1983, J BIOL CHEM, V258, P6266; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Newby ZER, 2008, NAT STRUCT MOL BIOL, V15, P619, DOI 10.1038/nsmb.1431; Newton GL, 2008, ARCH MICROBIOL, V190, P547, DOI 10.1007/s00203-008-0405-3; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; SCHAFER A, 1990, J BACTERIOL, V172, P1663, DOI 10.1128/jb.172.3.1663-1666.1990; Tapio S, 2006, MUTAT RES-REV MUTAT, V612, P215, DOI 10.1016/j.mrrev.2006.02.001; TURNER AW, 1949, NATURE, V164, P76, DOI 10.1038/164076a0; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	39	36	37	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40081	40087		10.1074/jbc.M110.184457	http://dx.doi.org/10.1074/jbc.M110.184457			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20947511	Green Published, hybrid			2022-12-27	WOS:000285185500053
J	Zheng, YX; Brash, AR				Zheng, Yuxiang; Brash, Alan R.			Dioxygenase Activity of Epidermal Lipoxygenase-3 Unveiled TYPICAL AND ATYPICAL FEATURES OF ITS CATALYTIC ACTIVITY WITH NATURAL AND SYNTHETIC POLYUNSATURATED FATTY ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLENE OXIDE SYNTHASE; SOYBEAN LIPOXYGENASE-1; LINOLEIC-ACID; FATTY-ACIDS; RETICULOCYTE LIPOXYGENASE; HYDROPEROXIDE ISOMERASE; MANGANESE LIPOXYGENASE; PERMEABILITY BARRIER; MINI-LIPOXYGENASE; INDUCTION PERIOD	Epidermal lipoxygenase-3 (eLOX3) exhibits hydroperoxide isomerase activity implicated in epidermal barrier formation, but its potential dioxygenase activity has remained elusive. We identified herein a synthetic fatty acid, 9E,11Z,14Z-20:3 omega 6, that was oxygenated by eLOX3 specifically to the 9S-hydroperoxide. Reaction showed a pronounced lag phase, which suggested that eLOX3 is deficient in its activation step. Indeed, we found that high concentrations of hydroperoxide activator (e. g. 65 mu M) overcame a prolonged lag phase (> 1 h) and unveiled a dioxygenase activity with arachidonic acid; the main products were the 5-, 9-, and 7-hydroperoxyeicosatetraenoic acids (HPETEs). These were R/S mixtures (ranging from similar to 50:50 to 73:27), and as the bis-allylic 7-HPETE can be formed only inside the enzyme active site, the results indicate there is oxygen availability along either face of the reacting fatty acid radical. That the active site oxygen supply is limited is implied from the need for continuous re-activation, as carbon radical leakage leaves the enzyme in the unactivated ferrous state. An Ala-to-Gly mutation, known to affect the positioning of O-2 in the active site of other lipoxygenase enzymes, led to more readily activated reaction and a significant increase in the 9R-over the 5-HPETE. Activation and cycling of the ferric enzyme are thus promoted using the 9E,11Z,14Z-20:3 omega 6 substrate, by continuous hydroperoxide activation, or by the Ala-to-Gly mutation. We suggest that eLOX3 represents one end of a spectrum among lipoxygenases where activation is inefficient, favoring hydroperoxide isomerase cycling, with the opposite end represented by readily activated enzymes in which dioxygenase activity is prominent.	[Brash, Alan R.] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; Vanderbilt Univ, Vanderbilt Inst Chem Biol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med, 23rd Ave S Pierce, Nashville, TN 37232 USA.	brash@vanderbilt.edu			National Institutes of Health [AR-051968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR-051968 (to A. R. B.).	Andreou A, 2010, J BIOL CHEM, V285, P14178, DOI 10.1074/jbc.M109.094771; Andreou AZ, 2008, PHYTOCHEMISTRY, V69, P1832, DOI 10.1016/j.phytochem.2008.03.002; Axelrod B., 1981, METH ENZYMOL, V441, P451, DOI [10.1016/0076-6879(81)71055-3, DOI 10.1016/0076-6879(81)71055-3]; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; Brash AR, 2007, FEBS J, V274, P3494, DOI 10.1111/j.1742-4658.2007.05909.x; BRASH AR, 1989, ARCH BIOCHEM BIOPHYS, V273, P414, DOI 10.1016/0003-9861(89)90500-6; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Brash AR, 2000, LIPIDS, V35, P947, DOI 10.1007/s11745-000-0604-0; Butovich IA, 2001, BBA-PROTEIN STRUCT M, V1546, P379, DOI 10.1016/S0167-4838(01)00162-5; Clapp CH, 2006, BIOCHEMISTRY-US, V45, P15884, DOI 10.1021/bi0619425; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; Cristea N, 2007, J LIPID RES, V48, P890, DOI 10.1194/jlr.M600505-JLR200; Cristea M, 2006, J BIOL CHEM, V281, P17612, DOI 10.1074/jbc.M510311200; DEGROOT JJM, 1975, BIOCHIM BIOPHYS ACTA, V377, P71, DOI 10.1016/0005-2744(75)90287-9; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Furstenberger G, 2007, PROSTAG OTH LIPID M, V82, P128, DOI 10.1016/j.prostaglandins.2006.05.006; Fukushige H, 2005, J AGR FOOD CHEM, V53, P5691, DOI 10.1021/jf047958o; Gao XQ, 2008, PLANTA, V227, P491, DOI 10.1007/s00425-007-0634-8; GARSSEN GJ, 1971, BIOCHEM J, V122, P327, DOI 10.1042/bj1220327; Glickman MH, 1996, BIOCHEMISTRY-US, V35, P12882, DOI 10.1021/bi960985q; HAINING JL, 1958, J BIOL CHEM, V232, P193; Huang LS, 2006, ARCH BIOCHEM BIOPHYS, V455, P119, DOI 10.1016/j.abb.2006.09.015; Ivanov I, 2005, FEBS J, V272, P2523, DOI 10.1111/j.1742-4658.2005.04673.x; Jobard F, 2002, HUM MOL GENET, V11, P107, DOI 10.1093/hmg/11.1.107; KEMAL C, 1987, BIOCHEMISTRY-US, V26, P7064, DOI 10.1021/bi00396a031; Kinzig A, 1999, GENOMICS, V58, P158, DOI 10.1006/geno.1999.5816; KRIEG P, 2010, 12 INT WINT EIC C MA; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; KUHN H, 1986, FEBS LETT, V203, P247, DOI 10.1016/0014-5793(86)80752-9; Meruvu S, 2005, J BIOL CHEM, V280, P36633, DOI 10.1074/jbc.M508260200; Moran JL, 2007, J INVEST DERMATOL, V127, P1893, DOI 10.1038/sj.jid.5700825; NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011; NUGTEREN DH, 1987, PROSTAGLANDINS, V33, P403, DOI 10.1016/0090-6980(87)90022-0; Perez-Gilabert M, 2005, J AGR FOOD CHEM, V53, P6140, DOI 10.1021/jf050521b; PISTORIUS EK, 1974, THESIS PURDUE U; Pratt DA, 2003, J AM CHEM SOC, V125, P5801, DOI 10.1021/ja034182j; Que L, 1996, CHEM REV, V96, P2607, DOI 10.1021/cr960039f; SALZMANN U, 1984, BIOCHIM BIOPHYS ACTA, V795, P535, DOI 10.1016/0005-2760(84)90183-8; SCHILSTRA MJ, 1994, BIOCHEMISTRY-US, V33, P3974, DOI 10.1021/bi00179a025; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Su C, 1998, J BIOL CHEM, V273, P13072, DOI 10.1074/jbc.273.21.13072; Tallman KA, 2001, J AM CHEM SOC, V123, P11827, DOI 10.1021/ja0169724; Yu ZY, 2003, P NATL ACAD SCI USA, V100, P9162, DOI 10.1073/pnas.1633612100; Zheng YX, 2008, J BIOL CHEM, V283, P5138, DOI 10.1074/jbc.M705780200; Zheng YX, 2010, J BIOL CHEM, V285, P39876, DOI 10.1074/jbc.M110.180794	52	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39866	39875		10.1074/jbc.M110.155374	http://dx.doi.org/10.1074/jbc.M110.155374			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20921226	Green Published, hybrid			2022-12-27	WOS:000285185500031
J	Chen, D; Gao, F; Li, B; Wang, HF; Xu, YX; Zhu, CQ; Wang, GH				Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Xu, Yuxia; Zhu, Cuiqing; Wang, Guanghui			Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE JUVENILE PARKINSONISM; DOPAMINE-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; DISEASE GENE-PRODUCT; LEWY-BODY FORMATION; PROTEIN LIGASE; CELL-DEATH; INDEPENDENT UBIQUITINATION; PC12 CELLS; MUTATIONS	Parkin is an E3 ubiquitin ligase that mediates the ubiquitination of protein substrates. The mutations in the parkin gene can lead to a loss of function of parkin and cause autosomal recessive juvenile onset parkinsonism. Recently, parkin was reported to be involved in the regulation of mitophagy. Here, we identify the Bcl-2, an anti-apoptotic and autophagy inhibitory protein, as a substrate for parkin. Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2. Overexpression of parkin, but not its ligase-deficient forms, decreases autophagy marker LC3 conversion, whereas knockdown of parkin increases LC3 II levels. In HeLa cells, a parkin-deficient cell line, knockdown of parkin does not change LC3 conversion. Moreover, overexpression of parkin enhances the interactions between Bcl-2 and Beclin 1. Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2.	[Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Wang, Guanghui] Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China; [Chen, Dong; Gao, Feng; Li, Bin; Wang, Hongfeng; Wang, Guanghui] Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Key Lab Brain Funct & Dis, Hefei 230027, Anhui, Peoples R China; [Xu, Yuxia; Zhu, Cuiqing] Fudan Univ, Shanghai Med Coll, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Fudan University	Wang, GH (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Sch Life Sci, Lab Mol Neuropathol, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017	Wang, Guanghui/0000-0001-8551-6468; Li, Bin/0000-0001-9341-4672	National Natural Sciences Foundation of China [30770664, 30970921]; National High-Tech Research and Development Program of China Project 973 [2006CB500703]; National High-Tech Research and Development Program of China Project 863 [2006AA02A408]; Chinese Academy of Sciences [KSCX2-YW-R138]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program of China Project 973(National Basic Research Program of China); National High-Tech Research and Development Program of China Project 863(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by National Natural Sciences Foundation of China Grants 30770664 and 30970921, National High-Tech Research and Development Program of China Project 973 Grant 2006CB500703 and Project 863 Grant 2006AA02A408, and Chinese Academy of Sciences Knowledge Innovation Project Grant KSCX2-YW-R138.	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Berger AK, 2009, HUM MOL GENET, V18, P4317, DOI 10.1093/hmg/ddp384; Casarejos MJ, 2009, J NEUROCHEM, V110, P1523, DOI 10.1111/j.1471-4159.2009.06248.x; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang Y, 2004, BRAIN RES REV, V46, P44, DOI 10.1016/j.brainresrev.2004.04.007; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Ko HS, 2006, J BIOL CHEM, V281, P16193, DOI 10.1074/jbc.C600041200; Ko HS, 2005, J NEUROSCI, V25, P7968, DOI 10.1523/JNEUROSCI.2172-05.2005; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moore DJ, 2008, J NEUROCHEM, V105, P1806, DOI 10.1111/j.1471-4159.2008.05261.x; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nichols WC, 2002, J MED GENET, V39, P489, DOI 10.1136/jmg.39.7.489; Offen D, 1997, CELL MOL NEUROBIOL, V17, P289, DOI 10.1023/A:1026390201168; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Ren Y, 2003, J NEUROSCI, V23, P3316; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Scott WK, 2001, JAMA-J AM MED ASSOC, V286, P2239, DOI 10.1001/jama.286.18.2239; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 1999, ANN NEUROL, V45, P668, DOI 10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; Takai N, 1998, J NEUROSCI RES, V54, P214, DOI 10.1002/(SICI)1097-4547(19981015)54:2<214::AID-JNR9>3.0.CO;2-H; Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; West AB, 2004, HUM GENET, V114, P327, DOI 10.1007/s00439-003-1074-6; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	51	127	135	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38214	38223		10.1074/jbc.M110.101469	http://dx.doi.org/10.1074/jbc.M110.101469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889974	Green Published, hybrid			2022-12-27	WOS:000284625600029
J	Kanu, N; Penicud, K; Hristova, M; Wong, B; Irvine, E; Plattner, F; Raivich, G; Behrens, A				Kanu, Nnennaya; Penicud, Kay; Hristova, Mariya; Wong, Barnaby; Irvine, Elaine; Plattner, Florian; Raivich, Gennadij; Behrens, Axel			The ATM Cofactor ATMIN Protects against Oxidative Stress and Accumulation of DNA Damage in the Aging Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELANGIECTASIA-LIKE DISORDER; CLASS-SWITCH RECOMBINATION; ATAXIA-TELANGIECTASIA; DEFICIENT MICE; SENESCENCE; FIBROBLASTS; ACTIVATION; OXYGEN; CELLS; GENE	Progressive accumulation of DNA damage is causally involved in cellular senescence and organismal aging. The DNA damage kinase ATM plays a central role in maintaining genomic stability. ATM mutations cause the genetic disorder ataxia telangiectasia, which is primarily characterized by progressive neurodegeneration and cancer susceptibility. Although the importance of ATM function to protect against oxidative DNA damage and during aging is well described, the mechanism of ATM activation by these stimuli is not known. Here we identify ATM interactor (ATMIN) as an essential component of the ATM signaling pathway in response to oxidative stress and aging. Embryos lacking ATMIN (atmin(Delta/Delta)) died in utero and showed increased numbers of cells positive for phosphorylated histone H2aX, indicative of increased DNA damage. atmin(Delta/Delta) mouse embryonic fibroblasts accumulated DNA damage and prematurely entered senescence when cultured at atmospheric oxygen levels (20%), but this defect was rescued by addition of an antioxidant and also by culturing cells at physiological oxygen levels (3%). In response to acute oxidative stress, atmin(Delta/Delta) mouse embryonic fibroblasts showed slightly lower levels of ATM phosphorylation and reduced ATM substrate phosphorylation. Conditional deletion of ATMIN in the murine nervous system (atmin(Delta N)) resulted in reduced numbers of dopaminergic neurons, as does ATM deficiency. ATM activity was observed in old, but not in young, control mice, but aging-induced ATM signaling was impaired by ATMIN deficiency. Consequently, old atmin(Delta N) mice showed accumulation of DNA damage in the cortex accompanied by gliosis, resulting in increased mortality of aging mutant mice. These results suggest that ATMIN mediates ATM activation by oxidative stress, and thereby ATMIN protects the aging brain by preventing accumulation of DNA damage.	[Behrens, Axel] Canc Res UK, Mammalian Genet Lab, London Res Inst, London WC2A 3Y, England; [Hristova, Mariya; Wong, Barnaby; Raivich, Gennadij] UCL, Perinatal Brain Repair Grp, Dept Obstet & Gynaecol, London WC1E 6HX, England; [Hristova, Mariya; Wong, Barnaby; Raivich, Gennadij] UCL, Dept Anat, London WC1E 6HX, England; [Irvine, Elaine] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Plattner, Florian] UCL, Inst Neurol, London WC1N 3BG, England	Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Behrens, A (corresponding author), Canc Res UK, Mammalian Genet Lab, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3Y, England.	axel.behrens@cancer.org.uk	Raivich, Gennadij/A-6770-2011; Raivich, Gennadij/AAL-7229-2021	Irvine, Elaine/0000-0001-5508-8140; Behrens, Axel/0000-0002-1557-1143; Plattner, Florian/0000-0002-3150-1866	London Research Institute from Cancer Research UK	London Research Institute from Cancer Research UK	This work was supported by a grant from The London Research Institute from Cancer Research UK.	Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Boder E, 1985, Kroc Found Ser, V19, P1; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dulic V, 2000, MOL CELL BIOL, V20, P6741, DOI 10.1128/MCB.20.18.6741-6754.2000; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Eilam R, 1998, P NATL ACAD SCI USA, V95, P12653, DOI 10.1073/pnas.95.21.12653; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; FARAGHER RGA, 1993, P NATL ACAD SCI USA, V90, P12030, DOI 10.1073/pnas.90.24.12030; FARRINGTON JA, 1973, BIOCHIM BIOPHYS ACTA, V314, P372, DOI 10.1016/0005-2728(73)90121-7; Frappart PO, 2006, NEUROMOL MED, V8, P495, DOI 10.1385/NMM:8:4:495; Grimes A, 2009, CANCER RES TREAT, V41, P187, DOI 10.4143/crt.2009.41.4.187; Kamsler A, 2001, CANCER RES, V61, P1849; Kanu N, 2008, CELL CYCLE, V7, P3483, DOI 10.4161/cc.7.22.7044; Kanu N, 2007, EMBO J, V26, P2933, DOI 10.1038/sj.emboj.7601733; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Lukas J, 2004, DNA REPAIR, V3, P997, DOI 10.1016/j.dnarep.2004.03.006; Lumsden JM, 2004, J EXP MED, V200, P1111, DOI 10.1084/jem.20041074; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Panda S, 2008, MECH AGEING DEV, V129, P332, DOI 10.1016/j.mad.2008.02.014; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peng J, 2009, FREE RADICAL BIO MED, V46, P312, DOI 10.1016/j.freeradbiomed.2008.10.045; Reina-San-Martin B, 2005, P NATL ACAD SCI USA, V102, P1590, DOI 10.1073/pnas.0406289102; Reina-San-Martin B, 2004, J EXP MED, V200, P1103, DOI 10.1084/jem.20041162; Reliene R, 2007, J NUTR, V137, p229S, DOI 10.1093/jn/137.1.229S; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; SHILOH Y, 1982, EXP CELL RES, V140, P191, DOI 10.1016/0014-4827(82)90169-0; Shull ERP, 2009, GENE DEV, V23, P171, DOI 10.1101/gad.1746609; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	49	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38534	38542		10.1074/jbc.M110.145896	http://dx.doi.org/10.1074/jbc.M110.145896			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20889973	Green Published, hybrid			2022-12-27	WOS:000284625600059
J	Khan, S; Lingrel, JB				Khan, Sohaib; Lingrel, Jerry B.			Thematic Minireview Series on Nuclear Receptors in Biology and Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University of Cincinnati; University of Cincinnati	Lingrel, JB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH 45267 USA.	jlingrel@asbmb.org		Khan, Sohaib/0000-0002-0792-9109					0	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38741	38742		10.1074/jbc.R110.196014	http://dx.doi.org/10.1074/jbc.R110.196014			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20959445	hybrid, Green Published			2022-12-27	WOS:000284941300001
J	Kumar, B; Kim, YC; DeMartino, GN				Kumar, Brajesh; Kim, Young-Chan; DeMartino, George N.			The C Terminus of Rpt3, an ATPase Subunit of PA700 (19 S) Regulatory Complex, Is Essential for 26 S Proteasome Assembly but Not for Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; SUBSTRATE ENTRY; CORE PARTICLE; AAA SUBUNITS; DEGRADATION; PATHWAY; BINDING; ROLES; GATE; POLYUBIQUITIN	PA700, the 19 S regulatory subcomplex of the 26 S proteasome, contains a heterohexameric ring of AAA subunits (Rpt1 to -6) that forms the binding interface with a heteroheptameric ring of alpha subunits (alpha 1 to -7) of the 20 S proteasome. Binding of these subcomplexes is mediated by interactions of C termini of certain Rpt subunits with cognate binding sites on the 20 S proteasome. Binding of two Rpt subunits (Rpt2 and Rpt5) depends on their last three residues, which share an HbYX motif (where Hb is a hydrophobic amino acid) and open substrate access gates in the center of the alpha ring. The relative roles of other Rpt subunits for proteasome binding and activation remain poorly understood. Here we demonstrate that the C-terminal HbYX motif of Rpt3 binds to the 20 S proteasome but does not promote proteasome gating. Binding requires the last three residues and occurs at a dedicated site on the proteasome. A C-terminal peptide of Rpt3 blocked ATP-dependent in vitro assembly of 26 S proteasome from PA700 and 20 S proteasome. In HEK293 cells, wild-type Rpt3, but not Rpt3 lacking the HbYX motif was incorporated into 26 S proteasome. These results indicate that the C terminus of Rpt3 was required for cellular assembly of this subunit into 26 S proteasome. Mutant Rpt3 was assembled into intact PA700. This result indicates that intact PA700 can be assembled independently of association with 20 S proteasome and thus may be a direct precursor for 26 S proteasome assembly under normal conditions. These results provide new insights to the non-equivalent roles of Rpt subunits in 26 S proteasome function and identify specific roles for Rpt3.	[Kumar, Brajesh; Kim, Young-Chan; DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	DeMartino, GN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	george.demartino@utsouthwestern.edu			National Institutes of Health [R01 DK46181]; Welch Foundation [I-500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK46181. This work was also supported by Welch Foundation Grant I-500 (to G. N. D.).	Adams GM, 1998, BIOCHEMISTRY-US, V37, P12927, DOI 10.1017/S1431927600024880; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foerster F, 2010, MOL CELL PROTEOMICS, V9, P1666, DOI 10.1074/mcp.R000002-MCP201; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2005, CHEMBIOCHEM, V6, P222, DOI 10.1002/cbic.200400313; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hendil KB, 2009, J MOL BIOL, V394, P320, DOI 10.1016/j.jmb.2009.09.038; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MCGUIRE MJ, 1989, BIOCHIM BIOPHYS ACTA, V995, P181, DOI 10.1016/0167-4838(89)90078-2; Nakamura Y, 2007, STRUCTURE, V15, P179, DOI 10.1016/j.str.2006.11.015; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; PUHLER G, 1992, EMBO J, V11, P1607, DOI 10.1002/j.1460-2075.1992.tb05206.x; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Stadtmueller BM, 2010, J BIOL CHEM, V285, P13, DOI 10.1074/jbc.C109.070425; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yu YD, 2010, EMBO J, V29, P692, DOI 10.1038/emboj.2009.382; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	51	26	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39523	39535		10.1074/jbc.M110.153627	http://dx.doi.org/10.1074/jbc.M110.153627			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937828	hybrid, Green Published			2022-12-27	WOS:000284941300078
J	Sun, YM; Fei, T; Yang, T; Zhang, F; Chen, YG; Li, HS; Xu, ZH				Sun, Yiming; Fei, Teng; Yang, Tao; Zhang, Feng; Chen, Ye-Guang; Li, Huashun; Xu, Zhiheng			The Suppression of CRMP2 Expression by Bone Morphogenetic Protein (BMP)-SMAD Gradient Signaling Controls Multiple Stages of Neuronal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; CELL-MIGRATION; GENE-TRANSFER; BRAIN; PHOSPHORYLATION; DPYSL2; GROWTH; ELECTROPORATION; SCHIZOPHRENIA	The formation of the functional mammalian cerebral cortex requires a concerted control of neurogenesis, neuronal migration, and neuronal morphogenesis. However, molecular mechanisms that control these processes are not well understood. We have found that the BMP signaling downstream transcription factor SMAD1 and CRMP2 (collapsin response mediator protein-2) are inversely and complementarily expressed in the developing neocortex. BMPs can suppress CRMP2 expression in cortical cells. Our ChIP assay demonstrates that both SMAD1 and -4 bind to CRMP2 promoter in the neocortex, and overexpression of SMAD1 and 4 in vivo suppresses CRMP2 expression. RNA interference of CRMP2 and overexpression of dominant negative forms of CRMP2 in utero cause accumulation of multipolar cells in the ventricular, subventricular, and intermediate zones and suppresses neurite outgrowth, suggesting that CRMP2 is required for multipolar to bipolar transition for directional neuronal migration and neurite outgrowth. Thus, our study reveals a novel mechanism that the BMP-SMAD signaling pathway controls neuronal migration and neurite outgrowth by suppressing the transcription of CRMP2.	[Sun, Yiming; Yang, Tao; Zhang, Feng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing 100101, Peoples R China; [Fei, Teng; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Li, Huashun] Sichuan Univ, W China Womens & Childrens Hosp, Dev & Stem Cell Inst, Chengdu 610041, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tsinghua University; Sichuan University	Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, 1 W Beichen Rd, Beijing 100101, Peoples R China.	zhxu@genetics.ac.cn	Yang, T/AFR-6763-2022; Chen, Ye-Guang/L-6998-2019; Fei, Teng/G-5324-2015; Fei, Teng/A-5963-2010	Fei, Teng/0000-0001-5707-0673; Xu, Zhiheng/0000-0002-4809-2851; Zhang, Feng/0000-0003-2887-8184; FEI, TENG/0000-0001-9620-0450	MOST (Ministry of Science and Technology) of China [2007CB947202, 2006CB500701, 2006AA02Z173, 2009DFA32450, 2009R0002]; NSF (China) [30725007, 30670663]; Chinese Academy of Sciences [KSCX1-YW-R-62/84]; National Natural Science Foundation of China [30725007, 30670663, 30921004]	MOST (Ministry of Science and Technology) of China(Ministry of Science and Technology, China); NSF (China)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from MOST of China, "973" program (2007CB947202 and 2006CB500701), "863" program (2006AA02Z173, 2009DFA32450, and 2009R0002); NSF (China) (30725007 and 30670663); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84). This work also was supported in part by grants from MOST (Ministry of Science and Technology) of China, "973" program (2007CB947202 and 2006CBS00701), "863" program (2006AA02Z173, 2009DFA32450, and 2009R0002); National Natural Science Foundation of China (30725007, 30670663 and 30921004); and the Chinese Academy of Sciences (Bairen plan and KSCX1-YW-R-62/84).	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Indraswari F, 2009, NEUROCHEM INT, V55, P235, DOI 10.1016/j.neuint.2009.03.005; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Koide T, 2010, J HUM GENET, V55, P469, DOI 10.1038/jhg.2010.38; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rakic P, 1996, P NATL ACAD SCI USA, V93, P9218, DOI 10.1073/pnas.93.17.9218; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Soutar MPM, 2009, CURR ALZHEIMER RES, V6, P269, DOI 10.2174/156720509788486572; Tabata H, 2003, J NEUROSCI, V23, P9996; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takata K, 2009, AM J PATHOL, V175, P17, DOI 10.2353/ajpath.2009.080908; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013; Zhao XZ, 2006, INT J NEUROPSYCHOPH, V9, P705, DOI 10.1017/S1461145705006267	34	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39039	39050		10.1074/jbc.M110.168351	http://dx.doi.org/10.1074/jbc.M110.168351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926379	Green Published, hybrid			2022-12-27	WOS:000284941300034
J	Tanaka, T; Sewell, H; Waters, S; Phillips, SEV; Rabbitts, TH				Tanaka, Tomoyuki; Sewell, Helen; Waters, Simon; Phillips, Simon E. V.; Rabbitts, Terence H.			Single Domain Intracellular Antibodies from Diverse Libraries EMPHASIZING DUAL FUNCTIONS OF LMO2 PROTEIN INTERACTIONS USING A SINGLE VH DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM-PROTEIN LMO2; T-CELL LEUKEMIA; ERYTHROLEUKEMIA CELLS; MEMBRANE-PROTEINS; MAMMALIAN-CELLS; SELECTION; COMPLEX; DIFFERENTIATION; CAPTURE; CRYSTALLIZATION	Interfering intracellular antibodies are valuable for biological studies as drug surrogates and as potential macromolecular drugs per se. Their application is still limited because of the difficulty of acquisition of functional intracellular antibodies. We describe the use of the new intracellular antibody capture procedure (IAC(3)) to facilitate direct isolation of functional single domain antibody fragments using four independent target molecules (LMO2, TP53, CRAF1, and Hoxa9) from a set of diverse libraries. Initially, these have variability in only one of the three antigen-binding CDR regions of VH or VL and first round single domains are affinity matured by iterative randomization of the two other CDRs and reselection. We highlight the approach using a single domain binding to LMO2 protein. Our results show that interfering with LMO2 protein function demonstrates a role specifically in erythroid differentiation, confirm a necessary and sufficient function for LMO2 as a cancer therapy target in T-cell neoplasia and allowed for the first time production of soluble recombinant LMO2 protein by co-expression with intracellular domain antibodies. Cocrystallization of LMO2 and the anti-LMO2 VH protein was successful. These results demonstrate that this third generation IAC3 offers a robust toolbox for various biomedical applications and consolidates functional features of the LMO2 protein complex, which includes the importance of Lmo2-Ldb1 protein interaction.	[Rabbitts, Terence H.] Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Phillips, Simon E. V.] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	Saint James's University Hospital; University of Leeds; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Rabbitts, TH (corresponding author), Univ Leeds, Leeds Inst Mol Med, Sect Expt Therapeut, St Jamess Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.	thr@leeds.ac.uk	Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609	Medical Research Council; Leukemia and Lymphoma Research; Leeds Institute of Molecular Medicine (University of Leeds); Bramall clinical studentship; MRC [G0600914, G0901686] Funding Source: UKRI; Medical Research Council [G0901686, G0600914] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukemia and Lymphoma Research; Leeds Institute of Molecular Medicine (University of Leeds); Bramall clinical studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council, from Leukemia and Lymphoma Research, and from the Leeds Institute of Molecular Medicine (University of Leeds).; Supported by a Leukemia and Lymphoma Research Gordon Pillar studentship and by the Medical Research Council.; Supported by a Bramall clinical studentship and by a Leukemia and Lymphoma Research clinical fellowship.	Appert A, 2009, CANCER RES, V69, P4784, DOI 10.1158/0008-5472.CAN-08-4774; ARCHER VEV, 1994, P NATL ACAD SCI USA, V91, P316, DOI 10.1073/pnas.91.1.316; Begay-Muller V, 2002, FEBS LETT, V521, P36, DOI 10.1016/S0014-5793(02)02814-4; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Colby DW, 2004, P NATL ACAD SCI USA, V101, P17616, DOI 10.1073/pnas.0408134101; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; FEARON ER, 1992, P NATL ACAD SCI USA, V89, P7958, DOI 10.1073/pnas.89.17.7958; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mao SF, 1997, ONCOGENE, V14, P1531, DOI 10.1038/sj.onc.1200988; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nam CH, 2008, ONCOGENE, V27, P4962, DOI 10.1038/onc.2008.130; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Perez-Martinez D, 2010, BIOESSAYS, V32, P589, DOI 10.1002/bies.201000009; Ramsland PA, 2002, J MOL RECOGNIT, V15, P248, DOI 10.1002/jmr.585; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Ruiz M, 2002, IMMUNOGENETICS, V53, P857, DOI 10.1007/s00251-001-0408-6; Ryan DP, 2008, PROTEINS, V70, P1461, DOI 10.1002/prot.21638; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; Tanaka T, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng023; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Tanaka T, 2008, J MOL BIOL, V376, P749, DOI 10.1016/j.jmb.2007.11.085; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tanaka T, 2010, NAT PROTOC, V5, P67, DOI 10.1038/nprot.2009.199; Tanaka T, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp069; Tse E, 2002, J MOL BIOL, V317, P85, DOI 10.1006/jmbi.2002.5403; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Visintin M, 2004, J IMMUNOL METHODS, V290, P135, DOI 10.1016/j.jim.2004.04.014; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yu GW, 2009, J MOL BIOL, V385, P1578, DOI 10.1016/j.jmb.2008.11.043	46	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3707	3716		10.1074/jbc.M110.188193	http://dx.doi.org/10.1074/jbc.M110.188193			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	20980262	hybrid, Green Published			2022-12-27	WOS:000286653200053
J	Torisawa, T; Nakayama, A; Furuta, K; Yamada, M; Hirotsune, S; Toyoshima, YY				Torisawa, Takayuki; Nakayama, Akiko; Furuta, Ken'ya; Yamada, Masami; Hirotsune, Shinji; Toyoshima, Yoko Y.			Functional Dissection of LIS1 and NDEL1 Towards Understanding the Molecular Mechanisms of Cytoplasmic Dynein Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL MIGRATION DEFECTS; EARLY EMBRYONIC LETHALITY; MOTILE PROPERTIES; BRAIN-TISSUE; PROTEIN; PURIFICATION; DIMERIZATION; TRANSPORT; DYNACTIN; COMPLEX	LIS1 and NDEL1 are known to be essential for the activity of cytoplasmic dynein in living cells. We previously reported that LIS1 and NDEL1 directly regulated the motility of cytoplasmic dynein in an in vitro motility assay. LIS1 suppressed dynein motility and inhibited the translocation of microtubules (MTs), while NDEL1 dissociated dynein from MTs and restored dynein motility following suppression by LIS1. However, the molecular mechanisms and detailed interactions of dynein, LIS1, and NDEL1 remain unknown. In this study, we dissected the regulatory effects of LIS1 and NDEL1 on dynein motility using full-length or truncated recombinant fragments of LIS1 or NDEL1. The C-terminal fragment of NDEL1 dissociated dynein from MTs, whereas its N-terminal fragment restored dynein motility following suppression by LIS1, demonstrating that the two functions of NDEL1 localize to different parts of the NDEL1 molecule, and that restoration from LIS1 suppression is caused by the binding of NDEL1 to LIS1, rather than to dynein. The truncated monomeric form of LIS1 had little effect on dynein motility, but an artificial dimer of truncated LIS1 suppressed dynein motility, which was restored by the N-terminal fragment of NDEL1. This suggests that LIS1 dimerization is essential for its regulatory function. These results shed light on the molecular interactions between dynein, LIS1, and NDEL1, and the mechanisms of cytoplasmic dynein regulation.	[Toyoshima, Yoko Y.] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; [Yamada, Masami; Hirotsune, Shinji] Osaka City Univ, Grad Sch Med, Dept Genet Dis Res, Osaka 5588585, Japan	University of Tokyo; Osaka Metropolitan University	Toyoshima, YY (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cyytoyo@mail.ecc.u-tokyo.ac.jp						AMOS LA, 1989, J CELL SCI, V93, P19; Bingham JB, 1998, METHOD ENZYMOL, V298, P171, DOI 10.1016/S0076-6879(98)98017-X; Cahana A, 2001, P NATL ACAD SCI USA, V98, P6429, DOI 10.1073/pnas.101122598; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; Furuta K, 2008, J BIOL CHEM, V283, P36465, DOI 10.1074/jbc.M803730200; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Hebbar S, 2008, J CELL BIOL, V182, P1063, DOI 10.1083/jcb.200803071; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; SLOBODA RD, 1982, METHOD ENZYMOL, V85, P409; Tarricone C, 2004, NEURON, V44, P809, DOI 10.1016/S0896-6273(04)00751-2; Toba S, 2004, CELL MOTIL CYTOSKEL, V58, P281, DOI 10.1002/cm.20018; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2009, TRENDS CELL BIOL, V19, P347, DOI 10.1016/j.tcb.2009.03.009; Wynshaw-Boris A, 2007, CLIN GENET, V72, P296, DOI 10.1111/j.1399-0004.2007.00888.x; Yamada M, 2008, EMBO J, V27, P2471, DOI 10.1038/emboj.2008.182	26	40	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 21	2011	286	3					1959	1965		10.1074/jbc.M110.169847	http://dx.doi.org/10.1074/jbc.M110.169847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	706BV	21036906	Green Published, hybrid			2022-12-27	WOS:000286191500037
J	George, J; Motshwene, PG; Wang, H; Kubarenko, AV; Rautanen, A; Mills, TC; Hill, AVS; Gay, NJ; Weber, ANR				George, Julie; Motshwene, Precious G.; Wang, Hui; Kubarenko, Andriy V.; Rautanen, Anna; Mills, Tara C.; Hill, Adrian V. S.; Gay, Nicholas J.; Weber, Alexander N. R.			Two Human MYD88 Variants, S34Y and R98C, Interfere with MyD88-IRAK4-Myddosome Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; PYOGENIC BACTERIAL-INFECTIONS; IRAK-4; COMPLEX; DEFICIENCY; ADAPTER; KINASE; SUPERFAMILY; RESPONSES; NETWORK	Innate immune receptors detect microbial pathogens and subsequently activate adaptive immune responses to combat pathogen invasion. MyD88 is a key adaptor molecule in both Toll-like receptor (TLR) and IL-1 receptor superfamily signaling pathways. This is illustrated by the fact that human individuals carrying rare, naturally occurring MYD88 point mutations suffer from reoccurring life-threatening infections. Here we analyzed the functional properties of six reported non-synonymous single nucleotide polymorphisms of MYD88 in an in vitro cellular system. Two variants found in the MyD88 death domain, S34Y and R98C, showed severely reduced NF-kappa B activation due to reduced homo-oligomerization and IRAK4 interaction. Structural modeling highlights Ser-34 and Arg-98 as residues important for the assembly of the Myddosome, a death domain (DD) post-receptor complex involving the DD of MyD88, IRAK4, and IRAK2 or IRAK1. Using S34Y and R98C as functional probes, our data show that MyD88 homo-oligomerization and IRAK4 interaction is modulated by the MyD88 TIR and IRAK4 kinase domain, demonstrating the functional importance of non-DD regions not observed in a recent Myddosome crystal structure. The differential interference of S34Y and R98C with some (IL-1 receptor, TLR2, TLR4, TLR5, and TLR7) but not all (TLR9) MyD88-dependent signaling pathways also suggests that receptor specificities exist at the level of the Myddosome. Given their detrimental effect on signaling, it is not surprising that our epidemiological analysis in several case-control studies confirms that S34Y and R98C are rare variants that may drastically contribute to susceptibility to infection in only few individuals.	[Weber, Alexander N. R.] German Canc Res Ctr, Div Toll Like Receptors & Canc, D-69120 Heidelberg, Germany; [Motshwene, Precious G.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1SG, England; [Rautanen, Anna; Mills, Tara C.; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics	Weber, ANR (corresponding author), German Canc Res Ctr, Div Toll Like Receptors & Canc, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	alexander.weber@dkfz.de		Weber, Alexander/0000-0002-8627-7056; Motshwene, Precious/0000-0002-0230-9410	Deutsche Forschungsgemeinschaft [We4195-1]; German Cancer Research Centre; UK Medical Research Council; Wellcome Trust; Biotechnology and Biological Sciences Research Council; European Union; Academy of Finland; BBSRC [BB/G002797/1] Funding Source: UKRI; MRC [G1000133] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G002797/1] Funding Source: researchfish; Medical Research Council [G1000133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Centre; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Academy of Finland(Academy of Finland); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Deutsche Forschungsgemeinschaft Grant We4195-1 (to A. N. R. W.) and by the German Cancer Research Centre.; Funded by grants from the UK Medical Research Council, the Wellcome Trust, and the Biotechnology and Biological Sciences Research Council.; Funded by the European Union FP6 GRACE grant and the Academy of Finland.	[Anonymous], 2003, NATURE, V426, P789; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; George J, 2010, J IMMUNOL, V184, P3025, DOI 10.4049/jimmunol.0901156; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Kubarenko AV, 2010, PROTEIN SCI, V19, P558, DOI 10.1002/pro.333; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 1999, MOL CELL BIOL, V19, P4643; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Loiarro M, 2009, J BIOL CHEM, V284, P28093, DOI 10.1074/jbc.M109.004465; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Park HH, 2007, ACTA CRYSTALLOGR F, V63, P229, DOI 10.1107/S1744309107007889; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pothlichet J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007582; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; SALI A, 1994, PROTEIN SCI, V3, P1582, DOI 10.1002/pro.5560030923; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wan YZ, 2009, J BIOL CHEM, V284, P10367, DOI 10.1074/jbc.M807822200; Watters TM, 2007, IMMUNOL CELL BIOL, V85, P411, DOI 10.1038/sj.icb.7100095; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	40	49	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1341	1353		10.1074/jbc.M110.159996	http://dx.doi.org/10.1074/jbc.M110.159996			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	20966070	Green Published, hybrid			2022-12-27	WOS:000286005000046
J	Hu, YL; Jiang, F; Guo, Y; Shen, XH; Zhang, Y; Zhang, R; Guo, G; Mao, XH; Zou, QM; Wang, DC				Hu, Yonglin; Jiang, Fan; Guo, Ying; Shen, Xihui; Zhang, Ying; Zhang, Rui; Guo, Gang; Mao, Xuhu; Zou, Quanming; Wang, Da-Cheng			Crystal Structure of HugZ, a Novel Heme Oxygenase from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTIDINE IRON LIGAND; PROXIMAL HISTIDINE; CORYNEBACTERIUM-DIPHTHERIAE; STAPHYLOCOCCUS-AUREUS; HMU O; REPLACEMENT; REFINEMENT; COMPLEX	The crystal structure of a heme oxygenase (HO) HugZ from Helicobacter pylori complexed with heme has been solved and refined at 1.8 angstrom resolution. HugZ is part of the iron acquisition mechanism of H. pylori, a major pathogen of human gastroenteric diseases. It is required for the adaptive colonization of H. pylori in hosts. Here, we report that HugZ is distinct from all other characterized HOs. It exists as a dimer in solution and in crystals, and the dimer adopts a split-barrel fold that is often found in FMN-binding proteins but has not been observed in hemoproteins. The heme is located at the intermonomer interface and is bound by both monomers. The heme iron is coordinated by the side chain of His(245) and an azide molecule when it is present in crystallization conditions. Experiments show that Arg(166), which is involved in azide binding, is essential for HugZ enzymatic activity, whereas His(245), surprisingly, is not, implying that HugZ has an enzymatic mechanism distinct from other HOs. The placement of the azide corroborates the observed gamma-meso specificity for the heme degradation reaction, in contrast to most known HOs that have alpha-meso specificity. We demonstrate through sequence and structural comparisons that HugZ belongs to a new heme-binding protein family with a split-barrel fold. Members of this family are widespread in pathogenic bacteria and may play important roles in the iron acquisition of these bacteria.	[Guo, Ying; Zhang, Rui; Guo, Gang; Mao, Xuhu; Zou, Quanming] Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China; [Wang, Da-Cheng] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zou, QM (corresponding author), Third Mil Med Univ, Coll Med Lab, Dept Clin Microbiol & Immunol, Chongqing 400038, Peoples R China.	qmzou@mail.tmmu.com.cn; dcwang@ibp.ac.cn			Minister of Science and Technology of China [2006CB806502, 2006CB910901, 2006AA02A322, 2009CB522606]; National Natural Science Foundation of China [30400019]; Natural Science Foundation Project of Chongqing [CSTC 2009BB5166]	Minister of Science and Technology of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing(Natural Science Foundation of Chongqing)	This work was supported by funding from Minister of Science and Technology of China Grants 2006CB806502, 2006CB910901, 2006AA02A322, and 2009CB522606, National Natural Science Foundation of China Grant 30400019, and Natural Science Foundation Project of Chongqing Grant CSTC 2009BB5166.	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chu GC, 2000, J BIOL CHEM, V275, P17494, DOI 10.1074/jbc.M000830200; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Dhaenens L, 1999, RES MICROBIOL, V150, P475, DOI 10.1016/S0923-2508(99)00109-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Ganz T, 2009, CURR OPIN IMMUNOL, V21, P63, DOI 10.1016/j.coi.2009.01.011; Guo Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-226; Jiang F, 2009, ACTA CRYSTALLOGR F, V65, P376, DOI 10.1107/S1744309109008094; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Oldham AL, 2008, CAN J MICROBIOL, V54, P97, DOI [10.1139/W07-122, 10.1139/w07-122]; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ridley KA, 2006, J BACTERIOL, V188, P7862, DOI 10.1128/JB.00994-06; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Sugishima M, 2002, J BIOL CHEM, V277, P45086, DOI 10.1074/jbc.M207267200; TAKAHASHI S, 1995, J AM CHEM SOC, V117, P6002, DOI 10.1021/ja00127a013; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wilks A, 2000, J BIOL CHEM, V275, P11686, DOI 10.1074/jbc.275.16.11686; WILKS A, 1995, J AM CHEM SOC, V117, P2925, DOI 10.1021/ja00115a027; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Wyckoff EE, 2004, J BACTERIOL, V186, P4142, DOI 10.1128/JB.186.13.4142-4151.2004	29	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 14	2011	286	2					1537	1544		10.1074/jbc.M110.172007	http://dx.doi.org/10.1074/jbc.M110.172007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	703TU	21030596	Green Published, hybrid			2022-12-27	WOS:000286005000066
J	Narayan, V; Pion, E; Landre, V; Muller, P; Ball, KL				Narayan, Vikram; Pion, Emmanuelle; Landre, Vivien; Mueller, Petr; Ball, Kathryn L.			Docking-dependent Ubiquitination of the Interferon Regulatory Factor-1 Tumor Suppressor Protein by the Ubiquitin Ligase CHIP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR IRF-1; HEAT-SHOCK PROTEINS; CHAPERONE FUNCTIONS; PROTEASOME PATHWAY; DNA-DAMAGE; E3 LIGASE; DEGRADATION; P53; COMPLEX; REPAIR	Characteristically for a regulatory protein, the IRF-1 tumor suppressor turns over rapidly with a half-life of between 20-40 min. This allows IRF-1 to reach new steady state protein levels swiftly in response to changing environmental conditions. Whereas CHIP ( C terminus of Hsc70-interacting protein), appears to chaperone IRF-1 in unstressed cells, formation of a stable IRF-1.CHIP complex is seen under specific stress conditions. Complex formation, in heat- or heavy metal-treated cells, is accompanied by a decrease in IRF-1 steady state levels and an increase in IRF-1 ubiquitination. CHIP binds directly to an intrinsically disordered domain in the central region of IRF-1 ( residues 106-140), and this site is sufficient to form a stable complex with CHIP in cells and to compete in trans with full-length IRF-1, leading to a reduction in its ubiquitination. The study reveals a complex relationship between CHIP and IRF-1 and highlights the role that direct binding or "docking" of CHIP to its substrate(s) can play in its mechanism of action as an E3 ligase.	[Narayan, Vikram; Pion, Emmanuelle; Landre, Vivien; Ball, Kathryn L.] Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Edinburgh EH4 2XR, Midlothian, Scotland; [Mueller, Petr] Masaryk Mem Canc Inst, Dept Expt Oncol, Brno 65653, Czech Republic	University of Edinburgh; Masaryk Memorial Cancer Institute	Ball, KL (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Cell Signalling Unit, CRUK Interferon & Cell Signalling Grp, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	kathryn.ball@ed.ac.uk	Muller, Petr/F-7762-2015; Narayan, Vikram/AAF-3964-2020; Muller, Petr/AAK-5014-2021	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Narayan, Vikram/0000-0002-6128-7944	Cancer Research UK [C377/A6355]; Scottish University; Internal Grant Agency of the Ministry of Health [MZ CR NS/9812-4]; Grantova Agentura Ceske Republiky [301/08/1468]	Cancer Research UK(Cancer Research UK); Scottish University; Internal Grant Agency of the Ministry of Health; Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic)	This work is funded by Cancer Research UK Programme Grant C377/A6355 (to K. L. B.).; Recipient of a Scottish Universities Life Sciences Alliance Ph.D. studentship.; Supported by Internal Grant Agency of the Ministry of Health Grant MZ CR NS/9812-4 and Grantova Agentura Ceske Republiky Grant 301/08/1468.	Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Flodstrom M, 1997, ENDOCRINOLOGY, V138, P2747, DOI 10.1210/en.138.7.2747; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Graf C, 2010, BIOCHEMISTRY-US, V49, P2121, DOI 10.1021/bi901829f; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; McDonough H, 2009, J BIOL CHEM, V284, P20649, DOI 10.1074/jbc.M109.011767; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Nakagawa K, 2000, EUR J BIOCHEM, V267, P1680, DOI 10.1046/j.1432-1327.2000.01163.x; Narayan V, 2009, J BIOL CHEM, V284, P25889, DOI 10.1074/jbc.M109.019505; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Nozawa H, 1998, INT J CANCER, V77, P522, DOI 10.1002/(SICI)1097-0215(19980812)77:4<522::AID-IJC8>3.0.CO;2-W; Pamment J, 2002, ONCOGENE, V21, P7776, DOI 10.1038/sj.onc.1205981; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pion E, 2009, CELL SIGNAL, V21, P1479, DOI 10.1016/j.cellsig.2009.05.004; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; Schaper F, 1998, BIOCHEM J, V335, P147, DOI 10.1042/bj3350147; Shang Y, 2009, BIOCHEM BIOPH RES CO, V386, P242, DOI 10.1016/j.bbrc.2009.06.043; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Tamura G, 1996, J PATHOL, V180, P371, DOI 10.1002/(SICI)1096-9896(199612)180:4<371::AID-PATH704>3.0.CO;2-2; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; WATANABE N, 1991, NUCLEIC ACIDS RES, V19, P4421, DOI 10.1093/nar/19.16.4421; Wawrzynow B, 2009, J BIOL CHEM, V284, P11517, DOI 10.1074/jbc.M809294200; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	38	41	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					607	619		10.1074/jbc.M110.153122	http://dx.doi.org/10.1074/jbc.M110.153122			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20947504	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000285782800063
J	Huang, YP; Ratovitski, EA				Huang, Yiping; Ratovitski, Edward A.			Phosphorylated TP63 Induces Transcription of RPN13, Leading to NOS2 Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CELL CARCINOMA-CELLS; DEUBIQUITINATING ENZYME; PROTEASOME DEGRADATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; P53 ACTIVATION; CANCER; CISPLATIN; DELTA-NP63-ALPHA	Head and neck squamous cell carcinoma cells exposed to cisplatin display ATM-dependent phosphorylation of the most predominant TP63 isoform (Delta Np63 alpha), leading to its activation as a transcription factor. Here, we found that the phospho-Delta Np63 alpha protein binds to the genomic promoter of RPN13 through the TP63-responsive element. We further found that the phospho-Delta Np63 alpha protein associates with other transcription factors (DDIT3 (also known as CHOP), NF-Y, and NF-kappa B), activating RPN13 gene transcription. Furthermore, cisplatin-induced and phospho-Delta Np63 kappa-dependent RPN13 gene transcription leads to NOS2 degradation. Finally, we show that RPN13 knockdown by siRNA essentially rescues NOS2 from cisplatin-dependent inactivation. These data provide a novel mechanism for the phospho-Delta Np63 alpha-dependent regulation of NOS2 function in cells upon cisplatin treatment, contributing to the cell death pathway of tumor cells.	[Huang, Yiping; Ratovitski, Edward A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21231 USA	Johns Hopkins University	Ratovitski, EA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Canc Res Bldg 2,Rm 2M05,1550 Orleans St, Baltimore, MD 21231 USA.	eratovi1@jhmi.edu			NIAID [R01-AI47224]; NIDCR [R01-DE13561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013561] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AI47224 from NIAID and R01-DE13561 from NIDCR (to E.A.R.).	Abrams SL, 2010, CELL CYCLE, V9, P1781, DOI 10.4161/cc.9.9.11483; Ambs S, 1998, BRIT J CANCER, V78, P233, DOI 10.1038/bjc.1998.470; Ambs S, 1997, FASEB J, V11, P443, DOI 10.1096/fasebj.11.6.9194524; Borst P, 2008, CELL CYCLE, V7, P1353, DOI 10.4161/cc.7.10.5930; Brune B, 2003, CELL DEATH DIFFER, V10, P864, DOI 10.1038/sj.cdd.4401261; Damia G, 2004, CELL CYCLE, V3, P46; Di Agostino S, 2008, CELL CYCLE, V7, P3440, DOI 10.4161/cc.7.21.6995; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Gordon C, 2002, CURR TOP MICROBIOL, V268, P175; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Helmbach H, 2002, J INVEST DERMATOL, V118, P923, DOI 10.1046/j.1523-1747.2002.01786.x; Hemish J, 2003, J BIOL CHEM, V278, P42321, DOI 10.1074/jbc.M308192200; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; Huang YP, 2008, CELL CYCLE, V7, P2846, DOI 10.4161/cc.7.18.6627; Huang YP, 2010, CELL CYCLE, V9, P328, DOI 10.4161/cc.9.2.10432; Huang YP, 2005, CELL CYCLE, V4, P1440, DOI 10.4161/cc.4.10.2086; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Hussain SP, 2008, CANCER RES, V68, P7130, DOI 10.1158/0008-5472.CAN-08-0410; Hussain SP, 2004, CANCER RES, V64, P6849, DOI 10.1158/0008-5472.CAN-04-2201; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kolodziejska KE, 2005, P NATL ACAD SCI USA, V102, P4854, DOI 10.1073/pnas.0500485102; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kroncke KD, 2003, BIOL CHEM, V384, P1365, DOI 10.1515/BC.2003.153; Leung EL, 2008, BRIT J CANCER, V98, P1803, DOI 10.1038/sj.bjc.6604375; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P4297, DOI 10.4161/cc.9.21.13817; Mazumdar T, 2010, P NATL ACAD SCI USA, V107, P13854, DOI 10.1073/pnas.0913495107; Melino G, 2000, CELL MOL LIFE SCI, V57, P612, DOI 10.1007/PL00000723; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nakaya N, 2000, ONCOGENE, V19, P6369, DOI 10.1038/sj.onc.1204100; Navarro-Lerida I, 2004, J BIOL CHEM, V279, P55682, DOI 10.1074/jbc.M406621200; Nawrocki ST, 2006, CANCER RES, V66, P3773, DOI 10.1158/0008-5472.CAN-05-2961; Nicotera P, 1999, CELL DEATH DIFFER, V6, P931, DOI 10.1038/sj.cdd.4400583; Nott A, 2009, CELL CYCLE, V8, P725, DOI 10.4161/cc.8.5.7805; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Pandit L, 2009, P NATL ACAD SCI USA, V106, P1211, DOI 10.1073/pnas.0810968106; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Peunova N, 2007, CELL CYCLE, V6, P3132, DOI 10.4161/cc.6.24.5146; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Ratovitski EA, 1999, J BIOL CHEM, V274, P30250, DOI 10.1074/jbc.274.42.30250; Ratovitski EA, 1999, J BIOL CHEM, V274, P993, DOI 10.1074/jbc.274.2.993; Richardson PG, 2005, CELL CYCLE, V4, P290; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Seminara AR, 2007, CELL CYCLE, V6, P1772, DOI 10.4161/cc.6.14.4438; SHAPOSHNIKOV JD, 1978, INT J CANCER, V21, P395, DOI 10.1002/ijc.2910210322; SHIMADA S, 1994, CANCER RES, V54, P3831; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sikora AG, 2010, CLIN CANCER RES, V16, P1834, DOI 10.1158/1078-0432.CCR-09-3123; Sos ML, 2009, CELL CYCLE, V8, P3652, DOI 10.4161/cc.8.22.9936; Staib F, 2005, CANCER RES, V65, P10255, DOI 10.1158/0008-5472.CAN-05-1714; Tanaka T, 2008, CELL CYCLE, V7, P1569, DOI 10.4161/cc.7.11.6061; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Wang X, 2003, CELL DEATH DIFFER, V10, P468, DOI 10.1038/sj.cdd.4401181; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zangen R, 2005, CELL CYCLE, V4, P1313, DOI 10.4161/cc.4.10.2066	58	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41422	41431		10.1074/jbc.M110.158642	http://dx.doi.org/10.1074/jbc.M110.158642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959455	Green Published, hybrid			2022-12-27	WOS:000285622600028
J	Krause, C; Korchynskyi, O; de Rooij, K; Weidauer, SE; de Gorter, DJJ; van Bezooijen, RL; Hatsell, S; Economides, AN; Mueller, TD; Lowik, CWGM; ten Dijke, P				Krause, Carola; Korchynskyi, Olexandr; de Rooij, Karien; Weidauer, Stella E.; de Gorter, David J. J.; van Bezooijen, Rutger L.; Hatsell, Sarah; Economides, Aris N.; Mueller, Thomas D.; Loewik, Clemens W. G. M.; ten Dijke, Peter			Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-5; VAN-BUCHEM-DISEASE; TGF-BETA; PARATHYROID-HORMONE; BMP ANTAGONIST; SOST GENE; OSTEOCYTES; EXPRESSION; DENSITY; CELLS	Sclerostin is expressed by osteocytes and has catabolic effects on bone. It has been shown to antagonize bone morphogenetic protein (BMP) and/or Wnt activity, although at present the underlying mechanisms are unclear. Consistent with previous findings, Sclerostin opposed direct Wnt3a-induced but not direct BMP7-induced responses when both ligand and antagonist were provided exogenously to cells. However, we found that when both proteins are expressed in the same cell, sclerostin can antagonize BMP signaling directly by inhibiting BMP7 secretion. Sclerostin interacts with both the BMP7 mature domain and pro-domain, leading to intracellular retention and proteasomal degradation of BMP7. Analysis of sclerostin knock-out mice revealed an inhibitory action of sclerostin on Wnt signaling in both osteoblasts and osteocytes in cortical and cancellous bones. BMP7 signaling was predominantly inhibited by sclerostin in osteocytes of the calcaneus and the cortical bone of the tibia. Our results suggest that sclerostin exerts its potent bone catabolic effects by antagonizing Wnt signaling in a paracrine and autocrine manner and antagonizing BMP signaling selectively in the osteocytes that synthesize simultaneously both sclerostin and BMP7 proteins.	[Krause, Carola; Korchynskyi, Olexandr; de Gorter, David J. J.; van Bezooijen, Rutger L.; ten Dijke, Peter] Univ Wurzburg, Dept Mol Cell Biol, D-97074 Wurzburg, Germany; [Krause, Carola; Korchynskyi, Olexandr; de Gorter, David J. J.; van Bezooijen, Rutger L.; ten Dijke, Peter] Univ Wurzburg, Ctr Biomed Genet, D-97074 Wurzburg, Germany; [de Rooij, Karien; Loewik, Clemens W. G. M.] Univ Wurzburg, Dept Endocrinol, D-97074 Wurzburg, Germany; [Weidauer, Stella E.; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot Mol Pflanzenphysiol & Biophys 1, Julius von Sachs Inst Biowissensch, D-97074 Wurzburg, Germany; [Hatsell, Sarah; Economides, Aris N.] Regeneron Pharmaceut Inc, Genome Engn Technol, Tarrytown, NY 10591 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Regeneron	ten Dijke, P (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Postzone S-1-P,Postbus 9600, NL-2300 RC Leiden, Netherlands.	P.ten_Dijke@lumc.nl	Dijke, Peter ten/AAG-4660-2021; Korchynskyi, Olexandr/ADA-6398-2022	Dijke, Peter ten/0000-0002-7234-342X; Hatsell, Sarah/0000-0003-1103-6087; de Rooij, Karien/0000-0001-7950-089X; Mueller, Thomas/0000-0003-1862-7357; Economides, Aris/0000-0002-6508-8942; Korchynskyi, Olexandr/0000-0002-4557-4003	Dutch Organization for Scientific Research [NWO 918.66.606]; Centre for Biomedical Genetics; European Union	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Biomedical Genetics; European Union(European Commission)	This work was supported by Dutch Organization for Scientific Research Grant NWO 918.66.606 and the Centre for Biomedical Genetics and European Union FP7 Program TALOS.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; BEIGHTON P, 1984, CLIN GENET, V25, P175; Bell E, 2003, DEVELOPMENT, V130, P1381, DOI 10.1242/dev.00344; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; BIEWENER AA, 1983, J EXP BIOL, V103, P131; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; BURGER EH, 1995, J NUTR, V125, pS2020, DOI 10.1093/jn/125.suppl_7.2020S; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; FROST HM, 1960, J BONE JOINT SURG AM, V42, P138, DOI 10.2106/00004623-196042010-00011; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; JONES WK, 1994, GROWTH FACTORS, V11, P215, DOI 10.3109/08977199409046919; Kamiya N, 2008, DEVELOPMENT, V135, P3801, DOI 10.1242/dev.025825; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; REYNOLDS TR, 1985, AM J PHYS ANTHROPOL, V67, P335, DOI 10.1002/ajpa.1330670406; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Silvestrini G, 2007, J MOL HISTOL, V38, P261, DOI 10.1007/s10735-007-9096-3; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Van Der Horst G, 2002, BONE, V31, P661, DOI 10.1016/S8756-3282(02)00903-1; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Wei AQ, 2008, SPINE J, V8, P466, DOI 10.1016/j.spinee.2007.04.021; Weidauer SE, 2009, BIOCHEM BIOPH RES CO, V380, P160, DOI 10.1016/j.bbrc.2009.01.062; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021; Zhou FF, 2008, J BIOL CHEM, V283, P14506, DOI 10.1074/jbc.M706136200; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41	74	125	146	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41614	41626		10.1074/jbc.M110.153890	http://dx.doi.org/10.1074/jbc.M110.153890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20952383	Green Published, hybrid			2022-12-27	WOS:000285622600049
J	Lu, HL; Kennedy, GG; Warshaw, DM; Trybus, KM				Lu, Hailong; Kennedy, Guy G.; Warshaw, David M.; Trybus, Kathleen M.			Simultaneous Observation of Tail and Head Movements of Myosin V during Processive Motion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LEUCINE-RICH PROTEOGLYCANS; DECORIN-DEFICIENT MICE; CYCLIN-DEPENDENT KINASES; HUMAN COLON-CANCER; C-MYC PROTEIN; FACTOR RECEPTOR; IN-VIVO; DOWN-REGULATION; MET RECEPTOR	Processive stepping of myosin Va (myoV) has been tracked by monitoring either the tail position (center of mass) or the position of one or both heads. Here, we combine these two approaches by attaching a quantum dot to one of the motor domains and a bead to the tail. Using laser trapping and total internal reflection microscopy, the position of one head and the tail are observed simultaneously as myoV moves processively on an actin filament bundle against the resistive load of the laser trap. The head moves one step (73 +/- 10 nm) for every two steps of the tail (35 +/- 9 nm). One tail step occurs concurrently with quantum dot-labeled head movement, whereas the other occurs with movement of the unlabeled head, consistent with a hand-over-hand model. Load increases the probability of the motor taking a back step. The back step is triggered by the motor taking a shorter forward step (head step, 68 +/- 11 nm; tail step, 32 +/- 10 nm), likely one actin monomer short of its preferred binding site. During a back step, the motor reverses its hand-over-hand motion, with the leading head detaching and reattaching to one of multiple actin sites behind the trailing head. After a back step, the motor can correct its mistake and step processively forward at resistive loads <0.7 piconewton or stall or detach at higher loads. Back stepping may provide a mechanism to ensure efficient cargo delivery even when myoV encounters obstacles within the actin cytoskeletal meshwork or when other motors are attached to the same cargo.	[Warshaw, David M.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Kennedy, Guy G.] Univ Vermont, Instrumentat & Model Facil, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Warshaw, DM (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, 149 Beaumont Ave, Burlington, VT 05405 USA.	david.warshaw@uvm.edu; kathleen.trybus@uvm.edu	lu, hailong/C-7754-2009		National Institutes of Health [GM078097, HL059408, GM094229]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078097, R01GM094229] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078097 (to K. M. T.) and HL059408 and GM094229 (to D.M.W.).	ADANY R, 1991, BIOCHEM J, V276, P301, DOI 10.1042/bj2760301; ADANY R, 1990, J BIOL CHEM, V265, P11389; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Arnold HK, 2008, CANCER METAST REV, V27, P147, DOI 10.1007/s10555-008-9128-9; Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brown EL, 2001, J CLIN INVEST, V107, P845, DOI 10.1172/JCI11692; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Csordas G, 2000, J BIOL CHEM, V275, P32879, DOI 10.1074/jbc.M005609200; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ferdous Z, 2010, J BIOMED MATER RES A, V93A, P419, DOI 10.1002/jbm.a.32545; Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Hakkinen L, 2000, LAB INVEST, V80, P1869, DOI 10.1038/labinvest.3780197; Haruyama N, 2009, MATRIX BIOL, V28, P129, DOI 10.1016/j.matbio.2009.01.005; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kamei J, 2003, BIOCHEM BIOPH RES CO, V312, P380, DOI 10.1016/j.bbrc.2003.10.129; KRUMDIECK R, 1992, J IMMUNOL, V149, P3695; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Li X, 2008, BLOOD, V112, P159, DOI 10.1182/blood-2007-11-124164; Liang FT, 2004, AM J PATHOL, V165, P977, DOI 10.1016/S0002-9440(10)63359-7; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; Malempati S, 2006, LEUKEMIA, V20, P1572, DOI 10.1038/sj.leu.2404317; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merline R, 2009, J PHYSIOL PHARMACOL, V60, P5; Migliore C, 2008, EUR J CANCER, V44, P641, DOI 10.1016/j.ejca.2008.01.022; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Ramirez F, 2003, MATRIX BIOL, V22, P101, DOI 10.1016/S0945-053X(03)00002-7; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Robinson PS, 2005, J BIOMECH ENG-T ASME, V127, P181, DOI 10.1115/1.1835363; Robinson PS, 2004, ANN BIOMED ENG, V32, P924, DOI 10.1023/B:ABME.0000032455.78459.56; Ruehland C, 2007, FEBS J, V274, P4246, DOI 10.1111/j.1742-4658.2007.05951.x; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Sanches JCT, 2010, J ANAT, V216, P144, DOI 10.1111/j.1469-7580.2009.01170.x; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Santra M, 2002, J BIOL CHEM, V277, P35671, DOI 10.1074/jbc.M205317200; SANTRA M, 1995, P NATL ACAD SCI USA, V92, P7016, DOI 10.1073/pnas.92.15.7016; Santra M, 2000, J BIOL CHEM, V275, P35153, DOI 10.1074/jbc.M006821200; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Schaefer L, 2004, AM J PATHOL, V165, P383, DOI 10.1016/S0002-9440(10)63305-6; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Schonherr E, 2004, J VASC RES, V41, P499, DOI 10.1159/000081806; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Seidler DG, 2006, J BIOL CHEM, V281, P26408, DOI 10.1074/jbc.M602853200; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sims K, 2009, DEV BIOL, V327, P410, DOI 10.1016/j.ydbio.2008.12.027; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Williams KJ, 2007, AM J PATHOL, V171, P1441, DOI 10.2353/ajpath.2007.070079; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200	102	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42068	42085		10.1074/jbc.M110.180265	http://dx.doi.org/10.1074/jbc.M110.180265			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974847	Green Published, hybrid			2022-12-27	WOS:000285622600092
J	Walseng, E; Furuta, K; Goldszmid, RS; Weih, KA; Sher, A; Roche, PA				Walseng, Even; Furuta, Kazuyuki; Goldszmid, Romina S.; Weih, Karis A.; Sher, Alan; Roche, Paul A.			Dendritic Cell Activation Prevents MHC Class II Ubiquitination and Promotes MHC Class II Survival Regardless of the Activation Stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXOPLASMA-GONDII; PLASMA-MEMBRANE; COMPLEXES; SURFACE; EXPRESSION; MATURATION; INFECTION; TRANSPORT; PARASITES; FUSION	The expression of MHC class II (MHC-II) on the surface of antigen-presenting cells, such as dendritic cells (DCs), is tightly regulated during cellular activation. Many cells, including DCs, are activated following stimulation of innate Toll-like receptors (TLRs) by products of microorganisms. In the resting (immature) state, MHC-II is ubiquitinated in immature DCs and is rapidly degraded; however, after activation of these cells with MyD88-dependent TLR ligands, MHC-II ubiquitination is blocked, and MHC-II survival is prolonged. We now show that DC activation using MyD88-dependent TLR ligands, MyD88-independent TLR ligands, and even infection with the intracellular parasite Toxoplasma gondii leads to identical changes in MHC-II expression, ubiquitination, and surface stability, revealing a conserved role for enhanced MHC-II stability after DC activation by different stimuli.	[Walseng, Even; Furuta, Kazuyuki; Weih, Karis A.; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Goldszmid, Romina S.; Sher, Alan] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Goldszmid, Romina S.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	National Institutes of Health of NCI and NIAID; NATIONAL CANCER INSTITUTE [ZIABC009404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000579] Funding Source: NIH RePORTER	National Institutes of Health of NCI and NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Programs of NCI and NIAID.	Aliberti J, 2004, IMMUNOL REV, V201, P26, DOI 10.1111/j.0105-2896.2004.00179.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; JOINER KA, 1990, SCIENCE, V249, P641, DOI 10.1126/science.2200126; Kang HK, 2004, BIOCHEM BIOPH RES CO, V322, P899, DOI 10.1016/j.bbrc.2004.07.205; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412; Mordue DG, 1999, J EXP MED, V190, P1783, DOI 10.1084/jem.190.12.1783; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Subauste CS, 2000, J IMMUNOL, V165, P1498, DOI 10.4049/jimmunol.165.3.1498; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	23	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41749	41754		10.1074/jbc.M110.157586	http://dx.doi.org/10.1074/jbc.M110.157586			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21047782	Green Published, hybrid			2022-12-27	WOS:000285622600062
J	Mendoza-Cozatl, DG; Zhai, ZY; Jobe, TO; Akmakjian, GZ; Song, WY; Limbo, O; Russell, MR; Kozlovskyy, VI; Martinoia, E; Vatamaniuk, OK; Russell, P; Schroeder, JI				Mendoza-Cozatl, David G.; Zhai, Zhiyang; Jobe, Timothy O.; Akmakjian, Garo Z.; Song, Won-Yong; Limbo, Oliver; Russell, Matthew R.; Kozlovskyy, Volodymyr I.; Martinoia, Enrico; Vatamaniuk, Olena K.; Russell, Paul; Schroeder, Julian I.			Tonoplast-localized Abc2 Transporter Mediates Phytochelatin Accumulation in Vacuoles and Confers Cadmium Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; HEAVY-METAL DETOXIFICATION; FISSION YEAST REQUIRES; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; PEPTIDES; GLUTATHIONE; SYNTHASE; GENES; IDENTIFICATION	Phytochelatins mediate tolerance to heavy metals in plants and some fungi by sequestering phytochelatin-metal complexes into vacuoles. To date, only Schizosaccharomyces pombe Hmt1 has been described as a phytochelatin transporter and attempts to identify orthologous phytochelatin transporters in plants and other organisms have failed. Furthermore, recent data indicate that the hmt1 mutant accumulates significant phytochelatin levels in vacuoles, suggesting that unidentified phytochelatin transporters exist in fungi. Here, we show that deletion of all vacuolar ABC transporters abolishes phytochelatin accumulation in S. pombe vacuoles and abrogates 35S-PC2 uptake into S. pombe microsomal vesicles. Systematic analysis of the entire S. pombe ABC transporter family identified Abc2 as a full-size ABC transporter (ABCC-type) that mediates phytochelatin transport into vacuoles. The S. pombe abc1 abc2 abc3 abc4 hmt1 quintuple and abc2 hmt1 double mutant show no detectable phytochelatins in vacuoles. Abc2 expression restores phytochelatin accumulation into vacuoles and suppresses the cadmium sensitivity of the abc quintuple mutant. A novel, unexpected, function of Hmt1 in GS-conjugate transport is also shown. In contrast to Hmt1, Abc2 orthologs are widely distributed among kingdoms and are proposed as the long-sought vacuolar phytochelatin transporters in plants and other organisms.	[Mendoza-Cozatl, David G.; Jobe, Timothy O.; Akmakjian, Garo Z.; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA; [Zhai, Zhiyang; Kozlovskyy, Volodymyr I.; Vatamaniuk, Olena K.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Song, Won-Yong; Martinoia, Enrico] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; [Limbo, Oliver; Russell, Matthew R.; Russell, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Cornell University; University of Zurich; Scripps Research Institute	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu	Zhai, Zhiyang/AAY-5475-2020; Jobe, Timothy O/A-7087-2012; Martinoia, Enrico/AAH-8712-2021	Jobe, Timothy O/0000-0002-5729-4981; Schroeder, Julian/0000-0002-3283-5972; Russell, Matthew/0000-0002-0291-7379; Mendoza Cozatl, David/0000-0002-9616-0791; Kozlovskyy, Volodymyr/0000-0002-2401-3178; Limbo, Oliver/0000-0003-1686-1414; Zhai, Zhiyang/0000-0003-3181-1773	NIEHS, National Institutes of Health [P42 ES010337]; Energy Biosciences Office of the Department of Energy [DE-FG0203ER15449]; EU [FOOD-CT-20060016253]; National Science Foundation [MCB-0923731]; Cornell University Agricultural Experiment Station CUAES Hatch [NYC-125433]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Energy Biosciences Office of the Department of Energy(United States Department of Energy (DOE)); EU(European Commission); National Science Foundation(National Science Foundation (NSF)); Cornell University Agricultural Experiment Station CUAES Hatch; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by grants from the NIEHS, National Institutes of Health (P42 ES010337, to J. I. S. and P. R.), the Energy Biosciences Office of the Department of Energy (DE-FG0203ER15449, to J. I. S.), the EU Project PHIME (Contract no. FOOD-CT-20060016253, to E. M.), National Science Foundation (MCB-0923731, to O. K. V.), and Cornell University Agricultural Experiment Station CUAES Hatch (NYC-125433, to O. K. V.).	Broderick JB, 2007, NAT CHEM BIOL, V3, P243, DOI 10.1038/nchembio0507-243; Chen A, 2006, PLANT PHYSIOL, V141, P108, DOI 10.1104/pp.105.072637; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen S, 2007, J BIOL CHEM, V282, P21561, DOI 10.1074/jbc.M702383200; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2001, EUR J BIOCHEM, V268, P3640, DOI 10.1046/j.1432-1327.2001.02293.x; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; Guo YY, 2010, SCI TOTAL ENVIRON, V408, P3113, DOI 10.1016/j.scitotenv.2010.04.018; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; HAYASHI Y, 1991, METHOD ENZYMOL, V205, P348; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HOWDEN R, 1995, PLANT PHYSIOL, V107, P1059, DOI 10.1104/pp.107.4.1059; Iwaki T, 2006, MICROBIOL-SGM, V152, P2309, DOI 10.1099/mic.0.28952-0; Iwema T, 2009, BIOCHEMISTRY-US, V48, P6041, DOI 10.1021/bi900440m; Kennedy PJ, 2008, TOXICOL SCI, V106, P124, DOI 10.1093/toxsci/kfn153; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Lu YP, 1997, P NATL ACAD SCI USA, V94, P8243, DOI 10.1073/pnas.94.15.8243; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mendoza-Cozatl DG, 2008, PLANT J, V54, P249, DOI 10.1111/j.1365-313X.2008.03410.x; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; MUTOH N, 1988, BIOCHEM BIOPH RES CO, V151, P32, DOI 10.1016/0006-291X(88)90555-4; Nagy R, 2009, J BIOL CHEM, V284, P33614, DOI 10.1074/jbc.M109.030247; Ogunseitan OA, 2009, SCIENCE, V326, P670, DOI 10.1126/science.1176929; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; ORTIZ DF, 1992, EMBO J, V11, P3491, DOI 10.1002/j.1460-2075.1992.tb05431.x; ORTIZ DF, 1995, J BIOL CHEM, V270, P4721, DOI 10.1074/jbc.270.9.4721; PLOCKE DJ, 1992, EUR J BIOCHEM, V207, P201, DOI 10.1111/j.1432-1033.1992.tb17038.x; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; REESE RN, 1988, J BIOL CHEM, V263, P12832; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Ryan JA, 2004, ENVIRON SCI TECHNOL, V38, p18A, DOI 10.1021/es040337r; SALT DE, 1993, J BIOL CHEM, V268, P12297; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Satarug S, 2010, ENVIRON HEALTH PERSP, V118, P182, DOI 10.1289/ehp.0901234; Schwartz MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009564; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; SPEISER DM, 1992, MOL CELL BIOL, V12, P5301, DOI 10.1128/MCB.12.12.5301; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Trompier D, 2006, J BIOL CHEM, V281, P20283, DOI 10.1074/jbc.M601072200; Van Belleghem F, 2007, NEW PHYTOL, V173, P495, DOI 10.1111/j.1469-8137.2006.01940.x; Vande Weghe JG, 2001, MOL MICROBIOL, V42, P29, DOI 10.1046/j.1365-2958.2001.02624.x; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; VOGELILANGE R, 1990, PLANT PHYSIOL, V92, P1086, DOI 10.1104/pp.92.4.1086; Wu JS, 1995, BIOCHEM MOL BIOL INT, V36, P1169; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	60	66	71	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40416	40426		10.1074/jbc.M110.155408	http://dx.doi.org/10.1074/jbc.M110.155408			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20937798	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000285414400004
J	Xuan, SH; Szabolcs, M; Cinti, F; Perincheri, S; Accili, D; Efstratiadis, A				Xuan, Shouhong; Szabolcs, Matthias; Cinti, Francesca; Perincheri, Suhdir; Accili, Domenico; Efstratiadis, Argiris			Genetic Analysis of Type-1 Insulin-like Growth Factor Receptor Signaling through Insulin Receptor Substrate-1 and -2 in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DIABETES-MELLITUS; TRANSCRIPTION FACTOR FOXO1; FORKHEAD PROTEIN FOXO1; GLYCEMIC CONTROL; RESISTANCE; MICE; SECRETION; IRS-2; DYSFUNCTION; DISRUPTION	Signaling by receptor tyrosine kinases regulates pancreatic beta cell function. Inactivation of insulin receptor (InsR), IGF1 receptor (Igf1r), or Irs1 in beta cells impairs insulin secretion. Conversely, Irs2 ablation impairs beta cell replication. In this study, we examined aspects of the Igf1r regulatory signaling cascade in beta cells. To examine genetically the involvement of Irs1 and Irs2 in Igf1r signaling, we generated double mutant mice lacking Igf1r specifically in pancreatic beta cells in an Irs1-or Irs2-null background. We show that Igf1r/Irs1 double mutants do not differ phenotypically from Irs1 single mutants and exhibit hyperinsulinemia, while maintaining normal beta cell mass and glucose tolerance. In contrast, lack of Igf1r function in beta cells aggravates the consequences of Irs2 ablation in double mutants and results in lethal diabetes by 6 weeks of age. This additivity of phenotypic manifestations indicates that Irs2 serves a pathway that is largely independent of Igf1r signaling. Consistent with the view that the latter is the InsR pathway, we show that combined beta cell-specific knock-out of both Insr and Igf1r results in a phenocopy of double mutants lacking Igf1r and Irs2. We conclude that Igf1r signals primarily through Irs1 and affects insulin secretion, whereas beta cell proliferation is mainly regulated by InsR using Irs2 as a downstream signaling effector. The insulin and IGF pathways appear to control beta cell functions independently and selectively.	[Xuan, Shouhong; Cinti, Francesca; Perincheri, Suhdir; Efstratiadis, Argiris] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Szabolcs, Matthias] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Efstratiadis, Argiris] Acad Athens, Biomed Res Fdn, Athens 11527, Greece	Columbia University; Columbia University; Columbia University; Academy of Athens	Accili, D (corresponding author), 1150 St Nicholas Av,Rm 238, New York, NY 10032 USA.	da230@columbia.edu	Cinti, Francesca/AAY-5534-2021	Cinti, Francesca/0000-0001-5170-7055	National Institutes of Health [DK58282, DK63608]; Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058282, R01DK058282, P30DK063608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russell Berrie Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58282 and DK63608 (Columbia University Diabetes & Endocrinology Research Center) and a research grant from the Russell Berrie Foundation (to A. E. and D. A.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; FRATTALI AL, 1993, J BIOL CHEM, V268, P7393; GREENWOOD RH, 1976, LANCET, V1, P444; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kido Y, 2002, J BIOL CHEM, V277, P36740, DOI 10.1074/jbc.M206314200; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1694, DOI 10.1152/ajpendo.00430.2006; Kitamura T, 2004, J CLIN INVEST, V113, P209, DOI 10.1172/JCI200417810; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Monnier L, 2007, DIABETES CARE, V30, P263, DOI 10.2337/dc06-1612; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Terauchi Y, 2003, J BIOL CHEM, V278, P14284, DOI 10.1074/jbc.M211045200; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Weng JP, 2008, LANCET, V371, P1753, DOI 10.1016/S0140-6736(08)60762-X; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Withers DJ, 1999, NAT GENET, V23, P32, DOI 10.1038/12631; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	48	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41044	41050		10.1074/jbc.M110.144790	http://dx.doi.org/10.1074/jbc.M110.144790			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947509	Green Published, hybrid			2022-12-27	WOS:000285414400067
J	Garcia, J; Han, D; Sancheti, H; Yap, LP; Kaplowitz, N; Cadenas, E				Garcia, Jerome; Han, Derick; Sancheti, Harsh; Yap, Li-Peng; Kaplowitz, Neil; Cadenas, Enrique			Regulation of Mitochondrial Glutathione Redox Status and Protein Glutathionylation by Respiratory Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPEROXIDE ANION; IDENTIFICATION; MODULATION; MECHANISMS; RELEASE; SITES	Brain and liver mitochondria isolated by a discontinuous Percoll gradient show an oxidized redox environment, which is reflected by low GSH levels and high GSSG levels and significant glutathionylation of mitochondrial proteins as well as by low NAD(P) H/NAD(P) values. The redox potential of brain mitochondria isolated by a discontinuous Percoll gradient method was calculated to be -171 mV based on GSH and GSSG concentrations. Immunoblotting and LC/MS/MS analysis revealed that succinyl-CoA transferase and ATP synthase (F-1 complex, alpha-subunit) were extensively glutathionylated; S-glutathionylation of these proteins resulted in a substantial decrease of activity. Supplementation of mitochondria with complex I or complex II respiratory substrates (malate/glutamate or succinate, respectively) increased NADH and NADPH levels, resulting in the restoration of GSH levels through reduction of GSSG and deglutathionylation of mitochondrial proteins. Under these conditions, the redox potential of brain mitochondria was calculated to be -291 mV. Supplementation of mitochondria with respiratory substrates prevented GSSG formation and, consequently, ATP synthase glutathionylation in response to H2O2 challenges. ATP synthase appears to be the major mitochondrial protein that becomes glutathionylated under oxidative stress conditions. Glutathionylation of mitochondrial proteins is a major consequence of oxidative stress, and respiratory substrates are key regulators of mitochondrial redox status (as reflected by thiol/disulfide exchange) by maintaining mitochondrial NADPH levels.	[Garcia, Jerome; Sancheti, Harsh; Yap, Li-Peng; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Cadenas, E (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, 1985 Zonal Ave, Los Angeles, CA 90089 USA.	cadenas@usc.edu		Sancheti, Harsh/0000-0001-8084-4550	National Institutes of Health [AA016911, AG016718, DK067215]; Tobacco-Related Disease Research Program [16RT-0186]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA016911 (to D. H.), AG016718 (to E. C.), and DK067215 (to N. K.). This work was also supported by Tobacco-Related Disease Research Program Grant 16RT-0186 (to E. C.).	Anderson MF, 2000, BRAIN RES PROTOC, V5, P95, DOI 10.1016/S1385-299X(99)00060-4; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandez-Checa JC, 1998, SEMIN LIVER DIS, V18, P389, DOI 10.1055/s-2007-1007172; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2005, BIOCHEMISTRY-US, V44, P11986, DOI 10.1021/bi0509393; Han D, 2003, MOL PHARMACOL, V64, P1136, DOI 10.1124/mol.64.5.1136; Han D, 2002, METHOD ENZYMOL, V349, P271, DOI 10.1016/S0076-6879(02)49341-X; Han D, 2006, AM J PHYSIOL-GASTR L, V291, pG1, DOI 10.1152/ajpgi.00001.2006; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kil IS, 2005, J BIOL CHEM, V280, P10846, DOI 10.1074/jbc.M411306200; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Lam PY, 2009, FREE RADICAL RES, V43, P431, DOI 10.1080/10715760902849813; MEISTER A, 1995, BBA-MOL BASIS DIS, V1271, P35, DOI 10.1016/0925-4439(95)00007-Q; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; REED DJ, 1990, ANNU REV PHARMACOL, V30, P603, DOI 10.1146/annurev.pa.30.040190.003131; RYDSTROM J, 2006, J BIOCHIM BIOPHYS AC, V1757, P721; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schroeter H, 2003, BIOCHEM J, V372, P359, DOI 10.1042/BJ20030201; SIES H, 1985, PHILOS T ROY SOC B, V311, P617, DOI 10.1098/rstb.1985.0168; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; Yap LP, 2010, METHOD ENZYMOL, V473, P137, DOI 10.1016/S0076-6879(10)73006-8; Yap LP, 2010, BIOCHEM J, V428, P85, DOI 10.1042/BJ20100164; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015	33	151	150	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39646	39654		10.1074/jbc.M110.164160	http://dx.doi.org/10.1074/jbc.M110.164160			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937819	Green Published, hybrid			2022-12-27	WOS:000285185500008
J	Mondin, M; Carta, M; Normand, E; Mulle, C; Coussen, F				Mondin, Magali; Carta, Mario; Normand, Elisabeth; Mulle, Christophe; Coussen, Francoise			Profilin II Regulates the Exocytosis of Kainate Glutamate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE VARIANTS; SUBUNIT; TRAFFICKING; ENDOCYTOSIS; PATHWAY; COMPLEX; BINDING	The trafficking of ionotropic glutamate receptors to and from synaptic sites is regulated by proteins that interact with their cytoplasmic C-terminal domain. Profilin IIa (PfnIIa), an actin-binding protein expressed in the brain and recruited to synapses in an activity-dependent manner, was shown previously to interact with the C-terminal domain of the GluK2b subunit splice variant of kainate receptors (KARs). Here, we characterize this interaction and examine the role of PfnIIa in the regulation of KAR trafficking. PfnIIa directly and specifically binds to the C-terminal domain of GluK2b through a diproline motif. Expression of PfnIIa in transfected COS-7 cells and in cultured hippocampal neurons from PfnII-deficient mice decreases the level of extracellular of homomeric GluK2b as well as heteromeric GluK2a/GluK2b KARs. Our data suggest a novel mechanism by which PfnIIa exerts a dual role on the trafficking of KARs, by a generic inhibition of clathrin-mediated endocytosis through its interaction with dynamin-1, and by controlling KARs exocytosis through a direct and specific interaction with GluK2b.	[Mondin, Magali; Carta, Mario; Normand, Elisabeth; Mulle, Christophe; Coussen, Francoise] Univ Bordeaux, CNRS, Lab Physiol Cellulaire Synapse, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Coussen, F (corresponding author), Univ Bordeaux, CNRS, Lab Physiol Cellulaire Synapse, UMR 5091, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	fcoussen@pcs.u-bordeaux2.fr		Mondin, Magali/0000-0001-5802-007X; Mulle, Christophe/0000-0003-2709-6615; Carta, Mario/0000-0003-1225-2742	Centre National de la Recherche Scientifique; Conseil Regional d'Aquitaine; European Commission [LSHM-CT-2005-019055]; Agence Nationale de la Recherche; European community [KAR TRAF/PIEF-GA-2009-235073]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); European community(European Commission)	This work was supported by grants from the Centre National de la Recherche Scientifique, the Conseil Regional d'Aquitaine, the European Commission (EUSynapse Project, Contract LSHM-CT-2005-019055), and the Agence Nationale de la Recherche (PresynGlu Project) (to C.M.). The European community's Seventh frame work, program (FP7) through an EIF fellowship (KAR TRAF/PIEF-GA-2009-235073) to M.C.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Coussen F, 2005, NEURON, V47, P555, DOI 10.1016/j.neuron.2005.06.033; Coussen F, 2002, J NEUROSCI, V22, P6426, DOI 10.1523/jneurosci.22-15-06426.2002; Coussen F, 2009, NEUROSCIENCE, V158, P25, DOI 10.1016/j.neuroscience.2007.12.052; Di Nardo A, 2000, J CELL SCI, V113, P3795; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Giesemann T, 2003, J NEUROSCI, V23, P8330; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Jaskolski F, 2005, J BIOL CHEM, V280, P22968, DOI 10.1074/jbc.M413166200; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Jaskolski F, 2004, J NEUROSCI, V24, P2506, DOI 10.1523/JNEUROSCI.5116-03.2004; Laezza F, 2007, MOL CELL NEUROSCI, V34, P539, DOI 10.1016/j.mcn.2006.12.003; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Ren Z, 2003, J BIOL CHEM, V278, P52700, DOI 10.1074/jbc.M309585200; Salinas GD, 2006, J BIOL CHEM, V281, P40164, DOI 10.1074/jbc.M608194200; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Winkler A, 1999, BRAIN RES PROTOC, V4, P69, DOI 10.1016/S1385-299X(99)00005-7; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014	28	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40060	40071		10.1074/jbc.M110.140442	http://dx.doi.org/10.1074/jbc.M110.140442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937818	Green Published, hybrid			2022-12-27	WOS:000285185500051
J	Zhang, XYZ; Lloubes, R; Duche, D				Zhang, Xiang Y. -Z.; Lloubes, Roland; Duche, Denis			Channel Domain of Colicin A Modifies the Dimeric Organization of Its Immunity Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMING DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CROSS-LINKING; OUTER-MEMBRANE; ION-CHANNEL; LOCALIZATION; INHIBITION; FRAGMENT; HELICES	Proteins conferring immunity against pore-forming colicins are localized in the Escherichia coli inner membrane. Their protective effects are mediated by direct interaction with the C-terminal domain of their cognate colicins. Cai, the immunity protein protecting E. coli against colicin A, contains four cysteine residues. We report cysteine cross-linking experiments showing that Cai forms homodimers. Cai contains four transmembrane segments (TMSs), and dimerization occurs via the third TMS. Furthermore, we observe the formation of intramolecular disulfide bonds that connect TMS2 with either TMS1 or TMS3. Co-expression of Cai with its target, the colicin A pore-forming domain (pfColA), in the inner membrane prevents the formation of intermolecular and intramolecular disulfide bonds, indicating that pfColA interacts with the dimer of Cai and modifies its conformation. Finally, we show that when Cai is locked by disulfide bonds, it is no longer able to protect cells against exogenous added colicin A.	[Duche, Denis] CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UPR 9027, F-13402 Marseille 20, France; [Zhang, Xiang Y. -Z.; Lloubes, Roland; Duche, Denis] Univ Mediterranee Aix Marseille, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Duche, D (corresponding author), CNRS, Inst Microbiol Mediterranee, Lab Ingn Syst Macromol, UPR 9027, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	duche@ibsm.cnrs-mrs.fr		LLOUBES, Roland/0000-0002-9520-1053; Duche, Denis/0000-0002-4208-6661	Agence Nationale de la Recherche [ANR-07-BLANC-67]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the Agence Nationale de la Recherche, SODATOL Project ANR-07-BLANC-67.	Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DUCHE D, 1995, J BACTERIOL, V177, P4935, DOI 10.1128/jb.177.17.4935-4939.1995; Duche D, 2002, BIOCHIMIE, V84, P455, DOI 10.1016/S0300-9084(02)01424-4; Duche D, 1999, J MOL BIOL, V285, P1965, DOI 10.1006/jmbi.1998.2423; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; ESPESSET D, 1994, MOL MICROBIOL, V13, P1111, DOI 10.1111/j.1365-2958.1994.tb00502.x; GELI V, 1989, MOL MICROBIOL, V3, P679, DOI 10.1111/j.1365-2958.1989.tb00216.x; GELI V, 1988, P NATL ACAD SCI USA, V85, P689, DOI 10.1073/pnas.85.3.689; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; JI TH, 1980, BIOCHIM BIOPHYS ACTA, V603, P371, DOI 10.1016/0005-2736(80)90382-X; Journet L, 2001, MOL MICROBIOL, V42, P331, DOI 10.1046/j.1365-2958.2001.02592.x; LEE GF, 1994, J BIOL CHEM, V269, P29920; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Nardi A, 2001, J BACTERIOL, V183, P6721, DOI 10.1128/JB.183.22.6721-6725.2001; Nardi A, 2001, J MOL BIOL, V307, P1293, DOI 10.1006/jmbi.2001.4524; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PILSL H, 1995, J BACTERIOL, V177, P6966, DOI 10.1128/jb.177.23.6966-6972.1995; Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t; Sato Y, 2004, J BIOL CHEM, V279, P22926, DOI 10.1074/jbc.M312194200; SCHRAMM E, 1988, MOL GEN GENET, V211, P176, DOI 10.1007/BF00338410; Schwem BE, 2006, J BIOL CHEM, V281, P37861, DOI 10.1074/jbc.M607453200; Slatin SL, 2002, P NATL ACAD SCI USA, V99, P1286, DOI 10.1073/pnas.022480199; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Smajs D, 2006, FEMS MICROBIOL LETT, V258, P108, DOI 10.1111/j.1574-6968.2006.00201.x; Smajs D, 2008, FEBS J, V275, P5325, DOI 10.1111/j.1742-4658.2008.06662.x; SONG HY, 1991, J BACTERIOL, V173, P2935, DOI 10.1128/JB.173.9.2935-2943.1991; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; ZHANG YL, 1993, J BIOL CHEM, V268, P10176	30	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38053	38061		10.1074/jbc.M110.144071	http://dx.doi.org/10.1074/jbc.M110.144071			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923759	Green Published, hybrid			2022-12-27	WOS:000284625600013
J	Di, L; Srivastava, S; Zhdanova, O; Sun, Y; Li, Z; Skolnik, EY				Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.			Nucleoside Diphosphate Kinase B Knock-out Mice Have Impaired Activation of the K+ Channel KCa3.1, Resulting in Defective T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; NM23/NDP KINASE; NM23-H1; GENE; METASTASIS; PHOSPHORYLATION; MECHANISM; COLITIS; TARGETS; IKCA1	Nucleoside diphosphate kinases (NDPKs) are encoded by the Nme (non-metastatic cell) gene family. Although they comprise a family of 10 genes, NDPK-A and -B are ubiquitously expressed and account for most of the NDPK activity. We previously showed that NDPK-B activates the K+ channel KCa3.1 via histidine phosphorylation of the C terminus of KCa3.1, which is required for T cell receptor-stimulated Ca2+ flux and proliferation of activated naive human CD4 T cells. We now report the phenotype of NDPK-B-/- mice. NDPK-B-/- mice are phenotypically normal at birth with a normal life span. Although T and B cell development is normal in NDPK-B-/- mice, KCa3.1 channel activity and cytokine production are markedly defective in T helper 1 (Th1) and Th2 cells, whereas Th17 function is normal. These findings phenocopy studies in the same cells isolated from KCa3.1(-/-) mice and thereby support genetically that NDPK-B functions upstream of KCa3.1. NDPK-A and -B have been linked to an astonishing array of disparate cellular and biochemical functions, few of which have been confirmed in vivo in physiological relevant systems. NDPK-B-/- mice will be an essential tool with which to definitively address the biological functions of NDPK-B. Our finding that NDPK-B is required for activation of Th1 and Th2 CD4 T cells, together with the normal overall phenotype of NDPK-B-/- mice, suggests that specific pharmacological inhibitors of NDPK-B may provide new opportunities to treat Th1- and Th2-mediated autoimmune diseases.	[Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.] NYU, Langone Med Ctr, Dept Internal Med, New York, NY 10016 USA; [Di, Lie; Srivastava, Shekhar; Zhdanova, Olga; Sun, Yi; Li, Zhai; Skolnik, Edward Y.] NYU, Langone Med Ctr, Dept Pharmacol, New York, NY 10016 USA; [Srivastava, Shekhar; Zhdanova, Olga; Skolnik, Edward Y.] NYU, Langone Med Ctr, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med,Div Nephrol, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Skolnik, EY (corresponding author), NYU, Langone Med Ctr, Dept Internal Med, 550 1St Ave, New York, NY 10016 USA.	skolnik@nyumc.org		Srivastava, Shekhar/0000-0001-5165-7385	National Institutes of Health [RO1GM084195, RO1AI052459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by National Institutes of Health Grants RO1GM084195 and RO1AI052459. To whom correspondence should be addressed. Tel.: 212-263-7458; Fax: 212-263-3110; E-mail: edward.skolnik@nyumc.org.	Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Desvignes T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-256; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Fournier E, 2003, CURR BIOL, V13, P1858, DOI 10.1016/j.cub.2003.09.034; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Hippe HJ, 2007, CIRC RES, V100, P1191, DOI 10.1161/01.RES.0000264058.28808.cc; Hippe HJ, 2009, P NATL ACAD SCI USA, V106, P16269, DOI 10.1073/pnas.0901679106; Hippe HJ, 2003, J BIOL CHEM, V278, P7227, DOI 10.1074/jbc.M210305200; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kaetzel DM, 2006, J BIOENERG BIOMEMBR, V38, P163, DOI 10.1007/s10863-006-9040-3; Klumpp S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.261pe13; Krishnan KS, 2001, NEURON, V30, P197, DOI 10.1016/S0896-6273(01)00273-2; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lee JH, 2009, MOL CELL BIOCHEM, V329, P141, DOI 10.1007/s11010-009-0124-3; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Murakami M, 2009, MOL CELL BIOCHEM, V329, P131, DOI 10.1007/s11010-009-0123-4; Nallamothu G, 2009, MOL CELL BIOCHEM, V329, P35, DOI 10.1007/s11010-009-0112-7; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Postel EH, 2009, DEV DYNAM, V238, P775, DOI 10.1002/dvdy.21887; Postel EH, 2009, MOL CELL BIOCHEM, V329, P45, DOI 10.1007/s11010-009-0110-9; Postel EH, 2003, J BIOENERG BIOMEMBR, V35, P31, DOI 10.1023/A:1023485505621; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983	33	65	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38765	38771		10.1074/jbc.M110.168070	http://dx.doi.org/10.1074/jbc.M110.168070			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20884616	Green Published, hybrid			2022-12-27	WOS:000284941300005
J	Okwan-Duodu, D; Datta, V; Shen, XZ; Goodridge, HS; Bernstein, EA; Fuchs, S; Liu, GY; Bernstein, KE				Okwan-Duodu, Derick; Datta, Vivekanand; Shen, Xiao Z.; Goodridge, Helen S.; Bernstein, Ellen A.; Fuchs, Sebastien; Liu, George Y.; Bernstein, Kenneth E.			Angiotensin-converting Enzyme Overexpression in Mouse Myelomonocytic Cells Augments Resistance to Listeria and Methicillin-resistant Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; MACROPHAGE POLARIZATION; IMMUNE EVASION; MICE; INNATE; SYSTEM; INFLAMMATION; INFECTION; RESPONSES; BACTERIA	Gene targeting in ES cells was used to substitute control of angiotensin converting enzyme (ACE) expression from the endogenous promoter to the mouse c-fms promoter. The result is an animal model called ACE 10/10 in which ACE is overexpressed by monocytes, macrophages, and other myelomonocytic lineage cells. To study the immune response of these mice to bacterial infection, we challenged them with Listeria monocytogenes or methicillin-resistant Staphylococcus aureus (MRSA). ACE 10/10 mice have a significantly enhanced immune response to both bacteria in vivo and in vitro. For example, 5 days after Listeria infection, the spleen and liver of ACE 10/10 mice had 8.0- and 5.2-fold less bacteria than wild type mice (WT). In a model of MRSA skin infection, ACE 10/10 mice had 50-fold less bacteria than WT mice. Histologic examination showed a prominent infiltrate of ACE-positive mononuclear cells in the skin lesions from ACE 10/10. Increased bacterial resistance in ACE 10/10 is directly due to overexpression of ACE, as it is eliminated by an ACE inhibitor. Critical to increased immunity in ACE 10/10 is the overexpression of iNOS and reactive nitrogen intermediates, as inhibition of iNOS by the inhibitor 1400W eliminated all in vitro and in vivo differences in innate bacterial resistance between ACE 10/10 and WT mice. Increased resistance to MRSA was transferable by bone marrow transplantation. The overexpression of ACE and iNOS by myelomonocytic cells substantially boosts innate immunity and may represent a new means to address serious bacterial infections.	[Okwan-Duodu, Derick; Shen, Xiao Z.; Goodridge, Helen S.; Bernstein, Ellen A.; Fuchs, Sebastien; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Datta, Vivekanand; Shen, Xiao Z.; Fuchs, Sebastien; Liu, George Y.; Bernstein, Kenneth E.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Liu, George Y.] Cedars Sinai Med Ctr, Dept Pediat, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Bernstein, KE (corresponding author), 110 N George Burns Rd,Davis 2021, Los Angeles, CA 90048 USA.	kbernst@cshs.org		Bernstein, Kenneth/0000-0001-8097-3272	National Institutes of Health [R01 K039777, R01 DK051445, R01 AI074832, R00 HL088000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL088000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported, in whole or in part, by National Institutes of Health Grants R01 K039777 (to K. E. B.), R01 DK051445 (to K. E. B.), R01 AI074832 (to G. Y. L.), and R00 HL088000 (to S. F.).	[Anonymous], 1999, JAMA, V282, P1123; Babu BR, 1998, CURR OPIN CHEM BIOL, V2, P491, DOI 10.1016/S1367-5931(98)80125-7; BECKERMAN KP, 1993, J IMMUNOL, V150, pA53; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bernstein KE, 2006, HYPERTENSION, V47, P509, DOI 10.1161/01.HYP.0000196266.23639.c6; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cole J, 2002, CIRC RES, V90, P87, DOI 10.1161/hh0102.102360; CORVOL P, 1995, METHOD ENZYMOL, V248, P283; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Han G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007804; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Houghton AM, 2009, NATURE, V460, P637, DOI 10.1038/nature08181; Kobayashi SD, 2009, CURR OPIN PHARMACOL, V9, P545, DOI 10.1016/j.coph.2009.07.009; LANGFORD KG, 1991, J BIOL CHEM, V266, P15559; Leehey DJ, 2000, KIDNEY INT, V58, pS93, DOI 10.1046/j.1523-1755.2000.07715.x; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez LR, 2009, J INVEST DERMATOL, V129, P2463, DOI 10.1038/jid.2009.95; Metzger R, 2000, ATHEROSCLEROSIS, V150, P21, DOI 10.1016/S0021-9150(99)00354-8; Montecucco F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/752406; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Platten M, 2009, P NATL ACAD SCI USA, V106, P14948, DOI 10.1073/pnas.0903958106; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; Richardson AR, 2006, MOL MICROBIOL, V61, P927, DOI 10.1111/j.1365-2958.2006.05290.x; Ruiz-Ortega M, 1998, J IMMUNOL, V161, P430; Sakiniene E, 1997, CLIN EXP IMMUNOL, V110, P370, DOI 10.1046/j.1365-2249.1997.4431456.x; Sasaki S, 1998, INFECT IMMUN, V66, P1017, DOI 10.1128/IAI.66.3.1017-1022.1998; Scharfstein J, 2008, BIOL CHEM, V389, P1015, DOI 10.1515/BC.2008.126; Shen XZ, 2008, J BIOL CHEM, V283, P9957, DOI 10.1074/jbc.M709574200; Shen XZ, 2007, AM J PATHOL, V170, P2122, DOI 10.2353/ajpath.2007.061205; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Stegbauer J, 2009, P NATL ACAD SCI USA, V106, P14942, DOI 10.1073/pnas.0903602106; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Tseng CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006387; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008	49	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39051	39060		10.1074/jbc.M110.163782	http://dx.doi.org/10.1074/jbc.M110.163782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937811	Green Published, hybrid			2022-12-27	WOS:000284941300035
J	Umanah, GKE; Huang, LY; Ding, FX; Arshava, B; Farley, AR; Link, AJ; Naider, F; Becker, JM				Umanah, George K. E.; Huang, Liyin; Ding, Fa-xiang; Arshava, Boris; Farley, Adam R.; Link, Andrew J.; Naider, Fred; Becker, Jeffrey M.			Identification of Residue-to-residue Contact between a Peptide Ligand and Its G Protein-coupled Receptor Using Periodate-mediated Dihydroxyphenylalanine Cross-linking and Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MATING PHEROMONE; ALPHA-FACTOR RECEPTOR; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE DOMAIN; AMINO-ACIDS; BINDING; ANALOGS; PURIFICATION; STE2P; FRAGMENTS	Fundamental knowledge about how G protein-coupled receptors and their ligands interact is important for understanding receptor-ligand binding and the development of new drug discovery strategies. We have used cross-linking and tandem mass spectrometry analyses to investigate the interaction of the N terminus of the Saccharomyces cerevisiae tridecapeptide pheromone, alpha-factor (WHWLQLKPGQPMY), and Ste2p, its cognate G protein-coupled receptor. The Trp(1) residue of alpha-factor was replaced by 3,4-dihydroxyphenylalanine (DOPA) for periodate-mediated chemical cross-linking, and biotin was conjugated to Lys(7) for detection purposes to create the peptide [DOPA(1),Lys(7)(BioACA),Nle(12)]alpha-factor, called Bio-DOPA(1)-alpha-factor. This ligand analog was a potent agonist and bound to Ste2p with similar to 65 nanomolar affinity. Immunoblot analysis of purified Ste2p samples that were treated with Bio-DOPA(1)-alpha-factor showed that the peptide analog cross-linked efficiently to Ste2p. The cross-linking was inhibited by the presence of either native alpha-factor or an alpha-factor antagonist. MALDI-TOF and immunoblot analyses revealed that Bio-DOPA(1)-alpha-factor cross-linked to a fragment of Ste2p encompassing residues Ser(251)-Met(294). Fragmentation of the cross-linked fragment and Ste2p using tandem mass spectrometry pinpointed the cross-link point of the DOPA(1) of the alpha-factor analog to the Ste2p Lys(269) side chain near the extracellular surface of the TM6-TM7 bundle. This conclusion was confirmed by a greatly diminished cross-linking of Bio-DOPA(1)-alpha-factor into a Ste2p(K269A) mutant. Based on these and previously obtained binding contact data, a mechanism of alpha-factor binding to Ste2p is proposed. The model for bound alpha-factor shows how ligand binding leads to conformational changes resulting in receptor activation of the signal transduction pathway.	[Umanah, George K. E.; Huang, Liyin; Becker, Jeffrey M.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Ding, Fa-xiang; Arshava, Boris; Naider, Fred] CUNY Coll Staten Isl, Dept Chem, New York, NY 10314 USA; [Ding, Fa-xiang; Arshava, Boris; Naider, Fred] CUNY Coll Staten Isl, Macromol Assemblies Inst, New York, NY 10314 USA; [Naider, Fred] CUNY Grad Sch & Univ Ctr, New York, NY 10314 USA; [Farley, Adam R.; Link, Andrew J.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	University of Tennessee System; University of Tennessee Knoxville; City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; College of Staten Island (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) Graduate School; Vanderbilt University	Becker, JM (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	jbecker@utk.edu			National Institutes of Health, NIGMS [GM22087]; National Institutes of Health [GM064779]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022087, R56GM022087, R01GM064779] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant GM22087.; Supported by National Institutes of Health Grant GM064779.	Abel MG, 1998, J PEPT RES, V52, P95; Bajaj A, 2007, BBA-MOL CELL RES, V1773, P707, DOI 10.1016/j.bbamcr.2007.02.002; Bauer A, 2003, EUR J BIOCHEM, V270, P570, DOI 10.1046/j.1432-1033.2003.03428.x; Beavis R, 2004, CURR PROTOC BIOINFOR; Blake AD, 1996, CHEM BIOL, V3, P967, DOI 10.1016/S1074-5521(96)90163-5; Burdine L, 2004, J AM CHEM SOC, V126, P11442, DOI 10.1021/ja045982c; Chapter MC, 2010, PHARMACOL THERAPEUT, V125, P39, DOI 10.1016/j.pharmthera.2009.07.006; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Ding FX, 2002, J PEPT RES, V60, P65, DOI 10.1034/j.1399-3011.2002.21004.x; Ding FX, 2001, BIOCHEMISTRY-US, V40, P1102, DOI 10.1021/bi0021535; Dinger MC, 2003, J BIOL CHEM, V278, P10562, DOI 10.1074/jbc.M205747200; Eglen RM, 2009, METHODS MOL BIOL, V552, P1, DOI 10.1007/978-1-60327-317-6_1; ERIOTOUBARGIOTA E, 1992, BIOCHEMISTRY-US, V31, P551, DOI 10.1021/bi00117a036; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Gurrath M, 2001, CURR MED CHEM, V8, P1605, DOI 10.2174/0929867013371798; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; Henry LK, 2002, BIOCHEMISTRY-US, V41, P6128, DOI 10.1021/bi015863z; Hornak V, 2010, J MOL BIOL, V396, P510, DOI 10.1016/j.jmb.2009.12.003; Huang LY, 2008, BIOCHEMISTRY-US, V47, P5638, DOI 10.1021/bi701866e; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764; Kraft P, 2001, ANAL BIOCHEM, V292, P76, DOI 10.1006/abio.2001.5072; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Lee BK, 2002, BIOCHEMISTRY-US, V41, P13681, DOI 10.1021/bi026100u; Lee BK, 2001, J BIOL CHEM, V276, P37950; Lee YH, 2006, J BIOL CHEM, V281, P2263, DOI 10.1074/jbc.M509987200; Link AJ, 2005, METHODS, V35, P274, DOI 10.1016/j.ymeth.2004.08.019; Liu B, 2006, J AM CHEM SOC, V128, P15228, DOI 10.1021/ja065794h; Lundgren Deborah H, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1303s28; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Naider F, 2004, PEPTIDES, V25, P1441, DOI 10.1016/j.peptides.2003.11.028; Naider F, 2007, BIOCHEMISTRY-US, V46, P3476, DOI 10.1021/bi602415u; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sommers CM, 1997, J MOL BIOL, V266, P559, DOI 10.1006/jmbi.1996.0816; Son CD, 2005, J PEPT RES, V65, P418, DOI 10.1111/j.1399-3011.2005.00248.X; Son CD, 2004, BIOCHEMISTRY-US, V43, P13193, DOI 10.1021/bi0496889; Tantry S, 2010, BIOCHEMISTRY-US, V49, P5007, DOI 10.1021/bi100280f; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Williams C, 2009, METHODS MOL BIOL, V552, P39, DOI 10.1007/978-1-60327-317-6_3; Wilm M, 2000, ADV PROTEIN CHEM, V54, P1, DOI 10.1016/S0065-3233(00)54001-7; Zhang YL, 1998, BIOCHEMISTRY-US, V37, P12465, DOI 10.1021/bi980787u; Zhang YL, 1997, J PEPT RES, V50, P319	48	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39425	39436		10.1074/jbc.M110.149500	http://dx.doi.org/10.1074/jbc.M110.149500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923758	hybrid, Green Published			2022-12-27	WOS:000284941300069
J	Verduci, L; Simili, M; Rizzo, M; Mercatanti, A; Evangelista, M; Mariani, L; Rainaldi, G; Pitto, L				Verduci, Lorena; Simili, Marcella; Rizzo, Milena; Mercatanti, Alberto; Evangelista, Monica; Mariani, Laura; Rainaldi, Giuseppe; Pitto, Letizia			MicroRNA (miRNA)-mediated Interaction between Leukemia/Lymphoma-related Factor (LRF) and Alternative Splicing Factor/Splicing Factor 2 (ASF/SF2) Affects Mouse Embryonic Fibroblast Senescence and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TUMOR-SUPPRESSOR; SR PROTEINS; REPRESSES TRANSCRIPTION; FACTOR SF2/ASF; DNA-BINDING; GENE; PROTOONCOGENE; EXPRESSION; POKEMON	Leukemia/lymphoma-related factor (LRF) is a transcriptional repressor, which by recruiting histone deacetylases specifically represses p19/ARF expression, thus behaving as an oncogene. Conversely, in mouse embryonic fibroblasts (MEF), LRF inhibition causes aberrant p19ARF up-regulation resulting in proliferative defects and premature senescence. We have recently shown that LRF is controlled by microRNAs. Here we show that LRF acts on MEF proliferation and senescence/apoptosis by repressing miR-28 and miR-505, revealing a regulatory circuit where microRNAs (miRNAs) work both upstream and downstream of LRF. By analyzing miRNA expression profiles of MEF transfected with LRF-specific short interfering RNAs, we found that miR-28 and miR-505 are modulated by LRF. Both miRNAs are predicted to target alternative splicing factor/splicing factor 2 (ASF/SF2), a serine/arginine protein essential for cell viability. In vertebrates, loss or inactivation of ASF/SF2 may result in genomic instability and induce G2 cell cycle arrest and apoptosis. We showed that miR-28 and miR-505 modulate ASF/SF2 by directly binding ASF/SF2 3'-UTR. Decrease in LRF causes a decrease in ASF/SF2, which depends on up-regulation of miR-28 and miR-505. Alteration of each of the members of the LRF/miR-28/miR-505/ASF/SF2 axis affects MEF proliferation and the number of senescent and apoptotic cells. Consistently, the axis is coordinately modulated as cell senescence increases with passages in MEF culture. In conclusion, we show that LRF-dependent miRNAs miR-28 and miR-505 control MEF proliferation and survival by targeting ASF/SF2 and suggest a central role of LRF-related miRNAs, in addition to the role of LRF-dependent p53 control, in cellular homeostasis.	[Verduci, Lorena; Simili, Marcella; Rizzo, Milena; Mercatanti, Alberto; Evangelista, Monica; Mariani, Laura; Rainaldi, Giuseppe; Pitto, Letizia] CNR, Inst Clin Physiol, Lab Gene & Mol Therapy, I-56124 Pisa, Italy; [Verduci, Lorena] Scuola Super Sant Anna, I-56127 Pisa, Italy; [Rainaldi, Giuseppe] Ist Toscano Tumori, I-50139 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Pitto, L (corresponding author), CNR, Inst Clin Physiol, Lab Gene & Mol Therapy, I-56124 Pisa, Italy.	l.pitto@ifc.cnr.it	Rizzo, Milena/L-1481-2016; Pitto, Letizia/A-3070-2014	Rizzo, Milena/0000-0001-5924-8615; Pitto, Letizia/0000-0002-8660-9516; EVANGELISTA, MONICA/0000-0002-5674-8523; Mercatanti, Alberto/0000-0001-5110-9688	Associazione Italiana per la Ricerca sul Cancro (AIRC) [4753]; Istituto Superiore di Sanita (ISS) [527/A/3A/4]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Sanita (ISS)	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (AIRC) (Project 4753) and Istituto Superiore di Sanita (ISS) (Project 527/A/3A/4).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Apostolopoulou K, 2007, J PATHOL, V213, P294, DOI 10.1002/path.2222; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; DIMRI GP, 1994, J BIOL CHEM, V269, P16180; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hanamura A, 1998, RNA, V4, P430; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Karni R, 2008, P NATL ACAD SCI USA, V105, P15323, DOI 10.1073/pnas.0801376105; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; KRAINER AR, 1990, GENE DEV, V4, P1158, DOI 10.1101/gad.4.7.1158; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kumar A, 2003, MOL CELL BIOL, V23, P6631, DOI 10.1128/MCB.23.18.6631-6645.2003; Lee DK, 2002, J BIOL CHEM, V277, P26761, DOI 10.1074/jbc.M202078200; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Maeda T, 2005, CANCER RES, V65, P8575, DOI 10.1158/0008-5472.CAN-05-1055; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; Manley JL, 1996, GENE DEV, V10, P1569, DOI 10.1101/gad.10.13.1569; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Morlando M, 2008, NAT STRUCT MOL BIOL, V15, P902, DOI 10.1038/nsmb.1475; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Pendergrast PS, 2002, MOL BIOL CELL, V13, P915, DOI 10.1091/mbc.01-08-0383; Pessler F, 2003, J BIOL CHEM, V278, P29327, DOI 10.1074/jbc.M302980200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitto L, 2009, PHYSIOL GENOMICS, V39, P210, DOI 10.1152/physiolgenomics.00085.2009; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; TACKE R, 1992, NUCLEIC ACIDS RES, V20, P5482, DOI 10.1093/nar/20.20.5482; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053; Zhang Z, 2004, MOL CELL, V16, P597, DOI 10.1016/j.molcel.2004.10.031; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	59	42	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39551	39563		10.1074/jbc.M110.114736	http://dx.doi.org/10.1074/jbc.M110.114736			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20923760	Green Published, hybrid			2022-12-27	WOS:000284941300081
J	Ariza, ME; Ramakrishnan, R; Singh, NP; Chauhan, A; Nagarkatti, PS; Nagarkatti, M				Ariza, Maria Eugenia; Ramakrishnan, Rupal; Singh, Narendra P.; Chauhan, Ashok; Nagarkatti, Prakash S.; Nagarkatti, Mitzi			Bryostatin-1, a Naturally Occurring Antineoplastic Agent, Acts as a Toll-like Receptor 4 (TLR-4) Ligand and Induces Unique Cytokines and Chemokines in Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; INTERFERON-BETA INDUCTION; RANTES CHEMOKINE; KAPPA-B; SIGNAL-TRANSDUCTION; T-CELLS; CLINICAL DEVELOPMENT; IFN-BETA; PHASE-I; ACTIVATION	Bryostatin-1 (Bryo-1), a natural macrocyclic lactone, is clinically used as an anti-cancer agent. In this study, we demonstrate for the first time that Bryo-1 acts as a Toll-like receptor 4 (TLR4) ligand. Interestingly, activation of bone marrow-derived dendritic cells (in vitro with Bryo-1) led to a TLR4-dependent biphasic activation of nuclear factor-kappa B (NF-kappa B) and the unique induction of cytokines (IL-5, IL-6, and IL-10) and chemokines, including RANTES (regulated on activation normal T cell expressed and secreted) and macrophage inflammatory protein 1 alpha (MIP1-alpha). In addition, EMSA demonstrated that Bryo-1-mediated induction of RANTES was regulated by NF-kappa B and the interferon regulatory factors (IRF)-1, IRF-3, and IRF-7 to the RANTES independently of myeloid differentiation primary response gene-88 (MyD88). Bryo-1 was able to induce the transcriptional activation of IRF-3 through the TLR4/MD2-dependent pathway. In vivo administration of Bryo-1 triggered a TLR-4-dependent T helper cell 2 (Th2) cytokine response and expanded a subset of myeloid dendritic cells that expressed a CD11c(high)CD8 alpha(-)CD11b(+)CD4(+) phenotype. This study demonstrates that Bryo-1 can act as a TLR4 ligand and activate innate immunity. Moreover, the ability of Bryo-1 to trigger RANTES and MIP1-alpha suggests that Bryo-1 could potentially be used to prevent HIV-1 infection. Finally, induction of a Th2 response by Bryo-1 may help treat inflammatory diseases mediated by Th1 cells. Together, our studies have a major impact on the clinical use of Bryo-1 as an anticancer and immunopotentiating agent.	[Ariza, Maria Eugenia; Ramakrishnan, Rupal; Singh, Narendra P.; Chauhan, Ashok; Nagarkatti, Prakash S.; Nagarkatti, Mitzi] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Nagarkatti, M (corresponding author), Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	mitzi.nagarkatti@uscmed.sc.edu		Nagarkatti, Prakash/0000-0003-2663-0759	National Institutes of Health [P01AT003961, R01DA016545, R01ES09098, R01AI053703, R01AI058300, R01HL05864]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058300, R01AI053703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P01AT003961, R01DA016545, R01ES09098, R01AI053703, R01AI058300, and R01HL05864.	Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bosco MC, 1997, BLOOD, V89, P3402, DOI 10.1182/blood.V89.9.3402; Clamp A, 2002, ANTI-CANCER DRUG, V13, P673, DOI 10.1097/00001813-200208000-00001; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Dearman RJ, 2009, IMMUNOLOGY, V126, P475, DOI 10.1111/j.1365-2567.2008.02922.x; Do Y, 2004, CELL IMMUNOL, V231, P8, DOI 10.1016/j.cellimm.2004.11.003; Do Y, 2004, CANCER RES, V64, P6756, DOI 10.1158/0008-5472.CAN-03-4002; Fiorentino L, 2002, J BIOL CHEM, V277, P35333, DOI 10.1074/jbc.M200446200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; HESS AD, 1988, TRANSPLANT P, V20, P487; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Kaisho T, 2001, TRENDS IMMUNOL, V22, P78, DOI 10.1016/S1471-4906(00)01811-1; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; KELSO A, 1995, IMMUNOL TODAY, V16, P374, DOI 10.1016/0167-5699(95)80004-2; Kirchhoff S, 1999, EUR J BIOCHEM, V261, P546, DOI 10.1046/j.1432-1327.1999.00308.x; Kortmansky J, 2003, CANCER INVEST, V21, P924, DOI 10.1081/CNV-120025095; Lee AH, 2000, BIOCHEM J, V350, P131, DOI 10.1042/0264-6021:3500131; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lokuta MA, 1996, J BIOL CHEM, V271, P13731, DOI 10.1074/jbc.271.23.13731; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; MARFAINGKOKA A, 1995, J IMMUNOL, V154, P1870; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Montoya CJ, 2006, J IMMUNOL, V177, P1028, DOI 10.4049/jimmunol.177.2.1028; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; NELSON PJ, 1993, J IMMUNOL, V151, P2601; O'Neill LAJ, 2002, TRENDS IMMUNOL, V23, P296, DOI 10.1016/S1471-4906(02)02222-6; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; PHILIP PA, 1993, J NATL CANCER I, V85, P1812, DOI 10.1093/jnci/85.22.1812; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; RAMSDELL JS, 1986, J BIOL CHEM, V261, P7073; Saito T, 1997, J INFECT DIS, V175, P497, DOI 10.1093/infdis/175.3.497; SCHEID C, 1994, CANCER IMMUNOL IMMUN, V39, P223, DOI 10.1007/s002620050118; SHIN HS, 1994, MOL CELL BIOL, V14, P2914, DOI 10.1128/MCB.14.5.2914; Singh NP, 2007, MOL PHARMACOL, V72, P1508, DOI 10.1124/mol.107.038984; STELLATO C, 1995, J IMMUNOL, V155, P410; Sun MK, 2006, CNS DRUG REV, V12, P1, DOI 10.1111/j.1527-3458.2006.00001.x; Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018; Vangelista L, 2008, VACCINE, V26, P3008, DOI 10.1016/j.vaccine.2007.12.023; Wang ZY, 2006, EXP HEMATOL, V34, P1115, DOI 10.1016/j.exphem.2006.04.025; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yan XY, 2007, LIFE SCI, V80, P307, DOI 10.1016/j.lfs.2006.09.022; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	50	25	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					24	34		10.1074/jbc.M110.135921	http://dx.doi.org/10.1074/jbc.M110.135921			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21036898	hybrid, Green Published			2022-12-27	WOS:000285782800003
J	Bakhti, M; Winter, C; Simons, M				Bakhti, Mostafa; Winter, Christine; Simons, Mikael			Inhibition of Myelin Membrane Sheath Formation by Oligodendrocyte-derived Exosome-like Vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; FYN TYROSINE KINASE; CNS MYELINATION; PREMYELINATING OLIGODENDROCYTES; PRECURSOR DIFFERENTIATION; MAMMALIAN TARGET; CELL; REMYELINATION; ACTIVATION; BIOLOGY	Myelin formation is a multistep process that is controlled by a number of different extracellular factors. During the development of the central nervous system (CNS), oligodendrocyte progenitor cells differentiate into mature oligodendrocytes that start to enwrap axons with myelin membrane sheaths after receiving the appropriate signal(s) from the axon or its microenvironment. The signals required to initiate this process are unknown. Here, we show that oligodendrocytes secrete small membrane vesicles, exosome-like vesicles, into the extracellular space that inhibit both the morphological differentiation of oligodendrocytes and myelin formation. The inhibitory effects of exosome-like vesicles were prevented by treatment with inhibitors of actomyosin contractility. Importantly, secretion of exosome-like vesicles from oligodendrocytes was dramatically reduced when cells were incubated by conditioned neuronal medium. In conclusion, our results provide new evidence for small and diffusible oligodendroglial-derived vesicular carriers within the extracellular space that have inhibitory properties on cellular growth. We propose that neurons control the secretion of autoinhibitory oligodendroglial-derived exosomes to coordinate myelin membrane biogenesis.	Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Winter, Christine; Simons, Mikael] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen	Simons, M (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37073 Gottingen, Germany.	msimons@gwdg.de		Bakhti, Mostafa/0000-0002-2307-1122; Simons, Mikael/0000-0001-5329-192X	European Research Council; EMBO; Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB [FZT 103]	European Research Council(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB(German Research Foundation (DFG))	This work was supported by an European Research Council starting grant, the EMBO Young Investigator Program YIP and by the Deutsche Forschungsgemeinshaft through the DFG-Research Center for Molecular Physiology of the Brain, CMPB (FZT 103) (to M. S.).	Baer AS, 2009, BRAIN, V132, P465, DOI 10.1093/brain/awn334; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Camara J, 2009, J CELL BIOL, V185, P699, DOI 10.1083/jcb.200807010; Chang A, 2002, NEW ENGL J MED, V346, P165, DOI 10.1056/NEJMoa010994; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Chong SYC, 2010, J CELL BIOL, V188, P305, DOI 10.1083/jcb.200905111; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Flores AI, 2008, J NEUROSCI, V28, P7174, DOI 10.1523/JNEUROSCI.0150-08.2008; Forrest AD, 2009, J NEUROSCI RES, V87, P3456, DOI 10.1002/jnr.22022; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Goto J, 2008, MOL CELL NEUROSCI, V38, P203, DOI 10.1016/j.mcn.2008.02.009; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Kippert A, 2007, J NEUROSCI, V27, P3560, DOI 10.1523/JNEUROSCI.4926-06.2007; Kippert A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-71; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kramer-Albers EM, 2007, PROTEOM CLIN APPL, V1, P1446, DOI 10.1002/prca.200700522; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Liang XQ, 2004, J NEUROSCI, V24, P7140, DOI 10.1523/JNEUROSCI.5319-03.2004; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Rajasekharan S, 2009, DEVELOPMENT, V136, P415, DOI 10.1242/dev.018234; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Robinson S, 1999, DEV BIOL, V216, P359, DOI 10.1006/dbio.1999.9466; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Simons M, 2007, CURR OPIN NEUROBIOL, V17, P533, DOI 10.1016/j.conb.2007.08.003; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Thery C., 2009, NAT REV IMMUNOL; Trajkovic K, 2006, J CELL BIOL, V172, P937, DOI 10.1083/jcb.200509022; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tyler WA, 2009, J NEUROSCI, V29, P6367, DOI 10.1523/JNEUROSCI.0234-09.2009; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19162, DOI 10.1073/pnas.0902834106	48	160	168	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					787	796		10.1074/jbc.M110.190009	http://dx.doi.org/10.1074/jbc.M110.190009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20978131	Green Published, hybrid			2022-12-27	WOS:000285782800078
J	Jiang, XH; Bai, Y; Rider, P; Kim, K; Zhang, CY; Lu, SW; Liu, FY				Jiang, Xiaohong; Bai, Yong; Rider, Paul; Kim, Kihoon; Zhang, Chen-Yu; Lu, Sangwei; Liu, Fenyong			Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SEQUENCES; HUMAN RIBONUCLEASE-P; IN-VITRO SELECTION; HUMAN CYTOMEGALOVIRUS; EFFECTIVE INHIBITION; ESCHERICHIA-COLI; MESSENGER-RNA; HAIRPIN RIBOZYME; ENZYME; CLEAVAGE	Ribonuclease P (RNase P) complexed with external guide sequence (EGS) represents a novel nucleic acid-based gene interference approach to modulate gene expression. We have previously used an in vitro selection procedure to generate EGS variants that efficiently direct human RNase P to cleave a target mRNA in vitro. In this study, a variant was used to target the mRNA encoding the protease of human cytomegalovirus (HCMV), which is essential for viral capsid formation and replication. The EGS variant was about 35-fold more active in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Moreover, a reduction of 95% in the expression of the protease and a reduction of 4,000-fold in viral growth were observed in HCMV-infected cells that expressed the EGS variant, whereas a reduction of 80% in the protease expression and an inhibition of 150-fold in viral growth were detected in cells that expressed the EGS derived from a natural tRNA sequence. No significant reduction in viral protease expression or viral growth was observed in cells that either did not express an EGS or produced a "disabled" EGS, which carried nucleotide mutations that precluded RNase P recognition. Our results provide direct evidence that engineered EGS variant is highly effective in blocking HCMV expression and growth by targeting the viral protease. Furthermore, these results demonstrate the utility of engineered EGS RNAs in gene targeting applications, including the inhibition of HCMV infection by blocking the expression of virus-encoded essential proteins.	[Jiang, Xiaohong; Rider, Paul; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Bai, Yong; Kim, Kihoon; Lu, Sangwei; Liu, Fenyong] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Jiang, Xiaohong; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Nanjing University	Lu, SW (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	sangwei@berkeley.edu; liu_fy@uclink4.berkeley.edu			National Institutes of Health [AI041927, DE014842]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants AI041927 and DE014842.	Bai Y, 2010, P NATL ACAD SCI USA, V107, P7269, DOI 10.1073/pnas.0912813107; Bertrand E, 1997, RNA, V3, P75; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Daftarian PM, 1996, J IMMUNOL, V157, P12; Donahue CP, 1997, RNA, V3, P961; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Fedor MJ, 2005, NAT REV MOL CELL BIO, V6, P399, DOI 10.1038/nrm1647; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; Gopalan V., 2006, RNA WORLD, V277; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kraus G, 2002, P NATL ACAD SCI USA, V99, P3406, DOI 10.1073/pnas.052651199; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; MATUSICKKUMAR L, 1994, J VIROL, V68, P5384, DOI 10.1128/JVI.68.9.5384-5394.1994; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Mocarski ES., 2007, FIELDS VIROLOGY, P2702; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Robbins PD, 1998, PHARMACOL THERAPEUT, V80, P35, DOI 10.1016/S0163-7258(98)00020-5; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Trang P, 2000, P NATL ACAD SCI USA, V97, P5812, DOI 10.1073/pnas.100101797; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wang J, 2000, RNA, V6, P571, DOI 10.1017/S1355838200992215; WELCH AR, 1991, P NATL ACAD SCI USA, V88, P10792, DOI 10.1073/pnas.88.23.10792; Yadava RS, 2004, RNA, V10, P863, DOI 10.1261/rna.5234204; Yu XK, 2005, P NATL ACAD SCI USA, V102, P7103, DOI 10.1073/pnas.0408826102; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	45	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					322	330		10.1074/jbc.M110.158857	http://dx.doi.org/10.1074/jbc.M110.158857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980254	Green Published, hybrid			2022-12-27	WOS:000285782800035
J	Tauber, E; Miller-Fleming, L; Mason, RP; Kwan, W; Clapp, J; Butler, NJ; Outeiro, TF; Muchowski, PJ; Giorgini, F				Tauber, Eran; Miller-Fleming, Leonor; Mason, Robert P.; Kwan, Wanda; Clapp, Jannine; Butler, Nicola J.; Outeiro, Tiago F.; Muchowski, Paul J.; Giorgini, Flaviano			Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; MODEL; GCN4; BIOINFORMATICS; TRANSCRIPTION; COACTIVATOR; ACTIVATION; EXPANSIONS	Huntington disease (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine tract in the huntingtin (htt) protein. To uncover candidate therapeutic targets and networks involved in pathogenesis, we integrated gene expression profiling and functional genetic screening to identify genes critical for mutant htt toxicity in yeast. Using mRNA profiling, we have identified genes differentially expressed in wild-type yeast in response to mutant htt toxicity as well as in three toxicity suppressor strains: bna4 Delta, mbf1 Delta, and ume1 Delta. BNA4 encodes the yeast homolog of kynurenine 3-monooxygenase, a promising drug target for HD. Intriguingly, despite playing diverse cellular roles, these three suppressors share common differentially expressed genes involved in stress response, translation elongation, and mitochondrial transport. We then systematically tested the ability of the differentially expressed genes to suppress mutant htt toxicity when overexpressed and have thereby identified 12 novel suppressors, including genes that play a role in stress response, Golgi to endosome transport, and rRNA processing. Integrating the mRNA profiling data and the genetic screening data, we have generated a robust network that shows enrichment in genes involved in rRNA processing and ribosome biogenesis. Strikingly, these observations implicate dysfunction of translation in the pathology of HD. Recent work has shown that regulation of translation is critical for life span extension in Drosophila and that manipulation of this process is protective in Parkinson disease models. In total, these observations suggest that pharmacological manipulation of translation may have therapeutic value in HD.	[Tauber, Eran; Miller-Fleming, Leonor; Mason, Robert P.; Clapp, Jannine; Butler, Nicola J.; Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Kwan, Wanda; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kwan, Wanda; Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Fisiol, P-1649028 Lisbon, Portugal; [Miller-Fleming, Leonor; Outeiro, Tiago F.] Univ Lisbon, Fac Med, Inst Mol Med, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal	University of Leicester; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Universidade de Lisboa; Universidade de Lisboa	Giorgini, F (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	fg36@le.ac.uk	Miller-Fleming, Leonor/J-4309-2015; Tauber, Eran/F-9826-2011; Outeiro, Tiago F/C-1067-2008; Tauber, Eran/AAA-1562-2022; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Miller-Fleming, Leonor/0000-0002-3593-6461; Tauber, Eran/0000-0003-4018-6535; Outeiro, Tiago F/0000-0003-1679-1727; Tauber, Eran/0000-0003-4018-6535; Outeiro, Tiago/0000-0003-1679-1727; Giorgini, Flaviano/0000-0001-7881-9508	Fundacao para a Ciencia e a Tecnologia; CHDI Foundation, Inc.; European Molecular Biology Organization; Marie Curie International Reintegration Grant; NINDS [NS47237]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER; MRC [G0700090] Funding Source: UKRI; NERC [NE/D012058/1] Funding Source: UKRI; Medical Research Council [G0700090] Funding Source: researchfish; Natural Environment Research Council [NE/D012058/1] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); CHDI Foundation, Inc.; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Marie Curie International Reintegration Grant(European Commission); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by the Fundacao para a Ciencia e a Tecnologia.; Supported by the CHDI Foundation, Inc.; Supported by the European Molecular Biology Organization and a Marie Curie International Reintegration Grant.; Supported by National Institutes of Health Grant NS47237 from NINDS.	Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Crocker SF, 2006, BRAIN RES, V1088, P176, DOI 10.1016/j.brainres.2006.02.102; Derkatch IL, 1997, GENETICS, V147, P507; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F., 2008, PROTEIN MISFOLDING B, P231; Giorgini F, 2008, J BIOL CHEM, V283, P7390, DOI 10.1074/jbc.M708192200; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Liang J, 2008, HUM MOL GENET, V17, P3784, DOI 10.1093/hmg/ddn276; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Manogaran AL, 2010, YEAST, V27, P159, DOI 10.1002/yea.1740; Mascarenhas C, 2008, MOL BIOL CELL, V19, P2995, DOI 10.1091/mbc.E07-11-1173; Matsuo R, 2005, FEBS LETT, V579, P2433, DOI 10.1016/j.febslet.2005.03.043; Mendes ND, 2006, BIOINFORMATICS, V22, P2996, DOI 10.1093/bioinformatics/btl537; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Monteiro PT, 2008, NUCLEIC ACIDS RES, V36, pD132, DOI 10.1093/nar/gkm976; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2020, R LANG ENV STAT COMP; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Runne H, 2008, J NEUROSCI, V28, P9723, DOI 10.1523/JNEUROSCI.3044-08.2008; Sipione S, 2002, HUM MOL GENET, V11, P1953, DOI 10.1093/hmg/11.17.1953; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Stevanin G, 2003, BRAIN, V126, P1599, DOI 10.1093/brain/awg155; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Takemaru K, 1997, P NATL ACAD SCI USA, V94, P7251, DOI 10.1073/pnas.94.14.7251; Takemaru K, 1998, MOL CELL BIOL, V18, P4971, DOI 10.1128/MCB.18.9.4971; Wettenhall JM, 2006, BIOINFORMATICS, V22, P897, DOI 10.1093/bioinformatics/btl025; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	53	35	35	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					410	419		10.1074/jbc.M110.101527	http://dx.doi.org/10.1074/jbc.M110.101527			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044956	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000285782800044
J	Hoagland, EN; Sherwood, TW; Lee, KG; Walker, CJ; Askwith, CC				Hoagland, Erin N.; Sherwood, Thomas W.; Lee, Kirsten G.; Walker, Christopher J.; Askwith, Candice C.			Identification of a Calcium Permeable Human Acid-sensing Ion Channel 1 Transcript Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROOT GANGLION NEURONS; GATED NA+ CHANNEL; MUTATIONS CAUSING NEURODEGENERATION; TARANTULA TOXIN PSALMOTOXIN-1; MAMMALIAN DEGENERIN MDEG; SENSORY NEURONS; CATION CHANNEL; CAENORHABDITIS-ELEGANS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING	The acid-sensing ion channels (ASICs) are proton-gated cation channels activated when extracellular pH declines. In rodents, the Accn2 gene encodes transcript variants ASIC1a and ASIC1b, which differ in the first third of the protein and display distinct channel properties. In humans, ACCN2 transcript variant 2 (hVariant 2) is homologous to mouse ASIC1a. In this article, we study two other human ACCN2 transcript variants. Human ACCN2 transcript variant 1 (hVariant 1) is not present in rodents and contains an additional 46 amino acids directly preceding the proposed channel gate. We report that hVariant 1 does not produce proton-gated currents under normal conditions when expressed in heterologous systems. We also describe a third human ACCN2 transcript variant (hVariant 3) that is similar to rodent ASIC1b. hVariant 3 is more abundantly expressed in dorsal root ganglion compared with brain and shows basic channel properties analogous to rodent ASIC1b. Yet, proton-gated currents from hVariant 3 are significantly more permeable to calcium than either hVariant 2 or rodent ASIC1b, which shows negligible calcium permeability. hVariant 3 also displays a small acid-dependent sustained current. Such a sustained current is particularly intriguing as ASIC1b is thought to play a role in sensory transduction in rodents. In human DRG neurons, hVariant 3 could induce sustained calcium influx in response to acidic pH and make a major contribution to acid-dependent sensations, such as pain.	Ohio State Univ, Sch Med, Dept Neurosci, Columbus, OH 43210 USA; [Walker, Christopher J.] Ohio State Univ, Sch Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Askwith, CC (corresponding author), 4197 Graves Hall,333 W 10th Ave, Columbus, OH 43210 USA.	askwith.1@osu.edu			National Institutes of Health [R01 NS062967, T32GM068412]; College of Medicine at The Ohio State University; American Heart Association [09PRE2200005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Medicine at The Ohio State University; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS062967.; Supported by National Institutes of Health Training Grant T32GM068412 and a fellowship awarded by the College of Medicine at The Ohio State University.; Supported by an American Heart Association Predoctoral Fellowship 09PRE2200005.	Adams CM, 1998, J BIOL CHEM, V273, P30204, DOI 10.1074/jbc.273.46.30204; Akata T, 2007, J ANESTH, V21, P220, DOI 10.1007/s00540-006-0487-5; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bashari E, 2009, AM J PHYSIOL-CELL PH, V296, pC372, DOI 10.1152/ajpcell.00200.2008; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Celotto C, 2008, BRAZ J MED BIOL RES, V41, P439, DOI 10.1590/S0100-879X2008005000026; Champigny G, 1998, J BIOL CHEM, V273, P15418, DOI 10.1074/jbc.273.25.15418; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chen XM, 2006, NEUROPHARMACOLOGY, V50, P964, DOI 10.1016/j.neuropharm.2006.01.007; Cheng JK, 2008, NEUROCHEM RES, V33, P1970, DOI 10.1007/s11064-008-9711-z; Cho JH, 2007, AM J PHYSIOL-CELL PH, V292, pC2161, DOI 10.1152/ajpcell.00598.2006; Chung WS, 2010, AM J PHYSIOL-CELL PH, V298, pC1198, DOI 10.1152/ajpcell.00511.2009; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Coryell MW, 2007, BIOL PSYCHIAT, V62, P1140, DOI 10.1016/j.biopsych.2007.05.008; Coryell MW, 2009, J NEUROSCI, V29, P5381, DOI 10.1523/JNEUROSCI.0360-09.2009; Coscoy S, 1999, J BIOL CHEM, V274, P10129, DOI 10.1074/jbc.274.15.10129; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Dib-Hajj SD, 1999, FEBS LETT, V462, P117, DOI 10.1016/S0014-5793(99)01519-7; Dube GR, 2009, CURR PHARM DESIGN, V15, P1750, DOI 10.2174/138161209788186263; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2000, NEUROREPORT, V11, P1607; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Hey JG, 2007, STROKE, V38, P670, DOI 10.1161/01.STR.0000251443.68897.99; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Salinas M, 2009, J BIOL CHEM, V284, P31851, DOI 10.1074/jbc.M109.043984; Sherwood T, 2009, J BIOL CHEM, V284, P27899, DOI 10.1074/jbc.M109.029009; Sherwood TW, 2008, J BIOL CHEM, V283, P1818, DOI 10.1074/jbc.M705118200; Sherwood TW, 2009, J NEUROSCI, V29, P14371, DOI 10.1523/JNEUROSCI.2186-09.2009; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Tominaga M., 2007, V179, P489; Ugawa S, 2005, MOL BRAIN RES, V136, P125, DOI 10.1016/j.molbrainres.2005.01.010; Ugawa S, 2001, NEUROREPORT, V12, P2865, DOI 10.1097/00001756-200109170-00022; Valeyev AY, 1996, J NEUROPHYSIOL, V76, P3555, DOI 10.1152/jn.1996.76.5.3555; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Vukicevic M, 2006, J BIOL CHEM, V281, P714, DOI 10.1074/jbc.M510472200; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 2001, ADV EXP MED BIOL, V502, P293; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2006, J MEMBRANE BIOL, V209, P59, DOI 10.1007/s00232-005-0840-x; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu TL, 2009, PROG NEUROBIOL, V87, P171, DOI 10.1016/j.pneurobio.2009.01.004; Zha XM, 2006, P NATL ACAD SCI USA, V103, P16556, DOI 10.1073/pnas.0608018103; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	77	44	46	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41852	41862		10.1074/jbc.M110.171330	http://dx.doi.org/10.1074/jbc.M110.171330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21036899	Green Published, hybrid			2022-12-27	WOS:000285622600073
J	Offman, MN; Krol, M; Silman, I; Sussman, JL; Futerman, AH				Offman, Marc N.; Krol, Marcin; Silman, Israel; Sussman, Joel L.; Futerman, Anthony H.			Molecular Basis of Reduced Glucosylceramidase Activity in the Most Common Gaucher Disease Mutant, N370S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-BETA-GLUCOSIDASE; LYSOSOMAL STORAGE DISORDERS; X-RAY-STRUCTURE; PHARMACOLOGICAL CHAPERONES; ENZYME THERAPY; IMINOSUGAR ISOFAGOMINE; REPLACEMENT THERAPY; DEFECTIVE ENZYME; GLUCOCEREBROSIDASE; MUTATIONS	Gaucher disease is caused by the defective activity of the lysosomal hydrolase, glucosylceramidase. Although the x-ray structure of wild type glucosylceramidase has been resolved, little is known about the structural features of any of the > 200 mutations. Various treatments for Gaucher disease are available, including enzyme replacement and chaperone therapies. The latter involves binding of competitive inhibitors at the active site to enable correct folding and transport of the mutant enzyme to the lysosome. We now use molecular dynamics, a set of structural analysis tools, and several statistical methods to determine the flexible behavior of the N370S Gaucher mutant at various pH values, with and without binding the chaperone, N-butyl-deoxynojirimycin. We focus on the effect of the chaperone on the whole protein, on the active site, and on three important structural loops, and we demonstrate how the chaperone modifies the behavior of N370S in such a way that it becomes more active at lysosomal pH. Our results suggest a mechanism whereby the binding of N-butyl-deoxynojirimycin helps target correctly folded glucosylceramidase to the lysosome, contributes to binding with saposin C, and explains the initiation of the substrate-enzyme complex. Such analysis provides a new framework for determination of the structure of other Gaucher disease mutants and suggests new approaches for rational drug design.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Silman, Israel] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Sussman, Joel L.] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel; [Krol, Marcin] Jagiellonian Univ, Dept Bioinformat & Telemed, Coll Med, PL-31531 Krakow, Poland	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Jagiellonian University; Collegium Medicum Jagiellonian University		tony.futerman@weizmann.ac.il		Sussman, Joel/0000-0003-0306-3878; Futerman, Anthony/0000-0003-0013-0115	Minerva postdoctoral fellowship	Minerva postdoctoral fellowship	Supported by a Minerva postdoctoral fellowship.	Alfonso P, 2005, BLOOD CELL MOL DIS, V35, P268, DOI 10.1016/j.bcmd.2005.05.007; Alfonso P, 2004, BLOOD CELL MOL DIS, V32, P218, DOI 10.1016/j.bcmd.2003.10.010; Atrian S, 2008, PROTEINS, V70, P882, DOI 10.1002/prot.21554; BARTON NW, 1991, NEW ENGL J MED, V324, P1464, DOI 10.1056/NEJM199105233242104; Beck M, 2007, HUM GENET, V121, P1, DOI 10.1007/s00439-006-0280-4; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Beutler E, 2004, PLOS MED, V1, P118, DOI 10.1371/journal.pmed.0010021; Brumshtein B, 2007, J BIOL CHEM, V282, P29052, DOI 10.1074/jbc.M705005200; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Brumshtein B, 2010, GLYCOBIOLOGY, V20, P24, DOI 10.1093/glycob/cwp138; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Case D.A., 2006, AMBER VERSION 9, V9; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chang HH, 2006, FEBS J, V273, P4082, DOI 10.1111/j.1742-4658.2006.05410.x; Damborsky Jiri, 2007, Biotechnology Journal, V2, P62, DOI 10.1002/biot.200600208; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; de Fost M, 2006, BLOOD CELL MOL DIS, V36, P53, DOI 10.1016/j.bcmd.2005.08.004; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Frisch M.J., 2016, GAUSSIAN16 REV B01; Futerman A.H., 2006, GAUCHER DIS; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Grabowski GA, 2003, ANNU REV GENOM HUM G, V4, P403, DOI 10.1146/annurev.genom.4.070802.110415; GRABOWSKI GA, 1995, ANN INTERN MED, V122, P33, DOI 10.7326/0003-4819-122-1-199501010-00005; GRABOWSKI GA, 1993, ADV HUM GENET, V21, P377; Hodanova K, 2003, EUR J HUM GENET, V11, P369, DOI 10.1038/sj.ejhg.5200974; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kacher Y, 2008, BIOL CHEM, V389, P1361, DOI 10.1515/BC.2008.163; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lee R E, 1982, Prog Clin Biol Res, V95, P177; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Lieberman RL, 2009, BIOCHEMISTRY-US, V48, P4816, DOI 10.1021/bi9002265; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Liou B, 2006, J BIOL CHEM, V281, P4242, DOI 10.1074/jbc.M511110200; Liou B, 2009, MOL GENET METAB, V97, P65, DOI 10.1016/j.ymgme.2009.01.006; Luan Z, 2009, CHEMBIOCHEM, V10, P2780, DOI 10.1002/cbic.200900442; Mezei M, 1997, J COMPUT CHEM, V18, P812, DOI 10.1002/(SICI)1096-987X(19970430)18:6<812::AID-JCC6>3.0.CO;2-V; Mitsui J, 2009, ARCH NEUROL-CHICAGO, V66, P571, DOI 10.1001/archneurol.2009.72; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Montfort M, 2004, HUM MUTAT, V23, P567, DOI 10.1002/humu.20043; Offman MN, 2006, BIOINFORMATICS, V22, P1838, DOI 10.1093/bioinformatics/btl192; Pastores GM, 2003, EXPERT OPIN INV DRUG, V12, P273, DOI 10.1517/13543784.12.2.273; PASTORES GM, 1993, BLOOD, V82, P408; Platt FM, 2005, ADV EXP MED BIOL, V564, P117; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Rosenbloom BE, 2005, BLOOD, V105, P4569, DOI 10.1182/blood-2004-12-4672; Salvioli R, 2005, BIOCHEM J, V390, P95, DOI 10.1042/BJ20050325; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; SHIRAN A, 1993, CANCER, V72, P219, DOI 10.1002/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Srinivasan R, 1999, P NATL ACAD SCI USA, V96, P14258, DOI 10.1073/pnas.96.25.14258; Steet R, 2007, BIOCHEM PHARMACOL, V73, P1376, DOI 10.1016/j.bcp.2006.12.015; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Vaccaro AM, 1997, J BIOL CHEM, V272, P16862, DOI 10.1074/jbc.272.27.16862; Wang GN, 2009, J MED CHEM, V52, P3146, DOI 10.1021/jm801506m; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i; Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104; Zimran A, 2005, BLOOD CELL MOL DIS, V34, P197, DOI 10.1016/j.bcmd.2005.03.004	65	30	32	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42105	42114		10.1074/jbc.M110.172098	http://dx.doi.org/10.1074/jbc.M110.172098			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980259	hybrid, Green Published			2022-12-27	WOS:000285622600095
J	Ryu, MH; Moskvin, OV; Siltberg-Liberles, J; Gomelsky, M				Ryu, Min-Hyung; Moskvin, Oleg V.; Siltberg-Liberles, Jessica; Gomelsky, Mark			Natural and Engineered Photoactivated Nucleotidyl Cyclases for Optogenetic Applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANYLYL CYCLASE; SWISS-MODEL; ADENYLYL; DOMAIN; LIGHT; ENVIRONMENT; INHIBITION; MECHANISMS; NEURONS; GENES	Cyclic nucleotides, cAMP and cGMP, are ubiquitous second messengers that regulate metabolic and behavioral responses in diverse organisms. We describe purification, engineering, and characterization of photoactivated nucleotidyl cyclases that can be used to manipulate cAMP and cGMP levels in vivo. We identified the blaC gene encoding a putative photoactivated adenylyl cyclase in the Beggiatoa sp. PS genome. BlaC contains a BLUF domain involved in blue-light sensing using FAD and a nucleotidyl cyclase domain. The blaC gene was overexpressed in Escherichia coli, and its product was purified. Irradiation of BlaC in vitro resulted in a small red shift in flavin absorbance, typical of BLUF photoreceptors. BlaC had adenylyl cyclase activity that was negligible in the dark and upregulated by light by 2 orders of magnitude. To convert BlaC into a guanylyl cyclase, we constructed a model of the nucleotidyl cyclase domain and mutagenized several residues predicted to be involved in substrate binding. One triple mutant, designated BlgC, was found to have photoactivated guanylyl cyclase in vitro. Irradiation with blue light of the E. coli cya mutant expressing BlaC or BlgC resulted in the significant increases in cAMP or cGMP synthesis, respectively. BlaC, but not BlgC, restored cAMP-dependent growth of the mutant in the presence of light. Small protein sizes, negligible activities in the dark, high light-to-dark activation ratios, functionality at broad temperature range and physiological pH, as well as utilization of the naturally occurring flavins as chromophores make BlaC and BlgC attractive for optogenetic applications in various animal and microbial models.	[Ryu, Min-Hyung; Moskvin, Oleg V.; Siltberg-Liberles, Jessica; Gomelsky, Mark] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Siltberg-Liberles, J (corresponding author), Univ Wyoming, Dept Mol Biol, 1000 E Univ Ave,Dept 3944, Laramie, WY 82071 USA.	jliberle@uwyo.edu; gomelsky@uwyo.edu	gomelsky, mark/F-6209-2010; Moskvin, Oleg/C-5916-2015	Moskvin, Oleg/0000-0003-1499-8900; Gomelsky, Mark/0000-0003-4077-3932	National Institutes of Health [RR016474-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health 2P20 Grant RR016474-09.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Airan RD, 2009, NATURE, V458, P1025, DOI 10.1038/nature07926; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Briggs WR, 2007, J BIOMED SCI, V14, P499, DOI 10.1007/s11373-007-9162-6; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gille A, 2004, J BIOL CHEM, V279, P19955, DOI 10.1074/jbc.M312560200; Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Iseki M, 2002, NATURE, V415, P1047, DOI 10.1038/4151047a; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Liu X, 2010, CELL, V141, P22, DOI 10.1016/j.cell.2010.03.019; Losi A, 2008, PHOTOCH PHOTOBIO SCI, V7, P1168, DOI 10.1039/b802472c; Lucas KA, 2000, PHARMACOL REV, V52, P375; Masuda S, 2005, FEBS LETT, V579, P4329, DOI 10.1016/j.febslet.2005.06.069; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Mussmann M, 2007, PLOS BIOL, V5, P1923, DOI 10.1371/journal.pbio.0050230; Nagahama T, 2007, NEUROSCI RES, V59, P81, DOI 10.1016/j.neures.2007.05.015; Ntefidou M, 2006, PHOTOCHEM PHOTOBIOL, V82, P1601, DOI 10.1562/2006-04-06-RA-867; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schroder-Lang S, 2007, NAT METHODS, V4, P39, DOI 10.1038/NMETH975; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sjulson L, 2008, CHEM REV, V108, P1588, DOI 10.1021/cr078221b; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993	44	154	162	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41501	41508		10.1074/jbc.M110.177600	http://dx.doi.org/10.1074/jbc.M110.177600			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21030591	Green Published, hybrid			2022-12-27	WOS:000285622600036
J	Sudiarta, IP; Fukushima, T; Sekiguchi, J				Sudiarta, I. Putu; Fukushima, Tatsuya; Sekiguchi, Junichi			Bacillus subtilis CwlP of the SP-beta Prophage Has Two Novel Peptidoglycan Hydrolase Domains, Muramidase and Cross-linkage Digesting DD-Endopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGG-WHITE LYSOZYME; GLYCYLGLYCINE ENDOPEPTIDASE; STAPHYLOCOCCUS-AUREUS; CELL-SEPARATION; CRYSTAL-STRUCTURES; GOOSE LYSOZYME; GENE-PRODUCT; COMPLEX; LYSOSTAPHIN; RESOLUTION	For bacteria and bacteriophages, cell wall digestion by hydrolases is a very important event. We investigated one of the proteins involved in cell wall digestion, the yomI gene product (renamed CwlP). The gene is located in the SP-beta prophage region of the Bacillus subtilis chromosome. Inspection of the Pfam database indicates that CwlP contains soluble lytic transglycosylase (SLT) and peptidase M23 domains, which are similar to Escherichia coli lytic transglycosylase Slt70, and the Staphylococcus aureus Gly-Gly endopeptidase LytM, respectively. The SLT domain of CwlP exhibits hydrolytic activity toward the B. subtilis cell wall; however, reverse phase (RP)HPLC and mass spectrometry revealed that the CwlP-SLT domain has only muramidase activity. In addition, the peptidase M23 domain of CwlP exhibited hydrolytic activity and could cleave D-Ala-diaminopimelic acid cross-linkage, a property associated with DD-endopeptidases. Remarkably, the M23 domain of CwlP possessed a unique Zn2+ -independent endopeptidase activity; this contrasts with all other characterized M23 peptidases (and enzymes similar to CwlP), which are Zn2+ dependent. Both domains of CwlP could hydrolyze the peptidoglycan and cell wall of B. subtilis. However, the M23 domain digested neither the peptidoglycans nor the cell walls of S. aureus or Streptococcus thermophilus. The effect of defined point mutations in conserved amino acid residues of CwlP is also determined.	[Sudiarta, I. Putu] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Ueda, Nagano 3868567, Japan; [Fukushima, Tatsuya; Sekiguchi, Junichi] Shinshu Univ, Res Ctr Human & Environm Sci, Dept Life Sci, Div Gene Res, Ueda, Nagano 3868567, Japan	Shinshu University; Shinshu University	Sekiguchi, J (corresponding author), Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, 3-15-1 Tokida, Ueda, Nagano 3868567, Japan.	jsekigu@shinshu-u.ac.jp		Sudiarta, I Putu/0000-0003-1381-388X	New Energy and Industrial Technology Department Organization (NEDO); Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [19380047];  [22248008];  [21780067]	New Energy and Industrial Technology Department Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	This work was supported by Grants-in-Aid for Scientific Research (B) (19380047) and (A) (22248008), and grants from the New Energy and Industrial Technology Department Organization (NEDO) (to J.S.), a Grant-in-Aid for Young Scientists (21780067) (to T.F.), and the Global COE programs (to J.S., T.F., and I.P.S.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Cohen DN, 2009, J MOL BIOL, V387, P607, DOI 10.1016/j.jmb.2009.02.001; DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475, DOI 10.1128/AEM.61.4.1475-1479.1995; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; Foster S.J., 2002, BACILLUS SUBTILIS IT, P21; Fujiwara T, 2005, J BACTERIOL, V187, P480, DOI 10.1128/JB.187.2.480-487.2005; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; Fukushima T, 2008, J BIOL CHEM, V283, P11117, DOI 10.1074/jbc.M706626200; Fukushima T, 2007, MOL GENET GENOMICS, V278, P371, DOI 10.1007/s00438-007-0255-8; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; Hirakawa H, 2008, J BIOCHEM, V144, P753, DOI 10.1093/jb/mvn133; Horsburgh GJ, 2003, J BACTERIOL, V185, P3813, DOI 10.1128/JB.185.13.3813-3820.2003; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; LECLERC D, 1989, CAN J MICROBIOL, V35, P749, DOI 10.1139/m89-125; MALCOLM BA, 1989, P NATL ACAD SCI USA, V86, P133, DOI 10.1073/pnas.86.1.133; Matsumura I, 1996, BIOCHEMISTRY-US, V35, P1881, DOI 10.1021/bi951671q; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Regamey A, 1998, MICROBIOL-UK, V144, P885, DOI 10.1099/00221287-144-4-885; Sambrook J., 2002, MOL CLONING LAB MANU; Shida T, 2001, J BIOL CHEM, V276, P28140, DOI 10.1074/jbc.M103903200; Sugai M, 1997, J BACTERIOL, V179, P1193, DOI 10.1128/jb.179.4.1193-1202.1997; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tong G, 1997, BIOCHEMISTRY-US, V36, P9859, DOI 10.1021/bi970495d; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7	36	24	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41232	41243		10.1074/jbc.M110.156273	http://dx.doi.org/10.1074/jbc.M110.156273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20980266	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000285622600009
J	Chow, JY; Xue, B; Lee, KH; Tung, A; Wu, L; Robinson, RC; Yew, WS				Chow, Jeng Yeong; Xue, Bo; Lee, Kang Hao; Tung, Alvin; Wu, Long; Robinson, Robert C.; Yew, Wen Shan			Directed Evolution of a Thermostable Quorum-quenching Lactonase from the Amidohydrolase Superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; PROTON RELAY SYSTEM; ENZYMATIC-ACTIVITIES; STRUCTURAL BASIS; ACTIVE-SITE; 5-MONOPHOSPHATE DECARBOXYLASE; SUPRAFAMILY; PHOSPHOTRIESTERASE; PROMISCUITY; EXPRESSION	A thermostable quorum-quenching lactonase from Geobacillus kaustophilus HTA426 (GI: 56420041) was used as an initial template for in vitro directed evolution experiments. This enzyme belongs to the phosphotriesterase-like lactonase (PLL) group of enzymes within the amidohydrolase superfamily that hydrolyze N-acylhomoserine lactones (AHLs) that are involved in virulence pathways of quorum-sensing pathogenic bacteria. Here we have determined the N-butyryl-L-homoserine lactone-liganded structure of the catalytically inactive D266N mutant of this enzyme to a resolution of 1.6 angstrom. Using a tunable, bioluminescence-based quorum-quenching molecular circuit, the catalytic efficiency was enhanced, and the AHL substrate range increased through two point mutations on the loops at the C-terminal ends of the third and seventh beta-strands. This E101N/R230I mutant had an increased value of k(cat)/K-m of 72-fold toward 3-oxo-N-dodecanoyl-L-homoserine lactone. The evolved mutant also exhibited lactonase activity toward N-butyryl-L-homoserine lactone, an AHL that was previously not hydrolyzed by the wild-type enzyme. Both the purified wild-type and mutant enzymes contain a mixture of zinc and iron and are colored purple and brown, respectively, at high concentrations. The origin of this coloration is suggested to be because of a charge transfer complex involving the beta-cation and Tyr-99 within the enzyme active site. Modulation of the charge transfer complex alters the lactonase activity of the mutant enzymes and is reflected in enzyme coloration changes. We attribute the observed enhancement in catalytic reactivity of the evolved enzyme to favorable modulations of the active site architecture toward productive geometries required for chemical catalysis.	[Xue, Bo; Tung, Alvin; Robinson, Robert C.] Inst Mol & Cell Biol, Singapore 138673, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Robinson, RC (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	rrobinson@imcb.a-star.edu.sg; bchyws@nus.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Xue, Bo/0000-0002-5172-2519	National Medical Research Council; National Research Foundation; Biomedical Research Council of A*STAR; National Research Program for Genomic Medicine	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR)); National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This research was supported by grants from the National Medical Research Council, the National Research Foundation, and the Biomedical Research Council of A*STAR.; We thank Professor Herbert Schweizer for providing the Tn7-based transposition materials. We thank the National Synchrotron Radiation Research Center, a facility supported by the National Science Council of Taiwan for provision of beam time and assistance in data collection. The Synchrotron Radiation Protein Crystallography Facility is supported by the National Research Program for Genomic Medicine.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Chapman E, 2002, BIOORGAN MED CHEM, V10, P551, DOI 10.1016/S0968-0896(01)00306-6; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chow JY, 2009, BIOCHEMISTRY-US, V48, P4344, DOI 10.1021/bi9004045; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAVIS JC, 1982, P NATL ACAD SCI-BIOL, V79, P4623, DOI 10.1073/pnas.79.15.4623; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Elias M, 2008, J MOL BIOL, V379, P1017, DOI 10.1016/j.jmb.2008.04.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2009, CURR OPIN CHEM BIOL, V13, P10, DOI 10.1016/j.cbpa.2009.01.014; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hawwa R, 2009, ARCH BIOCHEM BIOPHYS, V488, P109, DOI 10.1016/j.abb.2009.06.005; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Marti-Arbona R, 2005, BIOCHEMISTRY-US, V44, P7115, DOI 10.1021/bi050008r; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; PYRZ JW, 1986, J BIOL CHEM, V261, P1015; Seibert CM, 2005, BIOCHEMISTRY-US, V44, P6383, DOI 10.1021/bi047326v; Tawfik DS, 2006, SCIENCE, V311, P475, DOI 10.1126/science.1123883; Thoden JB, 2001, BIOCHEMISTRY-US, V40, P6989, DOI 10.1021/bi010682i; Vick JE, 2005, BIOCHEMISTRY-US, V44, P11722, DOI 10.1021/bi050963g; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wise EL, 2005, BIOCHEMISTRY-US, V44, P1816, DOI 10.1021/bi0478143; Wise EL, 2004, BIOCHEMISTRY-US, V43, P6438, DOI 10.1021/bi0497392; Xiang DF, 2009, BIOCHEMISTRY-US, V48, P2237, DOI 10.1021/bi802274f; Yew WS, 2005, BIOCHEMISTRY-US, V44, P1807, DOI 10.1021/bi047815v; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002; Yew WS, 2004, BIOCHEMISTRY-US, V43, P6427, DOI 10.1021/bi049741t	36	60	61	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40911	40920		10.1074/jbc.M110.177139	http://dx.doi.org/10.1074/jbc.M110.177139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20980257	hybrid, Green Published			2022-12-27	WOS:000285414400055
J	Kuettner, EB; Kettner, K; Keim, A; Svergun, DI; Volke, D; Singer, D; Hoffmann, R; Muller, EC; Otto, A; Kriegel, TM; Strater, N				Kuettner, E. Bartholomeus; Kettner, Karina; Keim, Antje; Svergun, Dmitri I.; Volke, Daniela; Singer, David; Hoffmann, Ralf; Mueller, Eva-Christina; Otto, Albrecht; Kriegel, Thomas M.; Straeter, Norbert			Crystal Structure of Hexokinase KlHxk1 of Kluyveromyces lactis A MOLECULAR BASIS FOR UNDERSTANDING THE CONTROL OF YEAST HEXOKINASE FUNCTIONS VIA COVALENT MODIFICATION AND OLIGOMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY CRYSTALLOGRAPHY; CONFORMATIONAL-CHANGE; DOMAIN MOTIONS; SUBCELLULAR-LOCALIZATION; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS INTERACTION; GLUCOKINASE ACTIVATORS; GLUCOSE REPRESSION; DIFFRACTION DATA; HIGH-RESOLUTION	Crystal structures of the unique hexokinase KlHxk1 of the yeast Kluyveromyces lactis were determined using eight independent crystal forms. In five crystal forms, a symmetrical ring-shaped homodimer was observed, corresponding to the physiological dimer existing in solution as shown by small-angle x-ray scattering. The dimer has a head-to-tail arrangement such that the small domain of one subunit interacts with the large domain of the other subunit. Dimer formation requires favorable interactions of the 15 N-terminal amino acids that are part of the large domain with amino acids of the small domain of the opposite subunit, respectively. The head-to-tail arrangement involving both domains of the two KlHxk1 subunits is appropriate to explain the reduced activity of the homodimer as compared with the monomeric enzyme and the influence of substrates and products on dimer formation and dissociation. In particular, the structure of the symmetrical KlHxk1 dimer serves to explain why phosphorylation of conserved residue Ser-15 may cause electrostatic repulsions with nearby negatively charged residues of the adjacent subunit, thereby inducing a dissociation of the homologous dimeric hexokinases KlHxk1 and ScHxk2. Two complex structures of KlHxk1 with bound glucose provide a molecular model of substrate binding to the open conformation and the subsequent classical domain closure motion of yeast hexokinases. The entirety of the novel data extends the current concept of glucose signaling in yeast and complements the induced-fit model by integrating the events of N-terminal phosphorylation and dissociation of homodimeric yeast hexokinases.	[Kettner, Karina; Kriegel, Thomas M.] Tech Univ Dresden, Carl Gustav Carus Med Fac, Inst Physiol Chem, D-01307 Dresden, Germany; [Kuettner, E. Bartholomeus; Keim, Antje; Volke, Daniela; Singer, David; Hoffmann, Ralf; Straeter, Norbert] Univ Leipzig, Fac Chem & Mineral, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, D-04103 Leipzig, Germany; [Svergun, Dmitri I.] DESY, Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Mueller, Eva-Christina; Otto, Albrecht] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Technische Universitat Dresden; Leipzig University; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kriegel, TM (corresponding author), Tech Univ Dresden, Carl Gustav Carus Med Fac, Inst Physiol Chem, Fetscherstr 74, D-01307 Dresden, Germany.	kriegel@mail.zih.tu-dresden.de; strater@bbz.uni-leipzig.de	Hoffmann, Ralf/ABD-8779-2020; Strater, Norbert/P-4856-2018	Svergun, Dmitri/0000-0003-0830-5696; Strater, Norbert/0000-0002-2001-0500				Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ahuatzi D, 2007, J BIOL CHEM, V282, P4485, DOI 10.1074/jbc.M606854200; Aleshin AE, 2000, J MOL BIOL, V296, P1001, DOI 10.1006/jmbi.1999.3494; ANDERSON CM, 1978, J MOL BIOL, V123, P1, DOI 10.1016/0022-2836(78)90373-X; ANDERSON CM, 1978, J MOL BIOL, V123, P15, DOI 10.1016/0022-2836(78)90374-1; ANDERSON WF, 1974, J MOL BIOL, V86, P261, DOI 10.1016/0022-2836(74)90017-5; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar D, 2003, J BIOL CHEM, V278, P39280, DOI 10.1074/jbc.M305706200; Behlke J, 1998, BIOCHEMISTRY-US, V37, P11989, DOI 10.1021/bi980914m; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BENNETT WS, 1980, J MOL BIOL, V140, P211, DOI 10.1016/0022-2836(80)90103-5; Blume A, 2009, CARBOHYD RES, V344, P1567, DOI 10.1016/j.carres.2009.01.002; Bolotin-Fukuhara M, 2000, FEBS LETT, V487, P66, DOI 10.1016/S0014-5793(00)02282-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; CASSART JP, 1995, FEBS LETT, V371, P191, DOI 10.1016/0014-5793(95)00909-S; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Golbik R, 2001, BIOCHEMISTRY-US, V40, P1083, DOI 10.1021/bi001745k; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HOGGETT JG, 1992, BIOCHEM J, V287, P567, DOI 10.1042/bj2870567; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kettner K, 2007, FEMS YEAST RES, V7, P683, DOI 10.1111/j.1567-1364.2007.00259.x; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KRIEGEL TM, 1994, BIOCHEMISTRY-US, V33, P148, DOI 10.1021/bi00167a019; Kuettner EB, 2007, ACTA CRYSTALLOGR F, V63, P430, DOI 10.1107/S1744309107018271; Kuser P, 2008, PROTEINS, V72, P731, DOI 10.1002/prot.21956; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Matschinsky FM, 2006, DIABETES, V55, P1; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; MCDONALD RC, 1979, J BIOL CHEM, V254, P2942; MCDONALD RC, 1979, BIOCHEMISTRY-US, V18, P338, DOI 10.1021/bi00569a017; Milkowski C, 2001, J BACTERIOL, V183, P5223, DOI 10.1128/JB.183.18.5223-5229.2001; Moreno F, 2005, BIOCHEM SOC T, V33, P265, DOI 10.1042/BST0330265; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; PRIOR C, 1993, MOL CELL BIOL, V13, P3882, DOI 10.1128/MCB.13.7.3882; Riboldi-Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003, DOI 10.1107/S0021889899008584; Riera A, 2008, BIOCHEM J, V415, P233, DOI 10.1042/BJ20080797; Rolland F, 2005, BIOCHEM SOC T, V33, P269, DOI 10.1042/BST0330269; Rolland F, 2001, TRENDS BIOCHEM SCI, V26, P310, DOI 10.1016/S0968-0004(01)01805-9; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Schaffrath R, 2000, FUNGAL GENET BIOL, V30, P173, DOI 10.1006/fgbi.2000.1221; SCHMIDT JJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P471, DOI 10.1016/0003-9861(73)90538-9; STEITZ TA, 1973, J MOL BIOL, V78, P551, DOI 10.1016/0022-2836(73)90475-0; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TIELENS AGM, 1994, J BIOL CHEM, V269, P24736; VOJTEK AB, 1990, EUR J BIOCHEM, V190, P371, DOI 10.1111/j.1432-1033.1990.tb15585.x; Weirich J, 1997, EUR J BIOCHEM, V249, P248, DOI 10.1111/j.1432-1033.1997.t01-1-00248.x; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	64	20	22	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41019	41033		10.1074/jbc.M110.185850	http://dx.doi.org/10.1074/jbc.M110.185850			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943665	Green Published, hybrid			2022-12-27	WOS:000285414400065
J	Kim, KS; Choi, HW; Yoon, HE; Kim, IY				Kim, Ki Soon; Choi, Hae Woong; Yoon, Hee Eun; Kim, Ick Young			Reactive Oxygen Species Generated by NADPH Oxidase 2 and 4 Are Required for Chondrogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; NOX-FAMILY; ENDOCHONDRAL OSSIFICATION; CELL-PROLIFERATION; GROWTH-FACTOR; IN-VITRO; EXPRESSION; INSULIN; CARTILAGE; SURVIVAL	Although generation of reactive oxygen species (ROS) by NADPH oxidases (Nox) is thought to be important for signal transduction in nonphagocytic cells, little is known of the role ROS plays in chondrogenesis. We therefore examined the possible contribution of ROS generation to chondrogenesis using both ATDC5 cells and primary chondrocytes derived from mouse embryos. The intracellular level of ROS was increased during the differentiation process, which was then blocked by treatment with the ROS scavenger N-acetylcysteine. Expression of Nox1 and Nox2 was increased upon differentiation of ATDC5 cells and primary mouse chondrocytes, whereas that of Nox4, which was relatively high initially, was decreased gradually during chondrogenesis. In developing limb, Nox1 and Nox2 were highly expressed in prehypertrophic and hypertrophic chondrocytes. However, Nox4 was highly expressed in proliferating chondrocytes and prehypertrophic chondrocytes. Depletion of Nox2 or Nox4 expression by RNA interference blocked both ROS generation and differentiation of ATDC5 cells, whereas depletion of Nox1 had no such effect. We also found that ATDC5 cells depleted of Nox2 or Nox4 underwent apoptosis. Further, inhibition of Akt phosphorylation along with subsequent activation of ERK was observed in the cells. Finally, depletion of Nox2 or Nox4 inhibited the accumulation of proteoglycan in primary chondrocytes. Taken together, our data suggest that ROS generated by Nox2 or Nox4 are essential for survival and differentiation in the early stage of chondrogenesis.	[Kim, Ki Soon; Choi, Hae Woong; Yoon, Hee Eun; Kim, Ick Young] Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, Seoul 136701, South Korea	Korea University	Kim, IY (corresponding author), Korea Univ, Sch Life Sci & Biotechnol, Lab Cellular & Mol Biochem, 1,5 Ka, Seoul 136701, South Korea.	ickkim@korea.ac.kr		Choi, Hae Woong/0000-0001-9372-1875	Korean Government [2007-0053186]; Korea University	Korean Government(Korean Government); Korea University	This work was supported by Grant 2007-0053186 from the National Research Foundation of Korea funded by the Korean Government. This work was also supported in part by a Korea University grant.	ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Giannoni E, 2008, CELL DEATH DIFFER, V15, P867, DOI 10.1038/cdd.2008.3; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Grange L, 2006, ANTIOXID REDOX SIGN, V8, P1485, DOI 10.1089/ars.2006.8.1485; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hidaka K, 2003, EXP CELL RES, V290, P254, DOI 10.1016/S0014-4827(03)00337-9; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Koh JM, 2006, J BONE MINER RES, V21, P1003, DOI [10.1359/jbmr.060406, 10.1359/JBMR.060406]; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lawlor MA, 2001, J CELL SCI, V114, P2903; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Mouche S, 2007, BBA-MOL CELL RES, V1773, P1015, DOI 10.1016/j.bbamcr.2007.03.003; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Nakajima A, 2003, ENDOCRINOLOGY, V144, P4659, DOI 10.1210/en.2003-0158; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Peshavariya H, 2009, N-S ARCH PHARMACOL, V380, P193, DOI 10.1007/s00210-009-0413-0; Phornphutkul C, 2006, MOL CELL ENDOCRINOL, V249, P107, DOI 10.1016/j.mce.2006.02.002; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Schroeder K, 2009, ARTERIOSCL THROM VAS, V29, P239, DOI 10.1161/ATVBAHA.108.174219; Shi DY, 2003, FEBS LETT, V542, P60, DOI 10.1016/S0014-5793(03)00338-7; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Wuelling M, 2010, PEDIATR NEPHROL, V25, P625, DOI 10.1007/s00467-009-1368-6; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yin WH, 2009, J BIOL CHEM, V284, P31972, DOI 10.1074/jbc.M109.056838	48	91	91	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40294	40302		10.1074/jbc.M110.126821	http://dx.doi.org/10.1074/jbc.M110.126821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20952384	Green Published, hybrid			2022-12-27	WOS:000285185500072
J	Landgraf, KE; Santell, L; Billeci, KL; Quan, C; Young, JC; Maun, HR; Kirchhofer, D; Lazarus, RA				Landgraf, Kyle E.; Santell, Lydia; Billeci, Karen L.; Quan, Clifford; Young, Judy C.; Maun, Henry R.; Kirchhofer, Daniel; Lazarus, Robert A.			Allosteric Peptide Activators of Pro-Hepatocyte Growth Factor Stimulate Met Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; AMINO-TERMINAL SEQUENCE; STRONG LIGAND-BINDING; FACTOR SCATTER FACTOR; C-MET; BOVINE TRYPSINOGEN; CRYSTAL-STRUCTURE; FACTOR/SCATTER FACTOR; ZYMOGEN ACTIVATION; STRUCTURAL BASIS	Hepatocyte growth factor (HGF) binds to its target receptor tyrosine kinase, Met, as a single-chain form (pro-HGF) or as a cleaved two-chain disulfide-linked alpha/beta-heterodimer. However, only two-chain HGF stimulates Met signaling. Proteolytic cleavage of the Arg(494)-Val(495) peptide bond in the zymogen- like pro-HGF results in allosteric activation of the serine protease-like beta-chain (HGF beta) which binds Met to initiate signaling. We use insights from the canonical trypsin-like serine protease activation mechanism to show that isolated peptides corresponding to the first 7-10 residues of the cleaved N terminus of the beta-chain stimulate Met phosphorylation by pro-HGF to levels that are similar to 25% of those stimulated by two-chain HGF. Biolayer interferometry data demonstrate that peptide VVNGIPTR (peptide V8) allosterically enhances proHGF beta binding to Met, resulting in a K-D(app) of 1.6 mu M, only 8-fold weaker than the Met/HGF beta-chain affinity. Most notably, in vitro cell stimulation with peptide V8 in the presence of pro-HGF leads to Akt phosphorylation, enhances cell survival, and facilitates cell migration between 75 and 100% of that found with two-chain HGF, thus revealing a novel approach for activation of Met signaling that bypasses proteolytic processing of pro-HGF. Peptide V8 is unable to enhance Met binding or signaling with HGF proteins having a mutated activation pocket (D672N). Furthermore, Gly substitution of the N-terminal Val residue in peptide V8 results in loss of all activity. Overall, these findings identify the activation pocket of the serine protease-like beta-chain as a "hot spot" for allosteric regulation of pro-HGF and have broad implications for developing selective allosteric activators of serine proteases and pseudoproteases.	[Kirchhofer, Daniel; Lazarus, Robert A.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Billeci, Karen L.; Young, Judy C.] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Quan, Clifford] Genentech Inc, Dept Small Mol Drug Discovery, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	lazarus.bob@gene.com						ANTONINI E, 1984, MOL CELL BIOCHEM, V60, P163; Ascenzi P, 1988, J Mol Recognit, V1, P130, DOI 10.1002/jmr.300010306; Bevan D, 2004, J PATHOL, V203, P831, DOI 10.1002/path.1578; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BODE W, 1984, EUR J BIOCHEM, V144, P185, DOI 10.1111/j.1432-1033.1984.tb08447.x; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; BODE W, 1979, J MOL BIOL, V127, P357, DOI 10.1016/0022-2836(79)90227-4; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; Botkjaer KA, 2009, BIOCHEMISTRY-US, V48, P9606, DOI 10.1021/bi900510f; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BUSSOLINO F, 1992, J CELL BIOL, V119, P629, DOI 10.1083/jcb.119.3.629; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Chirgadze DY, 1998, FEBS LETT, V430, P126, DOI 10.1016/S0014-5793(98)00558-4; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Conway K, 2006, WOUND REPAIR REGEN, V14, P2, DOI 10.1111/j.1743-6109.2005.00081.x; DeLano W.L, PYMOL MOL GRAPHICS S; DERMAN MP, 1995, AM J PHYSIOL-RENAL, V268, pF1211, DOI 10.1152/ajprenal.1995.268.6.F1211; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; GRANT DS, 1993, P NATL ACAD SCI USA, V90, P1937, DOI 10.1073/pnas.90.5.1937; HARTMANN G, 1992, P NATL ACAD SCI USA, V89, P11574, DOI 10.1073/pnas.89.23.11574; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; JACKSON KW, 1978, THROMB RES, V13, P693, DOI 10.1016/0049-3848(78)90159-7; Kataoka H, 2003, CANCER METAST REV, V22, P223, DOI 10.1023/A:1023051500010; Kataoka H, 2010, FEBS J, V277, P2230, DOI 10.1111/j.1742-4658.2010.07640.x; Khan AR, 1998, PROTEIN SCI, V7, P815; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Kirchhofer D, 2004, J BIOL CHEM, V279, P39915, DOI 10.1074/jbc.M404795200; Kirchhofer D, 2007, P NATL ACAD SCI USA, V104, P5306, DOI 10.1073/pnas.0700184104; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; LOKKER NA, 1992, EMBO J, V11, P2503, DOI 10.1002/j.1460-2075.1992.tb05315.x; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Matsumoto K, 1998, J BIOL CHEM, V273, P22913, DOI 10.1074/jbc.273.36.22913; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Nayeri F, 2006, J DERMATOL SCI, V43, P49, DOI 10.1016/j.jdermsci.2006.03.004; Olsen OH, 2008, CELL MOL LIFE SCI, V65, P953, DOI 10.1007/s00018-007-7480-5; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Pasternak A, 1998, BIOCHEMISTRY-US, V37, P16201, DOI 10.1021/bi980951d; Peek M, 2002, J BIOL CHEM, V277, P47804, DOI 10.1074/jbc.M209778200; SHIMOMURA T, 1995, EUR J BIOCHEM, V229, P257, DOI 10.1111/j.1432-1033.1995.0257l.x; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Tolbert WD, 2007, P NATL ACAD SCI USA, V104, P14592, DOI 10.1073/pnas.0704290104; Tolbert WD, 2010, P NATL ACAD SCI USA, V107, P13264, DOI 10.1073/pnas.1005183107; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Ultsch M, 1998, STRUCT FOLD DES, V6, P1383, DOI 10.1016/S0969-2126(98)00138-5; VINCENT JP, 1976, FEBS LETT, V63, P240, DOI 10.1016/0014-5793(76)80103-2; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; WATANABE S, 1994, BIOCHEM BIOPH RES CO, V199, P1453, DOI 10.1006/bbrc.1994.1394; Webb CP, 1998, ONCOGENE, V17, P2019, DOI 10.1038/sj.onc.1202135; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	72	16	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40362	40372		10.1074/jbc.M110.179721	http://dx.doi.org/10.1074/jbc.M110.179721			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937841	hybrid, Green Published			2022-12-27	WOS:000285185500079
J	Wang, QA; Pless, SA; Lynch, JW				Wang, Qian; Pless, Stephan A.; Lynch, Joseph W.			Ligand- and Subunit-specific Conformational Changes in the Ligand-binding Domain and the TM2-TM3 Linker of alpha 1 beta 2 gamma 2 GABA(A) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; DISTINCT STRUCTURAL-CHANGES; GATED ION-CHANNEL; CRYSTAL-STRUCTURE; LOOP F; BENZODIAZEPINE MODULATION; SIGNAL-TRANSDUCTION; GATING MECHANISM; PROTEIN MOBILITY; GLYCINE	Cys-loop receptor ligand binding sites are located at subunit interfaces where they are lined by loops A-C from one subunit and loops D-F from the adjacent subunit. Agonist binding induces large conformational changes in loops C and F. However, it is controversial as to whether these conformational changes are essential for gating. Here we used voltage clamp fluorometry to investigate the roles of loops C and F in gating the alpha 1 beta 2 gamma 2 GABA(A) receptor. Voltage clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. Previous attempts to define the roles of loops C and F using this technique have focused on homomeric Cys-loop receptors. However, the problem with studying homomeric receptors is that it is difficult to eliminate the possibility of bound ligands interacting directly with attached fluorophores at the same site. Here we show that ligands binding to the beta 2-alpha 1 interface GABA binding site produce conformational changes at the adjacent subunit interface. This is most likely due to agonist-induced loop C closure directly altering loop F conformation at the adjacent alpha 1-beta 2 subunit interface. However, as antagonists and agonists produce identical alpha 1 subunit loop F conformational changes, these conformational changes appear unimportant for gating. Finally, we demonstrate that TM2-TM3 loops from adjacent beta 2 subunits in alpha 1 beta 2 receptors can dimerize via K24'C disulfides in the closed state. This result implies unexpected conformational mobility in this crucial part of the gating machinery. Together, this information provides new insights into the activation mechanisms of Cys-loop receptors.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia (NHMRC); University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported in part by the Australian Research Council and the National Health and Medical Research Council of Australia (NHMRC).; Supported by a University of Queensland confirmation scholarship.	Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Buhr A, 1997, MOL PHARMACOL, V52, P676, DOI 10.1124/mol.52.4.676; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Casula MA, 2001, J NEUROCHEM, V77, P445, DOI 10.1046/j.1471-4159.2001.00289.x; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cromer BA, 2002, TRENDS BIOCHEM SCI, V27, P280, DOI 10.1016/S0968-0004(02)02092-3; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Davies M, 1998, J NEUROCHEM, V70, P2188; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Horenstein J, 2005, J BIOL CHEM, V280, P1573, DOI 10.1074/jbc.M410881200; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Jones MV, 1998, J NEUROSCI, V18, P8590; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Khatri A, 2010, J PHYSIOL-LONDON, V588, P59, DOI 10.1113/jphysiol.2009.179705; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Meera P, 2010, MOL PHARMACOL, V78, P918, DOI 10.1124/mol.109.062687; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Sedelnikova A, 2005, J BIOL CHEM, V280, P1535, DOI 10.1074/jbc.M409908200; Shan Q, 2002, J BIOL CHEM, V277, P44845, DOI 10.1074/jbc.M208647200; SIEGHART W, 2002, G Curr Top Med Chem, V2, P795; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Ueno S, 1997, J NEUROSCI, V17, P625; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Walters RJ, 2000, NAT NEUROSCI, V3, P1274, DOI 10.1038/81800; Wiltfong RE, 2009, J NEUROSCI, V29, P1626, DOI 10.1523/JNEUROSCI.4121-08.2009; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Yang Z, 2007, J BIOL CHEM, V282, P16803, DOI 10.1074/jbc.M611555200; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	54	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40373	40386		10.1074/jbc.M110.161513	http://dx.doi.org/10.1074/jbc.M110.161513			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20937799	Green Published, hybrid			2022-12-27	WOS:000285185500080
J	Xu, ZJ; Vagnarelli, P; Ogawa, H; Samejima, K; Earnshaw, WC				Xu, Zhenjie; Vagnarelli, Paola; Ogawa, Hiromi; Samejima, Kumiko; Earnshaw, William C.			Gradient of Increasing Aurora B Kinase Activity Is Required for Cells to Execute Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; CENTROMERE PROTEIN INCENP; INNER CENTROMERE; MITOTIC SPINDLE; SURVIVIN; PHOSPHORYLATION; ACTIVATION; INHIBITION; MECHANISM; BOREALIN	INCENP, Borealin, Survivin, and Aurora B kinase comprise the chromosomal passenger complex, an essential regulator of mitotic events. INCENP (inner centromere protein) binds and activates Aurora B through a feedback loop involving phosphorylation of a Thr-Ser-Ser (TSS) motif near the INCENP C terminus. Here, we have examined the role of the TSS motif in vertebrate cells using an DT40 INCENPON/OFF conditional knock-out cell line in which mutants are expressed in the absence of wild-type INCENP. Our analysis confirms that regulated phosphorylation of the two serine residues (presumably by Aurora B) is critical for full activation of the kinase and is essential for cell viability. Cells expressing INCENP mutants bearing either phospho-null (TAA) or phospho-mimetic (TEE) mutations exhibit significant levels of Aurora B kinase activity but fail to undergo normal spindle elongation or complete cytokinesis. This work confirms previous suggestions that INCENP can act as a rheostat, with different INCENP mutants promoting differing degrees of kinase activation. Our results also reveal that mitotic progression is accompanied by a requirement for progressively higher levels of Aurora B kinase activity.	[Xu, Zhenjie; Vagnarelli, Paola; Ogawa, Hiromi; Samejima, Kumiko; Earnshaw, William C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Samejima, K (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	kumiko.samejima@ed.ac.uk; bill.earnshaw@ed.ac.uk	Xu, Zhenjie/A-6443-2014; Earnshaw, William/AAY-7438-2020; Vagnarelli, Paola/AAI-1996-2020	Vagnarelli, Paola/0000-0002-0000-2271; Earnshaw, William/0000-0002-7191-0621	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (to the W. C. E. laboratory).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Ahonen LJ, 2009, CHROMOSOMA, V118, P71, DOI 10.1007/s00412-008-0178-0; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Carmena M, 2009, CURR OPIN CELL BIOL, V21, P796, DOI 10.1016/j.ceb.2009.09.008; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Civelekoglu-Scholey G, 2006, BIOPHYS J, V90, P3966, DOI 10.1529/biophysj.105.078691; COOKE CA, 1987, J CELL BIOL, V105, P2053, DOI 10.1083/jcb.105.5.2053; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; EARNSHAW WC, 1991, CHROMOSOMA, V100, P139, DOI 10.1007/BF00337241; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Xu ZJ, 2009, J CELL BIOL, V187, P637, DOI 10.1083/jcb.200906053	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40163	40170		10.1074/jbc.M110.181545	http://dx.doi.org/10.1074/jbc.M110.181545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956539	Green Published, hybrid			2022-12-27	WOS:000285185500061
J	Zhao, CY; Dahlman-Wright, K; Gustafsson, JA				Zhao, Chunyan; Dahlman-Wright, Karin; Gustafsson, Jan-Ake			Estrogen Signaling via Estrogen Receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER CELLS; ER-BETA; GENE-EXPRESSION; GENOME-WIDE; MESSENGER-RNA; TARGET GENE; CROSS-TALK; ALPHA; TRANSCRIPTION	Estrogens act by binding to and activating two estrogen receptors (ERs), ER alpha and ER beta. Transcriptional regulation by ERs is controlled by a complex array of factors such as ER-ligand binding, the DNA sequence bound by ERs, ER-interacting cofactors, and chromatin context. This minireview will provide an overview of the most recent advances in the identification of ER beta-regulated target gene networks and ER beta DNA-binding sites. We also highlight the recent work establishing new roles of ER beta signaling, including protective functions in the epithelial-mesenchymal transition and in atherosclerosis, as well as regulation of cell proliferation in the colon.	[Zhao, Chunyan; Dahlman-Wright, Karin; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Dept Biol & Biochem, Houston, TX 77204 USA	Karolinska Institutet; University of Houston System; University of Houston	Gustafsson, JA (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.	jan-ake.gustafsson@ki.se			Swedish Cancer Fund	Swedish Cancer Fund	This work was supported by grants from the Swedish Cancer Fund. This is the second article in the Thematic Minireview Series on Nuclear Receptors in Biology and Diseases. This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Alonso-Magdalena P, 2009, P NATL ACAD SCI USA, V106, P2859, DOI 10.1073/pnas.0812666106; Arnal JF, 2007, CURR OPIN LIPIDOL, V18, P554, DOI 10.1097/MOL.0b013e3282ef3bca; Bianco NR, 2003, MOL ENDOCRINOL, V17, P1344, DOI 10.1210/me.2002-0382; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Chen M, 2009, CARCINOGENESIS, V30, P841, DOI 10.1093/carcin/bgn288; Cheung E, 2010, ANNU REV PHYSIOL, V72, P191, DOI 10.1146/annurev-physiol-021909-135840; Cho NL, 2007, CANCER RES, V67, P2366, DOI 10.1158/0008-5472.CAN-06-3026; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Deroo BJ, 2010, MOL ENDOCRINOL, V24, P1703, DOI 10.1210/me.2009-0288; Fujimura T, 2001, BIOCHEM BIOPH RES CO, V289, P692, DOI 10.1006/bbrc.2001.6038; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Goulioumis AK, 2009, ONCOL REP, V22, P1063, DOI 10.3892/or_00000537; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; GULSHAN S, 1990, SCAND J IMMUNOL, V31, P691, DOI 10.1111/j.1365-3083.1990.tb02820.x; Hodgin JB, 2002, ENDOCRINOLOGY, V143, P4495, DOI 10.1210/en.2002-220844; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; KARAS RH, 1994, CIRCULATION, V89, P1943, DOI 10.1161/01.CIR.89.5.1943; Kininis Miltiadis, 2008, Nucl Recept Signal, V6, pe005, DOI 10.1621/nrs.06005; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lin CY, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1667; Lindner V, 1998, CIRC RES, V83, P224, DOI 10.1161/01.RES.83.2.224; Liu Y, 2008, P NATL ACAD SCI USA, V105, P2604, DOI 10.1073/pnas.0712085105; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Martin LA, 2005, ENDOCR-RELAT CANCER, V12, pS75, DOI 10.1677/erc.1.01023; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Newcomb PA, 2007, CANCER RES, V67, P7534, DOI 10.1158/0008-5472.CAN-06-4275; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Omoto Y, 2003, ONCOGENE, V22, P5011, DOI 10.1038/sj.onc.1206787; Palmieri C, 2004, CLIN CANCER RES, V10, P2421, DOI 10.1158/1078-0432.CCR-03-0215; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Secreto FJ, 2007, J CELL BIOCHEM, V101, P1125, DOI 10.1002/jcb.21205; Villablanca AC, 2009, J CARDIOVASC TRANSL, V2, P289, DOI 10.1007/s12265-009-9103-z; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Weige CC, 2009, CANCER RES, V69, P9118, DOI 10.1158/0008-5472.CAN-09-2348; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Wu Y, 2008, ACTA BIOCH BIOPH SIN, V40, P643, DOI 10.1111/j.1745-7270.2008.00443.x; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhao CY, 2010, CANCER RES, V70, P5174, DOI 10.1158/0008-5472.CAN-09-4407; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8	48	91	97	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39575	39579		10.1074/jbc.R110.180109	http://dx.doi.org/10.1074/jbc.R110.180109			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20956532	Green Published, hybrid			2022-12-27	WOS:000285185500001
J	Soprova, Z; Sauri, A; van Ulsen, P; Tame, JRH; den Blaauwen, T; Jong, WSP; Luirink, J				Soprova, Zora; Sauri, Ana; van Ulsen, Peter; Tame, Jeremy R. H.; den Blaauwen, Tanneke; Jong, Wouter S. P.; Luirink, Joen			A Conserved Aromatic Residue in the Autochaperone Domain of the Autotransporter Hbp Is Critical for Initiation of Outer Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHOGENIC ESCHERICHIA-COLI; PARALLEL BETA-HELICES; HEMOGLOBIN PROTEASE; PASSENGER DOMAIN; SERINE-PROTEASE; BACTERIAL AUTOTRANSPORTER; CRYSTAL-STRUCTURE; COMMON THEMES; SECRETION; PROTEINS	Autotransporters are bacterial virulence factors that share a common mechanism by which they are transported to the cell surface. They consist of an N-terminal passenger domain and a C-terminal beta-barrel, which has been implicated in translocation of the passenger across the outer membrane (OM). The mechanism of passenger translocation and folding is still unclear but involves a conserved region at the C terminus of the passenger domain, the so-called autochaperone domain. This domain functions in the stepwise translocation process and in the folding of the passenger domain after translocation. In the autotransporter hemoglobin protease (Hbp), the autochaperone domain consists of the last rung of the beta-helix and a capping domain. To examine the role of this region, we have mutated several conserved aromatic residues that are oriented toward the core of the beta-helix. We found that non-conservative mutations affected secretion with Trp(1015) in the cap region as the most critical residue. Substitution at this position yielded a DegP-sensitive intermediate that is located at the periplasmic side of the OM. Further analysis revealed that Trp(1015) is most likely required for initiation of processive folding of the beta-helix at the cell surface, which drives sequential translocation of the Hbp passenger across the OM.	[Soprova, Zora; Sauri, Ana; van Ulsen, Peter; Jong, Wouter S. P.; Luirink, Joen] Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 2300045, Japan; [den Blaauwen, Tanneke] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Dept Mol Cytol, NL-1098 XH Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Yokohama City University; University of Amsterdam	Luirink, J (corresponding author), Vrije Univ Amsterdam, Inst Mol Cell Biol, Dept Mol Microbiol, NL-1081 HV Amsterdam, Netherlands.	joen.luirink@falw.vu.nl	Luirink, Joen/AAB-8658-2021	den Blaauwen, Tanneke/0000-0002-5403-5597; Jong, W.S.P./0000-0002-8907-6954; Luirink, J./0000-0001-8431-0804; Jong, Wouter/0000-0002-4132-4605; van Ulsen, Peter/0000-0002-2164-1611	Netherlands Organization for Scientific Research (NWO)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by an "Aard en Levens Wetenschappen Open Program" grant from the Netherlands Organization for Scientific Research (NWO) (to A.S. and W.S.P.J.). and a Mosaic Grant from NWO (to Z.S.).	Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bernstein HD, 2007, TRENDS MICROBIOL, V15, P441, DOI 10.1016/j.tim.2007.09.007; Brandon LD, 2001, J BACTERIOL, V183, P951, DOI 10.1128/JB.183.3.951-958.2001; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Dautin N, 2007, ANNU REV MICROBIOL, V61, P89, DOI 10.1146/annurev.micro.61.080706.093233; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fink DL, 2003, J BACTERIOL, V185, P1608, DOI 10.1128/JB.185.5.1608-1615.2003; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Hashemzadeh-Bonehi L, 1998, MOL MICROBIOL, V30, P676, DOI 10.1046/j.1365-2958.1998.01116.x; Henderson IR, 2001, INFECT IMMUN, V69, P1231, DOI 10.1128/IAI.69.3.1231-1243.2001; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Ieva R, 2009, P NATL ACAD SCI USA, V106, P19120, DOI 10.1073/pnas.0907912106; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Johnson TA, 2009, J MOL BIOL, V389, P559, DOI 10.1016/j.jmb.2009.04.041; Jong WSP, 2007, MOL MICROBIOL, V63, P1524, DOI 10.1111/j.1365-2958.2007.05605.x; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Junker M, 2009, MOL MICROBIOL, V71, P1323, DOI 10.1111/j.1365-2958.2009.06607.x; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Kamen DE, 2000, BIOCHEMISTRY-US, V39, P15932, DOI 10.1021/bi001900v; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Konieczny MPJ, 2001, ANTON LEEUW INT J G, V80, P19, DOI 10.1023/A:1012084325728; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Miller J.H., 1992, SHORT COURSE BACTERI, P150; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oliver DC, 2003, J BACTERIOL, V185, P489, DOI 10.1128/JB.185.2.489-495.2003; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; Otto BR, 1998, J EXP MED, V188, P1091, DOI 10.1084/jem.188.6.1091; Otto BR, 2002, INFECT IMMUN, V70, P5, DOI 10.1128/IAI.70.1.5-10.2002; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Renn JP, 2008, BIOPOLYMERS, V89, P420, DOI 10.1002/bip.20924; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; Sauri A, 2009, MICROBIOL-SGM, V155, P3982, DOI 10.1099/mic.0.034991-0; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Simkovsky R, 2006, P NATL ACAD SCI USA, V103, P3575, DOI 10.1073/pnas.0509087103; Skillman KM, 2005, MOL MICROBIOL, V58, P945, DOI 10.1111/j.1365-2958.2005.04885.x; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Tajima N, 2010, J MOL BIOL, V402, P645, DOI 10.1016/j.jmb.2010.06.068; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; van Dooren SJM, 2001, FEMS MICROBIOL LETT, V205, P147, DOI 10.1016/S0378-1097(01)00454-2; Velarde JJ, 2004, J BIOL CHEM, V279, P31495, DOI 10.1074/jbc.M404424200; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Yen YT, 2008, TRENDS MICROBIOL, V16, P370, DOI 10.1016/j.tim.2008.05.003	49	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 3	2010	285	49					38224	38233		10.1074/jbc.M110.180505	http://dx.doi.org/10.1074/jbc.M110.180505			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	685JS	20923769	hybrid, Green Published			2022-12-27	WOS:000284625600030
J	Bebeacua, C; Bron, P; Lai, L; Vegge, CS; Brondsted, L; Spinelli, S; Campanacci, V; Veesler, D; van Heel, M; Cambillau, C				Bebeacua, Cecilia; Bron, Patrick; Lai, Livia; Vegge, Christina Skovgaard; Brondsted, Lone; Spinelli, Silvia; Campanacci, Valerie; Veesler, David; van Heel, Marin; Cambillau, Christian			Structure and Molecular Assignment of Lactococcal Phage TP901-1 Baseplate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; CRYSTAL-STRUCTURE; STRUCTURE REVEALS; TAIL STRUCTURE; LACTIS PHAGES; IDENTIFICATION; BACTERIOPHAGE-TP901-1; COMPLEXES; MECHANISM; EVOLUTION	P335 lactococcal phages infect the Gram(+) bacterium Lactococcus lactis using a large multiprotein complex located at the distal part of the tail and termed baseplate (BP). The BP harbors the receptor-binding proteins (RBPs), which allow the specific recognition of saccharidic receptors localized on the host cell surface. We report here the electron microscopic structure of the phage TP901-1 wild-type BP as well as those of two mutants bppL(-) and bppU(-), lacking BppL (the RBPs) or both peripheral BP components (BppL and BppU), respectively. We also achieved an electron microscopic reconstruction of a partial BP complex, formed by BppU and BppL. This complex exhibits a tripod shape and is composed of nine BppLs and three BppUs. These structures, combined with light-scattering measurements, led us to propose that the TP901-1 BP harbors six tripods at its periphery, located around the central tube formed by ORF46 (Dit) hexamers, at its proximal end, and a ORF47 (Tal) trimer at its distal extremity. A total of 54 BppLs (18 RBPs) are thus available to mediate host anchoring with a large apparent avidity. TP901-1 BP exhibits an infection-ready conformation and differs strikingly from the lactococcal phage p2 BP, bearing only 6 RBPs, and which needs a conformational change to reach its activated state. The comparison of several Siphoviridae structures uncovers a close organization of their central BP core whereas striking differences occur at the periphery, leading to diverse mechanisms of host recognition.	[Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] CNRS, UMR 6098, F-13288 Marseille 09, France; [Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] Univ Aix Marseille 1, F-13288 Marseille 09, France; [Spinelli, Silvia; Campanacci, Valerie; Veesler, David; Cambillau, Christian] Univ Aix Marseille 2, F-13288 Marseille 09, France; [van Heel, Marin] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AZ, England; [Bron, Patrick] CNRS, INSERM, Ctr Biochim Struct, U554,UMR 5048, F-34090 Montpellier, France; [Vegge, Christina Skovgaard; Brondsted, Lone] Univ Copenhagen, Dept Vet Dis Biol, DK-1870 Frederiksberg C, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Copenhagen	Cambillau, C (corresponding author), CNRS, UMR 6098, Campus Luminy,Case 932, F-13288 Marseille 09, France.	cambillau@afmb.univ-mrs.fr	Veesler, David/HCH-3986-2022	Brondsted, Lone/0000-0002-7930-5725; bron, patrick/0000-0002-3354-9513; Campanacci, Valerie/0000-0001-6407-6395	Marseille-Nice Geno-pole; CNRS; Agence Nationale de la Recherche [ANR-07-BLAN-0095]; Ministere francais de l'enseignement superieur et de la recherche [22976-2006]; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Marseille-Nice Geno-pole; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere francais de l'enseignement superieur et de la recherche; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in part, by grants from the Marseille-Nice Geno-pole and the CNRS and by Agence Nationale de la Recherche Grant ANR-07-BLAN-0095, "siphophages." This work was also supported by "ministere francais de l'enseignement superieur et de la recherche" Ph.D. Grant 22976-2006 (to D. V.). Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, supported by National Institutes of Health Grant P41 RR-01081.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; De Haard HJW, 2005, J BACTERIOL, V187, P4531, DOI 10.1128/JB.187.13.4531-4541.2005; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Effantin G, 2006, J MOL BIOL, V361, P993, DOI 10.1016/j.jmb.2006.06.081; HARAUZ G, 1986, OPTIK, V73, P146; HARAUZ G, 1984, ULTRAMICROSCOPY, V12, P309, DOI 10.1016/0304-3991(83)90245-0; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Kostyuchenko VA, 2005, NAT STRUCT MOL BIOL, V12, P810, DOI 10.1038/nsmb975; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Sulzenbacher G, 2002, ACTA CRYSTALLOGR D, V58, P2109, DOI 10.1107/S0907444902013938; Tremblay DM, 2006, J BACTERIOL, V188, P2400, DOI 10.1128/JB.188.7.2400-2410.2006; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Veesler D, 2009, J BIOL CHEM, V284, P30718, DOI 10.1074/jbc.M109.037812; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004	40	48	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39079	39086		10.1074/jbc.M110.175646	http://dx.doi.org/10.1074/jbc.M110.175646			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937834	Green Published, hybrid			2022-12-27	WOS:000284941300038
J	Li, HL; Ding, XD; Lopez, JR; Takeshima, H; Ma, JJ; Allen, PD; Eltit, JM				Li, Hongli; Ding, Xudong; Lopez, Jose R.; Takeshima, Hiroshi; Ma, Jianjie; Allen, Paul D.; Eltit, Jose M.			Impaired Orai1-mediated Resting Ca2+ Entry Reduces the Cytosolic [Ca2+] and Sarcoplasmic Reticulum Ca2+ Loading in Quiescent Junctophilin 1 Knock-out Myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; OPERATED CALCIUM-CHANNEL; TRPC CHANNELS; CRAC CHANNEL; ORAI1; STIM1; DEFICIENCY; RELEASE; ACTIVATION; DEPLETION	In the absence of store depletion, plasmalemmal Ca2+ permeability in resting muscle is very low, and its contribution in the maintenance of Ca2+ homeostasis at rest has not been studied in detail. Junctophilin 1 knock-out myotubes (JP1 KO) have a severe reduction in store-operated Ca2+ entry, presumably caused by physical alteration of the sarcoplasmic reticulum (SR) and T-tubule junction, leading to disruption of the SR signal sent by Stim1 to activate Orai1. Using JP1 KO myotubes as a model, we assessed the contribution of the Orai1-mediated Ca2+ entry pathway on overall Ca2+ homeostasis at rest with no store depletion. JP1 KO myotubes have decreased Ca2+ entry, [Ca2+](rest), and intracellular Ca2+ content compared with WT myotubes and unlike WT myotubes, are refractory to BTP2, a Ca2+ entry blocker. JP1 KO myotubes show down-regulation of Orai1 and Stim1 proteins, suggesting that this pathway may be important in the control of resting Ca2+ homeostasis. WT myotubes stably transduced with Orai1(E190Q) had similar alterations in their resting Ca2+ homeostasis as JP1 KO myotubes and were also unresponsive to BTP2. JP1 KO cells show decreased expression of TRPC1 and -3 but overexpress TRPC4 and -6; on the other hand, the TRPC expression profile in Orai1(E190Q) myotubes was comparable with WT. These data suggest that an important fraction of resting plasmalemmal Ca2+ permeability is mediated by the Orai1 pathway, which contributes to the control of [Ca2+] rest and resting Ca2+ stores and that this pathway is defective in JP1 KO myotubes.	[Li, Hongli; Ding, Xudong; Lopez, Jose R.; Allen, Paul D.; Eltit, Jose M.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	Harvard University; Brigham & Women's Hospital; Kyoto University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Eltit, JM (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	jmeltit@zeus.bwh.harvard.edu		Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health/NIAMS [2R01AR43140, RO1AG28856, RO1HL69000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR052354, R01AR043140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health/NIAMS Grants 2R01AR43140 (to P. D. A.), RO1AG28856 (to J. M. and H. T.), and RO1HL69000 (to J. M.).	Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Eltit JM, 2010, J BIOL CHEM, V285, P13781, DOI 10.1074/jbc.M110.107300; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hirata Y, 2006, BIOPHYS J, V90, P4418, DOI 10.1529/biophysj.105.076570; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Ito K, 2001, J CELL BIOL, V154, P1059, DOI 10.1083/jcb.200105040; Komazaki S, 2002, FEBS LETT, V524, P225, DOI 10.1016/S0014-5793(02)03042-9; Kurebayashi N, 2001, J PHYSIOL-LONDON, V533, P185, DOI 10.1111/j.1469-7793.2001.0185b.x; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; LOPEZ JR, 1983, BIOPHYS J, V43, P1, DOI 10.1016/S0006-3495(83)84316-1; Lopez JR, 2000, ANESTHESIOLOGY, V92, P1799, DOI 10.1097/00000542-200006000-00040; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Pan Z, 2002, NAT CELL BIOL, V4, P379, DOI 10.1038/ncb788; Perez CF, 2005, AM J PHYSIOL-CELL PH, V288, pC640, DOI 10.1152/ajpcell.00407.2004; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shin DM, 2008, NAT CELL BIOL, V10, P639, DOI 10.1038/ncb0608-639; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Yang TZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1591, DOI 10.1152/ajpcell.00133.2006; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	31	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39171	39179		10.1074/jbc.M110.149690	http://dx.doi.org/10.1074/jbc.M110.149690			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937810	Green Published, hybrid			2022-12-27	WOS:000284941300047
J	de Carvalho, FD; Quick, M				de Carvalho, Fernanda Delmondes; Quick, Matthias			Surprising Substrate Versatility in SLC5A6 Na+-COUPLEDI- TRANSPORT BY THE HUMAN Na+/MULTIVITAMIN TRANSPORTER (hSMVT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT MULTIVITAMIN TRANSPORTER; NA+/GLUCOSE COTRANSPORTER SGLT1; SYMPORTER NIS; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL EXPRESSION; IODIDE TRANSPORTER; BACTERIAL HOMOLOG; ESCHERICHIA-COLI; BINDING-SITE; MECHANISM	Iodide (I-) is an essential constituent of the thyroid hormones triiodothyronine and thyroxine, which are required for the development of the central nervous system in the fetus and newborn. I- uptake in the thyroid is mediated by the Na+/I- symporter (NIS). NIS has gained particular medical interest due to its sensitivity to the environmental pollutant perchlorate (ClO4-) and its implication in radioiodide cancer treatment. Recently, others have shown that I- absorption in the intestine is mediated by NIS (Nicola, J. P., Basquin, C., Portulano, C., Reyna-Neyra, A., Paroder, M., and Carrasco, N. (2009) Am. J. Physiol. Cell Physiol. 296, C654-662). However, their data suggest the participation of other systems in the homeostasis of I-, in particular because in vivo uptake studies revealed a ClO4--insensitive transport component. Here, we describe Na+-coupled I- uptake by the human Na+/multivitamin transporter (hSMVT), a related protein isolated from the placenta, where it was suggested to supply the fetus with the water-soluble vitamins biotin and pantothenic acid, and alpha-lipoic acid. hSMVT-mediated Na+/I- symport is inhibited by the other three organic hSMVT substrates but not by NIS substrates; notably, hSMVT is insensitive to ClO4-. Because hSMVT is found in the intestine and in many other tissues, we propose that hSMVT may play an important role in the homeostasis of I- in the body.	[de Carvalho, Fernanda Delmondes; Quick, Matthias] Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute	Quick, M (corresponding author), 650 W 168th St,BB1119, New York, NY 10032 USA.	mq2102@columbia.edu		Carvalho Poyraz, Fernanda/0000-0003-2488-6849				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ACLAND JD, 1959, J PHYSIOL-LONDON, V147, P260, DOI 10.1113/jphysiol.1959.sp006241; Balamurugan K, 2003, AM J PHYSIOL-GASTR L, V285, pG73, DOI 10.1152/ajpgi.00059.2003; Ball G. F., 2005, VITAMINS FOODS ANAL; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Coady MJ, 2004, J PHYSIOL-LONDON, V557, P719, DOI 10.1113/jphysiol.2004.063859; Dai G, 1996, NATURE, V379, P458, DOI 10.1038/379458a0; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Dohan O, 2003, MOL CELL ENDOCRINOL, V213, P59, DOI 10.1016/j.mce.2003.10.059; Dohan O, 2003, ENDOCR REV, V24, P48, DOI 10.1210/er.2001-0029; Dohan O, 2007, P NATL ACAD SCI USA, V104, P20250, DOI 10.1073/pnas.0707207104; Eskandari S, 1997, J BIOL CHEM, V272, P27230, DOI 10.1074/jbc.272.43.27230; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HIRAYAMA BA, 1992, BIOCHIM BIOPHYS ACTA, V1103, P37, DOI 10.1016/0005-2736(92)90054-P; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Longpre JP, 2010, BIOPHYS J, V98, P231, DOI 10.1016/j.bpj.2009.10.015; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 1999, J PHYSIOL-LONDON, V518, P195, DOI 10.1111/j.1469-7793.1999.0195r.x; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Nabokina SM, 2003, AM J PHYSIOL-RENAL, V284, pF737, DOI 10.1152/ajprenal.00364.2002; Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008; PANAYOTOVAHEIERMANN M, 1995, J BIOL CHEM, V270, P27099, DOI 10.1074/jbc.270.45.27099; PASTAN I, 1957, ENDOCRINOLOGY, V61, P93, DOI 10.1210/endo-61-1-93; Prasad PD, 1999, ARCH BIOCHEM BIOPHYS, V366, P95, DOI 10.1006/abbi.1999.1213; Prasad PD, 1998, J BIOL CHEM, V273, P7501, DOI 10.1074/jbc.273.13.7501; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Rodriguez AM, 2002, J CLIN ENDOCR METAB, V87, P3500, DOI 10.1210/jc.87.7.3500; Said HM, 1999, J NUTR, V129, p490S, DOI 10.1093/jn/129.2.490S; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Wang HP, 1999, J BIOL CHEM, V274, P14875, DOI 10.1074/jbc.274.21.14875; Wright EM, 1996, CURR OPIN CELL BIOL, V8, P468, DOI 10.1016/S0955-0674(96)80022-6; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	41	47	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					131	137		10.1074/jbc.M110.167197	http://dx.doi.org/10.1074/jbc.M110.167197			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980265	Green Published, hybrid			2022-12-27	WOS:000285782800014
J	Shkreta, L; Michelle, L; Toutant, J; Tremblay, ML; Chabot, B				Shkreta, Lulzim; Michelle, Laetitia; Toutant, Johanne; Tremblay, Michel L.; Chabot, Benoit			The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; PROGRAMMED CELL-DEATH; PROTEIN-PHOSPHORYLATION; TOPOISOMERASE-I; HISTONE H2AX; SR PROTEINS; HNRNP A1; INHIBITION; CANCER; STRESS	Alternative splicing often produces effectors with opposite functions in apoptosis. Splicing decisions must therefore be tightly connected to stresses, stimuli, and pathways that control cell survival and cell growth. We have shown previously that PKC signaling prevents the production of proapoptotic Bcl-x(S) to favor the accumulation of the larger antiapoptotic Bcl-x(L) splice variant in 293 cells. Here we show that the genotoxic stress induced by oxaliplatin elicits an ATM-, CHK2-, and p53-dependent splicing switch that favors the production of the proapoptotic Bcl-xS variant. This DNA damage-induced splicing shift requires the activity of protein-tyrosine phosphatases. Interestingly, the ATM/CHK2/p53/tyrosine phosphatases pathway activated by oxaliplatin regulates Bcl-x splicing through the same regulatory sequence element (SB1) that receives signals from the PKC pathway. Convergence of the PKC and DNA damage signaling routes may control the abundance of a key splicing repressor because SB1-mediated repression is lost when protein synthesis is impaired but is rescued by blocking proteasome-mediated protein degradation. The SB1 splicing regulatory module therefore receives antagonistic signals from the PKC and the p53-dependent DNA damage response pathways to control the balance of pro-and antiapoptotic Bcl-x splice variants.	[Shkreta, Lulzim; Michelle, Laetitia; Toutant, Johanne; Chabot, Benoit] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, Sherbrooke, PQ J1H 5N4, Canada; [Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Tremblay, Michel L.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3G 1Y6, Canada	University of Sherbrooke; McGill University; McGill University	Chabot, B (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, RNA RNP Grp, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	benoit.chabot@usherbrooke.ca		Chabot, Benoit/0000-0003-0994-0042	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-93791 from the Canadian Institutes of Health Research.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Barbier J, 2007, MOL CELL BIOL, V27, P7315, DOI 10.1128/MCB.00272-07; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Boon-Unge K, 2007, CHEM BIOL, V14, P1386, DOI 10.1016/j.chembiol.2007.11.004; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CLARKE MF, 1995, P NATL ACAD SCI USA, V92, P11024, DOI 10.1073/pnas.92.24.11024; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Du YCN, 2007, PLOS BIOL, V5, P2255, DOI 10.1371/journal.pbio.0050276; Feng Y, 2008, NAT STRUCT MOL BIOL, V15, P1040, DOI 10.1038/nsmb.1485; Filippov V, 2007, CANCER RES, V67, P7621, DOI 10.1158/0008-5472.CAN-07-0145; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jiang ZH, 1999, P SOC EXP BIOL MED, V220, P64, DOI 10.1046/j.1525-1373.1999.d01-11.x; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Katzenberger RJ, 2009, J BIOL CHEM, V284, P10737, DOI 10.1074/jbc.M809506200; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Marengo MS, 2008, RNA, V14, P1681, DOI 10.1261/rna.1048808; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Olopade OI, 1997, CANCER J SCI AM, V3, P230; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Pilch B, 2001, CANCER RES, V61, P6876; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Revil T, 2007, MOL CELL BIOL, V27, P8431, DOI 10.1128/MCB.00565-07; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossi F, 1996, NATURE, V381, P80, DOI 10.1038/381080a0; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Shkreta L, 2008, MOL CANCER THER, V7, P1398, DOI 10.1158/1535-7163.MCT-08-0192; Solier S, 2004, MOL CANCER RES, V2, P53; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stuible M, 2007, CHEMBIOCHEM, V8, P179, DOI 10.1002/cbic.200600287; Tisserant A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001418; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Venables JP, 2004, HUM MOL GENET, V13, P1525, DOI 10.1093/hmg/ddh165; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; Wu J Y, 2003, Prog Mol Subcell Biol, V31, P153; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698; Zhong XY, 2009, GENE DEV, V23, P482, DOI 10.1101/gad.1752109	52	37	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					331	340		10.1074/jbc.M110.162644	http://dx.doi.org/10.1074/jbc.M110.162644			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	20980256	hybrid, Green Published			2022-12-27	WOS:000285782800036
J	Vergnes, L; Chin, R; Young, SG; Reue, K				Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen			Heart-type Fatty Acid-binding Protein Is Essential for Efficient Brown Adipose Tissue Fatty Acid Oxidation and Cold Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN; MICE LACKING; GENE DELETION; UP-REGULATION; THERMOGENESIS; EXPRESSION; ADIPOCYTE; DEFICIENCY; OBESITY; IDENTIFICATION	Brown adipose tissue has a central role in thermogenesis to maintain body temperature through energy dissipation in small mammals and has recently been verified to function in adult humans as well. Here, we demonstrate that the heart-type fatty acid-binding protein, FABP3, is essential for cold tolerance and efficient fatty acid oxidation in mouse brown adipose tissue, despite the abundant expression of adiposetype fatty acid-binding protein, FABP4 (also known as aP2). Fabp3(-/-) mice exhibit extreme cold sensitivity despite induction of uncoupling and oxidative genes and hydrolysis of brown adipose tissue lipid stores. However, using FABP3 gain-and loss-of-function approaches in brown adipocytes, we detected a correlation between FABP3 levels and the utilization of exogenous fatty acids. Thus, Fabp3(-/-) brown adipocytes fail to oxidize exogenously supplied fatty acids, whereas enhanced Fabp3 expression promotes more efficient oxidation. These results suggest that FABP3 levels are a determinant of fatty acid oxidation efficiency by brown adipose tissue and that FABP3 represents a potential target for modulation of energy dissipation.	[Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Chin, Robert; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Vergnes, Laurent; Chin, Robert; Reue, Karen] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Reue, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Gonda 6506A,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	reuek@ucla.edu		vergnes, laurent/0000-0002-8804-589X; Young, Stephen/0000-0001-7270-3176	National Institutes of Health [P01 HL90553, U01 HL66621]; American Heart Association [09BGIA2080363]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553, U01HL066621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL90553 (to K. R. and S. G. Y.) and U01 HL66621 (to S. G. Y.). This work was also supported by American Heart Association Grant 09BGIA2080363 (to L. V.).	Arnyasi M, 2006, J ANIM BREED GENET, V123, P198, DOI 10.1111/j.1439-0388.2006.00588.x; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Binas B, 2007, MOL CELL BIOCHEM, V299, P75, DOI 10.1007/s11010-005-9043-0; Binas B, 1999, FASEB J, V13, P805, DOI 10.1096/fasebj.13.8.805; Brauch KM, 2005, PHYSIOL GENOMICS, V23, P227, DOI 10.1152/physiolgenomics.00076.2005; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Cabrero A, 2001, DIABETES, V50, P1883, DOI 10.2337/diabetes.50.8.1883; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Chmurzynska A, 2007, ANIM BIOTECHNOL, V18, P37, DOI 10.1080/10495390600671560; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cho S, 2008, BMB REP, V41, P29, DOI 10.5483/BMBRep.2008.41.1.029; Coe NR, 1999, J LIPID RES, V40, P967; Coe NR, 1998, BBA-LIPID LIPID MET, V1391, P287, DOI 10.1016/S0005-2760(97)00205-1; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daikoku T, 1997, FEBS LETT, V410, P383, DOI 10.1016/S0014-5793(97)00619-4; de Meis L, 2005, BIOSCIENCE REP, V25, P181, DOI 10.1007/s10540-005-2884-7; de Meis L, 2006, J BIOL CHEM, V281, P16384, DOI 10.1074/jbc.M600678200; Eddy SF, 2004, BBA-GENE STRUCT EXPR, V1676, P63, DOI 10.1016/j.bbaexp.2003.10.008; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Erol E, 2004, AM J PHYSIOL-ENDOC M, V287, pE977, DOI 10.1152/ajpendo.00139.2004; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Guerra C, 1998, J CLIN INVEST, V102, P1724, DOI 10.1172/JCI4532; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hittel D, 2001, BBA-GENE STRUCT EXPR, V1522, P238, DOI 10.1016/S0167-4781(01)00338-4; Hittel D, 2002, ARCH BIOCHEM BIOPHYS, V401, P244, DOI 10.1016/S0003-9861(02)00048-6; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee SH, 2004, J LIPID RES, V45, P1674, DOI 10.1194/jlr.M400039-JLR200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Murphy EJ, 2004, J BIOL CHEM, V279, P34481, DOI 10.1074/jbc.M314263200; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; ROSS SR, 1992, P NATL ACAD SCI USA, V89, P7561, DOI 10.1073/pnas.89.16.7561; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Shabalina IG, 2010, BBA-BIOENERGETICS, V1797, P968, DOI 10.1016/j.bbabio.2010.02.033; Shearer J, 2005, DIABETES, V54, P3133, DOI 10.2337/diabetes.54.11.3133; Shin Hyoung Doo, 2003, Hum Mutat, V22, P180; Storch J, 2002, MOL CELL BIOCHEM, V239, P25, DOI 10.1023/A:1020546321508; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Ueno T, 2008, AM J HYPERTENS, V21, P691, DOI 10.1038/ajh.2008.40; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOOTAN MG, 1994, J BIOL CHEM, V269, P10517; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Yamashita H, 2008, BIOCHEM BIOPH RES CO, V377, P632, DOI 10.1016/j.bbrc.2008.10.041; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	61	67	70	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 7	2011	286	1					380	390		10.1074/jbc.M110.184754	http://dx.doi.org/10.1074/jbc.M110.184754			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	700YZ	21044951	hybrid, Green Published			2022-12-27	WOS:000285782800041
J	Ishii, T; Shiomi, Y; Takami, T; Murakami, Y; Ohnishi, N; Nishitani, H				Ishii, Takashi; Shiomi, Yasushi; Takami, Toshihiro; Murakami, Yusuke; Ohnishi, Naho; Nishitani, Hideo			Proliferating Cell Nuclear Antigen-dependent Rapid Recruitment of Cdt1 and CRL4(Cdt2) at DNA-damaged Sites after UV Irradiation in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE; S-PHASE; H2AX PHOSPHORYLATION; EUKARYOTIC CELLS; CHROMOSOMAL DNA; RE-REPLICATION; PCNA; DEGRADATION; CHROMATIN	The licensing factor Cdt1 is degraded by CRL4(Cdt2) ubiquitin ligase dependent on proliferating cell nuclear antigen (PCNA) during S phase and when DNA damage is induced in G(1) phase. Association of both Cdt2 and PCNA with chromatin was observed in S phase and after UV irradiation. Here we used a micropore UV irradiation assay to examine Cdt2 accumulation at cyclobutane pyrimidine dimer-containing DNA-damaged sites in the process of Cdt1 degradation in HeLa cells. Cdt2, present in the nucleus throughout the cell cycle, accumulated rapidly at damaged DNA sites during G1 phase. The recruitment of Cdt2 is dependent on prior PCNA chromatin binding because Cdt2 association was prevented when PCNA was silenced. Cdt1 was also recruited to damaged sites soon after UV irradiation through its PIP-box. As Cdt1 was degraded, the Cdt2 signal at damaged sites was reduced, but PCNA, cyclobutane pyrimidine dimer, and XPA (xeroderma pigmentosum, complementation group A) signals remained at the same levels. These findings suggest that Cdt1 degradation following UV irradiation occurs rapidly at damaged sites due to PCNA chromatin loading and the recruitment of Cdt1 and CRL4Cdt2, before DNA damage repair is completed.	[Ishii, Takashi; Shiomi, Yasushi; Takami, Toshihiro; Murakami, Yusuke; Ohnishi, Naho; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kouto 3-2-1, Kamigori, Hyogo 6781297, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Naito Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-aid for Scientific Research (B), Scientific Research on Priority Areas, and the Global Center of Excellence Program from the Ministry of Education, Culture, Sport, Science, and Technology of Japan and the Naito Foundation (to H.N.); and Grants-in-aid for Scientific Research and the Uehara Memorial Foundation (to Y.S.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Liu EB, 2004, J BIOL CHEM, V279, P17283, DOI 10.1074/jbc.C300549200; Marteijn JA, 2009, J CELL BIOL, V186, P835, DOI 10.1083/jcb.200902150; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsumoto M, 2007, J CELL SCI, V120, P1104, DOI 10.1242/jcs.03391; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Terai K, 2010, MOL CELL, V37, P143, DOI 10.1016/j.molcel.2009.12.018; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597; Xouri G, 2007, CELL CYCLE, V6, P1549, DOI 10.4161/cc.6.13.4455; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200	40	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41993	42000		10.1074/jbc.M110.161661	http://dx.doi.org/10.1074/jbc.M110.161661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20929861	hybrid, Green Published			2022-12-27	WOS:000285622600085
J	Kretzer, NM; Cherian, MT; Mao, CJ; Aninye, IO; Reynolds, PD; Schiff, R; Hergenrother, PJ; Nordeen, SK; Wilson, EM; Shapiro, DJ				Kretzer, Nicole M.; Cherian, Milu T.; Mao, Chengjian; Aninye, Irene O.; Reynolds, Philip D.; Schiff, Rachel; Hergenrother, Paul J.; Nordeen, Steven K.; Wilson, Elizabeth M.; Shapiro, David J.			A Noncompetitive Small Molecule Inhibitor of Estrogen-regulated Gene Expression and Breast Cancer Cell Growth That Enhances Proteasome-dependent Degradation of Estrogen Receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; CYCLIN D1; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; COACTIVATOR INTERACTION; ENDOCRINE RESISTANCE; PEPTIDE ANTAGONISTS; ANDROGEN RECEPTOR; RESPONSE ELEMENTS; NUCLEAR RECEPTORS	The mechanisms responsible for 17 beta-estradiol (E-2)-stimulated breast cancer growth and development of resistance to tamoxifen and other estrogen receptor alpha (ER alpha) antagonists are not fully understood. We describe a new tool for dissecting ER alpha action in breast cancer, p-fluoro-4-(1,2,3,6,-tetrahydro-1,3-dimethyl-2-oxo-6-thionpurin-8-ylthio) (TPSF), a potent small-molecule inhibitor of estrogen receptor alpha that does not compete with estrogen for binding to ER alpha. TPSF noncompetitively inhibits estrogen-dependent ER alpha-mediated gene expression with little inhibition of transcriptional activity by NF-kappa B or the androgen or glucocorticoid receptor. TPSF inhibits E-2-ER alpha-mediated induction of the proteinase inhibitor 9 gene, which is activated by ER alpha binding to estrogen response element DNA, and the cyclin D1 gene, which is induced by tethering ER alpha to other DNA-bound proteins. TPSF inhibits anchorage-dependent and anchorage-independent E-2-ER alpha-stimulated growth of MCF-7 cells but does not inhibit growth of ER-negative MDA-MB-231 breast cancer cells. TPSF also inhibits ER alpha-dependent growth in three cellular models for tamoxifen resistance; that is, 4-hydroxytamoxifen-stimulated MCF7ER alpha HA cells that overexpress ER alpha, fully tamoxifen-resistant BT474 cells that have amplified HER-2 and AIB1, and partially tamoxifen-resistant ZR-75 cells. TPSF reduces ER alpha protein levels in MCF-7 cells and several other cell lines without altering ER alpha mRNA levels. The proteasome inhibitor MG132 abolished down-regulation of ER alpha by TPSF. Thus, TPSF affects receptor levels at least in part due to its ability to enhance proteasome-dependent degradation of ER alpha. TPSF represents a novel class of ER inhibitor with significant clinical potential.	[Cherian, Milu T.; Aninye, Irene O.; Shapiro, David J.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Kretzer, Nicole M.; Mao, Chengjian] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Hergenrother, Paul J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Reynolds, Philip D.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Schiff, Rachel] Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA; [Nordeen, Steven K.] Univ Colorado, Dept Pathol, Denver, CO 80045 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; University of Colorado System; University of Colorado Denver	Shapiro, DJ (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	djshapir@illinois.edu		Aninye, Irene/0000-0002-1747-9148	National Institutes of Health [RO1 DK 071909, RO1 HD 16910, PO1-CA77739]; Endocrine Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK 071909 (to D. J. S.) and RO1 HD 16910 and PO1-CA77739 (to E. M. W.). This work was also supported by a Bridge grant from the Endocrine Society (to D. J. S.). The University of Illinois at Urbana-Champaign has filed a novel use patent that claims TPSF. D. J. Shapiro, N. M. Patterson, M. Cherian, and C. Mao are co-inventors on the patent.	Abukhdeir AM, 2008, P NATL ACAD SCI USA, V105, P288, DOI 10.1073/pnas.0710887105; Anderson H, 2007, J STEROID BIOCHEM, V106, P49, DOI 10.1016/j.jsbmb.2007.05.024; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Arteaga CL, 1999, JNCI-J NATL CANCER I, V91, P46, DOI 10.1093/jnci/91.1.46; CANNEY PA, 1987, LANCET, V1, P36; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Castro-Rivera E, 2001, J BIOL CHEM, V276, P30853, DOI 10.1074/jbc.M103339200; Chang CY, 2003, METHOD ENZYMOL, V364, P118; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; CORADINI D, 1995, CANCER DETECT PREV, V19, P348; Cunningham TD, 2007, CELL IMMUNOL, V245, P32, DOI 10.1016/j.cellimm.2007.03.004; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Glass CK, 2000, GENE DEV, V14, P121; Grillo M, 2006, BREAST CANCER RES TR, V95, P185, DOI 10.1007/s10549-005-9066-y; Grunberg SM, 2006, CANCER INVEST, V24, P727, DOI 10.1080/07357900601062339; Gunther JR, 2008, ACS CHEM BIOL, V3, P282, DOI 10.1021/cb800056r; Henderson BE, 2000, CARCINOGENESIS, V21, P427, DOI 10.1093/carcin/21.3.427; Hoffmann J, 2004, J NATL CANCER I, V96, P210, DOI 10.1093/jnci/djh022; HOWELL A, 1992, ANN ONCOL, V3, P611, DOI 10.1093/oxfordjournals.annonc.a058286; Ishii Y, 2008, CANCER RES, V68, P852, DOI 10.1158/0008-5472.CAN-07-2879; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Jiang XG, 2006, ENDOCRINOLOGY, V147, P1419, DOI 10.1210/en.2005-0996; Jiang XG, 2008, ENDOCRINOLOGY, V149, P5366, DOI 10.1210/en.2008-0857; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Jordan VC, 2001, ANN NY ACAD SCI, V949, P72; Katzenellenbogen BS, 1997, BREAST CANCER RES TR, V44, P23, DOI 10.1023/A:1005835428423; KATZENELLENBOGEN JA, 1973, BIOCHEMISTRY-US, V12, P4085, DOI 10.1021/bi00745a010; Kilker RL, 2006, CANCER RES, V66, P11478, DOI 10.1158/0008-5472.CAN-06-1755; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Krieg SA, 2001, MOL ENDOCRINOL, V15, P1971, DOI 10.1210/me.15.11.1971; Kummer JA, 2007, CELL DEATH DIFFER, V14, P1486, DOI 10.1038/sj.cdd.4402152; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; LaFrate AL, 2008, BIOORGAN MED CHEM, V16, P10075, DOI 10.1016/j.bmc.2008.10.007; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Naughton C, 2007, MOL ENDOCRINOL, V21, P2615, DOI 10.1210/me.2007-0110; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; NORDEEN SK, 1989, MOL ENDOCRINOL, V3, P1270, DOI 10.1210/mend-3-8-1270; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Powell E, 2010, J BIOL CHEM, V285, P16125, DOI 10.1074/jbc.M110.104356; Qin CH, 1999, ENDOCRINOLOGY, V140, P2501, DOI 10.1210/en.140.6.2501; Ramondetta LM, 2009, CANCER-AM CANCER SOC, V115, P1867, DOI 10.1002/cncr.24197; REESE JC, 1992, MOL CELL BIOL, V12, P4531, DOI 10.1128/MCB.12.10.4531; REESE JC, 1991, NUCLEIC ACIDS RES, V19, P6595, DOI 10.1093/nar/19.23.6595; Robertson JFR, 2007, ONCOLOGIST, V12, P774, DOI 10.1634/theoncologist.12-7-774; ROMAIN S, 1994, INT J CANCER, V59, P17, DOI 10.1002/ijc.2910590105; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; ten Berge RL, 2003, HISTOPATHOLOGY, V43, P462, DOI 10.1046/j.1365-2559.2003.01726.x; ten Berge RL, 2003, J PATHOL, V200, P4, DOI 10.1002/path.1331; ten Berge RL, 2002, BLOOD, V99, P4540, DOI 10.1182/blood.V99.12.4540; THORPE SM, 1993, EUR J CANCER, V29A, P971, DOI 10.1016/S0959-8049(05)80204-7; van Houdt IS, 2005, CLIN CANCER RES, V11, P6400, DOI 10.1158/1078-0432.CCR-05-0306; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wang SY, 2004, BIOTECHNIQUES, V37, P807, DOI 10.2144/04375RR01; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180	75	17	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41863	41873		10.1074/jbc.M110.183723	http://dx.doi.org/10.1074/jbc.M110.183723			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	21041310	hybrid, Green Published			2022-12-27	WOS:000285622600074
J	Melani, R; Tomati, V; Galietta, LJV; Zegarra-Moran, O				Melani, Raffaella; Tomati, Valeria; Galietta, Luis J. V.; Zegarra-Moran, Olga			Modulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity and Genistein Binding by Cytosolic pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CL-CHANNEL ACTIVITY; CHLORIDE-CHANNEL; AFFINITY ACTIVATORS; DELTA-F508 CFTR; ATP-BINDING; WILD-TYPE; INHIBITION; DOMAINS; POTENTIATORS; SENSITIVITY	Potentiators are molecules that increase the activity of the cystic fibrosis transmembrane conductance regulator (CFTR). Some potentiators can also inhibit CFTR at higher concentrations. The activating binding site is thought to be located at the interface of the dimer formed by the two nucleotide-binding domains. We have hypothesized that if binding of potentiators involves titratable residues forming salt bridges, then modifications of cytosolic pH (pH(i)) would alter the binding affinity. Here, we analyzed the effect of pH(i) on CFTR activation and on the binding of genistein, a well known CFTR potentiator. We found that pH(i) does modify CFTR maximum current (I-m) and half-activation concentration (K-d): I-m = 127.7, 185.5, and 231.8 mu A/cm(2) and K-d = 32.7, 56.6 and 71.9 mu M at pH 6, 7.35, and 8, respectively. We also found that the genistein apparent dissociation constant for activation (K-a) increased at alkaline pH(i), near cysteine pK (K-a = 1.83, 1.81 and 4.99 mu M at pH(i) 6, 7.35, and 8, respectively), suggesting the involvement of cysteines in the binding site. Mutations of cysteine residues predicted to be within (Cys-491) or outside (Cys-1344) the potentiator-binding site showed that Cys-491 is responsible for the sensitivity of potentiator binding to alkaline pH(i). Effects of pH(i) on inhibition by high genistein doses were also analyzed. Our results extend previous data about multiple effects of pH(i) on CFTR activity and demonstrate that binding of potentiators involves salt bridge formation with amino acids of nucleotide-binding domain 1.	[Melani, Raffaella; Tomati, Valeria; Galietta, Luis J. V.; Zegarra-Moran, Olga] Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini	Zegarra-Moran, O (corresponding author), Ist Giannina Gaslini, Genet Mol Lab, I-16148 Genoa, Italy.	ozegarra@unige.it	Tomati, Valeria/AAB-4543-2021; Galietta, Luis JV/HCG-8692-2022	Tomati, Valeria/0000-0003-3761-1916; Galietta, Luis/0000-0001-8686-3461	Italian Cystic Fibrosis Foundation [FFC2/2008]; Mille Bambini a Via Margutta Onlus, Blunotte; Lega Italiana Fibrosi Cistica-Associazione Toscana	Italian Cystic Fibrosis Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Mille Bambini a Via Margutta Onlus, Blunotte; Lega Italiana Fibrosi Cistica-Associazione Toscana	This work was supported by Italian Cystic Fibrosis Foundation Grant FFC2/2008, Mille Bambini a Via Margutta Onlus, Blunotte, and Lega Italiana Fibrosi Cistica-Associazione Toscana.	Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Al-Nakkash L, 2001, J PHARMACOL EXP THER, V296, P464; ALBERTY RA, 1951, J BIOL CHEM, V193, P425; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; Berger AL, 2005, J BIOL CHEM, V280, P5221, DOI 10.1074/jbc.M412972200; Caci E, 2003, AM J PHYSIOL-LUNG C, V285, pL180, DOI 10.1152/ajplung.00351.2002; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; GREEN WN, 1991, ANNU REV PHYSIOL, V53, P341, DOI 10.1146/annurev.ph.53.030191.002013; GRIBKOFF VK, 1994, J BIOL CHEM, V269, P10983; Harrington MA, 2002, BIOPHYS J, V82, P1278, DOI 10.1016/S0006-3495(02)75484-2; Huang SY, 2009, J MOL GRAPH MODEL, V27, P822, DOI 10.1016/j.jmgm.2008.12.005; Kurth M. J., 2005, MOL PHARM, V67, P1797; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Melin P, 2005, J MEMBRANE BIOL, V208, P203, DOI 10.1007/s00232-005-7001-0; Moran O, 2005, FEBS LETT, V579, P3979, DOI 10.1016/j.febslet.2005.06.026; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Murthy M, 2005, EUR J PHARMACOL, V516, P118, DOI 10.1016/j.ejphar.2005.04.037; Noel S, 2006, J PHARMACOL EXP THER, V319, P349, DOI 10.1124/jpet.106.104521; Pedemonte N, 2005, MOL PHARMACOL, V68, P1736, DOI 10.1124/mol.105.015149; Reddy MM, 1998, AM J PHYSIOL-CELL PH, V275, pC1040, DOI 10.1152/ajpcell.1998.275.4.C1040; Sheppard DN, 1999, PHYSIOL REV, V79, P23; SHERRY AM, 1994, AM J PHYSIOL, V266, pC870, DOI 10.1152/ajpcell.1994.266.3.C870; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang F, 1998, J GEN PHYSIOL, V111, P477, DOI 10.1085/jgp.111.3.477; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zegarra-Moran O, 2007, J BIOL CHEM, V282, P9098, DOI 10.1074/jbc.M611411200; Zielonka J, 2003, FREE RADICAL BIO MED, V35, P958, DOI 10.1016/S0891-5849(03)00472-6	37	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41591	41596		10.1074/jbc.M110.166850	http://dx.doi.org/10.1074/jbc.M110.166850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20974851	Green Published, hybrid			2022-12-27	WOS:000285622600046
J	Pike, JE; Henry, RA; Burgers, PMJ; Campbell, JL; Bambara, RA				Pike, Jason E.; Henry, Ryan A.; Burgers, Peter M. J.; Campbell, Judith L.; Bambara, Robert A.			An Alternative Pathway for Okazaki Fragment Processing RESOLUTION OF FOLD-BACK FLAPS BY Pif1 HELICASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DNA-POLYMERASE-DELTA; SINGLE-STRANDED-DNA; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; FLAP ENDONUCLEASE-1; PRIMER REMOVAL; LIGATABLE NICK; YEAST; MATURATION	Two pathways have been proposed for eukaryotic Okazaki fragment RNA primer removal. Results presented here provide evidence for an alternative pathway. Primer extension by DNA polymerase delta (pol delta) displaces the downstream fragment into an RNA-initiated flap. Most flaps are cleaved by flap endonuclease 1 (FEN1) while short, and the remaining nicks joined in the first pathway. A small fraction escapes immediate FEN1 cleavage and is further lengthened by Pif1 helicase. Long flaps are bound by replication protein A (RPA), which inhibits FEN1. In the second pathway, Dna2 nuclease cleaves an RPA-bound flap and displaces RPA, leaving a short flap for FEN1. Pif1 flap lengthening creates a requirement for Dna2. This relationship should not have evolved unless Pif1 had an important role in fragment processing. In this study, biochemical reconstitution experiments were used to gain insight into this role. Pif1 did not promote synthesis through GC-rich sequences, which impede strand displacement. Pif1 was also unable to open fold-back flaps that are immune to cleavage by either FEN1 or Dna2 and cannot be bound by RPA. However, Pif1 working with pol delta readily unwound a full-length Okazaki fragment initiated by a fold-back flap. Additionally, a fold-back in the template slowed pol delta synthesis, so that the fragment could be removed before ligation to the lagging strand. These results suggest an alternative pathway in which Pif1 removes Okazaki fragments initiated by fold-back flaps in vivo.	[Pike, Jason E.; Henry, Ryan A.; Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Burgers, Peter M. J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; Washington University (WUSTL); California Institute of Technology	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	Burgers, Peter M/AAW-6621-2021		National Institutes of Health [GM024441, GM078666, GM032431]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032431, R01GM024441, R01GM078666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.), GM078666 (to J. L. C.), and GM032431 (to P. M. J. B.).	Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bartos JD, 2008, J BIOL CHEM, V283, P21758, DOI 10.1074/jbc.M800856200; Boule JB, 2006, NUCLEIC ACIDS RES, V34, P4147, DOI 10.1093/nar/gkl561; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Burgers PMJ, 1998, J BIOL CHEM, V273, P19756, DOI 10.1074/jbc.273.31.19756; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Kao HI, 2003, CRIT REV BIOCHEM MOL, V38, P433, DOI 10.1080/10409230390259382; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kornberg A., 1992, DNA REPLICATION, VSecond, P113; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Pike JE, 2009, J BIOL CHEM, V284, P25170, DOI 10.1074/jbc.M109.023325; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200	37	38	39	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					41712	41723		10.1074/jbc.M110.146894	http://dx.doi.org/10.1074/jbc.M110.146894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20959454	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000285622600058
J	Schmid, S; Mordstein, M; Kochs, G; Garcia-Sastre, A; tenOever, BR				Schmid, Sonja; Mordstein, Markus; Kochs, Georg; Garcia-Sastre, Adolfo; tenOever, Benjamin R.			Transcription Factor Redundancy Ensures Induction of the Antiviral State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTERFERON-INDUCED TRANSCRIPTION; NECROSIS-FACTOR-ALPHA; REGULATORY FACTOR-I; CRYSTAL-STRUCTURE; GENE-EXPRESSION; NUCLEAR FACTORS; BETA ENHANCER; DNA-BINDING; POSITIVE FEEDBACK	The transcriptional response to virus infection is thought to be predominantly induced by interferon (IFN) signaling. Here we demonstrate that, in the absence of IFN signaling, an IFN-like transcriptome is still maintained. This transcriptional activity is mediated from IFN-stimulated response elements (ISREs) that bind to both the IFN-stimulated gene factor 3 (ISGF3) as well as to IFN response factor 7 (IRF7). Through a combination of both in vitro biochemistry and in vivo transcriptional profiling, we have dissected what constitutes IRF-specific, ISGF3-specific, or universal ISREs. Taken together, the data presented here suggest that IRF7 can induce an IFN-like transcriptome in the absence of type-I or -III signaling and therefore provides a level of redundancy to cells to ensure the induction of the antiviral state.	[tenOever, Benjamin R.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; tenOever, Benjamin R.] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Mordstein, Markus; Kochs, Georg] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Freiburg	tenOever, BR (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Benjamin.tenOever@mssm.edu		Garcia-Sastre, Adolfo/0000-0002-6551-1827; Schmid, Sonja/0000-0002-1946-5970	National Institutes of Health NIAID [R01AI080624, R01AI046954, U19AI083025, U01AI082970]; CRIP (Center for Research in Influenza Pathogenesis) [HHSN266200700010C]; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, U01AI082970, R01AI080624, U19AI083025] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRIP (Center for Research in Influenza Pathogenesis); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health NIAID Grants R01AI080624 (to B. R. t. O.) and R01AI046954, U19AI083025, and U01AI082970 and by CRIP (Center for Research in Influenza Pathogenesis, HHSN266200700010C), a NIAID-funded Center of Excellence for Influenza Research and Surveillance (CEIRS) (to A.G.-S.).	Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Asano A, 2003, GENE, V306, P105, DOI 10.1016/S0378-1119(03)00428-1; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Baum A, 2010, AMINO ACIDS, V38, P1283, DOI 10.1007/s00726-009-0374-0; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; COHEN B, 1988, EMBO J, V7, P1411, DOI 10.1002/j.1460-2075.1988.tb02958.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Dumoutier L, 2004, J BIOL CHEM, V279, P32269, DOI 10.1074/jbc.M404789200; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Izaguirre A, 2003, J LEUKOCYTE BIOL, V74, P1125, DOI 10.1189/jlb.0603255; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; LUSTER AD, 1987, MOL CELL BIOL, V7, P3723, DOI 10.1128/MCB.7.10.3723; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Peters KL, 2002, P NATL ACAD SCI USA, V99, P6322, DOI 10.1073/pnas.092133199; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; RUTHERFORD MN, 1988, EMBO J, V7, P751, DOI 10.1002/j.1460-2075.1988.tb02872.x; SANCEAU J, 1995, J BIOL CHEM, V270, P27920, DOI 10.1074/jbc.270.46.27920; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; SHIRAYOSHI Y, 1988, P NATL ACAD SCI USA, V85, P5884, DOI 10.1073/pnas.85.16.5884; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	60	85	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 31	2010	285	53					42013	42022		10.1074/jbc.M110.165936	http://dx.doi.org/10.1074/jbc.M110.165936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	698VV	20943654	Green Published, hybrid			2022-12-27	WOS:000285622600087
J	Bryde, S; Hennrich, H; Verhulst, PM; Devaux, PF; Lenoir, G; Holthuis, JCM				Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Devaux, Philippe F.; Lenoir, Guillaume; Holthuis, Joost C. M.			CDC50 Proteins Are Critical Components of the Human Class-1 P-4-ATPase Transport Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PUTATIVE AMINOPHOSPHOLIPID TRANSLOCASES; YEAST PLASMA-MEMBRANE; SODIUM-POTASSIUM PUMP; LIPID ASYMMETRY; PHOSPHOLIPID TRANSLOCATION; CRYSTAL-STRUCTURE; PHOSPHATIDYLSERINE ASYMMETRY; SACCHAROMYCES-CEREVISIAE; HEREDITARY CHOLESTASIS	Members of the P4 subfamily of P-type ATPases catalyze phospholipid transport and create membrane lipid asymmetry in late secretory and endocytic compartments. P-type ATPases usually pump small cations and the transport mechanism involved appears conserved throughout the family. How this mechanism is adapted to flip phospholipids remains to be established. P4-ATPases form heteromeric complexes with CDC50 proteins. Dissociation of the yeast P-4-ATPase Drs2p from its binding partner Cdc50p disrupts catalytic activity (Lenoir, G., Williamson, P., Puts, C. F., and Holthuis, J. C. (2009) J. Biol. Chem. 284, 17956-17967), suggesting that CDC50 subunits play an intimate role in the mechanism of transport by P4-ATPases. The human genome encodes 14 P4-ATPases while only three human CDC50 homologues have been identified. This implies that each human CDC50 protein interacts with multiple P4-ATPases or, alternatively, that some human P4-ATPases function without a CDC50 binding partner. Here we show that human CDC50 proteins each bind multiple class-1 P4-ATPases, and that in all cases examined, association with a CDC50 subunit is required for P4-ATPase export from the ER. Moreover, we find that phosphorylation of the catalytically important Asp residue in human P4-ATPases ATP8B1 and ATP8B2 is critically dependent on their CDC50 subunit. These results indicate that CDC50 proteins are integral part of the P4-ATPase flippase machinery.	[Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Holthuis, Joost C. M.] Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, NL-3584 CH Utrecht, Netherlands; [Bryde, Susanne; Hennrich, Hanka; Verhulst, Patricia M.; Holthuis, Joost C. M.] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands; [Bryde, Susanne; Devaux, Philippe F.] Inst Biol Physicochim, CNRS, UMR 7099, F-75005 Paris, France; [Lenoir, Guillaume] CEA, iBiTecS Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France; [Lenoir, Guillaume] CNRS, URA Syst Membranaires Photobiol Stress & Detoxica, F-91191 Gif Sur Yvette, France; [Lenoir, Guillaume] Univ Paris 11, F-91405 Orsay, France	Utrecht University; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Holthuis, JCM (corresponding author), Univ Utrecht, Dept Membrane Enzymol, Bijvoet Ctr, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	j.c.holthuis@uu.nl	Lenoir, Guillaume/I-4002-2019; Holthuis, Joost/AAL-9157-2020	Lenoir, Guillaume/0000-0002-8759-5179; Holthuis, Joost/0000-0001-8912-1586	Dutch Organization of Sciences (NWO-CW); Utrecht High Potential Program; European Union	Dutch Organization of Sciences (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); Utrecht High Potential Program; European Union(European Commission)	This work was supported by grants from the Dutch Organization of Sciences (NWO-CW), the Utrecht High Potential Program (to J. C. M. H.).; Supported by the European Union Framework V Program (the Flippase Project).	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; CANTLEY LC, 1978, J BIOL CHEM, V253, P7361; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Darland-Ransom M, 2008, SCIENCE, V320, P528, DOI 10.1126/science.1155847; Devaux PF, 2000, BIOCHIMIE, V82, P497, DOI 10.1016/S0300-9084(00)00209-1; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Eppens EF, 2001, J HEPATOL, V35, P436, DOI 10.1016/S0168-8278(01)00158-1; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Kato U, 2002, J BIOL CHEM, V277, P37855, DOI 10.1074/jbc.M205564200; Katoh Y, 2004, ONCOL REP, V12, P939; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paterson JK, 2006, BIOCHEMISTRY-US, V45, P5367, DOI 10.1021/bi052359b; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pomorski T, 1999, BIOCHEMISTRY-US, V38, P142, DOI 10.1021/bi981244n; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; SARKADI B, 1986, J BIOL CHEM, V261, P9552; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SMITH RL, 1980, J BIOL CHEM, V255, P9852; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; ZACHOWSKI A, 1989, NATURE, V340, P75, DOI 10.1038/340075a0; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	49	91	96	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40562	40572		10.1074/jbc.M110.139543	http://dx.doi.org/10.1074/jbc.M110.139543			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20961850	hybrid, Green Published			2022-12-27	WOS:000285414400019
J	Jones, MK; Zhang, L; Catte, A; Li, L; Oda, MN; Ren, G; Segrest, JP				Jones, Martin K.; Zhang, Lei; Catte, Andrea; Li, Ling; Oda, Michael N.; Ren, Gang; Segrest, Jere P.			Assessment of the Validity of the Double Superhelix Model for Reconstituted High Density Lipoproteins A COMBINED COMPUTATIONAL-EXPERIMENTAL APPROACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRON-SCATTERING; FORCE-FIELD; APOA-I; HDL; CHOLESTEROL; STABILITY; PHOSPHATIDYLCHOLINE; RECOMBINANTS; SIMULATION; MORPHOLOGY	For several decades, the standard model for high density lipoprotein (HDL) particles reconstituted from apolipoprotein A-I (apoA-I) and phospholipid (apoA-I/HDL) has been a discoidal particle similar to 100 angstrom in diameter and the thickness of a phospholipid bilayer. Recently, Wu et al. (Wu, Z., Gogonea, V., Lee, X., Wagner, M. A., Li, X. M., Huang, Y., Undurti, A., May, R. P., Haertlein, M., Moulin, M., Gutsche, I., Zaccai, G., Didonato, J. A., and Hazen, S. L. (2009) J. Biol. Chem. 284, 3660536619) used small angle neutron scattering to develop a new model they termed double superhelix (DSH) apoA-I that is dramatically different from the standard model. Their model possesses an open helical shape that wraps around a prolate ellipsoidal type I hexagonal lyotropic liquid crystalline phase. Here, we used three independent approaches, molecular dynamics, EM tomography, and fluorescence resonance energy transfer spectroscopy (FRET) to assess the validity of the DSH model. (i) By using molecular dynamics, two different approaches, all-atom simulated annealing and coarse-grained simulation, show that initial ellipsoidal DSH particles rapidly collapse to discoidal bilayer structures. These results suggest that, compatible with current knowledge of lipid phase diagrams, apoA-I cannot stabilize hexagonal I phase particles of phospholipid. (ii) By using EM, two different approaches, negative stain and cryo-EM tomography, show that reconstituted apoA-I/HDL particles are discoidal in shape. (iii) By using FRET, reconstituted apoA-I/HDL particles show a 28 -34-angstrom intermolecular separation between terminal domain residues 40 and 240, a distance that is incompatible with the dimensions of the DSH model. Therefore, we suggest that, although novel, the DSH model is energetically unfavorable and not likely to be correct. Rather, we conclude that all evidence supports the likelihood that reconstituted apoA-I/HDL particles, in general, are discoidal in shape.	[Jones, Martin K.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jones, Martin K.; Catte, Andrea; Li, Ling; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA; [Jones, Martin K.; Catte, Andrea; Segrest, Jere P.] Univ Alabama Birmingham, Ctr Computat & Struct Dynam, Birmingham, AL 35294 USA; [Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA; [Zhang, Lei; Ren, Gang] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Oda, Michael N.] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Segrest, JP (corresponding author), 1808 7th Ave S,BDB 630, Birmingham, AL 35294 USA.	segrest@uab.edu	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Catte, Andrea/0000-0002-1124-1788; Li, Ling/0000-0002-9245-7387	National Institutes of Health [P01 HL-34343]; W. M. Keck Foundation [011808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 HL-34343 (to J. P. S.). This work was also supported by W. M. Keck Foundation (No. 011808, to G. R.).	Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; ANANTHARAMAIAH GM, 1985, J BIOL CHEM, V260, P248; Atkinson D, 1980, Ann N Y Acad Sci, V348, P284, DOI 10.1111/j.1749-6632.1980.tb21308.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; Catte A, 2008, BIOPHYS J, V94, P2306, DOI 10.1529/biophysj.107.115857; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Davidson WS, 2007, J BIOL CHEM, V282, P22249, DOI 10.1074/jbc.R700014200; Feller S E, 1997, Pac Symp Biocomput, P142; FORTE T, 1971, J CLIN INVEST, V50, P1141, DOI 10.1172/JCI106586; FORTE TM, 1971, BIOCHIM BIOPHYS ACTA, V248, P381, DOI 10.1016/0005-2760(71)90026-9; Gogonea V, 2010, BIOCHEMISTRY-US, V49, P7323, DOI 10.1021/bi100588a; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones MK, 2009, BIOCHEMISTRY-US, V48, P11196, DOI 10.1021/bi901242k; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; MASSEY JB, 1981, BIOCHEMISTRY-US, V20, P1575, DOI 10.1021/bi00509a026; MASSEY JB, 1985, BIOCHEMISTRY-US, V24, P7110, DOI 10.1021/bi00346a014; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1987, J LIPID RES, V28, P719; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Schlenkrich Michael, 1996, P31; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Shih AY, 2008, BIOPHYS J, V94, pL87, DOI 10.1529/biophysj.108.131581; SLOOP CH, 1983, J LIPID RES, V24, P1429; TALL AR, 1977, BIOCHIM BIOPHYS ACTA, V487, P145, DOI 10.1016/0005-2760(77)90051-0; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; WLODAWER A, 1979, FEBS LETT, V104, P231, DOI 10.1016/0014-5793(79)80821-2; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; YEAGLE PL, 1987, MEMBRANES CELLS, P68; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	48	48	48	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41161	41171		10.1074/jbc.M110.187799	http://dx.doi.org/10.1074/jbc.M110.187799			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20974855	Green Published, hybrid			2022-12-27	WOS:000285414400078
J	Liu, QA; Gehring, K				Liu, Qian; Gehring, Kalle			Heterodimerization of BAK and MCL-1 Activated by Detergent Micelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; BH3-ONLY PROTEINS; BH3 DOMAINS; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL APOPTOSIS; OLIGOMERIZES BAK; DOWN-REGULATION; CYTOCHROME-C; DEATH; BCL-X(L)	BAK is a key protein mediating mitochondrial outer membrane permeabilization; however, its behavior in the membrane is poorly understood. Here, we characterize the conformational changes in BAK and MCL-1 using detergents to mimic the membrane environment and study their interaction by in vitro pulldown experiments, size exclusion chromatography, titration calorimetry, and NMR spectroscopy. The nonionic detergent IGEPAL has little impact on the structure of MCL-1 but induces a conformational change in BAK, whereby its BH3 region is able to engage the hydrophobic groove of MCL-1. Although the zwitterionic detergent CHAPS induces only minor conformational changes in both proteins, it is still able to initiate heterodimerization. The complex of MCL-1 and BAK can be disrupted by a BID-BH3 peptide, which acts through binding to MCL-1, but a mutant peptide, BAK-BH3-L78A, with low affinity for MCL-1 failed to dissociate the complex. The mutation L78A in BAK prevented binding to MCL-1, thus demonstrating the essential role of the BH3 region of BAK in its regulation by MCL-1. Our results validate the current models for the activation of BAK and highlight the potential value of small molecule inhibitors that target MCL-1 directly.	McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Liu, Qian; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Gehring, Kalle] McGill Univ, Quebec Eastern Canada High Field NMR Facil, Montreal, PQ H3A 2A7, Canada	McGill University; McGill University; McGill University	Gehring, K (corresponding author), 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019; liu, qian/HDM-2936-2022	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; 	Canadian Institutes of Health Research [MOP-81277]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-81277.	Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Derenne S, 2002, BLOOD, V100, P194, DOI 10.1182/blood.V100.1.194; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Gillissen B, 2010, J CELL BIOL, V188, P851, DOI 10.1083/jcb.200912070; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Haker G, 2007, ARCH BIOCHEM BIOPHYS, V462, P150, DOI 10.1016/j.abb.2006.12.022; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Ivashyna O, 2009, J BIOL CHEM, V284, P23935, DOI 10.1074/jbc.M109.023853; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim HA, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1972; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Losonczi JA, 2000, BIOCHEMISTRY-US, V39, P11024, DOI 10.1021/bi000919v; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawai H, 2009, BIOCHEM BIOPH RES CO, V378, P529, DOI 10.1016/j.bbrc.2008.11.073; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zhang LL, 2004, J BIOL CHEM, V279, P33865, DOI 10.1074/jbc.M403499200	52	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41202	41210		10.1074/jbc.M110.144857	http://dx.doi.org/10.1074/jbc.M110.144857			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	21036904	hybrid, Green Published			2022-12-27	WOS:000285414400082
J	Maurer, LM; Tomasini-Johansson, BR; Ma, WJ; Annis, DS; Eickstaedt, NL; Ensenberger, MG; Satyshur, KA; Mosher, DF				Maurer, Lisa M.; Tomasini-Johansson, Bianca R.; Ma, Wenjiang; Annis, Douglas S.; Eickstaedt, Nathan L.; Ensenberger, Martin G.; Satyshur, Kenneth A.; Mosher, Deane F.			Extended Binding Site on Fibronectin for the Functional Upstream Domain of Protein F1 of Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STAPHYLOCOCCUS-AUREUS FNBPA; N-TERMINAL MODULES; EXTRACELLULAR-MATRIX; CIRCULAR-DICHROISM; GELATIN-BINDING; (6)F1(1)F2(2)F2 FRAGMENT; CONFORMATIONAL-CHANGE; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURES	The 49-residue functional upstream domain (FUD) of Streptococcus pyogenes F1 adhesin interacts with fibronectin (FN) in a heretofore unknown manner that prevents assembly of a FN matrix. Biotinylated FUD (b-FUD) bound to adsorbed FN or its recombinant N-terminal 70-kDa fibrin-and gelatin-binding fragment (70K). Binding was blocked by FN or 70K, but not by fibrin-or gelatin-binding subfragments of 70K. Isothermal titration calorimetry showed that FUD binds with K-d values of 5.2 and 59 nM to soluble 70K and FN, respectively. We tested sets of FUD mutants and epitope-mapped monoclonal antibodies (mAbs) for ability to compete with b-FUD for binding to FN or to block FN assembly by cultured fibroblasts. Deletions or alanine substitutions throughout FUD caused loss of both activities. mAb 4D1 to the (FNI)-F-2 module had little effect, whereas mAb 7D5 to the (FNI)-F-4 module in the fibrin-binding region, 5C3 to the (FNI)-F-9 module in the gelatin-binding region, or L8 to the G-strand of (FNIII)-F-1 module adjacent to 9FNI caused loss of binding of b-FUD to FN and decreased FN assembly. Conversely, FUD blocked binding of 7D5, 5C3, or L8, but not of 4D1, to FN. Circular dichroism indicated that FUD binds to 70K by beta-strand addition, a possibility supported by modeling based on crystal structures of peptides bound to (FNI)-F-2-(FNI)-F-5 of the fibrin-binding domain and (FNI)-F-8-(FNI)-F-9 of the gelatin-binding domain. Thus, the interaction likely involves an extensive anti-parallel beta-zipper in which FUD interacts with the E-strands of (FNI)-F-2-(FNI)-F-5 and (FNI)-F-8-(FNI)-F-9.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 1300 Univ Ave,Rm 4285, Madison, WI 53706 USA.	dfm1@medicine.wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493	National Institutes of Health [HL021644]; American Heart Association [0815362G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL021644 (to D. F. M.).; Supported by American Heart Association Grant 0815362G.	Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; BEYCHOK S, 1966, SCIENCE, V154, P1288, DOI 10.1126/science.154.3754.1288; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; CHERNOUSOV MA, 1991, J BIOL CHEM, V266, P10851; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; DZAMBA BJ, 1994, J BIOL CHEM, V269, P19646; Ellis IR, 2010, EXP CELL RES, V316, P2465, DOI 10.1016/j.yexcr.2010.04.003; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Ensenberger MG, 2001, J BIOL CHEM, V276, P35606, DOI 10.1074/jbc.M105417200; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Lin YP, 2009, J BIOL CHEM, V284, P23547, DOI 10.1074/jbc.M109.031369; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; MOSHER DF, 1993, CURR OPIN STRUC BIOL, V3, P214, DOI 10.1016/S0959-440X(05)80155-1; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; ODERMATT E, 1989, BIOL EXTRACELLULAR M, P29; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Ozeri V, 2001, MOL MICROBIOL, V41, P561, DOI 10.1046/j.1365-2958.2001.02535.x; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schor SL, 1999, J CELL SCI, V112, P3879; Schwarz-Linek U, 2004, J BIOL CHEM, V279, P39017, DOI 10.1074/jbc.M405083200; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Schwarz-Linek U, 2006, MICROBES INFECT, V8, P2291, DOI 10.1016/j.micinf.2006.03.011; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 1990, Protein Expr Purif, V1, P104, DOI 10.1016/1046-5928(90)90002-G; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; WILLIAMS MJ, 1994, J MOL BIOL, V235, P1302, DOI 10.1006/jmbi.1994.1083; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu JL, 2010, J BIOL CHEM, V285, P8563, DOI 10.1074/jbc.M109.062646; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zhang QH, 1996, J BIOL CHEM, V271, P33284, DOI 10.1074/jbc.271.52.33284; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	73	49	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					41087	41099		10.1074/jbc.M110.153692	http://dx.doi.org/10.1074/jbc.M110.153692			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20947497	hybrid, Green Published			2022-12-27	WOS:000285414400071
J	Moore, SA; Ferhatoglu, Y; Jia, YH; Al-Jiab, RA; Scott, MJ				Moore, Stanley A.; Ferhatoglu, Yurdagul; Jia, Yunhua; Al-Jiab, Rami A.; Scott, Maxwell J.			Structural and Biochemical Studies on the Chromo-barrel Domain of Male Specific Lethal 3 (MSL3) Reveal a Binding Preference for Mono- or Dimethyllysine 20 on Histone H4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DOSAGE COMPENSATION; X-CHROMOSOME; FUNCTIONAL-INTEGRATION; LYSINE METHYLATION; ACTIVE GENES; COMPLEX; DNA; ACETYLATION; ACETYLTRANSFERASE; MOF	We have determined the human male specific lethal 3 (hMSL3) chromo-barrel domain structure by x-ray crystallography to a resolution of 2.5 angstrom (r = 0.226, R-free = 0.270). hMSL3 contains a canonical methyllysine binding pocket made up of residues Tyr-31, Phe-56, Trp-59, and Trp-63. A six-residue insertion between strands beta(1) and beta(2) of the hMSL3 chromo-barrel domain directs the side chain of Glu-21 into the methyllysine binding pocket where it hydrogen bonds to the NH group of a bound cyclohexylamino ethanesulfonate buffer molecule, likely mimicking interactions with a histone tail dimethyllysine residue. In vitro binding studies revealed that both the human and Drosophila MSL3 chromo-barrel domains bind preferentially to peptides representing the mono or dimethyl isoform of lysine 20 on the histone H4 N-terminal tail (H4K20Me(1) or H4K20Me(2)). Mutation of Tyr-31 to Ala in the hMSL3 methyllysine-binding cage resulted in weaker in vitro binding to H4K20Me(1). The same mutation in the msl3 gene compromised male survival in Drosophila. Combined mutation of Glu-21 and Pro-22 to Ala in hMSL3 resulted in slightly weaker in vitro binding to H4K20Me(1), but the corresponding msl3 mutation had no effect on male survival in Drosophila. We propose MSL3 plays an important role in targeting the male specific lethal complex to chromatin in both humans and flies by binding to H4K20Me(1). Binding studies on the related dMRG15 chromo-barrel domain revealed that MRG15 prefers binding to H4K20Me(3).	[Moore, Stanley A.; Ferhatoglu, Yurdagul; Jia, Yunhua] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Al-Jiab, Rami A.; Scott, Maxwell J.] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand	University of Saskatchewan; Massey University	Moore, SA (corresponding author), A3 Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	stan.moore@usask.ca	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735	Saskatchewan Health Research Foundation; University of Saskatchewan College of Medicine; Canadian Institutes for Health Research (CIHR) [MOP 79377]; National Science and Engineering Council of Canada (NSERC); Canadian foundation for innovation (CFI); University of Saskatchewan	Saskatchewan Health Research Foundation; University of Saskatchewan College of Medicine; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian foundation for innovation (CFI)(Canada Foundation for Innovation); University of Saskatchewan	This work was supported by Canadian Institutes for Health Research Grant MOP 79377 (to S. M.), the Saskatchewan Health Research Foundation regional partnership program, and bridge funding from the University of Saskatchewan College of Medicine.; We thank Bradley McLellan, Massey University, New Zealand, for cloning the dMSL3 chromo-barrel domain fragment; George Wong for purification conditions for the dMSL3 chromo-barrel domain; and Andrew Welham who carried out the initial characterization of the dMSL3 and hMSL3 chromo-barrel domains. Ewa Kerc contributed to the cloning of the hMSL3 chromo-barrel domain. Robert Shearer cloned the D. melanogaster MRG15 chromo-barrel domain and conducted the initial purification studies. We thank Edwin Smith for generously providing cDNAs for the hMSL proteins, and Prof. Mitzi Kuroda, Harvard Medical School, for providing the msl3-TAP construct for Drosophila transgenic studies. David Sanders (Dept of Chemistry, University of Saskatchewan) provided access to the Nanodrop device. Jeremy Lee graciously conducted the ethidium bromide fluorescence assays. SPR data were collected at the Saskatchewan Structural Sciences Centre, University of Saskatchewan. We thank Pawel Grochulski and James Gorin of the Canadian Light Source CMCF small-gap undulator beamline for timely access and expert assistance with data collection. The Canadian Light Source is funded by the Canadian Institutes for Health Research (CIHR), the National Science and Engineering Council of Canada (NSERC), the Canadian foundation for innovation (CFI) and the University of Saskatchewan.	Alekseyenko AA, 2006, GENE DEV, V20, P848, DOI 10.1101/gad.1400206; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buscaino A, 2006, EMBO REP, V7, P531, DOI 10.1038/sj.embor.7400658; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Demakova OV, 2003, CHROMOSOMA, V112, P103, DOI 10.1007/s00412-003-0249-1; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gelbart ME, 2009, DEVELOPMENT, V136, P1399, DOI 10.1242/dev.029645; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; GORMAN M, 1995, DEVELOPMENT, V121, P463; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu WG, 2000, EMBO J, V19, P5202, DOI 10.1093/emboj/19.19.5202; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legube G, 2006, GENE DEV, V20, P871, DOI 10.1101/gad.377506; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Morales V, 2005, MOL CELL BIOL, V25, P5947, DOI 10.1128/MCB.25.14.5947-5954.2005; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; MORGAN AR, 1979, NUCLEIC ACIDS RES, V7, P547, DOI 10.1093/nar/7.3.547; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Prakash SK, 1999, GENOMICS, V59, P77, DOI 10.1006/geno.1999.5844; Qi D, 2006, GENETICS, V174, P241, DOI 10.1534/genetics.106.059980; Raja SJ, 2010, MOL CELL, V38, P827, DOI 10.1016/j.molcel.2010.05.021; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Sakaguchi A, 2008, GENETICS, V179, P317, DOI 10.1534/genetics.108.087650; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Scott MJ, 2008, RNA BIOL, V5, P13, DOI 10.4161/rna.5.1.5943; Scott MJ, 2000, EMBO J, V19, P144, DOI 10.1093/emboj/19.1.144; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Smith ER, 2000, MOL CELL BIOL, V20, P312, DOI 10.1128/MCB.20.1.312-318.2000; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Sun BF, 2008, J BIOL CHEM, V283, P36504, DOI 10.1074/jbc.M806564200; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Talasz H, 2005, J BIOL CHEM, V280, P38814, DOI 10.1074/jbc.M505563200; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8; WETLAUFER DB, 1962, ADV PROTEIN CHEM, V17, P303; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang HB, 2009, BIOCHEM CELL BIOL, V87, P151, DOI 10.1139/O08-131; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	71	32	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40879	40890		10.1074/jbc.M110.134312	http://dx.doi.org/10.1074/jbc.M110.134312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20943666	Green Published, hybrid			2022-12-27	WOS:000285414400052
J	Yamamoto, Y; Mochida, S; Miyazaki, N; Kawai, K; Fujikura, K; Kurooka, T; Iwasaki, K; Sakisaka, T				Yamamoto, Yasunori; Mochida, Sumiko; Miyazaki, Naoyuki; Kawai, Katsuhisa; Fujikura, Kohei; Kurooka, Takao; Iwasaki, Kenji; Sakisaka, Toshiaki			Tomosyn Inhibits Synaptotagmin-1-mediated Step of Ca2+- dependent Neurotransmitter Release through Its N-terminal WD40 Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SYMPATHETIC NEURONS; CERVICAL GANGLION NEURONS; SNARE COMPLEX-FORMATION; SYNAPTIC VESICLE CYCLE; MEMBRANE-FUSION; C2B DOMAIN; TRANSMITTER RELEASE; CALCIUM SENSOR; CELL-CULTURE; I FUNCTIONS	Neurotransmitter release is triggered by Ca2+ binding to a low affinity Ca2+ sensor, mostly synaptotagmin-1, which catalyzes SNARE-mediated synaptic vesicle fusion. Tomosyn negatively regulates Ca2+ -dependent neurotransmitter release by sequestering target SNAREs through the C-terminal VAMP-like domain. In addition to the C terminus, the N-terminal WD40 repeats of tomosyn also have potent inhibitory activity toward Ca2+ -dependent neurotransmitter release, although the molecular mechanism underlying this effect remains elusive. Here, we show that through its N-terminal WD40 repeats tomosyn directly binds to synaptotagmin-1 in a Ca2+ -dependent manner. The N-terminal WD40 repeats impaired the activities of synaptotagmin-1 to promote SNARE complex-mediated membrane fusion and to bend the lipid bilayers. Decreased acetylcholine release from N-terminal WD40 repeat-microinjected superior cervical ganglion neurons was relieved by microinjection of the cytoplasmic domain of synaptotagmin-1. These results indicate that, upon direct binding, the N-terminal WD40 repeats negatively regulate the synaptotagmin-1-mediated step of Ca2+ -dependent neurotransmitter release. Furthermore, we show that synaptotagmin-1 binding enhances the target SNARE-sequestering activity of tomosyn. These results suggest that the interplay between tomosyn and synaptotagmin-1 underlies inhibitory control of Ca2+ -dependent neurotransmitter release.	[Yamamoto, Yasunori; Kawai, Katsuhisa; Fujikura, Kohei; Kurooka, Takao; Sakisaka, Toshiaki] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan; [Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Osaka Univ, Inst Prot Res, Res Ctr Struct & Funct Prote, Suita, Osaka 5650871, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Japan Sci & Technol Agcy, Suita, Osaka 5650871, Japan	Kobe University; Tokyo Medical University; Osaka University; Japan Science & Technology Agency (JST)	Sakisaka, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp	Miyazaki, Naoyuki/P-3436-2018; Miyazaki, Naoyuki/D-7435-2012	Miyazaki, Naoyuki/0000-0002-4880-7300; Miyazaki, Naoyuki/0000-0002-4880-7300	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ichiro Kanehara Foundation; Uehara Memorial Foundation; Core Research for Evolutional Science and Technology; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ichiro Kanehara Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants-in-aid for the national project on Targeted Proteins Research Program (to T. S.), for scientific research C (to T. S.), for scientific research on priority areas (to T. S. and S. M.), for scientific research on innovative areas (to Y. Y.), and for the Global Center of Excellence Program F11 (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by a grant provided by The Ichiro Kanehara Foundation (to T. S.), and by a grant provided by The Uehara Memorial Foundation (to T. S.). Part of this work was also supported by Core Research for Evolutional Science and Technology, the Japan Science and Technology Agency (to N. M. and K. I.).	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JOHNSON M, 1976, NATURE, V262, P308, DOI 10.1038/262308a0; KO CP, 1976, BRAIN RES, V117, P437, DOI 10.1016/0006-8993(76)90752-6; KO CP, 1976, BRAIN RES, V117, P461, DOI 10.1016/0006-8993(76)90753-8; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Ma H, 2007, NEUROSCI RES, V57, P491, DOI 10.1016/j.neures.2006.12.015; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; MIZOGUCHI A, 1989, MOL BRAIN RES, V5, P31, DOI 10.1016/0169-328X(89)90015-6; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MOCHIDA S, 1995, J PHYSIOLOGY-PARIS, V89, P83, DOI 10.1016/0928-4257(96)80555-9; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; OLAGUE PH, 1978, DEV BIOL, V67, P424, DOI 10.1016/0012-1606(78)90210-5; OLAGUE PH, 1974, P NATL ACAD SCI USA, V71, P3602, DOI 10.1073/pnas.71.9.3602; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; REES R, 1974, J COMP NEUROL, V157, P1, DOI 10.1002/cne.901570102; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Sakaba T, 2002, NEUROSCI RES, V44, P343, DOI 10.1016/S0168-0102(02)00174-8; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2003, NEURON, V37, P99, DOI 10.1016/S0896-6273(02)01145-5; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; WAKSHULL E, 1979, J NEUROPHYSIOL, V42, P1426, DOI 10.1152/jn.1979.42.5.1426; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	58	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 24	2010	285	52					40943	40955		10.1074/jbc.M110.156893	http://dx.doi.org/10.1074/jbc.M110.156893			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	696AN	20978127	Green Published, hybrid			2022-12-27	WOS:000285414400058
J	Looke, M; Reimand, J; Sedman, T; Sedman, J; Jarvinen, L; Varv, S; Peil, K; Kristjuhan, K; Vilo, J; Kristjuhan, A				Looke, Marko; Reimand, Jueri; Sedman, Tiina; Sedman, Juhan; Jaervinen, Lari; Vaerv, Signe; Peil, Kadri; Kristjuhan, Kersti; Vilo, Jaak; Kristjuhan, Arnold			Relicensing of Transcriptionally Inactivated Replication Origins in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; BIDIRECTIONAL PROMOTERS; PERVASIVE TRANSCRIPTION; MCM PROTEINS; GENOME; COMPLEX; CDC45P	DNA replication origins are licensed in early G(1) phase of the cell cycle where the origin recognition complex (ORC) recruits the minichromosome maintenance (MCM) helicase to origins. These pre-replicative complexes (pre-RCs) remain inactive until replication is initiated in the S phase. However, transcriptional activity in the regions of origins can eliminate their functionality by displacing the components of pre-RC from DNA. We analyzed genome-wide data of mRNA and cryptic unstable transcripts in the context of locations of replication origins in yeast genome and found that at least one-third of the origins are transcribed and therefore might be inactivated by transcription. When investigating the fate of transcriptionally inactivated origins, we found that replication origins were repetitively licensed in G(1) to reestablish their functionality after transcription. We propose that reloading of pre-RC components in G(1) might be utilized for the maintenance of sufficient number of competent origins for efficient initiation of DNA replication in S phase.	[Kristjuhan, Kersti; Kristjuhan, Arnold] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Reimand, Jueri; Vilo, Jaak] Univ Tartu, Inst Comp Sci, EE-51010 Tartu, Estonia	University of Tartu; University of Tartu	Kristjuhan, A (corresponding author), Riia 23, EE-51010 Tartu, Estonia.	arnoldk@ut.ee	Vilo, Jaak/AAK-2228-2020; Sedman, Juhan/H-1820-2011; Vilo, Jaak/A-7183-2008; Reimand, Jüri/U-9264-2019	Vilo, Jaak/0000-0001-5604-4107; Vilo, Jaak/0000-0001-5604-4107; Reimand, Jüri/0000-0002-2299-2309; Sedman, Juhan/0000-0003-2081-1452; Kristjuhan, Arnold/0000-0002-5842-4952	Wellcome Trust [081756]; European Molecular Biology Organization [1454]	Wellcome Trust(Wellcome TrustEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	This work was supported by the Wellcome Trust International Senior Research Fellowship Grant 081756 and European Molecular Biology Organization Installation Grant 1454.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Blow JJ, 2009, EMBO REP, V10, P406, DOI 10.1038/embor.2009.5; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103; Donato JJ, 2006, PLOS GENET, V2, P1328, DOI 10.1371/journal.pgen.0020141; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Mori S, 2007, J BIOL CHEM, V282, P4447, DOI 10.1074/jbc.M609671200; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Nieduszynski CA, 2007, NUCLEIC ACIDS RES, V35, pD40, DOI 10.1093/nar/gkl758; Pryde F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005882; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	25	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					40004	40011		10.1074/jbc.M110.148924	http://dx.doi.org/10.1074/jbc.M110.148924			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20962350	hybrid, Green Published			2022-12-27	WOS:000285185500045
J	Xu, DZ; Yao, YX; Jiang, XJ; Lu, L; Dai, W				Xu, Dazhong; Yao, Yixin; Jiang, Xuejun; Lu, Luo; Dai, Wei			Regulation of PTEN Stability and Activity by Plk3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; POLO-LIKE KINASES; CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; SIGNALING PATHWAY; PROTEIN STABILITY; CANCER CELLS; LUNG-CANCER; PHOSPHORYLATION; POLO-LIKE-KINASE-3	By studying primary isogenic murine embryonic fibroblasts (MEFs), we have shown that PLK3 null MEFs contain a reduced level of phosphatase and tensin homolog (PTEN) and increased Akt1 activation coupled with decreased GSK3 beta activation under normoxia and hypoxia. Purified recombinant Plk3, but not a kinase-defective mutant, efficiently phosphorylates PTEN in vitro. Mass spectrometry identifies threonine 366 and serine 370 as two putative residues that are phosphorylated by Plk3. Immunoblotting using a phosphospecific antibody confirms these sites as Plk3 phosphorylation sites. Moreover, treatment of MEFs with LiC1, an inhibitor of GSK3 beta and CK2, only partially suppresses the phosphorylation, suggesting Plk3 as an additional kinase that phosphorylates these sites in vivo. Plk3-targeting mutants of PTEN are expressed at a reduced level in comparison with the wild-type counterpart, which is associated with an enhanced activity of PDK1, an upstream activator of Akt1. Furthermore, the reduced level of PTEN in PLK3 null MEFs is stabilized by treatment with MG132, a proteosome inhibitor. Combined, our study identifies Plk3 as a new player in the regulation of the PI3K/PDK1/Akt signaling axis by phosphorylation and stabilization of PTEN.	[Xu, Dazhong; Yao, Yixin; Dai, Wei] NYU, Langone Med Ctr, Dept Environm Med & Pharmacol, Sch Med, Tuxedo Pk, NY 10987 USA; [Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10024 USA; [Lu, Luo] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Torrance, CA 90502 USA	New York University; NYU Langone Medical Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dai, W (corresponding author), NYU, Langone Med Ctr, Dept Environm Med & Pharmacol, Sch Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@med.nyu.edu		Xu, Dazhong/0000-0001-9264-3342; Dai, Wei/0000-0003-0169-8327; Yao, Yixin/0000-0003-1891-7186	National Institutes of Health, USPHS [CA074229, CA113349, AG009953]; NATIONAL CANCER INSTITUTE [R01CA074229, R01CA113349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY018343, R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA074229 and CA113349 from USPHS (to W. D.) and AG009953 (to D. X.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Bardos JI, 2004, BIOESSAYS, V26, P262, DOI 10.1002/bies.20002; Bin OY, 1999, ONCOGENE, V18, P6029, DOI 10.1038/sj.onc.1202983; Brauer PM, 2009, CELL CYCLE, V8, P2728, DOI 10.4161/cc.8.17.9389; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chizhikov V, 2001, MOL CARCINOGEN, V30, P151, DOI 10.1002/mc.1023; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Fukumoto S, 2001, J BIOL CHEM, V276, P17479, DOI 10.1074/jbc.C000880200; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Jiang N, 2006, J BIOL CHEM, V281, P10577, DOI 10.1074/jbc.M513156200; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Li B, 1996, J BIOL CHEM, V271, P19402, DOI 10.1074/jbc.271.32.19402; Maccario H, 2007, BIOCHEM J, V405, P439, DOI 10.1042/BJ20061837; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Perotti D, 1999, HAEMATOLOGICA, V84, P110; Phillips RJ, 2005, J BIOL CHEM, V280, P22473, DOI 10.1074/jbc.M500963200; Rong Y, 2006, J NEUROPATH EXP NEUR, V65, P529, DOI 10.1097/00005072-200606000-00001; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang L, 2008, J BIOL CHEM, V283, P25928, DOI 10.1074/jbc.M801326200; Wang Q, 2002, MOL CELL BIOL, V22, P3450, DOI 10.1128/MCB.22.10.3450-3459.2002; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Xie SQ, 2001, J BIOL CHEM, V276, P43305, DOI 10.1074/jbc.M106050200; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Yang G, 2008, DEVELOPMENT, V135, P3587, DOI 10.1242/dev.028118; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249; Zhong H, 2000, CANCER RES, V60, P1541	44	51	56	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 17	2010	285	51					39935	39942		10.1074/jbc.M110.166462	http://dx.doi.org/10.1074/jbc.M110.166462			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	692WB	20940307	hybrid, Green Published			2022-12-27	WOS:000285185500038
J	Balakrishnan, L; Polaczek, P; Pokharel, S; Campbell, JL; Bambara, RA				Balakrishnan, Lata; Polaczek, Piotr; Pokharel, Subhash; Campbell, Judith L.; Bambara, Robert A.			Dna2 Exhibits a Unique Strand End-dependent Helicase Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OKAZAKI FRAGMENT MATURATION; REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; ENZYMATIC-PROPERTIES; XENOPUS DNA2; YEAST; CLEAVAGE; HELICASE/NUCLEASE; ENDONUCLEASE; SUBSTRATE	Dna2 endonuclease/helicase participates in eukaryotic DNA transactions including cleavage of long flaps generated during Okazaki fragment processing. Its unusual substrate interaction consists of recognition and binding of the flap base, then threading over the 5'-end of the flap, and cleaving periodically to produce a terminal product similar to 5 nt in length. Blocking the 5'-end prevents cleavage. The Dna2 ATP-driven 5' to 3' DNA helicase function promotes motion of Dna2 on the flap, presumably aiding its nuclease function. Here we demonstrate using two different nuclease-dead Dna2 mutants that on substrates simulating Okazaki fragments, Dna2 must thread onto an unblocked 5' flap to display helicase activity. This requirement is maintained on substrates with single-stranded regions thousands of nucleotides in length. To our knowledge this is the first description of a eukaryotic helicase that cannot load onto its tracking strand internally but instead must enter from the end. Biologically, the loading requirement likely helps the helicase to coordinate with the Dna2 nuclease function to prevent creation of undesirably long flaps during DNA transactions.	Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Polaczek, Piotr; Pokharel, Subhash; Campbell, Judith L.] CALTECH, Braun Labs, Pasadena, CA 91125 USA	University of Rochester; California Institute of Technology		robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441, GM087666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM024441 (to R. A. B.) and GM087666 (to J. L. C.).	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Davey MJ, 2003, CURR BIOL, V13, pR594, DOI 10.1016/S0960-9822(03)00523-2; Formosa T, 1999, GENETICS, V151, P1459; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kao HI, 2004, J BIOL CHEM, V279, P50840, DOI 10.1074/jbc.M409231200; Kim DH, 2005, NUCLEIC ACIDS RES, V33, P1372, DOI 10.1093/nar/gki255; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lesur I, 2004, MOL BIOL CELL, V15, P1297, DOI 10.1091/mbc.E03-10-0742; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; LOHMAN TM, 1992, MOL MICROBIOL, V6, P5, DOI 10.1111/j.1365-2958.1992.tb00831.x; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pokharel S, 2009, J AM CHEM SOC, V131, P11882, DOI 10.1021/ja9034076; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Stewart JA, 2010, NUCLEIC ACIDS RES, V38, P920, DOI 10.1093/nar/gkp1055; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Wawrousek KE, 2010, CELL CYCLE, V9, P1156, DOI 10.4161/cc.9.6.11049; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	41	25	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38861	38868		10.1074/jbc.M110.165191	http://dx.doi.org/10.1074/jbc.M110.165191			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20929864	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000284941300015
J	Devaiah, BN; Lu, HX; Gegonne, A; Sercan, Z; Zhang, HE; Clifford, RJ; Lee, MP; Singer, DS				Devaiah, Ballachanda N.; Lu, Hanxin; Gegonne, Anne; Sercan, Zeynep; Zhang, Hongen; Clifford, Robert J.; Lee, Maxwell P.; Singer, Dinah S.			Novel Functions for TAF7, a Regulator of TAF1-independent Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II TRANSACTIVATOR; MHC CLASS-I; ACETYLTRANSFERASE ACTIVITY; GENE-TRANSCRIPTION; BASAL PROMOTER; COMPLEX; CIITA; EXPRESSION; TAF(II)250; TAT	The transcription factor TFIID components TAF7 and TAF1 regulate eukaryotic transcription initiation. TAF7 regulates transcription initiation of TAF1-dependent genes by binding to the acetyltransferase (AT) domain of TAF1 and inhibiting the enzymatic activity that is essential for transcription. TAF7 is released from the TAF1-TFIID complex upon completion of preinitiation complex assembly, allowing transcription to initiate. However, not all transcription is TAF1-dependent, and the role of TAF7 in regulating TAF1-independent transcription has not been defined. The IFN gamma-induced transcriptional co-activator CIITA activates MHC class I and II genes, which are vital for immune responses, in a TAF1-independent manner. Activation by CIITA depends on its intrinsic AT activity. We now show that TAF7 binds to CIITA and inhibits its AT activity, thereby repressing activated transcription. Consistent with this TAF7 function, siRNA-mediated depletion of TAF7 resulted in increased CIITA-dependent transcription. A more global role for TAF7 as a regulator of transcription was revealed by expression profiling analysis: expression of 30-40% of genes affected by TAF7 depletion was independent of either TAF1 or CIITA. Surprisingly, although TAF1-dependent transcripts were largely down-regulated by TAF7 depletion, TAF1-independent transcripts were predominantly up-regulated. We conclude that TAF7, until now considered only a TFIID component and regulator of TAF1-dependent transcription, also regulates TAF1-independent transcription.	[Singer, Dinah S.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Zhang, Hongen; Clifford, Robert J.; Lee, Maxwell P.] NCI, Lab Populat Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, DS (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	dinah.singer@nih.gov			NATIONAL CANCER INSTITUTE [ZIASC010375, ZIABC009285, ZIABC011250] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Fontes JD, 1999, MICROBES INFECT, V1, P863, DOI 10.1016/S1286-4579(99)80529-2; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Gegonne A, 2006, P NATL ACAD SCI USA, V103, P602, DOI 10.1073/pnas.0510031103; Gegonne A, 2001, P NATL ACAD SCI USA, V98, P12432, DOI 10.1073/pnas.211444798; Gegonne A, 2008, P NATL ACAD SCI USA, V105, P5367, DOI 10.1073/pnas.0801637105; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Harton JA, 2000, MOL CELL BIOL, V20, P6185, DOI 10.1128/MCB.20.17.6185-6194.2000; HAYASHIDA T, 1994, GENE, V141, P267; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; HOWCROFT TK, 1995, IMMUNITY, V3, P127; HOWCROFT TK, 1993, SCIENCE, V260, P1320, DOI 10.1126/science.8493575; Kirshner S, 2000, MOL ENDOCRINOL, V14, P82, DOI 10.1210/me.14.1.82; Lee MP, 2005, GENOME RES, V15, P1189, DOI 10.1101/gr.3873705; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; Masternak K, 2000, GENE DEV, V14, P1156; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Mozes E, 2005, LUPUS, V14, P308, DOI 10.1191/0961203305lu2079oa; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Raval A, 2001, MOL CELL, V7, P105, DOI 10.1016/S1097-2765(01)00159-9; RILEY JL, 1995, IMMUNITY, V2, P533, DOI 10.1016/1074-7613(95)90033-0; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; SINGER DS, 1990, CRIT REV IMMUNOL, V10, P235; Tavassoli P, 2010, MOL ENDOCRINOL, V24, P696, DOI 10.1210/me.2009-0229; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; van den Elsen PJ, 1999, MICROBES INFECT, V1, P887, DOI 10.1016/S1286-4579(99)80532-2; Vora AR, 1997, BRIT J CANCER, V76, P836, DOI 10.1038/bjc.1997.472; Weissman JD, 1998, P NATL ACAD SCI USA, V95, P11601, DOI 10.1073/pnas.95.20.11601; Weissman JDJ, 2000, J BIOL CHEM, V275, P10160, DOI 10.1074/jbc.275.14.10160; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; ZHOU H, 1995, IMMUNITY, V2, P545, DOI 10.1016/1074-7613(95)90034-9; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	34	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					38772	38780		10.1074/jbc.M110.173864	http://dx.doi.org/10.1074/jbc.M110.173864			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937824	hybrid, Green Published			2022-12-27	WOS:000284941300006
J	McLuskey, K; Paterson, NG; Bland, ND; Isaacs, NW; Mottram, JC				McLuskey, Karen; Paterson, Neil G.; Bland, Nicholas D.; Isaacs, Neil W.; Mottram, Jeremy C.			Crystal Structure of Leishmania major Oligopeptidase B Gives Insight into the Enzymatic Properties of a Trypanosomatid Virulence Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-FACTOR; PROLYL OLIGOPEPTIDASE; ACTIVE-SITE; BRUCEI; CRUZI; ENDOPEPTIDASE; PEPTIDASE; PURIFICATION; REPLACEMENT; REFINEMENT	Oligopeptidase B (OPB) is a serine peptidase with dibasic substrate specificity. It is found in bacteria, plants, and trypanosomatid pathogens, where it has been identified as a virulence factor and potential drug target. In this study we expressed active recombinant Leishmania major OPB and provide the first structure of an oligopeptidase B at high resolution. The crystallographic study reveals that OPB comprises two domains, a catalytic and a propeller domain, linked together by a hinge region. The structure has been determined in complex with the oligopeptide, protease-inhibitor antipain, giving detailed information on the enzyme active site and extended substrate binding pockets. It shows that Glu-621 plays a critical role in the S1 binding pocket and, along with Phe-603, is largely responsible for the enzyme substrate specificity in P1. In the S2 binding pocket, Tyr-499 was shown to be important for substrate stability. The structure also allowed an investigation into the function of residues highlighted in other studies including Glu-623, which was predicted to be involved in the S1 binding pocket but is found forming an inter-domain hydrogen bond. Additional important salt bridges/hydrogen bonds between the two domains were observed, highlighting the significance of the domain interface in OPB. This work provides a foundation for the study of the role of OPBs as virulence factors in trypanosomatids. It could facilitate the development of specific OPB inhibitors with therapeutic potential by exploiting its unique substrate recognition properties as well as providing a model for OPBs in general.	[McLuskey, Karen; Paterson, Neil G.; Isaacs, Neil W.] Univ Glasgow, Westchem Sch Chem, Glasgow G12 8TA, Lanark, Scotland; [Bland, Nicholas D.; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow; University of Glasgow	McLuskey, K (corresponding author), Glasgow Biomed Res Ctr, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	Karen.McLuskey@glasgow.ac.uk	Bland, Nicholas/A-8038-2008	Bland, Nicholas/0000-0002-7692-5689; Mottram, Jeremy/0000-0001-5574-3766; McLuskey, Karen/0000-0002-9841-4943; Paterson, Neil/0000-0003-4292-6971	MRC [G9722968, G0000508]; Wellcome Trust; Medical Research Council [G0000508, G9722968] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the MRC (Grant Numbers G9722968 and G0000508) and by a Wellcome Trust Value in People Award (to K. McL.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker SC, 1997, J MOL BIOL, V269, P440, DOI 10.1006/jmbi.1997.1070; BARRETT AJ, 1992, BIOL CHEM H-S, V373, P353, DOI 10.1515/bchm3.1992.373.2.353; BARRETT AJ, 1995, ARCH BIOCHEM BIOPHYS, V318, P247, DOI 10.1006/abbi.1995.1227; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Burleigh BA, 2002, CELL MICROBIOL, V4, P701, DOI 10.1046/j.1462-5822.2002.00226.x; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hemerly JP, 2003, BIOCHEM J, V373, P933, DOI 10.1042/BJ20030342; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Juhasz T, 2005, J MOL BIOL, V346, P907, DOI 10.1016/j.jmb.2004.12.014; KANATANI A, 1991, J BIOCHEM-TOKYO, V110, P315, DOI 10.1093/oxfordjournals.jbchem.a123577; KORNBLATT MJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P25, DOI 10.1016/0003-9861(92)90360-9; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morty RE, 1999, J BIOL CHEM, V274, P26149, DOI 10.1074/jbc.274.37.26149; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Morty RE, 1998, FEBS LETT, V433, P251, DOI 10.1016/S0014-5793(98)00914-4; Morty RE, 2002, J BACTERIOL, V184, P3329, DOI 10.1128/JB.184.12.3329-3337.2002; Morty RE, 2001, INFECT IMMUN, V69, P2757, DOI 10.1128/IAI.69.4.2757-2761.2001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NDUNGU JM, 1992, PARASITOL RES, V78, P553, DOI 10.1007/BF00936451; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Troeberg L, 1996, EUR J BIOCHEM, V238, P728, DOI 10.1111/j.1432-1033.1996.0728w.x; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Usuki H, 2009, BBA-PROTEINS PROTEOM, V1794, P1673, DOI 10.1016/j.bbapap.2009.07.024; Velankar S, 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [10.1093/nar/gkq985, 10.1093/nar/gkp916]; Venalainen JI, 2004, EUR J BIOCHEM, V271, P2705, DOI 10.1111/j.1432-1033.2004.04199.x; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F	56	46	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39249	39259		10.1074/jbc.M110.156679	http://dx.doi.org/10.1074/jbc.M110.156679			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20926390	hybrid, Green Published			2022-12-27	WOS:000284941300054
J	Vozzolo, L; Loh, B; Gane, PJ; Tribak, M; Zhou, LH; Anderson, I; Nyakatura, E; Jenner, RG; Selwood, D; Fassati, A				Vozzolo, Luciano; Loh, Belinda; Gane, Paul J.; Tribak, Maryame; Zhou, Lihong; Anderson, Ian; Nyakatura, Elisabeth; Jenner, Richard G.; Selwood, David; Fassati, Ariberto			Gyrase B Inhibitor Impairs HIV-1 Replication by Targeting Hsp90 and the Capsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHROMATIN-REMODELING COMPLEX; NONDIVIDING CELLS; GENE-EXPRESSION; DNA GYRASE; TERMINAL DIMERIZATION; MOLECULAR CHAPERONE; QUANTITATIVE ASSAY; CRYSTAL-STRUCTURE; CYCLOPHILIN-A	Chemical genetics is an emerging approach to investigate the biology of host-pathogen interactions. We screened several inhibitors of ATP-dependent DNA motors and detected the gyrase B inhibitor coumermycin A1 (C-A1) as a potent antiretroviral. C-A1 inhibited HIV-1 integration and gene expression from acutely infected cell, but the two activities mapped to distinct targets. Target discovery identified Hsp90 as the C-A1 target affecting viral gene expression. Chromatin immunoprecipitation revealed that Hsp90 associates with the viral promoter and may directly regulate gene expression. Molecular docking suggested that C-A1 binds to two novel pockets at the C terminal domain of Hsp90. C-A1 inhibited Hsp90 dimer formation, suggesting that it impairs viral gene expression by preventing Hsp90 dimerization at the C terminus. The inhibition of HIV-1 integration imposed by C-A1 was independent of Hsp90 and mapped to the capsid protein, and a point mutation at residue 105 made the virus resistant to this block. HIV-1 susceptibility to the integration block mediated by C-A1 was influenced by cyclophilin A. Our chemical genetic approach revealed an unexpected function of capsid in HIV-1 integration and provided evidence for a role of Hsp90 in regulating gene expression in mammalian cells. Both activities were amenable to inhibition by small molecules and represent novel antiretroviral drug targets.	[Nyakatura, Elisabeth; Fassati, Ariberto] UCL, Wohl Vir Ctr, London W1T 4JF, England; [Vozzolo, Luciano; Loh, Belinda; Tribak, Maryame; Zhou, Lihong; Anderson, Ian; Nyakatura, Elisabeth; Jenner, Richard G.; Fassati, Ariberto] UCL, Med Res Council Ctr Med Mol Virol, Div Infect & Immun, London W1T 4JF, England; [Gane, Paul J.; Selwood, David] UCL, Wolfson Inst Biomed Res, Med Chem Grp, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Fassati, A (corresponding author), UCL, Wohl Vir Ctr, 46 Cleveland St, London W1T 4JF, England.	a.fassati@ucl.ac.uk	Jenner, Richard/J-8683-2012; Loh, Belinda/AAT-1236-2021	Jenner, Richard/0000-0002-2946-6811; Loh, Belinda/0000-0003-1364-6911; Selwood, David/0000-0002-6817-5064; Gane, Paul/0000-0002-9153-5240; Fassati, Ariberto/0000-0003-1934-5327	Wellcome Trust; University College London Hospital Charities Clinical Research and Development Committee [F144]; Medical Research Council; MRC [G9721629, G0900950, G0600081] Funding Source: UKRI; Medical Research Council [G0600081, G0900950B, G9721629, G0900950, G9721629B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); University College London Hospital Charities Clinical Research and Development Committee; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust and University College London Hospital Charities Clinical Research and Development Committee Grant F144 (to A. F.).; Supported by Medical Research Council Ph.D. studentship.	Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; [Anonymous], 2008, AIDS EP UPD 2009; Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; BABA M, 1989, International Journal of Experimental and Clinical Chemotherapy, V2, P15; BACHUR NR, 1993, MOL PHARMACOL, V44, P1064; Bonnet F, 2008, CURR OPIN ONCOL, V20, P534, DOI 10.1097/CCO.0b013e32830a5080; Bower M, 2008, BLOOD, V111, P3986, DOI 10.1182/blood-2007-10-115659; Bruce JW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000207; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Burlison JA, 2006, ORG LETT, V8, P4855, DOI 10.1021/ol061918j; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Ciuffi A, 2008, CURR GENE THER, V8, P419, DOI 10.2174/156652308786848021; Cutino-Moguel T, 2006, TRAFFIC, V7, P978, DOI 10.1111/j.1600-0854.2006.00449.x; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Grattinger M, 1999, VIROLOGY, V257, P247, DOI 10.1006/viro.1999.9668; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Hartkoorn RC, 2010, PHARMACOGENET GENOM, V20, P112, DOI 10.1097/FPC.0b013e328335b02d; Hazuda D, 2009, ANNU REV PHARMACOL, V49, P377, DOI 10.1146/annurev.pharmtox.011008.145553; Homme MB, 2005, BIOPHYS J, V88, P2078, DOI 10.1529/biophysj.104.053298; Hue S, 2009, J VIROL, V83, P2645, DOI 10.1128/JVI.01556-08; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; KAPLAN SA, 1970, J PHARM SCI, V59, P1569, DOI 10.1002/jps.2600591105; Kellam P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-201; Kim RH, 2008, CARCINOGENESIS, V29, P2425, DOI 10.1093/carcin/bgn225; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Loh B, 2010, CHEM BIOL DRUG DES, V75, P461, DOI 10.1111/j.1747-0285.2010.00956.x; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Martin CJ, 2008, J MED CHEM, V51, P2853, DOI 10.1021/jm701558c; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Mbisa Jean L., 2009, V485, P55, DOI 10.1007/978-1-59745-170-3_5; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; NEWMARK HL, 1970, J PHARM SCI, V59, P1246, DOI 10.1002/jps.2600590905; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pannecouque C, 2002, CURR BIOL, V12, P1169, DOI 10.1016/S0960-9822(02)00952-1; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Qi ML, 2008, J VIROL, V82, P12001, DOI 10.1128/JVI.01518-08; Ratzke C, 2010, P NATL ACAD SCI USA, V107, P16101, DOI 10.1073/pnas.1000916107; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Shafer RW, 2008, AIDS REV, V10, P67; SMITH CL, 1978, NATURE, V275, P420, DOI 10.1038/275420a0; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; TACHEDJIAN G, 1992, ANTIVIR CHEM CHEMOTH, V3, P183, DOI 10.1177/095632029200300309; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Uetrecht J. P., 2007, DRUG METABOLISM CHEM, P120; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; YANG HL, 1979, P NATL ACAD SCI USA, V76, P3304, DOI 10.1073/pnas.76.7.3304; Yin L, 1998, J VIROL, V72, P6430, DOI 10.1128/JVI.72.8.6430-6436.1998; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	74	64	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC	2010	285	50					39314	39328		10.1074/jbc.M110.155275	http://dx.doi.org/10.1074/jbc.M110.155275			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	689PT	20937817	hybrid, Green Published			2022-12-27	WOS:000284941300059
